publication_number,title,abstract,claims,ipc_classification,publication_date,assignee,legal_status
WO2025196014A1,Compostable top lid structure for a beverage preparation capsule,"The invention relates to a capsule (100) for preparing a beverage in a beverage production machine, the capsule (100) comprising a capsule body (200) delimiting a chamber (250) for containing a beverage substance (500), an injection wall (220) closing the chamber at a first end and a delivery wall (300) closing the chamber (250) at a second end of the capsule body (200). The delivery wall (300) comprises in a layered manner a carrier layer (320) for carrying the subsequent layers, an optional filter layer (310) and a barrier layer (340) applied on the carrier layer (320), the barrier layer (310) providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340), at least one protective layer (350) applied on the side of the barrier layer facing the chamber (250) for protecting the barrier layer at least against moisture, and a connecting layer (330), on the side of the delivery wall (300) facing the chamber (300) for connection of the delivery wall (300) to the rim portion (211). The connecting layer (330) is made of biodegradable material and comprise at least a non-woven aliphatic or aliphatic aromatic polyester selected in the list comprising Polylactic acid (PLA), Polyhydroxy alkanoate (PHA), Polybutylene succinate (PBS), Polybutylene succinate-co-adipate (PBSA), Polybutylene adipate-co-terephthalate (PBAT), Polybutylene sebacate-co-terephthalate (PBSeT), and their respective copolymers, and combination thereof. The invention also relates to a system comprising the proposed capsule and to a use of the proposed capsule for preparing a beverage in a beverage production machine.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A capsule (100) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the capsule (100) comprises:</seg-main>
<seg-clauses>- a capsule body (200) comprising a sidewall (210) delimiting a chamber (250) for containing a substance (500) forthe preparation of the beverage, and a rim portion (211) delimiting an opening (230) in the sidewall (210);</seg-clauses>
<seg-clauses>- an injection wall (220), closing the chamber at a first end, for injecting a fluid in the chamber (250) for preparing the beverage upon interaction of the fluid with the substance (500); and</seg-clauses>
<seg-clauses>- a delivery wall (300) being connected to the capsule body (200), preferably to the rim portion (211), to close the chamber (250) at a second end of the capsule body (200), the delivery wall (300) comprising in a layered manner and in this order: o a filter layer (310), facing away from the chamber (250) made of biodegradable material for filtering out particles from the prepared beverage dispensed via the delivery wall (300), o a carrier layer (320) made of biodegradable material, the carrier layer (320) being adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule (100), and o a barrier layer (340) made of biodegradable material for providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340) being preferably made of a different material than the filter layer (310) and/or the carrier layer (320); the barrier layer (340) being applied on the surface of the carrier layer (320) facing the chamber (250). wherein the delivery wall (300) further comprises: o at least one protective layer (350) applied on the side of the barrier layer facing the chamber (250) for protecting the barrier layer at least against moisture, and o a connecting layer (330) applied as an external layer on the side of the delivery wall (3",B65D85/804,20250925,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2023366292A1,Processes for cell expansion,"A process for the expansion of mammalian cells, the process comprising dynamically stirring cells in a bioreactor to produce an expanded cell culture, as well as products produced via said processes.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for expanding mammalian cells in a stirred tank bioreactor, the bioreactor comprising </seg-main><seg-clauses>mammalian cells and a cell culture medium, the process comprising dynamically stirring the cells in the bioreactor to produce an expanded cell culture.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process of claim 1, wherein </seg-main><seg-clauses>the dynamic stirring comprises stirring the cells at a stirring speed that is altered during production of the expanded cell culture.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The process of claim 2, wherein </seg-main><seg-clauses>the stirring speed is increased from a first stirring speed to a second stirring speed.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. The process of claim 2 or 3, wherein </seg-main><seg-clauses>the stirring speeds are in the range of 150 to 800 RPM.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5. The process of claim 3 or 4, wherein </seg-main><seg-clauses>the first stirring speed is increased to a second stirring speed at a rate of 6.25 to 20 RPM per hour.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-main>6. The process of claims 4 or 5, wherein </seg-main><seg-clauses>the first stirring speed is 150 RPM to 300 RPM and the second stirring speed is 400 RPM to 500 RPM.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""5""><seg-main>7. The process of claim 5, wherein </seg-main><seg-clauses>the first stirring speed is 250 RPM, and optionally the second stirring speed is 400 RPM.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""2,3""><seg-main>8. The process of claim 2 or 3, wherein </seg-main><seg-clauses>the stirring powers are in the range of 3 to 600 W/m3.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""3,8""><seg-main>9. The process of claims 3 or 8, wherein </seg-main><s","C12N5/074, C12M3/00",20250410,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3034187C,Omega 3 fatty acids and choline as neuroprotectant in patients with no dementia,,,"A61K31/14, A61K31/202, A61P25/28",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2851195C1,Compositions containing breast milk oligosaccharides for use in subjects to support language skill development,"FIELD: nutritional composition designed to improve language development in a subject.SUBSTANCE: nutritional composition containing at least one breast milk oligosaccharide (BMO) containing 3'-sialyllactose (3-SL), 6'-sialyllactose (6-SL), 3-fucosyllactose and any combination thereof, a source of fat, a source of carbohydrates and/or a source of protein, used to improve language development in an infant or young child. The method for improving language development in a subject comprises obtaining breast milk, which is fed to an infant or young child, from mothers secreting A-tetrasaccharide in their milk, and administering to said infant or young child a nutritional composition of the above composition as a supplement to said breast milk.EFFECT: improvement of language skills in infants or young children.12 cl, 5 dwg","1. Применение питательной композиции, содержащей по меньшей мере один олигосахарид грудного молока (ОГМ), содержащий 3'-сиалиллактозу (3-SL), 6'-сиалиллактозу (6-SL), 3-фукозиллактозу и любую их комбинацию, источник жира, источник углеводов и/или источник белка, для улучшения развития языковых навыков у субъекта.
2. Применение по п. 1, причем развитие языковых навыков включает в себя языковые навыки восприятия информации и/или языковые навыки передачи информации на основе оценки по подшкале Маллена.
3. Применение по п. 1, причем олигосахарид грудного молока содержит 3'-сиалиллактозу (3-SL).
4. Применение по п. 1, причем олигосахарид грудного молока содержит комбинацию 3'-сиалиллактозы (3-SL), 6'-сиалиллактозы (6-SL).
5. Применение по п. 1, причем олигосахарид грудного молока содержит 3-фукозиллактозу (3-FL), а развитие языковых навыков представляет собой языковые навыки передачи информации.
6. Применение по любому из пп. 1-5, причем субъект рожден от матери с положительным результатом анализа на А-тетрасахарид и/или субъекта вскармливают материнским молоком, содержащим A-тетрасахарид.
7. Применение по любому из предшествующих пунктов, причем олигосахарид(ы) присутствует(ют) в общем количестве от 50 мг/л до 5000 мг/л, например от 50 мг/л до 2500 мг/л, от 60 мг/л до 2000 мг/л, от 80 мг/л до 1000 мг/л питательной композиции.
8. Применение по любому из предшествующих пунктов, причем указанная питательная смесь представляет собой детскую смесь, начальную детскую смесь, детскую смесь для прикармливаемых детей или смесь последующего уровня, детское питание, детскую композицию на зерновой основе, обогатитель или добавку.
9. Способ улучшения развития языковых навыков у субъекта, включающий следующие стадии:
получение материнского молока, которым вскармливается младенец или ребенок младшего возраста, от матерей, секретирующих A-тетрасахарид в своем молоке, введение указанному младенцу или ребенку младшего возраста питательной композиции, содержащей по меньшей мере один олигос",A23L33/21,20251120,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119679814A,Vitamin-containing composition and use thereof,"The present invention relates to a composition comprising at least one vitamin for use in promoting, supporting or optimizing one or more of the following: (i) de novo myelination; (ii) brain structure; (iii) brain connection; (iv) intellectual potential; (v) cognitive potential; (vi) learning potential; and (vii) cognitive function, wherein the composition is for administration to the female subject.","<div class=""indep-clm"" num=""1"">1.一种组合物，所述组合物包含至少一种维生素，用于促进、支持或优化雌性个体的后代的以下各项中的一个或多个：</div>
<div class=""indep-clm"" num=""1"">(i)从头髓鞘形成；</div>
<div class=""indep-clm"" num=""1"">(ii)脑结构；</div>
<div class=""indep-clm"" num=""1"">(iii)脑连接；</div>
<div class=""indep-clm"" num=""1"">(iv)智力潜能；</div>
<div class=""indep-clm"" num=""1"">(v)认知潜能；</div>
<div class=""indep-clm"" num=""1"">(vi)学习潜能；以及</div>
<div class=""indep-clm"" num=""1"">(vii)认知功能，</div>
<div class=""indep-clm"" num=""1"">其中所述组合物用于施用于所述雌性个体，并且其中所述后代为胎儿、新生儿、婴儿或儿童，并且其中所述组合物用于在孕前、怀孕期间或泌乳期间或它们的组合施用于所述雌性个体。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述组合物促进、支持或优化整个脑的有髓鞘物质的量和/或空间分布。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据任一前述权利要求所述的组合物，其中所述组合物促进、支持或优化所述从头髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的组合物，其中所述雌性个体为人类。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的组合物，其中所述维生素为B12、叶酸或它们的组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的组合物，其中所述组合物还包含以下成分中的一种或多种：矿物质、脂肪酸衍生物、胆碱和磷脂或其代谢物或代谢前体。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求7所述的组合物，其中所述磷脂选自磷脂酰胆碱、磷脂酰肌醇、磷脂酰丝氨酸、磷脂酰乙醇胺、鞘磷脂及它们的混合物，以及前述任一者的代谢前体和代谢物，以及它们的混合物。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的组合物，其中所述组合物还包含胆碱。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的组合物，其中所述组合物为孕前(怀孕之前)补充剂和/或母体补充剂(怀孕和/或泌乳补充剂)的形式。</div>
<div class=""indep-clm"" num=""10"">10.至少一种维生素，用于促进、支持或优化雌性个体的后代的以下各项中的一个或多个：</div>
<div class=""indep-clm"" num=""10"">(i)从头髓鞘形成；</div>
<div class=""indep-clm"" num=""10"">(ii)脑结构；</div>
<div class=""indep-clm"" num=""10"">(iii)脑连接；</div>
<div class=""indep-clm"" num=""10"">(iv)智力潜能；</div>
<div class=""indep-clm"" num=""10"">(v)认知潜能；</div>
<div class=""indep-clm"" num=""10"">(vi)学习潜能；以及</div>
<div class=""indep-clm"" num=""10"">(vii)认知功能，</div>
<div class=""indep-clm"" num=""10"">其中所述维生素用于在孕前、怀孕期间或泌乳期间或它们的组合施用于所述雌性个体。</div>
<div class=""indep-clm"" num=""11"">11.一种促进、支持或优化雌性个体的后代的以下各项中的一个或多个的方法：</div>
<div class=""indep-clm"" num=""11"">(i)从头髓鞘形成；</div>
<div class=""indep-","A61K31/714, A61K31/519, A61P25/00, A61K31/14",20250325,雀巢产品有限公司,['Pending']
CN119233760A,Method for producing coffee composition,Methods for producing coffee compositions derived from medium and high yield extracts while also having improved taste and fragrance are disclosed. Coffee compositions produced by such methods are also disclosed.,"<div class=""indep-clm"" num=""1"">1.用于生产咖啡组合物的方法，所述方法包括通过正向渗透浓缩咖啡提取物以生产液体浓缩物，其中所述咖啡提取物包含基于所述咖啡提取物的干重大于或等于18重量％的量的一种或多种单糖。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述正向渗透在高于15℃的温度下进行。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2中任一项所述的方法，还包括干燥所述液体浓缩物以生产可溶性粉末。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的方法，还包括在所述正向渗透之前通过反向渗透浓缩所述咖啡提取物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的方法，其中使用氯化镁、氯化钠、柠檬酸钾或它们的一些组合作为汲取溶液进行所述正向渗透。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的方法，其中所述咖啡组合物包含糠醇、吡啶和一种或多种单糖，其中所述糠醇与所述吡啶的浓度比大于或等于30；并且所述单糖的浓度总和大于或等于18重量％。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的方法，其中所述咖啡组合物还包含2-乙基-6-甲基吡嗪、2-乙基-5-甲基吡嗪、2-乙基-3-甲基吡嗪、2,3,5-三甲基吡嗪、2-乙基-3,6-二甲基吡嗪、2-乙基-3,5-二甲基吡嗪和2,3-二乙基-5-甲基吡嗪，其中2-乙基-6-甲基吡嗪、2-乙基-5-甲基吡嗪、2-乙基-3-甲基吡嗪、2,3,5-三甲基吡嗪、2-乙基-3,6-二甲基吡嗪、2-乙基-3,5-二甲基吡嗪和2,3-二乙基-5-甲基吡嗪的绝对含量的总和大于或等于50.0mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""8"" parent=""6,7"">8.根据权利要求6或7中任一项所述的方法，其中所述咖啡组合物的所述糠醇的绝对含量大于或等于2,000mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""9"" parent=""6,7,8"">9.根据权利要求6至8中任一项所述的方法，其中所述咖啡组合物还包含一种或多种2-乙酰基噻唑、2-乙酰基吡嗪和2-乙酰基吡啶，其中2-乙酰基噻唑、2-乙酰基吡嗪和2-乙酰基吡啶的绝对含量的总和大于或等于2.70mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""10"" parent=""6,7,8,9"">10.根据权利要求6至9中任一项所述的方法，其中所述咖啡组合物还包含2,3-丁二酮，其中所述糠醇与所述2,3-丁二酮的浓度比大于或等于30。</div>
<div class=""dep-clm"" num=""11"" parent=""6,7,8,9,10"">11.根据权利要求6至10中任一项所述的方法，其中所述咖啡组合物包含半乳糖，所述半乳糖的量基于所述咖啡组合物的干重大于或等于8重量％。</div>
<div class=""dep-clm"" num=""12"" parent=""6,7,8,9,10,11"">12.根据权利要求6至11中任一项所述的方法，其中所述咖啡组合物包含甘露糖，所述甘露糖的量基于所述咖啡组合物的干重大于或等于8重量％。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5"">13.根据权利要求1至5中任一项所述的方法，其中所述咖啡组合物包含大于或等于18重量％的量的一种或多种单糖；和绝对含量大于或等于50.0的一种或多种烷基吡嗪、绝对含量大于或等于2,000的糠醇、或大于或等于2.70的一种或多种N-杂环化合物。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的方法，其中所述咖啡组合物包含吡啶，其中所述糠醇与所述吡啶的浓度比大于或等于30。</div>
<div class=""dep-clm"" num=""15"" parent=""13,14"">15.根据权利要求13或14中任一项所述的方法，其中所述咖啡组合物还包含2,3-","A23F5/24, A23F5/28, A23F5/36",20241231,雀巢产品有限公司,['Pending']
US20250241343A1,An instant porridge composition,"The present invention relates to an instant porridge composition comprising grain flake, lipid, flour and flavor, wherein the grain flake has a thickness between 0.3 to 1 mm.","<div class=""indep-clm"" num=""1""><seg-main>1. An instant porridge composition comprising </seg-main><seg-clauses>grain flake, lipid, flour and flavor, wherein the grain flake has a thickness between 0.3 to 1 mm.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. An instant porridge composition as claimed in claim 1, wherein </seg-main><seg-clauses>the weight of the grain flake is 15 to 70 wt % by weight of the total composition.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. An instant porridge composition of claim 1, wherein </seg-main><seg-clauses>the grain flake has a length between 2.5 to 15 mm.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. An instant porridge composition of claim 1, wherein </seg-main><seg-clauses>the grain flake is selected from the group consisting of wheat flake, barley flake, oat flake, maize flake, rye flake, Sorghum flake, millet flake and a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. An instant porridge composition of claim 1, wherein </seg-main><seg-clauses>the grain flake is a combination of a millet flake and a barley flake.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. An instant porridge composition of claim 1, wherein </seg-main><seg-clauses>the grain flake is a combination of 15 to 45 wt % millet flake (based on the total composition) and 8 to 30 wt % barley flake (based on the total composition).</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. An instant porridge composition as claimed in claim 1, wherein </seg-main><seg-clauses>the flour is selected from the group consisting of wheat flour, oat flour, corn flour, rice flour, barley flour, millet flour, pulse flour and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. An instant porridge composition as claimed in claim 1, wherein </seg-main><seg-clauses>the flour ",A23L7/143,20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250223550A1,Method for producing milk like products,"A method of producing a mammalian milk like product, for example a human milk like product comprising generating lactocytes derived from mammalian mammary epithelial cells, for example human mammary epithelial cells, and expressing the mammalian milk like product, for example the human milk like product from lactocytes.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for producing a mammalian milk like product, comprising:</seg-main>
<seg-clauses>A) Culturing mammary epithelial cells in a culture medium to generate lactocyte mammary-like gland organoids; and</seg-clauses>
<seg-clauses>B) Secreting the mammalian milk like product from said lactocytes.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the time duration of step A) is no longer than 14 days.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the lactocyte mammary-like gland organoids from step A) express one or more mammary gland positive cell markers.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the lactocyte mammary-like gland organoids from step A) have increased mRNA expression of one or more milk bioactive markers post-induction compared to pre-induction.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the lactocyte mammary-like gland organoids from step A) have increased mRNA expression of LTF post-induction compared to pre-induction.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the lactocyte mammary-like gland organoids from step A) have increased mRNA expression of MFGE8 post-induction compared to pre-induction.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method of claim 1, wherein </seg-main><seg-clauses>the culture medium is a MammoCult medium, in an appropriate 3D culture system.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The method of claim 1, wherein </seg-main><seg-clauses><seg-main>step A) further comprises:</seg-main>
<seg-clauses>i) culturing","C12N5/071, A23C9/20, C12N5/00, C12P21/02",20250710,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
JP2025081671A,Compositions and methods using thymol and/or carvacrol for induction of autophagy,"To provide compositions and methods for administration that are capable of inducing autophagy in an individual in need thereof, and which can concomitantly promote protein synthesis and removal of damaged cellular materials.SOLUTION: Compositions and methods can use a combination of thymol and/or carvacrol, optionally with high protein for induction of autophagy in an individual in need thereof. Preferably, a formulation containing a combination of thymol and/or carvacrol, optionally with protein, is administered to the individual in an amount effective to induce autophagy, for example in muscle. The formulation can concomitantly promote protein synthesis and removal of damaged cellular materials.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 細胞機能不全、ゲノム損傷、ミトコンドリア機能の変化若しくはミトコンドリア密度の低下に関連する疾患又は状態の治療、予防又は管理を必要とする個体において、前記治療、予防又は管理に使用するための、チモール及び／又はカルバクロールを含む組成物。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 健康な中高年者において、抗酸化能力の増加、酸化ストレスの低減、免疫機能の維持、及び／又は認知機能の維持に使用するための、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 前記ミトコンドリア関連の疾患又は状態が、ストレス、肥満、代謝率の低下、メタボリックシンドローム、真性糖尿病、糖尿病合併症、高脂血症、遊離脂肪酸の上昇、肝疾患、ＮＡＦＬＤ、ＮＡＳＨ、神経変性疾患、脳卒中、認知障害、ストレス誘発性又はストレス関連性認知機能障害、気分障害、不安障害、加齢に伴う神経細胞死又は神経機能障害、筋骨格障害、フレイル、プレフレイル、慢性腎疾患、胃腸障害、外傷、感染、がん、黄斑変性、及びこれらの組み合わせからなる群から選択される、請求項１に記載の組成物。 </div>
<div class=""indep-clm"" num=""4"">【請求項4】</div>
<div class=""indep-clm"" num=""4""> オートファジーの誘導を必要とする個体においてオートファジーの誘導に使用するための、有効量のチモール及び／又はカルバクロールを含む組成物。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> チモール及び／又はカルバクロールが高タンパク質と組み合わされている、請求項１～４のいずれか一項に記載の組成物。 </div>
<div class=""dep-clm"" num=""6"" parent=""5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""5""> 前記高い量のタンパク質が、前記組成物の少なくとも約２５エネルギー％である量のタンパク質である、請求項５に記載の組成物。 </div>
<div class=""dep-clm"" num=""7"" parent=""5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""5,6""> 前記高い量のタンパク質が、前記組成物の６ｇ／１００ｋｃａｌを超えるタンパク質／エネルギー比を提供する量の前記タンパク質である、請求項５又は６に記載の組成物。 </div>
<div class=""dep-clm"" num=""8"" parent=""5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""5,6,7""> 前記タンパク質の少なくとも一部が、（ｉ）動物源由来のタンパク質、（ｉｉ）植物源由来のタンパク質、及び（ｉｉｉ）これらの混合物からなる群から選択される、請求項５～７のいずれか一項に記載の組成物。 </div>
<div class=""dep-clm"" num=""9"" parent=""5,6,7,8"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""5,6,7,8""> 前記タンパク質の少なくとも一部が、（ｉ）乳タンパク質、（ｉｉ）ホエイタンパク質、（ｉｉｉ）カゼイン塩、（ｉｖ）カゼインミセル、（ｖ）エンドウ豆タンパク質、（ｖｉ）大豆タンパク質、及び（ｖｉｉ）これらの混合物からなる群から選択される、請求項５～８のいずれか一項に記載の組成物。 </div>
<div class=""dep-clm"" num=""10"" parent=""5,6,7,8,9"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""5,6,7,8,9""> 前記タンパク質が、（ｉ）前記タンパク質の少なくとも５０重量％がカゼインである配合、（ｉｉ）前記タン","A23L33/10, A61K31/05, A61P43/00, A61P3/04, A61P3/00",20250527,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US20250194644A1,Mimicking health benefits of physical exercise in cats,"A method of mimicking health benefits of physical exercise in a cat can include administering a high protein diet to a cat, the high protein diet including from about 110% to about 350% of a Recommended Daily Allowance (RDA) of protein for the cat on a daily basis. The high protein diet in this example is sufficient to increase a 12,13-diHOME blood level for an 18-24 hour period per day compared to a baseline blood level without the need for physical exercise.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of mimicking health benefits of physical exercise in a cat, </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a high protein diet to a cat, the high protein diet including from about 110% to about 350% of a Recommended Daily Allowance (RDA) of protein for the cat on a daily basis, wherein the high protein diet is sufficient to increase a 12,13-diHOME blood level for an 18-24 hour period per day compared to a baseline blood level without the need for physical exercise.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the high protein diet includes from about 150% to about 250% of the RDA of protein and the 12,13-diHOME blood level is increased by at least 2-fold over the 18-24 hour period compared to the baseline blood level.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the 12,13-diHOME blood level is higher over the 18-24 hour period compared to the baseline blood level without the cat engaging in physical exercise.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the RDA of protein for the cat is 26 wt % based on 100% of a MER for the cat, and wherein the high protein diet includes administering a cat food on a daily basis containing from about 30 wt % to about 75 wt % protein calculated based on the 100% of the MER for the cat.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of claim 4, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>administering a decreased caloric intake diet having from about 50% to about 95% of the MER for the cat, wherein the cat food still includes an equivalent of the about 40 wt % to about 75 wt % protein calculated based on the 100% of the MER","A23K20/147, A23K50/42",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025061388A1,Recovery of natural colouring in plant-based beverages after thermal treatment,,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a plant based liquid, said method comprising </seg-main><seg-clauses>a. Dissolving a plant protein source in water to form a plant protein mixture with a pH of 6.5 or greater; </seg-clauses><seg-clauses>b. Adding a powdered or liquid red beet extract to the plant protein mixture at a pH greater than 6 and stirring to dissolve; </seg-clauses><seg-clauses>c. Optionally incubating the plant protein mixture with enzymes; </seg-clauses><seg-clauses>d. Optionally adding a hydrocolloid(s) to the plant protein mixture; </seg-clauses><seg-clauses>e. Dispersing oil in the plant protein mixture; </seg-clauses><seg-clauses>f. Homogenizing the plant protein mixture to form an emulsion; </seg-clauses><seg-clauses>g. Applying a thermal treatment to the emulsion; and </seg-clauses><seg-clauses>h. Applying a shear treatment to the thermal treated emulsion to form a plant based liquid.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 , wherein </seg-main><seg-clauses>sodium ascorbate is dissolved in the plant protein mixture before or during step e).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1 , wherein </seg-main><seg-clauses>sodium ascorbate and citric acid are dissolved in the plant protein mixture before or during step e).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2""><seg-main>4. The method according to claims 1 and 2, wherein </seg-main><seg-clauses>the plant protein source is derived from a legume source such as red bean, adzuki bean (Vigna angularis), red kidney bean (Phaseolus vulgaris), pea (Pisum sativum), faba bean (Vicia faba), chickpea (Cicer arietinum) or lentil (Lens culinaris).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any preceding claim, wherein </seg-main><seg-clauses>a sugar is dissolved in the plant pro","A23C9/13, A23C11/10, A23L29/269, A23L29/30, A23L33/105",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CA3004976A1,Cocoa polyphenols and soluble dietary fiber for use in the treatment or prevention disorders associated with an above-normal number of granulocytes in a tissue,The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use hi the prevention or treatment of a disorder associated with an above-normal number of granulocytes hi a tissue.,"Claims <div class=""indep-clm"" num=""1""><seg-main>1. Composition comprising </seg-main><seg-clauses>at least one cocoa polyphenol and at least one fermentable dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of eosinophils according to claim 1, wherein </seg-main><seg-clauses>the disorder associated with an above-normal number of granulocytes in a tissue is an eosinophilic gastrointestinal disorder, an allergy, in particular, a food allergy, an gastrointestinal syndrome, allergy associated with aeroallergen including asthma and allergic rhinithis, lung allergic inflammation or skin atopic dermatitis. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes according to any of the above claims, wherein </seg-main><seg-clauses>the eosinophilic gastrointestinal disorder is caused by a food allergy or aeroallergens. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of eosinophils according to any of the above claims, wherein </seg-main><seg-clauses>the eosinophilic gastrointestinal disorder is eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, or eosinophilic colitis; wherein the eosinophilic gastrointestinal disorder preferably is eosinophilic esophagitis. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes according to any of the above claims, wherein </seg-main><seg-clauses>","A61K31/05, A61P1/00",20250506,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023342231A1,Beverage extraction system,"The invention concerns a system comprising an extraction device of a beverage preparation machine and a pod, wherein - the pod comprises a pod body and a top lid, and - the extraction device comprises : - upstream and downstream pod enclosing parts relatively translatable between an open position for inserting and/or ejecting the pod and a closed position for forming an extraction chamber enclosing the pod during extraction, the downstream part comprising a downstream plane piercing arrangement for opening the lid of the pod, and wherein the body and the lid of the pod are made of a multilayer paper material comprising a layer of paper coated with at least a layer of plastic, and wherein the downstream piercing arrangement and the multilayer material of the second enclosing wall (32) of the pod are designed to enable a progressive piercing of the top lid.","<div class=""indep-clm"" num=""1""><seg-main>1. System comprising </seg-main><seg-clauses><seg-main>a beverage preparation machine and a pod containing a beverage ingredient, preferably roast and ground coffee,</seg-main>
<seg-main class=""seg-enter"">wherein the pod (3) comprises a first and a second enclosing walls (31, 3T, 32), said first and second pod enclosing walls defining a chamber for enclosing the beverage ingredient (33), and</seg-main>
<seg-main class=""seg-enter"">wherein said first and second pod enclosing walls of the pod are made of a multilayer paper material, said multilayer paper material comprising at least one layer of paper </seg-main><seg-clauses><seg-main>(A) assembled with at least one layer of plastic (B), preferably a compostable plastic layer, and</seg-main>
<seg-main class=""seg-enter"">wherein said multilayer paper material is oriented so that at least one layer of plastic faces the internal part of the chamber of the pod,</seg-main>
<seg-main class=""seg-enter"">and</seg-main>
<seg-main class=""seg-enter"">wherein the beverage preparation machine comprises an extraction device for extracting a beverage from the pod, and said extraction device comprises :</seg-main>
<seg-clauses>- upstream and downstream pod enclosing parts (1, 2) relatively movable between an open position for inserting and/or ejecting the pod (3) and a closed position for forming an extraction chamber (5) enclosing the pod during extraction,</seg-clauses>
<seg-clauses>- the upstream part (2) bearing :</seg-clauses>
<seg-clauses class=""seg-enter"">. an upstream piercing arrangement (22) for opening the first enclosing wall (31) of the pod and</seg-clauses>
<seg-clauses class=""seg-enter"">. a liquid injector (25),</seg-clauses>
<seg-clauses><seg-main>- the downstream part (1) comprising a downstream piercing arrangement (12) for opening the second enclosing wall (32) of the pod, said downstream piercing arrangement comprising a plate (121) wherein :</seg-main>
<seg-main class=""seg-ent","A47J31/36, B65D65/46, B65D85/804",20250123,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12240685B2,Flexible package for food or beverage preparation having a rigid part,"The present invention is directed to a closed flexible package comprising: (i) flexible or semi-flexible lateral walls (<b>2</b>) that form a flatten package body, and (ii) a cup-shaped bottom portion adapted to the insertion of a fluid injection element of the machine, the package body and cup-shaped bottom portion being formed from a one-piece elongated primary flat blank sheet made of flexible material, preferably a fiber-based material, that is folded in a U-shape around its transversal symmetry axis, and sealed along its lateral and upper edges, wherein said cup-shaped bottom portion is a hollow volume having a concave lower side and convex lateral sides, and the profile curvature of said lower side being identical to the profile curvature of each of said lateral sides.","<div class=""indep-clm"" num=""1""><seg-main>1. A flexible or semi-flexible closed package for containing </seg-main><seg-clauses><seg-main>an ingredient for preparing an edible product in a food or beverage preparation machine by mixing the ingredient with a mixing fluid injected in the flexible or semi-flexible closed package by the food or beverage preparation machine, the flexible or semi-flexible closed package comprising:</seg-main>
<seg-clauses>(i) a plurality of flexible or semi-flexible lateral walls that form a flattened package body, and</seg-clauses>
<seg-clauses>(ii) a cup-shaped bottom portion adapted for insertion of a fluid injection element of the food or beverage preparation machine,</seg-clauses>
<seg-clauses class=""seg-enter"">the flattened package body and the cup-shaped bottom portion being formed from a one-piece elongated primary flat blank sheet made of flexible material folded in a U-shape around a transversal symmetry axis and sealed along lateral and upper edges, wherein the cup-shaped bottom portion is a hollow volume having a concave lower side and convex lateral sides, a profile curvature of the concave lower side being identical to a profile curvature of each of the lateral sides, the one-piece elongated primary flat blank sheet comprising a primary hole that is punched through a thickness of the one-piece elongated primary flat blank sheet, the primary hole being located on the concave lower side of the cup-shaped bottom portion, and wherein the flexible or semi-flexible closed package further comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">a secondary thickness reinforcement sheet located at least on an inner surface of the cup-shaped bottom portion of the flexible or semi-flexible closed package, the secondary thickness reinforcement sheet comprising a secondary hole, and</seg-clauses>
<seg-clauses class=""seg-enter"">a tertiary thin sheet sandwiched between the flexible or semi-flexible lateral walls of the flexible or semi-flexi","B65D85/804, B65D65/42",20250304,SOCIETE DES PRODUITS NESTLE S.A,['Active']
US20250256493A1,Multi-layer metallized paper-based packaging material,"The present invention is directed to a multi-layer metallized paper-based packaging material (<b>1</b>) comprising, from its outer side to its inner side: —a paper layer (<b>2</b>) having a grammage comprised in the range of 40 to 120 g/m<sup>2</sup>, —at least one first organic layer (<b>3</b>) of a biodegradable polymer selected within the list of: polyvinylalcohol (PVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, in an amount of 0.5 to 15 g/m<sup>2</sup>, preferably in an amount of 1 to 10 g/m<sup>2</sup>, —a vacuum deposited inorganic layer (<b>4</b>), comprising a metal, a metalloid, or a combination thereof, said inorganic layer having a thickness comprised between 1 and 100 nm, and—at least one second organic layer (<b>5</b>) made of a biodegradable polymer having tensile strength above 30 MPa and elongation at break above 850%, said second organic layer (<b>5</b>) being applied in an amount between 0.5 and 30 g/m<sup>2</sup>, preferably in an amount between 1 to 10 g/m<sup>2</sup>.","<div class=""indep-clm"" num=""1""><seg-con>1. A multi-layer metallized paper-based packaging material </seg-con><seg-trans>comprising, </seg-trans><seg-refi>from its outer side to its inner side:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a paper layer having a grammage comprised in the range of 40 to 120 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one first organic layer of a biodegradable polymer or copolymer selected from the group consisting of: polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), and combinations thereof, in an amount of 0.5 to 15 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a vacuum deposited, or transfer metallized inorganic layer, comprising a material from the group consisting of metal, a metalloid, and combinations thereof, said inorganic layer having a thickness comprised between 1 and 100 nm, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one second organic layer made of a biodegradable polymer having tensile strength above 30 MPa and elongation at break above 850%, said second organic layer being applied in an amount between 0.5 and 30 g/m<sup>2</sup>.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The multi-layer metallized paper-based packaging material according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the biodegradable polymer used for said second organic layer is selected from the group consisting of: a polycaprolactone (PCL), a thermoplastic starch (TPS), or polybutylene adipate terephthalate (PBAT).</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The multi-layer metallized paper-based packaging material according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the first organic layer further comprises a mineral filler selected from the group consisting of: kaolin, calcium carbonate, talc, silica, woll","B32B27/10, B32B27/30, B32B27/36",20250814,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024260462A1,Compositions and methods for improving metabolic health,"Methods and compositions improve metabolic health. A method for improving metabolic health includes administering to an individual in need thereof a composition comprising milk protein, preferably 20-40 % by dry weight of the composition; and a mixture of lactose, glucose, galactose and galactooligosaccharide, preferably 35-55% by dry weight of the composition. The mixture of lactose, glucose, galactose, and galactooligosacchride can contain 0.1-30% by weight of the lactose, 8-40% by weight of 35-55% by dry weight of the glucose, 0.1-20% by weight of the galactose and 40-90% by weight of the galactooligosaccharide.",,"A23L33/125, A61K31/7004, A61K31/7016, A61K31/702, A61P3/00",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023346091A1,Compositions and methods for digestive health in an canine,"Compositions and methods from providing a digestive health benefit to a canine include the use of a prebiotic fiber blend comprising pumpkin, inulin, and, optionally, psyllium.","<div class=""indep-clm"" num=""1""><seg-con>1. A prebiotic fiber blend for a canine </seg-con><seg-trans>comprising </seg-trans><seg-refi>pumpkin, inulin, and, optionally, psyllium.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pumpkin is present in the fiber blend in an amount from about 20 % to about 50 %.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the inulin is present in the fiber blend in an amount from about 10 % to about 40 %.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fiber blend comprises psyllium, and wherein the psyllium is present in the fiber blend in an amount from about 20 % to about 50 %.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5. A pet food composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>the prebiotic fiber blend of claim 1.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6. The pet food composition of claim 5, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>protein, carbohydrates, fat, and a preservative, wherein the fiber blend is present in the pet food composition in an amount from about 0.1 % to about 10 %.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""5""><seg-con>7. The pet food composition of claim 5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pumpkin is present in the pet food composition in an amount from about 0.01 % to about 5 %, the inulin is present in the pet food composition in an amount from about 0.01 % to about 5 %, and the psyllium is present in the pet food composition in an amount from about 0.01 % to about 5 %.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""5""><seg-con>8. The pet food composition","A23K10/30, A23K20/163, A23K50/40, A23K50/42",20250227,SOCIETE DES PRODUITS NESTLE SA,['Pending']
AU2019409827B2,Composition for preventing or reducing transepidermal water loss and improving skin barrier function,"The present invention relates to the use of a milk whey protein hydrolysate for preventing or treating transepidermal water loss (TEWL) and/or TEWL-associated disorders or/and enhancing skin barrier function in young and adult mammals. The protein hydrolysate may be used in the prevention or treatment of TEWL-associated disorders, such as atopic dermatitis, dry or reactive skin or skin dehydration. It may also be used in the cosmetic use of improving skin appearance.","<div class=""indep-clm"" num=""1""><seg-con>1. Method of treating transepidermal water loss (TEWL) and/or a TEWL-associated disorder and/or of enhancing skin barrier function or skin hydration in a young or adult mammal, the method </seg-con><seg-trans>comprising: </seg-trans><seg-refi>administering to the young or adult mammal a composition comprising a milk whey partial protein hydrolysate, wherein the composition has a non-protein nitrogen (NPN) / total nitrogen (TN) % in the range 75%-85%.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. Use of a composition in the manufacture of a medicament for treating transepidermal water loss (TEWL) and/or a TEWL-associated disorder in a young or adult mammal, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a milk whey partial protein hydrolysate, and wherein the composition has a non-protein nitrogen (NPN) / total nitrogen (TN) % in the range 75%-85%.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Method according to claim 1, or use according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the milk whey partial protein hydrolysate has a milk origin from an animal selected from the group consisting of cow, goat, sheep, camel, buffalo and a mixture thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The method according to claim 1 or claim 3, or the use according to claim 2 or claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is an infant formula dry powder, and the milk whey partial protein hydrolysate is 8-12 wt.% of the composition.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,3,4""><seg-con>5. The method according to any one of claims 1 and 3 to 4, or the use according to any one of claims 2 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the method is a method of treatment of a TEWL-associated disorder, selected from the group consisting of ichthyosis vulgaris, diaper rash","A61P17/00, A23J1/20, A61K8/64, A61Q19/00, A61Q19/08",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019340821B2,Capsule for beverage preparation with integrally formed sealing member,"The invention relates to a capsule (10) designed for preparing a beverage upon injection of liquid into the capsule by means of a beverage preparation machine (20), the capsule (10) having a longitudinal axis (y) and comprising a cup-shaped base body (1) being provided with a closed end (1a) and lateral sidewalls (1b) for holding beverage preparation ingredients and a flange-like rim (2) arranged at an open end (1c) of the base body (1) and radially ending with a curled outer edge (2c); in which - the capsule (10) is in a first state before being used in the beverage preparation machine, wherein the capsule further comprises a sealing member (3) for providing a fluid sealing engagement with a sealing profile of a capsule engagement member (21) of the beverage preparation machine (20), said sealing profile having at least one sealing surface (21a, 21b, 21c), wherein the base-body (1), the flange-like rim (2) and the sealing member (3) are made integrally from metallic material such as aluminum as a one piece element, and wherein the sealing member (3) comprises at least one dedicated surface (4) located at the junction between the sidewalls (1b) of the base body (1) and the flange-like rim (2), said dedicated surface (4) being in the form of at least one step extending over the flange-like rim (2), and in which - the capsule (10) is in a second state after being used in the beverage preparation machine. The capsule is characterized in that, in the second state, after engagement between the sealing profile of the capsule engagement member (21) and the at least one step of the dedicated surface (4), the at least one step is plastically deformed and the capsule (10) comprises, at the location of the at least one step (4), a flange-like rim (2) having a profile corresponding to the shape of at least one of the sealing surface (21a, 21b, 21c), said profile presenting at least three contiguous surfaces (S1, S2, S3) having each a different orientation.","<div class=""indep-clm"" num=""1""><seg-main>1. A capsule designed for preparing a beverage upon injection of liquid into the capsule by means of a beverage preparation machine, the capsule having </seg-main><seg-clauses><seg-main>a longitudinal axis and comprising a cup-shaped base body being provided with a closed end and lateral sidewalls for holding beverage preparation ingredients and a flange-like rim arranged at an open end of the base body and radially ending with a curled outer edge; in which</seg-main>
<seg-clauses><seg-main>- the capsule is in a first state before being used in the beverage preparation machine,</seg-main>
<seg-main class=""seg-enter"">wherein the capsule further comprises a sealing member for providing a fluid sealing engagement with a sealing profile of a capsule engagement member of the beverage preparation machine, said sealing profile having at least one sealing surface,</seg-main>
<seg-main class=""seg-enter"">wherein the base-body, the flange-like rim and the sealing member are made integrally from metallic material such as aluminum as a one piece element, and</seg-main>
<seg-main class=""seg-enter"">wherein, in the first state, the sealing member comprises at least one dedicated surface located at the junction between the sidewalls of the base body and the flange-like rim, said dedicated surface being in the form of at least one step extending over the flange-like rim, and in which</seg-main>
<seg-clauses>- the capsule is in a second state after being used in the beverage preparation machine;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, in the second state, after engagement between the sealing profile of the capsule engagement member and the at least one step of the dedicated surface, the at least one step is plastically deformed and the capsule comprises, at the initial location of the at least one step, a profile presenting at least three contiguous surfaces having each a different orientation and corresponding to the shape of the",B65D85/804,20250710,SOCIÉTÉ DES PRODUITS NESTLÉ S.A..,['Active']
RU2838215C1,Beverage preparation device with capsule recognition,"FIELD: beverage preparation devices.SUBSTANCE: device (1) for preparing and dispensing beverage (2), such as tea, coffee, hot chocolate, cold chocolate, milk, soup or a baby food product, comprising a capsule recognition module (8) for recognizing the type of capsule (3) inserted into capsule (3) device (1), wherein capsule recognition module (8) comprises light source (82) for illuminating at least part of surface of capsule (3) and optical sensor (81) for detecting optical property of at least part of surface of capsule (3); and wherein the capsule recognition module (8) is configured to: determine the optical property correction value by detecting the optical property of at least a portion of the surface of capsule (3) when said light source (82) is turned off; determining at least one selective value of the optical property by detecting the optical property of at least a portion of the surface of capsule (3), when light source (82) is on; calculating the corrected sampled value using the correction value and at least one sampled value; determining the type of capsule by comparing the corrected sampled value with at least one reference value, wherein at least one reference value relates to the type of capsule.EFFECT: beverage preparation and dispensing device allows automatic correct identification of capsules.24 cl, 11 dwg","1. Устройство (1) для приготовления и выдачи напитка (2), такого как чай, кофе, горячий шоколад, холодный шоколад, молоко, суп или продукт детского питания, содержащее:
- блок (10) экстракции для экстракции содержимого капсулы (3) с ингредиентом напитка с получением указанного напитка (2);
- блок (40) управления для управления блоком (10) экстракции, чтобы экстрагировать содержимое такой капсулы (3), такой как блок управления, получающий питание от сети электропитания;
- выходной канал (20) для выдачи указанного напитка (2), полученного путем экстракции содержимого такой капсулы (3), в емкость (4) пользователя, такую как чашка или кружка, расположенную в области для размещения емкости, на такой как опора (5, 6) емкости, для сбора указанного напитка (2); и
- модуль (8) распознавания капсулы для распознавания типа указанной капсулы (3), вставленной в указанное устройство (1), содержащий:
- источник (82) света для освещения по меньшей мере части поверхности такой капсулы (3); и
- оптический датчик (81) для обнаружения оптического свойства указанной по меньшей мере части поверхности такой капсулы (3),
причем модуль (8) распознавания капсулы выполнен с возможностью:
- определения корректирующего значения указанного оптического свойства путем обнаружения указанного оптического свойства указанной по меньшей мере части поверхности такой капсулы (3), когда указанный источник (82) света выключен;
- определения по меньшей мере одного выборочного значения указанного оптического свойства путем обнаружения указанного оптического свойства указанной по меньшей мере части поверхности такой капсулы (3), когда указанный источник (82) света включен;
- вычисления скорректированного выборочного значения с помощью указанного корректирующего значения и указанного по меньшей мере одного выборочного значения; и
- определения указанного типа указанной капсулы путем сравнения указанного скорректированного выборочного значения с по меньшей мере одним эталонным значением, причем указанное по мен",A47J31/36,20250414,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023314209A1,Beverage or foodstuff preparation system,"A system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or foodstuff thereof, the container (6) including: a body portion (62) comprising a storage portion (58) for containing a precursor material; a closing member (56) to close the storage portion (58), and; a machine-readable code (44) storing preparation information, the machine (4) including: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6), and; electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), wherein the code reading system (18) includes a positioning mechanism (110) to apply a variable loading condition to the container (6), and the code reading system (18) includes a detection system (150) to detect a reading position if a predetermined condition for reading the code (44) is met, and if said condition is met, then the electrical circuitry (16) configured to process the code (44) to extract the preparation information in the reading position.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container and a machine for preparing a beverage and/or foodstuff thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body portion comprising a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine-readable code storing preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code of the container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information read from the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the code reading system includes a positioning mechanism to apply a variable loading condition to the container to selectively deform the body portion of the container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and the code reading system includes a detection system to detect a reading position if a predetermined condition, which is based on a force and/or displacement applied to the container, for reading the code is met,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and if said condition is met, then the electrical circuitry configured to read the code to extract the preparation information in the reading position.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the load","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12226448B2,Peanut oral immunotherapy dosing schedule for missed doses,"The present disclosure relates to improved oral immunotherapy methods for treating peanut allergy. In certain embodiments, the disclosure provides methods for continuing an oral immunotherapy for the treatment of a peanut allergy after missing a scheduled oral administration of one or more consecutive doses of a pharmaceutical composition comprising peanut protein.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of continuing an oral immunotherapy for the treatment of a peanut allergy in a patient after missing a scheduled administration of one or more consecutive doses of a pharmaceutical composition comprising </seg-main><seg-clauses><seg-main>peanut protein, wherein the patient began an oral immunotherapy and missed one or more doses of the up-dosing phase or the maintenance phase of the oral immunotherapy, the oral immunotherapy comprising:</seg-main>
<seg-clauses>(i) an up-dosing phase comprising orally administering to the patient a series of escalating doses of the pharmaceutical composition with a single dose administered on a daily basis, wherein the series of escalating doses administered during the up-dosing phase comprises doses of 3 mg to 300 mg peanut protein, and wherein a given dose is administered to the patient for at least a predetermined period of time before the dose is escalated, and</seg-clauses>
<seg-clauses><seg-main>(ii) a maintenance phase comprising orally administering to the patient a plurality of maintenance doses of the pharmaceutical composition after completion of the up-dosing phase, wherein the maintenance dose of the pharmaceutical composition comprise about 300mg peanut protein and are administered daily;</seg-main>
<seg-main class=""seg-enter"">the method comprising:</seg-main>
<seg-main class=""seg-enter"">orally administering to the patient a dose of the pharmaceutical composition after missing the scheduled one or more consecutive doses, wherein:</seg-main>
<seg-clauses>(1) if one or two consecutive doses are missed, the dose administered to the patient is the same as the most recently administered dose;</seg-clauses>
<seg-clauses><seg-main>(2) if three or four consecutive doses are missed, the dose administered to the patient is reduced compared to the most recently administered dose, wherein the dose is reduced by:</seg-main>
<seg-clauses>(i) 25% or more, and the dose is administere","A61K38/16, A61K9/00",20250218,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
EP4574157A2,Mixture of hmos and bifidobacteria,"The invention relates to a composition for infants or young children comprising at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria and a prebiotic mixture of human milk oligosaccharides consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL) that can be useful for (i) preventing and/or treating bacterial infections; (ii) modulating the microbiota; and/or iii) preventing and/or treating allergy in an infant or a young child.","<div class=""indep-clm"" num=""1""><seg-main>1.  A composition for infants or young children comprising </seg-main><seg-clauses><seg-main>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL); wherein the bifidobacteria comprises <i>Bifidobacterium longum</i> </seg-main><seg-clauses>subsp. <i>infantis</i> or combination of <i>Bifidobacterium animalis</i> </seg-clauses><seg-clauses>subsp. <i>lactis</i> and <i>Bifidobacterium longum</i> subsp. <i>infantis;</i> wherein at least one of the bifidobacteria is <i>Bifidobacterium longum</i> </seg-clauses><seg-clauses>subsp. <i>infantis</i> LMG 11588 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The composition of claim 1, comprising </seg-main><seg-clauses><seg-main>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and 3-fucosyllactose (3FL); wherein the bifidobacteria comprises <i>Bifidobacterium longum</i> </seg-main><seg-clauses>subsp. <i>infantis</i> or combination of <i>Bifidobacterium animalis</i> </seg-clauses><seg-clauses>subsp. <i>lactis</i> and <i>Bifidobacterium longum</i> subsp. <i>infantis;</i> wherein at least one of the bifidobacteria is <i>Bifidobacterium longum</i> </seg-clauses><seg-clauses>subsp. <i>infantis</i> LMG 11588 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-clauses></seg-clauses></div>
<div class=""dep-clm""",A61K31/745,20250625,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250087329A1,Personalised recommended daily intake for nutrients based on individual genetic risk scores,"Systems and methods determine personalized recommended daily intake, for example, the recommended daily allowance (RDA) for nutrients based on genetic information of the individual. In several embodiments, the systems and methods can be used to determine recommendations for specific nutrient supplements, foods, beverages, meals, menus, diets and recipes for an individual which are more accurately adapted to their needs based on their personal genetic risk scores. A particularly preferred method calculates a polygenic risk score of the individual for the nutrient, based on the SNP genotype profile of the individual; classifies the individual in a corresponding genetic risk group of a plurality of genetic risk groups based on the polygenic risk score of the individual, wherein each of the plurality of genetic risk groups is associated with a different daily dose of the nutrient necessary to reach a sufficient blood level of the nutrient for subjects in the genetic risk group (wherein the daily dose for each group is preferably calculated by an intake need estimate algorithm, such as a dose-response algorithm); and identifies to the individual the daily dose of the nutrient for the corresponding genetic risk group, as the personalised recommended daily intake of the nutrient for the individual.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a personalized recommended daily intake of a nutrient for an individual, the method comprising:</seg-main>
<seg-clauses>(i) determining a SNP genotype profile of the individual from a DNA sample from the individual;</seg-clauses>
<seg-clauses>(ii) calculating a polygenic risk score of the individual for the nutrient, based on the SNP genotype profile of the individual;</seg-clauses>
<seg-clauses>(iii) classifying the individual in a corresponding genetic risk group of a plurality of genetic risk groups based on the polygenic risk score of the individual,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein each of the plurality of genetic risk groups is associated with a predetermined polygenic risk score or a predetermined range of polygenic risk scores that do not overlap with ranges of the other genetic risk groups,</seg-clauses>
<seg-clauses class=""seg-enter"">the polygenic risk score for the individual matches the predetermined polygenic risk score of the corresponding genetic risk group or is included in the predetermined range of the corresponding genetic risk group,</seg-clauses>
<seg-clauses class=""seg-enter"">each of the plurality of genetic risk groups is associated with a different daily dose of the nutrient necessary to reach a sufficient blood level of the nutrient for subjects in the genetic risk group; and</seg-clauses>
<seg-clauses>(v) identifying to the individual the daily dose of the nutrient for the corresponding genetic risk group, as the personalised recommended daily intake of the nutrient for the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the plurality of genetic risk groups are classified by a genetic-based dose-response model.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The method of claim 2, wherein </seg-main><seg-clauses><seg-main>the genetic-base","G16H20/60, A23L33/00, A61K31/593, A61K31/714, G16B20/20",20250313,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250114432A1,Whey protein micelles against muscle atrophy and sarcopenia,,,"A61K38/17, A23C21/00, A23L33/00, A23L33/19, A61K9/107",20250410,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120152709A,Compositions and methods for reducing biological age of adult animals using glycine,"The present disclosure relates generally to compositions and methods for reducing the biological age and/or reducing the rate of biological age increase in an adult animal. More specifically, the present disclosure relates to administering formulations comprising an effective amount of glycine and/or functional derivatives, alone or in combination with a dietary regimen such as caloric limiting, elderly diet or low protein diet. The preparation can reduce the biological age of tissues, organs or physiological systems in adult animals in need at the same time; or treating, preventing or delaying the onset of organ disease, or the decline of organ function, or a condition associated therewith, in the adult animal in need thereof.","<div class=""indep-clm"" num=""1""><seg-con>1.用于降低有需要的成年动物的生物学年龄和/或降低有需要的成年动物的生物学年龄增加速率的方法，所述方法</seg-con><seg-trans>包括：</seg-trans><seg-refi>向所述成年动物饲喂包含有效量的甘氨酸和/或功能性衍生物的组合物。</seg-refi></div>
<div class=""indep-clm"" num=""2"">2.用于降低有需要的成年动物中的组织、器官或生理系统的生物学年龄的方法，所述方法包括向所述成年动物饲喂包含有效量的甘氨酸和/或功能性衍生物的组合物。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中所述组织、器官或生理系统是免疫、胃肠、泌尿、肌肉、心血管和/或神经系统。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的方法，其中所述组织是缺乏甘氨酸的组织。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的方法，其中所述组织是骨骼肌。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的方法，其中所述甘氨酸以二肽形式提供，所述二肽诸如N-乙酰半胱氨酸基甘氨酸(GlyNAC)。</div>
<div class=""indep-clm"" num=""7"">7.用于治疗、预防或延缓有需要的成年动物的器官疾病的发作、或器官功能的衰退、或与其相关的病症的方法，所述方法包括向所述成年动物饲喂包含有效量的甘氨酸和/或功能性衍生物的组合物。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中所述有需要的动物在其一个或多个组织中缺乏甘氨酸。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的方法，其中所述有需要的动物具有与其实足年龄相比增加的生物学年龄。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据任一前述权利要求所述的方法，其中所述增加的生物学年龄由所述成年动物的DNA甲基化图谱确定。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据任一前述权利要求所述的方法，其中所述动物是衰老的动物。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求所述的方法，其中所述动物是宠物动物，优选狗或猫。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据任一前述权利要求所述的方法，其中所述动物是人。</div>
<div class=""dep-clm"" num=""14"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13"">14.根据任一前述权利要求所述的方法，其中所述组合物选自食物组合物、膳食补充剂、营养组合物、营养制品、在食用前用水或乳重构的粉末状营养产品、食品添加剂、药物、饮品、干或湿宠物食品及其组合。</div>
<div class=""dep-clm"" num=""15"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13,14"">15.根据任一前述权利要求所述的方法，其中所述组合物是以下的一部分；或与以下一起施用：选自热量限制饮食、老年饮食或低蛋白饮食的膳食方案。</div>","A61K31/198, A61K38/05, A61P39/00",20250613,雀巢产品有限公司,['Pending']
AU2023315037A1,Method for improving flowering of a plant of the family rubiaceae,"The invention relates to a method for accelerating the time to flowering of a plant and/or for increasing the amount of flowers and/or fruits produced by said plant of the family rubiaceae, the method comprising providing a plant seed or plant part which is capable of regeneration, cultivating the same to a stage in which a cultivated shoot is obtained that comprises a fork from which an orthotropic shoot and at least two plagiotropic branches have developed, pruning the cultivated shoot at said fork by removing at least the orthotropic shoot and maintaining at least one plagiotropic branch to obtain a pruned shoot, cultivating the pruned shoot until flowers form on the at least one plagiotropic branch to obtain a flowered shoot.","<div class=""indep-clm"" num=""1""><seg-main>1. Method for accelerating the time to flowering of and/or increasing the number of flowers formed by a plant of the family rubiaceae, the method comprising</seg-main>
<seg-clauses>a. providing a plant seed or plant part which is capable of regeneration,</seg-clauses>
<seg-clauses>b. cultivating the same to a stage in which a cultivated shoot is obtained that comprises a fork from which an orthotropic shoot and at least two plagiotropic branches have developed,</seg-clauses>
<seg-clauses>c. pruning the cultivated shoot at said fork by removing at least the orthotropic shoot and maintaining at least one plagiotropic branch to obtain a pruned shoot,</seg-clauses>
<seg-clauses>d. cultivating the pruned shoot until flowers form on the at least one plagiotropic branch to obtain a flowered shoot</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1, characterized in that </seg-main><seg-clauses>the cultivated shoot obtained in step b. and pruned in step c. comprises only one fork and/or is characterized in that the fork recited in step b. and used for pruning in step c. is the first fork that has developed in the cultivated shoot.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Method according to claim 1 or 2, characterized in that </seg-main><seg-clauses>the cultivating in step d. further comprises continually removing any newly formed orthotropic shoots.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Method according to any one of the preceding claims, characterized in that </seg-main><seg-clauses>subsequently to step d., it comprises a step e. of bud formation which occur 250 days after, preferably 220 days after cutting for further rooting.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Method according to any one of the preceding claims, characterized in that </seg-main><seg-clauses>subsequen","A01G7/06, A01H5/08, A01H6/76",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CA3001081C,Beverage preparation machine comprising location system,"The present disclosure provides, in an aspect, a beverage preparation machine for preparing at least one beverage from a beverage material, the machine being provided with a modem for communication with a remote resource, and being configured to send machine remote management data to said remote resource. The machine comprises location system configured for automatic geolocation of the machine, and the machine is configured to send to the remote resource location information determined by said location system, for example, to confirm or correct the location of a machine, to correct mistakes that can occur when a machine is installed or moved, or to take appropriate measures when a machine is stolen. In another aspect, a system comprising such a beverage preparation machine and a remote resource with which it is configured to communicate, and to a method for remote management of a beverage preparation machine.","13 CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A system for beverage preparation comprising: </seg-main><seg-clauses><seg-main>- a beverage preparation machine said machine comprising: </seg-main><seg-clauses>- a communication interface for communication with a remote resource, and </seg-clauses><seg-clauses>- a location system configured for automatic geolocation of the machine, and configured to transmit to the remote resource, via the communication interface, location information determined by said location system, and </seg-clauses><seg-clauses>- a remote resourceto which said machine is configured to send location information, wherein the remote resource hosts a database comprising a human entered location of the machine; </seg-clauses><seg-clauses>- wherein the system is configured for comparing the location of the machine from the database and a location determined by the location system. </seg-clauses></seg-clauses></div><div class=""indep-clm"" num=""2""><seg-main>2. A system according to Claim 1 whereinthe communicationinterface of the beverage preparation machine comprises </seg-main><seg-clauses>a wireless modem configured to communicate over a cellular network, the location system being configured to provide location information based on multilateration in the cellular network. </seg-clauses></div><div class=""indep-clm"" num=""3""><seg-main>3. A system according to Claim1 whereinthe location system of the beveragepreparation machine comprise </seg-main><seg-clauses>a satellite-based positioning system. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A system according to claim 3, wherein </seg-main><seg-clauses>the location system of the beverage preparation machine comprise a Global Positioning System. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1"">5. The system according to claim 1, configured so that, if a discrepancy between the location of the machine from the database and a location determined by the location ",A47J31/52,20251021,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2843875C1,Triglyceride ingredient containing synthetic tags and the method of its preparation,"FIELD: chemistry.SUBSTANCE: group of inventions relate to fat-and-oil industry. triglyceride ingredient containing synthetic tag with 70% or more of palmitic acid esterified in sn-2 position, and containing triglycerides OPO 18:1–16:0–18:1 and OPL 18:1–16:0–18:2, wherein the ratio of triglycerides OPO and OPL is in range of 1:0.3 to 1:1.5, which also contains OPM 18:1–16:0–14:0 and further comprises at least one triglyceride selected from the group consisting of: PPO 16:0–16:0–18:1, SPO 18:0–16:0-18:1, LaPO 12:0–16:0–18:1, OPPa 16:1–16:0–18:1, LPP 16:0–16:0–18:2, LPL 18:2–16:0–18:2 and LPPa 16:1–16:0–18:2, wherein the ratio between OPO and each of such triglycerides, if any, is in range of 1:0.2 to 1:0.6 for PPO, from 1:0.05 to 1:0.5 for LaPO, from 1:0.05 to 1:0.5 for SPO, from 1:0.05 to 1:0.3 for OPM, from 1:0.05 to 1:0.3 for OPPa, from 1:0.05 to 1:0.4 for LPP, from 1:0 to 1:0.5 for LPL and from 1:0 to 1:0.5 for LPPa. Method for producing a triglyceride ingredient comprising synthetic TAG with palmitic acid content in sn-2 position, equal to or greater than 70% of total content of palmitines, and having a specialized triglyceride profile having a palmitic acid residue at position sn-2, comprising steps of: a) subjecting tripalmitin and/or triglycerides rich in palmitic acid in sn-2 position to an alcoholysis step carried out in the presence of immobilized lipase and a primary or secondary alcohol with chain length C3-C5, to obtain a mixture of products containing 2-monopalmitin, wherein step a) is performed at temperature ranging from 40 °C to 70 °C; b) purifying 2-monopalmitin-containing mixture obtained in step a) through a fractionation process by selective crystallisation of 2-monopalmitin and subsequent removal of the remaining liquid fraction (supernatant); c) subjecting the mixture obtained in step b), to an esterification step in the presence of a mixture of fatty acids selected to ensure the formation of a specialized triglyceride profile, and immobilized lipase, wherein steps a), b) and c) are carried out without a solvent.EFFECT: invention allows to produce a lipid fraction for an infant formula that most closely reflects the profile of triglycerides of human breast milk bearing a palmitic acid residue in sn-2 position.11 cl, 5 dwg, 4 tbl, 6 ex","1. Триглицеридный ингредиент, содержащий синтетические TAG с 70% или более пальмитиновой кислоты, эстерифицированной в положении sn-2, и содержащий триглицериды OPO 18 : 1 - 16 : 0 - 18 : 1 и OPL 18 : 1 - 16 : 0 - 18 : 2, причем соотношение между триглицеридами OPO и OPL находится в диапазоне от 1 : 0,3 до 1 : 1,5, который также содержит OPM 18:1-16:0-14:0 и также дополнительно содержит по меньшей мере один триглицерид, выбранный из группы, состоящей из: PPO 16 : 0 - 16 : 0 - 18 : 1, SPO 18 : 0 - 16 : 0 - 18 : 1, LaPO 12 : 0 - 16 : 0 - 18 : 1, OPPa 16 : 1 - 16 : 0 - 18 : 1, LPP 16 : 0 - 16 : 0 - 18 : 2, LPL 18 : 2 - 16 : 0 - 18 : 2 и LPPa 16 : 1 - 16 : 0 - 18 : 2, причем соотношение между OPO и каждым из таких триглицеридов при их наличии находится в диапазоне от 1 : 0,2 до 1 : 0,6 для PPO, от 1 : 0,05 до 1 : 0,5 для LaPO, от 1 : 0,05 до 1 : 0,5 для SPO, от 1 : 0,05 до 1 : 0,3 для OPM, от 1 : 0,05 до 1 : 0,3 для OPPa, от 1 : 0,05 до 1 : 0,4 для LPP, от 1 : 0 до 1 : 0,5 для LPL и от 1 : 0 до 1 : 0,5 для LPPa.
2. Триглицеридный ингредиент по п. 1, который содержит триглицериды PPO 16 : 0 - 16 : 0 - 18 : 1, SPO 18 : 0 - 16 : 0 - 18 : 1 и LaPO 12 : 0 - 16 : 0 - 18 : 1, OPM 18 : 1 - 16 : 0 - 14 : 0, OPPa 16 : 1 - 16 : 0 - 18 : 1, LPP 16 : 0 - 16 : 0 - 18 : 2, LPL 18 : 2 - 16 : 0 - 18 : 2 и LPPa 16 : 1 - 16 : 0 - 18 : 2.
3. Триглицеридный ингредиент по п. 1 или 2, который содержит количество OPO в диапазоне от 20 до 25% от общего количества триглицеридов в ингредиенте, количество OPL в диапазоне от 10 до 25%, количество OPP в диапазоне от 7 до 15%, количество OPS в диапазоне от 1 до 5%, количество OPLa в диапазоне от 1 до 5%, количество OPM в диапазоне от 1% до 5%, количество OPPa в диапазоне от 1 до 5% и количество LPP в диапазоне от 0,5 до 7%, количество LPL в диапазоне от 2 до 7% и количество LPPa в диапазоне от 0 до 5%.
4. Способ получения триглицеридного ингредиента, содержащего синтетические TAG по любому из пп. 1-3 с содержанием пальмитиновой кислоты в положении sn",A23D9/04,20250721,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250128465A1,Method for manufacturing a PHA container,"The invention relates to a method for manufacturing a plastic container, the method comprising the following steps: o providing an injected preform, o heating the preform (S<b>2</b>), and o performing stretch blow molding (S<b>3</b>) of the preform, thereby forming the container. The preform is made of a material comprising 40 to 99.9 weight percent of Polyhydroxyalkanoate (PHA). In the heating step, the preform is brought to a temperature comprised in a range between 1° C. and 20° C. under the melting temperature of the PHA. The present invention thus makes it possible to perform ISBM of Polyhydroxyalkanoate to produce a plastic container.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for manufacturing a plastic container,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing an injected preform,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the preform, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>performing stretch blow molding of the preform, thereby forming the container wherein,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the preform is made of a material comprising 40 to 99.9 weight percent of Polyhydroxyalkanoate (PHA),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and in the heating step, the preform is brought to a temperature of between 1° C. and 20° C. under the melting temperature of the PHA.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the PHA has random monomeric repeating units having of the formula:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/01/28/46/5/1745481038767/US20250128465A1-C00003.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064340%3B1765067940%26q-key-time%3D1765064340%3B1765067940%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D8317ab4253c4cdefab276f7e630e76bc057e52bb&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A00%20GMT"" class=""img-anchor"" img-id=""US20250128465A1-C00003"" image_type=""chemistry"" official_size=""1402""></seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>wherein R<sup>1 </sup>is selected from the group consisting of CH3 and a C3 to C19 alkyl group.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. A method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><s","B29C49/00, B29C49/12, B29C49/18, B29C49/64, B29K67/00",20250424,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250280859A1,Method of making a seafood analogue,,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a seafood analogue, said method comprising</seg-main>
<seg-clauses><seg-main>a. Preparing a dough by</seg-main>
<seg-clauses>i. mixing konjac glucomannan, cell wall fiber, and seaweed, in water, wherein the seaweed is whole seaweed or seaweed water extract;</seg-clauses>
<seg-clauses>ii. Adjusting the pH of the dough by adding alkaline solution while mixing;</seg-clauses></seg-clauses>
<seg-clauses><seg-main>b. Preparing gel pieces by</seg-main>
<seg-clauses>i. Dividing the dough from step a) into portions and heating one portion to a temperature of between 80° C. to 100° C. to form a gel; or preparing a dough according to step a) and heating it to a temperature of between 80° C. to 100° C. to form a gel;</seg-clauses>
<seg-clauses>ii. Cooling the gel and mechanically disrupting to form gel pieces;</seg-clauses></seg-clauses>
<seg-clauses>c. Mixing the gel pieces with the dough prepared in step a) or a portion of dough from step b i.) to produce a mixture;</seg-clauses>
<seg-clauses>d. Shaping the mixture from step c); and</seg-clauses>
<seg-clauses>e. Heating.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the cell wall fiber is a pea inner cell wall fiber.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the cell wall fiber is present at a concentration of about 6 wt % in the dough.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>3 to 10 wt % of a protein source.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>between 3 to 6 wt % pea starch and between 2 to 5 wt % tapioca starch is mixed in step a).</seg-clauses></div>
<div class=""dep-clm"" num=""6"" p","A23L17/00, A23J3/14, A23J3/22, A23L17/60, A23L29/212",20250911,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024238731A1,Compostable top lid structure for a beverage preparation capsule,"The invention concerns a capsule (100) for the preparation of a beverage, comprising: - a capsule body (200) comprising a sidewall (210) delimiting a chamber (250) containing a beverage ingredient (500), and a rim portion (211) delimiting an opening (230) in the sidewall (210); - an injection wall (220) for injecting a fluid in the chamber for preparing the beverage upon interaction of the fluid with the beverage ingredient; and - a delivery wall (300) being connected to the capsule body to close the chamber, the delivery wall being made of biodegradable materials and comprising in a layered manner: o a carrier layer (320) adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule, and o a filter layer (310) provided opposite to the chamber (250) with respect to the carrier layer (320); and o a bonding layer (360) at least partially joining the filter layer (310) and the carrier layer (320) to each other on opposite sides thereof; According to the invention, the delivery wall (300) comprises a workup to break which is: - comprised between 50 and 90 N.mm in wet conditions, wet conditions being defined according to the tensile test following ASTM D882 after sample wetting in gauge length with 1.25 ml of water at room temperature; and - at least 20% lower in wet conditions than in dry conditions, dry conditions being defined according to the standard test following ASTM D882. Preferably, the capsule is fully biodegradable and compostable, and the capsule body is made of cellulose-based pulp-molded material, preferably made of wood pulp.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule (100) for the preparation of a beverage in a beverage machine</seg-con><seg-trans>, </seg-trans><seg-comp>comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>- a capsule body (200) with a three-dimension shape comprising </seg-comp><seg-comp>a sidewall (210) delimiting a chamber (250) for containing a beverage/foodstuff ingredient (500), and a rim portion (211) delimiting an opening (230) in the sidewall (210);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>- an injection wall (220) for injecting a fluid in the chamber (250) for preparing the beverage upon interaction of the fluid with the beverage ingredient (500); and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>- a delivery wall (300) being connected to the capsule body (200) to close the chamber (250), the delivery wall (300) being made of biodegradable materials and comprising in a layered manner:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>o a carrier layer (320) adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>o a filter layer (310) for filtering out particles from the prepared beverage dispensed via the delivery wall, the filter layer (310) being provided opposite to the chamber (250) with respect to the carrier layer (320); and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>o a bonding layer (360) at least partially joining the filter layer (310) and the carrier layer (320) to each other on opposite sides thereof, preferably through adhesive bonding or heat-sealing and provided between the carrier layer (320) and the filter layer (310);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the delivery wall (300) comprises a workup to break which is:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>- comprised between 50 and 90 N.mm in wet conditions, wet",B65D85/804,20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020246928B2,Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs,"A method increases production of ketones derived from oral consumption of medium chain triglycerides (MCT) by an individual. The method includes orally administering to the individual a composition containing the MCTs and then subsequently orally administering to the individual a meal at least about ten minutes after the oral administration of the composition containing the MCTs and within about one hour of the oral administration of the composition containing the MCTs. For example, the meal can be administered about thirty minutes after the administration of the composition containing the MCTs. The ketone production is increased relative to ketone production from oral administration of the MCTs and the meal at approximately the same time. The meal can be breakfast. The composition containing the MCTs can be a liquid oral nutritional supplement (ONS) providing incomplete nutrition.","<div class=""indep-clm"" num=""1""><seg-con>1.     A method of increasing production of ketones derived from oral</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>consumption of medium chain triglycerides (MCT) by an individual, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>orally administering to the individual a composition comprising the MCTs; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>subsequently orally administering to the individual a meal after the oral administration of the composition comprising the MCTs and within about one hour of the oral administration of the composition comprising the MCTs;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the composition is administered to the individual in a serving comprising at least about 15.0 g of the MCTs up to about 30.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual is elderly.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method of claim 1 or 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising the MCTs is a liquid.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The method of any one of claims 1 to 3 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the meal is administered between about ten minutes after the administration of the composition comprising the MCTs and about one hour after the administration of the composition comprising the MCTs.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The method of any one of claims 1 to 4 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the meal is administered betw","A61K31/23, A61P3/04, A61P3/10, A61P21/00, A61P25/00",20250515,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN119112913A,Composition for reducing pain and/or feeling of pain in infants and young children,"The present invention relates to a composition comprising a mixture of human milk oligosaccharides consisting of 2 '-fucosyllactose and difucosyllactose for use in reducing pain and/or pain in infants or young children. The composition is particularly effective in restoring the sensitivity of the bi-directional pain transmission pathway in the braingut axis to a normal level. The composition is particularly useful for reducing abdominal pain, such as pain associated with gastrointestinal discomfort, functional gastrointestinal disorders and/or gastrointestinal diseases, and thus also helps to reduce crying and improve sleep quality, overall quality of life, mood, paddling, personality and/or happiness in the infants and young children.","<div class=""indep-clm"" num=""1"">1.营养组合物，所述营养组合物包含人乳低聚糖混合物，所述人乳低聚糖混合物由2'-岩藻糖基乳糖(2'-FL)和二岩藻糖基乳糖(DiFL)组成，所述营养组合物用于减少12个月以下婴儿或一至三岁以下幼儿的疼痛和/或疼痛感的方法中。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用于所述用途的营养组合物，其中所述用途为用于减少婴儿或幼儿的腹痛和/或内脏敏感性。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的用于所述用途的营养组合物，其中所述用途为将脑肠轴中双向疼痛传输途径的敏感性恢复到正常水平。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中所述用途为用于减少与胃肠不适和/或与功能性肠胃障碍和/或与胃肠疾病相关的疼痛。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中所述婴儿或所述幼儿经历疼痛。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的用于所述用途的营养组合物，其中所述婴儿或所述幼儿经历腹痛。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的用于所述用途的营养组合物，其中所述婴儿或所述幼儿经历与胃肠不适和/或功能性肠胃障碍和/或胃肠疾病相关的疼痛。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的用于所述用途的营养组合物，其中胃肠不适选自绞痛、胃气胀和/或痛性痉挛，功能性肠胃障碍选自功能性消化不良、功能性便秘、功能性腹泻、肠易激综合征(IBS)、腹型偏头痛和/或再发性腹痛(RAP)、非特异性功能性腹痛(FAP-NOS)，并且胃肠疾病选自炎性肠病(IBD)、感染性腹泻和/或坏死性小肠结肠炎(NEC)。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中2'-FL和DiFL以5:1至14:1，诸如5:1至12:1、5:1至10:1、6:1至10:1或7:1至9:1的2'-FL:DiFL重量比存在。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中所述人乳低聚糖混合物相对于所述组合物以0.15g/L至15g/L，诸如相对于所述组合物以0.5g/L至10g/L、0.75g/L至7.5g/L、1g/L至5g/L或1g/L至2g/L的量存在。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中以干重计，所述人乳低聚糖混合物相对于组合物以0.11g/100g至11g/100g，诸如以干重计，相对于组合物以0.4g/100g至7.5g/100g、0.6g/L至6g/L、0.8g/100g至3.8g/100g或0.8g/100g至1.5g/100g的量存在。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的用于所述用途的营养组合物，其中所述HMO混合物以一定量提供于本发明的所述营养组合物中，使得所述营养组合物的正常食用为食用其的所述婴儿或幼儿提供0.1g/天至10g/天，诸如0.2g/天至9g/天、0.3g/天至8g/天、0.4g/天至7g/天、0.5g/天至6g/天、0.6g/天至5g/天、0.8g/天至3g/天、0.9g/天至2g/天或1g/天至1.5g/天的总日剂量。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据前述权利要求中任一项所述的用于所述用途的营养组合物，所述营养组合物包含选自包含以下项的列表的至少另一种低聚糖和/或其纤维和/或其前体：低聚半","A61K31/7016, A23C9/152, A23L33/125, A61P25/00, A61P29/00",20241213,雀巢产品有限公司,['Pending']
US20240423232A1,A chocolate product comprising a milk analogue product,The present invention relates to chocolate compositions comprising plant-based milk alternatives.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a chocolate product, said method comprising</seg-main>
<seg-clauses>a. Mixing a plant flour and water;</seg-clauses>
<seg-clauses>b. An enzyme treatment step, wherein the plant flour is treated with an amylase and preferably at least one further enzyme;</seg-clauses>
<seg-clauses>c. An enzyme deactivation step;</seg-clauses>
<seg-clauses>d. Adding plant protein to the enzyme treated plant flour aqueous solution to form a plant protein mixture, preferably having a pH of between 6 and 9;</seg-clauses>
<seg-clauses>e. Homogenizing the plant protein mixture;</seg-clauses>
<seg-clauses>f. Applying a thermal treatment to form a plant-based liquid;</seg-clauses>
<seg-clauses>g. Drying the plant-based liquid to form a plant-based composition; and</seg-clauses>
<seg-clauses>h. Combining the dry composition with other ingredients to form a chocolate product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the total enzyme used is added at between 0.01wt % and </seg-clauses><seg-clauses>2.0wt % of the plant flour.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the plant flour is selected from the group consisting of a cereal flour, a seed flour, a nut flour and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein is derived from a legume source.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1 wherein </seg-main><seg-clauses>the plant protein is a concentrate or an isolate.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the weight ratio between the plant flour and the plant ","A23G1/48, A23G1/38, A23G1/44, A23L7/104",20241226,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12433316B2,Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI),,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating exocrine pancreatic insufficiency (EPI), the method comprising </seg-main><seg-clauses><seg-main>administering to an individual in need thereof an effective amount of a nutritional composition having </seg-main><seg-clauses>(1) a total protein consisting essentially of hydrolyzed protein and </seg-clauses><seg-clauses>(2) a total fat comprising monoacylglycerols (MAG) that are at least about 30 wt % of the total fat, the total fat optionally further comprising medium chain triglycerides (MCT) and/or fatty acids, wherein the nutritional composition has an energy density of 1.0-2.0 kcal/ml.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, the method comprising </seg-main><seg-clauses><seg-main>administering to the individual the nutritional composition having at least one characteristic selected from the group consisting of:</seg-main>
<seg-clauses>(i) an energy density of 1.0-1.5 kcal/ml;</seg-clauses>
<seg-clauses>(ii) the total fat that is about 10 to about 90 energy % of the nutritional composition;</seg-clauses>
<seg-clauses>(iii) an amount of medium chain triglycerides (MCT) that is about 1.0 wt % to about 10.0 wt % of the nutritional composition;</seg-clauses>
<seg-clauses>(iv) the MAG that are about 0.1 wt % to about 10.0 wt % of the nutritional composition;</seg-clauses>
<seg-clauses>(v) the total protein that is about 5 to about 50 energy % of the nutritional composition;</seg-clauses>
<seg-clauses>(vi) a total carbohydrates that is about 5 to about 85 energy % of the nutritional composition; and</seg-clauses>
<seg-clauses>(vii) the total carbohydrates that consist essentially of one or more of maltodextrin, maltose, maltotriose, sucrose, fructose, lactose, galactose, and high-maltose corn syrup, and optionally comprise slowly digested carbohydrates.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3","A23L33/12, A23L33/00, A23L33/125, A23L33/17, A61K9/00",20251007,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120112295A,Human milk oligosaccharides for improving gut microbiome and methods for determining state of maturation of gut,"The present invention provides methods for inducing the enteric microbiome trajectory of a formula-fed infant to converge with a reference enteric microbiome trajectory obtained from a human milk-fed infant, comprising administering to the formula-fed infant an effective amount of a mixture of human milk oligosaccharides (HMOs). The invention also provides methods for determining the gut maturity status of a formula-fed infant comprising providing a reference gut microbiome trajectory obtained from a human milk-fed infant.","<div class=""indep-clm"" num=""1""><seg-con>1.人乳低聚糖(HMO)的混合物，其用于诱导配方奶粉喂养的婴儿的肠道微生物组轨迹与从人乳喂养的婴儿获得的参考肠道微生物组轨迹趋同，其中所述HMO的混合物包含以下或由以下</seg-con><seg-trans>组成：</seg-trans><seg-refi>2'-岩藻糖基乳糖(2'FL)、2',3-二岩藻糖基乳糖(diFL)、乳-N-四糖(LNT)、3'-唾液酸乳糖(3'-SL)和6'-唾液酸乳糖(6'-SL)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述使用的HMO的混合物，其中基于HMO的总重量，所述HMO的混合物包含以下或由以下</seg-con><seg-trans>组成：</seg-trans><seg-refi>(i)约55重量％至约60重量％的量的2'FL；(ii)约5重量％至约7重量％的量的diFL；(iii)约18重量％至约20重量％的量的LNT；(iv)约6重量％至约8重量％的量的3'-SL；以及(v)约9重量％至约11重量％的量的6'-SL。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述使用的HMO的混合物，其中所述HMO的混合物以婴儿配方奶粉的形式施用，任选地其中所述HMO的混合物以初生婴儿配方奶粉、较大婴儿配方奶粉和/或成长乳的形式施用。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述使用的HMO的混合物，其中所述HMO的混合物以以下形式施用：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(a)初生婴儿配方奶粉，其包含约0.5g/L至约5.0g/L、约1.0g/L至约3.0g/L或约1.5g/L至约2.5g/L的HMO的总量，任选地其中所述初生婴儿配方奶粉包含：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(i)约0.5g/L至约3.0g/L、优选约0.70g/L至约1.05g/L或约1.16g/L至约1.74g/L的量的2'FL；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(ii)约0.05g/L至约0.3g/L、优选约0.05g/L至约0.11g/L或约0.12g/L至约0.18g/L的量的diFL；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(iii)约0.1g/L至约1.0g/L、优选约0.23g/L至约0.36g/L或约0.39g/L至约0.58g/L的量的LNT；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(iv)约0.05g/L至约0.3g/L、优选约0.09g/L至约0.13g/L或约0.14g/L至约0.21g/L的量的3'-SL；以及</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(v)约0.05g/L至约0.5g/L、优选约0.12g/L至约0.17g/L或约0.19g/L至约0.28g/L的量的6'-SL；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(b)较大婴儿配方奶粉，其包含约0.1g/L至约2.0g/L、约0.2g/L至约1.0g/L、约0.3g/L至约0.8g/L、约0.35g/L至约0.65g/L的HMO的总量，任选地其中所述较大婴儿配方奶粉包含：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(i)约0.19g/L至约0.34g/L量的2'FL；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(ii)约0.03g/L至约0.05g/L的量的diFL；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(iii)约0.06g/L至约0.11g/L的量的LNT；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">(iv)约0.04g/L至约0.09g/L的量的3'-SL；以及</div>
<div clas","A61K31/702, A61P1/00, C12Q1/689, G16H50/30, A23L33/125",20250606,雀巢产品有限公司,['Pending']
US12290200B2,Code and container of system for preparing a beverage or foodstuff,,"<div class=""indep-clm"" num=""1""><seg-con>1. A container for a foodstuff or beverage preparation machine, the container </seg-con><seg-trans>containing </seg-trans><seg-refi>beverage or foodstuff material and comprising a plurality of codes, each code encoding preparation information for a foodstuff or beverage preparation process by the foodstuff or beverage preparation machine, the plurality of codes is formed in a grid with adjacent columns aligned or with adjacent columns offset, each code comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a reference portion and a data portion, and each code has a peripheral length of 600-1600 μm, wherein a ratio of the peripheral length of the code to a diameter of the container is 0.006 to 0.08:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the reference portion comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>three reference units uniquely defining a reference point; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a reference line extending from the reference point,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the reference portion arranged within a circular encoding area; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the data portion comprising a data unit arranged on a virtual line, the virtual line extending from the reference point and arranged at an angle α to the reference line, the data unit arranged a distance from the reference point, and the distance encoding a parameter of the preparation information;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the plurality of codes is formed in a tessellating pattern.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the data unit is arranged at any continuous distance from the reference point.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The conta","A47J31/44, B65D85/804, G06K19/06",20250506,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025093519A1,Multilayer metallized paper-based packaging material,"The present invention relates to a multi-layer paper-based packaging material (1) with a metallic appearance comprising, from its inner side to its outer side: a paper layer (2) having a grammage in the range of 30 to 120 g/m2; at least one inorganic barrier layer (3) selected within the list of: metals, metalloids, or a combination thereof, said inorganic layer having a thickness comprised between 1 and 100 nm; and an ink layer (4), wherein at least a portion of the ink layer is transparent or translucent.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A multi-layer paper-based packaging material </seg-main><seg-clauses>(1) with a metallic appearance comprising, from its inner side to its outer side: a paper layer (2) having a grammage in the range of 30 to 120 g/m<sup>2</sup>; at least one inorganic barrier layer (3) selected within the list of: metals, metalloids, or a combination thereof, said inorganic layer having a thickness comprised between 1 and 100 nm; and an ink layer (4), wherein at least a portion of the ink layer is transparent or translucent.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The multi-layer paper-based packaging material according to claim 1, further comprising </seg-main><seg-clauses>a paperboard on the inner side of the paper layer.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The multi-layer paper-based packaging material according to claim 1 or claim 2, further comprising </seg-main><seg-clauses>at least one organic barrier layer (5) located between the paper layer and the at least one inorganic barrier layer, the at least one organic barrier layer comprising a polymer selected within the list of: polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, in an amount of 0.5 to 20 g/m<sup>2</sup>, preferably in an amount of 1 to 10 g/m<sup>2</sup>, more preferably in an amount of 2 to 8 g/m<sup>2</sup>.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The multi-layer paper-based packaging material according to any one of the preceding claims, further comprising </seg-main><seg-clauses>at least one organic heat seal layer (6) located between the at least one inorganic barrier layer and the ink layer, said heat seal layer in an amount comprised between 2 and 20 g/m<sup>2</sup>, preferably in an amount comprised between 4 and 9 g/m<sup>2</sup>.</seg-clauses></div>
<div class=""dep-clm"" n","D21H19/02, B65D65/42, D21H19/08, D21H19/82, D21H21/26",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025228942A1,Edible chew having a high content of amylose for oral use by infants and young children,"The present invention relates to an article, also referred to as an edible chew, which has a high amylose content and can be applied to oral use by infants and young children especially during teething and/or for soothing, as well as to a method of manufacture of this edible chew.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An article comprising </seg-main><seg-clauses>at least one cereal flour having an amylose content of more than 30 wt.%, relative to the total starch content of the cereal flour.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The article according to claim 1, comprising </seg-main><seg-clauses>at least 40 wt.-%, still more preferably at least 50 wt.-%, at least 55 wt.-%, at least 60 wt.-%, at least 65 wt.-%, at least 70 wt.-%, of amylose as a proportion by weight of the total starch content of the cereal flour.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The article according to claim 1 or 2, wherein </seg-main><seg-clauses>the article comprises one or more types of cereal flour.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The article according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the cereal flour is selected from rice flour, wheat flour, corn flour, barley flour, sorghum flour, and millet flour, wherein the cereal flour is preferably wheat flour.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The article according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the cereal flour is present in an amount of 40 to 90 wt.-%, more preferably 45 to 80 wt.-%, even more preferably 45 to 70 wt.-% based on the total weight of the article.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The article according to any one of claims 1 to 5, further comprises </seg-main><seg-clauses>milk powder.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The article according to any one of claims 1 to 6, further comprises </seg-main><seg-clauses>1 to 15 wt.-%, 1 to 10 wt.-%, preferably 1 to 7 wt.-% milk powder.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-main>8. The article according to an","A21D13/06, A21D13/40, A21D13/48, A23L33/00, A23P30/10",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12290207B2,Handy large processing jug,"A machine (<b>1</b>) comprises a tank (<b>10</b>) having a cavity (<b>10</b>′) for containing and processing a liquid food substance, such as milk or a milk-based substance. A stirring tool (<b>15</b>) is provided in the cavity (<b>10</b>) for imparting a mechanical effect on the food substance. A base (<b>20</b>) supports the tank (<b>10</b>). The base (<b>20</b>) has an upright outside gripping surface (<b>21</b>) located under the tank (<b>10</b>) and seizable by an adult human hand such that the base (<b>20</b>) with the supported tank (<b>10</b>) can be carried and displaced single-handed by seizure of the upright outside gripping surface (<b>21</b>). The tank (<b>10</b>) extends horizontally beyond the gripping surface (<b>21</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a tank having a cavity for containing and processing a liquid food,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a stirring tool in the cavity for imparting a mechanical effect on a food substance in the cavity, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a base supporting the tank, the base having an upright outside gripping surface located under the tank and seizable by an adult human hand such that the base with the tank can be carried and displaced single-handed by seizure of the upright outside gripping surface,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the tank extends horizontally beyond the upright outside gripping surface;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the tank has an outer horizontal tank perimeter and wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the tank extends horizontally beyond the upright outside gripping surface over a predominant part of the outer horizontal tank perimeter; and/or</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the outer horizontal tank perimeter has a circumference in the range of 15 to 70 cm; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the tank has an outer tank surface, the cavity has a cavity height, the outer horizontal tank perimeter extending along the outer tank surface, the outer tank surface being located horizontally beyond the upright outside gripping surface over the outer horizontal tank perimeter over the cavity height; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein an outside housing forms the upright outside gripping surface, the outside housing extending upright along at least part of the outer tank surface, the outside housing comprising a substantially horizontal and/or inclined intermediate portion extending","A47J43/046, A47J43/07",20250506,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023369903A1,Multilayer metallized paper-based packaging material,"The present invention is directed to a multi-layer metallized paper-based packaging material (1) comprising, from its outer side to its inner side: - a paper layer (2) having a grammage in the range of 30 to 120 g/m",,"D21H19/02, D21H19/20, D21H19/22, D21H19/24, D21H19/82",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12258253B2,System for introducing an additive into a container comprising a static microdoser,"The invention relates to a system for introducing an additive into a container (<b>2</b>). The system comprises an automated device for transporting the container (<b>2</b>) in a horizontal plane (P), such as a rotary wheel. The system further comprises a static microdoser (<b>5</b>) having a nozzle from which a jet (<b>7</b>) of an additive issues upon passage of an opening of the container (<b>2</b>). Additive is so injected into said container (<b>2</b>). According to the invention, the nozzle of the static microdoser (<b>5</b>) is inclined relative to a direction orthogonal to said horizontal plane (P). This limits splashing, in particular when the jet (<b>7</b>) of additive hits an inner wall of the container (<b>2</b>) that is free of liquid. This can be facilitated by an acceleration applied on the container (<b>2</b>) which inclines the free surface (<b>8</b>) of the liquid material present in the container (<b>2</b>). A preferred application is the introduction of a flavored concentrate into a bottle of water.","<div class=""indep-clm"" num=""1""><seg-con>1. A system for introducing an additive into a container, the system </seg-con><seg-trans>comprising </seg-trans><seg-refi>an automated device for transporting the container along a trajectory in a horizontal plane, the system further comprising a static microdoser having a nozzle from which a jet of the additive issues upon passage of an opening of the container in proximity to the nozzle to introduce the additive into said container, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the nozzle of the static microdoser is inclined relative to a direction orthogonal to said horizontal plane, wherein the nozzle of the static microdoser is inclined such that the jet of the additive enters into the container through the opening and hits a lateral inner wall of said container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the container is partially filled with a main liquid material before introduction of the additive, and wherein the lateral inner wall hit by the jet of the additive is situated above a free surface of the main liquid material.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the automated device for transporting the container comprises a conveyor configured to transport the container along a linear or curved trajectory.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The system according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lateral inner wall of the container has a rounded or cylindrical shape, the container having a central axis, wherein the static microdoser is positioned such that the jet of the additive crosses the opening of the container at a distance from the central axis of the container.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The system according to claim 1, </seg-con><seg-trans>wherein </se","B67C3/20, B65B3/12",20250325,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025181070A1,Ambient storage acidic dairy products or plant based analogues thereof or synthetic analogues thereof with carbohydrates DP3+ and processes of production,The invention relates to ambient storage acidic dairy products or plant-based analogues thereof with live lactic acid bacteria and with carbohydrates DP3+. The ambient storage acidic dairy products may be fermented or acidified. The invention also relates to processed for producing such ambient storage acidic dairy products or plant-based analogues thereof.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Process for producing an ambient storage acidic dairy product or plant-based analogue thereof or synthetic analogue thereof with live lactic acid bacteria, wherein </seg-main><seg-clauses><seg-main>the ambient storage acidic dairy product or plant-based analogue thereof or synthetic analogue thereof is fermented, and wherein said process comprises the steps of: </seg-main><seg-clauses>a) providing a milk base or the plant-based milk analogue base or synthetic milk analogue base comprising metabolizable carbohydrates having a degree of polymerization of DPI and/or DP2, </seg-clauses><seg-clauses>b) inoculating said milk base or said plant-based milk analogue base or said synthetic milk analogue basewith a first culture comprising one or more lactic acid bacteria and/or yeast strains capable of metabolizing said metabolizable carbohydrate having a degree of polymerization DPI and/or DP2 to obtain an inoculated milk base or an inoculated plant-based milk analogue base or an inoculated synthetic milk analogue base, </seg-clauses><seg-clauses>c) fermenting the inoculated milk base or the inoculated plant-based milk analogue base with said first culture until reaching a pH of 4.7 or less to obtain a fermented dairy product or plant-based analogue thereof or synthetic analogue thereof, wherein the fermented dairy product or plant-based analogue thereof or synthetic analogue thereof comprises less than 5.0wt.% metabolizable carbohydrates having a degree of polymerization of DPI to DP2, </seg-clauses><seg-clauses>d) adding in the fermented dairy product or plant-based analogue thereof or synthetic analogue thereof a carbohydrate DP3+ ingredient comprising carbohydrates having a degree of polymerization of DP3 and/or greater (DP3+) to form a fermented dairy product or plant-based analogue thereof or synthetic analogue thereof with carbohydrates DP3+, </seg-clauses><seg-clauses>e) treating the fermented dairy product or plant-","A23C9/123, A23C9/152, A23C9/154",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12234046B2,Methods of making and transporting frozen food compositions and re-using components utilized therein,"A method of transporting one or more frozen food compositions can include providing a first container; dispensing at least one comestible ingredient into the first container, the dispensing of the at least one comestible ingredient into the first container is performed at a first location; positioning a first lid on the first container containing the at least one comestible ingredient; freezing the first container with the first lid thereon and the at least one comestible ingredient therein to form a first frozen food composition in the first container; attaching a first jacket to at least one of (a) the first container with the first frozen food composition therein or (b) the first lid on the first container with the first frozen food composition therein; and transporting the first frozen food composition to a second location by transporting the first container in the first jacket to the second location.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of transporting one or more frozen food compositions, the method comprising:</seg-main>
<seg-clauses><seg-main>providing a first container;</seg-main>
<seg-main class=""seg-enter"">dispensing at least one comestible ingredient into the first container, the dispensing of the at least one comestible ingredient into the first container is performed at a first location;</seg-main>
<seg-main class=""seg-enter"">positioning a first lid on the first container containing the at least one comestible ingredient;</seg-main>
<seg-main class=""seg-enter"">freezing the first container with the first lid thereon and the at least one comestible ingredient therein to form a first frozen food composition in the first container;</seg-main>
<seg-main class=""seg-enter"">transporting the first container with the first lid thereon and the first frozen food composition therein from the first location to an intermediate location;</seg-main>
<seg-main class=""seg-enter"">attaching a first jacket to at least one of </seg-main><seg-clauses>(a) the first container with the first frozen food composition therein or </seg-clauses><seg-clauses>(b) the first lid on the first container with the first frozen food composition therein, wherein the attaching of the first jacket is performed at the intermediate location;</seg-clauses>
<seg-clauses class=""seg-enter"">positioning the first jacket holding the first container in an insulated tote at the intermediate location;</seg-clauses>
<seg-clauses class=""seg-enter"">transporting the first frozen food composition to a second location different than the first location by transporting the insulated tote containing the first container in the first jacket from the intermediate location to the second location;</seg-clauses>
<seg-clauses class=""seg-enter"">cleaning the first container, the first lid, and the jacket after the first frozen food composition has been removed from the first container, the cleaning is performe","B65B25/00, A23G9/08, A23G9/28, A23G9/30, B65B61/26",20250225,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023355745A1,Beverage or foodstuff preparation system,"A container for use with a beverage or foodstuff preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by said machine to process the precursor material, the code readable by a code reading system of the machine, which comprises: a lighting system to project an emission to the code, and; a camera system for obtaining a digital image of the code, the code arranged to overlap the precursor material, and; a support layer to support the code, the support layer at least partially light transparent to the emission from the lighting system, wherein the code comprises reflector layer, which is configured to reflect the emission before it is transmitted to a support layer, and the precursor material is arranged to absorb the emission.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for use with a beverage or foodstuff preparation machine, the container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code for storing preparation information used by said machine to process the precursor material, the code configured to be readable by a code reading system of the machine, which comprises: a lighting system to project an emission to the code, the code arranged to overlap the precursor material such that an emission from the lighting system projects into the precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the code comprises a reflector layer, which is configured to reflect the emission,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container further comprising a support layer to support the code, the support layer being made with a material at least partially transparent to the emission from the lighting system,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the reflector layer is arranged to reflect the emission before it is transmitted to a support layer, and the precursor material is arranged to absorb the emission.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the precursor material is absorbent to at least 60% of the emission from the lighting system.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3 The container of either of claims 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the precursor material comprises ground coffee.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-con>4. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the reflector layer is configured to diffusively reflect th",B65D85/804,20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025114192A1,Nutrient deficiencies and interactions in medical conditions,"Methods and systems use a particular medication administered to a patient to identify one or more nutrient deficiencies associated with the particular medication, identify one or more drug-nutrient interactions associated with the particular medication, and/or identify one or more symptoms or side effects associated with the particular medication. Information stored in a database contains one or more of these associations and is used for the identification. The method may then provide one or more nutritional interventions and/or one or more dietary recommendations based on (i) the one or more nutrient deficiencies, (ii) the one or more drug-nutrient interactions, and/or (iii) the one or more symptoms or side effects.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>Claim 1 : A method to personalize nutrition based on a particular medication administered to a patient, the particular medication is administered to the patient to treat a medical condition in the patient, the method comprising: </seg-main><seg-clauses>storing, in a database, information about a plurality of medications, a plurality of nutrient deficiencies, and a plurality of nutritional interventions, wherein the information associates each of the plurality of medications with one or more of the nutrient deficiencies and associates each of the nutrient deficiencies with one of or more of the nutritional interventions; accepting user input identifying the particular medication administered to the patient; identifying at least one of the plurality of medications in the information stored by the database as corresponding to the particular medication administered to the patient; identifying the one or more of the nutrient deficiencies associated with the particular medication in the information stored by the database; identifying the one or more of the nutritional interventions associated with the one or more of the nutrient deficiencies associated with the particular medication in the information stored by the database; and providing, to the patient, the one or more of the nutritional interventions associated with the one or more of the nutrient deficiencies associated with the particular medication in the information stored by the database, wherein a formulation and/or amount of the one or more of the nutritional interventions provided to the patient is effective to treat the one or more nutrient deficiencies associated with the particular medication.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>Claim 2: The method of claim 1, wherein </seg-main><seg-clauses>the information stored by the database also associates one or more drug-nutrient interactions associated with each of the plurality of med",G16H20/60,20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250151744A1,Shelf-stable fermented plant-based food product packaged in a flexible container and process for producing such product,"The present invention relates to a process for preparing a packaged food product consisting of a shelf-stable plant-based fermented dairy analogue contained in a flexible container is disclosed. In particular, the shelf-stable plant-based fermented dairy analogue has a satisfactory and stable texture, including a texture suitable for consumption with a flexible container, such as flexible pouch. It also relates to resulting packaged food product consisting of a shelf-stable plant-based fermented dairy analogue contained in a flexible.","<div class=""indep-clm"" num=""1""><seg-con>1. Process for preparing a packaged food product </seg-con><seg-trans>consisting of </seg-trans><seg-refi>a shelf-stable plant-based fermented dairy analogue contained in a flexible container, wherein said process comprises the steps of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(a) providing a plant-based food composition comprising plant protein-containing ingredient, cereal flour and hydrophilic liquid, wherein the plant-based food composition comprises 2.0 to 5.5 wt % plant proteins, wherein the plant protein-containing ingredient is different from the cereal flour,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(b) heating the plant-based food composition at 55°° C. to 80° C. for 5 to 15 minutes to obtain a gelatinized plant-based food composition,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(c) homogenizing the gelatinized plant-based food composition at a pressure above 50 bar,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(d) heat treating the gelatinized plant-based food composition at a temperature from 80°° C. to 100° C. for 30 seconds to 10 minutes,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(e) inoculating the heat-treated and homogenized plant-based food composition with at least one starter culture to obtain an inoculated plant-based food composition,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(f) fermenting the inoculated plant-based food composition until reaching a pH of 3.0 to 5.0, to obtain a plant-based fermented dairy analogue,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(g) heat-treating the plant-based fermented dairy analogue at a temperature from 75° C. to 125° C. for 3 seconds to 15 minutes to obtain a shelf-stable fermented dairy analogue,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(h) hot filling the shelf-stable fermented dairy analogue into a flexible container at a temperature of 80°° ","A23C11/10, A23L2/66, A23L7/104, A23L11/50, A23L29/212",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2832646C2,Food butyrate and use thereof,"FIELD: chemistry.SUBSTANCE: present invention relates to use of a compound selected from compounds of formulas (1), (2), (3), (4):or a combination thereof as a food source of butyrate. In formulas (1), (2), (3), (4) R1, R2, R3, R4, R5 and R6 independently represent a long-chain fatty acid having from 16 to 20 carbon atoms.EFFECT: obtaining a food source of butyrate having improved organoleptic properties as compared to available solutions.15 cl, 2 dwg, 2 tbl, 5 ex","1. Применение соединения, выбранного из соединения формулы (1), (2), (3), (4):

<img src='' class=""img-anchor img-center"" img-id=""00000013""/>

или их комбинации в качестве пищевого источника бутирата,
причем R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>и R<sup>6</sup>независимо представляют собой длинноцепочечную жирную кислоту, содержащую от 16 до 20 атомов углерода.
2. Применение по п. 1, в котором используется комбинация соединения формулы (1) и соединения формулы (2), причем предпочтительно комбинация присутствует в композиции, содержащей соединение формулы (1) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов в композиции и соединение формулы (2) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов в композиции.
3. Применение по п. 1, в котором используется комбинация соединения формулы (1) и соединения формулы (2), причем предпочтительно комбинация присутствует в композиции, содержащей соединение формулы (1) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов, содержащих бутиратный остаток, в композиции и соединение формулы (2) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов, содержащих бутиратный остаток, в композиции.
4. Применение по пп. 1, 2 или 3, в котором используется комбинация соединения формулы (1), соединения формулы (2), соединения формулы (3) и соединения формулы (4).
5. Применение по пп. 1 или 2–4, в которой R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>и/или R<sup>6</sup>представляют собой ненасыщенную жирную кислоту, предпочтительно мононенасыщенную.
6. Применение по пп. 1 или 2–4, в котором R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>и/или R<sup>6</sup>выбирают из группы, состоящей из олеиновой кислоты, пальмитиновой кислоты или линолевой кислоты.
7. Применение по пп. 1 или 2–4, в котором каждая из функциональных групп R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>","A23L33/135, A61K31/22, A61K31/23, A61K31/231, A61P3/02",20241226,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US12376603B2,Apparatus for depositing,"An apparatus for depositing a food product comprising a nozzle having a pressurised chamber and a food product outlet; a valve needle movable relative between a closed position and to one of a plurality of discrete open positions; and an actuator configured to set the position of the valve needle relative to the outlet, wherein the nozzle is further able to rotate in use to change the direction of flow of a food product being deposited by the apparatus.","<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for depositing a food product, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a nozzle having a chamber for receiving a food product under a positive pressure, the chamber being provided with a food product outlet, the outlet being provided with a first sealing surface;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a valve needle comprising a second sealing surface and being movable relative to the outlet between a closed position in which the first sealing surface is proximate to the second sealing surface, and to one of a plurality of discrete open positions relative to the outlet;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an actuator configured to set the position of the valve needle relative to the outlet, the actuator operable to set the position of the valve needle to the closed position and any one of the plurality of open positions for depositing the food product; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the nozzle is further configured to rotate in use to change the direction of flow of a food product being deposited by the apparatus.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The apparatus according claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a mould cavity transporter configured in use to move one or more mould cavities relative to the rotating nozzle for depositing the food product into the one or more mould cavities.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The apparatus according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-comp>a controller, the controller configured to:</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-comp>control the actuator to set the position of the valve needle; and</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-comp>control the ",A23G1/20,20250805,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025149453A1,Uses of bifidobacterium longum transitional microorganism,Treating and/or preventing an allergy and/or allergic sensitization. The present invention relates to a Bifidobacterium longum transitional microorganism for use in treating and/or preventing an allergy and/or allergic sensitization in an infant or young child.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A Bifidobacterium longum (B. longum) transitional microorganism for use in treating and/or preventing an allergy and/or allergic sensitization in an infant or young child, wherein </seg-main><seg-clauses>the Bifidobacterium longum transitional microorganism comprises a strain deposited with Collection nationale de cultures de micro-organismes (CNCM) under deposit number CNCM I-5942 or a B. longum transitional strain having an identifying characteristic of the B. longum transitional strain deposited under deposit number CNCM I-5942</seg-clauses></div>
<div class=""indep-clm"" num=""2"">2. A B. longum transitional microorganism strain for use in treating and/or preventing an allergy and/or allergic sensitization in an infant or young child, which has an Average Nucleotide Identity (ANI) of at least 98.1% to a B. longum strain deposited with the CNCM under deposit number CNCM I-5942.</div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. A B. longum transitional strain for use according to any preceding claim wherein </seg-main><seg-clauses>the B. longum transitional strain is not resistant to any one of tetracycline, erythromycin, clindamycin and ampicillin; preferably wherein the B. longum transitional strain is not resistant to any of tetracycline, erythromycin, clindamycin, ampicillin, gentamycin, streptomycin, chloramphenicol and vancomycin.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. A B. longum transitional strain for use according to any preceding claim wherein </seg-main><seg-clauses>the B. Longum transitional strain comprises a glycosyl hydrolase family 43_17 (GH43_17) gene; suitably wherein the GH43_17 gene comprises SEQ ID NO: 7 or a sequence with at least 60% sequence identity to SEQ ID NO: 7.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The Bifidobacterium longum transitional microorganism for use according to claim 1 , wherein </seg-main><seg-cl","A61K35/745, A23L33/135, A23L33/21, A23L33/00, A61K31/70",20250717,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025229022A1,Exosomes and uses thereof,,,"C12N5/071, A61K35/20",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025012343A1,Composition and process for a water-soluble dietary fibre containing instant oil fried noodle,The present invention relates to a composition and process for the production of a water- soluble dietary fibre containing instant oil fried noodle. In particularly the invention relates to a process for the production of a water-soluble dietary fibre containing instant oil fried noodle using a pre-blend of wheat flour and water-soluble dietary fibre.,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A process for the production of an instant oil fried noodle comprising </seg-main><seg-clauses>45 to 80wt% of cereal flour by weight of the total composition, 6 to 25wt% of water-soluble dietary fibre by weight of the total composition, 0.2 to </seg-clauses><seg-clauses><seg-main>3.5wt% of Kansui salts by weight of the total composition, 0.5 to 10wt% wheat gluten by weight of the total composition and 10 to 30 wt% of oil by weight of the total composition, the process comprising the steps of: </seg-main><seg-clauses>a) Mixing 50 to 90wt% of water-soluble dietary fibre and 10 to 50wt% of cereal flour; </seg-clauses><seg-clauses>b) Hydrating and heating the mixture of step a) to a temperature between 60 to 100°C, wherein a ratio of dry fibre-flour mix to water is 1 :1 to 1 :5; </seg-clauses><seg-clauses>c) Drying the mixture of step b) at a temperature between 50 to 150°C to obtain a pre-mix; </seg-clauses><seg-clauses>d) Mixing 7.5 to 35wt% of the pre-mix from step c), cereal flour, wheat gluten and optionally other dry ingredients with the Kansui salts and water to form a dough; </seg-clauses><seg-clauses>e) Sheeting and slitting the dough to obtain noodle strands; </seg-clauses><seg-clauses>f) Steaming the noodle strands from step e) by using saturated steam within 0.5 to 15 min; </seg-clauses><seg-clauses>g) Cutting the noodle strands from step f) and optionally folding; </seg-clauses><seg-clauses>h) Pre-drying to remove moisture before frying at a temperature between 50 to 120 °C and 15 to 500 sec; </seg-clauses><seg-clauses>i) Frying the noodle strands from step h) in oil at a temperature between 110 to 170 °C and a frying time between 30 to 200 seconds; </seg-clauses><seg-clauses>j) Cooling.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A process for the production of an instant oil fried noodle as claimed in claim 1 , wherein </seg-main><seg-clauses>10 to 30wt% of the ","A23L7/109, A23L29/30, A23L33/00, A23L33/21",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12433443B2,Fluid-processing device for a beverage preparation machine,"A fluid processing device (<b>10</b>) for a beverage preparation machine is described. The fluid processing device (<b>10</b>) is configured for processing a fluid substance to be introduced into a container (C) for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container (C). The fluid processing device (<b>10</b>) comprises a fluid processing body (<b>12</b>) provided with an inlet portion (<b>14</b>). The fluid processing body (<b>12</b>) comprises in turn at least one inlet means (<b>18</b>) for introducing the fluid substance into the container (C). The inlet means (<b>18</b>) is provided at the inlet portion (<b>14</b>) of the fluid processing body (<b>12</b>). The fluid processing body (<b>12</b>) also comprises an outlet portion (<b>16</b>) and at least one outlet means (<b>20</b>) for dispensing the beverage product from the container (C). The outlet means (<b>20</b>) is provided at the outlet portion (<b>16</b>) of the fluid processing body (<b>12</b>). Preferably, the fluid processing body (<b>12</b>) is a needle-shaped fluid processing body (<b>12</b>) comprising at least one end portion (<b>26; 28</b>) configured for perforating, piercing and/or tearing a specific portion or wall of the container (C) before the introduction of the fluid substance into the container (C).","<div class=""indep-clm"" num=""1""><seg-con>1. A fluid processing device for a beverage preparation machine, the fluid processing device being configured for processing a fluid substance to be introduced into a container (C) for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container (C), the fluid processing device </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fluid processing body provided with an inlet portion, wherein the fluid processing body comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one inlet member for introducing the fluid substance into the container (C), the at least one inlet member being provided at the inlet portion;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an outlet portion;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one outlet member for dispensing the beverage product from the container (C), the at least one outlet member being provided at the outlet portion; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one sealing member to be engaged with the container (C) for preventing leakage of the fluid substance and/or the beverage product from the container (C) at least when the fluid substance is introduced into the container (C).</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Fluid processing device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fluid processing body is a needle-shaped fluid processing body, comprising at least one end portion configured for perforating, and/or piercing and/or tearing a specific portion or wall of the container (C) before the introduction of the fluid substance into the container (C).</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Fluid processing device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fluid processing body further comprises:</seg-refi></d","A47J31/40, A47J31/36",20251007,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20240409303A1,Beverage or foodstuff container and preparation system,"A container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including: a storage portion comprising a cavity with sidewall, a flange portion and a base for containing a precursor material, and a closing member to close the storage portion. At least the storage portion, is formed of wood pulp-based material, and the storage portion comprises two or more of: —a perforation region, arranged at the base of the storage portion, which is treated to facilitate comparatively easier perforation by a penetrator of the machine than a portion that is not treated; —stiffener portions, arranged to extend along the base from a periphery to contiguous the perforation region to stiffen the base to resist displacement when the base is perforated by a penetrator of the machine; and—a shoulder that extends outwardly from the flange portion to a rim of the sidewall proximal the base, to define a void defining region of the sidewall that is arranged between the shoulder and the base to increase the rigidity of the base.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container </seg-con><seg-trans>including:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a storage portion comprising a cavity with sidewall, a flange portion and a base for containing a precursor material, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein at least part the storage portion, is formed of wood pulp-based material, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the storage portion comprises two or more of the</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a perforation region, arranged at the base of the storage portion, which is treated to facilitate comparatively easier perforation by a penetrator of the machine than a portion that is not treated;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>stiffener portions, arranged to extend along the base from a periphery to contiguous the perforation region to stiffen the base to resist displacement when the base is perforated by a penetrator of the machine; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a shoulder that extends outwardly from the flange portion to a rim of the sidewall proximal the base, to define a void defining region of the sidewall that is arranged between the shoulder and the base to increase the rigidity of the base.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the shoulder is arranged to extend along the periphery of the sidewall to a region contiguous the stiffener portions.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stiffener portions compr","B65D85/804, A47J31/36, B65D65/46",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250151744A1,Shelf-stable fermented plant-based food product packaged in a flexible container and process for producing such product,"The present invention relates to a process for preparing a packaged food product consisting of a shelf-stable plant-based fermented dairy analogue contained in a flexible container is disclosed. In particular, the shelf-stable plant-based fermented dairy analogue has a satisfactory and stable texture, including a texture suitable for consumption with a flexible container, such as flexible pouch. It also relates to resulting packaged food product consisting of a shelf-stable plant-based fermented dairy analogue contained in a flexible.","<div class=""indep-clm"" num=""1""><seg-con>1. Process for preparing a packaged food product </seg-con><seg-trans>consisting of </seg-trans><seg-refi>a shelf-stable plant-based fermented dairy analogue contained in a flexible container, wherein said process comprises the steps of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(a) providing a plant-based food composition comprising plant protein-containing ingredient, cereal flour and hydrophilic liquid, wherein the plant-based food composition comprises 2.0 to 5.5 wt % plant proteins, wherein the plant protein-containing ingredient is different from the cereal flour,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(b) heating the plant-based food composition at 55°° C. to 80° C. for 5 to 15 minutes to obtain a gelatinized plant-based food composition,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(c) homogenizing the gelatinized plant-based food composition at a pressure above 50 bar,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(d) heat treating the gelatinized plant-based food composition at a temperature from 80°° C. to 100° C. for 30 seconds to 10 minutes,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(e) inoculating the heat-treated and homogenized plant-based food composition with at least one starter culture to obtain an inoculated plant-based food composition,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(f) fermenting the inoculated plant-based food composition until reaching a pH of 3.0 to 5.0, to obtain a plant-based fermented dairy analogue,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(g) heat-treating the plant-based fermented dairy analogue at a temperature from 75° C. to 125° C. for 3 seconds to 15 minutes to obtain a shelf-stable fermented dairy analogue,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(h) hot filling the shelf-stable fermented dairy analogue into a flexible container at a temperature of 80°° ","A23C11/10, A23L2/66, A23L7/104, A23L11/50, A23L29/212",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023353552A1,"Capsule, system and method for delivering a filter-like coffee extract","The invention concerns a capsule for preparing a filter-type coffee extract comprising a substantially rigid capsule body having a circumferential sidewall extending around an inner space of the capsule, a base wall covering the inner space at a first end of the sidewall, a flange arranged circumferentially at a second end of the sidewall of the base body, a lid removably attached to the flange and covering the inner space at a second end of the sidewall opposite the base wall and tightly closing the capsule, and a filter element positioned in the inner space of the capsule between the beverage ingredient and the lid in which the inner space of the capsule is at least partially filled with ground coffee, preferably roast and ground coffee, having a particle size distribution D4,3 of 500 microns +/- 30 microns and a fraction of fine particles between 2 and 9 % of the roast and ground coffee. The invention also relates to a system comprising said capsule, to the use of said capsule or system and to a method for delivering a filter-like coffee extract.","<div class=""indep-clm"" num=""1""><seg-main>1. Capsule for preparing a filter-type coffee extract comprising</seg-main>
<seg-clauses>- a substantially rigid capsule body having a circumferential sidewall extending around an inner space of the capsule,</seg-clauses>
<seg-clauses>- a base wall covering the inner space at a first end of the sidewall,</seg-clauses>
<seg-clauses>- a flange arranged circumferentially at a second end of the sidewall of the capsule body,</seg-clauses>
<seg-clauses>- a lid removably attached to the flange and covering the inner space at a second end of the sidewall opposite the base wall and tightly closing the capsule, and</seg-clauses>
<seg-clauses>- a filter element positioned in the inner space of the capsule between the beverage ingredient and the lid,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the inner space of the capsule is at least partially filled with ground coffee, preferably roast and ground coffee, having a particle size distribution D4,3 of 500 microns +/- 30 microns and a fraction of fine particles between 2 and 9 % of the roast and ground coffee.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Capsule according to claim 1 wherein </seg-main><seg-clauses>the fine particles have an average diameter of less than 50 microns.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Capsule according to claim 1 or 2 wherein </seg-main><seg-clauses>the ground coffee inside the capsule is in an amount between 4 and 5.5 grams.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Capsule according to anyone of the preceding claims, wherein </seg-main><seg-clauses>the ground coffee in the capsule has a density between 380 and 450 g/l.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Capsule according to anyone of the preceding claims, wherein </seg-main><seg-clauses>the coffee extract is delivered in a flow time of less than 40 s fo",B65D85/804,20250220,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20240415786A1,Compositions and methods using an autophagy inducer to enhance intermittent fasting,"Compositions contain an autophagy inducer and are administered before, during and/or after an intermittent fasting (IF) diet, preferably a time-restricted feeding (TRF) regimen or an alternate day fasting (ADF) regimen. For example, enhanced intermittent fasting provided by the compositions and methods disclosed herein can include improvement of at least one of longevity, cardiometabolic health, body composition (e.g., fat mass reduction), cellular ageing (e.g., reduction in inflammation markers), cellular renewal, ketosis, weight loss, glycemic control, blood pressure, satiety, or treatment of gastroesophageal reflux disease (GERD). Another aspect is a method of treating or preventing an inflammatory condition, such as rheumatoid arthritis and/or osteoarthritis, by administering an autophagy inducer before, during and/or after an intermittent fasting (IF) diet. An example of an autophagy inducer suitable for the compositions and methods is thymol, optionally in combination with medium chain triglycerides (MCTs).","<div class=""indep-clm"" num=""1""><seg-con>1. A method of enhancing an intermittent fasting (IF) diet, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a composition to a subject before, during and/or after the IF diet, the composition comprising an autophagy inducer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the autophagy inducer comprises at least one of thymol.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises medium chain triglycerides (MCTs)</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises at least one additional ingredient selected from the group consisting of protein, a gum, a vitamin, a mineral, a natural flavor, and a natural color.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a vitamin.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a mineral.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the autophagy inducer is selected from the group consisting of thymol, carvacrol, cannabidiolic acid (CBDA), spermidine, urolithin, rapamycin, valproic acid, a polyphenol, caffeine, metformin, 1-[4-(4-propanoylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one, a 5′ AMP-activated protein kinase (AMPK) activator, an L-type calcium channel inhibitor, a ketone, palmitic acid, 5-aminoimidazole-4-carboxamide riboside (AICAR), verapami","A61K31/05, A23L33/00, A61P39/00",20241219,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025242791A1,Composition comprising iron-containing green plant material concentrate in combination with compounds sensitive to oxidation or ironintolerant microorganisms,"A composition comprising an added iron source and at least one compound sensitive to oxidation and/or at least one iron-intolerant microorganism is disclosed. The at least one compound sensitive to oxidation is selected from fats, vitamins, polyphenols and mixtures thereof and the at least one iron-intolerant microorganism is probiotic bacteria. The added iron source is an iron-containing green plant material concentrate which comprises at least 500 ppm iron by dry weight of iron-containing green plant material concentrate.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>an added iron source and at least one compound sensitive tooxidation selected from fats, vitamins, polyphenols and mixtures thereof and/or at least oneiron-intolerant microorganism which is probiotic bacteria, wherein the added iron source is aniron-containing green plant material concentrate which comprises at least 500 ppm iron by dryweight of iron-containing green plant material concentrate, and wherein the at least one compound sensitive to oxidation does not come from the iron-containing green plant materialconcentrate.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>which has a molar ratio of iron to oxalic acid ofat least 0.3 and/or a molar ratio of iron to phytic acid of at least 5.</seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses><seg-main>the iron-containinggreen plant concentrate is obtainable or obtained by the process comprising the steps of: </seg-main><seg-clauses>a) suspending a green plant material in an aqueous liquid to form a green plant material suspension, </seg-clauses><seg-clauses>b) blending the green plant material suspension to disrupt the plant cells within the green plant material suspension thereby releasing their intracellular material and resulting in a green plant material slurry, </seg-clauses><seg-clauses>c) applying a physical mean on the green plant material slurry to separate and obtain an iron-containing green plant material concentrate, </seg-clauses><seg-clauses>d) optionally, drying the iron-containing green plant material concentrate.</seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>th","A23L33/105, A23L33/115, A23L33/135, A23L33/15, A23L33/16",20251127,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
TW202519255A,High protein tablet,,,"A61K38/16, A61K9/20",20250516,瑞士商雀巢製品股份有限公司,['Pending']
CN119968130A,Flavoring products comprising stabilized polyunsaturated fatty acids,,,"A23L23/00, A23L23/10, A23L29/00, A23L29/238, A23L33/00",20250509,雀巢产品有限公司,['Pending']
ES3009693T3,"Syrup binder system for preparing food, and preparation process and use thereof","La presente invención se refiere al sector alimentario. En concreto, se refiere a un sistema aglutinante de jarabe para la preparación de alimentos que contienen cereales extruidos o inflados y/o frutos secos, como sachima compuesto (sachima complejado), barras de cereales, caramelos de arroz crujientes o barras de frutos secos, etc., a su proceso de preparación y uso, y a un alimento que contiene dicho sistema aglutinante.","1. Sistema aglutinante de sirope para alimentos, cuyo sistema aglutinante comprende un azúcar, un poliol, fibra alimenticia que tiene una capacidad de retención de agua superior a 8 ml/g, un emulsionante, aceite comestible, y agua. 2. Sistema aglutinante de sirope de acuerdo con la reivindicación 1, que comprende además celulosa o un derivado de esta, p. ej., éter de celulosa, éster de celulosa, o éster de éter de celulosa, preferentemente éter de celulosa, p. ej., carboximetilcelulosa o un derivado de esta, p. ej., una sal, tal como carboximetilcelulosa sódica o carboximetilcelulosa cálcica; preferentemente, la celulosa o el derivado de esta, está presente en una cantidad de 0, 002-2 % en peso, preferentemente de 0, 005-1, 5 % en peso y con mayor preferencia de 0, 01-1 % en peso basado en el peso total del sistema aglutinante de sirope. 3. Sistema aglutinante de sirope de acuerdo con cualquiera de las reivindicaciones anteriores, en donde el poliol es un poliol que tiene 2-5 grupos hidroxi, preferentemente un poliol que tiene 2-5 grupos hidroxi y 3-5 átomos de carbono, tal como alcohol dihídrico, p. ej., propilenglicol, y alcohol trihídrico, p. ej., glicerol; preferentemente, el poliol está presente en una cantidad de 1-25 % en peso, preferentemente de 5-20 % en peso y con mayor preferencia de 6-15 % en peso basado en el peso total del sistema aglutinante de sirope. 4. Sistema aglutinante de sirope de acuerdo con cualquiera de las reivindicaciones anteriores, en donde la fibra alimenticia está presente en una cantidad de 0, 1-8% en peso, preferentemente de 0, 2-6% en peso y con mayor preferencia de 0, 5-5 % en peso basado en el peso total del sistema aglutinante de sirope; preferentemente, la fibra alimenticia se selecciona de uno o más de fibra cítrica, fibra de soja, fibra de patata y fibra de cera de calabaza. 5. Sistema aglutinante de sirope de acuerdo con cualquiera de las reivindicaciones anteriores, en donde el emulsionante está presente en una cantidad de 0","A23G3/34, A23G3/48, A23L7/109, A23L7/126, A23L25/00",20250331,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2849424C2,Centrifugal chamber with director for capsule positioning,"FIELD: coffee preparation.SUBSTANCE: device (1) is designed to prepare a beverage (4) from a flavouring ingredient (5a) supplied inside a capsule (5b) in a processing cavity (5) by mixing it with water (4') and centrifuging them around a processing axis (30'). The device (1) has a manipulation system (10, 20) comprising a first manipulator (10) for the ingredient and a second manipulator (20) for the ingredient, which are designed to be movable relative to each other from a capsule transfer configuration to a capsule processing configuration. The device has a capsule feed channel (60) provided with a capsule guide (61, 61a). The guide (61, 61a) is connected to a capsule stop (61b) for immobilising the fed capsule (5b) between the first and second ingredient manipulators (10, 20). The guide is integral with or attached to an elastic arm (61c) and is movable towards and away from the processing axis (30') between the capsule immobilisation position and the release position.EFFECT: improvement of the beverage preparation process.23 cl, 14 dwg","1. Устройство (1) для приготовления напитка (4) из вкусоароматического ингредиента (5a), подаваемого внутри капсулы (5b) в полость (5) обработки, путем смешивания упомянутого ингредиента (5a) с водой (4') в упомянутой капсуле (5b) и приведения в центробежное движение такого ингредиента (5a) и упомянутой воды (4') вокруг оси (30') обработки с образованием упомянутого напитка (4), причем устройство (1) содержит:
- вращающуюся систему (10, 20) манипулирования для ингредиента для удержания упомянутой капсулы (5b) и вращения упомянутого вкусоароматического ингредиента (5a) и воды во время центрифугирования вокруг оси (30') обработки, причем система (10, 20) манипулирования для ингредиента имеет по меньшей мере одно выходное отверстие (25) для напитка и по меньшей мере один штуцер (24) подвода воды для подачи упомянутой воды (4') к упомянутому ингредиенту (5a), при этом система (10, 20) имеет первый манипулятор (10) для ингредиента и второй манипулятор (20) для ингредиента, которые выполнены с возможностью перемещения относительно друг друга из:
- конфигурации передачи ингредиента для приема упомянутого ингредиента (5a) внутри упомянутой капсулы (5b) первым и вторым манипуляторами (10, 20) для капсулы и/или высвобождения упомянутой капсулы (5b) из первого и второго манипуляторов (10, 20) для ингредиента; в
- конфигурацию обработки ингредиента для центрифугирования упомянутого ингредиента (5a) и воды (4') внутри упомянутой капсулы (5b) путем вращения вокруг оси (30') обработки;
- и наоборот;
- привод (41) манипулятора, например двигатель или рукоятку, приводимую в действие пользователем, выполненный с возможностью относительного перемещения первого и второго манипуляторов (10, 20) для капсулы между конфигурациями передачи и обработки; и
- раму и/или корпус (40) устройства, которые неподвижны, когда система (10, 20) манипулирования для ингредиента вращается для центрифугирования, и которые поддерживают систему (10, 20) манипулирования для ингредиента,
причем рама и/или корп",A47J31/22,20251024,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
RU2836324C1,Method for production of chocolate product (embodiments) and chocolate product,"FIELD: food industry.SUBSTANCE: invention relates to confectionary industry. Proposed is a method for production of a chocolate product involving production of material obtained from a cocoa-based substrate. Method involves treating a cocoa-based substrate with at least one enzyme selected from amylases, wherein the cocoa-based substrate is selected from cocoa powder and/or cocoa mass. Method also involves treating cocoa flesh with at least one enzyme selected from at least one cellulase and/or at least one pectinase. Method involves mixing cocoa pulp and a cocoa-based substrate. Then the dried product is dried and mixed with cocoa butter. In another embodiment, the method for production of a chocolate product involves additional mixing with ingredients selected from a group containing sugar, an emulsifier, milk-based ingredients and flavor additives and mixtures thereof. Also disclosed is a chocolate product produced by said method, containing cocoa butter and 20.0 wt.% to 90.0 wt.% of a mixture of cocoa pulp treated with an enzyme and a cocoa-based substrate treated with an enzyme.EFFECT: invention is aimed at improving the consistency of the product and the process by fermentation and/or enzymatic hydrolysis of the paste, and not individual beans (reducing the number of poorly fermented beans); providing controlled fermentation of paste with specific controlled microorganisms; reduced contamination, since the cocoa shell is not subjected to fermentation and drying in potentially unsuitable conditions; increased content of fibers in chocolate products in a controlled manner within the framework of a more orderly process and more homogeneous conditions of drying and roasting due to removal of individual beans from the process.13 cl, 3 dwg, 12 ex","1. Способ производства шоколадного продукта, включающий получение материала, полученного из субстрата на основе какао, включающий следующие стадии:
i. обработка субстрата на основе какао по меньшей мере одним ферментом, причём субстрат на основе какао выбран из какао-порошка и/или какао-массы;
ii. обработка мякоти какао по меньшей мере одним ферментом,
при этом способ включает смешивание мякоти какао и субстрата на основе какао;
iii. стадия сушки; и
iv. смешивание высушенного продукта с маслом какао,
причём по меньшей мере один фермент на стадии i. выбран из амилаз
и по меньшей мере один фермент на стадии ii. выбран из по меньшей мере одной целлюлазы и/или по меньшей мере одной пектиназы.
2. Способ по п. 1, в котором по меньшей мере один фермент на стадии i. выбран из амилоглюкозидазы, глюкоамилазы и альфа-амилазы.
3. Способ по п. 1 или 2, в котором на стадии сушки получают высушенную смесь, содержащую менее 10,0 масс.% воды.
4. Способ по п. 3, в котором смесь содержит от 40 масс.% до 95 масс.% мякоти и от 5 масс.% до 60 масс.% субстрата на основе какао.
5. Способ по любому из пп. 1–4, в котором общее количество используемого фермента составляет от 0,10 до 20% суммарной массы субстрата и мякоти какао, предпочтительно от 0,20 до 10%, более предпочтительно от 0,5 до 5,0%.
6. Способ по любому из пп. 2–5, в котором смесь ферментов содержит целлюлазу, пектиназу, альфа-амилазу и амилоглюкозидазу.
7. Способ по любому из пп. 1–6, в котором субстрат на основе какао и мякоть какао смешивают перед обработкой ферментом.
8. Способ по любому из пп. 1–7, в котором этапы обработки ферментами на стадиях i. и ii. являются параллельными или последовательными.
9. Способ по любому одному из пп. 1–8, который включает:
ферментативную обработку смеси мякоти какао и какао-порошка и/или тёртого какао, причём для ферментативной обработки используется смесь ферментов, которая содержит по меньшей мере одну целлюлазу, по меньшей мере одну пектиназу и по меньшей мере одну амилазу, причём общее ко",A23G1/00,20250312,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250116672A1,Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using tryptophan as biomarker and improved methods and compositions thereof,"The present invention relates to the use of tryptophan as biomarker for detecting and/or quantifying improvements of the mood disorder status and/or excessive emotional reaction of a subject. It also relates to a method for detecting and/or quantifying mood disorder, improvements of the mood disorder status and/or excessive emotional reaction of a subject, in particular for monitoring the progress of an intervention to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject, wherein the intervention comprises the administration of a probiotic. It also relates to an improved method to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject in need, comprising administering to the subject, an effective amount of a composition combining a probiotic with tryptophan or functional derivative thereof.","<div class=""ccl-clm"" num=""2"">1-2. (canceled)</div>
<div class=""indep-clm"" num=""3""><seg-con>3. Method for detecting and/or quantifying mood disorder, improvements of the mood disorder status and/or excessive emotional reaction of a subject, </seg-con><seg-trans>comprising</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-refi>assessing the level of tryptophan in a body sample obtained from a subject to be tested, and</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>comparing the subject's tryptophan level to a predetermined reference value, and</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>wherein an increased tryptophan level in the sample compared to the predetermined reference value indicates an improvement of the mood disorder status and/or excessive emotional reaction of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the mood disorder is mild to severe.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-con>5. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined reference value was obtained previously from the same subject.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""3""><seg-con>6. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined reference value is based on an average tryptophan level in the same body fluid in a control population.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""3""><seg-con>7. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the levels of the biomarkers in the sample and in the reference are determined by mass spectrometry, according to by ultra-performance liquid or gas chromatography coupled to tandem mass spectrometry.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""3""><seg-con>8. The method according to claim 3, </seg-con><seg-trans>","G01N33/68, A61K35/00, A61K35/745",20250410,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3001078C,Compositions and methods using a polyphenol for musculoskeletal health,"(57) Abstract: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.","CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a therapeutically effective amount of curcumin and a fatty acid for: </seg-main><seg-clauses>(i) treating sarcopenia without electrical muscle stimulation in an elderly individual above the age of 60 years, wherein the individual has sarcopenia, </seg-clauses><seg-clauses>(ii) preventing sarcopenia without electrical muscle stimulation in an elderly individual above die age of 60 years, wherein the individual is at risk of having sarcopenia, </seg-clauses><seg-clauses>(iii) reducing age-associated loss of muscle functionality without electrical muscle stimulation in an elderly individual above the age of 60 years, </seg-clauses><seg-clauses>(iv) increasing muscle functionality after muscle atrophy, without electrical muscle stimulation, in an elderly individual above the age of 60 years, and/or </seg-clauses><seg-clauses>(v) improving, without electrical muscle stimulation, recovery of muscle functionality after injury or surgery of muscle in an elderly individual above the age of 60 years. </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses>the fatty acid is an n-3 fatty acid. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to claim 1 or 2, wherein </seg-main><seg-clauses>said composition further comprises a protein source. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The composition for use according to claim 3, wherein </seg-main><seg-clauses>the protein source comprises a protein selected from the group consisting of whey protein, casein protein, pea protein, soy protein, wheat protein, corn protein, rice protein, proteins from legumes, cereals and grains, and combinations thereof. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5. ","A23L33/10, A23L33/105, A23L33/12, A23L33/185, A23L29/00",20250812,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023411092A1,A reinforced moulded fibre capsule for food and beverage preparation,"The present invention concerns packaging item (1) comprising a tridimensional body (2) made of rigid or semi-rigid moulded fiber pulp, said body forming a compartment for enclosing a product and adapted to be closed by closing means, characterized in that said body (2) further comprises a reinforcing mesh (7) embedded at least partially into the mass of fiber pulp, said mesh (7) comprising fibres selected within the list of: natural plant fibres, animal fibres, biopolymer synthetic fibres, or a combination thereof, said fibres being impregnated with a dried water-soluble biopolymer, a dried water-soluble compostable polymer, a dried starch-based solution, or a combination thereof, or said fibres being impregnated with a cured polypeptide.","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (1) comprising </seg-main><seg-clauses>a tridimensional body (2) made of rigid or semi-rigid moulded fiber pulp, said body forming a compartment for enclosing a product and adapted to be closed by closing means (5), characterized in that said body (2) further comprises a reinforcing rigid mesh (7) embedded at least partially into the mass of fiber pulp, said mesh (7) comprising fibres selected within the list of: natural plant fibres, animal fibres, biopolymer synthetic fibres, or a combination thereof, said fibres being impregnated with a dried water-soluble biopolymer, a dried watersoluble compostable polymer, a dried starch-based solution, or a combination thereof, or said fibres being impregnated with a cured polypeptide.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A packaging item (1) according to the preceding claim 1, which further comprises </seg-main><seg-clauses>a multilayer film liner (3) attached to the inner surface of the fiber pulp body (2).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A packaging item (1) according to any one of the preceding claims 1 or 2, wherein </seg-main><seg-clauses><seg-main>said liner (3) comprises from outside to inside:</seg-main>
<seg-clauses>(i) an outermost polymeric layer comprising a biodegradable polymer selected within the list of: polybutylene succinate (PBSA / bioPBS), polybutylene adipate terephthalate (PBAT), starch, cellulose derivates, polylactic acid (PLA), polyhydroxyalcanoates (PHA), or a combination thereof, said outermost layer having a thickness comprised between 10 and 100 pm, and said first layer having an elongation at break comprised between 10% and 800%, a melt flow rate (MFR) comprised between 2 and</seg-clauses>
<seg-clauses class=""seg-enter"">4 when measured at 150°C during 10 minutes with a pressure of 2.16 kg, and said first layer having a melting point temperature comprised bel","D21J3/10, B65D65/46, B65D85/804",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250194847A1,Capsule system with recognition means and adaptable opening and injection mechanism,A beverage preparation device prepares a beverage upon interaction of ingredients provided in a capsule with liquid supplied thereto. The device includes an injection module containing a first enclosing member and a cooperating second enclosing member designed for being moved relatively to each other. The first enclosing member is equipped with capsule opening and injection means for opening a first inlet face of a capsule and injecting liquid into the capsule. The first and second enclosing members are designed for being brought into at least a first capsule insertion position for inserting a capsule between the enclosing members and a second capsule enclosing position in which the opening and injection means engage the liquid inlet face of the capsule. The device further includes control means designed for setting at least the capsule enclosing position based on information read from the capsule and/or based on information provided by a user input.,,"A47J31/36, A47J31/44, A47J31/52",20250619,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120265137A,Coffee bean baking system,A coffee bean roaster includes: a roaster unit having a roaster chamber to roast a dose of coffee beans; a quantitative feeding unit; and a coffee bean reservoir to contain a plurality of doses of coffee beans wherein the dosing unit is arranged to extract a predetermined dose of coffee beans from the plurality of doses of coffee beans in the reservoir and to transfer the predetermined dose of coffee beans to the roasting unit.,"<div class=""indep-clm"" num=""1""><seg-con>1.一种咖啡豆烘焙机，所述咖啡豆烘焙机</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>烘焙单元，所述烘焙单元具有烘焙室，所述烘焙室用以烘焙一定剂量的咖啡豆；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>定量给料系统，所述定量给料系统包括定量给料单元和咖啡豆贮存器，所述咖啡豆贮存器用以容纳多个剂量的咖啡豆，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述定量给料单元被布置成从所述贮存器的所述多个剂量的咖啡豆中提取预定剂量的咖啡豆，并且将所述预定剂量的咖啡豆转移到所述烘焙单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述烘焙单元包括：烘焙室入口，所述烘焙室入口被布置成与所述定量给料单元的剂量出口配合；和单独的烘焙室出口，所述单独的烘焙室出口用于排出已烘焙咖啡豆，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述烘焙室入口能够在打开位置与闭合位置之间移动，在所述闭合位置，所述烘焙室入口阻挡来自空气传输系统的空气和/或穿过其传输的咖啡豆，并且在所述打开位置，所述烘焙室入口使得咖啡豆能够从所述定量给料系统的剂量出口传输穿过所述烘焙室入口到所述烘焙室，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述烘焙室出口能够在打开位置与闭合位置之间移动，在所述闭合位置，所述烘焙室出口阻挡来自空气传输系统的空气和/或穿过其传输的咖啡豆，并且在所述打开位置，所述烘焙室出口使得咖啡豆能够传输穿过所述烘焙室出口，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述烘焙单元包括：空气入口，所述空气入口被布置成将空气从空气传输系统转移到所述烘焙室；和单独的空气出口，所述单独的空气出口用于排出来自所述空气传输系统的排出空气和来自所述烘焙室的材料，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述空气出口能够在打开位置与闭合位置之间移动，在所述闭合位置，所述空气出入口阻挡来自所述空气传输系统的空气离开所述烘焙室，并且在所述打开位置，所述空气出入口使得来自所述空气传输系统的空气能够离开所述烘焙室，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述烘焙单元能够配置成具有以下构型中的一个或多个构型：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>烘焙构型，在所述烘焙构型中，所述烘焙室入口和所述烘焙室出口被布置在闭合位置，并且所述空气出口被布置在打开位置；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>定量给料构型，在所述定量给料构型中，所述烘焙室入口被布置在打开位置并且所述烘焙室出口被布置在闭合位置，并且所述空气出口被布置在闭合位置；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>提取构型，在所述提取构型中，所述烘焙室出口被布置在打开位置，并且所述空气入口被布置在打开位置。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的咖啡豆烘焙机，其中所述烘焙单元的所述烘焙室的内部体积为0.25升至0.75升，并且由所述定量给料单元提取的所述预定剂量的咖啡豆为100g至200g的未烘焙咖啡豆。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的咖啡豆烘焙机，其中所述定量给料系统包括定位系统，所述定位系统用以将所述贮存器中的所述咖啡豆引导到分料单元，以从已定位的咖啡豆中分出所述预定剂量的咖啡豆。</div>
<div class=""dep-clm"" num=""4"" parent=","A23F5/04, A23N12/08, A47J31/42, A23N12/12, G01F11/46",20250704,雀巢产品有限公司,['Pending']
US20250177458A1,Uses of bifidobacterium longum microorganisms having the capacity to degrade both HMO and plant-derived glycans,The present invention relates to the use of a <i>Bifidobacterium longum </i>transitional microorganism to metabolise one or more glycan substrates selected from the group recited in any of Tables 1 to 3.,"<div class=""ccl-clm"" num=""7"">1-7. (canceled)</div>
<div class=""indep-clm"" num=""8""><seg-con>8. A method of promoting the growth of a <i>Bifidobacterium longum </i>transitional microorganism in the gut microbiota of an infant and/or of a young child, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the infant and/or to the young child a composition comprising one or more glycan substrates selected from the group recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-con>9. A method of promoting/assisting the transition from a milk-based diet to solid food in an infant and/or in a young child, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the infant and/or to the young child a combination of a <i>Bifidobacterium longum </i>transitional microorganism and one or more glycan substrates, wherein the one or more glycan substrates is selected from the groups recited in any of Tables 1 to 3 and the <i>Bifidobacterium longum </i>transitional microorganism is capable of metabolizing said one or more glycan substrates.</seg-refi></div>
<div class=""ccl-clm"" num=""12"">10-12. (canceled)</div>
<div class=""dep-clm"" num=""13"" parent=""8""><seg-con>13. A method according to claim 8, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Bifidobacterium longum </i>transitional microorganism encodes one or more CAZymes selected from the group recited in Table 1.</seg-refi></div>
<div class=""dep-clm"" num=""14"" parent=""8""><seg-con>14. A method according to any claim 8, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Bifidobacterium longum </i>microorganism has an Average Nucleotide Identity (ANI) of at least 98% with at least one <i>Bifidobacterium longum </i>strain selected in the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686 and CNCM I-5687, and any combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""15"" parent=""8""><seg-con>15. A method accordin","A61K35/745, A61K35/00, A61K47/36, C12N1/20, C12R1/01",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025093691A1,Combination of plant proteins and oleogels in high moisture extrusion,"The present invention relates to a process for preparing a texturized plant-based food product, the process comprising the steps of a) feeding a chamber, for example an extrusion barrel, with a composition comprising plant protein, water, and an oleogel; b) conveying the composition from step a) through the chamber; and c) cooling the composition from step b).","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A process for preparing a texturized plant-based food product, the process comprising the steps of: </seg-main><seg-clauses>a) feeding a chamber, for example an extrusion barrel, with a composition comprising plant protein, water, and an oleogel; </seg-clauses><seg-clauses>b) conveying the composition from step a) through the chamber; </seg-clauses><seg-clauses>c) cooling the composition from step b), wherein the oleogel is assembled and functionalized by an amphiphilic oleogelator.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process according to claim 1, wherein </seg-main><seg-clauses>the oleogel has been assembled and functionalized with an amphiphilic oleogelator selected from a polar lipid oleogelator, a carbohydrate oleogelator, a protein oleogelator, or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The process according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the oleogel comprises a liquid oil, for example high oleic sunflower oil.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. The process according to any one of claims 2 and 3, wherein </seg-main><seg-clauses>the amphiphilic oleogelator is a protein oleogelator selected from canola protein isolate, soy protein isolate, pea protein isolate, and faba bean isolate.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""2,3""><seg-main>5. The process according to any one of claims 2 and 3, wherein </seg-main><seg-clauses>the amphiphilic oleogelator is a polar lipid oleogelator composed of monoglyceride alone or in combination with lecithin.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""2,3""><seg-main>6. The process according to any one of claims 2 and 3, wherein </seg-main><seg-clauses>the amphiphilic oleogelator is a carbohydrate oleogelator with amphiphilic character.</seg-clauses></div>
<div class=""dep-clm"" num=""7""","A23J3/16, A23J3/18, A23D7/05, A23J3/22, A23J3/26",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250221442A1,Apparatus and method for roasting coffee beans,"An apparatus for roasting coffee beans includes: a vessel to contain coffee beans, a heating device to heat coffee beans contained in the vessel, and a control system operable to control the heating device and configured to apply a roasting recipe. For a customised quantity m of coffee beans of type Ny introduced inside the vessel, the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel and the type Ny of coffee beans introduced inside the vessel, and based on the obtained type Ny, the control system is configured to get access at least to a roasting recipe Ry. The recipe is adapted to the roasting of one pre-determined quantity M of beans of type Ni, and to the pre-determined quantity M, and based on the accessible roasting recipe Ry and on the obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe to be applied to the quantity m of coffee beans of type Ny introduced inside the vessel.","<div class=""indep-clm"" num=""1""><seg-con>1: An apparatus for roasting coffee beans </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a vessel to contain coffee beans,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a heating device to heat coffee beans contained in the vessel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control system operable to control the heating device and configured to apply a roasting recipe providing a temperature T<sub>@t1</sub>, to be applied at discrete successive times t<sub>1</sub>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, for a customised quantity m of coffee beans of type Ny introduced inside the vessel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the control system is configured to obtain at least:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the quantity m of coffee beans introduced inside the vessel, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the type Ny of coffee beans introduced inside the vessel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>based on the obtained type Ny, the control system is configured to get access at least to a roasting recipe Ry, said recipe being adapted to the roasting of one pre-determined quantity M of beans of type Ny, and to the pre-determined quantity M,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>based on the accessible roasting recipe Ry, on the accessible pre-determined quantity M and on the obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe to be applied to the quantity m of coffee beans of type Ny introduced inside the vessel.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The apparatus according to claim 1, </s","A23N12/08, A23F5/04, A23N12/12, A47J31/42, A47J42/52",20250710,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250297215A1,Method for producing milk like products,"A method for producing mammary gland cells and a method of producing a mammalian milk like product, for example a human milk like product, comprising generating lactocytes derived from mammalian adult breast milk stem cells (mBSC), for example from human adult breast milk stem cells (hBSC) and expressing the mammalian milk like product, for example the human milk like product from lactocytes.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing a population of mammary gland cells, comprising:</seg-main>
<seg-clauses>i) culturing mammalian breast milk stem cells (mBSCs) in a culture medium comprising bone morphogenic protein 4 (BMP4) and/or retinoic acid (RA) to generate embryoid bodies (EBs), and</seg-clauses>
<seg-clauses>ii) growing the EBs to generate a population of mammary cells.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the culture medium comprises bone morphogenic protein 4 (BMP4) and retinoic acid (RA).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the culturing step i) comprises culturing the mBSCs in MammoCult medium and BMP4, in a 3D-suspension culture system, for example 3D-suspension condition, thereby directing the hBSCs to differentiate towards non-neural ectoderm cells.</seg-clauses></div>
<div class=""ccl-clm"" num=""4"">4. (canceled)</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the growing step ii) comprises growing the formed EBs in a 3D embedding system comprising RA, for example a mixed floating gel composed of matrix protein such as Matrigel and/or Collagen I for at least 30 days to generate lactocytes.</seg-clauses></div>
<div class=""ccl-clm"" num=""8"">6-8. (canceled)</div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-main>9. The method of claim 1, wherein </seg-main><seg-clauses>the mammary gland cells are human mammary gland cells.</seg-clauses></div>
<div class=""dep-clm"" num=""10"" parent=""1""><seg-main>10. The method of claim 1, wherein </seg-main><seg-clauses>BMP4 is added to the culture medium between day 0 and day 10, where day 0 is the time point where the hBSCs are first added to the culture medium.</seg-clauses></div>
<div class=""ccl-clm"" num=""11"">11. (canceled)</div>
<div class=""dep-c","C12N5/071, C12N5/00, C12N5/0775, C12P1/00",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025012104A1,Dairy product analogues comprising sesame seed fat,Dairy product analogues with improved sensory properties are disclosed. The dairy product analogues comprise plant proteins and sesame seed fat. Processes for preparing such dairy product analogues are also disclosed.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A dairy product analogue which comprises </seg-main><seg-clauses>plant proteins and sesame seed fat, wherein the sesame seed fat and at least 80% of the plant proteins of the dairy product analogue are different from sesame seed proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A dairy product analogue according to claim 1, wherein </seg-main><seg-clauses>the sesame seed fat is provided as sesame seed oil, preferably roasted sesame seed oil.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>all the plant proteins of the dairy product analogue are different from sesame seed proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the plant proteins comprise, preferably consist of plant proteins selected from the group consisting of cereal proteins, pulse proteins and combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% plant proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% sesame seed fat.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7. A dairy product analogue according to any one of the preceding claims, which is beverage.</div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8. A dairy product analogue according to claim 7, wherein </seg-main><seg-clauses>the beverage is a liquid beverage or powdered beverage.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,","A23C11/06, A23C11/10, A23L11/60, A23L11/65, A23L11/50",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119546529A,Beverage or foodstuff container and preparation system,"The present invention relates to a container for use with a machine for preparing beverages and/or foodstuffs or precursors thereof, the container comprising: a storage portion for containing a precursor material; a closing member for closing the storage portion; and an annular flange-like rim made of a cellulose pulp-based material, the flange-like rim comprising: an annular force ring and at least two different additional portions, i.e., a first portion (61) connected to the annular force ring (63); and a second portion (62) extending from the storage portion (58), on which a closure membrane (56) is sealed, said second portion (62) connecting the storage portion (58) and the closure membrane (56). The invention also relates to a set of different containers as well as a container system and a system comprising a container and a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-con>1.容器，所述容器被设计用于插入制备机器中并且与所述制备机器一起使用，所述制备机器用于通过将液体引入所述容器中并且使液体穿过储存在所述容器中的前体材料来从所述前体材料制备饮料和/或食料或其前体，所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>-杯形主体，所述杯形主体包括底端和开口端，所述杯形主体形成用于容纳所述前体材料的储存部分(58)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-闭合膜(56)，所述闭合膜用于在所述杯形主体的所述开口端处闭合所述储存部分；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-环形凸缘状边沿(60)，所述环形凸缘状边沿至少部分地与饮料制备机器(4)的闭合构件(36)接合，所述环形凸缘状边沿(60)由纤维素浆基材料制成并且从所述杯形主体向外延伸，所述凸缘状边沿(60)包括环形力环(63)，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述凸缘状边沿(60)还包括至少两个不同的部分，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-第一部分(61)，所述第一部分与所述环形力环(63)连接；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-第二部分(62)，所述第二部分从所述储存部分(58)延伸，所述闭合膜(56)密封在所述第二部分上，所述第二部分(62)连接所述储存部分(58)和所述闭合膜(56)。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的容器，其中包括所述第一部分(61)、所述第二部分(62)和所述环形力环(63)的所述凸缘状边沿(60)与所述杯形主体成一体。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的容器，其中所述凸缘状边沿(60)的所述第一部分(61)和所述第二部分(62)是平行的。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2"">4.根据权利要求1或2所述的容器，其中所述第一部分(61)和所述第二部分(62)相对于彼此以角度α倾斜。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的容器，其中所述第一部分(61)与所述第二部分(62)之间的所述角度α介于+/-0.1°与+/-88.5°之间。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的容器，其中所述凸缘状边沿(60)的所述第一部分(61)具有低于240微米的总厚度。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的容器，其中所述凸缘状边沿(60)的所述第一部分(61)包括编码元件(19)。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的容器，其中所述编码元件(19)位于所述凸缘状边沿(60)的面向所述储存部分(58)的一侧上。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的容器，其中所述凸缘状边沿的所述第二部分(62)的宽度介于0.2cm与1cm之间。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的容器，其中所述凸缘状边沿(60)的所述第一部分(61)与所述第二部分(62)之间的深度(d)介于0.1mm与6mm之间。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5",B65D85/804,20250228,雀巢产品有限公司,['Pending']
WO2025149250A1,Beverage extraction device,"The invention concerns a beverage extraction device (100), for extracting a beverage from a pod comprising a beverage ingredient, comprising an ejection device (150) of the pod (10) which is movable with respect to a pod holding part (120) to tilt the pod (10) with respect to a holding piercing arrangements (121), the ejection device (150) comprising a seat portion (151) for the pod (10) movable between a rest position, wherein the seat portion (151) is at an end of the pod holding part (120) to contact a flange (12') of the pod (10), and an ejecting position, wherein the seat portion (151) is moved away from the pod holding part (120) to tilt the pod (10) with respect to the holding piercing arrangement (121), and vice versa, and wherein the ejection device (150) is provided with a recess (154) facing the extraction chamber (130) and able to separate the ejection device (150) at least partly from an inner lateral wall (120') of the pod holding part (120) when in the rest position.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . Beverage extraction device (100) for extracting a beverage from a pod (10) containing </seg-main><seg-clauses>a beverage ingredient, preferably roast and ground coffee, the beverage extraction device (100) comprising a pod holding part (120), for housing a pod (10) and provided with a holding piercing arrangement (121 ) for opening an enclosing wall (11 ) of the pod (10), and a pod enclosing part (110), provided with an enclosing piercing arrangement for opening an enclosing wall (13) of the pod (10) opposite to the holding piercing arrangement (121 ), wherein the pod holding part (120) and the pod enclosing part (1 10) are relatively movable between an open position, for inserting and/or ejecting the pod (10), and a closed position, for forming an extraction chamber (130) able to enclose the pod (10) during extraction, and vice versa, wherein the beverage extraction device (100) is provided with an ejection device (150) of the pod (10) which is movable with respect to the pod holding part (120) to tilt the pod (10) with respect to the holding piercing arrangements (121 ), wherein the ejection device (150) comprises a seat portion (151 ) for the pod (10) movable between a rest position, wherein the seat portion (151 ) is at an end of the pod holding part (120) to contact a flange (12’) of the pod (10), and an ejecting position, wherein the seat portion (151 ) is moved away from the end of the pod holding part (120) to tilt the pod (10) with respect to the holding piercing arrangement (121 ), and vice versa, and wherein the ejection device (150) is provided with a recess (154) facing the extraction chamber (130) and able to separate the ejection device (150) at least partly from an inner lateral wall (120’) of the pod holding part (120) when in the rest position.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Beverage extraction device (100) according to claim 1 , wherein </seg-main><seg-cl","A47J31/06, A47J31/36, A47J31/44",20250717,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12186281B2,Oral solid cannabinoid oil composition for treating gastrointestinal disorders,,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for preparing an oral pharmaceutical dosage form, the method comprising:</seg-main>
<seg-clauses><seg-main>wet granulating microcrystalline cellulose and a cannabinoid oil together forming a solid matrix in which the cannabinoid oil is bound in the microcrystalline cellulose; and</seg-main>
<seg-main class=""seg-enter"">combining the solid matrix with at least one pharmaceutical excipient to form the oral pharmaceutical dosage form,</seg-main>
<seg-main class=""seg-enter"">the oral pharmaceutical dosage form comprising a plurality of individual particulates, wherein the individual particulates are spheroidal and comprise:</seg-main>
<seg-clauses>(a) a solid core including an effective amount of the cannabinoid oil bound in the microcrystalline cellulose (MCC) in a ratio of the cannabinoid oil to the MCC of 0.5:1 to 1.5:1; and</seg-clauses>
<seg-clauses><seg-main>(b) an enteric coating over the solid core,</seg-main>
<seg-main class=""seg-enter"">wherein the individual particulates are selected from the group consisting of:</seg-main>
<seg-clauses><seg-main>(i) the individual particulates have an average diameter of 0.5 mm to </seg-main><seg-clauses>1.7 mm and further comprise an enteric coating material and a disintegrant combination configured for the individual particulates to release at least about 50% of the cannabinoid oil in a subject's duodenum for treating inflammation of the duodenum;</seg-clauses></seg-clauses>
<seg-clauses><seg-main>(ii) the individual particulates have an average diameter of 0.5 to </seg-main><seg-clauses>1.7 mm and are configured to release at least about 50% of the cannabinoid oil in a subject's jejunum for treating inflammation of the jejunum; and</seg-clauses></seg-clauses>
<seg-clauses><seg-main>(iii) the individual particulates have an average diameter of 0.5 to </seg-main><seg-clauses>1.7 mm and are configured to release at least about 50% of the cannabinoid oil in a subject's ileum f","A61K31/05, A61K9/16, A61K9/50",20250107,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2024250412A1,Chocolate mousse comprising egg and free from texturizing ingredient and process for preparing same,"The present invention relates to the field of chocolate mousse comprising egg, especially chocolate mousse comprising egg and free from texturizing ingredient. The invention also relates to a process for the preparation of a chocolate mousse comprising egg and free from texturizing ingredient. The invention is further directed to a chocolate mousse comprising egg and free from texturizing ingredient that may be obtained by carrying out the process according to the invention.","<div class=""indep-clm"" num=""1""><seg-main>1. Chocolate mousse composition comprising:</seg-main>
<seg-clauses>-  from 20 to 60 % of at least one dairy ingredient,</seg-clauses>
<seg-clauses>-  from 10 to 40 % of at least one chocolate ingredient,</seg-clauses>
<seg-clauses>-  from 10 to 40 % of at least one egg ingredient,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the composition is free from texturizing agent.</seg-clauses>
<seg-clauses class=""seg-enter"">the percentages being defined by weight of ingredient as compared to the total weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Composition according to claim 1 comprising : </seg-main><seg-clauses>-  from 30 to 50 % of at least one dairy ingredient,</seg-clauses>
<seg-clauses>-  from 20 to 40 % of at least one chocolate ingredient,</seg-clauses>
<seg-clauses>-  from 10 to 30 % of at least one egg ingredient,</seg-clauses>
<seg-clauses class=""seg-enter"">the percentages being defined by weight of ingredient as compared to the total</seg-clauses>
<seg-clauses class=""seg-enter"">weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Composition according to claim 1 or 2 wherein </seg-main><seg-clauses>the dairy ingredient is selected from the group consisting of liquid milk, milk fat, milk powder, milk proteins, dairy curd, cream, buttermilk, condensed milk, butter and combinations thereof, preferably the group consisting of liquid milk, milk fat, cream, butter and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Composition according to any one of claim 1 to 3, wherein </seg-main><seg-clauses>the chocolate ingredient is selected from the group consisting of chocolate, cocoa and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Composition according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the ","A23G1/52, A23G1/00, A23P30/40",20250925,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
JP2025004126A,Compositions and methods using combination of curcumin and an omega-3 fatty acid for cellular energy,"To provide methods and compositions that can treat or prevent a mitochondria-related disease, or a condition associated with altered mitochondrial function, or a reduced mitochondrial density.SOLUTION: The present invention provides a method of increasing antioxidant capacity, reducing oxidative stress, and/or enhancing mitochondrial function, the method comprising administering to an individual in need thereof an effective amount of a combination of curcumin and an omega-3 fatty acid.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 抗酸化能を向上させる、酸化ストレスを低減する、及び／又はミトコンドリア機能を向上する方法であって、投与を必要とする個体に、有効量のクルクミンとオメガ－３脂肪酸との組み合わせを投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記組み合わせが、１日当たり約５００ｍｇ～約５ｇの前記オメガ－３脂肪酸を提供する量で投与される、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記組み合わせが、１日当たり約０．０１ｍｇ～約２．０ｇの前記クルクミンを提供する量で投与される、請求項１又は２に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記組み合わせが、経口投与される、請求項１～３のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記組み合わせが、前記クルクミンの少なくとも一部を提供する植物抽出物を含む食品製品として投与される、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記個体が、中高年者及び高齢者からなる群から選択される、請求項１～５のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記個体が、ＩＣＵの患者である、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""indep-clm"" num=""8"">【請求項8】</div>
<div class=""indep-clm"" num=""8""> ミトコンドリア関連疾患、若しくはミトコンドリア機能の変化に関連する状態、若しくはミトコンドリア密度の低下を治療する、その発生率を低減する、及び／又はその重症度を低減する方法であって、投与を必要とする個体に、有効量のクルクミンとオメガ－３脂肪酸との組み合わせを経口投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""8"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""8""> 前記ミトコンドリア関連疾患又は状態が、ストレス、肥満、代謝速度の低下、メタボリックシンドローム、真性糖尿病、糖尿病による合併症、高脂血症、神経変性疾患、認知障害、ストレス誘発性又はストレス因関連認知機能不全、気分障害、不安障害、加齢性神経細胞死又は機能不全、筋骨格障害、フレイル、プレフレイル、慢性腎疾患、腎不全、外傷、感染症、がん、難聴、黄斑変性、ミオパチー及びジストロフィー、並びにこれらの組み合わせからなる群から選択される、請求項８に記載の方法。 </div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""8,9""> 前記ミトコンドリア関連疾患又は状態が、幼少期ストレス及び／又はその影響を含む、請求項８又は９に記載の方法。 </div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10""> 前記ミトコンド","A61K31/12, A61K31/202, A61P3/04, A61P3/06, A61P13/12",20250114,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
RU2834436C1,Method of making package from recyclable material,"FIELD: packing and storage.SUBSTANCE: invention relates to a method of making package (200) for enclosing substance (500). Flat sheet (100) made from recyclable paper material and having two opposite side edge portions (101, 102), is provided and moulded into tube (120) by folding flat sheet (100) so that two side edge sections (101, 102) overlap each other on overlap section (123). Tube (120) is thermally sealed along section (123) of overlap with formation of longitudinal sealing seam (130) and thermally sealed across longitudinal sealing seam (130) to close tube (120) by means of first transverse sealing seam (141) at first end (121) of tube. Tube (120) is filled with substance (500) and thermally sealed across longitudinal sealing seam (130) to close tube (120) by means of second transverse sealing seam (142) at second end (122) of the tube. First and second amounts of glue (300–302) are applied on flat sheet (100) at first and second sections (151, 152) of triple joint, where longitudinal sealing seam (130) and corresponding transverse sealing seams (141, 142), respectively, intersect. Glue (300–302) bonds corresponding section (151, 152) of the triple joint when thermally sealing corresponding end (121, 122) of the tube to form a corresponding transverse sealing seam (141, 142). Invention also relates to package (200) containing substance (500), and device (600) for production of such package (200).EFFECT: thus, it is possible to produce packing with high speed and in completely automated process, as well as without excessive costs for reconfiguration or re-equipment of already existing devices.15 cl, 7 dwg","1. Способ изготовления упаковки (200) для заключения в ней вещества (500), включающий:
<img src='' class=""img-anchor"" img-id=""00000001""/>обеспечение плоского листа (100), изготовленного из пригодного для вторичной переработки бумажного материала и имеющего два противоположных боковых краевых участка (101, 102),
<img src='' class=""img-anchor"" img-id=""00000001""/>формование плоского листа (100) в трубку (120) путем складывания плоского листа (100) таким образом, чтобы два боковых краевых участка (101, 102) по меньшей мере частично перекрывали друг друга на участке (123) перекрытия,
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) вдоль участка (123) перекрытия с образованием продольного запечатывающего шва (130),
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) поперек продольного запечатывающего шва (130) для закрытия трубки (120) с помощью первого поперечного запечатывающего шва (141) на первом конце (121) трубки,
<img src='' class=""img-anchor"" img-id=""00000001""/>наполнение трубки (120) веществом (500), подлежащим упаковыванию,
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) поперек продольного запечатывающего шва (130) для закрытия трубки (120) с помощью второго поперечного запечатывающего шва (142) на втором конце (122) трубки, противоположном первому концу (121) трубки по отношению к веществу (500), подлежащему упаковыванию, с образованием упаковки (200), заключающей в себе указанное вещество (500),
отличающийся тем, что способ дополнительно включает:
<img src='' class=""img-anchor"" img-id=""00000001""/>нанесение первого количества клея (300, 301) на плоский лист (100) на первом участке (151) тройного стыка, на котором пересекаются продольный запечатывающий шов (130) и первый поперечный запечатывающий шов (141),
<img src='' class=""img-anchor"" img-id=""00000001""/>нанесение второго количества клея (300, 302) на плоский лист (100) на втором участке (152) тройного стыка, на","B65B9/06, B65B51/02, B65B51/10, B65B51/26, B65D65/46",20250210,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025052202A1,Methods of monitoring feeding behaviors of pets,"The present disclosure relates to the monitoring feeding behavior(s) of a pet(s), under the control of at least one processor. An example method includes obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl. The load sensor can have a sensitivity of +/-50 grams or less and the load data is obtained can occur at a sample rate from 10 samples to 150 samples per second. The example method can also include sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples, and identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.","CLAIMS
What Is Claimed Is:
<div class=""indep-clm"" num=""1""><seg-con>1. A method of monitoring feeding behavior of a pet, under the control of at least one processor, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl, wherein the load sensor has a sensitivity of +/-50 grams or less and the load data is obtained at a sample rate from 10 samples to 150 samples per second; sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples; and identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 , </seg-con><seg-trans>further comprising </seg-trans><seg-refi>excluding load data in identifying the feeding behavior if determined to be a result of human interaction, a false trigger, or an accidental interaction with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the feeding behavior is a count-based feeding behavior selected from lapping, licking, or biting.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method of claim 3, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>characterizing the count- based feeding behavior by counting individual micro-events of the feeding behavior within a single time increment or a time period spanning multiple time increments, wherein the individual micro-events include individual laps, individual licks, or individual bites.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of claim 4, </seg-con><seg-trans>wherein </seg-tr","A01K5/01, A01K5/02, A01K29/00, G01G19/56",20250313,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
WO2024261203A1,Compositions and methods using a nettle concentrate for cellular energy,"Compositions comprising a nettle concentrate are provided. The compositions can be administered to an individual in need thereof for (i) improving a physiological state linked to metabolic fatigue in one or more cells, and/or (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and/or (iii) enhancing mitochondrial function, and/or (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the compositions can be administered for treating or preventing a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","19229-EP-EPA CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a nettle concentrate, in an effective amount for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, and/or </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and/or </seg-clauses><seg-clauses>(iii) enhancing mitochondrial function, and/or </seg-clauses><seg-clauses><seg-main>(iv) treating or preventing a calcium deficiency / depletion disorder in an individual, wherein the nettle concentrate is obtainable or obtained by the process comprising the steps of: </seg-main><seg-clauses>a) suspending a nettle material in an aqueous liquid to form a nettle material suspension, </seg-clauses><seg-clauses>b) blending the nettle material suspension to obtain a nettle material slurry, </seg-clauses><seg-clauses>c) applying a physical mean on the nettle material slurry to separate and obtain a nettle concentrate, </seg-clauses><seg-clauses>d) optionally, drying the nettle concentrate. </seg-clauses></seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to any one of the preceding claims, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue, muscle weakness, lack of vitality, weakness or lack of energy, in particular lack of physical energy. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according to any one of preceding claims, wherein </s","A23L2/52, A23L33/10, A23L33/105, A23L33/15, A23L33/00",20241226,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250319058A1,Compositions and methods using a combination of fisetin and quercetin for cellular energy,"Composition comprising a combination of fisetin or derivative thereof and quercetin or derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency/depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency/depletion disorder in an individual comprising administering a composition comprising a combination of fisetin and/or a derivative thereof and quercetin and/or a derivative, in a therapeutically effective amount to the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1"">4. Method according to claim 1, for preventing or treating muscle fatigue from exercise.</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the effective amount of a combination of fisetin and/or a derivative thereof and quercetin and/or a derivative is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the derivative of fisetin is selected from the group consisting of glucuronidated forms thereof, sulfated fo","A61K31/352, A61K31/7048, A61K45/06, A61P3/14",20251016,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025027434A1,Compositions and methods for diagnosing and/or treating chronic kidney disease,"Compositions and methods diagnose and/or treat chronic kidney disease (CKD) using one or more feline circulating proteins as markers for early-stage CKD. A method of diagnosing chronic kidney disease (CKD) in a feline can include measuring an amount of each of at least one circulating protein from the feline. The at least one circulating protein is one or more of adiponectin (ADIPOQ), cathelicidin (CAMP), kinesin-like protein (KIF12), plasma retinol-binding protein (RBP4), Ig-like domain-containing protein (ZKSCAN1), coagulation factor X (F10), fibronectin (FN1) and mixtures thereof. The method also includes performing comparison of the amount of each of the at least one circulating protein from the feline to a corresponding predetermined value or a corresponding predetermined range. The method also includes diagnosing the feline as having early-stage CKD or not having early-stage CKD, based on the comparison.",,G01N33/68,20250206,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
WO2025153581A1,Plant-based compositions and methods for management of chronic kidney disease,"A method for managing chronic kidney disease includes administering to an individual in need thereof a composition containing a plant based protein. The composition may have low glycemic index and may adhere to chronic kidney disease dietary restrictions. Additionally, the composition may have a PDCAAS score of 1. The method may also include managing chronic kidney disease at a pre-dialysis stage of the disease and managing chronic kidney disease in patients with diabetes.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>Claim 1 : A composition for managing chronic kidney disease, the composition comprising </seg-main><seg-clauses>a plant-based protein in an amount between about 3 grams and about 12 grams per 100 ml or per 100 g of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>Claim 2: The composition of claim 1, wherein </seg-main><seg-clauses>the composition has a glycemic index below 70.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>Claim 3: The composition of claim 1 or claim 2, wherein </seg-main><seg-clauses>the composition further comprises a carbohydrate and a fiber.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>Claim 4: The composition of claim 3, wherein </seg-main><seg-clauses>the carbohydrate comprises at least one carbohydrate with a low glycemic index.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>Claim 5: The composition of claim 4, wherein </seg-main><seg-clauses>the at least one carbohydrate with a low glycemic index comprises isomaltulose.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>Claim 6: The composition of any one of claims 1-5, wherein </seg-main><seg-clauses>the composition further comprises a free amino acid, and the composition has a Protein Digestibility Corrected Amino Acids Score score of 1.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>Claim 7: The composition of any one of claims 1-6, wherein </seg-main><seg-clauses>the composition further comprises an omega-3 fatty acid.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-main>Claim 8: The composition of any one of claims 1-7, wherein </seg-main><seg-clauses>the composition conforms to chronic kidney disease diet restrictions.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""8""><seg-main>Claim 9: The composition of claim 8, wherein </seg-main","A23L33/185, A23L33/21, A61K31/7004, A61K31/736, A61K38/16",20250724,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250316361A1,"Systems and methods for estimating, from food frequency questionnaire based nutrients intake data, the relative amounts of faecalibacterium prausnitzii (FPRAU) in the gut microbiome ecosystem and associated recommendations to improve faecalibacterium prausnitzii","The present invention relates to systems and methods for estimating an individual's <i>Faecalibacterium prausnitzii </i>(<i>Fprau</i>) amounts and for providing personalized recommendations to maintain or improve the <i>Fprau</i>. In several embodiments of the invention, the individual's <i>Fprau </i>amounts are estimated based on their Food FrequencyQuestionnaire (FFQ) records. In several embodiments, the methods are implemented by a computer system. In several embodiments of the invention, personalized recommendations and dietary advice are given to the individual to maintain or improve said individual's <i>Fprau. </i>","<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining the gut <i>Faecalibacterium prausnitzii </i>(<i>Fprau</i>) status comprising:</seg-main>
<seg-clauses>(i) determining the gut <i>Fprau </i>status in a subject and</seg-clauses>
<seg-clauses>(ii) providing recommendations to improve or maintain <i>Fprau </i>status in said subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1 wherein </seg-main><seg-clauses>the determination of gut <i>Fprau </i>status is by a food frequency questionnaire to determine the nutrients intake to predict the <i>Fprau </i>status of said subject.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1 wherein </seg-main><seg-clauses>the determination of gut <i>Fprau </i>status is additionally by a biological sample to quantify the microbiome diversity of said subject.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. Method according to claim 1 wherein </seg-main><seg-clauses>said method is computer-implemented.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1 wherein </seg-main><seg-clauses>said method involves evaluation of feature parameters related to gut <i>Fprau </i>status as low, medium or high.</seg-clauses></div>
<div class=""indep-clm"" num=""6""><seg-main>6. A computer implemented method comprising:</seg-main>
<seg-clauses>(i) determination of the gut <i>Fprau </i>status in a subject;</seg-clauses>
<seg-clauses>(ii) providing a recommendation of a personalized fiber composition; and</seg-clauses>
<seg-clauses>(iii) delivering a personalized nutritional recommendation.</seg-clauses></div>
<div class=""ccl-clm"" num=""7"">7. (canceled)</div>
<div class=""indep-clm"" num=""8""><seg-main>8. A method for optimizing one or more dietary interventions for a subject comprising:</seg-main>
<seg-clauses>(i) determining the<i>Fprau </i>status of a subject according","G16H20/60, G16H10/20, G16H50/20",20251009,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250228810A1,Compositions for use,"A paediatric supplement or human milk fortifier composition comprising at least one nutrient selected in the list consisting of: ALA, DHA, EPA, 2′FL, LNnT, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said paediatric supplement or human milk fortifier composition is tailored or adapted for an infant born via C-section who is breast fed and/or to fortify the breast milk of a woman who has given birth via C-section. Said paediatric supplement or human milk fortifier composition is beneficial to prevent nutrition inadequacy an infant born via C-section and promote associated health benefits.","<div class=""indep-clm"" num=""1""><seg-main>1. A paediatric supplement or human milk fortifier composition comprising </seg-main><seg-clauses>at least one nutrient selected from the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">alpha linolenic acid (ALA) in a daily amount ranging from 19 to 80 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">docosahexaenoic acid (DHA) in a daily amount ranging from 13 to 25 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">eicosapentanoic acid (EPA) in a daily amount ranging from 6 to 9 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">2-fucosyllactose (2′-FL) in a daily amount ranging from 280 to 1050 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">Lacto-N-neotetraose (LNnT) in a daily amount ranging from 30 to 50 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin A in a daily amount ranging from 224 to 342 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine in a daily amount ranging from 6.6 to 10 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine monophosphate in a daily amount ranging from 10 to 15 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B2 in a daily amount ranging from 9 to 19 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B6 in a daily amount ranging from 15 to 68 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B9 in a daily amount ranging from 1.1 to 9 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">calcium in a daily amount ranging from 10 to 16 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">phosphorus in a daily amount ranging from 4.5 to 14 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">GD3 in a daily amount ranging from 8 to 12 mg; and</seg-clauses>
<seg-clauses class=""seg-enter"">GM3 in a daily amount ranging from 1 to 1.5 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">and any combination thereof.</seg-clauses></div>
<div class=""ccl-clm"" num=""2"">2. (canceled)</div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A paediatric supplement or ","A61K31/202, A23L33/00, A61K31/07, A61K31/4415, A61K31/51",20250717,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023332002A1,Co-extraction method for preparing a stable oil body solution from seed material and cereal bran,"The invention relates to a method of preparing an oil body solution. The method comprises the preparation of a suspension of seed material and cereal bran. The suspension is thereafter mechanically disrupted to form a slurry, the pH of the obtained slurry is adjusted to greater than 6 to form an oil body solution. The oil body solution is then heat-treated. The invention also relates to an oil body solution or a powder thereof and to food products comprising said oil body solution or powder thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of preparing an oil body solution, said method comprising </seg-main><seg-clauses><seg-main>the steps of</seg-main>
<seg-clauses>a. preparing a suspension of seed material and cereal bran in an aqueous phase, preferably water, wherein the seed material and cereal bran are present in a dry weight ratio of between 50:50 to 95:5; and wherein the aqueous phase is free from organic solvent,</seg-clauses>
<seg-clauses>b. mechanically disrupting the suspension to form a slurry;</seg-clauses>
<seg-clauses>c. adjusting the pH of the slurry to greater than 6, preferably to between 6.5 to 10 to form an oil body solution;</seg-clauses>
<seg-clauses>d. optionally, filtering or centrifuging the oil body solution to concentrate the oil body solution;</seg-clauses>
<seg-clauses>e. heat</seg-clauses><seg-clauses>-treating the oil body solution, and</seg-clauses>
<seg-clauses>f. optionally, drying the oil body solution to form a powder.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the seed material has a protein content between 13 and 30% and a carbohydrate content between 8 and 27%, and the cereal bran has a protein content between 8 and 20%, a carbohydrate content between 16 and 80%.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to any preceding claims, wherein </seg-main><seg-clauses>the cereal bran has a total phenolic compounds content between 0.1 and 20 mg Gallic Acid Equivalent (GAE) per g of cereal bran on a dry weight basis.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any preceding claims, wherein </seg-main><seg-clauses>the omega-3 content of the seed material is between 10 and 60% of its oil content.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A method according to any precedi","C11B1/04, A23D9/02, A23D9/05, C11B1/10",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025114799A2,Methods using a DNA methylation profile of a canine,The present invention provides a method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising a) providing a DNA methylation profile from a sample obtained from the dog; and b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and </seg-clauses><seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for determining a biological age of a dog; said method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and </seg-clauses><seg-clauses>b) determining a biological age for the dog using the DNA methylation profile, wherein the DNA methylation profile is linked to the mortality risk and/or probability of a healthy lifespan for the dog and wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A method for selecting a lifestyle regime, dietary regime or therapeutic intervention for a dog, the method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; </seg-clauses><seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile, wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1 ; and </seg-clauses><seg-clauses>c) selecting a suitable lifestyle regime, dietary regime or therapeutic intervention for the dog based on the mortality risk and/or probability of a healthy lifespan determined in step b).</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A method for determining the efficacy of a lifestyle regime, dietary regime or therapeutic inter",C12Q1/6883,20250605,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
US20250311761A1,Method for the preparation of a nutritional powder,The present invention relates to a method for the preparation of a nutritional powder comprising free amino acids and/or extensively hydrolyzed protein as well as to a nutritional powder obtained by said method. The present invention further relates to the use of a carbohydrate to improve the sensorial properties of a nutritional composition comprising free amino acids and/or extensively hydrolyzed protein.,"<div class=""indep-clm"" num=""1""><seg-con>1. A process for the preparation of a nutritional powder </seg-con><seg-trans>comprising </seg-trans><seg-refi>free amino acids and/or extensively hydrolyzed protein, comprising the steps of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>preparing a liquid concentrate comprising free amino acids and/or extensively hydrolyzed protein;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>spray-drying the liquid concentrate to form a nutritional powder, wherein the spray-drying of the liquid concentrate is performed in the presence of solid carbohydrate particles.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The process according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional powder comprises from 9.5 to 18 wt. % free amino acids and/or extensively hydrolyzed protein, based on the total weight of the nutritional powder.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The process according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the amino acids are selected from the group consisting of amino acids or salts thereof: L-lysine, L-leucine, L-proline, L-glutamine, L-arginine, L-valine, glycine, L-isoleucine, L-threonine, L-serine, L-phenylalanine, L-tyrosine, L-aspartic acid, L-histidine, L-alanine, L-cystine, L-aspartate, L-tryptophan, L-methionine, magnesium L-aspartate, L-lysine acetate, and L-Arginine-L-Aspartat.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The process according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional powder comprises from 40 to 55 wt. % carbohydrates, based on the total weight of the nutritional powder.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The process according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the carbohydrates are selected from the group consisting of maltodextrin, maltose, s","A23L33/175, A23J3/30, A23L29/212, A23L33/00, A23L33/115",20251009,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023348096A1,Uses of bifidobacterium longum transitional microorganism,The present invention relates to a,"<div class=""indep-clm"" num=""1"">1. A Bifidobacterium Longum transitional microorganism for use in preventing and/or reducing the risk of an infection in an infant or young child.</div>
<div class=""indep-clm"" num=""2""><seg-main>2. A prebiotic for use in preventing and/or reducing the risk of an infection in an infant or young child; wherein </seg-main><seg-clauses>the prebiotic is a glycan substrate or a human milk oligosaccharide (HMO).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The Bifidobacterium Longum transitional microorganism for use according to claim 1 wherein </seg-main><seg-clauses>the Bifidobacterium Longum transitional microorganism is used in combination with a prebiotic selected from a glycan substrate or a human milk oligosaccharide (HMO).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. A prebiotic for use according to claim 2, wherein </seg-main><seg-clauses>the prebiotic is used in combination with a Bifidobacterium Longum transitional microorganism.</seg-clauses></div>
<div class=""indep-clm"" num=""5""><seg-main>5. A combination of a Bifidobacterium Longum transitional microorganism and a prebiotic for use in preventing and/or reducing the risk on an infection in an infant or young child; wherein </seg-main><seg-clauses>the prebiotic is selected from glycan substrate or a human milk oligosaccharide (HMO).</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""3,5""><seg-main>6. The Bifidobacterium longum transitional microorganism, prebiotic or combination for use according to any of claims 2-5 wherein </seg-main><seg-clauses>the prebiotic is a glycan substrate selected from the group recited in any of Tables 1 to 3.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""3,5""><seg-main>7. The Bifidobacterium longum transitional microorganism, prebiotic or combination for use according to any of claims 2-5, wherein </seg-main><seg-clauses>the prebiotic is a HMO selected from the group consisting o","A61K35/745, A61K31/702, A61P11/00, A61P31/12",20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025036668A1,Multi-layer metallized paper-based packaging material,"A multi-layer metallized paper-based packaging material comprising, from its outer side to its inner side: an outer side polymeric layer (1); a paper layer (2); an adhesive layer (3); a metallization layer (4); a polymeric film (5); and (6) an inner side polymeric layer; processes for preparing the multi-layer metallized paper-based packaging material.",,"B32B15/08, B32B15/085, B32B15/20, B32B27/08, B32B27/10",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
EP4649837A2,Infant formula,"An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein the infant formula comprises 0.8-2.5 g/L 2'-fucosyllactose (2'FL) and/or 0.05-0.2 g/L lacto-N-neotetraose (LNnT).","<div class=""indep-clm"" num=""1""><seg-main>1.  An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises </seg-main><seg-clauses>0.8-2.5 g/L 2'-fucosyllactose (2'FL) and/or 0.05-0.2 g/L lacto-N-neotetraose (LNnT).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The infant formula for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises </seg-main><seg-clauses>0.8-1.5 g/L, 1-1.5 g/L, or about 1 g/L 2'FL, preferably wherein the infant formula comprises about 1 g/L 2'FL.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3.  The infant formula for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises </seg-main><seg-clauses>1.5-2.5 g/L, 1.5-2 g/L, 1.6-2 g/L, or about 1.8 g/L 2'FL, preferably wherein the infant formula comprises about 1.8 g/L 2'FL.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The infant formula for use according to any preceding claim, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises </seg-main><seg-clauses>0.05-0.15 g/L or about 0.1 g/L LNnT, preferably wherein the infant formula comprises about 0.1 g/L LNnT.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  The infant formula for use according to any preceding claim, wherein </seg-main><seg-clauses>the infant formula comprises 2'FL and LNnT.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6.  The infant formula for use according to claim 5, wherein </seg-main><seg-clauses>the infant formula comprises about 1.8 g/L 2'FL and about 0.1 g/L LNnT.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7.  The infant formula for use according to any preceding claim, wherein </s",A23L33/00,20251119,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024285932A1,Thin donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.3 cm to about 1.6 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.6 cm to about 2.0 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual dry kibble pieces of the serving are about 1.3 cm to about 1.6 cm in average diameter and about 3 mm to about 5 mm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the small adult dog exhibits a reduced feeding speed and increased eating duration on average compared to the feeding speed of the same volume of a comparative solid round dry kibble having a diameter of about 1 cm or less.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>during feeding, the small adult dog exhibits a lower frequency of labored swallowing and increased chewing duration on average compared to when the small adult dog is feeding on the same volume of a comparative solid round dry kibble having a diameter of about 1 cm or less.</seg-refi></div>
<div","A23K40/00, A23K50/42",20250918,SOCIETE DES PRODUITS NESTLE SA,['Pending']
US12257259B2,Nutritional composition comprising 2′-Fucosyllactose (2′ FL) to improve the gastrointestinal barrier,"The present invention relates to nutritional compositions comprising 2′-Fucosyllactose (2′FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving a gastrointestinal barrier, inhibiting barrier dysfunction, prevention of barrier leakiness, protecting tight junction structure, or protecting intestinal epithelial lining integrity of an infant </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>premature, small for gestational age and low birth weight babies, the method comprising administering a synthetic nutritional composition comprising 2′-Fucosyllactose (2′FL) to the infant,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the improving the gastrointestinal barrier comprises improving barrier protection,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the improving, the inhibiting and/or the protecting is achieved by increasing kynurenic acid production by microbiota of the infant consuming the synthetic nutritional composition, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the 2′FL is present in an amount of 0.25 to 1.9 g/L or 0.15 to 1.5 g/100 g of the synthetic nutritional composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improving the gastrointestinal barrier further comprises improving barrier maturation, improving barrier structure, improving barrier function, and/or improving barrier repair.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improving the gastrointestinal barrier further comprises improving barrier function and/or improving barrier structure.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the inhibiting barrier leakiness comprises inhibiting pathogens, allergens and/or toxic compounds t","A61K31/702, A23L33/00, A23L33/125, A61K31/07, A61K31/122",20250325,SOCIETE DES PRODUITS NESTLE S.A,['Active']
US12459715B2,Multi-layer flexible packaging material,"The present invention relates generally to the field of multi-layer flexible packaging material. In particularly, the present invention relates to a multi-layer flexible packaging material comprising a paper layer, an aluminium layer, a nanoclay barrier coating layer, and a sealing layer applied to the surface of the nanoclay barrier coating layer representing the inner surface of the multi-layer flexible packaging material, said multilayer flexible barrier material being deprived of a polyolefin layer, such as a polyethylene (PE), polyethylene terepthalate (PET) or a polypropylene (PP) layer. The present invention further relates to the use of the multi-layer flexible packaging material in accordance with the present invention to package dry food.","<div class=""indep-clm"" num=""1""><seg-con>1. A multi-layer flexible packaging material </seg-con><seg-trans>comprising </seg-trans><seg-refi>the following layers from an outer surface to an inner surface:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an aluminium layer having a thickness in the range of 20-500 nm,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a paper layer having a grammage of 40 to 120 g/m2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a nanoclay barrier coating layer having a grammage in the range of 0.4-4 g/m2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a sealing layer applied to a surface of the nanoclay barrier coating layer representing the inner surface of the multi-layer flexible packaging material, wherein the sealing layer is selected from the group consisting of acrylic acid copolymers, vinyl acetate, ethyl vinyl acetate, modified xylanes, chemically modified starch, and combinations thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and the multi-layer flexible packaging material being deprived of a polyolefin layer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The multi-layer flexible packaging material in accordance with claim 1, </seg-con><seg-trans>wherein:</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a primer is applied to an outer surface of the paper layer;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>the aluminium layer is applied to a surface of the primer applied to the outer surface of the paper layer by means of vacuum deposition process;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a protection layer is applied to a surface of the aluminium layer;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a primer is applied to a inner surface of the paper layer;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>the nanoclay barrier coating layer","B65D65/42, D21H11/14, D21H19/08, D21H19/22, D21H19/40",20251104,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024200882B9,"Omega-3 fatty acid, homocystein and vitamin D levels to identify and attenuate cognitive aging in individuals","A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and 5 homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject. 20 24 20 08 82 12 F eb 2 02 4 A B S T R A C T 1 2 F e b 2 0 2 4 A m e t h o d f o r i d e n t i f y i n g p r e - d i s p o s i t i o n t o c o g n i t i v e d e c l i n e i n a s u b j e c t , t h e m e t h o d c o m p r i s i n g d e t e r m i n i n g l e v e l s o f : ( a ) o m e g a - 3 f a t t y a c i d s , a n d v i t a m i n D o r a m e t a b o l i t e t h e r e o f ; ( b ) o m e g a - 3 f a t t y a c i d s , a n d h o m o c y s t e i n e ; ( c ) v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d 5 h o m o c y s t e i n e ; o r ( d ) o m e g a - 3 f a t t y a c i d s , v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d h o m o c y s t e i n e , i n d e p e n d e n t l y i n o n e o r m o r e s a m p l e s o b t a i n e d f r o m t h e s u b j e c t . 2 0 2 4 2 0 0 8 8 2 A B S T R A C T 1 2 F e b 2 0 2 4 2 0 2 4 2 0 0 8 8 2","<div class=""indep-clm"" num=""1""><seg-main>1.     A method for identifying pre-disposition to cognitive decline in a subject, the</seg-main>
<seg-main class=""seg-enter"">method comprising </seg-main><seg-clauses>determining levels of: omega-3 fatty acids, and</seg-clauses>
<seg-clauses class=""seg-enter"">5          homocysteine; independently in one or more samples obtained from the</seg-clauses>
<seg-clauses class=""seg-enter"">subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.     The method of claim 1, wherein:</seg-main>
<seg-clauses>(a) a level of omega-3 fatty acids is determined and a decrease in the</seg-clauses>
<seg-clauses class=""seg-enter"">10                     level of omega-3 fatty acids in the sample from the subject</seg-clauses>
<seg-clauses class=""seg-enter"">compared to a reference value is indicative of pre-disposition to cognitive decline; and</seg-clauses>
<seg-clauses>(b) a level of homocysteine is determined and an increase in the level of homocysteine in the sample from the subject compared to a</seg-clauses>
<seg-clauses class=""seg-enter"">15                      reference value is indicative of pre-disposition to cognitive decline.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.     The method of claim 1 or claim 2, wherein </seg-main><seg-clauses>the one or more samples are</seg-clauses>
<seg-clauses class=""seg-enter"">independently selected from the group consisting of a blood sample, plasma sample and serum sample.</seg-clauses>
<seg-clauses class=""seg-enter"">20</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.     The method of any one of the preceding claims, wherein </seg-main><seg-clauses>the level of omega-3</seg-clauses>
<seg-clauses class=""seg-enter"">fatty acids is determined in a blood sample, preferably an erythrocyte sample; and/or the level of homocysteine is determined in a plasma sample.</seg-clauses>
<seg-clauses class=""seg-enter"">25   </seg-claus","A61K31/202, A61K31/14, A61K31/4415, A61K31/51, A61K31/592",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019300084B2,MCT formulations for increasing ketone exposure and methods of making and using such formulations,"A composition effective for treating or preventing a condition for which extended exposure to ketones is beneficial contains medium chain triglycerides (MCTs) and also contains proteins in a weight ratio of at least 0.1 g protein/1.0 g of the compound. Other aspects are directed to a method of extending blood exposure to ketones derived from oral absorption of a food product by an individual; a method of improving or maintaining at least one of neurologic health, cognitive function, or exercise performance; and a method of making the composition.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of extending blood exposure to ketones derived from oral absorption of a composition by an individual, the method comprising </seg-main><seg-clauses><seg-main>administering to the individual the composition comprising medium chain triglycerides (MCTs), in an amount of at least 1 %wt, based on the composition, and further comprising proteins in a weight ratio of at least </seg-main><seg-clauses>1.0 g protein/1.0 g of the MCTs.</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of extending blood exposure to ketones derived from oral absorption of a composition by an individual, the method comprising </seg-main><seg-clauses><seg-main>administering to the individual the composition comprising medium chain triglycerides (MCTs), in an amount of at least 1 %wt, based on the composition, and further comprising proteins in a weight ratio of at least </seg-main><seg-clauses>1.7 g protein/1.0 g of the MCTs.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of claim 1 or 2 wherein </seg-main><seg-clauses><seg-main>the composition further comprises at least one ingredient selected from the group comprising </seg-main><seg-clauses>(i) carbohydrates in a weight ratio of at least 0.1 g carbohydrate/1.0 g of the MCTs and/or </seg-clauses><seg-clauses>(ii) lipids, other than the MCTs, in a weight ratio of at least 0.1 g lipids/1.0 g of the MCTs.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of any one of claims 1 to 3 wherein </seg-main><seg-clauses>the composition is a liquid.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3""><seg-main>5. The method of any one of claims 1 to 3 wherein </seg-main><seg-clauses>the composition is a powder.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""4""><seg-main>6. The method of claim 4 wherein </seg-main><seg-clauses>the MCTs are at","A61K31/23, A23C9/152, A61K35/20, A61K38/01",20250417,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN119584900A,Beverage or food preparation system,"The present disclosure provides a system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or a food product thereof, the container (6) comprising: a body portion (62) comprising a storage portion (58) for containing a precursor material; a closure member (56) to close the storage portion (58); and a machine-readable code (44) storing preparation information, the machine (4) comprising: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6); and electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44) wherein the code reading system (18) comprises a positioning mechanism (110) to apply a variable loading condition to the container (6), and the code reading system (18) comprises a detection system (150) to detect a reading position in the event that a predetermined condition for reading the code (44) is satisfied, and in the event that said condition is satisfied, the electrical circuitry (16) is configured to process the code (44) to extract the preparation information at the reading position.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括容器以及用于制备饮料和/或其食品的机器，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>主体部分，所述主体部分包括用于容纳前体材料的储存部分；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>闭合构件，所述闭合构件用以闭合所述储存部分；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>机器可读代码，所述机器可读代码存储制备信息，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述机器包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码读取系统，所述代码读取系统用以读取所述容器的代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>处理单元，所述处理单元用于处理所述容器的所述前体材料；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>电气电路系统，所述电气电路系统用以基于从所述代码读取的所述制备信息来控制所述处理单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述代码读取系统包括用以将可变的加载条件施加到所述容器以选择性地使所述容器的所述主体部分变形的定位机构，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且所述代码读取系统包括用以在满足用于读取所述代码的预定条件的情形下检测读取位置的检测系统，所述预定条件基于施加到所述容器的力和/或位移，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且在满足所述条件的情形下，所述电气电路系统被配置为读取所述代码以在所述读取位置提取所述制备信息。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述加载条件基于以下项是可变的：</div>
<div class=""dep-clm"" num=""2"" parent=""1"">所述容器的几何尺寸，其中所述几何尺寸是所述主体部分的距离所述闭合构件的深度，以及/或者</div>
<div class=""dep-clm"" num=""2"" parent=""1"">所述容器的刚度。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的系统，其中用于读取所述代码的所述预定条件包括满足第一条件和/或不同的第二条件。</div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的系统，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-refi>所述第一条件基于由所述定位机构施加到所述容器的力处于目标力或已经超过目标力阈值；并且/或者</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-refi>所述第二条件基于由所述定位机构施加到所述容器的位移已经超过阈值。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的系统，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-refi>所施加的力基于施加到用于所述定位机构的驱动系统的电流；并且/或者</seg-refi></div>
<div ","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20250307,雀巢产品有限公司,['Pending']
US20250108391A1,Fluid dispensing system with adapter for a table top dispenser,"A fluid dispensing system including a fluid dispenser that is operable in a stand-alone mode, and a housing that is configured to removably receive the fluid dispenser for operation of the fluid dispenser in a housed mode. When the fluid dispenser is placed on top of a horizontal support surface for operation of the fluid dispenser in the stand-alone mode, a pump mechanism of the fluid dispenser is manually activatable to dispense an allotment of fluid by manually depressing an activation member of the pump mechanism. When the fluid dispenser is received by the housing for operation of the fluid dispenser in the housed mode, the pump mechanism is activatable by activating an actuation mechanism of the housing","<div class=""indep-clm"" num=""1""><seg-con>1. A method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>attaching an adapter to an actuation mechanism of a fluid dispenser housing, the fluid dispenser housing being configured to removably receive a mountable fluid dispenser and to dispense fluid from the mountable fluid dispenser upon activation of the actuation mechanism;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the adapter allows the fluid dispenser housing to removably receive a table top fluid dispenser and to dispense fluid from the table top fluid dispenser upon activation of the actuation mechanism; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the adapter is attached to the actuation mechanism of the fluid dispenser housing without interfering with the fluid dispenser housing being able to receive the mountable fluid dispenser.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>further comprising:</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>after the adapter has been attached to the actuation mechanism, placing the mountable fluid dispenser in engagement with the fluid dispenser housing without detaching the adapter from the actuation mechanism.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method according to claim 2, </seg-con><seg-trans>further comprising:</seg-trans></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-refi>activating the actuation mechanism to dispense the fluid from the mountable fluid dispenser without detaching the adapter from the actuation mechanism.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to claim 3, </seg-con><seg-trans>further comprising:</seg-trans></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-comp>removing the mountable fluid dispenser from the fluid dispenser housi","B05B11/00, A47K5/12, B05B11/10",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020286602B2,Reduced nicotinamideribosides for treating or preventing kidney disease,"The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of kidney diseases and conditions. In one embodiment of the invention, said compounds and compositions of the invention improve kidney function by reducing formation of kidney cysts, reducing glomerule dilatation, reducing renal cell apoptosis and preventing increases in blood urea nitrogen. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat acute kidney injury (AKI), chronic kidney disease, diabetic nephropathy, focal segmental glomerulosclerosis, nephrotic syndrome, renal fibrosis and kidney cancer.","<div class=""indep-clm"" num=""1""><seg-main>1. 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide when used in preventing and/or treating kidney diseases and conditions selected from acute kidney injury and chronic kidney disease, in a subject, comprising </seg-main><seg-clauses>delivering to the subject in need an effective unit dose form of 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A composition comprising </seg-main><seg-clauses>1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide when used in preventing and/or treating kidney disease selected from acute kidney injury and chronic kidney disease.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The composition according to claim 2 which is selected from the group consisting of: </seg-main><seg-clauses>a food or beverage product, a food supplement, an oral nutritional supplement (ONS), a medical food, and combinations thereof.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4.A method of treating or preventing kidney disease selected from acute kidney injury and chronic kidney disease, comprising </seg-main><seg-clauses>administering to a subject in need a composition according to claim 2 or claim 3 consisting essentially of 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide without other NAD+ precursors.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. Method according to claim 4 for preventing and/or treating kidney disease in a subject in need comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>i) providing the subject a composition consisting essentially of 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide and</seg-clauses>
<seg-clauses>ii) administering the composition to said subject</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the subject is selected from the group consisting of: human, cat, dog, cow, horse, pig","A61K31/706, A23L2/00, A61K9/00, A61P13/12, A61P35/00",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019412555B2,Pet foods comprising gravy topping comprising methylcellulose and methods of making such pet foods,"A multi-layered pet food can contain a first edible composition that is a gravy comprising methylcellulose; and a second edible composition having a flat upper surface against which the gravy is positioned. A method of preparing a multi-layered pet food can include: preparing a first edible composition that is a gravy at a first temperature, the gravy comprising methylcellulose; filling the gravy into a container; heating the gravy in the container to a second temperature to jellify the gravy; and filling a second edible composition into and on top of the first layer. The multi-layered pet food can be administered to a pet such as a companion animal.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of making a multi-layered pet food </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>preparing a first edible composition that is a gravy comprising from about 0.1 weight % to about 5.0 weight % methylcellulose and from about 0.1 weight % to about 5.0 weight % guar, at a first temperature, wherein the first temperature is from about 10°C to about 26° C;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>filling a first layer comprising the gravy into a container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the container comprising the gravy to a second temperature from about 40 °C to about 70 °C to jellify the gravy;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>filling a second layer comprising a second edible composition into the container and on top of the first layer, wherein the first layer and the second layer are discrete layers.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to Claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>transporting the container from a filling location into a heating zone after the filling of the first layer and prior to the heating.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method according to Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the heating zone comprises an infrared heat source.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to Claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the infrared heat source is configured below the container.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method according to Claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>transporting the container into a non-heating zone after the heating and before the filling of the second layer.</seg-refi></div>
<div c","A23K20/163, A23K40/00",20250417,SOCIETE DES PRODUITS NESTLE SA,['Active']
CA2982008A1,Code and container of system for preparing a beverage or foodstuff,"A container for a foodstuff or beverage preparation machine, the container for containing beverage or foodstuff preparation material and comprising on a surface thereof a code encoding preparation information, the code comprising a reference portion and a data portion: the reference portion comprising a linear arrangement of at least two reference units defining a reference line r, the data portion comprising at least one data unit, wherein said data unit is arranged on an encoding line D that intersects the reference line r, the data unit occupies any continuous distance d along the encoding line D as a variable to at least partially encode a parameter of the preparation information, whereby said encoding line D is circular and is arranged with a tangent thereto orthogonal the reference line r at said intersection point.","25 CLAIMS: <div class=""indep-clm"" num=""1""><seg-main>1. A container for a beverage or foodstuff preparation machine, the container for containing </seg-main><seg-clauses>beverage or foodstuff material and comprising a code encoding preparation information, the code comprising a reference portion and a data portion: the reference portion comprising an arrangement of at least two reference units to define virtually a reference line (r); the data portion comprising a data unit, wherein the data unit is arranged on a virtual encoding line (D) that intersects the reference line (r) at an intersection point, the data unit is arranged a distance (d) from said intersection point as a variable to at least partially encode a parameter of the preparation information, whereby said virtual encoding line (D) is circular and is arranged with a tangent thereto orthogonal the reference line (r) at said intersection point, wherein the data unit comprises a first data unit and a second data unit, the first data unit and the second data unit arranged along the virtual encoding line (D) that intersects the reference line (r), the first data line arranged at a first associated distance (d1) from the intersection point along the virtual encoding line (D), and the second data line arranged at a second associated distance (d2) from the intersection point along the virtual encoding line (D), wherein the virtual encoding line (D) is circular or a segment of a circle and is arranged with the tangent thereto orthogonal the reference line (r) at the intersection point, wherein an overall distance (d) is determined as an average d=0.5(d1+d2) of the first associated distance and the second associated distance, and wherein a value of the parameter (Vp) is encoded in the preparation information. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The container according to claim 1, wherein </seg-main><seg-clauses>the data unit is configured to occupy any continuous distance along","B65D85/804, A47J31/44",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12484605B2,Thickeners and nutritional products to promote safe swallowing for individuals with dysphagia and methods of making and using same,"A thickener is disclosed, as well as a nutritional product including the thickener, uses thereof, methods for the manufacture thereof, methods for improving the cohesiveness of a nutritional product, and related systems. The nutritional products have improved cohesiveness for promoting safer and more efficient swallowing of food boluses for individuals having swallowing difficulties such as dysphagia. In a preferred embodiment, the nutritional product includes a thickener comprising a beta-glucan and an additive. Preferably, the nutritional product has a relaxation time, determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment, of from 10 ms to 2000 ms at a temperature of 20° C.","<div class=""indep-clm"" num=""1""><seg-main>1. A thickener comprising </seg-main><seg-clauses>a beta-glucan and an additive, wherein the thickener is formulated for providing a nutritional product a relaxation time, determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment, of more than 10 ms (milliseconds) at a temperature of 20° C., wherein the additive comprises a combination selected from the group consisting of</seg-clauses>
<seg-clauses class=""seg-enter"">(1a) CMC in combination with guar gum, or locust bean gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1b) locust bean gum in combination with guar gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1c) Tara gum in combination with guar gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(i)) HPMC in combination with carrageenan iota or carrageenan kappa;</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(ii)) HPMC in combination with guar gum, and at least one of carrageenan iota, carrageenan kappa, carrageenan lambda, konjac, or locust bean gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(iii)) HPMC in combination with locust bean gum, and at least one of carrageenan iota, carrageenan kappa, or tara gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(iv)) HPMC in combination with tara gum, and at least one of carrageenan kappa, konjac, or locust bean gum;</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(v)) HPMC in combination with carrageenan iota, and at least one of konjac or locust bean gum; and</seg-clauses>
<seg-clauses class=""seg-enter"">(1d(vi)) HPMC in combination with konjac, and at least one of carrageenan kappa, sodium alginate, or locust bean gum.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The thickener of claim 1, wherein </seg-main><seg-clauses>the additive comprises a gum.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The thickener of claim 1, wherein </seg-main><seg-clauses>a weight ratio of the beta-glucan and the","A23L29/269, A23L2/52, A23L29/238, A23L29/244, A23L29/256",20251202,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2844749C1,Method of roasting coffee beans,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is a method for roasting coffee beans in roasting system (10) comprising roasting device (1) and smoke purification unit (2) configured to treat smoke, wherein said unit comprises at least electrostatic precipitator (222), which comprises at least one cell (222a, 222b), and wherein said cell comprises ionisation wires (2221), collecting electrodes (2222), repulsive electrodes (2223) and is supplied with electric power for applying a high voltage to the ionisation wires and at least part of the electrodes, wherein during each roasting operation method includes steps of monitoring voltage across ionisation wires and/or voltage across the electrodes during the roasting operation, the monitored voltage is compared with a given upper voltage threshold V1 and one given lower voltage threshold V2 and the cleaning demand status is displayed, if during time Δt of the roasting operation, the monitored voltage is less than the specified upper voltage threshold value V1 and simultaneously is greater than the specified lower voltage threshold value V2. Also disclosed is a coffee bean roasting system and a machine-readable data medium having a computer program stored thereon and containing instructions for enabling said system to implement the described method.EFFECT: group of inventions makes it possible to inform the operator on the onset of the moment, when it is absolutely necessary to clean the smoke filter of the electrostatic precipitator.12 cl, 6 dwg","1. Способ обжаривания кофейных зерен в системе (10) обжаривания, содержащей:
- устройство (1) для обжаривания, и
- блок (2) очистки дыма, выполненный с возможностью очистки дыма, образуемого устройством для обжаривания, причем указанный блок очистки дыма содержит по меньшей мере электростатический осадитель (222),
. при этом указанный электростатический осадитель содержит по меньшей мере одну ячейку (222a, 222b), и
. при этом указанная ячейка содержит ионизационные провода (2221), собирающие электроды (2222) и отталкивающие электроды (2223), и
. при этом указанная ячейка снабжается электроэнергией для подачи высокого напряжения на ионизационные провода и по меньшей мере часть электродов,
причем во время каждой операции обжаривания, выполняемой в устройстве для обжаривания, при этом способ включает стадии, на которых:
- контролируется напряжение на ионизационных проводах и/или напряжение на электродах в течение операции обжаривания,
- сравнивается контролируемое напряжение с заданным верхним пороговым значением V1 напряжения и с одним заданным нижним пороговым значением V2 напряжения, и
- отображается статус потребности в очистке, если в течение времени Δt операции обжаривания контролируемое напряжение меньше указанного заданного верхнего порогового значения V1 напряжения и одновременно больше указанного заданного нижнего порогового значения V2 напряжения.
2. Способ по п. 1, в котором соотношение V1/V2 больше 10.
3. Способ по п. 1 или 2, в котором статус потребности в очистке отображается, если:
- контролируемое напряжение меньше указанного по меньшей мере одного заданного верхнего порогового значения V1 напряжения и одновременно больше указанного заданного нижнего порогового значения V2 напряжения,
и
- период времени Δt превышает заданное пороговое значение Δt1 времени.
4. Способ по предшествующему пункту, в котором заданное пороговое значение времени Δt1 составляет меньше 10 секунд, предпочтительно приблизительно 5 секунд.
5. Способ по п. 1 или 2, в котором статус ","A23F5/04, A23N12/08",20250805,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119855770A,Beverage capsule made from molded cellulose with improved oxygen and moisture barrier,"The present invention relates to an improved packaging article (1) comprising a body (2) made of a rigid or semi-rigid molded cellulose slurry, said article further comprising a multilayer film liner (3) attached to the inner surface of the cellulose slurry body (2), said liner comprising, from inside to outside: a biodegradable outermost organic adhesive layer (7), the biodegradable outermost organic bonding layer is used for attaching the inner liner to the molded cellulose slurry; an organic intermediate barrier layer (8) comprising a modified alcohol-based polymer (BVOH); and an innermost biodegradable organic structural layer (9).","<div class=""indep-clm"" num=""1""><seg-con>1.一种包装物品(1)，所述包装物品包括由刚性或半刚性模制纤维素浆料制成的主体(2)，<u>其特征在于</u>所述物品(1)还包括附接到所述纤维素浆料主体(2)的内表面的多层膜内衬(3)，所述内衬从外到内</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>(i)最外有机粘合层(7)，所述最外有机粘合层用于将所述内衬附接到所述模制纤维素浆料，所述粘合层包括选自以下列表内的生物可降解聚合物：聚琥珀酸丁二醇酯(PBSA/bioPBS)、聚己二酸对苯二甲酸丁二醇酯(PBAT)、淀粉、纤维素衍生物、聚乳酸(PLA)、聚羟基烷酸酯(PHA)或它们的组合，所述最外层具有在10μm与100μm之间的厚度、在10％与800％之间的断裂伸长率，当在150℃下在2.16kg的压力下测量10分钟时在2与4之间的熔体流动速率(MFR)，并且所述最外层具有低于80℃的熔点温度，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(ii)有机中间阻隔层(8)，所述有机中间阻隔层包含接枝马来酸酐的丁烯二醇乙烯醇共聚物(BVOH)、接枝马来酸酐的聚乙醇酸(PGA)或它们的混合物，并且具有在180℃与230℃之间的熔点温度和在1μm与20μm之间的厚度，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(iii)最内有机结构层(9)，所述最内有机结构层包括选自以下列表内的生物可降解聚合物：聚琥珀酸丁二醇酯(PBSA)、聚己二酸对苯二甲酸丁二醇酯(PBAT)、淀粉、纤维素衍生物、聚乳酸(PLA)、聚羟基烷酸酯(PHA)或它们的组合，所述层具有在10μm与100μm之间的厚度、在10％与1000％之间的断裂伸长率、当在190℃下在2.16kg的压力下测量10分钟时在4与10之间的熔体流动速率(MFR)，并且所述最内层也具有在110℃与180℃之间的熔点温度。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的包装物品(1)，其是用于围封初级包装的次级包装，所述次级包装优选选自以下列表内：小袋、角片包裹、管、袋、盒、砖、容器或它们的组合。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的包装物品(1)，所述包装物品是用于饮料制备的胶囊(1)，所述胶囊包括杯状主体(2)和附接到所述主体(2)的至少一个封闭隔膜(5)，所述主体(2)和所述至少一个隔膜(5)限定封闭的配料隔室(6)，所述胶囊被适配为被饮料制备机器的水注入装置刺穿，用于在压力下将水注入所述隔室中，以在其中制备饮料。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的包装物品(1)，其中所述杯形主体(2)包括周缘(4)，所述封闭隔膜(5)附接至所述周缘上。</div>
<div class=""dep-clm"" num=""5"" parent=""3,4"">5.根据前述权利要求3或4中任一项所述的包装物品(1)，其中所述封闭隔膜(5)由挤出涂布纸、纤维纺丝涂布纸或包含相容聚合物材料的聚合物膜制成。</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">6.根据前述权利要求3至5中任一项所述的包装物品(1)，其中所述隔室(6)内的配料是烘焙并且研磨的咖啡。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求1至6中任一项所述的包装物品(1)，其中至少所述最外层(7)、最内层(9)以及阻隔层(8)是共挤出层。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的包装物品(1)，其中所述最内层(9)的所述聚合物是退火聚合物。</div>",B65D85/804,20250418,雀巢产品有限公司,['Pending']
US20250241341A1,Beverage comprising vitamin d or its derivatives having improved stability,"The present invention relates to a beverage comprising vitamin D or its derivatives, a hydrocolloid and a triglyceride and to a packaged beverage comprising said beverage. The present invention also relates to a process for obtaining such beverage and to the use thereof.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 1.10<sup>−7</sup>% and 8.10<sup>−5</sup>% by weight of vitamin D or its derivatives with respect to the total weight of beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 0,0005% and 1,2% by weight of hydrocolloid with respect to the total weight of beverage, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 0,000003% and 0.2% by weight of triglyceride with respect to the total weight of beverage.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The beverage according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the triglyceride is a medium chain triglyceride.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The beverage according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hydrocolloid is selected from the group consisting of polysaccharides such as including acacia gum, xanthan gum, gelatin, carrageenan gum, gellan gum, karaya gum, larch gum, dextran, chitosan, alginate, hyaluronic acid, guar gum, pectin, cellulose, tara gum, tamarind gum, ghatti gum, curdlan gum, konjac glucomannan, scleroglucan, pullulan, agar, tragacanth gum, <i>Portulaca oleracea </i>gum, galactomannan, pectin, starch or modified starch, cellulose derivative.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The beverage according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>monoglyceride or its derivatives.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The beverage according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the monoglyceride is an unsaturated monoglyceride.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The beverage according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said beve",A23L2/52,20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120379909A,Dispensing system,"The invention relates to a dispensing system (100, 200, 300, 400, 500) for dispensing bulk material (1), comprising: a flexible or semi-flexible bag (10) comprising a compartment (11) for storing the bulk material (1), a dispensing section (12), and a hanger portion (13) by means of which the bag (10) can be suspended, such that the bulk material (1) can flow out of the bag (10) by gravity from the compartment (11) via the dispensing section (12); a dispensing mechanism (110, 210, 310, 410, 510) attached to the bag (10), where the dispensing mechanism (110, 210, 310, 410, 510) comprises two components (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) which are manually movable relative to each other so as to move between: a closed position in which the dispensing section (12) is moved by the two parts (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) in order to prevent the bulk material (1) from flowing out of the bag (10) via the dispensing section (12); and an open position in which the dispensing section (12) is moved by the two parts (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) deploys or is allowed to deploy to form a dispensing channel (12.4) such that the bulk material (1) can flow out of the bag (10) by gravity from the compartment (11) via the dispensing section (12); and a resilient element (120, 220, 320, 420, 520) arranged to force the two components (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) faces the closed position.",,"B65D47/20, B65D47/28, B65D75/58, B65D83/06, B65D33/16",20250725,雀巢产品有限公司,['Pending']
JP2025020268A,Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia,"To provide liquid concentrates for preparing a nutritional product by dilution.SOLUTION: A liquid concentrate comprises a thickening component selected from the group consisting of a β-glucan, at least one plant-extracted gum, at least one plant-derived mucilage, and combinations thereof, in a concentration greater than 10 wt.% and less than or equal to 25 wt.%. The liquid concentrate is formulated such that dilution into a nutritional product provides the nutritional product with: a shear viscosity less than 200 mPas at a shear rate of 50 s-1 at 20°C; and a relaxation time, measured by a Capillary Breakup Extensional Rheometry (CaBER) experiment, of more than 10 ms (milliseconds) at a temperature of 20°C.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> β－グルカン、少なくとも１つの植物抽出ガム、少なくとも１つの植物由来粘質物、及びこれらの組み合わせからなる群から選択される増粘成分を含む濃縮液であって、前記濃縮液が、希釈剤での希釈により、</div>
<div class=""indep-clm"" num=""1""> ２０℃で、５０ｓ<sup> －１</sup>の剪断速度で２００ｍＰａｓ超、かつ最大約２，０００ｍＰａｓの剪断粘度と、</div>
<div class=""indep-clm"" num=""1""> キャピラリー破断式伸長粘度計（ＣａＢＥＲ）実験によって測定したときに、２０℃の温度で１０ｍｓ（ミリ秒）超となる緩和時間と、</div>
<div class=""indep-clm"" num=""1""> を有する栄養製品を形成するよう配合されている、濃縮液。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２００ｍＰａｓ超、かつ最大約５００ｍＰａｓである、請求項１に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２５０ｍＰａｓ～約４００ｍＰａｓである、請求項１又は２に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記増粘成分が、β－グルカン、好ましくはオート麦β－グルカンを含む、請求項１～３のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記濃縮液が、最大２００：１、好ましくは５０：１～１００：１の比率で希釈剤で希釈される、請求項１～４のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記栄養製品が、医薬製剤、栄養製剤、栄養補助食品、機能性食品、及び飲料製品、並びにこれらの組み合わせからなる群から選択される投与可能な形態である、請求項１～５のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記増粘成分が、前記濃縮液の０．０１重量％～２５重量％である、請求項１～６のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記濃縮液が、水を更に含み、前記栄養製品が、以下からなる群から選択される少なくとも１つの配合を有する：</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉ）前記希釈剤が、水、乳、水と、この水に加えて更に少なくとも１つの成分とを含む飲料、液体経口栄養補助食品（ＯＮＳ）、又は食品製品のうちの１つ以上であり、前記濃縮液を前記希釈剤で希釈することにより、前記希釈剤と、前記増粘成分と、前記濃縮液に由来する水とから本質的に構成される又はこれらから構成される前記栄養製品を直接形成する、</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉｉ）前記濃縮液","A23L33/10, A23L29/206, A23L2/52",20250212,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
AU2019348522B2,Adaptive service unit of a beverage machine,"A machine (1) for preparing a beverage has: a body (1') comprising a seat (4) and a beverage processing line (1'', 1''') extending from a liquid inlet (1'') to a beverage dispenser (1'''); and a service unit (10) that is removably received in or on the seat (4) and that comprises a foot part (11) and a recipient part (12) removably received in or on the foot part (11) so as to be supported thereby. The foot part (11) has a bottom face (11') configured to rest on an external horizontal support surface (100) when the service unit (10) is removed from the seat (4). When the recipient part (12) is received in or on the foot part (11), the recipient part (12) is movable relative to the foot part (11) from a first stable position when the service unit (10) rests on the external horizontal support surface (100) to a second stable position when the service unit (10) is received in or on the seat (4), and vice versa.","2019348522  17 Dec 2024
The claims defining the invention are as follows :-
<div class=""indep-clm"" num=""1""><seg-main>1. A machine for preparing a beverage, comprising:</seg-main>
<seg-clauses>- a body comprising a seat and a beverage processing</seg-clauses>
<seg-clauses class=""seg-enter"">5 line extending from a liquid inlet to a beverage dispenser; and</seg-clauses>
<seg-clauses>- a service unit that is removably received in or on the seat and that comprises a foot part and a recipient part removably received in or on the foot part so as</seg-clauses>
<seg-clauses class=""seg-enter"">10 to be supported thereby, the foot part having a bottom face configured to rest on an external horizontal support surface when the service unit is removed from the seat,</seg-clauses>
<seg-clauses class=""seg-enter"">the recipient part being configured to store:</seg-clauses>
<seg-clauses class=""seg-enter"">15  - un-used beverage ingredient and/or beverage liquid</seg-clauses>
<seg-clauses class=""seg-enter"">and/or cleaning fluid, to be supplied to the beverage processing line; and/or</seg-clauses>
<seg-clauses>- used beverage ingredient and/or waste beverage liquid and/or used cleaning fluid, collected from the</seg-clauses>
<seg-clauses class=""seg-enter"">20 beverage processing line,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, when the recipient part is received in or on the foot part, the recipient part is movable relative to the foot part from a first stable position when the service unit rests on said external horizontal support surface to</seg-clauses>
<seg-clauses class=""seg-enter"">25 a second stable position when the service unit is received in or on the seat, and vice versa, the first and second stable positions being different.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine of claim 1, wherein </seg-main><seg-clauses>the liquid inlet is connected to a source of liquid.</seg-clauses>
<seg-clauses class=""seg-enter"">30   </seg-clauses><",A47J31/44,20250123,SOCIÉTÉ DES PRODUITS NESTLÉ SA,['Active']
AU2019290925B9,Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor,"A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD + ) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.","<div class=""indep-clm"" num=""1""><seg-main>1.     A method of treating or preventing at least one physical state selected from the</seg-main>
<seg-main class=""seg-enter"">group consisting of </seg-main><seg-clauses>oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, the method comprising administering to an individual in need thereof an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of 0-hydroxybutyrate (BHB) and salts thereof and 0-hydroxypentanoate (BHP) and salts thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.     The method of Claim 1, wherein </seg-main><seg-clauses>the at least one physical state is selected from the</seg-clauses>
<seg-clauses class=""seg-enter"">group consisting of deleterious effects of aging, muscle loss, type I diabetes, type II diabetes, complications from diabetes, insulin resistance, metabolic syndrome, dyslipidemia, overweight, obesity, raised cholesterol levels, raised triglyceride levels, elevated fatty acid levels, fatty liver disease, cardiovascular disease, myopathy such as statin-induced myopathy, non-alcoholic steatohepatitis, tinnitus, dizziness, alcohol hangover, hearing impairment, osteoporosis, hypertension, atherosclerosis/coronary artery disease, myocardial damage after stress, traumatic brain injury, cystic fibrosis, inflammation, cancer, HIV infection, stroke, migraine and brain ischemia.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3.     Use of an effective amount of a combination of Nicotinamide Riboside (NR) and</seg-main>
<seg-main class=""seg-enter"">at least one of 0-hydroxybutyrate (BHB) and salts thereof and 0-hydroxypentanoate (BHP) and salts thereof in the manufacture of a medicament for treating or preventing at least one physical state selected from the group consisting of </seg-main><seg-clauses>type I diabetes, type II diabe","A61K31/19, A61K31/405, A61K31/4425, A61K31/455, A61K31/706",20250821,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024240448A1,Beverage extraction system,"The invention concerns a system comprising an extraction device of a beverage preparation machine and a capsule, wherein - the capsule comprises a capsule body and a delivery wall forming a chamber, and - the extraction device comprises upstream and downstream capsule enclosing parts relatively movable between an open position for inserting and/or ejecting the capsule and a closed position for forming an extraction chamber enclosing the capsule during extraction, the downstream part comprising a extraction plate with engaging means in the form of pyramidal elements for opening the delivery wall of the capsule, wherein the delivery wall of the capsule is made of biodegradable materials and comprises in a layered manner at least a carrier layer adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule, and an adhesive layer provided on the side of the carrier layer that is oriented towards the chamber for joining the delivery wall and the capsule body, and wherein pyramidal elements of the downstream part and the delivery wall of the capsule are designed so that - in a first step, the delivery wall interacts with the pyramidal elements and assumes an imprint of the pyramidal elements on its surface facing the pyramidal elements without visible piercing of the delivery wall, - in a second step, upon contact of the fluid injected in the capsule with the surface of the delivery wall facing the chamber of the capsule, permeable openings appear in the structure of the delivery wall through cavities in the structure of one or more of the layers of the delivery wall, and - during a third step, the formed beverage is drained from the capsule and contacts the extraction plate. Preferably, the capsule of the system of the invention is compostable and made of cellulose- based material, preferably molded-pulp cellulose-based material. The invention also relates to the use of a capsule in the system of the invention.",,"A47J31/36, B65D85/804",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12317913B2,Dietary butyrate,"A compound having the formula (1), (2), (3), or (4), or combinations thereof, for use to maintain or increase muscle function and/or mass in a subject, and/or prevent or reduce muscle wasting in a subject, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently, a long chain fatty acid having between 16 and 20 carbons.
<img src='' class=""img-anchor sg-l"" img-id=""US12317913-C00001""/>","<div class=""indep-clm"" num=""1""><seg-main>1. A method for maintaining or increasing skeletal muscle function and/or mass and preventing or reducing muscle wasting, the method comprising </seg-main><seg-clauses>administering to an individual in need of same a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/B2/12/31/79/13/1748959973813/US12317913-C00006.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064334%3B1765067934%26q-key-time%3D1765064334%3B1765067934%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D14efb908532bf7a34805d34bc9b72128a39b944d&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A54%20GMT"" class=""img-anchor"" img-id=""US12317913-C00006"" image_type=""chemistry"" official_size=""8505""></seg-clauses>
<seg-clauses class=""seg-enter"">or combinations thereof, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently an acyl group of a long chain fatty acid having between 16 and 20 carbons.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for maintaining or increasing skeletal muscle function and/or mass and preventing or reducing muscle wasting comprising </seg-main><seg-clauses>administering to an individual in need of same a composition comprising a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/B2/12/31/79/13/1748959973813/US12317913-C00007.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064334%3B1765067934%26q-key-time%3D1765064334%3B1765067934%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D1532842a8e231ab462e982fbb37801e1abdcd917&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A54%20GMT"" class=""img-anchor"" img-id=""US12317913-C00007"" image_type=""chemistry"" of","A23L33/115, A23L29/00, A61K31/22, A61K31/231, A61P21/00",20250603,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12185735B2,Beverage composition useful in beverage capsules,Beverage compositions which are useful in beverage capsules may contain roast and ground coffee and dried coffee extract obtained by extracting coffee at a temperature below 60° C. Such capsules are useful for the preparation of coffee beverages in beverage preparation machines.,"<div class=""indep-clm"" num=""1""><seg-con>1. A method of producing a coffee beverage in a beverage preparation apparatus, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing a beverage capsule containing a dried roast and ground coffee mixture prepared by a process comprising the steps of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>roasting and grinding coffee beans into roast and ground coffee beans,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>extracting a portion of the roast and ground coffee beans with water at an extraction temperature below 60° C. to form a liquid extract, and drying the liquid extract to form a dried coffee extract,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>mixing a remainder of the roast and ground coffee beans with the dried coffee extract to form the dried roast and ground coffee mixture, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>filling a chamber of the beverage capsule with the dried roast and ground coffee mixture;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>inserting the beverage capsule into the beverage preparation apparatus which is adapted to receive the beverage capsule;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating, by the beverage preparation apparatus, water; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>injecting, by the beverage preparation apparatus, the water into the beverage capsule to form the coffee beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the water is injected into the beverage capsule at an injection temperature between 2° C. and 30° C.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>a ratio by weight of the remainder of the roast and ground coffee beans to the dried coffee extract is between 20:1 and 1:10.</seg-refi></","A23F5/40, A23F5/26, B65D85/804",20250107,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250000118A1,A chocolate product comprising a milk analogue product,"The invention relates to a reduced dairy chocolate product, preferably a vegan chocolate product composition comprising a dried emulsion of a plant protein.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a chocolate product, said method comprising</seg-main>
<seg-clauses>a. Adding plant protein to water to form a plant protein mixture;</seg-clauses>
<seg-clauses>b. Adding sugar, polyol, or one or more polysaccharides to mixtures thereof to the plant protein mixture;</seg-clauses>
<seg-clauses>c. Addition of an enzyme and an enzyme treatment</seg-clauses>
<seg-clauses>d. Dispersing a fat source in the plant protein mixture;</seg-clauses>
<seg-clauses>e. Homogenizing the plant protein mixture;</seg-clauses>
<seg-clauses>f. Applying a thermal treatment to form a plant-based liquid;</seg-clauses>
<seg-clauses>g. Drying the plant-based liquid to form a plant-based composition; and</seg-clauses>
<seg-clauses>h. Combining the dry composition with other ingredients to form a chocolate product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein is derived from a legume source.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the enzyme treatment is carried out using an amylase, preferably an alpha-amylase.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>step b. involves the addition of a mixture of a sugar and at least one polysaccharide.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar is selected from the group consisting of sucrose, fructose, glucose, dextrose, galactose, allulose, maltose, high dextrose equivalent hydrolysed starch syrup, xylose, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the polyol is selected fro","A23G1/44, A23G1/00, A23G1/36, A23G1/40, A23G1/42",20250102,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
EP4541728A1,Beverage preparation pod and beverage preparation capsule,"A beverage pod (10, 11) configured for preparing a beverage upon injection of liquid into the pod (10, 11) is provided. The pod (10, 11) comprises: a pouch (12) configured for holding beverage preparation ingredients therein; a ring-shaped support (14) extending at least partially around a top portion of the pouch (12), wherein the ring-shaped support (14) provides a top opening (16) of the pod (10, 11); and a lid (18) connected to the support (14) and/or the pouch (12) for closing the top opening (16), wherein the pod (10, 11) is configured for receiving liquid through the pouch (12) such that the liquid is mixed with the beverage preparation ingredients inside the pouch for forming a beverage, and wherein the lid (18) is configured for dispensing the beverage from an inside of the pouch (12) to an outside of the pod (10, 11).","<div class=""indep-clm"" num=""1""><seg-main>1.  A beverage pod (10, 11) configured for preparing a beverage upon injection of liquid into the pod (10, 11), the pod (10, 11) comprising: </seg-main><seg-clauses>- a pouch (12) configured for holding beverage preparation ingredients therein, </seg-clauses><seg-clauses>- a ring-shaped support (14) extending at least partially around a top portion of the pouch (12), wherein the ring-shaped support (14) provides a top opening (16) of the pod (10, 11), and </seg-clauses><seg-clauses>- a lid (18) connected to the support (14) and/or the pouch (12) for closing the top opening (16), </seg-clauses><seg-clauses>- wherein the pod (10, 11) is configured for receiving liquid through the pouch (12) such that the liquid is mixed with the beverage preparation ingredients inside the pouch for forming a beverage, and </seg-clauses><seg-clauses>- wherein the lid (18) is configured for dispensing the beverage from an inside of the pouch (12) to an outside of the pod (10, 11).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The pod (10, 11) of claim 1, wherein </seg-main><seg-clauses>the lid (18) is configured to be pierced by a pyramid plate (36), wherein the pyramid plate (18) is configured for creating a plurality of openings in the lid (18) for dispensing the beverage therethrough.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The pod (10, 11) of any one of claims 1-2, wherein </seg-main><seg-clauses>the pouch (12) includes a section having a first rigidity and the ring-shaped support (14) includes a section having a second rigidity higher than the first rigidity, preferably wherein the ring-shaped support (14) is a ring section of the pouch (12) and/or a separate ring element (20) connected to the pouch (12).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The pod (10, 11) of any one of claims 1-3, wherein </seg-main><seg-clauses>the pod (10, 11) is con",B65D85/804,20250423,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120152708A,Combination for brain health and improvement of mental performance,"The present invention relates to compositions comprising at least one of taurine and a vitamin B, in particular vitamin B9, for use in increasing glutathione levels in the brain and/or improving the sensations of mental performance such as motivated performance, and/or the ability to maintain concentration and persistent attention, and/or energy and viability.","<div class=""indep-clm"" num=""1"">1.一种组合物，所述组合物包含比率为约1:2500的牛磺酸:维生素B9。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，所述组合物用于在个体中增加脑中的谷胱甘肽水平和/或改善精神表现。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的组合物，所述组合物用于改善个体的动机表现、专注和/或持续注意力、疲劳。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的组合物，所述组合物还包含B族维生素中的至少一种。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的组合物，其中B族维生素中的所述至少一种选自维生素B6和/或维生素B12。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，其中牛磺酸和维生素B9以如下比率被包含，所述比率使得所述组合物中牛磺酸和维生素B9的相应量为约100mg和0.04mg、或120mg和0.05mg、或150mg和0.06mg、或200mg和0.08mg、或300mg和0.12mg、或400mg和0.16mg、或500mg和0.2mg、或600mg和0.24mg、或800mg和0.32mg、或1000mg和0.4mg、或2000mg和0.8mg、或3000mg和1.2mg。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">7.根据权利要求1至5中任一项所述的组合物，其中将牛磺酸以至少约500mg的量施用于人。</div>
<div class=""dep-clm"" num=""8"" parent=""5"">8.根据权利要求5所述的组合物，其中所述组合物还包含以下中的至少一者：</div>
<div class=""dep-clm"" num=""8"" parent=""5"">量为约0.2mg至约1.2mg的维生素B9，</div>
<div class=""dep-clm"" num=""8"" parent=""5"">量为约1.3mg至约7.8mg的维生素B6，</div>
<div class=""dep-clm"" num=""8"" parent=""5"">量为约2.4mcg至约14.4mcg的维生素B12。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的组合物，其中根据FDA指南，牛磺酸和/或所述维生素B中的至少一种以基于体表从人剂量到动物剂量的等效转换的量向动物或宠物施用。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的组合物，其中所述组合物呈食物组合物、膳食补充剂、营养组合物、营养制品、在食用前在水或乳中重构的粉末状营养产品、食品添加剂、药物、饮料和饮品的形式，包括基于咖啡的产品、口腔营养补充剂(ONS)、完整营养配方、药品、医疗或食物产品。</div>
<div class=""indep-clm"" num=""11"">11.根据前述权利要求中任一项所述的组合物在需要以下中的至少一项的健康个体中的用途：i)改善动机表现；ii)改善专注和/或持续注意力；</div>
<div class=""indep-clm"" num=""11"">iii)减少疲劳。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的组合物，所述组合物用于改善细胞保护作用和氧化应激。</div>","A61K31/185, A61K31/4415, A61K31/519, A61K31/714, A61P17/18",20250613,雀巢产品有限公司,['Pending']
EP4640045A2,Systems and methods for animal health monitoring,"The present disclosure provides systems and methods for animal health monitoring. Load data can be obtained from a plurality of load sensors associated with a platform carrying contained litter thereabove, wherein individual load sensors of the plurality of load sensors are separated from one another and receive pressure input from the platform independent of one another. If the load data is determined or not to be from an animal interaction with the contained litter, an animal behavior property associated with an animal is recognized if a determination is made based on load data that the interaction with the contained litter was due to the animal interaction. The animal behavior property is classified into an animal classified event using a machine learning classifier. A change in the animal classified event is identified as compared to a previously recorded event associated with the animal.","<div class=""indep-clm"" num=""1""><seg-con>1.  A method of monitoring health of an animal, under the control of at least one processor, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>obtaining load data from an animal monitoring device including a plurality of load sensors associated with a platform carrying contained litter thereabove, wherein individual load sensors of the plurality of load sensors are separated from one another and receive and communicate pressure input from the platform independent of one another; recognizing an animal behavior property associated with the animal based on the load data collected independently from the plurality of load sensors; classifying the animal behavior property into an animal classified event using a machine learning classifier, wherein classifying the animal behavior property includes using both a time domain based on a time domain feature and a frequency domain based on a frequency domain feature; and correlating the animal classified event with a physical, behavioral, or mental health issue associated with the animal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the time domain feature comprises a mean, a median, a standard deviation, a range, an autocorrelation, or a combination thereof, wherein the frequency domain features comprises a median, an energy, a power spectral density, or a combination thereof, and wherein both the time domain feature and the frequency domain feature are created as an input or inputs for the machine learning classifier.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.  The method of claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>classifying the animal behavior property includes using multiple time domain features, multiple frequency domain features, or both.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  The method of any",A01K1/01,20251029,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250228794A1,"Homovanillyl alcohol (HVA), HVA isomer, methods of making compositions comprising such compounds, and methods using such compounds","A composition contains at least one of homovanillyl alcohol (HVA) or its previously unidentified isomer (isoHVA). Additionally or alternatively, the composition contains a precursor of HVA and/or isoHVA (e.g., hydroxytyrosol, oleuropein aglycone, oleuropein, demethyloleuropein, oleuroside, verbascoside or mixtures thereof) and also contains at least one probiotic and/or at least one enzyme which convert the precursor to HVA and/or isoHVA in vivo (and/or an intermediate compound then subjected to methylation in vivo to form HVA and/or isoHVA). The composition can be administered to an individual to treat or reduce incidence of impaired mobility in an older adult; stimulate bone formation and/or inhibit bone resorption; treat or reduce incidence of synovitis in an individual in need or at risk thereof; treat or reduce incidence of articular cartilage degradation subsequent to synovitis in an individual having or recovering from synovitis; or treat or reduce incidence of cartilage breakdown.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating or preventing cartilage breakdown, or reducing incidence of cartilage breakdown, in an individual in need thereof, the method comprising:</seg-main>
<seg-clauses>orally administering to the individual a therapeutically or prophylactically effective amount of homovanillyl alcohol and/or 3-hydroxy-4-methoxyphenethanol.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the individual is an elderly individual.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the administration to the individual is daily for at least one month.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the orally administering to the individual is daily for at least one month.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the homovanillyl alcohol and/or 3-hydroxy-4-methoxyphenethanol is administered in a food composition comprising an enriched plant extract that provides at least a portion of the homovanillyl alcohol and/or 3-hydroxy-4-methoxyphenethanol.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The method of claim 5, wherein </seg-main><seg-clauses>the food composition is substantially free of at least one compound selected from the group consisting of verbascoside, luteolin-7-glucoside, apigenin-7-glucoside, diosmetin-7-glucoside, luteolin, diosmetin, rutin, catechin, tyrosol, hydroxytyrosol, vanillin, vanillic acid and caffeic acid.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""5""><seg-main>7. The method of claim 5, wherein </seg-main><seg-clauses>the enriched plant extract is enriched in the homovanillyl alcohol and/or 3-hydroxy-4-methoxyphenethanol.</seg-clauses></div>
<div ","A61K31/085, A23L33/00, A23L33/105, A23L33/135, A61K35/741",20250717,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025108867A1,Compositions comprising a combination of fisetin and oleuropein for use in treating bone disorders,The present invention relates to use of a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and fisetin and/or derivative for use to prevent or treat bone disorders or maintenance of bone health in an individual.,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1. Composition comprising </seg-main><seg-clauses>an effective amount of a combination of oleuropein and/or metabolite thereof and fisetin and/or derivative for use to prevent or treat bone disorders or maintenance of bone health in an individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The composition according to Claim 1, characterised in that said composition is suitable for oral administration.</div>
<div class=""indep-clm"" num=""3""><seg-main>3. The combination for use according to any preceding claim, wherein </seg-main><seg-clauses>the individual is a human or an animal, preferably wherein the animal is a pet.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2""><seg-main>4. The composition for use according to any preceding claim, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,4""><seg-main>5. The composition for use according to any preceding claim, wherein </seg-main><seg-clauses>the metabolite of fisetin is selected from the group consisting of glucuronidated forms thereof, sulfated forms thereof, derivatives and mixtures thereof, preferably gerardol.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,4,5"">6. The composition for use according to any preceding claim, further comprising calcium.</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,4,5,6""><seg-main>7. The composition for use according to any preceding claim, wherein </seg-main><seg-clauses>the composition further comprises at least one compound selected from the group consisting of antioxidants, anti-inflammatory compounds, glycosaminoglycans, prebiotics, fibres, probiotics, fatty acids, enzymes, minerals, ","A61K31/352, A61K31/7048, A61K31/05, A61K31/351, A61K33/06",20250530,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250176583A1,confectionery,The present invention relates to milk-based confectionery comprising an oligosaccharide mixture.,"<div class=""indep-clm"" num=""1""><seg-main>1. A chocolate product comprising:</seg-main>
<seg-clauses>a. a milk product comprising a carbohydrate mixture, wherein the milk product is present in an amount of between 0.5 wt % and 25 wt % of the chocolate product and the milk product comprises between 10 wt % and 90 wt % carbohydrate mixture based on the weight of the milk product, wherein the carbohydrate mixture comprises between 10 wt % and 100 wt % galactooligosaccharide,</seg-clauses>
<seg-clauses>b. a polyol present in an amount of between 10 wt % and 50 wt % of the chocolate product, and</seg-clauses>
<seg-clauses>c. a fibre present in an amount of between 0.5 wt % and 50 wt % of the chocolate product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the polyol is selected from the group comprising isomalt, sorbitol, maltitol, mannitol, xylitol, erythritol, threitiol, arabitol, lactitol, galactitol and hydrogenated starch hydrolysates and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the chocolate product comprises between 5 wt % and 20 wt % of the milk product.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the chocolate product comprises between 17 wt % and 45 wt % of the polyol.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>from 0 wt % to 15 wt % of the total carbohydrates in the mixture is lactose.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A chocolate product according to claim 1, wherein </seg-main><seg-clauses><seg-main>the carbohydrate mixture is a composition expressed as dry matter percentage by weight of the mixtu","A23G1/46, A23G1/40",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024266362A1,Nutritional composition,"The present invention provides a combination comprising or consisting of lacto-N- fucopentaose-l (LNFP-I), a LNFP-1 metabolizing Bifidobacterium, for example Bifidobacterium longum subsp. infantis and a galactose source, or a nutritional composition comprising lacto- N-fucopentaose-l (LNFP-I), aa LNFP-1 metabolizing Bifidobacterium, for example Bifidobacterium longum subsp. infantis and a galactose source, wherein the galactose source consists of a structure of Formula (I): Hex1(n)-Hex2(m) (Formula I) wherein: Hex1 is galactose, Hex2 is galactose or glucose, n = 1-9, and m = 1.","<div class=""indep-clm"" num=""1""><seg-main>1. A nutritional composition comprising </seg-main><seg-clauses>lacto-N-fucopentaose-l (LNFP-I), a LNFP-1 metabolizing Bifidobacterium, for example Bifidobacterium longum subsp. infantis, and a galactose source, wherein the galactose source consists of a structure of Formula I:</seg-clauses>
<seg-clauses class=""seg-enter"">Hex1(n)-Hex2(m) [Formula I]</seg-clauses>
<seg-clauses class=""seg-enter"">wherein:</seg-clauses>
<seg-clauses class=""seg-enter"">Hex1 is galactose,</seg-clauses>
<seg-clauses class=""seg-enter"">Hex2 is galactose or glucose,</seg-clauses>
<seg-clauses class=""seg-enter"">n = 1-9, and</seg-clauses>
<seg-clauses class=""seg-enter"">m = 1.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The nutritional composition according to claim 1, wherein </seg-main><seg-clauses>the LNFP-1 metabolizing Bifidobacterium is selected from the list consisting of: Bifidobacterium lactis, </seg-clauses><seg-clauses>B. longum, Bifidobacterium breve, </seg-clauses><seg-clauses>B. longum subsp. infantis, </seg-clauses><seg-clauses>B. longum subsp. iuvenis, </seg-clauses><seg-clauses>B. bifidum, </seg-clauses><seg-clauses>B. pseudocatenulatum, </seg-clauses><seg-clauses>B. kashiwanohense, and any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The nutritional composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the LNFP-1 metabolizing Bifidobacterium is Bifidobacterium longum subsp. infantis.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The nutritional composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the galactose source is selected from galacto-oligosaccharides (GOS), Bovine Milk-derived Oligosaccharides (BMOS) and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The nutritional composition according to any one of the prec","A23L33/135, A23L33/00, A23L33/21",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12357647B2,Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children,,,"A61K31/702, A23L33/00, A23L33/10, A23L33/125, A23L33/135",20250715,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025114776A1,Compositions and methods for increasing the palatability of dry pet food,,,"A23K20/26, A23K50/00, A23K50/42, A23L33/00, A23K40/30",20250605,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
CN120152623A,Dry animal digest composition,"The dry animal digest composition may include dry animal digest particles having an animal fat content of about 16% by weight or less and a moisture content of about 3% by weight or less. The dried animal digest particles in this example have a volume diameter particle size distribution in which D10 is from about 20 [mu] m to about 50 [mu] m, D50 is from about 60 [mu] m to about 150 [mu] m, and D90 is from about 160 [mu] m to about 275 [mu] m. In addition, the dried animal digest composition is substantially free of silica flow promoters.","<div class=""indep-clm"" num=""1"">1.干燥动物消化物组合物，所述干燥动物消化物组合物包含干燥动物消化物颗粒，所述干燥动物消化物颗粒具有约16重量％或更少的动物脂肪含量和约3重量％或更少的水分含量，其中所述干燥动物消化物颗粒具有体积直径粒度分布，其中D10为约20μm至约50μm，D50为约60μm至约150μm，并且D90为约160μm至约275μm，并且其中所述干燥动物消化物组合物基本上不含二氧化硅流动助剂。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的干燥动物消化物组合物，其中基于体积直径低于30μm的干燥动物消化物颗粒的百分比为3％至20％。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的干燥动物消化物组合物，其中基于体积直径低于45μm的干燥动物消化物颗粒的百分比为5％至25％。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物颗粒的体积平均直径为约60μm至约160μm。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的干燥动物消化物组合物，其中D10为约25μm至约40μm，D50为约75μm至约125μm，D90为约185μm至约250μm，或其组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物组合物完全不含所述二氧化硅流动助剂，并且还不含选自以下的化学流动助剂：粘土、面粉、粉煤灰、生石灰、淀粉、沸石、硅酸盐、硬脂酸盐、磷酸盐、多糖、脂肪酸盐、硅藻土、竹笋、玉米芯、豌豆纤维、豌豆壳、柑橘纤维、纤维素粉末、微晶纤维素或其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物颗粒为约40重量％至约80重量％的蛋白质和约10重量％至约16重量％的动物脂肪。</div>
<div class=""dep-clm"" num=""8"" parent=""1"">8.根据权利要求1所述的干燥动物消化物组合物，其中用于制备所述干燥动物消化物颗粒的动物组织的约80重量％至100重量％来自肝脏组织。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的干燥动物消化物组合物，其中用于制备所述干燥动物消化物颗粒的动物组织被预处理以去除动物脂肪。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物组合物的100重量％来自所述干燥动物消化物颗粒。</div>
<div class=""dep-clm"" num=""11"" parent=""1"">11.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物组合物的约25重量％至约99.99重量％来自所述干燥动物消化物颗粒，并且所述动物消化物组合物的约0.01重量％至约75重量％包含选自以下的一种或多种添加剂：磷酸盐化合物、焦磷酸盐化合物、焦磷酸四钠(TSPP)、胆碱化合物、氨基酸、维生素、益生菌、蛋黄和酵母。</div>
<div class=""dep-clm"" num=""12"" parent=""1"">12.根据权利要求1所述的干燥动物消化物组合物，其中所述干燥动物消化物颗粒包括酵母。</div>
<div class=""indep-clm"" num=""13"">13.宠物食物组合物，所述宠物食物组合物包含：</div>
<div class=""indep-clm"" num=""13"">粗磨食物；和</div>
<div class=""indep-clm"" num=""13"">施用于所述粗磨食物的干燥动物消化物组合物，其中所述干燥动物消化物组合物包含干燥动物消化物颗粒，其中基于所述宠物食物组合物的总重量计，所述宠物食物组合物包含约0.5重量％至约5重量％的所述干燥动物消化物颗粒，其中基于所述干燥动物消化物颗粒的总重量计，所述干燥动物消化物颗粒具有约16重量％或更少的动物脂肪含量和约3重量％或更少的水分含量，其中所述干燥动物消化物颗粒具有体积直径粒度分布，其中D10为约20μm至约50μm，D50为约60μm至约150μm，并且D90为约160μm至约275","A23K10/14, A23K10/26, A23K20/142, A23K20/147, A23K20/158",20250613,雀巢产品有限公司,['Pending']
CN120732160A,Infant nutrition containing hydrolyzed protein and palmitic acid,"The present invention relates to a composition for use in an infant or young child formula comprising a partially hydrolyzed protein and an oil mixture comprising palmitic acid wherein the palmitic acid esterified at the sn-2 position of the triacylglycerol is present in an amount of from 20% to 60% by weight of the total palmitic acid. Furthermore, the present invention relates to an infant formula comprising said composition and the use of said composition or infant formula.","<div class=""indep-clm"" num=""1"">1.一种用于婴儿或幼儿配方食品中的组合物，所述组合物包含部分水解的蛋白质和含被酯化成三酰基甘油的棕榈酸的油混合物，其中在所述三酰基甘油的sn-2位酯化的棕榈酸的量占总棕榈酸的20重量％至60重量％，并且在所述三酰基甘油的sn-1(3)位酯化的棕榈酸的量占总棕榈酸的40重量％至80重量％。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述部分水解的蛋白质为部分水解的乳清蛋白质。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的组合物，其中所述部分水解的蛋白质具有8％至24％的水解度。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，其中所述组合物还包含离子钙。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的组合物，其中所述离子钙为选自柠檬酸钙、氢氧化钙、氧化钙、氯化钙、碳酸钙、葡萄糖酸钙、磷酸钙、焦磷酸钙、三磷酸钙、甘油磷酸钙、乳酸钙和硫酸钙的一种或多种。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">6.根据权利要求4或5中任一项所述的组合物，其中所述组合物的离子钙含量为至少1.7mmo1/L。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的组合物，其中以总脂肪酸的总量计，所述油混合物的棕榈酸含量为至少8重量％。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的组合物，其中以重量计所述部分水解的蛋白质与所述sn-2棕榈酸酯之间的比率为1.5：1至35：1。</div>
<div class=""indep-clm"" num=""9"">9.一种婴儿配方食品，包含根据权利要求1至8中任一项所述的组合物。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的婴儿配方食品，其中所述油混合物的棕榈酸含量为8重量％至30重量％。</div>
<div class=""dep-clm"" num=""11"" parent=""9"">11.根据权利要求9所述的婴儿配方食品，其中所述部分水解的蛋白质的量占蛋白质总量的至少50％。</div>
<div class=""dep-clm"" num=""12"" parent=""1,9,10,11"">12.根据权利要求1至8中任一项所述的组合物或根据权利要求9至11中任一项所述的婴儿配方食品，用于向婴儿或幼儿施用以减少所述婴儿或幼儿的钙排泄。</div>
<div class=""dep-clm"" num=""13"" parent=""1,9,10,11"">13.根据权利要求1至8中任一项所述的组合物或根据权利要求9至11中任一项所述的婴儿配方食品，用于向婴儿或幼儿施用以改善钙稳态、增加钙吸收、增加钙存留、增加钙利用和/或减少棕榈酸皂形成。</div>
<div class=""dep-clm"" num=""14"" parent=""1,9,10,11"">14.根据权利要求1至8中任一项所述的组合物或根据权利要求9至11中任一项所述的婴儿配方食品，用于向婴儿或幼儿施用以软化粪便、预防粪便硬结和/或降低粪便硬结的风险、预防便秘和/或降低便秘的风险、改善喂养耐受性、降低哭闹不安的频率和持续时间、以及缓解消化不适和急腹痛。</div>
<div class=""dep-clm"" num=""15"" parent=""1,9,10,11"">15.根据权利要求1至8中任一项所述的组合物或根据权利要求9至11中任一项所述的婴儿配方食品，用于向婴儿或幼儿施用以改善睡眠持续时间、改善睡眠质量和量、改善婴儿和父母生活质量、以及减轻母亲焦虑。</div>
<div class=""dep-clm"" num=""16"" parent=""1,9,10,11"">16.根据权利要求1至8中任一项所述的组合物或根据权利要求9至11中任一项所述的婴儿配方食品，用于向婴儿或幼儿施用以增加骨矿化、增加骨强度和/或增加骨矿物质密度。</div>","A23L33/18, A23L33/12, A23L33/19, A23L33/16, A23L33/165",20251003,雀巢产品有限公司,['Pending']
US20250289701A1,Device for preparing and dispensing beverages with an improved arrangement of solenoid valves,"The invention concerns a machine (<b>10</b>) for preparing and dispensing beverages comprising at least one beverage preparation apparatus (<b>18</b>), which is designed for preparing and dispensing beverages, and at least one water supply apparatus (<b>20</b>), which is provided with one or more water delivering pipes (<b>22</b>) to the beverage preparation apparatus (<b>18</b>), and with one or more solenoid valves (<b>50, 52, 54</b>) each coupled to a respective water delivery pipe; wherein the solenoid valves (<b>50, 52, 54</b>) are positioned within an housing chamber at a door compartment of a main casing (<b>12</b>) to be immediately and easily accessible when the door (<b>16</b>) is open during respective adjustment and/or maintenance operations.","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing and dispensing beverages </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a main casing, able to define a housing chamber of a plurality of apparatuses of the machine and provided with at least one opening which defines a door compartment to said housing chamber;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one door, which is provided with an outer surface and an inner surface oriented towards said housing chamber, wherein said door is hinged to said main casing at a hinging axis and is configured to close said door compartment in the machine operating configuration;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one beverage preparation apparatus, which is designed for preparing and dispensing beverages;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one water supply apparatus, which is provided with one or more water delivering pipes to said beverage preparation apparatus, and with one or more solenoid valves each coupled to a respective water delivery pipe; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one additive substances feeding apparatus, which is provided with one or more additive substances delivering pipes to said beverage preparation apparatus;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein said beverage preparation apparatus comprises:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one mixing and dispensing nozzle; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one alcove, which is obtained on said door and which defines a seat open on the outer surface of said door to hold at least one container into which the beverage dispensed through said nozzle flows;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the solenoid valves are positioned within said housing chamber at the door co","B67D1/00, B67D1/08, B67D1/12",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020247196B2,Methods using medium chain triglycerides administered prior to a meal to decrease postprandial glucose from the meal,"A method reduces postprandial glucose from a meal. The method includes orally administering to an individual a composition containing medium chain triglycerides (MCT) and then subsequently orally administering the meal to the individual after the oral administration of the composition containing the MCTs and within about one hour of the oral administration of the composition containing the MCTs. For example, the meal can be administered about thirty minutes after the administration of the composition containing the MCTs. The postprandial glucose is reduced relative to postprandial glucose from (i) postprandial glucose from administration of an identically formulated composition containing MCTs at approximately the same time as the administration of the meal and (ii) postprandial glucose from administration of the meal without any MCTs within about one hour before or within about one hour afterward. The composition containing the MCTs can be a liquid oral nutritional supplement (ONS) providing incomplete nutrition.","<div class=""indep-clm"" num=""1""><seg-main>1.     A method of reducing postprandial glucose from a meal, the method</seg-main>
<seg-main class=""seg-enter"">comprising:</seg-main>
<seg-clauses>orally administering to an individual a composition comprising medium chain triglycerides (MCT); and</seg-clauses>
<seg-clauses class=""seg-enter"">subsequently orally administering the meal to the individual after the oral administration of the composition comprising the MCTs; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the meal is administered between about fifteen minutes after the administration of the composition comprising the MCTs and about forty minutes after the administration of the composition comprising the MCTs.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.     The method of claim 1 wherein </seg-main><seg-clauses>the individual has at least one condition</seg-clauses>
<seg-clauses class=""seg-enter"">selected from the group consisting of obesity, diabetes and pre-diabetes.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.     The method of claim 1 or claim 2 wherein </seg-main><seg-clauses>the individual is an aging</seg-clauses>
<seg-clauses class=""seg-enter"">subject.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4.     The method of claim 3 wherein </seg-main><seg-clauses>the individual is elderly.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.     The method of any one of claims 1 to 4 wherein </seg-main><seg-clauses>the composition</seg-clauses>
<seg-clauses class=""seg-enter"">comprising the MCTs is a liquid.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6.     The method of any one of claims 1 to 5 wherein </seg-main><seg-clauses>the composition is</seg-clauses>
<seg-clauses class=""seg-enter"">administered to the individual in a serving comprising at least about 15.0 g of the MCTs up to about 30.0 g of the MCTs.</seg-","A61K31/23, A61P3/10",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CA3025173C,Compositions and methods that modulate phosphorus or enzymes in a companion animal,"A specific type of organ health marker in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of organ health marker or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the specific type of organ health marker. The specific type of organ health marker can be one or more of phosphorus, alkaline phosphatase, aspartate aminotransferase, or gamma- glutamyltransferase.","CLAIMS: <div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>protein, carbohydrates, fat, fiber, and at least 8 distinct metabolites including at least 2 distinct metabolites for modulating each of phosphorus, alkaline phosphatase, aspartate aminotransferase, and gamma-glutamyltransferase in a companion animal; wherein the metabolite that modulates phosphorus is selected from the group consisting of homocysteine, erythritol, arabitol, betaine, N-acetylphenylalanine, 3-hydroxybutyrate (BHBA), citrulline, mannose, 2-oxindole-3-acetate, N-acetyltryptophan, glycerate, xylonate, threitol, 3-aminoisobutyrate, arachidonate (20:4n6), gamma-glutamylphenylalanine, phenylalanine, trigonelline (N1-methylnicotinate), allantoin, glutathione (oxidized (GSSG)), Nacetylserine, arabinose, and mixtures thereof; wherein the metabolite that modulates alkaline phosphatase is selected from the group consisting of lysine, gamma-glutamylphenylalanine, arabinose, phenylalanine, and mixtures thereof; wherein the metabolite that modulates aspartate aminotransferase is selected from the group consisting of 3-ureidopropionate, threitol, erythronate, gulono-l,4-lactone, Cglycosyltryptophan, urea, 2-hydroxyglutarate, butyrylcamitine, dimethylglycine, pseudouridine, eicosapentaenoate (EPA; 20:5n3), uracil, 1-linoleoylglycerophosphoinositol, dihomo-linolenate (20:3n3 or n6), phosphate, and mixtures thereof; wherein the metabolite that modulates gamma-glutamyltransferase is selected from the group consisting of 3-aminoisobutyrate, trigonelline (N'-methylnicotinate), N-acetylserine, taurochenodeoxycholate, erythritol, 15-methylpalmitate, allantoin, taurocholate, threitol, 3- phosphoglycerate, betaine, arabitol, sebacate (decanedioate), stachydrine, citrulline, citrate, glycolate (hydroxyacetate), campesterol, and mixtures thereof; wherein the pet food composition provides at least a 5% increase or at least a 5% decrease in the amount","A23K10/00, A23K20/142, A23K20/153, A23K20/158, A23K50/40",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
JP2025122083A,Compositions and methods to treat or prevent metabolic fatigue using at compound oleuropein or metabolite thereof,"To provide a method of treating or preventing a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.SOLUTION: There is provided a method for achieving at least one result selected from the group consisting of (i) improvement in a physiological state linked to metabolic fatigue in one or more cells, (ii) increased mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) treatment or prevention of a calcium deficiency/depletion disorder, the method comprises orally administering an effective amount of at least one of oleuropein or metabolite thereof to an individual.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> （ｉ）１つ以上の細胞における代謝疲労に関連する生理学的状態の改善、（ｉｉ）１つ以上の細胞におけるミトコンドリアエネルギー及びミトコンドリアカルシウム取り込みの増加、並びに（ｉｉｉ）カルシウム欠乏／枯渇障害の治療又は予防、からなる群から選択される少なくとも１つの結果を達成するための方法であって、</div>
<div class=""indep-clm"" num=""1""> 有効量のオレウロペイン又はその代謝産物のうちの少なくとも１つを、個体に経口投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記１つ以上の細胞のうちの少なくとも一部分が、肝臓、腎臓、脳、及び骨格筋からなる群から選択される少なくとも１つの身体部分の一部である、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記代謝疲労に関連する生理学的状態に、筋疲労又は筋力低下、エネルギーの欠如、身体的エネルギーの欠如、体力の欠如又は体力低下が含まれる、請求項１又は２に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記有効量のオレウロペイン又はその代謝産物のうちの少なくとも１つを、少なくとも１週間、毎日経口投与する、請求項１～３のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記オレウロペインの代謝産物が、オレウロペインアグリコン、ヒドロキシチロソール、ホモバニリルアルコール、イソホモバニリルアルコール、これらのグルクロン酸抱合形態、これらのサルフェート形態、これらの誘導体、及びこれらの混合物からなる群から選択される、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記有効量のオレウロペイン又はその代謝産物のうちの少なくとも１つを、食品組成物、ダイエタリーサプリメント、栄養組成物、ニュートラシューティカルズ、飲料、摂取前に水又はミルクで再構成される粉末栄養製品、食品添加物、医薬、ドリンク、ペットフード、及びこれらの組み合わせからなる群から選択される組成物で投与する、請求項１～５のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記有効量のオレウロペイン又はその代謝産物のうちの少なくとも１つを、カルシウムを更に含む組成物で投与する、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記有効量のオレウロペイン又はその代謝産物のうちの少なくとも１つを、タンパク質、炭水化物、脂肪、及びこれらの混合物からなる群から選択される成分を更に含む食品製品で投与する、請求項１～７のいずれか一項に記載の方法。 </div>
<div class=""indep-clm"" num=""9"">【請求項9】</div>
<div class=""indep-clm"" num=""9""> ミトコンドリア関連疾患又はミトコンドリア機能の変化に関連する状態を、それらの処置を必要としている個体において又はそれらのリスクがある個体において、治療又は予防","A23L33/10, A23L33/105, A61K31/7048, A61K31/05, A61P1/16",20250820,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
CN119894783A,Beverage or food preparation system,"A container for use with a beverage or food preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by the machine to process the precursor material, the code being readable by a code reading system of the machine, the code reading system comprising: an illumination system for projecting emitted light to the code; and a camera system for obtaining a digital image of a code, the code being arranged to overlap with the precursor material; and a support layer supporting a code, the support layer being at least partially transparent to emitted light from the lighting system, the code comprising: an absorbing layer configured to absorb the emitted light and a reflecting layer configured to reflect the emitted light, the reflecting layer being arranged to reflect the emitted light before the emitted light is transmitted to the support layer.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于与饮料或食品制备机器一起使用的容器，所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>储存部分，所述储存部分用于容纳前体材料；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码，所述代码用于存储由所述机器用来处理所述前体材料的制备信息，所述代码被配置为能够由所述机器的代码读取系统读取，所述代码读取系统包括照明系统，所述照明系统用于将发射光投射到所述代码，所述代码被布置成与所述前体材料重叠，使得来自所述照明系统的发射光投射到所述前体材料中；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述代码包括：被配置为吸收所述发射光的吸收层和被配置为反射所述发射光的反射层，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述容器进一步包括支撑所述代码的支撑层，所述支撑层由对来自所述照明系统的所述发射光至少部分透明的材料制成，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述反射层被布置成在所述发射光被透射到所述支撑层之前反射所述发射光。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的容器，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述反射层是连续的；</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述反射层连接到所述支撑层以邻接所述支撑层；并且</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述支撑层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，并且其中，当在所述平面中观察时所述反射层与整个所述支撑层重叠。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-comp>所述支撑层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，所述深度方向从外表面延伸；</seg-comp><seg-comp>并且</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-comp>所述吸收层在所述深度方向上布置在所述反射层与所述外表面之间，使得所述吸收层相对于所述反射层最接近所述外表面；并且</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-comp>所述反射层在所述深度方向上布置在所述支撑层与所述外表面之间。</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述容器的包括所述支撑层和所述代码的部分被配置为当每个穿透器受到大于5N至15N的力时能够被一个或多个穿透器穿透，每个穿透器具有成70度至30度的尖端。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述支撑层具有50微米至150微米的厚度。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中：</",B65D85/804,20250425,雀巢产品有限公司,['Pending']
CA3021169C,MCT-based nutrition blend for cardiac protection and treating degenerative mitral valve disease in companion animals,"A method of treating degenerative mitral valve disease (DMVD) in a companion animal having DMVD, a method of preventing DMVD in a companion animal at risk thereof, and a method of maintaining or improving cardiac health in a companion animal. The methods include orally administering to the companion animal a composition containing medium chain triglycerides and optionally one or more of omega-3 fatty acids, vitamin E, lysine, taurine, magnesium, or sulfur-containing amino acids.","﻿CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. Use of a composition comprising </seg-main><seg-clauses><seg-main>a therapeutically effective amount of medium chain triglycerides for treating degenerative mitral valve disease (DMVD) in a companion animal previously identified as being at risk of DMVD by a factor selected from the group consisting of </seg-main><seg-clauses>(i) a measured concentration of N-terminal pro B-type natriuretic peptide in the companion animal, </seg-clauses><seg-clauses>(ii) a detected enlarged heart of the companion animal, </seg-clauses><seg-clauses>(iii) a detected heart murmur in the companion animal, </seg-clauses><seg-clauses>(iv) a identified history of one or more of coughing, exercise intolerance, decreased appetite, difficulty breathing, or temporary loss of consciousness caused by a fall in blood pressure in the companion animal, </seg-clauses><seg-clauses>(v) the companion animal was identified as a small breed, </seg-clauses><seg-clauses>(vi) detected mitral regurgitation, </seg-clauses><seg-clauses>(vii) measured changes in serotonin, transforming growth factor beta, or nitric oxide signaling pathways, </seg-clauses><seg-clauses>(viii) measured changes in energy metabolism, and </seg-clauses><seg-clauses>(ix) combinations thereof. </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The use of claim 1, wherein </seg-main><seg-clauses>the measured changes in energy metabolism (viii) are compromised long chain fatty acid beta-oxidation, compromised branched chain fatty acid alpha¬ oxidation, compromised ketolysis or increased glucose intake and glycolysis. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The use of Claim 1 or 2, wherein </seg-main><seg-clauses>the composition further comprises a component selected from the group consisting of an omega-3 fatty acid, Vitamin E, magnesium, lysine, a sulfur-containing amino acid, and mixtures thereof. </seg-clauses></d","A23K10/00, A23K20/158, A23K50/40",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019411483B2,A nutritional composition comprising 2'-Fucosyllactose (2' FL) to improve the gastrointestinal barrier,"The present invention relates to nutritional compositions comprising 2'- Fucosyllactose (2'FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving a gastrointestinal barrier in a subject </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>an infant (child under the age of 12 months), a young child (between 1 year and less than 3 years), or a child (aged from 3 years to less than 8 years), the method comprising administering a nutritional composition comprising 2'-Fucosyllactose (2'FL) to the subject, wherein said improvement to the gastrointestinal barrier is improved barrier protection, and wherein 2'FL is present in an amount of 0.25 to 1.9 g/L or 0.15 to 1.5 g/lOOg of the nutritional composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>2'FL is present in an amount of 0.75 to 1.65 g/L or 0.19 to 1.5 g/lOOg of the nutritional composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said improving the gastrointestinal barrier comprises improving the prevention of barrier dysfunction, improving the prevention of barrier leakiness, improving the protection of tight junction structure, and improving the protection of the intestinal epithelial lining integrity.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said prevention of barrier leakiness is prevention of pathogens, allergens and/or toxic compounds to migrate from the gut into the body through the gastrointestinal barrier.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The method according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said improvement, said prevention and/or said protection is achieved by downregulation of TNF","A23L33/00, A23C9/20, A23L33/21, A61K31/702, A61P1/00",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250082128A1,Beverage preparation with simple capsule transfer,"A machine (<b>1</b>) is configured to prepare a beverage from a capsule (<b>5</b>) having a body containing an ingredient The beverage is prepared by circulating a liquid into the capsule and centrifugally driving the capsule. The machine has a first capsule handler (<b>10</b>) and a second capsule handler (<b>20</b>) that are movable one relative to the other from a capsule transfer configuration to a capsule processing configuration for centrifuging the capsule (<b>5</b>) by rotation about a processing axis (<b>30</b>′) of the first and second capsule handlers (<b>10,20</b>). The machine has a capsule insertion passage (<b>60</b>) associated with one or more capsule insertion guides (<b>61</b>) configured to guide the capsule (<b>5</b>) towards a capsule holding position in a space (<b>100</b>′) between the first and second capsule handlers (<b>10,20</b>) in their transfer configuration. The capsule insertion guide(s) (<b>61</b>) comprise(s) at least a rotatable portion (<b>38</b>) that is stationary relative to at least one of the first and second capsule handlers (<b>10,20</b>) and rotates therewith when the first and second capsule handlers (<b>10,20</b>) are rotated for centrifugation.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule processing machine for preparing a beverage from a capsule </seg-con><seg-trans>having </seg-trans><seg-refi>a body containing an ingredient by circulating a liquid into such capsule and centrifugally driving such capsule, comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first capsule handler and a second capsule handler that are movable one relative to the other from:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule transfer configuration for receiving said capsule by the first and second capsule handlers and/or releasing said capsule from the first and second capsule handlers; to</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule processing configuration for centrifuging said capsule by rotation about a processing axis of the first and second capsule handlers; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule insertion passage associated with one or more capsule insertion guides configured to guide said capsule towards a capsule holding position in a space between the first and second capsule handlers in their transfer configuration, for instance the space being associated with a holding device, such as one or more stop members configured to hold said capsule in the space prior to being held by at least one of the first and second capsule handlers relatively moving towards and/or into the capsule processing configuration,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the first and second capsule handlers are rotated for centrifugation and which supports the first and second capsule handlers,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the capsule insertion guide(s) comprise(s) at least a rotatable portion that is stationary relative to at least one of the first and second capsule handlers and rotates therewith when the first and second capsule handlers","A47J31/40, A47J31/22, A47J31/44",20250313,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250331505A1,Methods of monitoring feeding behaviors of pets,"The present disclosure relates to the monitoring feeding behavior(s) of a pet(s), under the control of at least one processor. An example system includes a pet bowl comprising a load sensor configured to obtain load data while the pet is interacting with contents of the pet bowl. The load sensor can have a sensitivity of +/−50 grams or less and the load data can occur at a sample rate from 10 samples to 150 samples per second. The system also includes a processor configured to sequentially group the load data in 0.01 second to 5 second time increments. The individual time increments can include multiple samples. The processor can also identify a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.","<div class=""indep-clm"" num=""1""><seg-con>1. A system for monitoring feeding behavior of a pet, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pet bowl comprising a load sensor configured to obtain load data while the pet is interacting with contents of the pet bowl, wherein the load sensor has a sensitivity of +/−50 grams or less and the load data is obtained at a sample rate from 10 samples to 150 samples per second;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processor configured to sequentially group the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the processor further configured to identify a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the processor is further configured to exclude load data in identifying the feeding behavior if determined to be a result of human interaction, a false trigger, or an accidental interaction with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the feeding behavior is a count-based feeding behavior selected from lapping, licking, or biting.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The system of claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the processor is further configured to characterize the count-based feeding behavior by counting individual micro-events of the feeding behavior within a single time increment or a time period spanning multiple time increments, wherein the individual micr",A01K29/00,20251030,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250326568A1,Kit for the preparation of a beverage in a centrifugal brewing device,"Kit for preparation of a beverage in a centrifugal brewing device by feeding liquid in a capsule and rotating the capsule along a central axis to produce centrifugal forces on the liquid traversing the capsule thereby forcing the beverage out of the capsule by such centrifugal forces. The capsule includes containment walls forming a main cavity of central axis containing beverage ingredients. The kit also includes an insert which is separate from the capsule, and the insert has a ring-shaped portion intended to form a valve engaging portion engaging against a valve of the centrifugal brewing device.","<div class=""indep-clm"" num=""1""><seg-con>1: A kit to be inserted in a centrifugal brewing device, the kit </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule configured for preparation of a beverage in the centrifugal brewing device by feeding liquid in the capsule and rotating the capsule along a central axis to produce a centrifugal force on the liquid traversing the capsule to force the beverage out of the capsule by the centrifugal force, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the capsule comprises containment walls forming a main cavity of the central axis; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the kit further comprising an insert independent from the centrifugal brewing device and which is separate from the capsule,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert comprises a ring-shaped portion forming a valve engaging portion configured for engagement against a valve means of the centrifugal brewing device,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert further comprises transversal annular or circular portion which is inwardly and integrally connected to the ring-shaped portion,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert is hollow at and around the central axis, and the transversal annular or circular portion has one or more through-openings for allowing liquid flow outwardly or through the insert, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the ring-shaped portion extends axially beyond above and/or below the transversal annular or circular portion and has an outer diameter larger than the largest diameter of the capsule.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The kit of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ring-shaped portion has a structure in relief and/or recess on an upper surface and/or a lower surface thereof, the ","B65D85/804, A23F5/26, A47J31/22, A47J31/36",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119255734A,Beverage pouch system with pouch identification,"The invention relates to an extraction device for extracting a beverage ingredient from a capsule (3), said capsule (3) comprising a code (34), said device comprising:-upstream and downstream capsule enclosing parts (1, 2), the upstream and downstream capsule encapsulating parts are relatively movable between an open position and a closed position for inserting and removing the capsule (3); the invention relates to a device (1) comprising a path (41), a code reader (71),-a removable capsule stent (6),-a top insertion section (4) for introducing the capsule stent (6) into the device,-a capsule stent stop (42) for stopping the capsule stent (6) in an intermediate temporary position inside said path (41), and wherein in the intermediate temporary position, the capsule stent (6) is inserted into the path (41). The bag holder (6) is configured to hold the bag such that the code (34) arranged on the bag faces the code reader (71), and wherein during introduction of the bag holder into the device, when the bag holder reaches the intermediate temporary position, an operation of reading the code by the code reader is triggered by movement of the bag holder (6).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于通过将提取液体供应到囊包中来提取饮料配料的提取装置，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述囊包(3)</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-囊包主体(31)，所述囊包主体包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>侧壁(311)和底部壁(313)，所述侧壁和所述底部壁限定腔室，所述腔室在底部和顶部开口(312)之间轴向地延伸，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部封盖(32)，所述顶部封盖封闭所述囊包主体的所述顶部开口，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-机器可读代码(34)，所述机器可读代码存储制备信息，所述代码布置在所述囊包上，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述装置包括上游囊包包封部件和下游囊包包封部件(1,2)，所述上游囊包包封部件和所述下游囊包包封部件能够沿水平纵向轴线(XX')在用于插入和移除所述囊包(3)的打开位置和用于在提取期间形成包封所述囊包的提取室(5)的闭合位置之间相对移动，优选地能够相对平移，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述装置包括代码读取器(71)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述装置包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-能够移除的囊包支架(6)，所述支架包括用于接收和保持所述囊包的囊包接收孔(61)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部插入部段(4)，所述顶部插入部段被构造用于将所述囊包支架(6)引入所述装置中，所述顶部插入部段包括路径(41)，以用于将所述囊包支架引导到所述上游囊包包封部件和所述下游囊包包封部件(1,2)之间的提取区域，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-囊包支架止动器(42)，所述囊包支架止动器用于将所述囊包支架(6)停止在所述路径(41)内部的中间临时位置，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，在所述中间临时位置，所述囊包支架(6)被构造为保持所述囊包，使得布置在所述囊包上的所述代码(34)面向所述代码读取器(71)，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中在将所述囊包支架引入所述装置中期间，当所述囊包支架到达所述中间临时位置时，通过所述囊包支架(6)的移动触发所述代码读取器读取所述代码的操作。</seg-refi></div>
<div class=""indep-clm"" num=""2"">2.根据前一权利要求所述的提取装置，其中所述囊包接收孔(61)和所述顶部插入部段(4)被构造为当所述囊包支架(6)在中间位置时，将所述代码(34)定向在所述代码读取器(71)的前方。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的提取装置，其中所述代码读取器(71)能够在以下两者之间移动：</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-回缩位置，在所述回缩位置处，所述代码读取器定位在所述插入部段的所述路径(41)之外，和</div>
<div class=""dep-clm"" num=""3"" ",A47J31/44,20250103,雀巢产品有限公司,['Pending']
WO2025103921A1,"Package comprising a face comprising a removable section comprising a pull TAB, and methods of making and using such a package","An opening arrangement includes a substantially planar top face and a tearable foil membrane underneath the top face. The top face contains a removable portion. A first section of the removable portion is not sealed to the tearable foil membrane, and a second section of the removable portion is sealed to an opening-forming portion of the tearable foil membrane. The opening arrangement further includes an extended sealing flange extending outward and/or upward from adjacent the removable portion of the top face and adjacent the opening-forming portion of the tearable foil membrane. The opening arrangement is configured for a user to pull the first section of the removable portion of the top face to remove the removable portion while the opening-forming portion of the tearable foil membrane remains sealed to the removable portion, and the opening-forming portion is removed in one piece with the removable portion, to thereby form an opening extending completely through the opening arrangement.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An opening arrangement comprising </seg-main><seg-clauses><seg-main>a substantially planar top face, and the opening arrangement further comprising a tearable foil membrane underneath the top face, wherein the top face comprises a removable portion, a first section of the removable portion is not sealed to the tearable foil membrane, and a second section of the removable portion is sealed to an opening-forming portion of the tearable foil membrane, wherein the opening arrangement further comprises an extended sealing flange extending outward and/or upward from adjacent the removable portion of the top face and adjacent the opening-forming portion of tearable foil membrane, wherein the opening arrangement is configured for a user to pull the first section of the removable portion of the top face to remove the removable portion while the opening-forming portion of the tearable foil membrane remains sealed to the removable portion, and the openingforming portion is removed in one piece with the removable portion, to thereby form an opening extending completely through the opening arrangement, wherein one or more of </seg-main><seg-clauses>(a) the removable portion of the top face, </seg-clauses><seg-clauses>(b) the opening-forming portion of the tearable foil membrane, or </seg-clauses><seg-clauses>(c) the opening in the opening arrangement formed by removal of the removable portion and the opening-forming portion of the tearable foil membrane, has a lateral sides having a width which continuously increases as the lateral sides extends from the center of the opening arrangement toward the extended sealing flange.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The opening arrangement of Claim 1 , wherein </seg-main><seg-clauses>the removable portion in the top face is substantially coplanar with the remainder of the top face and/or does not overlap any portion of the remainder of ",B65D77/20,20250522,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025180996A1,Methods of determining a perceived immune fitness of an individual,"The present disclosure provides a method of identifying and/or quantifying a perceived immune fitness of an individual. The method comprises identifying a frequency and/or a severity of one or more conditions experienced by an individual. The one or more conditions includes sore throat, headaches, flu, runny nose, coughing, cold sores, boils, mild fever, warts, pneumonia, bronchitis, sinusitis, sudden high fever, ear infection, diarrhea, meningitis, eye infection, sepsis, long healing injuries, shortness of breath, skin problems, muscle and joint pain, and common cold. The method further includes calculating a perceived immune fitness score of the individual based on up to 10 of the one or more conditions with the highest frequency and/or severity.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of identifying and/or quantifying a perceived immune fitness of an individual, the method comprising: </seg-main><seg-clauses>identifying a frequency and/or a severity of one or more conditions experienced by an individual, wherein the one or more conditions is selected from the group consisting of: sore throat, headaches, flu, runny nose, coughing, cold sores, boils, mild fever, warts, pneumonia, bronchitis, sinusitis, sudden high fever, ear infection, diarrhea, meningitis, eye infection, sepsis, long healing injuries, shortness of breath, skin problems, muscle and joint pain, and common cold; and calculating a perceived immune fitness score of the individual based on up to 10 of the one or more conditions with the highest frequency and/or severity.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the calculating of the perceived immune fitness score of the individual is further based on a sex of the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of any one of claims 1 and 2, wherein </seg-main><seg-clauses>the calculating of the perceived immune fitness score of the individual is further based on an age of the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of any one of claims 1-3, wherein </seg-main><seg-clauses>the perceived immune fitness score of the individual is determined one or more times at discrete intervals.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method of any one of claims 1-4, the method comprising </seg-main><seg-clauses>assigning a value to each of the one or more conditions experienced by the individual, the value representative of the frequency and/or the severity of the corresponding condition, and the value of each of the one or more conditions is on a scale of 1 ","G16H20/60, G16H50/20, G16H50/30",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025026962A1,Capsule for the preparation of a beverage,"A biodegradable and/or compostable capsule for use with a beverage preparation machine (10) for preparing a beverage and/or foodstuff thereof is disclosed. The capsule comprises a cup-shaped body (1) and a closing membrane (2) for closing the cup-shaped body, both elements defining a closed cavity for a beverage and/or foodstuff ingredient, preferably roast and ground coffee, and a liner (20) or a coating having barrier function providing barrier function to the cup-shaped body. The cup-shaped body is made of cellulose-based material, preferably molded pulp-based material and comprises a bottom wall (4), a tubular lateral side wall (5), an annular flange (3) connected to the lateral wall for the closing membrane to seal thereon, and an outwardly extending rim portion (6) connected to the annular flange. The rim portion is made of cellulose-based material and comprises a curved and/or curled end portion (6A) comprising a treated region in which the cellulose-based material has a porosity that is less than 40%, preferably between 0% to 25%.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A capsule for use with a beverage preparation machine (10) for preparing a beverage and/or foodstuff thereof, the capsule is biodegradable and/or compostable and comprises: </seg-main><seg-clauses>a cup-shaped body (1) and a closing membrane (2) for closing the cup-shaped body (1), the cup-shaped body (1) and the closing membrane </seg-clauses><seg-clauses>(2) defining a closed cavity for holding a beverage and/or foodstuff ingredient, preferably roast and ground coffee, and a liner (20) or coating having barrier function providing barrier function to the cup-shaped body (1); said cup-shaped body (1) is made of cellulose-based material, preferably pulp-base material, and comprises a bottom wall (4), a tubular lateral side wall (5), an annular flange (3) connected to the lateral wall (5) for the closing membrane (2) to seal thereon, and an outwardly extending rim portion (6) connected to the annular flange (3), characterized in that the rim portion (6) is made of cellulose-based material and comprises a curved and/or curled end portion (6A) comprising a treated region (6B) in which the cellulose-based material has a porosity that is less than 40%, preferably between 0% to 25%.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule according to claim 1, characterized in that </seg-main><seg-clauses>the rim portion (6) is integrally made with the annular flange (3) which is also made of cellulose-based material.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The capsule according to any of claims 1 or 2, characterized in that </seg-main><seg-clauses>the treated region (6B) extends over the entire rim portion (6) or is limited to a portion of the rim portion (6).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. The capsule according to any of the preceding claims, wherein </seg-main><seg-clauses>the treated region (6B) is a compressed re","B65D85/804, A47J31/36, B65D65/46",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US12213618B2,Beverage preparation machine,"The invention concerns a beverage preparation machine (<b>1</b>) in which the beverage is prepared by introducing at least one jet of liquid, such as water, in a container (<b>2</b>) comprising a beverage ingredient (<b>3</b>), said machine comprising a nozzle (<b>11</b>) connected to a liquid supplying system (<b>12</b>), said nozzle comprising a tube (<b>110</b>), said tube comprising a liquid inlet (<b>111</b>) and a liquid outlet (<b>112</b>), the jet of liquid emerging from said liquid outlet, wherein the nozzle (<b>11</b>) comprises a sleeve (<b>120</b>), said sleeve presenting an internal section (Ss) greater than the internal section (So) of the liquid outlet end of the tube and said sleeve surrounding the jet of liquid emerging from the liquid outlet (<b>112</b>) of the tube.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for preparing a beverage with a beverage preparation machine, the beverage preparation machine </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one nozzle connected to a liquid supplying system, the at least one nozzle comprising a tube, the tube comprising a liquid inlet and a liquid outlet, wherein the at least one nozzle further comprises a sleeve, the sleeve presenting an internal section greater than an internal section of the liquid outlet of the tube, and the sleeve surrounding the liquid outlet of the tube, and wherein the sleeve comprises at least one opening in a lateral wall of the sleeve, the opening being positioned near the liquid outlet end of the tube, the method comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>introducing a beverage ingredient in a container in the beverage preparation machine;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>introducing at least one jet of liquid into the container through the liquid outlet of the at least one nozzle, wherein the sleeve surrounds the at least one the jet of liquid emerging from the liquid outlet; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sucking air through the at least one opening into the sleeve such that the air in the sleeve is flowing in the sleeve around the at least one jet of liquid, wherein the at least one jet of liquid enters inside the beverage in preparation, carrying along air bubbles in the beverage and producing foaming.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>further comprising, </seg-trans><seg-refi>before the introducing of the at least one jet of liquid, measuring the height of the container.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>moving, during the introducing","A47J31/46, A47J31/40",20250204,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019384322B2,"Beverages having clear appearance, shelf stability, high protein, and neutral pH","A method of making a beverage includes adding one or more other ingredients to hydrolyzed protein to form the beverage, which is clear, shelf-stable, and high protein and has a neutral pH and an energy content of at least about 100 kcal per 240 ml of the beverage. Optionally the hydrolyzed protein is obtained by subjecting protein to a protease. In some embodiments, the high protein is at least about 15 g or at least about 20 g of protein/100 kcal, and in some embodiments the energy content is at least about 150 kcal/240 ml or at least about 200 kcal/240 ml. Other aspects are directed to the resultant beverage, a method of producing a high protein beverage containing hydrolyzed protein, a method of increasing transparency in a high protein beverage containing hydrolyzed protein, and a method of providing nutrition to an individual.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of making a beverage, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>hydrolyzing protein with a protease; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>adding one or more other ingredients to the hydrolyzed protein to form the beverage, which has clear appearance, shelf-stability, high protein, a neutral pH and an energy content of at least about 100 kcal per 240 ml of the beverage,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the high protein in the beverage is 10 g to 25 g protein/100 kcal of the beverage; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the one or more other ingredients comprise sugar in an amount up to 25% of the energy content of the beverage.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the protease is selected from the group consisting of trypsin, chymotrypsin, pancreatin, papain, bromelain, and pepsin and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method of claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the energy content is about 100 kcal to about 360 kcal per 240 ml of the beverage, preferably wherein the energy content is about 100 kcal to about 300 kcal per 240 ml of the beverage, more preferably wherein the high protein in the beverage is about 10 g to about 20 g protein/100 kcal of the beverage and the energy content is about 100 kcal to about 200 kcal per 240 ml of the beverage.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The method of any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage comprises the protease.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The","A23L2/66, A23F3/00, A23L2/84, A23L33/18",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
JP2025098243A,Meal plan recommendation system based on patient,,,G16H10/00,20250701,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Inactive']
CN119384285A,Application of bifidobacterium longum transition type microorganism,Treating and/or preventing allergy and/or allergic sensitization. The present invention relates to a Bifidobacterium longum transition microorganism for use in the treatment and/or prevention of allergies and/or allergic sensitization in infants or young children.,"<div class=""indep-clm"" num=""1"">1.长双歧杆菌过渡型微生物，所述长双歧杆菌过渡型微生物用于治疗和/或预防婴儿或幼儿的变态反应和/或变态反应性致敏。</div>
<div class=""indep-clm"" num=""2"">2.益生元，所述益生元用于通过促进长双歧杆菌过渡型微生物在婴儿或幼儿的肠道中的生长和/或存活来治疗和/或预防所述婴儿或幼儿的变态反应，其中所述益生元是：</div>
<div class=""indep-clm"" num=""2"">i.聚糖底物，所述聚糖底物适当地选自表1至表3中任一者列举的组；和/或</div>
<div class=""indep-clm"" num=""2"">ii.人乳低聚糖(HMO)，所述人乳低聚糖(HMO)适当地选自由2'-O-岩藻糖基乳糖(2'-FL)、3'-O-岩藻糖基乳糖(3'-FL)、乳糖二岩藻四糖/二岩藻糖基乳糖(di-FL)、3'-O-唾液酸乳糖(3'-SL)、6'-O-唾液酸乳糖(6'-SL)、乳糖-N-四糖(LNT)和乳糖-N-新四糖(LNnT)以及它们的任何组合组成的组。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述使用的长双歧杆菌过渡型微生物，其中所述长双歧杆菌过渡型微生物与益生元结合地使用，并且其中所述益生元是：</div>
<div class=""dep-clm"" num=""3"" parent=""1"">i.聚糖底物，所述聚糖底物适当地选自表1至表3中任一者列举的组；和/或</div>
<div class=""dep-clm"" num=""3"" parent=""1"">ii.人乳低聚糖(HMO)，所述人乳低聚糖(HMO)适当地选自由2'-O-岩藻糖基乳糖(2'-FL)、3'-O-岩藻糖基乳糖(3'-FL)、乳糖二岩藻四糖/二岩藻糖基乳糖(di-FL)、3'-O-唾液酸乳糖(3'-SL)、6'-O-唾液酸乳糖(6'-SL)、乳糖-N-四糖(LNT)和乳糖-N-新四糖(LNnT)以及它们的任何组合组成的组。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述使用的益生元，其中所述益生元与长双歧杆菌过渡型微生物结合地使用。</div>
<div class=""indep-clm"" num=""5"">5.长双歧杆菌过渡型微生物和益生元的组合，所述组合用于治疗和/或预防婴儿或幼儿的变态反应和/或变态反应性致敏；其中所述益生元是：</div>
<div class=""indep-clm"" num=""5"">i.聚糖底物，所述聚糖底物适当地选自表1至表3中任一者列举的组；和/或</div>
<div class=""indep-clm"" num=""5"">ii.人乳低聚糖(HMO)，所述人乳低聚糖(HMO)适当地选自由2'-O-岩藻糖基乳糖(2'-FL)、3'-O-岩藻糖基乳糖(3'-FL)、乳糖二岩藻四糖/二岩藻糖基乳糖(di-FL)、3'-O-唾液酸乳糖(3'-SL)、6'-O-唾液酸乳糖(6'-SL)、乳糖-N-四糖(LNT)和乳糖-N-新四糖(LNnT)以及它们的任何组合组成的组。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据权利要求2至5中任一项所述使用的长双歧杆菌过渡型微生物、益生元或组合，其中所述益生元是选自表1至表3中任一者列举的组的聚糖底物。</div>
<div class=""dep-clm"" num=""7"" parent=""2,3,4,5"">7.根据权利要求2至5中任一项所述使用的长双歧杆菌过渡型微生物、益生元或组合，其中所述益生元是选自由2'-FL、3'-FL、di-FL、3'-SL、6'-SL、LNT和LNnT以及它们的任何组合组成的组的HMO。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3,4,5,7"">8.根据权利要求2至5或7中任一项所述使用的长双歧杆菌过渡型微生物、益生元或组合，其中所述HMO是3'-FL。</div>
<div class=""dep-clm"" num=""9"" parent=""2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述使用的长双歧杆菌过渡型微生物、益生元或组合，其中所述长双歧杆菌过渡型微生物能够代谢所述HMO和/或所述聚糖底物。</div>
<div class=""dep-clm"" num=""10"" parent=""2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述使用的长双歧杆菌过渡型微生物、益生元或组合，其中所述长双歧杆菌过渡型微生","A61K35/745, A23L33/135, A23L33/21, A23L33/00, A61K31/70",20250128,雀巢产品有限公司,['Pending']
US20250121014A1,Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using butyrate as biomarker and improved methods and compositions thereof,"The present invention relates to the use of butyrate as biomarker for detecting and/or quantifying improvements of the mood disorder status and/or excessive emotional reaction of a subject. It also relates to a method for detecting and/or quantifying mood disorder, improvements of the mood disorder status and/or excessive emotional reaction of a subject, in particular for monitoring the progress of an intervention to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject, wherein the intervention comprises the administration of a probiotic. It also relates to an improved intervention to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject in need, comprising administering to the subject, an effective amount of a composition combining a probiotic with butyrate.","<div class=""ccl-clm"" num=""2"">1-2. (canceled)</div>
<div class=""indep-clm"" num=""3""><seg-con>3. Method for detecting and/or quantifying mood disorder,</seg-con></div>
<div class=""indep-clm"" num=""3""><seg-con>improvements of the mood disorder status and/or excessive emotional reaction of a subject, </seg-con><seg-trans>comprising</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-refi>assessing the level of butyrate in a body sample obtained from a subject to be tested, and</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>comparing the subject's butyrate level to a predetermined reference value,</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>wherein an increased butyrate level in the sample compared to the predetermined reference value indicates an improvement of the mood disorder status and/or excessive emotional reaction of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the mood disorder is mild to severe.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-con>5. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined reference value was obtained previously from the same subject.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""3""><seg-con>6. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined reference value is based on an average butyrate level in the same body fluid in a control population.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""3""><seg-con>7. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the levels of the biomarkers in the sample and in the reference are determined by mass spectrometry, according to by ultra-performance liquid or gas chromatography coupled to tandem mass spectrometry.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""3""><seg-con>8. The method",A61K35/745,20250417,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2839586C1,Roasting apparatus calibration method,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is a method of calibrating an apparatus (X) for roasting coffee beans to reproduce roasting recipes for coffee beans determined using one specific roasting apparatus (M), involving: introducing at least one second temporary temperature sensor into the chamber of the roasting apparatus to be calibrated, or replacing said chamber with a temporary calibration chamber, wherein said temporary calibration chamber comprises at least one second temperature sensor, controlling the heating device to reproduce a predetermined curve Rset, wherein said predetermined curve provides a number of points representing temperature for use at predetermined successive times t1, t2, ..., tfinal, respectively, wherein said control is based on temperature Treg measured by at least one first temperature sensor (5), measurement of temperature Tcal during reproduction of a predetermined curve Rset as a function of time inside the chamber on at least one second temperature sensor, which makes it possible to determine at least a set of points, comparison of temperature measured at at least one moment in time ti with temperature at said same point in time ti of a predetermined reference curve Rref obtained using a control apparatus (M) for frying, wherein said reference curve Rref represents the temperature Tref measured in the chamber of the particular control apparatus (M) during control of the heating device of the control apparatus to reproduce said predetermined curve Rset, calibrating the roasting apparatus (X) based on said comparison by applying a correction in the feedback loop of the temperature Treg measured by the first temperature sensor, or by applying the temperature correction provided by the frying curves for the frying apparatus (X). Also disclosed is an apparatus for roasting coffee beans, in which the control system is configured to implement the described calibration method, and a computer-readable data medium containing instructions which, when executed by a computer, processor or control unit, cause the computer, processor or control unit to perform the described calibration method.EFFECT: group of inventions provides identical roasting of coffee beans at the same roasting profile in different roasting devices.18 cl, 10 dwg","1. Способ калибровки аппарата (X) для обжаривания кофейных зерен для воспроизведения рецептур обжаривания кофейных зерен, определенных с помощью одного конкретного контрольного аппарата (М) для обжаривания,
причем указанный аппарат (X) для обжаривания кофейных зерен содержит:
- камеру (1) для размещения кофейных зерен,
- нагревательное устройство (2), выполненное с возможностью подачи горячего воздуха в камеру,
- по меньшей мере один первый датчик (5) температуры для измерения температуры воздуха, подаваемого нагревательным устройством, причем указанный первый датчик температуры расположен за пределами камеры,
- систему (80) управления, выполненную с возможностью управления нагревательным устройством (2) и выполненную с возможностью воспроизведения кривых обжаривания, причем указанные кривые обжаривания обеспечивают по меньшей мере набор точек, представляющих температуру, которую нужно применять в отдельные последовательные моменты времени ti соответственно, причем указанное управление нагревательного устройства (2) осуществляют посредством регулирования контура обратной связи на основе температуры Treg, измеренной по меньшей мере одним первым датчиком (5) температуры,
причем указанный процесс калибровки включает стадии:
a - введение по меньшей мере одного второго временного датчика температуры внутрь камеры аппарата для обжаривания, подлежащего калибровке, или замена указанной камеры временной калибровочной камерой, причем указанная временная калибровочная камера содержит по меньшей мере один второй датчик температуры,
b - управление нагревательным устройством для воспроизведения предварительно заданной кривой Rset, причем указанная предварительно заданная кривая обеспечивает ряд точек, представляющих температуру для применения в предварительно заданные последовательные моменты времени t1, t2, …, tfinal соответственно, причем указанное управление основано на температуре Treg, измеренной по меньшей мере одним первым датчиком (5) температуры,
c - измерение температур","A23N12/08, A23F5/04, A23N12/12, G01N25/00",20250506,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250019108A1,"Process for the production of a container for the preparation of a beverage in a beverage preparation device, sealing station for carrying out a sealing step of said process, and a container obtained by said process","The present invention concerns a process for producing a container for the preparation of a beverage in a beverage preparation device, wherein, in the final container obtained, at least 70% of the surface of a compacted beverage ingredient body (<b>2</b>) contained therein, is in contact with the container walls (<b>3, 4</b>).","<div class=""indep-clm"" num=""1""><seg-main>1. A process for producing a container for the preparation of a beverage in a beverage preparation device, comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>a. providing an injection wall of said container comprising a paper layer, said injection wall comprising: a peripheral sealing edge, and an inner portion capable of being punctured by an injection member of the beverage preparation device for circulating water under pressure inside said container;</seg-clauses>
<seg-clauses>b. providing a beverage delivery wall of said container comprising a paper layer, said delivery wall comprising: a peripheral sealing edge, and an inner portion capable of being opened by an opening member of the beverage preparation device when the pressure inside said container presses said inner portion against said opening member, to let the beverage flow out, wherein at least one, preferably both, of said inner portions of said injection and delivery walls has a cup shape;</seg-clauses>
<seg-clauses>c. placing a compacted body of beverage ingredient in the cup-shaped inner portion of the injection or delivery wall;</seg-clauses>
<seg-clauses>d. placing the injection and delivery walls one above the other such that the sealing edges of said injection and delivery walls are superimposed, in order to form a preliminary container chamber containing said ingredient body and comprising a preliminary headspace not filled by said compacted ingredient body;</seg-clauses>
<seg-clauses><seg-main>e. providing a sealing station comprising: first and second housing elements forming a sealing chamber for housing the inner portions of said injection and delivery walls, wherein said first and second housing elements are configured for being moved towards each other for sealing said edges, and such that the surfaces of said sealing chamber are in contact with external surfaces of said inner portions of the injection and delivery wa","B65B51/10, B65B29/02, B65D85/804",20250116,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12232518B2,Apparatus and method for roasting coffee beans,"The invention concerns an apparatus for roasting coffee beans comprising: —a vessel (<b>1</b>) to contain coffee beans, —a heating device (<b>12</b>) to heat coffee beans contained in the vessel, —a control system (<b>180</b>) operable to control the heating device and configured to apply a roasting recipe (R) providing the temperature T<sub>@t1</sub>, T<sub>@t2</sub>, . . . to be applied at discrete successive times t<sub>1</sub>, t<sub>2</sub>, . . . , respectively, wherein for a customised quantity m of coffee beans introduced inside the vessel, —the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel, and —the control system is configured to get access to at least one series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and to said pre-determined quantities Mi, Mi+1, . . . , and —based on said accessible series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and based on said obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe (R) to be applied on said obtained quantity m of coffee beans introduced inside the vessel.","<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for roasting coffee beans, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a vessel to contain coffee beans;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a heating device to heat coffee beans contained in the vessel; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control system operable to control the heating device and configured to apply a roasting recipe providing the temperature T<sub>@t1</sub>, T<sub>@t2</sub>, . . . to be applied at discrete successive times t<sub>1</sub>, t<sub>2</sub>, . . . , respectively,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein, for a customised quantity m of coffee beans introduced inside the vessel,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the control system is configured to get access to at least one series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and to the pre-determined quantities Mi, Mi+1, . . . , and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>based on the accessible series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and based on the obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe to be applied on the obtained quantity m of coffee beans introduced inside the vessel,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the control system is configured to determine","A47J42/52, A23F5/04, A23N12/08, A23N12/12",20250225,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12397026B2,Dietary supplement,"An oral composition comprising at least one probiotic bacteria selected from the genera: <i>Lactobacillus, Bifidobacterium</i>, and <i>Bacillus</i>, and ferric pyrophosphate.","<div class=""indep-clm"" num=""1""><seg-con>1. An oral composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one probiotic bacteria selected from the group consisting of: <i>Lactobacillus rhamnosus </i>CGMCC 1.3724, <i>Bifidobacterium lactis </i>CNCM I-3446, and a mixture thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>ferric pyrophosphate, wherein the ferric pyrophosphate has a particle size distribution D<sub>90 </sub>of 200 microns or less, a particle size distribution D<sub>97 </sub>of 25 microns or less, and an average particle size of about 0.001 microns to about 10 microns; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one pharmaceutically acceptable additive or excipient selected from the group consisting of stabilizers, fillers, emulsifiers, surfactants, solubilising agents, adsorbents, flowing agents, buffers, lubricants, wetting agents, carriers, antioxidants, thickeners, anticaking agents, coating agents, taste masking agents, preservatives, flavouring agents and dyes.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ferric pyrophosphate is in the form of a colloid.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the at least one probiotic bacteria is the mixture of <i>Lactobacillus rhamnosus </i>CGMCC 1.3724 and <i>Bifidobacterium lactis </i>CNCM I-3446.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the at least one probiotic bacteria comprises <i>Lactobacillus rhamnosus </i>CGMCC 1.3724.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The composition according to claim 1, </seg-con><seg-trans>wherein </seg","A61K35/747, A23L33/00, A23L33/135, A23L33/16, A61K9/00",20250826,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250073195A1,Medium chain triglyceride compositions,A composition comprising medium-chain triglycerides (MCTs) wherein the composition comprises (i) a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8) and (ii) a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10); wherein the ratio of MCT-C8 to MCT-C10 is from 10:90 to 90:10 (mol/mol) and wherein the combined amount of MCT-C8 and MCT-C10 make up at least 50 mol % of the MCTs in the composition.,"<div class=""indep-clm"" num=""1""><seg-main>1: A composition comprising </seg-main><seg-clauses><seg-main>medium-chain triglycerides (MCTs) wherein the composition comprises </seg-main><seg-clauses>(i) a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8) and </seg-clauses><seg-clauses>(ii) a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10); wherein the ratio of MCT-C8 to MCT-C10 is from 20:80 to 80:20 (mol/mol) and wherein the combined amount of MCT-C8 and MCT-C10 make up at least 50 mol % of the MCTs in the composition.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2: The composition according to claim 1, wherein </seg-main><seg-clauses>the ratio of MCT-C8 to MCT-C10 is about 20:80 (mol/mol).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3: The composition according to claim 1, wherein </seg-main><seg-clauses>the combined amount of the MCTs in the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4: The composition according to claim 1, wherein </seg-main><seg-clauses>the three fatty acid moieties each with 8 carbon atoms are octanoic acid moieties and/or the three fatty acid moieties each with 10 carbon atoms are decanoic acid moieties.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5: The composition according claim 1, wherein </seg-main><seg-clauses>said composition further comprises one or more agents that promote or sustain neurologic health or enhance cognitive function wherein said agents are selected from the group consisting of vitamins, choline, phosphatidylserine, alpha-lipoic acid, CoQ10, acetyl-L-carintine, herbal extracts (such as <i>Gingko biloba, Bacopa monniera, Convolvulus pluricaulis </i>and <i>Leucojum aestivum</i>), omega-3 or omega-6 polyunsaturated fatty acids (such as eicosapentaenoic acid, docosapentaenoic acid or docosahexaenoic acid as free fatty acid), aliphatic ester (such","A61K31/21, A23K20/158, A23L33/12",20250306,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250228809A1,Compositions for use,"A paediatric supplement or human milk fortifier composition comprising at least one nutrients selected in the list consisting of: ALA, DHA, EPA, 2FL, LNnT, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said paediatric supplement or human milk fortifier composition is tailored or adapted for a child born via C-section who is breast fed and/or to fortify the breast milk of a woman who has given birth via C-section. Said paediatric supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a child born via C-section and promote associated health benefits.","<div class=""indep-clm"" num=""1""><seg-main>1. A paediatric supplement or human milk fortifier composition comprising </seg-main><seg-clauses>at least one nutrient selected from the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">alpha linolenic acid (ALA) in a daily amount ranging from 19 to 80 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">docosahexaenoic acid (DHA) in a daily amount ranging from 13 to 25 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">eicosapentanoic acid (EPA) in a daily amount ranging from 6 to 9 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">2-fucosyllactose (2′-FL) in a daily amount ranging from 280 to 1050 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">Lacto-N-neotetraose (LNnT) in a daily amount ranging from 30 to 50 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin A in a daily amount ranging from 224 to 342 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine in a daily amount ranging from 6.6 to 10 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine monophosphate in a daily amount ranging from 10 to 15 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B2 in a daily amount ranging from 9 to 19 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B6 in a daily amount ranging from 15 to 68 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B9 in a daily amount ranging from 1.1 to 9 kg;</seg-clauses>
<seg-clauses class=""seg-enter"">calcium in a daily amount ranging from 10 to 16 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">phosphorus in a daily amount ranging from 4.5 to 14 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">GD3 in a daily amount ranging from 8 to 12 mg; and</seg-clauses>
<seg-clauses class=""seg-enter"">GM3 in a daily amount ranging from 1 to 1.5 mg; and</seg-clauses>
<seg-clauses class=""seg-enter"">combinations thereof.</seg-clauses></div>
<div class=""ccl-clm"" num=""2"">2. (canceled)</div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A paediatric supplement or hum","A61K31/202, A23L33/00, A61K31/07, A61K31/4415, A61K31/51",20250717,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119654074A,Method for producing moist salty products,"The present invention relates to a method for producing a moist salty product. In particular, the present invention relates to a method for producing a moist salty product comprising the steps of mixing a composition comprising water, oil, soluble fibers having a molecular weight of less than 6000 g/mol and a flavoring agent, pasteurizing the mixture, and after cooling, adding ungelatinized starch, followed by packaging the moist salty product.","<div class=""indep-clm"" num=""1""><seg-con>1.用于生产湿润咸味产品的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)将组合物混合，所述组合物包含基于所述总湿润咸味产品计15</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>重量％至60重量％的水、基于所述总湿润咸味产品计0重量％至</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>25重量％的油、基于所述总湿润咸味产品计4重量％至30重量％的可溶性纤维和基于所述总湿润咸味产品计5重量％至65重量％的风味剂；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)对步骤a)的混合物进行巴氏灭菌；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>c)将巴氏灭菌的混合物冷却至低于未糊化淀粉的糊化温度；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>d)添加基于所述总湿润咸味产品计0.5重量％至20重量％的未糊化淀粉并进一步混合；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>e)对所述湿润咸味产品进行包装；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述可溶性纤维的分子量低于6000g/mol并且其中所述湿润咸味产品不是凝胶。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用于生产湿润咸味产品的方法，其中所述湿润咸味产品包含介于30重量％至75重量％(基于所述总湿润咸味产品计)之间的总固体含量。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1至2中任一项所述的用于生产湿润咸味产品的方法，其中所述组合物包含15重量％至45重量％的水(基于所述总湿润咸味产品计)、5重量％至25重量％的油(基于所述总湿润咸味产品计)、4重量％至30重量％的可溶性纤维(基于所述总湿润咸味产品计)和5重量％至60重量％的风味剂(基于所述总湿润咸味产品计)。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的用于生产湿润咸味产品的方法，其中所述未糊化淀粉以3重量％至20重量％(基于所述总湿润咸味产品计)的量存在。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的用于生产湿润咸味产品的方法，其中所述未糊化淀粉选自玉米淀粉、马铃薯淀粉或其组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的用于生产湿润咸味产品的方法，其中所述可溶性纤维选自可溶性玉米纤维、可溶性菊苣根纤维、可溶性甜菜纤维或其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的用于生产湿润咸味产品的方法，其中所述可溶性纤维选自分子量介于1000g/mol至2000g/mol之间的可溶性菊苣根纤维。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的用于生产湿润咸味产品的方法，其中步骤b)中的所述巴氏灭菌在至少70℃的温度进行。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的用于生产湿润咸味产品的方法，其中将步骤c)中的所述混合物冷却至介于25℃至65℃之间的温度。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的用于生产湿润咸味产品的方法，其","A23B2/40, A23L23/00, A23L23/10, A23L29/20, A23L29/212",20250318,雀巢产品有限公司,['Pending']
CN120153098A,Method for determining contribution of dog variety to test dog genome,"The present invention relates to a method for determining the contribution of a dog variety to the genome of a test dog, the method comprising: a) providing a DNA methylation profile of a sample obtained from the test dog; and b) determining the contribution of a dog variety to the genome of the test dog by comparing at least a portion of the DNA methylation profile of the test dog to a reference DNA methylation profile from a different dog variety.","<div class=""indep-clm"" num=""1""><seg-con>1.确定狗品种对测试狗基因组的贡献的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a)提供来自从所述测试狗获得的样本的DNA甲基化图谱；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>b)通过将所述测试狗的所述DNA甲基化图谱的至少一部分与来自不同狗品种的参考DNA甲基化图谱进行比较来确定狗品种对所述测试狗基因组的贡献。</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2.用于为测试狗选择膳食、药物或生活方式方案的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""2""><seg-comp>a)提供来自从所述测试狗获得的样本的DNA甲基化图谱；</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-comp>b)通过将所述测试狗的所述DNA甲基化图谱的至少一部分与来自不同狗品种的参考DNA甲基化图谱进行比较来确定狗品种对所述测试狗基因组的贡献；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-comp>c)基于在步骤b)中确定的狗品种对所述测试狗基因组的贡献，为所述测试狗选择合适的膳食、药物或生活方式方案。</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-con>3.用于预防或降低测试狗发展疾病的风险的方法；所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-comp>a)提供来自从所述测试狗获得的样本的DNA甲基化图谱；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>b)通过将所述测试狗的所述DNA甲基化图谱的至少一部分与来自不同狗品种的参考DNA甲基化图谱进行比较来确定狗品种对所述测试狗基因组的贡献；其中对所述测试狗基因组有贡献的至少一个狗品种与发展疾病的倾向相关；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>c)基于在步骤b)中确定的所述至少一个狗品种对所述测试狗基因组的贡献，为所述测试狗选择膳食、药物或生活方式方案；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>其中所述膳食、药物或生活方式方案预防或降低所述测试狗发展疾病的风险。</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的方法，其中步骤a)包括确定来自从所述测试狗获得的样本的DNA甲基化图谱。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的方法，其中根据包括以下方面的方法来确定DNA甲基化：(i)以下步骤中的一者或多者：(a)用APOBEC或使用亚硫酸氢盐转化来处理样本DNA以使未甲基化胞嘧啶脱氨基；(b)基于捕获的富集；和/或(c)高通量测序或阵列；或(ii)从头测序。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的方法，其中确定至少两个狗品种对所述测试狗基因组的贡献。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的方法，其中使用机器学习将所述测试狗的所述DNA甲基化图谱与来自不同狗品种的参考DNA甲基化图谱进行比较。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中所述参考DNA甲基化图谱包含来自至少2个、至少4个、至少10",C12Q1/6888,20250613,雀巢产品有限公司,['Pending']
WO2025247763A1,Beverage preparation machine with outlet,"A machine (1) is configured for preparing a beverage (4) from a flavouring ingredient (5a) in a processing cavity (5) by mixing therein said ingredient (5a) with water (4'). The processing cavity (5) is delimited by an ingredient handling system (10, 20) associated with at least one water inlet (24) for supplying the water (4') to the ingredient (5a) in the cavity (5). The beverage (4) is dispensed out of the machine (1) via an outlet (25) so as to flow by gravity from the outlet (25) into a dispensing area (40) in which a user-receptacle (42) can be placed. The machine has a beverage passage (26) extending from the processing cavity (5) to the beverage outlet (25). Such outlet (25) is located above a bottom level (5') of the processing cavity (5) so that the beverage dispensing area (40) extends upright in front of the cavity (5).","Claims <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for preparing a beverage (4) from a flavouring ingredient (5a) in a processing cavity (5) by mixing therein said ingredient (5a) with water (4’), such as a cavity (5) for holding said ingredient (5a) supplied within a capsule (5b), such machine (1) comprising: </seg-main><seg-clauses><seg-main>- an ingredient handling system (10,20) delimiting the processing cavity (5), the system (10,20) having at least one water inlet (24) for supplying said water (4’) to said ingredient (5a) in the processing cavity (5), for instance the system (10,20) having a first ingredient handler (10) and a second ingredient handler (20) that are movable one relative to the other from: </seg-main><seg-clauses>- a distant ingredient transfer configuration for receiving said ingredient (5a) by the first and second handlers (10,20) and/or releasing said ingredient (5a) from the first and second ingredient handlers (10,20), optionally at least one of the handlers (10,20) being associated with a guide (20’) for guiding said ingredient (5) towards and/or from the handlers (10,20) in the transfer configuration; to </seg-clauses><seg-clauses>- a proximate ingredient processing configuration for mixing said ingredient (5a) and said water (4’), optionally said water (4’) having been thermally conditioned, e.g. by a heater or a cooler, and/or pressurized, e.g. by a pump; and </seg-clauses><seg-clauses>- vice versa; </seg-clauses><seg-clauses><seg-main>- a beverage outlet (25) fluidically connected to the cavity (5) and configured to dispense out of such machine </seg-main><seg-clauses>(1) said beverage (4) that flows, e.g. freely falls, by gravity from the outlet (25) into a beverage dispensing area (40) delimited by a placing surface (41) for placing a user-receptacle (42), such as a cup or mug, to collect the dispensed beverage (4); and</seg-clauses></seg-clauses>
<seg-clauses>- a beverage passage (26) extending from the processing cav","A47J31/40, A47J31/46, A47J31/60, A47J31/22",20251204,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025120135A1,Reliable capsule removal system,"A machine (1) has a capsule extraction module (10,20) for preparing a beverage from an ingredient contained in a capsule (100) by supplying an extraction liquid (e.g. water) into such capsule (100). The extraction module (10,20) has: first and second capsule enclosure parts (10,20) movable relative to each other between a proximate position for enclosing and processing the capsule (100) to prepare a beverage in the module (10,20) and a distant position for inserting the capsule (100) and removing the capsule (100) from the module (10,20); and a capsule removal arrangement (40,50) for assisting removal of such capsule (100) when the first and second parts (10,20) are brought from the proximate to the distant position. At least one of the first and second capsule enclosure parts (10,20) has a corresponding cooperating face (11,21) extending over a corresponding capsule (101). At least one of first and second pushers (40,50) comprises a pusher face (41,51) for pushing the corresponding capsule face (101,102) away from the corresponding cooperating enclosure part face (11,21). The first pusher face (41) and the first cooperating enclosure part face (11) have a surface area ratio of at least 0.1 and/or at most 10; and/or the second pusher face (51) and the second cooperating enclosure part face (21) have a surface area ratio of at least 0.05 and/or at most 0.2.","CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for preparing a beverage from an ingredient contained in a capsule (100) by supplying an extraction liquid, e.g. water, into such capsule, comprising </seg-main><seg-clauses><seg-main>a capsule extraction module (10,20) having: </seg-main><seg-clauses>- a first capsule enclosure part (10) and a second capsule enclosure part (20) movable relative to each other between a proximate position for enclosing in an enclosure (30) formed by the parts (10,20) said capsule (100) to process it and prepare a beverage therefrom and a distant position for inserting said capsule (100) into the enclosure (30) and removing said capsule (100) from the enclosure (30); and </seg-clauses><seg-clauses><seg-main>- a capsule removal arrangement (40,50) for assisting removal of such capsule (100) when the first and second parts (10,20) are brought from the proximate to the distant position, the first capsule enclosure part (10) having a first cooperating face (11) configured to extend over a first capsule face (101) and/or the second capsule enclosure part (20) having a second cooperating face (21) configured to extend over a second capsule face (102), optionally said capsule (100) having a lateral face (103) extending between said first and second capsule faces (101,102), e.g. a cylindrical and/or conical lateral face (103), the capsule removal arrangement (40,50) comprising a first pusher (40) with a first pusher face (41) for contacting and pushing said first capsule face (101) away from said first cooperating face (11) and/or a second pusher (50) with a second pusher face (51) for pushing said second capsule face (102) away from the second cooperating face (21), optionally said first cooperating face (11) extending around said first pusher face (41) and/or said second cooperating face (21) extending around said second pusher face (51), characterised in that in the proximate position of the first and second capsule enclosure",A47J31/36,20250612,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US12290492B2,Extensional viscosity to promote safe swallowing of food boluses,"Nutritional products having improved cohesiveness of food boluses and methods of making and using same are provided. The nutritional products may include nutritional compositions and high molecular weight, water-soluble polymers such that the nutritional products have extensional viscosities that provide improved cohesiveness to the nutritional products and Trouton ratios of at least 6. Methods of administering such nutritional products to patients having impaired swallowing ability and/or dysphagia are also provided.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of replacing saliva in an individual in need thereof, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>administering an effective amount of a liquid nutritional product to the individual, the liquid nutritional product comprising a nutritional composition and a food-grade polymer,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the food grade polymer is selected from the group consisting of okra gum, konjac mannan, tara gum, fenugreek gum, tamarind gum, cassia gum, cactus mucilage, mallow mucilage, flax seed mucilage, marshmallow mucilage, ribwort mucilage, mullein mucilage, cetraria mucilage, and combinations thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the liquid nutritional product comprises an amount of the food-grade polymer such that the liquid nutritional product has an increased cohesiveness relative to the nutritional composition and has a Trouton ratio of 6 to 15.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liquid nutritional product has an extensional viscosity greater than 100 mPa s.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food grade polymer is okra gum and/or cactus mucilage.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food grade polymer is selected from the group consisting of mallow mucilage, ribwort mucilage, mullein mucilage, and mixtures thereof.</seg-refi></div>","A23L29/206, A23L29/238, A23L29/25, A23L33/00, A61K31/07",20250506,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025040607A1,Moulded pulp article,,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing a moulded pulp article (1), the method comprising: </seg-main><seg-clauses>a) shaping the pulp (2); </seg-clauses><seg-clauses>b) applying a composite phase (3) comprising a polymer and particles (4) of metal, metalloid, or oxides thereof to the pulp; and </seg-clauses><seg-clauses>c) converting the composite phase (3) to a coating (5) comprising the polymer and a continuous barrier (6) at least partially embedded within the polymer, the continuous barrier (6) comprising metal, metalloid, or oxides thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>applying the composite phase (3) comprises applying a thin film comprising the polymer and particles (4) of metal, metalloid, or oxides thereof, the particles (4) being dispersed throughout the polymer, to the surface of the pulp (2).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>applying the composite phase (3) comprises applying an aqueous dispersion of polymer and particles (4) of metal, metalloid, or oxides thereof to the surface of the pulp (2).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any one of claims 1 to 3, wherein: </seg-main><seg-clauses>i. steps a), b), and </seg-clauses><seg-clauses>c) occur in order; or </seg-clauses><seg-clauses>ii. step b) occurs before step a), which occurs before step c); or </seg-clauses><seg-clauses>iii. wherein steps a) and c) occur simultaneously.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>converting the composite phase (3) to a coating (5) comprises fusing the</seg-clauses>
<seg-clauses class=""seg-enter"">particles (4) of metal, metalloid, or oxi","D21J3/10, D21J7/00, D21H21/14, B65D65/42, D21H17/63",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US12351444B2,System comprising a static microdoser for introducing an additive into a container,"The invention relates to a system for introducing an additive into a container (<b>4</b>) partially filled with a main liquid material. It comprises an automated conveyor for transporting the container (<b>4</b>) along a straight horizontal trajectory (T) at a substantially constant container speed (Vc). It further comprises a static microdoser (<b>6</b>) having a nozzle (<b>9</b>) from which at least one jet (<b>8</b>) of an additive issues upon passage of an opening (<b>7</b>) of the container (<b>4</b>). The system is configured to introduce a given mass of additive into the container. The nozzle of the microdoser (<b>6</b>) is inclined relative to a vertical direction that is perpendicular to the trajectory (T). The inclination of the nozzle, the number, the shape and the speed (Vj) of the at least one jet, the mass of additive, and the container speed (Vc) are configured such that the specific kinetic energy of the impact of the at least one jet on the free surface of the main liquid material is less than 3000 mJ/m<sup>2</sup>.","<div class=""indep-clm"" num=""1""><seg-con>1. A system for introducing an additive into a container partially filled with a main liquid material, the system </seg-con><seg-trans>comprising </seg-trans><seg-refi>an automated conveyor for transporting the container along a straight horizontal trajectory (T) at a substantially constant container speed (Vc),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the system further comprising a static microdoser having a nozzle from which at least one jet of an additive issues upon passage of an opening of the container in proximity to the nozzle to introduce the additive into said container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the nozzle of the microdoser is inclined relative to a vertical direction that is perpendicular to the trajectory (T),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the system is configured to introduce a given quantity of additive into the container, said quantity having a mass (m),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the at least one jet hits a free surface of the main liquid material at a relative impact speed (V), over an area A of said free surface of the main liquid material; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the system is configured, with regard to the inclination of the nozzle, to the number, the shape and the speed (Vj) of the at least one jet, to the mass (m), and to the container speed (Vc), such that</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the specific kinetic energy (I) of the impact of the at least one jet on the free surface of the main liquid material, defined by the formula:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi><maths id=""MATH-US-00008"" num=""00008""><math overflow=""scroll""><mrow><mi>I</mi><mo>=</mo><mfrac><mrow><mfrac><mn>1</mn><mn>2</mn></mfrac><mo>⁢</mo><mi>m</mi><mo>*</mo><msup><mi>V</mi><mn>2</mn></msup></mrow><mi>A</mi></mfrac></mrow></math","B67C3/22, B67C3/02, B67C3/20, B67C3/24, B67C3/28",20250708,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2024252201A1,Thin donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.","[0062]
CLAIMS
What Is Claimed Is:
<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.3 cm to about 1.6 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.6 cm to about 2.0 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual dry kibble pieces of the serving are about 1.3 cm to about 1.6 cm in average diameter and about 3 mm to about 5 mm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the small adult dog exhibits a reduced feeding speed and increased eating duration on average compared to the feeding speed of the same volume of a comparative solid round dry kibble having a diameter of about 1 cm or less.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>during feeding, the small adult dog exhibits a lower frequency of labored swallowing and increased chewing duration on average compared to when the small adult dog is feeding on the same volume of a comparative solid round dry kibble having a diameter of about 1","A23K40/00, A23K50/42",20241212,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
US20240407399A1,Thin donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, an average diameter from about 1.3 cm to about 2.0 cm, and an average thickness from about 3 mm to about 6 mm.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.3 cm to about 1.6 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.6 cm to about 2.0 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual dry kibble pieces of the serving are about 1.3 cm to about 1.6 cm in average diameter and about 3 mm to about 5 mm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the small adult dog exhibits a reduced feeding speed and increased eating duration on average compared to the feeding speed of the same volume of a comparative solid round dry kibble having a diameter of about 1 cm or less.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>during feeding, the small adult dog exhibits a lower frequency of labored swallowing and increased chewing duration on average compared to when the small adult dog is feeding on the same volume of a comparative solid round dry kibble having a diameter of about 1 cm or less.</seg-refi></div>
<div","A23K50/42, A23K40/00",20241212,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250057353A1,Beverage pod system with pod ejector,"The invention concerns a device for extracting a beverage ingredient by supplying an extraction liquid such as heated water into in a pod, and comprising: —upstream and downstream pod enclosing parts (<b>1, 2</b>) relatively translatable between an open position for inserting and/or ejecting the pod (<b>3</b>) and a closed position for forming an extraction chamber (<b>5</b>) enclosing the pod during extraction, —an insertion section (<b>4</b>) for inserting the pod in the device, said insertion section being designed to position the pod with the lid facing the downstream piercing arrangement (<b>12</b>), and —a pod holder (<b>11</b>), said pod holder being attached to a peripheral area (<b>13</b>) of the downstream part wherein the central part (<b>131</b>) of the peripheral area of the downstream enclosing part, the downstream plane piercing arrangement (<b>12</b>) and the cage (<b>21</b>) of the upstream enclosing part form the extraction chamber (<b>5</b>), the edge (<b>211</b>) of the opened end of the cage defined by the upstream enclosing part facing/leaning on the central part (<b>131</b>) of the peripheral area of the downstream enclosing part, and wherein the peripheral area (<b>13</b>) of the downstream enclosing part is able to pivot around a bottom transversal axis (YY′) and in the upstream direction.","<div class=""indep-clm"" num=""1""><seg-con>1. A device for extracting a beverage ingredient by supplying an extraction liquid such as heated water into a pod,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said pod </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a side wall and a bottom wall defining a chamber, said chamber extending axially between the bottom and a top end of the sidewall, said top end defining a top opening</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a circumferential annular body flange projecting radially outward from the top end of the sidewall, said body flange comprising a top surface opposite to the chamber with respect to the opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pod body containing a beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a plane top lid attached to the top surface of the circumferential flange, said plane top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said device comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>upstream and downstream pod enclosing parts relatively translatable along a longitudinal axis (XX′) between an open position for inserting and/or ejecting the pod and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the upstream part defining a cage and bearing an upstream piercing arrangement for opening the bottom wall of the pod and a liquid injector,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the downstream part defining a plate transverse to the longitudinal axis (XX′), said plate comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-r","A47J31/36, A47J31/40, B65D85/804",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2840495C1,Method for increasing of chocolate tropic resistance,,,A23G1/30,20250526,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023305090A1,Confectionery product,The present invention relates to a confectionery product comprising a first layer and a second layer. The present invention relates to a process which can be used for the preparation of such a confectionery product.,"<div class=""indep-clm"" num=""1""><seg-main>1. A process of preparing a confectionery product comprising </seg-main><seg-clauses><seg-main>at least two layers, wherein said two layers are both moulded, the process comprising:</seg-main>
<seg-clauses>(a)     depositing the first layer in a mould;</seg-clauses>
<seg-clauses>(b) depositing a second layer in the mould on top of the first layer;</seg-clauses>
<seg-clauses>(c)     optional further component addition;</seg-clauses>
<seg-clauses>(d)    cooling; and</seg-clauses>
<seg-clauses>(e) demoulding, wherein both layers have portions directly in contact with the mould until the demoulding step, wherein the first layer post-demoulding has a hardness of between 1.90 N and 20.0 N at 20°C.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A process according to claim 1, wherein </seg-main><seg-clauses>the first layer has a ratio of solid fat content at 0°C to solid fat content at 30°C between 1.36 and 1.63 and/or has a ratio of solid fat content at 10°C to solid fat content at 30°C between 1.27 and 1.53.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A process according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the first layer has a solid fat content of 30% to 75% at 20°C.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A process according to any preceding claim, wherein </seg-main><seg-clauses>the first layer has a solid fat content of 30% to 70% at 30°C.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A process according to any preceding claim, wherein </seg-main><seg-clauses>the first layer has a solid fat content of 40% to 80% at 15°C.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A process according to any preceding claim, wherein </seg-main><seg-clauses>the first layer has a solid fat content of: from 45% to 75%, preferably from 50% to 75%, and mos","A23G1/00, A23G1/54, A23G3/34, A23G3/54",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025132739A1,Machine with lid detection,"A machine (10, 56) for processing a liquid food substance, such as milk or a milk-based substance, is provided. The machine (10, 56) comprises a jug (14) having a container (16), the container (16) delimiting a food cavity for containing said liquid food substance, and a lid (38) such as a removable lid (38) for covering the food cavity; a base (12) having one or more walls forming a seat for removably receiving the container (16); a lid detection system (36) configured for detecting a closed and/or an open state of the lid (38) when the container (16) is received in the seat, and a control unit (40) for controlling the machine (10, 56), wherein the control unit (40) includes a printed circuit board (42), and the lid detection system (36) comprises a sensor that is rigidly fixed to the printed circuit board (42).","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A machine (10, 56) for processing a liquid food substance,such as milk or a milk-based substance, comprising:</seg-main><seg-clauses>- a jug (14) having a container (16), the container (16)delimiting a food cavity for containing said liquid food substance, and a lid (38) such as a removable lid (38) for covering the food cavity;</seg-clauses><seg-clauses>- a base (12) having one or more walls forming a seat forremovably receiving the container (16);</seg-clauses><seg-clauses>- a lid detection system (36) configured for detecting a closedand/or an open state of the lid (38) when the container (16) is received in the seat; and</seg-clauses><seg-clauses>- a control unit (40) for controlling the machine (10, 56), thecontrol unit (40) including a printed circuit board (42), characterized in that the lid detection system (36) includes a sensor (46) that is rigidly fixed to the printed circuit board (42).</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine of claim 1, wherein </seg-main><seg-clauses><seg-main>the control unit isconfigured to compare:</seg-main><seg-clauses>- a characteristic measured by the detection system indicativeof the closed state and/or the open state of the lid (38); to- an expected value thereof when the lid (38) is in the closedstate or in the open state.</seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The machine of claim 1 or 2, wherein </seg-main><seg-clauses>the control unit beingconfigured to indicate the closed state or the open state of the lid (38) to a user of the machine (10, 56).</seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The machine (10, 56) of any preceding claim, wherein </seg-main><seg-clauses>thesensor (46) is at least one selected from the group including a mechanical sensor e.</seg-clauses><seg-clauses>g. an electrically-monitored mechanical sensor, a magnetic sensor, a capaci","A47J43/046, A47J43/07",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN119923213A,Beverage capsule system,"The invention relates to an extraction device for extracting beverage ingredients by supplying an extraction liquid into a capsule, said extraction device comprising:-upstream and downstream capsule enclosing parts (1, 2), wherein the upstream capsule enclosing part (1) is translatable along a horizontal longitudinal axis (XX ') between an open position for inserting and removing the capsule (3) and a closed position for forming an extraction chamber enclosing the capsule during extraction, the holder (21) comprises a side wall (211) translatable between the open position and the closed position and an end wall (22) movable inside the side wall (211), wherein the side wall (211) and the end wall (22) are actuated by a common motor (10) and a common actuator (8).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于通过将提取液体供应到囊包中来提取饮料配料的提取装置，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述提取装置</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-上游囊包包封部件和下游囊包包封部件(1,2)，其中所述上游囊包包封部件(2)能够沿水平纵向轴线(XX')在用于插入和移除所述囊包(3)的打开位置和用于在提取期间形成包封所述囊包的提取室的闭合位置之间平移，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述上游部件(2)限定保持架(21)并且包括液体出口开口(223)和用于刺穿所述囊包的底壁(313)的刺穿元件(222)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述下游部件(1)包括横向于所述纵向轴线(XX')的板，所述板包括用于打开所述囊包的封盖(32)的下游平面刺穿排布结构(12)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-囊包支架，所述囊包支架被构造为：当所述上游囊包包封部件和所述下游囊包包封部件处于所述打开位置时，将所述囊包保持在所述上游囊包包封部件和所述下游囊包包封部件之间，所述囊包支架被构造为将所述囊包的所述封盖(32)保持在所述下游平面刺穿排布结构(12)前方，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中在所述上游囊包包封部件(1)中，所述保持架(21)包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-侧壁(211)，所述侧壁沿保持架纵向轴线在打开的前端(214)与后端(213)之间延伸，所述侧壁能够在所述打开位置和所述闭合位置之间平移，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-端壁(22)，所述端壁横向于所述保持架纵向轴线，所述端壁具有正面(22a)，所述正面承载所述刺穿元件(222)和所述液体出口开口(223)，其中所述端壁(22)能够在所述上游囊包包封部件的所述保持架的所述侧壁(211)内部纵向移动，并且其中所述侧壁(211)和所述端壁(22)由一个共用马达(10)和共用致动器(8)致动，所述共用致动器连接到所述侧壁(211)和所述端壁(22)，使得当所述上游囊包包封部件(2)从所述打开位置平移到所述闭合位置时：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-首先，所述侧壁(211)从所述打开位置平移到所述闭合位置，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>以形成围绕所述囊包的所述提取室，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-然后，所述端壁(22)在所述侧壁(211)内部从向后位置移动到向前位置，以刺穿所述囊包的所述底壁。</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2.根据前一权利要求所述的提取装置，其中所述上游囊包包封部件的所述侧壁(211)由两个侧向片材(4)保持并且能够在所述两个侧向片材之间滑动，每个所述侧向片材均附接到第一固定横向末端轴(6b)和第二固定横向前部轴(6a)，并且</seg-con></div>
<div class=""indep-clm"" num=""2""><seg-con>其中所述共用致动器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""2""><seg-refi>-弯头接合机构(81)，所述弯头接合机构包括推杆(811)和曲柄(812)的两个对称组件，每个曲柄附接到所述横向末端轴(6b)，并且每个杆附接到所述上游囊包包封部件的滑动侧壁(211)，和</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg",A47J31/36,20250502,雀巢产品有限公司,['Pending']
EP4541728A1,Beverage preparation pod and beverage preparation capsule,"A beverage pod (10, 11) configured for preparing a beverage upon injection of liquid into the pod (10, 11) is provided. The pod (10, 11) comprises: a pouch (12) configured for holding beverage preparation ingredients therein; a ring-shaped support (14) extending at least partially around a top portion of the pouch (12), wherein the ring-shaped support (14) provides a top opening (16) of the pod (10, 11); and a lid (18) connected to the support (14) and/or the pouch (12) for closing the top opening (16), wherein the pod (10, 11) is configured for receiving liquid through the pouch (12) such that the liquid is mixed with the beverage preparation ingredients inside the pouch for forming a beverage, and wherein the lid (18) is configured for dispensing the beverage from an inside of the pouch (12) to an outside of the pod (10, 11).","<div class=""indep-clm"" num=""1""><seg-main>1.  A beverage pod (10, 11) configured for preparing a beverage upon injection of liquid into the pod (10, 11), the pod (10, 11) comprising: </seg-main><seg-clauses>- a pouch (12) configured for holding beverage preparation ingredients therein, </seg-clauses><seg-clauses>- a ring-shaped support (14) extending at least partially around a top portion of the pouch (12), wherein the ring-shaped support (14) provides a top opening (16) of the pod (10, 11), and </seg-clauses><seg-clauses>- a lid (18) connected to the support (14) and/or the pouch (12) for closing the top opening (16), </seg-clauses><seg-clauses>- wherein the pod (10, 11) is configured for receiving liquid through the pouch (12) such that the liquid is mixed with the beverage preparation ingredients inside the pouch for forming a beverage, and </seg-clauses><seg-clauses>- wherein the lid (18) is configured for dispensing the beverage from an inside of the pouch (12) to an outside of the pod (10, 11).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The pod (10, 11) of claim 1, wherein </seg-main><seg-clauses>the lid (18) is configured to be pierced by a pyramid plate (36), wherein the pyramid plate (18) is configured for creating a plurality of openings in the lid (18) for dispensing the beverage therethrough.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The pod (10, 11) of any one of claims 1-2, wherein </seg-main><seg-clauses>the pouch (12) includes a section having a first rigidity and the ring-shaped support (14) includes a section having a second rigidity higher than the first rigidity, preferably wherein the ring-shaped support (14) is a ring section of the pouch (12) and/or a separate ring element (20) connected to the pouch (12).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The pod (10, 11) of any one of claims 1-3, wherein </seg-main><seg-clauses>the pod (10, 11) is con",B65D85/804,20250423,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2836386C1,Beverage preparation system,"FIELD: beverage preparation devices.SUBSTANCE: invention relates to a beverage preparation system comprising module (1) for preparing a beverage from package (10). Said package comprises lower side (101), which comprises area (104) of flexible material, made with possibility of opening. Module (1) comprises package holder (2), liquid treatment device (11) configured to open opening area (104), and drive device (12) for moving said liquid treatment device (11) and said package (10) to each other. Package holder (2) comprises movable locking device (24) for arrangement of package (10) inside package chamber (22) during beverage preparation. Lower part of package (10) contains fixing devices (103) in the form of a hole or a deformable area. Movable locking device (24) comprises positioning means (242) for movement inside corresponding hole (103) of the package holder in the chamber or for movement inside corresponding deformable area (103) of the package holder in the chamber and fitting into the obtained deformed area.EFFECT: efficient piercing of a beverage preparation container.21 cl, 12 dwg","1. Система приготовления напитка, содержащая модуль (1) для приготовления напитка из упаковки (10),
- указанная упаковка (10) содержит ингредиент напитка, указанный ингредиент выполнен с возможностью смешивания с жидкостью для получения напитка, указанная упаковка представляет собой плоскую форму, ориентированную вдоль плоскости (P), указанная упаковка содержит нижнюю сторону (101), а указанная нижняя сторона (101) указанной упаковки содержит область (104), выполненную для открывания, указанная открывающаяся область выполнена из гибкого материала, и
- указанный модуль (1) содержит:
держатель упаковки (2), выполненный с возможностью приема и удержания указанной упаковки, указанный держатель упаковки (2) содержит камеру (22) для упаковки (10), выполненную с возможностью приема указанной упаковки через входной канал верхнего блока (222) и для удержания указанной упаковки в вертикальном положении внутри модуля, указанная камера представляет нижнее отверстие (221), выполненное с возможностью обеспечения доступа к нижней части (101) указанного держателя упаковки в камере, и
устройство для обработки жидкости (11), содержащее:
по меньшей мере одно впускное отверстие (111) для введения жидкости в указанную упаковку для приготовления напитка путем смешивания указанной жидкости с ингредиентом, содержащимся в указанной упаковке; и
по меньшей мере один выходной канал (112) для выдачи указанного напитка из указанной упаковки,
указанное устройство для обработки жидкости выполнено с возможностью открытия зоны открывания (104) упаковки, и указанное устройство для обработки жидкости представляет собой заостренную часть, направленную вверх внутри модуля, и
привод (12) для перемещения указанного устройства для обработки жидкости (11) и указанной упаковки (10) в другое положение таким образом, что устройство для обработки жидкости открывает нижнюю часть (101) указанной упаковки и располагает указанное устройство для обработки жидкости (11) и указанную упаковку (10) по отношению друг к д","B65D85/804, A47J31/40, A47J31/44",20250314,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20240417771A1,Method for producing milk like products,"A method for producing mammary gland cells and a method of producing a mammalian milk like product, for example a human milk like product comprising generating lactocytes derived from mammalian induced pluripotent stem cells (miPSC), for example human induced pluripotent stem cells (hiPSC), and expressing the mammalian milk like product, for example the human milk like product from lactocytes.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing a population of mammary gland cells, comprising:</seg-main>
<seg-clauses>i) culturing mammalian induced pluripotent stem cells (miPSCs) in a culture medium retinoic acid (RA) to generate embryoid bodies (EBs), and</seg-clauses>
<seg-clauses>ii) growing the EBs to generate a population of mammary cells.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the culturing step i) comprises culturing the miPSCs in MammoCult medium, in a 3D-suspension culture system, thereby directing the iPSCs to differentiate towards non-neural ectoderm cells.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the growing step ii) comprises growing the EBs in a 3D embedding system comprising RA for at least 30 days, for example for 32 days.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method of claim 3, wherein </seg-main><seg-clauses><seg-main>step ii) is distinguished into further substeps and comprises the following steps: </seg-main><seg-clauses>ii) and iii):</seg-clauses>
<seg-clauses>ii) incubation of mEBs (mammospheres) in complete EpiCultB medium supplemented with EpiCult proliferation supplement, Parathyroid hormone (pTHrP), and RA for 5 days,</seg-clauses>
<seg-clauses>iii) promotion of branch and alveolar differentiation and mammary cell specification by incubating mEBs (mammospheres) in EpiCultB medium supplemented with EpiCult proliferation supplement, hydrocortisone, insulin, FGF10 and HGF for 20 days.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-main>5. The method of claim 3, wherein </seg-main><seg-clauses><seg-main>step ii) is distinguished into further substeps and comprises the following steps: </seg-main><seg-clauses>ii) and iii):</seg-clauses>
<seg-clauses>ii) embedding the formed mEBs (","C12P21/02, C12N5/071, C12P19/04",20241219,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023327691A1,Methylated phloretin analogs as inhibitors of SGLT2,"The present invention relates to compositions and methods for improving metabolic health. Specifically, the present disclosure relates to using a methylated phloretin analog as a sodium-glucose transporter-2 (SGLT2) inhibitor for improving metabolic health.","<div class=""indep-clm"" num=""1""><seg-con>1. A composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>an effective amount of at least one methylated phloretin analog for use in inhibition of SGLT2.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the methylated phloretin analog is selected from the group consisting of Phloretin-4-methyl-ether, 4’-O-Methylphloretin, Calomelanone and Flavokavain A.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The composition according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the methylated phloretin analog is obtained from a plant or plant extract.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The composition according to any of claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the methylated phloretin analog is from unripe apple or orange peel.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The composition according to any of claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the inhibition of SGLT2 is in muscle and/or kidney tissues.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. The composition according to any of claims 1 to 5, for use in treating and/or preventing a condition, disorder, or disease related to type 2 diabetes and/or obesity in a subject in need thereof.</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">7. The composition according to any of claims 1 to 5, for use in treating and/or preventing a condition, disorder, or disease related to cardiovascular, weight management, renal, kidney, brain in a subject in need thereof.</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5"">8. The composition according to any of claims 1 to 5, for use in treating and/or preventing a condition, disorder, or disease responsive to SGLT2 inhibition in a subje","A61K31/12, A61P3/10",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250268286A1,"Beverages having clear appearance, shelf stability, high protein, and neutral ph","A method of making a beverage includes adding one or more other ingredients to hydrolyzed protein to form the beverage, which is clear, shelf-stable, and high protein and has a neutral pH and an energy content of at least about 100 kcal per 240 ml of the beverage. Optionally the hydrolyzed protein is obtained by subjecting protein to a protease. In some embodiments, the high protein is at least about 15 g or at least about 20 g of protein/100 kcal, and in some embodiments the energy content is at least about 150 kcal/240 ml or at least about 200 kcal/240 ml. Other aspects are directed to the resultant beverage, a method of producing a high protein beverage containing hydrolyzed protein, a method of increasing transparency in a high protein beverage containing hydrolyzed protein, and a method of providing nutrition to an individual.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of increasing transparency of a beverage </seg-con><seg-trans>having </seg-trans><seg-refi>high protein, at least a portion of the high protein comprising hydrolyzed protein, the method comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>hydrolyzing protein with a protease to form the hydrolyzed protein; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>adding one or more other ingredients to the hydrolyzed protein to form the beverage having high protein, and the beverage also has clear appearance, shelf-stability, a neutral pH and an energy content of at least about 100 kcal per 240 ml of the beverage, and optionally the high protein consists essentially of the hydrolyzed protein.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the protease is selected from the group consisting of trypsin, chymotrypsin, pancreatin, papain, bromelain, and pepsin and mixtures thereof and/or wherein the protein subjected to the hydrolyzing by the protease comprises whey protein.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the high protein in the beverage is about 10 g to about 25 g protein/100 kcal of the beverage, and the energy content is about 100 kcal to about 360 kcal per 240 ml of the beverage, preferably about 100 kcal to about 300 kcal per 240 ml of the beverage and more preferably about 100 kcal to about 200 kcal per 240 ml of the beverage.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage comprises the protease.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>inactivating the protease.</seg-refi></div>
","A23L2/66, A23F3/00, A23L2/60, A23L2/84",20250828,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120225074A,Muscle inositol and prevention of accelerated growth,"The present invention relates to a composition for preventing accelerated growth of offspring comprising a combination of Lactobacillus and Bifidobacterium, myo-inositol, and at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12, vitamin D and mixtures thereof, and wherein the composition is administered to the mother of the offspring before and/or during pregnancy and/or during lactation. The invention also relates to a multi-component kit for preventing accelerated growth of offspring.","<div class=""indep-clm"" num=""1"">1.用于预防后代的加速生长的组合物，所述组合物包含乳杆菌和双歧杆菌益生菌的组合，肌肉肌醇，以及至少一种选自维生素B2、维生素B6、维生素B12、维生素D及其混合物的维生素，并且其中将所述组合物在孕前和/或怀孕和/或哺乳期期间施用给所述后代的母亲。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的组合物，所述组合物降低在后续生命中经历多余脂肪量的风险。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项用于所述用途的组合物，其中所述乳杆菌是能够以保藏号CGMCC 1.3724获得的鼠李糖乳杆菌菌株，并且所述双歧杆菌是作为CNCM I-3446保藏的乳双歧杆菌BB12菌株。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项用于所述用途的组合物，其中所述加速生长在所述后代的生命的前2年至5年期间发生。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物包含肌肉肌醇、维生素B2、维生素B6、维生素B12、维生素D，并包含鼠李糖乳杆菌CGMCC 1.3724和乳双歧杆菌BB12 CNCMI-3446的组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物包含0.2g至5g的肌肉肌醇、0.14mg至14mg的维生素B2、0.19mg至19mg的维生素B6、0.26μg至26μg的维生素B12、1.5μg至100μg的维生素D、10<sup>5</sup>cfu至10<sup>12</sup>cfu的鼠李糖乳杆菌CGMCC 1.3724和10<sup>5</sup>cfu至10<sup>12</sup>cfu的乳双歧杆菌BB12 CNCMI-3446，所有量均由每日剂量限定。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物还包含锌。</div>
<div class=""dep-clm"" num=""8"" parent=""6"">8.根据权利要求6用于所述用途的组合物，其中所述组合物包含每日剂量为1.1mg至40mg的量的锌。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物通过预防所述加速生长而进一步预防所述后代在后续生命中的代谢障碍的发展。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项用于所述用途的组合物，其中所述代谢障碍是心血管代谢障碍、肥胖、多余脂肪量堆积和/或超重。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项用于所述用途的组合物，其中所述后代的母亲是哺乳动物，例如选自猫、狗和人类的哺乳动物。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物用于在怀孕期间，例如在怀孕的整个第二孕期和第三孕期期间施用给所述后代的母亲。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物呈用于在乳或水中重构的粉末状营养组合物、食物产品、饮品、营养补充剂或营养品的形式。</div>
<div class=""indep-clm"" num=""14"">14.用于预防后代的加速生长的多组分套盒，所述多组分套盒含有至少两种物理上分开的组合物，每种组合物包含至少一种选自维生素B2、维生素B6、维生素B12和维生素D的成分，所述分开的组合物中的至少一种包含肌肉肌醇并且所述分开的组合物中的至少一种包含乳杆菌和双歧杆菌益生菌的组合，其中将所述两种物理上","A23L33/125, A23L33/135, A23L33/15, A23L33/155, A23L33/16",20250627,雀巢产品有限公司,['Pending']
AU2023355741A1,Beverage or foodstuff preparation system,"A container for use with a beverage or foodstuff preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by said machine to process the precursor material, the code readable by a code reading system of the machine, which comprises: a lighting system to project an emission to the code, and; a camera system for obtaining a digital image of the code, and; a support layer to support the code, the support layer arranged for specular reflection of the emission from the lighting system, the code comprising: an absorber layer, which is configured to absorb the emission and a reflector layer, which is configured to diffusively reflect the emission, the reflector layer arranged to reflect the emission before it is transmitted to the support layer.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for use with a beverage or foodstuff preparation machine, the container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code for storing preparation information used by said machine to process the precursor material, the code configured to be readable by a code reading system of the machine, which comprises a lighting system to project an emission to the code, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a support layer to support the code, the support layer arranged for specular reflection of the emission from the lighting system such that at least 50% or 70% or 80% of the emission reflected from the support layer is reflected as specular,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the code comprising: an absorber layer, which is configured to absorb the emission and a reflector layer, which is configured to diffusively reflect the emission, the reflector layer arranged to reflect the emission before it is transmitted to the support layer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein:</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the reflector layer is continuous;</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the reflector layer is connected to the support layer to adjoin the support layer, and;</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the support layer extends in a plane defined by lateral and longitudinal directions and has a through thickness in a depth direction, and where the reflector layer to overlap the entire the support layer when viewed in said plane.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The container either of claims 1 or 2, </seg-con",B65D85/804,20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119924522A,Improvement of muscle function in elderly males,"The present invention provides a composition comprising a protein source and an antioxidant, optionally in combination with an omega-3 fatty acid, which composition is capable of treating or preventing sarcopenia in an elderly male, reducing loss of muscle function (e.g., muscle strength, walking speed, etc. And/or improving muscle function recovery of old men after amyotrophy.","<div class=""indep-clm"" num=""1"">1.包含蛋白质源和抗氧化剂的组合物在制备用于减少老年男性的肌肉力量损失、增加老年男性的肌肉力量和/或改善老年男性在肌肉萎缩后的肌肉力量恢复的产品中的用途，其中所述组合物由n-3脂肪酸、抗氧化剂和蛋白质源组成，其中所述抗氧化剂为姜黄素和芦丁的组合，且其中所述蛋白质源为乳清蛋白，且其中所述组合物以每天为每千克所述老年男性体重提供0.1至0.4克所述蛋白质源的量施用。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用途，其中所述组合物每周施用至少两次，持续至少一个月的时间段。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的用途，其中所述组合物以每天为每千克所述老年男性体重提供0.01至0.04克亮氨酸的量施用。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1，2或3所述的用途，其中所述老年男性患有肌肉减少症。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的用途，其中所述产品是食物组合物、饮食补充剂、营养组合物、营养品、在食用前用水或乳重构的粉末状营养产品、食物添加剂、药物、饮料或它们的组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的用途，其中乳清蛋白与姜黄素和芦丁的组合的重量比为300：1至2：1。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的用途，其中所述组合物还包含维生素D。</div>
<div class=""indep-clm"" num=""8"">8.一种组合物，其由n-3脂肪酸、抗氧化剂和蛋白质源组成，其中所述抗氧化剂为姜黄素和芦丁的组合，且其中所述蛋白质源为乳清蛋白，且其中所述组合物包含基于所述组合物的干重计0.2％至100％的量的所述蛋白质源，且其中所述组合物以每天为每千克所述老年男性体重提供0.1至0.4克所述蛋白质源的量施用。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的组合物，其中乳清蛋白与姜黄素和芦丁的组合的重量比为300：1至2：1。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求8或9所述的组合物，其中所述组合物还包含维生素D。</div>","A23L33/12, A61K38/17, A61K31/12, A61K31/7048, A61K31/201",20250506,雀巢产品有限公司,['Pending']
US20250255428A1,Centrifugal chamber with capsule opening elements,"A machine (<b>1</b>) is configured for preparing a beverage (<b>4</b>) from a flavouring ingredient (<b>5</b><i>a</i>) supplied within a capsule (<b>5</b><i>b</i>) in a processing cavity (<b>5</b>) by mixing it with water (<b>4</b>′) and centrifuging them about a processing axis (<b>30</b>′). The machine (<b>1</b>) has a handling system (<b>10,20</b>) including a first ingredient handler (<b>10</b>) and a second ingredient handler (<b>20</b>) that are movable one relative to the other from a capsule transfer configuration to an capsule processing configuration. The handling system (<b>10,20</b>) has (a) beverage outlet(s) (<b>25</b>) and (a) water inlet(s) (<b>24</b>), the outlet(s) (<b>25</b>) and/or the inlet(s) (<b>24</b>) being associated with a capsule opener (<b>24′,25</b>′) having an opening edge (<b>24″,25</b>″) and a capsule opening direction (<b>30</b>″) along which the opening edge (<b>24″,25</b>″) and the capsule (<b>5</b><i>b</i>) are relatively moved to open the capsule (<b>5</b><i>b</i>) by the opening edge (<b>24″,25</b>″). The opener (<b>24′,25</b>′) delimits a fluid passage (<b>24</b><i>a′,</i><b>24</b><i>b′,</i><b>25</b><i>a′,</i><b>25</b><i>b</i>′) located in the opening direction (<b>30</b>″) behind the opening edge (<b>24″,25</b>″).",,"A47J31/22, A47J31/36",20250814,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023346095A1,Compositions and methods for digestive health in an feline,"Compositions and methods from providing a digestive health benefit to a feline include the use of a prebiotic fiber blend comprising pumpkin, inulin, and, optionally, wheat bran aleurone.","<div class=""indep-clm"" num=""1""><seg-con>1. A prebiotic fiber blend for a feline </seg-con><seg-trans>comprising </seg-trans><seg-refi>pumpkin, inulin, and, optionally, wheat bran aleurone.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pumpkin is present in the fiber blend in an amount from about 20 % to about 50 %.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the inulin is present in the fiber blend in an amount from about 10 % to about 40 %.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The prebiotic fiber blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fiber blend comprises wheat bran aleurone, and wherein the wheat bran aleurone is present in the fiber blend in an amount from about 20 % to about 50 %.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5. A pet food composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>the prebiotic fiber blend of claim 1.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6. The pet food composition of claim 5, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>protein, carbohydrates, fat, and a preservative, wherein the fiber blend is present in the pet food composition in an amount from about 0.1 % to about 10 %.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""5""><seg-con>7. The pet food composition of claim 5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pumpkin is present in the pet food composition in an amount from about 0.01 % to about 5 %, the inulin is present in the pet food composition in an amount from about 0.01 % to about 5 %, and the wheat bran aleurone is present in the pet food composition in an amount from about 0.01 % to about 5 %.</seg-refi></div>
<div class=""dep-clm"" num=""8"" par","A23K10/00, A23K10/30, A23K20/163, A23K50/40",20250227,SOCIETE DES PRODUITS NESTLE SA,['Pending']
JP2025004126A,Compositions and methods using combination of curcumin and an omega-3 fatty acid for cellular energy,"To provide methods and compositions that can treat or prevent a mitochondria-related disease, or a condition associated with altered mitochondrial function, or a reduced mitochondrial density.SOLUTION: The present invention provides a method of increasing antioxidant capacity, reducing oxidative stress, and/or enhancing mitochondrial function, the method comprising administering to an individual in need thereof an effective amount of a combination of curcumin and an omega-3 fatty acid.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 抗酸化能を向上させる、酸化ストレスを低減する、及び／又はミトコンドリア機能を向上する方法であって、投与を必要とする個体に、有効量のクルクミンとオメガ－３脂肪酸との組み合わせを投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記組み合わせが、１日当たり約５００ｍｇ～約５ｇの前記オメガ－３脂肪酸を提供する量で投与される、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記組み合わせが、１日当たり約０．０１ｍｇ～約２．０ｇの前記クルクミンを提供する量で投与される、請求項１又は２に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記組み合わせが、経口投与される、請求項１～３のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記組み合わせが、前記クルクミンの少なくとも一部を提供する植物抽出物を含む食品製品として投与される、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記個体が、中高年者及び高齢者からなる群から選択される、請求項１～５のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記個体が、ＩＣＵの患者である、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""indep-clm"" num=""8"">【請求項8】</div>
<div class=""indep-clm"" num=""8""> ミトコンドリア関連疾患、若しくはミトコンドリア機能の変化に関連する状態、若しくはミトコンドリア密度の低下を治療する、その発生率を低減する、及び／又はその重症度を低減する方法であって、投与を必要とする個体に、有効量のクルクミンとオメガ－３脂肪酸との組み合わせを経口投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""8"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""8""> 前記ミトコンドリア関連疾患又は状態が、ストレス、肥満、代謝速度の低下、メタボリックシンドローム、真性糖尿病、糖尿病による合併症、高脂血症、神経変性疾患、認知障害、ストレス誘発性又はストレス因関連認知機能不全、気分障害、不安障害、加齢性神経細胞死又は機能不全、筋骨格障害、フレイル、プレフレイル、慢性腎疾患、腎不全、外傷、感染症、がん、難聴、黄斑変性、ミオパチー及びジストロフィー、並びにこれらの組み合わせからなる群から選択される、請求項８に記載の方法。 </div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""8,9""> 前記ミトコンドリア関連疾患又は状態が、幼少期ストレス及び／又はその影響を含む、請求項８又は９に記載の方法。 </div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10""> 前記ミトコンド","A61K31/12, A61K31/202, A61P3/04, A61P3/06, A61P13/12",20250114,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
RU2843643C1,Recyclable paper laminate and carton package for beverages made therefrom,"FIELD: packaging and storage.SUBSTANCE: invention relates to the field of paper-based packaging materials and relates to the structure of a barrier multilayer material having high barrier properties and suitable for secondary processing in secondary paper pulp flow, and carton package for beverages made from it. Structure of the paper-based barrier multilayer packaging material is formed in form of a single sheet and contains, from its outer surface to its inner surface, the following layers: polymer dispersion coating having thickness of 1 mcm to 10 mcm; cardboard having density from 120 g/m2 to 500 g/m2; a water-based or solvent-free adhesive having thickness of 1 mcm to 10 mcm; a metallized barrier paper layer (MBPL) having a basic weight of 30 g/m2 to 120 g/m2 and a water vapour transmission rate (WVTR) in range of 10 to 0.1 g/m2/day, when measured at temperature of 38 °C and relative air humidity 90%, and oxygen transmission rate (OTR) in range from 100 to 0.1 cm3/m2/day, measured at 23 °C and relative humidity 50%; waterproof polyolefin coating made with possibility of sealing and having thickness from 10 mcm to 50 mcm.EFFECT: invention provides a packaging laminate which enables to produce packages using existing moulding methods, which also have high barrier properties and a shape suitable for storage and transportation, while having significantly reduced content of plastic polymer, so that they can be recycled together with other paper packaging, such as old boxes of corrugated cardboard (OCC) or mixed paper wastes, and to do so generally in a paper recycling stream, as well as having high abrasion resistance, wherein metal layer is not damaged by mechanical stress during storage, transportation or use of packaging material.10 cl, 1 dwg","1. Структура (1) барьерного многослойного упаковочного материала на основе бумаги, сформированная в виде единого листа и содержащая от ее наружной поверхности до внутренней поверхности следующие слои:
(i) по меньшей мере один слой полимерного дисперсионного покрытия (9), выбранного из списка: сополимер этилена и акриловой кислоты или метакриловой кислоты, винилацетат, стиролакрилат, акриловый полимер, модифицированный поливиниловый спирт, этилацетат, полигидроксиалканоат (PHA) и их сополимеры, полиуретан (PU), полибутиленадипат-терефталат (PBAT), полибутиленсукцинат (PBS), поли(бутиленсукцинат-со-адипат) (PBSA), полимолочная кислота (PLA) или любая их смесь с минеральным наполнителем или без него, причем указанное покрытие имеет толщину от 1 до 10 мкм;
(ii) картон (8), имеющий грамматуру от 120 до 500 г/м<sup>2</sup>;
(iii) слой (7) бессольвентного клея или клея на водной основе, выбранного из списка: поливинилацетат (PVAc), полиуретан (PU), акриловый полимер, поливиниловый спирт (PVOH), этиленвиниловый спирт (EVOH), сополимер бутендиола и винилового спирта (BVOH), клей на основе крахмала или их смесь, причем указанный клеевой слой имеет толщину в диапазоне от 1 до 10 мкм;
(iv) барьерная металлизированная бумага (MBPL), имеющая основную плотность от 30 до 120 г/м<sup>2</sup>, предпочтительно от 45 до 90 г/м<sup>2</sup>, и скорость проникновения водяных паров (WVTR) от 10 до 0,1 г/м<sup>2</sup>/сут, предпочтительное значение WVTR составляет от 1,0 до 0,1 г/м<sup>2</sup>/сут при измерении при 38°C и относительной влажности воздуха 90%, а также скорость проникновения кислорода (OTR) в диапазоне от 100 до 0,1 см<sup>3</sup>/м<sup>2</sup>/сут при измерении при 23°C и относительной влажности воздуха 50%, предпочтительное значение OTR составляет от 1,0 до 0,1 см<sup>3</sup>/м<sup>2</sup>/сут;
(v) водонепроницаемое полиолефиновое герметизируемое покрытие (2) из любого из следующих материалов: полиэтилен низкой плотности (LDPE), линейный полиэтилен низкой плотности (LLDPE) и","B32B29/00, B32B7/12, B32B27/10, B65D65/40, B65D65/42",20250717,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US12433445B2,Cleaning apparatus for a beverage preparation machine,"A cleaning apparatus for a beverage preparation machine comprises at least one fluid processing device comprising a fluid processing body provided with an outflow portion for the outflow of a cleaning fluid. The fluid processing body comprises at least one of the following means: inlet means for introducing a fluid substance into a container for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container; outlet means for allowing the outflow of the beverage product from the container once the fluid substance is introduced into the container and is mixed with the ingredient. The cleaning apparatus further comprises a cleaning device comprising a cleaning body, which in turn comprises one or more movable elements defining a chamber for housing at least a portion of the fluid processing body, and movement means for moving the one or body are dimensioned and shaped such that, in the active position, the one or more movable elements enclose at least a portion of the fluid processing body in the chamber, such that the cleaning fluid can circulate in a space between the fluid processing body and the one or more movable elements when said cleaning fluid is ejected from the outflow portion of the fluid processing body. In the inactive position the one or more movable elements are moved away from the fluid processing body, such that the fluid processing body and the container can be functionally connected together for the preparation of the beverage product and/or the outflow of the beverage product.","<div class=""indep-clm"" num=""1""><seg-con>1. A cleaning apparatus for a beverage preparation machine, the cleaning apparatus </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one fluid processing device comprising a fluid processing body provided with an outflow portion for the outflow of a cleaning fluid, wherein the fluid processing body comprises the following members:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an inlet member for introducing a fluid substance into a container (C) for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container (C); and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an outlet member for allowing the outflow of the beverage product from the container (C) once the fluid substance is introduced into the container (C) and is mixed with the ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the cleaning apparatus further comprises a cleaning device comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a cleaning body comprising one or more movable elements defining a chamber for housing at least a portion of the fluid processing body; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a movement member for moving the one or more movable elements between an active position and an inactive position,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and wherein the one or more movable elements and the fluid processing body are dimensioned and shaped such that:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>in the active position, the one or more movable elements enclose at least a portion of the fluid processing body in the chamber, such that the cleaning fluid can circulate in a space between the fluid processing body and the one or more movable elements when the cleaning fluid is ejected from the outflow portion of the fluid processing body; and</seg-refi></div>
<div class","A47J31/60, A47J31/36",20251007,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20240408859A1,Biodegradable laminating film and container made out of it,"A biodegradable laminating film having the layer structure A/B, wherein the 0.5 to 7 μm thick layer A comprises a polyurethane or acrylate adhesive; and wherein the 5 to 150 μm thick layer B comprises an aliphatic polyester and/or aliphatic-aromatic polyester, wherein the aliphatic-aromatic polyester is composed as follows: b1-i) 30 to 70 mol %, based on components b1-i and b1-ii, of a C6-C18 aliphatic dicarboxylic acid; b1-ii) 30 to 70 mol %, based on components b1-i and b1-ii, of an aromatic dicarboxylic acid; b1-iii) 98 to 100 mol %, based on components b1-i and b1-ii, of 1,3-propanediol or 1,4-butanediol; b1-iv) 0 to 2% by weight, based on components b1-i to b1-iii, of a chain extender and/or branching agent. The invention further relates to a food and/or beverage container comprising a substrate and a biodegradable laminating film coating, as the one described.","<div class=""indep-clm"" num=""1""><seg-main>1. A biodegradable laminating film having </seg-main><seg-clauses>the layer structure A/B, wherein the 0.5 to 7 μm thick layer A comprises a polyurethane or acrylate adhesive; and wherein the 5 to 150 μm thick layer B comprises an aliphatic polyester and/or aliphatic-aromatic polyester, wherein the aliphatic-aromatic polyester is composed as follows:</seg-clauses>
<seg-clauses class=""seg-enter"">b1-i) 30 to 70 mol %, based on components b1-i and b1-ii, of a C6-C18 aliphatic dicarboxylic acid;</seg-clauses>
<seg-clauses class=""seg-enter"">b1-ii) 30 to 70 mol %, based on components b1-i and b1-ii, of an aromatic dicarboxylic acid;</seg-clauses>
<seg-clauses class=""seg-enter"">b1-iii) 98 to 100 mol %, based on components b1-i and b1-ii, of 1,3-propanediol or 1,4-butanediol;</seg-clauses>
<seg-clauses class=""seg-enter"">b1-iv) 0 to 2% by weight, based on components b1-i to b1-iii, of a chain extender and/or branching agent.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Laminating film according to claim 1, wherein </seg-main><seg-clauses>layer B is composed of:</seg-clauses>
<seg-clauses class=""seg-enter"">b1) 60 to 100% by weight of an aliphatic-aromatic polyester selected from the group consisting of: Polybutylene adipate-coterephthalate, Polybutylene azelate-coterephthalate and Polybutylene sebacate-coterephthalate;</seg-clauses>
<seg-clauses class=""seg-enter"">b2) 0 to 15% by weight, preferably 3 to 12% by weight, of a polyhydroxyalkanoate, preferably a polylactic acid;</seg-clauses>
<seg-clauses class=""seg-enter"">b3) 0 to 25% by weight, preferably 3 to 20% by weight, of a mineral filler.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A laminating film according to claim 1, wherein </seg-main><seg-clauses>layer A is formed from an aqueous polyurethane dispersion, wherein at least 60% by weight of the polyurethane is composed of:</seg-clauses>
<seg-clauses class=""seg-enter"">a1) at","B32B27/36, B32B7/12, B32B27/08, B32B33/00, B32B37/12",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025228507A1,Method for producing milk like products,"The invention provides isolated human breast milk exosomes, and compositions thereof. The present invention also provides in vitro methods for producing said exosomes comprising generating lactocytes derived from human induced pluripotent stem cells (hiPSC), expressing the human milk like product from lactocytes, and purifying the exosomes from the human milk like product. The invention also provides therapeutic uses of the isolated human breast milk exosomes, and compositions thereof.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. An isolated human breast milk exosome, wherein </seg-main><seg-clauses>Hypoxia up-regulated protein</seg-clauses>
<seg-clauses class=""seg-enter"">1 (HYOU1), Apolipoprotein A-IV (APOA4) and Procollagen-lysine,2-oxoglutarate 5- dioxygenase 1 (PLOD1) are not detected by liquid chromatography - mass spectrometry in the exosome.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The exosome of claim 1, wherein </seg-main><seg-clauses>C4a anaphylatoxin (CFA), Hypoxia up- regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4), Procollagen-lysine,2- oxoglutarate 5-dioxygenase 1 (PLOD1), Threonine— tRNA ligase 1, cytoplasmic (TARSI), and Cytosolic non-specific dipeptidase (CNDP2) are not detected by liquid chromatography - mass spectrometry in the exosome.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The exosome of claim 1 or claim 2, wherein </seg-main><seg-clauses>the exosome comprises lactotransferrin (LTF), annexin A2 (ANXA2) and lactadherin (MFGE8), MUC1 and tetraspanins CD9, CD81 and CD63.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The exosome of any one of claims 1 to 3, wherein </seg-main><seg-clauses>the exosome comprises one or more miRNAs selected from miR-148a-3p, miR-22-3p, miR-125b-5b and miR-6126.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more lipids selected from cholesterol esters, ceramides, triacylglycerides, diacylglycerides, lyso-phospholipids, total phospholipids, alkanyl phospholipids, and alkenyl phospholipids.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6 The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more phospholipids selected from sphingomyelins, phosphatidylcholine, phosphatidylethanolamine, phosp","C12N5/071, A61K35/20",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250314015A1,A marine biodegradable and recyclable paper-based packaging material with high moisture and oxygen barrier properties,The present invention is directed to a marine biodegradable and recyclable multi-layer metallized paper-based packaging material comprising a layered arrangement of superimposed organic and inorganic materials for providing barrier to oxygen and moisture: the organic and inorganic layers are made of materials which are selected for their marine biodegradable properties. In one embodiment of the present invention the multi-layer metallized paper-based packaging material can be recycled with other paper packaging materials.,"<div class=""indep-clm"" num=""1""><seg-con>1. A marine biodegradable and recyclable multi-layer metallized paper-based packaging material </seg-con><seg-trans>comprising, </seg-trans><seg-refi>from its outer side to its inner side:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a paper layer having a grammage ranging from 30 to 120 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one first organic layer comprising at least one polymer being marine biodegradable according to standards ISO 22403:2020 or its equivalent ASTM D6691:2017, said at least one polymer being selected within the list of: a polyhydroxyalcanoate (PHA), a microfibrillated or nanofibrillated cellulose, a polyglycolide (PGA), or a combination thereof, said at least one polymer being applied as a layer in an amount of 0.5 to 15 g/m<sup>2</sup>, said biodegradable polymer having a melting temperature comprised between 160° C. and 200° C.,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a vacuum deposited or transfer-metallized inorganic layer, comprising a metal, a metalloid, or a combination thereof, said inorganic layer having a thickness ranging from between 1 and 100 nm, and at least one second organic layer comprising at least one polymer being marine biodegradable according to standards ISO 22403:2020 or its equivalent ASTM D6691:2017, said at least one polymer being selected within the list of: a polyhydroxyalcanoate (PHA), a polycaprolactone (PCL), a protein-based extrusion grade or dispersion, or a combination thereof, said at least one polymer being applied in an amount between 0.5and 30 g/m<sup>2</sup>, said biodegradable polymer having a melting temperature comprised between 30° C. and 160° C.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The multi-layer metallized paper-based packaging material according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the biodegradable polymer of said second organic","D21H19/82, B65D65/42, B65D65/46, D21H19/08, D21H19/28",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025200673A1,Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines,"A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of treating a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>administering to the surgical patient a specialized immunonutrition supplement comprising a component selected from the group consisting of L-arginine, omega-3 fatty acids, vitamin A, nucleotides, and mixtures thereof, the supplement is administered to the surgical patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the surgical patient to a post-operative day that is three to seven days after the bladder surgery.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement comprises L-arginine and is administered to the surgical patient in a daily dose that provides between about 5 g and about 30 g of the L-arginine per day.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement comprises omega-3 fatty acids and is administered to the surgical patient in a daily dose that provides an amount of the omega-3 fatty acids that comprises about 0.5 g to about 10.0 g of eicosapentaenoic acid and docosahexaenoic acid in total per day.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement comprises Vitamin A and is administered to the surgical patient in a daily dose that provides at least about 500 pg RE of the Vitamin A per day.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement comprises nucleotides ","A61K31/07, A61K31/198, A61K31/202, A61K31/70, A61P35/00",20250220,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025233092A1,Composition for maintaining and/or improving eye health or visual function,The present invention relates to compositions for use in maintaining and/or improving eye health and/or visual function in an individual consisting essentially of taurine and vitamin B9.,"CLAIMS
<div class=""indep-clm"" num=""1"">1 . A composition for use in maintaining and/or improving eye health and/or visual function in an individual consisting essentially of taurine and vitamin B9.</div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1 , wherein </seg-main><seg-clauses>taurine and vitamin B9 are comprised in a ratio of about 1 :2500.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to any of claim 1 or 2, wherein </seg-main><seg-clauses>it is for use in increasing glutathione levels in the central nervous system (CNS) and/or in the ocular bulb and/or preventing or treating eye condition, disease or disorder comprising glaucoma, diabetic retinopathy, age- related macular degeneration, cataracts, visual fatigue, dry eyes, conjunctivitis, impaired visual function and/or oxidative stress induced by UV lights or blue lights of screen.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according to any one of the preceding claims, wherein </seg-main><seg-clauses>the visual function includes visual acuity, contrast sensitivity, color, depth and/or motion perception, eye hydration.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>taurine and Vitamin B9 are comprised in the ratio so that the respective amounts of taurine and Vitamin B9 in the composition are from about 50 mg to about 3000 mg and from about 0.02 mg to about 1 .2 mg.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>taurine and Vitamin B9 are comprised in the ratio so that the respective amounts of taurine and Vitamin B9 in the composition are about 50 mg and 0.02 mg, or 70 mg and 0.028 mg, or ","A61K31/185, A61K31/714, A61K45/06, A61K9/00, A61P27/06",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250324992A1,"Foaming liquid creamers for aerosol packaging, and methods of making and using such foaming liquid creamers and aerosol packagings","A foaming liquid creamer contains water, a lipid, a buffer salt, a stabilizer, and a dairy protein. Optionally the foaming liquid creamer further contains a sugar and/or a flavor. The buffer salt may include at least one of sodium bicarbonate or dipotassium phosphate. The stabilizer may include at least one of carrageenan, carboxymethyl cellulose (CMC), microcrystalline cellulose (MCC), or guar gum. The dairy protein may include at least one of micellar casein or sodium caseinate. The emulsifier may include mono- and di-glycerides. The lipid may include an oil. The foaming liquid creamer may additionally include an emulsifier such as mono- and di-glycerides. Another aspect is an aerosol packaging which includes the foaming liquid creamer in a pressurized container, and the aerosol packaging has an actuator nozzle.","<div class=""indep-clm"" num=""1""><seg-con>1. A foaming liquid creamer </seg-con><seg-trans>comprising </seg-trans><seg-refi>water, a lipid, a buffer salt, a stabilizer, and a dairy protein.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The foaming liquid creamer of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a sugar.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The foaming liquid creamer of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the buffer salt comprises at least one of sodium bicarbonate or dipotassium phosphate.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The foaming liquid creamer of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stabilizer comprises at least one of carrageenan, carboxymethyl cellulose (CMC), microcrystalline cellulose (MCC), or guar gum.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The foaming liquid creamer of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dairy protein comprises at least one of micellar casein or sodium caseinate.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The foaming liquid creamer of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>an emulsifier.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The foaming liquid creamer of claim 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the emulsifier comprises mono- and di-glycerides.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The foaming liquid creamer of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lipid comprises an oil.</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-con>9. The foaming liquid creamer of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a flavor.</seg-refi></div>
<div class=""indep-clm"" num=""10""><seg-con>10. An aerosol packaging </seg-con><s","A23C11/08, A23L29/00, A23L29/238, A23L29/256, A23L29/262",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2018358125B2,Methods of oral immunotherapy,"The present disclosure relates to improved oral immunotherapy methods for treating food allergies, and particularly peanut allergy. Biomarkers, such as a level of peanut-specific IgE and/or peanut-specific IgG4s are used by the methods described herein. Such methods include a method of treating a subject for a peanut allergy, methods of assessing the suitability of a treatment for a peanut allergy, a method of evaluating a symptom in a subject during the course of treatment of a peanut allergy, a method of monitoring treatment for a peanut allergy in a subject, a method of reducing the risk or incidence of an adverse event in a subject receiving treatment for a peanut allergy, a method of adjusting a dose of an allergenic peanut composition, and a method of assessing a likelihood of an allergic reaction that requires administration of epinephrine to a subject receiving treatment for a peanut allergy.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of treating a subject for a peanut allergy, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>measuring a level of peanut-specific IgEs in the subject;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>selecting the subject for treatment based on the measured level of peanut-specific IgEs in the subject being at or below a predetermined threshold, wherein the predetermined threshold for the level of peanut-specific IgEs is about 100 kU/L; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>administering to the subject at least one dose of an allergenic peanut composition.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.      The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dose is administered to the subject as part of an oral</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>immunotherapy dosing regimen, optionally wherein the dose is administered to the subject during an initial escalation phase, an up-dosing phase, and/or a maintenance phase of the oral immunotherapy dosing regimen.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.     The method of claim 1 or claim 2, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>measuring a level of peanut-specific IgG4s</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>and measuring a ratio of peanut-specific IgE to peanut-specific IgG4 during the course of treatment, and/or wherein the selecting is based on the level of peanut-specific IgEs and the ratio of peanutspecific IgE to peanut-specific IgG4.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4.      A method of treating a subject for a peanut allergy, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""4""><seg-comp>measuring a level of peanut-specific IgEs in the subject;</seg-comp></div>
<div class=""inde","A61K39/35, A61P37/08",20250904,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024271293A1,A process for molding cellulosic material into a tridimensional package,"The present invention relates to a process for molding cellulosic pulp in one step, into a tridimensional packaging item comprising several layers comprising cellulosic and non-cellulosic material, by passing a mold with cavities through several consecutive baths containing different formulations corresponding to the various layers, to superimpose the various components without the need to separate process steps as in the prior art.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for manufacturing a tridimensional packaging item (10) comprising </seg-main><seg-clauses><seg-main>at least two layers, one support cellulosic pulp layer (22), and one oxygen and/or moisture barrier layer (23), said process comprising at least the steps of:</seg-main>
<seg-clauses>i) providing a mold (11) comprising at least two, male and female, cavities (17, 16) that are movable relative to one another, wherein the distance (D) between the two cavities is regulated at micrometric scales, and both cavities comprising at least one liquid tight gas permeable portion connected to a vacuum source,</seg-clauses>
<seg-clauses>ii) positioning the cavities (16, 17) at a distance (D) from each other that is comprised between 0.1 mm and 5 mm, so as to create a channel (20) between the internal surfaces of said cavities,</seg-clauses>
<seg-clauses>iii) immersing said mold (11) in a first bath containing a first cellulosic pulp composition comprising a slurry of cellulosic fibres, and optionally polymers in fibres or polymer dispersion form,</seg-clauses>
<seg-clauses>iv) applying vacuum (V) through the wall of a first cavity within the channel to suck said first composition into the channel (20), and depositing solid material contained in said first composition onto the surface of said first cavity to create a cellulosic support layer (22),</seg-clauses>
<seg-clauses>v) moving the cavities (16, 17) from one another, to maintain a distance between the surface of said solid material deposited on the first cavity and the surface of the second cavity,</seg-clauses>
<seg-clauses>vi) immersing said mold (11) in a second bath containing a second barrier composition (BC) comprising a slurry of cellulosic fibres and an organic polymer and/or inorganic material in fibres or polymer dispersion form,</seg-clauses>
<seg-clauses>vii) applying vacuum (V) through the wall of the second cavity within the channel, to suck said second compo","D21J7/00, D21J3/10",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250234902A1,Compositions and methods for providing a health benefit to a growing animal,"Compositions and methods provide a health benefit to a growing animal by administering a food composition to the animal, and the food composition includes a brain development blend. The brain development blend generally contains DHA, EPA, taurine, choline, thiamine, riboflavin, pantothenic acid, niacin, pyridoxine, vitamin B12, and folic acid.","<div class=""indep-clm"" num=""1""><seg-con>1: A food composition for a growing animal, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food composition comprises a brain development blend, wherein the brain development blend comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 5% to about 35% DHA,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 5% to about 35% EPA,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 5% to about 35% taurine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 5% to about 40% choline,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.01% to about 5% thiamine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.01% to about 5% riboflavin,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.01% to about 5% pantothenic acid,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.1% to about 5% niacin,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.01% to about 5% pyridoxine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.0001% to about 1% vitamin B12, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from about 0.001% to about 1% folic acid;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the food composition contains an effective amount of the brain development blend sufficient to provide a health benefit selected from the group consisting of enhanced brain and cognitive development, increased trainability, increased episodic learning, increased episodic memory, reduced spherical aberration of the eye, enhanced photopic vision, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The food composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food composition comprises:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>f","A23K20/105, A23K20/142, A23K20/158, A23K20/163, A23K20/174",20250724,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250026518A1,Process for the production of a container for the preparation of a beverage in a beverage preparation device and a container obtained by said process,"The present invention concerns a process for producing a container for the preparation of a beverage in a beverage preparation device, comprising the steps of: a. providing a water injection wall (<b>3</b>) of said, b. providing a beverage delivery wall (<b>4</b>) of said container, wherein at least one, preferably both, of said injection and delivery walls (<b>3, 4</b>) has a cup shape, c. placing a beverage M ingredient body in said at least one cup shaped wall (<b>4</b>), d. sealing together edge portions (<b>3</b>A, <b>4</b>A) of said injection and delivery walls (<b>4, 3</b>) in a sealing station, such as to form a chamber (<b>1</b>), wherein said sealing station comprise a housing element having a housing temperature (Th), wherein said body (<b>2</b>) is shaped and dimensioned such as not to completely fill said chamber (<b>1</b>), said process being characterized in that, after the sealing step, the container is cooled to a cooling temperature (Tc) being either: —at least 15° C. lower than the temperature of the housing, or —comprised between −10° C. and +25° C.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for producing a container for the preparation of a beverage in a beverage preparation device, comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>a. providing an injection wall of said container, comprising a paper layer through which water is to be introduced in the container, wherein said injection wall is able to be punctured by an injection member of the beverage preparation device for circulating water under pressure inside said container,</seg-clauses>
<seg-clauses>b. providing a beverage delivery wall of said container, comprising a paper layer through which the beverage is to be dispensed out of the container, wherein said delivery wall is able to be opened by an opening member of the beverage preparation device, wherein at least one of said injection and delivery walls has a cup shape,</seg-clauses>
<seg-clauses>c. placing a beverage ingredient in said at least one cup shaped wall, wherein said beverage ingredient is a body formed by a compacted beverage ingredient,</seg-clauses>
<seg-clauses>d. sealing together edge portions of said injection and delivery walls in a sealing station, such as to form a chamber in which said body formed by a compacted beverage ingredient is stored,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said sealing station comprises a housing element for housing at least partially said injection and/or delivery walls and wherein said housing element at the beginning of the sealing has a housing temperature (Th), and wherein said body is shaped and dimensioned such as not to completely fill said chamber;</seg-clauses>
<seg-clauses class=""seg-enter"">after the sealing step, the container is cooled at a cooling temperature (Tc), being either:</seg-clauses>
<seg-clauses class=""seg-enter"">at least 15° C. lower than the temperature of the housing, or</seg-clauses>
<seg-clauses class=""seg-enter"">comprised between −10° C. and +25° C.,</seg-clauses>
<seg","B65B29/02, B65B51/32",20250123,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023362572A1,Liquid foodstuff comprising β-glucan; hydrolysate from an oat-based material; and related methods,"A liquid foodstuff containing β-glucan having an average molecular weight between 400 kDa and 5000 kDa, preferably between 500 kDa and 3000 kDa, and the liquid foodstuff having a shear viscosity between 0.0001 Pa∙s (pascal second) and 0.3 Pa∙s, preferably between 0.001 Pa∙s and 0.2 Pa∙s, when measured at 25 °C at a shear rate of 0.1 s","<div class=""indep-clm"" num=""1""><seg-con>1.     A liquid foodstuff </seg-con><seg-trans>comprising </seg-trans><seg-refi>P-glucans having an average molecular weight between</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>400 kDa and 5000 kDa, preferably between 500 kDa and 3000 kDa, and the liquid foodstuff having a shear viscosity between 0.0001 Pa-s (pascal second) and 0.3 Pa-s, preferably between 0.001 Pa-s and 0.2 Pa-s, when measured at 25 °C at a shear rate of 0.1 s’1, 1 s’1, 10 s’1 and 100 s’1, wherein the liquid foodstuff has a P-glucan content of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least 0.5g of the P-glucans per serving of the liquid foodstuff; and/or between 0.1g and 1.5g of the P-glucans per 100ml of the liquid foodstuff.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The liquid foodstuff of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liquid foodstuff further comprises one or more of dairy ingredients, plant-based milks, cereals, oils, emulsifiers, stabilizers, sweeteners, flavors, or minerals.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The liquid foodstuff of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liquid foodstuff is selected from the group consisting of a liquid beverage and a soup, and preferably is a ready-to-drink (RTD) beverage.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The liquid foodstuff of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liquid foodstuff comprises a hydrolysate from an oat-based material comprising at least one of oat, barley, or rye, and the hydrolysate comprises at least a portion of the P-glucans.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The liquid foodstuff of Claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oat-based material comprises oat bran.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-con>6","A23L7/104, A23L7/10, A23L33/21",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250221563A1,"Container for use with a machine for preparing a beverage and/or foodstuff, system, use, and methods of encoding and reading preparation information","A container arranged for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising a plurality of elements, wherein the elements of the code are arranged circumferentially to be read sequentially when the container is rotated about an axis of rotation relative a code reader, wherein the code is arranged as a plurality of directly adjoining discrete positions and an absence or presence of a primary element at a discrete position encodes the preparation information, wherein boundary elements are arranged at a boundary between two or more adjoining primary elements, and/or at a boundary between two or more adjoining absences of primary elements, and the boundary elements are of different reflective properties to a primary element or an absence of a primary element.","<div class=""indep-clm"" num=""1""><seg-con>1. A container arranged for </seg-con><seg-trans>containing </seg-trans><seg-refi>a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising a plurality of elements,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the code is arranged as a plurality of directly adjoining discrete positions and an absence or presence of a primary element at a discrete position encodes the preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>boundary elements are arranged at a boundary between two or more adjoining primary elements, and/or at a boundary between two or more adjoining primary element absences,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the boundary elements are of different reflective properties to a primary element and/or a primary element absence, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the discrete positions and the boundary elements of the code are arranged circumferentially to be read sequentially when the container is rotated about an axis of rotation relative a code reader.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the boundary elements are only arranged at a boundary between two or more adjoining primary elements, and/or at a boundary between two or more adjoining primary element absences so that a boundary between a primary element and a primary element absence does not include a boundary element and the boundary elements entirely separate the adjoining primary elements and/or adjoining primary element absences.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>a ","A47J31/44, G06K7/10, G06K19/06",20250710,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119184282A,Dietary butyrate,"The present invention relates to dietary butyrates, in particular nutritional compositions for providing a butyrate or butyric acid source, comprising a compound of formula (1) wherein R6 is a long chain fatty acid having 16 to 20 carbons. # imgabs0 #","<div class=""indep-clm"" num=""1"">1.提供丁酸盐或丁酸来源的营养组合物在制备用于治疗炎性肠病、克罗恩氏病或溃疡性结肠炎的药物中的用途，所述营养组合物包含具有下式的化合物作为所述营养组合物中主要的含丁酸酯部分的甘油三酯</div>
<div class=""indep-clm"" num=""1""><img src="""" class=""img-anchor"" img-id=""FDA0005051515220000011""></div>
<div class=""indep-clm"" num=""1"">其中R<sup>6</sup>为具有16至20个碳的长链脂肪酸。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的营养组合物的用途，其中所述式(1)的化合物是所述营养组合物中所述丁酸盐或丁酸的主要来源。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的营养组合物的用途，其中所述式(1)的化合物提供至少20％、至少30％、至少40％、至少50％、或至少60％、至少70％、至少80％、至少90％、至少95％或基本上所有的由所述营养组合物提供的所述含丁酸酯部分的甘油三酯。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的营养组合物的用途，其中所述营养组合物是用于提供丁酸盐来源的膳食补充剂。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的膳食补充剂，所述膳食补充剂为胶囊、液体、片剂、小袋或粉末的形式。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3"">6.根据权利要求1至3中任一项所述的营养组合物的用途，其中所述营养组合物为婴儿配方食品或较大婴儿配方食品的形式。</div>
<div class=""indep-clm"" num=""7"">7.具有下式的化合物在营养组合物中用于提供具有改善的感官特性的丁酸盐或丁酸来源的用途</div>
<div class=""indep-clm"" num=""7""><img src="""" class=""img-anchor"" img-id=""FDA0005051515220000012""></div>
<div class=""indep-clm"" num=""7"">其中R<sup>6</sup>为具有16至20个碳的长链脂肪酸，其中所述式(1)的化合物是所述营养组合物中主要的含丁酸酯部分的甘油三酯。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的化合物的用途，其中所述营养组合物选自强化食品、医疗食品或用于特殊医疗目的食品、特殊膳食用食品、膳食补充剂、婴儿配方食品或较大婴儿配方食品。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,6,7,8"">9.根据权利要求1至6中任一项所述的营养组合物的用途或根据权利要求7或8所述的化合物的用途，其中所述具有式(1)的化合物以占所述组合物中总甘油三酯的至少3重量％的量存在于包含具有式(1)的化合物的组合物中。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,6,7,8"">10.根据权利要求1至6中任一项所述的营养组合物的用途或根据权利要求7或8所述的化合物的用途，其中所述具有式(1)的化合物以占所述组合物中总的含丁酸酯部分的甘油三酯的至少30重量％、优选地占所述组合物中所述总的含丁酸酯部分的甘油三酯的至少50重量％的量存在于包含具有式(1)的化合物的组合物中。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,7,8"">11.根据权利要求1至5中任一项所述的营养组合物的用途或根据权利要求7或8所述的化合物的用途，其中所述具有式(1)的化合物以占所述组合物中总的含丁酸酯部分的甘油三酯的至少60重量％、至少70重量％、至少80重量％或至少90重量％的量存在于包含所述具有式(1)的化合物的组合物中。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,7,8,9,10,11"">12.根据权利要求1至5或9至11中任一项所述的营养组合物的用途或根据权利要求7至11中任一项所述的化合物的用途，其中R<sup>6</sup>选自由以下项组成的组：","A23L29/00, A23L33/115, A23L33/00, A61K31/23, A61P1/04",20241227,雀巢产品有限公司,['Pending']
US20250213635A1,Use of a composition for managing postprandial glucose response and associated disorders,"The present invention generally relates to the use of a composition comprising mulberry leaf extract, a source of fiber and a source of unsaturated fatty acids to decrease postprandial glucose (PPG) response. More particularly, it relates to the use of such composition, administered with a meal, to decrease postprandial glucose (PPG) response. The invention also relates to a composition comprising a mulberry leaf extract, a source of fiber and a source of unsaturated fatty acids, administered with a meal, for use in the treatment and/or prevention of a disorder linked to postprandial glucose and/or postprandial insulin in a subject.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of reducing postprandial glucose from a meal, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>orally administering to an individual a composition comprising at least one mulberry extract (ME), at least one source of fiber and at least one source of unsaturated fatty acids, with the meal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual has or is at risk of having at least one condition selected from the group consisting of overweight, obesity, type-1 diabetes, type-2 diabetes, gestational diabetes mellitus and pre-diabetes.</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-con>3. A method of treating or preventing at least one condition for which reduced postprandial glucose and/or postprandial insulin from a meal is beneficial, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-refi>orally administering to an individual in need thereof or at risk thereof a composition comprising at least one mulberry extract (ME), at least one source of fiber and at least one source of unsaturated fatty acids, with the meal.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4. A method of improving glycemic control and/or T2D management; help manage weight loss; regulating appetite after a meal by increasing GLP-1, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""4""><seg-refi>orally administering to an individual in need thereof or at risk thereof a composition comprising at least one mulberry extract (ME), at least one source of fiber and at least one source of unsaturated fatty acids, with the meal.</seg-refi></div>
<div class=""ccl-clm"" num=""7"">5-7. (canceled)</div>
<div class=""dep-clm"" num=""8"" parent=""3""><seg-con>8. The method according to claim 3, </seg-con><seg-trans>wh","A61K36/605, A61K31/201, A61K31/202, A61K31/445, A61K31/733",20250703,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2024261103A1,Low sugar-based food compositions with roasted ingredient,"The present invention relates to a low sugar food composition, for example cereal based composition, with organoleptic properties for infants and young children comprising a plant-based roasted ingredient. The said food composition has low level of process contaminants and possess desired colour and aroma markers thus imparting desired organoleptic properties. The methods for preparing such compositions are disclosed too and comprise incorporation of a roasted plant based ingredient into a cereal based compound and water to form a slurry which is then further processed to obtain a finished product.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A low sugar food composition with organoleptic properties for infants and young children comprising </seg-main><seg-clauses>a plant-based roasted ingredient, wherein the total sugars in the composition is less than 5g/100g; wherein said composition has a* colour space parameter comprising a a*value above 0; and wherein the roasted ingredient is obtainable by roasting to an extent that when said roasted ingredient is added to the food composition, the said food composition comprises sum of pyrazines containing 2-ethyl-6-methylpyrazine, 2-ethyl-5- methylpyrazine, 2,3,5-trimethylpyrazine, 2-ethyl-3-methylpyrazine, 2-ethyl-3,6- dimethylpyrazine and 2-ethyl-3,5-dimethylpyrazine in amount lower than or equal to 20 parts per billion (ppb).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition of claim 1 wherein </seg-main><seg-clauses>total amount of sugars refers to monosaccharides, for example glucose, fructose and galactose, and di-saccharides, for example sucrose, lactose and maltose, except naturally occurring lactose from dairy ingredients.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition of claim 1 wherein </seg-main><seg-clauses>the amount of furan is below 50 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The composition of claim 1 wherein </seg-main><seg-clauses>the amount of acrylamide is below 60 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition of anyone of claims 1 to 4 wherein </seg-main><seg-clauses>the concentration ratio of HDMF to Strecker aldehydes is higher than 0.5.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition of anyone of the claims 1 to 5 wherein </seg-main><seg-clauses>the total amount of Strecker aldehydes containing 3-methylbutanal, 2-methylbutanal, methional and phenylacetaldehyde is greater","A23L7/00, A23L27/20, A23L27/21, A23L33/20, A23L33/00",20241226,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
EP4534143A2,"A nutritional composition comprising 2' FL, difl, LNT, lnnt, 3' SL and 6' SL to improve the gastrointestinal barrier","The present invention relates to nutritional compositions comprising 2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) for use in improving gastrointestinal barrier. In particular, the present invention relates to improving the gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-con>1.  A nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-comp>2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) for use in improving the gastrointestinal barrier in an infant (child under the age of 12 month) or a young child (between 1 year and less than 3 years); </seg-comp><seg-comp>or a nutritional composition in the form of a growing-up milk comprising 2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) for use in improving the gastrointestinal barrier in a child (aged from 3 years to less than 8 years).</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  The nutritional composition for use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said improvement to the gastrointestinal barrier is improved barrier maturation, improved barrier structure, improved barrier function, improved barrier protection and/or improved barrier repair.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.  The nutritional composition for use according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said improvement to the gastrointestinal barrier is improved barrier function, improved barrier structure, and/or improved barrier protection.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  The nutritional composition for use according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said improvement to the gastrointestinal barrier is improved barrier protection and/or improved barrier structure.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.  The nutritional composition for use according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said use for",A61P1/00,20250409,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
MX381981B,Reduced sugar frozen confection composition,"The present invention relates to a frozen confection composition with a total carbohydrates content not exceeding 29 wt. -% based on the total composition, comprising an added sugar content not exceeding 15wt. -% based on the total composition, which added sugar comprises a combination of sucrose and glucose syrup.","REIVINDICACIONES
<div class=""indep-clm"" num=""1"">1. Una composition de confitura congelada con un contenido de carbohidratos total que no excede 29 % en peso basado en la composition total, caracterizada porque comprende 8.4 a 10.8 % en peso basado en la composition total de un azucar anadido que consiste esencialmente de una combination de sacarosa y jarabe de glucosa, y en donde la composition de confitura congelada tiene un contenido de solidos totales mayor que 17 % basado en el peso de la composition total y que esta libre de edulcorantes intensos y policies que producen menos de 16.74 kJ (4 Kcal) por g, y que tiene un contenido total de oligosacaridos y polisacaridos menor que 10 % en peso basado en la composition total.</div>
<div class=""indep-clm"" num=""2"">2. Una composition de confitura congelada de conformidad con la revindication 1, caracterizada porque el contenido de azucar anadido es de 8.4 a 10.6 % en peso basado en la composition total.</div>
<div class=""indep-clm"" num=""3"">3. Una composition de confitura congelada de conformidad con cualquiera de las reivindicaciones 1 a 2, caracterizada porque el contenido de carbohidratos totales esta comprendido de 16.4 a 19, preferentemente de 16.7 a 18 % en peso basado en la composition total.</div>
<div class=""indep-clm"" num=""4"">4. Una composition de confitura congelada de conformidad con cualquier revindication anterior, caracterizada porque ademas comprende glicerol en una cantidad de 0.5 a 2, preferentemente de 0.5 a 1 % en peso basado en la composition total.</div>
<div class=""indep-clm"" num=""5"">5. Una composition de confitura congelada de conformidad con cualquier revindication anterior, caracterizada porque ademas comprende un sabor multifuncional en una cantidad de 0.05 a 4 % en peso basado en la composition total.</div>
<div class=""indep-clm"" num=""6"">6. Una composition de confitura congelada de conformidad con cualquier</div>
<div class=""indep-clm"" num=""6"">INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL</di","A23G9/34, A23L29/30, A23L33/20",20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN120203237A,Nutritional composition and infant formula for promoting brain myelination,"The present invention relates to nutritional compositions and infant formulas that promote brain myelination. More specifically, the present invention relates to nutritional compositions for infants and young children and related health benefits. The present invention relates to a nutritional composition for promoting or supporting an optimal myelination trajectory in the brain, in particular to a nutritional composition comprising a phospholipid, a metabolic precursor thereof and/or a metabolite thereof, for use in promoting or supporting an optimal myelination trajectory in the brain, such trajectory being close to the trajectory observed in infants fed only with human breast milk (HBM) several months before life.","<div class=""indep-clm"" num=""1"">1.一种用于婴儿和/或幼儿的营养组合物，所述营养组合物包含磷脂、其代谢前体和/或其代谢物，用于促进和/或支持脑中的最佳髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述脑中的最佳髓鞘形成轨迹接近于在出生后早期几个月中仅用人类母乳喂养的婴儿中所观察到的髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的组合物，其中所述组合物促进和/或支持通过最佳的脑和认知功能发育和/或防止神经认知缺陷所表征的健康状态。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，所述组合物包含高于200mg/Kg的量的鞘磷脂和/或磷脂酰胆碱和/或磷脂酰肌醇。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，所述组合物还包含铁。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，所述组合物还包含DHA。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的组合物，所述组合物还包含叶酸。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的组合物，其中所述组合物还包含胆碱。</div>
<div class=""indep-clm"" num=""9"">9.权利要求1至8中任一项所述的组合物用于促进和/或支持婴儿或幼儿脑中的最佳髓鞘形成轨迹的用途。</div>
<div class=""indep-clm"" num=""10"">10.权利要求1至8中任一项所述的组合物用于防止婴儿或幼儿脑中未达最佳的髓鞘形成轨迹的用途。</div>
<div class=""indep-clm"" num=""11"">11.用于促进和/或支持婴儿和/或幼儿脑中的最佳髓鞘形成轨迹的方法，所述方法包括给所述婴儿和/或幼儿施用包含鞘磷脂、其代谢前体和/或其代谢物的营养组合物。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中将权利要求1至8中任一项所述的组合物施用给婴儿和/或幼儿。</div>
<div class=""indep-clm"" num=""13"">13.一种营养组合物，所述营养组合物包含：</div>
<div class=""indep-clm"" num=""13"">高于200mg/kg的量的鞘磷脂和/或磷脂酰肌醇和/或磷脂酰胆碱；</div>
<div class=""indep-clm"" num=""13"">高于5mg/100g的量的铁；</div>
<div class=""indep-clm"" num=""13"">高于30mg/100g的量的胆碱；</div>
<div class=""indep-clm"" num=""13"">高于30mg/100g的量的DHA；</div>
<div class=""indep-clm"" num=""13"">高于50mcg/100g的量的叶酸。</div>
<div class=""indep-clm"" num=""14"">14.一种营养组合物，所述营养组合物包含：</div>
<div class=""indep-clm"" num=""14"">在200mg/kg至2.5g/kg范围内的量的鞘磷脂和/或磷脂酰肌醇和/或磷脂酰胆碱；</div>
<div class=""indep-clm"" num=""14"">在5mg/100g至40mg/100g范围内的量的铁；</div>
<div class=""indep-clm"" num=""14"">在30mg/100g至1000mg/100g范围内的量的胆碱；</div>
<div class=""indep-clm"" num=""14"">在30mg/100g至300mg/100g范围内的量的DHA；</div>
<div class=""indep-clm"" num=""14"">在50mcg/100g至500mcg/100g范围内的量的叶酸。</div>","A23L33/115, A23L33/10, A23L33/12, A23L33/15, A23L33/16",20250627,雀巢产品有限公司,['Pending']
MX395642B,Process for treating sweet whey such as to obtain a protein material suitable for hypoallergenic infant formulae,"The invention concerns a process for the treatment of a sweet whey material containing cGMP (caseinoGlycoMacroPeptide), said process comprising the following steps: - Decationising the sweet whey material so as to obtain sweet whey material having a pH value of 1 to 4.5; - Treating said sweet whey in a fluidized bed reactor comprising a specific volume of an anionic resin, at a temperature between 10 and 18Â°C, wherein said sweet whey contacts said resin for a sufficient amount of time so that the resin absorbs between 52% and 58% of the cGMP present in the sweet whey; and - Recovering a protein material. Advantageously, the protein material is suitable for hypoallergenic infant formulae.","REIVINDICACIONES
<div class=""indep-clm"" num=""1""><seg-main>1. Un proceso para el tratamiento de un material de suero de leche dulce que contiene cGMP (caseinoglicomacropeptido), el proceso esta caracterizado porque comprende:</seg-main>
<seg-clauses>- descationizar el material de suero de leche dulce para obtener suero de leche dulce que tiene un valor de pH de 1 a 4.5;</seg-clauses>
<seg-clauses>- tratar el suero de leche dulce en un reactor de lecho fluidizado que comprende un volumen especifico de una resina anionica, a una temperatura entre 10y18°Cya una relacion entre la proteina y la resina de 0.20 a 0.35 kg/L, en donde el suero de leche dulce entra en contact© con la resina anionica durante un tiempo suficiente de manera que la resina anionica absorba entre el 52 % y el 58 % del cGMP presente en el suero de leche dulce y al menos el 90 % de los aniones presentes en el suero de leche dulce; y</seg-clauses>
<seg-clauses>- recuperar un material proteico adecuado para la formula infantil hipoalergenica, el material proteico que comprende una relacion triptofano:treonina entre 0.350 y 0.360.</seg-clauses></div>
<div class=""indep-clm"" num=""2"">2. El proceso de conformidad con la reivindicacion 1, caracterizado porque la resina anionica absorbe el 55 % del cGMP.</div>
<div class=""indep-clm"" num=""3"">3. El proceso de conformidad con la reivindicacion 1, caracterizado porque la resina anionica absorbe al menos el 90 % de los aniones presentes en el suero de leche dulce.</div>
<div class=""indep-clm"" num=""4"">4. El proceso de conformidad con la reivindicacion 3, caracterizado porque los aniones se seleccionan del grupo que consiste en cloro, fosforo, citrato,</div>
<div class=""indep-clm"" num=""4"">INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL</div>
<div class=""indep-clm"" num=""4"">sulfato, lactato y combinaciones de los mismos.</div>
<div class=""indep-clm"" num=""5"">5. El proceso de conformidad con la reivindicacion 1, caracterizado porque la resina anionica absorbe al menos el 9","A23C9/146, A23C21/00, A23J1/20, A23J3/08, A23L33/18",20250325,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
JP2025023974A,Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia,"To provide liquid concentrates for preparing nutritional products by dilution, a resultant nutritional product, as well as a method of treating a dysphagia or a method for mitigating risks of aspiration during swallowing of nutritional products.SOLUTION: There is provided a liquid concentrate comprising a thickening component selected from a group consisting of β-glucan, at least one plant-extracted gum, at least one plant-derived mucilage and combinations thereof. The liquid concentrate is diluted with a diluent to form a nutritional product that has a shear viscosity, measured at a shear rate of 50 s-1 at 20°C, of greater than 200 mPas and up to about 2,000 mPas and a relaxation time, determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment, of more than 10 ms (milliseconds) at a temperature of 20°C.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> β－グルカン、少なくとも１つの植物抽出ガム、少なくとも１つの植物由来粘質物、及びこれらの組み合わせからなる群から選択される増粘成分を含む濃縮液であって、前記濃縮液が、希釈剤での希釈により、</div>
<div class=""indep-clm"" num=""1""> ２０℃で、５０ｓ<sup> －１</sup>の剪断速度で２００ｍＰａｓ超、かつ最大約２，０００ｍＰａｓの剪断粘度と、</div>
<div class=""indep-clm"" num=""1""> キャピラリー破断式伸長粘度計（ＣａＢＥＲ）実験によって測定したときに、２０℃の温度で１０ｍｓ（ミリ秒）超となる緩和時間と、</div>
<div class=""indep-clm"" num=""1""> を有する栄養製品を形成するよう配合されている、濃縮液。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２００ｍＰａｓ超、かつ最大約５００ｍＰａｓである、請求項１に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２５０ｍＰａｓ～約４００ｍＰａｓである、請求項１又は２に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記増粘成分が、β－グルカン、好ましくはオート麦β－グルカンを含む、請求項１～３のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記濃縮液が、最大２００：１、好ましくは５０：１～１００：１の比率で希釈剤で希釈される、請求項１～４のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記栄養製品が、医薬製剤、栄養製剤、栄養補助食品、機能性食品、及び飲料製品、並びにこれらの組み合わせからなる群から選択される投与可能な形態である、請求項１～５のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記増粘成分が、前記濃縮液の０．０１重量％～２５重量％である、請求項１～６のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記濃縮液が、水を更に含み、前記栄養製品が、以下からなる群から選択される少なくとも１つの配合を有する：</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉ）前記希釈剤が、水、乳、水と、この水に加えて更に少なくとも１つの成分とを含む飲料、液体経口栄養補助食品（ＯＮＳ）、又は食品製品のうちの１つ以上であり、前記濃縮液を前記希釈剤で希釈することにより、前記希釈剤と、前記増粘成分と、前記濃縮液に由来する水とから本質的に構成される又はこれらから構成される前記栄養製品を直接形成する、</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉｉ）前記濃縮液","A23L33/10, A23L29/206, A23L2/52",20250219,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
CA3117597C,Dietary butyrate,"A compound having the formula (1), (2). (3) or (4), or combinations thereof, for use in the prevention or treatment of dehydration, and/or in the treatment of diarrhea, wherein RI, R2. R3, R4. R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons.",,"A23L5/00, A23L33/00, A23L33/12",20250513,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
JP2025063268A,Dietary butyrate and its uses,,"<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 非アルコール性脂肪性肝疾患の予防及び／又は治療に使用するための、次式を有する化合物又はこれらの組み合わせ。</div>
<div class=""indep-clm"" num=""1""> 【化1】<img src=""https://data-fulltext-image.patsnap.com/JP/A/20/25/06/32/68/1744736873213/2025063268000015.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064343%3B1765067943%26q-key-time%3D1765064343%3B1765067943%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Def488c9961ba57d1877e9ec6dba33d3cabab9c9a&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A03%20GMT"" class=""img-anchor img-center"" img-id=""2025063268000015"" image_type=""chemistry"" official_size=""21761""></div>
<div class=""indep-clm"" num=""1""> ［式中、Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及びＲ<sup> ６</sup>は、独立して、１６～２０個の炭素を有する長鎖脂肪酸である。］ </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 式（１）を有する化合物と式（２）を有する化合物との組み合わせが使用され、好ましくは、前記組み合わせが、式（１）を有する化合物をトリグリセリド全量の少なくとも１０重量％の量で含み且つ式（２）を有する化合物をトリグリセリド全量の少なくとも１０重量％の量で含む組成物中に存在する、請求項１に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 式（１）を有する化合物と式（２）を有する化合物との組み合わせが使用され、前記組み合わせが、式（１）を有する化合物をブチレート部分含有トリグリセリド全量の少なくとも１０重量％の量で含み且つ式（２）を有する化合物をブチレート部分含有トリグリセリド全量の少なくとも１０重量％の量で含む組成物中に存在する、請求項１に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 式（１）を有する化合物と、式（２）を有する化合物と、式（３）を有する化合物と、式（４）を有する化合物と、の組み合わせが使用された、請求項１、２、又は３に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及び／又はＲ<sup> ６</sup>が、不飽和脂肪酸であり、好ましくはモノ不飽和脂肪酸である、請求項１又は２～４のいずれか一項に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4""> Ｒ<sup> １</sup>、Ｒ","A61K31/22, A61P1/16, A23L33/10, A23C9/152",20250415,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
AU2023389267A1,Detection of variation in a noodle package,"An automated system (100) for detecting variation of articles (104) in a noodle package (102) is disclosed. The automated system (100) includes a light source (106) to illuminate light on a noodle package (102), photoelectric sensor (108) configured to capture signals based on the light absorbed and reflected by one of: the articles (104) in the noodle package (102) and inner walls of the noodle package (102) and an article detection engine (110) to: correlate the captured signals with pre-stored data to detect a variation in at least one of: type of article (104) and number of articles (104) in the package (102), wherein the variation is from a predefined type and number of the article (104) intended to be in the noodle package (102) and rejection of the noodle package (102) upon finding a variation in the at least one of: type of the article (104) and number of the article (104) in the noodle package (102).","<div class=""indep-clm"" num=""1""><seg-con>1. An automated system (100) for detecting variation of articles (104) in a noodle package (102), the automated system (100) </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>one light source (106) to illuminate light on a noodle package (102);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>one photoelectric sensor (108) configured to capture signals based on the light absorbed and reflected by one of: the one or more articles (104) in the noodle package (102) and inner walls of the noodle package (102) ;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>an article detection engine (110) to:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>correlate the captured signals with pre-stored data to detect a variation in at least one of: type of article (104) and number of articles (104) in the noodle package (102), wherein the variation is from a predefined type and number of the article (104) intended to be in the noodle package (102);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>facilitate rejection of the noodle package (102) upon finding a variation in the at least one of: type of the article (104) and number of the article (104) in the noodle package (102);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the articles comprise a taste maker sachet, a liquid sachet or a combination thereof and wherein the photoelectric sensor (108) is a 3D Photo acoustic sensor and wherein a 3D Photo acoustic imaging is employed for the correlation of the captured signals.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The automated system (100) as claimed m claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the noodle package (102) is a sealed noodle package (102) covering the articles (104) .</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The automated system (100) as claimed in claim 1,</seg","G01N21/90, B07C5/34, G01N21/17, G01N21/359, G01N29/24",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023297150A1,Methods of enhancing palatability and/or reducing sugar in wet pet foods,"A method of making a wet food formulated for administration to a pet includes incorporating at least one of spinach or tomato into the wet food in an amount effective to enhance palatability of the wet food and/or reduce added sugar in the wet food. The method may include producing the wet food as a chunks-in-gravy composition and may include one or more of the following steps: (i) producing the gravy by a process comprising adding spinach to one or more other ingredients of the gravy; (ii) producing the gravy by a process comprising adding tomato to one or more other ingredients of the gravy, and preferably also incorporating free form cysteine into in the gravy; and (iii) producing the chunks by a process comprising adding both spinach and tomato to one or more other ingredients of the chunks. The method may include producing the wet food as a loaf composition, preferably by incorporating both spinach and tomato into the loaf composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of making a wet food formulated for administration to a pet, method </seg-con><seg-trans>comprising </seg-trans><seg-refi>incorporating at least one of spinach or tomato into the wet food in an amount effective to enhance palatability of the wet food and/or reduce added sugar in the wet food.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of Claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>producing the wet food as a chunks-in-gravy composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the incorporating of the at least one of spinach or tomato into the wet food comprises producing the gravy by a process comprising adding spinach to one or more other ingredients of the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. The method of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the incorporating of the at least one of spinach or tomato into the wet food comprises producing the gravy by a process comprising adding tomato to one or more other ingredients of the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of Claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the process of producing the gravy further comprises incorporating free form cysteine into in the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""2""><seg-con>6. The method of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the incorporating of the at least one of spinach or tomato into the wet food comprises producing the chunks by a process comprising adding both spinach and tomato to one or more other ingredients of the chunks.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7.     The method of Claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>producing the wet food as a ","A23K10/30, A23K50/45, A23K50/48",20241212,SOCIETE DES PRODUITS NESTLE SA,['Pending']
WO2025131784A1,Moulded pulp articles with improved barrier properties,"The present invention relates to a moulded pulp article comprising, from outermost layer to innermost layer, a shaped pulp; a polymer interlayer; and an inorganic barrier layer selected within the list of: metals, metalloids, oxides thereof, or a combination thereof, as well as to methods of producing such moulded pulp articles, uses for such moulded pulp articles, and packaged edible products comprising such moulded pulp articles.","CLAIMS:
<div class=""indep-clm"" num=""1""><seg-main>1 . A moulded pulp article (1) comprising, </seg-main><seg-clauses>from outermost layer to innermost layer: a shaped pulp (2); a polymer interlayer (3); and an inorganic barrier layer (4) selected within the list of: metals, metalloids, oxides thereof, or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The moulded pulp article of claim 1 , wherein </seg-main><seg-clauses>the polymer interlayer comprises a biodegradable polymer, optionally a polymer selected from polylactic acid (PLA), polyhydroxyalkanoates (PHA), polycaprolactone (PCL) polyglycolic acid (PGA), poly(butylene succinate-co-butylene adipate) (PBSA), polybutylene adipate terephthalate (PBAT), lignin, polyhydroxylated polysaccharides (such as starch, cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose), proteins (such as casein, zein, soy protein, silk), PVOH, EVOH, PGA, BVOH, or mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The moulded pulp article of claim 1 or claim 2, wherein </seg-main><seg-clauses>the inorganic barrier layer is selected from aluminium, aluminium oxide (AIO<sub>X</sub>), silicon oxide (SiO<sub>x</sub>), or combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The moulded pulp article of any preceding claim, further comprising </seg-main><seg-clauses>an organic barrier layer (5).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The moulded pulp article of claim 4, wherein </seg-main><seg-clauses>the organic barrier layer comprises a biodegradable polymer, optionally a polymer selected from PVOH, EVOH, PGA, BVOH, or mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The moulded pulp article of any preceding claim, further comprising </seg-main><seg-clauses>a contact layer (6).</seg-clauses></div>
<div class=""dep-clm","B32B27/36, D21H17/24, D21H17/63, D21H19/10, D21H19/20",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN119923214A,Beverage dispensing machine and method for controlling the same,"The invention relates to a beverage dispensing machine comprising a delivery path (2) having a delivery unit (4) for delivering a liquid through the beverage dispensing machine (1), and a dispensing unit (5) for dispensing the delivered liquid. The beverage dispensing machine (1) further comprises a detector (7) for detecting a cleaning command, and a control unit configured to activate a cleaning process based on the detection of the cleaning command by the detector (7), wherein the cleaning process comprises delivering the liquid along the delivery path (2). The invention also relates to a method for controlling such a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-con>1.饮料分配机(1)，所述饮料分配机</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>·输送路径(2)，所述输送路径具有</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>o输送单元(4)，所述输送单元用于输送液体通过所述饮料分配机(1)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>o分配单元(5)，所述分配单元用于分配输送的液体，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·检测器(7)，所述检测器用于检测清洁命令，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·控制单元，所述控制单元被配置为基于所述检测器(7)对所述清洁命令的检测来激活清洁过程，其中所述清洁过程包括沿着所述输送路径(2)输送所述液体，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述输送单元(4)包括储罐(40)，所述储罐用于携带一定量的液体，所述一定量的液体优选地经由入口(3)供给，待输送到所述分配单元(5)，并且/或者</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述输送单元(4)，优选地所述储罐(40)，包括用于冷却优选地在所述储罐(40)中的所述液体的冷却装置(41)，并且/或者</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述输送单元(4)，优选地所述储罐(40)，包括用于加热优选地在所述储罐(40)中的所述液体的加热器(42)，并且/或者</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述输送单元(4)还包括用于沿着所述输送路径(2)和/或闭合循环回路(O)输送所述液体的泵(43,44)，并且/或者</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述饮料分配机(1)还包括用于将液体供给到所述输送路径(2)中的供给罐(100)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的饮料分配机(1)，其中所述输送路径(2)还包括用于将液体供给到所述输送单元(4)的入口(3)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的饮料分配机(1)，其中所述检测器(7)是存在传感器，和/或光学检测器如条形码读取器，和/或代码读取器如RFID代码读取器。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的饮料分配机(1)，所述饮料分配机还包括可移除的连接器(6)，当定位在所述饮料分配机中时，所述可移除的连接器通过限定所述闭合循环回路(O)形成清洁路径(C)。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">5.根据前述权利要求2至4中任一项所述的饮料分配机(1)，所述饮料分配机还包括可移除的连接器(6)，所述可移除的连接器能够流体连接至所述分配单元(5)，用于在所述清洁过程期间接收所输送的液体，</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">其中所述可移除的连接器(6)优选地被设计用于将所述分配单元(5)和所述入口(3)流体连接作为所述清洁路径(C)，以形成所述闭合循环回路(O)。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">6.根据权利要求4或5所述的饮料分配机(1)，其中所述可移除的连接器(6)优选地包括空间(60)，当与所述输送路径(2)流体连接时，所述空间用于优选地沿着所述闭合循环回路(O)携带一定量的液体。</div>
<div class=""dep-clm"" num=""7"" parent=""4,5","A47J31/46, A47J31/60",20250502,雀巢产品有限公司,['Pending']
CN119836249A,Beverage or food preparation system,"A system comprising: a container for containing a precursor material, the container for use with a machine for preparing a beverage and/or a food product or a precursor thereof, the container comprising a machine-readable code storing preparation information for use with a preparation process performed by the machine; a machine for preparing a beverage and/or food product or a precursor thereof, the machine comprising: a code reading system to read the code of the container; a processing unit for processing the precursor material of the container; and electrical circuitry to control the processing unit based on preparation information read from the code, and comprising an electronic memory to store corresponding preparation information based on one or more previous reads of the corresponding code of the container; wherein the electrical circuitry is configured to: read the preparation information from the code; retrieving the corresponding preparation information from the electronic memory; the read preparation information is corrected based on the corresponding preparation information, and the processing unit is controlled based on the corrected preparation information.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>用于容纳前体材料的容器，所述容器用于与用于制备饮料和/或食品或其前体的机器一起使用，所述容器包括存储与由所述机器执行的制备过程一起使用的制备信息的机器可读代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>用于制备饮料和/或食品或其前体的机器，所述机器包括：代码读取系统，所述代码读取系统用以读取所述容器的所述代码；处理单元，所述处理单元用于处理所述容器的前体材料；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>电气电路系统，所述电气电路系统用以基于从所述代码读取的制备信息来控制所述处理单元，并且包括用以存储对应的制备信息的电子存储器，所述对应的制备信息基于容器的对应的代码的一次或多次先前读取；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述电气电路系统被配置为：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>从所述代码中读取所述制备信息；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>从所述电子存储器检索所述对应的制备信息；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>基于所述对应的制备信息来校正读取的制备信息，以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>基于校正的制备信息来控制所述处理单元。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述电气电路系统被配置为：</div>
<div class=""dep-clm"" num=""2"" parent=""1"">识别所述容器，以及</div>
<div class=""dep-clm"" num=""2"" parent=""1"">基于所述身份与从所述相同身份的先前容器获得的所述对应的制备信息之间的存储的关系，从所述电子存储器检索所述对应的制备信息。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的系统，其中所述电气电路系统被配置为基于由所述代码编码的标识符来识别所述容器。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的系统，其中所述标识符被编码为一个或多个离散位置，所述离散位置包括或不存在数据单元。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一前述权利要求所述的系统，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>由所述代码存储的所述制备信息包括为参数编码的参数值；</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>由所述电子存储器存储的所述对应的制备信息包括所述参数值的校正值，并且</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>所述电气电路系统被配置为基于所述校正值来校正所述参数值。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的系统，其中所述校正值包括从所述参数的多个相关联的参数值得出的平均值，所述参数是从对容器的对应的代码的所述先前读取获得的。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的系统，其中所述电气电路系统被配置成具有存储在栈存储器使用机制中的所述参数的所述多个参数值。</div>
<","A47J31/44, A47J31/52",20250415,雀巢产品有限公司,['Pending']
US20250332134A1,Compositions for use,"A maternal supplement or human milk fortifier composition comprising at least one nutrientselected in the list consisting of: ALA, DHA, EPA, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said maternal supplement or human milk fortifier composition is specifically tailored or adapted for a woman who has delivered via C-section who is breast feeding. Said maternal supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a woman who has delivered via C-section and promote associated health benefits.","<div class=""indep-clm"" num=""1""><seg-main>1. A maternal supplement composition comprising </seg-main><seg-clauses>at least one nutrient selected from the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">alpha linolenic acid (ALA) in a daily amount ranging from 0.1 to 2.6 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">docosahexaenoic acid (DHA) in a daily amount ranging from 35 to 700 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">eicosapentanoic acid (EPA) in a daily amount ranging from 10 to 200 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin A in a daily amount ranging from 130 to 3000 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine in a daily amount ranging from 0.14 to </seg-clauses><seg-clauses>2.8 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">thiamine monophosphate in a daily amount ranging from 0.14 to </seg-clauses><seg-clauses>2.8 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B2 in a daily amount ranging from 0.16 to 3.2 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B6 in a daily amount ranging from 0.2 to 100 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">vitamin B9 in a daily amount ranging from 50 to 1000 μg;</seg-clauses>
<seg-clauses class=""seg-enter"">phosphorus in a daily amount ranging from 70 to 4000 mg; and</seg-clauses>
<seg-clauses class=""seg-enter"">gangliosides in a daily amount ranging from 0.1 to 12.6 mg; and</seg-clauses>
<seg-clauses class=""seg-enter"">combinations thereof.</seg-clauses></div>
<div class=""ccl-clm"" num=""2"">2. (canceled)</div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A maternal supplement composition according to claim 1 wherein </seg-main><seg-clauses>the maternal supplement composition comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">alpha linolenic acid (ALA) in a daily amount ranging from 0.1 to 2.6 mg;</seg-clauses>
<seg-clauses class=""seg-enter"">docosahexaenoic acid (DHA) in a daily amount ranging from 35 to 700 mg; and</seg-clauses>
<seg","A61K31/202, A23L33/00, A61K31/07, A61K31/4415, A61K31/51",20251030,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119403564A,Use of microbiota modulators for enhancing bone development and/or bone strength,"The present invention relates to the use of a microbiota modulator for enhancing bone development and/or bone strength wherein the microbiota modulator modulates the abundance of one or more bacterial classification populations in the intestinal tract of a subject, the classified population of one or more bacteria is selected from the group consisting of Enterobacter butyricum, Selicobacter sanguineus, Paraprevor claralatus and Amino Cercaceae.","<div class=""indep-clm"" num=""1"">1.微生物群调节剂，其用于增强受试者的骨发育和/或骨强度，其中所述微生物群调节剂调节一种或多种细菌分类群在所述受试者的肠道中的丰度，所述一种或多种细菌分类群选自产丁酸肠杆菌、血苏黎世杆菌、克拉拉副普雷沃菌和氨基酸球菌科。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的微生物群调节剂，其中所述微生物群调节剂是产丁酸肠杆菌和/或血苏黎世杆菌。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1用于所述用途的微生物群调节剂，其中所述微生物群调节剂是低聚糖混合物，所述低聚糖混合物包含至少一种唾液酸化低聚糖、至少一种岩藻糖基化低聚糖和/或至少一种N-乙酰化低聚糖。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1用于所述用途的微生物群调节剂，其中所述微生物群调节剂是包含低聚糖混合物和产丁酸肠杆菌和/或血苏黎世杆菌的组合，其中所述低聚糖混合物包含至少一种唾液酸化低聚糖、至少一种岩藻糖基化低聚糖和/或至少一种N-乙酰化低聚糖，并且其中所述低聚糖混合物和产丁酸肠杆菌和/或血苏黎世杆菌单独、同时或按顺序施用。</div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-con>5.根据权利要求3或权利要求4用于所述用途的微生物群调节剂，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-refi>(a)所述至少一种唾液酸化低聚糖选自由以下组成的组：3'-唾液酸乳糖(3'-SL)、6'-唾液酸乳糖(6'-SL)、唾液酸乳糖-N-四糖b(LSTb)、唾液酸乳糖-N-四糖c(LSTc)、二唾液酸乳糖-N-四糖以及它们的组合，优选其中所述至少一种唾液酸化低聚糖选自3'-唾液酸乳糖(3'-SL)、6'-唾液酸乳糖(6'-SL)以及它们的组合；</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-refi>(b)所述至少一种岩藻糖基化低聚糖选自由以下组成的组：2'-岩藻糖基乳糖(2'FL)、3-岩藻糖基乳糖(3FL)、二岩藻糖基乳糖(diFL)、乳糖-N-岩藻戊糖-I(LNFP-I)、乳糖-N-岩藻戊糖-II(LNFP-II)、乳糖-N-岩藻戊糖-III(LNFP-III)、乳糖-N-岩藻戊糖-V(LNFP-V)、乳糖-新岩藻戊糖V(LNnFP-V)、乳糖-N-二岩藻糖基己糖-I(LNDFH-1)、乳糖-N-新二岩藻糖基己糖(LNnDFH)、单岩藻糖基乳糖-N-己糖-III(MFNLH-III)、二岩藻糖基乳糖-N-己糖-a(DFLNHa)以及它们的组合，优选其中所述至少一种岩藻糖基化低聚糖选自由以下组成的组：2'-岩藻糖基乳糖(2'FL)、二岩藻糖基乳糖(diFL)以及它们的组合；和/或</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-refi>(c)所述至少一种N-乙酰化低聚糖选自由以下组成的组：N-乙酰基-葡萄糖胺、N-乙酰基-半乳糖胺、乳糖-N-四糖(LNT)、乳糖-N-新四糖(LNnT)以及它们的组合，优选其中所述至少一种N-乙酰化低聚糖选自乳糖-N-四糖(LNT)、乳糖-N-新四糖(LNnT)以及它们的组合。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">6.根据权利要求3至权利要求5中任一项用于所述用途的微生物群调节剂，其中所述低聚糖混合物包含：(a)唾液酸乳糖(3'-SL)和6'-唾液酸乳糖(6'-SL)；(b)2'-岩藻糖基乳糖(2'FL)和二岩藻糖基乳糖(diFL)；和/或(c)乳糖-N-四糖(LNT)和乳糖-N-新四糖(LNnT)；优选其中所述低聚糖混合物包含2'-岩藻糖基乳糖(2'FL)、二岩藻糖基乳糖(diFL)、乳糖-N-四糖(LNT)和乳糖-N-新四糖(LNnT)或者由它们组成。</div>
<div class=""dep-clm"" num=""7"" parent=""3,4,5,6"">7.根据权利要求3至权利要求6中任一项用于所述用途的微生物群调节剂，其中低聚糖混合物包含：</div>
<div class=""dep-clm"" num=""7"" parent=""3,4,5,6","A61K35/742, A61K31/702, A61P19/00, A61P19/10",20250207,雀巢产品有限公司,['Pending']
WO2025031844A1,Compostable POD for beverage preparation,"The invention relates to a pod (100, 200) for preparing a beverage in a beverage production machine, wherein the pod (100, 200) is made of a biodegradable, preferably compostable, material composition and comprises a pod body (110) composed of two half-shells (101, 102) being connected to each other along their respective circumferential flange (140) so as to delimit a chamber (103) for containing a substance (105) for the preparation of the beverage, wherein at least one half-shell comprises in a layered manner:. A primary layer (171) made of a paper-based material,. A secondary layer (172) comprising at least an oxygen barrier function and optionally a water barrier function, and. A, at least partial, tertiary layer (173) comprising a filter function, wherein the primary layer (171) of at least one of the half-shell (101, 102) comprises at least one traversing hole (106), over at least a delivery portion (130) of the half-shell (101, 102), said delivery portion being adapted to interact with external opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod (100, 200) through an injection portion (120) on the other half-shell (101, 102), to dispense the prepared beverage from the pod (100, 200). The invention also relates to the use of said pod in a beverage production machine.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A pod (100, 200) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the pod (100, 200) is made of a biodegradable, preferably compostable, material composition and comprises a pod body (110) composed of two half-shells (101, 102) being connected to each other along their respective circumferential flange (140) so as to delimit a chamber (103) for containing a substance (105) for the preparation of the beverage, wherein at least one half-shell comprises in a layered manner:</seg-main>
<seg-clauses>• A primary layer (171) made of a paper-based material,</seg-clauses>
<seg-clauses>• A secondary layer (172) comprising at least an oxygen barrier function and/or a water vapor or moisture barrier function, and</seg-clauses>
<seg-clauses>• A, at least partial, tertiary layer (173) comprising a filter function, wherein the primary layer (171) of at least one of the half-shell (101, 102) comprises at least one traversing hole (106), over at least a delivery portion (130) of the half-shell (101, 102), said delivery portion being adapted to interact with external opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod (100, 200) through an injection portion (120) on the other half-shell (101, 102), to dispense the prepared beverage from the pod (100, 200).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The pod (100,200) according to claim 1, wherein </seg-main><seg-clauses>the primary layer (171) comprises between 1 and 150 traversing holes (106) forming a first pattern (108).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The pod (100,200) according to claim 1 or 2, wherein </seg-main><seg-clauses>the primary layer (171) further comprises at least a non-traversing element, preferably an engraved surface and/or scratch, forming a second pat","B65D65/46, B65D85/804",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250312307A1,Compositions and methods using a combination of fisetin and quercetin for use in cartilage degeneration,"The present invention relates to use of a composition comprising an effective amount of a combination of fisetin and/or derivative thereof and quercetin and/or derivative for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of fisetin and/or derivative thereof and quercetin and/or derivative for use to prevent or treat cartilage degeneration in an individual.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use to prevent or treat cartilage degeneration in an individual comprising </seg-main><seg-clauses>administering a composition comprising an effective amount of a combination of fisetin and/or derivative thereof and quercetin and/or derivative.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1, wherein </seg-main><seg-clauses>the derivative of fisetin is selected from the group consisting of glucuronidated forms thereof, sulfated forms thereof, derivatives and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1, wherein </seg-main><seg-clauses>the derivative of quercetin is selected from the group consisting of quercetin 3-O-galactoside, quercetin 3-O-glucoside (izoquercetin), quercetin 3-O-xyloside, quercetin 3-O-rhamnoside (quercitrin), quercetin 3-O-glucuronide, quercetin 7-O-glucoside, quercetin 3-O-diglucoside, quercetin 3,4′-diglucoside, quercetin 3-O-rhamnoside-7O-glucoside, quercetin 3-O-rutinoside (rutin), quercetin3-O-6″-acetylglucoside, quercetin 3-methyl ether, quercetin 3,3′-dimethyl ether, isorhamnetin and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1"">4. Method according to claim 1, further comprising calcium.</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the composition further comprises at least one compound selected from the group consisting of antioxidants, anti-inflammatory compounds, glycosaminoglycans, prebiotics, fibres, probiotics, fatty acids, enzymes, minerals, trace elements and vitamins.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the composition is selected from the group consisting of food compositions, dietary supplements, nutritional compositions, oral nutritional supplem","A61K31/352, A61K31/7048, A61K33/06, A61K45/06, A61P19/02",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250107554A1,"Edible animal chews containing concentrated fruit juice, and methods of making and using such edible animal chews","An edible pet chew contains a concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible pet chew. A method of making an edible pet chew includes extruding a composition containing concentrated fruit juice, the concentrated fruit juice present in the composition in an amount effective as both a humectant and a plasticizer in the composition being extruded. A method of cleaning teeth of a pet includes orally administering an edible chew to the pet, the edible chew containing concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible chew. The concentrated fruit juice may replace at least a portion of glycerin and/or propylene in the edible chew, while maintaining or increasing at least one of texture or occupation time for the edible pet chew.","<div class=""indep-clm"" num=""1""><seg-con>1. An edible pet chew </seg-con><seg-trans>comprising </seg-trans><seg-refi>concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible pet chew.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The edible pet chew of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible chew is substantially free of glycerin and substantially free of propylene glycol.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The edible pet chew of claim 1 or claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible pet chew further comprises a starch.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The edible pet chew of any of claims 1-3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the concentrated fruit juice is selected from the group consisting of: plum, apple, carob, dates, blueberry, strawberry, pear, grape, peach, and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The edible pet chew of any of claims 1-4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the concentrated fruit juice is a mixture of apple and carob.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The edible pet chew of any of claims 1-5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible pet chew has a property that is at least one of improved texture or increased occupation time, relative to a reference edible pet chew that comprises glycerin and/or propylene glycol instead of the concentrated fruit juice but otherwise identically formulated.</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-con>7. A method of making an edible pet chew, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""7""><seg-refi>extruding a composition comprising concentrated fruit juice, the concentrated fruit juice present in the composi","A23K10/30, A23K20/163, A23K40/25, A23K50/40, A61C17/00",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020273426B2,Rotary press for compressing a pressing food material,"The present invention is directed to a rotary press (1) for compressing a pressing food material (M), like food powder, into food tablets (T), comprising a feeding system (2) comprising a feeder (20) for continuously supplying the pressing food material (M) and a feeding pipe (21) for providing the pressing food material (M) received from the feeder (20), a press system (3) comprising a rotary die plate (30) being drivable about a rotational axis (R) and comprising a plurality of die cavities (31) for successively receiving an amount of pressing food material (M) provided by the feeding pipe (21) and to produce food tablets (T) inside the die cavities (31) by means of punches (32) upon a rotational movement of the die cavities (31) of the rotary die plate (30) with respect to the feeding system (2), an analog sensor (4) for detecting a fill level (L) of the pressing food material (M) in the feeding pipe (21), and a control unit (5) configured to control a feeding speed of the feeder (20) for continuously supplying the pressing food material (M) based on the detected fill level (L) to keep the fill level (L) at a defined fill level set point (LSP). The present invention is further directed to a method for pressing a food tablet (T), like a bouillon cube, by compression of a pressing food material (M), like a food powder, with a rotary press (1).","<div class=""indep-clm"" num=""1""><seg-main>1. A rotary press for compressing a pressing food material into food tablets, comprising: </seg-main><seg-clauses>• a feeding system comprising a feeder for continuously supplying the pressing food material and a feeding pipe for providing the pressing food material received from the feeder,</seg-clauses>
<seg-clauses>• a press system comprising a rotary die plate being drivable about a rotational axis and comprising a plurality of die cavities for successively receiving an amount of pressing food material provided by the feeding pipe and to produce food tablets inside the die cavities by means of punches upon a rotational movement of the die cavities of the rotary die plate with respect to the feeding system,</seg-clauses>
<seg-clauses>• an analog sensor for detecting a fill level of the pressing food material in the feeding pipe, and</seg-clauses>
<seg-clauses>• a control unit configured to control a feeding speed of the feeder for continuously supplying the pressing food material based on the detected fill level to keep the fill level at a defined fill level set point;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the analog sensor is a LED infrared sensor, and wherein the analog sensor consists of one transmitter and one receiver, being provided on opposite sides of the feeding pipe at the same level.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The rotary press according to claim 1, wherein </seg-main><seg-clauses>the control unit is further configured to control the feeding speed independent from a speed of the press system.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The rotary press according to claim 1 or claim 2, further comprising </seg-main><seg-clauses>a press control unit configured to control the speed of the press system independent from the feeding speed and the detected fill level, wherein the control unit comprises the press control unit.</se","B30B11/08, B30B15/30",20250626,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2840153C1,Ground coffee dispensing system,"FIELD: food industry.SUBSTANCE: invention relates to system (110) for dispensing ground coffee, in particular for preparing a coffee beverage. Said system (110) comprises one or more receiving compartments (13, 14) for storing one or different types of roasted coffee beans, one or more dispensers (60, 70) for dispensing coffee beans that are stored in one or more receiving compartments (13, 14), mill (30) for receiving coffee beans which are supplied by one or more of said dispensers (60, 70) in order to grind said coffee beans and then to dispense such ground coffee beans, wherein mill (30) is movable to different grinding positions for different degrees of grinding, respectively, wherein one or more dosing devices (60, 70) are located between one or more receiving compartments (13, 14) and mill (30), control unit (91) for controlling one or more dosing devices (60, 70) and mill (30), wherein control unit (91) is configured to control one or more of one or more of dosing devices (60, 70) so as to output to mill (30) a certain number of coffee beans, and controlling mill (30) such that mill (30) grinds said certain number of coffee beans and, thus, dispenses ground coffee beans until mill (30) is empty, so that mill (30) can then be moved into one of different grinding positions. One or more of dosing devices (60, 70) is configured to act as one or more fixing elements for holding the coffee beans within one or more receiving compartments (13, 14), so that the coffee beans in receiving compartments (13, 14) at least partially cover or at least partially rest on one or more metering devices (60, 70), preventing the dispensing of coffee beans from receiving compartments (13, 14), and one or more dosing devices (60, 70) are configured to selectively block or stop the dispensing of coffee beans, so that only certain or required quantity of coffee beans is dispensed to mill (30) by one or more of dosing devices (60, 70).EFFECT: invention is aimed at possibility to produce balanced coffee drink with good taste from organoleptic point of view, and also provides an improved automatic process of grinding coffee beans for different types of coffee beverage without sacrificing quality of different types of coffee beverage.19 cl, 5 dwg",,A47J31/42,20250519,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025056442A1,Method of making fermented plant-based products having kokumi characteristics and products thereof,"The method comprises a step of providing a plant protein substrate and a step of fermenting the plant protein substrate with a starter culture comprising Lactobacillus johnsonii. It also relates to such a fermented plant-based product and to Lactobacillus johnsonii strains suitable for the invention. It also relates to peptides that impart and/or enhance kokumi, method for preparing such peptides, composition comprising such peptides and use of such peptides as flavouring agent.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a fermented plant-based product, said method comprising </seg-main><seg-clauses>providing a plant protein substrate, and fermenting the plant protein substrate with a starter culture comprising Lactobacillus johnsonii.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein of the plant protein substrate is pulse protein, preferably pea protein.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to claim 1 or 2, wherein </seg-main><seg-clauses>the plant protein substrate is a plant protein suspension.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the Lactobacillus johnsonii is selected from the list consisting of Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-5910, Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-1225, Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-2474 or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fermentation step of the plant protein substrate with the starter culture lasts at least 16 hours, preferably at least 18 hours.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fermented plant-based product is a fermented plant-based food or beverage, preferably fermented plant-based dairy analogue or plant-based meat analogue.</seg-clauses></div>
<div class=""indep-clm"" num=""7""><seg-main>7. A fermented plant-based product which comprises </seg-main><seg-clauses>plant pro","A23L11/30, A23L11/50, A23L11/60, A23L27/00, C12N1/20",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2019366767B2,Apparatus and method for roasting coffee beans,"The invention concerns a method for roasting coffee beans with a roasting apparatus (10) said roasting apparatus being positioned in a room and said roasting apparatus comprising : • - a roasting device (1), and • - a smoke treating unit (3) configured to treat the smoke produced in the roasting device (1) and to prevent the dispense of air contaminants in the room.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for roasting coffee beans with a roasting apparatus said roasting apparatus being positioned in a room and said roasting apparatus comprising:</seg-main>
<seg-clauses>5   - a roasting device, and</seg-clauses>
<seg-clauses>- a smoke treating unit comprising a contaminants treating device configured to treat the smoke produced in the roasting device and to prevent the dispense of air contaminants, including coffee aromas, in the room,</seg-clauses>
<seg-clauses class=""seg-enter"">said roasting method comprising the step of introducing coffee beans in the roasting device</seg-clauses>
<seg-clauses class=""seg-enter"">0 and the step of heating said coffee beans during a time, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein a part of the whole quantity of smoke produced during the time of the step of heating is dispensed in the room without being treated by said contaminants treating device configured to prevent the dispense of coffee aromas in the room,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein:</seg-clauses>
<seg-clauses class=""seg-enter"">5           - the contaminants treating device configured to prevent the dispense of air</seg-clauses>
<seg-clauses class=""seg-enter"">contaminants, including coffee aromas, in the room, is an afterburner or a catalytic converter or a device that diverts contaminants away from the room or a filter configured to trap coffee aromas including a carbon filter or charcoal filter, and</seg-clauses>
<seg-clauses>- the roasting apparatus comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">!0          - a smoke collecting device connected to the roasting device and configured to collect</seg-clauses>
<seg-clauses class=""seg-enter"">smoke produced in the roasting device, and</seg-clauses>
<seg-clauses>- a smoke diverting device positioned between the smoke collecting device and the contaminants treating device configured to prevent the dispense of coffee aromas in the room","A23N12/08, A23F5/04, A23N12/12",20250123,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
WO2025021741A1,Foldable measuring spoon,"The invention relates to a foldable measuring spoon (1) to be formed by folding a flat sheet (10) of a predetermined shape into a folded state. The spoon (1) comprises a head (2) and a handle (3). The sheet (10) comprises a plurality of sections (4, 5) being consecutively arranged in a row. These sections (4, 5) comprise two handle sections (4) being arranged at two opposite ends of the row, and a plurality of side wall sections (5; 5', 5'') being consecutively arranged in the row between the two handle sections (4) along an arc (A) to define a circumferentially closed side wall (50) delimiting the volume (V) when the sheet (10) is folded to form the measuring spoon (1). Each side wall section (5; 5', 5'') is directly connected to each of the two adjacent sections (4, 5) in the row by a folding line (6), respectively, so that each handle section (4) is directly connected only to one other of the two side wall sections (5; 5') being outermost in the row by one of the folding lines (6), and the one or more side wall section(s) (5; 5'') being arranged in the row between the two outermost side wall sections (5; 5') are each directly connected to each of the two adjacent side wall sections (5) by one of the folding lines (6), respectively. Each side wall section (5) preferably shares with the respective adjacent one of the sections (4, 5) in the row exactly two of the folding lines (6) being positioned at opposite ends of the respective side wall section (5) with respect to an extension direction of the arc (A). The sheet (10) is designed such that, when the handle sections (4) are folded to lie flat on each other to form the handle (3), the side wall sections (5) are folded about the folding lines (6) to form the circumferentially closed side wall (50) of the head (2).","Claims i. <div class=""indep-clm"" num=""1""><seg-main>A foldable measuring spoon </seg-main><seg-clauses><seg-main>(i) to be formed by folding a sheet (to) of a predetermined shape into a folded state, wherein the measuring spoon </seg-main><seg-clauses><seg-main>(i) comprises:</seg-main>
<seg-clauses>• a head (2) defining a volume (V) with an opening (20) for receiving a food product, and</seg-clauses>
<seg-clauses><seg-main>• a handle (3) extending from the head (2) to carry the head (2) and the food product, wherein the sheet (10) comprises a plurality of sections (4, 5) being consecutively arranged in a row, the sections (4, 5) comprising:</seg-main>
<seg-clauses>• two handle sections (4) being arranged at two opposite ends of the row, and</seg-clauses>
<seg-clauses>• a plurality of side wall sections (5; 5’, 5”) being consecutively arranged in the row between the two handle sections </seg-clauses><seg-clauses><seg-main>(4) along an arc </seg-main><seg-clauses><seg-main>(A) to define a circumferentially closed side wall (50) delimiting the volume (V) when the sheet (10) is folded to form the measuring spoon (1), wherein each side wall section (5; 5’, 5”) is directly connected to each of the two adjacent sections (4, 5) in the row by a folding line (6), respectively, so that</seg-main>
<seg-clauses>• one of the handle sections (4) is directly connected only to one of the two side wall sections (5; 5’) being outermost in the row by one of the folding lines (6), and the other one of the handle sections (4) is directly connected only to the other one of the two side wall sections (5; 5’) being outermost in the row by another one of the folding lines (6), and</seg-clauses>
<seg-clauses>• the one or more side wall section(s) (5; 5”) being arranged in the row between the two outermost side wall sections (5; 5’) are each directly connected to each of the two adjacent side wall sections </seg-clauses><seg-clauses>(5) by one of the folding lines (6), respectively, wherein ea","A47G21/02, A47G21/04, B65D77/24, A47G21/00, G01F19/00",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12167990B2,Vitamin composition,"A composition comprising: (i) a mixture containing a lipid-soluble vitamin dissolved in a lipid, and (ii) bran; wherein the mixture is absorbed into and/or adsorbed onto the bran and wherein the lipid does not originate from the bran. Also provided are processes for providing a stabilised vitamin composition.","<div class=""indep-clm"" num=""1""><seg-main>1. A food product consisting of </seg-main><seg-clauses>a vitamin composition, the vitamin composition consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">a mixture containing a lipid-soluble vitamin dissolved in a vegetable oil;</seg-clauses>
<seg-clauses class=""seg-enter"">bran selected from the group consisting of defatted bran having less than about 5 wt. % fat, reduced phytic acid bran having less than about 5 wt. % phytic acid, and combinations thereof;</seg-clauses>
<seg-clauses class=""seg-enter"">optionally an antioxidant; and</seg-clauses>
<seg-clauses class=""seg-enter"">optionally an emulsifier; and</seg-clauses>
<seg-clauses class=""seg-enter"">optionally one or more minerals; and</seg-clauses>
<seg-clauses class=""seg-enter"">optionally water, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the mixture is absorbed into and/or adsorbed onto the bran; the lipid-soluble vitamin is selected from the group consisting of vitamin A, provitamin A, vitamin A ester, and combinations thereof; and the vegetable oil is selected from the group consisting of palm oil and sunflower oil.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The food product according to claim 1, wherein </seg-main><seg-clauses>the bran is selected from the group consisting of rice bran, wheat bran, oat bran, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The food product according to claim 1, wherein </seg-main><seg-clauses>the weight ratio of the mixture to bran is from about 1:200 to about 1:1.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The food product according to claim 1, wherein </seg-main><seg-clauses>the amount of the lipid-soluble vitamin in the vegetable oil is from about 0.1 wt. % to about 5 wt. %.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The food product according to claim 1, wherein </seg-main>","A61K31/07, A61K47/44, A61K47/46",20241217,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025073737A1,"Package product, package set comprising at least two package products, method for manufacturing such package products","The package product (1) comprises: a container body (2) defining a cavity (6) and an opening, a dose of food component (4) within the cavity (6) for interacting with a fluid to prepare a food product, and a packaging (10) comprising: a protection sheet (14) covering the container body (2) and not covering the opening, and a closure sheet (12) covering the opening (8) and part of the protection sheet (14), such that the container body (2) is enclosed between the protection sheet (14) and the closure sheet (12). The closure sheet (12) and the container body (2) are attached to each other along a body attaching section (16). The body attaching section (16) extends around the opening (8) such that the closure sheet (12) defines a membrane portion (18) sealing the cavity (6). The closure sheet (12) and protection sheet (14) are attached to each other along a sheet attaching section (20). The sheet attaching section (20) extends around the body attaching section (16).","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. Package product (1) comprising: </seg-main><seg-clauses>a container body (2) defining a cavity (6) and an opening (8) of the cavity (6), a dose of food component (4) contained within the cavity (6), the dose of food component (4) being suitable for interacting with a fluid introduced into the cavity (6) so as to prepare a food product, and a packaging (10) comprising: a protection sheet (14) arranged to cover an outer side (2.2) of the container body (2) and to not cover the opening (8), and a closure sheet (12) arranged to cover the opening (8) and at least part of the protection sheet (14), such that the container body (2) is enclosed, preferably sealed close, between the protection sheet (14) and the closure sheet (12), wherein the closure sheet (12) and the container body (2) are attached to each other along a body attaching section (16), the body attaching section (16) extending around the opening (8) such that the closure sheet (12) defines a membrane portion (18) sealing the cavity (6), and wherein the closure sheet (12) and the protection sheet (14) are attached to each other along a sheet attaching section (20), the sheet attaching section (20) extending around the body attaching section (16).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Package product (1) according to claim 1, wherein </seg-main><seg-clauses>the closure sheet (12) has a line of weakness (22) extending around part or all of the body attaching section (16), preferably along part or all of the sheet attaching section (20), such that the closure sheet (12) defines a lid portion (24), the line of weakness (22) being configured such that it allows at least partial separation of the lid portion (24) from the rest of the closure sheet (12) so as to define a release opening in the closure sheet (12) for the container body (2) and the membrane portion (18) to be released from the protection sheet (14).</seg-clauses></div",B65D85/804,20250410,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US12389875B2,Low density pet litters and methods of making and using such pet litters,"Compacting expanded perlite fines in the presence of a small amount of binder (starch and/or clay) and water, followed by drying, produces particles with low density, good integrity, and surprisingly higher absorption by volume than non-compacted expanded perlite or non-swelling clay. Furthermore, addition of a small amount of clumping agent (e.g., guar gum) to the compacted granules results in a clumping litter with low density, good integrity and comparable clumping ability to traditional clay clumping litter.","<div class=""indep-clm"" num=""1""><seg-con>1. A pet litter </seg-con><seg-trans>comprising </seg-trans><seg-refi>dried particles of compacted material comprising 50 wt. % to 85 wt. % expanded perlite, wherein the dried particles further comprise a binder comprising starch, wherein the dried particles do not contain a clumping agent and wherein the dried particles have a density of about 25.0 lb/ft<sup>3 </sup>to about 45 lb/ft<sup>3</sup>.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The pet litter of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried particles of compacted material have a moisture content from about 0.25 wt. % to about 10.0 wt %.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The pet litter of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried particles of compacted material have a size from 8 (2,380 microns) to 30 mesh (595 microns).</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The pet litter of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried particles comprise about 1.0 wt. % to about 4.0 wt. % starch.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The pet litter of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried particles have an attrition less than or about 5.0%.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The pet litter of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>an additive selected from the group consisting of an odor control agent, a fragrance, an anti-microbial agent, an anti-sticking agent, an agent for controlling pH, a dye, a coloring agent, a de-dusting agent, a disinfectant, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The pet litter of claim 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the odor control agent is activated carbon.</seg-refi></div>
<div cla","A01K1/015, A01K1/01, B01J20/10, B01J20/12, B01J20/20",20250819,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025140835A1,Extracting arrangement of a beverage extraction device,"The invention concerns an extracting arrangement (121; 131), for extracting a beverage from a pod comprising a beverage ingredient, comprising a plurality of opening elements (122; 132) rising from at least one piercing surface (123; 133), facing in use an enclosing wall (11) of the pod (10) to open, and a plurality of traversing holes, to evacuate the beverage dispensed from the opened enclosing wall (11), wherein each of the opening elements (122; 132) presents an outlet opening (122''; 132'') cooperating with the traversing holes and/or a tip end (122'; 132'), wherein the tip ends (122'; 132') and/or the outlet openings (122; 132) are arranged to lay on a non-planar virtual surface facing in use the enclosing wall (11), so as to substantially match with the enclosing wall (11) of the pod (10).","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Extracting arrangement (121 ; 131) for extracting a beverage from pod (10) containing </seg-main><seg-clauses>a beverage ingredient, preferably roast and ground coffee, the extracting arrangement (121 ; </seg-clauses><seg-clauses>131) comprising a plurality of opening elements (122; 132) rising from at least one extracting surface (123; 133), facing in use a non-planar enclosing wall (11) of the pod (10) to open and the opening elements (122; 132) defining outlet openings of the enclosing wall (11), and a plurality of traversing holes, to evacuate the beverage dispensed from the outlet opening of the opened enclosing wall (11), wherein each of the opening elements (122; 132) presents an outlet opening (122”; 132”) cooperating with the traversing holes and/or a tip end (122’; 132’), wherein the tip ends (122’; 132’) and/or the outlet openings (122”; 132”) are arranged to lay on a non-planar virtual surface facing in use the enclosing wall (11) so as to substantially match with the non-planar enclosing wall (11 ) of the pod (10) to open , and wherein the tip ends (122’; 132’) and/or the outlet openings (122”; 132”) are arranged so that they are at different position in the centre portion of the extracting arrangement (121 ; </seg-clauses><seg-clauses>131) compared to the position in the side portions of the extracting arrangement (121 ; </seg-clauses><seg-clauses>131) adjacent to the centre portion.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Extracting arrangement (121 ; 131) according to claim 1 , wherein </seg-main><seg-clauses>the virtual surface is a curved virtual surface or a stepped virtual surface.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Extracting arrangement (121 ; 131) according to claim 1 or2, wherein </seg-main><seg-clauses>the virtual surface is concave.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Extracting","A47J31/06, A47J31/36",20250703,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2024209752A1,Mixing device for beverage preparation,"The invention concerns a mixing device (1) comprising : - a whipper housing (2), a whipper (3) and a back wall (4), - a drive shaft (81) for driving the whipper, - the whipper housing comprising a front wall (21), said front wall facing the radial front surface (32) of the whipper, and wherein said whipper (3) is disc shaped, and wherein at least a part of the surface of the radial front surface (32) of the whipper is rough and presents an arithmetic maximum surface roughness (Sz) of at least 200 μm.","<div class=""indep-clm"" num=""1""><seg-main>1. Mixing device (1) comprising :</seg-main>
<seg-clauses>- a whipper housing (2), a whipper (3) and a back wall (4), the whipper housing and the back wall forming a whipper chamber in which is lodged the whipper, and the whipper housing comprising a beverage inlet (11) and a beverage outlet (7),</seg-clauses>
<seg-clauses><seg-main>- a drive shaft (81) for driving the whipper, said drive shaft being supported by the back wall, and wherein :</seg-main>
<seg-clauses>- the whipper presents a radial back surface (33) facing the whipper housing back wall (4) and a radial front surface (32) opposed to the radial back surface,</seg-clauses>
<seg-clauses>- the whipper housing comprises a front wall (21), said front wall facing the radial front surface (32) of the whipper, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said whipper (3) is disc shaped, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein at least a part of the surface of the radial front surface (32) of the whipper is rough and presents an arithmetic maximum surface roughness (Sz) of at least 200 pm, preferably at least 400 pm.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Mixing device according to Claim 1, wherein </seg-main><seg-clauses>the rough part of the surface of the radial front surface (32) of the whipper presents an arithmetic mean surface roughness (Sa) of at least 30 pm, preferably at least 40 pm.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Mixing device according to Claim 1 or 2, wherein </seg-main><seg-clauses>the rough surface of the radial front surface (32) of the whipper presents a pattern, preferably a geometric pattern, said pattern being engraved on the surface of the radial front surface (32) of the whipper</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. Mixing device according to Claim 3, wherein </seg-main><seg-clauses>the arithmetic",A47J31/40,20250703,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12377599B2,Method for heating a preform and corresponding method for forming a container,"Method for heating a preform (<b>1</b>) comprising: introducing the preform (<b>1</b>) into a heating apparatus (<b>5</b>) comprising an array of infrared emitters (<b>50</b>) arranged in multiple columns (Cj) and multiple rows (Ri), orienting angularly the preform at an input angular position by rotating the preform around the longitudinal axis; setting power levels of the infrared emitters (<b>50</b>) so as to divide the array of infrared emitters (<b>50</b>) into subsets of columns (SCn), each subset of columns (SCn) generating heat at a different power level from an adjacent subset of columns (SCn); and heating the preform (<b>1</b>) with the array of infrared emitters (<b>50</b>) while translating the preform (<b>1</b>) in a direction parallel to the rows (Ri) of the array at a translation speed, and simultaneously rotating said preform (<b>1</b>) around its longitudinal axis (A<b>1</b>) in front of said infrared emitters (<b>50</b>) at a rotation speed.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for heating a preform </seg-con><seg-trans>comprising </seg-trans><seg-refi>an open neck portion at a first end, a closed base portion at a second end, and a body portion extending along a longitudinal axis between the neck portion and the base portion, the preform being made in a thermoplastic material configured to withstand less than 5 Mpa at a stretch ratio above 250% while elongated under a strain rate of 16/s, the method comprising the following steps:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>introducing the preform into a heating apparatus comprising an array of infrared emitters arranged in a plurality of columns and a plurality of rows, the preform and the array of infrared emitters being disposed such that the longitudinal axis and the plurality of columns of the array of infrared emitters are parallel or directed obliquely with respect to each other;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>orienting angularly the preform at an input angular position by rotating the preform around the longitudinal axis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>setting power levels of the array of infrared emitters so as to divide the array of infrared emitters into subsets of the plurality of columns, each subset of the plurality of columns generating heat at a different power level from an adjacent subset of columns;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the preform with the array of infrared emitters while translating the preform in a direction parallel to the plurality of rows of the array of infrared emitters at a translation speed, and simultaneously rotating the preform around its longitudinal axis in front of the array of infrared emitters at a rotation speed,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the rotation speed, the translation speed, the input angular position and the power levels of the infrared emitters being","B29C49/64, B29C49/00, B29C49/12, B29C49/02, B29C49/06",20250805,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2844866C1,Engineered variants of lipases,"FIELD: biotechnology.SUBSTANCE: presented is recombinant lipase containing an amino acid sequence having at least 80 % identity with the sequence SEQ ID NO: 868, wherein said amino acid sequence contains at least a substitution at position 149, 161, 174, 175, 189, 225, 271 or 293 or any combination thereof, where positions are defined relative to SEQ ID NOs: 2. Invention also discloses a recombinant polynucleotide encoding said recombinant lipase, an expression vector containing a recombinant polynucleotide, a host cell for producing recombinant lipase containing the expression vector. Invention also discloses a method of producing recombinant lipase using said host cell, pharmaceutical composition for treating excretory pancreatic insufficiency containing recombinant lipase, and a method of treating or preventing symptoms of excretory pancreatic insufficiency in a subject using said pharmaceutical composition.EFFECT: invention provides improved thermal stability, protease stability and stability at pH 2.5–5 of engineered lipases, as well as effective treatment of excretory pancreatic insufficiency.54 cl, 10 tbl, 8 ex","1. Рекомбинантная липаза, содержащая аминокислотную последовательность, имеющую по меньшей мере 80% идентичность с последовательностью SEQ ID NO: 868, где указанная аминокислотная последовательность содержит по меньшей мере замену в положении 149, 161, 174, 175, 189, 225, 271 или 293 или любую их комбинацию, где положения определены относительно SEQ ID NO: 2.
2. Рекомбинантная липаза по п. 1, где указанная аминокислотная последовательность указанной рекомбинантной липазы содержит по меньшей мере замену 149A/C/D/E/F/G/H/I/K/L/M/N/P/Q/R/S/V/W/Y, 161A/C/D/E/F/G/H/I/K/M/N/P/Q/S/T/V/W/Y, 174A/C/D/F/G/H/I/K/L/M/N/P/Q/T/V/W/Y, 175A/C/D/E/F/G/H/I/K/L/M/N/P/R/S/T/V/W/Y, 189A/C/D/E/F/G/H/i/K/L/M/N/P/Q/R/T/V/W/Y, 225A/C/D/E/F/G/H/I/K/L/N/P/Q/R/S/T/V/W/Y, 271A/C/D/E/F/H/I/K/L/M/N/P/Q/R/S/T/V/W/Y, 293A/C/D/E/F/G/H/I/K/L/M/N/P/R/S/T/V/W/Y или любые их комбинации, где положения определены относительно SEQ ID NO: 2.
3. Рекомбинантная липаза по п. 1 или 2, где указанная аминокислотная последовательность указанной рекомбинантной липазы содержит по меньшей мере замену в положении 149, где замена представляет собой 149A/C/D/E/F/G/H/I/K/L/M/N/P/Q/R/S/V/W/Y.
4. Рекомбинантная липаза по любому из пп. 1-3, где указанная аминокислотная последовательность содержит по меньшей мере замену в положении 161, причем замена представляет собой 161A/C/D/E/F/G/H/I/K/M/N/P/Q/S/T/V/W/Y.
5. Рекомбинантная липаза по любому из пп. 1-4, где указанная аминокислотная последовательность указанной рекомбинантной липазы содержит по меньшей мере замену в положении 174, причем замена представляет собой 174A/C/D/F/G/H/I/K/L/M/N/P/Q/T/V/W/Y.
6. Рекомбинантная липаза по любому из пп. 1-5, где указанная аминокислотная последовательность указанной рекомбинантной липазы содержит по меньшей мере замену в положении 175, причем замена представляет собой 175A/C/D/E/F/G/H/I/K/L/M/N/P/R/S/T/V/W/Y.
7. Рекомбинантная липаза по любому из пп. 1-6, где указанная аминокислотная последовательность указанной рекомбинантной липазы сод","C12N9/20, C12N15/52, C12N15/63, A61K38/46, A61P1/18",20250808,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
JP2025108699A,Serpin production,"To provide a medium for increasing serpin production in a bacterium expressing serpin, the bacterium, and a composition comprising the bacterium.SOLUTION: The present invention provides a medium comprising a fructose disaccharide at concentration of 0.5 to 1 wt.% or a medium comprising a fructooligosaccharide (FOS) at concentration of 0.5 to 1 wt.% for increasing protein production in Bifidobacterium longum subsp. longum.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> ビフィドバクテリウム・ロンガム亜種ロンガムにおけるセルピンタンパク質産生を増加させるための、フルクトース二糖、フラクトオリゴ糖（ＦＯＳ）、又はこれらの組み合わせの使用。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記ビフィドバクテリウム・ロンガム亜種ロンガムが、前記フルクトース二糖、フラクトオリゴ糖（ＦＯＳ）、又はこれらの組み合わせを０．０２～５重量％の濃度で含む培地で培養される、請求項１に記載の使用。 </div>
<div class=""indep-clm"" num=""3"">【請求項3】</div>
<div class=""indep-clm"" num=""3""> ビフィドバクテリウム・ロンガム亜種ロンガムにおけるセルピンタンパク質レベルを増加させる方法であって、前記方法が、培養培地でビフィドバクテリウム・ロンガム亜種ロンガムを増殖させる工程を含み、前記培養培地が、フルクトース二糖、ＦＯＳ、又はこれらの組み合わせを含むことを特徴とする、方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""3""> 前記培養培地が、前記フルクトース二糖、ＦＯＳ、又はこれらの組み合わせを０．０２～５重量％の濃度で含む、請求項３に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,3"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,3""> 前記ビフィドバクテリウム・ロンガム亜種ロンガムが、ビフィドバクテリウム・ロンガム亜種ロンガム株ＣＮＣＭ Ｉ－２１６９、ビフィドバクテリウム・ロンガム亜種ロンガム株ＣＮＣＭ Ｉ－２１７１、ビフィドバクテリウム・ロンガム亜種ロンガム株ＡＴＣＣ ＢＡＡ－９９９、ビフィドバクテリウム・ロンガム亜種ロンガム株ＡＴＣＣ １５７０８、ビフィドバクテリウム・ロンガム亜種ロンガム株ＤＳＭ ２００９７、ビフィドバクテリウム・ロンガム亜種ロンガム株ＮＣＩＭＢ ８８０９、ビフィドバクテリウム・ロンガム亜種ロンガム株ＣＮＣＭ Ｉ－２６１８（ＮＣＣ ２７０５）、ビフィドバクテリウム・ロンガム亜種ロンガム株ＣＮＣＭ Ｉ－２１７０、ビフィドバクテリウム・ロンガム亜種ロンガム株ＡＴＣＣ １５７０７（Ｔ）、又はこれらの組み合わせから選択される、請求項１若しくは２に記載の使用、又は請求項３若しくは４に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4""> 前記ビフィドバクテリウム・ロンガム亜種ロンガムが、ビフィドバクテリウム・ロンガム株ＣＮＣＭ Ｉ－２６１８（ＮＣＣ ２７０５）である、請求項１、２若しくは５に記載の使用、又は請求項３、４若しくは５に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記フルクトース二糖又はＦＯＳが、サッカロース、ラクツロース、及びこれらの組み合わせから選択される、請求項１、２、５若しくは６のいずれか一項に記載の使用、又は請求項３～６のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6""> 前記フルクトース二糖又はＦＯＳが、２～１０の範囲のＤＰを有するＦＯＳである、請求項１、２、５若しくは６のいずれか一項に記載の使用、又は請求項３～６のいずれか一項に記載の方法。 </div>
<div class=""indep-clm"" num=""9"">【請求項9】</div>
<div class=""indep-clm"" num=""9""> ビフィドバクテリウム・ロンガム亜種ロンガム","C12N1/20, A61K35/745, A61P1/04, A61P29/00, A61P37/08",20250723,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US20250011059A1,A capsule for the preparation of a beverage and a method for manufacturing said capsule,"A capsule for the preparation of a beverage in a beverage preparation device (<b>10</b>) and a method for manufacturing said capsule are described. The capsule comprises a cup-shaped body (<b>1</b>) and a cover (<b>2</b>) for closing the cup-shaped body (<b>1</b>). The cup-shaped body (<b>1</b>) comprises a bottom wall (<b>4</b>), a lateral wall (<b>5</b>) and an annular flange (<b>3</b>) for the cover (<b>2</b>) to seal thereon. The lateral wall (<b>5</b>) is made at least of a first structural layer (<b>5</b>A) and the bottom wall (<b>4</b>) is made at least of a second structural layer (<b>4</b>A). The cup-shaped body (<b>1</b>) comprises an oxygen barrier liner (<b>14</b>) attached to the inner surface (<b>5</b>C) of at least the first structural layer (<b>5</b>A) of the lateral wall (<b>5</b>). The oxygen barrier liner (<b>14</b>) comprises at least a polymer, preferably a biopolymer. The bottom wall (<b>4</b>) is suitable for being pierced by a piercing member (<b>12</b>) of the beverage preparation device (<b>10</b>). The first layer (<b>5</b>A) of the lateral wall (<b>5</b>) and the second layer (<b>4</b>A) of the bottom wall (<b>4</b>) are made of different materials: the first structural layer (<b>5</b>A) of the lateral wall (<b>5</b>) is made of cellulose pulp, and the second structural layer (<b>4</b>A) of the bottom wall (<b>4</b>) comprises between 0% and 60% of cellulose pulp and between 40% and 100% of a polymer, preferably a biopolymer.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule for the preparation of a beverage in a beverage preparation device </seg-con><seg-trans>comprising: </seg-trans><seg-refi>a cup-shaped body and a cover for closing the cup-shaped body, wherein said cup-shaped body comprises a bottom wall, a lateral wall and an annular flange for the cover to seal thereon; wherein said lateral wall is made at least of a first structural layer and said bottom wall is made at least of a second structural layer and the cup-shaped body comprises an oxygen barrier liner attached to the inner surface of at least said first structural layer of said lateral wall, wherein said oxygen barrier liner comprises at least a polymer, preferably a biopolymer; and wherein the bottom wall is suitable for being pierced by a piercing member of the beverage preparation device;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the first structural layer of the lateral wall is made of cellulose pulp; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the second structural layer of the bottom wall comprises: between 0% and 60% of cellulose pulp and between 40% and 100% of a polymer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The capsule according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oxygen barrier liner is attached at least to the inner surface of the first structural layer of the lateral wall, and to the inner surface of the second structural layer of the bottom wall.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The capsule according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a polymer of the bottom wall is the same as at least a polymer of the oxygen liner, such as to increase the attachment of said oxygen liner to the bottom wall.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The capsule a","B65D65/40, B29D22/00, B29K1/00, B32B1/00, B32B3/26",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119997852A,Beverage preparation machine,"The invention relates to a beverage preparation machine for preparing a beverage from a capsule of beverage ingredients, said machine comprising:-an extraction device comprising an upstream capsule enclosing part and a downstream capsule enclosing part (1, 2) which are relatively movable; -a liquid supply system; -a motor (10) for actuating the movement of at least one of the upstream and downstream container enclosing parts (1, 2) wherein the liquid supply system comprises a first peristaltic valve (741) capable of supplying water to the common connector from the cold pipe or the hot pipe and a second peristaltic valve (742) capable of supplying water to the common connector from the cold pipe or the hot pipe. And a second peristaltic valve capable of supplying water to the first tube or the second tube, and wherein the machine comprises a mechanical trigger attached to at least one of the movable capsule encapsulation members, the trigger is designed and positioned so as to close or open the water path and the capsule path in the tubes (751, 752, 771, 772) in accordance with the movement of at least one of the upstream and downstream capsule encapsulating members (1, 2) during a sequence of preparing a beverage from the capsule.",,"A47J31/36, A47J31/46",20250513,雀巢产品有限公司,['Pending']
US20250151945A1,Beverage preparation by stable capsule centrifugation,"A capsule processing machine (<b>1</b>) is configured for preparing a beverage from a capsule (<b>5</b>) having a body containing an ingredient by circulating a liquid into such capsule (<b>5</b>) and centrifugally driving such capsule (<b>5</b>). The machine (<b>1</b>) has a first capsule handler (<b>10</b>) and a second capsule handler (<b>20</b>) that are movable one relative to the other from: a capsule transfer configuration for receiving/releasing the capsule (<b>5</b>); to a capsule processing configuration for centrifuging the capsule (<b>5</b>) about a processing axis (<b>30</b>′). The machine (<b>1</b>) has a handler support device (<b>30</b>) for supporting the first and second capsule handlers (<b>10,20</b>) and a machine frame and/or housing (<b>40</b>) which is stationary during centrifugation. The handler support device (<b>30</b>) is configured to be and remain angularly fixed relative to the first and second capsule handlers (<b>10,20</b>) and to rotate therewith about the processing axis (<b>30</b>′) when the first and second capsule handlers (<b>10,20</b>) are rotated for centrifugation.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule processing machine for preparing a beverage from a capsule </seg-con><seg-trans>having </seg-trans><seg-refi>a body containing an ingredient by circulating a liquid into such capsule and centrifugally driving such capsule, comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first capsule handler and a second capsule handler that are movable one relative to the other from:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule transfer configuration for receiving said capsule by the first and second capsule handlers and/or releasing said capsule from the first and second capsule handlers; to</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule processing configuration for centrifuging said capsule by rotation about a processing axis of the first and second capsule handlers; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a handler support device for supporting the first and second capsule handlers; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the first and second capsule handlers are rotated for centrifugation and which supports the first and second capsule handlers and the handler support device,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the handler support device is configured to be and remain angularly fixed relative to the first and second capsule handlers and to rotate therewith about the processing axis when the first and second capsule handlers are rotated for centrifugation.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The machine of claim 1, which </seg-con><seg-trans>comprises </seg-trans><seg-refi>an actuator that is configured to actuate the first and/or second capsule handlers to relatively move the first and second capsule handlers between the capsule transfer and processing configurations, optionally the actuator being connected","A47J31/22, A47J31/44",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA2969161C,Milk concentrates with improved mouth feel,"The present invention relates to a milk concentrate comprising caseins and whey proteins in the ratio of 90:10 to 60:40, wherein the caseins/whey protein aggregates have a volume based mean diameter value Dv50 of at least 1 pm as measured by laser diffraction. The invention also relates to a process for preparing a milk concentrate comprising the steps of providing a liquid milk concentrate, adjusting pH to 5.7-6.4, heat treating for 3-3OOs at 80-150°C and cooling to <70°C. Also, the use of the milk concentrate for producing a ready-to-drink beverage, culinary sauces and concentrated milk concentrates is described.","CLAIMS: <div class=""indep-clm"" num=""1""><seg-main>1. A milk concentrate comprising </seg-main><seg-clauses>caseins and whey proteins in the ratio of 90:10 to 60:40, wherein caseins/whey protein aggregates have a volume based mean diameter value Dv50 of 1 pm - 60 pm as measured by laser diffraction, wherein the milk concentrate at total solids between 35% to50% (w/w) exhibits a shear viscosity of at least 1000 mPa.s measured at a shear stress of 10 Pa, a shear viscosity of at least 400 mPa.s measured at a shear rate of 100 1/s and a viscosity ratio between these two conditions of at least 2.0 as determined on flow curves obtained with a rheometer at 20°C. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The milk concentrate of claim 1, wherein </seg-main><seg-clauses>the volume based mean diameter value ranges from 5-10 pm. </seg-clauses></div><div class=""indep-clm"" num=""3""><seg-main>3. A process for preparing a milk concentrate of claim 1, comprising </seg-main><seg-clauses><seg-main>the steps of: </seg-main><seg-clauses>a) homogenizing a milk; </seg-clauses><seg-clauses>b) concentrating the homogenized milk to produce a liquid milk concentrate having at least 25% total solids at temperature below 25°C; </seg-clauses><seg-clauses>c) adjusting pH between 5.7 and 6.4; </seg-clauses><seg-clauses>d) heat treating the concentrate at 80-150° C for 3 to 300 seconds so that the milk concentrate comprises caseins/whey protein aggregates having a mean diameter value Dv50 of at least 1 pm as measured by laser diffraction; </seg-clauses><seg-clauses>e) cooling the composition below 70° C. </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The process of claim 3, wherein </seg-main><seg-clauses>the cooling step comprises cooling the composition below 60°C. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5. A process of claim 3 or 4, comprising </seg-main><seg-clauses>further the steps of: readjust","A23C9/15, A23C9/154, A23J1/20, A23J3/08, A23C21/06",20251007,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12245615B2,Method of producing a food or beverage product with free divalent cations protein aggregation,"A food or beverage product with improved texture and mouthfeel. The food or beverage product includes aggregated proteins comprising micellar casein and whey protein aggregates. The product has a pH of 6.1-7.1, a concentration of 6-40 wt. % milk solids, a casein to whey protein ratio of 90/10-60/40, and a concentration of 3-8 mM free divalent cations. The agglomerates have a size of 5-50 microns mean diameter D(4,3) as measured by laser diffraction.","<div class=""indep-clm"" num=""1""><seg-con>1. A food or beverage product </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>agglomerated proteins comprising aggregates of micellar caseins and whey proteins, a ratio of the micellar caseins to the whey proteins is in a range of 90/10-60/40;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>6-40 wt. % milk solids; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>3-8 mM free divalent cations;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the food or beverage product has a pH of 6.1-7.1, and the agglomerated proteins have a mean diameter D<sub>(4,3) </sub>of 10-40 microns as measured by laser diffraction;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the agglomerated proteins comprise the micellar caseins and beta-lactoglobulin from the whey proteins.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The food or beverage product of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the free divalent cations are selected from the group consisting of Ca<sup>2+</sup>, Mg<sup>2+</sup> and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The food or beverage product of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the free divalent cations are Ca<sup>2+</sup>.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The food or beverage product of claim 1 </seg-con><seg-trans>comprising </seg-trans><seg-refi>3.5-6.5 mM of the free divalent cations.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The food or beverage product of claim 1 </seg-con><seg-trans>comprising </seg-trans><seg-refi>0-36 wt. % fat.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The food or beverage product of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the product is a food product comprising an oil-in-water emul","A23J3/10, A23C9/152, A23G9/32, A23G9/38",20250311,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119896329A,Nutritional composition and infant formula for promoting myelination of brain,"The present invention relates to nutritional compositions and infant formulas for promoting myelination of the brain. More specifically, the present invention relates to compositions for promoting, supporting or optimizing a subject's re-myelination, and/or brain structure, and/or brain connectivity, and/or one or more of cognitive potential, learning potential, and intellectual potential, and/or cognitive function.","<div class=""indep-clm"" num=""1"">1.一种合成营养组合物，所述组合物包含胆碱，用于促进、支持或优化个体、特别是配方食品喂养的个体的重新髓鞘形成、特别是重新髓鞘形成轨迹、和/或脑结构、和/或脑连接、和/或智力潜能和/或认知潜能和/或学习潜能和/或认知功能，其中脑结构是指整个脑的、和/或特定脑区域中的有髓鞘物质的量和/或空间分布，并且其中如果在标准化的神经发育测试中所述个体的分数与营养良好的母亲的完全母乳喂养的个体的分数的差异小于一个标准偏差，则所述认知功能被优化。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的合成营养组合物，其中所述个体为人类婴儿或儿童，并且优选地为配方食品喂养的人类婴儿或儿童。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的合成营养组合物，其中所述组合物包含高于30mg/100g所述组合物干重的量的胆碱。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的合成营养组合物，其中所述组合物还包含以下成分中的一种或多种：矿物质、和/或维生素、和/或磷脂、和/或脂肪酸衍生物，其中所述脂肪酸衍生物是除磷脂外的包含脂肪酸的化合物。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的合成营养组合物，其中所述维生素为叶酸和/或维生素B12。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-con>6.根据权利要求4或5所述的合成营养组合物，其中所述矿物质选自铁、锌、钙、磷、铜以及它们的组合；其中所述脂肪酸衍生物包含二十二碳六烯酸和/或花生四烯酸和/或神经酸和/或硬脂酸，并且其中所述磷脂为式(I)的化合物或式(I)的化合物的混合物</seg-con></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-con><img src="""" class=""img-anchor"" img-id=""FDA0005229532210000011""></seg-con></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-trans>其中，</seg-trans></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>R<sup>1</sup>为O，</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>X为NH或O</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>R<sup>2</sup>为C2-C44饱和或不饱和的、直链或支链的酰基基团；</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>R<sup>3</sup>为式(II)或式(III)的取代基</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi><img src="""" class=""img-anchor"" img-id=""FDA0005229532210000021""></seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>其中，R<sup>5</sup>为C2-C44饱和或不饱和的、直链或支链的酰基基团；并且</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>R<sup>6</sup>为C2-C44饱和烷基或烯基基团；并且</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>R<sup>4</sup>选自：C5或C6取代或未取代的环状烷基或烯基基团，或者</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-refi>—(CH2)n—R<sup>7</sup>，其中n为1至4、特","A23L33/115, A23L33/10, A23L33/12, A23L33/15, A23L33/16",20250429,雀巢产品有限公司,['Pending']
WO2025093591A1,Protein GELS rich in vegetable content,"A vegetable protein gel, wherein said gel comprises vegetable puree or re-hydrated vegetable powder; between 10 to 25 wt% of one or more plant protein isolate or plant protein concentrate; optionally 2 to 15 wt% of one or more vegetable oil; optionally 0.1 to 1 wt% of sodium bicarbonate; and optionally 0.1 to 1 wt% salt and spices; wherein the water content of the gel is at least 55 wt%, and wherein the water to plant protein wt% ratio is 6 or less.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A vegetable protein gel, said gel comprising </seg-main><seg-clauses>a. Vegetable puree or re-hydrated vegetable powder; </seg-clauses><seg-clauses>b. Between 10 to 25 wt% of one or more plant protein isolate or plant protein concentrate; </seg-clauses><seg-clauses>c. Optionally 2 to 15 wt% of one or more vegetable oil; </seg-clauses><seg-clauses>d. Optionally 0.1 to 1 wt% of sodium bicarbonate; and </seg-clauses><seg-clauses>e. Optionally 0.1 to 1 wt% salt and spices; wherein the water content of the gel is at least 55 wt%, and wherein the water to plant protein wt% ratio is 6 or less.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The vegetable protein gel according to claim 1, wherein </seg-main><seg-clauses>the water to plant protein wt% ratio is between 3.5 to 6.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The vegetable protein gel according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the vegetable puree comprises between 80 to 98% water.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The vegetable protein gel according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the vegetable puree is made from a vegetable selected from one or more of carrot, bell pepper, spinach, tomato, broccoli, pumpkin, butternut, beetroot, green pea, and radish.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The vegetable protein gel according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the vegetable puree is made from a vegetable selected from carrot, bell pepper, broccoli and spinach.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The vegetable protein gel according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the vegetable puree is made from a green vegetable.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,","A23J3/16, A23L19/00, A23P30/10",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2024200698B2,Methods and compositions for increasing energy expenditure using cinnamaldehyde,"Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical. The composition comprising cinnamaldehyde can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of increasing at least one characteristic </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>energy expenditure, sympathetic nervous system activity, and fat oxidation, the method comprising orally administering to a mammal maintaining a body mass index (BMI) of 18.5-25, a composition that is a food product comprising cinnamaldehyde in an amount that is orally tolerable, and in a concentration of 17.48 ppm to 6191.0 ppm relative to the composition.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cinnamaldehyde is administered to the mammal in an amount of about 1.25 mg/kg body weight per day.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cinnamaldehyde is present in the composition in a concentration of about 350 ppm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising cinnamaldehyde is administered to the mammal once daily.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises cinnamon essential oil extract that provides at least a portion of the cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6.       The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the cinnamaldehyde is</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-refi>selected from the group consisting of isolated cinnamaldehyde and synthesized cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. The method of any one of claims 1 to 6 </seg-con><seg-trans>wherein </seg-trans","A61K31/11, A61K36/54, A61P3/04, A61P43/00",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2020219179B2,Soluble coffee powder,The present invention relates to a soluble beverage powder consisting of dried coffee extract. In particular to a soluble coffee powder having a gold appearance. Further aspects of the invention are a powder mix for preparing a beverage and a process for making a soluble beverage powder.,"<div class=""indep-clm"" num=""1""><seg-main>1. A soluble beverage powder consisting of </seg-main><seg-clauses><seg-main>dried coffee extract, the powder having a colour difference AE from gold below 100, wherein skeletal density of the powder is from 0.7 to </seg-main><seg-clauses>1.4 g/mL, wherein the powder comprises particles comprising at least one plate having a mean thickness of between 0.3 and 90 microns and two or more plates comprised within a particle are substantially parallel.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The soluble beverage powder according to claim 1 having </seg-main><seg-clauses>a gloss at 60° geometry of at least 0.5 gloss units.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The soluble beverage powder according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the skeletal density of the powder is from 0.9 to 1.3 g/mL.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The soluble beverage powder according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the powder comprises particles comprising at least one plate having a mean thickness of between 5 and 50 microns.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The soluble beverage powder according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the two or more substantially parallel plates are separated by a gap.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The soluble beverage powder according to claim 5, wherein </seg-main><seg-clauses>the gap is greater than the mean thickness of the plates and less than 10 times the mean thickness of the plates.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The soluble beverage powder according to any one of claims 1 to 6 wherein </seg-main><seg-clauses>the powder is a glassy amorphous solid.</seg-clauses></div>
<div class=""","A23F5/24, A23F5/28",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20250176578A1,Process for preparing fermented dairy product analogue with non-dairy ingredients comprising beta-glucans,"The invention relates to a process for preparing a fermented dairy product analogue having reduced sliminess and/or stickiness while using non-dairy ingredients comprising beta-glucans. The process comprises the following steps. An edible suspension comprising hydrophilic liquid and at least one non-dairy ingredient is provided. The non-dairy ingredient comprises beta-glucans and is selected from the group consisting of plant ingredient, fungal ingredient, or a combination thereof. After providing the edible suspension, ascorbic acid is added into said edible suspension. The resulting edible suspension comprising ascorbic acid is then homogenized, heat-treated, inoculated with a starter culture, and fermented to obtain a fermented dairy product analogue. The invention also relates to a fermented dairy product analogue obtainable by such a process, to a method for reducing the adhesiveness of a fermented dairy product analogue and to the use of ascorbic acid for reducing adhesiveness of a fermented dairy product analogue.","<div class=""indep-clm"" num=""1""><seg-main>1. Process for preparing a fermented dairy product analogue comprising the steps of:</seg-main>
<seg-clauses>a) providing an edible suspension comprising hydrophilic liquid and at least one non-dairy ingredient, wherein the non-dairy ingredient comprises beta-glucans and wherein the non-dairy ingredient is selected from the group consisting of plant ingredient, fungal ingredient and a combination thereof,</seg-clauses>
<seg-clauses>b) adding ascorbic acid into the edible suspension to obtain an edible suspension comprising ascorbic acid,</seg-clauses>
<seg-clauses>c) homogenizing the edible suspension comprising ascorbic acid,</seg-clauses>
<seg-clauses>d) heat</seg-clauses><seg-clauses>-treating the edible suspension comprising ascorbic acid,</seg-clauses>
<seg-clauses>e) inoculating the homogenised and heat-treated edible suspension comprising ascorbic acid with a starter culture to obtain an inoculated edible suspension comprising ascorbic acid, and</seg-clauses>
<seg-clauses>f) fermenting the inoculated edible suspension comprising ascorbic acid until reaching a pH of less than 5.0 to obtain a fermented dairy product analogue.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Process according to claim 1, wherein </seg-main><seg-clauses>the non-dairy ingredient comprises at least 0.5 wt. % beta-glucans, with respect to the total weight of the non-dairy ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Process according to claim 1, wherein </seg-main><seg-clauses>the non-dairy ingredient is a cereal ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. Process according to claim 3, wherein </seg-main><seg-clauses>the cereal ingredient is originated from the group consisting of oat, barley, rye, wheat and a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-main>5. Process according to claim 3, wherein",A23C11/10,20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12369612B2,Extensively hydrolysed infant formula,"An extensively hydrolysed infant formula (eHF) comprising protein, carbohydrate and fat, wherein the eHF comprises about 2.4 g or less protein per 100 kcal, wherein about 30% or less by weight of the fat is medium chain triglycerides (MCTs), and wherein the eHF may further comprise 2′-fucosyllactose (2′FL) and/or lacto-N-neotetraose (LNnT).","<div class=""indep-clm"" num=""1""><seg-con>1. An extensively hydrolysed infant formula (eHF) </seg-con><seg-trans>comprising </seg-trans><seg-refi>protein, carbohydrate and fat, wherein extensively hydrolysed is defined as at least 95% of peptides by weight have a molecular mass of less than about 3000 Da, wherein the eHF comprises about 2.4 g or less protein per 100 kcal, and wherein about 30% or less by weight of the fat is medium chain triglycerides (MCTs) and wherein the eHF comprises 2′-fucosyllactose (2′FL) and/or lacto-N-neotetraose (LNnT).</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises 0.5-3 g/L of 2′FL.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises 0.2-1 g/L of LNnT.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises about 1.8 g or more of the protein per 100 kcal.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises 1.8-2.4 g of the protein per 100 kcal.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises about 2.2 g of the protein per 100 kcal.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>about 25% or less by weight of the fat is the medium chain triglycerides (MCTs).</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises no medium chain triglycerides (MCTs).</seg-","A23L33/00, A23L33/12, A23L33/125, A23L33/175, A23L33/18",20250729,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12370173B2,Pet food compositions that modulate vitamin D and bone mineral content in a companion animal,,"<div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>protein, carbohydrates, fat, fiber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least 6 distinct metabolites comprising first and second distinct metabolites for modulating bone mineral content, third and fourth distinct metabolites for modulating 25(OH) vitamin D3, and fifth and sixth distinct metabolites for modulating 1,25(OH)<sub>2 </sub>vitamin D3 in a companion animal;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the first and second distinct metabolites that modulate the bone mineral content are selected from the group consisting of creatinine, X-14625, gamma-glutamylleucine, ethanolamine, histidine, 4-acetylphenyl sulfate, phosphoethanolamine (PE), X-14352, pseudouridine, myo-inositol, X-15375, X-17299, 1-methylguanosine, xylitol, X-11787, pyroglutamine, and mixtures thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the third and fourth distinct metabolites that modulate the 25(OH) vitamin D3 are selected from the group consisting of arachidonate (20:4n6), pantothenate (Vitamin B5), X-17612, mannose, X-17147, anserine, X-17010, cytidine, prolylhydroxyproline, arabonate, 3-hydroxybutyrate (BHBA), docosapentaenoate (DPA; 22:5n3), adrenate (22:4n6), X-12195, N-acetylalanine, dihomolinoleate (20:2n6), stearate (18:0), palmitate (16:0), arabitol, taurolithocholate, glutamate, 17-methylstearate, docosapentaenoate (n6 DPA; 22:5n6), sphingomyelin, glycerate, oleate (18: 1n9), X-11378, and mixtures thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the fifth and sixth distinct metabolites that modulate the 1,25(OH)<sub>2 </sub>vitamin D3 are selected from the group consisting of arachidonate (20: 4n6), X-11378, pantothenate (Vitamin B5), mannose, isobutyrylcarnitine (C4), sphingomyelin, 3-hydroxybutyrate (BHBA), prolylhydr","A61P35/00, A23K10/00, A23K20/00, A23K20/142, A23K20/147",20250729,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023343156A1,Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal,"The present disclosure provides compositions and methods for providing a health benefit to an animal utilizing southern ocean mackerel oil. For example, a pet food composition for treating an inflammatory condition in a companion animal can comprise southern ocean mackerel oil and a preservative.","<div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition for treating an inflammatory condition in a companion animal </seg-con><seg-trans>comprising </seg-trans><seg-refi>southern ocean mackerel oil and a preservative.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the southern ocean mackerel oil is present in the composition in an amount from about 0.1 % to about 10 %.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the southern ocean mackerel oil comprises at least 30% omega-3 fatty acids and no more than 5% omega-6 fatty acids.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the southern ocean mackerel oil comprises at least 3% of eicosatetraenoic acid, at least 1% of steridonic acid, at least 8% of eicosapentanaeoic acid, at least 15% of docosahexaenoic acid, and at least 2% of docosapentaenoic acid.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises protein in an amount from about 20 % to about 50 %.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises carbohydrate in an amount of from about 5 % to about 70 %.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7.     The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises fat in an</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-refi>amount of from about 5 % to about 40 %.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8.     The composition of cla","A23K10/22, A23K20/158, A23L33/115",20250213,SOCIETE DES PRODUITS NESTLE SA,['Pending']
MX375242B,Method of improving microbiological stability in a still water-based beverage and microbiologically shelf-stable still water-based beverages,The present invention relates to a method of improving microbiological stability in a still water-based beverage with respect to undesirable growth of microbiological spoilage such as yeast and/or mould growth during their preparation and/or storage.,"REIVINDICACIONES
<div class=""indep-clm"" num=""1""><seg-main>1. Un metodo para mejorar la estabilidad microbiologica en una bebida acida a base de agua quieta, caracterizado porque comprende carbonatar la bebida, en donde la concentracion de dioxide de carbono en la bebida a base de agua quieta resultante es de 500 mg/L a 1,000 mg/L, la bebida acida a base de agua quieta tiene un pH de 2 a 4, y</seg-main>
<seg-main class=""seg-enter"">en donde la etapa de carbonatar ademas comprende las etapas de:</seg-main>
<seg-clauses>- usar una unidad dosificadora para transferir el dioxido de carbono liquido de un tanque a una valvula dosificadora, y</seg-clauses>
<seg-clauses>- abrir la valvula dosificadora para transferir el dioxido de carbono en forma solida a una botella.</seg-clauses></div>
<div class=""indep-clm"" num=""2"">2. El metodo de conformidad con la reivindicacion 1, caracterizado porque la concentracion de dioxido de carbono en la bebida acida a base de agua quieta resultante es de 750 mg/L a 1,000 mg/L.</div>
<div class=""indep-clm"" num=""3"">3. El metodo de conformidad con la reivindicacion 1, caracterizado porque comprende ademas la etapa de ahadir al menos un conservador.</div>
<div class=""indep-clm"" num=""4"">4. El metodo de conformidad con la reivindicacion 3, caracterizado porque la concentracion total de los conservadores en la bebida acida a base de agua quieta esta debajo de 1,000 mg/L.</div>
<div class=""indep-clm"" num=""5"">5. El metodo de conformidad con la reivindicacion 3, caracterizado porque la concentracion total de los conservadores en la bebida acida a base de agua quieta esta debajo de 400 mg/L.</div>
<div class=""indep-clm"" num=""6"">6. El metodo de conformidad con la reivindicacion 3, caracterizado porque el conservador se selecciona del grupo que comprende dioxido de azufre, acido sorbico y</div>
<div class=""indep-clm"" num=""6"">10</div>
<div class=""indep-clm"" num=""6"">15</div>
<div class=""indep-clm"" num=""6"">20</div>
<div class=""indep-clm"" num=""6"">25</div>
<div","A23L2/44, A23L2/02, A23L2/54, A23L2/68, A23B70/10",20250306,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119097632A,Human milk oligosaccharides against future excessive fat mass accumulation and related health disorders,"The present invention relates to human milk oligosaccharides against future excessive fat mass accumulation and related health disorders, in particular to nutritional compositions comprising at least one fucosylated oligosaccharide for use in infants or young children, the present invention relates to a fucosylated oligosaccharide having at least one fucose group linked by an alpha 1, 3 bond, at least one fucose group linked by an alpha 1, 4 bond, or a combination thereof, for use in reducing and/or preventing future excessive accumulation of fat mass and/or health disorders associated with excessive accumulation of fat mass, in which the fucosylated oligosaccharide has at least one fucose group linked by an alpha 1, 3 bond, at least one fucose group linked by an alpha 1, 4 bond, or a combination thereof. The invention also relates to a nutritional composition for use in promoting healthy growth.","<div class=""indep-clm"" num=""1"">1.包含至少一种岩藻糖基化低聚糖的营养组合物在制备用于预防婴儿或幼儿日后的脂肪量过度积聚和/或日后的超重、肥胖以及过早肥胖反弹的非治疗用产品中的用途；其中所述岩藻糖基化低聚糖具有至少一个由α1,3键连接的岩藻糖基团、至少一个由α1,4键连接的岩藻糖基团、或它们的组合，其中所述婴儿或幼儿是携带SNP rs3894326的母亲所生的，其中所述至少一种岩藻糖基化低聚糖选自：3'岩藻糖基化乳糖(3FL)、DFL、LNFP II、LNFPIII、LNFP V、以及它们的组合。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用途，其中所述至少一种岩藻糖基化低聚糖选自：3'岩藻糖基化乳糖、DFL以及它们的组合。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的用途，其中与脂肪量过度积聚相关的健康障碍为过早肥胖反弹。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2"">4.根据权利要求1或2所述的用途，其中所述至少一种岩藻糖基化低聚糖以0.02重量％至10重量％的所述营养组合物的量存在。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2"">5.根据权利要求1或2所述的用途，其中所述至少一种岩藻糖基化低聚糖以0.1重量％至5重量％的所述营养组合物的量存在。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2"">6.根据权利要求1或2所述的用途，其中所述至少一种岩藻糖基化低聚糖以0.2重量％至1.5重量％的所述营养组合物的量存在。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2"">7.根据权利要求1或2所述的用途，其中所述营养组合物还包含至少一种由1,2岩藻糖基化乳糖和/或2岩藻糖基化乳糖组成的岩藻糖基化低聚糖。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2"">8.根据权利要求1或2所述的用途，所述组合物还包含至少一种另外的低聚糖和/或纤维和/或人乳低聚糖的前体，所述低聚糖和/或纤维和/或人乳低聚糖的前体选自由以下项组成的列表：GOS、FOS、XOS、菊粉、聚葡萄糖、唾液酸化低聚糖、唾液酸、岩藻糖、N-乙酰化低聚糖以及它们的任意组合。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2"">9.根据权利要求1或2所述的用途，所述组合物还包含至少一种益生菌，所述益生菌的量为10<sup>3</sup>cfu/g至10<sup>12</sup>cfu/g所述组合物(干重)。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2"">10.根据权利要求1或2所述的用途，其中所述营养组合物为婴儿配方食品、1段婴儿配方食品、较大或2段婴儿配方食品、婴孩食物、婴儿谷物组合物、成长乳、强化剂或补充剂。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2"">11.根据权利要求1或2中所述的用途，其中所述营养组合物用于促进婴儿或幼儿健康生长。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据权利要求1-12中任一项所定义的营养组合物用于降低婴儿或幼儿日后出现超重的风险的非治疗用途。</div>
<div class=""indep-clm"" num=""13"">13.具有至少一个由α1,3键连接的岩藻糖基团、至少一个由α1,4键连接的岩藻糖基团或它们的组合的岩藻糖基化低聚糖用于制备施用于婴儿或幼儿的营养组合物的用途，所述组合物用于降低和/或避免过早肥胖反弹、日后的脂肪量过度积聚；和/或用于预防日后的超重和肥胖，其中所述婴儿或幼儿是携带SNP rs3894326的母亲所生的婴儿，其中所述至少一种岩藻糖基化低聚糖选自：3'岩藻糖基化乳糖(3FL)、DFL、LNFP II、LNFP III、LNFP V、以及它们的组合。</div>
<div class=""indep-clm"" num=""14""><seg-con>14.用于预防婴儿或幼儿日后的过早肥胖反弹、脂肪过度积聚和/或与脂肪量过度积聚相关的健康障碍的方法，该方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class","A61K31/702, A23L33/21, A61P3/04",20241210,雀巢产品有限公司,['Pending']
AU2023348239A1,Beverage or foodstuff preparation system,"A system comprising: a container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a machine- readable code storing preparation information for use with a preparation process performed by said machine; a machine for preparing a beverage and/or foodstuff or a precursor thereof, the machine including: a code reading system to read the code of the container; a processing unit for processing precursor material of the container, and; electrical circuitry to control the processing unit based on preparation information read from the code, and comprising electronic memory to store corresponding preparation information, which is based on one or more prior reads of a corresponding code of a container; wherein the electrical circuitry is configured to: read the preparation information from the code; retrieve the corresponding preparation information from the electronic memory; correct the read preparation information based on the corresponding preparation information, and; control the processing unit based on the corrected preparation information.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff ora precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine for preparing a beverage and/or foodstuff or a precursor thereof, the machine including: a code reading system to read the code of the container; a processing unit for processing precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on preparation information read from the code, and comprising electronic memory to store corresponding preparation information, which is based on one or more prior reads of a corresponding code of a container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the electrical circuitry is configured to:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>read the preparation information from the code;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>retrieve the corresponding preparation information from the electronic memory;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>correct the read preparation information based on the corresponding preparation information, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>control the processing unit based on the corrected preparation information.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the electrical circuitry is configured to:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>identify the container, and;</seg-refi></div>
<div class=""dep-clm"" n","A47J31/44, A47J31/52",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025061643A1,Improved composite materials for food application,"The present invention relates to a method of manufacturing a fibre-based composite material, to the fibre-based composite material thus obtained, and to the use of the fibre-based composite material for preparing an item.","CLAIMS:
<div class=""indep-clm"" num=""1""><seg-main>1. A method for manufacturing a fibre-based composite material, comprising the steps of: </seg-main><seg-clauses>a) providing substrate comprising cellulosic fibres; </seg-clauses><seg-clauses>b) preparing a mixture comprising one or more alkoxy silane monomers and an acid catalyst in water; </seg-clauses><seg-clauses>c) applying said mixture to said substrate; </seg-clauses><seg-clauses>d) reacting said mixture with the cellulosic fibres of said substrate; </seg-clauses><seg-clauses>e) subjecting said mixture to the sol-gel process; </seg-clauses><seg-clauses>f) drying the treated substrate to obtain the composite material.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1 , wherein </seg-main><seg-clauses>said cellulosic fibres are selected from the group consisting of cellulose fibres, jut, beggase, hemp, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of claim 1 or claim 2, wherein </seg-main><seg-clauses>the one or more alkoxy silane monomers are selected from the group tetraethyl orthosilicate, triethoxy(methyl)alkoxy silane, triethoxy(ethyl)alkoxy silane, riethoxy(propyl)alkoxy silane, butyltriethoxyalkoxy silane, triethoxy(isopentyl)alkoxy silane, (3,3-dimethylbutyl)triethoxyalkoxy silane, triethoxy(vinyl)alkoxy silane, 3-(triethoxysilyl)propan-1 -amine, 3- (triethoxysilyl)propyl methacrylate, tetraethyl orthosilicate, trimethoxy(methyl)alkoxy silane, trimethoxy(ethyl)alkoxy silane, trimethoxy(propyl)alkoxy silane, butyltrimethoxyalkoxy silane, trimethoxy(isopentyl)alkoxy silane, (3,3-dimethylbutyl)trimethoxyalkoxy silane, trimethoxy(vinyl)alkoxy silane, 3-(trimethoxysilyl)propan-1 -amine, and 3- (trimethoxysilyl)propyl methacrylate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of any of claims 1 to 3, wherein </seg-main><seg-clauses>alkoxy silane-to-cellulose ","D21H17/13, B65D65/42, D21H19/16, D21H19/20, D21H19/32",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN119894784A,Beverage or food preparation system,"A container for use with a beverage or food preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by the machine to process the precursor material, the code being readable by a code reading system of the machine, the code reading system comprising: an illumination system for projecting emitted light to the code; and a camera system for obtaining a digital image of the code; and a support layer supporting a code, the support layer being arranged for specular reflection of emitted light from the lighting system, the code comprising an absorbing layer configured to absorb the emitted light and a reflecting layer configured to diffuse-reflect the emitted light, the reflecting layer being arranged to reflect the emitted light before the emitted light is transmitted to the support layer.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于与饮料或食品制备机器一起使用的容器，所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>储存部分，所述储存部分用于容纳前体材料；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码，所述代码用于存储由所述机器用来处理所述前体材料的制备信息，所述代码被配置为能够由所述机器的代码读取系统读取，所述代码读取系统包括照明系统，所述照明系统用于将发射光投射到所述代码；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>支撑层，所述支撑层用于支撑所述代码，所述支撑层被布置用于来自所述照明系统的所述发射光的镜面反射，使得从所述支撑层反射的所述发射光的至少50％或70％或80％被镜面反射，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述代码包括被配置为吸收所述发射光的吸收层和被配置为漫反射所述发射光的反射层，所述反射层被布置成在所述发射光被透射到所述支撑层之前反射所述发射光。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的容器，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述反射层是连续的；</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述反射层连接到所述支撑层以邻接所述支撑层；并且</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>所述支撑层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，并且其中，当在所述平面中观察时所述反射层与整个所述支撑层重叠。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-comp>所述支撑层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，所述深度方向从外表面延伸；</seg-comp><seg-comp>并且</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-comp>所述吸收层在所述深度方向上布置在所述反射层与所述外表面之间，使得所述吸收层相对于所述反射层最接近所述外表面；并且</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-comp>所述反射层在所述深度方向上布置在所述支撑层与所述外表面之间。</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述吸收层被布置成当在所述平面中观察时与整个所述反射层重叠。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述支撑层被配置为提供包括所述支撑层、所述反射层和所述吸收层的层压件的拉伸强度的至少60％或80％或90％。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,",B65D85/804,20250425,雀巢产品有限公司,['Pending']
CN120418162A,Dispensing system,"The invention relates to a dispensing system (100, 200, 300, 400, 500) for dispensing a bulk material (1), the dispensing system comprising: a flexible or semi-flexible bag (10) comprising: a compartment (11) for storing the bulk material (1); a distribution section (12); and a hanging part (13) by means of which the bag (10) can be hung in such a way that the bulk material (1) can flow out of the bag (10) from the compartment (11) via the dispensing section (12) under the action of gravity; a dispensing mechanism (110, 210, 310, 410, 510) attached to the bag (10), where the dispensing mechanism (110, 210, 310, 410, 510) comprises two components (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) which are manually movable relative to each other so as to be moved between a closed position in which the dispensing section (12) is dispensed by the two parts (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) in order to prevent the bulk material (1) from flowing out of the bag (10) via the dispensing section (12); in the open position, the dispensing section (12) is moved by the two parts (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) is deployed or allowed to be deployed to form a dispensing channel (12.4) such that the bulk material (1) can flow out of the bag (10) from the compartment (11) via the dispensing section (12) under gravity; and a resilient element (120, 220, 320, 420, 520) arranged to force the two components (111, 112; 211, 212; 311, 312; 311, 312; 411, 412; 411, 412; 511, 512) is oriented towards the closed position.",,"B65D47/20, B65D75/58",20250801,雀巢产品有限公司,['Pending']
US20250064091A1,Fermented ready to drink hemp beverage,The present invention relates to a ready to drink beverage composition comprising fermented hemp or fermented hemp extract. A further aspect of the invention is a method of preparing a ready to drink beverage composition.,"<div class=""indep-clm"" num=""1""><seg-con>1. A beverage composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>fermented hemp or fermented hemp extract wherein the weight ratio of the sum of 3-methylbutyl acetate and 3-methylbutanol to 3-methylbutanal is greater than 2000 and the beverage composition is a ready to drink beverage.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The beverage composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight ratio of the sum of 2-methylbutyl acetate and 2-methylbutanol to 2-methylbutanal is greater than 2000.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The beverage composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight ratio of the sum of 3-methylbutyl acetate, 2-methylbutyl acetate, isobutyl acetate, 2-phenylethyl acetate and 2-phenylethanol to 2,3-butanedione is greater than 50.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The beverage composition of claim 1 </seg-con><seg-trans>having </seg-trans><seg-refi>an ethanol content below 1.2 wt %.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5. A method of preparing a beverage composition </seg-con><seg-trans>comprising;</seg-trans></div>
<div class=""indep-clm"" num=""5""><seg-comp>a. steeping hemp in water to form an aqueous hemp extract and steeped hemp;</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>b fermenting the aqueous hemp extract in the presence or absence of the steeped hemp; and</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>wherein the fermentation is performed by yeast comprising <i>Pichia </i>yeast and the beverage composition is a ready to drink beverage.</seg-comp></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6. The method of claim 5 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Pichia </i>yeast is <i>Pichia kluyveri. </i></seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""5"">",A23L2/38,20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2025226837A1,A nutritional composition for use to enhance executive function,"Abstract Use of a human milk oligosaccharide, or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a subject. Abstract Use of a human milk oligosaccharide, or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a subject. 20 25 22 68 37 08 S ep 2 02 5 A b s t r a c t U s e o f a h u m a n m i l k o l i g o s a c c h a r i d e , o r a n u t r i t i o n a l c o m p o s i t i o n c o m p r i s i n g a h u m a n m i l k o l i g o s a c c h a r i d e , t o e n h a n c e e x e c u t i v e f u n c t i o n i n a s u b j e c t . 2 0 2 5 2 2 6 8 3 7 0 8 S e p 2 0 2 5","<div class=""indep-clm"" num=""1""><seg-con>1. Use of a human milk oligosaccharide or a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a human milk oligosaccharide to enhance executive function in a subject.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. Use of a human milk oligosaccharide or a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a human milk oligosaccharide according to claim 1 wherein, the human milk oligosaccharide is selected from the group consisting of 2'-fucosyllactose (2'FL), diFL, LNT, LNnT, a sialyllactose and any combination of the foregoing.</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-con>3. Use of a human milk oligosaccharide or a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a human milk oligosaccharide according to claim 1 or 2 wherein, the subject is a mammal.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4. Use of a human milk oligosaccharide or nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a human milk oligosaccharide according to claim 3 wherein the subject is a human infant or child.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Use of a nutritional composition comprisinga human milk oligosaccharide accordingto anyone of claims 1 to 4 </seg-con><seg-trans>wherein, </seg-trans><seg-refi>said composition is an infant formula, a starter infant formula, a follow-on formula, a preterm infant formula, a fortifier, a human milk fortifier, a baby food formula, a growing-up milk, an infant cereal composition, a food product, a medical food product for clinical nutrition, a supplement, a pet food product, or supplement for pets.</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-con>6. Use of a human milk oligosaccharide or a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a human milk oligosaccharide according to any one of claims 1","A61K31/702, A61P25/00",20250925,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025125119A1,Blood and milk derived mirnas from a biological sample as indicators of stress and animal welfare,"The present invention relates miRNA biomarkers and in particular to a combination of miRNA biomarkers, e.g. exosome-derived microRNA, as indicators of welfare in bovines. In particular, the present invention relates to the identification of heat stress in bovines allowing to propose management actions to improve productive animal welfare at the individual or the herd levels.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A method of determining at least one welfare parameter of at least one head of cattle, the method comprising </seg-main><seg-clauses>i. determining in a biological sample the level of at least one miRNA that regulates the cell cycle, wherein the miRNA is selected from SEQ ID NOs: 1 , 2 or 3 or a functional variant thereof, wherein the functional variant has at least 60% overall sequence identity to SEQ ID NO:1 , 2 and 3 respectively; and </seg-clauses><seg-clauses>ii. comparing the level of the at least one miRNA to a reference level; wherein where the level of the at least one miRNA is above said reference level the welfare of the at least one head of cattle is or has been compromised; and wherein said biological sample is blood and/or milk.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of determining at least one welfare parameter of at least one head of cattle, the method comprising </seg-main><seg-clauses>i. determining in a biological sample the level of a miRNA as defined in SEQ ID NO: 1 , a miRNA as defined in SEQ ID NO: 2 and a miRNA as defined in SEQ ID NO: 3 or functional variants thereof, wherein the functional variant has at least 60% overall sequence identity to SEQ ID NO: 1 , 2 and 3 respectively; and </seg-clauses><seg-clauses>ii. comparing the level of each of the miRNAs to a reference level; wherein where the level of each miRNA is above said reference level the welfare of the at least one head of cattle is or has been compromised.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The method of claim 2, wherein </seg-main><seg-clauses>said biological sample is blood and/or milk.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A method for improving at least one welfare parameter of at least one head of cattle, the method comprising: </seg-main><seg-clauses>i. determining in a first biological sample from at least one head of cattle th",C12Q1/6883,20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025119708A1,Method for reducing emissions from manure,"The present invention relates to a method for reducing emissions from manure and improving plant growth, the method comprising adding 1.7 - 3.5 g of hydrogen peroxide (H2O2) per 1 kg manure and adding 10 - 60 g of biochar per 1 kg manure to manure. Furthermore, the invention relates to a manure additive for reducing emissions from manure and improving plant growth comprising H2O2 and biochar. Furthermore, the invention relates to an organic fertilizer comprising manure and the manure additive.","Claims
<div class=""indep-clm"" num=""1""><seg-con>1. Method for reducing emissions from manure and improving plant growth, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>adding 1.7 - 3.5 g of hydrogen peroxide (H2O2) per 1 kg manure and adding 10 - 60 g of biochar per 1 kg manure to manure.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the manure is stored with hydrogen peroxide (H2O2) and biochar, or the manure with hydrogen peroxide (H2O2) and biochar is distributed onto fields, preferably by spray irrigation, surface spreading, injection, or broadcasting.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hydrogen peroxide (H2O2) and/or the biochar limit(s) the generation of gaseous emissions from the manure including greenhouse gases (CO2, CH4, N2O) and odorous compounds (H2S) under strict anaerobic or/and aerobic conditions as well as atmospheric conditions.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>1.7 - 2.8 g of hydrogen peroxide (H2O2) per 1 kg manure and/or 20 - 50 g of biochar per 1 kg manure is/are added to the manure.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>calcium cyanamide</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>(CaCIS ) is added to the manure, preferably in an amount of 0.17 - 0.3 g calcium cyanamide (CaCIS ) per 1 kg of manure.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hydrogen perox","C05F3/00, A01C3/00, C05C11/00, C05F11/02",20250612,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025045941A1,A machine for preparing and dispensing beverages provided with a sanitization arrangement,,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A machine (10) for preparing and dispensing beverages comprising:</seg-main>
<seg-clauses>- at least a casing (12), able to define at least a housing chamber of one or more apparatuses of the machine (10) for preparing and dispensing beverages and provided with at least one opening which defines a compartment to said housing chamber;</seg-clauses>
<seg-clauses>- at least one beverage preparation apparatus (18), which is designed for preparing and dispensing beverages comprising at least one dispensing nozzle (28) of beverages;</seg-clauses>
<seg-clauses>- at least one water supply apparatus (20) arranged within said housing chamber, which is provided with a water feeding connector and with one or more water delivering pipes (22) to said beverage preparation apparatus (18), and with one or more solenoid valves (50, 52, 54) each coupled to a respective water delivery pipe; and</seg-clauses>
<seg-clauses>- a main control unit (34) able to run the operations for preparing and dispensing beverages, said main control unit (34) being operatively connected to said solenoid valves (50, 52, 54) by a main wiring loom to control the flow in the respective water delivery pipe (22) according to a user selection of the beverage to be dispended; the machine (10) for preparing and dispensing beverages is characterized in that it comprises a secondary control unit (210), operatively connected to said solenoid valves (50, 52, 54) to control said solenoid valves (50, 52, 54) and the flow in the respective water delivery pipe (22) according to one or more predefined commands in a request of sanitization and independently from said main control unit (34) when said machine (10) for preparing and dispensing beverages is powered off, and wherein said secondary control unit (210) is provided with an electronic connector able to allow the electronic connection between said secondary control unit (210) and a sanitization device (500) to contr","B67D1/00, B67D1/07, B67D1/08",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2019379262B2,Liquid creamer,"The present invention relates to creamers for food products such as coffee and tea. In particular, the invention relates to a liquid creamer comprising casein based protein, phospholipids, gellan gum, bicarbonate, citrate and oil. Further aspects of the invention are a beverage comprising a liquid creamer and a process for preparing a liquid creamer.","<div class=""indep-clm"" num=""1""><seg-con>1. A liquid creamer </seg-con><seg-trans>comprising </seg-trans><seg-refi>casein-based protein, phospholipids, gellan gum, bicarbonate, citrate and oil, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the casein-based protein is present at a level between 0.45 and 1.55 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the phospholipids are present at a level between 0.1 and 0.7 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the gellan gum is present at a level between 0.02 and 0.04%, wherein the gellan gum is a high acyl gellan gum,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the bicarbonate is present at a level between 0.07 and 0.15 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the citrate is present at a level between 0.12 and 0.24 %, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the oil is present at a level between 6 and 16 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>all percentages being as a weight percentage of the liquid creamer,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the liquid creamer has a shelf life of at least 6 months at 4°C, 20°C or 30 °C.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The liquid creamer according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the casein-based protein is selected from the group consisting of caseinates, micellar casein and combinations of these.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The liquid creamer according to claim 1 or 2, which contains less than 0.001 wt.% monoacylglycerols, diacylglycerols and diacetylated tartaric acid esters of monoglycerides.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. The liquid creamer according to any one of claims 1 to 3, which contains less than 0.001 wt.% phosphate salts.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5. The liquid creamer ","A23C11/02, A23F5/02, A23L29/269",20250220,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
EP4591763A2,Dosing device,"The present invention relates to a dosing device (100) that is integrally made of molded pulp fiber. The dosing device (100) comprises a container portion (200) for receiving and retaining a dosage material having an opening (250) at an upper side (US) of the dosing device (100) to access the dosage material. The dosing device (100) comprises a handle portion (300) for manually moving the container portion (200) in a dosing process. The handle portion (300) is connected to an outer surface (211) of the container body (210) by a connecting portion (350) of the handle portion (300). A rim portion (252) of the container portion (200), which delimits the opening (250), and the handle portion (300) extend in a common plane (CP) and define a circumferential edge (101) of the dosing device (101). The dosing device (100) comprises a ribbing portion (400), which extends from the circumferential edge (101) at least at the handle portion (300) to a lower side of the dosing device (100), for dissipating mechanical stresses arising in the dosing process. The invention relates also to a method for manufacturing the dosing device (100) and a use of the dosing device (100) for dosing a dosage material.","<div class=""indep-clm"" num=""1""><seg-main>1.  Dosing device (100) integrally made of molded pulp fiber comprising </seg-main><seg-clauses>- a container portion (200) having a defined volume (255) for receiving and retaining a dosage material, the container portion (200) having a container body (210) delimiting the defined volume (255), the container body (210) having a rim portion (252) circumferentially delimiting an opening (250) at an upper side (US) of the dosing device (100) to access the defined volume (255); </seg-clauses><seg-clauses>- a handle portion (300) for manually moving the container portion (200) relatively to the dosage material in a dosing process; wherein the handle portion (300) is connected to an outer surface (211) of the container body (210) by a connecting portion (350) of the handle portion (300) and extends from the container body (210) along a longitudinal axis (LA); wherein the rim portion (252) and the handle portion (300) extend in a common plane (CP) and define a circumferential edge (101) of the dosing device (100) extending in the common plane (CP); and </seg-clauses><seg-clauses>- a ribbing portion (400), which extends from the circumferential edge (101) at least at the handle portion (300) to a lower side of the dosing device (100) such that mechanical stresses acting on the container body (210) in the dosing process are dissipated by the handle portion (300).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  Dosing device (100) according to claim 1, wherein </seg-main><seg-clauses>the ribbing portion (400) extends from the circumferential edge (101) at least at the handle portion (300) at opposite sides of the longitudinal axis (LA), and wherein preferably the ribbing portion (400) extends from the circumferential edge (101) at the rim portion (252) and/or preferably from the entire circumferential edge (101) of the dosing device (100), more preferred extends along the circumferential edge (101) in a contin",A47G21/00,20250730,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019409528B2,Human milk fortifier composition,"The present invention relates to a preterm human milk fortifier composition, more specifically to a preterm milk fortifier composition providing 2'-FL and /or LNFP-I in amounts that are missing in human milk of women who gave birth to a preterm infant. In particular the present invention relates to a fortifier composition designed for infants as a supplement to preterm human breast milk at the time the infant leaves the hospital (discharge) and after. The invention furthermore relates to the use of said preterm human milk fortifier composition.","<div class=""indep-clm"" num=""1""><seg-main>1. A human milk fortifier composition comprising </seg-main><seg-clauses><seg-main>at least one ingredient selected</seg-main>
<seg-main class=""seg-enter"">in the group consisting of: 2'-fucosyllactose (2'-FL) and lacto-N-fucosylpentaose-I</seg-main>
<seg-main class=""seg-enter"">5 (LNFP-I) and a mixture thereof;</seg-main>
<seg-main class=""seg-enter"">which further comprises</seg-main>
<seg-clauses>- 6'-galactosyllactose (GSLT6);</seg-clauses>
<seg-clauses>- Lacto-N-neotetraose (LnNT);</seg-clauses>
<seg-clauses>- Lacto-N-tetraose (LNT);</seg-clauses>
<seg-clauses class=""seg-enter"">10 - 6'-sialyllactose (6'SL) or 6'-sialyllactose sodium salt; and</seg-clauses>
<seg-clauses>- Sialyllactose-N-tetraose-c (SLTNTC);</seg-clauses>
<seg-clauses class=""seg-enter"">and/or</seg-clauses>
<seg-clauses>- alpha-lactalbumin;</seg-clauses>
<seg-clauses>- casein; and</seg-clauses>
<seg-clauses class=""seg-enter"">15 - lactoferrin;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the human milk fortifier is not human milk.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The human milk fortifier composition according to claim 1 which further comprises </seg-main><seg-clauses>at least one ingredient selected in the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">20 - ingredients providing copper, for example cupric carbonate, cupric citrate, cupric gluconate, cupric sulphate, cupric lysine complex or mixtures thereof;</seg-clauses>
<seg-clauses>- ingredients providing selenium, for example sodium selenite, sodium selenate,sodium hydrogen selenite or mixtures thereof;</seg-clauses>
<seg-clauses>- ingredients providing zinc, for example zinc acetate, zinc chloride, zinc citrate, 25 zinc gluconate, zinc lactate, zinc oxide, zinc sulphate, zinc carbonate or mixtures</seg-clauses>
<seg-clauses class=""seg-enter"">thereof;</seg-clauses>
<seg-clauses>- ingredients providing alpha-tocopherol, for exam","A23L33/10, A23L33/00, A61K31/702",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20250045665A1,Food contaminant assessment,"The invention concerns a computer-implemented method for predicting risks associated with the presence of contaminants in a food. The method can comprise receiving a query defining a food, a geography and a contaminant. The method can then determine a risk that the food contains the contaminant in relation to the geography. The method also comprises providing a response to the query comprising one or more recommended management actions in relation to the determined risk.","<div class=""indep-clm"" num=""1""><seg-con>1. A computer-implemented method for predicting and managing risks associated with the presence of contaminants in a food or feed product, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing at least one ingredient present in said food or feed product from a user query, and at least one marketing country for the product,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>obtaining a geographic origin for said at least one ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>calculating a risk score that the food or feed contains a contaminant in relation to said ingredient present in the food or feed product and their respective geographical origin, said calculation being based on the combination of at least one query data selected from the group consisting of: type of contaminant, type of food or feed, type of geography, with at least one input data selected within the list of contaminant intrinsic relevance, contaminant likelihood to be used or to be found in the food environment, contaminant maximum residue level, contaminant maximum limits status, analytical data, and contaminant derived properties,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing a response to the query comprising one or more specified management actions in relation to the determined risk score, as follows:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>if the score corresponds to no risk identified, the management action corresponds to an authorization to integrate the ingredient in the food or feed product, or</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>if the score corresponds to a risk identified that requires the ingredient not to be used, the management action corresponds to a recommendation to take at least one action within the following choices:</seg-refi></d",G06Q10/0635,20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250344730A1,Low sugar-based food compositions with roasted ingredient,The present invention relates to a low sugar food composition with organoleptic properties for infants and young children comprising a plant-based roasted ingredient. The said food composition has low level of process contaminants and possess desired colour and aroma markers thus imparting desired organoleptic properties. The methods for preparing such compositions are disclosed too.,"<div class=""indep-clm"" num=""1""><seg-main>1. A low sugar food composition with organoleptic properties for infants and young children comprising </seg-main><seg-clauses>a plant-based roasted ingredient, wherein the total sugars in the composition is less than 5 g/100 g; wherein said composition has a* colour space parameter comprising a a*value above 0; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the roasted ingredient is obtainable by roasting to an extent that when said roasted ingredient is added to the food composition, the said food composition comprises sum of pyrazines containing 2-ethyl-6-methylpyrazine, 2-ethyl-5-methylpyrazine, 2,3,5-trimethylpyrazine, 2-ethyl-3-methylpyrazine, 2-ethyl-3,6-dimethylpyrazine and 2-ethyl-3,5-dimethylpyrazine in amount greater than 20 parts per billion (ppb).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition of claim 1 wherein </seg-main><seg-clauses>total amount of sugars refers to mono-saccharides, except naturally occurring lactose from dairy ingredients.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition of claim 1 wherein </seg-main><seg-clauses>the amount of furan is below 50 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The composition of claim 1 wherein </seg-main><seg-clauses>the amount of acrylamide is below 60 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The composition of claim 1 wherein </seg-main><seg-clauses>the total amount of Strecker aldehydes containing 3-methylbutanal, 2-methylbutanal, methional and phenylacetaldehyde is greater than 150 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The composition of claim 1 wherein </seg-main><seg-clauses>the amount of 4-hydroxy-2,5-dimethyl-3 (2H)-furanone (HDMF) is greater than 200 ppb.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The composition of claim 1 wh","A23L19/18, A23L7/126, A23L29/00",20251113,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12382976B2,Maceration composition and method for preparing same,"The invention concerns a method for preparing a maceration composition made from at least one component selected from the group comprising fruits, vegetables, plants and spices, said method comprising the following steps: •Macerating the component by dipping it into water in order to have the equivalent of 15 to 80 g of component for 1 L of maceration composition, at a temperature of 15° C. to 25° C. for a period of 30 to 120 minutes, thus obtaining a solid material in a maceration; •Separating the maceration from the solid material: •Acidifying the maceration and/or the water to obtain a maceration composition having a pH between 3.1 and 3.5. The invention also relates to a maceration composition obtainable according to this method, wherein said maceration comprises between 20 and 40 g/L of sugar. The invention eventually relates to a bottled beverage comprising at least one maceration composition according to the invention.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for preparing a maceration composition made from at least one component </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>apple, banana, pear, kiwi, passion fruit, mango, pomegranate, papaya, peach, apricot, watermelon, melon, strawberry, blackcurrant, currant, gooseberry, raspberry, blueberry, blackberry, cranberry, cherry, grape, cucumber, vegetables, plants and spices, the method comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>macerating the at least one component by dipping the at least one component into water in order to have the equivalent of 15 to 80 g of the at least one component for 1 L of the maceration composition, at a temperature of 15° C. to 25° C., for a period of 30 to 120 minutes, thus obtaining a solid material in a maceration;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>separating the maceration from the solid material; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>acidifying the maceration and/or the water to obtain the maceration composition, the maceration composition having a pH between 3.1 and 3.5.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the maceration composition comprises an equivalent of 25 to 50 g of the at least one component for 1 L of the maceration composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the separating comprises at least one of a decanting step, a clarifying step, and a filtering step.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>mixing the maceration composition with sugar.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The me","A23L2/02, A23B70/30, A23L2/60, A23L2/68, A23L2/72",20250812,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024263731A1,Compositions comprising human milk oligosaccharides for use in a subject to support brain development and/or cognitive development,"The invention provides a nutritional composition comprising at least one lacto-N- fucopentaose, especially lacto-N-fucopentaose-I (LNFP-I) or a combination of lacto-N-fucopentaose-I (LNFP-I), lacto-N-fucopentaose-II (LNFP-II) and lacto-N-fucopentaose-III (LNFP-III), for use in improving brain development and/or cognitive development in a subject. A nutritional composition comprising at least one lacto-N-fucopentaose, especially lacto-N-fucopentaose-I (LNFP-I) or a combination of lacto-N-fucopentaose-I (LNFP-I), lacto-N-fucopentaose-II (LNFP-II) and lacto-N-fucopentaose-III (LNFP-III), and Bifidobacterium kashiwanohense is also provided.","<div class=""indep-clm"" num=""1""><seg-main>1. A nutritional composition comprising </seg-main><seg-clauses>at least one lacto-N-fucopentaose (LNFP) for use in improving brain development and/or cognitive development in a subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The nutritional composition for use according to claim 1, wherein </seg-main><seg-clauses>the improvement in brain development and/or cognitive development comprises or consists of an improvement in the development of auditory brain networks, sensorimotor brain networks, default mode brain networks, language, fine motor skills, or combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The nutritional composition for use according to claim 2, wherein </seg-main><seg-clauses>the improvement in language development comprises or consists of an improvement in receptive language and/or expressive language based on a score of Mullen sub-scale or of the Bayley sub-scale.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. The nutritional composition for use according to claim 2 or claim 3, wherein </seg-main><seg-clauses>the improvement in language development comprises or consists of an improvement in expressive language based on a score of Mullen sub-scale or of the Bayley sub-scale.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The nutritional composition for use according to any one of the preceding claims, wherein </seg-main><seg-clauses>the improvement in brain development and/or cognitive development comprises or consists of an improvement in expressive language based on a score of Mullen sub-scale or of the Bayley sub-scale.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The nutritional composition for use according to claim 5, wherein </seg-main><seg-clauses>the nutritional composition is for use in improving brain development and/or cognitive develo","A23L33/21, A23C9/20, A23L33/00, A23L33/135, A61K31/702",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12403152B2,Compositions and methods using a nicotinamide adenine dinucleotide (NAD<sup>+</sup>) precursor and at least one ketone or ketone precursor,"A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, in particular neurodegenerative disease, depression, anxiety, decreased/low motivation, impaired cognitive function, mild cognitive impairment. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of (1) reducing risk, incidence and/or severity of or (2) mitigating deterioration of brain structure and function associated with the onset of Alzheimer's Disease (AD) in an individual in need thereof, the method comprising </seg-main><seg-clauses>administering to the individual an effective amount of a composition consisting essentially of Tryptophan and medium chain triglycerides (MCTs).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the composition is administered enterally.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the composition is selected from the group consisting of a food product, a food supplement, an oral nutritional supplements (ONS), a medical food, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the Tryptophan is administered in the same composition as at least a portion of the MCTs.</seg-clauses></div>","A23L33/00, A23L33/125, A61K9/00, A61K31/121, A61K31/19",20250902,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12233048B2,Sustained release melatonin compositions,"The present invention relates to a composition comprising melatonin encapsulated within a calcium alginate hydrogel. It further provides an orally administrable dosage form comprising such a composition held within a gel, wherein the gel is formed using starch as a gelling agent. Processes to produce these compositions, as well as their use in therapy, are also disclosed.","<div class=""indep-clm"" num=""1""><seg-con>1. An orally administrable dosage form </seg-con><seg-trans>comprising </seg-trans><seg-refi>a composition comprising melatonin encapsulated within a calcium alginate hydrogel, wherein the composition is held within a gel, wherein the gel is formed using starch as a gelling agent, and wherein the weight ratio of the melatonin to the calcium alginate hydrogel is from 5:95 to 15:85,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the dosage form further comprising additional melatonin which is not encapsulated within the calcium alginate hydrogel.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 1 to 3 wt % of the composition based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 0.01 to 0.03 wt % of the additional melatonin which is not encapsulated within the calcium alginate hydrogel, based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The dosage form according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the starch in the gelling agent comprises potato starch.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 7 to 17 wt % of the starch based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 8 to 18 wt % water based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The dosage form according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-","A61K31/4045, A61K9/00, A61K47/12, A61K47/26, A61K47/36",20250225,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250287971A1,Aerated confectionery,"The invention relates to a water-based aerated confectionery product and methods of making the same. In particular, the invention relates to stable acidic aqueous mousses comprising aggregated plant-derived protein, such as hydrolysed pea protein, and sugar. In one aspect, the invention provides a plan-based, water-based acrated confectionery having a pHI less than 5.5 and a water activity less than 0.67, wherein the aerated confectionery comprises 30 wt % to 90 wt % sugar and between 1 wt % to 8 wt % aggregated protein. The aggregated plant-derived protein stabilises the water-based aerated confectionery.","<div class=""indep-clm"" num=""1""><seg-main>1. A water-based aerated confectionery, wherein </seg-main><seg-clauses>the water-based aerated confectionery:</seg-clauses>
<seg-clauses class=""seg-enter"">has a pH less than 5.5; and</seg-clauses>
<seg-clauses class=""seg-enter"">has a water activity less than 0.67; and</seg-clauses>
<seg-clauses class=""seg-enter"">comprises 30 wt % to 90 wt % sugar;</seg-clauses>
<seg-clauses class=""seg-enter"">comprises between 1 wt % to 8 wt % plant-based protein, and</seg-clauses>
<seg-clauses class=""seg-enter"">the protein stabilises the water-based aerated confectionery.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the confectionery is a mousse or a foam.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the confectionery has a pH between 2 and 5.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is aggregated.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is hydrolysed protein.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is present in an amount at least 2 wt % of the aerated confectionery.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. A water-based aerated confectionery according to claim 1, comprising </seg-main><seg-clauses>sugar at between 40 wt % and 90 wt %, wherein the sugar comprises or consists of:</seg-clauses>
<seg-clauses class=""seg-enter"">at least two different sugars; or</seg-clauses>
<seg-clause","A23G3/52, A23G3/34, A23G3/44, A23G3/48",20250918,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025168558A1,Plant-based composition comprising heat stable canola protein,"The present invention relates to the field of plant-based compositions comprising canola protein isolate, a calcium salt, a vegetable oil and water. The invention also relates to a method for producing said plant-based compositions.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A plant-based composition comprising </seg-main><seg-clauses>at least one canola protein isolate (CPI), at least one calcium salt, at least one vegetable oil and water, wherein the calcium salt is selected in the group consisting of calcium chloride, calcium lactate, calcium citrate, calcium gluconate, calcium sulphate, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Plant-based composition according to claim 1, wherein </seg-main><seg-clauses>the composition has a pH below 7, preferably comprised between 4 and 6.5, more preferably between 5 and 6.5.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Plant-based composition according to claim 1 or 2, wherein </seg-main><seg-clauses>the composition has a viscosity ranging from 10 to 50 cP measured at 25 °C at shear rate 100 s<sup>-1</sup>, preferably from 15 to 30 cP.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Plant-based composition according to any of claims 1 to 3, wherein </seg-main><seg-clauses><seg-main>the composition comprises from 0.5 to 10 wt% of canola protein isolate, preferably from </seg-main><seg-clauses>1 .5 to 5 wt%, more preferably from 2 to 4 wt%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Plant-based composition according to any of claims 1 to 4, wherein </seg-main><seg-clauses>the composition comprises from 1.5 to 3 wt% of vegetable oil, preferably from 1 to 3.5 wt%, more preferably from 0.5 to 5 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. Plant-based composition according to any of claims 1 to 5, wherein </seg-main><seg-clauses>the composition comprises canola isolate protein and vegetable oil in a weight ratio comprised between 1 :1 and 1.5:1, preferably between 2:1 and 0.5:1 .</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><se","A23C11/10, A23C11/02, A23C11/06, A23L2/38, A23L2/66",20250814,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025036685A1,"Polymer, packaging material and process for preparing polymer","A polymer comprising repeating units comprising in the backbone an aromatic cyclic moiety, wherein a helical polymer structure is provided by pi-pi interactions between aromatic cyclic moieties, packaging comprising the polymer and process for preparing the polymer and the packaging. The polymer confers moisture and gas barrier properties on the packaging.","Claims
<div class=""indep-clm"" num=""1""><seg-con>1. A polymer </seg-con><seg-trans>comprising </seg-trans><seg-refi>repeating units comprising in the backbone an aromatic cyclic moiety, wherein a helical polymer structure is provided by pi-pi interactions between aromatic cyclic moieties.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A polymer according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the aromatic moiety is selected from the group consisting of benzene, naphthalene, anthracene, pyridine, quinoline, isoquinoline, pyrazine, quinoxaline, acridine, pyrimidine, quinazoline, pyridazine, cinnoline, and phthalazine.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A polymer according to claim 1 or claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>repeating units contain two aromatic moieties in the backbone independently selected from the group consisting of benzene, naphthalene, anthracene, pyridine, quinoline, isoquinoline, pyrazine, quinoxaline, acridine, pyrimidine, quinazoline, pyridazine, cinnoline, and phthalazine.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A polymer according to any of claims 1 to 3, </seg-con><seg-trans>comprising </seg-trans><seg-refi>repeating units of formula (I)<img src='' class=""img-anchor img-center"" img-id=""IMGF000026_0001""/></seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>wherein</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>0, 1 or 2 of X<sup>1</sup>, X<sup>2</sup>, X<sup>3</sup>and X<sup>4</sup>are N,</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>2, 3 or 4 of X<sup>1</sup>, X<sup>2</sup>, X<sup>3</sup>and X<sup>4</sup>are CR<sup>1</sup>,</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>0, 1 or 2 of Y<sup>1</sup>, Y<sup>2</sup>, Y<sup>3</sup>, Y<sup>4</sup>, Y<sup>5</sup>and Y<sup>6</sup>are N,</seg-refi></div>
<div class=""dep-clm"" nu","C08G63/06, C08G69/44, C08G61/12",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2024256142A1,Bulk dosing unit and related system,"The invention concerns a bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), wherein a sliding assembly (122) of the bulk dosing unit (100; 200) is provided for sliding a dosing element (121) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa, wherein in the closed position an opening portion (121'') of the dosing element (121) is able to be arranged spaced away from a container aperture (11) of a bulk product container and simultaneously a device engagement portion (123'') is able to arrange an aperture cover (12) of a bulk product container (10) to completely cover a container aperture (11) of a bulk product container (10) and in the maximum dispensing position the opening portion (121'') of the dosing element (121) is able to be superimposed to a container aperture (11) of a bulk product container (10) and simultaneously the device engagement portion (123') is able to arrange an aperture cover (12) of a bulk product container (10) to substantially completely uncover a container aperture (11) of a bulk product container (10), allowing the dosing of a bulk product to be dispensed according to the position of the dosing element (121) in between the closed position and the maximum dispensing position.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), said bulk dosing unit (100; 200) comprising: </seg-main><seg-clauses>a containment housing (110) which defines a containment volume for receiving a bulk product container (10); a dispensing opening (112) defined on said containment housing (110) for dispensing a bulk product; a feeding assembly (130) arranged at least partly inside said containment housing (110) and able to move a bulk product in a bulk product container (10) toward said dispensing opening (112); a dosing device (120) able to be actuated for dispensing and dosing a bulk product; characterized in that said dosing device (120) comprises a dosing element (121) and a sliding assembly (122) for sliding said dosing element (121) at said dispensing opening (112) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa, wherein said dosing device (120) comprises one or more device engagement portions (123’, 123”), arranged toward said containment volume and able to engage an aperture cover (12) of a bulk product container (10), wherein said dosing element (121) has at least an opening portion (121”), and wherein in said closed position said opening portion (121”) is able to be arranged spaced away from a container aperture (11) of a bulk product container (10) and simultaneously said device engagement portion (123”) is able to arrange an aperture cover (12) of a bulk product container (10) in a fully closed position, to completely cover a container aperture (11) of a bulk product container (10), and in said maximum dispensing position said opening portion (121”) is able to be superimposed to a container aperture (11) of a bulk product container (10) and simultaneously said device engagement portion (123’) is able to arrange an aperture cover","G07F11/44, G07F13/02, B65D47/00, B65D83/00, G07F11/00",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20240424010A1,"Nicotinamide riboside trioleates chloride, compositions containing this compound, and methods of making and using this compound","Nicotinamide riboside trioleates chloride (NRTOC1) is a novel hydrophobic derivative of nicotinamide riboside chloride. It can be used in a composition formulated for oral administration, preferably a beverage, such as a Ready-to-Drink (RTD) beverage scaled in a container or a powder formulated for reconstitution in a diluent to form a reconstituted beverage.","<div class=""ccl-clm"" num=""1"">1. (canceled)</div>
<div class=""indep-clm"" num=""2""><seg-main>2. A composition comprising </seg-main><seg-clauses>nicotinamide riboside trioleates chloride (NRTOCl).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The composition of claim 2, wherein </seg-main><seg-clauses>the composition is formulated for oral administration.</seg-clauses></div>
<div class=""ccl-clm"" num=""6"">4-6. (canceled)</div>
<div class=""indep-clm"" num=""7""><seg-main>7. A method of promoting an increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues, the method comprising </seg-main><seg-clauses>administering nicotinamide riboside trioleates chloride (NRTOCl) to an individual.</seg-clauses></div>
<div class=""indep-clm"" num=""8""><seg-main>8. A method of decreasing at least one of DNA damage or mitochondria damage and/or treating or preventing at least one condition selected from the group consisting of </seg-main><seg-clauses>(a) a neurodegenerative condition; </seg-clauses><seg-clauses>(b) overweight or obesity; </seg-clauses><seg-clauses>(c) a cardiovascular disease such as heart disease; </seg-clauses><seg-clauses>(d) one or more of diabetes, hyperinsulinemia, an insulin resistance disorder, or insulin insensitivity; </seg-clauses><seg-clauses>(d) muscle degeneration; </seg-clauses><seg-clauses>(e) a disease or disorder associated with aging; </seg-clauses><seg-clauses>(f) a viral infection such as HIV, hepatitis B, SARS-COV-2 or COVID-19; </seg-clauses><seg-clauses>(g) stress; </seg-clauses><seg-clauses>(h) a blood clotting disorder; </seg-clauses><seg-clauses>(i) inflammation; </seg-clauses><seg-clauses>(j) cancer; </seg-clauses><seg-clauses>(k) an eye disorder; and </seg-clauses><seg-clauses>(1) flushing, the method comprising administering nicotinamide riboside trioleates chloride (NRTOCl) to a subject in need thereof or at risk thereof.</seg-clauses></div>
<div class=""ccl-clm"" num=""10"">9-10. (canc","A61K31/706, A61K9/107",20241226,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12357226B2,Determining medical staffing for oral immunotherapy,"Described herein are systems and methods for determining medical staffing requirements for administering OIT to patients. Specifically, the methods and systems disclosed herein can determine the time required by a medical staff at a given treatment location to devote to administering OIT to patients as well as the number of patients undergoing OIT over a selected time period. The methods and systems disclosed herein can further provide the time required by providers and clinical staff at a given treatment location to devote to administering OIT to patients.",,"A61B5/00, G16H20/10, G16H40/20",20250715,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119866184A,Compositions and methods for treating muscle decline associated with kidney disease or dysfunction,"The compositions comprise at least two ingredients selected from the group consisting of fish oil, L-arginine, vitamin E, vitamin C, vitamin B3, vitamin B5, vitamin B6, vitamin B1, vitamin B2, folic acid, biotin, vitamin B12, and are formulated for the prevention and/or treatment of a disease or condition associated with muscle decline in a subject in need thereof. Preferably, the subject in need is an individual at risk of or having renal failure, renal dysfunction or/and nephropathy, such as chronic nephropathy, protein energy consumption, end-stage nephropathy, renal failure due to hospitalization in an intensive care unit, acute kidney injury, and the muscle decline is selected from the group consisting of muscle depletion, muscle loss due to renal failure or dysfunction, muscle decline associated with chronic kidney disease, muscle loss due to hospitalization in intensive care units during renal failure, metabolic acidosis during chronic kidney disease, protein energy depletion, or a combination thereof. The method enables the prevention and/or treatment of at least one outcome of a disease or condition associated with muscle decline in a subject at risk of or having renal failure, renal dysfunction or/and kidney disease. The composition and the method can be used to improve the level of at least one amino acid.","<div class=""indep-clm"" num=""1"">1.用于预防和/或治疗有需要的受试者的与肌肉衰退相关联的疾病或病症的营养组合物，所述营养组合物包含至少两种选自由以下项组成的组的成分：</div>
<div class=""indep-clm"" num=""1"">鱼油，</div>
<div class=""indep-clm"" num=""1"">L-精氨酸，</div>
<div class=""indep-clm"" num=""1"">维生素E，</div>
<div class=""indep-clm"" num=""1"">维生素C，</div>
<div class=""indep-clm"" num=""1"">维生素B3，</div>
<div class=""indep-clm"" num=""1"">维生素B5，</div>
<div class=""indep-clm"" num=""1"">维生素B6，</div>
<div class=""indep-clm"" num=""1"">维生素B1，</div>
<div class=""indep-clm"" num=""1"">维生素B2，</div>
<div class=""indep-clm"" num=""1"">叶酸，</div>
<div class=""indep-clm"" num=""1"">生物素，</div>
<div class=""indep-clm"" num=""1"">维生素B12。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的营养组合物，其中所述营养组合物包含至少两种选自由以下项组成的组的成分：</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约100mg至约5000mg的鱼油，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约100mg至约50000mg的L-精氨酸，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约1mg至约80000mg的维生素E，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.1mg至约2000mg的维生素C，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.2mg至约10mg的维生素B3，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.08mg至约500mg的维生素B5，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约50mg的维生素B6，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约5mg的维生素B1，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约5mg的维生素B2，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.01mg至约5mg的叶酸，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.01mg至约0.1mg的生物素，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.001mg至约5mg的维生素B12。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的营养组合物，其中所述受试者是处于肾衰竭、肾功能障碍或/和肾病的风险或患有肾衰竭、肾功能障碍或/和肾病的个体。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的营养组合物，其中所述个体是人、家畜或宠物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的营养组合物，其中所","A23L33/115, A23L33/15, A23L33/175, A61P13/12, A61P3/02",20250422,雀巢产品有限公司,['Pending']
CN119233932A,Method for producing packages from recoverable material,"The invention relates to a method for producing a package (100) for encapsulating a substance (S). A flat sheet (110) made of recyclable material and having two opposing side edge sections (111, 112) is provided and formed into a tube (130) by folding the flat sheet (110) such that the two side edge sections (111, 112) overlap one another at an overlap section (139). The tube (130) is heat sealed along the overlap section (139) to form a longitudinal seal joint (131) and is heat sealed across the longitudinal seal joint (131) to close the tube (130) with a first transverse seal joint (134) at a first tube end (132). The tube (130) is filled with the substance (S) and is heat sealed across the longitudinal sealing joint (131) to close the tube (130) at a second tube end (133) with a second transverse sealing joint (135). A heat sealable sealing strip (700) is provided. A first segment (701) and a second segment (702) of the sealing strip (700) are respectively arranged at a first triple point section and a second triple point section (171, 172) where the longitudinal sealing joint (131) and the corresponding transverse sealing joint (134, 135) intersect. The segments (701, 702) of the sealing strip (700) seal the respective triple point sections (171, 172) when thermally sealing the respective pipe ends (132, 133) to form the respective transverse seal joints (134, 135). The invention also relates to a package (100) encapsulating a substance (S) and a machine (500) for producing the package (100).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于生产用于包封物质(S)的可回收包装(100)的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>●提供由可回收材料制成并具有两个相对的侧边缘区段(111,112)的平片(110)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●通过折叠所述平片(110)将所述平片(110)形成为管(130)，使得所述两个侧边缘区段(111,112)在重叠区段(139)处至少部分彼此重叠，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●沿所述重叠区段(139)热密封所述管(130)以形成纵向密封接头(131)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●跨所述纵向密封接头(131)热密封所述管(130)，以在第一管端部(132)处用第一横向密封接头(134)封闭所述管(130)，●用待包装的物质(S)填充所述管(130)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●跨所述纵向密封接头(131)热密封所述管(130)，以在相对于待包装的所述物质(S)与所述第一管端部(132)相对的第二管端部(133)处用第二横向密封接头(135)封闭所述管(130)，从而形成包封所述物质(S)的包装(100)，其特征在于所述方法还包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●提供可热密封的密封条(700)，使得</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>○所述密封条(700)的第一片段(701)设置在所述纵向密封接头(131)和所述第一横向密封接头(134)相交的第一三重点区段(171)处，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>○所述密封条(700)的第二片段(702)设置在所述纵向密封接头(131)和所述第二横向密封接头(135)相交的第二三重点区段(172)处，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述密封条(700)的相应的片段(701,702)在热密封相应的管端部(132,133)时密封相应的三重点区段(171,172)，以形成相应的横向密封接头(134,135)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中在将所述平片(110)形成为管(130)的步骤之前或期间，和/或在热密封所述纵向密封接头(131)的步骤之前或期间，提供所述密封条(700)的所述相应的片段(701,702)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的方法，其中所述密封条(700)的至少一部分、优选地所述第一片段(701)和/或所述第二片段(702)的至少一部分被设置成使得所述相应的片段(701,702)中的每个片段在所述重叠区段(139)处、优选地沿着所述重叠区段(139)的整个长度夹置于所述两个侧边缘区段(111,112)之间。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.根据前述权利要求中任一项所述的方法，其中提供所述相应的片段(701,702)的步骤中的至少一个步骤</seg-con><seg-trans>包括以下步骤：</seg-trans><seg-refi>将所述相应的片段(701,702)、优选地所述密封条(700)布置在所述两个侧边缘区段(111,112)之间的所述重叠区段(139)处，使得所述相应的片段(701,702)优选地在热密封所述纵向密封接头(131)的所述步骤之后延伸到相应的三重点区段(171,172)。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据前","B65B9/20, B65B51/04, B65B51/26, B65B51/30, B29C65/50",20241231,雀巢产品有限公司,['Pending']
RU2849908C2,System and method for forming a compostable capsule for beverages from a sheet having a controlled moisture content,"FIELD: manufacture of a compostable capsule.SUBSTANCE: invention relates to a system and method for manufacturing a compostable capsule for prepared foods. The capsule (900) is made from a sheet (600) made of a biodegradable cellulose-based material. The system (100) comprises a forming line (200) that includes a processing unit (300) for moving the sheet (600) along a direction (TD) of travel through the system (100). The forming line (200) further comprises a moistening unit (400) for moistening a side of the sheet (600) with a moistening agent (401) and a forming unit (800) for forming a portion of the moistened sheet (600) into a three-dimensional shape to form a capsule element (910) capsule element that forms a capsule cavity (911). The forming line (200) further comprises a humidity sensor system (500) for visually registering the humidity level of the section of the moistened sheet (600). The values relating to the moisture level recorded by the moisture sensor system (500) are received by a control unit (700), which is additionally designed to control the moistening unit (400) based on these values. The invention also relates to a method of manufacturing a compostable capsule (900), whereby the moisture level of at least the moistened sheet section (600) is visually recorded and used to control the moistening process of the sheet side (600) accordingly.EFFECT: improvement of the structural integrity and shelf life of the resulting capsule.15 cl, 4 dwg","1. Система (100) для изготовления компостируемой капсулы (900) для приготавливаемых продуктов из листа (600), выполненного из биоразлагаемого материала на основе целлюлозы, причем система (100) содержит по меньшей мере одну линию (200) формования, которая содержит:
- блок (300) обработки для перемещения листа (600) вдоль направления (TD) перемещения через систему (100);
- блок (400) увлажнения для увлажнения по меньшей мере одной стороны листа (600) увлажнителем (401); и
- блок (800) формования для формования части увлажненного листа (600) в трехмерную форму с образованием элемента (910) капсулы, образующего полость (911) капсулы;
при этом по меньшей мере одна линия (200) формования дополнительно содержит
систему (500) датчиков влажности для визуальной регистрации уровня влажности по меньшей мере секции увлажненного листа (600) и
блок (700) управления, выполненный с возможностью приема значений, относящихся к уровню влажности, регистрируемой системой (500) датчиков влажности, и управления блоком (400) увлажнения на основании этих значений.
2. Система (100) по п. 1, в которой система (500) датчиков влажности содержит оптический прибор (510), предпочтительно камеру и более предпочтительно камеру с высоким разрешением для захвата визуального изображения по меньшей мере секции увлажненного листа (600), представляющего уровень влажности, причем предпочтительно визуальное изображение содержит множество пикселей, при этом более предпочтительно каждое из принятых значений связано с одним или несколькими пикселями.
3. Система (100) по п. 1 или 2, в которой система (500) датчиков влажности содержит источник (520) света, предпочтительно светодиодный источник (521, 522, 523, 524, 525) света, предназначенный для излучения света одной или более определенных длин волн в видимом спектре, причем источник (520) света расположен таким образом, что излучаемый свет (531) направлен на по меньшей мере секцию увлажненного листа (600), чтобы он отражался предпочтительно в направлении оптиче","B31B50/00, B31B50/74, B31F1/00, B31F1/36, B65B29/02",20251031,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN120225458A,Beverage dispensing unit for machine for preparing and dispensing beverage and machine for preparing and dispensing beverage comprising said dispensing unit,,"<div class=""indep-clm"" num=""1""><seg-con>1.一种用于制备并分配饮料的机器(100)的饮料分配单元(10)，所述饮料分配单元(10)</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-喷嘴(12)，所述喷嘴连接到管道(14)，所述饮料和/或用于制作所述饮料的配料在所述管道中流动，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-凹室(16)，所述凹室限定用于保持容器(C)的支座(18)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>通过所述喷嘴(12)分配的所述饮料和/或用于制作所述饮料的所述配料流入所述容器(C)中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述凹室(16)包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-开口(20)，所述开口用于将所述容器(C)插入所述支座(18)中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-上部部分(22)，所述喷嘴(12)至少部分地设置在所述上部部分中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-下部部分(24)，所述下部部分用于支撑所述容器(C)，所述下部部分基本上设置在所述喷嘴(12)下方，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述凹室(16)包括喷嘴保护主体(26)，所述喷嘴保护主体包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)保护壁(28)，所述保护壁设置在所述凹室(16)中并且位于所述喷嘴(12)的下端(30)下方，所述保护壁(28)的形状和尺寸被设定成基本上防止使用者以使所述容器(C)与所述喷嘴(12)接触的方式在所述支座(18)中移动所述容器(C)，并且/或者防止使用者触碰所述喷嘴(12)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)饮料分配通道(32)，所述饮料分配通道用于使饮料通过所述保护壁(28)从所述喷嘴(12)流出到所述凹室(16)的所述下部部分(24)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述保护壁(28)的下部部分(38)包括外表面(40)，所述外表面面向所述凹室(16)的所述下部部分(24)，其中所述外表面(40)包括多个凸起或凹陷元件(42)，所述多个凸起或凹陷元件用于在所述容器(C)的口部(C1)被推压成与所述外表面(40)接触的情况下防止所述容器(C)的所述口部(C1)与所述喷嘴保护主体(26)之间出现紧密接触，从而确保所述容器(C)的过量填充物沿着所述容器(C)的外侧流向所述凹室(16)的所述下部部分(24)而不流向所述喷嘴(12)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的饮料分配单元(10)，其中所述饮料分配单元</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-连接构件(34,35)，所述连接构件用于将所述喷嘴保护主体(26)可移除地连接到所述凹室(16)，以便允许从所述凹室(16)移除所述喷嘴保护主体(26)，从而能够周期性地清洁所述喷嘴保护主体(26)。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的饮料分配单元(10)，其中所述饮料分配通道(32)包括用于使所述饮料流出的通孔(36)，所述通孔(36)由所述保护壁(28)的所述下部部分(38)界定。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一","B67D1/08, B67D1/00",20250627,雀巢产品有限公司,['Pending']
WO2024251710A1,Beverage preparation machine with reliable dispensing,"A machine (1) for dispensing a beverage (100) has a beverage processing unit (5) and a beverage outlet (10) in fluid communication with the unit (5). The outlet (10) includes an outlet conduit (11) extending along a flow direction (12) and having a lower conduit part (11a) with a bottom end (13). A bottom dispensing opening (14) is located at the bottom end (13) to dispense beverage (100) from the bottom end (13) to an area (2) for placing a user-recipient (9). Above its bottom end (13), the lower conduit part (11a) has a single lateral dispensing opening (14a) that is configured to dispense beverage (100) above the bottom opening (14) from the lower conduit part (11a) to the placement area (2) when the bottom opening (14) is partly or fully obstructed at the bottom end (13).","Claims <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for dispensing a beverage (100) comprises </seg-main><seg-clauses><seg-main>a beverage processing unit (5) and a beverage outlet (10) in fluid communication with the unit (5), the outlet (10) including an outlet conduit (11) extending along a flow direction (12) and having a lower conduit part (11a) with a bottom end (13), a bottom dispensing opening (14) being located at the bottom end (13) to dispense beverage (100) from the bottom end (13) to an area (2) for placing a user-recipient (9), e.g. a cup or a mug, to collect such dispensed beverage (100), optionally the beverage outlet (10) and/or the processing unit (5) being located at least partly in a stationary frame and/or housing (4), for instance: </seg-main><seg-clauses>- the beverage outlet (10) being movable relative to the stationary frame and/or housing </seg-clauses><seg-clauses>(4) between a dispensing position in which the beverage outlet (10) dispenses via the lower conduit part (11a) said beverage (100) to said area (2) and a non-dispensing position in which the beverage outlet (10) prevents dispensing via the lower conduit part (11a) to said area (2), e.g. the beverage outlet (10) directing waste liquid towards a waste collector (3); and/or </seg-clauses><seg-clauses>- the processing unit (5) having a first part (53) and a second part (54) that are relatively movable between a proximate configuration in which they delimit a chamber (55) for containing and processing a beverage ingredient therein and a distant configuration for receiving in the chamber (55) and/or evacuating from the chamber (55) such ingredient, characterised in that above its bottom end (13) the lower conduit part (11a) has a single lateral dispensing opening (14a) that is configured to dispense beverage (100) above the bottom opening (14) from the lower conduit part (11a) to said area (2) for placing a user- recipient (9) when the bottom opening (14) is partly or full","A47J31/06, A47J31/46",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2024229572A1,confectionery,"The invention relates to a confectionery composition and methods of making the same. In particular, the invention relates to confectionery fillings comprising water, sugar fat, hydrocolloid and protein. Also provided is a process for the manufacture of a confectionery composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A confectionery composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>hydrocolloid in an amount of 0.1wt% to 10wt%, preferably 0.1 to 5 wt%.</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>protein in an amount of 0.5wt% to 15wt%, preferably, 1.7 to 6.5wt%.</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>water in an amount of 10wt% to 40wt%, preferably 10 to 20wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sugar in an amount of 35wt% to 80wt%, preferably 35 to 67wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>fat in an amount of 2wt% to 35wt%, wherein the percentages are the weight percentages of the confectionery composition.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A confectionery composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the viscosity of the composition is between 5 Pa.S'1 and 40 Pa.S'1.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A confectionery composition according to claims 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sugar comprises a mixture of fructose and glucose.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A confectionery composition according to claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 10wt% to 50wt% of the sugar in the aqueous phase is fructose.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A confectionery composition according to claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 20wt% to 65wt% of the sugar in the aqueous phase is glucose and/or dextrose.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A confectionery composition according to any preceding claim, </seg-con><seg-","A23G1/54, A23G3/34, A23G3/40, A23G3/42, A23G3/44",20250814,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119654142A,Methylated phloretin analogs as inhibitors of SGLT2,"The present invention relates to compositions and methods for improving metabolic health. In particular, the present disclosure relates to the use of methylated phloretin analogs as sodium-glucose transporter 2 (SGLT2) inhibitors for improving metabolic health.","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含用于SGLT2的抑制的有效量的至少一种甲基化根皮素类似物。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述甲基化根皮素类似物选自根皮素-4-甲基-醚、4′-O-甲基根皮素、卡洛梅酮和黄卡瓦胡椒素A。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的组合物，其中所述甲基化根皮素类似物由植物或植物提取物获得。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，其中所述甲基化根皮素类似物来自未成熟的苹果或橙皮。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，其中所述SGLT2的抑制是在肌肉和/或肾组织中进行的。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，所述组合物用于治疗和/或预防对其有需要的受试者的与2型糖尿病和/或肥胖相关的病症、障碍或疾病。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">7.根据权利要求1至5中任一项所述的组合物，所述组合物用于治疗和/或预防对其有需要的受试者的与心血管、重量管理、肾脏、肾、脑相关的病症、障碍或疾病。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5"">8.根据权利要求1至5中任一项所述的组合物，所述组合物用于治疗和/或预防对其有需要的受试者的对SGLT2抑制有应答的病症、障碍或疾病。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的组合物，其中所述组合物为食物、饮料或膳食补充剂。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的组合物，其中所述组合物还包含药学上可接受的载体。</div>
<div class=""indep-clm"" num=""11"">11.治疗和/或预防对其有需要的受试者的与2型糖尿病和/或肥胖相关的病症、障碍或疾病的方法，所述方法包括施用权利要求1至10中任一项的包含所述的化合物的组合物。</div>
<div class=""indep-clm"" num=""12"">12.治疗和/或预防对其有需要的受试者的对SGLT2抑制有应答的病症、障碍或疾病的方法，所述方法包括施用权利要求1至10中任一项的包含所述的化合物的组合物。</div>
<div class=""indep-clm"" num=""13"">13.药物组合物，所述药物组合物包含作为活性成分的治疗有效量的权利要求1至10中任一项所述的化合物或其药学上可接受的盐或溶剂化物，以及药学上可接受的载体，所述药物组合物用于SGLT2的抑制。</div>
<div class=""indep-clm"" num=""14"">14.抑制SGLT2的体外方法，所述体外方法包括使权利要求1至10中任一项所述的化合物与SGLT2接触并且确定SGLT2的抑制。</div>","A61K31/12, A61P3/10",20250318,雀巢产品有限公司,['Pending']
WO2025031844A1,Compostable POD for beverage preparation,"The invention relates to a pod (100, 200) for preparing a beverage in a beverage production machine, wherein the pod (100, 200) is made of a biodegradable, preferably compostable, material composition and comprises a pod body (110) composed of two half-shells (101, 102) being connected to each other along their respective circumferential flange (140) so as to delimit a chamber (103) for containing a substance (105) for the preparation of the beverage, wherein at least one half-shell comprises in a layered manner:. A primary layer (171) made of a paper-based material,. A secondary layer (172) comprising at least an oxygen barrier function and optionally a water barrier function, and. A, at least partial, tertiary layer (173) comprising a filter function, wherein the primary layer (171) of at least one of the half-shell (101, 102) comprises at least one traversing hole (106), over at least a delivery portion (130) of the half-shell (101, 102), said delivery portion being adapted to interact with external opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod (100, 200) through an injection portion (120) on the other half-shell (101, 102), to dispense the prepared beverage from the pod (100, 200). The invention also relates to the use of said pod in a beverage production machine.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A pod (100, 200) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the pod (100, 200) is made of a biodegradable, preferably compostable, material composition and comprises a pod body (110) composed of two half-shells (101, 102) being connected to each other along their respective circumferential flange (140) so as to delimit a chamber (103) for containing a substance (105) for the preparation of the beverage, wherein at least one half-shell comprises in a layered manner:</seg-main>
<seg-clauses>• A primary layer (171) made of a paper-based material,</seg-clauses>
<seg-clauses>• A secondary layer (172) comprising at least an oxygen barrier function and/or a water vapor or moisture barrier function, and</seg-clauses>
<seg-clauses>• A, at least partial, tertiary layer (173) comprising a filter function, wherein the primary layer (171) of at least one of the half-shell (101, 102) comprises at least one traversing hole (106), over at least a delivery portion (130) of the half-shell (101, 102), said delivery portion being adapted to interact with external opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod (100, 200) through an injection portion (120) on the other half-shell (101, 102), to dispense the prepared beverage from the pod (100, 200).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The pod (100,200) according to claim 1, wherein </seg-main><seg-clauses>the primary layer (171) comprises between 1 and 150 traversing holes (106) forming a first pattern (108).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The pod (100,200) according to claim 1 or 2, wherein </seg-main><seg-clauses>the primary layer (171) further comprises at least a non-traversing element, preferably an engraved surface and/or scratch, forming a second pat","B65D65/46, B65D85/804",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
RU2845962C1,Coffee beans roasting system checking method,,"1. Способ проверки системы обжаривания, содержащей:
- по меньшей мере одно устройство для обжаривания, причем указанное устройство выделяет дым во время нагревания кофейных зерен, и
- по меньшей мере один блок очистки дыма, выполненный с возможностью очистки по меньшей мере части потока дыма, выделяемого по меньшей мере одним устройством для обжаривания, при этом указанный блок очистки дыма содержит по меньшей мере одно съемное фильтрующее устройство,
- устройство перекачивания дыма, выполненное с возможностью направления дыма из устройства для обжаривания в указанное по меньшей мере одно фильтрующее устройство,
причем по меньшей мере один блок очистки дыма содержит по меньшей мере одну пару первого и второго датчиков температуры, при этом первый датчик температуры выполнен с возможностью измерения температуры T1 потока дыма перед указанным по меньшей мере одним съемным фильтрующим устройством, а второй датчик температуры выполнен с возможностью измерения температуры T2 потока дыма после указанного по меньшей мере одного съемного фильтрующего устройства,
причем способ включает в себя стадии, на которых:
- эксплуатируют устройство для обжаривания с получением горячего газа,
- контролируют первую и вторую температуры, измеряемые одной из пар первого и второго датчиков температуры, в течение по меньшей мере времени указанной эксплуатации,
- наблюдают за различием поведения контролируемых температур с течением времени,
- сравнивают указанное наблюдаемое различие поведения с заданным различием поведения, соответствующим наличию указанного по меньшей мере одного съемного фильтрующего устройства между двумя датчиками температуры,
- отображается сигнал тревоги, если наблюдаемое различие поведения отличается от заданного различия поведения.
2. Способ по п. 1, в котором стадия эксплуатации устройства для обжаривания с получением горячего газа представляет собой операцию обжаривания кофейных зерен, операцию предварительного нагрева устройства для обжаривания или операцию иници",A23N12/08,20250828,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2024230092A1,Filling for confectionery and confectionery comprising that filling,"The invention relates to a confectionery composition and methods of making the same. In particular, the invention relates to confectionery fillings comprising water, sugar fat, protein, and optionally hydrocolloid. Also provided is a process for the manufacture of a confectionery composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A confectionery composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>hydrocolloid in an amount of 0wt% to 10wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>protein in an amount of 0.5wt% to 15wt%, preferably, 1.7 to 6.5wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>water in an amount of 10wt% to 40wt%, preferably 10 to 20wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sugar in an amount of 35wt% to 80wt%, preferably 35 to 67wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>fat in an amount of 2wt% to 35wt%, wherein the percentages are the weight percentages of the confectionery composition.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A confectionery composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the viscosity of the composition is between 5 Pa.S1 and 40 Pa.S1.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A confectionery composition according to claims 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sugar comprises a mixture of fructose and glucose.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A confectionery composition according to claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 10wt% to 50wt% of the sugar in the aqueous phase is fructose.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A confectionery composition according to claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 20wt% to 65wt% of the sugar in the aqueous phase is glucose and/or dextrose.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A confectionery composition according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-","A23G1/54, A23G3/34, A23G3/40, A23G3/42, A23G3/44",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250164507A1,Compositions and methods for diagnosing and treating cardiomyopathy in a feline,"The present invention relates to methods and compositions for diagnosing and enabling treatment of cardiomyopathy (CM) in a feline. In one embodiment, a method of diagnosing CM in a feline can comprise measuring an amount of at least one metabolite from the feline; comparing the amount of the at least one metabolite from the feline to a corresponding predetermined value or a corresponding predetermined range; and diagnosing the feline as preclinical CM, clinical CM, or not having CM, based on the comparison.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of diagnosing cardiomyopathy (CM) in a feline, the method comprising: </seg-main><seg-clauses><seg-main>measuring an amount of at least one metabolite from the feline, wherein the at least one metabolite is selected from the group consisting of tauro-beta-muricholate, 1-stearoyl-2-linoleoyl-GPE (18:0/18:</seg-main><seg-clauses><seg-main>2), 1-stearoyl-2-oleoyl-GPE (18: 0/18:</seg-main><seg-clauses><seg-main>1), 1-stearoyl-2-linoleoyl-GPI (18:0/18:</seg-main><seg-clauses><seg-main>2), 1-behenoyl-GPC (22:0), 1-linoleoyl-GPI (18:2), taurodeoxycholic acid 3-sulfate, 1-palmitoyl-2-linoleoyl-GPE (16:0/18:</seg-main><seg-clauses><seg-main>2), asparagine, 1-palmitoyl-2-oleoyl-GPE (16:0/18:</seg-main><seg-clauses><seg-main>1), 1-arachidoyl-GPC (20:0), phosphatidylcholine (18:0/20:2, 20:0/18:</seg-main><seg-clauses>2), taurodeoxycholate, glycerol, cystine, C-glycosyltryptophan, cysteine-glutathione disulfide, N-acetylglucosaminylasparagine, N-lactoyl valine, 5-(galactosylhydroxy)-lysine, 3-hydroxymyristate, hydroxyasparagine, guanidinosuccinate, N-lactoyl tyrosine, 1-methylhistidine, glucuronate, ribonate, 1-methylguanidine, N,N-dimethylalanine, 11-dehydrocorticosterone, cortisol, 2R,3R-dihydroxybutyrate, mannitol/sorbitol, n-propanol glucuronide, and mixtures thereof;</seg-clauses>
<seg-clauses class=""seg-enter"">comparing the amount of the at least one metabolite from the feline to a corresponding predetermined value or a corresponding predetermined range; and</seg-clauses>
<seg-clauses class=""seg-enter"">diagnosing the feline as preclinical CM, clinical CM, or not having CM, based on the comparison.</seg-clauses></seg-clauses></seg-clauses></seg-clauses></seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, comprising </seg-main><seg-clauses>obtaining a sample of at least one of serum or plasma from the feline, wherein the measuring of the amount of each","G01N33/68, G01N33/74, G01N33/92",20250522,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12297601B2,Paper-based flexible packaging material with high barrier properties and a process to produce it,"The present invention relates generally to the field of polymer dispersion coated, paper-based flexible packaging materials. In particular, the present invention relates to improving the barrier properties of polymer dispersion coated 5 paper-based flexible packaging materials. Embodiments of the present invention relate to a process for improving the barrier properties of polymer dispersion coated paper-based flexible packaging materials comprising the step of applying an Al2O3 coating to at least one surface of the dispersion coated paper-based flexible packaging materials, for example by using atomic layer deposition; and an Al2O3-coated paper material 10 obtainable by such a process.","<div class=""indep-clm"" num=""1""><seg-con>1. A process for improving barrier properties of polymer dispersion coated paper-based flexible packaging materials </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>applying an Al<sub>2</sub>O<sub>3 </sub>coating having a thickness in the range of 8-70 nm, to at least one surface of the polymer dispersion coated paper-based flexible packaging material, wherein the Al<sub>2</sub>O<sub>3 </sub>coating is applied to the at least one surface of the polymer dispersion coated paper-based flexible packaging materials by atomic layer deposition at a temperature in the range of 40° C.-80° C. with trimethylaluminum (TMA) and H<sub>2</sub>O or O<sub>2 </sub>as precursors,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the process further comprises a plasma pre-treatment of the at least one surface of the polymer dispersion coated paper-based flexible packaging materials before the Al<sub>2</sub>O<sub>3 </sub>coating is applied.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The process in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the Al<sub>2</sub>O<sub>3 </sub>coating that is applied to the at least one surface of the polymer dispersion coated paper-based flexible packaging materials has a thickness in the range of 45-55 nm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The process in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the Al<sub>2</sub>O<sub>3 </sub>coating that is applied to the at least one surface of the polymer dispersion coated paper-based flexible packaging materials has a thickness in the range of 20-30 nm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The process in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymer dispersion coated paper-based flexible packaging materials has a grammage i","D21H27/10, D21H19/38, D21H19/82, D21H23/30, D21H23/50",20250513,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12374452B2,Systems and methods for animal health monitoring,"The present disclosure provides systems and methods for animal health monitoring. Load data can be obtained from a plurality of load sensors associated with a platform carrying contained litter thereabove, wherein individual load sensors of the plurality of load sensors are separated from one another and receive pressure input from the platform independent of one another. If the load data is determined or not to be from an animal interaction with the contained litter, an animal behavior property associated with an animal is recognized if a determination is made based on load data that the interaction with the contained litter was due to the animal interaction. The animal behavior property is classified into an animal classified event using a machine learning classifier. A change in the animal classified event is identified as compared to a previously recorded event associated with the animal.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of monitoring the health of an animal, under the control of at least one processor, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>obtaining load data from an animal monitoring device including a plurality of load sensors associated with a platform carrying contained litter thereabove, wherein individual load sensors of the plurality of load sensors are separated from one another and receive pressure input from the platform independent of one another;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determining if the load data is from an animal interaction with the contained litter;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>recognizing an animal behavior property associated with the animal if determined based on load data that the interaction with the contained litter was due to the animal interaction;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>classifying the animal behavior property into an animal classified events using a machine learning classifier, wherein the classifying includes analyzing the load data from the plurality of load sensors at a phase level via a phase separation algorithm to separate the load data into multiple phases while the animal is interacting with the contained litter; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>identifying a change in the animal classified event as compared to a previously recorded event associated with the animal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>classifying the animal behavior comprises an in box event, a urination event, a defecation event, a non-elimination event, or a combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>correlating the",G16H40/63,20250729,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019275853B2,Dispenser of bulk material,"The invention concerns A container (10) for storing, metering and dispensing bulk material, the container comprising : - a tank (1) to store the bulk material, said tank comprising a close top end and an opened bottom end, and said tank presenting an essentially cylindrical shape, - a dispensing closure (2) to dispense the bulk material from the opened bottom end of the tank, said dispensing closure comprising :. an inner rotatable member (22) with at least one aperture (221), said inner rotatable member being rotatable around a longitudinal central axis (XX) and said inner rotatable member comprising central connecting means (223) designed to removably engage with a rotating shaft extending along the central axis (XX),. an outer fixed member (21) with a central aperture (213) and at least one outlet aperture (211) therein, wherein the inner rotatable member (22) is configured for being selectively rotatable with respect to the outer fixed member (21) such that at least in one rotational position of the inner member, the at least one aperture (221) of the inner member overlaps with the at least one outlet aperture (211) of the outer fixed member for enabling the dispensing of the bulk material from the container, wherein the tank comprises at least one longitudinal straight rib (15) projecting inside the internal volume of the tank.","2019275853 25 Mar 2025
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS: -
<div class=""indep-clm"" num=""1""><seg-main>1. A container for storing, metering and dispensing bulk material, the container comprising :</seg-main>
<seg-clauses>5   - a tank to store the bulk material, said tank comprising a close top end and an opened</seg-clauses>
<seg-clauses class=""seg-enter"">bottom end, and said tank presenting an essentially cylindrical shape,</seg-clauses>
<seg-clauses>- a dispensing closure to dispense the bulk material from the opened bottom end of the tank, said dispensing closure comprising :</seg-clauses>
<seg-clauses class=""seg-enter"">. an inner rotatable member with at least one aperture, said inner rotatable member 0 being rotatable around a longitudinal central axis and said inner rotatable member comprising a central connecting means designed to removably engage with an external rotating shaft extending along the central axis,</seg-clauses>
<seg-clauses class=""seg-enter"">. an outer fixed member with a central aperture designed for the passage of the external rotating shaft and with at least one outlet aperture therein,</seg-clauses>
<seg-clauses class=""seg-enter"">5 wherein the inner rotatable member is configured for being selectively rotatable with respect to the outer fixed member such that at least in one rotational position of the inner member, the at least one aperture of the inner member overlaps with the at least one outlet aperture of the outer fixed member for enabling the dispensing of the bulk material from the container,</seg-clauses>
<seg-clauses class=""seg-enter"">!0 wherein the tank comprises at least one longitudinal straight rib projecting inside the internal volume of the tank.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Container according to Claim 1 wherein </seg-main><seg-clauses>the rib extends from the top end of the tank to the bottom end of the tank.</seg-clauses>
<seg-clauses class=""seg-enter"">25</seg-clause","A47J31/40, A47J42/50",20250424,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20240415315A1,Beverage pod system with improved seal,"The invention concerns a system of pod and a device for extracting a beverage ingredient by supplying an extraction liquid such as heated water into in the pod and comprising:—upstream and downstream pod enclosing parts (<b>1, 2</b>) relatively translatable along a longitudinal axis (XX′) between an open position for inserting and/or ejecting the pod (<b>3</b>) and a closed position for forming an extraction chamber (<b>5</b>) enclosing the pod during extraction,—the upstream part (<b>2</b>) defining a cage (<b>21</b>) and bearing an upstream piercing arrangement(<b>22</b>) for opening the bottom wall (<b>313</b>) of the pod and a liquid injector (<b>25</b>),—the downstream part (<b>1</b>) defining a plate transverse to the longitudinal axis (XX′), said plate comprising a downstream plane piercing arrangement (<b>12</b>) for opening the lid (<b>32</b>) of the pod, and a peripheral area (<b>13</b>), and wherein the periphery of the opened end (<b>211</b>) of the cage (<b>21</b>) defined by the upstream enclosing part is covered by a seal (<b>24</b>) comprises a ridge (<b>241</b>) rising in the downstream direction, and wherein, in the closed position of the downstream and the upstream enclosing parts (<b>1, 2</b>) a central part of the flange of the pod is pinched by the ridge (<b>241</b>) of the seal of the upstream enclosing part against the peripheral area (<b>13</b>) of the plate of the downstream part. FIG. <b>3</b>A","<div class=""indep-clm"" num=""1""><seg-con>1. System </seg-con><seg-trans>comprising </seg-trans><seg-refi>an extraction device and a pod,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the pod comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a side wall and a bottom wall defining a chamber, said chamber extending axially between the bottom and a top opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a circumferential annular flange projecting radially outward from the top opening, said flange comprising an upper surface opposite to the chamber with respect to the opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pod body containing a beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top lid attached to the upper surface of the circumferential flange, said top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the extraction device comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>upstream and downstream pod enclosing parts relatively translatable along a longitudinal axis (XX′) between an open position for inserting and/or ejecting the pod and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the upstream part defining a cage and bearing an upstream piercing arrangement for opening the bottom wall of the pod and a liquid injector,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the downstream part defining a plate transverse to the longitudinal axis (XX′), said plate comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a downstream plane piercing ",A47J31/06,20241219,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2845437C1,Apparatus and method of roasting coffee beans,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is apparatus (1) for roasting coffee beans, comprising: chamber (10) configured to receive coffee beans for roasting, wherein chamber (10) includes opening (13), and a device for roasting coffee beans received into chamber (10), wherein chamber (10) is movable relative to an axis of movement to different positions, wherein said positions include a roasting position which is configured to roast coffee beans received in chamber (10), and a bean discharge position in which chamber (10) is configured to discharge coffee beans through opening (13) from chamber (10) in which same opening (13) defines a direction of access for removing the coffee beans from chamber (10), as well as for supplying coffee beans into chamber (10). Additionally, described is a method for coffee beans roasting with usage of the said apparatus.EFFECT: group of inventions makes it possible to provide for an apparatus that makes the coffee beans roasting method more convenient and safer.15 cl, 14 dwg","1. Аппарат (1) для обжаривания кофейных зерен, включающий в себя:
камеру (10), выполненную с возможностью приема кофейных зерен для обжаривания, причем камера (10) включает в себя отверстие (13), и
устройство для обжаривания кофейных зерен, принятых в камеру (10),
причем камера (10) выполнена с возможностью перемещения относительно оси перемещения в разные положения, при этом эти положения включают в себя положение обжаривания и положение выгрузки зерен, причем
• в положении обжаривания устройство выполнено с возможностью обжаривания кофейных зерен, принятых в камеру (10), и
• в положении выгрузки зерен камера (10) выполнена с возможностью выгрузки кофейных зерен через отверстие (13) из камеры (10),
в котором то же отверстие (13) определяет направление доступа для удаления кофейных зерен из камеры (10), а также для подачи кофейных зерен в камеру (10).
2. Аппарат (1) по п. 1, в котором камера (10) выполнена с возможностью поворота в разные положения, и/или при этом ось перемещения проходит горизонтально.
3. Аппарат (1) по п. 1 или 2, в котором камера (10) выполнена с возможностью перемещения вручную в каждое из разных положений, при этом аппарат (1) дополнительно включает в себя пользовательский интерфейс (32) для ручного перемещения камеры (10) в каждое из разных положений, или
камера (10) выполнена с возможностью перемещения автоматически в каждое из разных положений, при этом аппарат (1) дополнительно включает в себя в себя блок управления и приводной блок, функционально соединенный с блоком управления, для автоматического перемещения камеры (10) в разные положения.
4. Аппарат (1) по любому из предшествующих пунктов, включающий в себя сопрягаемую часть (70) для накрывания отверстия (13) и зацепления с ним в положении обжаривания для закрытия и герметизации камеры (10) для обжаривания кофейных зерен.
5. Аппарат (1) по п. 4, в котором отверстие (13) расположено таким образом, что, когда камера (10) перемещается в положение обжаривания, отверстие (13) перемещается к ","A23N12/10, A23F5/04, A47J31/00",20250819,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023386299A1,Multilayer metallized paper-based packaging material,"The present invention relates to an oxygen-barrier substrate comprising or consisting of a graft copolymer comprising a vinyl alcohol polymer backbone and polypeptide branches. The present invention also relates to a packaging material comprising at least one oxygen-barrier layer comprising or consisting of a graft copolymer comprising a vinyl alcohol polymer backbone and polypeptide branches, in particular a multi-layer metallized paper-based packaging material.","<div class=""indep-clm"" num=""1""><seg-main>1. An oxygen-barrier substrate comprising </seg-main><seg-clauses>or consisting of a graft copolymer comprising a vinyl alcohol polymer backbone and polypeptide branches.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The oxygen-barrier substrate according to claim 1, wherein </seg-main><seg-clauses>the vinyl alcohol polymer backbone is polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, preferably wherein the vinyl alcohol polymer backbone is polyvinylalcohol (PVOH).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The oxygen-barrier substrate according to claim 1 or 2, wherein </seg-main><seg-clauses>the polypeptide is collagen or a hydrolysed form thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The oxygen-barrier substrate according to any preceding claim, wherein </seg-main><seg-clauses>the polypeptide branches are coupled to the vinyl alcohol polymer backbone by a linker, optionally wherein the graft copolymer comprises the following formula: 3olypeptide</seg-clauses>
<seg-clauses class=""seg-enter"">, Linker</seg-clauses>
<seg-clauses class=""seg-enter"">O</seg-clauses>
</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The oxygen-barrier substrate according to any preceding claim, wherein </seg-main><seg-clauses>the polypeptide branches are coupled to the vinyl alcohol polymer backbone by a polycarboxylic acid or an anhydride thereof, optionally wherein the graft copolymer comprises the following formula:</seg-clauses>
</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The oxygen-barrier substrate according to any preceding claim, wherein </seg-main><seg-clauses><seg-main>the polypeptide branches are coupled to the vinyl alcohol polymer backbone by:</seg-main>
<seg-clauses>(a) a tricarboxylic acid or an anhydride thereof; optional","C08F8/30, B32B27/10, B32B27/30, C08F8/32",20250417,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
KR1020250083570A,Packaged ambient coffee beverage with aerated texture upon hand shaking,밀폐 용기 내의 커피 음료로 본질적으로 이루어진 음료가 개시된다.  음료는 흔듦으로써 거품이 형성되어 쾌적한 에어레이션 질감/입안 느낌을 제공할 수 있다.,"<div class=""indep-clm"" num=""1"">청구항 1</div>
<div class=""indep-clm"" num=""1"">본원 발명의 상세한 설명에 기재된 모든 발명.</div>","A23F5/24, A23C9/152, A23C9/156, A23F5/44",20250610,소시에떼 데 프로듀이 네슬레 소시에떼아노님,['Pending']
EP4640046A2,Systems and methods for animal health monitoring,"The present disclosure provides systems and methods for animal health monitoring. Load data can be obtained from an animal monitoring device including three or more load sensors associated with a platform carrying contained litter there above, wherein individual load sensors of the three or more load sensors are separated from one another and receive pressure input from the platform independent of one another, wherein the three or more load sensors individually sample loads at from 2.5 Hz to 110 Hz. An animal behavior property associated with the animal can be recognized if it is determined based on load data that the interaction with the contained litter was due to the animal interaction with the contained litter. The animal behavior property can be classified into an animal classified event using a machine learning classifier.","<div class=""indep-clm"" num=""1""><seg-con>1.  A method of identifying a cat, under the control of at least one processor, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>obtaining load data from an animal monitoring device including a plurality of load sensors associated with a platform carrying contained litter thereabove; processing the load data to determine an animal behavior property associated with an interaction of the cat with the contained litter; analyzing the load data to identify a movement pattern of the cat, wherein the movement pattern comprises at least one of distance covered, speed, acceleration, direction of movement, or alignment within the litter box; classifying the movement pattern into a cat-specific signature using a machine learning classifier, wherein the classification includes applying a phase separation algorithm to distinguish the movement pattern from those of other cats; and identifying the specific cat based on the cat-specific signature.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the movement pattern further comprises identifying a preferred quadrant of the litter box based on the percentage of total observations in each quadrant.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.  The method of claim 1 or 2, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>generating a notification indicating the identification of the specific cat, wherein the notification is transmitted to a client device associated with the cat's owner.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  The method of any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the phase separation algorithm is capable of distinguishing between multiple discrete animal eliminations, including both urination and defecation events.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,",A01K1/01,20251029,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250313402A1,Beverage or foodstuff container and preparation system,"The invention concerns container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including: a storage portion for containing a precursor material, a closing member to close the storage portion and an annular flange-like rim made of cellulose pulp-based material, the flange-like rim comprising an annular force ring and at least two distinct additional portions, namely-a first portion (<b>61</b>) connected to the annular force ring (<b>63</b>); and-a second portion (<b>62</b>) extending from the storage portion (<b>58</b>) on which the closing membrane (<b>56</b>) is sealed, said second portion (<b>62</b>) connecting the storage portion (<b>58</b>) and the closing membrane (<b>56</b>). The invention also concerns a set of different containers is also proposed as well as a container system and a system comprising a container and a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-con>1. A container designed for insertion in and use with a preparation machine for preparing a beverage and/or foodstuff or a precursor thereof from a precursor material stored in the container by introducing liquid in the container and passing liquid through the precursor material, the container </seg-con><seg-trans>including:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a cup-shaped body comprising a bottom end and an open end, the cup-shaped body forming a storage portion for containing the precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing membrane to close the storage portion at the open end of the cup-shaped body; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an annular flange-like rim at least partially engaging with a closing member of the beverage preparation machine, said annular flange-like rim being made of cellulose pulp-based material and extending outwardly from the cup-shaped body, the flange-like rim comprising an annular force ring,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the flange-like rim further comprises at least two distinct portions,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first portion connected to the annular force ring; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a second portion extending from the storage portion on which the closing membrane is sealed, said second portion connecting the storage portion and the closing membrane.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the flange-like rim including the first portion, the second portion and the annular force ring, is integral with the cup-shaped body.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the first and second porti","B65D85/804, A47J31/40, A47J31/46, A47J31/52",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250344725A1,beverage,,,"A23L2/60, A23L2/66, A23L2/68, A23L33/155, A23L33/16",20251113,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
JP2025121900A,Engineered lipase variants,"To provide engineered lipase polypeptides and compositions thereof.SOLUTION: Engineered lipase polypeptides according to the invention have been optimized to provide improved thermostability, protease stability, and stability under a wide range of pH conditions, including acidic (pH<7) and basic (pH>7) conditions. The invention also relates to use of compositions comprising the engineered lipase polypeptides for therapeutic and/or nutritional purposes. Further provided are polynucleotides encoding the engineered lipase polypeptides, as well as methods for producing the engineered polynucleotides and lipase polypeptides.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 配列番号２に対して少なくとも７０％、少なくとも７５％、少なくとも８０％、少なくとも８５％、少なくとも９０％、少なくとも９１％、少なくとも９２％、少なくとも９３％、少なくとも９４％、少なくとも９５％、少なくとも９６％、少なくとも９７％、少なくとも９８％、または少なくとも９９％の配列同一性を含むアミノ酸配列を含む組換えリパーゼ。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記組換えリパーゼが、配列番号９４、３５０、４４２、５４０、６４６、７５８および／または８６８に対して少なくとも８５％、８６％、８７％、８８％、８９％、９０％、９１％、９２％、９３％、９４％、９５％、９６％、９７％、９８％、９９％またはそれを超える配列同一性を有するポリペプチド配列を含む、請求項１に記載の組換えリパーゼ。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 前記組換えリパーゼが、配列番号２に対して少なくとも８５％、８６％、８７％、８８％、８９％、９０％、９１％、９２％、９３％、９４％、９５％、９６％、９７％、９８％、９９％またはそれを超える配列同一性を有するポリペプチド配列を含み、前記ポリペプチド配列は、２、３、４、２２、２７／４６／９７／１３６／１４９／３８５、２７／４６／３８５、２７／７０／１３６／２３１／３８５、２７／１３６／３２３／３８５、２７／１４９、２７／１４９／３８５、２７／３８５、３４、３８、４１、４４、４６／７０、４６／１４９／１８３／２３１／３８５、４８、７０、７３、７３／３０５、８２、８２／９４／１０１／１９４／１９９、８２／９４／１９９、８３、８５、８７、８９、９２、９４、９６、９７／１４９／３８５、１３５、１３６／３８５、１４０、１４１、１４２、１４４、１４６、１４９、１４９／２３１／３８５、１５１、１７４、１７５、１７８、１８１、１８３／３８５、１８９、１９４、１９４／１９９、１９５、１９５／２３１／３８５、１９９、１９９／２１３、２１０、２１２、２１３、２１３／３３０、２１６、２１８、２１９、２２６、２３１／３８５、２３８、２４７、２５０、２７０、２７４、２８１、２９２、２９６、３００、３０８、３３０、３３８、３７９および３８５から選択される１またはそれを超える位置に少なくとも１つの置換または置換の組を含み、前記ポリペプチド配列のアミノ酸位置は、配列番号２を参照して付番されている、請求項１に記載の組換えリパーゼ。 </div>
<div class=""dep-clm"" num=""4"" parent=""1"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1""> 前記組換えリパーゼが、配列番号９４に対して少なくとも８５％、８６％、８７％、８８％、８９％、９０％、９１％、９２％、９３％、９４％、９５％、９６％、９７％、９８％、９９％またはそれを超える配列同一性を有するポリペプチド配列を含み、前記ポリペプチド配列は、３／４／９６／２９６／３００、３／２９２／２９６、４、４／１１／１４９／２９２／２９６／３００、４／９６／１４９／２３１／２９６／３００、４／９６／１４９／２９２／２９６／３００、４／９６／２１９／２９６、４／９６／２３１／２９６／３００、４／９６／２９２／２９６／３００、４／１４９／１７４、４／１７４／２１９／２９２／２９６、４／２３１／２９６／３００、２７、２７／３４／８２、２７／７３／８２／２１８、２７／８９、２７／８９／１７８、２７／８９／２１８、２７／２１８、３４／７３／２１８、３４／８２、３４／２１８、７３／８２、７３／８２／１８３、９４／１４６／１７５、９６／１４９／１７４／２９２／２９６、９６／１４９／２３１／２９２／２９６、９６／１４９／２９２／２９６、９６／１７４／２１９／２３１／２９２／２９６、９６／２３１／２９６、１４６／１７５／１８９／２８１、１４９／１７４／２９２／２９６、１４９／１７４／３００、１４９／２１９／２３１／２９２／２９６／３００、１４９／２３１／２９２／２９６、１４９／２３１／２９２／２９６／３００、１４９／２９６、１４９／２９６／３００、１７４／２３１、１７４／２９","C12N9/20, C12N15/55",20250820,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
CN120583902A,Beverage preparation using rotating impeller,"A device (1) configured for processing at least one beverage ingredient fluid (21, 22). The device (1) has: a machining surface (10, 10A, 10B) which can be rotated about an axis of rotation (10 '); an actuator (20) configured to actuate the machining surface (10, 10A, 10B) to rotate about the axis of rotation (10 '); at least one fluid input line (30, 30A, 30B, 31, 32, 33) having a fluid delivery aperture (30 ', 30A', 30B ') configured to deliver the beverage ingredient fluid (21, 22) to the processing surface (10, 10A, 10B); and at least one fluid output line (40, 40B) having a receiving aperture (40 ', 40B') configured to direct a fluid (41) away from the machining surface (10, 10A, 10B). The machining surface (10, 10A, 10B) has a central region (11, 11A, 11B) at the axis of rotation (10 ') and a peripheral region (12, 12A, 12B) remote from the axis of rotation (10') so as to extend between the central region (11, 11A, 11B) and the peripheral region (12, 12A, 12B). The central region (11, 11A, 11B) is positioned closer to the or each fluid delivery aperture (30 ', 30A') than the or each receiving aperture (40 ', 40B').","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于加工至少一种饮料配料流体(21,22)的装置(1)，所述装置</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-流体加工表面(10,10A,10B)，所述流体加工表面能够围绕旋转轴线(10')旋转，任选地，所述加工表面(10,10A,10B)连续延伸或者设置有一个或多个中断部分，诸如凸部或凹部，例如通孔(101)和/或盲孔(102)；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-致动器(20)，例如马达，诸如电动马达，所述致动器被配置成例如经由机械联接器和/或磁性联接器致动所述加工表面(10,10A,10B)以围绕所述旋转轴线(10')旋转，任选地，所述致动器(20)被配置成致动所述加工表面(10,10A,10B)，以使所述加工表面(10,10A,10B)以在500RPM至25000RPM，诸如1000RPM至20000RPM，例如2000RPM至18000RPM，例如3000RPM至16000RPM的范围内的速度围绕所述旋转轴线(10')旋转；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-至少一条流体输入管线(30,30A,30B,31,32,33)，所述至少一条流体输入管线具有流体输送孔(30',30A',30B')，所述流体输送孔被构造成将所述饮料配料流体(21,22)输送到所述加工表面(10)，任选地，所述流体输入管线(30,30A,30B,31,32,33)中的每条管线均具有此类输送孔(30',30A',30B')，例如，所述饮料配料流体(21,22)作为单个配料或作为配料的组合来输送；和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-至少一条流体输出管线(40,40B)，所述至少一条流体输出管线具有接收孔(40',40B')，所述接收孔被构造成引导流体(41)远离所述加工表面(10,10A,10B)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>此类装置(1)任选地还包括热调节器，诸如加热器和/或冷却器，所述热调节器被构造成在由所述输送孔输送时以及在由所述接收孔(40',40B')接收之前热调节所述饮料配料流体(21,22)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其特征在于，所述加工表面(10,10A,10B)具有在所述旋转轴线(10')处的中心区域(11,11A,11B)和远离所述旋转轴线(10')的周边区域(12,12A,12B)，以便在所述中心区域(11,11A,11B)和所述周边区域(12,12A,12B)之间延伸，所述中心区域(11,11A,11B)被定位成相比于所述或每个接收孔(40',40B')更靠近所述或每个流体输送孔(30',30A',30B')，任选地，所述或至少一个或全部流体输送孔(30',30A',30B')面向所述加工表面(10,10A,10B)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的装置，其中所述加工表面(10,10A,10B)基本上平面地或锥形地或球形地或椭圆形地从所述中心区域(11,11A,11B)延伸到所述周边区域(12,12A,12B)，任选地，所述加工表面(10,10A,10B)基本上具有以下的形状：平坦圆盘；球形或椭圆形盖；或者带有钝角孔径角的锥形表面，例如至少120度，诸如至少135度，例如至少150度，例如至少165度的钝角。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的装置，所述装置包括多个不同的加工表面(10,10A,10B)，每个加工表面均由此类流体加工表面形成，两个此类不同的加工表面(10,10A,10B)各自具有在所述旋转轴线(10')处的对应的中心区域(11,11A,11B)和远离所述旋转轴线(10')的对应的周边区域(12,12A,12B)，以便在其中心区域(11,11A,11B)和其周边区域(12,12A,12B)之间延伸，两个此类不同的加工表面(10,10A,10B)各自与至少一条对应的流体输入管线(30","A47J31/41, A47J31/40, A47J31/44",20250902,雀巢产品有限公司,['Pending']
US20250049089A1,Secretory iga-biotic complexes and uses thereof,"The present invention relates to complexes between secretory immunoglobulin A (sIgA) and biotic including probiotics, their components and/or inanimate preparations of said beneficial bacteria and/or postbiotics to promote controlled immune responses to prevent and/or treat viral infections in a mammal.","<div class=""indep-clm"" num=""1""><seg-con>1. A composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a secretory immunoglobulin A-biotic (sIgA-biotic) complex.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said biotic is a bacterium, its components and/or inanimate preparations of said bacterium.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The composition according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said bacterium is a <i>Bifidobacterium </i>or a <i>Lactobacillus. </i></seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. The composition according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said bacterium is a <i>Bifidobacterium. </i></seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""2""><seg-con>5. The composition according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said <i>Bifidobacterium </i>is selected from the group consisting of <i>Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium juvenis, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium adolescentis </i>and <i>Bifidobacterium animalis. </i></seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""2""><seg-con>6. The composition according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said bacterium is a <i>Lactobacillus. </i></seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""2""><seg-con>7. The composition according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said <i>Lactobacillus </i>is selected from the group consisting of <i>Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus salivarius </i>and <i>Lactobacillus johnsonii. </i></seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><s","A23L33/135, A23L33/00, A23L33/18",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250049754A1,Compositions comprising urolithin for treating muscle decline and a kidney dysfunction,"The present disclosure generally relates to methods and compositions comprising urolithin that treat or prevent a disease or condition associated with muscle decline and/or a kidney dysfunction. Moreover, methods and compositions comprising urolithin for increasing the urinary creatinine and/or for decreasing the albumin/creatinine ratio and/or for increasing the albumin reabsorption. In addition, methods and compositions comprising urolithin to improve the lean mass of a muscle and/or to improve the muscle fiber size and/or to improve the level of at least one amino acid are disclosed. Also disclosed are methods and compositions comprising urolithin to improve the level of at least one metabolic product and/or to improve the level of at least one nucleotide and/or to improve the level of at least one nicotinamide adenine dinucleotide and/or to increase the level of glutathione (GSH) and/or glutathione disulfide (GSSG) and/or to increase the level of succinate and/or malate and/or to increase the level of phosphocreatine.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of treating and/or preventing a disease or condition associated with muscle decline and/or a kidney dysfunction, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a subject in need thereof an effective amount of a composition comprising urolithin or an urolithin or a pharmaceutically acceptable salt thereof.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the disease or condition is selected from the group consisting of chronic kidney disease, metabolic induced muscle wasting, end-stage renal disease, dialysis, diabetes, muscle loss and/or kidney failure due to hospitalization in the intensive care unit, Pompe disease, metabolic acidosis, methylmalonic aciduria, disuse atrophy, protein-energy wasting and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the muscle decline and/or the kidney dysfunction is treated and/or prevented in an early stage of chronic kidney disease and/or a late stage of chronic kidney disease.</seg-refi></div>
<div class=""ccl-clm"" num=""4"">4. (canceled)</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising urolithin or urolithin or a pharmaceutically acceptable salt thereof is administered enterally.</seg-refi></div>
<div class=""ccl-clm"" num=""6"">6. (canceled)</div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising urolithin or the urolithin or a pharmaceutically acceptable salt thereof is administered in a composition selected from the group consisting of a food product, a food for special medical purposes (FSMP), a nutritional supplement, a dairy-ba","A61K31/37, A61P13/12",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025132298A1,Compositions for promoting sleep in a young individual,"The present disclosure generally relates to compositions and methods for use in promoting sleep associated with increase of propionate, in a young individual. Some embodiments are directed to a composition comprising a combination of galacto-oligosaccharide (GOS), Vitamins B1, B2 and B6, minerals zinc, iron and copper, and amino acids histidine, isoleucine, lysine, and leucine for use in promoting sleep in a young individual via increase of propionate.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A composition for use in promoting sleep in a young individual comprising </seg-main><seg-clauses>a combination of at least one galacto-oligosaccharide (GOS) and at least three ingredients selected from vitamin Bl, vitamin B2, vitamin B6, zinc, iron, copper, histidine, isoleucine, lysine, leucine.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>it comprises at least one galacto-oligosaccharide (GOS) in a daily amount ranging from about 0.001 to about 12 g and at least three ingredients selected from</seg-main>
<seg-clauses>- vitamin Bl in a daily amount ranging from about 0.8 to about 2 mg;</seg-clauses>
<seg-clauses>- vitamin B2 in a daily amount ranging from about 1 to about 3 mg;</seg-clauses>
<seg-clauses>- vitamin B6 in a daily amount ranging from about 0.9 to about 5 mg;</seg-clauses>
<seg-clauses>- zinc in a daily amount ranging from about 6 to about 13 mg;</seg-clauses>
<seg-clauses>- iron in a daily amount ranging from about 8 to about 29 mg;</seg-clauses>
<seg-clauses>- copper in a daily amount ranging from about 0.6 to about 1.1 mg;</seg-clauses>
<seg-clauses>- histidine in a daily amount ranging from about 0.2 to about 1 g;</seg-clauses>
<seg-clauses>- isoleucine in a daily amount ranging from about 0.3 to about 2 g;</seg-clauses>
<seg-clauses>- lysine in a daily amount ranging from about 0.4 to about 3 g;</seg-clauses>
<seg-clauses>- leucine in a daily amount ranging from about 0.6 to about 4 g;</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition for use according to claim 1, wherein </seg-main><seg-clauses>the young individual is an infant, a toddler, a young child or a child.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according to any one of the preceding claims, wherein </seg-main><","A61K31/702, A61K31/198, A61K31/4178, A61K31/4415, A61K31/51",20250626,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2024266636A1,Method for brewing coffee,"The invention concerns a method to prepare de filter coffee with a full automatic coffee machine (100) comprising : - a brewing chamber (1), an upper piston (2), a lower piston (3) movable inside said brewing chamber (1), wherein the brewing chamber and/or the upper piston are relatively movable between at least two different first and second closed positions configured for brewing roasted and ground coffee powder, wherein the first closed position is configured for compacting coffee during brewing and the second closed position defines the largest possible closed volume of the brewing chamber, - a water fluid system comprising at least a water supply (101) and a water pump (102) wherein said system is connected to the water inlet (13) of the coffee extraction unit, wherein the method comprises the steps of : - moving the chamber (1) and the upper piston (2) relatively one to the other to the second closed position defining the largest possible closed volume of the brewing chamber, then - supplying pumped water in pulses.","<div class=""indep-clm"" num=""1""><seg-main>1. A method to prepare a filter coffee with a full automatic coffee machine (100), said machine comprising </seg-main><seg-clauses><seg-main>a coffee extraction unit (10), said coffee extraction unit comprising :</seg-main>
<seg-clauses>- a brewing chamber (1) for receiving roasted and ground coffee powder, said chamber comprising an upper rim (12) and a bottom wall (11), and</seg-clauses>
<seg-clauses>- an upper piston (2), said upper piston being configured to be movable through the upper rim of the brewing chamber and inside the brewing chamber further to the relative movement of the brewing chamber and the upper piston, and</seg-clauses>
<seg-clauses>- a water inlet (13),</seg-clauses>
<seg-clauses>- a liquid outlet duct (21) guiding extracted coffee beverage to a dispensing area (106),</seg-clauses>
<seg-clauses>- a lower piston (3) movable inside said brewing chamber (1) between :</seg-clauses>
<seg-clauses class=""seg-enter"">. a lowest position wherein the lower piston lies at the bottom (11) of the brewing chamber, and</seg-clauses>
<seg-clauses class=""seg-enter"">. a highest position wherein the lower piston is at the upper rim (12) of the brewing chamber,</seg-clauses>
<seg-clauses>- a discharge device (4) for spent coffee,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the brewing chamber and/or the upper piston are relatively movable between :</seg-clauses>
<seg-clauses class=""seg-enter"">. an open position for introducing roasted and ground coffee powder or ejecting extracted roasted and ground coffee powder, where the upper piston (2) is at a distance from the upper rim (12) of the chamber and outside the chamber, and</seg-clauses>
<seg-clauses class=""seg-enter"">. different closed positions configured for brewing roasted and ground coffee powder,</seg-clauses>
<seg-clauses>- a water fluid system comprising at least a water supply (101), a water pump (102), and preferably a water heating device (104), wherein ","A47J31/00, A47J31/36",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024263790A1,Method for producing milk like products,"The invention provides isolated human breast milk exosomes, and compositions thereof. The present invention also provides in vitro methods for producing said exosomes comprising generating lactocytes derived from human induced pluripotent stem cells (hiPSC), expressing the human milk like product from lactocytes, and purifying the exosomes from the human milk like product.","<div class=""indep-clm"" num=""1""><seg-main>1. An isolated human breast milk exosome, wherein </seg-main><seg-clauses>the exosome does not comprise one or more proteins selected from C4a anaphylatoxin (CFA), Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4), Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1), Threonine—tRNA ligase 1, cytoplasmic (TARSI), and Cytosolic non-specific dipeptidase (CNDP2).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The exosome of claim 1, wherein </seg-main><seg-clauses>the exosome comprises lactotransferrin (LTF), annexin A2 (ANXA2) and lactadherin (MFGE8), MUC1 and tetraspanins CD9, CD81 and CD63.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The exosome of claim 1 or 2, wherein </seg-main><seg-clauses>the exosome comprises one or more miRNAs selected from miR-148a-3p, miR-22-3p, miR-125b-5b and miR-6126.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more lipids selected from cholesterol esters, ceramides, triacylglycerides, diacylglycerides, lyso-phospholipids, total phospholipids, alkanyl phospholipids, and alkenyl phospholipids.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more phospholipids selected from sphingomyelins, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome has a diameter of 50 to lOOnm.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-main>7.    The exosome of claim 6, wherein </seg-main><seg-clauses>the exosome hasa diameter size of 65 to 75nm.</seg-clauses></div>
<div","C12N5/071, A61K35/20",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250222685A1,A tridimensional biodegradable container with improved sensory properties,"The present invention concerns a tridimensional hollow container for containing an edible product, said container having a body formed of a first polymeric layer formed of poly hydroxyalcanoate (PHA) having a thickness comprised between 50 μm and 1.5 mm, and wherein: (i) said container body comprises a second layer deposited onto the internal surface of said first layer, and comprising a metalloid, a carbon thin film, or a combination thereof, said second layer having a thickness lower than 100 nm, and (ii) said container body further comprises an intermediate polymeric layer located between said first and second layers, said intermediate layer having a root mean square roughness value (“RMS”) below 20 nm, said intermediate layer having a thickness comprised between 1 and 100 μm.","<div class=""indep-clm"" num=""1""><seg-main>1. A tridimensional hollow container for containing </seg-main><seg-clauses><seg-main>an edible product, said container having a body formed of a first polymeric layer, said first layer being formed of polyhydroxyalcanoate (PHA) having a thickness between 50 μm and 1.5 mm, and wherein:</seg-main>
<seg-clauses>(i) said container body comprises a second layer deposited onto the internal surface of said first layer, said second layer comprising a metalloid, a carbon thin film, or a combination thereof, said second layer having a thickness lower than 100 nm, and</seg-clauses>
<seg-clauses>(ii) said container body further comprises an intermediate polymeric layer located between said first and second layers, said intermediate layer having a roughness mean square value (“RMS”) below 20 nm, said intermediate layer having a thickness comprised between 1 and 100 μm.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A container according to claim 1, wherein </seg-main><seg-clauses>said metalloid is selected from the group consisting of silicon oxide (SiOx), boron trioxide (B<sub>2</sub>O<sub>3</sub>), germanium dioxide (GeO<sub>2</sub>), and a combination thereof, and the carbon film is a diamond-like carbon (DLC).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A container according to claim 1, wherein </seg-main><seg-clauses>said intermediate layer comprises a polymer selected from the group consisting of: polyethylene terepthalate (PET), polylactic acid (PLA), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polybutylene adipate-terephthalate (PBAT), poly-glycolic acid (PGA), starch (TPS), polycaprolactone (PCL), and a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A container according to claim 1, wherein </seg-main><seg-clauses>said intermediate layer is a co-extruded layer of a polybutylene succinate-co","B32B27/36, B32B1/00, B32B27/08",20250710,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024264071A1,Compositions and methods for improving immune health,"Methods and compositions improve immune health. A method for improving immune health includes administering to an individual in need thereof a composition comprising milk protein, preferably 20-40 % by dry weight of the composition; and a mixture of lactose, glucose, galactose and galactooligosaccharide, preferably 32-55% by dry weight of the composition. The mixture of lactose, glucose, galactose, and galactooligosacchride can contain 0.1-30% by weight of the lactose, 8-40% by weight of 32-55% by dry weight of the glucose, 0.1-20% by weight of the galactose and 40-90% by weight of the galactooligosaccharide.","<div class=""indep-clm"" num=""1""><seg-main>Claim 1: A method for improving immune health, the method comprising </seg-main><seg-clauses>administering to an individual in need thereof a low sugar, low lactose, milk-based composition comprising galactooligosaccharide.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>Claim 2: The method of claim 1, wherein </seg-main><seg-clauses><seg-main>the milk-based composition comprises: milk protein, preferably at 20-40 % by dry weight of the composition; and</seg-main>
<seg-main class=""seg-enter"">a mixture of lactose, glucose, galactose and galactooligosaccharide, the mixture preferably at 32-55% by dry weight of the composition;</seg-main>
<seg-main class=""seg-enter"">preferably, the mixture comprising: </seg-main><seg-clauses>0.1-30% by weight of the lactose, 8-40% by weight of the glucose, 0.1-20% by weight of the galactose and 40-90% by weight of the galactooligosaccharide.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>Claim 3: The method of claim 1 or claim 2, wherein </seg-main><seg-clauses><seg-main>the improving of immune health comprises at least one result selected from the group consisting of: </seg-main><seg-clauses>(a) protection from infections, such as viral respiratory infections; </seg-clauses><seg-clauses>(b) protection against pathogens; </seg-clauses><seg-clauses>(c) reducing inflammation; </seg-clauses><seg-clauses>(d) preventing and/or attenuating oxidative stress; </seg-clauses><seg-clauses>(e) improving intestinal barrier; </seg-clauses><seg-clauses>(f) reducing intestinal permeability; </seg-clauses><seg-clauses>(g) promoting growth of Bifidobacterium', </seg-clauses><seg-clauses>(h) increasing Bifidobacterium shunt pathway; </seg-clauses><seg-clauses>(i) increasing NAD salvage pathway; and </seg-clauses><seg-clauses>(j) preventing and/or treating allergic asthma, </seg-clauses><seg-clauses>(k) promoting immune homeostasis; </seg-clauses><seg-cla","A23L33/125, A61K31/7004, A61K31/7016, A61K31/702, A61P1/00",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120112177A,Reduction of broad bean pyrimidine glucoside and/or concomitant broad bean pyrimidine nucleosides in broad bean ingredients and food products,"The invention relates to a method for reducing the content of broad bean pyrimidine glucoside and/or broad bean pyrimidine nucleoside in broad bean components. A liquid broad bean-based component is provided, and then at least one broad bean pyrimidine glucoside and/or a broad bean pyrimidine nucleoside degrading enzyme is added to the liquid broad bean-based component having a pH of 6.0 or higher. The broad bean-based ingredient is then incubated with the at least one broad bean pyrimidine glucoside and/or broad bean pyrimidine nucleoside degrading enzyme. The invention also relates to a broad bean-based ingredient, a food product prepared with a broad bean-based ingredient and a method for producing such a food product.","<div class=""indep-clm"" num=""1""><seg-con>1.降低蚕豆类成分中的蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷含量的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)提供为液体的蚕豆类成分或将蚕豆类成分悬浮于水性液体中以形成为液体的蚕豆类成分，其中所述蚕豆类成分包含蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)向所述蚕豆类成分中添加至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶，其中所述蚕豆类成分具有6.0或更高的pH，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>c)将所述蚕豆类成分与所述至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶一起孵育以获得经处理的蚕豆类成分，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>d)任选地，使所述经处理的蚕豆类成分中的所述蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶部分或完全失活，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>e)任选地，冷却所述经处理的蚕豆类成分。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述蚕豆类成分具有介于pH 6.0与pH 9.0之间的pH。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的方法，其中所述蚕豆类成分是全蚕豆、蚕豆粉、蚕豆蛋白浓缩物或蚕豆蛋白分离物。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的方法，其中所述至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶选自由以下项组成的列表：β-葡糖苷酶、具有β-葡糖苷酶副活性的酶或其混合物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的方法，其中所述至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶是具有与选自以下的一个或多个氨基酸序列至少70％相同的氨基酸序列的一种或多种β-葡糖苷酶：SEQ ID NO：1、SEQ NO：2、SEQ NO：3、SEQ NO：4和SEQ IDNO：5。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的方法，其中所述至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶包括来自杏仁的蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的方法，一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶包括来自海栖热袍菌(Thermotoga maritima)的蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的方法，其中在步骤c)中通过所述至少一种蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷降解酶将所述蚕豆类成分中的蚕豆嘧啶葡糖苷和/或伴蚕豆嘧啶核苷的含量降低至少30％，优选至少50％。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的方法，所述方法包括在步骤e)之后干燥所述经处理的蚕豆类成分以获得为粉末的蚕豆类成分的步骤。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的方法，其中在步骤a)中将至少1重量％的蚕豆类成分悬浮于所述水性液体中。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的方法，其中将孵育的步骤c)进行少于2小时。</div>
<div cla","A23L11/30, A23L11/00, A23L5/20, C12N9/42, A23J3/14",20250606,雀巢产品有限公司,['Pending']
CN119730733A,Kit for promoting developmental myelination,"The present invention relates to a kit of nutrient blend compositions for young individuals, in particular children between 0 and 66 months of age, each of these compositions having age-specific ingredients. The kit of nutrient blend compositions is particularly intended to promote myelination of a targeted brain region, in particular of the social brain, of children at a specific age and brain development stage.","<div class=""indep-clm"" num=""1"">1.按年龄定制的营养物质共混组合物的套盒，所述营养物质共混组合物用于依次施用于年幼个体以用于促进目标脑区域的髓鞘形成，所述套盒包括以下组合物中的至少两种组合物：</div>
<div class=""indep-clm"" num=""1"">a)用于施用于0至20个月年龄的年幼个体的营养物质共混组合物A，所述营养物质共混组合物A包含选自以下的至少三种成分：</div>
<div class=""indep-clm"" num=""1"">维生素B1、维生素B2、维生素B6、锌、铁、铜、组氨酸、异亮氨酸、赖氨酸、亮氨酸、维生素A、叶酸盐、镁、磷、钾、硒、3'-SL、丙氨酸、胱氨酸、谷氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、酪氨酸、缬氨酸；</div>
<div class=""indep-clm"" num=""1"">b)用于施用于20至30个月年龄的年幼个体的营养物质共混组合物B，所述营养物质共混组合物B包含选自以下的至少三种成分：</div>
<div class=""indep-clm"" num=""1"">DPA、ARA、鞘磷脂、磷脂酰胆碱、十八碳四烯酸、低聚果糖、6'-SL、硬脂四烯酸、β隐黄质、α乳白蛋白、神经节苷脂、磷脂酰肌醇、3'-SL、二十碳四烯酸；</div>
<div class=""indep-clm"" num=""1"">c)用于施用于30至66个月年龄的年幼个体的营养物质共混组合物C，所述营养物质共混组合物C包含选自以下的至少三种成分：</div>
<div class=""indep-clm"" num=""1"">DHA、鞘磷脂、磷脂酰胆碱、组氨酸、异亮氨酸、亮氨酸、缬氨酸、α胡萝卜素、叶酸、α乳白蛋白、神经节苷脂、磷脂酰肌醇、磷脂酰乙醇胺、二十碳烯酸、硬脂四烯酸、DPA、3'-SL、</div>
<div class=""indep-clm"" num=""1"">6'-SL、丙氨酸、精氨酸、天冬氨酸、胱氨酸、谷氨酸、甘氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、色氨酸、酪氨酸、α生育酚、十八碳四烯酸、二十碳五烯酸、磷、磷脂酰丝氨酸。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的套盒，其中</div>
<div class=""dep-clm"" num=""2"" parent=""1"">a)所述营养物质共混组合物A用于施用于6至20个月年龄的年幼个体；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">b)所述营养物质共混组合物B用于施用于20至30个月年龄的年幼个体；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">c)所述营养物质共混组合物C用于施用于30至60个月年龄的年幼个体。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的套盒，其中</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">a)所述组合物A包含选自以下的至少三种成分：维生素B1、维生素B2、维生素B6、锌、铁、铜、组氨酸、异亮氨酸、赖氨酸、亮氨酸；</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">b)所述组合物B包含选自以下的至少三种成分：DPA、ARA、鞘磷脂、磷脂酰胆碱、十八碳四烯酸、低聚果糖、6'-SL；</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">c)所述组合物C包含选自以下的至少三种成分：DHA、鞘磷脂、磷脂酰胆碱、组氨酸、异亮氨酸、亮氨酸、缬氨酸。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的套盒，其中</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">a)所述组合物A包含选自以下的至少三种成分：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">-每日量为至少约0.8mg的维生素B1；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">-每日量为至少约1mg的维生素B2；</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">-每日量为至少约0.9mg的维生素B6；</div>
<div class=""dep-clm"" num=""","A23L33/12, A23L33/15, A23L33/155, A23L33/175, A23L33/28",20250328,雀巢产品有限公司,['Pending']
US20250182872A1,Methods using a DNA methylation profile of a canine,The present invention provides a method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising a) providing a DNA methylation profile from a sample obtained from the dog; and b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising:</seg-main>
<seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and</seg-clauses>
<seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for determining a biological age of a dog; said method comprising:</seg-main>
<seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and</seg-clauses>
<seg-clauses>b) determining a biological age for the dog using the DNA methylation profile, wherein the DNA methylation profile is linked to the mortality risk and/or probability of a healthy lifespan for the dog and wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A method for selecting a lifestyle regime, dietary regime or therapeutic intervention for a dog, the method comprising:</seg-main>
<seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog;</seg-clauses>
<seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile, wherein the DNA methylation profile comprises at least one methylation site as listed in Table 1; and</seg-clauses>
<seg-clauses>c) selecting a suitable lifestyle regime, dietary regime or therapeutic intervention for the dog based on the mortality risk and/or probability of a healthy lifespan determined in step b).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A method for determining the efficacy of a lifestyle regime, dietary regime or therapeutic inte","G16H20/10, C12Q1/6806, C12Q1/6827, C12Q1/6874, G16B20/20",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250177458A1,Uses of bifidobacterium longum microorganisms having the capacity to degrade both HMO and plant-derived glycans,The present invention relates to the use of a <i>Bifidobacterium longum </i>transitional microorganism to metabolise one or more glycan substrates selected from the group recited in any of Tables 1 to 3.,"<div class=""ccl-clm"" num=""7"">1-7. (canceled)</div>
<div class=""indep-clm"" num=""8""><seg-con>8. A method of promoting the growth of a <i>Bifidobacterium longum </i>transitional microorganism in the gut microbiota of an infant and/or of a young child, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the infant and/or to the young child a composition comprising one or more glycan substrates selected from the group recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-con>9. A method of promoting/assisting the transition from a milk-based diet to solid food in an infant and/or in a young child, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the infant and/or to the young child a combination of a <i>Bifidobacterium longum </i>transitional microorganism and one or more glycan substrates, wherein the one or more glycan substrates is selected from the groups recited in any of Tables 1 to 3 and the <i>Bifidobacterium longum </i>transitional microorganism is capable of metabolizing said one or more glycan substrates.</seg-refi></div>
<div class=""ccl-clm"" num=""12"">10-12. (canceled)</div>
<div class=""dep-clm"" num=""13"" parent=""8""><seg-con>13. A method according to claim 8, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Bifidobacterium longum </i>transitional microorganism encodes one or more CAZymes selected from the group recited in Table 1.</seg-refi></div>
<div class=""dep-clm"" num=""14"" parent=""8""><seg-con>14. A method according to any claim 8, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Bifidobacterium longum </i>microorganism has an Average Nucleotide Identity (ANI) of at least 98% with at least one <i>Bifidobacterium longum </i>strain selected in the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686 and CNCM I-5687, and any combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""15"" parent=""8""><seg-con>15. A method accordin","A61K35/745, A61K35/00, A61K47/36, C12N1/20, C12R1/01",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
ES3013900T3,Method to check a coffee beans roasting system,"La invención se refiere a un método para comprobar un sistema de tostado (10), comprendiendo dicho sistema: un aparato de tostado (2), produciendo dicho aparato humo, y - una unidad de tratamiento de humo (3) configurada para tratar el flujo de humo producido por el aparato de tostado, y que comprende un dispositivo de filtrado (221) y un par de sensores de temperatura (24, 26) configurados para medir las temperaturas del flujo de humo aguas arriba y aguas abajo del dispositivo de filtrado (221), en donde, durante una operación de tostado, el método comprende los pasos de: - comparar los rendimientos de las temperaturas durante al menos un período de tiempo de la operación de tostado, y - si los rendimientos son similares a lo largo del tiempo, entonces mostrar una alarma.","1. Un método para verificar un sistema de tostado (10) , comprendiendo dicho sistema: - al menos un aparato tostador (2) , produciendo dicho aparato humo durante el calentamiento de los granos de café, y - al menos una unidad de tratamiento de humo (3) configurada para tratar al menos una parte del flujo de humo producido por el al menos un aparato tostador, comprendiendo dicha unidad de tratamiento de humo al menos un dispositivo de filtrado extraíble (221, 222, 223) , - un impulsor de humo (23) configurado para impulsar el humo del aparato tostador (2) a dicho al menos un dispositivo de filtrado, en donde la al menos una unidad de tratamiento de humo (3) comprende al menos un par de unos sensores de temperatura primero y segundo, estando configurado el primer sensor de temperatura (24) para medir la temperatura T del flujo de humo corriente arriba de dicho al menos un dispositivo de filtrado extraíble y el segundo sensor de temperatura (26) configurado para medir la temperatura T2 del flujo de humo corriente abajo de dicho al menos un dispositivo de filtrado extraíble, en donde el método comprende las etapas de: - operar el aparato tostador para producir gas caliente, - monitorear las temperaturas primera y segunda medidas por uno de los pares de unos sensores de temperatura primero y segundo durante al menos un período de tiempo de dicha operación, - observar la diferencia de comportamientos de las temperaturas monitoreadas a lo largo del tiempo, - comparar dicha diferencia de comportamientos observada con una diferencia de comportamientos predeterminada que corresponde a la presencia de dicho al menos un dispositivo de filtrado extraíble entre los dos sensores de temperatura, - si la diferencia de comportamiento observada difiere de la diferencia de comportamientos predeterminada, entonces visualizar una alarma. 2. Método de acuerdo con la reivindicación 1, en donde la etapa de operar el aparato tostador para producir gas caliente es una operación de tostado de ","A23N12/08, A23F5/04, A23N12/12",20250415,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019395755B2,Stable aqueous composition comprising oligosaccharides,The present invention concerns a stable aqueous composition comprising oligosaccharides having a glucose unit at the reducing end and characterised in that the pH of such aqueous composition ranges from 5.5 to 6.5.5,"2019395755  15 Apr 2025
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS :-
<div class=""indep-clm"" num=""1""><seg-main>1. A method of supporting digestive health, gut and/or mucosal maturation and/or immune maturation in an infant who was born by C-section or was 5              born preterm, or who is small for gestational age and/or who had a low or</seg-main>
<seg-main class=""seg-enter"">very low weight at birth (LWB or VLBW), the method comprising </seg-main><seg-clauses>administering the infant an aqueous composition comprising at least one oligosaccharide having a glucose unit at the reducing end and the aqueous composition having pH ranging from 5.5 to 6.5, wherein</seg-clauses>
<seg-clauses class=""seg-enter"">0                     the aqueous composition comprises at least one oligosaccharide</seg-clauses>
<seg-clauses class=""seg-enter"">having a glucose unit at the reducing end at a concentration ranging from 8 to 35 %w/w of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the aqueous composition does 5               not comprise other nutrients in addition to the at least one</seg-clauses>
<seg-clauses class=""seg-enter"">oligosaccharide.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. Use of an aqueous composition in the manufacture of a medicament for supporting digestive health, gut and/or mucosal maturation and/or 20              immune maturation in an infant who was born by C-section or was born</seg-main>
<seg-main class=""seg-enter"">preterm, or who is small for gestational age and/or who had a low or very low weight at birth (LWB or VLBW), wherein </seg-main><seg-clauses>the aqueous composition comprises at least one oligosaccharide having a glucose unit at the reducing end and has pH ranging from 5.5 to 6.5, wherein</seg-clauses>
<seg-clauses class=""seg-enter"">25                     the aqueous composition comprises at least one oligosa","A23L33/21, A23L29/30, A61K31/702, A61P1/00, A61P1/12",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2020296221B2,Roasting apparatus,"The invention concerns an apparatus (10) for roasting coffee beans comprising : - a roasting chamber (1) presenting a bottom opening (11), - an air driver (2) configured to drive a flow of air inside the roasting chamber through the bottom opening of said chamber, - an electrical heater (3) positioned below the bottom opening of the chamber configured to heat said flow of air driven to the bottom opening of the roasting chamber, wherein the apparatus comprises a conduit (6) to drive the flow of hot air from the heater (3) to the bottom opening (11) of the roasting chamber, and wherein said conduit (6) comprises a local transversal constriction (61), and wherein at least one temperature probe is positioned at said local transversal constriction (61) of the conduit.","<div class=""indep-clm"" num=""1""><seg-main>1. Apparatus for roasting coffee beans comprising:</seg-main>
<seg-clauses>- a roasting chamber presenting a bottom opening,</seg-clauses>
<seg-clauses class=""seg-enter"">5   - an air driver configured to drive a flow of air inside the roasting chamber through the bottom</seg-clauses>
<seg-clauses class=""seg-enter"">opening of said chamber,</seg-clauses>
<seg-clauses>- an electrical heater positioned below the bottom opening of the chamber configured to heat said flow of air driven to the bottom opening of the roasting chamber,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the apparatus comprises a conduit to drive the flow of hot air from the heater to the 0 bottom opening of the roasting chamber, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said conduit comprises a local transversal constriction reducing the section of the conduit to a minimum transversal section, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein at least one temperature probe is positioned at said minimum transversal section of the conduit.</seg-clauses>
<seg-clauses class=""seg-enter"">5</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The apparatus according to Claim 1, wherein </seg-main><seg-clauses>said apparatus comprises a controller arranged to control said apparatus, said controller being adapted to control the electrical heater and/or the air driver based on the temperature of the flow of air measured by the at least one temperature probe.</seg-clauses>
<seg-clauses class=""seg-enter"">! 0</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The apparatus according to Claim 1 or 2, wherein </seg-main><seg-clauses>at least two temperature probes are positioned at said minimum transversal section of the conduit, each probe being positioned at different radial positions.</seg-clauses>
<seg-clauses class=""seg-enter"">25   </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><",A23N12/08,20250710,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US12484608B2,Nutritional composition and infant formula for promoting de novo myelination,"A synthetic nutritional composition containing a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for promoting, supporting, or optimizing de novo myelination, brain structure, brain connectivity, intellectual potential, cognitive potential, and/or learning potential and cognitive function in a formula-fed subject, wherein </seg-main><seg-clauses>the formula-fed subject is a human infant or child, wherein the brain structure refers to an amount and/or a spatial distribution of myelinated matter throughout the brain of the formula-fed subject and/or within specific brain regions of the formula-fed subject, and wherein the cognitive function is optimized if scores of the formula-fed subject in a standardized neurodevelopmental test are less than one standard deviation different from that of an exclusively breastfed subject born to a well-nourished mother, the method comprising administering a synthetic nutritional composition comprising a phospholipid, a metabolic precursor, and/or a metabolite thereof to the formula-fed subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the phospholipid is a compound of formula (I) or a mixture of compounds of formula (I)</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/B2/12/48/46/08/1764665051181/US12484608-C00015.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064306%3B1765067906%26q-key-time%3D1765064306%3B1765067906%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Deae273cb63a812d5dce3a0066305406aad84ed1b&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A26%20GMT"" class=""img-anchor"" img-id=""US12484608-C00015"" image_type=""chemistry"" official_size=""2013""></seg-clauses>
<seg-clauses class=""seg-enter"">wherein,</seg-clauses>
<seg-clauses class=""seg-enter"">R<sup>1 </sup>is O;</seg-clauses>
<seg-clauses class=""seg-enter"">X is NH or O;</seg-clauses>
<seg-cla","A23L33/00, A23L33/12, A23L33/15, A23L33/16, A24B15/38",20251202,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019409543B2,Mixed triglyceriges,"A composition comprising a compound having the formula (1), (2), (3), (4) or combinations thereof, wherein n1, n2, n3, n4, n5 and n6 are independently 4 to 10.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a compound having the formula (1), a compound having the formula (2), a compound having the formula (3) and a compound having the formula (4), wherein the compounds having the formula (1), (2), (3) 5 and (4) comprise at least 50% by weight of the total triglycerides in the composition</seg-main>
<seg-clauses>(1)</seg-clauses>



<seg-clauses class=""seg-enter"">wherein n1, n2, n3, n4, n5 and n6 are independently 4 to 10.</seg-clauses>
<seg-clauses class=""seg-enter"">10   </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the compounds having</seg-clauses>
<seg-clauses class=""seg-enter"">formula (1), (2), (3) and (4), comprise at least 60%, 70%, 80%, 90%, 95% or 99% by weight of the total triglycerides of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition according to claim 1 comprising </seg-main><seg-clauses>a compound having the</seg-clauses>
<seg-clauses class=""seg-enter"">15 formula</seg-clauses>

<seg-clauses class=""seg-enter"">2019409543 28 Apr 2025</seg-clauses>



<seg-clauses class=""seg-enter"">or combinations thereof.</seg-clauses>
<seg-clauses class=""seg-enter"">5   </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The composition according to claim 3, wherein </seg-main><seg-clauses>the composition comprises</seg-clauses>
<seg-clauses class=""seg-enter"">the compound having formula (5), the compound having formula (6), the compound having formula (7) and the compound having formula (8).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5. The composition according to claim 3 or claim 4, wherein </seg-main><seg-clauses>the compound 10 having formula (5) comprises 20 to 30% by weight of the total triglycerides of the composition, the compound having formula (6) c","A23D9/02, A61K31/215, C11C3/10",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2024260161A1,Compositions and methods for improving brain health,"A method for improving brain health includes administering to an individual in need thereof a composition comprising milk protein, preferably 20-40 % by dry weight of the composition; and a mixture of lactose, glucose, galactose and galactooligosaccharide, preferably 32-55% by dry weight of the composition. The mixture of lactose, glucose, galactose, and galactooligosacchride can contain 0.1-30% by weight of the lactose, 8-40% by weight of 32-55% by dry weight of the glucose, 0.1-20% by weight of the galactose and 40-90% by weight of the galactooligosaccharide.","<div class=""indep-clm"" num=""1""><seg-main>Claim 1: A method for improving brain health, the method comprising </seg-main><seg-clauses>administering to an individual in need thereof a low sugar, low lactose, milk-based composition comprising galactooligosaccharide.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>Claim 2: The method of claim 1, wherein </seg-main><seg-clauses><seg-main>the milk-based composition comprises: milk protein, preferably at 20-40 % by dry weight of the composition; and</seg-main>
<seg-main class=""seg-enter"">a mixture of lactose, glucose, galactose and galactooligosaccharide, the mixture preferably at 32-55% by dry weight of the composition;</seg-main>
<seg-main class=""seg-enter"">preferably, the mixture comprising: </seg-main><seg-clauses>0.1-30% by weight of the lactose, 8-40% by weight of the glucose, 0.1-20% by weight of the galactose and 40-90% by weight of the galactooligosaccharide.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>Claim 3: The method of claim 1 or claim 2, wherein </seg-main><seg-clauses><seg-main>the improving of brain health comprises at least one result selected from the group consisting of: </seg-main><seg-clauses>(a) improved cognition; </seg-clauses><seg-clauses>(b) reducing inflammation; </seg-clauses><seg-clauses>(c) preventing and/or attenuating oxidative stress; </seg-clauses><seg-clauses>(d) attenuating neuronal damage following stroke; </seg-clauses><seg-clauses>(e) stress management; </seg-clauses><seg-clauses>(f) protection against neurodegenerative diseases including but not limited to Alzheimer’s; </seg-clauses><seg-clauses>(g) protection against neuronal damage; and </seg-clauses><seg-clauses><seg-main>(h) reducing neuroinflammation, </seg-main><seg-clauses>(i) improving brain function; </seg-clauses></seg-clauses><seg-clauses>(j) improve blood brain barrier integrity protection; </seg-clauses><seg-clauses>(k) attenuating and/or preventing anxiet","A23L33/125, A23L33/21, A61K31/702, A61P25/24, A61P25/28",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12440531B2,Composition for use in improving endothelial function by enhancing flow mediated dilation,"The present invention relates to a composition comprising esterase treated decaffeinated green coffee extract (HDGCE) for use in a method of improving cardiovascular endpoints such as endothelial function by enhancing flow mediated dilation in a subject, wherein the subject is administered an effective dose of HDGCE with an amount of 100-400 mg/day.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving cardiovascular flow and reducing the risk of cardiovascular diseases in healthy subjects as measured by changes in measured flow mediated dilation (FMD) in a subject, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the subject is administered an effective dose of a composition comprising esterase treated decaffeinated green coffee extract (HDGCE) in an amount of 100-400 mg/day.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is in the form of a functional food product.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a weight ratio of caffeic acid:ferulic acid of at least 2:1.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition has a weight ratio of caffeic acid:ferulic acid ranging from 3:1 to 10:1.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition has a total content of caffeic acid and ferulic acid between 30 and 80 mg and the composition is a heat-treated composition.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition has a total content of caffeic acid and ferulic acid of between 35 and 60 mg and the composition is a heat-treated composition.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is a liquid beverage composition.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><s","A61K36/74, A23L33/105, A61P3/10, A61P9/08",20251014,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025149496A1,Compostable top lid structure for a beverage preparation capsule,"The invention concerns a capsule (1) for preparing a beverage in a beverage production machine, wherein the capsule (1) has a rotational symmetry and comprises: - a storage portion (2) in the form of a cup-shaped capsule body (5) comprising a sidewall (52), delimiting a chamber (6) for containing a substance (7) for the preparation of the beverage, and a flange portion (3) delimiting a circular opening (51) in the capsule body (5); - a closing membrane (4) made of biodegradable and/or compostable materials, the closing membrane (4) being connected; along its periphery; to the flange portion (3) of the capsule body (5), to close the chamber (6), and comprising in a layered manner: • a carrier layer (41), and • a barrier layer (42) providing a, preferably bidirectional, barrier against oxygen and/or water vapor or moisture, the barrier layer (42) being positioned on the surface of the closing membrane (4) that is oriented towards the chamber (6), wherein the carrier layer (41) has a radial extension (d) that is smaller than the radial extension (D) of the closing membrane (4). The invention is also related to a system for preparing a beverage using said capsule and to the use of the claimed capsule.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A capsule (1) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the capsule </seg-main><seg-clauses><seg-main>(1) has a rotational symmetry along an axis A and comprises:</seg-main>
<seg-clauses>- a storage portion (2) in the form of a cup-shaped capsule body (5) made of biodegradable, preferably compostable, material, comprising a sidewall (52), delimiting a chamber (6) for containing a substance (7) for the preparation of the beverage, and a flange portion (3) delimiting a circular opening (51) in the capsule body (5);</seg-clauses>
<seg-clauses>- a closing membrane (4) made of biodegradable and/or compostable materials, the closing membrane (4) being connected; along its periphery; to the flange portion (3) of the capsule body (5), to close the chamber (6), and comprising in a layered manner: o a carrier layer (41), and o a barrier layer (42) providing a, preferably bidirectional, barrier against oxygen and/or water vapor or moisture, the barrier layer (42) being positioned on the surface of the closing membrane (4) that is oriented towards the chamber (6), wherein the carrier layer (41) has a radial extension (d) that is smaller than the radial extension (D) of the closing membrane (4).</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule (1) according to claim 1, wherein </seg-main><seg-clauses>the carrier layer (41) of the closing membrane (4) extends over the circular opening (51) without extending over the flange portion (3) of the capsule body (5).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The capsule (1) according to claim 1 or 2, wherein </seg-main><seg-clauses>the carrier layer (41) comprises a central opening centered on the rotational axis of the capsule (1).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The capsule (1) according ",B65D85/804,20250717,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250185685A1,Coffee beverage,The present invention relates to a coffee beverage and a method of manufacturing a coffee beverage.,,"A23F5/36, A23F5/26, A23F5/28",20250612,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120152720A,Compositions and methods for preventing or treating joint disorders using combination of oleuropein and taurine,"The present invention relates to the use of a composition comprising an effective amount of oleuropein and/or a metabolite thereof in combination with taurine and/or a functional derivative for maintaining joint health in a subject or preventing or treating joint disorders in a subject. In particular, the present invention relates to a composition comprising an effective amount of oleuropein and/or a metabolite thereof in combination with taurine and/or a functional derivative for use in the prevention or treatment of cartilage degeneration in a subject.","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含有效量的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合，所述组合物用于预防或治疗个体的软骨退行性变。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的组合物，其中所述橄榄苦苷的代谢物选自橄榄苦苷苷元、羟基酪醇、橄榄酸、高香草醇、异高香草醇、其葡糖醛酸化形式、其硫酸化形式、其衍生物及其混合物。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2用于所述用途的组合物，其中所述牛磺酸的官能衍生物选自牛磺罗定、牛磺胺、牛磺酰胺和1,4,5-氧杂噻嗪烷-4,4-二氧化物、4-(2-羟基乙基)-1-哌嗪乙磺酸、N-酰基牛磺酸、乙酰基高牛磺酸、N,N-二乙酰基水杨基氧乙基牛磺酸、酰基甲基牛磺酸、高牛磺酸和亚牛磺酸。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项用于所述用途的组合物，所述组合物还包含钙。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项用于所述用途的组合物，其中所述组合物还包含至少一种选自以下的化合物：抗氧化剂、抗炎化合物、糖胺聚糖、益生元、纤维、益生菌、脂肪酸、酶、矿物质、微量元素和/或维生素。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项用于所述用途的组合物，其中所述组合物选自食物组合物、膳食补充剂、营养组合物、口服营养补充剂、医疗食品、营养品、饮料、在食用前用水或乳重构的粉末状营养产品、食品添加剂、特殊医疗用途食品(FSMP)、药物、饮品、宠物食品及其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项用于所述用途的组合物，其中所述组合物呈固体粉末、粉末棒、胶囊或溶液的形式。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项用于所述用途的组合物，其中所述用途是用于i)维持或改善衰老期间的关节功能，包括软骨功能，ii)减轻关节疼痛，包括炎性疼痛和/或伤害感受性疼痛。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项用于所述用途的组合物，其中所述用途是改善所述个体的活动性和/或运动性。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项用于所述用途的组合物，其中所述用途是抑制或减少骨关节炎中的软骨退行性变。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项用于所述用途的组合物，其中所述个体为中老年人、老年人。</div>
<div class=""indep-clm"" num=""12""><seg-con>12.制造根据前述权利要求中任一项用于所述用途的营养组合物的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans><seg-refi>提供用于营养组合物的一种或多种成分、橄榄苦苷或其代谢物和牛磺酸和/或官能衍生物以及任选的另外的钙，以及混合。</seg-refi></div>
<div class=""indep-clm"" num=""13"">13.套件，所述套件包括在一个或多个容器中的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的套件，其中所述一个或多个容器包括至少一个第一容器，所述至少一个第一容器储存与所述牛磺酸和/或官能衍生物分开的橄榄苦苷和/或代谢物，所述牛磺酸和/或官能衍生物储存在至少一个第二容器中，并且所述套件还包括用于将所述橄榄苦苷与所述牛磺酸混合成单位剂型的说明书。</div>
<div class=""dep-clm"" num=""15"" parent=""13,14"">15.根据权利要求13或14所述的套件，其中所述一个或多个容器各自包括橄榄苦","A61K31/7048, A61K31/185, A61P19/02, A23L33/10",20250613,雀巢产品有限公司,['Pending']
EP4483890A2,Vitamin b2 and myo-inositol for treating and preventing gestational diabetes,"The present invention relates to a maternal nutrition composition comprising myo-inositol and vitamin B2. Such a composition has been specifically designed to provide optimized nutrition to a woman desiring to get pregnant, to a pregnant woman and/or to a lactating woman. The present invention also relates to vitamin B2 for use to treat or prevent gestational diabetes mellitus and a condition associated therewith in a pregnant subject or its offspring, wherein said vitamin B2 is administered to said subject before and/or during pregnancy and/or during lactation.",,A61K35/747,20250101,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250250058A1,Bag-in-box package,"The invention relates to a bag-in-box package (<b>1</b>) being made of a material composition which is recyclable in the paper recycling stream. The package (<b>10</b>) comprises: a box (<b>10</b>) made of a cellulose fiber material, and a bag (<b>30</b>) comprising cellulose-based material and having an oxygen and moisture barrier function. The bag (<b>30</b>) is placed at least partially inside the box (<b>10</b>) and non-detachably connected to the box (<b>10</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A bag-in-box package being made of a material composition which is recyclable in the paper recycling stream, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a box made of a cellulose fiber material, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a bag comprising cellulose-based material and having an oxygen and moisture barrier function,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the bag is placed at least partially inside the box and non-detachably connected to the box.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The bag-in-box package according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bag is made of a multi-layered bag structure comprising:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>a first layer made of or comprising cellulose-based material, and</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>a second layer made of a material having an oxygen and/or moisture barrier function.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The bag-in-box package according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the first layer is the outermost layer of the multi-layered bag structure facing to an outside of the bag.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. The bag-in-box package according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the second layer comprises a coating, wherein the coating is selected from the group consisting of a metallization coating, an SiOx based coating, an AlOx based coating, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""2""><seg-con>5. The bag-in-box package according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the second layer comprises a multi-layered barrier structure.</seg-refi></div>
<div class=","B65D5/60, B65B5/02, B65B9/20, B65D5/66, B65D65/40",20250807,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2020225573B2,A pet food composition and process for preparation thereof,"The present invention relates to a process for making a pet food composition comprising a red seaweed as a natural gelling agent with enhanced palatability. The compositions of the invention can be devoid of commonly used, chemically treated gelling agents such as carrageenan, alginate, agar, gellan gum.","2020225573   21 Jul 2025
5 THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:-
<div class=""indep-clm"" num=""1""><seg-con>1. A process for making a hydrocolloid system for pet food </seg-con><seg-trans>comprising </seg-trans><seg-refi>mixing mechanically disrupted red seaweed and hydrocolloid thickeners in water, wherein mechanically disrupted seaweed refers to ground seaweed,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10          milled seaweed, cut seaweed,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the maximum average longest diameter of each seaweed piece after grinding, milling, or cutting is between 150 micron and 3 mm,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the mechanically disrupted seaweed is water-washed, wherein the mechanically disrupted seaweed is not chemically modified,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>15                wherein the hydrocolloid thickeners are selected from xanthan gum and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>locust bean gum.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The process of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>adding a potassium source to produce a gravy,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>20                wherein the gravy comprises 0.2 - 2 % wt. mechanically disrupted red</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>seaweed,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>wherein preferably the gravy comprises 0.3-0.6 % wt. of mechanically disrupted red seaweed.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>25       </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The process of claim 2 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>the gravy comprises 0.1 to 2 % wt. of the</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-refi>po","A23K20/163, A23K50/48, A23L29/212, A23L29/231, A23L29/238",20250814,SOCIETE DES PRODUITS NESTLE SA,['Pending']
AU2019400099B2,Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia,"A liquid concentrate formulated for dilution into a nutritional product is disclosed, as well as the resultant nutritional product, uses thereof, methods for the manufacture thereof, and methods for improving the cohesiveness of the nutritional product. The nutritional products have improved cohesiveness for promoting safer swallowing of food boluses for individuals having swallowing difficulties such as dysphagia. In a preferred embodiment, the nutritional product is prepared by diluting a liquid concentrate of one or more of a beta-glucan, a plant-extracted gum such as okra gum, or a plant-derived mucilage. Preferably, the resultant nutritional product has a shear viscosity greater than 200 mPas and up to about 2,000 mPas, preferably greater than 200 mPas and up to about 500 mPas, more preferably 250 mPas to about 450 mPas, most preferably 250 mPas to about 400 mPas, when measured at a shear rate of 50s","<div class=""indep-clm"" num=""1""><seg-main>1. A nutritional product made by diluting in a diluent an amount of a liquid concentrate, the liquid concentrate comprising </seg-main><seg-clauses>a thickening component consisting of a beta-glucan, optionally in combination with at least one plant-extracted gum and/or at least one plant-derived mucilage,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the thickening component is 0.01 wt.% to 25 wt.% of the liquid concentrate and the liquid concentrate is diluted in the diluent in a diluent: liquid concentrate ratio up to 200:1 forming the nutritional product having:</seg-clauses>
<seg-clauses class=""seg-enter"">a shear viscosity greater than 200 mPas and up to about 2,000 mPas at a shear rate of 50 s'1 at 20° C, and</seg-clauses>
<seg-clauses class=""seg-enter"">a relaxation time, determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment, of more than 10 ms (milliseconds) at a temperature of 20° C, wherein the diluent is one or more of water, milk, a beverage comprising water and further comprising at least one component additional to the water, a liquid oral nutritional supplement (ONS), or a food product, and the dilution of the liquid concentrate in the diluent directly forms the nutritional product such that the nutritional product consists of the diluent, the thickening component, and the water from the liquid concentrate.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The nutritional product according to Claim 1, wherein </seg-main><seg-clauses>the liquid concentrate is diluted in the diluent in a diluent:!iquid concentrate ratio from 50:1 to 100:1.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The nutritional product according to Claim 1 or 2, wherein </seg-main><seg-clauses>the thickening component is 10 wt% to 25 wt% of the liquid concentrate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The nutritional product","A23L29/206, A23L29/269, A23L33/21",20250522,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2836838C1,Roasting method,"FIELD: electrical engineering.SUBSTANCE: result is achieved by a method of roasting coffee beans using roasting apparatus (X), wherein said roasting apparatus comprises a control system configured to control the heating device and reproduce roasting recipes, wherein said control is carried out by adjusting the feedback loop based on the temperature Treg measured by the at least one temperature sensor, wherein prior to roasting of coffee beans by means of reproduction of roasting recipes of coffee beans, determined by means of one specific control device (M) for roasting, adjustment of feedback loop control, wherein said adjustment comprises stage of applying preset correction to adjust feedback loop.EFFECT: improving the calibration accuracy of coffee bean roasting apparatus.18 cl, 9 dwg","1. Способ обжаривания кофейных зерен с помощью аппарата (X) для обжаривания, причем указанный аппарат (X) для обжаривания содержит:
- камеру (1) для размещения кофейных зерен,
- нагревательное устройство (2), выполненное с возможностью подачи горячего воздуха в камеру,
- по меньшей мере один первый датчик (5) температуры для измерения температуры воздуха, подаваемого нагревательным устройством,
- систему управления (80), выполненную с возможностью управления нагревательным устройством (2) и выполненную с возможностью воспроизведения рецептур обжаривания, причем указанные рецептуры обжаривания представляют температуру, которую нужно применять в отдельные последовательные моменты времени ti соответственно, причем указанное управление нагревательного устройства (2) осуществляют посредством регулирования контура обратной связи на основе температуры Treg, измеренной по меньшей мере одним датчиком (5) температуры,
причем перед осуществлением новой операции обжаривания кофейных зерен с помощью аппарата (X) для обжаривания путем воспроизведения рецептур Rset обжаривания кофейных зерен, указанные рецептуры Rset обжаривания обеспечивают по меньшей мере набор точек (Tset@ti; ti), определяемый с помощью одного конкретного контрольного аппарата (M) для обжаривания, причем в аппарате (X) для обжаривания регулирование контура обратной связи является настраиваемым,
причем указанная операция настройки включает стадии:
- обеспечение по меньшей мере одного из условий Ci новой операции обжаривания в аппарате (X) для обжаривания,
- сравнение каждого введенного условия Ci новой операции обжаривания с соответствующим условием эталона Ci-ref, изначально применяемого во время определения рецептур Rset обжаривания с помощью указанного контрольного аппарата (M) для обжаривания,
- если имеется разность между введенным условием Ci новой операции обжаривания в аппарате (X) для обжаривания и соответствующим условием эталона CiRef в контрольном аппарате (M) для обжаривания, то:
- на основании указ","G05D23/19, G05B13/04, A23F5/04",20250324,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025082889A1,"Capsule compostable top lid structure, sheet material for making the same and method","The invention relates to a sheet material (3) from which at least one delivery wall (300) for closing a chamber (250) of a capsule body (200) of a beverage capsule (100) for preparing a beverage, can be obtained by cutting or punching of the sheet material (3), the delivery wall (300) comprising in a layered manner in the following order: - a carrier layer (320) forming a base layer for carrying subsequent layers, - a barrier layer (340) for providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340) being preferably made of a different material than the carrier layer (320); the barrier layer (340) being applied on the carrier layer (320), - an optional protective layer (350) provided on the surface of the barrier layer (340) opposite the carrier layer (320), and - an adhesive layer (330) positioned on the surface of the delivery wall (300) that is oriented towards the chamber (250) for sealing the delivery wall (300) to a rim portion (211) of the capsule body (200), the adhesive layer covering a maximum of 90%, preferably 80%, most preferably 70% of the delivery wall and being at least applied around the perimeter of the delivery wall (300), along its periphery, over a radial distance D comprised between 3 and 12 mm, preferably between 5 and 10 mm, wherein the sheet material (3) comprises cutting area identification means (370, 380) of at least one delivery wall (300) for a cutting device adapted to cut the at least one delivery wall (300) from the sheet material (3). The invention also concerns a method for obtaining, from the sheet material of the invention, at least one delivery wall (300) for closing a chamber (250) of a capsule body (200) of a beverage capsule (100) for preparing a beverage.","Claims
<div class=""indep-clm"" num=""1""><seg-con>1. Sheet material (3) from which at least one delivery wall (300) for closing a chamber (250) of a capsule body (200) of a beverage capsule (100) for preparing a beverage, can be obtained by cutting or punching of the sheet material (3), the delivery wall (300) </seg-con><seg-trans>comprising </seg-trans><seg-comp>in a layered manner in the following order: a carrier layer (320) forming a base layer for carrying subsequent layers, a barrier layer (340) for providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340) being preferably made of a different material than the carrier layer (320); </seg-comp><seg-comp>the barrier layer (340) being applied on the carrier layer (320), an optional protective layer (350) provided on the surface of the barrier layer (340) opposite the carrier layer (320), and an adhesive layer (330) positioned on the surface of the delivery wall (300) that is oriented towards the chamber (250) for sealing the delivery wall (300) to a rim portion (211) of the capsule body (200), the adhesive layer covering a maximum of 90%, preferably 80%, most preferably 70% of the delivery wall and being at least applied around the perimeter of the delivery wall (300), along its periphery, over a radial distance D comprised between 3 and 12 mm, preferably between 5 and 10 mm, wherein the sheet material (3) comprises cutting area identification means (370, 380) of at least one delivery wall (300) for a cutting device adapted to cut the at least one delivery wall (300) from the sheet material (3).</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Sheet material (3) according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the delivery wall further comprises a filter layer (310) on the surface of the carrier layer (320) opposite the barrier layer (340), for filtering out particles from the prepared beverage dispensed via the delivery wall (300).</","B32B27/36, B65D85/804, B32B3/26, B32B5/02, B32B7/12",20250424,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20240407586A1,Ergonomic beverage machine,"A machine (<b>1</b>) for preparing a beverage from an ingredient (<b>2</b>) includes: —a body (<b>10</b>) comprising a fluid line (<b>11, 11</b><i>a, </i><b>11</b><i>b, </i><b>11</b><i>c, </i><b>11</b><i>d, </i><b>11</b><i>e</i>) extending from a source of liquid to a beverage outlet (<b>11</b>) located at or on a body front face (<b>12</b>) delimiting a front area for locating a beverage collection user-recipient; —a first module (<b>20</b>) that is assemblable to the body (<b>10</b>) and that is disassemblable therefrom by said user; and—a second module (<b>30</b>) different to the first module (<b>20</b>), the second module (<b>30</b>) being assemblable to the body (<b>10</b>) and being disassemblable therefrom by said user. The body (<b>10</b>) has a side face (<b>14</b>) that is different to the front face (<b>12</b>). The side face (<b>12</b>) has: a first assembly arrangement (<b>122</b>) for assembly by the user of the first module (<b>20</b>) to the body (<b>10</b>); and a second assembly arrangement (<b>123</b>) for assembly by the user of the second module (<b>30</b>) to the body (<b>10</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A machine (1) for preparing a beverage from an ingredient, the machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body comprising a fluid line extending from a source of liquid to a beverage outlet located at or on a body front face defining a front area for locating a beverage collection user-recipient;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first module that is assemblable to the body and that is disassemblable therefrom by said user; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a second module different to the first module, the second module being assemblable to the body and being disassemblable therefrom by said user,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the body further comprising a side face that is different to the front face,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the side face has: a first assembly arrangement for assembly by said user of the first module to the body; and a second assembly arrangement for assembly by said user of the second module to the body.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the side face and the first and/or second assembly arrangement(s) are so configured that the first and/or second module(s) is/are assemblable to the assembly arrangement from outside the body adjacent the side face.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the front face extends along a horizontal front average direction and the side face extends along a horizontal side average direction, the horizontal front average direction and the horizontal side average direction being at an angle (α) relative to one another in the range of 45° to 135°.</seg-refi></div>
<div class=""dep-clm"" num=""4"" par","A47J31/36, A47J31/46",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12178228B2,Powdered thickener maintaining its extensional properties when reconstituted and for promoting safe swallowing by individuals with dysphagia,"A thickening powder promotes safe swallowing of a composition by an individual with dysphagia and can be used in methods of treating dysphagia, promoting safe swallowing of a composition, and mitigating a risk of aspiration during swallowing of a composition. The powder contains beta-glucan and maltodextrin in an amount that is neutral toward or enhances the extensional properties of the composition. Optionally the thickening powder can also include a low molecular weight carbohydrate such as sucrose or lactose. The powder can be diluted in a liquid comprising at least one of water or milk to form at least a portion of a composition such as a nutritional product and to improve the cohesiveness of the composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of treating a swallowing disorder in an individual </seg-con><seg-trans>having </seg-trans><seg-refi>the swallowing disorder, the method comprising administering to the individual a composition comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>beta-glucan; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>maltodextrin,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the composition having a shear viscosity of about 1 mPas to about 200 mPas when measured at a shear rate of 50 s<sup>−1 </sup>and a relaxation time determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment of about 10 to about 2,000 milliseconds (ms) at a temperature of 20° C.,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the composition comprises the maltodextrin and the beta-glucan in a weight ratio of about 10:1 to about 300:1.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is a liquid.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the maltodextrin is maltodextrin DE 20.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises at least one of a sucrose or lactose.</seg-refi></div>","A23L29/269, A23L2/39, A23L29/212, A61K9/00, A61K9/14",20241231,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250031739A1,Powdered thickener maintaining its extensional properties when reconstituted and for promoting safe swallowing by individuals with dysphagia,"A thickening powder promotes safe swallowing of a composition by an individual with dysphagia and can be used in methods of treating dysphagia, promoting safe swallowing of a composition, and mitigating a risk of aspiration during swallowing of a composition. The powder contains beta-glucan and maltodextrin in an amount that is neutral toward or enhances the extensional properties of the composition. Optionally the thickening powder can also include a low molecular weight carbohydrate such as sucrose or lactose. The powder can be diluted in a liquid comprising at least one of water or milk to form at least a portion of a composition such as a nutritional product and to improve the cohesiveness of the composition.",,"A23L29/269, A23L2/39, A23L29/212, A61K9/00, A61K9/14",20250130,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3042407C,Flow-optimized pour over coffee brewing system,A pour-over coffee dripper is presented. The dripper includes a container having a first opening and a second opening of different sizes and a sidewall extending between the first opening and the second opening. Ridges are formed on an inside surface of the sidewall extending in straight lines between the first opening and the second opening.,"WHAT IS CLAIMED IS: <div class=""indep-clm"" num=""1""><seg-con>1. A liquid dripper </seg-con><seg-trans>comprising: </seg-trans><seg-refi>a container having a first opening and a second opening of different sizes; a sidewall connecting the first opening to the second opening; and ridges formed on an inside surface of the sidewall and extending in straight lines between the first opening and the second opening, wherein the ridges grow thicker as the ridges approach the second opening. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The liquid dripper of claim 1 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a bottom surface in a plane parallel to a plane of the first opening, wherein the second opening is formed in the bottom surface. </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The liquid dripper of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sidewall is slanted with respect to the bottom surface such that an area of the first opening is larger than an area of the bottom surface in parallel planes. </seg-refi></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The liquid dripper of claim 3 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a base extending out of an outside surface of the sidewall such that a portion of the sidewall forms an inner ring, wherein the first opening is on one side of the base and the inner ring is on the other side of the base. </seg-refi></div><div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The liquid dripper of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the second opening forms a nozzle through which liquid exits the container, and wherein the nozzle extends from the bottom surface less than the inner ring. </seg-refi></div><div class=""dep-clm"" num=""6"" parent=""4""><seg-con>6. The liquid dripper of claim 4 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>ribs formed on the base and extending toward the inner ri",A47J31/06,20251007,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119630322A,Beverage or food preparation system,"The present disclosure provides a system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or food product, the container (6) comprising: a body portion (62) having a storage portion (58) comprising a cavity extending in a depth direction for containing a precursor material; a closure member (56) to close the storage portion (58); a machine-readable code (44) storing preparation information, said code (44) being arranged on the closure member (56), the machine (4) comprising: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6); and electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44) wherein the code reading system (18) comprises a code reader (46) and a positioning mechanism (110) to deform the body portion (62) of the container (6) from an undeformed configuration to a deformed configuration, wherein the positioning mechanism (110) is adapted to deform the body portion (62) in the deformed configuration to effect subsequent deformation of the closure member (56) such that the closure member presents a relatively more uniform surface for reading the code (44).","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括容器以及用于制备饮料和/或食品的机器，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>主体部分，所述主体部分具有包括腔体的储存部分，所述腔体在深度方向上延伸以用于容纳前体材料；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>闭合构件，所述闭合构件用以闭合所述储存部分；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>机器可读代码，所述代码存储制备信息，并且所述代码布置在所述闭合构件上，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述机器包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码读取系统，所述代码读取系统用以读取所述容器的所述代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>处理单元，所述处理单元用于处理所述容器的所述前体材料；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>电气电路系统，所述电气电路系统用以基于从所述代码读取的所述制备信息来控制所述处理单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述代码读取系统包括代码读取器和用以使所述容器的所述主体部分从未变形配置变形为变形配置的定位机构，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述定位机构被适配为使所述主体部分在所述变形配置中发生变形以实现所述闭合构件的后续变形，使得所述闭合构件呈现用于读取所述代码的相对更均匀的表面。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述容器的所述主体部分包括连接所述储存部分和所述闭合构件的凸缘部分，并且所述代码布置在所述闭合构件的中心区域上，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">并且在所述变形配置中，与所述未变形配置相比，所述凸缘部分发生变形以实现沿横向方向的曲率改变，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">并且在所述变形配置中，与所述未变形配置相比，所述闭合构件的所述中心区域比所述闭合构件的外围区域产生更小的曲率，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">其中所述中心区域是指所述闭合构件的至少包括几何中心并且与包括周边的所述外围区域分开的区域。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的系统，其中所述代码布置在所述闭合构件的中心区域上，并且在所述变形配置中，与所述未变形配置相比，所述闭合构件的所述中心区域在反向深度方向上移位，</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">其中所述中心区域是指所述闭合构件的至少包括几何中心并且与包括周边的外围区域分开的区域。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的系统，其中在所述变形配置中，所述闭合构件被布置成物理地接触所述代码读取器，并且所述代码读取器的读取头被成形为在形状上对应于处于所述变形配置中的所述闭合构件的形状。</div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-con>5.根据权利要求3或4中任一项所述的系统，其中所述容器被配置为：当所述容器在横向方向上经受三点弯曲时，相对于所述未变形配置，在所述变形配置中所述闭合构件的所述中心区域在反向深度方向上移位2mm至6mm，其</seg-con><seg-trans>包括：</seg","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20250314,雀巢产品有限公司,['Pending']
CN120501181A,"Transparent milk beverage, preparation method thereof and gel prepared from transparent milk beverage","The invention discloses a transparent milk beverage, a preparation method thereof and a gel prepared from the transparent milk beverage, the milk beverage comprises water, more than 1.0% of isolated whey protein, 0.20-1.00% of hydrosol and 0.03-0.40% of buffer salt based on the weight of the milk beverage; wherein the milk beverage is colorless transparent liquid, and the pH of the milk beverage at room temperature is 6-8. According to the technical scheme provided by the invention, the milk beverage meets the standard of GB/T21732-2008 milk beverage, is colorless transparent liquid, is kept stable in shelf life, and can be gelatinized by simply adding acid, so that the application scene of the milk beverage is enriched.","<div class=""indep-clm"" num=""1""><seg-con>1.一种乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>其包含水、大于1.0％的分离乳清蛋白、0.20-1.00％的水溶胶和0.03-0.40％缓冲盐，基于所述乳饮料的重量计；其中所述乳饮料为无色透明液体，其在室温下的pH为6-8。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述水溶胶包含卡拉胶。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3.根据权利要求2所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述水溶胶还包含至少一种其他胶，所述至少一种其他胶选自黄原胶、海藻酸盐、琼脂、红藻胶、罗望子胶、刺槐豆胶、果胶、魔芋胶、凝胶多糖、瓜尔胶、结冷胶和明胶中的一种或多种。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述其他胶与卡拉胶的重量比为(0-50):100。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据权利要求1-4中任一项所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述缓冲盐中的阳离子包括钾离子、钠离子、钙离子、镁离子中的一种或多种；所述缓冲盐中的阴离子包括柠檬酸根、乳酸根、磷酸根、磷酸氢根、磷酸二氢根、碳酸氢根中的一种或多种。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述缓冲盐包括柠檬酸钾、柠檬酸钠、柠檬酸钙、磷酸钾、磷酸钠、磷酸镁中的一种或多种。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7.根据权利要求1-6中任一项所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述乳饮料在室温下的的pH为7.2-8.0。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-con>8.根据权利要求1-7中任一项所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述乳饮料在20℃下的剪切粘度为8-50mPa·s。</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""><seg-con>9.根据权利要求1-8中任一项所述的乳饮料，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述乳饮料还包含4-20％碳水化合物，基于乳饮料的重量计。</seg-refi></div>
<div class=""indep-clm"" num=""10""><seg-con>10.一种制备权利要求1-9中任一项所述的乳饮料的方法，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>包括将水、乳清蛋白、水溶胶和缓冲盐混合，以得到所述乳饮料。</seg-refi></div>
<div class=""indep-clm"" num=""11"">11.一种凝胶，其通过权利要求1-9中任一项所述的乳饮料与酸性物质混合制备。</div>
<div class=""dep-clm"" num=""12"" parent=""11""><seg-con>12.根据权利要求11所述的凝胶，</seg-con><seg-trans>其特征在于，</seg-trans><seg-r","A23L2/38, A23L2/66, A23L2/52",20250819,雀巢产品有限公司,['Pending']
AU2021375256A9,Coffee brewing apparatus,"The invention concerns a full automatic coffee machine (100) comprising a coffee extraction unit (10) with : - a brewing chamber (1) for receiving coffee powder, - an upper piston (2), - a lower piston (3) movable inside said brewing chamber (1) between a lowest position and a highest position - wherein the lower piston (3) comprises a piston rod (31), which comprises an internal channel (311) extending from a channel inlet (311a) at the lateral wall surface of the rod to a channel outlet (311 b) at the bottom wall surface of the rod, and wherein the channel inlet (311a) is designed and positioned on the lateral wall surface of the rod so that said channel inlet (311a) overlaps the bottom wall (11) of the brewing chamber only when the lower piston is in the highest position.",,"A47J31/36, A47J31/44, A47J31/46",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12290201B2,System for assisting the personalized preparation of infant formula including a connected electronic scale,The invention relates to a computer program executable on a computer (<b>4</b>) for assisting the preparation of infant formula in an infant feeding container using an electronic scale (<b>2</b>) arranged in communication with the computer. The invention also relates to an electronic scale (<b>2</b>) for assisting the preparation of infant formula comprising a communication module (<b>16</b>) arranged to communicate with the computer (<b>4</b>) hosting the computer program.,"<div class=""indep-clm"" num=""1""><seg-con>1. A computer program executable on a computer for assisting preparation of an infant formula in an infant feeding container using an electronic scale, the electronic scale arranged in communication with the computer, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the computer program is configured to:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>store at least one personal infant profile comprising information related to an identified infant,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>pair an infant formula product selected from a plurality of infant formula products with the at least one personal infant profile, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>compute from the pairing of the infant formula product and the at least one personal infant profile, a coaching instruction set comprising preparation information and instruction data, the instruction data selected from the group consisting of a time related to a frequency or period of preparation of the infant formula, a number of preparations per day, infant formula product information, and combinations thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determine in the coaching instruction set a water quantity set point and an infant formula quantity set point for enabling the scale to control the weighing the water quantity set point and the infant formula quantity set point,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the coaching instruction set enabling control of operations of the electronic scale for preparation of an individual infant formula,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the coaching instruction set configured to be communicated to or be generated by the electronic scale for enabling the electronic scale for the control of the operations,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein conditions and/or a time at which the preparation has","G01G19/414, A47J31/40, A47J31/52, G01G23/37, G01K3/00",20250506,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120225569A,Multi-layer metallized paper-based packaging material,"The present invention relates to a cellulose substrate comprising or consisting of a cellulose graft copolymer comprising a polypeptide branch. The invention also relates to a packaging material, in particular a multilayer metallized paper-based packaging material, comprising at least one paper layer comprising or consisting of a cellulose graft copolymer comprising polypeptide branches.","<div class=""indep-clm"" num=""1"">1.纤维素基材，所述纤维素基材包含含有多肽支链的纤维素接枝共聚物或由其组成。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的纤维素基材，其中所述多肽是胶原或其水解形式。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的纤维素基材，其中所述多肽支链通过连接基团与所述纤维素偶联，任选地其中所述纤维素接枝共聚物具有下式：</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><img src="""" class=""img-anchor"" img-id=""FDA0005406035770000011""></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任何前述权利要求所述的纤维素基材，其中所述多肽支链通过多元羧酸或其酸酐与所述纤维素偶联，任选地其中所述纤维素接枝共聚物具有下式：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><img src="""" class=""img-anchor"" img-id=""FDA0005406035770000012""></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任何前述权利要求所述的纤维素基材，其中所述多肽支链通过以下与所述纤维素偶联：</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">(a)三羧酸或其酸酐；任选地其中所述三羧酸或其酸酐选自柠檬酸、异柠檬酸、乌头酸或丙三羧酸或其酸酐中的一种或多种；优选地其中所述三羧酸或其酸酐是柠檬酸或其酸酐；更优选地其中所述三羧酸或酸酐是柠檬酸；或</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">(b)二羧酸或其酸酐；任选地其中所述二羧酸或其酸酐选自丙二酸、琥珀酸、戊二酸、己二酸、庚二酸、辛二酸、壬二酸或癸二酸或其酸酐中的一种或多种；优选地其中所述二羧酸或其酸酐是琥珀酸或其酸酐；更优选地其中所述二羧酸或其酸酐是琥珀酸酐。</div>
<div class=""indep-clm"" num=""6"">6.包装材料，所述包装材料包含根据权利要求1至5中任一项所述的纤维素基材。</div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7.根据权利要求6所述的包装材料，其中所述包装材料是多层金属化纸基包装材料(1)，所述多层金属化纸基包装材料从其外侧到其内侧</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-comp>(i)克重在30g/m<sup>2</sup>至120g/m<sup>2</sup>范围内的纸层(2)，其中所述纸层包含根据权利要求1至5中任一项所述的纤维素基材或由其组成，</seg-comp></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-comp>(ii)聚合物的至少一个有机阻隔层(3)，所述聚合物选自以下项的列表：聚乙烯醇(PVOH)、乙烯-乙烯醇(EVOH)、丁烯二醇-乙烯醇共聚物(BVOH)或其组合，所述聚合物的量为0.5g/m<sup>2</sup>至20g/m<sup>2</sup>，</seg-comp></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-comp>(iii)至少一个无机阻隔层(4)，所述至少一个无机阻隔层选自以下项的列表：金属、准金属或其组合，所述无机层的厚度为1nm至100nm，和</seg-comp></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-comp>(iv)至少一个有机热密封层(5)，所述至少一个有机热密封层包含能够热密封的聚合物，所述热密封层(5)以由2g/m<sup>2</sup>至20g/m<sup>2</sup>的量组成的量施加。</seg-comp></div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的多层金属化纸基包装材料(1)，其中所述无机阻隔层包含选自以下项的列表的金属或准金属","C08B3/00, C08B3/12, C08L1/10",20250627,雀巢产品有限公司,['Pending']
AU2024304988A1,Bulk dosing unit and related system,"The invention concerns a bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), wherein a sliding assembly (122) of the bulk dosing unit (100; 200) is provided for sliding a dosing element (121) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa, wherein in the closed position an opening portion (121'') of the dosing element (121) is able to be arranged spaced away from a container aperture (11) of a bulk product container and simultaneously a device engagement portion (123'') is able to arrange an aperture cover (12) of a bulk product container (10) to completely cover a container aperture (11) of a bulk product container (10) and in the maximum dispensing position the opening portion (121'') of the dosing element (121) is able to be superimposed to a container aperture (11) of a bulk product container (10) and simultaneously the device engagement portion (123') is able to arrange an aperture cover (12) of a bulk product container (10) to substantially completely uncover a container aperture (11) of a bulk product container (10), allowing the dosing of a bulk product to be dispensed according to the position of the dosing element (121) in between the closed position and the maximum dispensing position.","<div class=""indep-clm"" num=""1""><seg-main>1. A bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), said bulk dosing unit (100; 200) comprising:</seg-main>
<seg-clauses>- a containment housing (110) which defines a containment volume for receiving a bulk product container (10);</seg-clauses>
<seg-clauses>- a dispensing opening (112) defined on said containment housing (110) for dispensing a bulk product;</seg-clauses>
<seg-clauses>- a feeding assembly (130) arranged at least partly inside said containment housing (110) and able to move a bulk product in a bulk product container (10) toward said dispensing opening (112);</seg-clauses>
<seg-clauses>- a dosing device (120) able to be actuated for dispensing and dosing a bulk product; characterized in that said dosing device (120) comprises a dosing element (121) and a sliding assembly (122) for sliding said dosing element (121) at said dispensing opening (112) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said dosing device (120) comprises one or more device engagement portions (123’, 123”), arranged toward said containment volume and able to engage an aperture cover (12) of a bulk product container (10),</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said dosing element (121) has at least an opening portion (121”), and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein in said closed position said opening portion (121”) is able to be arranged spaced away from a container aperture (11) of a bulk product container (10) and simultaneously said device engagement portion (123”) is able to arrange an aperture cover (12) of a bulk product container (10) in a fully closed position, to completely cover a container aperture (11) of a bulk product container (10), and in said maximum dispensing po","G07F11/44, B65D47/00, B65D83/00, G07F11/00, G07F13/02",20251204,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025132299A1,Compositions for preventing or treating atopic disease and/or respiratory infection,"The present disclosure generally relates to compositions and methods for one or more health benefits, for example preventing or treating atopic disease and/or respiratory infection, in a young individual by increasing propionate production by gut microbiota. Some embodiments are directed to a composition comprising a combination of at least one galacto-oligosaccharide (GOS) and at least three ingredients selected from vitamins B1, B2 and B6, minerals zinc, iron and copper, and amino acids histidine, isoleucine, lysine, and leucine for use in increasing propionate production by the gut microbiota in a young individual.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A composition for use in increasing propionate production by the gut microbiota of a young individual comprising </seg-main><seg-clauses>a combination of at least one galacto-oligosaccharide (GOS) and at least three ingredients selected from vitamin Bl, vitamin B2, vitamin B6, zinc, iron, copper, histidine, isoleucine, lysine, leucine.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses>it comprises at least one galacto-oligosaccharide (GOS) in a daily amount ranging from about 0.001 to about 12 g and at least three ingredients selected from</seg-clauses>
<seg-clauses>- vitamin B 1 in a daily amount ranging from about 0.8 to about 2 mg;</seg-clauses>
<seg-clauses>- vitamin B2 in a daily amount ranging from about 1 to about 3 mg;</seg-clauses>
<seg-clauses>- vitamin B6 in a daily amount ranging from about 0.9 to about 5 mg;</seg-clauses>
<seg-clauses>- zinc in a daily amount ranging from about 6 to about 13 mg;</seg-clauses>
<seg-clauses>- iron in a daily amount ranging from about 8 to about 29 mg;</seg-clauses>
<seg-clauses>- copper in a daily amount ranging from about 0.6 to about 1.1 mg;</seg-clauses>
<seg-clauses>- histidine in a daily amount ranging from about 0.2 to about 1 g;</seg-clauses>
<seg-clauses>- isoleucine in a daily amount ranging from about 0.3 to about 2 g;</seg-clauses>
<seg-clauses>- lysine in a daily amount ranging from about 0.4 to about 3 g;</seg-clauses>
<seg-clauses>- leucine in a daily amount ranging from about 0.6 to about 4 g;</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>it comprises at least one galacto-oligosaccharide (GOS) in an amount ranging from about 0.001 to about 2.5 g per 100 ml of liquid and at least three ingredients selected from</seg-main>
<seg-clauses>- vitamin B","A61K31/702, A61K31/198, A61K31/4178, A61K31/4415, A61K31/51",20250626,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2024239535A1,Compostable top lid structure for a beverage preparation capsule,"The invention concerns a capsule (100) for preparing a beverage in a beverage production machine, wherein the capsule (100) comprises: - a capsule body (200) comprising a sidewall (210) delimiting a chamber (250) for containing a substance (500) for the preparation of the beverage, and a rim portion (211) delimiting an opening (230) in the sidewall (210); - an injection wall (220) for injecting a fluid in the chamber (250) for preparing the beverage upon interaction of the fluid with the substance (500); and - a delivery wall (300) being connected to the capsule body (200), preferably to the rim portion (211), to close the chamber (250), the delivery wall (300) comprising in a layered manner: o a carrier layer (320) made of a biodegradable material, the carrier layer (320) being adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule (100), and o a filter layer (310) made of a biodegradable material for filtering out particles from the prepared beverage dispensed via the delivery wall (300), wherein the delivery wall (300) comprises, on its surface that is oriented towards the chamber (250), an adhesive layer (330), applied in one or more layer, which covers a maximum of 90% of the surface of the delivery wall (300) and which at least extends all around the perimeter of the delivery wall (300), along its periphery, over a radial distance radial D comprised between 3 mm and 12 mm, preferably between 5 mm and 10 mm.","<div class=""indep-clm"" num=""1""><seg-main>1. A capsule (100) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the capsule (100) comprises:</seg-main>
<seg-clauses>- a capsule body (200) comprising a sidewall (210) delimiting a chamber (250) for containing a substance (500) forthe preparation of the beverage, and a rim portion (211) delimiting an opening (230) in the sidewall (210);</seg-clauses>
<seg-clauses>- an injection wall (220) for injecting a fluid in the chamber (250) for preparing the beverage upon interaction of the fluid with the substance (500); and</seg-clauses>
<seg-clauses>- a delivery wall (300) being connected to the capsule body (200), preferably to the rim portion (211), to close the chamber (250), the delivery wall (300) comprising in a layered manner:</seg-clauses>
<seg-clauses class=""seg-enter"">o a carrier layer (320) made of a biodegradable material, the carrier layer (320) being adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule (100), and</seg-clauses>
<seg-clauses class=""seg-enter"">o a filter layer (310) made of a biodegradable material for filtering out particles from the prepared beverage dispensed via the delivery wall (300),</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the delivery wall (300) comprises, on its surface that is oriented towards the chamber (250), an adhesive layer (330), applied in one or more layers, which covers a maximum of 90% of the surface of the delivery wall (300) and at least extends all around the perimeter of the delivery wall (300), along its periphery over a radial distance D comprised between 3 mm and 12 mm, preferably between 5 mm and 10 mm.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule (100) according to claim 1, wherein, </seg-main><seg-clauses>in the layered delivery wall (300), the carrier layer (320) is-connected to the rim portion (211) for ",B65D85/804,20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025067648A1,Mixture of HMOS and bifidobacterium longum transitional microorganism,"The present invention relates to a composition comprising a Bifidobacterium longum transitional microorganism and a mixture of human milk oligosaccharides (HMOs) consisting of 2'-fucosyllactose (2'-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and 3-fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT). The invention also relates to the use of the composition for preventing, reducing the risk of and/or treating an infection in a subject. The invention also provides the composition for use in promoting a long-term immune benefit in a subject, preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A composition comprising </seg-main><seg-clauses>a Bifidobacterium longum transitional microorganism and a HMO mixture consisting of 2'-fucosyllactose (2’-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1 , wherein </seg-main><seg-clauses><seg-main>the Bifidobacterium longum transitional microorganism:</seg-main>
<seg-clauses>(i) is capable of metabolizing the HMO(s);</seg-clauses>
<seg-clauses>(ii) preferentially utilizes 3-FL over 2’-FL;</seg-clauses>
<seg-clauses>(iii) is capable of metabolizing a glycan substrate selected from the group recited in any of Tables 1 to 3; and/or</seg-clauses>
<seg-clauses>(iv) encodes one or more CAZymes selected from the group recited in Table 1 , preferably wherein the Bifidobacterium longum transitional microorganism further encodes one or more CAZymes selected from Table 2 and 3.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the Bifidobacterium longum transitional microorganism has an Average Nucleotide Identity (ANI) of at least 98% with at least one Bifidobacterium longum strain selected from the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686, CNCM I-5687, CMCC-P0001 (ATCC BAA-2753), and any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses><seg-main>the composition further comprises Bifidobacterium longum </seg-main><seg-clauses>subsp. infantis and/or Bifidobacterium lactis.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-ma","A61K35/745, A23L33/135, A23L33/00, A61K31/702, A61P11/06",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025219965A1,"Foaming liquid creamers for aerosol packaging, and methods of making and using such foaming liquid creamers and aerosol packagings","A foaming liquid creamer contains (i) water; (ii) at least one of micellar casein or sodium caseinate; (iii) at least one carbohydrate source; (iv) at least one lipid; (v) at least one buffer salt; (vi) at least one stabilizer; (vii) at least one sweetener; and (viii) at least one emulsifier. The carbohydrate source may include glucose syrup, preferably glucose syrup DE 25-29. The buffer salt may include dipotassium phosphate. The stabilizer may include at least one of carrageenan, carboxymethyl cellulose (CMC), or microcrystalline cellulose (MCC). The lipid may include coconut oil. The at least one emulsifier may include mono- and di-glycerides. The sweetener may include at least one of sucralose or acesulfame. The foaming liquid creamer may also contain a flavor. Another foaming liquid creamer contains (i) water; (ii) at least one of non-fat milk solids or milk fat; and (iii) sugar. Another aspect is an aerosol packaging which includes one of these foaming liquid creamers in a pressurized container, and the aerosol packaging has an actuator nozzle.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A foaming liquid creamer comprising </seg-main><seg-clauses>(i) water; </seg-clauses><seg-clauses>(ii) at least one of micellar casein or sodium caseinate; </seg-clauses><seg-clauses>(iii) at least one carbohydrate source; </seg-clauses><seg-clauses>(iv) at least one lipid; </seg-clauses><seg-clauses>(v) at least one buffer salt; </seg-clauses><seg-clauses>(vi) at least one stabilizer; </seg-clauses><seg-clauses>(vii) at least one sweetener; and </seg-clauses><seg-clauses>(viii) at least one emulsifier.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The foaming liquid creamer of claim 1 , wherein </seg-main><seg-clauses>the at least one carbohydrate source comprises glucose syrup.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The foaming liquid creamer of claim 1 or claim 2, wherein </seg-main><seg-clauses>the at least one buffer salt comprises dipotassium phosphate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The foaming liquid creamer of any of claims 1-3, wherein </seg-main><seg-clauses>the at least one stabilizer comprises at least one of carrageenan, carboxymethyl cellulose (CMC), or microcrystalline cellulose (MCC).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The foaming liquid creamer of any of claims 1-4, wherein </seg-main><seg-clauses>the at least one lipid comprises coconut oil.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The foaming liquid creamer of any of claims 1 -5, wherein </seg-main><seg-clauses>the at least one emulsifier comprises mono- and di-glycerides.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The foaming liquid creamer of any of claims 1 -6, wherein </seg-main><seg-clauses>the at least one sweetener comprises at least one of sucralose or acesulfame.</seg-clauses></div>
<div class=""dep-clm"" num=""",B65D83/20,20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025120122A1,Reliable capsule beverage dispensing system,"A machine (1) is arranged to prepare a beverage from an ingredient contained in a capsule (100) by supplying an extraction liquid therein, The machine (1) has: a machine outlet ((55)) configured to dispense beverage externally towards aa user - recipient (9); and a seat (10,20) for holding the capsule (100) during beverage preparation. The seat ((1100,,2200)) includes: a seat liquid inlet (14,14') configured for delivering the extraction liquid to the capsule (100); and at least one seat outlet (15,15') at the capsule (100) configured to guide beverage from the capsule (100). The seat outlet (15,15') is associated with a capsule outlet opener (15a, 15a'). The machine (1) has a beverage passage (5') extending from the seat outlet(s) (15,15') up to the machine outlet (5). The seat outlet (s) (15,15'), the beverage passage (5') and the machine outlet (5) form an outflow path (5,15,15') having a direction of beverage flow extending therealong and a flow cross - section transverse to the direction of flow along the outflow path (5,15,15'). The flow cross - section along the direction of flow has a smallest cross - section with a surface area of at least 4.5 mm2. For example, the capsule (100) is made of a soft and/or tearable material, such as a material that is cellulosic,, cellulose-based or a cellulosic material, such as wood pulp or wood pulpbased or paper-based or cardboard-based material.","CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for preparing a beverage from an ingredient contained in a capsule (100) by supplying an extraction liquid, e.g. water, into such capsule (100) for instance from a liquid source (2) via a liquid driver (3) and thermal conditioner (4), such machine (1) comprising: </seg-main><seg-clauses>- a machine outlet (5) configured to dispense beverage externally towards an area (6) for placing a user- recipient (9), such as a cup or a mug; and </seg-clauses><seg-clauses><seg-main>- a seat (10,20) for holding such capsule (100) during beverage preparation, the seat (10,20) having: </seg-main><seg-clauses>- a seat liquid inlet (14,14’) configured for delivering said extraction liquid to such capsule (100), such as a liquid inlet (14,14’) associated with one or more capsule inlet openers (14a,14a’); and </seg-clauses><seg-clauses>- at least one seat outlet (15,15’) at said capsule (100) during beverage preparation, said at least one seat outlet (15,15’) being configured to guide beverage from said capsule (100), such seat outlet (15,15’) being associated with a capsule outlet opener (15a,15a’,15a’’), e.g. an opener delimiting a peripheral beverage passage (15d) and/or an inside beverage passage (15d’’), such machine (1) comprising a beverage passage (5’) extending from the seat outlet(s) (15,15’) up to the machine outlet (5), said at least one seat outlet (15,15’), the beverage passage (5’) and the machine outlet (5) forming an outflow path (5,15,15’) having a direction of beverage flow extending therealong and a flow cross-section transverse to the flow direction along the outflow path (5,15,15’), optionally, the seat (10,20) being connected to a motor to drive during beverage preparation the seat (10,20) in rotation to centrifuge said capsule (100) so as to mix</seg-clauses>
<seg-clauses class=""seg-enter"">said ingredient and said extraction liquid to form said beverage, characterized in that said flow cross-sectio",A47J31/36,20250612,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2019394578B2,Food or beverage product with agglomerated pea protein,"The present invention relates to a method of producing a food or beverage product, in particular to a method for forming agglomerated pea proteins in an ingredient composition. The invention also relates food or beverage product comprising agglomerated pea proteins.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of producing a food or beverage product, the method </seg-con><seg-trans>comprising;</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing an aqueous ingredient composition comprising pea protein at a concentration of 1.0 to 6 wt.%;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>adding to the ingredient composition 4.0 - 20 mM of divalent cations available to complex the pea protein;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and subsequently heat treating the ingredient composition at a pH of to 6.6 - 7.3 to form agglomerates comprising pea protein wherein the heat treatment is performed at a temperature of 80°C to 125°C for a period of 30 seconds to 20 minutes, or at a temperature of above 125 °C for 3 - 45 seconds.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A method according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the agglomerates have a D[4,3] mean diameter as measured by laser diffraction of 2 to 50 microns.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A method according to claim 1 or 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ingredient composition is subjected to homogenization.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A method according to any one of claims 1 to 3 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pea protein is a pea protein isolate.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A method according to any one of claims 1 to 4 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the divalent cations are selected from the group consisting of calcium cations, magnesium cations and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A method according to any one of claims 1 to 5 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the divalent cations are provi","A23L2/62, A23C11/06, A23J3/14, A23J3/28, A23L2/66",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
AU2023348162A1,Compostable pod shaped from a sheet of cellulose-based material,"The invention relates to a pod (100) for preparing a beverage in a beverage production machine. The pod (100) is made of a home-compostable material composition and comprises a pod body (120) being composed of two half-shells (200). The half-shells (200) are joined to each other so as to delimit a chamber (211) for containing a substance (500) for the preparation of the beverage. Each of the half-shells (200) is shaped from a sheet of biodegradable cellulose-based material having a barrier function. Each of the half-shells (200) comprises a bottom (250), a circumferential sidewall (240) and a circumferential rim (230), where the rim (230) of the respective other half-shell (200) is joined. The rim (230) and the sidewall (240) are directly connected by a circumferential rim transition area (234), which has a rim radius (R34) between 1mm and 3mm. Further, the sidewall (240) and the bottom (250) are directly connected by a circumferential bottom transition area (254), which has a bottom radius (R452) of 10mm and 20mm.","<div class=""indep-clm"" num=""1""><seg-main>1. A pod (100) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses>the pod (100) is made of a home-compostable material composition,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the pod (100) comprises a pod body (120) being composed of two half-shells (200) joined to each other so as to delimit a chamber (211) for containing a substance (500) for the preparation of the beverage,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein each of the half-shells (200) is shaped from a sheet of biodegradable cellulose-based material having a barrier function, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein each of the half-shells (200) comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">® a bottom (250),</seg-clauses>
<seg-clauses>• a circumferential sidewall (240) extending from the bottom (250) to a circumferential edge (241) of the sidewall (240) to define a cavity (210), wherein the sidewall (240) tapers from the circumferential edge (241) towards the bottom (250),</seg-clauses>
<seg-clauses class=""seg-enter"">® a circumferential rim (230) extending laterally outwards from the circumferential edge (241) for being joined with the rim (230) of the respective other half-shell (200) so that their cavities (210) together define the chamber (211), wherein a circumferential inner edge (231) of the rim (230) delimits an opening (212) of the cavity (210),</seg-clauses>
<seg-clauses class=""seg-enter"">wherein a circumferential rim transition area (234), which directly connects the rim (230) and the sidewall (240), has a rim radius (R34) of between 1mm and 3mm, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein a circumferential bottom transition area (254), which directly connects the sidewall (240) and the bottom (250), has a bottom radius (R452) of between 10mm and 20mm.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The pod (100) according to claim",B65D85/804,20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12396463B2,Process for manufacturing a dough base,"The present invention relates to a process for manufacturing a dough base, particularly for a dough base, which is a pie or a pizza dough. The claimed process comprises a step, wherein the pressing surface is vibrating with an ultrasonic frequency during the pressing step.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for manufacturing a dough base, comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>i) preparing a dough comprising flour, a raising agent and water,</seg-clauses>
<seg-clauses>ii) placing a portion of the dough onto a receiving surface of a pressing device, the pressing device having a pressing surface opposed to the receiving surface, wherein the pressing surface meets one of the following:</seg-clauses>
<seg-clauses class=""seg-enter"">the pressing surface is square and has a side length of 3 cm to 30 cm, and</seg-clauses>
<seg-clauses class=""seg-enter"">the pressing surface is circular and has a diameter of 3 cm to 35 cm,</seg-clauses>
<seg-clauses>iii) pressing the receiving surface and the pressing surface together in order to flatten the portion of the dough into a dough base,</seg-clauses>
<seg-clauses>iv) after the pressing step, separating the pressing surface from the receiving surface in order to release the dough base from the pressing device; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the pressing surface is by vibrating with an ultrasonic frequency during the pressing step.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process for manufacturing a dough base according to claim 1, wherein </seg-main><seg-clauses>the pressing surface is a surface of a sonotrode or a surface linked to a sonotrode.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The process for manufacturing a dough base according to claim 1, wherein </seg-main><seg-clauses>the pressing surface is vibrating with a frequency of 15-70 kHz during the pressing step.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The process for manufacturing a dough base according to claim 1, wherein </seg-main><seg-clauses>the pressing surface is vibrating with a peak amplitude of 5-150 μm during the pressing step.</seg-","A21D13/41, A21C11/00",20250826,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2022223631A9,A recyclable paper-based laminate and a beverage carton made therefrom,"The present invention concerns a paper-based barrier multilayer packaging material structure (1) being formed as a unitary sheet and comprising from its outer surface to its inner surface, the following layers:- a polymer dispersion coating (9) having a thickness of 1 to 10 μm,- a paperboard (8) having a grammage of between 120 g/m","<div class=""indep-clm"" num=""1""><seg-main>1. A paper-based barrier multilayer packaging material structure </seg-main><seg-clauses><seg-main>(1) being formed as a unitary sheet and comprising from its outer surface to its inner surface, the following layers:</seg-main>
<seg-clauses>(i) at least one layer of a polymer dispersion coating (9) selected within the list of: ethylene-acrylic or methacrylic acid copolymer, vinyl acetate, styrene acrylate, acrylic, modified polyvinylalcohol, ethyl acetate, polyhydroxyalcanoate (PHA) and their copolymers, polyurethane (PU), polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), poly(butylene succinate-co-adipate) (PBSA), polylactic acid (PLA), or any mixture thereof, with or without a mineral filler, said coating having a thickness of 1 to 10 pm,</seg-clauses>
<seg-clauses>(ii) a paperboard (8) having a grammage of between 120 g/m2 and 500 g/m2,</seg-clauses>
<seg-clauses>(iii) a layer of water-based or solvent-less adhesive (7) selected within the list of: polyvinylacetate (PVAc), polyurethane (PU), acrylic, polyvinylalcohol (PVOH), ethylenevinylalcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), a starch-based adhesive, or a mixture thereof, said adhesive layer having a thickness comprised between 1 pm and 10 pm,</seg-clauses>
<seg-clauses>(iv) a barrier metallized paper (MBPL) having substance weight between 30-120 g/m2, preferably 45 to 90 g/m2 and a Water Vapour Transmission Rate (WVTR) of 10 to 0.1 g/m2/d, preferably a WVTR of 1.0 to 0.1 g/m2/d measured at 38°C and 90% RH, and an Oxygen Transmission Rate (OTR) comprised between 100 and 0.1</seg-clauses>
<seg-clauses class=""seg-enter"">cc/m2/d, measured at 23°C and 50% RH, preferably an OTR comprised between 1.0 and 0.1 cc/m2/d,</seg-clauses>
<seg-clauses>(v) a water-resistant polyolefin sealable coating </seg-clauses></seg-clauses><seg-clauses>(2) of any of the following: low density polyethylene (LDPE), linear low-density polyethylene (LLDPE), o","B32B1/02, B32B7/12, B32B29/00",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025180998A1,Methods utilizing DNA methylation of canines,"The application is in the field of methods using DNA methylation of canines. The present invention relates to a method of determining the contribution of a dog breed to a test dog genome, comprising: a) providing a DNA methylation profile from a sample obtained from the test dog; b) obtaining the identity of one or both alleles for a genetic marker in the test dog genome; and c) determining the contribution of a dog breed to the test dog genome by comparing at least part of the DNA methylation profile and at least one genetic marker of the test dog to reference DNA profiles from different dog breeds. A method for selecting a dietary, pharmacological, or lifestyle regime for a test dog, the method based on the contribution of a dog breed to the test dog genome. A method for preventing or reducing the risk of a test dog developing a disease; the method comprising selecting a dietary, pharmacological, or lifestyle regime for the test dog based on the contribution of the at least one dog breed to the test dog genome. Computer products for carrying out the said methods.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of determining the contribution of a dog breed to a test dog genome, comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the test dog; </seg-clauses><seg-clauses>b) obtaining the identity of one or both alleles for a genetic marker in the test dog genome from a sample obtained from the test dog; and </seg-clauses><seg-clauses>c) determining the contribution of a dog breed to the test dog genome by comparing at least part of the DNA methylation profile and at least one genetic marker of the test dog to a reference DNA methylation profile and a reference genetic marker profile from at least one reference dog breed.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for selecting a dietary, pharmacological, or lifestyle regime for a test dog, the method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the test dog; </seg-clauses><seg-clauses>b) obtaining the identity of one or both alleles for a genetic marker in the test dog genome from a sample obtained from the test dog; </seg-clauses><seg-clauses>c) determining the contribution of a dog breed to the test dog genome by comparing at least part of the DNA methylation profile and at least one genetic marker of the test dog to a reference DNA methylation profile and a reference genetic marker profile from at least one reference dog breed; and </seg-clauses><seg-clauses>d) selecting a suitable dietary, pharmacological, or lifestyle regime for the test dog based on the contribution of a dog breed to the test dog genome determined in step c).</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A method for preventing or reducing the risk of a test dog developing a disease; the method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the test dog; </seg-clauses><seg-clauses>b)","C12Q1/6883, A01K67/027, C12Q1/6888",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2835606C1,Coffee beans roasting device,"FIELD: food industry.SUBSTANCE: invention relates to coffee industry. Disclosed is coffee bean roasting device (1), comprising: chamber (10) in which coffee beans for roasting can be placed, and apparatus (80) for roasting coffee beans placed in chamber (10), wherein chamber (10) is limited by at least lower part (11) and side wall (12), comprising outer side (121), which is oriented so that it faces away from chamber (10), and wherein temperature sensor (90) is provided on outer side (121) for determining the temperature in the inner part of chamber (10), in which chamber (10) has a height to which coffee beans can be placed in chamber (10), wherein temperature sensor (90) is located at a given height or below, and outer side (121) of side wall (12) comprises recess (123), and wherein temperature sensor (90) is at least partially located in recess (123).EFFECT: higher reliability of temperature measurement inside the chamber.14 cl, 5 dwg","1. Устройство (1) для обжаривания кофейных зерен, содержащее:
камеру (10), в которой могут быть размещены кофейные зерна для обжаривания, и
аппарат (80) для обжаривания кофейных зерен, размещенных в камере (10),
причем камера (10) ограничена по меньшей мере нижней частью (11) и боковой стенкой (12), проходящей от нижней части (11), при этом боковая стенка (12) содержит наружную сторону (121), которая ориентирована так, чтобы она была обращена в сторону от камеры (10), и при этом датчик (90) температуры предусмотрен на наружной стороне (121) боковой стенки (12) для определения температуры во внутренней части камеры (10), в котором
камера (10) имеет высоту, до которой в камере (10) могут быть размещены кофейные зерна, причем датчик (90) температуры расположен на данной высоте или ниже, и
наружная сторона (121) боковой стенки (12) содержит углубление (123), и при этом датчик (90) температуры по меньшей мере частично расположен в углублении (123).
2. Устройство (1) по п. 1, в котором датчик (90) температуры расположен так, что датчик (90) температуры не выступает из наружной стороны (121) боковой стенки (12).
3. Устройство (1) по п. 1 или 2, в котором углубление (123) выполнено с возможностью формирования выступа (124) на внутренней стороне (122) боковой стенки (12), причем внутренняя сторона (122) ориентирована так, чтобы она была обращена к внутренней части камеры (10).
4. Устройство (1) по п. 3, в котором выступ (124) выполнен с возможностью осуществления непосредственного контакта с кофейными зернами, размещенными в камере (10).
5. Устройство (1) по любому из пп. 1-4, в котором углубление (123) сформировано посредством выдавливания рельефа в боковой стенке (12).
6. Устройство (1) по любому из предшествующих пунктов, в котором датчик (90) температуры является выполненным с возможностью передачи первого сигнала, относящегося к определяемой температуре, для отображения определяемой температуры и/или в котором датчик (90) температуры является выполненным с возможностью ","A23N12/08, A23F5/04, A47J31/00, A47J31/42",20250228,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2019410254B2,Apparatus and method for roasting coffee beans,"The invention concerns an apparatus for roasting coffee beans comprising : - a vessel (1) to contain coffee beans, - a heating device (12) to heat coffee beans contained in the vessel, - a control system (180) operable to control the heating device and configured to apply a roasting recipe (R), wherein for a customised quantity m of coffee beans of type Ny introduced inside the vessel, - the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel and the type Ny of coffee beans introduced inside the vessel, and - based on the obtained type Ny, the control system is configured to get access at least to a roasting recipe Ry, said recipe being adapted to the roasting of one pre-determined quantity M of beans of type Ni, and to said pre-determined quantity M, and - based on the accessible roasting recipe Ry and on said obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe (R) to be applied to the quantity m of coffee beans of type Ny introduced inside the vessel.","<div class=""indep-clm"" num=""1""><seg-main>1. An apparatus for roasting coffee beans comprising :</seg-main>
<seg-clauses>- a vessel to contain coffee beans,</seg-clauses>
<seg-clauses class=""seg-enter"">5   - a heating device to heat coffee beans contained in the vessel,</seg-clauses>
<seg-clauses>- a control system operable to control the heating device and configured to apply a roasting recipe (R) providing the temperature T@ti, T@t2, ... to be applied at discrete successive times ti, t2.....respectively,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, for any customised quantity m of coffee beans of type Ny introduced inside the 0 vessel,</seg-clauses>
<seg-clauses>- the control system is configured to obtain at least:</seg-clauses>
<seg-clauses class=""seg-enter"">. the customised quantity m of coffee beans introduced inside the vessel, and</seg-clauses>
<seg-clauses class=""seg-enter"">. the type Ny of coffee beans introduced inside the vessel, and</seg-clauses>
<seg-clauses class=""seg-enter"">5   - based on the obtained type Ny, the control system is configured to get access at least to a</seg-clauses>
<seg-clauses class=""seg-enter"">roasting recipe Ry, said recipe being adapted to the roasting of one pre-determined quantity M of beans of type Ny, and to said pre-determined quantity M, and</seg-clauses>
<seg-clauses>- based on the accessible roasting recipe Ry, on the accessible pre-determined quantity M !0 and on said obtained customised quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe (R) to be applied to the customised quantity m of coffee beans of type Ny introduced inside the vessel.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The apparatus for roasting coffee beans according to Claim 1, wherein </seg-main><seg-clauses>the control system 25 is configured to determine said roasting recipe (R) to be applied on the coffee beans from said accessible roasting r","A23N12/08, A23F5/04, A23N12/12",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CA3117597A1,Dietary butyrate,"A compound having the formula (1), (2). (3) or (4), or combinations thereof, for use in the prevention or treatment of dehydration, and/or in the treatment of diarrhea, wherein RI, R2. R3, R4. R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons.","CA 03117597 2021-04-23 WO 2020/126979 PCT/EP2019/085250 CLAIMS  <div class=""indep-clm"" num=""1""><seg-main>1. A compound having </seg-main><seg-clauses>the formula 0 H2C-0 H2C-0) CH2OR4 o H2C-0)0 (1) I I I CHOW (2) (3) (4) 0 CHOR2 HC- 0) HC-0 )L/\ H2C-0 CH2OR3 CH2OR5 or CH2OR6 or combinations thereof, for use in the prevention or treatment of dehydration, such as dehydration due to diarrhea, wherein R1, R2, R3, R4, R5 and R6are independently, a long chain fatty acid having between 16 and 20 carbons. </seg-clauses>
 </div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A compound, or combinations thereof, for use according to claim 1, wherein </seg-main><seg-clauses>the compound or combinations thereof are for administration in combination with an oral rehydration solution (ORS). </seg-clauses>
 </div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A compound, or combinations thereof, for use according to claim 1 or 2, wherein </seg-main><seg-clauses>the compound or combinations thereof are present in an oral rehydration solution (ORS), a nutritional composition, a dietary supplement, an infant formula or a follow on-formula. </seg-clauses>
 </div><div class=""indep-clm"" num=""4""><seg-main>4. An oral rehydration solution comprising </seg-main><seg-clauses>a compound having the formula H 2 C ______ O H2CO C H2OR4 o H 2C -0)0 (1) (2) (3) (4) CHOW 0 CHOR2 HC __ 0 H C-0 H 2 C 0) CH2OR3 C H2OR5 or CH2OR6 or combinations thereof, wherein R1, R2, R3, R4, R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons. </seg-clauses>
 </div><div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. An oral hydration solution according to claim 4, further comprising </seg-main><seg-clauses>a prebiotic, preferably wherein the prebiotic is PHGG (partially hydrolysed guar gum). </seg-clauses>
 </div><div class=""dep-clm"" num=""6"" parent=""5"">6. An oral rehydration solution according to claim 5 in the form of a powder for rehydration in a liquid, a tablet for","A23L5/00, A23L33/00, A23L33/12, A61K45/06, A61K9/00",20250513,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2020309774B2,Handy large processing jug,"A machine (1) comprises a tank (10) having a cavity (10') for containing and processing a liquid food substance, such as milk or a milk-based substance. A stirring tool (15) is provided in the cavity (10') for imparting a mechanical effect on the food substance. A base (20) supports the tank (10). The base (20) has an upright outside gripping surface (21) located under the tank (10) and seizable by an adult human hand such that the base (20) with the supported tank (10) can be carried and displaced single-handed by seizure of the upright outside gripping surface (21). The tank (10) extends horizontally beyond the gripping surface (21).","<div class=""indep-clm"" num=""1""><seg-main>1. A machine comprising </seg-main><seg-clauses>a tank having a cavity for containing and processing a liquid food substance, a stirring tool in the cavity for imparting a mechanical</seg-clauses>
<seg-clauses class=""seg-enter"">5 effect on said food substance in the cavity, and a base supporting the tank, the base having an upright outside gripping surface located under the tank and seizable by an adult human hand such that the base with the supported tank can be carried and displaced single-handed by</seg-clauses>
<seg-clauses class=""seg-enter"">10 seizure of the upright outside gripping surface,</seg-clauses>
<seg-clauses class=""seg-enter"">the tank extending horizontally beyond the outside gripping surface,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the tank has an outer horizontal tank perimeter and wherein:</seg-clauses>
<seg-clauses class=""seg-enter"">15 - the tank extends horizontally beyond the outside gripping surface over a predominant part of its tank perimeter; and/or</seg-clauses>
<seg-clauses>- the perimeter has a circumference in the range of 15 to 70 cm,</seg-clauses>
<seg-clauses class=""seg-enter"">20 and wherein the tank has an upright outer tank surface and the cavity has a height, the outer horizontal perimeter extending along the outer tank surface, the outer tank surface being located horizontally beyond the outside gripping surface over substantially its entire</seg-clauses>
<seg-clauses class=""seg-enter"">25 tank perimeter over substantially the entire cavity height,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the machine has an outside housing that forms the upright outside gripping surface, the outside housing extending upright along at least part of the outer tank 30 surface, the   housing   comprising a substantially</seg-clauses>
<seg-clauses class=""seg-enter"">horizontal and/or inclined intermediate portion, extending from a top of the upright outside gripping surface to a bottom of ","A47J43/07, A47J43/046",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024278517A1,Compositions and methods using high protein for induction of autophagy,"Compositions and methods can use high protein for induction of autophagy in an individual in need thereof. Preferably, a formulation containing protein in an amount effective to induce autophagy, for example in muscle, is administered to the individual. The formulation can concomitantly promote protein synthesis and removal of damaged cellular materials. The recipient of administration can be a critically ill patient, for example a patient in the Intensive Care Unit (ICU), and/or an ageing patient, for example an elderly individual or an individual with sarcopenia.",,"A61P21/00, A61K31/132, A61K38/01, A61K38/17, A61K47/42",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250186418A1,Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for rehabilitation,"Composition containing Nicotinamide and vitamin B6 are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for treating muscle injury, and/or promoting muscle repair, improving skeletal muscle regeneration, maintaining or increasing skeletal muscle function and/or skeletal muscle mass in an individual with muscle injury.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of at least one of </seg-main><seg-clauses>(i) treating muscle injury, </seg-clauses><seg-clauses>(ii) promoting muscle repair, </seg-clauses><seg-clauses>(iii) improving skeletal muscle regeneration, or </seg-clauses><seg-clauses>(iv) maintaining or increasing skeletal muscle function and/or skeletal muscle mass in an individual with muscle injury, the method comprising administering a therapeutically effective amount of a combination of vitamin B6 and nicotinamide to the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the vitamin B6 is administered in an amount of 1.0-25.0 mg of the vitamin B6 per day.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the nicotinamide is administered in an amount of about 10 mg/day to about 2000 mg of the nicotinamide per day.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the vitamin B6 is administered in an amount of 10-20.0 mg of the vitamin B6 per day, and the nicotinamide is administered in an amount of about 500 mg to about 1000 mg of the nicotinamide per day.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the vitamin B6 and the nicotinamide are administered in a vitamin B6: nicotinamide ratio from about 1:100 to about 1:9.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the vitamin B6 and the nicotinamide are administered in a vitamin B6: nicotinamide ratio from from about 1:45 to 1:30.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clau","A61K31/4415, A61K31/455, A61P21/00",20250612,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250042647A1,Capsule for the preparation of a beverage and a method for manufacturing said capsule,"A capsule for the preparation of a beverage in a beverage preparation device (<b>10</b>), comprising: a cup-shaped body (<b>1</b>) with a bottom wall (<b>4</b>), a lateral wall (<b>5</b>) and a flange (<b>3</b>), and a cover (<b>2</b>) sealed onto the flange (<b>3</b>) for closing the cup-shaped body (<b>1</b>), wherein said bottom wall (<b>4</b>) comprises at least a fluid injection portion (<b>7</b>), suitable for being pierced by a piercing member (<b>12</b>) of the beverage preparation device (<b>10</b>), and at least a surrounding portion (<b>13</b>A, <b>13</b>B) surrounding said first fluid injection portion (<b>7</b>); wherein the cup-shaped body (<b>1</b>) comprises a cellulose pulp layer (<b>14</b>), and an oxygen barrier liner (<b>15</b>) attached to said cellulose pulp layer (<b>14</b>); wherein the thickness (T<b>1</b>) of said fluid injection portion (<b>7</b>) is less than the thickness (T<b>2</b>) of said at least a surrounding portion (<b>13</b>A, <b>13</b>B), and wherein the density of at least the cellulose pulp layer (<b>14</b>) of said fluid injection portion (<b>7</b>) having reduced thickness is increased with respect to the density of the cellulose pulp of said surrounding portion (<b>13</b>A, <b>13</b>B); such as to improve the piercing of said fluid injection portion by the piercing member and to increase the stiffness of this fluid injection portion with respect to the stiffness of said surrounding portion (<b>13</b>A, <b>13</b>B).","<div class=""indep-clm"" num=""1""><seg-main>1. A capsule for the preparation of a beverage in a beverage preparation device, comprising: </seg-main><seg-clauses>a cup-shaped body with a bottom wall, a lateral wall and a flange, and a cover sealed onto the flange for closing the cup-shaped body, wherein:</seg-clauses>
<seg-clauses class=""seg-enter"">said bottom wall comprises at least a fluid injection portion, suitable for being pierced by a piercing member of the beverage preparation device, and at least a surrounding portion surrounding said first fluid injection portion;</seg-clauses>
<seg-clauses class=""seg-enter"">the cup-shaped body comprises a cellulose pulp layer, and an oxygen barrier liner attached to said cellulose pulp layer;</seg-clauses>
<seg-clauses class=""seg-enter"">the thickness (T<b>1</b>) of said fluid injection portion is less than the thickness (T<b>2</b>) of said at least a surrounding portion,</seg-clauses>
<seg-clauses class=""seg-enter"">the density of at least the cellulose pulp layer of said fluid injection portion having reduced thickness is increased with respect to the density of the cellulose pulp of said surrounding portion,</seg-clauses>
<seg-clauses class=""seg-enter"">such as to improve the piercing of said fluid injection portion by the piercing member and to increase the stiffness of this fluid injection portion with respect to the stiffness of said surrounding portion.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule according to claim 1, wherein </seg-main><seg-clauses>the thickness of said fluid injection portion is decreased by 10%-80% with respect to the thickness of said at least a surrounding portion.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The capsule according to claim 1, wherein:</seg-main>
<seg-clauses>only the thickness of the cellulose pulp layer of the fluid injection portion is less than the thickness of the cellulose pulp layer of said at least a surround","B65D85/804, B32B1/00, B32B3/02, B32B3/30, B32B27/08",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3006448C,Heat sterilized high protein compositions with hydrolyzed protein from a continuous process with at least one endopeptidase,"The present invention is directed to a heat sterilized composition comprising: a protein source in an amount of 5 to 20% by weight of the composition, said protein source comprising hydrolyzed protein; wherein the protein source has been treated in a continuous process with at least one endopeptidase, typically for a finite length of time. Furthermore, the invention concerns a heat sterilized high protein composition having low viscosity and being devoid of bitterness, comprising hydrolyzed heat sensitive protein source having a degree of protein hydrolysis in NPN/TN of 20 to 50% and at least one heat inactivated endopeptidase. The present invention is furthermore directed to a continuous process for preparing a heat sterilized composition which comprises a protein source containing hydrolyzed protein, the process comprising the following steps: (i) Providing an aqueous solution of a protein source; (ii) Performing a continuous hydrolysis step wherein the aqueous solution of a protein source is treated with at least one endopeptidase by heating at 40 to 90°C and for a finite length of time of 2 to 20 minutes; (iii) heat inactivation of the endopeptidase. The invention also concerns a method of controlling viscosity and preventing bitter taste of a heat sterilized high protein composition, the method comprising providing an aqueous solution of a protein source and continuously hydrolyzing the aqueous solution of a protein source with at least one endopeptidase prior to heat inactivation of the said endopeptidase. Finally, the invention concerns the use of hydrolyzed protein prepared in a continuous process as described herein by treatment with at least one endopeptidase for a finite length of time, for preparing a heat sterilized composition and/or for controlling the viscosity of a liquid composition, wherein the composition comprises 5 to 20 weight % total protein. The invention also concerns medical uses and treatments applying or using the inventive heat sterilized composition.",,"A23J3/08, A23J3/34",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2024252198A1,Large donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing less than about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving can be donut-shaped and have an average inner-hole diameter from about 3 mm to about 8 mm and are about 8 mm to about 2 cm in average diameter. The dry kibble can also have an average thickness from about 8 mm to about 2 cm.","CLAIMS
What Is Claimed Is:
<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, wherein the individual dry kibble pieces of the serving are about 8 mm to about 2 cm in average diameter and about 8 mm to about 2 cm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.1 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.4 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average thickness is from about 1.1 cm to about 1.8 cm.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a moisture content from about 4 wt% to about 10 wt%.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a stiffness from about 40 N/mm to about 120 N/mm.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>after dispensing the serving and the small adult dog begins feeding on the dry kibble, from about 45% to about 75% of the first three minutes of feeding on average includes chew time.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The met","A23K50/42, A23K40/00",20241212,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
US12325563B2,Anti-refill bottle cap,"A separate bottle cap comprising a bottle body connector (<b>1</b>), an outer cap (<b>2</b>), an anti-backflow assembly (<b>3</b>) and an inner cap (<b>4</b>), wherein the bottle body connector (<b>1</b>) is a hollow cylinder, a lower end thereof is fit and connected to a bottle body, the anti-backflow assembly (<b>3</b>) is provided between the bottle body connector (<b>1</b>) and the inner cap (<b>4</b>), a lower end of the outer cap (<b>2</b>) is sleeved on the anti-backflow assembly (<b>3</b>) and locks an inner wall of the bottle body connector (<b>1</b>), and the outer cap (<b>2</b>) is provided on the inner cap (<b>4</b>), wherein the anti-backflow assembly (<b>3</b>) comprises a piston anti-backflow water blocking member (<b>31</b>) and a water sealing connector (<b>32</b>), and the piston anti-backflow water blocking member (<b>31</b>) is movably connected with the water scaling connector (<b>32</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A separate bottle cap </seg-con><seg-trans>comprising </seg-trans><seg-refi>a bottle body connector, an outer cap, an anti-backflow assembly and an inner cap, wherein the bottle body connector is a hollow cylinder, a lower end thereof is fit and connected to a bottle body, the anti-backflow assembly is provided between the bottle body connector and the inner cap, a lower end of the outer cap is sleeved on the anti-backflow assembly and locks an inner wall of the bottle body connector, and the outer cap is provided on the inner cap; wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the anti-backflow assembly comprises a piston anti-backflow water blocking member and a water sealing connector, and the piston anti-backflow water blocking member is movably connected with the water sealing connector,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a fluid passage is provided in the water sealing connector, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a cross three-dimensional bump is formed by the fluid passage and a piston anti-backflow water blocking member is configured to adaptively cover the cross-three dimensional bump.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The separate bottle cap according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the piston anti-backflow water blocking member is a hat shape with a brim, and an annular retaining wall is formed on the brim of an outer wall of the piston anti-backflow water blocking member.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The separate bottle cap according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>a lower end of an inner wall of the piston anti-backflow water blocking member is formed as a conical structure.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. The separate bottle cap according to claim 2, </seg-con><seg-tran","B65D49/04, B65D41/32, B65D41/34, B65D51/18",20250610,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2839785C1,Improved flexible package for preparation of food or beverage product having rigid part,"FIELD: packaging and storage.SUBSTANCE: invention relates to a closed flexible sachet; the said sachet contains a beverage ingredient and is adapted for application in a device for preparation of beverages by way of piercing the sachet and injecting liquid into it for mixing with the said ingredient. Proposed package comprises flexible or semi-flexible sidewalls 2 that form flattened package body and cup-like bottom part to receive device fluid injection element. Package body and the cup-shaped lower part are formed from a single elongated primary flat blank sheet made of a flexible material, preferably a fibre-based material, which is folded in U-shape around its transverse axis of symmetry and is soldered at its side edges and top edge. Bowl-shaped lower part is a hollow volume having a concave bottom side and convex sides, and the curvature of the profile of said lower side is identical to the curvature of the profile of each of said lateral sides.EFFECT: provision of the possibility to produce package from environmentally safe material that can be easily connected to the device for beverages preparation without extraneous inclusions and in a tight manner.15 cl, 23 dwg","1. Гибкая или полугибкая закрытая упаковка (1) для размещения ингредиента для приготовления пищевого продукта в устройстве для приготовления пищевых или питьевых продуктов путем смешивания упомянутого ингредиента с жидкостью для смешивания, вводимой в упомянутую упаковку упомянутым устройством, причем упомянутая упаковка (1) содержит:
(i) гибкие или полугибкие боковые стенки (2), которые образуют уплощенный корпус упаковки, и
(ii) чашеобразную нижнюю часть (3), выполненную с возможностью вставки элемента впрыска жидкости устройства,
при этом корпус упаковки и чашеобразная нижняя часть образованы из цельного удлиненного первичного плоского листа (5) заготовки, изготовленного из гибкого материала, предпочтительно материала на основе волокон, который сложен в U-образной форме вокруг своей поперечной оси симметрии (Lx) и запаян по своим боковым краям и верхнему краю (4, 34), причем упомянутая чашеобразная нижняя часть (3) представляет собой полый объем, имеющий вогнутую нижнюю сторону (7) и выпуклые боковые стороны (8), а кривизна профиля упомянутой нижней стороны (7) идентична кривизне профиля каждой из упомянутых боковых сторон (8), при этом первичный лист (5) содержит первичное отверстие (15), которое пробито сквозь всю его толщину, при этом упомянутое первичное отверстие (15) расположено на нижней стороне (7) упомянутой чашеобразной нижней части (3), и при этом упомянутая упаковка (1) дополнительно содержит:
- вторичный усиливающий толщину лист (11), расположенный на по меньшей мере внутренней поверхности чашеобразной нижней части (3) упомянутой упаковки, причем упомянутый вторичный лист содержит вторичное отверстие (16), и
- третичный тонкий лист (14), расположенный между стенками упаковки и вторичным усиливающим толщину листом (11).
2. Упаковка (1) по п. 1, в которой упомянутая чашеобразная нижняя часть (3) имеет форму шестигранной призмы, причем упомянутая призма имеет два противоположных вертикальных края (9), выровненных относительно поперечной оси (Lx) упаковк",B65D85/804,20250512,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025093522A1,Multilayer metallized paper-based packaging material,"The present invention is related to a multi-layer metallized paper- based packaging material comprising: a paper layer having a grammage in the range of 30 to 120 g/m2; at least one organic barrier layer (3) of a polymer selected within the list of: polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, in an amount of 0.5 to 20 g/m2; at least one inorganic barrier layer (4) selected within the list of: metals, metalloids, or a combination thereof, said inorganic layer having a thickness comprised between 1 and 100 nm; and at least one organic heat seal layer (5) said heat seal layer (5) being applied in an amount comprised between 2 and 20 g/m2; wherein the at least one organic barrier layer is provided by depositing an aqueous solution of the polymer onto the paper layer, the solution having a concentration of from 1 to 30 wt%, and then drying at a temperature of from 70 to 100 °C for a time of 0.5 to 30 seconds. The present invention also relates to a method for producing said multi-layer metallized paper-based packaging material.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A multi-layer metallized paper-based packaging material (1) comprising, </seg-main><seg-clauses>from its outer side to its inner side: a paper layer (2) having a grammage in the range of 30 to 120 g/m<sup>2</sup>, at least one organic barrier layer (3) of a polymer selected within the list of: polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, in an amount of 0.5 to 20 g/m<sup>2</sup>, at least one inorganic barrier layer (4) selected within the list of: metals, metalloids, oxides thereof, or a combination thereof, said inorganic layer having a thickness comprised between 1 and 100 nm, and at least one organic heat seal layer </seg-clauses><seg-clauses>(5) said heat seal layer (5) being applied in an amount comprised between 2 and 20 g/m<sup>2</sup>, preferably in an amount comprised between 4 and 9 g/m<sup>2</sup>, wherein the at least one organic barrier layer is provided by depositing an aqueous solution or dispersion of the polymer onto the paper layer, the solution having a concentration of from 1 to 30 wt%, and then drying at a temperature of 70 to 100 °C for a time of 0.5 to 30 seconds.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A multi-layer metallized paper-based packaging material (1) comprising, </seg-main><seg-clauses><seg-main>from its outer side to its inner side:</seg-main>
<seg-clauses>- a paper layer (2) having a grammage in the range of 30 to 120 g/m<sup>2</sup>, at least one organic barrier layer (3) of a polymer selected within the list of: polyvinylalcohol (PVOH), ethylene vinyl alcohol (EVOH), butenediol vinyl alcohol co-polymer (BVOH), or a combination thereof, in an amount</seg-clauses>
<seg-clauses class=""seg-enter"">of 0.5 to 20 g/m<sup>2</sup>, wherein the degree of crystallinity of the polymer of the at least one organic barrier layer (3) is in the range of 35 to 39%; at least one inorganic barr","D21H19/02, D21H27/10, D21H19/82, D21H21/16, B65D65/42",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250144074A1,Sustained release melatonin compositions,"A composition includes melatonin encapsulated within a calcium alginate hydrogel. An orally administrable dosage form comprising such a composition held within a gel, and the gel is formed using starch as a gelling agent. Processes to produce these compositions, as well as their use in therapy, are also disclosed.","<div class=""indep-clm"" num=""1""><seg-main>1: A composition comprising </seg-main><seg-clauses>melatonin encapsulated within a calcium alginate hydrogel.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2: The composition according to claim 1, wherein </seg-main><seg-clauses>the weight ratio of the melatonin to the calcium alginate hydrogel is from 5:95 to 15:85.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3: The composition according to claim 1, wherein </seg-main><seg-clauses>the weight ratio of the melatonin to the calcium alginate hydrogel is about 10:90.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4: The composition according to claim 1, comprising </seg-main><seg-clauses>from 4 to 10 wt % water based on total weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5: The composition according to claim 1, comprising </seg-main><seg-clauses>from 6 to 8 wt % water based on total weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6: The composition according to claim 1, further comprising </seg-main><seg-clauses>sodium and lactate ions.</seg-clauses></div>
<div class=""indep-clm"" num=""7""><seg-main>7: An orally administrable dosage form comprising </seg-main><seg-clauses>a composition comprising melatonin encapsulated within a calcium alginate hydrogel, wherein the composition is held within a gel, wherein the gel is formed using starch as a gelling agent.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8: The dosage form according to claim 7, comprising </seg-main><seg-clauses>from 1 to 3 wt % of the composition based on total weight of the dosage form.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""7""><seg-main>9: The dosage form according to claim 7, further comprising </seg-main><seg-clauses>additional melatonin which is not encapsulated within the calcium alginate hydrogel.<","A61K31/4045, A61K9/00, A61K47/12, A61K47/26, A61K47/36",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025120147A1,Beverage foaming and dispensing device,"A beverage container (10) delimits an inside cavity (10') configured to contain at least one beverage liquid component (100). The container (10) comprises: a container inlet (11) configured to guide a pressurized fluid (101) into the inside cavity (10') from outside said container (10); a container outlet (19') configured to guide a processed beverage (100a) from inside the cavity (10') to outside the container (10); and a beverage passage (19) extending from the container outlet (19') into the cavity (10') and having a beverage passage inlet (19'') in the cavity (10'). The container inlet (11) and the beverage passage inlet (19'') are located such that during operation the beverage liquid component (100) contained inside the cavity (10') is pressurized and driven into the beverage passage inlet (19'') and along the beverage passage (19) and out of the container outlet (19') under the effect of the pressurized fluid (101) fed via the container inlet (11). The beverage passage (19) has a gas passage inlet (19''') and a mixing area (19a) that is fluidically connected to the container outlet (19'), to the beverage passage inlet (19'') and to the gas passage inlet (19'''). The inside cavity (10') with the beverage passage (19) is so configured that when driven by the pressurized fluid (101) fed into the cavity (10'), the beverage liquid component (100) and a beverage gas component (102) contained in the cavity (10') are passed into the mixing area (19a) via the beverage passage inlet (19'') and the gas passage inlet (19'''), respectively. The beverage liquid component (100) and the beverage gas component (102) are mixed together in the mixing area (19a) to form together the processed beverage (100a) that is dispensed via the container outlet (19').","Claims <div class=""indep-clm"" num=""1""><seg-main>1. A beverage container (10) delimits an inside cavity (10’) configured to contain at least one beverage liquid component (100) and comprises: </seg-main><seg-clauses>- a container inlet (11) configured to guide a pressurized fluid (101) into the inside cavity (10’) from outside said container (10), optionally the inlet (11) being provided with an anti-return valve (11a); </seg-clauses><seg-clauses>- a container outlet (19’) configured to guide a processed beverage (100a) from inside the cavity (10’) to outside the container (10), optionally the container outlet (19’) being provided with an outlet valve (19a’) and/or the cavity (10’) being connected to outside such container (10) via an overpressure or safety valve (19b’), the overpressure or safety valve (19b’) being for instance in fluid communication with the container inlet (11); and </seg-clauses><seg-clauses>- a beverage passage (19) extending from the container outlet (19’) into the cavity (10’) and having a beverage passage inlet (19’’) in the cavity (10’), the beverage passage (19) being for instance formed by a substantially tubular member, e.g. an upright substantially tubular member, the container inlet (11) and the beverage passage inlet (19’’) being located such that during operation said beverage liquid component (100) contained inside the cavity (10’) is pressurized and driven into the beverage passage inlet (19’’) and along the beverage passage (19) and out of the container outlet (19’) by said pressurized fluid (101) fed via the container inlet (11) into the inside cavity (10’), optionally the beverage passage (19) extending inside and/or from a container lid part (10a) closing an opening (10b) of said beverage container (10), such as a lid part (10a) that is removable from the opening (10b), the container inlet (11) being for instance provided in the lid part (10a),</seg-clauses>
<seg-clauses class=""seg-enter"">characterized in that the beverage passa","B67D1/04, B67D1/12",20250612,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250360151A1,Nutritional composition comprising GOS and hmos,"The present invention relates to a combination of galacto-oligosaccharides (GOS) and a mixture of human milk oligosaccharides (HMOs), or nutritional compositions comprising the combination. The combination or compositions are for use in treating and/or preventing stress and/or a mood disorder in an infant, young child and/or child. The mixture of HMOs consists or consists essentially of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or of lacto-N-tetraose (LNT) and 6′ sialyllactose (6′SL). The present invention also relates to the use of a combination of galacto-oligosaccharides (GOS) and a mixture of human milk oligosaccharides (HMOs), or compositions comprising the combination, for treating and/or preventing stress and/or a mood disorder in an infant, young child and/or child, wherein the mixture of HMOs consists or consists essentially of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or of lacto-N-tetraose (LNT) and 6′ sialyllactose (6′SL).","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in treating and/or preventing stress and/or a mood disorder in an infant, young child and/or child, comprising </seg-main><seg-clauses>administering a combination of galacto-oligosaccharides (GOS) and a mixture of human milk oligosaccharides (HMOs) to the infant or child, wherein the mixture of HMOs consists or consists essentially of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or of lacto-N-tetraose (LNT) and 6′ sialyllactose (6′SL).</seg-clauses></div>
<div class=""ccl-clm"" num=""2"">2. (canceled)</div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the combination restores the functionality of the bi-directional transmission pathways in the gut-brain axis to healthy levels.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the combination increases the production of gamma-aminobutyric acid (GABA) by the gut microbiota of the infant, young child and/or child and thereby treats stress and/or a mood disorder in the infant, young child and/or child.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the mood disorder is anxiety or depression.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the GOS are present in an amount of 2.4 g/L or 1.1 to 2.8 g/100 g of composition on a dry weight basis.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clauses>the mixture of HMOs consists or consists essentially of 2′FL and DFL.</seg-clauses></div>
<div class=""ccl-clm"" num=""8"">8. (canceled)</div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-main>9. The method according to claim 1, wherein </seg-main><seg-clauses>the","A61K31/702, A61P25/22, A61P25/24",20251127,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025190540A1,Promoting butyrate-producing bacteria in the gut microbiome,The present invention relates to a bifidogenic prebiotic for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; wherein the bifidogenic prebiotic is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A bifidogenic prebiotic for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidogenic prebiotic is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A Bifidobacterium microorganism for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; </seg-con><seg-trans>wherein </seg-trans><seg-refi>the Bifidobacterium is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-con>3. A combination of a bifidogenic prebiotic and a Bifidobacterium microorganism for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child </seg-con><seg-trans>wherein </seg-trans><seg-refi>the combination is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,3""><seg-con>4. A bifidogenic prebiotic, Bifidobacterium microorganism or a combination for use according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>levels of butyrate are increased in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,3,4""><seg-con>5. A bifidogenic prebiotic, Bifidobacterium microorganism or a combination for use according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg","A61K35/745, A23L33/135, A23L33/00, A61K31/702, A61K45/06",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119894385A,Methods for providing health benefits in animals,"The present disclosure provides methods and compositions for treating glomerular hyperfiltration, reducing glycogen storage in tissue, or reducing uremic toxins in an animal, the methods and compositions comprise orally administering to the animal a composition comprising a medium chain triglyceride, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arginine, an antioxidant, and a group B vitamin.","<div class=""indep-clm"" num=""1"">1.用于在动物中治疗肾小球过度滤过，减少组织中的糖原贮积，或减少尿毒症毒素的方法，所述方法包括向所述动物口服施用包含中链甘油三酯、二十碳五烯酸(EPA)、二十二碳六烯酸(DHA)、精氨酸、抗氧化剂和B族维生素的组合物。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述B族维生素包括烟酸、泛酸盐、吡哆醇、硫胺素、核黄素、生物素、叶酸和钴胺素。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中所述烟酸为RDA的约1倍至约30倍，所述泛酸盐为所述RDA的约1倍至约50倍，所述吡哆醇为所述RDA的约1倍至约30倍，所述硫胺素为所述RDA的约1倍至约200倍，所述核黄素为所述RDA的约1倍至约100倍，所述生物素为所述RDA的约1倍至约40倍，所述叶酸为所述RDA的约1倍至约50倍，并且所述钴胺素为所述RDA的约1倍至约50倍。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的方法，其中所述中链甘油三酯为所述组合物的约0.1重量％至约60重量％。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的方法，其中所述中链甘油三酯为所述组合物的约1重量％至约20重量％。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的方法，其中所述中链甘油三酯包括选自以下的中链脂肪酸：辛酸、癸酸以及它们的混合物。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的方法，其中所述DHA为所述组合物的约0.1重量％至约5.0重量％，所述EPA为所述组合物的约0.1重量％至约5.0重量％，所述精氨酸为所述组合物的约1重量％至约10重量％，所述维生素E为所述RDA的约1倍至约50倍，所述维生素C为所述组合物的约0.001重量％至1重量％，并且所述B族维生素为所述RDA的约1倍至100倍。</div>
<div class=""dep-clm"" num=""8"" parent=""1"">8.根据权利要求1所述的方法，其中所述组合物还包含附加的ω-3脂肪酸、抗氧化剂、防腐剂或它们的混合物。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的方法，其中所述组合物为完全且营养平衡的宠物食物。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的方法，其中所述组合物为补充剂。</div>
<div class=""dep-clm"" num=""11"" parent=""1"">11.根据权利要求1所述的方法，其中所述动物为伴侣动物。</div>
<div class=""dep-clm"" num=""12"" parent=""1"">12.根据权利要求1所述的方法，其中所述动物具有选自由以下组成的组的健康状况：肾病、肥胖症、糖尿病、代谢综合征、透明变性、高血压、甲状腺功能减退、神经病、心血管疾病以及它们的组合。</div>
<div class=""dep-clm"" num=""13"" parent=""1"">13.根据权利要求1所述的方法，其中所述动物为老年动物。</div>
<div class=""dep-clm"" num=""14"" parent=""1"">14.根据权利要求1所述的方法，其中每日向所述动物施用所述组合物，持续至少一周。</div>
<div class=""dep-clm"" num=""15"" parent=""1"">15.根据权利要求1所述的方法，其中所述组合物以每天提供约10mgMCT/kg所述动物的体重至约500mg MCT/kg所述动物的体重的量施用。</div>","A23K20/142, A23K20/158, A23K20/174, A23K50/40",20250425,雀巢产品有限公司,['Pending']
EP4491069A1,"Machine, deformation unit for such a machine and method for preparing a beverage with such a machine",The preparation machine (1) comprises a preparation unit (2) having i) a chamber (5) for receiving the capsule (100) and ii) means for injecting the fluid in the capsule (100) to prepare the beverage. The preparation machine (1) further comprises a deformation unit (4) having a deformation element (7) movable to deform the capsule body (101) such that the beverage component (103) is released from the cavity (102) of the capsule (100).,"<div class=""indep-clm"" num=""1""><seg-main>1.  Preparation machine (1) for preparing a beverage by injecting a fluid in a capsule (100), the capsule (100) having </seg-main><seg-clauses>i) a capsule body (101) defining a cavity (102) and </seg-clauses><seg-clauses><seg-main>ii) a beverage component (103) contained within the cavity (102), wherein the preparation machine (1) comprises: </seg-main><seg-clauses><seg-main>- a preparation unit (2) having </seg-main><seg-clauses>i) a preparation chamber (5) for receiving the capsule (100) and </seg-clauses><seg-clauses>ii) means for injecting the fluid in the capsule (100) to prepare the beverage, and </seg-clauses></seg-clauses><seg-clauses>- a deformation unit (4) having a deformation element (7), the deformation element (7) being movable so as to deform the capsule body (101) such that at least part of the beverage component (103) is released from the cavity (102) after the capsule (100) has been processed in the preparation unit (2).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  Preparation machine (1) according to claim 1, wherein </seg-main><seg-clauses>the deformation element (7) includes a punch.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  Preparation machine (1) according to any one of the preceding claims, further comprising </seg-main><seg-clauses>a driving unit (10) configured to move the deformation element (7), the driving unit (10) including a motor or a manual actuator.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  Preparation machine (1) according to any one of the preceding claims, wherein </seg-main><seg-clauses>the deformation unit (4) further comprises an abutment wall (14), the deformation element (7) being configured to move, preferably in translation, toward the abutment wall (14) so as to push the capsule (100) against the abutment wall (14).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" pare","A47J31/36, A47J31/44, A47J31/60",20250115,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12358683B2,Recyclable container comprising a cardboard-based socket element and a paper-based receptacle element,"The present invention concerns a recyclable container (<b>1</b>) comprising a cardboard-based socket element (<b>2</b>) and a paper-based receptacle element (<b>3</b>), wherein the receptacle element is connected to the socket element in a way that a product can flow from the receptacle element through the socket element, so that the product can be dispensed by the bulk dispensing device. The container is recyclable with the paper stream.","<div class=""indep-clm"" num=""1""><seg-con>1. A container recyclable in a paper stream recycling process, </seg-con><seg-trans>comprising </seg-trans><seg-refi>a cardboard-based socket element and a paper-based receptacle element partially fitted therein, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the socket element is to be connected to a bulk dispensing device and comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an essentially square or rectangular base area,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>four substantially square or rectangular wall members, each located at each one of the four edges of the base area and extending upwardly therefrom, and being connected to each other to form, with the base area, a rigid parallelepipedal socket opened at its upper side,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a connection element that can be connected to the bulk dispensing device, said connection element comprising a dispensing opening with an area of 50-350 cm<sup>2</sup>, preferably of 60-90 cm<sup>2</sup>, said dispensing opening being closed by a frangible membrane made of a paper having a grammage of between 30 g/m<sup>2 </sup>and 150 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said socket element being rigid and made of cardboard having a grammage comprised of between 150 g/m<sup>2 </sup>and 800 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the receptacle element comprises a closable opening for filling said receptacle element with a product to be dispensed by the bulk dispensing device, and comprises lateral walls and a bottom wall defining a containment volume of 5 to 20 litres, said receptacle element being flexible and having lateral walls made of a paper having a grammage greater than that of the frangible membrane and between 50 g/m<sup>2 </sup>and 350 g/m<sup>2</sup>,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-re","B65D5/72, B65D65/42",20250715,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250149147A1,Method for determining the gut microbiome status,The present invention provides methods for determining the gut microbiome status of a subject given one or more CAZyme abundances provided from the subject's gut metagenomic data. The present invention also provides methods for maintaining or improving the gut microbiome status of a subject.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for providing a trained regression model for determining the gut microbiome status of a subject, wherein </seg-main><seg-clauses><seg-main>the method comprises:</seg-main>
<seg-clauses>(a) providing gut metagenomic data from a population of healthy subjects; and</seg-clauses>
<seg-clauses>(b) training a regression model on the gut metagenomic data, wherein the age of the healthy subjects at data collection is regressed on one or more carbohydrate-active enzyme (CAZyme) abundances provided from the gut metagenomic data.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the CAZymes are selected from the group consisting of glycoside hydrolases (GH), glycosyltransferases (GT), Polysaccharide Lyases (PL), Carbohydrate esterases (CE), and their associated carbohydrate binding modules (CBMs).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the method further comprises obtaining the gut metagenomic data from the population of healthy subjects.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the healthy subjects are infants and/or children.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the regression model is a tree-based regression model, preferably a random forest regression model.</seg-clauses></div>
<div class=""ccl-clm"" num=""7"">6-7. (canceled)</div>
<div class=""indep-clm"" num=""8""><seg-main>8. A method for determining the gut microbiome status of a subject, wherein </seg-main><seg-clauses><seg-main>the method comprises:</seg-main>
<seg-clauses>(a) providing a trained regression model by a method comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">","G16H20/60, G16B40/20",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025031901A1,Emulsion gels,"The present invention provides an emulsion gel comprising at least about 400 kcal/100g, wherein the emulsion gel comprises an E471 emulsifier and an E472 emulsifier, and wherein the ratio of the total weight of E471 emulsifier to the total weight of E472 emulsifier is from about 1.8:1.0 to about 1.0:1.0.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An emulsion gel comprising </seg-main><seg-clauses><seg-main>320 kcal/100g to 480 kcal/100 g energy, wherein the emulsion gel comprises an E471 emulsifier and an E472 emulsifier, and wherein the ratio of the total weight of E471 emulsifier to the total weight of E472 emulsifier is from about 1.8: </seg-main><seg-clauses>1.0 to about 1.0:1.0.</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. An emulsion gel comprising </seg-main><seg-clauses><seg-main>at least about 400 kcal/100g, wherein the emulsion gel comprises an E471 emulsifier and an E472 emulsifier, and wherein the ratio of the total weight of E471 emulsifier to the total weight of E472 emulsifier is from about 1.8: </seg-main><seg-clauses>1.0 to about 1.0: 1.0.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The emulsion gel according to claim 1 or 2, wherein </seg-main><seg-clauses><seg-main>the emulsion gel comprises:</seg-main>
<seg-clauses>(a) emulsifier in a total amount of from about 1 .0 wt% to about 1.8 wt%, from about 1.1 wt% to about 1 .7 wt%, or from about 1 .2 wt% to about 1.6 wt%;</seg-clauses>
<seg-clauses>(b) E471 emulsifier in a total amount of from about 0.5 wt% to about 1.2 wt%, from about 0.6 wt% to about 1.1 wt%, or from about 0.7 wt% to about 1.0 wt%; and/or</seg-clauses>
<seg-clauses>(c) E472 emulsifier in a total amount of from about 0.3 wt% to about 0.9 wt%, from about 0.4 wt% to about 0.8 wt%, or from about 0.5 wt% to about 0.7 wt%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The emulsion gel according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the ratio of the total weight of E471 emulsifier to the total weight of E472 emulsifier is from about 1.7: 1.0 to about 1.1 : 1.0, from about 1.6: 1.0 to about 1 .2: 1.0, or from about 1 .5: 1.0 to about 1.3: 1.0, optionally wherein the ratio of the total weight","A61P1/06, A23L29/10, A23L29/238, A23L29/256, A23L33/00",20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
JP2025020269A,System for production of homogenous single-phase beverage for administration to individual having dysphagia,"To provide a system for production of a homogenous single-phase beverage for administration to an individual having dysphagia.SOLUTION: A system comprises: a container containing a liquid concentrate comprising a thickening component selected from the group consisting of a β-glucan, at least one plant-extracted gum, at least one plant-derived mucilage, and combinations thereof, the liquid concentrate being formulated for dilution into a nutritional product so as to increase the shear viscosity of the nutritional product to a level greater than 200 mPas and less than or equal to about 2,000 mPas at a shear rate of 50 s-1 at 20°C, and increase the relaxation time, measured by a Capillary Breakup Extensional Rheometry (CaBER) experiment, to more than 10 ms (milliseconds) at a temperature of 20°C; and a metering pump connected to the container and configured to dispense an amount of the liquid concentrate per pump performed on the metering pump by a user that is approximately equal to a predetermined amount.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> β－グルカン、少なくとも１つの植物抽出ガム、少なくとも１つの植物由来粘質物、及びこれらの組み合わせからなる群から選択される増粘成分を含む濃縮液であって、前記濃縮液が、希釈剤での希釈により、</div>
<div class=""indep-clm"" num=""1""> ２０℃で、５０ｓ<sup> －１</sup>の剪断速度で２００ｍＰａｓ超、かつ最大約２，０００ｍＰａｓの剪断粘度と、</div>
<div class=""indep-clm"" num=""1""> キャピラリー破断式伸長粘度計（ＣａＢＥＲ）実験によって測定したときに、２０℃の温度で１０ｍｓ（ミリ秒）超となる緩和時間と、</div>
<div class=""indep-clm"" num=""1""> を有する栄養製品を形成するよう配合されている、濃縮液。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２００ｍＰａｓ超、かつ最大約５００ｍＰａｓである、請求項１に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記栄養製品の剪断粘度が、５０ｓ<sup> －１</sup>の剪断速度で測定したときに、２５０ｍＰａｓ～約４００ｍＰａｓである、請求項１又は２に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記増粘成分が、β－グルカン、好ましくはオート麦β－グルカンを含む、請求項１～３のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記濃縮液が、最大２００：１、好ましくは５０：１～１００：１の比率で希釈剤で希釈される、請求項１～４のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記栄養製品が、医薬製剤、栄養製剤、栄養補助食品、機能性食品、及び飲料製品、並びにこれらの組み合わせからなる群から選択される投与可能な形態である、請求項１～５のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記増粘成分が、前記濃縮液の０．０１重量％～２５重量％である、請求項１～６のいずれか一項に記載の濃縮液。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記濃縮液が、水を更に含み、前記栄養製品が、以下からなる群から選択される少なくとも１つの配合を有する：</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉ）前記希釈剤が、水、乳、水と、この水に加えて更に少なくとも１つの成分とを含む飲料、液体経口栄養補助食品（ＯＮＳ）、又は食品製品のうちの１つ以上であり、前記濃縮液を前記希釈剤で希釈することにより、前記希釈剤と、前記増粘成分と、前記濃縮液に由来する水とから本質的に構成される又はこれらから構成される前記栄養製品を直接形成する、</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> （ｉｉ）前記濃縮液","A23L33/10, A23L2/52, A23L29/206",20250212,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
WO2025078557A1,Compositions comprising a probiotic strain for improving muscle strength,"The invention provides a nutritional composition comprising pre-conditioned L. reuteri as a probiotic strain. The nutritional composition can be particularly enriched in vitamins and minerals, and is useful for improving the muscle condition of a subject, particularly the muscle strength in an infant, a young child or a child.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A nutritional composition comprising </seg-main><seg-clauses>L reuteri as a probiotic strain, wherein L reuteri is preconditioned.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The nutritional composition according to claim 1 , wherein </seg-main><seg-clauses>L. reuteri is pre-conditioned with galacto-oligosaccharide (GOS).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The nutritional composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses><seg-main>the pre-conditioned L. reuteri is obtained or obtainable by a process comprising the following steps: </seg-main><seg-clauses>a) cultivating a probiotic L. reuteri strain in the presence of galacto-oligosaccharide (GOS) in a growth medium, thereby pre-conditioning the probiotic L. reuteri strain; </seg-clauses><seg-clauses>b) harvesting the pre-conditioned L. reuteri from the growth medium.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The nutritional composition according to claim 3, wherein </seg-main><seg-clauses>the process is comprising the following further step: </seg-clauses><seg-clauses>c) adding (fresh) GOS to the pre-conditioned probiotic L. reuteri strain obtained from step b).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The nutritional composition according to any of the preceding claims, further comprising </seg-main><seg-clauses>at least one vitamin.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The nutritional composition according to claim 5, wherein </seg-main><seg-clauses>the at least one vitamin is selected form the list consisting of: vitamin A, vitamin B1 , vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B7, vitamin B5, vitamin B9, and any combinations thereof; preferably a combination comprising or consisting of high a","A23L33/135, A23L33/00, A61K35/747, A61P21/00",20250417,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2025200329A1,Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor,"A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD+) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating or preventing at least one physical state selected from the group consisting of </seg-main><seg-clauses>oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, the method comprising administering to an individual in need thereof an effective amount of a combination of a tryptophan and a medium chain triglyceride (MCT).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of Claim 1, wherein </seg-main><seg-clauses>the at least one physical state is selected from the group consisting of deleterious effects of aging, muscle loss, type I diabetes, type II diabetes, complications from diabetes, insulin resistance, metabolic syndrome, dyslipidemia, overweight, obesity, raised cholesterol levels, raised triglyceride levels, elevated fatty acid levels, fatty liver disease, cardiovascular disease, neurodegenerative disease, depression, anxiety, decreased /low motivation, impaired cognitive function, myopathy such as statin-induced myopathy, nonalcoholic steatohepatitis, tinnitus, dizziness, alcohol hangover, hearing impairment, osteoporosis, hypertension, atherosclerosis/coronary artery disease, myocardial damage after stress, traumatic brain injury, cystic fibrosis, inflammation, cancer, HIV infection, stroke, migraine and brain ischemia.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of Claim 1, wherein </seg-main><seg-clauses>the combination is administered enterally.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of Claim 1, wherein </seg-main><seg-clauses>the combination is administered in a composition selected from the group consisting of a food product, a food supplement, an oral nutritional supplements (ONS), a medical food, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""","A61K31/19, A61K31/405, A61K31/4425, A61K31/455, A61K31/706",20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019400059B2,Beverage preparation machine with capsule recognition,,,A47J31/44,20250417,SOCIÉTÉ DES PRODUITS NESTLÉ SA,['Active']
JP2024170640A,Dietary butyrate,"To provide a dietary source including butyrate with improved organoleptic properties for use in the prevention and/or treatment of cardiovascular disorders.SOLUTION: The present invention provides compounds having the formulae (1), (2), (3) and (4), or combinations thereof, for use in the treatment or prevention of cardiovascular disorders in a subject, where R1, R2, R3, R4, R5, and R6 independently represent a long chain fatty acid with 16 to 20 carbons.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 対象における心血管障害の予防又は治療に使用するための、次式を有する化合物又はこれらの組み合わせ。</div>
<div class=""indep-clm"" num=""1""> 【化1】<img src=""https://data-fulltext-image.patsnap.com/JP/A/20/24/17/06/40/1733831435869/2024170640000007.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064364%3B1765067964%26q-key-time%3D1765064364%3B1765067964%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Dce5dd4b53559230fae489cec71ab1c91b05a3ba9&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A24%20GMT"" class=""img-anchor img-center"" img-id=""2024170640000007"" image_type=""chemistry"" official_size=""21648""></div>
<div class=""indep-clm"" num=""1""> ［式中、Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及びＲ<sup> ６</sup>は、独立して、１６～２０個の炭素を有する長鎖脂肪酸である。］ </div>
<div class=""indep-clm"" num=""2"">【請求項2】</div>
<div class=""indep-clm"" num=""2""> 対象における心血管障害の治療又は予防に使用するための、次式を有する化合物又はこれらの組み合わせを含む、組成物。</div>
<div class=""indep-clm"" num=""2""> 【化2】<img src=""https://data-fulltext-image.patsnap.com/JP/A/20/24/17/06/40/1733831435869/2024170640000008.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064364%3B1765067964%26q-key-time%3D1765064364%3B1765067964%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D8447646fca51bd46dd3389f6f8edcb172513d284&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A24%20GMT"" class=""img-anchor img-center"" img-id=""2024170640000008"" image_type=""chemistry"" official_size=""21592""></div>
<div class=""indep-clm"" num=""2""> ［式中、Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及びＲ<sup> ６</sup>は、独立して、１６～２０個の炭素を有する長鎖脂肪酸である。］ </div>
<div class=""dep-clm"" num=""3"" parent=""2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""2""> 前記組成物が、式（１）を有する前記化合物、式（２）を有する前記化合物、式（３）を有する前記化合物、及び式（４）を有する前記化合物を含む、請求項２に記載の使用のための組成物。 </div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">【","A61K31/23, A61P9/10, A61P9/04, A61K31/231, A61P3/04",20241210,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
EP4538356A1,Dietary butyrate,"The invention relates to a compound having the formula (1), (2), (3) or (4) or combinations thereof, for use in therapy, particularly for use in treating inflammatory bowel disease, for example Crohn's Disease or Ulcerative Colitis.","<div class=""indep-clm"" num=""1""><seg-main>1.  A compound having </seg-main><seg-clauses>the formula <img src=""https://data-fulltext-image.patsnap.com/EP/A1/45/38/35/6/1744855184995/imgb0025.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064343%3B1765067943%26q-key-time%3D1765064343%3B1765067943%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D30c8d4f94fe9aa69b5878c1af602d74292654944&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A03%20GMT"" class=""img-anchor"" img-id=""IMGB0025"" image_type=""chemistry"" official_size=""20496""> or combinations thereof, for use in therapy, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> are independently a long chain fatty acid having between 16 and 20 carbons.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2.  A compound having </seg-main><seg-clauses>the formula <img src=""https://data-fulltext-image.patsnap.com/EP/A1/45/38/35/6/1744855184995/imgb0026.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064343%3B1765067943%26q-key-time%3D1765064343%3B1765067943%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D6dc044d5316c83088906798a5da0c4a3d7ff577f&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A03%20GMT"" class=""img-anchor"" img-id=""IMGB0026"" image_type=""chemistry"" official_size=""20659""> or combinations thereof, for use in treating inflammatory bowel disease, for example, Crohn's Disease or Ulcerative Colitis, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> are independently a long chain fatty acid having between 16 and 20 carbons.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3.  Use according to claim 1 or 2, wherein </seg-main><seg-clauses>a combination of a compound having formula (1) and a compound having formula (2) is used, preferably where","C11C3/00, C11C3/10, A23L29/00, A23L33/00, A23L33/115",20250416,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019395713B2,Powdered thickener maintaining its extensional properties when reconstituted and for promoting safe swallowing by individuals with dysphagia,"A thickening powder promotes safe swallowing of a nutritional product by an individual with dysphagia and can be used in methods of treating dysphagia, promoting safe swallowing of a nutritional product, and mitigating a risk of aspiration during swallowing of a nutritional product. The powder contains beta-glucan and at least one carrier ingredient in an amount that is neutral toward or enhances the extensional properties of the nutritional product. The at least one carrier ingredient can be one or more of maltodextrin, isomaltulose, sucrose or lactose. The powder can be diluted in a diluent to form an aqueous solution that is at least a portion of a nutritional product and to improve the cohesiveness of the nutritional product. Preferably, the resultant nutritional product has a shear viscosity greater than 200 mPas and up to about 2,000 mPas, preferably greater than 200 mPas and up to about 500 mPas, more preferably 250 mPas to about 450 mPas, most preferably 250 mPas to about 400 mPas, when measured at a shear rate of 50s","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating a swallowing disorder or mitigating a risk of aspiration during swallowing in an individual having </seg-main><seg-clauses><seg-main>the swallowing disorder, the method comprising orally administering to the individual a nutritional product in which at least a portion thereof is made by diluting in a diluent a thickening powder to form an aqueous solution,</seg-main>
<seg-main class=""seg-enter"">wherein the thickening powder comprises a beta-glucan and at least one carrier ingredient selected from the group consisting of maltodextrin, isomaltulose, sucrose, lactose, and combinations thereof;</seg-main>
<seg-main class=""seg-enter"">wherein the weight ratio of beta-glucan to the at least one carrier ingredient is in a weight ratio of about 10:1 to 300:1;</seg-main>
<seg-main class=""seg-enter"">wherein the weight ratio of diluent:thickening powder is from 50:1 to 100:1;</seg-main>
<seg-main class=""seg-enter"">wherein the diluent is one or more of water, milk, a beverage comprising water and further comprising at least one component additional to the water, a liquid oral nutritional supplement (ONS), or a food product;</seg-main>
<seg-main class=""seg-enter"">wherein the thickening powder is diluted from a unit dosage form of the thickening powder that is an amount effective for administration of the nutritional product to the individual to achieve at least one of </seg-main><seg-clauses>(i) supplemental nutrition, </seg-clauses><seg-clauses>(ii) hydration and </seg-clauses><seg-clauses>(ii) replacement of one or more full meals; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the nutritional product comprises an amount of the aqueous solution that maintains or enhances extensional viscosity properties of the nutritional product and provides to the nutritional product a shear viscosity greater than 200 mPas and up to about 2,000 mPas at a shear rate of 50 s'1 at 20° C.</seg-clauses></seg-clauses></div>
","A23L29/269, A23L33/21",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2018408336B2,Beverage preparation machine with capsule recognition,"Machine for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food, comprising a capsule recognition module for recognizing a capsule inserted in said machine at a capsule recognition position, the capsule recognition module comprising a camera for capturing an image of at least part of said capsule in said capsule recognition position; wherein the capsule recognition module comprises a neural network computing device, said neural network computing device being configured to determine a type of said capsule amongst a plurality of predefined capsule types on the basis of an image of at least part of said capsule captured by said camera.","2018408336 30 Jan 2025
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS : -
<div class=""indep-clm"" num=""1""><seg-main>1. Machine for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup 5 or baby food, such machine comprising:</seg-main>
<seg-clauses>- an extraction unit for extracting a beverage ingredient capsule to form said beverage, e.g. a unit having a first part and a second part that are relatively movable between a distant position for inserting and/or removing 10 a capsule and a close position, such as a close position in which the first and second parts delimit an extraction chamber, for securing and extracting such capsule, optionally at least one of said parts has a capsule opener e.g. one or more capsule piercers and/or at least 15 one of said parts has an opening for an inflow of liquid to be mixed with an ingredient contained in such capsule;</seg-clauses>
<seg-clauses>- a control unit for controlling the extraction unit to extract such capsule, such as a control unit powered by the mains e.g. via an electric cord;</seg-clauses>
<seg-clauses class=""seg-enter"">20   - an outlet for dispensing said beverage formed by</seg-clauses>
<seg-clauses class=""seg-enter"">extracting such capsule to a user-receptacle, such as a cup or a mug, located in a receptacle placing area, such as on a receptacle support e.g. an external placement support on which such machine is located or a machine 25 support e.</seg-clauses><seg-clauses>g. a movable or removable machine support, to collect said beverage,</seg-clauses>
<seg-clauses>- a capsule recognition module for recognizing a capsule inserted in said machine at a capsule recognition position, the capsule recognition module comprising a 30 camera for capturing a digital image of at least part of said capsule in said capsule recognition position;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the capsule recognition module comprises a neural network computing device, sai",A47J31/44,20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119816732A,Methods of providing and determining effective weight loss diet for dogs,"The present disclosure provides a method of determining the efficacy of a weight loss diet in a canine, the method comprising analyzing a biomarker of a serum or plasma sample from the canine before and after administration of the weight loss diet wherein the biomarker is selected from the group consisting of 3-methylhistidine, 1-methylhistidine, and combinations thereof, and determining that the weight loss diet is effective if the amount of the biomarker has decreased.","<div class=""indep-clm"" num=""1""><seg-con>1.一种确定犬类减重饮食功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>分析来自所述犬类的第一血清或血浆样品的生物标志物，所述生物标志物选自由以下组成的组：3-甲基组氨酸、1-甲基组氨酸以及它们的组合；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>确定所述第一血清或血浆样品中所述生物标志物的量；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>在已经对所述犬类施用了所述减重饮食后，分析第二血清或血浆样品的所述生物标志物；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>确定所述第二血清或血浆样品中所述生物标志物的量；以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>如果所述第二血清样品或血浆样品中所述生物标志物的所述量比所述第一血清样品中所述生物标志物的所述量已经减少，则确定所述减重饮食是有效的，或如果所述第二血清样品或血浆样品中所述生物标志物的所述量与所述第一血清或血浆样品中所述生物标志物的所述量相比尚未改变或相比增加，则确定所述减重饮食是无效的。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中已经规律地向所述犬类施用所述减重饮食。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的方法，其中已经向所述犬类施用所述减重饮食至少1个月。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的方法，其中所述减重包括完全且均衡的宠物食物。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的方法，所述方法还包括向所述犬类施用所述减重饮食。</div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6.根据权利要求1所述的方法，</seg-con><seg-trans>其中，</seg-trans><seg-refi>当所述减重饮食有效时，所述减重饮食提供选自由以下组成的组的健康益处：保持瘦体重、减重期间最小化瘦体重、体脂肪减少、体重减少、体重增加减少、胰岛素抵抗减少、糖尿病风险降低、前驱糖尿病风险降低、低胆固醇、低葡萄糖、低甘油三酯、低胰岛素、低瘦蛋白、胰岛素敏感性改善、预防前驱糖尿病、延迟前驱糖尿病的发作、治疗前驱糖尿病、预防糖尿病、延迟糖尿病的发作、治疗糖尿病、预防胰岛素抵抗、延迟胰岛素抵抗的发作、治疗胰岛素抵抗、预防超重或肥胖、延迟超重或肥胖的发作、治疗超重或肥胖、促进代谢健康、促进更好的血糖控制、降低慢性炎症和促炎细胞因子、改善自主日间活动、减少日间和夜间躁动、增加饱腹感以及它们的组合。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7.根据权利要求1所述的方法，</seg-con><seg-trans>其中，</seg-trans><seg-refi>当所述减重饮食无效时，向所述犬类建议不同的减重饮食。</seg-refi></div>
<div class=""indep-clm"" num=""8""><seg-con>8.一种为犬类提供有效减重饮食的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""8""><seg-comp>分析来自所述犬类的第一血清或血浆样品的生物标志物，所述生物标志物选自由以下组成的组：3-甲基组氨酸、1-甲基组氨酸以及它们的组合；</seg-comp></div>
<div class=""indep-clm"" num=""8""><seg-comp>确定所述第一血清或血浆样品中所述生物标志物的所述量；</seg-comp></div>
<div class=""indep-clm"" num=""8""><seg-comp>在已经对所述犬类施用了所述减重饮食后，分析第二血清或血浆样品的所述生物标","G01N33/50, G01N33/68",20250411,雀巢产品有限公司,['Pending']
US20250072401A1,Methods of monitoring feeding behaviors of pets,"The present disclosure relates to the monitoring feeding behavior(s) of a pet(s), under the control of at least one processor. An example method includes obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl. The load sensor can have a sensitivity of +/−50 grams or less and the load data is obtained can occur at a sample rate from 10 samples to 150 samples per second. The example method can also include sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples, and identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of monitoring feeding behavior of a pet, under the control of at least one processor, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl, wherein the load sensor has a sensitivity of +/−50 grams or less and the load data is obtained at a sample rate from 10 samples to 150 samples per second;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>excluding load data in identifying the feeding behavior if determined to be a result of human interaction, a false trigger, or an accidental interaction with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the feeding behavior is a count-based feeding behavior selected from lapping, licking, or biting.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method of claim 3, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>characterizing the count-based feeding behavior by counting individual micro-events of the feeding behavior within a single time increment or a time period spanning multiple time increments, wherein the individual micro-events include individual laps, individual licks, or individual bites.</seg-",A01K29/00,20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025008277A1,Combination for dietary management of gut health,"The present invention provides a combination comprising lactose and human milk oligosaccharides (HMOs) 2'-fucosyllactose (2'-FL), lacto-/V-neotetraose (LNnT), 3- fucosyllactose (3'-FL), at least one of 3'-sialyllactose (3'-SL) or 6'-sialyllactose (6'-SL), and optionally lacto-N-tetraose (LNT) for use in the dietary management of dysbiosis of the gut microbiota in a subject or for use in the dietary management of a disease or disorder associated with metabolism and/or accumulation of BCFA in a subject.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A combination comprising </seg-main><seg-clauses><seg-main>lactose and human milk oligosaccharides (HMOs) 2'- fucosyllactose (2’-FL), lacto-/V-neotetraose (LNnT), 3-fucosyllactose (3’-FL), and at least one of 3’-sialyllactose (3’-SL) or 6’-sialyllactose (6’-SL) for use in</seg-main>
<seg-clauses>(a) the dietary management of dysbiosis of the gut microbiota in a subject;</seg-clauses>
<seg-clauses>(b) the dietary management of a disease or disorder associated with metabolism and/or accumulation of branched chain fatty acids (BCFA) in a subject; or</seg-clauses>
<seg-clauses>(c) the reduction of BCFA in a subject.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The combination for use according to claim 1 , wherein </seg-main><seg-clauses>the composition comprises the HMOs 2’-FL, LNnT, 3’-FL, 3’-SL, 6’-SL, and lacto-N-tetraose (LNT).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The combination for use according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the combination is for use in the dietary management of dysbiosis of the gut microbiota, and wherein the dysbiosis includes increased production of BCFA, such as isobutyrate, isovalerate, and/or isocaproate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The combination for use according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the combination is for use in the dietary management of dysbiosis of the gut microbiota in a subject, and wherein the dysbiosis of the gut microbiota is associated with an intestinal disorder and/or an extra- intestinal disorder; optionally wherein the intestinal disorder is one or more of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and coeliac disease and/or wherein the extra-intestinal disorder is one or more of allergy, asthma, atopic dermatitis, metabolic syndrome, cardiovascular disease, ob","A23L33/21, A23L33/00, A61K31/7016, A61K31/702, A61P1/00",20250109,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2024286491A1,Large donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing less than about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving can be donut-shaped and have an average inner-hole diameter from about 3 mm to about 8 mm and are about 8 mm to about 2 cm in average diameter. The dry kibble can also have an average thickness from about 8 mm to about 2 cm.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, wherein the individual dry kibble pieces of the serving are about 8 mm to about 2 cm in average diameter and about 8 mm to about 2 cm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.1 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.4 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average thickness is from about 1.1 cm to about 1.8 cm.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a moisture content from about 4 wt% to about 10 wt%.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a stiffness from about 40 N/mm to about 120 N/mm.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>after dispensing the serving and the small adult dog begins feeding on the dry kibble, from about 45% to about 75% of the first three minutes of feeding on average includes chew time.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The method of claim 1, </seg-con><","A23K50/42, A23K40/00",20250918,SOCIETE DES PRODUITS NESTLE SA,['Pending']
AU2024238639A1,Beverage capsule system with repeated code,"A system comprising a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material, the container including: a code arrangement comprising a plurality of code repetitions, each code encoding a binary sequence to at least partially encode preparation information, the machine including: a code reading system to read the code repetitions; a processing unit for processing the precursor material of the container, and; electrical circuitry to control the processing unit based on the preparation information, wherein electrical circuitry is configured to: read the code repetitions to obtain the binary sequence for each code; implement a code decoder to determine a number of bit errors associated with the binary sequence, and; determine a recipe based on the binary sequence and the number of bit errors.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code arrangement comprising a plurality of code repetitions, each code repetition encoding a binary sequence to at least partially encode preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code repetitions;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein electrical circuitry is configured to:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>read the code repetitions to obtain the binary sequence for each code repetition;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>implement a code decoder to determine a number of bit errors associated with the binary sequence, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determine a recipe based on the binary sequence and the number of bit errors.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the electrical circuitry is configured to implement the code decoder to determine an invalid binary sequence if the binary sequence is not associated with a recipe.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The system of either of claims 1 or ","A47J31/44, B65D85/804, G06K19/00",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250026560A1,Beverage or foodstuff container and preparation system,"A container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including: a storage portion for containing a precursor material, a closing member to close the storage portion and an annular flange-like rim comprising an annular force ring made of a wood pulp-based material, wherein the annular force ring is of essentially S-shaped when seen in transversal cross-section. A set of different containers is also proposed as well as a container system and a system comprising a container and a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-con>1. A container designed for insertion in and use with a preparation machine for preparing a beverage and/or foodstuff or a precursor thereof from a precursor material stored in the container by introducing liquid in the container and passing liquid through the precursor material, the container </seg-con><seg-trans>including:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container body comprising a bottom end and an open end, the container body forming a storage portion for containing the precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion at the open end of the container body; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an annular flange-like rim at least partially made of cellulose pulp-based material, extending outwardly from the container body and connecting the storage portion and the closing member, the rim having at least a flat segment and comprising an annular force ring designed for being engaged by an enclosing member of the preparation machine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the annular force ring is made of cellulose pulp-based material and is of essentially S-shaped when seen in transversal cross-section, comprising at least:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first portion linked to the flat segment of the rim, and forming with said flat segment an angle comprised between 2° and 85°; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a second portion extending from the first portion on the side opposite the flat segment of the rim, said second portion comprising at least a flat and/or curved extension.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the annular force ring comprises a third portion extending between the flat segment of the flang","B65D85/804, A47J31/36, A47J31/44",20250123,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12161666B2,Composition comprising cinnamaldehyde and zinc to improve swallowing,"Compositions contain an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition containing the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition containing cinnamaldehyde is administered to a human. The composition containing cinnamaldehyde may be a medicament, a food product or a supplement to a food product.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for promoting a swallowing reflex, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a patient in need of promotion of the swallowing reflex a composition comprising cinnamaldehyde and zinc,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the cinnamaldehyde is present in the composition at a concentration of about 100 ppm or less, and a cinnamaldehyde:zinc molar ratio in the composition is 1:0.5 to 1:0.005.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cinnamaldehyde is present in the composition in an amount that is tolerable to ingest and, in combination with the zinc, effective to promote a swallowing reflex in the patient.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method of claim 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>promotion of the swallowing reflex comprises an effect selected from the group consisting of provoking the swallowing reflex, increasing the ability of the patient to swallow, increasing the efficacy of the swallowing reflex, decreasing a delay in swallowing, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises cinnamon essential oil extract that provides at least a portion of the cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the cinnamaldehyde is selected from the group consisting of isolated cinnamaldehyde and synthesized cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the zinc is selected from the group ","A61K33/30, A23L29/00, A23L33/10, A23L33/115, A23L33/16",20241210,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120603499A,"Medicaments, compositions and methods for supporting behavioral development","The present invention relates to one or more human milk oligosaccharides (HMOs) for use in supporting behavioral development in a subject, wherein the one or more HMOs comprise or consist of: (a) lactose-N-difucohexaose I (LNDFHI); and/or (b) 2 '-fucosyllactose (2' FL), 3-fucosyllactose (3FL), lactose difucotetraose (LDFT), lactose-N-fucopentasaccharide II (LNFPII), lactose-N-fucopentasaccharide I (LNFP-I), lactose-N-fucopentasaccharide III (LNFP-III), lactose-N-difucohexaose I (LND-I), monofucosyl-lactose-N-hexaose III (MFLNH-III), lactose-N-fucopentasaccharide V (LNFP-V), lactose-N-neodifucohexaose (LNnDFH) and lactose-N-fucopentasaccharide VI (LNFP-VI), and a method for preparing the same.","<div class=""indep-clm"" num=""1""><seg-con>1.在支持受试者的行为发展中使用的一种或多种人乳低聚糖(HMO)，其中所述一种或多种HMO包含以下或由以下</seg-con><seg-trans>组成：</seg-trans><seg-refi>(a)乳糖-N-二岩藻六糖I(LNDFHI)；和/或(b)2'-岩藻糖基乳糖(2'FL)、3-岩藻糖基乳糖(3FL)、乳糖二岩藻四糖(LDFT)、乳糖-N-岩藻五糖II(LNFPII)、乳糖-N-岩藻五糖I(LNFP-I)、乳糖-N-岩藻五糖III(LNFP-III)、乳糖-N-二岩藻六糖I(LND-I)、单岩藻糖基-乳糖-N-六糖III(MFLNH-III)、乳糖-N-岩藻五糖V(LNFP-V)、乳糖-N-新二岩藻六糖(LNnDFH)和乳糖-N-岩藻五糖VI(LNFP-VI)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述使用的一种或多种HMO，其中所述一种或多种HMO包含LNDFHI或由其组成。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述使用的一种或多种HMO，其中所述一种或多种HMO包含以下或由以下</seg-con><seg-trans>组成：</seg-trans><seg-refi>2'FL、3FL、LDFT、LNFPII、LNFP-I、LNFP-III、LND-I、MFLNH-III、LNFP-V、LNnDFH和LNFP-VI。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO通过口服施用进行施用。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO单独、同时或顺序施用，优选地其中所述一种或多种HMO同时施用。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO以约0.5g/天至约10g/天的总量施用于所述受试者。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO呈营养组合物的形式。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述使用的一种或多种HMO，其中所述营养组合物是婴儿配方食品、较大婴儿配方食品或成长乳，优选地其中所述营养组合物是婴儿配方食品。</div>
<div class=""dep-clm"" num=""9"" parent=""7,8"">9.根据权利要求7或8所述使用的一种或多种HMO，其中所述营养组合物包含约0.5g/L至约10g/L的总量的所述一种或多种HMO。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据任一前述权利要求所述使用的一种或多种HMO，其中所述受试者是婴儿、学步儿童或幼儿，优选地其中所述受试者是婴儿。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据任一前述权利要求所述使用的一种或多种HMO，其中所述受试者的年龄为约12个月或更小、约11个月或更小、约10个月或更小、或约9个月或更小。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO改善所述受试者的社会情感技能。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO减少所述受试者的消极情感，优选地其中所述受试者的消极情感通过婴儿行为问卷修订版(IBQ-R)来确定。</div>
<div class=""indep-clm"" num=""14""><seg-c","A23L33/21, A23L33/00, A61K31/702, A61P25/00",20250905,雀巢产品有限公司,['Pending']
CA3055016C,Apparatus for aerating a pasty product and for mixing with another product,"The invention relates to an apparatus for aerating a pasty product. The apparatus comprises a housing (1) with an inlet (4) for the pasty product to be aerated and an outlet (5) for the aerated product. The apparatus comprises at least a first set of a rotor and a stator (21) and a second set of a rotor and a stator (22). The apparatus further comprises a gas injector (6) for injecting, upstream of the first set of a rotor and a stator (21), a gas into the pasty product to be aerated. The apparatus further comprises an intermediate mixing chamber (7) provided in the housing between the first and the second sets of a rotor and a stator (21, 22). A secondary product introduction means protrudes into the intermediate mixing chamber (7) so as to issue into said intermediate mixing chamber (7). A method for aerating a pasty product is also provided.","38 CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. An apparatus for aerating a pasty product, the apparatus comprising </seg-main><seg-clauses>a housing extending in a longitudinal direction, said housing comprising an inlet for the pasty product to be aerated and an outlet for the aerated product, and, within the housing, at least a first set of a rotor and a stator and a second set of a rotor and a stator, wherein each set of a rotor and a stator has complementary toothed rims oppositely orientated in the longitudinal direction, said apparatus comprising a drive shaft, the rotors of each set of a rotor and a stator being coupled to said drive shaft, said apparatus further comprising a gas injector for injecting, upstream of the first set of a rotor and a stator, a gas into the pasty product to be aerated, wherein the apparatus further comprises an intermediate mixing chamber provided in the housing between the first and the second sets of a rotor and a stator, and a secondary product introduction means which protrudes into the intermediate mixing chamber so as to issue into said intermediate mixing chamber. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The apparatus according to claim 1, wherein </seg-main><seg-clauses>the secondary product introduction means comprise a fluid injector. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The apparatus according to claim 2, wherein </seg-main><seg-clauses>the intermediate mixing chamber is a volume free of mechanical parts except for said fluid injector. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The apparatus according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the secondary product introduction means forms a secondary pasty product inlet. CA 3055016 Date reçue / Received date 2024-10-1039 </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The apparatus according to any one of claims 1 ","A23P30/40, B01F23/233, B01F23/235, B01F27/27",20251021,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250297216A1,Method for producing milk like products,"A method for producing mammary gland cells and a method of producing a mammalian milk like product, for example a human milk like product comprising generating lactocytes derived from mammalian induced pluripotent stem cells (miPSC), for example human induced pluripotent stem cells (hiPSC), and expressing the mammalian milk like product, for example the human milk like product from lactocytes.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing a population of mammary gland cells, comprising:</seg-main>
<seg-clauses>i) culturing mammalian induced pluripotent stem cells (miPSCs) in a culture medium comprising bone morphogenic protein 4 (BMP4) and retinoic acid (RA) to generate embryoid bodies (EBs), and</seg-clauses>
<seg-clauses>ii) growing the EBs to generate a population of mammary cells.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the culturing step i) comprises culturing the miPSCs in MammoCult medium and BMP4, in a 3D-suspension culture system, thereby directing the iPSCs to differentiate towards non-neural ectoderm cells.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the culturing step i) comprises culturing the miPSCs in MammoCult medium and BMP4, in a 3D-suspension culture system, thereby directing the iPSCs to differentiate towards non-neural ectoderm cells.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the growing step ii) comprises growing the formed EBs in a 3D embedding system comprising RA to generate lactocytes.</seg-clauses></div>
<div class=""ccl-clm"" num=""12"">5-12. (canceled)</div>
<div class=""dep-clm"" num=""13"" parent=""1""><seg-main>13. The method of claim 1, wherein </seg-main><seg-clauses>BMP4 is added to the culture medium in a concentration of 5 to 20 ng/ml.</seg-clauses></div>
<div class=""dep-clm"" num=""14"" parent=""1""><seg-main>14. The method of claim 1, wherein </seg-main><seg-clauses>RA is added to the culture medium in a concentration of 1 μM.</seg-clauses></div>
<div class=""dep-clm"" num=""15"" parent=""1""><seg-main>15. The method of claim 1, wherein </seg-main><seg-clauses>the EBs express one or more mammary gland positive progenitor-cell markers.</seg-clauses></div>
<div class","C12N5/071, C12N5/00, C12N5/074, C12P1/00",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120379539A,Food powder with improved stability and method for preparing same,"The present invention relates to a method for preparing a food powder having improved stability, in particular reduced moisture absorption capacity and reduced moisture absorption stability. The method comprises providing a liquid food composition, drying the liquid food composition, and adding crystalline monosaccharides and/or disaccharides to the food powder. In particular, up to 30% of the monosaccharides and/or disaccharides of the food powder are amorphous and the remainder of the monosaccharides and/or disaccharides of the food powder is crystalline.","<div class=""indep-clm"" num=""1""><seg-con>1.制备食品粉末的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a.提供液体食品组合物，其中所述液体食品组合物包含按液体食品组合物的干重计至多20wt％的单糖和/或二糖，并且还包含不同于单糖和/或二糖的至少一种组分；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b.干燥所述液体食品组合物以获得食品粉末；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>c.向所述食品粉末中添加结晶单糖和/或二糖，其中所述食品粉末的所述单糖和/或二糖的至多30％、优选至多10％是无定形的，并且所述食品粉末的单糖和/或二糖的其余部分是结晶的。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述液体食品组合物不含单糖和/或二糖。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的方法，其中所述食品粉末不含无定形单糖和/或二糖。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的方法，其中所述食品粉末的总单糖和/或二糖含量为10wt.％至80wt.％，优选10wt.％至70wt.％，更优选10wt.％至60wt.％,甚至更优选20wt.％至60wt.％。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的方法，其中所述液体食品组合物的不同于单糖和/或二糖的所述至少一种组分选自由以下组成的列表：蛋白质、脂肪、乳化剂、盐或其混合物。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的方法，其中所述液体食品组合物的所述蛋白质由乳品蛋白质、植物蛋白质或其混合物组成。</div>
<div class=""dep-clm"" num=""7"" parent=""5,6"">7.根据权利要求5或6所述的方法，其中所述脂肪选自由以下组成的列表：植物脂肪、乳脂或其混合物。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的方法，其中所述食品粉末是基于乳品的食品粉末或其基于植物的类似物，优选乳粉或其基于植物的类似物。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的方法，其中步骤a)的所述液体食品组合物通过包括以下步骤的方法制备：</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">-将至少一种蛋白质成分和任选的盐分散到水性液体中以形成液体食品组合物：</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">-任选地，将所述液体食品组合物与至少一种脂肪和任选的至少一种乳化剂混合；</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">-任选地，热处理所述液体食品组合物；</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">-任选地，将所述液体食品组合物均质化。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8"">10.根据权利要求1至8所述的方法，其中步骤a)的所述液体食品组合物通过包括以下步骤的方法制备：</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8"">-提供包含单糖和/或二糖的液体食品组合物；</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8"">-通过过滤，优选超滤，去除所述液体食品组合物的部分或全部单糖：</div>
<div class=","A23C1/05, A23C9/18, A23C9/142, A23C1/16, A23C9/156",20250725,雀巢产品有限公司,['Pending']
CN120202164A,Beverage dispensing unit for machine for preparing and dispensing beverage and machine for preparing and dispensing beverage comprising said dispensing unit,"A beverage dispensing unit (10) for dispensing a beverage, the beverage dispensing unit comprising a nozzle (12) and a recess (16) provided with a nozzle protection body (26) comprising: a protection wall (28) for substantially preventing a user from moving a container (C) in contact with the nozzle (12); and a beverage dispensing channel (32). The lower portion (38) of the 5 protective wall (28) comprises a collector tray (44) comprising: a first inner wall (48) having an upper edge (50) defining a through hole (36); and a second inner wall (52) disposed externally with respect to the first inner wall (48).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于制备并分配饮料的机器(100)的饮料分配单元(10)，所述饮料分配单元(10)</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-喷嘴(12)，所述喷嘴连接到管道(14)，所述饮料和/或用于制作所述饮料的配料在所述管道中流动，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-凹室(16)，所述凹室限定用于保持容器(C)的支座(18)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>通过所述喷嘴(12)分配的所述饮料和/或用于制作所述饮料的所述配料流入所述容器(C)中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述凹室(16)包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-开口(20)，所述开口用于将所述容器(C)插入所述支座(18)中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-上部部分(22)，所述喷嘴(12)至少部分地设置在所述上部部分中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-下部部分(24)，所述下部部分用于支撑所述容器(C)，所述下部部分基本上设置在所述喷嘴(12)下方，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述凹室(16)包括喷嘴保护主体(26)，所述喷嘴保护主体包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)保护壁(28)，所述保护壁设置在所述凹室(16)中并且位于所述喷嘴(12)的下端(30)下方，所述保护壁(28)的形状和尺寸被设定成基本上防止使用者以使所述容器(C)与所述喷嘴(12)接触的方式在所述支座(18)中移动所述容器(C)，并且/或者防止使用者触碰所述喷嘴(12)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)饮料分配通道(32)，所述饮料分配通道用于使饮料通过所述保护壁(28)从所述喷嘴(12)流出到所述凹室(16)的所述下部部分(24)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述保护壁(28)的下部部分(38)包括收集器托盘(44)，所述收集器托盘面向所述喷嘴(12)并且与所述喷嘴(12)分离，用于收集在所述喷嘴(12)与所述保护壁(28)之间可能出现的任何饮料溢出物，其中所述收集器托盘(44)包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-下表面(46)，所述下表面面向所述喷嘴(12)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-第一内壁(48)，所述第一内壁背离所述内表面(46)、朝向所述喷嘴(12)延伸并且包括界定所述通孔(36)的上边缘(50)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>第二内壁(52)，所述第二内壁背离所述内表面(46)、朝向所述喷嘴(12)延伸并且相对于所述第一内壁(48)设置在外部。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的饮料分配单元(10)，其中所述饮料分配单元</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-连接构件(34,35)，所述连接构件用于将所述喷嘴保护主体(26)可移除地连接到所述凹室(16)，以便允许从所述凹室(16)移除所述喷嘴保护主体(26)，从而能够周期性地清洁所述喷嘴保护主体(26)。</seg-r","B67D1/08, B67D1/00, B67D1/16",20250624,雀巢产品有限公司,['Pending']
AU2023386300A1,Multilayer metallized paper-based packaging material,"The present invention relates to a cellulosic substrate comprising or consisting of a cellulose graft copolymer comprising polypeptide branches. The present invention also relates to a packaging material comprising at least one paper layer comprising or consisting of a cellulose graft copolymer comprising polypeptide branches, in particular a multi-layer metallized paper-based packaging material.","<div class=""indep-clm"" num=""1""><seg-con>1. A cellulosic substrate </seg-con><seg-trans>comprising </seg-trans><seg-refi>or consisting of a cellulose graft copolymer comprising polypeptide branches.</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>5</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The cellulosic substrate according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polypeptide is collagen or a hydrolysed form thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The cellulosic substrate according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the io polypeptide branches are coupled to the cellulose by a linker, optionally wherein the cellulose graft copolymer comprises the following formula:</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>Polypeptide n ’ r- Linker                              -»</seg-refi></div>

<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>o</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>I inker _</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>Polypeptide</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The cellulosic substrate according to any preceding claim, </seg-con><seg-trans>wherein</seg-trans></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>15 the polypeptide branches are coupled to the cellulose by a polycarboxylic acid or an anhydride thereof, optionally wherein the cellulose graft copolymer comprises the following formula:</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The cellulosic substrate according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polypeptide branches are coupled to the cellulose by:</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>5                     (a) a tricarboxylic acid or an anhydride thereof; optionally wherein</se","C08B3/00, C08B3/12, C08L1/10",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3004976C,Cocoa polyphenols and soluble dietary fiber for use in the treatment or prevention disorders associated with an above-normal number of granulocytes in a tissue,The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use hi the prevention or treatment of a disorder associated with an above-normal number of granulocytes hi a tissue.,"Claims <div class=""indep-clm"" num=""1""><seg-con>1. Composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one cocoa polyphenol and at least one fermentable dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of eosinophils according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the disorder associated with an above-normal number of granulocytes in a tissue is an eosinophilic gastrointestinal disorder, an allergy, in particular, a food allergy, an gastrointestinal syndrome, allergy associated with aeroallergen including asthma and allergic rhinithis, lung allergic inflammation or skin atopic dermatitis. </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes according to any of the above claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eosinophilic gastrointestinal disorder is caused by a food allergy or aeroallergens. </seg-refi></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of eosinophils according to any of the above claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eosinophilic gastrointestinal disorder is eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, or eosinophilic colitis; wherein the eosinophilic gastrointestinal disorder preferably is eosinophilic esophagitis. </seg-refi></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Composition for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes according t","A61K31/05, A61P1/00",20250506,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025011991A1,"Extracted concentrated mucilage from OKRA, related compositions such as concentrates and powders, and methods of making and using the OKRA mucilage","New and innovative compositions contain extracted concentrated mucilage from okra, and methods are disclosed for producing the compositions. At least a portion of the composition can be used in a ready-to-drink (RTD) beverage or as a powder, and can be used to treat individuals with dysphagia. An example method includes at least one step selected from the group consisting of: blanching fresh or frozen whole okra pods; cutting okra into pieces; submerging the okra pieces in water; separating okra mucilage liquid concentrate from the okra pieces by filtration; adding an excipient material; homogenizing a mixture containing the okra mucilage liquid concentrate; heat treating or sterilizing the mixture; and adjusting an okra mucilage concentration in the heat treated or sterilized mixture to reach a relaxation time of at least 10 milliseconds, preferably between 50 milliseconds and 400 milliseconds, and most preferably between 100 milliseconds and 200 milliseconds at 20°C.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing composition comprising </seg-main><seg-clauses><seg-main>extracted concentrated mucilage from okra, the method comprising at least one step selected from the group consisting of:</seg-main>
<seg-clauses>(i) blanching fresh or frozen whole okra pods;</seg-clauses>
<seg-clauses>(ii) cutting a plurality of okra pieces from okra pods;</seg-clauses>
<seg-clauses>(iii) submerging the plurality of okra pieces in water;</seg-clauses>
<seg-clauses><seg-main>(iv) separating okra mucilage liquid concentrate from the plurality of okra pieces by filtration under an acting force or pressure selected from a group comprising: </seg-main><seg-clauses>(a) a gravitational force, </seg-clauses><seg-clauses>(b) a static pressure, </seg-clauses><seg-clauses>(c) preferably, a centrifugal force, or </seg-clauses><seg-clauses>(d) a combination of the static pressure and the centrifugal force;</seg-clauses>
<seg-clauses>(v) adding an excipient material to the okra mucilage liquid concentrate;</seg-clauses></seg-clauses>
<seg-clauses>(vi) homogenizing, by stirring, a mixture comprising the okra mucilage liquid concentrate and, optionally, the added excipient material;</seg-clauses>
<seg-clauses>(vii) heat treating or sterilizing the mixture; and</seg-clauses>
<seg-clauses><seg-main>(viii) adjusting, by </seg-main><seg-clauses>(a) dilution or </seg-clauses><seg-clauses>(b) evaporation under partial vacuum, an okra mucilage concentration in the heat treated or sterilized mixture to a relaxation time of at least 10 milliseconds, preferably between 50 milliseconds and 400 milliseconds, and most preferably between 100 milliseconds and 200 milliseconds, the relaxation time measured from a filament formed from the mixture in a Capillary Breakup Extensional Rheometer (CaBER) at 20°C.</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of Claim 1, further comprising: </s","A23L29/206, A61K36/185, A23L33/00, A61P1/06, A23L33/21",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12458655B2,Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section,"The present invention relates to a composition comprising at least one human milk oligosaccharide and/or a precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants or young children born by C-section.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for achieving at least one result </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>improving gut protection against microbial and pathogen overgrowth, promoting gut development and maturation, decreasing gut inflammation, and promoting enteral feeding tolerance, in an infant or young child born by C-section, the method comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>administering an effective amount of a composition comprising a mixture of human milk oligosaccharides to the infant or young child born by C-section,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the mixture comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>2′-fucosyllactose (2FL) that is 60 to 70 wt. % of the mixture of human milk oligosaccharides;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) that are 20 to 30 wt. % of the mixture of human milk oligosaccharides and in a ratio of LNT:LNnT between 2:1 and 1:1; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>6′ sialyllactose (6SL) that is 10 to 20 wt. % of the mixture of human milk oligosaccharides,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the composition does not contain any galactooligosaccharides (GOS) other than the LNT and the LNnT.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ratio of LNT:LNnT is between 2:1.2 and 2:1.6.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ratio of LNT:LNnT is 1.3:1.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the infant or young child is a preterm infant bo","A61K31/702, A23L33/00, A23L33/125, A23L33/135, A23L33/21",20251104,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025125989A1,Mimicking health benefits of physical exercise in cats,"A method of mimicking health benefits of physical exercise in a cat can include administering a high protein diet to a cat, the high protein diet including from about 110% to about 350% of a Recommended Daily Allowance (RD A) of protein for the cat on a daily basis. The high protein diet in this example is sufficient to increase a 12,13-diHOME blood level for an 18-24 hour period per day compared to a baseline blood level without the need for physical exercise.","19396 CLAIMS What Is Claimed Is: <div class=""indep-clm"" num=""1""><seg-con>1. A method of mimicking health benefits of physical exercise in a cat, </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a high protein diet to a cat, the high protein diet including from about 110% to about 350% of a Recommended Daily Allowance (RDA) of protein for the cat on a daily basis, wherein the high protein diet is sufficient to increase a 12,13-diHOME blood level for an 18-24 hour period per day compared to a baseline blood level without the need for physical exercise. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the high protein diet includes from about 150% to about 250% of the RDA of protein and the 12,13-diHOME blood level is increased by at least 2-fold over the 18-24 hour period compared to the baseline blood level. </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the 12,13-diHOME blood level is higher over the 18-24 hour period compared to the baseline blood level without the cat engaging in physical exercise. </seg-refi></div><div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the RDA of protein for the cat is 26 wt% based on 100% of a MER for the cat, and wherein the high protein diet includes administering a cat food on a daily basis containing from about 30 wt% to about 75 wt% protein calculated based on the 100% of the MER for the cat. </seg-refi></div><div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of claim 4, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>administering a decreased caloric intake diet having from about 50% to about 95% of the MER for the cat, wherein the cat food still includes an equivalent of the about 40 wt% to about 75 wt% protein calculated ","A23K20/147, A23K50/40, A23L33/17",20250619,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
US20250302854A1,Anti-inflammatory phytonutrients for use in the treatment or prevention of synovitis,"Compositions for treatment or prevention of synovitis contain a therapeutically effective amount of at least one of oleuropein, rutin or curcumin and preferably contain at least oleuropin. Methods for treatment or prevention of synovitis include administering such compositions. The compositions can additionally include one or more of quercetin, hydroxytyrosol or vitamin D.","<div class=""indep-clm"" num=""1""><seg-con>1: A method of treating or preventing synovitis, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to an individual having or at risk of the synovitis a composition comprising a therapeutically effective amount of oleuropein, hydroxytyrosol and vitamin D.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the synovitis is associated with a condition selected from the group consisting of lupus, gout, arthritis and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The method of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the condition is arthritis that is selected from the group consisting of rheumatoid arthritis, osteoarthritis, osteochondritis disease, osteoarthrosis and a combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises at least one of quercetin, rutin, curcumin and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5: The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oleuropein is isolated from a plant extract.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6: The method ofclaim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual is selected from the group consisting of an aging human and an elderly human.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7: The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is administered daily for at least one month.</seg-refi></div>
<div class=""indep-clm"" num=""8""><seg-con>8: A composition for treating or preventing synovitis, the composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a therapeutically e","A61K31/7028, A61K31/12, A61K31/121, A61K31/7016, A61K31/7048",20251002,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019373665B2,Capsule system with recognition means and adaptable opening and injection mechanism,"The invention relates to a beverage preparation device (100) for preparing a beverage upon interaction of ingredients provided in a capsule (5) with liquid supplied thereto, the device comprising an injection module (10) comprising a first (1) and a cooperating second enclosing member (2) designed for being moved relatively to each other, the first enclosing member being equipped with capsule opening and injection means (3) for opening a first inlet face (5a) of a capsule (5) and inject liquid into the capsule, the first and second enclosing member (1,2) being designed for being brought into at least a first capsule insertion position for inserting a capsule between the enclosing members (1,2) and a second capsule enclosing position in which the opening and injection means (3) engage the liquid inlet face (5a) of the capsule (5), the device (100) further comprising control means (13) designed for setting at least the capsule enclosing position based on information read from the capsule and/or based on information provided by a user input.","<div class=""indep-clm"" num=""1""><seg-main>1. A beverage preparation device for preparing a beverage upon interaction of ingredients provided in a capsule with liquid supplied thereto, the device comprising:</seg-main>
<seg-clauses>an injection module comprising a first and a cooperating second enclosing member designed for being moved relatively to each other, the first enclosing member being equipped with capsule opening and injection means for opening a first inlet face of a capsule and injecting liquid into the capsule,</seg-clauses>
<seg-clauses class=""seg-enter"">the first and second enclosing member being designed for being brought into at least a first capsule insertion position for inserting a capsule between the enclosing members and a second capsule enclosing position in which the opening and injection means engage the liquid inlet face of the capsule,</seg-clauses>
<seg-clauses class=""seg-enter"">the device further comprising control means designed for adapting the capsule enclosing position adjusting a distance between the respective first and second enclosing members to the capsule inserted to the device based on information read from the capsule and/or based on information provided by a user input.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The device according to claim 1, wherein </seg-main><seg-clauses>the control means are designed for adapting the enclosing position during a beverage preparation process with a capsule in the device based on information read from the capsule and/or based on information provided by a user input.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The device according to claim 1 or 2, wherein </seg-main><seg-clauses>the control means are designed for adapting a penetration depth of the opening and injection means into the capsule at least in the capsule enclosing position.</seg-clauses>
<seg-clauses class=""seg-enter"">2019373665   10 Feb 2025</seg-clauses></div>
<div cl","A47J31/36, A47J31/44",20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US12365501B2,Process for the production of a container for the preparation of a beverage in a beverage preparation device and a container obtained by said process,"The present invention concerns a process for producing a container for the preparation of a beverage in a beverage preparation device, comprising the steps of: a. providing a water injection wall (<b>3</b>) of said, b. providing a beverage delivery wall (<b>4</b>) of said container, wherein at least one, preferably both, of said injection and delivery walls (<b>3, 4</b>) has a cup shape, c. placing a beverage ingredient body in said at least one cup shaped wall (<b>4</b>), d. sealing together edge portions (<b>3</b>A, <b>4</b>A) of said injection and delivery walls (<b>4, 3</b>) in a sealing station, such as to form a chamber (<b>1</b>), wherein said sealing station comprise a housing element having a housing temperature (Th), wherein said body (<b>2</b>) is shaped and dimensioned such as not to completely fill said chamber (<b>1</b>), said process being characterized in that, after the sealing step, the container is cooled to a cooling temperature (Tc) being either: —at least 15° C. lower than the temperature of the housing, or—comprised between −10° C. and +25° C.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for producing a container for the preparation of a beverage in a beverage preparation device, comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>a. providing an injection wall of said container, comprising a paper layer through which water is to be introduced in the container, wherein said injection wall is able to be punctured by an injection member of the beverage preparation device for circulating water under pressure inside said container,</seg-clauses>
<seg-clauses>b. providing a beverage delivery wall of said container, comprising a paper layer through which the beverage is to be dispensed out of the container, wherein said delivery wall is able to be opened by an opening member of the beverage preparation device, wherein at least one of said injection and delivery walls has a cup shape,</seg-clauses>
<seg-clauses>c. placing a beverage ingredient in said at least one cup shaped wall, wherein said beverage ingredient is a body formed by a compacted beverage ingredient,</seg-clauses>
<seg-clauses>d. sealing together edge portions of said injection and delivery walls in a sealing station, such as to form a chamber in which said body formed by a compacted beverage ingredient is stored,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said sealing station comprises a housing element for housing at least partially said injection and/or delivery walls and wherein said housing element at the beginning of the sealing has a housing temperature (Th), and wherein said body is shaped and dimensioned such as not to completely fill said chamber;</seg-clauses>
<seg-clauses class=""seg-enter"">after the sealing step, the container is cooled at a cooling temperature (Tc), being either:</seg-clauses>
<seg-clauses class=""seg-enter"">at least 15° C. lower than the temperature of the housing, or</seg-clauses>
<seg-clauses class=""seg-enter"">comprised between −10° C. and +25° C.,</seg-clauses>
<seg","B65B51/00, B65B29/02, B65B51/32",20250722,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2840734C1,Coffee beverage product and method for production thereof,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is a coffee beverage product containing from 1 wt.% to 25 wt.% of coffee solids; 1–11 wt.% of milk protein; 0.01–3 wt.% of galactose; 0.5–15 wt.% of galactooligosaccharide; 0.01–4.5 wt.% of lactose and 0.01–3 wt.% of glucose; all weight percentage in terms of dry substance. Additionally, one describes a method for production of such a coffee drinking product.EFFECT: group of inventions allows to reduce the quantity of sugar in the product while replacing it with a more useful ingredient, that is galactooligosaccharide, while preserving an acceptable taste, texture and sweetness.8 cl, 3 tbl, 3 ex","1. Кофейный питьевой продукт, содержащий от 1 до 25 мас.% твёрдых веществ кофе; 1-11 мас.% молочного белка; 0,01-3 мас.% галактозы; 0,5-15 мас.% галактоолигосахарида; 0,01-4,5 мас.% лактозы и 0,01-3 мас.% глюкозы; всё весовое процентное содержание в пересчёте на сухое вещество.
2. Кофейный питьевой продукт по п. 1, содержащий вспенивающий ингредиент.
3. Кофейный питьевой продукт по п. 1 или 2, в котором продукт представляет собой готовый к употреблению продукт или порошкообразный продукт из кофейных смесей.
4. Кофейный питьевой продукт по любому из предшествующих пунктов, в котором твёрдые вещества кофе представляют собой порошкообразный высушенный водный экстракт обжаренного и молотого кофе.
5. Способ получения кофейного питьевого продукта по любому из предшествующих пунктов, включающий стадии обеспечения ферментативно обработанного бета-галактозидазой сухого молока и смешивания упомянутого сухого молока с твёрдыми веществами кофе.
6. Способ по п. 5, в котором ферментативно обработанное бета-галактозидазой молоко содержит 2-5 мас.% лактозы; 10-13 мас.% глюкозы; 1-4 мас.% галактозы и 28-33 мас.% галактоолигосахарида; всё весовое процентное содержание в пересчёте на сухое вещество.
7. Способ по п. 5 или 6, в котором молоко представляет собой цельное молоко или обезжиренное молоко.
8. Способ по любому из пп. 5-7, в котором ферментативно обработанное бета-галактозидазой молоко находится в форме порошка.","A23F5/14, A23F5/40",20250528,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20240407398A1,Large donut-shaped dry kibble for small adult dogs,"Methods for feeding small adult dogs include dispensing a serving of dry kibble to a small adult dog weighing less than about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving can be donut-shaped and have an average inner-hole diameter from about 3 mm to about 8 mm and are about 8 mm to about 2 cm in average diameter. The dry kibble can also have an average thickness from about 8 mm to about 2 cm.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of feeding a small adult dog, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dispensing a serving of dry kibble to a small adult dog weighing up to about 11 kg, wherein from about 20% to 100% of individual dry kibble pieces of the serving are donut-shaped having an average inner-hole diameter from about 3 mm to about 8 mm, wherein the individual dry kibble pieces of the serving are about 8 mm to about 2 cm in average diameter and about 8 mm to about 2 cm in average thickness.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.1 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average diameter is from about 1.4 cm to about 2 cm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the average thickness is from about 1.1 cm to about 1.8 cm.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a moisture content from about 4 wt % to about 10 wt %.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dry kibble has a stiffness from about 40 N/mm to about 120 N/mm.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>after dispensing the serving and the small adult dog begins feeding on the dry kibble, from about 45% to about 75% of the first three minutes of feeding on average includes chew time.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The method of claim 1, </seg-con","A23K50/42, A23K40/00",20241212,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250089927A1,Beverage preparation system,"The invention concerns a beverage production system comprising a pack (<b>10</b>) comprising two holes and a module (<b>1</b>) for producing a beverage from said pack,—said module (<b>1</b>) comprising: a movable fluid processing device (<b>11</b>) to introduce a fluid in said pack and to dispense a beverage from the pack, and. a pack holder assembly (<b>2</b>) comprising a pack chamber (<b>22</b>) and a movable locking device (<b>24</b>) configured to move between:—a first fixing position wherein said locking device interacts with and locks the pack (<b>10</b>) received in the chamber inside the pack holder assembly, and,—a second release position wherein said locking device does not interact with the pack (<b>10</b>) received in the chamber, and said movable locking device (<b>24</b>) comprising two pins (<b>242</b>) configured to fit in the holes (<b>103</b>) of the pack in the first fixing position.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage production system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a pack and a module for producing a beverage from said pack,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising an ingredient, said ingredient being configured to be mixed with a fluid to produce a beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack presenting a plane shape oriented along a plane and comprising two longitudinal plane walls extending along this plane, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the bottom side of said pack being configured for being openable, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein said pack comprises at least two holes and/or deformable areas,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said module comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a movable fluid processing device configured to cooperate with the bottom of the pack to introduce a fluid in said pack and to dispense a beverage from the pack, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pack holder assembly, said pack holder assembly comprising a pack chamber and a movable locking device wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pack chamber is adapted for receiving said pack through an upper pack inlet and for holding said pack so that the plane of the plane shape is oriented in an essentially vertical position inside the module, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamber presenting a bottom opening configured to enable access of the movable fluid processing device to at least the bottom side of said pack hold in the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the movable locking device is configured to move between:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first fixing position wherein ","A47J31/40, A47J31/44, A47J31/46, B65D85/804",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250040561A1,"Fermented beverage composition comprising nuts, optionally seeds, and legume","The invention relates to a fermented plant-based beverage composition comprising nuts, optionally seeds, and legumes, the nuts, optionally seeds and legumes present 25 to 50 wt. % of the total solids in the beverage composition, at least 50 wt. % of the nuts are roasted, preferably least 50 wt. % of the nuts and optionally seeds are roasted, and at least 50 wt. % of the nuts and seeds are milled wholesome nuts and seeds, and wherein the beverage composition being fermented with strains comprising lactic acid bacteria 1) <i>Lactobacillus delbrueckii </i>subsp. <i>bulgaricus </i>and 2) <i>Streptococcus thermophilus</i>, and having a pH of 4.0 to 5.5, preferably a pH of 4.2-4.5. The invention also relates to a process of making such a beverage.","<div class=""indep-clm"" num=""1""><seg-main>1. A fermented plant-based beverage composition comprising </seg-main><seg-clauses><seg-main>nuts and legumes,</seg-main>
<seg-main class=""seg-enter"">the nuts and legumes present 25 to 50 wt. % of the total solids in the beverage composition,</seg-main>
<seg-main class=""seg-enter"">at least 50 wt. % of the nuts are roasted, and</seg-main>
<seg-main class=""seg-enter"">at least 50 wt. % of the nuts, and wherein</seg-main>
<seg-main class=""seg-enter"">the beverage composition being fermented with strains comprising lactic acid bacteria </seg-main><seg-clauses>1) <i>Lactobacillus delbrueckii </i></seg-clauses><seg-clauses>subsp. <i>bulgaricus </i>and </seg-clauses><seg-clauses>2) <i>Streptococcus thermophilus</i>, and having a pH of 4.0 to 5.5, preferably a pH of 4.2-4.5.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A fermented beverage composition according to claim 1, comprising </seg-main><seg-clauses>5-20 wt. % total solids (TS).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses><seg-main>the fermented beverage composition comprises </seg-main><seg-clauses>0.5-3 wt. % legumes.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses>the legumes are selected from the group consisting of pea, soy, faba, chickpea and a combination thereof, wherein the legumes are preferably in the form of protein isolates or concentrates.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses>nuts are present in amounts of 1 to 6 wt. %.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A fermented beverage composition according to claim 1, comprising </seg-ma","A23C11/10, A23C9/127",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12486337B2,"Natural hydrocolloid systems for pet food compositions, pet food compositions comprising same, and preparations thereof","A natural hydrocolloid system can be used in, e.g., pet food compositions. Another aspect of the present disclosure is pet food compositions comprising such a natural hydrocolloid system, and preparation methods thereof. The hydrocolloid system can use blends of fruit fibers, such as citrus and apple fibers, and/or plant-based polysaccharides, such as <i>psyllium</i>, okra, chia, flaxseed, or seaweed; and can provide a gravy and even a jelly with functionalities comparable to the existing gravies. The blends can replace currently used hydrocolloids and can be used in new recipes with natural and clean labels.","<div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a gravy or jelly comprising a hydrocolloid system, the hydrocolloid system comprising a fruit fiber and further comprising a plant-based polysaccharide; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>food chunks dispersed in the gravy or jelly,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the gravy or jelly is from about 55 wt % to about 65 wt % of the pet food composition, and the food chunks are from about 35 wt % to about 45 wt % of the pet food composition,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the hydrocolloid system further comprises a calcium source at a concentration of the calcium source in the gravy or jelly from about 0.1 wt % to about 1 wt %.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. The pet food composition of 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the gravy or jelly is about 60 wt % of the pet food composition, and the food chunks are about 40 wt % of the pet food composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The pet food composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food chunks comprise an ingredient selected from the group consisting of meat, gluten, a vegetable protein source, and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The pet food composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fruit fiber comprises at least one of citrus fiber or apple fiber.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The pet food composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant-based polysaccharide comprises at least one of psyllium, okra, seaweed, chia, flaxseed, or combinations thereof.</seg-refi></div>
<div class=""dep-cl","C08B37/00, A23K10/20, A23K10/30, A23K20/163, A23K20/24",20251202,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2840662C1,Biodegradable capsule with integrated opening means,"FIELD: beverage preparation devices.SUBSTANCE: invention relates to a capsule for preparing a beverage by injecting a fluid into a closed chamber for accommodating a substance for preparing the beverage. Invention also relates to a method of producing capsule (100). Capsule (100) for preparing a beverage comprises body (200) which defines closed chamber (210) for placing a substance for preparing a beverage by injecting a fluid medium into chamber (210). Capsule body (200) comprises retaining wall (220) defining a portion of chamber (210). Capsule (100) further comprises device (300) for opening closed chamber (210). At that, opening device (300) and retaining wall (220) are located relative to each other so that engagement between retaining wall (220) and opening device (300) is performed under action of injected fluid medium pressure, increasing in closed chamber (210), for opening of closed chamber (210). Capsule body (200) with its support wall (220), as well as opening device (300) are made of a biodegradable material.EFFECT: providing the capsule with a self-opening mechanism that is built into the capsule and is made from biodegradable and/or suitable for composting materials, which simplifies and improves recycling of the capsule after use.14 cl, 4 dwg",,"B65D85/804, B65D65/46",20250527,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250205189A1,Dietary butyrate for treating or preventing an allergic disorder,"A compound having the formula
<img src='' class=""img-anchor sg-l"" img-id=""US20250205189A1-C00001""/>
or combinations thereof, for use in the treatment or prevention of an allergic disorder, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently, a long chain fatty acid having between 16 and 20 carbons.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating or preventing an allergic disorder in a subject, the method comprising </seg-main><seg-clauses>administering to the subject an infant formula comprising a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/02/05/18/9/1750943900858/US20250205189A1-C00007.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064328%3B1765067928%26q-key-time%3D1765064328%3B1765067928%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Db87e2b11aab5d2797f6d27994539ffe0191461c1&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A48%20GMT"" class=""img-anchor"" img-id=""US20250205189A1-C00007"" image_type=""chemistry"" official_size=""8044""></seg-clauses>
<seg-clauses class=""seg-enter"">or combinations thereof, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently, a long chain fatty acid having between 16 and 20 carbons, wherein the infant formula further comprises a protein source, a carbohydrate source and a lipid source.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of manufacturing an infant formula for treating or preventing an allergic disorder, the method comprising </seg-main><seg-clauses>mixing a protein source, a carbohydrate source, a lipid source and a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/02/05/18/9/1750943900858/US20250205189A1-C00008.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064328%3B1765067928%26q-key-time%3D1765064328%3B1765067928%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D9c00e0574cfa0343d5899cda75e238a12acf43a3&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A48%20GMT"" class=""img-anc","A61K31/23, A23L33/00, A23L33/115, A61P37/08",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120359334A,Enhanced molded fiber capsules for food and beverage preparation,"The invention relates to a packaging article (1) comprising a three-dimensional body (2) made of a rigid or semi-rigid moulded fibrous pulp, said body forming compartments for enclosing the product and being adapted to be closed by closing means, characterised in that said body (2) further comprises a reinforcing mesh (7) at least partially embedded in a block of fibrous pulp, said reinforcing mesh (7) being made of a rigid or semi-rigid moulded fibrous pulp. The web (7) comprises a fiber selected from the group consisting of natural plant fibers, animal fibers, biopolymer synthetic fibers or a combination thereof, the fiber being impregnated with a dried water-soluble biopolymer, a dried water-soluble compostable polymer, a dried starch-based solution or a combination thereof, or the fiber being impregnated with a solidified polypeptide.","<div class=""indep-clm"" num=""1""><seg-con>1.包装物品(1)，所述包装物品包括由刚性或半刚性模制纤维浆料制成的三维主体(2)，所述主体形成用于包封产品的隔室并且被适配为由封闭装置(5)封闭，<u></seg-con><seg-trans>其特征在于</seg-trans><seg-refi></u>，所述主体(2)还包括至少部分地嵌入到纤维浆料的块体中的增强刚性网(7)，所述网(7)包含选自以下列表的纤维：天然植物纤维、动物纤维、生物聚合物合成纤维或其组合，所述纤维浸渍有干燥的水溶性生物聚合物、干燥的水溶性可堆肥聚合物、干燥的基于淀粉的溶液或其组合，或所述纤维浸渍有固化的多肽。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据前一权利要求1所述的包装物品(1)，所述包装物品还包括附接到所述纤维浆料主体(2)的内表面的多层膜内衬(3)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据前述权利要求1或2中任一项所述的包装物品(1)，其中所述内衬(3)从外到内</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(i)最外侧聚合物层，所述最外侧聚合物层包含选自以下列表的生物可降解聚合物：聚琥珀酸丁二醇酯(PBSA/bioPBS)、聚己二酸对苯二甲酸丁二醇酯(PBAT)、淀粉、纤维素衍生物、聚乳酸(PLA)、聚羟基烷酸酯(PHA)或其组合，所述最外层具有在10μm与100μm之间的厚度，并且所述第一层具有在10％与800％之间的断裂伸长率、当在150℃下在2.16kg的压力下在10分钟内测量时在2与4之间的熔体流动速率(MFR)，并且所述第一层具有低于80℃的熔点温度，</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(ii)第一接合层，所述第一接合层包含生物可降解的改性或官能化的聚烯烃，具有在180℃与230℃之间的熔点温度和在1μm与12μm之间的厚度，</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(iii)阻隔层，所述阻隔层包含选自以下列表的聚合物：丁烯二醇乙烯醇共聚物(BVOH)、聚乙烯醇(PVOH)或其组合，并且具有在180℃与230℃之间的熔点温度和在1μm与15μm之间的厚度，</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(iv)第二接合层，所述第二接合层包含生物可降解的改性或官能化的聚烯烃，具有在180℃与230℃之间的熔点温度和在1μm与10μm</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>之间的厚度，</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(v)最内侧聚合物层，所述最内侧聚合物层包含选自以下列表的生物可降解聚合物：聚琥珀酸丁二醇酯(PBSA)、聚己二酸对苯二甲酸丁二醇酯(PBAT)、淀粉、纤维素衍生物、聚乳酸</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(PLA)、聚羟基烷酸酯(PHA)或其组合，所述第一层具有在</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>10μm与100μm之间的厚度，并且所述最内层具有在10％与1000％之间的断裂伸长率、当在190℃下在2.16kg的压力下在10分钟内测量时在4与10之间的熔体流动速率(MFR)，并且所述第一层具有在110℃与180℃之间的熔点温度。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2""><seg-con>4.根据前述权利要求1或2中任一项所述的包装物品(1)，其中所述内衬(3)从外到内</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""4"" pa","D21J3/10, B65D65/46, B65D85/804",20250722,雀巢产品有限公司,['Pending']
WO2025040608A1,Moulded pulp article,"The present invention relates to a method of producing a moulded pulp article (1), the method comprising: a) applying a composite phase (2) to the pulp (3), the composite phase (2) comprising precursor particles (4); b) shaping the pulp (3); and c) converting the composite phase (2) to a ceramic coating (5) by heating the composite phase; and moulded pulp articles.",,"D21J3/10, D21J7/00, D21H17/63, B65D25/14, D21H17/64",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250127192A1,Wet pet food systems,"The present disclosure is drawn to wet pet food systems and methods of packaging wet pet foods. The wet pet food systems include a sealed pouch constructed of a monomaterial of polypropylene and a wet pet food contained within the sealed pouch. The wet pet food can include a member selected from the group consisting of a mousse, a chunk-in-loaf, and chunks-in-gravy. The wet pet food includes an antioxidant including a soy sauce.","<div class=""indep-clm"" num=""1""><seg-con>1. A wet pet food system, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a sealed pouch constructed of a monomaterial of polypropylene; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a wet pet food contained within the sealed pouch, the wet pet food including a member selected from the group consisting of a mousse, a chunk-in-loaf, and chunks-in-gravy, wherein the wet pet food comprises an antioxidant including a soy sauce.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is recyclable.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is constructed of a monolayer of polypropylene.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is more permeable to oxygen and water than an aluminum barrier pouch.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the soy sauce is included in the wet pet food at from about 0.1 wt % to about 3 wt % based on a dehydrated soy sauce weight of a total weight of the wet pet food.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the soy sauce is added to the wet pet food at from about 0.25 wt % to about 2 wt % based on a dehydrated soy sauce weight of a total weight of the wet pet food.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wet pet food includes fr","A23K30/00, A23K10/20, A23K10/30, A23K50/48, B65B25/00",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019407799B2,Method for roasting coffee beans,"The invention concerns an apparatus for roasting coffee beans comprising : - a vessel (1) to contain coffee beans, - an electrical heating device (13) to heat coffee beans contained in the vessel, - at least one temperature sensor (23) to measure temperature in the vessel, - a control system (180) operable to control the heating device, wherein the control system is configured to : - apply a roasting recipe dedicated to the roasting of partially pre- roasted beans comprising at least a temperature versus time profile by controlling the electrical heating device based on the measure of the temperature sensor, - detect a decrease of the consumption of electrical power of the heating device in function of time, - stop heating if no decrease of the consumption of electrical power happens after a set reference time ti. - continue or stop the electrical heating device depending on the type of identified beans.","<div class=""indep-clm"" num=""1""><seg-main>1. An apparatus for roasting coffee beans comprising :</seg-main>
<seg-clauses>- a vessel to contain coffee beans,</seg-clauses>
<seg-clauses class=""seg-enter"">5   - an electrical heating device to heat coffee beans contained in the vessel,</seg-clauses>
<seg-clauses>- at least one temperature sensor to measure temperature in the vessel,</seg-clauses>
<seg-clauses><seg-main>- a control system operable to control the heating device,</seg-main>
<seg-main class=""seg-enter"">wherein the control system is configured to :</seg-main>
<seg-clauses>- apply a roasting recipe dedicated to the roasting of partially pre-roasted beans comprising 0 at least a temperature versus time profile by controlling at least the electrical heating device based on the measure of the temperature sensor,</seg-clauses>
<seg-clauses>- detect a decrease of the consumption of electrical power of the heater in function of time, </seg-clauses><seg-clauses>- stop heating if no decrease of the consumption of electrical power happens after a set reference time ti.</seg-clauses>
<seg-clauses class=""seg-enter"">5</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The apparatus according to Claim 1, wherein </seg-main><seg-clauses>the control system is configured to measure at least one electrical parameter representative of the consumption of electrical power by the heating device during the time the roasting recipe is applied,</seg-clauses>
<seg-clauses class=""seg-enter"">:0   </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The apparatus according to Claim 2, wherein </seg-main><seg-clauses>the electrical parameter representative of</seg-clauses>
<seg-clauses class=""seg-enter"">the consumption of electrical power is the current of the electrical heating device.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The apparatus according to any one of Claims 1 to 3, wherein </seg-main>","A23N12/08, A23F5/04, A23N12/12",20250123,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
WO2025088118A1,Edible plant-based pastes for preparing dairy analogues,"The invention relates an edible plant-based paste that can be reconstituted into an aqueous liquid to form a plant-based dairy analogue, preferably a plant-based dairy drink analogue. Said edible plant-based paste comprises i) at least one fat component, ii) at least one non-soy grain component having a protein content of less than 28wt.% and iii) at least one protein component having a protein content of more than 30wt.%. The invention also relates to a process for manufacturing such an edible plant-based paste and to a method for preparing a plant-based dairy analogue by reconstituting such an edible plant-based paste in an aqueous liquid.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An edible plant-based paste which comprises:</seg-main>
<seg-clauses>- at least one fat component,</seg-clauses>
<seg-clauses>- at least one non-soy grain component having a protein content of less than 28wt.%,</seg-clauses>
<seg-clauses>- at least one protein component having a protein content of more than 30wt.%, wherein the protein component is different from the non-soy grain component,</seg-clauses>
<seg-clauses>- optionally, at least one sugar component, preferably sucrose, and</seg-clauses>
<seg-clauses>- optionally, at least one hydrocolloid.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The edible plant-based paste according to claim 1, wherein </seg-main><seg-clauses>the non-soy grain component is provided as a non-soy grain flour.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The edible plant-based paste according to any one of the preceding claims, wherein </seg-main><seg-clauses>the non-soy grain component, preferably non-soy grain flour, comes from a grain selected from legumes, nuts, oilseeds, cereals and combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The edible plant-based paste according to any one of the preceding claims, wherein </seg-main><seg-clauses>the non-soy grain component, preferably non-soy grain flour, comes from cereal, preferably comes from oat.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The edible plant-based paste according to any one of the preceding claims, wherein </seg-main><seg-clauses>the non-soy grain component, preferably non-soy grain flour, is fully or partially hydrolysed.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The edible plant-based paste according to any one of the preceding claims, wherein </seg-main><seg-clauses>the non-soy grain component has protein content of less than 25wt.%, prefera","A23C11/02, A23J3/08, A23J3/14, A23L11/60, A23L11/65",20250501,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20240410864A1,Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using conjugated bile acids as biomarker and improved methods and compositions thereof,"The present invention relates to the use of glycine-conjugated bile acids as biomarker for detecting and/or quantifying improvements of the mood disorder status and/or excessive emotional reaction of a subject. It also relates to a method for detecting and/or quantifying mood disorder, improvements of the mood disorder status and/or excessive emotional reaction of a subject, in particular for monitoring the progress of an intervention to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject, wherein the intervention comprises the administration of a probiotic. It also relates to an improved method to treat or ameliorate a mood disorder status and/or excessive emotional reaction in a subject in need, comprising administering to the subject, an effective amount of a composition combining a probiotic with glycine or derivative thereof.","<div class=""ccl-clm"" num=""2"">1-2. (canceled)</div>
<div class=""indep-clm"" num=""3""><seg-main>3. Method for detecting and/or quantifying mood disorder, improvements of the mood disorder status and/or excessive emotional reaction of a subject, comprising</seg-main>
<seg-clauses><seg-main>assessing the level of at least one conjugated bile acid in a body sample obtained from a subject to be tested, and</seg-main>
<seg-main class=""seg-enter"">comparing the subject's conjugated bile acid level to a predetermined reference value, wherein:</seg-main>
<seg-clauses>i) an increased level of conjugated bile acid cholic acid (CA) and/or chenodeoxycholic acid (CDCA), in the sample compared to the predetermined reference value and/or</seg-clauses>
<seg-clauses>ii) a decreased level of conjugated bile acid ursodeoxycholic acid (UDCA), in the sample compared to the predetermined reference value,</seg-clauses>
<seg-clauses class=""seg-enter"">indicates an improvement of the mood disorder status and/or excessive emotional reaction of the subject.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method according to claim 3, wherein </seg-main><seg-clauses>the mood disorder is mild to severe.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-main>5. The method according to claim 3, wherein </seg-main><seg-clauses>the predetermined reference value was obtained previously from the same subject.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""3""><seg-main>6. The method according to claim 3, wherein </seg-main><seg-clauses>the predetermined reference value is based on an average conjugated bile acids level in the same body fluid in a control population.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""3""><seg-main>7. The method according to claim 3, wherein </seg-main><seg-clauses>the levels of the biomarkers in the sample and in the reference are determined by mass spectrometry, according to by ultra-performance liquid ","G01N30/88, A61K31/198, A61K35/00, A61K35/741, G01N30/02",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
KR1020250084986A,"Bottle, method of making the same and use of fdca and diol monomers in such bottle",,"<div class=""indep-clm"" num=""1"">청구항 1</div>
<div class=""indep-clm"" num=""1"">본원 발명의 설명에 기재된 것을 특징으로 하는, 병.</div>","B65D1/02, B29B11/14, B29C49/00, B29C49/52, C08G63/672",20250611,소시에떼 데 프로듀이 네슬레 소시에떼아노님,['Pending']
CN120659549A,"Combination of isoflavone source and at least one natural extract for treating, preventing or supporting improvement of cognitive symptoms associated with menopause","The invention relates to a method for treating or preventing cognitive menopause symptoms. The method comprises administering to a human female suffering from or at risk of the cognitive menopause symptom an effective amount of an isoflavone source in combination with at least one of a natural extract for supporting cognitive performance and a natural extract for promoting calm and alleviating tension. The combination may be administered in a composition further comprising one or more of vitamin B12, vitamin B6, vitamin B complex, iron, magnesium, and/or a freshener/cooling agent. A single or multiple doses of the composition may be administered per day, the multiple doses including a first dose and a second dose. A first dose may be administered to the human female in the morning and a second dose may be administered to the human female at night.","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含异黄酮来源与用于支持认知表现的天然提取物和用于促进平静和减轻紧张的天然提取物中的至少一种的组合。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述组合物为单位剂型，所述单位剂型包含有效治疗或预防认知性绝经症状的量的所述组合物。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的组合物，其中所述组合物是严格素食的。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，其中所述异黄酮来源选自大豆提取物、红三叶草提取物及其组合。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，其中用于促进平静和减轻紧张的所述天然提取物选自柠檬香蜂草提取物、春黄菊提取物、茴香提取物、南非醉茄提取物及其组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，其中用于支持认知表现的所述天然提取物选自人参提取物和绿茶提取物。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的组合物，所述组合物还包含选自菊粉、胶原、胶原肽、低聚果糖及其组合的附加成分。</div>
<div class=""indep-clm"" num=""8"">8.用于治疗或预防认知性绝经症状的方法，所述方法包括向有需要或处于风险中的人类女性施用有效量的异黄酮来源与用于支持认知表现的天然提取物和用于促进平静和减轻紧张的天然提取物中的至少一种的组合。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的方法，其中所述异黄酮来源包括红三叶草提取物。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求8或权利要求9所述的方法，其中所述组合包含用于支持认知表现的天然提取物，其中所述用于支持认知表现的天然提取物包含人参提取物并且以包含含有至少12mg人参皂苷的量的所述人参提取物的剂量施用于所述有需要或处于风险中的人类女性。</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">11.根据权利要求8至10中任一项所述的方法，其中所述组合包含用于促进平静和减轻紧张的天然提取物，其中所述用于促进平静和减轻紧张的天然提取物包含柠檬香蜂草提取物并且以包含含有至少18mg迷迭香酸的量的所述柠檬香蜂草提取物的剂量施用于所述有需要或处于风险中的人类女性。</div>
<div class=""dep-clm"" num=""12"" parent=""8,9,10,11"">12.根据权利要求8至11中任一项所述的方法，其中所述组合以组合物施用，所述组合物还包含选自维生素B12、维生素B6、镁及其组合的一种或多种维生素和矿物质。</div>
<div class=""dep-clm"" num=""13"" parent=""8,9,10,11,12"">13.根据权利要求8至12中任一项所述的方法，其中所述认知性绝经症状选自潮热、夜间盗汗、睡眠障碍、疲劳、紧张、焦虑、注意力障碍、记忆损害及其组合。</div>
<div class=""dep-clm"" num=""14"" parent=""8,9,10,11,12,13"">14.根据权利要求8至13中任一项所述的方法，其中所述组合以组合物施用，所述组合物还包含清新剂。</div>
<div class=""dep-clm"" num=""15"" parent=""8,9,10,11,12,13,14"">15.根据权利要求8至14中任一项所述的方法，其中每天施用单个剂量的所述组合物。</div>
<div class=""dep-clm"" num=""16"" parent=""8,9,10,11,12,13,14,15"">16.根据权利要求8至15中任一项所述的方法，其中每天施用多个剂量的所述组合物，所述多个剂量包括其中所述组合包含第一异黄酮来源和用于支持认知表现的天然提取物的第一剂量，所述多个剂量还包括其中所述组合包含第二异黄酮来源和用于促进平静和减轻紧张的天然提取物的第二剂量，并且所述第二剂量与","A23L33/105, A61K31/4415, A61K31/714, A61K36/258, A61K36/53",20250916,雀巢产品有限公司,['Pending']
US20250302855A1,Compositions and methods using a combination of oleuropein and fisetin for use in cartilage degeneration,"The present invention relates to use of a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and fisetin and/or derivative for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and fisetin and/or derivative for use to prevent or treat cartilage degeneration in an individual.","<div class=""indep-clm"" num=""1""><seg-main>1. Method for use to prevent or treat cartilage degeneration in an individual comprising </seg-main><seg-clauses>administering a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and fisetin and/or derivative to an individual in need thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1, wherein </seg-main><seg-clauses>the metabolite of fisetin is selected from the group consisting of glucuronidated forms thereof, sulfated forms thereof, derivatives and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1"">4. Method according to claim 1, further comprising calcium.</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the composition further comprises at least one compound selected from the group consisting of antioxidants, anti-inflammatory compounds, glycosaminoglycans, prebiotics, fibres, probiotics, fatty acids, enzymes, minerals, trace elements and/or vitamins.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the composition is selected from the group consisting of food compositions, dietary supplements, nutritional compositions, oral nutritional supplement, medical food, nutraceuticals, beverages, powdered nutritional products to be reconstituted in water or milk before consumption, food additives, food for special medical purpose (FSMP) medicaments, d","A61K31/7048, A61K31/352, A61K33/06, A61P19/02",20251002,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025114592A1,Nutritional composition for promoting social development,The present invention relates to a nutritional composition comprising lactoferrin as an active ingredient for use in promoting social development and/or in promoting social behaviours in a young individual. The present invention further relates to uses and methods for promoting social development and/or for promoting social behaviours in a young individual.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1 . A composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>lactoferrin as an active ingredient in effective amount for use in promoting social development in a young individual.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>lactoferrin is comprised at amount ranging from at least about 190 ng/pL to at least about 5050 ng/pL.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The composition according to any one of the preceding claims, for use in promoting behaviours in social interactions, such as play, and/or in response to novelty and/or new situations and/or with new people/strangers in the young individual.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. The composition according to any one of the preceding claims, for use in promoting surgency and/or extraversion in the young individual.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the young individual is an infant, a toddler or a young child, preferably an infant.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>it is administered to the young individual from birth to about 5 years of age, preferably from birth to 18 weeks of age, more preferably during the first 6 weeks of life of the young individual.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. The composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>social development is promoted in a young individual from birth to about 5 years of age, preferably from birth to 18 months of age, more preferably from about 2 to abo","A61K38/40, A61P25/22, A61P25/24, A61P43/00",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025103915A1,Manufacturing process and manufacturing line for manufacturing an engraved cellulose-based container,"The invention relates to a manufacturing process for producing a biodegradable, preferably compostable, single-use food and/or beverage containers (1) for use in a beverage production machine, on a single-use container manufacturing line (20), the manufacturing process comprising: a) supplying a cellulose-based container body (2) having an external surface and an outwardly extending peripheral rim (6), b) filing the container body (2) with a food and/or beverage ingredient (10), c) applying a closing element (7) over the container body (2), d) sealing the closing element (7) with the peripheral rim (6) of the container body (2), According to the invention, the manufacturing process further comprises a step of marking (a1) the container body (2) on its external surface by printing and/or by laser engraving, said marking step taking place before the step of filling the container body (step b) with the food and/or beverage ingredient. The invention also relates to a manufacturing line to implement the proposed manufacturing process and to a single-use food and/or beverage containers produced using the proposed manufacturing process.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. Manufacturing process for producing a biodegradable, preferably compostable, single-use food and/or beverage containers </seg-main><seg-clauses><seg-main>(1) for use in a beverage production machine, on a single-use container manufacturing line (20), the manufacturing process comprising: </seg-main><seg-clauses>a) supplying a cellulose-based container body (2) having an external surface and an outwardly extending peripheral rim (6), </seg-clauses><seg-clauses>b) filing the container body (2) with a food and/or beverage ingredient (10), </seg-clauses><seg-clauses>c) applying a closing element (7) over the container body (2), </seg-clauses><seg-clauses>d) sealing the closing element (7) with the peripheral rim (6) of the container body (2), characterized in that the manufacturing process further comprises a step of marking (al) the container body (2) on its external surface by printing and/or by laser engraving, said marking step taking place before the step of filling the container body (step b) with the food and/or beverage ingredient.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Manufacturing process according to claim 1, wherein </seg-main><seg-clauses>during the marking step (al), the container body (2) is marked by printing and/or laser engraving in one or more locations of the container body (2).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Manufacturing process according to claim 1 or 2, wherein </seg-main><seg-clauses>the closing element of the container (1) is a closing membrane (7a) or a second container body (7b) respectively forming when sealed with the peripheral rim (6) of the container body (2), a capsule (la) or a pod (lb).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Manufacturing process according to any one of claims 1 to 3, in which, </seg-main><seg-clauses>when the container is a capsule (la), ",B65B29/02,20250522,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN119855769A,"Capsules, systems, and methods for delivering follicular coffee extract","The present invention relates to a capsule for preparing a follicular coffee extract, the capsule comprising: a substantially rigid capsule body having a peripheral side wall extending around an interior space of the capsule; a base wall covering the interior space at a first end of the sidewall; a flange circumferentially arranged at a second end of the sidewall of the base body; a cover removably attached to the flange and covering the internal space at a second end of the side wall opposite the base wall and tightly enclosing the capsule; and a filter element positioned in the interior space of the capsule between the beverage ingredient and the lid, where the interior space of the capsule is at least partially filled with ground coffee, preferably baked and ground coffee, the particle size distribution D4 of the baked and ground coffee, 3 is 500 [mu] m +/-30 [mu] m and the fraction of fine particles in the roasted and ground coffee is between 2% and 9%. The invention also relates to a system comprising said capsule, to the use of said capsule or said system and to a method for delivering a follicular coffee extract.","<div class=""indep-clm"" num=""1""><seg-con>1.用于制备滤泡型咖啡萃取物的胶囊，所述胶囊包括</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>-大体刚性的胶囊主体，所述胶囊主体具有围绕所述胶囊的内部空间延伸的周向侧壁；</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-comp>-基壁，所述基壁在所述侧壁的第一端部处覆盖所述内部空间；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-凸缘，所述凸缘在所述胶囊主体的所述侧壁的第二端部处周向地布置；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-盖，所述盖以可移除方式附接到所述凸缘，并且在所述侧壁的与所述基壁相对的第二端部处覆盖所述内部空间并且紧密地封闭所述胶囊；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>-过滤元件，所述过滤元件在所述胶囊的所述内部空间中定位在所述饮料成分与所述盖之间，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述胶囊的所述内部空间至少部分地填充有研磨咖啡，优选地为烘焙并且研磨的咖啡，所述烘焙并且研磨的咖啡的粒度分布D4,3为500微米+/-30微米并且细微粒子在所述烘焙并且研磨的咖啡中的分数为2％和9％之间。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的胶囊，其中所述细微粒子具有小于50微米的平均直径。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的胶囊，其中所述胶囊内的所述研磨咖啡的量在4克和5.5克之间。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的胶囊，其中所述胶囊中的所述研磨咖啡具有380g/l至450g/l之间的密度。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的胶囊，其中对于150mL的咖啡萃取物体积，所述咖啡萃取物在小于40s的流动时间内递送，不考虑可能的后续萃取之间的任何重新启动时间。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的胶囊，其中所述胶囊内的所述研磨咖啡在2巴至6巴的压力下萃取。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的胶囊，其中所述胶囊在使用前具有5毫巴至100毫巴之间的内部压力。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的胶囊，其中包括多个预成形出口开口的承载盘设置在所述盖和所述过滤元件之间。</div>
<div class=""dep-clm"" num=""9"" parent=""7"">9.根据权利要求7所述的胶囊，其中所述承载盘包括介于50个和150个之间的出口开口，并且所述承载盘的开口表面比高于4％。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的胶囊，其中所述过滤元件具有根据ISO 9237的在600l/m2/s与2500l/m2/s之间的孔隙度，以将细粉保留在所述胶囊内。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的胶囊，其中在将所述咖啡萃取物供应至容器之前，所述过滤元件保留来自所述咖啡的脂质部分，优选为油。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的胶囊，其中所得的咖啡萃取物中的总固体(TC)低于1.5％，并且优选地在0",B65D85/804,20250418,雀巢产品有限公司,['Pending']
AU2020214721B2,"Syrup binder system for preparing food, and preparation process and use thereof","The present invention relates to the food field. Specifically, the present invention relates to a syrup binder system for preparing a food containing extruded or puffed cereal and/or nuts, such as compound sachima (complexed sachima), cereal bars, crunchy rice candy or nut bars, etc., a preparation process and use thereof, and a food containing the syrup binder system.","<div class=""indep-clm"" num=""1""><seg-main>1. Syrup binder system for food, which binder system comprises </seg-main><seg-clauses>a sugar, a polyol, dietary fiber having water holding capacity greater than 8 ml/g, preferably of 8-15 mg/g, and more preferably of 9-14 mg/g, an emulsifier, edible oil, and water.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Syrup binder system according to claim 1, further comprising </seg-main><seg-clauses>cellulose or a derivative thereof, e.g., cellulose ether, cellulose ester, or cellulose ether ester, preferably cellulose ether, e.g., carboxymethylcellulose or a derivative thereof, e.g., a salt, such as sodium carboxymethylcellulose or calcium carboxymethylcellulose; preferably, the cellulose or the derivative thereof is present in an amount of 0.002-2 wt%, preferably 0.005-1.5 wt % and more preferably 0.011 wt % based on the total weight of the syrup binder system.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Syrup binder system according to any one of the preceding claims, wherein </seg-main><seg-clauses>the polyol is a polyol having 2-5 hydroxy groups, preferably a polyol having 2-5 hydroxy groups and 3-5 carbon atoms, such as dihydric alcohol, e.g., propylene glycol, and trihydric alcohol, e.g. glycerol; preferably, the polyol is present in an amount of 1-25 wt%, preferably 5-20 wt % and more preferably 6-15 wt % based on the total weight of the syrup binder system.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Syrup binder system according to any one of the preceding claims, wherein </seg-main><seg-clauses>the dietary fiber is present in an amount of 0.1-8 wt%, preferably 0.2-6 wt% and more preferably 0.5-5 wt% based on the total weight of the syrup binder system; preferably, the dietary fiber is selected from one or more of citric fiber, soy fiber, potato fiber, and wax gourd fiber.</seg-clauses>
<seg-clauses class=""seg-enter"">2020214721  1","A23G3/34, A23G3/48, A23L7/109, A23L7/126, A23L25/00",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025219967A1,"Foaming liquid creamers for aerosol packaging, and methods of making and using such foaming liquid creamers and aerosol packagings","A foaming liquid creamer contains water, a lipid, a buffer salt, a stabilizer, and a dairy protein. Optionally the foaming liquid creamer further contains a sugar and/or a flavor. The buffer salt may include at least one of sodium bicarbonate or dipotassium phosphate. The stabilizer may include at least one of carrageenan, carboxymethyl cellulose (CMC), microcrystalline cellulose (MCC), or guar gum. The dairy protein may include at least one of micellar casein or sodium caseinate. The emulsifier may include mono- and di-glycerides. The lipid may include an oil. The foaming liquid creamer may additionally include an emulsifier such as mono- and di- glycerides. Another aspect is an aerosol packaging which includes the foaming liquid creamer in a pressurized container, and the aerosol packaging has an actuator nozzle.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A foaming liquid creamer </seg-con><seg-trans>comprising </seg-trans><seg-refi>water, a lipid, a buffer salt, a stabilizer, and a dairy protein.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The foaming liquid creamer of claim 1 , </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a sugar.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The foaming liquid creamer of claim 1 or claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the buffer salt comprises at least one of sodium bicarbonate or dipotassium phosphate.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The foaming liquid creamer of any of claims 1-3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stabilizer comprises at least one of carrageenan, carboxymethyl cellulose (CMC), microcrystalline cellulose (MCC), or guar gum.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The foaming liquid creamer of any of claims 1-4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dairy protein comprises at least one of micellar casein or sodium caseinate.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The foaming liquid creamer of any of claims 1-5, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>an emulsifier.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The foaming liquid creamer of claim 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the emulsifier comprises mono- and di-glycerides.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-con>8. The foaming liquid creamer of any of claims 1-7, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lipid comprises an oil.</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""><seg-con>9. The foaming liquid creamer of any of claims 1-8, </seg-con><seg-trans>further comprising </seg-trans>","B65D83/30, B65D83/20",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119110787A,Capsule for producing beverage,"The present invention relates to a capsule for use in a beverage preparation machine, said capsule containing soluble and/or extractable beverage ingredients, said capsule comprising:-a capsule body (2) defining a chamber (21),-a top membrane (3) closing a top opening and adapted to be punctured for injecting a liquid into the capsule, and-a bottom membrane (4), -a bottom membrane (2) arranged inside the chamber (21) so as to define a dosing chamber between the top membrane (3) and said bottom membrane, and-an opening device (5), the opening device is arranged inside the chamber and is adapted to open the chamber by opposite engagement of the opening device with the bottom membrane (4) during injection of the liquid under the action of an increase in liquid pressure in the dispensing chamber, the bottom membrane being a laminated multilayer material, the invention relates to an opening device (5) comprising a laminated multilayer material comprising, in order:-a layer of vegetable parchment (41), and-an adhesive layer (42), and-a layer of non-woven material (43) comprising fibres wherein said fibres are biodegradable fibres, and wherein the layer of vegetable parchment faces the opening device (5).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于在饮料制备机器中使用的胶囊(1)，所述胶囊包含可溶和/或可提取的饮料配料，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述胶囊</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-胶囊主体(2)，所述胶囊主体限定腔室(21)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部膜片(3)，所述顶部膜片封闭顶部开口并且适配为被刺破以将液体注入所述胶囊中，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-底部膜片(4)，所述底部膜片设置在所述腔室(21)内部以便在所述顶部膜片(3)与所述底部膜片之间界定配料腔室，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-打开装置(5)，所述打开装置设置在所述腔室内部并且被适配为在注入所述液体期间在所述配料腔室中的液体压力增加的作用下通过所述打开装置与所述底部膜片(4)的相对接合来打开所述腔室，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述底部膜片是层压的多层材料，所述层压的多层材料依次包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-植物羊皮纸层(41)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-粘合层(42)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-非织造材料层(43)，所述非织造材料层包括纤维，其中所述纤维是可生物降解纤维，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述植物羊皮纸层面对所述打开装置(5)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的胶囊，其中所述非织造材料层的所述可生物降解纤维选自由PLA、PHA(聚羟基链烷酸酯)、PHB(聚(羟基丁酸酯))、PHB(V)(聚(羟基丁酸酯-共-羟基戊酸酯))、PBS(聚(琥珀酸丁二醇酯))、生物聚酯和纤维素纤维诸如棉花、亚麻、木纤维及其组合组成的纤维组。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的胶囊，其中所述非织造材料的所述可生物降解纤维包括熔点为至少约100℃的可热密封纤维。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的胶囊，其中所述非织造材料的所述纤维仅由聚乳酸(PLA)构成。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的胶囊，其中所述非织造材料的克重在5g/m<sup>2</sup>和100g/m<sup>2</sup>之间，有利地在20g/m<sup>2</sup>和40g/m<sup>2</sup>之间，并且优选地为大约30g/m<sup>2</sup>。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的胶囊，其中所述粘合层(42)是丙烯酸粘合剂。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的胶囊，其中所述植物羊皮纸(41)的克重在30g/m<sup>2</sup>和120g/m<sup>2</sup>之间，有利地在60g/m<sup>2</sup>和80g/m<sup>2</sup>之间，并且优选地为大约70g/m<sup>2</sup>。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的胶",B65D85/804,20241210,雀巢产品有限公司,['Pending']
US20250283874A1,"Methods of determining a health status of a dog based on one or more biomarkers, and methods of treating a mortality risk identified by the health status","The present invention relates to a method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising determining the level of one or more biomarker(s) in one or more samples obtained from the dog, wherein the one or more biomarker(s) is selected from white blood cell count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, serum globulin, serum calcium, platelet count, and/or red blood cell count.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising </seg-main><seg-clauses>determining the level of one or more biomarker(s) in one or more samples obtained from the dog, wherein the one or more biomarker(s) is selected from the group consisting of white blood cell count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, serum globulin, serum calcium, platelet count, and red blood cell count.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is white blood cell count.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is serum albumin.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is serum alkaline phosphatase.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1 wherein </seg-main><seg-clauses>the method comprises measuring each of white blood cell count, serum albumin and serum alkaline phosphatase.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1 wherein </seg-main><seg-clauses>the method comprises measuring each of white blood cells count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, and serum globulin.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1 wherein </seg-main><seg-clauses>the one or more sample(s) is a blood sample.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" ","G01N33/50, G01N33/569, G01N33/573, G01N33/66, G01N33/68",20250911,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250204560A1,Wholesome sugar beet derived product having light colour and improved taste and mouthfeel and method of making thereof,"The invention relates to a method of making a sugar beet derived product, said method comprising the steps of obtaining sugar beet pieces by peeling and cutting sugar beet; heat treating the sugar beet pieces; reducing the size of the sugar beet pieces; forming a sugar beet paste from the sugar beet pieces; and pasteurizing the sugar beet paste.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a sugar beet derived product, said method comprising the steps of</seg-main>
<seg-clauses>a) Obtaining sugar beet pieces by peeling and cutting sugar beet;</seg-clauses>
<seg-clauses>b) Heat treating the sugar beet pieces;</seg-clauses>
<seg-clauses>c) Reducing the size of the sugar beet pieces;</seg-clauses>
<seg-clauses>d) Forming a sugar beet paste from the sugar beet pieces; and</seg-clauses>
<seg-clauses>e) Pasteurizing the sugar beet paste.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar beet or sugar beet pieces are soaked in acid solution having a pH between 2 to 5.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar beet pieces are heat treated.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the reduction in size of the sugar beet pieces in step c) is performed under an atmosphere comprising over 80%, preferably over 90% nitrogen gas.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar beet paste is subjected to a cavitation step.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar beet paste is further concentrated until it has a total solids content of 25 to 30%.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar beet paste undergoes a crystallization step.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The method according to claim 1, wherein </seg-main><seg-clauses>the crystallization step comprises w",A23L19/10,20250626,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120435570A,MiRNAs from biological samples as indicators of stress in bovine animals,"The present invention relates to miRNA biomarkers, such as exosome-derived microRNAs, from biological samples as indicators of welfare in bovine animals. In particular, the present invention relates to the identification of heat stress in bovine animals, allowing management measures to be proposed to improve productive animal welfare at individual or veterinary levels.","<div class=""indep-clm"" num=""1"">1.确定至少一头牛的至少一个福利参数的方法，所述方法包括</div>
<div class=""indep-clm"" num=""1"">i.确定生物样品中调节细胞周期的至少一种miRNA的水平，其中所述miRNA选自SEQ IDNO:94、123、93、84、81、134、85、74、83、113、1、132、112和111或其功能变体，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的总体序列同一性；以及</div>
<div class=""indep-clm"" num=""1"">ii.将所述至少一种miRNA的水平与参考水平进行比较，其中如果所述选自SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111的一种或多种miRNA高于所述参考水平，则所述至少一头牛的至少一个福利参数已经受到损害或受到损害，或者如果所述选自SEQ IDNO:81和134的一种或多种miRNA低于所述参考水平，则所述至少一头牛的至少一个福利参数已经受到损害或受到损害。</div>
<div class=""indep-clm"" num=""2"">2.改善至少一头牛的至少一个福利参数的方法，所述方法包括</div>
<div class=""indep-clm"" num=""2"">i.确定第一生物样品中调节细胞周期的至少一种miRNA的水平，其中所述miRNA选自SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111或其功能变体，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的序列同一性；</div>
<div class=""indep-clm"" num=""2"">ii.将所述至少一种miRNA的水平与参考水平进行比较，其中如果所述选自SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111的一种或多种miRNA高于所述一个或多个参考水平，则所述至少一头牛的至少一个福利参数已经受到损害，或者如果所述选自SEQ IDNO:81和134的一种或多种miRNA低于所述一个或多个参考水平，则所述至少一头牛的至少一个福利参数已经受到损害；</div>
<div class=""indep-clm"" num=""2"">iii.改善所述至少一头牛的福利；</div>
<div class=""indep-clm"" num=""2"">iv.确定第二生物样品中选自SEQ ID NO:94、123、93、84、81、</div>
<div class=""indep-clm"" num=""2"">134、85、74、83、113、1、132、112和111或其功能变体的至少一种miRNA的水平，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的序列同一性；以及</div>
<div class=""indep-clm"" num=""2"">v.将所述第一生物样品中的所述至少一种miRNA的水平与所述第二生物样品中的水平进行比较，其中如果所述第二生物样品中的SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111或55或其功能变体的水平低于所述第一生物样品中的水平或低于所述参考样品中的水平，则所述一头牛的福利已经改善，其中所述功能变体分别与SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111具有至少60％的序列同一性；或者</div>
<div class=""indep-clm"" num=""2"">如果所述第二生物样品中的SEQ ID NO:81或134的水平高于所述第一生物样品中的水平或高于所述参考样品，则所述一头牛的福利已经改善。</div>
<div class=""indep-clm"" num=""3"">3.改善至少一头牛的乳产量、乳质量、肉产量或肉质量中的至少一者的方法，所述方法包括</div>
<div class=""indep-clm"" num=""3"">i.确定第一生物样品中参与调节细胞周期的至少一种miRNA的水平，其中所述miRNA选自SEQ ID NO:94、123、93、84、85、</div>
<div class=""indep-clm"" num=""3"">74、83、113、1、132、112和111或其功",C12Q1/6876,20250805,雀巢产品有限公司,['Pending']
JP2024178313A,Toilet sand composition,To provide an improved toilet sand composition which overcomes demerits and drawbacks related to an existing malodor control technique.SOLUTION: Provided are compositions and a method comprising a fragrance and from about 0.5 weight % to about 5.0 weight % of a granular malodor adsorbent which can be used to eliminate malodor in animal waste. The granular malodor absorbent may be granular molecular sieves or granulated activated carbon and has a pore size from about 0.4 nm to about 2.0 nm and a total surface area from about 100 m2/g to about 1500 m2/g.SELECTED DRAWING: None,"<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 芳香剤と顆粒状悪臭吸着剤とを含む、悪臭制御用の動物用トイレ砂組成物であって、前記顆粒状悪臭吸着剤が、約０．０５重量％～約５．０重量％の量で存在し、かつ約０．４ｎｍ～約２．０ｎｍの孔径及び約１００ｍ<sup> ２</sup>／ｇ～約１５００ｍ<sup> ２</sup>／ｇの総表面積を有し、前記顆粒状悪臭吸着剤が、悪臭を実質的に吸着し、前記芳香剤を実質的に放出する、動物用トイレ砂組成物。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記顆粒状悪臭吸着剤が、モレキュラーシーブ顆粒及び活性炭顆粒からなる群から選択される、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 前記顆粒状悪臭吸着剤が、約－８～約６０のメッシュサイズを有する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""4"" parent=""1"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1""> 前記芳香剤が、約０．０５重量％～約０．４重量％の量で存在する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""5"" parent=""1"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1""> 前記芳香剤がカプセル化されていない、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""6"" parent=""1"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1""> 吸収性基材を更に含む、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""7"" parent=""6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""6""> 前記吸収性基材が、吸収性コアと前記吸収性コアを取り囲む別個の層とを含む吸収性顆粒を含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""8"" parent=""6"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""6""> 前記吸収性基材が粘土を含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""9"" parent=""6"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""6""> 前記吸収性基材が、膨潤粘土でコーティングされた非膨潤粘土コアを含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""10"" parent=""6"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""6""> 前記吸収性基材が、膨潤粘土でコーティングされた膨張パーライトコアを含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""11"" parent=""9,10"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""9,10""> 前記膨潤粘土がナトリウムベントナイトである、請求項９又は１０に記載の組成物。 </div>
<div class=""dep-clm"" num=""12"" parent=""1"">【請求項12】</div>
<div class=""dep-clm"" num=""12"" parent=""1""> 前記顆粒状悪臭吸着剤が、前記芳香剤よりも悪臭に対してより高い親和性を有する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""13"" parent=""1"">【請求項13】</div>
<div class=""dep-clm"" num=""13"" parent=""1""> 前記顆粒状悪臭吸着剤が、前記悪臭の少なくとも２５％を吸着する",A01K1/015,20241224,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
AU2024265675A1,A recyclable packaging with barrier to oxygen and moisture,"The present invention is directed to a packaging item (1) comprising: (i) at least one packaging body (2) having a tubular shape and closed at one of its extremities (4) by a permanent bottom wall (5), to define at least one compartment for packaging contents, and at least one dispensing opening (6) configured to allow the packaged contents to be dispensed from said packaging item (1), said packaging body (2) and bottom wall (5) being made of a multilayer oxygen and moisture barrier laminate comprising a cellulosic support layer, and (ii) a removable closure element (7) being made of an oxygen and moisture barrier laminate comprising a paper layer.","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (1) comprising:</seg-main>
<seg-clauses>(i) at least one packaging body (2) having a tubular shape and closed at one of its extremities (4) by a permanent bottom wall (5), to define at least one compartment for packaging contents, and at least one dispensing opening (6) configured to allow the packaged contents to be dispensed from said packaging item (1), said packaging body (2) and bottom wall </seg-clauses><seg-clauses>(5) being made of a multilayer oxygen and moisture barrier laminate comprising a cellulosic support layer, and organic and/or inorganic barrier layer(s), the cellulosic support layer of the body (2) having a grammage comprised between 120 and 600 g/m2, said multilayer laminate having a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, such that the Oxygen Transmission Rate (OTR) is below 1, preferably below 0.5 cm3/m2/day measured at 23°C and 50% relative humidity (RH), and the Water Vapour Transmission rate (WVTR) is below 1, preferably below 0.5 g/m2/day measured at 23°C and 85% RH,</seg-clauses>
<seg-clauses>(ii) a removable closure element (7) being made of an oxygen and moisture barrier laminate comprising a paper layer, at least one organic and/or inorganic barrier layer, the paper layer having a grammage comprised between 30 and 120 g/m2, and a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, and such that the Oxygen Transmission Rate (OTR) is below 1, preferably below 0.5 cm3/m2/day measured at 23°C and 50% relative humidity (RH), and the Water Vapour Transmission rate (WVTR) is below 1, preferably below 0.5 g/m2/day measured at 23°C and 85% RH.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A packaging item (1) according to claim 1, wherein </seg-main><seg-clauses>said removable closure element (7) comprises a pull tab (8) to facilitate manual removal from the pa","B65D3/22, B32B27/10, B65D17/50, B65D77/20",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250242963A1,Transparent cellulosic packaging,The invention is directed to a three-dimensional food packaging (<b>100</b>) having a packaging interior (V) and being made of a cellulosic fibrous material (<b>200</b>). At least a portion (<b>111</b>) of the food packaging (<b>100</b>) delimiting at least part of the packaging interior (V) is impregnated with a polymer (<b>300</b>) such that the impregnated portion (<b>111</b>) has a light transmittance above 60% for visible light.,"<div class=""indep-clm"" num=""1""><seg-con>1. A three-dimensional food packaging made of a cellulosic fibrous material and defining a packaging interior, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the food packaging defining at least part of the packaging interior is impregnated with a polymer such that the impregnated portion has a light transmittance above 60% for visible light.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The three-dimensional food packaging according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the impregnated portion has a light transmittance above 65% for visible light.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The three-dimensional food packaging according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymer is a food grade material, is biodegradable and has a refractive index similar or identical to the cellulosic fibrous material.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The three-dimensional food packaging according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymer is selected from the group consisting of Polyolefin, Polyacrylate, Polycaprolactone, Polyester, Polyalcohol, Polyhydroxyalkanoate, thermoplastic starch, cellulose derivative, Epoxy resin, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The three-dimensional food packaging according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the impregnated portion comprises a concentration of the polymer that is continuous along at least one of its extension directions.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The three-dimensional food packaging according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the impregnated portion comprises at least one sealing portion having a concentration of the polymer that allows for s","B65D5/42, B65D25/54, B65D33/04, B65D75/52, D21H17/36",20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025201672A1,Mixture of HMOS and bifidobacterium longum transitional microorganism,"The present invention relates to a composition comprising a Bifidobacterium longum transitional microorganism and a mixture of human milk oligosaccharides (HMOs) consisting of 2'-fucosyllactose (2'-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally lacto-N-fucopentaose I (LNFP-I), 3- fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT), wherein the Bifidobacterium longum transitional microorganism has an Average Nucleotide Identity (ANI) of at least 98% with CNCM I-5942. The invention also relates to the use of the composition for preventing, reducing the risk of and/or treating an infection in a subject. The invention also provides the composition for use in promoting a long-term immune benefit in a subject, preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>a Bifidobacterium longum transitional microorganism and aHMO mixture consisting of 2'-fucosyllactose (2’-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally lacto-N-fucopentaose I (LNFP-I), 3-fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT), wherein theBifidobacterium longum transitional microorganism has an Average Nucleotide Identity (ANI)of at least 98% with the B. longum transitional strain deposited under deposit number CNCMI-5942 and/or has at least one identifying characteristic of the B. longum transitional straindeposited under deposit number CNCM I-5942.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses><seg-main>the Bifidobacterium longum transitionalmicroorganism: </seg-main><seg-clauses>(i) is capable of metabolizing the HMO(s); </seg-clauses><seg-clauses>(ii) preferentially utilizes 3-FL over 2’-FL; and/or </seg-clauses><seg-clauses>(iii) is capable of metabolizing a glycan substrate selected from inulin or arabinan.</seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the Bifidobacterium longumtransitional microorganism has an Average Nucleotide Identity (ANI) of at least 99%,preferably at least 99.9%, with the Bifidobacterium longum strain deposited with the CNCMunder deposit number CNCM I-5942.</seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>thecomposition further comprises Bifidobacterium longum subsp. infantis.</seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of the preceding claims, wher","A23L33/135, A23L33/21, A23L33/00, A61K31/702, A61K35/745",20251002,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2844171C1,Diagnosing heart disease and degenerative mitral valve disease in canine,"FIELD: biotechnology; veterinary science.SUBSTANCE: disclosed is a method for diagnosing early degenerative mitral valve disease in a canine, including measurement of normalized relative number of faecal bacteria using microbiome, including specified genera and species of bacteria; calculating a dysbiosis index based on faecal bacteria; determining that the canine has a heart disease if the dysbiosis index exceeds −1.0 (embodiments).EFFECT: inventions provide longer life of diseased dogs due to early diagnosis of heart disease in an animal.13 cl, 5 tbl, 1 ex","1. Способ диагностики заболевания сердца у животного из семейства собачьих, а именно ранней стадии дегенеративного заболевания митрального клапана, включающий:
измерение нормализованной относительной численности фекальных бактерий, включаяFaecalibacterium,Turicibacter,Streptococcus,E. Coli,Blautia, FusobacteriumиC. hiranonis;
вычисление индекса дисбиоза на основе фекальных бактерий; и
определение того, что животное из семейства собачьих имеет заболевание сердца, если индекс дисбиоза превышает -1,0.
2. Способ по п. 1, дополнительно включающий определение того, что животное из семейства собачьих имеет раннюю стадию дегенеративного заболевания митрального клапана, когда индекс дисбиоза составляет от -1 до 0,5.
3. Способ по п. 2, дополнительно включающий определение того, что ранняя стадия дегенеративного заболевания митрального клапана представляет собой стадию B1, когда индекс дисбиоза составляет от -1 до -0,25.
4. Способ по п. 2, дополнительно включающий определение того, что ранняя стадия дегенеративного заболевания митрального клапана представляет собой стадию B2, когда индекс дисбиоза составляет от -0,25 до 0,5.
5. Способ по п. 1, дополнительно включающий определение того, что животное из семейства собачьих имеет застойную сердечную недостаточность, когда индекс дисбиоза превышает 0,5.
6. Способ диагностики ранней стадии дегенеративного заболевания митрального клапана у животного из семейства собачьих, включающий:
измерение нормализованной относительной численности биомаркера, выбранного из группы, состоящей изCatenibacterium mitsuokai,Butyricicoccus pullicaecorum,Bacteroides coprocola,Bacteroides plebeius,Allobaculum stercoricanisили их комбинаций; и
определение того, что животное из семейства собачьих имеет раннюю стадию дегенеративного заболевания митрального клапана, если нормализованная относительная численностьCatenibacterium mitsuokaiсоставляет от 0,3 до 3, нормализованная относительная численностьButyricicoccus pullicaecorumсоставляет от 0,14 до 0,35, норм","C12Q1/02, C12Q1/689",20250728,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ СА,['Active']
EP4556225A1,Bio-based polymer beverage capsules,,,"B32B27/36, B32B1/00, B32B7/02, B32B7/12, B32B27/08",20250521,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12357688B2,Methods of oral immunotherapy,"The present disclosure relates to improved oral immunotherapy methods for treating food allergies, and particularly peanut allergy. Biomarkers, such as a level of peanut-specific IgE and/or peanut-specific IgG4s are used by the methods described herein. Such methods include a method of treating a subject for a peanut allergy, methods of assessing the suitability of a treatment for a peanut allergy, a method of evaluating a symptom in a subject during the course of treatment of a peanut allergy, a method of monitoring treatment for a peanut allergy in a subject, a method of reducing the risk or incidence of an adverse event in a subject receiving treatment for a peanut allergy, a method of adjusting a dose of an allergenic peanut composition, and a method of assessing a likelihood of an allergic reaction that requires administration of epinephrine to a subject receiving treatment for a peanut allergy.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of reducing the risk or incidence of an adverse event in a subject receiving treatment for a peanut allergy, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>measuring a level of peanut-specific IgEs and a level of peanut-specific IgG4s in the subject;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>measuring a ratio of the peanut-specific IgEs to the peanut-specific IgG4s; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>administering a reduced dose, delaying the administration of a dose, or delaying administration of an increase of a dose of an allergenic peanut composition if the level of peanut-specific IgEs is above a predetermined threshold, and if the ratio of the peanut-specific IgEs to the peanut-specific IgG4s increases during treatment compared to an earlier measurement during treatment or within 7 days of the start of treatment.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the treatment is oral immunotherapy.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined threshold of the peanut-specific IgEs is 100 KU/L.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the adverse event is an allergic reaction.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering the dose to the subject.</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-con>6. A method of monitoring treatment for a peanut allergy in a subject, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""6""><seg-refi>measuring a level of peanut-specific IgEs and ","A61K39/35, A61K9/00, A61K39/00, A61P37/08, G01N33/68",20250715,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250295144A1,Symbiotic culture of bacteria and yeast for production of water kefir,"The present Invention relates to a beverage composition, preferably a fermented beverage composition, comprising gluconic acid and lactic acid, wherein the concentration ratio of gluconic acid to lactic acid is greater than 1, preferably between 2 to 10.","<div class=""indep-clm"" num=""1""><seg-main>1. A beverage composition comprising </seg-main><seg-clauses>gluconic acid and lactic acid, wherein the concentration ratio of gluconic acid to lactic acid is greater than 1.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The beverage composition according to claim 1, wherein </seg-main><seg-clauses>the beverage composition further comprises ethanol, wherein the ethanol is present at a concentration less than 10 g/L.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The beverage composition according to claim 1, wherein </seg-main><seg-clauses>the beverage composition further comprises sugar, wherein the sugar is present at a concentration less than 50 g/L.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The beverage composition according to claim 1, wherein </seg-main><seg-clauses>the beverage composition further comprises 2-phenylethanol, 3-methlylbutanol, and 3-methylbutanal at a combined concentration of greater than 3 mg/L.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A beverage composition according to claim 1, wherein </seg-main><seg-clauses>the beverage composition comprises <i>Zymomonas mobilis </i>cells.</seg-clauses></div>
<div class=""ccl-clm"" num=""8"">6-8. (canceled)</div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-main>9. The beverage composition according to claim 1 wherein </seg-main><seg-clauses>the beverage composition comprises fewer than 10 species of bacteria and yeast.</seg-clauses></div>
<div class=""indep-clm"" num=""10""><seg-main>10. A starter culture for preparing a fermented beverage composition, wherein </seg-main><seg-clauses><seg-main>said starter culture comprises</seg-main>
<seg-clauses>a. <i>Zymomonas mobilis</i>; and</seg-clauses>
<seg-clauses>b. lactic acid bacteria, for example Liquorilactobacillus <i>hordei</i>; and</seg-clauses>
<seg-clauses>c. <i>Saccharomyces</i>, for example <i>Saccharomy","A23L2/38, A23L2/02, A23L2/68, C12N1/18, C12N1/20",20250925,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120035700A,Multi-layer metallized paper-based packaging material,"The invention relates to a multilayer metallized paper-based packaging material (1) comprising, from its outer side to its inner side:-a paper layer (2) having a grammage in the range of 30 g/m2 to 120 g/m2; -at least one organic barrier layer (3) of a polymer selected from the list of polyvinyl alcohol (PVOH), ethylene-vinyl alcohol (EVOH), butenediol-vinyl alcohol copolymer (BVOH) or combinations thereof in an amount of from 0.5 g/m2 to 20 g/m2; -at least one inorganic barrier layer (4) selected from the list of: a metal, a metalloid or a combination thereof, the inorganic layer having a thickness of between 1 nm and 100 nm; and-at least one organic heat seal layer (5) made of an acrylic or methacrylic polymer grafted with at least one type of ionomer, the heat seal layer being applied in an amount of between 2 g/m2 and 20 g/m2.","<div class=""indep-clm"" num=""1"">1.多层金属化纸基包装材料(1)，所述多层金属化纸基包装材料从其外侧到其内侧包括：</div>
<div class=""indep-clm"" num=""1"">-纸层(2)，所述纸层具有在30g/m<sup>2</sup>至120g/m<sup>2</sup>范围内的克重，</div>
<div class=""indep-clm"" num=""1"">-至少一个聚合物的有机阻隔层(3)，所述聚合物选自以下项的列表：聚乙烯醇(PVOH)、乙烯-乙烯醇(EVOH)、丁烯二醇</div>
<div class=""indep-clm"" num=""1"">-乙烯醇共聚物(BVOH)或它们的组合，其量为0.5g/m<sup>2</sup>至20g/m<sup>2</sup>，优选地其量为1g/m<sup>2</sup>至10g/m<sup>2</sup>，更优选地其量为2g/m<sup>2</sup>至8g/m<sup>2</sup>，</div>
<div class=""indep-clm"" num=""1"">-至少一个无机阻隔层(4)，所述至少一个无机阻隔层选自以下项的列表：金属、准金属或它们的组合，所述无机层具有介于1nm与100nm之间的厚度，和</div>
<div class=""indep-clm"" num=""1"">-至少一个有机热封层(5)，所述至少一个有机热封层由丙烯酸或甲基丙烯酸聚合物与至少一种类型的离聚物接枝制成，所述热封层(5)以介于2g/m<sup>2</sup>与20g/m<sup>2</sup>之间的量，优选地以介于4g/m<sup>2</sup>与9g/m<sup>2</sup>之间的量施加。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的多层金属化纸基包装材料(1)，其中所述无机层包含选自以下项的列表的金属或准金属：铝、氧化铝(AlOx)或氧化硅(SiOx)，所述金属和/或准金属通过真空沉积或转移金属化沉积。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求1或2中任一项所述的多层金属化纸基包装材料(1)，其中接枝到所述丙烯酸或甲基丙烯酸聚合物上的所述离聚物是钠离聚物。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求1至3中任一项所述的多层金属化纸基包装材料(1)，其中与离聚物接枝的所述丙烯酸或甲基丙烯酸聚合物具有介于85g/mol与90g/mol之间的分子量。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求1至4中任一项所述的多层金属化纸基包装材料(1)，其中所述有机层中的每个有机层通过水性分散体或通过水溶液沉积而沉积到相邻层上。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据前述权利要求5所述的多层金属化纸基包装材料(1)，其中所述有机阻隔层(3)通过水溶液沉积而沉积，并且所述有机热封层(5)通过水性分散体涂布而沉积。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的多层金属化纸基包装材料(1)，其中所述纸层(2)在其外表面上覆盖有油墨层(6)。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据前述权利要求7所述的多层金属化纸基包装材料(1)，其中优选地所述油墨层选自以下项的列表：水基油墨、无溶剂油墨或它们的组合。</div>
<div class=""dep-clm"" num=""9"" parent=""7,8"">9.根据前述权利要求7或8中任一项所述的多层金属化纸基包装材料(1)，其中所述纸层或所述油墨层在其外表面上被最外面的罩印清漆(OPV)层(7)覆盖。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据前述权利要求9所述的多层金属化纸基包装材料(1)，其中所述最外面的罩印清漆层(7)是苯乙烯丙烯酸清漆。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的多层金属化纸基包装材料(1)，其中所述包装材料具有低于0.5g/m<sup>2</sup>/天的水蒸气透过率(WVTR)(在23℃、85％相对湿","D21H19/02, D21H19/20, D21H19/22, D21H19/24, D21H19/82",20250523,雀巢产品有限公司,['Pending']
US12213616B2,Beverage dispenser with powder container,"The invention concerns a beverage preparation machine (<b>100</b>) for preparing a beverage from a beverage ingredient powder, said machine comprising:—at least one container (<b>1, 1</b><i>a, </i><b>1</b><i>b, </i><b>1</b><i>c, </i><b>1</b><i>d</i>) configured for storing a beverage ingredient powder and comprising a powder outlet (<b>11, 11</b><i>a, </i><b>11</b><i>b, </i><b>11</b><i>c, </i><b>11</b><i>d</i>) for dispensing at least one dose of said beverage ingredient powder, and—a rotating device (<b>2</b>) to rotate said at least one container (<b>1</b>) around a rotational axis (XX′), wherein said rotational axis is inclined with respect to vertical and said rotational axis is positioned externally to said at least one container.","<div class=""indep-clm"" num=""1""><seg-con>1. Beverage preparation machine for preparing a beverage from a beverage ingredient powder, the machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one container configured for storing a beverage ingredient powder and comprising a powder outlet for dispensing at least one dose of the beverage ingredient powder, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a rotating device to rotate the at least one container around a rotational axis,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the rotational axis is inclined with respect to vertical and the rotational axis is positioned externally to the at least one container.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Beverage preparation machine according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the rotational axis is inclined with respect to vertical according to an angle of at least 15° with respect to vertical, and at most 90°.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Beverage preparation machine according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the internal wall of the container presents a shape and/or an internal movable element configured to agitate powder during rotation of the container around the rotational axis.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Beverage preparation machine according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the machine comprises at least one dosing device configured to cooperate with the powder outlet of the at least one container.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. Beverage preparation machine according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the machine comprises several containers and all the containers are configured to rotate around one common rotational ","A47J31/40, A47J31/44",20250204,INOV3,['Active']
US20250035648A1,Compositions and methods for diagnosing and/or treating chronic kidney disease,"Compositions and methods diagnose and/or treat chronic kidney disease (CKD) using one or more feline circulating proteins as markers for early-stage CKD. A method of diagnosing chronic kidney disease (CKD) in a feline can include measuring an amount of each of at least one circulating protein from the feline. The at least one circulating protein is one or more of adiponectin (ADIPOQ), cathelicidin (CAMP), kinesin-like protein (KIF12), plasma retinol-binding protein (RBP4), Ig-like domain-containing protein (ZKSCAN1), coagulation factor X (F10), fibronectin (FN1) and mixtures thereof. The method also includes performing comparison of the amount of each of the at least one circulating protein from the feline to a corresponding predetermined value or a corresponding predetermined range. The method also includes diagnosing the feline as having early-stage CKD or not having early-stage CKD, based on the comparison.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of diagnosing chronic kidney disease (CKD) in a feline, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>measuring an amount of each of at least one circulating protein from the feline, wherein the at least one circulating protein is selected from the group consisting of adiponectin (ADIPOQ), cathelicidin (CAMP), kinesin-like protein (KIF12), plasma retinol-binding protein (RBP4), Ig-like domain-containing protein (ZKSCAN1), coagulation factor X (F10), fibronectin (FN1) and mixtures thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>performing comparison of the amount of each of the at least one circulating protein from the feline to a corresponding predetermined value or a corresponding predetermined range; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>diagnosing the feline as having early-stage CKD or not having early-stage CKD, based on the comparison.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>obtaining a sample of at least one of serum or plasma from the feline, wherein the measuring of the amount of each of the at least one circulating protein is performed on the sample of at least one of serum or plasma.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the measuring and the comparison uses at least two of the circulating proteins selected from the group consisting of adiponectin (ADIPOQ), cathelicidin (CAMP), kinesin-like protein (KIF12), plasma retinol-binding protein (RBP4), Ig-like domain-containing protein (ZKSCAN1), coagulation factor X (F10), fibronectin (FN1) and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>th","G01N33/68, A61K31/198, A61K31/202, A61K31/355, A61K45/06",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020296311B2,Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids,"A method of potentiating musculoskeletal effect of one or more anabolic amino acids in an individual in need thereof can include administering to the individual in need thereof a composition containing the one or more anabolic amino acids, the composition also containing one or more autophagy-inducing compounds in a total amount effective for the composition to be at least neutral regarding autophagy. In another aspect, a method of overcoming one or more negative effects of one or more anabolic amino acids by preventing degenerative processes related to loss of autophagy can include administering to an individual in need thereof a composition containing the one or more anabolic amino acids, the composition further containing the one or more autophagy-inducing compounds in a total amount effective for the composition to be at least neutral regarding autophagy.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>one or more anabolic amino acids, the composition further comprising one or more autophagy-inducing compounds selected from the group consisting of thymol, carvacrol, spermidine, urolithin, rapamycin, Torin1, valproic acid, polyphenols, caffeine, L-type calcium channel inhibitors, ketones, 4,4’-dimethoxychalcone and mixtures thereof, in a total amount effective for the composition to be at least neutral regarding autophagy for use in an individual in need thereof for potentiating musculoskeletal effect of one or more anabolic amino acids of the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the one or more anabolic amino acids are selected from the group consisting of Leucine, Isoleucine, Arginine, Glutamine, Citrulline and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the one or more anabolic amino acids comprise at least one of Leucine, Arginine or Glutamine, in an amount effective to activate mTOR in the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the composition induces autophagy in skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the individual is an ageing individual.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses><seg-main>the individual has sarcopenia or frailty or is at risk of developing sarcopenia or frailty, optionally wherein the ","A61P21/00, A61K31/198",20251002,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019374925B2,Compositions and methods using a combination of curcumin and an omega-3 fatty acid for cellular energy,,,"A61K31/12, A23L33/00, A61K9/00, A61K31/201, A61K31/202",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CA2995152A1,Beverage machine with an ergonomic user-interface,"A machine (1) for preparing and dispensing a beverage (2) comprises : - a main body (10) containing a unit (11, 12, 13, 14, 15) for preparing said beverage (2) to be dispensed via an outlet (21) to an external user-recipient (3) at a user-recipient placement location (30); - an auxiliary body (20) that is movable relative to the main body (10) inwards into the main body (10) into a retracted position and outwards from the main body (10) into a deployed position; - a control unit (16) for controlling the preparation unit (11, 12, 13, 14, 15) to supply said beverage (2) to the outlet (21); and - a user-interface (17, 17') connected to the control unit (16). The user-interface (17, 17') is located on the auxiliary body (20) and is movable therewith.","5 10 15 20 25 30 Date Reçue/Date Received 2023-11-14 - 25 - CLAIMS: <div class=""indep-clm"" num=""1""><seg-main>1. A machine for preparing and dispensing a beverage, such machine comprising: </seg-main><seg-clauses>a main body containing a unit for preparing said beverage to be dispensed via an outlet to an external user-recipient at a user-recipient placement location, wherein the unit is a beverage preparation unit comprising at least one of: a source of liquid, a liquid sensor, a pump for driving a liquid from said source to the outlet, and a thermal fluid conditioner; an auxiliary body that is movable relative to the main body inwards into the main body into a retracted position and outwards from the main body into a deployed position, the auxiliary body forming a beverage dispensing head that includes the outlet so that the user-recipient placement location is located vertically below the outlet when the head is in its deployed position,</seg-clauses><seg-clauses>- a control unit for controlling the preparation unit to supply said beverage to the outlet; and a user-interface connected to the control unit, wherein the user-interface is located on the auxiliary body and is movable therewith. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine of claim 1, wherein </seg-main><seg-clauses>the beverage is tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The machine of claim 1 or 2, wherein </seg-main><seg-clauses>the source of liquid is water. 5 10 15 20 25 30 Date Reçue/Date Received 2023-11-14 - 26 - 4. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>The machine of claim 1 to 3, wherein </seg-main><seg-clauses>the liquid sensor is a flowmeter. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The machine of any one of claims 1 to 4, wherein </seg-main><seg-clauses>the thermal fluid condit",A47J31/44,20250923,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025238243A1,Pectin emulsion hydrocolloid-based gel composition for a confectionery product,"The invention relates to a hydrocolloid-based gel composition for a confectionery product, said composition comprising 0.5 – 3.5 wt% pectin, wherein the pectin is equal or greater than 50% methylesterified; 5 – 20 wt% oil or melted fat; 0 – 0.15 wt% divalent ions, preferably calcium or magnesium ions; not less than 55 wt% sugars, preferably sucrose, maltose, glucose syrup, and/or maltodextrin; water; and wherein the composition has a pH not greater than pH 4.5, preferably a pH between 2.0 to 4.5.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A hydrocolloid-based gel composition for a confectionery product, said composition comprising</seg-main>
<seg-clauses>0.5 - 3.5 wt% pectin, wherein the pectin is equal or greater than 50% methylesterified;</seg-clauses>
<seg-clauses class=""seg-enter"">5 - 20 wt% oil or melted fat;</seg-clauses>
<seg-clauses class=""seg-enter"">0 - 0.15 wt% divalent ions, preferably calcium or magnesium ions; not less than 55 wt% sugars, preferably sucrose, maltose, glucose syrup, and/or maltodextrin;</seg-clauses>
<seg-clauses class=""seg-enter"">Water; and wherein the composition has a pH not greater than pH 4.5, preferably a pH between 2.0 to 4.5.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the pectin equal or greater than 60% methylesterified, most preferably equal or greater than 70% methylesterified.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the composition comprises between 1.5 to 3.5 wt% pectin, or between 1.5 to </seg-clauses><seg-clauses>2.5 wt% pectin.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the pectin comprises between 15 to 80% galacturonic acid.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the composition comprises between 10 to 20 wt% oil or melted fat.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the pectin is citrus pectin or a mixture of citrus pectin and apple pectin.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-m","A23G1/40, A23G3/42, A23L29/231",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2019411230B2,"Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children","The invention relates to a nutritional composition for infants and young children comprising proteins, carbohydrates and lipids, wherein said proteins comprise ionic complexes of lactoferrin with acid milk proteins, said complexes having a negative charge at the pH of the infant formula. The nutritional composition is used for providing a satiety feeling and/or a better sleep and/or limiting nocturnal awaking in infants or young children.","<div class=""indep-clm"" num=""1""><seg-main>1. A nutritional composition for infants or young children comprising </seg-main><seg-clauses>proteins, carbohydrates and lipids, wherein said proteins comprise ionic complexes of lactoferrin with acid milk proteins, said complexes having a negative charge at the</seg-clauses>
<seg-clauses class=""seg-enter"">5 pH of the infant formula;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said acid milk proteins are selected from the group consisting of alphalactalbumin (ALAC), beta-lactoglobulin (BLG), whey protein isolate (WPI), whey protein concentrate (WPC), whey protein hydrolysate, casein, and combinations thereof, and</seg-clauses>
<seg-clauses class=""seg-enter"">0          wherein in said ionic complexes, the weight ratio of lactoferrin to acid milk proteins</seg-clauses>
<seg-clauses class=""seg-enter"">ranges from 1:0.25 to 1:3, in particular 1: 1,1:1.5 or 1: 2.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition of claim 1, wherein </seg-main><seg-clauses>said proteins comprise a mixture of whey protein and casein, wherein the ratio of whey protein to casein is between 50:50 and 80:20.</seg-clauses>
<seg-clauses class=""seg-enter"">5   </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition of claim 1 or 2, wherein </seg-main><seg-clauses>the whey protein is enriched with alpha</seg-clauses>
<seg-clauses class=""seg-enter"">lactalbumin (ALAC).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition of any one of claims 1 to 3, wherein </seg-main><seg-clauses>the ALAC content in the whey protein is at least 10% by weight, preferably at least 14% by weight, more preferably at least 20 % to 50% by weight.</seg-clauses>
<seg-clauses class=""seg-enter"">20   </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition of any one of claims 1 to 4, wherein </seg-main><seg-clauses>lactoferrin ","A23L33/19, A23C9/20, A61K38/18, A61K38/40",20250417,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2024241471A1,Beverage capsule system with code area and code-free area,A system comprises a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material. The container has a code to at least partially encode preparation information. The machine includes: a code reading system to read the code; a processing unit for processing the precursor material of the container; and electrical circuitry to control the processing unit based on the preparation information. The electrical circuitry is configured to: read the code to obtain a code read; determine a characteristic of a neighbouring non-code portion in proximity of a code portion of the code read; correct an associated characteristic of the code portion based on the determined characteristic of the neighbouring non-code portion to account for variations of the characteristic in the non-code portion.,"<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code to at least partially encode preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein electrical circuitry is configured to:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>read the code to obtain a code read;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determine a characteristic of a neighbouring non-code portion in proximity of a code portion of the code read;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>correct an associated characteristic of the code portion based on the determined characteristic of the neighbouring non-code portion to account for variations of the characteristic in the non-code portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the code is arranged on an encoding line and:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>reading of the code comprises reading along the encoding line to obtain the code read;</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>determine a characteristic of a","A47J31/44, B65D85/804, G06K19/00",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250177491A1,Complex coacervates of lactoferrin and osteopontin,"The present invention relates to a complex coacervate comprising lactoferrin and osteopontin, processes of producing the same and composition comprising the same. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin in the treatment and/or prevention of metabolic diseases and/or inflammatory diseases. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin for promoting bone development, growth, strength and/or healing, or preventing and/or treating a bone disease.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for use in promoting bone development, growth, strength and/or healing in a subject, or preventing and/or treating a bone disease in a subject </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a subject in need a complex coacervate comprising lactoferrin and osteopontin.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the complex coacervate comprises protein in an amount of 5 to 50% w/w.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the complex coacervate comprises water in an amount of 50 to 95% w/w.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to any claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the complex coacervate has a diameter of at least 500 nm in the shortest dimension.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method according to any claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the complex coacervate has a zeta potential in the range of −15 and +15 mV.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the complex coacervate is administered in the form of a composition.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The method according to claim 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is selected from the group consisting of food compositions, pet food compositions, drinks, nutritional formulas and nutraceuticals.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""6""><seg-con>8. The method according to claim 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is in a form selected from the group consi","A61K38/40, A61K9/00, A61K38/19",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4527261A1,A beverage capsule opener,"The present invention relates to a capsule opener (1, 100) for emptying solid and/or liquid contents of an extracted beverage capsule. The capsule (2) comprises a body (4) forming a compartment containing the contents and a lid for closing said compartment. The capsule opener (1, 100) comprises a bottom portion (10, 110) and a storage compartment (20, 120). The bottom portion (10, 110) includes a bottom portion housing with at least one cutting protrusion (12, 112, 115). The at least one protrusion (12) is arranged for piercing through and opening the lid. The storage compartment (20, 120) is configured to receive the solid and/or liquid contents from the capsule (2). The storage compartment (20, 120) is arranged below the at least one protrusion (12).","<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule opener (1, 100) for emptying solid and/or liquid contents of an extracted beverage capsule, the capsule (2) comprising </seg-main><seg-clauses>a body (4) forming a compartment containing the contents and a lid for closing said compartment, the capsule opener (1, 100) comprising: a bottom portion (10, 110) including a bottom portion housing with at least one protrusion (12), the at least one protrusion (12) being arranged for piercing through and opening the lid, and a storage compartment (20, 120) for receiving the solid and/or liquid contents from the capsule (2), wherein the storage compartment (20, 120) is arranged below the at least one protrusion (12).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The capsule opener (1, 100) of claim 1, wherein </seg-main><seg-clauses>the bottom portion (10, 110) comprises a sieve (114) and wherein the sieve (114) is arranged between the storage compartment (20, 120) and the at least one protrusion (12, 112 115),</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3.  The capsule opener (1, 100) of claim 2, wherein </seg-main><seg-clauses>the sieve (114) has mesh openings of at least 3 mm in width, length and/or diameter.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The capsule opener (100) of any one of the preceding claims, the capsule opener (100) further comprising </seg-main><seg-clauses>a capsule holder (130); wherein the capsule holder (130) includes a holding ring (131) configured to hold a flange (4) of the capsule </seg-clauses><seg-clauses>(2) against the bottom portion (110).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  The capsule opener (1, 100) of any one of the preceding claims, wherein </seg-main><seg-clauses>bottom portion (10, 110) comprises a manual gripping portion (121).</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><s",A47J31/44,20250326,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020209429B2,Agents and methods for increasing stem cell function,Use of a urolithin for increasing stem cell function in a population of haematopoietic stem and/or progenitor cells (HSPCs).,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of increasing haematopoietic stem cell function in a subject, the method comprising </seg-main><seg-clauses>administering a urolithin to the subject, wherein the haematopoietic 5 stem cell function comprises engraftment.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of treating or preventing leukopenia and/or thrombocytopenia; in a subject in need thereof, the method comprising </seg-main><seg-clauses>administering a urolithin to the subject in need thereof.</seg-clauses>
<seg-clauses class=""seg-enter"">10</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The method according to claim 2, wherein </seg-main><seg-clauses>the urolithin is in the form of a pharmaceutical or nutritional composition, optionally in the form of a food product, food supplement, nutraceutical, food for special medical purpose (FSMP), nutritional supplement, dairy-based drink, low-volume liquid supplement or meal replacement 15 beverage.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A method of increasing haematopoietic stem cell function in a subject comprising </seg-main><seg-clauses>contacting an isolated population of haematopoietic stem and/or progenitor cells (HSPCs) with a urolithin, and administering the population of HSPCs to the subject in 20 need thereof, wherein the stem cell function comprises engraftment.</seg-clauses></div>
<div class=""indep-clm"" num=""5""><seg-main>5. A method of treating or preventing leukopenia and/or thrombocytopenia; and/or treating or preventing cancer in a subject comprising </seg-main><seg-clauses>contacting a population of haematopoietic stem and/or progenitor cells (HSPCs) with a urolithin, and 25 administering the population of HSPCs to the subject in need thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5""><seg-main>6. The method according to any one of claims 2-5, wherein </seg-main><seg-clauses>the urolithin i","A61K31/366, A61P7/02, A61P7/06, A61P31/00, A61P35/00",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20250289700A1,Device for preparing and dispensing beverages with an improved arrangement of the dispensing nozzle,"The invention concerns a machine (<b>10</b>) for preparing and dispensing beverages comprising a water supply apparatus (<b>20</b>) and an additive substances feeding apparatus (<b>24</b>) arranged within an housing chamber defined in the main casing (<b>12</b>) of the machine (<b>10</b>), and a beverage preparation apparatus (<b>18</b>) comprising a nozzle (<b>28</b>) and an alcove (<b>64</b>), wherein a door (<b>16</b>) is hinged to the main casing (<b>12</b>) and is configured to close the housing chamber in the machine (<b>10</b>) operating configuration, and wherein all the water delivery pipes (<b>22</b>) of the water supply apparatus (<b>20</b>) and all the additive substances delivering pipes (<b>26</b>) of the additive substances feeding apparatus (<b>24</b>) are hydraulically connected to the nozzle (<b>28</b>), which is designed for mixing water with said additive substances, so as to obtain the beverage, and for delivering the beverage, wherein the nozzle (<b>28</b>) is fixed to the alcove (<b>64</b>) to ensure easy access to the apparatuses of the machine (<b>10</b>) arranged within the housing chamber when the door (<b>16</b>) is open.","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing and dispensing beverages </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a main casing, able to define a housing chamber of a plurality of apparatuses of the machine and provided with at least one opening which defines a door compartment to said housing chamber;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one door, which is provided with an outer surface and an inner surface oriented towards said housing chamber, wherein said door is hinged to said main casing at a hinging axis and is configured to close said housing chamber in the machine operating configuration;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one beverage preparation apparatus, which is designed for preparing and dispensing beverages;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one water supply apparatus, which is provided with one or more water delivering pipes to said beverage preparation apparatus; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one additive substances feeding apparatus, which is provided with one or more additive substances delivering pipes to said beverage preparation apparatus;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein said beverage preparation apparatus comprises:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one mixing and dispensing nozzle; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one alcove, which is obtained on said door and which defines a seat open on the outer surface of said door to hold at least one container into which the beverage dispensed through said nozzle flows;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the water supply apparatus and said additive substances feeding apparatus are arranged within said housing chamber and all the water delivery pipes and all the addit","B67D1/00, B67D1/08",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025093658A1,High protein tablet,"The invention relates to a high protein tablet, and in particular an easily dispersible firm tablet, which has a high protein content.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A firm protein tablet comprising:</seg-main>
<seg-clauses>8 to 25% by weight of a binder, based on the total weight of the tablet; and</seg-clauses>
<seg-clauses class=""seg-enter"">40 to 92% by weight of a protein, based on the total weight of the tablet, wherein the tablet has a dispersion time of less than 180 seconds in 200 ml of water at a temperature of 90°C.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A firm protein tablet for dispersion in water comprising:</seg-main>
<seg-clauses>8 to 25% by weight of a binder, based on the total weight of the tablet; and</seg-clauses>
<seg-clauses class=""seg-enter"">40 to 92% by weight of a protein, based on the total weight of the tablet, wherein the protein powder has a defined dissolution behaviour, measured by dispersing ca. 0.1 gram the protein powder in 120 ml water at 25 °C; measuring the initial D[4,3] value and nine further D[4,3] values at 8 second intervals after the initial value, and identifying the highest D[4,3] value from the nine further D[4,3] values, wherein the protein powder has an initial D[4,3] value of 1-1,000 pm, and the percentage change between the initial D[4,3] value and the highest D[4,3] value is from -10% to +100%.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The firm protein tablet of claim 1 or claim 2 comprising </seg-main><seg-clauses>10 to 20% by weight of a binder, based on the total weight of the tablet.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The firm protein tablet of any one of claims 1 to 3, comprising </seg-main><seg-clauses>45 to 80% by weight of a protein, based on the total weight of the tablet.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3""><seg-main>5. The firm protein tablet of any one of claims 1 to 3, comprising </seg-main><seg-clauses>60 to 75% by weight of a protein, based on the total weight of the tablet.</seg-clauses>","A23J3/00, A23L2/395, A23L33/17, A23P10/28",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250295157A1,Methods for the improvement and maintenance of weight loss,"A nutritional composition for use in a weight loss dietary intervention or maintenance of weight, particularly following a dietary intervention, preferably a low caloric diet intervention. The nutritional composition contains one or more amino acids, or combinations thereof, selected from the group consisting of: proline, histidine, glycine, and/or hydroxyproline, that can be used to help the weight loss in obese subjects that are resistant to weight loss by caloric restricted dietary interventions alone. In addition, the nutritional composition can be used to help maintain the weight loss, particularly after dietary intervention.","<div class=""indep-clm"" num=""1""><seg-con>1: A method for weight loss in a subject </seg-con><seg-trans>having </seg-trans><seg-refi>an obesity-related disorder selected from the group consisting of diabetes, stroke, high cholesterol, cardiovascular disease, insulin resistance, coronary heart disease, hypertension, fatty liver, and combinations thereof, the method comprising administering to the subject a nutritional composition comprising at least one amino acid selected from the group consisting of proline, histidine, glycine, and hydroxyproline.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the method comprises a low caloric intervention.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the low caloric dietary intervention is between 600 kcal/day and 1500 kcal/day for up to 12 weeks for the subject.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises at least proline.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5: The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises at least proline and histidine.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6: The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises at least proline, histidine and glycine.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7: The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises proline, histidine, glycine and hydroxyproline.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8: The m","A23L33/175, A23L33/00",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2846717C2,"Container for use with a beverage and/or food preparation device, system, use and methods of encoding and reading information on preparation","FIELD: kitchen equipment.SUBSTANCE: invention relates to electrically controlled systems for the preparation of a beverage or a food product, by means of which a beverage or a food product is obtained from a portion capsule. Container is configured to accommodate precursor material for use with a device for preparing a beverage and/or a food product. Container includes a machine-readable code storing preparation information for use in the preparation process performed by said device, the code comprising a plurality of elements, wherein the code elements are arranged in a circumferential direction for sequential reading during the container rotation about the rotation axis relative to the code reader. Code is arranged in the form of a plurality of directly adjacent discrete positions, and the absence or presence of the primary element in the discrete position codes the preparation information, wherein the boundary elements are located on a boundary between two or more adjacent primary elements and/or on a boundary between two or more adjacent absences of primary elements, and the boundary elements have reflective properties different from the primary element or the absence of the primary element.EFFECT: accuracy of determining code.18 cl, 16 dwg","1. Контейнер, выполненный с возможностью размещения материала-предшественника для применения с устройством для приготовления напитка и/или продукта питания, причем контейнер включает код, при этом код содержит множество элементов,
причем код расположен в виде множества непосредственно смежных дискретных позиций с отсутствием или присутствием первичного элемента в дискретной позиции,
при этом граничные элементы расположены на границе между двумя или более смежными первичными элементами и/или на границе между двумя или более смежными отсутствиями первичных элементов,
и граничные элементы имеют отражающие свойства, отличные от первичного элемента и/или отсутствия первичного элемента,
причем дискретные позиции и граничные элементы кода расположены по окружности для последовательного считывания при вращении контейнера вокруг оси вращения относительно считывателя кода.
2. Контейнер по п. 1, в котором граничные элементы расположены только на границе между двумя или более смежными первичными элементами и/или на границе между двумя или более смежными отсутствиями первичных элементов, так что граница между первичным элементом и отсутствием первичного элемента не содержит граничного элемента, и граничные элементы полностью разделяют смежные первичные элементы и/или смежные отсутствия первичных элементов.
3. Контейнер по любому из пп. 1 или 2, в котором граничный элемент не кодирует информацию о приготовлении.
4. Контейнер по любому предшествующему пункту, в котором граничные элементы имеют:
имеют среднюю длину дуги менее 50%, или 40%, или 30%, или 25% и более 5%, или 10%, или 15% от средней длины дуги дискретной позиции.
5. Контейнер по любому предшествующему пункту, в котором:
дискретные позиции имеют среднюю длину дуги 2,6 градуса ± 20%, или 10%, или 5%;
и граничные элементы имеют среднюю длину дуги 0,5 или 0,44 градуса ± 5%, или 10%, или 20%.
6. Контейнер по любому предшествующему пункту, в котором граничные элементы выполнены с возможностью быть видимыми для считывателя ко",B65D85/804,20250912,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250366653A1,Beverage preparation device with thermally optimised architecture,"A method prepares a beverage from a capsule in a machine, the capsule containing a flavouring ingredient. The method includes: placing the capsule into a receiving space; bringing a holder and a cover from an open position into a closed position; delivering water conditioned by a thermal conditioner into an inlet of the cover, the thermal conditioner forming a conditioner cavity that defines or contains the cover; preparing the beverage by mixing the flavouring ingredient in the capsule with the water conditioned by the thermal conditioner; delivering the beverage via an outlet arrangement; and collecting the delivered beverage on a collecting surface of the thermal conditioner.","<div class=""indep-clm"" num=""1""><seg-con>1: A method of preparing a beverage from a capsule in a machine, the capsule </seg-con><seg-trans>containing </seg-trans><seg-refi>a flavouring ingredient, the method comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>placing the capsule into a receiving space;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>bringing a holder and a cover from an open position into a closed position;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>delivering water conditioned by a thermal conditioner into an inlet of the cover, the thermal conditioner forming a conditioner cavity that defines or contains the cover;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>preparing the beverage by mixing the flavouring ingredient in the capsule with the water conditioned by the thermal conditioner;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>delivering the beverage via an outlet arrangement; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>collecting the delivered beverage on a collecting surface of the thermal conditioner.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least one of the holder and the cover is connected to a driver that is arranged to drive the at least one of the holder and the cover in rotation when the holder and the cover are in the closed position.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>guiding the beverage from the collecting surface of the thermal conditioner to a dispensing area configured to receive a user-receptacle for collecting the beverage from the machine.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>guiding the beverage from the c","A47J31/36, A47J31/06, A47J31/22, A47J31/54",20251204,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119698457A,Co-extraction method for preparing stable oil body solution from seed material and grain bran,,,"C11B1/04, C11B1/10, A23D9/05, A23D9/02",20250325,雀巢产品有限公司,['Pending']
AU2023381100A1,Nutritional composition for improving social-emotional development,"The present invention relates to a combination of DHA, ARA, iron, folic acid, Vitamin B12 and phospholipids and to a nutritional composition comprising such a combination for use in improving social-emotional skills and/or in promoting mood, social and joy-related behaviours in an infant, a toddler or a young child. The present invention also relates to a synthetic nutritional composition comprising DHA, ARA, iron, folic acid, Vitamin B12 and phospholipids in specific amounts. The present invention further relates to uses and methods for improving social-emotional skills and/or for promoting mood, social and joy-related behaviours in an infant, a toddler or a young child.","<div class=""indep-clm"" num=""1"">1. A combination of DHA, ARA, iron, folic acid, Vitamin B12 and phospholipids for use in improving social-emotional skills and/or in promoting mood and joy behaviour in an infant, a toddler or a young child.</div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A combination for use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the phospholipids are sphingomyelin, phosphatidylcholine, phosphatidylinositol, phosphatidylserine and phosphatidylethanolamine.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A combination for use according to claims 1 or 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the phospholipids are phosphatidylcholine,          phosphatidylinositol,          phosphatidylserine,</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>5 phosphatidylethanolamine and sphingomyelin and wherein such phospholipids are comprised at respective amounts ranging from 25 to 35 % w/w phosphatidylcholine based on total phospholipids, amounts ranging from 5 to 15% w/w phosphatidylinositol on total phospholipids, amounts ranging from 5 to 10% w/w phosphatidylserine on total phospholipids, amounts ranging from 21 to 30 % io w/w phosphatidylethanolamine on total phospholipids and amounts ranging from 20 to 30% w/w sphingomyelin on total phospholipids.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. A combination for use according to anyone of claims 1 to 3 a c social fear, in particular for improving inhibited approaches and/or distress in social situations that involves novelty/uncertainty in an infant older than 12 months, a toddler or a 15 young child.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3"">5. A combination for use according to anyone of claims 1 to 3 for promoting high intensity pleasure, in particular pleasure and enjoyment related to high stimulus intensity, rate, complexity, novelty and incongruity, and for reducing sadness, in part","A61K31/202, A23L33/00, A61K31/683, A61K31/685, A61K31/688",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119677435A,Bulk distributor,"The invention relates to a bulk dispenser (1) for dispensing a flowable product, such as a food product, in particular coffee beans. The bulk dispenser (1) comprises: a receiving receptacle (10) having a receiving area (11) for receiving at least a bottom portion (161) of a package (160) containing a flowable product; a cutting element (20) having a cutting edge (21) for cutting the bottom portion (161); and a cutting actuator (40, 60) for actuating the cutting element (21) in order to move the cutting edge (21) in the piercing direction between a retracted position, in which the cutting edge (21) is retracted from the receiving region (11), and an extended position, in which the cutting edge (21) is extended from the receiving region (11). The cutting edge (21) protrudes into the receiving area (11) so as to enter the bottom portion (161) when the package (160) is received in the receiving area (11); and moving along a defined trajectory wherein the cutting edge (21) is in or towards the extended position to cut a bottom opening (162) in the bottom portion (161) when the bottom portion (161) is received in the receiving socket (10). The bulk dispenser (1) further comprises a locking element (80) for locking the package (161) in the receiving socket (10) at least in a direction parallel to the piercing direction; a dispensing opening (90) for allowing the flowable product to flow out of the package (161) by gravity through the bottom opening (162) cut into the bottom portion (161); and a dispenser element (91) for controlling the flow of the flowable product through the dispensing opening (90) out of the dispenser (1).","<div class=""indep-clm"" num=""1""><seg-con>1.一种散装分配器(1)，所述散装分配器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>·接收插口(10)，所述接收插口具有用于接收容纳可流动的产品的包装(160)的至少底部部分(161)的接收区域(11)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>·切割元件(20)，所述切割元件具有用于切割所述底部部分(161)的切割刃(21)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>·切割致动器(40,60)，所述切割致动器用于致动所述切割元件(21)以使所述切割刃(21)</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>○沿着穿刺方向在回缩位置与伸出位置之间移动，在所述回缩</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>位置中，所述切割刃(21)从所述接收区域(11)回缩，在所述伸出位置中，所述切割刃(21)突出到所述接收区域(11)中以便当所述包装(160)被接收在所述接收区域(11)中时进入所述底部部分(161)；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>○沿着限定的轨迹移动，其中所述切割刃(21)处于所述伸出</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>位置中或朝向所述伸出位置移动，以当所述底部部分(161)被接收在所述接收插口(10)中时在所述底部部分中切割底部开口(162)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>·锁紧元件(80)，所述锁紧元件用于至少在平行于所述穿刺方向的方向上将所述包装(161)锁定在所述接收插口(10)中；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>·分配开口(90)，所述分配开口用于允许所述可流动的产品依靠重力穿过切入所述底部部分(161)中的所述底部开口(162)流出所述包装(161)；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>·分配器元件(91)，所述分配器元件用于控制所述可流动的产品流动穿过所述分配开口(90)、流出所述分配器(1)的流动。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的散装分配器(1)，其中所述分配开口(90)被所述切割元件(20)包围和/或所述切割刃(21)的所述轨迹包围。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的散装分配器(1)，其中在所述接收插口(10)的顶视图中，所述轨迹沿循二维路径，优选地为圆的弧段，并且更优选地为具有角度α<360°、甚至更优选地α<355°、最优选地在345°<α<355°之间的圆的弧段。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的散装分配器(1)，其中所述切割致动器被构造用于以组合运动、优选地以螺线运动或以螺旋运动来致动所述切割元件(21)，以使所述切割刃(21)至少部分地同时沿着所述穿刺方向以及沿着所述轨迹移动。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3""><seg-con>5.根据权利要求1至3中任一项所述的散装分配器(1)，其中所述切割致动器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3""><seg-comp>·穿刺致动器(40)，所述穿刺致动器用于致动所述切割元件(20)以使所述切割刃(21)沿着所述穿刺方向移动；</seg-comp><seg-comp>和</seg-comp></div>
<","A47F1/03, A47F1/035, A47J31/36",20250321,雀巢产品有限公司,['Pending']
AU2024269014A1,"Nutritional compositions, supplements, and fortifiers","The present invention relates to a nutritional composition, supplement, or fortifier comprising L-arginine, L-citrulline, a vitamin mixture, and a mineral mixture. The present invention also relates to methods of enhancing immune responses, treating, preventing, and/or reducing the occurrence of infection, and reducing the occurrence or reoccurrence of one or more symptoms of infection, in particular in subjects with tuberculosis.","<div class=""indep-clm"" num=""1""><seg-main>1. A nutritional composition, supplement, or fortifier comprising </seg-main><seg-clauses>L-arginine, L-citrulline, a vitamin mixture, and a mineral mixture.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The nutritional composition, supplement, or fortifier according to claim 1, wherein </seg-main><seg-clauses>the L-arginine is present in an amount such that the nutritional composition, supplement, or fortifier provides L-arginine in a dosage of about 0.5 g/day or more and L-citrulline in a dosage of about 0.5 g/day or more.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The nutritional composition, supplement, or fortifier according to claim 1 or 2, wherein </seg-main><seg-clauses>the L-arginine and L-citrulline are present in a weight ratio of from about 0.1:1 to about 10:1, from about 0.2:1 to about 5:1, from about 0.25:1 to about 4:1, from about 0.3:1 to about 3:1, from about 0.5:1 to about 2:1, or about 1:1.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The nutritional composition, supplement, or fortifier according to any preceding claim, wherein </seg-main><seg-clauses>the vitamin mixture comprises vitamin A, vitamin D2, vitamin E, vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, folic acid, and vitamin B12, optionally wherein each of vitamin A, vitamin D2, vitamin E, vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, folic acid, and vitamin B12 is present in an amount such that the nutritional composition, supplement, or fortifier provides the vitamin in a dosage of about 50% RDA/day or more.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The nutritional composition, supplement, or fortifier according to any preceding claim, wherein </seg-main><seg-clauses>the mineral mixture comprises potassium, magnesium, iron, zinc, and selenium, optionally wherein each of potassium, magnesium, iron, zinc,","A61K31/197, A23L33/15, A23L33/16, A23L33/17, A61P37/04",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12196595B2,Recyclable dosing device,"The present invention relates generally to the field of recyclable dosing devices. In particular, the present invention relates to a dosing device made from moulded pulp fiber. The dosing device comprises a container member with a defined volume corresponding to a pre-determined amount of composition to be dosed. The dosing device may be to be used for dosing food materials. Embodiments of the present invention relate to biodegradable and/or compostable dosing devices. The present invention also relates to process for manufacturing such a dosing device.","<div class=""indep-clm"" num=""1""><seg-con>1. A dosing device </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container member and a handle member both made from molded pulp fiber, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container member has a defined volume corresponding to a pre-determined amount of a composition to be dosed,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the molded pulp fiber comprises cellulose, hemicellulose and lignin, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the molded pulp fiber further comprises a compound selected from the group consisting of alkyl ketene dimer wax, a fluorine containing polymer moiety, sodium silicate, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the molded pulp fiber is made from pulp comprising cellulosic fibrous material prepared by chemically and mechanically separating cellulose fibers from material containing the cellulose fibers.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The dosing device in accordance with claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the material containing cellulose fibers is selected from the group consisting of wood, fiber crops, waste paper, rags, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dosing device is recyclable and/or compostable.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the container member has a material thickness in the range of 300 μm-3 mm.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The dosing de","G01F19/00, D21J1/16, D21J3/00",20250114,SOCIETE DES PRODUITS NESTLE S.A,['Active']
WO2025119806A1,Recombinant wild type patatin-2 and mutants thereof,"The invention relates a recombinant wild type patatin-2 or mutant thereof. It also relates to polynucleotide expression vector, host cell and method for producing such recombinant proteins. It also relates to composition and product comprising such recombinant proteins.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A recombinant wild type patatin-2 or mutant thereof which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. A recombinant wild type patatin-2 or mutant thereof according to claim 1, which has at least 90% sequence identity to wild type patatin-2.</div>
<div class=""indep-clm"" num=""3""><seg-main>3. A recombinant patatin-2 mutant which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2, and which comprises one or more mutations and/or one or more non-native post-translational modifications (PTMs), wherein said one or more mutations and/or said one or more non-native PTMs reduce or eliminate the lipid acyl hydrolase activity in the recombinant wild type patatin-2 mutant compared to the wild type patatin-2.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A recombinant patatin-2 mutant which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2, and which comprises one or more mutations selected from the list consisting of S54A and D193A.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A recombinant patatin-2 according to claim 1 or 2 or a recombinant wild type patatin- 2 mutant according to any of claims 1 to 4, wherein </seg-main><seg-clauses>the wild type patatin-2 is a wild type patatin-2 of Solanum tuberosum, preferably wild type patatin-2 of Solanum tuberosum consisting of SEQ ID NO:1.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A recombinant wild type patatin-2 according to claim 1, 2 or 5 or recombinant patatin- 2 mutant according to any of claims 1 to 5 which </seg-main><seg-clauses>does not comprise an amino acid sequence consis","C07K14/415, C12N9/20",20250612,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023201538B2,Methods and compositions using Bifidobacterium longum to treat or prevent depressive symptoms,"13 Mar 2023 Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; ""empty"" feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings 2023201538 of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof. These depressive symptoms can be associated with a depressive state or depressive disorder or can be found sub-clinically or not associated with these depressive states/disorders (e.g., not part of a syndrome or psychiatric disorder).","<div class=""indep-clm"" num=""1""><seg-con>1.     A method of supplementing a regimen for treatment of a depressive</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>symptom, the regimen </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to an individual in need thereof a synthetic pharmaceutical compound, and an edible composition comprising a therapeutically effective amount or a prophylactically effective amount of Bifidobacterium longum ATCC BAA-999 to the individual, wherein the depressive symptom is a secondary condition caused by irritable bowel syndrome (IBS), wherein the depressive symptom is selected from the group consisting of depressed mood; sadness; ""empty"" feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof, and wherein the combination of the synthetic pharmaceutical compound and the edible composition treats the depressive symptom.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.     The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises an</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>ingredient selected from the group consisting of a fat, a protein, a carbohydrate and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.     The method of claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>prebiotic.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.     The method of claim 3, </seg-con><s","A61K35/745, A61P25/24",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12426613B2,Methods and devices for heating or cooling viscous materials,"Methods and devices heat or cool viscous materials, such as meat emulsions useful for producing food and other products. The devices have a heat exchanger including a first plate, a second plate attached to the first plate, and a first spacer and a second spacer arranged between the first plate and the second plate. The first plate, the second plate, the first spacer, and the second spacer define at least one temperature controlled passage for a product to pass through the heat exchanger.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for making a food product, the method comprising:</seg-main>
<seg-clauses>introducing a meat emulsion into a device; and</seg-clauses>
<seg-clauses class=""seg-enter"">subjecting the meat emulsion to a pressure of 100 psi to 500 psi in the device,</seg-clauses>
<seg-clauses class=""seg-enter"">the device comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">a first pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a first energy exchanging plate attached to the first pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a second pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a second energy exchanging plate attached to the second pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a first spacer and a second spacer arranged between the first energy exchanging plate and the second energy exchanging plate, wherein the first energy exchanging plate, the second energy exchanging plate, the first spacer and the second spacer define a first temperature controlled passage for a first product to pass through the device;</seg-clauses>
<seg-clauses class=""seg-enter"">a third energy exchanging plate attached to the second pressure plate on an opposing side of the second pressure plate from the second energy exchanging plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a fourth energy exchanging plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a third spacer and a fourth spacer arranged between the third energy exchanging plate and the fourth energy exchanging plate, wherein the third energy exchanging plate, the fourth energy exchanging plate, the third spacer and the fourth spacer define a second temperature controlled passage for a second product to pass through the device;</seg-clauses>
<seg-clauses class=""seg-enter"">a third pressure plate attached to the fourth energy exchanging plate on an opposing side of the fourth energy exchanging plate from the second temperature controlle","A23L13/60, A22C7/00, A22C11/00, A23B4/005, A23B4/06",20250930,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250009687A1,Compositions and methods using a combination of nutrients to support cognition and emotional health in a mammal,"Compositions and methods can use at least one of (a) a combination of spermidine and ellagic acid or (b) a combination of docosahexaenoic acid (DHA) and curcumin to enhance cognition and emotional health in a mammal. The mammal is preferably an ageing or elderly human or an ageing or elderly companion animal, preferably an elderly dog.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of enhancing cognitive function and emotional health in a mammal, the method comprising </seg-main><seg-clauses><seg-main>administering a composition comprising at least one of </seg-main><seg-clauses>(a) a combination of spermidine and ellagic acid or </seg-clauses><seg-clauses>(b) a combination of docosahexaenoic acid (DHA) and curcumin to the mammal.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the mammal is an ageing or elderly human or an ageing or elderly companion animal.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the mammal has a phenotype associated with age-related cognitive impairment.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the enhancing of emotional health comprises decreasing at least one of anxiety, stress, aggressivity, despair, lack of focus, or irritability and/or improving at least one of mood or social behavior.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the administering uses at least one route selected from the group consisting of oral, enteral, parenteral and intravenous injection.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the composition has a form selected from the group consisting of a pet food, a dietary supplement, and a food product formulated for human consumption.</seg-clauses></div>
<div class=""indep-clm"" num=""7""><seg-main>7. A unit dosage form of a composition comprising </seg-main><seg-clauses><seg-main>at least one of </seg-main><seg-clauses>(a) a combination of spermidine and ellagic acid or </seg-clauses><seg-clauses>(b) a combination of docosah","A61K31/132, A61K31/12, A61K31/202, A61K31/37",20250109,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250261662A1,Coffee compositions,Coffee compositions that are derived from medium- and high-yield extracts while also having improved taste and aroma. Processes for producing such coffee compositions are also disclosed.,"<div class=""indep-clm"" num=""1""><seg-con>1: A coffee composition </seg-con><seg-trans>comprising </seg-trans><seg-comp>furfuryl alcohol; pyridine; </seg-comp><seg-comp>and one or more monosaccharides, wherein a ratio of concentrations of the furfuryl alcohol to the pyridine is greater than or equal to 30.</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>2: </seg-comp></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>The coffee composition of claim 1 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>2-ethyl-6-methylpyrazine, 2-ethyl-5 methylpyrazine, 2-ethyl-3-methylpyrazine, 2,3,5-trimethylpyrazine, 2-ethyl-3,6 dimethylpyrazine, 2-ethyl-3,5-dimethylpyrazine, and 2,3-diethyl-5-methylpyrazine,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>wherein the sum of the absolute content of 2-ethyl-6-methylpyrazine, 2-ethyl-5-methylpyrazine, 2-ethyl-3 methy 1 pyrazine, 2,3,5-trimethy 1 pyrazine, 2-ethy 1-3,6-dimethy 1 pyrazine, 2-ethy 1-3,5 dimethy 1 pyrazine, and 2,3-diethyl-5-methylpyrazine is greater than or equal to 50.0 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The coffee composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the absolute content of the furfuryl alcohol is greater than or equal to 2,000 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The coffee composition of claim 1 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>one or more of 2-acethylthiazole, 2-acetylpyrazine, and 2-acetylpyridine,</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>wherein the sum of the absolute content of 2-acethylthiazole, 2-acetylpyrazine, and 2-acetylpyridine is greater than or equal to 2.70 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5: The coffe","A23F5/24, A23F5/36",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250268280A1,Compositions and methods for dehydrated pet food blends,"The present invention provides compositions and methods directed to a dehydrated pet food blend. The dehydrated pet food blend can comprise about 15% to about 50% protein. about 5% to about 40% fat, and about 5% to about 50% carbohydrate. Additionally, the blend can comprise semi-moist kibbles, dried meal, and dehydrated vegetables.","<div class=""indep-clm"" num=""1""><seg-con>1. A dehydrated pet food blend, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>about 15% to about 50% protein;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>about 5% to about 40% fat; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>about 5% to about 50% carbohydrate;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the composition comprises semi-moist kibbles, dried meal, and dehydrated vegetables.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the semi-moist kibbles have a moisture content from about 10% to about 30% by weight.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the semi-moist kibbles are present in the blend in an amount from about 10% to about 50% by weight.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried meal has a moisture content from about 5% to about 12% by weight.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried meal is present in the blend in an amount from about 40% to about 90% by weight.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dehydrated vegetables have a moisture content from about 1% to about 10% by weight.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The dehydrated pet food blend of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dehydrated vegetables are present in the blend in an ","A23K20/147, A23K10/20, A23K10/30, A23K20/158, A23K20/163",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025220690A1,"Omega-3 fatty acid, homocystein and vitamin D levels to identify and attenuate cognitive aging in individuals","A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and 5 homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject. 20 25 22 06 90 19 A ug 2 02 5 A B S T R A C T A m e t h o d f o r i d e n t i f y i n g p r e - d i s p o s i t i o n t o c o g n i t i v e d e c l i n e i n a s u b j e c t , t h e m e t h o d 2 0 2 5 2 2 0 6 9 0 1 9 A u g 2 0 2 5 c o m p r i s i n g d e t e r m i n i n g l e v e l s o f : ( a ) o m e g a - 3 f a t t y a c i d s , a n d v i t a m i n D o r a m e t a b o l i t e t h e r e o f ; ( b ) o m e g a - 3 f a t t y a c i d s , a n d h o m o c y s t e i n e ; ( c ) v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d 5 h o m o c y s t e i n e ; o r ( d ) o m e g a - 3 f a t t y a c i d s , v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d h o m o c y s t e i n e , i n d e p e n d e n t l y i n o n e o r m o r e s a m p l e s o b t a i n e d f r o m t h e s u b j e c t .","<div class=""indep-clm"" num=""1""><seg-main>1. A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of:</seg-main>
<seg-clauses>(a) omega-3 fatty acids, and vitamin D or a metabolite thereof;</seg-clauses>
<seg-clauses class=""seg-enter"">5              (b) omega-3 fatty acids, and homocysteine;</seg-clauses>
<seg-clauses>(c) vitamin D or a metabolite thereof, and homocysteine; or</seg-clauses>
<seg-clauses>(d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the method comprises determining levels of omega-3 10          fatty acids, vitamin D or a metabolite thereof, and homocysteine.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of claim 1 or 2, wherein:</seg-main>
<seg-clauses>(a) a level of omega-3 fatty acids is determined and a decrease in the level of omega-3 fatty acids in the sample from the subject compared to a reference value is indicative of pre-disposition to cognitive decline;</seg-clauses>
<seg-clauses class=""seg-enter"">15              </seg-clauses><seg-clauses>(b) a level of vitamin D or a metabolite thereof is determined and a decrease</seg-clauses>
<seg-clauses class=""seg-enter"">in the level of vitamin D or metabolite thereof in the sample from the subject compared to a reference value is indicative of pre-disposition to cognitive decline; and/or</seg-clauses>
<seg-clauses>(c) a level of homocysteine is determined and an increase in the level of</seg-clauses>
<seg-clauses class=""seg-enter"">20                    homocysteine in the sample from the subject compared to a reference</seg-clauses>
<seg-clauses class=""seg-enter"">value is indicative of pre-disposition to cognitive decline.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent","A61K31/202, A61K31/14, A61K31/4415, A61K31/51, A61K31/592",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2024256701A1,Pectin emulsion gels with improved mouthfeel,"The present invention relates to a pectin based emulsion, said emulsion comprising between 0.5 and 6 wt% pectin, 3 and 40 wt% oil, and water, wherein the emulsion has a pH which is less than 5, an average oil droplet size in the emulsion is below 20 pm, and the pectin is high methoxy pectin with degree of methoxy (DM) > 60.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A pectin based emulsion, said emulsion comprising </seg-main><seg-clauses>between 0.5 and 6 wt% pectin, between 3 and 40 wt% oil, and water, wherein the emulsion has a pH which is less than 5, an average oil droplet size in the emulsion is below 20 pm, and the pectin is high methoxy pectin with degree of methoxy (DM) > 60.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The pectin based emulsion according to claim 1, wherein </seg-main><seg-clauses>the emulsion has a pH which is less than 4.5, preferably less than 4.2, more preferably about 3.5.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The pectin based emulsion according to claim 1 or 2, wherein </seg-main><seg-clauses>said emulsion comprises about 1.5-2.0 wt% pectin and about 10-15 wt% oil.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The pectin based emulsion according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the pectin is high methoxy pectin with DM of 70.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The pectin based emulsion according to any one of claims 1 to 4, said emulsion further comprising </seg-main><seg-clauses>fruit powder, vegetable powder, for example pulse flour, purified fibers, or purified starch.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The pectin based emulsion according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the water is deionized water, tap water, or mineral water.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The pectin based emulsion according to any one of claims 1 to 6, wherein </seg-main><seg-clauses>the water is replaced by a puree, for example a vegetable puree, or a fruit puree, or a pulse puree.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-main>8. The pectin based ","A23L29/231, A23L35/00, A23D7/005, A23L23/00, A23L27/60",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
EP4623700A2,Process for manufacturing a natural creamer with high tolerance to acidity and minerals in beverage,"Natural Creamers for providing whitening and indulgent texture/mouthfeel of beverage and food products are provided. The creamers have long-term stability, high whitening capacity and a pleasant mouthfeel when added to beverage and food, while being free from artificial additives the creamers comprising plant oil and plant proteins, and being further characterized in that the creamers comprise baking soda and citrus fruit juice concentrate, wherein the citrus fruit juice concentrate comprises acid component comprising citric acid and malic acid.","<div class=""indep-clm"" num=""1""><seg-main>1.  A creamer free of artificial additives, the creamer comprising </seg-main><seg-clauses>plant oil and proteins, further <b>characterized in that</b> the creamer comprises baking soda and citrus fruit juice concentrate, wherein the citrus fruit juice concentrate comprises an acid component comprising citric acid and malic acid.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The creamer of claim 1, wherein </seg-main><seg-clauses>the ratio of baking soda to acid component is between 1 to 3.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The creamer of claim 1 or claim 2, wherein </seg-main><seg-clauses>citrus fruit juice concentrate comprises an ingredient selected from the group consisting of lemon juice, grape fruit, orange, berries, lime and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The creamer of any one of claims 1 to 3, wherein </seg-main><seg-clauses>the ratio of proteins : fat is more than 1 : 25; and wherein the Lumisizer instability index is less than 40.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  The creamer of any one of claims 1 to 4 wherein </seg-main><seg-clauses>the creamer pH is greater than 6.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6.  The creamer of any one of claims 1 to 5, wherein </seg-main><seg-clauses>the proteins are plant proteins selected from the group consisting of pea protein, potato protein, pumpkin protein, almond protein, lentil protein, rice protein, peanut protein, quinoa protein, oat protein coconut protein and combinations of these.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7.  The creamer of any one of claims 1 to 6 wherein </seg-main><seg-clauses>the creamer comprises added sugar.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8.  The cream",A23L2/68,20251001,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12357003B2,Soluble instant coffee and process for preparation,The present invention relates to a dried coffee powder obtainable by a process comprising membrane filtration of a low temperature extract of roasted and ground coffee beans to reduce the concentration of low molecular weight components and drying the filtered coffee extract.,"<div class=""indep-clm"" num=""1""><seg-con>1. An instant coffee product, the instant coffee product </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a jar; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a dried coffee powder within the jar, the dried coffee powder obtained by a process comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>extracting coffee solids from roasted and ground coffee beans using water at a temperature between 0 and 140° C. to obtain a first coffee extract;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>performing membrane filtration of the first coffee extract to reduce a concentration of low molecular weight components and obtain filtered coffee extract, the low molecular weight components having a molecular weight less than about 1 kDa; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>drying the filtered coffee extract.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The instant coffee product of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the performing of the membrane filtration comprises filtering the first coffee extract using a selectively-permeable membrane to reduce the concentration of the low molecular weight components, wherein the low molecular weight components comprise low molecular weight coffee solids that pass through the selectively-permeable membrane to form a permeate, and wherein high molecular weight coffee solids that are retained by the selectively-permeable membrane form a retentate; and</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>wherein the drying of the filtered coffee extract comprises drying the retentate.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The instant coffee product of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the selectively-permeable membrane is selectively permeable to the components having molecular w","A23F5/30, A23F5/18, A23F5/26, A23F5/34, A23F5/36",20250715,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119836233A,Compositions and methods for providing health benefits in animal bodies using mackerel oil,"The present disclosure provides compositions and methods for using South Ocean mackerel oil to provide health benefits to animals. For example, a pet food composition for treating an inflammatory condition in a companion animal may comprise South Ocean mackerel oil and a preservative.","<div class=""indep-clm"" num=""1"">1.用于治疗伴侣动物的炎性病症的宠物食物组合物，所述宠物食物组合物包含南洋鲭鱼油和防腐剂。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述南洋鲭鱼油以约0.1％至约10％的量存在于所述组合物中。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的组合物，其中所述南洋鲭鱼油包含至少30％的ω-3脂肪酸和不超过5％的ω-6脂肪酸。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的组合物，其中所述南洋鲭鱼油包含至少3％的二十碳四烯酸、至少1％的硬脂四烯酸、至少8％的二十碳五烯酸、至少15％的二十二碳六烯酸和至少2％的二十二碳五烯酸。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的组合物，其中所述组合物还包含约20％至约50％的量的蛋白质。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的组合物，其中所述组合物还包含约5％至约70％的量的碳水化合物。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的组合物，其中所述组合物还包含约5％至约40％的量的脂肪。</div>
<div class=""dep-clm"" num=""8"" parent=""1"">8.根据权利要求1所述的组合物，其中所述组合物为主食组合物。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的组合物，其中所述组合物为补充剂。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的组合物，其中所述炎性病症选自由以下项组成的组：炎症、关节炎、刺激性皮肤、齿龈肿胀、过敏、哮喘、自身免疫疾病、乳糜泻、肾小球性肾炎、肝炎、炎性肠病、再灌注损伤、移植排斥、痛风、肌炎、硬皮病、系统性红斑狼疮、血管炎、牛皮癣。</div>
<div class=""dep-clm"" num=""11"" parent=""1"">11.根据权利要求1所述的组合物，其中所述组合物能够治疗选自由以下项组成的组的成员：癌症、心脏病、糖尿病、肾病和认知障碍。</div>
<div class=""indep-clm"" num=""12"">12.制造宠物食物组合物的方法，所述方法包括将南洋鲭鱼油和防腐剂与蛋白质、脂肪和碳水化合物中的至少一种掺混以形成所述宠物食物组合物。</div>
<div class=""dep-clm"" num=""13"" parent=""12"">13.根据权利要求12所述的方法，其中所述南洋鲭鱼油以约0.1％至约10％的量存在于所述组合物中。</div>
<div class=""dep-clm"" num=""14"" parent=""12"">14.根据权利要求12所述的方法，其中所述宠物食物组合物是主食组合物。</div>
<div class=""dep-clm"" num=""15"" parent=""12"">15.根据权利要求12所述的方法，其中所述宠物食物组合物是补充剂。</div>","A23K10/22, A23K20/158, A23L33/115",20250415,雀巢产品有限公司,['Pending']
AU2023343153A1,Methods for providing and determining an efficacious weight loss diet for a canine,"The present disclosure provides a method of determining the efficacy of a weight loss diet for a canine, the method comprising analyzing a serum or plasma sample from the canine for a biomarker before and after administration of the weight loss diet, wherein the biomarker is selected from the group consisting of 3-methylhistidine, 1-methylhistidine, and a combination thereof, and determining the weight loss diet is efficacious if the amount of the biomarker has decreased.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of determining the efficacy of a weight loss diet for a canine, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>analyzing a first serum or plasma sample from the canine for a biomarker selected from the group consisting of 3-methylhistidine, 1-methylhistidine, and a combination thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determining the amount of the biomarker in the first serum or plasma sample;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>analyzing a second serum or plasma sample for the biomarker after the canine has been administered the weight loss diet;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determining the amount of the biomarker in the second serum or plasma sample; and determining the weight loss diet is efficacious if the amount of the biomarker in the second serum or plasma sample has decreased from the amount of the biomarker in the first serum sample or determining the weight loss diet is inefficacious if the amount of the biomarker in the second serum or plasma sample has not changed or increased from the amount of the biomarker in the first serum or plasma sample.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight loss diet has been administered to the canine on a regular basis.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight loss diet has been administered to the canine for at least 1 month.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight loss comprises a complete and balanced pet food.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg","G01N33/50, G01N33/68",20250206,SOCIETE DES PRODUITS NESTLE SA,['Pending']
CN120129478A,Beverage preparation machine,"The invention relates to a beverage preparation machine and a capsule containing beverage ingredients, in which a machine-readable code (34) storing preparation information is arranged on a surface of at least one of the envelope walls, in which the beverage preparation machine comprises:-extraction means for extracting a beverage from the capsule, and-a code reading system for reading the code of the bag, and wherein the code reading system comprises a code reader (9) and a positioning mechanism for moving the bag and the code reader relative to each other from a holding position in which the bag is held in the holding position, to a reading position in which the bag is read by the code reader. The capsule is separated from a read head (91) of the code reader, and wherein the beverage preparation machine comprises a read position in which the code of the capsule is in contact with the read head, and wherein the beverage preparation machine comprises a pre-piercing arrangement (28) configured to pierce the capsule before the code of the capsule is read in the read position.","<div class=""indep-clm"" num=""1""><seg-con>1.系统，所述系统包括饮料制备机器和囊包，所述囊包包含饮料配料，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包(3)包括第一包封壁和第二包封壁(31,31',32)，所述第一包封壁和第二包封壁限定用于包封所述饮料配料(33)的腔室，并且其中存储制备信息的机器可读代码(34)被布置在所述包封壁中的至少一个包封壁的表面上，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述饮料制备机器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-提取装置，所述提取装置用于从所述囊包中提取饮料，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-代码读取系统，所述代码读取系统用于读取所述囊包的所述代码，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-电气电路，所述电气电路用于基于从所述代码读取的所述制备信息来控制所述提取装置，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述代码读取系统包括代码读取器(9)和定位机构，所述定位机构用于使所述囊包和所述代码读取器相对于彼此从保持位置移动到读取位置：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.在所述保持位置中，所述囊包与所述代码读取器的读取头(91)分离，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.在所述读取位置中，所述囊包的所述代码与所述读取头接触，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述饮料制备机器包括预刺穿排布结构(28)，所述预刺穿排布结构被构造成在所述读取位置中读取所述囊包的所述代码之前刺穿所述囊包。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述预刺穿排布结构(28)被构造成刺穿与要由所述读取头接触的壁相对的壁。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的系统，其中所述饮料制备机器包括预刺穿排布结构(28)，所述预刺穿排布结构被构造成在所述定位机构使所述囊包和/或所述代码读取器相对于彼此从所述保持位置移动到所述读取位置时刺穿所述囊包。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的系统，其中所述定位机构包括推进装置(27)，所述推进装置被构造成将所述囊包从所述保持位置推进到所述读取位置，并且其中所述推进装置承载所述预刺穿排布结构(28)。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据前述权利要求中任一项所述的系统，其中所述饮料制备机器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>-提取装置，所述提取装置用于从所述囊包中提取饮料，并且所述提取装置包括上游囊包包封部件和下游囊包包封部件(1,2)，其中所述囊包包封部件中的至少一个囊包包封部件能够在以下位置之间向另一囊包包封部件移动：</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>.打开位置，所述打开位置用于将所述囊包插入到所述提取装置中以及将所述囊包从所述提取装置中移除，和</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>.闭合位置，所述闭合位置用于在提取期间形成包封所述囊包的提取腔室，</seg-refi></div>
<div class=""dep",A47J31/44,20250610,雀巢产品有限公司,['Pending']
US20250281438A1,"Compositions and methods using at least one glycine or derivative thereof and/or at least one n-acetylcysteine or derivative thereof, and at least one thymol and/or carvacrol",,"<div class=""indep-clm"" num=""1""><seg-con>1. A method for treating, preventing or managing nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis, hepatic steatosis (fatty liver) and/or associated liver damage in an individual in need thereof </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the individual a composition comprising an effective amount of a combination of at least one glycine or functional derivative thereof and/or at least one N-acetylcysteine or functional derivative thereof, and at least one thymol and/or carvacrol.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A method for preventing hepatotoxicity and/or liver damage </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a composition comprising an effective amount of a combination of at least one glycine or functional derivative thereof and/or at least one N-acetylcysteine or functional derivative thereof, and at least one thymol and/or carvacrol to an individual in need of same.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the combination is in an amount effective to decrease hepatic triglycerides and/or circulating AST and ALT enzymes.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the at least one glycine or functional derivative thereof is selected from the group consisting of L-glycine, L-glycine ethyl ester, D-Allylglycine; N-[Bis(methylthio)methylene]glycine methyl ester; Boc-allyl-Gly-OH (dicyclohexylammonium) salt; Boc-D-Chg-OH; Boc-Chg-OH; (R)-N-Boc-(2′-chlorophenyl)glycine; Boc-L-cyclopropylglycine; Boc-L-cyclopropylglycine; (R)-N-Boc-4-fluorophenylglycine; Boc-D-propargylglycine; Boc-(S)-3-thienylglycine; Boc-(R)-3-thienylglycine; D-a-Cyclohexylglycine; L-a-Cyclopropylglycine; N-(2-fluorophenyl","A61K31/198, A61K31/05, A61K45/06, A61P1/16",20250911,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250344898A1,Coffee brewing apparatus,"The invention concerns a full automatic coffee machine (<b>100</b>) comprising: —a brewing chamber (<b>1</b>), an upper piston (<b>2</b>), a lower piston (<b>3</b>) movable inside said brewing chamber (<b>1</b>), wherein the brewing chamber and/or the upper piston are relatively movable between a first closed position configured for compacting coffee during brewing and the second closed position is configured for not compacting coffee during brewing, —a pressurized hot water fluid system comprising at least a water supply (<b>101</b>), a water heating device (<b>104</b>) and a water pump (<b>102</b>) wherein said system is connected to the water inlet (<b>13</b>) of the coffee extraction unit, wherein the fluid supply system comprises a pressure bypass valve (<b>107</b>) downstream the water pump and wherein the predetermined threshold pressure of the fluid dispensed by said pressure bypass valve is adjustable, and wherein the full automatic coffee machine comprises a control system configured: —to move the brewing chamber and/or the upper piston to the first closed position or to the second position for brewing coffee powder, and —to adjust the predetermined threshold pressure of the fluid dispensed by the pressure bypass valve to a first predetermined threshold pressure, respectively to a second predetermined threshold pressure, when the brewing chamber and/or the upper piston is moved to the first closed position, respectively to the second position.","<div class=""indep-clm"" num=""1""><seg-con>1. A full automatic coffee machine, said machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a coffee extraction unit, said coffee extraction unit comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a brewing chamber for receiving roasted and ground coffee powder, said chamber comprising an upper rim and a bottom wall, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an upper piston,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said upper piston being configured to be movable through the upper rim of the brewing chamber and inside the brewing chamber further to the relative movement of the brewing chamber and the upper piston, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a water inlet,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a liquid outlet duct,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a lower piston movable inside said brewing chamber between:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a lowest position wherein the lower piston lies at the bottom of the brewing chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a highest position wherein the lower piston is at the upper rim of the brewing chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a discharge device for spent coffee,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the brewing chamber and/or the upper piston are relatively movable between:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an open position for introducing roasted and ground coffee powder or ejecting extracted roasted and ground coffee powder, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least two different first and second closed positions configured for brewing roasted and ground coffee powder, wherein the first closed position is configured for compacting coffee d","A47J31/36, A47J31/06, A47J31/42, A47J31/46, A47J31/52",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023376695A1,Reduction of vicine and/or convicine in faba ingredients and food products,"The invention relates to a method of reducing vicine and/or convicine content in a faba ingredient. A liquid faba ingredient is provided and then at least one vicine and/or convicine-degrading enzyme is added to the liquid faba ingredient having a pH of 6.0 or higher. The faba ingredient is then incubated with the at least one vicine and/or convicine-degrading enzyme. The invention also relates to faba ingredient, to food products prepared with faba ingredient and method for producing such food products.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of reducing vicine and/or convicine content in a faba ingredient, said method comprising the steps of:</seg-main>
<seg-clauses>a) Providing a faba ingredient which is liquid or suspending a faba ingredient into an aqueous liquid to form a faba ingredient which is liquid, wherein the faba ingredient comprises vicine and/or convicine,</seg-clauses>
<seg-clauses>b) Adding at least one vicine and/or convicine-degrading enzyme to the faba ingredient, wherein the faba ingredient has a pH of 6.0 or higher,</seg-clauses>
<seg-clauses>c) Incubating the faba ingredient with the at least one vicine and/or convicine-degrading enzyme to obtain a treated faba ingredient,</seg-clauses>
<seg-clauses>d) Optionally, partially or fully inactivating the vicine and/or convicine-degrading enzyme in the treated faba ingredient,</seg-clauses>
<seg-clauses>e) Optionally, cooling the treated faba ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the faba ingredient has a pH between pH 6.0 and pH 9.0.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the faba ingredient is whole faba bean, faba bean flour, faba bean protein concentrate or faba bean protein isolate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the at least one vicine and/or convicine-degrading enzyme is selected from the list consisting of betaglucosidase, enzyme having beta-glucosidase side activity or a mixture thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the at least one vicine and/or convicine-degrading enzyme is","A23L11/30, A23J3/14, A23L5/20, A23L11/00, C12N9/42",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12433451B2,Roasting and grinding apparatus for coffee beans,"The invention relates to a roasting and grinding apparatus for coffee beans comprising a roasting device (<b>50</b>) and an associated grinding device (<b>60</b>); the roasting device (<b>50</b>) being configured for receiving coffee beans of a certain type that will be roasted, the roasting device (<b>50</b>) comprising reading means (<b>53</b>) to identify the characteristics of the coffee beans dispensed to it, the roasting device (<b>50</b>) further comprising a control unit configuring the roasting profile of the beans according to the characteristics retrieved from the reading means (<b>53</b>) and/or from the characteristics of the beans in a database (<b>51</b>) in this control unit and/or according to the user's input; the roasted coffee beans being dispensed into a beans container (<b>10, 20</b>), the beans container (<b>10, 20</b>) comprising programmable identification means where product parameters of the roasted coffee beans of a certain type are encoded on it by an encoder (<b>52</b>) in the roasting device; the grinding device (<b>60</b>) comprising one or more housings for receiving one or more beans containers (<b>10, 20</b>); the grinding device (<b>60</b>) comprising a reader (<b>62</b>) to obtain the information of the product parameters of the roasted coffee beans of the one or more beans containers (<b>10, 20</b>); the grinding device (<b>60</b>) further comprising a control unit configured to adapt the grinding size and the quantity of roasted coffee beans to be delivered from the coffee beans containers (<b>10, 20</b>) for obtaining a certain coffee quantity and/or a certain coffee blend quantity from each beans container to be grinded according to these product parameters and/or according to a recipes database (<b>64</b>), and/or according to the user's input. The invention further relates to a method for roasting and grinding coffee beans using a roasting and grinding apparatus as the ones described, and to the use of such a roasting and grinding apparatus.","<div class=""indep-clm"" num=""1""><seg-main>1. A roasting and grinding system for coffee beans comprising:</seg-main>
<seg-clauses>a roasting device configured for receiving coffee beans from a first container and roasting the coffee beans, the roasting device comprising a first reader configured to read an optical or electromagnetically readable code of the first container to identify a characteristics of the coffee beans, the roasting device further comprising a roasting device control unit to configure a roasting profile of the coffee beans, wherein the roasting profile is configured according to;</seg-clauses>
<seg-clauses>(a) the characteristics identified by the first reader,</seg-clauses>
<seg-clauses>(b) an additional characteristics of the coffee beans in a database in the roasting device control unit,</seg-clauses>
<seg-clauses>(c) a user input, or</seg-clauses>
<seg-clauses>(d) any combination of (a), (b), and/or </seg-clauses><seg-clauses><seg-main>(c),</seg-main>
<seg-main class=""seg-enter"">wherein the roasting device is further configured to dispense roasted coffee beans into one or more beans containers, wherein the roasting device further comprises an encoder configured to encode a product parameter of the roasted coffee beans on a programmable identification means of the one or more beans containers;</seg-main>
<seg-main class=""seg-enter"">the one or more beans containers configured to receive the roasted coffee beans from the roasting device, wherein the one or more beans containers comprise the programmable identification means;</seg-main>
<seg-main class=""seg-enter"">a grinding device comprising one or more housings for receiving the one or more beans containers, the grinding device comprising a second reader to obtain the product parameter of the roasted coffee beans from the programmable identification means of the one or more beans containers, the grinding device further comprising a grinding device control unit configured to adapt a grinding size ","A47J42/50, A23F5/04, A23F5/08, A23N12/08, A23N12/12",20251007,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019364928B2,Pack for preparing food or beverage products,"The invention relates to a pack (100) for the preparation of a food or beverage product comprising an insert (10) and a container (20), the container (20) being configured by at least one flexible sheet folded in such a way to configure a container where the ingredients for the food or beverage product are stored, the water to extract and/or infuse and/or dissolve and/or reconstitute the ingredients in the container (20) and to prepare the food or beverage product being introduced through the insert (10) through an injection hole (11) and into an inlet chamber (191), the food or beverage product once prepared being also dispensed through this insert (10), the pack (100) presenting a generally plane shape and being essentially vertically oriented during food or beverage production with the insert (10) arranged at the lower side of the pack (100) so the water is supplied into the volume of the container in an upward direction; such that the pack (100) further comprises an inlet channel (30) arranged at the inlet chamber (191) and extending vertically inside the volume of the container (20) in such a way that the water introduced via the insert (10) is conducted by the channel (30) and enters the inner volume of the container (20) through this channel (30), the height (Hpipe) of the channel (30) in the volume of the container being such that it is arranged above the ingredients in the container and allows the water exiting the channel (30) to wet the ingredients from the upper part of these, avoiding turbulence. The invention further relates to the use of a pack (100) for preparing a food or beverage product and to a method for preparing such a food or beverage product.","<div class=""indep-clm"" num=""1""><seg-con>1. Pack for the preparation of a food or beverage product </seg-con><seg-trans>comprising </seg-trans><seg-refi>an insert and a container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>5                         the container being configured by at least one flexible sheet folded in</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>such a way to configure a container where the ingredients for the food or beverage product are stored,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the water to extract and/or infuse and/or dissolve and/or reconstitute the ingredients in the container and to prepare the food or beverage product</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10                  being introduced through the insert through an injection hole and into an</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>inlet chamber, the food or beverage product once prepared being also dispensed through this insert,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pack presenting a generally plane shape and being essentially vertically oriented during food or beverage production with the insert</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>15                 arranged at the lower side of the pack so the water is supplied into the</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>volume of the container in an upward direction;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the pack further comprises an inlet channel arranged at the inlet chamber and extending vertically inside the volume of the container in such a way that the water introduced via the insert is conducted by the</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>20                 channel and enters the inner volume of the container through this channel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the height (HPipe) of the channel in the volume of t","B65D75/58, B65D85/804",20250313,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250339455A1,Compositions and methods using a combination of oleuropein and fisetin for cellular energy,,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency/depletion disorder in an individual comprising administering to an individual in need of same a composition comprising a combination of oleuropein and/or a metabolite thereof and fisetin and/or a derivative, in a therapeutically effective amount.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1"">4. Method according to claim 1, for preventing or treating muscle fatigue from exercise.</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the effective amount of a combination of oleuropein and/or a metabolite thereof and fisetin and/or a derivative is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, ","A61K31/7048, A61K31/352, A61K45/06",20251106,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
MX386578B,Non-meat food products having appearance and texture of cooked meat,"Non-meat food products are provided that have the appearance and the texture of cooked meat. Methods for making such non-meat food products are also provided. In an embodiment, a method includes mixing dry ingredients comprising vegetable proteins with wet ingredients including water and/or oil to form a non-meat dough; heating the non-meat dough under pressure; maintaining the pressure while transferring the heated non-meat dough to a cooling device; and gradually cooling the heated non-meat dough while gradually decreasing pressure on the heated non-meat dough, to form a non-meat food product. The mixing can be performed by a batch or continuous mixer; the heating can be performed by a device selected from the group consisting of a high shear emulsifier, a heat exchanger, and a dielectric heater; and the gradual cooling can be performed by a heat exchanger.","REIVINDICACIONES
<div class=""indep-clm"" num=""1""><seg-main>1. Un metodo para la produccion continua de un producto alimenticio no carnico sin el uso de extrusion, el metodo esta caracterizado porque comprende:</seg-main>
<seg-main class=""seg-enter"">mezclar </seg-main><seg-clauses>(i) ingredientes secos que comprenden protelnas vegetales con </seg-clauses><seg-clauses>(ii) ingredientes humedos que comprenden aceite para formar una masa no carnica, y el aceite es de 3 % en peso a 14 % en peso de la masa no carnica, en donde el aceite se selecciona del grupo que consiste en aceite de frijol de soya, aceite de maiz, aceite de girasol, aceite de girasol de alto contenido oleico, aceite de oliva, aceite de canola, aceite de cartamo, aceite de mani, aceite de palma, aceite de semilla de algodon, aceite de coco, aceite de almendra, aceite de avellana, aceite de semilla de uva y combinaciones de estos, y los ingredientes secos ademas comprenden uno o mas de levadura, sebo, color caramelo, achiote, clorofilina, cochinilia, betanina, curcuma, azafran, pimenton, licopeno, jugo de baya del sauco, pandan, guisante de mariposa, dioxido de titanic, cualquier colorante alimentario adecuado, vitaminas o minerales;</seg-clauses>
<seg-clauses class=""seg-enter"">bombear la masa no carnica para al menos mantener la presion sobre la masa no carnica y despues calentar la masa no carnica a presion, en donde el calentamiento se realiza a una temperatura de 138 °C a 180 °C, y la presion es de 0.48 MPa a 3.45 MPa (de 4.8 bar a 34.5 bar);</seg-clauses>
<seg-clauses class=""seg-enter"">bombear la masa no carnica calentada en una bomba de</seg-clauses>
<seg-clauses class=""seg-enter"">desplazamiento positive de alta presion despues del calentamiento; y</seg-clauses>
<seg-clauses class=""seg-enter"">INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL</seg-clauses>
<seg-clauses class=""seg-enter"">enfriar gradualmente la masa no carnica calentada para formar un producto alimenticio no carnico, en donde la masa no ","A23J3/18, A23J3/22, A23K10/30, A23K20/147, A23K20/158",20250319,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025157814A1,Structured confectionery product,"The present invention relates to a filled confectionery product comprising a cocoa-based shell and backing layer surrounding a fat-based confectionery filling, wherein the filled confectionery product has a total saturated fat content less than 6% and a total sugar content of less than 3.4%; and wherein the combined saturated fat content of the shell and backing layer comprise greater than 50% of the total saturated fat fraction in the filled confectionery product.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 A filled confectionery product comprising </seg-main><seg-clauses>a cocoa-based shell and backing layer surrounding a fat-based confectionery filling, wherein the filled confectionery product has a total saturated fat content less than 6% and a total sugar content of less than 3.4%; and wherein the combined saturated fat content of the shell and backing layer comprise greater than 50% of the total saturated fat fraction in the filled confectionery product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2 The filled confectionery product according to claim 1 , wherein </seg-main><seg-clauses>the combined saturated fat content of the shell and backing layer comprise more than 75% of the total saturated fat fraction in the filled confectionery product.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3 The filled confectionery product according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the shell has a saturated fat content of not less than 10%, preferably between 10 to 15%, when expressed as a percentage by weight of shell.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4 The filled confectionery product according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the backing layer has a saturated fat content of not less than 5%, preferably between 5 to 10%, when expressed as a percentage by weight of backing layer.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5 The filled confectionery product according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the filling has a saturated fat content of not more than 3%, when expressed as a percentage by weight of filling.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6 The filled confectionery product according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the filling comprises not less t","A23G1/00, A23G1/36, A23G1/54, A23G3/34, A23G3/40",20250731,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12162238B2,Process and equipment for manufacturing a reinforced sachet,"The present invention is directed to a process for manufacturing a flexible package suitable for containing a food or beverage ingredient and suitable for use with a food or beverage preparation machine, wherein said process comprises punching a flexible flat blank sheet between a plunger and a cavity that are movable relative to one another. According to the invention, the plunger has a concave end side and convex lateral sides, and the profile curvature of its end side is identical to the profile curvature of each of its lateral sides.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for manufacturing a flexible package suitable for containing </seg-main><seg-clauses><seg-main>a food or beverage ingredient and suitable for use with a food or beverage preparation machine, wherein said process comprises:</seg-main>
<seg-clauses>(i) providing a primary flat blank sheet made of flexible material, said primary flat blank sheet having an elongated shape with two flaps extending symmetrically around a transversal axis,</seg-clauses>
<seg-clauses>(ii) placing the primary flat blank sheet in a forming station such that its center is located between a plunger and a cavity that are movable relative to one another and have complementary shapes, said plunger having a concave lower end side and convex lateral sides, a profile curvature of the lower end side being identical to a profile curvature of each of its the lateral sides,</seg-clauses>
<seg-clauses>(iii) deforming the primary flat blank sheet by moving the plunger and the cavity towards one another, so that said primary flat blank sheet is folded around the transversal axis to lift the flaps and form an unsealed U-shaped package having side walls that form a flatten package body and a bottom portion, said bottom portion being a cup-shaped hollow volume having a shape of said plunger, and</seg-clauses>
<seg-clauses>(iv) sealing lateral edges of said U-shaped package,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the process further comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">placing a pair of plates underneath said primary flat blank sheet in step (ii), both plates being initially coplanar and each plate supporting one of the two flaps of the primary flat blank sheet, said plates being symmetrically pivotable around respective axes that are located on opposite sides of said plunger, and</seg-clauses>
<seg-clauses class=""seg-enter"">pivoting both plates during step (iii), so that an edge of each plate which is most distant from said ","B31B70/00, B31B70/26, B31B70/84, B65B3/02, B65B29/02",20241210,SOCIETE DES PRODUITS NESTLE S.A,['Active']
CN119255716A,Instant food powder comprising pea protein and oat protein and free of dairy protein,"The present invention relates to a spray-dried beverage or food powder comprising 10% to 35% by weight of pea protein; 2% to 15% by weight of other plant proteins; 3% to 8% by weight, preferably 4% to 5% by weight, of fibers selected from cereals, pseudo-cereal seeds, or a combination thereof; 0% to 30% by weight, preferably 12% to 18% by weight, of a vegetable oil or fat; optionally, a fortifying source; and optionally a stabilizing salt, and wherein the total protein content is from 12% to 40% by weight. The invention also relates to a method for making the beverage or food powder.","<div class=""indep-clm"" num=""1"">1.喷雾干燥的饮料或食物粉末，所述喷雾干燥的饮料或食物粉末包含</div>
<div class=""indep-clm"" num=""1"">10重量％至35重量％的豌豆蛋白质，</div>
<div class=""indep-clm"" num=""1"">2重量％至15重量％的其他植物蛋白质，</div>
<div class=""indep-clm"" num=""1"">3重量％至8重量％、优选地4重量％至5重量％的纤维，所述纤维选自谷物、假谷物种子或其组合，</div>
<div class=""indep-clm"" num=""1"">0重量％至30重量％、优选地12重量％至18重量％的植物油或脂肪，</div>
<div class=""indep-clm"" num=""1"">任选的强化源，以及</div>
<div class=""indep-clm"" num=""1"">任选的稳定盐，并且其中总蛋白质含量为12重量％至40重量％。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的饮料或食物粉末，其中所述其他植物蛋白质选自燕麦蛋白质、稻米蛋白质或其组合。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的饮料或食物粉末，其中所述粉末包含</div>
<div class=""dep-clm"" num=""3"" parent=""1"">10重量％至20重量％的豌豆蛋白质，</div>
<div class=""dep-clm"" num=""3"" parent=""1"">6重量％至12重量％的其他植物蛋白质，</div>
<div class=""dep-clm"" num=""3"" parent=""1"">5重量％至8重量％的纤维，优选燕麦粉中所含的纤维，以及</div>
<div class=""dep-clm"" num=""3"" parent=""1"">0重量％至25重量％的添加的糖。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的饮料或食物粉末，其中所述植物蛋白质呈分离物或浓缩物或粉的形式，所述分离物优选地包含75重量％至90重量％的蛋白质，所述浓缩物优选地包含50重量％至70重量％的蛋白质，并且所述粉优选地包含5重量％至30重量％的蛋白质。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的饮料粉末或食物，所述饮料粉末或食物包含10重量％至35重量％的豌豆蛋白质分离物。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的饮料粉末或食物，所述饮料粉末或食物包含30重量％至65重量％的燕麦粉、稻米粉或其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的饮料或食物粉末，其中所述谷物中的淀粉已经过酶处理。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的饮料或食物粉末，所述饮料或食物粉末没有添加的糖。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的饮料或食物粉末，所述饮料或食物粉末不含动物产品。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的饮料或食物粉末，其中强化源选自磷酸三钙、碳酸钙、乳酸钙、氯化钙、乳糖葡萄糖酸钙、磷酸二钙、柠檬酸三钙、铁、任何强化矿物质或其组合。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的饮料或食物粉末，其中所述饮料粉末包含附加纤维，所述附加纤维来自选自菊苣根、甜菜根、甘蔗、洋姜、可溶性玉米纤维、抗性糊精、聚葡萄糖或其组合的纤维来源。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的饮料或食物粉末，其中所述纤维选自豌豆、燕麦","A23L33/185, A23L2/66, A23C11/10, A23L2/52, A23L11/60",20250103,雀巢产品有限公司,['Pending']
AU2019415009B2,Compositions and methods for diagnosing and treating degenerative mitral valve disease in a canine,"The present invention relates to methods and compositions for diagnosing and treating degenerative mitral valve disease in a canine. In one embodiment, a method of diagnosing early stage degenerative mitral valve disease in a canine can comprise measuring a normalized relative abundance of a biomarker selected from the group consisting of","<div class=""indep-clm"" num=""1""><seg-con>1. A method of diagnosing early stage degenerative mitral valve disease in a canine, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>5                 measuring a normalized relative abundance of a biomarker selected from</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the group consisting of Erysipelatoclostridium, Ruminococcaceae UCG014, Butyricicoccus, Faecalibacterium, and combinations thereof; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>determining that the canine has early stage degenerative mitral valve disease if the Erysipelatoclostridium is from 0 to 0.5 normalized relative</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10          abundance, the Ruminococcaceae UCG014 is from 0 to 0.1 normalized relative</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>abundance, the Butyricicoccus is from 0 to 0.1 normalized relative abundance, or the Faecalibacterium is from 0 to 0.1 normalized relative abundance.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>determining is based on two biomarkers.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>15</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>determining is based on three biomarkers.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>determining is based on all four biomarkers.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>20       </seg-refi></div><div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>determining is based on Erysipelatoclostridium.</seg-refi></div>
<div class=""dep-clm"" num=""6"" paren","C12Q1/689, A23K10/16, A23K50/00",20250605,SOCIETE DES PRODUITS NESTLE SA,['Active']
WO2025237886A1,Composition for prevention and treatment of inflammation or improving immune regulation,"The present invention relates to a combination comprising cellulose, xyloglucan and pectin in effective amount for use in preventing or treating an inflammatory condition and/or disease in a young individual, preferably in infant during weaning period. The present invention further relates to compositions and methods for preventing or treating an inflammatory condition and/or disease in a young individual, preferably in an infant during weaning period.",,"A61K31/717, A23L33/24, A61K31/732, A61P1/14, A61P29/00",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2020215758B2,System of coded package and apparatus,"The invention concerns a system (10) of a package (2) containing a product and an apparatus (1) using said product, the apparatus being refilled by the product contained in the package, wherein a code (21) related to the contained product is associated to the package, said code being a two dimension code and said code presenting a predetermined surface S","<div class=""indep-clm"" num=""1""><seg-main>1. A system of a package containing </seg-main><seg-clauses><seg-main>a product and an apparatus using said product, the apparatus being refilled by the product contained in the package,</seg-main>
<seg-main class=""seg-enter"">5 wherein a code related to the contained product is associated to the package, said code being a two dimension code and said code presenting a predetermined surface SCOde, and</seg-main>
<seg-main class=""seg-enter"">wherein the apparatus comprises a code reader to read the code associated to the package, said code reader being an image capturing device, said image capturing device being</seg-main>
<seg-main class=""seg-enter"">0 defined by :</seg-main>
<seg-clauses>- a predetermined focal range,</seg-clauses>
<seg-clauses>- a horizontal angle of view a and a vertical angle of view p, wherein the apparatus comprises a housing structure and a cavity inside the housing structure, said cavity extending from a back side at the inside of the housing structure to a</seg-clauses>
<seg-clauses class=""seg-enter"">5 front side at the external surface of the housing and comprising at least one lateral wall extending between the back side and the front side of the cavity, wherein the image capturing device is positioned at the back side of the cavity and the optical axis of the image capturing device extends in direction of the middle of the front side of the cavity,</seg-clauses>
<seg-clauses class=""seg-enter"">:0 wherein the front side of the cavity consists in a hole in the external surface of the housing structure, said hole presenting a surface Shoie such that:</seg-clauses>
<seg-clauses class=""seg-enter"">1 ,2 Scode — Shoie — 6 Scode wherein the distance extending between the back side of the cavity and the front side of the cavity is comprised in the focal range of the image capturing device, and</seg-clauses>
<seg-clauses class=""seg-enter"">25 wherein the at least one lateral wall of the cavity is configured to sur",G06K7/00,20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2023378256A1,Thymol or carvacrol for use in reducing the biological age or of the rate of its increase,"The present disclosure generally relates to compositions and methods to reduce the biological age and/ or reduce the rate of increase of the biological age of an adult animal. More specifically, the present disclosure relates to administering a formulation comprising an effective amount of thymol and/or carvacrol, alone or in combination with a dietary regime such as caloric restriction, senior diet or low protein diet. The formulation can concomitantly reduce the biological age of a tissue, organ or physiological system in the adult animal in need; or treat, prevent, or delay the onset of an organ disease, or decline of organ function, or condition relating thereto in an adult animal in need.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for reducing the biological age and/ or reduce the rate of increase of the biological age of an adult animal in need, the method </seg-con><seg-trans>comprising: </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of thymol and/or carvacrol.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A method for reducing the biological age of a tissue, organ or physiological system in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of thymol and/or carvacrol.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue, organ or physiological system is immune, gastrointestinal, urinary, muscular, cardiovascular, and/or neurological system.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue is skeletal muscle.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5. A method for treating, preventing, or delaying the onset of an organ disease, or decline of organ function, or condition relating thereto in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of thymol and/or carvacrol.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A method according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the animal in need has an increased biological age compared to its chronological age.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""3""><seg-con>7. A method according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the increased biological age is determined from the DNA methylation","A61K31/05, A23K10/00, A23K20/111, A23K50/40, A23L33/00",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024235840A1,An extrusion process for preparing a food flavor product,"The invention relates generally to an extrusion process for preparing a food flavor product. More specifically, the present invention relates to an extrusion process for preparing a food flavor product wherein at least one vent stuffer is located within the last 2/3 part of the total length of the extruder barrel.","<div class=""indep-clm"" num=""1""><seg-main>1. An extrusion process for preparing a food flavor product comprising the steps of:</seg-main>
<seg-clauses>a) feeding an extruder barrel (7) with a composition comprising at least one carrier, at least one amino nitrogen source and at least one sugar source;</seg-clauses>
<seg-clauses><seg-main>b) extruding the composition from step </seg-main><seg-clauses>a) at a temperature between 35 to 170°C, wherein at least one vent stuffer is located within the last 2/3 part of the total length of the extruder barrel.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The extrusion process for preparing a food flavor product as claimed in claim 1, wherein </seg-main><seg-clauses>the carrier is selected from the group of maltodextrin, starch, flour, salt, fibers or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 2, wherein </seg-main><seg-clauses>the food flavor product comprises the carrier in an amount of 5-95wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 3, wherein </seg-main><seg-clauses>the amino nitrogen source is selected from the group of cysteine, methionine, arginine, glutathione, asparagine, glutamic acid, lysine, glutamine, thiamine, alanine, glycin, threonine, plant protein, yeast extract, bacterial extract, vegetable extract, hydrolyzed plant protein or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 4, wherein </seg-main><seg-clauses>the</seg-clauses>
<seg-clauses class=""seg-enter"">food flavor product comprises the amino nitrogen source in an amount of 0.1-","A23L27/26, A23L27/21",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025061644A1,Capsule and method of forming capsule,"A capsule designed for insertion in a beverage production device for preparing a beverage from a substance contained in the capsule by introducing liquid in the capsule and passing liquid through the substance using centrifugal forces, wherein the capsule comprises a molded pulp layer defining: a body comprising a bottom end and an open end, spaced apart in the axial direction, an enclosure between the body and upper wall for containing an amount of beverage substance, the capsule comprising a flange-like rim extending outwardly from the body, the flange-like rim comprising an annular flange portion; wherein the annular flange portion forms a curl extending transversally and axially beyond the flange-portion. A method of preparing a capsule, the method comprising: a. providing a pulp molding tool defining the shape of a capsule comprising a body comprising a bottom end and an open end, spaced apart in the axial direction, an enclosure between the body and upper wall for containing an amount of beverage substance, the capsule comprising a flange-like rim extending outwardly from the body, the flange-like rim comprising an annular flange portion, b. shaping the pulp by aspiration, pressing and drying to form the capsule, and c. forming a curl in a flange-like rim of the capsule.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A capsule designed for insertion in a beverage production device for preparing a beverage from a substance contained in the capsule by introducing liquid in the capsule and passing liquid through the substance using centrifugal forces, wherein </seg-main><seg-clauses>the capsule comprises a molded pulp layer defining: a body comprising a bottom end and an open end, spaced apart in the axial direction, an enclosure between the body and upper wall for containing an amount of beverage substance, the capsule comprising a flange-like rim extending outwardly from the body, the flange-like rim comprising an annular flange portion; wherein the annular flange portion forms a curl extending transversally and axially beyond the flangeportion.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule according to claim 1, wherein </seg-main><seg-clauses>the capsule comprises a fiber layer, preferably a natural fiber layer, for example seed hairs such as cotton, stem or bast fibers such as flax or hemp, leaf fibers such as sisal, or husk fibers such as coconut, or a combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The capsule according to claim 1 or 2, wherein </seg-main><seg-clauses>the capsule comprises a woven fiber layer, preferably a woven fiber matrix layer.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. The capsule according to claim 2 or 3, wherein </seg-main><seg-clauses>the fiber layer comprises fibers having a fiber diameter of from about 10 to about 20 pm, preferably from about 12 to about 16 pm.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4""><seg-main>5. The capsule according to any of claims 2 to 4, wherein </seg-main><seg-clauses>the fiber layer comprises fibers having a tensile strength of from about 1200 mPa to about 2000 mPa, preferably from about 1500 mPa to about 1800 mPa.</seg-clauses></div",B65D85/804,20250327,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025011786A1,Piercing arrangement and related beverage extraction system,"The invention concerns a piercing arrangement (12) for piercing a pod containing a beverage ingredient being an assembly of an upper sub-part plate (12a) and a lower sub-part plate (12b), comprising a plate (121) provided with opening elements (122) rising from an upper surface (1211), and traversing holes (123), wherein each of the opening elements (122) present a tip end (1221), and a surface comprising a beverage outlet opening (1222) cooperating with the traversing holes (123), and wherein, for each of said opening elements (122), the beverage outlet opening (1222) is positioned above an intermediate position (h) between the upper surface (1211) of the plate and the tip end (1221) of the opening element, and the beverage outlet opening (1222) is a slit extending along a plane parallel to the plane of the upper surface (1211) of the plate, and wherein the upper sub-part plate (12a) and the lower sub-part plate (12b) are designed so that, when assembled, the beverage outlet opening (1222) and/or the opening element (122) are formed.",,"A47J31/36, A47J31/06",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2019240811B2,Heat management for food processor,A machine (1) for processing a liquid food substance includes: a jug (20) having a container (21) and delimiting a food cavity (21') for containing the liquid food substance; and a base (10) that has one or more walls (11) forming a seat (11') for removably receiving the container (21). The base (10) and/or the container (21) has one or more thermally insulating spacers (11a) spacing the base wall(s) (11) from thermally conditioned outside container wall(s) (21a) when the container (21) is received in or on the seat (11') so as to prevent or inhibit thermal transfer from the container (21) into the base (10) via the base wall(s) (11) from the container wall(s) (21a) adjacent the base wall(s) (11).,"2019240811   19 Nov 2024
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS : -
<div class=""indep-clm"" num=""1""><seg-main>1. A machine for processing a liquid food substance, the machine comprising:</seg-main>
<seg-clauses>5  - a jug having a container and delimiting a food cavity</seg-clauses>
<seg-clauses class=""seg-enter"">for containing said liquid food substance; and</seg-clauses>
<seg-clauses>- a base that has one or more walls forming a seat configured to removably receive the container,</seg-clauses>
<seg-clauses class=""seg-enter"">the container having at least one outside container wall 10 that can be thermally conditioned by said liquid food substance in the cavity and/or by processing said liquid food substance in the cavity and that faces the base wall (s) when the container is in or on the base seat, wherein the base and/or the container comprises one or 15 more thermally insulating spacers in the form of ribs or protrusions, spacing the base wall(s) from the container wall (s) when the container is received in or on the seat so as to prevent or inhibit thermal transfer from the container into the base via the base wall (s) from the 20 thermally conditioned container wall(s) adjacent the base wall (s) .</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine of claim 1, wherein </seg-main><seg-clauses>the container has a removable lid for covering the cavity.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The machine of claim 1 or claim 2, wherein </seg-main><seg-clauses>the 25 container comprises a thermally radiating or absorbing element.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The  machine of claim 3, wherein </seg-main><seg-clauses>the thermally</seg-clauses>
<seg-clauses class=""seg-enter"">radiating  or absorbing element is an electrically</seg-clauses>
<seg-clauses class=""seg-enter"">resistive element or a thermocouple element.</seg-clauses>
<seg-clauses class=""seg-","A47J41/00, A47J43/046",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12350332B2,Compositions comprising secretory IgA and probiotics,"The present invention relates to methods for producing compositions comprising secretory IgA and one or more probiotics. In particular, the invention relates to methods for producing compositions in which the secretory IgA and one or more probiotics are associated. The invention also relates to compositions obtainable by the methods and uses of the compositions, for example in reducing or preventing a non-viral infection and/or inflammation.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for production of a composition comprising </seg-main><seg-clauses><seg-main>secretory IgA and a probiotic, the method comprising the steps of:</seg-main>
<seg-clauses>(a) providing a source of SIgA in the form of milk or a fraction thereof;</seg-clauses>
<seg-clauses>(b) pasteurizing the milk at a temperature of 82-84° C. for a duration of 5-7 seconds(s); and</seg-clauses>
<seg-clauses>(c) admixing with the probiotic, wherein the admixing is carried out at a temperature of 1-45° </seg-clauses><seg-clauses>C. for a duration of 10-1440 minutes (min).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the admixing of step (c) is carried out at a temperature of 36-38° </seg-clauses><seg-clauses>C. for a duration of 28-32 min.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the amount of secretory IgA per 2×10<sup>7 </sup>CFU of the probiotic in the mixture of step (c) is 0.34 ng-20 μg.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the concentration of the probiotic in the mixture of step (c) is 1×10<sup>6</sup>-1×10<sup>11 </sup>CFU/mL.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the milk provided in step (a) has not been exposed to a temperature of greater than 70° C., following expression.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the probiotic is <i>Bifidobacterium lactis </i>or <i>Bifidobacterium longum </i>subspecies <i>infantis. </i></seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method of claim 1, wherein </seg-main><seg-clauses>the secretory IgA and the probiotic a","A61K39/395, A61K35/745, A61P29/00, A61P31/00, C07K16/04",20250708,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12458054B2,Apparatus and method for roasting coffee beans,"The invention relates to an apparatus (<b>1</b>) and a method for more convenient roasting of coffee beans. The apparatus (<b>1</b>), which is provided for roasting coffee beans, comprises: a chamber (<b>10</b>) in which coffee beans can be received for roasting, wherein the chamber (<b>10</b>) comprises an opening (<b>13</b>), and a device for roasting the coffee beans received in the chamber (<b>10</b>). The chamber (<b>10</b>) is movable with respect to a movement axis into different positions, wherein these positions comprise a roasting position, preferably a bean reception position, and a bean discharge position, wherein in the roasting position the device is arranged to roast the coffee beans received in the chamber (<b>10</b>), in the bean reception position, if present, the chamber (<b>10</b>) is arranged to receive, via the opening (<b>13</b>), coffee beans for subsequent roasting in the roasting position, and in the bean discharge position the chamber (<b>10</b>) is arranged such that the coffee beans can be discharged via the opening (<b>13</b>) from the chamber (<b>10</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for roasting coffee beans, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a chamber in which coffee beans can be received for roasting, wherein the chamber comprises an opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a device comprising a heater to heat air and a fan to transport the heated air into the chamber to roast the coffee beans received in the chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a housing partially surrounding the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a mating part for covering and engaging with the opening in the roasting position in order to close and seal the chamber for roasting the coffee beans such that the heated air flows out of the chamber through the mating part;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the chamber is movable with respect to a movement axis into different positions, wherein these positions comprise a roasting position, a bean discharge position, and a bean reception position, wherein</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>in the roasting position the device is arranged to roast the coffee beans received in the chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>in the bean discharge position the chamber is arranged such that the coffee beans can be discharged via the opening from the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>in the bean reception position the chamber is arranged to receive, via the opening, coffee beans for subsequent roasting in the roasting position, wherein in the bean reception position the chamber is tilted at an angle between the roasting position and the bean discharge position.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The apparatus according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg","A23N12/08, A23F5/04, A23L5/10, A23N12/10, A23N12/12",20251104,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2020286380B2,Recover dietary supplement,"The present invention is directed to a method of replacing collagen broken down during physical activity using a novel dietary supplement. The supplement composition of the present invention comprises collagen, glutamine, taurine, and, optionally, the nine essential amino acids. The uptake of collagen is enhanced using this combination of components to levels substantially near the pre-workout levels.","<div class=""indep-clm"" num=""1""><seg-con>1. A dietary supplement composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>collagen in an amount of about 15-25 grams per serving of the composition, glutamine in an amount of about 0.5-1.5 grams per serving of the composition, and taurine in an amount of about 0.1-0.2 grams per serving of the composition, wherein said serving of the composition is 36-38 grams or 24 fluid ounces, wherein the composition comprises nine essential amino acids selected from the group consisting of: leucine, isoleucine, valine, lysine, phenylalanine, threonine, tryptophan, histidine, and methionine, in a total amount of about 6-10 grams per serving of the composition.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.     The dietary supplement composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is a powder.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3.     The dietary supplement composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is a liquid.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4.     The dietary supplement composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>collagen is present in an amount of</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>about 17-23 grams per serving of the composition, glutamine in an amount of about 0.75-1.25</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>grams per serving of the composition, and taurine in an amount of about 0.125-0.175 grams per serving of the composition.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dietary supplement composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>collagen is present in an amount of about 20 grams per serving of the composition, glutamine in an amount of about 0.97 grams per serving of the composition, and taurin","A61K38/39, A23L33/175, A23L33/18, A61K38/01, A61P21/00",20250626,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN119947592A,Enhancing palatability of dry pet food by fat modification,"The pet food product may include a dry pet food grain; a modified fat comprising a first lipid and further comprising a second lipid such that the modified fat has at least one characteristic increased relative to the first lipid, the at least one increased characteristic selected from the group consisting of hardness, crystallinity, viscosity and solid fat content; a liquid digest on the dry pet food roughage and/or modified fat; and a dry animal digest on at least one of the dry pet food roughage, the modified fat, and the liquid digest.","<div class=""indep-clm"" num=""1"">1.宠物食物产品，所述宠物食物产品包含：</div>
<div class=""indep-clm"" num=""1"">干燥宠物食物粗粮；</div>
<div class=""indep-clm"" num=""1"">改性的脂肪，所述改性的脂肪包含第一脂质并且还包含第二脂质，使得所述改性的脂肪具有相对于所述第一脂质增加的至少一种特性，所述至少一种增加的特性选自硬度、结晶度、粘度和固体脂肪含量；</div>
<div class=""indep-clm"" num=""1"">在所述干燥宠物食物粗粮和/或所述改性的脂肪上的液体消化物；以及</div>
<div class=""indep-clm"" num=""1"">在所述干燥宠物食物粗粮、所述改性的脂肪和所述液体消化物中的至少一种上的干燥动物消化物。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的宠物食物产品，其中所述干燥宠物食物粗粮包含挤出物，所述挤出物包含蛋白质、碳水化合物或脂肪中的至少一种。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的宠物食物产品，其中所述改性的脂肪中的所述第一脂质包含β′结构和/或β结构。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的宠物食物产品，其中所述改性的脂肪中的所述第一脂质是牛脂、猪油或家禽脂肪中的至少一种。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的宠物食物产品，其中所述改性的脂肪中的所述第一脂质包含家禽脂肪。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的宠物食物产品，其中所述改性的脂肪中的所述第二脂质包含β结构或β′结构，优选β结构。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的宠物食物产品，其中所述改性的脂肪中的所述第二脂质包含饱和甘油单酯或棕榈硬脂中的至少一种。</div>
<div class=""indep-clm"" num=""8""><seg-con>8.增强干燥宠物食物粗粮的适口性的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""8""><seg-comp>(a)将改性的脂肪施加在所述干燥宠物食物粗粮上，所述改性的脂肪包含第一脂质并且还包含第二脂质，使得所述改性的脂肪具有相对于所述第一脂质增加的至少一种特性，所述至少一种增加的特性选自硬度、结晶度、粘度和固体脂肪含量；</seg-comp></div>
<div class=""indep-clm"" num=""8""><seg-comp>(b)在步骤(a)的同时或在其后的预定时间内将液体消化物施加至所述干燥宠物食物粗粮和/或所述改性的脂肪；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""8""><seg-comp>(c)在步骤(b)的同时或在其后的预定时间内将干燥消化物施加至所述干燥宠物食物粗粮、所述改性的脂肪和所述液体消化物中的至少一种。</seg-comp></div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的方法，所述方法包括在步骤(a)之前形成所述干燥宠物食物粗粮，其中所述干燥宠物食物粗粮的形成包括挤出蛋白质、碳水化合物或脂肪中的至少一种。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求8或权利要求9所述的方法，其中所述改性的脂肪中的所述第一脂质包含β′结构和/或β结构。</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">11.根据权利要求8至10中任一项所述的方法，其中所述改性的脂肪中的所述第一脂质是牛脂、猪油或家禽脂肪中的至少一种。</div>
<div class=""dep-clm"" num=""12"" parent=""8,9,10,11"">12.根据权利要求8至11中任一项所述的方法，其中所述改性的脂肪中的所述第一脂","A23K10/20, A23K20/147, A23K40/25, A23K40/30, A23K50/42",20250506,雀巢产品有限公司,['Pending']
US20250297083A1,A method for producing a compound comprising a polyhydroxyalcanoate and cellulose,"Process for manufacturing a biodegradable compound, said process comprising the steps of, in order: (i) providing an extruder with at least one rotating screw, at least two feeding units suitable for being fed with ingredients, and an extruder die, (ii) feeding the first feeding unit with a PHA polymer and maleic anhydride (MA), (iii) feeding the second feeding unit with cellulosic fibres, (iv) rotating the screw to mix the PHA and maleic anhydride ingredients and graft said maleic anhydride onto said PHA molecules to form PHA grafted with MA (“PHA-g-MA”) in an amount of 1 to 10%, preferably 1 to 3% of the total content of PHA, and then mixing said PHA-g-MA with cellulosic fibres to form a molten compound of PHA-g-MA and cellulosic fibres, (v) passing said molten compound through said extruder die and shaping said extruded compound into different compound formats.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for manufacturing a biodegradable compound, said compound comprising </seg-main><seg-clauses><seg-main>a mixture of cellulosic fibres and at least one type of polyhydroxyalcanoate polymer (PHA), said process comprising the steps of, in order:</seg-main>
<seg-clauses>(i) providing an extruder comprising a heater, at least one rotating screw, at least two feeding units suitable for being fed with ingredients, and an extruder die, the temperature of said extruder being set between 130° C. and 190° C.,</seg-clauses>
<seg-clauses>(ii) feeding the first feeding unit with a PHA polymer and maleic anhydride (MA), wherein the ratio of maleic anhydride to PHA is comprised between 0.1 and 10,</seg-clauses>
<seg-clauses><seg-main>(iii) feeding the second feeding unit with cellulosic fibres, said cellulosic fibres being hardwood cellulose fibres having a length of 15 μm to 150 μm, and having a density of at least </seg-main><seg-clauses>1.0 g/cm3,</seg-clauses></seg-clauses>
<seg-clauses>(iv) rotating the at least one screw to mix the PHA and maleic anhydride ingredients and graft said maleic anhydride onto said PHA molecules to form PHA grafted with MA (“PHA-g-MA”) in an amount of 1 to 10%, of the total content of PHA, and then mixing said PHA-g-MA with cellulosic fibres to form a molten compound of PHA-g-MA and cellulosic fibres,</seg-clauses>
<seg-clauses>(v) passing said molten compound through said extruder die, and shaping said extruded compound into, a product selected from the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">compound pellets, by cutting said extrudate compound cord with a knife system,</seg-clauses>
<seg-clauses class=""seg-enter"">a compound film or compound plates (in this case, the extruder die takes the form of a cast line), and</seg-clauses>
<seg-clauses class=""seg-enter"">a compound tridimensional item, by injection moulding or extrusion blow-moulding said extruded compound into a ","C08L1/02, B29B9/06, B29B9/14, B29K1/00, B29K67/00",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023359918A1,Sustained release melatonin compositions,"The present invention relates to a composition comprising melatonin encapsulated within a calcium alginate hydrogel. It further provides an orally administrable dosage form comprising such a composition held within a gel, wherein the gel is formed using starch as a gelling agent. Processes to produce these compositions, as well as their use in therapy, are also disclosed.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>melatonin encapsulated within a calcium alginate hydrogel, and optionally further comprising additional melatonin that is not encapsulated by the calcium.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A composition according to claim 1, wherein </seg-main><seg-clauses>the weight ratio of melatonin to calcium alginate hydrogel is from 5:95 to 15:85.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. A composition according to claim 2, wherein </seg-main><seg-clauses>the weight ratio of melatonin to calcium alginate hydrogel is about 10:90</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A composition according to any one of claims 1 to 3, comprising </seg-main><seg-clauses>from 4 to 10 wt % water based on the total weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. A composition according to claim 4, comprising </seg-main><seg-clauses>from 6 to 8 wt % water based on the total weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A composition according to any one of claims 1 to 5, further comprising </seg-main><seg-clauses>sodium and lactate ions.</seg-clauses></div>
<div class=""indep-clm"" num=""7""><seg-main>7. An orally administrable dosage form comprising </seg-main><seg-clauses>a composition according to any one of claims 1 to 6 held within a gel, wherein the gel is formed using starch as a gelling agent.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8. A dosage form according to claim 7, comprising </seg-main><seg-clauses>from 1 to 3 wt % of the composition according to any one of claims 1 to 6 based on the total weight of the dosage form.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""7,8""><seg-main>9. A dosage form according to claim 7 or claim 8, further compr","A61K9/00, A61K9/14, A61K47/34, A61K47/36",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12166374B2,Low power standby circuit,"Standby circuit for an electric appliance, the standby circuit comprising: an AC power input for connection to an AC power source, for example to the mains; an AC power output for connection to a control circuit of an electric appliance; a control circuit power line connecting the AC power input to the AC power output, the control circuit power line comprising a control circuit power switch for closing and opening the control circuit power line; a logic device for controlling the control circuit power switch; an auxiliary AC to DC converter connected to the AC power input for supplying DC power to the logic device when the control circuit power line is open; a power-on AC to DC converter connected to the AC power output for supplying DC power to the logic device when the control circuit power line is closed; one or more passive and/or active input components for sensing an input of a user of said electric appliance and generating a corresponding signal; wherein the logic device is configured to receive the signal from the one or more passive and/or active input components, and to control the control circuit power switch based on this signal. Electric appliance comprising such a standby circuit and method for bringing such an appliance from its standby mode to its operative mode.","<div class=""indep-clm"" num=""1""><seg-con>1. A standby circuit for an electric appliance, the standby circuit </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>an alternating current (AC) power input for connection to an AC power source,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an AC power output for connection to a control circuit of an electric appliance,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control circuit power line connecting the AC power input to the AC power output, the control circuit power line comprising a control circuit power switch for closing and opening the control circuit power line;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a logic device for controlling the control circuit power switch;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an auxiliary AC to direct current (DC) converter connected to the AC power input for supplying DC power to the logic device when the control circuit power line is open;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a power-on AC to DC converter connected to the AC power output for supplying DC power to the logic device when the control circuit power line is closed;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>one or more passive and/or active input components for sensing an input of a user of the electric appliance and generating a corresponding signal; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the logic device is configured to receive the corresponding signal from the one or more passive and/or active input components, and to control the control circuit power switch based on the corresponding signal,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the standby circuit further comprises a communication interface for communicating with the control circuit of the electric appliance when the control circuit is powered on, wherein the communication interface","H02J1/10, A47J31/52, H02J9/00",20241210,SOCIETE DES PRODUITS NESTLE S.A,['Active']
US20250248422A1,Emulsion comprising vitamin d or its derivatives having improved stability,,"<div class=""indep-clm"" num=""1""><seg-con>1. An emulsion </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 0.0000002% and 0.1% by weight of vitamin D or its derivatives with respect to the total weight of emulsion,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 0.0001% and 10% by weight of triglyceride with respect to the total weight of emulsion, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>between 0.01% to 50% by weight of hydrocolloid with respect to the total weight of emulsion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The emulsion according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the triglyceride is a medium chain triglyceride.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The emulsion according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hydrocolloid is selected from the group consisting of polysaccharides including <i>acacia </i>gum, xanthan gum, gelatin, carrageenan gum, gellan gum, karaya gum, larch gum, dextran, chitosan, alginate, hyaluronic acid, guar gum, pectin, cellulose, tara gum, tamarind gum, ghatti gum, curdlan gum, konjac glucomannan, scleroglucan, pullulan, agar, tragacanth gum, <i>Portulaca oleracea </i>gum, galactomannan, pectin, starch or modified starch, cellulose derivative and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The emulsion according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said emulsion further comprises a monoglyceride or its derivatives.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The emulsion according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the monoglyceride is an unsaturated monoglyceride.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4""><seg-con>6. The emulsion according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg","A23L2/52, A23D7/005, A23D7/01, A23D9/013",20250807,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2839183C1,Beverage preparation device with device housing and liquid tank made with possibility of disconnection,"FIELD: beverage preparation devices.SUBSTANCE: device includes a device housing enclosing functional elements of the device. Functional elements of the device include circulation tubes for liquid, a pump for liquid transfer, a liquid heater and a cooking chamber for beverage preparation. Device also includes liquid tank made with possibility of disconnection for movement along axis of movement. In the inserted position, the tank is completely functionally inserted inside the device housing so that liquid can be supplied by means of a pump for liquid pumping from the liquid tank through the liquid circulation tubes and through the liquid heater into the cooking chamber for the beverage preparation. Device body includes a first hole and a second hole, which are located on opposite sections of device body wall. When the liquid tank is in the inserted position, the first opening is configured to open a part of the liquid tank such that, as a result of pushing said open part of the liquid tank, the liquid tank moves along the axis of movement and from the inserted position through said second opening. Beverage preparation device additionally includes the first connector located at least partially in the device body and the second connector located at least partially on the liquid tank. In the inserted position of the liquid tank, the first connector and the second connector are connected to each other for supplying liquid from the liquid tank. First connector includes a distal end with a connecting hole. First connector is made so that the connecting hole opens in the direction parallel to the axis of movement.EFFECT: providing a beverage preparation device that is more compact and easier to refill with a liquid.14 cl, 15 dwg","1. Устройство (1) для приготовления напитков, включающее:
- корпус (2) устройства, охватывающий функциональные элементы (6) устройства, причем функциональные элементы (6) устройства включают в себя по меньшей мере циркуляционные трубки для жидкости, насос для перекачки жидкости, нагреватель жидкости и варочную камеру для приготовления напитка; и
- бак (7) для жидкости, выполненный с возможностью отсоединения для перемещения вдоль оси перемещения, чтобы во вставленном положении бак был полностью функционально вставлен внутрь корпуса (2) устройства так, чтобы обеспечить подачу жидкости с помощью насоса для перекачки жидкости из бака (7) для жидкости по циркуляционным трубкам для жидкости и через нагреватель жидкости в варочную камеру для приготовления напитка для смешивания жидкости с содержащимся в ней ингредиентом напитка для приготовления напитка,
при этом корпус (2) устройства включает в себя первое отверстие (51) и второе отверстие (41), которые расположены на противоположных участках (4, 5) стенки корпуса (2) устройства, и
при этом, когда бак (7) для жидкости находится во вставленном положении, первое отверстие (51) выполнено с возможностью открытия части бака (7) для жидкости таким образом, что в результате проталкивания упомянутой открытой части бака (7) для жидкости бак (7) для жидкости перемещается вдоль оси перемещения и из вставленного положения через упомянутое второе отверстие (41),
при этом устройство (1) для приготовления напитков дополнительно включает в себя первый соединитель (9), расположенный по меньшей мере частично в корпусе (2) устройства, и второй соединитель (10), расположенный по меньшей мере частично на баке (7) для жидкости, причем во вставленном положении бака (7) для жидкости первый соединитель (9) и второй соединитель (10) соединены друг с другом для подачи жидкости из бака (7) для жидкости, при этом первый соединитель (9) включает в себя дистальный конец (91) с соединительным отверстием (93), причем первый соединитель (9) выполнен так,",A47J31/44,20250428,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025045657A1,Compositions comprising human milk oligosaccharides for use in a subject to support brain development and/or social-emotional development,"The invention provides a fucosylated human milk oligosaccharide (HMO) for use in improving brain development and/or social-emotional development in a subject, wherein the fucosylated HMO is 3-fucosyllactose (3-FL), and wherein the subject is an infant, a young child or a child.","Claims
<div class=""indep-clm"" num=""1""><seg-con>1 . A fucosylated human milk oligosaccharide (HMO) for use in improving brain development and/or social-emotional development in a subject, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fucosylated HMO is 3- fucosyllactose (3-FL), and wherein the subject is an infant, a young child or a child.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fucosylated HMO for use in improving brain development and/or social-emotional development in a subject, wherein the fucosylated HMO is 3-fucosyllactose (3-FL), and wherein the subject is an infant, a young child or a child.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The fucosylated HMO for use according to claim 1 or the nutritional composition for use according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the infant is at least 5 months old.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The fucosylated HMO for use according to claim 1 or claim 3, or the nutritional composition for use according to claim 2 or claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improvement in brain development and/or social-emotional development in the subject comprises or consists of an improvement in the development of brain network(s) associated with social-emotional functions.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The fucosylated HMO for use according to any one of claims 1 , 3, or 4, or the nutritional composition for use according to any one of claims 2 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>improving brain development and/or social-emotional development in the subject comprises or consists of promoting the default mode network (DMN).</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5""><seg-con>6. The nutritional composition for use according to","A23L33/00, A23L33/21",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2024261216A1,Compositions and methods using a mint concentrate for cellular energy,"Compositions comprising a peppermint concentrate are provided. The compositions can be administered to an individual in need thereof for (i) improving a physiological state linked to metabolic fatigue in one or more cells, and/or (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and/or (iii) enhancing mitochondrial function, and /or (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the compositions can be administered for treating or preventing a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a mint concentrate, in an effective amount for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, and/or </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and/or </seg-clauses><seg-clauses>(iii) enhancing mitochondrial function, and/or </seg-clauses><seg-clauses><seg-main>(iv) treating or preventing a calcium deficiency / depletion disorder in an individual, wherein the mint concentrate is obtainable or obtained by the process comprising the steps of: </seg-main><seg-clauses>a) suspending a mint material in an aqueous liquid to form a mint material suspension, </seg-clauses><seg-clauses>b) blending the mint material suspension to obtain a mint material slurry, </seg-clauses><seg-clauses>c) applying a physical mean on the mint material slurry to separate and obtain a mint concentrate, </seg-clauses><seg-clauses>d) optionally, drying the mint concentrate. </seg-clauses></seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to any one of the preceding claims, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue, muscle weakness, lack of vitality, weakness or lack of energy, in particular lack of physical energy. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according to any one of preceding claims, wherein </seg-main><seg-clauses>the effect","A23L2/02, A23L2/52, A23L33/10, A23L33/105, A23L33/15",20241226,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250182847A1,method,"A method for generating a biological clock including a DNA methylation profile which is suitable for use with at least two different sample types, the method includes: (i) providing a first set of DNA methylation profiles generated from the at least two different sample types from a plurality of subjects; (ii) generating a composite DNA methylation profile from the first set of DNA methylation profiles, wherein the composite DNA methylation profile comprises methylation sites that have a matched status in the different sample types; and (iii) using the composite DNA methylation profile to generate a biological clock using reference DNA methylation profiles from one of the at least two sample types.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for generating a biological clock comprising </seg-main><seg-clauses><seg-main>a DNA methylation profile which is suitable for use with at least two different sample types, the method comprising:</seg-main>
<seg-clauses>(i) providing a first set of DNA methylation profiles generated from the at least two different sample types from a plurality of subjects;</seg-clauses>
<seg-clauses>(ii) generating a composite DNA methylation profile from the first set of DNA methylation profiles, wherein the composite DNA methylation profile comprises methylation sites that have a matched status in the at least two different sample types;</seg-clauses>
<seg-clauses>(iii) using the composite DNA methylation profile to generate a biological clock using reference DNA methylation profiles from at least of one of the at least two sample types.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 wherein </seg-main><seg-clauses><seg-main>step (ii) comprises comparing the first set of DNA methylation profiles and:</seg-main>
<seg-clauses>(1) including a methylation site in the composite DNA methylation profile if the methylation site has a matched status in the DNA methylation profiles from the at least two different sample types; and/or</seg-clauses>
<seg-clauses>(2) excluding a methylation site from the composite DNA methylation profile if the methylation site does not have a matched status in the DNA methylation profiles from the at least two different sample types.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1 wherein </seg-main><seg-clauses>a matched DNA methylation site has a substantially identical methylation status in the at least two different sample types.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1 wherein </seg-main><seg-clause","G16B20/10, C12Q1/6874, C12Q1/6883, G16B30/00, G16B40/20",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120201930A,Edible plant-based paste and method for producing edible plant-based paste,"The present invention relates to an edible plant-based paste comprising soybean with good organoleptic properties. In particular, the edible plant-based paste comprises at least 15% by weight of soybean, vegetable oil and hard fat in a weight ratio of 4: 1 to 14: 1, and at least one food grade polyglycerol ester. The invention also relates to a method for producing such an edible plant-based paste.","<div class=""indep-clm"" num=""1"">1.可食用植物基糊状物，所述可食用植物基糊状物包含：</div>
<div class=""indep-clm"" num=""1"">-至少15重量％的大豆，优选30％的大豆，</div>
<div class=""indep-clm"" num=""1"">-重量比为4：1至14：1的植物油与硬脂肪，其中所述硬脂肪具有80℃或更低的熔点，</div>
<div class=""indep-clm"" num=""1"">-至少一种食品级聚甘油酯，优选聚甘油聚蓖麻油酸酯(PGPR)。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的可食用植物基糊状物，所述可食用植物基糊状物还包含不同于大豆的油籽。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的可食用植物基糊状物，所述可食用植物基糊状物包含至少10重量％、优选10重量％至70重量％、更优选10重量％至40重量％的不同于大豆的油籽。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3所述的可食用植物基糊状物，其中所述不同于大豆的油籽选自由以下组成的列表：甜瓜籽、芝麻籽、葵花籽或其混合物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物包含0.5重量％至3.5重量％的食品级聚甘油酯。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物不含卵磷脂。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的可食用植物基糊状物，其中所述硬脂肪具有40℃至80℃的熔点。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物包含固体甜味剂，优选蔗糖。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求9所述的可食用植物基糊状物，所述可食用植物基糊状物包含6重量％至30重量％的固体甜味剂，优选蔗糖。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物包含至少30重量％、30重量％至60重量％、优选35重量％至45重量％的脂肪。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的可食用植物基糊状物，其中大豆与总脂肪的比率为0.2至0.9。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的可食用植物基糊状物，其中所述可食用植物基糊状物的所述脂肪仅由植物脂肪组成。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物具有低于200微米的D90粒度。</div>
<div class=""dep-clm"" num=""14"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13"">14.根据前述权利要求中任一项所述的可食用植物基糊状物，所述可食用植物基糊状物在20℃和300s-1的剪切速率下具有2000mPa.s至15000mPa.s的粘度。</div>
<div class=""indep-clm"" num=""15""><seg-con>15.用于生产可食用植物基糊状物的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""15""><seg-refi>a)提供大豆、优选完整的大豆的步骤，</seg-refi></div>
<div c",A23D7/00,20250624,雀巢产品有限公司,['Pending']
RU2839600C1,Roasting apparatus,"FIELD: food industry.SUBSTANCE: invention relates to coffee industry. Disclosed is apparatus (10) for roasting coffee beans, comprising housing (4), roasting chamber (1) having lower opening (11) and upper opening (12), air supply working member (2), configured to actuate air inside the roasting chamber through the lower opening of said chamber, heater (3) located under the lower opening of the chamber, collector (6) of smoke and particles configured to collect smoke and particles from upper opening (12) of the roasting chamber, wherein roasting chamber (1) is attached to housing (4) with possibility of removal, wherein lower opening (11) of roasting chamber is combined with opening (41) for outlet of hot air in housing, and upper opening (12) of the roasting chamber is combined with collector (6) of smoke and particles, when the roasting chamber is attached to the housing, system (5) for fixing the chamber for attachment of the roasting chamber to the housing with possibility of removal.EFFECT: invention makes it possible to provide an apparatus for frying with an improved system for fixing the roasting chamber.4 cl, 9 dwg","1. Аппарат (10) для обжаривания кофейных зерен, содержащий:
корпус (4),
обжарочную камеру (1), имеющую нижнее отверстие (11) и верхнее отверстие (12);
рабочий орган (2) подачи воздуха, выполненный с возможностью приведения в движение воздуха внутри обжарочной камеры через нижнее отверстие упомянутой камеры;
нагреватель (3), расположенный под нижним отверстием камеры, причем упомянутый нагреватель выполнен с возможностью нагрева воздуха, приводимого в движение внутри обжарочной камеры;
причем рабочий орган подачи воздуха и нагреватель расположены внутри корпуса (4), и при этом корпус содержит отверстие (41) для выпуска горячего воздуха, выполненное с возможностью обеспечения прохождения горячего воздуха из корпуса в нижнее отверстие (11) камеры;
коллектор (6) дыма и частиц, выполненный с возможностью сбора дыма и частиц из верхнего отверстия (12) обжарочной камеры;
причем обжарочная камера (1) прикреплена к корпусу (4) с возможностью извлечения, при этом нижнее отверстие (11) обжарочной камеры объединено с отверстием (41) для выпуска горячего воздуха в корпусе, а верхнее отверстие (12) обжарочной камеры объединено с коллектором (6) дыма и частиц, когда обжарочная камера прикреплена к корпусу;
систему (5) фиксации камеры для крепления обжарочной камеры к корпусу с возможностью извлечения, причем упомянутая система (5) фиксации камеры содержит:
нижнее устройство (51) для соединения нижнего отверстия (11) камеры с отверстием (41) для выпуска горячего воздуха в корпусе, причем упомянутое нижнее устройство выполнено с возможностью приема нижней части (1a) камеры и удержания камеры;
верхнее крепежное устройство (52) для соединения верхнего отверстия (12) камеры с коллектором (6) дыма и частиц, причем упомянутое верхнее крепежное устройство содержит:
соединительный канал (521), выполненный с возможностью перемещения и с возможностью соединения верхнего отверстия (12) камеры с коллектором (6) дыма и частиц, причем положение соединительного канала (521), выполненного с возмож",A23N12/08,20250506,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2024270313A1,Methods and composition for palatable pet foods,"Pet food compositions and methods of making such pet food compositions are disclosed including utilizing a palatant selected from the group consisting of dimethyl sulphide, isoamyl alcohol, 2-methyloxolan-3-one, 2,5-dimethylpyrazine, 2-ethyl-3,5-dimethylpyrazine, furfural, furfuryl alcohol, and combinations thereof, wherein the composition has at least one combination of compounds as provided in Table 10 in ratios as provided in Table 10.","<div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a palatant selected from the group consisting of dimethyl sulphide, isoamyl alcohol, 2-methyloxolan-3-one, 2,5-dimethylpyrazine, 2-ethyl-3,5-dimethylpyrazine, furfural, furfuryl alcohol, and combinations thereof, wherein the composition has at least one combination of compounds as provided in Table 10 in ratios as provided in Table 10:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Table 10</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Combination Compounds Ratio 1 Dimethyl sulphide to 2-Acetylthiophene >3.5 Isoamyl alcohol to Tetrahydrothiophen-3-one >5 2 Dimethyl sulphide to 2-Acetylthiophene >3.5 2-methyloxolan-3-one to Tetrahydrothiophen-3-one >5 3 Isoamyl alcohol to Tetrahydrothiophen-3-one >5 2,5-Dimethylpyrazine to 2-Heptanone >1.5 4 2-methyloxolan-3-one to Tetrahydrothiophen-3-one >5 2,5-Dimethylpyrazine to 2-Heptanone >1.5 5 Isoamyl alcohol to Tetrahydrothiophen-3-one >5 2,5-Dimethylpyrazine to 2-Heptanone >1.5 6 2,5-Dimethylpyrazine to 2-Heptanone >1.5 2,5-Dimethylpyrazine to Tetrahydrothiophen-3-one >25 7 Dimethyl sulphide to 2-Acetylthiophene >3.5 2,5-Dimethylpyrazine to Tetrahydrothiophen-3-one >25 8 2,5-Dimethylpyrazine to 2-Heptanone >1.5 2,5-Dimethylpyrazine to 2-Acetylthiophene >6 9 Dimethyl sulphide to 2-Acetylthiophene >3.5 2,5-Dimethylpyrazine to 2-Acetylthiophene >6 10 2,5-Dimethylpyrazine to 2-Acetylthiophene >6 2-Ethyl-3,5-dimethylpyrazine to Dimethyl trisulphide >0.15 11 2,5-Dimethylpyrazine to Tetrahydrothiophen-3-one >25 2-Ethyl-3,5-dimethylpyrazine to Dimethyl trisulphide >0.15</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>12 2,5-Dimethylpyrazine to 2-Heptanone >1.5 2-Ethyl-3,5-dimethylpyrazine to Dimethyl trisulphide >0.15 13 2-methyloxolan-3-one to Tetrahydrothiophen-3-one >5 2-Ethyl-3,5-dimethylpyrazine to Dimethyl trisulphide >0.15 14 Isoamyl alcohol to Tetrahydrothiophen-3-one >5 2-","A23K20/105, A23K20/121, A23K20/137, A23K50/48",20250911,SOCIETE DES PRODUITS NESTLE SA,['Pending']
US12478209B2,Beverage preparation device with thermally optimised architecture,,"<div class=""indep-clm"" num=""1""><seg-main>1. A capsule processing machine for preparing a beverage from a capsule having </seg-main><seg-clauses>a body containing a flavouring ingredient, by passing water into the capsule to be mixed with the flavouring ingredient in the capsule, the capsule processing machine comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">a beverage processing unit having:</seg-clauses>
<seg-clauses class=""seg-enter"">a holder delimiting a receiving space for receiving the capsule;</seg-clauses>
<seg-clauses class=""seg-enter"">a cover for covering the holder, the cover and the holder being relatively movable between:</seg-clauses>
<seg-clauses class=""seg-enter"">an open position for placing the capsule into the receiving space and/or removing the capsule from the receiving space; and</seg-clauses>
<seg-clauses class=""seg-enter"">a closed position for preparing the beverage from the capsule in the receiving space;</seg-clauses>
<seg-clauses class=""seg-enter"">a beverage outlet arrangement extending between the holder and the cover and/or through the cover, the beverage outlet arrangement configured to deliver the beverage from the processing unit; and</seg-clauses>
<seg-clauses class=""seg-enter"">a water inlet extending through the cover and configured to guide the water into the receiving space, wherein the water is mixed with the flavouring ingredient in the capsule to form the beverage in the receiving space; and</seg-clauses>
<seg-clauses class=""seg-enter"">a thermal conditioner, wherein a body of the thermal conditioner forms a conditioner cavity that defines or contains at least a part of the cover,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the body of the thermal conditioner forms a beverage collecting surface, and wherein the machine further comprises a discharge arrangement configured to guide the beverage from the beverage collecting surface to a dispensing area configured to receive a user-receptacle for collecting the bevera","A47J31/36, A47J31/06, A47J31/22, A47J31/54",20251125,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
MX374200B,Method and device for producing a fiber composite material,,,B29B15/12,20250305,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025093461A1,Method of determining the health status of a dog,"The present invention provides a method for determining a biological age, mortality risk and/or probability of a healthy lifespan of a dog; said method comprising: a) determining a biological age, mortality risk and/or probability of a healthy lifespan of the dog using the level of one or more biomarker(s) in one or more samples obtained from the dog, wherein the one or more biomarker(s) is selected from white blood cell count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, serum globulin, serum calcium, platelet count, and/or red blood cell count; and b) determining a biological age, mortality risk and/or probability of a healthy lifespan for the dog using a DNA methylation profile from the dog.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a biological age, mortality risk and/or probability of a healthy lifespan of a dog; said method comprising using </seg-main><seg-clauses>(i) the level of one or more biomarker(s) in one or more samples obtained from the dog, and </seg-clauses><seg-clauses>(ii) a DNA methylation profile from the dog to determine a biological age, mortality risk and/or probability of a healthy lifespan of the dog; wherein the one or more biomarkers are selected from white blood cell count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, serum globulin, serum calcium, platelet count, and/or red blood cell count.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 ; wherein </seg-main><seg-clauses><seg-main>said method comprises: </seg-main><seg-clauses>a) determining a biological age, mortality risk and/or probability of a healthy lifespan of the dog using the level of one or more biomarker(s) in one or more samples obtained from the dog, wherein the one or more biomarker(s) is selected from white blood cell count, serum albumin, serum alkaline phosphatase, serum creatine kinase, haemoglobin, haematocrit, mean corpuscular haemoglobin, serum glucose, mean red cell volume, serum globulin, serum calcium, platelet count, and/or red blood cell count; and </seg-clauses><seg-clauses>b) determining a biological age, mortality risk and/or probability of a healthy lifespan for the dog using a DNA methylation profile from the dog.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The method according to claim 2 wherein </seg-main><seg-clauses>the biological age, mortality risk and/or probability of a healthy lifespan of the dog determined in step a) and the biological age, mortality risk and/or probability of a healthy lifes","C12Q1/6883, G01N33/50, G16H50/30",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
TW202515797A,Capsule for the preparation of a beverage,"A biodegradable and/or compostable capsule for use with a beverage preparation machine for preparing a beverage and/or foodstuff thereof is disclosed. The capsule comprises a cup-shaped body and a closing membrane for closing the cup-shaped body, both elements defining a closed cavity for a beverage and/or foodstuff ingredient, preferably roast and ground coffee, and a liner or a coating having barrier function, providing barrier function to the cup-shaped body. The cup-shaped body is made of cellulose-based material, preferably molded pulp-based material and comprises a bottom wall, a tubular lateral side wall, an annular flange connected to the lateral wall for the closing membrane to seal thereon, and an outwardly extending rim portion connected to the annular flange. The annular flange is made of cellulose-based material and comprises a first portion in which the cellulose-based material has a porosity comprised between","<div class=""indep-clm"" num=""1""><seg-con>1. 一種與一飲料製備機器(10)一起使用以製備其飲料及/或食物之膠囊，該膠囊係可生物降解及/或可堆肥的，且</seg-con><seg-trans>包括： </seg-trans><seg-refi>一杯形本體(1)及用於閉合該杯形本體(1)之一閉合膜(2)，該杯形本體(1)及該閉合膜(2)界定用於固持一飲料及/或食物成分之一閉合空腔，該飲料及/或食物成分較佳地為烘焙及研磨咖啡；及一本體襯墊(20)或具有障壁功能之一塗層，其為該杯形本體(1)提供障壁功能； 該杯形本體(1)由纖維素基材料製成，較佳地由紙漿基材料製成，且包括一底壁(4)、一管狀側壁(5)、連接至該側壁(5)以供該閉合膜(2)密封於其上之一環形凸緣(3)，及連接至該環形凸緣(3)之一向外延伸之邊緣部分(6)， 其特徵在於 該環形凸緣(3)由纖維素基材料製成，且包括一第一部分(3A)，其中該纖維素基材料具有包括在介於30%與70%之間、較佳地介於50%與70%之間之一孔隙度， 該環形凸緣(3)之該第一部分(3A)與該飲料製備機器(10)之一膠囊圍封構件(9)之一邊緣(8)協作，用於改進在飲料製備期間之密封性。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. 如請求項1之膠囊，其中該環形凸緣(3)之該第一部分(3A)自該側壁(5)延伸，並且與該膠囊之該側壁(5)及該環形凸緣(3)兩者一體成形。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. 如請求項1或2中任一項之膠囊，其中該第一部分(3A)在該環形凸緣(3)上延伸包括在介於0.4 mm與0.9 mm之間、較佳地介於0.5 mm與0.75 mm之間之一徑向距離(d1)。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. 如前述請求項中任一項之膠囊，其中該第一部分(3A)具有包括在介於0.9 mm與1.5 mm之間之一厚度，該厚度大於該側壁(5)之厚度。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5. 如前述請求項中任一項之膠囊，其中該第一部分(3A)具有包括在介於0.2 g/cm3與1 g/cm3之間、較佳地介於0.4 g/cm3與1 g/cm3之間、更佳地介於0.6 g/cm3與1 g/cm3之間、最佳地介於0.8 g/cm3與1 g/cm3之間之該纖維素基材料之一密度。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. 如前述請求項中任一項之膠囊，其中該環形凸緣(3)進一步包括鄰近該第一部分(3A)並自該第一部分向外延伸之一第二部分(3B)，該第二部分(3B)具有包括在介於0.4 mm與0.8 mm之間、較佳地介於0.5 mm與0.7 mm之間之一厚度，且自該第一部分(3A)開始延伸包括在介於0.5 mm與0.9 mm之間之一徑向距離(d2)。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7. 如請求項6之膠囊，其中該第二部分(3B)具有小於40%之所包括的該纖維素基材料之一孔隙度。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. 如前述請求項中任一項之膠囊，其中該邊緣部分(6)由纖維素基材料與該環形凸緣(3)一體地製成，且包括一捲曲或彎曲的端部部分(6A)，該捲曲或彎曲的端部部分包括一處理區域(6B)，其中該纖維素基材料具有小於40%、較佳地介於0%至25%之間之一孔隙度。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9. 如請求項8之膠囊，其中該處理區域(6B)係一壓縮區域，較佳地處於一玻璃態。</div>
<div class=""dep-clm"" num=""10"" parent=""6,7,8,9"">10. 如請求項6或7中任一項與如請求項8或9中任一項組合之膠囊，其中該處理區域(6B)部分地或完全地延伸至該環形凸緣(3)之該第二部分(3B)上。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11. 如前述請求項中任一項之膠囊，其中該杯形本體(1)由包括至少50%、較佳地範圍自80%至100%之重量百分比之纖維素纖維之纖維素紙漿製成。</div>
<div class=""de","B65D85/804, A23P10/30, B65D65/46",20250416,瑞士商雀巢製品股份有限公司,['Pending']
CN119799025A,Paper-plastic container and preparation method thereof,"The invention provides a paper-plastic container and a preparation method thereof. The paper-plastic container provided by the embodiment of the invention comprises the following components in percentage by mass: 55-65% of sugarcane fiber and 35-45% of wood fiber. According to the paper-plastic container disclosed by the embodiment of the invention, the raw materials are renewable, and the paper-plastic container has good degradability, does not pollute the environment and has relatively high mechanical strength.","<div class=""indep-clm"" num=""1""><seg-con>1.一种纸塑容器，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述纸塑容器按质量分数计包括：55％至65％的甘蔗纤维及35％至45％的木纤维。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的纸塑容器，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述纸塑容器包括：</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>纸塑杯体，所述纸塑杯体具有一端开口的容置腔，所述容置腔用于容纳目标物；</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>纸塑外沿，所述纸塑外沿环绕所述纸塑杯体的所述开口的外周设置，且所述纸塑外沿与所述纸塑杯体弯折相连；以及</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>纸塑凸台，所述纸塑凸台设置于所述纸塑外沿背离所述纸塑杯体的一侧且环绕所述纸塑外沿的外周设置；</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>其中，所述纸塑杯体、所述纸塑外沿、所述纸塑凸台为一体结构，所述纸塑凸台的厚度大于所述纸塑杯体的厚度，所述纸塑杯体的厚度大于所述纸塑外沿的厚度。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3.根据权利要求1所述的纸塑容器，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述纸塑容器承放100℃的液体时，5000rad/min至8000rad/min的转速进行旋转，可耐受60s至180s的旋转。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4.根据权利要求1所述的纸塑容器，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述纸塑容器采用凹模吸浆，并经定型、热压后制得。</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5.一种纸塑容器的制备方法，</seg-con><seg-trans>其特征在于，</seg-trans><seg-comp>包括：</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>提供吸浆模及纸塑浆料，其中，所述纸塑浆料包括甘蔗纤维及木纤维，所述纸塑浆料中，所述甘蔗纤维与所述木纤维的质量比的范围为55:45至65:35；</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>将所述吸浆模置于所述纸塑浆料中进行吸浆，进行定型后，得到纸塑坯件；以及</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>对所述纸塑坯件进行热压，得到所述纸塑容器。</seg-comp></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的纸塑容器的制备方法，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述吸浆模为凹模，所述吸浆模具有凹模腔。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7.根据权利要求6所述的纸塑容器的制备方法，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述吸浆模包括吸浆模体、第一网面及第二网面；所述吸浆模体具有所述凹模腔，所述第一网面及所述第二网面依次层叠设置在围合成所述凹模腔的侧壁的表面，所述吸浆模体具有位于所述凹模腔的且间隔设置的多个第一通孔，所述第一网面具有间隔设置的多个第一网孔，所述第二网面具有间隔设置的多个第二网孔，所述第一通孔的孔径大于所述第一网孔的孔径，所述第一网孔的","C08L97/02, A47G19/22, A47G19/03, D21J5/00, D21H11/00",20250411,雀巢产品有限公司,['Pending']
WO2025132325A1,Method for preparing milk based liquid,"The invention concerns a method for producing a milk-based liquid in a beverage preparation apparatus, said apparatus comprising : - at least one mixing chamber configured for producing a liquid by receiving and mixing a dose of soluble powder with water and by dispensing the reconstituted liquid, wherein the method comprises the steps of : - producing a first part of the milk based liquid by supplying the mixing chamber with a dose of soluble dairy milk powder and water so as to reconstitute a dairy milk and dispensing said first part made of dairy milk, and - producing a second part of the milk based liquid by supplying the mixing chamber with a dose of soluble plant-based milk powder and water so as to reconstitute a plant based milk and dispensing the second part made of plant-based milk, wherein the first and the second parts of the milk based liquid are mixed together to form the final milk based liquid.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Method for producing a milk based liquid in a beverage preparation apparatus (100, 101 ), said apparatus comprising :</seg-main>
<seg-clauses>- at least one supply of soluble plant-based milk powder or concentrate,</seg-clauses>
<seg-clauses>- at least one supply of soluble dairy milk powder or concentrate,</seg-clauses>
<seg-clauses>- a water supply system,</seg-clauses>
<seg-clauses><seg-main>- at least one mixing chamber (1 ) configured for producing a liquid by receiving and mixing a dose of soluble powder or concentrate with water and by dispensing the reconstituted liquid, wherein the method comprises the steps of :</seg-main>
<seg-clauses>- producing a first part of the milk based liquid by supplying the mixing chamber with a dose of soluble dairy milk powder or concentrate and water so as to reconstitute a dairy milk and dispensing said first part made of dairy milk, and</seg-clauses>
<seg-clauses>- producing a second part of the milk based liquid by supplying the mixing chamber with a dose of soluble plant-based milk powder or concentrate and water so as to reconstitute a plant based milk and dispensing the second part made of plant-based milk, wherein the first and the second parts of the milk based liquid are mixed together to form the final milk based liquid.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to Claim 1 , wherein </seg-main><seg-clauses>the first part of the milk based liquid represents 30 to 70 % in volume of the final milk based liquid, preferably 50 to 70 % in volume.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Method according to Claim 1 or 2, wherein :</seg-main>
<seg-clauses>- in a first step, the first part of the milk based liquid is produced and dispensed in a container (10), and</seg-clauses>
<seg-clauses>- in a second step, the second part of the milk based liquid is produced and dispensed in t",A47J31/40,20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250326564A1,"Actuator nozzle for aerosol packaging, and methods of making and using such actuator nozzles and aerosol packagings","An actuator nozzle has a lower portion comprising a base configured to connect to a container, and the base includes a lower orifice. The actuator nozzle also has an upper portion including a tapered section on one side of the upper portion, the tapered section tapers inward as the tapered section extends upward from the lower portion, the upper portion further having a substantially vertical section on an opposite side of the upper portion from the tapered section. The actuator nozzle also has an upper orifice in fluid communication with the lower orifice by an interior channel of the actuator nozzle, the upper orifice angled downward from a top of the tapered section of the upper portion to a top of the substantially vertical section of the upper portion.","<div class=""indep-clm"" num=""1""><seg-con>1. An actuator nozzle </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a lower portion comprising a base configured to connect to a container, the base comprising a lower orifice;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an upper portion comprising a tapered section on one side of the upper portion, the tapered section tapers inward as the tapered section extends upward from the lower portion, the upper portion further comprising a substantially vertical section on an opposite side of the upper portion from the tapered section; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an upper orifice in fluid communication with the lower orifice by an interior channel of the actuator nozzle, the upper orifice angled downward from a top of the tapered section of the upper portion to a top of the substantially vertical section of the upper portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The actuator nozzle of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the upper orifice has a shape that is oval or semi-circle and has a maximum width at or adjacent to the top of the tapered section.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The actuator nozzle of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lower portion of the actuator nozzle is substantially symmetrical throughout an entirety of the height of the lower portion.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The actuator nozzle of claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>one or more pressure points configured to actuate and/or permit actuation of a valve on which the actuator nozzle is mounted.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The actuator nozzle of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more pressure points are po","B65D83/28, B65D83/16",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2849974C2,"Device for preparing a beverage, system containing such a device, method of preparation in such a device and use of capsules for preparing a beverage","FIELD: devices for preparing beverages.SUBSTANCE: group of inventions relates to a device for preparing beverages, to a system containing such a device, to a method of preparation in such a device, and to the use of a capsule for preparing beverages. The device is designed to prepare a beverage from a flavouring ingredient supplied inside a capsule in a processing chamber by mixing it with water and centrifuging them around a processing axis. The device has a manipulation system comprising a first ingredient manipulator and a second ingredient manipulator, which are designed to be movable relative to each other from a capsule transfer configuration to a capsule processing configuration. The manipulation system has a beverage outlet(s) and water supply fitting(s), wherein the outlet(s) and/or fitting(s) are connected to a capsule opening device having an opening edge and an opening direction for the capsule, along which the opening edge and the capsule move relative to each other to open the capsule (5b) with the opening edge. The opening device limits a channel for a fluid medium located in the opening direction behind the opening edge.EFFECT: improved control of the extraction process.35 cl, 14 dwg","1. Устройство (1) для приготовления напитка (4) из вкусоароматического ингредиента (5a), подаваемого внутри капсулы (5b) в полость (5) обработки, путем смешивания упомянутого ингредиента (5a) с водой (4’) в упомянутой капсуле (5b) и центробежного приведения в движение такого ингредиента (5a) и упомянутой воды (4’) вокруг оси (30’) обработки с образованием упомянутого напитка (4), причем устройство (1) содержит:
- вращающуюся систему (10, 20) манипулирования для ингредиента для удержания упомянутой капсулы (5b) и вращения упомянутого вкусоароматического ингредиента (5a) и воды во время центрифугирования вокруг оси (30’) обработки, причем система (10, 20) манипулирования для ингредиента имеет по меньшей мере одно выходное отверстие (25) для напитка и по меньшей мере один штуцер (24) подвода воды для подачи упомянутой воды (4’) к упомянутому ингредиенту (5a), при этом система (10, 20) имеет первый манипулятор (10) для ингредиента и второй манипулятор (20) для ингредиента, которые выполнены с возможностью перемещения относительно друг друга из
конфигурации передачи ингредиента для приема упомянутого ингредиента (5a) внутри упомянутой капсулы (5b) первым и вторым манипуляторами (10, 20) для ингредиента и/или высвобождения упомянутой капсулы (5b) из первого и второго манипуляторов (10, 20) для ингредиента в
конфигурацию обработки ингредиента для центрифугирования упомянутого ингредиента (5a) и воды (4’) внутри упомянутой капсулы (5b) путем вращения вокруг оси (30’) обработки,
и наоборот; и
- раму и/или корпус (40) устройства, которые неподвижны, когда система (10, 20) манипулирования для ингредиента вращается для центрифугирования, и которые поддерживает систему (10, 20) манипулирования для ингредиента,
причем одно или более из выходного(ых) отверстий (25) для напитка и штуцера(ов) (24) подвода воды связаны с одним или более устройствами (24’, 25’) для открывания капсул;
при этом по меньшей мере одно открывающее устройство (24’, 25’) упомянутого(ых) устройства (устройств)","A47J31/22, A47J31/36",20251101,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2025203141A1,Methods and compositions for increasing energy expenditure using cinnamaldehyde,"Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical. The composition comprising cinnamaldehyde can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for weight maintenance </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a mammal in need thereof a composition comprising cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cinnamaldehyde is administered in an amount of about 1.25 mg/kg body weight per day.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cinnamaldehyde is present in the composition in a concentration of 17.48 ppm to 6191.0 ppm.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising cinnamaldehyde is administered once daily.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises cinnamon essential oil extract that provides at least a portion of the cinnamaldehyde.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the cinnamaldehyde is selected from the group consisting of isolated cinnamaldehyde and synthesized c innamaldehyde.</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-con>7.      A method for promoting weight loss </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a mammal</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-refi>in need thereof a composition comprising cinnamaldehyde.</seg-refi></div>
<div class=""indep-clm"" num=""8""><seg-con>8. A method for preventing obesity or overweight </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to a mammal at risk thereof a composition comprising cinnamaldehyde.</seg-refi></div>
<div class=""inde","A61K31/11, A61K36/54, A61P3/04, A61P43/00",20250522,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120435234A,"Liquid foodstuffs comprising beta-glucan, hydrolysate from oat-based material, and related methods","The present disclosure provides a liquid foodstuff containing a beta-glucan having an average molecular weight of between 400 kDa and 5000 kDa, preferably between 500 kDa and 3000 kDa, and having a shear viscosity of between 0.0001 Pa * s (Pa * s) and 0.3 Pa * s, preferably between 0.001 Pa * s and 0.2 Pa * s, when measured at 25 DEG C at shear rates of 0.1 s <-1 >, 1 s <-1 >, 10 s <-1 > and 100 s <-1 >. The liquid foodstuff preferably has a beta-glucan content of one or more of the following: at least 0.5 g of the beta-glucan per serving; or between 0.1 g and 1 g of the beta-glucan per 100 ml of the liquid foodstuff, preferably at least 0.75 g per portion of the liquid foodstuff; or between 0.35 g and 1.5 g of the beta-glucan per 100 ml of the liquid foodstuff.","<div class=""indep-clm"" num=""1"">1.液体食料，所述液体食料包含具有介于400kDa与5000kDa之间、优选介于500kDa与3000kDa之间的平均分子量的β-葡聚糖，并且当在25℃在0.1s<sup>-1</sup>、1s<sup>-1</sup>、10s<sup>-1</sup>和100s<sup>-1</sup>的剪切速率下测量时，所述液体食料具有介于0.0001Pa·s(帕秒)与0.3Pa·s之间、优选介于0.001Pa·s与0.2Pa·s之间的剪切粘度，其中所述液体食料具有以下β-葡聚糖含量：</div>
<div class=""indep-clm"" num=""1"">每份所述液体食料至少0.5g的所述β-葡聚糖；和/或</div>
<div class=""indep-clm"" num=""1"">每100ml所述液体食料介于0.1g与1.5g之间的所述β-葡聚糖。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的液体食料，其中所述液体食料还包含乳品成分、植物基乳、谷物、油、乳化剂、稳定剂、甜味剂、调味剂或矿物质中的一者或多者。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的液体食料，其中所述液体食料选自由液体饮料和汤组成的组，并且优选为即饮型(RTD)饮料。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的液体食料，其中所述液体食料包含来自燕麦基材料的水解产物，所述燕麦基材料包含燕麦、大麦或黑麦中的至少一者，并且所述水解产物包含所述β-葡聚糖的至少一部分。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的液体食料，其中所述燕麦基材料包含燕麦麸。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">6.根据权利要求4至5中任一项所述的液体食料，其中所述水解产物包含：</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">淀粉，其量为所述燕麦基材料中的初始淀粉的0干重％至20干重％、优选0重量％至10重量％；和</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">β-葡聚糖，其量为所述燕麦基材料中的初始β-葡聚糖的70干重％至100干重％、优选80重量％至100重量％。</div>
<div class=""dep-clm"" num=""7"" parent=""4,5,6"">7.根据权利要求4至6中任一项所述的液体食料，其中所述水解产物通过包括使所述燕麦基材料经受包含α-淀粉酶、任选的蛋白酶和任选的淀粉葡糖苷酶的酶组合物的方法来产生。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的液体食料，其中所述方法中的所述酶组合物的量为所述燕麦基材料的0.001重量％至5重量％、优选0.001重量％至2重量％。</div>
<div class=""dep-clm"" num=""9"" parent=""7,8"">9.根据权利要求7至8中任一项所述的液体食料，其中所述酶组合物由所述α-淀粉酶、任选的所述蛋白酶和任选的所述淀粉葡糖苷酶组成。</div>
<div class=""dep-clm"" num=""10"" parent=""7,8,9"">10.根据权利要求7至9中任一项所述的液体食料，其中所述方法在4℃至95℃、优选50℃至80℃的温度范围下进行，并且持续1分钟至10小时、优选15分钟至4小时。</div>
<div class=""indep-clm"" num=""11"">11.液体食料，所述液体食料用于通过减弱有需要的个体的餐后血糖应答(PGPR)而不引起餐后胰岛素应答的变化来预防或减轻所述个体的与碳水化合物、纤维或糖中的一者或多者的摄取相关的健康问题，其中所述液体食料是根据权利要求1至10中任一项所述的食料。</div>
<div class=""indep-clm"" num=""12"">12.液体食料，所述液体食料用于通过降低有需要的个体的总胆固醇和低密度脂蛋白(LDL)胆固醇的水平、增加纤维摄取、改善血糖调节、促进消化健康和规律性和/或支持体重管理来预防或减轻所述个体的与碳水化合物、纤维或糖中的一者或多者的摄取相关的健康问题，其中所述液体食料是根据权利要求1至10中任一项所述的食料。</div>
<div class=""indep-clm"" num=","A23L7/104, A23L7/10, A23L33/21",20250805,雀巢产品有限公司,['Pending']
US20250242997A1,Compostable pod for beverage preparation,"The invention relates to a pod (<b>100, 200</b>) for preparing a beverage in a beverage production machine, wherein the pod (<b>100, 200</b>) is made of a biodegradable, preferably compostable, material composition and comprises a pod body (<b>110</b>) composed of two half-shells (<b>101, 102</b>) being connected to each other along their respective circumferential flange (<b>140</b>) so as to delimit a chamber (<b>103</b>) for containing a substance (<b>105</b>) for the preparation of the beverage. The at least one half-shell comprises in a layered manner: • A primary layer (<b>171</b>) made of a paper-based material; • A secondary layer (<b>172</b>) with at least an oxygen barrier function and optionally a water barrier function; and • An at least partial, tertiary layer (<b>173</b>) with a filter function, The primary layer of said at least one half-shell (<b>106</b>) comprises at least one non-traversing pre-cut hole and/or scratch forming a pre-cut pattern (<b>108</b>) or scratch's pattern (I, CE) over at least a delivery portion (<b>130</b>) of the half-shell adapted to interact with external opening elements of the beverage production machine, under the effect of rising pressure of the fluid being injected into the pod (<b>100, 200</b>) through an injection portion (<b>120</b>) on the other half-shell (<b>101, 102</b>), to dispense the prepared beverage from the pod (<b>100, 200</b>). The invention also relates to the use of said pod in a beverage production machine.","<div class=""indep-clm"" num=""1""><seg-con>1. A pod for preparing a beverage in a beverage production machine, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pod is made of a biodegradable material composition and comprises a pod body composed of two half-shells being connected to each other along their respective circumferential flange so as to define a chamber for containing a substance for the preparation of the beverage, wherein at least one half-shell comprises in a layered manner:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>A primary layer made of a paper-based material,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>A secondary layer with at least an oxygen barrier function, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>An at least partial tertiary layer with a filter function,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the primary layer of said at least one half-shell comprises at least one non-traversing, pre-cut hole and/or scratch, forming a pre-cut hole's pattern or scratch's pattern, over at least a delivery portion of the half-shell adapted to interact with external opening elements of the beverage production machine, under the effect of rising pressure of the fluid being injected into the pod through an injection portion on the other half-shell, to dispense the prepared beverage from the pod-.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The pod according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the primary layer is made of stretchable and/or formable paper-based material having an elongation at break of at least 6%.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The pod according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the primary layer is arranged opposite to the chamber with respect to the secondary layer.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The pod according",B65D85/804,20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025132751A1,Machine with inclined top face,"A machine (10, 88) for processing a liquid food substance, such as milk or a milk-based substance, is provided. The machine (10, 88) comprises a jug (14) having a container (16) delimiting a food cavity for containing said liquid food substance and optionally a lid, e.g. a removable lid (38), for covering the food cavity, a base (12) forming a seat (52) for removably receiving the container (16), the base (12) having a bottom face (18) configured for placing the machine (10) on an external support surface (82), a top face (20) opposite the bottom face (18), and at least one peripheral side face (22) extending between the bottom face (18) and the top face (20), wherein the at least one peripheral side face (22) includes a front portion (24) configured for facing a user of the machine (10) and a rear portion (36) configured for facing away from the user; wherein a user interface (34) is provided along the top face (20); and wherein a height of the rear portion (26) is greater than a height of the front portion (24) such that the top face (20) is inclined to face the user when processing said liquid food substance.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A machine (10, 88) for processing a liquid food substance,such as milk or a milk-based substance, comprising:</seg-main><seg-clauses>- a jug (14) having a container (16) delimiting a food cavityfor containing said liquid food substance and optionally a lid, e.g. a removable lid (38), for covering the food cavity;</seg-clauses><seg-clauses>- a base (12) having one or more walls forming a seat (52) forremovably receiving the container (16); and</seg-clauses><seg-clauses>- the base (12) having a bottom face (18) configured for placingthe machine (10) on an external support surface (82), a top face (20) opposite the bottom face (18), and at least one peripheral side face (22) extending between the bottom face (18) and the top face (20) wherein the at least one peripheral side face (22) includes a front portion (24) configured for facing a user of the machine (10) when processing said liquid food substance and a rear portion (36) configured for facing away from the user when processing said liquid food substance, wherein a user interface (34) is provided along the top face (20) for allowing the user of the machine (10) to interact with the machine (10) when processing said liquid food substance, and wherein a height of the rear portion (26) is greater than a height of the front portion (24) such that the top face (20) is inclined to face the user when processing said liquid food substance.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine (10, 88) of claim 1, wherein </seg-main><seg-clauses>the lid (38) hasan outer lid face (40), and the outer lid face (40) extends flush or substantially flush with the top face (20) when the lid (38) is arranged on the container (16) and the container (16) is received in the seat (52) for processing said liquid food substance.</seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The machine (10, 88) of any preceding claim, wherein </s","A47J36/32, A47J43/046, A47J43/07",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025140834A1,Beverage extraction device,,,"A47J31/06, A47J31/44",20250703,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250000117A1,A chocolate product comprising a milk analogue product,"The invention relates to a reduced dairy chocolate product, preferably a vegan chocolate product composition comprising a dried plant protein.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a chocolate product, said method comprising</seg-main>
<seg-clauses>a. Adding plant protein to water to form a plant protein mixture;</seg-clauses>
<seg-clauses class=""seg-enter"">b Adding sugar, polyol, or one or more polysaccharides or mixtures thereof to the plant protein mixture;</seg-clauses>
<seg-clauses>c.</seg-clauses>
<seg-clauses>d. Homogenizing the plant protein mixture;</seg-clauses>
<seg-clauses>e. Applying a thermal treatment to form a plant-based liquid;</seg-clauses>
<seg-clauses>f. Spray drying the plant-based liquid to form a plant-based composition; and</seg-clauses>
<seg-clauses>g. Combining the dry composition with other ingredients to form a chocolate product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein is derived from a legume source.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein is a concentrate or an isolate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>step b. involves the addition of a mixture of a sugar and at least one polysaccharide.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the sugar is selected from the group consisting of sucrose, fructose, glucose, dextrose, galactose, allulose, maltose, high dextrose equivalent hydrolysed starch syrup, xylose, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the polyol is selected from the group consisting of sorbitol, mannitol, isomalt, maltitol, lactitol, xylitol, erythritol or glycerol.</seg-clauses></div>
<div class=""","A23G1/44, A23G1/00, A23G1/36, A23G1/40, A23J3/14",20250102,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250248557A1,Beverage pod system with pod holder,"The invention concerns an extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod, said pod comprising a pod body with a bottom wall and a top lid, said extraction device comprising: —upstream and downstream pod enclosing parts relatively movable, and—a removable pod holder, said holder comprising a pod receiving hole to receive and hold the pod, and—a top insertion section configured for introducing the pod holder in the device and for positioning said holder between the upstream and downstream pod enclosing parts, and wherein the top insertion section is configured to introduce the holder along a vertical direction from the top of the device, and wherein the pod receiving hole and the top insertion section are configured to position the lid of the pod vertically when the removable pod holder is positioned inside the device.","<div class=""indep-clm"" num=""1""><seg-con>1. An extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said pod </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising a side wall and a bottom wall defining a chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said extraction device comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>upstream and downstream pod enclosing parts relatively movable, along a horizontal longitudinal axis between an open position for inserting and removing the pod and a closed position for forming an extraction chamber enclosing the pod during extraction, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a removable pod holder, said holder comprising a pod receiving hole to receive and hold the pod, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top insertion section configured for introducing the pod holder in the device and positioning said holder between the upstream and downstream pod enclosing parts,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the top insertion section is configured to introduce the holder along a vertical direction from the top of the device, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the pod receiving hole and the top insertion section are configured to position the lid of the pod vertically when the removable pod holder s introduced inside the device.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Extraction device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the upstream enclosing part bears an upstream piercing a","A47J31/36, A47J31/44",20250807,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3127399C,"Syrup binder system for preparing food, and preparation process and use thereof","The present invention relates to the food field. Specifically, the present invention relates to a syrup binder system for preparing a food containing extruded or puffed cereal and/or nuts, such as compound sachima (complexed sachima), cereal bars, crunchy rice candy or nut bars, etc., a preparation process and use thereof, and a food containing the syrup binder system.","22 CLAIMS: <div class=""indep-clm"" num=""1""><seg-main>1. Syrup binder system for food, said binder system comprising </seg-main><seg-clauses>a sugar, a polyol, dietary fiber having water holding capacity greater than 8 ml/g, an emulsifier, edible oil, and water. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The syrup binder system according to claim 1, further comprising </seg-main><seg-clauses>cellulose or a derivative thereof. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The syrup binder system according to claim 1 or 2, wherein </seg-main><seg-clauses>the polyol is a polyol having 2-5 hydroxy groups. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The syrup binder system according to any one of claims 1-3, wherein </seg-main><seg-clauses>the dietary fiber is present in an amount of 0.1-8 wt% based on the total weight of the syrup binder system. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The syrup binder system according to any one of claims 1-4, wherein </seg-main><seg-clauses>the emulsifier is present in an amount of 0.01-5 wt%. </seg-clauses></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The syrup binder system according to any one of claims 1-5, further capable of comprising </seg-main><seg-clauses>one or more of flavouring substances, pigments, edible salts, preservatives, antioxidants, vitamins, minerals, trace elements and nutriments. </seg-clauses></div><div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The syrup binder system according to any one of claims 1-6, a syrup binder having </seg-main><seg-clauses>a water activity ranging from 0.3 to 0.7. </seg-clauses></div><div class=""indep-clm"" num=""8""><seg-main>8. A process for preparing the syrup binder system according to any one of claims 1-7, comprising: </seg-main><seg-clauses>(a) providing a syrup mixture having a Brix value of 80%-90%, wherein the syrup","A23L7/109, A23L7/126, A23L25/00, A23L29/30",20251125,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12408691B2,Process of calibration of a roasting apparatus,"The invention concerns process of calibration of a coffee beans roasting apparatus in order to reproduce coffee beans roasting recipes defined with one specific master roasting apparatus, said calibration process comprising the steps of: a—introducing at least one second temporary temperature probe inside the chamber of the roasting apparatus, b—controlling the heating device to reproduce a preset curve R said control being based on the temperature Treg regulated by the at least one first temperature probe, c—during the reproduction of the preset curve Rset, measuring the temperature Tcal in function of time inside the chamber, d—comparing the temperature Tcal@ti with the temperature Tref@ti of a pre-determined calibration curve Rref obtained with the master roasting apparatus (M), said calibration curve Rref representing the temperature Tref measured in the chamber of the specific master apparatus (M) while controlling the heating device of the master apparatus to reproduce said preset curve Rset, e—based on this comparison, calibrating the roasting apparatus by applying a correction, to the temperature Treg regulated by the first temperature probe inside the control system of the roasting apparatus.","<div class=""indep-clm"" num=""1""><seg-con>1. Calibration process of a coffee beans roasting apparatus, in order to reproduce coffee beans roasting recipes defined with one specific master roasting apparatus,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said coffee beans roasting apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a chamber to contain coffee beans,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a heating device configured to supply hot air to the chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one first temperature probe to measure the temperature of air supplied by the heating device, said first temperature probe being positioned outside the chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control system configured to control the heating device and configured to reproduce roasting curves, said roasting curves providing at least a set of points representing the temperature to be applied at discrete successive times ti, respectively, said control of the heating device implementing a feedback loop regulation based on the temperature Treg measured by the at least one first temperature probe,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said calibration process comprising the steps of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a—introducing at least one second temporary temperature probe inside the chamber of the roasting apparatus to be calibrated or replacing said chamber by a temporary calibration chamber, said temporary calibration chamber comprising at least one second temperature probe,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b—controlling the heating device to reproduce a preset curve Rset, said preset curve providing a series of points representing the temperature Tset@t1, Tset@t2, . . . Tset@tfinal to be applied at preset corresponding successive times t1, t2, . . . , tfinal respecti","A23F5/04, A23N12/12, G01K1/02, G05D23/19",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025131787A1,Packaged paper-based capsules,"The present invention relates to a packaged capsule comprising: (i) a capsule comprising cellulosic fibres, wherein the capsule is surface-coated with a lining which is (a) an inorganic coating; or (b) a natural polymer coating; the capsule is at least partially filled with an edible product suitable for human consumption; and the capsule is sealed with a membrane comprising cellulosic fibres, wherein the membrane is surface-coated with the same lining as the capsule; and (ii) a packaging comprising at least 80% wt of cellulosic fibres based upon the total weight of the packaging, a metallized polymer coating in contact with the cellulosic fibres, and a polymer coating in contact with the metallized polymer coating; wherein the capsule is placed within the packaging; to methods for the manufacture of the packaged capsule, and to a packet comprising a plurality of the packaged capsules.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A packaged capsule comprising:</seg-main>
<seg-clauses><seg-main>(i) a capsule comprising cellulosic fibres, wherein the capsule is surface-coated with a lining which is:</seg-main>
<seg-clauses>(a) an inorganic coating; or</seg-clauses>
<seg-clauses>(b) a natural polymer coating; the capsule is at least partially filled with an edible product suitable for human consumption; and the capsule is sealed with a membrane comprising cellulosic fibres, wherein the membrane is surface-coated with the same lining as the capsule; and</seg-clauses></seg-clauses>
<seg-clauses>(ii) a packaging comprising at least 80% wt of cellulosic fibres based upon the total weight of the packaging, a metallized polymer coating in contact with the cellulosic fibres, and a polymer coating in contact with the metallized polymer coating; wherein the capsule is placed within the packaging.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A packaged capsule as claimed in claim 1, wherein </seg-main><seg-clauses>the cellulosic fibres in the capsule and/or the membrane are selected from cellulose fibres from wood, jut, bagasse, hemp, straw, bamboo and combinations thereof, preferably cellulose fibres from wood, jut, bagasse, hemp, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A packaged capsule as claimed in claim 1 or claim 2, wherein </seg-main><seg-clauses>the inorganic coating is a polymer from a sol-gel process of a mixture of one or more alkoxy silane monomers and an acid catalyst in water.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A packaged capsule as claimed in claim 3, wherein </seg-main><seg-clauses>the one or more alkoxy silane monomers are selected from tetraethyl orthosilicate, triethoxy methylsilane, triethoxy(methyl)alkoxy silane, triethoxy(ethyl)alkoxy silane, triethoxy(propyl)alkoxy</seg-clauses>
<seg-clauses class=""seg-ent",B65D85/804,20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025068343A1,Composition for use in increasing spermidine production by microbiota,The present invention relates to compositions comprising at least one source of protein and at least one source of prebiotic for use in increasing spermidine production by the gut microbiota. The composition can be used in preventing and/or treating age-related disorders.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A composition comprising </seg-main><seg-clauses>at least one source of protein and at least one source of prebiotic for use in increasing spermidine production by the gut microbiota of a subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition as claimed in claim 1 , wherein </seg-main><seg-clauses>the source of protein is at least one selected from the group: pulses, grain, nuts, algae, oil crop and/or its press cakes, animal proteins or combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>pulses are at least one selected from the group comprising faba bean, chick pea, green pea, lentil.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>grains are at least one selected from the group comprising rice, oat, quinoa, wheat, barley.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""2""><seg-main>5. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>nuts are at least one selected from walnut, almond, pistachio.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""2""><seg-main>6. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>algae are at least one selected from seaweed, microalgae.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""2""><seg-main>7. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>oil crop and/or its press cakes are selected from soy, canola, peanut, bambara.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""2""><seg-main>8. The composition as claimed in claim 2, wherein </seg-main><seg-clauses>animal proteins are at least one selected from milk, egg, seafood, poultry, red meat, white meat.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""><seg-main>9.","A23L33/185, A23L33/21, A61K31/702, A61K36/48, A61P3/00",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023381096A1,Human milk oligosaccharides for improving gut microbiome and methods for determining gut maturation status,"The present invention provides methods for inducing a formula-fed infant's gut microbiome trajectory to converge with that of a reference gut microbiome trajectory obtained from human milk-fed infants, the methods comprising administering an effective amount of a mixture of human milk oligosaccharides (HMOs) to the formula-fed infant. The present invention also provides methods for determining the gut maturation status of a formula-fed infant, the methods comprising providing a reference gut microbiome trajectory obtained from human milk-fed infants.","<div class=""indep-clm"" num=""1""><seg-main>1. A mixture of human milk oligosaccharides (HMOs) for use in inducing a formula-fed infant’s gut microbiome trajectory to converge with that of a reference gut microbiome trajectory obtained from human milk-fed infants, wherein </seg-main><seg-clauses>the mixture of HMOs comprises or consists of 2’-fucosyllactose (2’FL), 2’,3-difucosyllactose (diFL), lacto-N-tetraose (LNT), 3’-sialyllactose (3’-SL), and 6’-sialyllactose (6’-SL).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The mixture of HMOs for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the mixture of HMOs comprises or consists of: </seg-main><seg-clauses>(i) 2’FL in an amount of from about 55 wt% to about 60 wt%; </seg-clauses><seg-clauses>(ii) diFL in an amount of from about 5 wt% to about 7 wt%; </seg-clauses><seg-clauses>(iii) LNT in an amount of from about 18 wt% to about 20 wt%; </seg-clauses><seg-clauses>(iv) 3’-SL in an amount of from about 6 wt% to about 8 wt%; and </seg-clauses><seg-clauses>(v) 6’-SL in an amount of from about 9 wt% to about 11 wt%, based on the total weight of HMOs.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The mixture of HMOs for use according to claim 1 or 2, wherein </seg-main><seg-clauses>the mixture of HMOs is administered in the form of an infant formula, optionally wherein the mixture of HMOs is administered in the form of a starter infant formula, a follow-up formula, and/or a growing-up milk.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The mixture of HMOs for use according to any preceding claim, wherein </seg-main><seg-clauses><seg-main>the mixture of HMOs is administered in the form of:</seg-main>
<seg-clauses><seg-main>(a) a starter infant formula comprising a total amount of HMOs of from about 0.5 g/L to about 5.0 g/L, from about 1.0 g/L to about 3.0 g/L, or from about 1.5 g/L to about 2.5 g/L, optiona","A61K31/702, A23L33/00, A23L33/125, A61P1/00, C12Q1/689",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020260309B2,Coffee composition and process,The present invention relates to a coffee composition with improved aroma and a method of producing a coffee composition wherein two different types of coffee beans are roasted separately.,"<div class=""indep-clm"" num=""1""><seg-main>1. A coffee composition comprising </seg-main><seg-clauses>furfural and (E)-P-damascenone wherein the ratio of concentrations of furfural to (E )-P-damascenone is from 400 to 1000.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The coffee composition according to claim 1 comprising </seg-main><seg-clauses>4-ethylguaiacol and 2,3-pentanedione wherein the ratio of concentrations of 2,3-pentanedione to 4-ethylguaiacol is from 5 to 20.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The coffee composition according to claim 1 or claim 2 comprising </seg-main><seg-clauses>N-caffeoyl-tryptophan and 4-ethylguaiacol wherein the ratio of concentrations of 4-ethylguaiacol to N-caffeoyl-tryptophan is from 1500 to 3000.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The coffee composition according to any one of claims 1 to 3 comprising </seg-main><seg-clauses>at least 20 wt.% coffee solids originating from Robusta beans as a percentage of total coffee solids.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The coffee composition according to any one of claims 1 to 4 comprising </seg-main><seg-clauses>at least 45 mg of 2,3-butanedione per kg of soluble coffee solids.</seg-clauses></div>
<div class=""indep-clm"" num=""6""><seg-main>6. A method of producing a coffee composition, the method comprising;</seg-main>
<seg-clauses>a) roasting a first type of green coffee beans to a roast colour of between 60 and 120 CTN; </seg-clauses><seg-clauses>b) roasting a second type of green coffee beans to a roast colour of between 30 and 100 CTN;</seg-clauses>
<seg-clauses>c) optionally, extracting the roasted beans obtained in step a) and the roasted beans obtained in step b) with water;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the roast colour of the roasted beans obtained in step a) is at least 20 CTN higher than the roast colour ","A23F5/04, A23F5/10",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023348237A1,Beverage or foodstuff preparation system,"A system comprising: a container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a plurality of machine-readable codes, each code storing preparation information for use with a preparation process performed by said machine, each code comprising a plurality of units defining a data portion arranged at a predetermined position with respect to a reference portion, the reference portions of adjoining codes arranged to define vertices of a quadrilateral with at least two equal sides; a machine for preparing a beverage and/or foodstuff or a precursor thereof, the machine including: a processing unit for processing precursor material of the container, and; electrical circuitry to control the processing unit based on preparation information read from the code, and; a code reading system to read the code of the container by obtaining, with an image capturing device, a digital image of the code which is equal angular quadrilateral in shape; wherein the container and code reading system are configured to obtain the quadrilateral shaped digital image arranged oblique to said quadrilateral defined by the adjoining codes with said digital image to comprise at least two reference portions of the codes.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a plurality of machine-readable codes, each code storing preparation information for use with a preparation process performed by said machine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>each code comprising a plurality of units defining a data portion arranged at a predetermined position with respect to a reference portion, the reference portions of adjoining codes arranged to define vertices of an equal angular quadrilateral with at least two equal sides;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine for preparing a beverage and/or foodstuff or a precursor thereof, the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing precursor material of the container, and; electrical circuitry to control the processing unit based on preparation information read from the code, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code of the container by obtaining, with an image capturing device, a digital image of the code which is equal angular quadrilateral in shape;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the container and code reading system are configured to obtain the quadrilateral shaped digital image arranged oblique to said quadrilateral defined by the adjoining codes with said digital image to comprise at least two reference portions of the codes, with sides of the quadrilateral shaped digital image angled to the quadrilateral defined by the adjoining codes.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the quad","A47J31/44, A47J31/52",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025045796A1,Powdered food emulsion compositions with lentil proteins,"The invention relates to a powdered food emulsion composition. It comprises at least one fat ingredient and a lentil protein ingredient. The lentil protein ingredient is selected from the list consisting of lentil protein concentrate, lentil flour or a mixture thereof. Moreover, the lentil proteins of the lentil protein ingredient are not hydrolysed. The invention also relates to a method for preparing such a powdered food emulsion composition.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A powdered food emulsion composition, which </seg-con><seg-trans>comprises </seg-trans><seg-refi>at least one fat ingredient and a lentil protein ingredient, wherein the lentil protein ingredient is selected from the list consisting of lentil protein concentrate, lentil flour or a mixture thereof, and wherein the lentil proteins of the lentil protein ingredient are not hydrolysed.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The powdered food emulsion composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the proteins of the lentil protein ingredient are not hydrolysed.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The powdered food emulsion composition according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the proteins of the powdered food emulsion composition are not hydrolysed.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The powdered food emulsion composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lentil protein ingredient is not hydrolysed.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The powdered food emulsion composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the proteins of the lentil protein ingredient consist only of lentil proteins.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The powdered food emulsion composition according to any one of the preceding claims, which </seg-con><seg-trans>comprises </seg-trans><seg-refi>at least 0.5wt% lentil proteins by dry weight, preferably 0.5 to 30wt.% lentil proteins by dry weight.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. The powdered food emulsion composition according to any one of the preceding claims, </seg-con><seg-trans","A23L9/20, A23C11/10, A23C11/06, A23C1/12, A23D7/005",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025051662A1,Compositions and methods using spermidine to reduce biological age of an adult animal,,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A method for reducing the biological age and/or for reducing the rate of increase of the biological age of an adult animal in need, the method </seg-con><seg-trans>comprising: </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of spermidine.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A method for reducing the biological age of a tissue, organ or physiological system in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of spermidine.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue, organ or physiological system is immune, gastrointestinal, urinary, muscular, cardiovascular, and/or neurological system.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue has a deficiency in spermidine.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4""><seg-con>5. A method according to any of claims 2-4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue is skeletal muscle.</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-con>6. A method for treating, preventing, or delaying the onset of an organ disease, or decline of organ function, or condition relating thereto in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of spermidine.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. A method according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the animal in need has an increased biological age compared to its chronological age.</seg-refi></div>
<div class=""dep-cl","A61K31/132, A61K45/06, A61P43/00, A23K10/00",20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023380408A1,Dried animal digest compositions,,"<div class=""indep-clm"" num=""1""><seg-con>1. A dried animal digest composition, </seg-con><seg-trans>comprising </seg-trans><seg-refi>dried animal digest particles having an animal fat content of about 16 wt% or less and a moisture content of about 3 wt% or less, wherein the dried animal digest particles have a volume diameter particle size distribution where D10 is from about 20 pm to about 50 pm, D50 is from about 60 pm to about 150 pm, and D90 is from about 160 pm to about 275 pm, and wherein the dried animal digest composition is substantially devoid of silicon dioxide flow aid.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The dried animal digest composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the percentage of dried animal digest particles below 30 pm based on volume diameter is from 3% to 20%.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The dried animal digest composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the percentage of dried animal digest particles below 45 pm based on volume diameter is from 5% to 25%.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The dried animal digest composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>a volume mean diameter of the dried animal digest particles is from about 60 pm to about 160 pm.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dried animal digest composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>D10 is from about 25 pm to about 40 pm, D50 is from about 75 pm to about 125 pm, D90 is from about 185 pm to about 250 pm, or a combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The dried animal digest composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dried animal digest composition is completely devoid of the silicon dioxide flow aid, and is also devoid of chemic","A23K10/14, A23K10/26, A23K20/142, A23K20/147, A23K20/158",20250424,SOCIETE DES PRODUITS NESTLE SA,['Pending']
CN120035653A,Method for cell expansion,"A method for expanding mammalian cells, and products produced by the method, the method comprising dynamically agitating cells in a bioreactor to produce expanded cell cultures.","<div class=""indep-clm"" num=""1"">1.一种用于在搅拌槽生物反应器中扩增哺乳动物细胞的方法，所述生物反应器包含哺乳动物细胞和细胞培养基，所述方法包括动态搅拌所述生物反应器中的所述细胞以产生扩增的细胞培养物。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述动态搅拌包括以在所述扩增的细胞培养物的生产期间改变的搅拌速度搅拌所述细胞。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中将所述搅拌速度从第一搅拌速度增加至第二搅拌速度。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3所述的方法，其中所述搅拌速度在150RPM至800RPM范围内。</div>
<div class=""dep-clm"" num=""5"" parent=""3,4"">5.根据权利要求3或4所述的方法，其中所述第一搅拌速度以每小时6.25RPM至20RPM的速率增加至第二搅拌速度。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">6.根据权利要求4或5所述的方法，其中所述第一搅拌速度为150RPM至300RPM，并且所述第二搅拌速度为400RPM至500RPM。</div>
<div class=""dep-clm"" num=""7"" parent=""5"">7.根据权利要求5所述的方法，其中所述第一搅拌速度为250RPM，并且任选地，所述第二搅拌速度为400RPM。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3"">8.根据权利要求2或3所述的方法，其中搅拌功率在3W/m<sup>3</sup>至600W/m<sup>3</sup>的范围内。</div>
<div class=""dep-clm"" num=""9"" parent=""3,8"">9.根据权利要求3或8所述的方法，其中第一搅拌功率以每小时2.35W/m<sup>3</sup>至23.53W/m<sup>3</sup>的速率增加至第二搅拌功率。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的方法，其中所述第一搅拌速度为3W/m<sup>3</sup>至32W/m<sup>3</sup>并且所述第二搅拌速度为70W/m<sup>3</sup>至150W/m<sup>3</sup>。</div>
<div class=""dep-clm"" num=""11"" parent=""10"">11.根据权利要求10所述的方法，其中所述第一搅拌功率为约18W/m<sup>3</sup>，并且任选地所述第二搅拌功率为75W/m<sup>3</sup>。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求所述的方法，其中所述扩增方法的所述动态搅拌具有3天至30天，任选地5天的持续时间。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据任一前述权利要求所述的方法，其中所述搅拌速度从第2天至第3天改变，其中所述扩增方法在第0天启动。</div>
<div class=""dep-clm"" num=""14"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13"">14.根据任一前述权利要求所述的方法，其中用于扩增的所述细胞为人细胞，和/或其中用于扩增的所述细胞为干细胞。</div>
<div class=""dep-clm"" num=""15"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13,14"">15.根据权利要求1至14中任一项所述的方法，其中用于扩增的所述细胞选自以下中的任一者：多能干细胞(PSC)、肌肉干细胞/卫星细胞(MuSC/SC)、脂肪来源的干细胞(ADSC)、脂肪细胞、上皮细胞、间充质干细胞/基质细胞(MSC)、纤维脂肪形成祖细胞(FAPS)、诱导性多能干细胞(iPSC)、母乳干细胞(BMSC)、胚胎样干细胞(ELC-C)、化学诱导性多能干细胞(CiPSC)和化学诱导性全能干细胞(CiTotiSC)，任选地其中用于扩增的所述细胞为iPSC。</div>
<div class=""dep-clm"" num=""16"" parent=""1,2,3,4,5,6","C12N5/074, C12M3/00",20250523,雀巢产品有限公司,['Pending']
CN119947591A,Compositions and methods for digestive health of felines,"Compositions and methods for providing digestive health benefits to felines comprise the use of a prebiotic fiber blend comprising pumpkin, inulin, and optionally wheat bran aleurone.","<div class=""indep-clm"" num=""1"">1.用于猫科动物的益生元纤维共混物，所述益生元纤维共混物包含南瓜、菊粉和任选的小麦麸糊粉。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的益生元纤维共混物，其中所述南瓜以约20％至约50％的量存在于所述纤维共混物中。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的益生元纤维共混物，其中所述菊粉以约10％至约40％的量存在于所述纤维共混物中。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的益生元纤维共混物，其中所述纤维共混物包含小麦麸糊粉，并且其中所述小麦麸糊粉以约20％至约50％的量存在于所述纤维共混物中。</div>
<div class=""indep-clm"" num=""5"">5.宠物食物组合物，所述宠物食物组合物包含根据权利要求1所述的益生元纤维共混物。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的宠物食物组合物，所述宠物食物组合物还包含蛋白质、碳水化合物、脂肪和防腐剂，其中所述纤维共混物以约0.1％至约10％的量存在于所述宠物食物组合物中。</div>
<div class=""dep-clm"" num=""7"" parent=""5"">7.根据权利要求5所述的宠物食物组合物，其中所述南瓜以约0.01％至约5％的量存在于所述宠物食物组合物中，所述菊粉以约0.01％至约5％的量存在于所述宠物食物组合物中，并且所述小麦麸糊粉以约0.01％至约5％的量存在于所述宠物食物组合物中。</div>
<div class=""dep-clm"" num=""8"" parent=""5"">8.根据权利要求5所述的宠物食物组合物，其中所述宠物食物组合物为完全且均衡的宠物食物。</div>
<div class=""indep-clm"" num=""9"">9.补充剂，所述补充剂包含根据权利要求1所述的益生元纤维共混物。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的补充剂，其中所述纤维共混物以约0.1％至约50％的量存在于所述补充剂中。</div>
<div class=""indep-clm"" num=""11"">11.向猫科动物提供消化健康益处的方法，所述方法包括向所述猫科动物施用益生元纤维共混物，其中所述益生元纤维共混物包含南瓜、菊粉和任选的小麦麸糊粉。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中将所述益生元纤维共混物定期施用于所述猫科动物。</div>
<div class=""dep-clm"" num=""13"" parent=""11"">13.根据权利要求11所述的方法，其中所述益生元纤维共混物作为宠物食物组合物的一部分施用于所述猫科动物。</div>
<div class=""dep-clm"" num=""14"" parent=""11"">14.根据权利要求11所述的方法，其中所述消化健康益处选自治疗腹泻、增加粪便质量、增加微生物组多样性、减少炎症、增加有益细菌、减少蛋白质分解代谢产物、减少病原菌、减少餐后葡萄糖波动及其组合。</div>
<div class=""dep-clm"" num=""15"" parent=""11"">15.根据权利要求11所述的方法，其中所述南瓜以约20％至约50％的量存在于所述纤维共混物中，其中所述菊粉以约10％至约40％的量存在于所述纤维共混物中，并且其中所述小麦麸糊粉以约20％至约50％的量存在于所述纤维共混物中。</div>","A23K10/00, A23K10/30, A23K20/163, A23K50/40",20250506,雀巢产品有限公司,['Pending']
US20250171178A1,Method for manufacturing a compostable pod,"The invention relates to a method for manufacturing a pod (<b>100</b>) for preparing a beverage in a beverage production machine, the machine having opening elements for opening the pod (<b>100</b>) under the effect of rising pressure of fluid being injected into the pod (<b>100</b>). In the method, two formable sheet elements (<b>200</b>) are provided, into one of which an opening (<b>210</b>) is cut. A second sheet material (<b>300</b>) is provided and connected with the respective sheet element (<b>200</b>) at a connection area (<b>230</b>) that circumferentially surrounds the opening (<b>210</b>). The so connected sheet material (<b>300</b>) forms a delivery wall (<b>110</b>) of the pod (<b>100</b>), through which during the beverage preparation process the prepared beverage is dispensed from the pod (<b>100</b>). The two sheet elements (<b>200</b>) are formed into the shape of a half-shell (<b>101, 102</b>), respectively, whereby the connection area (<b>230</b>) is pinched from opposite sides of the sheet element (<b>200</b>) when forming the respective half-shell (<b>101, 102</b>). An injection wall (<b>120</b>) for injecting a fluid into the pod (<b>100</b>) is formed. A substance (<b>105</b>) for the beverage is provided and the two half-shells (<b>101, 102</b>) are connected to form a pod body (<b>130</b>) around the substance (<b>105</b>). Therein, the pod body (<b>130</b>) together with the delivery wall (<b>110</b>) and the injection wall (<b>120</b>) delimit a chamber containing the substance (<b>105</b>). The delivery wall (<b>110</b>) is configured to be opened upon interaction with the opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod (<b>100</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A method for manufacturing a pod for preparing a beverage in a beverage production machine, </seg-con><seg-trans>comprising </seg-trans><seg-comp>the steps of:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>providing two sheet elements each being made of a formable material;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>cutting an opening into one of the sheet elements;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>covering the opening with a sheet material and connecting the sheet material and the respective sheet element at a connection area circumferentially surrounding the opening, the so connected sheet material forming a delivery wall;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>forming the two sheet elements into the shape of a half-shell, respectively;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>forming an injection wall of the pod for injecting a fluid into the pod;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>providing a substance required for the preparation of the beverage;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>connecting the two half-shells to form a pod body around the substance to form the pod, the pod body together with the delivery wall and the injection wall defining a chamber containing the substance for preparing the beverage upon interaction of the substance with the fluid injected through the injection wall, and the delivery wall being adapted to be opened upon interaction with opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod to dispense the prepared beverage from the pod, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the connection area is pinched from opposite sides of the sheet element when forming the respective half-shell.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method","B65B29/02, B65B9/00, B65B9/04, B65B51/22, B65B61/06",20250529,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2838232C1,Roasting apparatus calibration system,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is a coffee bean roasting system, comprising a coffee bean roasting apparatus, comprising a roasting chamber, a heating device, at least one first temperature sensor for controlling the temperature of air supplied by the heating device, which is located outside the chamber, a control system configured to control the heating device and made with possibility to reproduce frying curves, wherein each of frying curves provides, at least a set of points representing a temperature to be applied at separate successive times ti, respectively, wherein said control of the heating device is based on a temperature Treg, controlled by at least one first temperature sensor, and at least one second temperature sensor configured to be temporarily inserted into the roasting apparatus to measure the temperature inside the roasting chamber, and at least one means configured to create a pressure loss of the hot air flow, while there are no coffee beans in the chamber, for simulating the presence of coffee beans inside the chamber during a roasting operation. Also disclosed is a calibration chamber configured to be introduced instead of a roasting chamber of a roasting apparatus, and a method of calibrating the apparatus for roasting said system for roasting coffee beans.EFFECT: group of inventions enables to ensure identical roasting at the same roasting profile in different roasting apparatuses.19 cl, 13 dwg","1. Система для обжаривания кофейных зерен, содержащая:
- аппарат для обжаривания кофейных зерен, причем указанный аппарат содержит:
обжарочную камеру, предназначенную для обжаривания кофейных зерен,
- нагревательное устройство для подачи потока горячего воздуха в камеру,
по меньшей мере один первый датчик температуры для регулирования температуры воздуха, подаваемого нагревательным устройством, причем указанный первый датчик температуры расположен за пределами камеры,
систему управления, выполненную с возможностью управления нагревательным устройством и выполненную с возможностью воспроизведения кривых обжаривания, причем каждая из указанных кривых обжаривания обеспечивает, по меньшей мере, набор точек, представляющих температуру, которую нужно применять в отдельные последовательные моменты времени ti соответственно, причем указанное управление нагревательного устройства основано на температуре Treg, регулируемой по меньшей мере одним первым датчиком температуры, и
- по меньшей мере один второй датчик температуры, выполненный с возможностью временного введения внутрь аппарата для обжаривания для измерения температуры внутри обжарочной камеры, и
- по меньшей мере одно средство, выполненное с возможностью создания потери давления потока горячего воздуха, в то время как в камере отсутствуют кофейные зерна, для имитации наличия кофейных зерен внутри камеры во время операции обжаривания.
2. Система для обжаривания кофейных зерен по предшествующему пункту, в которой:
- нагревательное устройство аппарата для обжаривания содержит рабочий орган подачи воздуха и нагреватель, а система управления аппарата для обжаривания выполнена с возможностью управления указанным рабочим органом подачи воздуха для настройки потока воздуха,
и
- средство, выполненное с возможностью создания потери давления потока горячего воздуха, в то время как в камере отсутствуют кофейные зерна, представляет собой рабочий орган подачи воздуха.
3. Система для обжаривания кофейных зерен по п. 1 или 2, в кото","A23N12/08, A23F5/04, A23N12/12, G01N31/00, G01N25/00",20250414,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
RU2840608C1,Method for dispensing ground coffee,"FIELD: crushing or grinding materials.SUBSTANCE: invention relates to a method for dispensing ground coffee for preparing a coffee beverage. Method includes the following steps: providing device (110) comprising one or more receiving compartments (13, 14) for storing one or different types of roasted coffee beans, one or more dispensers (60, 70) for dispensing coffee beans that are being stored in one or more receiving compartments (13, 14), and mill (30) for receiving coffee beans dispensed by one or more of said dispensers (60, 70), mill (30) being configured to move to different grinding positions for different degrees of grinding, respectively, storing the coffee beans in receiving compartments (13, 14), at least partially covering or at least partially resting on one or more of dosing devices (60, 70), preventing coffee beans from dispensing from receiving compartments (13, 14), setting mill (30) in such a way that mill (30) is in a certain grinding position, dispensing, by means of one or more devices (60, 70), the certain number of coffee beans to be dispensed to mill (30) after mill (30) installation step, and milling, by means of mill (30), said certain number of coffee beans and, thus, dispensing such ground coffee beans until no coffee beans remain in mill (30).EFFECT: proposed invention is aimed at the possibility to produce a balanced coffee beverage with a good taste from an organoleptic point of view as well as ensures an improved automatic coffee beans grinding process for various coffee beverage types without detriment to the quality of the various coffee beverage types.16 cl, 5 dwg","1. Способ выдачи молотого кофе для приготовления кофейного напитка, включающий следующие стадии:
- обеспечение устройства (110), которое содержит один или более приемных отсеков (13, 14) для хранения одного или разных видов обжаренных кофейных зерен, одно или более устройств (60, 70) дозирования для выдачи кофейных зерен, которые хранятся в одном или более приемных отсеках (13, 14), и мельницу (30) для приема кофейных зерен, выданных одним или более устройствами (60, 70) дозирования, причем мельница (30) выполнена с возможностью перемещения в разные положения помола для разных степеней помола соответственно,
- хранение кофейных зерен в приемных отсеках (13, 14), по меньшей мере частично покрывающими или по меньшей мере частично опирающимися на одно или более устройств (60, 70) дозирования, предотвращая выдачу кофейных зерен из приемных отсеков (13, 14),
- установка мельницы (30) таким образом, чтобы мельница (30) находилась в определенном положении помола,
- выдача с помощью одного или более устройств (60, 70) дозирования определенного количества кофейных зерен в мельницу (30) после стадии установки мельницы (30), и
- помол с помощью мельницы (30) упомянутого определенного количества кофейных зерен и, таким образом, выдача таких молотых кофейных зерен до тех пор, пока в мельнице (30) не останется кофейных зерен.
2. Способ по п. 1, дополнительно включающий стадию перемещения мельницы (30), предпочтительно с помощью приводного блока, например двигателя, в одно из разных положений помола после стадии помола.
3. Способ по п. 1 или 2, в котором мельница (30) содержит два размольных элемента (31, 32), которые разнесены на определенное расстояние и выполнены с возможностью перемещения относительно друг друга, чтобы помолоть поступившие кофейные зерна между двумя размольными элементами (31, 32), и дополнительно включающий стадию изменения упомянутого расстояния, чтобы перемещать размольные элементы (31, 32) и, таким образом, мельницу (30) между разными положениями помола.
4",A47J31/42,20250526,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
EP4505917A2,Beverage preparation machine with capsule recognition,"Method for training a capsule recognition module of a machine for preparing and dispensing a beverage, comprising feeding capsules of various types to one or more capsule recognition positions, taking a picture of at least part of each capsule fed at the corresponding capsule recognition position, feeding the captured pictures as image data input to a neural network computing device running a neural network computer program, comparing the output of the neural network computer program with an actual sample capsule, feeding back the result of the comparison to the neural network computer program in order for the neural network computer program to adjust the neural network parameters, wherein the training of the capsule recognition module is completed when the result from the comparison is equal to, or above, a desired rate of successful recognition.","<div class=""indep-clm"" num=""1""><seg-main>1.  A method for training a capsule recognition module of a machine for preparing and dispensing a beverage, wherein </seg-main><seg-clauses><seg-main>said capsule recognition module is configured to recognizes a type of a capsule by capturing an image of said capsule and feeding it as input to a trained neural network computing device, wherein the method comprises: </seg-main><seg-clauses>- feeding capsules of various types to one or more capsule recognition positions; </seg-clauses><seg-clauses>- taking a picture of at least part of each capsule fed at the corresponding capsule recognition position; </seg-clauses><seg-clauses>- feeding the captured pictures as image data input to a neural network computing device running a neural network computer program; </seg-clauses><seg-clauses>- comparing the output of the neural network computer program with an actual sample capsule; </seg-clauses><seg-clauses>- feeding back the result of the comparison to the neural network computer program in order for the neural network computer program to adjust the neural network parameters; wherein the training of the capsule recognition module is completed when the result from the comparison is equal to, or above, a desired rate of successful recognition.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The method according to the preceding claim, wherein </seg-main><seg-clauses>the neural network parameters comprises at least one between weights and biases of one or more synaptic connections of the neural network computer program.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The method according to one of the preceding claims, wherein </seg-main><seg-clauses>the training of the neural network computer program is performed on a training bench outside the beverage preparation machine.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4.  The method accordin",A47J31/44,20250212,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2021403857A9,Compositions for use in promoting accelerated butyrate production in young children,"The present invention relates to composition comprising 2'-FL for use in promoting accelerated butyrate production in the gut thereby preventing and/or treating a health disorder, and/or promoting a health benefit in young children consuming the composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-comp>2-fucosylactose (2’-FL), for use in promoting accelerated butyrate production in the gut of the young child consuming the nutritional compositionin to prevent and/or treat a health disorder, and/or to promote a health benefit in young childwherein the health disorder is selected from the list consisting of </seg-comp><seg-comp>inflammation, infections, allergies, metabolic health disorders such as obesity later in life, type 2 diabetes, insulin resistance, and/or wherein the health benefit is selected from the list consisting of gut maturation, gut brain axis connection, colonic healing especially in case of colitis, anti-cancer effects.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A nutritional composition for use according to any of the preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-refi>promotion of butyrate production occurs within 4, for example 3, for example 2 or for example 1, weeks from start of consumption of the nutritional composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. A nutritional composition for use according to claim 9, </seg-con><seg-trans>wherein </seg-trans><seg-refi>gastrointestinal</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A nutritional composition for use according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>2’FL is present in an amount of 0.005 to 8 g/L or 0.004 to 6.8 g/100g of composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A nutritional composition for use according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises human milk oligosaccharides consisting of 2’-FL.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A nu","A23L33/125, A23C9/20, A23L33/00, A61K31/702, A61K45/06",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025114593A1,Nutritional composition for promoting emotional development,"The present invention relates to a nutritional composition comprising osteopontin as an active ingredient for use in promoting emotional development in a young individual, preferably in an infant. The present invention further relates to uses and methods for promoting emotional development in a young individual, preferably in an infant.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>osteopontin as an active ingredient in an effective amount for use in promoting emotional development in a young individual.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>osteopontin is comprised at amount ranging from at least about 50 ng/pL to at least about 900 ng/pL.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The composition as claimed in anyone of the preceding claims, for use in promoting regulation of emotions and/or behavior or regulation domain on Infant Behavior Questionnaire- Revised (IBQ-R) scale in a young individual.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the young individual is an infant, a toddler or a young child, preferably an infant.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>it is administered to the young individual from birth to about 5 years of age, preferably from birth to 18 weeks of age, more preferably during first 6 weeks of life of the young individual.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The composition according to anyone of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>emotional development is promoted in a young individual from birth to about 5 years of age, preferably from birth to 18 months of age, more preferably from about 2 to about 6 months of age, more preferably in about 3 months of age.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. The composition according to any one of the preceding claims, </seg-con><s","A61K38/19, A61P25/22, A61P25/24, A61P43/00",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12338044B2,Attachment for a beverage container,"An attachment for a beverage container may include a cap configured to attach to an opening in the beverage container. The cap includes an opening. The attachment also include a tube passing through the cap. A beverage in the beverage container can flow through the tube and out of the opening in the cap. The attachment also includes a container attached to the tube and configured to hold a liquid. The container includes an opening to allow the liquid to flow from the container into the tube and out of the opening in the cap. The attachment also comprises a restrictor between the opening of the container and the tube, such that the liquid begins to exit the opening in the cap before the beverage begins to exit the opening in the cap.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage dispensing system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>an attachment comprising a cap attached to a beverage container opening in a beverage container, the cap comprising a cap opening and a tube passing through the cap, wherein the cap opening is located proximate to a first end of the tube, and a second end of the tube is located within the beverage container with the cap attached to the beverage container, such that the attachment is configured for a beverage contained in the beverage container to flow through the tube and out of the cap opening, the cap further comprises a liquid container attached to the tube and configured to hold a liquid, the liquid container comprising a liquid container opening to allow the liquid to flow from the container into the tube and out of the cap opening, the cap further comprises a restrictor between the liquid container opening and the tube for controlling and restricting the flow of the liquid from the liquid container into the tube, the cap further comprising a second restrictor within the tube, the restrictor, the second restrictor, and the tube configured such that the liquid begins to exit the cap opening before the beverage begins to exit the cap opening; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the beverage container comprising the beverage container opening, wherein the attachment is attached to the beverage container opening.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. An attachment for a beverage container, the attachment </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""2""><seg-refi>a cap configured to attach to an opening in the beverage container, the cap comprising an opening;</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>a tube passing through the cap, wherein the opening in the cap is located proximate to a first end of the tube","B65D51/28, A47G19/22, B65D1/32, B65D81/32, G01F11/04",20250624,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119699586A,Nutritional composition and infant formula for promoting brain myelination,"The present invention relates to nutritional compositions and infant formulas that promote brain myelination. More specifically, the present invention relates to nutritional compositions for infants and young children and related health benefits. In particular, the present invention relates to a nutritional composition comprising a vitamin or a mixture thereof for promoting or supporting an optimal myelination trajectory in the brain, such trajectory being close to the trajectory observed in infants fed only with human breast milk (HBM) several months before life.","<div class=""indep-clm"" num=""1"">1.一种用于婴儿和/或幼儿的营养组合物，所述营养组合物包含维生素或其混合物，用于促进和/或支持脑中的最佳髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述脑中的最佳髓鞘形成轨迹接近于在出生后早期几个月中仅用人类母乳喂养的婴儿中所观察到的髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的组合物，其中所述组合物促进和/或支持通过最佳的脑和认知功能发育和/或防止神经认知缺陷所表征的健康状态。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，所述组合物包含高于50mcg/100g的量的叶酸和/或高于0.01mcg/100g的量的维生素B12。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，所述组合物还包含铁。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，所述组合物还包含DHA。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的组合物，所述组合物还包含鞘磷脂。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的组合物，其中所述组合物还包含胆碱。</div>
<div class=""indep-clm"" num=""9"">9.权利要求1至8中任一项所述的组合物用于促进和/或支持婴儿或幼儿脑中的最佳髓鞘形成轨迹的用途。</div>
<div class=""indep-clm"" num=""10"">10.权利要求1至8中任一项所述的组合物用于防止婴儿或幼儿脑中未达最佳的髓鞘形成轨迹的用途。</div>
<div class=""indep-clm"" num=""11"">11.用于促进和/或支持婴儿和/或幼儿脑中的最佳髓鞘形成轨迹的方法，所述方法包括给所述婴儿和/或幼儿施用包含叶酸的营养组合物。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中将权利要求1至8中任一项所述的组合物施用给婴儿和/或幼儿。</div>
<div class=""indep-clm"" num=""13"">13.一种营养组合物，所述营养组合物包含：</div>
<div class=""indep-clm"" num=""13"">高于200mg/kg的量的鞘磷脂；</div>
<div class=""indep-clm"" num=""13"">高于5mg/100g的量的铁；</div>
<div class=""indep-clm"" num=""13"">高于30mg/100g的量的胆碱；</div>
<div class=""indep-clm"" num=""13"">高于30mg/100g的量的DHA；</div>
<div class=""indep-clm"" num=""13"">高于50mcg/100g的量的叶酸；和或高于0.01mcg/100g的量的维生素B12。</div>
<div class=""indep-clm"" num=""14"">14.一种营养组合物，所述营养组合物包含：</div>
<div class=""indep-clm"" num=""14"">在200mg/kg至2g/kg范围内的量的鞘磷脂；</div>
<div class=""indep-clm"" num=""14"">在5mg/100g至40mg/100g范围内的量的铁；</div>
<div class=""indep-clm"" num=""14"">在30mg/100g至1000mg/100g范围内的量的胆碱；</div>
<div class=""indep-clm"" num=""14"">在30mg/100g至300mg/100g范围内的量的DHA；</div>
<div class=""indep-clm"" num=""14"">在50mcg/100g至500mcg/100g范围内的量的叶酸；高于0.1mcg/100g至10mcg/100g的量的维生素B12。</div>","A23L33/15, A23L33/16, A23L33/12, A23L33/10, A23L33/115",20250328,雀巢产品有限公司,['Pending']
AU2023355747A1,Beverage preparation machine,"The invention concerns a beverage preparation machine for preparing a beverage from a beverage ingredient pod, said machine comprising : - an extraction device comprising upstream and downstream pod enclosing parts (1, 2) relatively movable, - a liquid supply system, - a motor (10) to actuate the movement of at least one of the upstream and downstream container enclosing parts (1, 2), wherein the liquid supply system comprises : - a first peristaltic valve (741) to enable the supply of the common connector with water either from a cold tube or from a hot tube, - a second peristaltic valve (742) to enable the supply of a first tube or a second tube with water, and wherein the machine comprises mechanical triggers attached to at least one of the movable pod enclosing parts, said triggers being designed and positioned so as to close or open water paths in the tubes (751, 752, 771, 772) and pod paths according to the movement of at least one of the upstream and downstream pod enclosing parts (1, 2) during the sequence of preparation of a beverage from the pod.",,"A47J31/36, A47J31/46",20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120225570A,Multi-layer metallized paper-based packaging material,"The present invention relates to an oxygen barrier substrate comprising or consisting of a graft copolymer comprising a vinyl alcohol polymer backbone and polypeptide branches. The invention also relates to a packaging material, in particular a multilayer metallized paper-based packaging material, comprising at least one oxygen barrier layer comprising or consisting of a graft copolymer comprising a vinyl alcohol polymer backbone and polypeptide branches.","<div class=""indep-clm"" num=""1"">1.氧气阻隔基材，所述氧气阻隔基材包含接枝共聚物或由接枝共聚物组成，所述接枝共聚物包含乙烯醇聚合物主链和多肽支链。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的氧气阻隔基材，其中所述乙烯醇聚合物主链是聚乙烯醇(PVOH)、乙烯-乙烯醇(EVOH)、丁烯二醇-乙烯醇共聚物(BVOH)或其组合，优选地其中所述乙烯醇聚合物主链是聚乙烯醇(PVOH)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的氧气阻隔基材，其中所述多肽是胶原或其水解形式。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的氧气阻隔基材，其中所述多肽支链通过连接基团与所述乙烯醇聚合物主链偶联，任选地其中所述接枝共聚物包括下式：</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><img src="""" class=""img-anchor"" img-id=""FDA0005387895640000011""></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的氧气阻隔基材，其中所述多肽支链通过多元羧酸或其酸酐与所述乙烯醇聚合物主链偶联，任选地其中所述接枝共聚物包括下式：</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><img src="""" class=""img-anchor"" img-id=""FDA0005387895640000012""></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的氧气阻隔基材，其中所述多肽支链通过下列与所述乙烯醇聚合物主链偶联：</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">(a)三羧酸或其酸酐；任选地其中所述三羧酸或其酸酐选自柠檬酸、异柠檬酸、乌头酸或丙三羧酸或其酸酐中的一者或多者；优选地其中所述三羧酸或其酸酐是柠檬酸或其酸酐；更优选地其中所述三羧酸或酸酐是柠檬酸；或</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">(b)二羧酸或其酸酐；任选地其中所述二羧酸或其酸酐选自丙二酸、琥珀酸、戊二酸、己二酸、庚二酸、辛二酸、壬二酸或癸二酸或其酸酐中的一者或多者；优选地其中所述二羧酸或其酸酐是琥珀酸或其酸酐；更优选地其中所述二羧酸或其酸酐是琥珀酸酐。</div>
<div class=""indep-clm"" num=""7"">7.包装材料，所述包装材料包含根据权利要求1至6中任一项所述的氧气阻隔基材。</div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-con>8.根据权利要求7所述的包装材料，其中所述包装材料是多层金属化纸基包装材料(1)，所述多层金属化纸基包装材料从其外侧到其内侧</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-refi>(i)纸层(2)，所述纸层的克重在30g/m<sup>2</sup>至120g/m<sup>2</sup>的范围内，</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-refi>(ii)至少一个有机阻隔层(3)，所述至少一个有机阻隔层的量为0.5g/m<sup>2</sup>至20g/m<sup>2</sup>，其中至少一个有机阻隔层包含根据权利要求1至6中任一项所述的氧气阻隔基材或由所述氧气阻隔基材组成，</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-refi>(iii)至少一个无机阻隔层(4)，所述至少一个无机阻隔层选自以下项的列表：金属、准金属或其组合，所述无机层的厚度为1nm至100nm，和(iv)至少一个有机热密封层(5)，所述至少一个有机热密封层包含能够热密封的聚合物，所述热密封层(5)以由2g/m<sup>2</sup>至20g/m<sup>2</sup>的量组成的量施加，任选地其中所述有机层中的每个","C08F8/30, C08F8/32, B32B27/10, B32B27/30",20250627,雀巢产品有限公司,['Pending']
US12329310B2,Beverage preparation machine with capsule recognition,"Machine for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food, comprising a capsule recognition module for recognizing a capsule inserted in said machine at a capsule recognition position, the capsule recognition module comprising a camera for capturing an image of at least part of said capsule in said capsule recognition position; wherein the capsule recognition module comprises a neural network computing device, said neural network computing device being configured to determine a type of said capsule amongst a plurality of predefined capsule types on the basis of an image of at least part of said capsule captured by said camera.","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing and dispensing a beverage, the machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>an extraction unit configured for extracting a capsule to form the beverage;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control unit configured for controlling the extraction unit to extract the capsule;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>an outlet for dispensing the beverage formed by extracting the capsule to a user-receptacle,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a capsule recognition module for recognizing the capsule inserted in the machine at a capsule recognition position, the capsule recognition module comprising a camera for capturing a digital image of at least part of the capsule in the capsule recognition position; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the capsule recognition module comprising a light source and a neural network computing device, the neural network computing device being configured to determine a type of the capsule amongst a plurality of predefined capsule types on the basis of the digital image of at least part of the capsule captured by the camera,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein lighting from the light source and image capture conditions in the capsule recognition position correspond to training conditions for which the neural network computing device is configured by training to recognize the capsule,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the camera has a fixed position in an enclosure, the enclosure comprising an opening for receiving the capsule, the capsule recognition position arranged in the enclosure, and the light source configured to emit light to the capsule at the capsule recognition position.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The machine according t","A47J31/44, A47J31/52, G06N3/08",20250617,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025219966A1,"Actuator nozzle for aerosol packaging, and methods of making and using such actuator nozzles and aerosol packagings","An actuator nozzle has a lower portion comprising a base configured to connect to a container, and the base includes a lower orifice. The actuator nozzle also has an upper portion including a tapered section on one side of the upper portion, the tapered section tapers inward as the tapered section extends upward from the lower portion, the upper portion further having a substantially vertical section on an opposite side of the upper portion from the tapered section. The actuator nozzle also has an upper orifice in fluid communication with the lower orifice by an interior channel of the actuator nozzle, the upper orifice angled downward from a top of the tapered section of the upper portion to a top of the substantially vertical section of the upper portion.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. An actuator nozzle </seg-con><seg-trans>comprising: </seg-trans><seg-refi>a lower portion comprising a base configured to connect to a container, the base comprising a lower orifice; an upper portion comprising a tapered section on one side of the upper portion, the tapered section tapers inward as the tapered section extends upward from the lower portion, the upper portion further comprising a substantially vertical section on an opposite side of the upper portion from the tapered section; and an upper orifice in fluid communication with the lower orifice by an interior channel of the actuator nozzle, the upper orifice angled downward from a top of the tapered section of the upper portion to a top of the substantially vertical section of the upper portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The actuator nozzle of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the upper orifice has a shape that is oval or semi-circle and has a maximum width at or adjacent to the top of the tapered section.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The actuator nozzle of claim 1 or claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lower portion of the actuator nozzle is substantially symmetrical throughout an entirety of the height of the lower portion.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The actuator nozzle of any of claims 1-3, </seg-con><seg-trans>comprising </seg-trans><seg-refi>one or more pressure points configured to actuate and/or permit actuation of a valve on which the actuator nozzle is mounted.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The actuator nozzle of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more pressure points are positioned on the tapered section of the upper portion.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-c","B65D83/30, B65D83/20",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119212565A,Compositions and methods for dehydrated pet food blends,"The present invention provides compositions and methods relating to dehydrated pet food blends. The dehydrated pet food blend may include from about 15% to about 50% protein, from about 5% to about 40% fat, and from about 5% to about 50% carbohydrate. In addition, the blend may include a semi-wet coarse food, a dry coarse powder, and a dehydrated vegetable.","<div class=""indep-clm"" num=""1"">1.脱水宠物食品共混物，其包含：</div>
<div class=""indep-clm"" num=""1"">约15％至约50％的蛋白质；</div>
<div class=""indep-clm"" num=""1"">约5％至约40％的脂肪；以及</div>
<div class=""indep-clm"" num=""1"">约5％至约50％的碳水化合物；</div>
<div class=""indep-clm"" num=""1"">其中组合物包含半湿粗磨食物、干粗粉和脱水蔬菜。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物具有约10重量％至约30重量％的水分含量。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物以约10重量％至约50重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的脱水宠物食品共混物，其中所述干粗粉具有约5重量％至约12重量％的水分含量。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的脱水宠物食品共混物，其中所述干粗粉以约40重量％至约90重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的脱水宠物食品共混物，其中所述脱水蔬菜具有约1重量％至约10重量％的水分含量。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的脱水宠物食品共混物，其中所述脱水蔬菜以约5重量％至约30重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""8"" parent=""1"">8.根据权利要求1所述的脱水宠物食品共混物，其还包含抗氧化剂、矿物质或维生素，并且还包含防腐剂。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物涂有动物消化物。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的脱水宠物食品共混物，其中所述共混物被配制为完全且营养均衡的宠物食品。</div>
<div class=""indep-clm"" num=""11""><seg-con>11.用于制造脱水宠物食品共混物的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""11""><seg-comp>挤出半湿粗磨食物；</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>挤出干粗磨食物；</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>研磨所述干粗磨食物以形成干粗粉；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>将所述半湿粗磨食物和所述干粗粉与脱水蔬菜混合以形成所述脱水宠物食品共混物。</seg-comp></div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中所述半湿粗磨食物具有约10重量％至约30重量％的水分含量并且以约10重量％至约50重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""13"" parent=""11"">13.根据权利要求11所述的方法，其中所述干粗粉具有约5重量％至约12重量％的水分含量，并且以约40重量％至约90重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""14"" parent=""11"">14.根据权利要求11所述的方法，其中所述脱水蔬菜具有约1重量％至约10重量％的水分含量，并且以约5重量％至约30重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""15"" parent=""11"">","A23K30/20, A23K40/25",20241227,雀巢产品有限公司,['Pending']
EP4556400A1,Capsule and method of producing the same,"A capsule (10) configured for preparing a beverage upon injection of liquid into the capsule (10). The capsule (10) comprises a cup-shaped body (12) including a side wall (14), a top opening (16), and a bottom opening (26). The body (12) has a substantially cylindrical or frusto-conical shape. The body (12) is made of a first multilayer oxygen and/or moisture barrier material (20) comprising a paper or cardboard and an organic and/or inorganic barrier layer. The paper or cardboard has a grammage comprised between 40 and 450 g/m2 and the first material has a cellulose content higher than 30%, preferably higher than 50%, more preferably higher than 90%. The capsule (10) comprises a bottom closure (22) connected to the cup-shaped body (12) to close the bottom opening (26) and a sealing lid (24) connected to the cup-shaped body (12) to close the top opening (16).","<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule (10) configured for preparing a beverage upon injection of liquid into the capsule (10), the capsule (10) comprising: </seg-main><seg-clauses>- a cup-shaped body (12) including a side wall (14), the body (12) having a substantially cylindrical or frusto-conical shape with a top opening (16) and a bottom opening (26), wherein the body (12) is made of a first multilayer oxygen and/or moisture barrier material (20) comprising a paper or cardboard and an organic and/or inorganic barrier layer, the paper or cardboard having a grammage comprised between 40 and 450 g/m<sup>2</sup> and the first material having a cellulose content higher than 30%, preferably higher than 50%, more preferably higher than 90%; </seg-clauses><seg-clauses>- a bottom closure (22) connected to the cup-shaped body (12) to close the bottom opening (26) of the cup-shaped body (12); and </seg-clauses><seg-clauses>- a sealing lid (24) connected to the cup-shaped body (12) to close the top opening (16) of the cup-shaped body (12).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The capsule (10) according to claim 1, wherein </seg-main><seg-clauses>the side wall (14) comprises a top rim or flange (18) surrounding the top opening (16); preferably wherein the top rim or flange (18) is integrally formed with the side wall (14) and/or wherein the top rim or flange (18) extends radially outward and/or away from a longitudinal axis (L) of the capsule (10) from a main section (48) of the side wall (14); and/or wherein the side wall (14) comprises a bottom rim or flange (50) surrounding the bottom opening (26); preferably wherein the bottom rim or flange (50) is integrally formed with the side wall (14) and/or wherein the bottom rim or flange (50) extends radially inward and/or towards a longitudinal axis (L) of the capsule (10) from a main section (48) of the side wall (14).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""",B65D85/804,20250521,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4541729A1,Beverage preparation capsule and method of producing the same,,"<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule (10, 32) configured for preparing a beverage upon injection of liquid into the capsule (10, 32), the capsule (10, 32) comprising: </seg-main><seg-clauses>- a cup-shaped main body (12) including a bottom wall (14) and a side wall (16), </seg-clauses><seg-clauses>- a sealing lid (18) connected to the side wall (16), wherein the lid (18), the bottom wall (14), and the side wall (16) define a compartment for holding beverage preparation ingredients therein, and </seg-clauses><seg-clauses>- a scoring line (24, 34) extending on the lid (18) and being configured for weakening the lid (18).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The capsule (10, 32) of claim 1, wherein </seg-main><seg-clauses>the lid (18) has a substantially circular shape and the scoring line (24, 34) has a substantially circular shape adapted to the substantially circular shape of the lid (18).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The capsule (10, 32) of claims 1 or 2, wherein </seg-main><seg-clauses>the scoring line (24, 34) extends - about 360° around a central point (25) of the lid (18), or </seg-clauses><seg-clauses>- in a range between about 300° and about 360°, preferably in a range between about 310° and about 330° around a central point (25) of the lid (18), or - 330° or less, preferably 310° or less around a central point (25) of the lid (18); </seg-clauses><seg-clauses>- and wherein the scoring line (24, 34) extends along an external periphery of the lid (18) between a central section of the lid and a peripheral rim section of the lid (18), wherein the peripheral rim section is attached to a flange (22) of the side wall (16).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The capsule (10, 32) of any one of claims 1-3, wherein </seg-main><seg-clauses>the scoring line (24, 34) extends in a peripheral rim section of the lid (18), the periphe",B65D85/804,20250423,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4628088A1,Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms,"Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; ""empty"" feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof. These depressive symptoms can be associated with a depressive state or depressive disorder or can be found sub-clinically or not associated with these depressive states/disorders (e.g., not part of a syndrome or psychiatric disorder).","<div class=""indep-clm"" num=""1""><seg-con>1.  An edible composition comprising <i>Bifidobacterium longum</i> ATCC BAA-999 for use in a method of supplementing a regimen for treatment of a depressive symptom, the regimen </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to an individual in need thereof a synthetic pharmaceutical compound, comprising administering an edible composition comprising a therapeutically effective amount or a prophylactically effective amount of <i>Bifidobacterium longum</i> ATCC BAA-999 to the individual, wherein the combination of the synthetic pharmaceutical compound and the edible composition treats the depressive symptom.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  The method of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the depressive symptom is a secondary condition caused by an underlying medical condition selected from the group consisting of an endocrine disease, a cardiovascular disease, a pulmonary disease, a cancer, an autoimmune disease and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3.  The method of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the underlying medical condition is selected from the group consisting of a thyroid abnormality, a heart attack, a chronic obstructive pulmonary disease and rheumatoid arthritis.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  The method of any one of Claims 1-3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises an ingredient selected from the group consisting of a fat, a protein, a carbohydrate and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.  The method of any one of claims Claim 1-4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a prebiotic.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.  The method of Cl","A61K35/745, A61P25/24",20251008,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025119806A1,Recombinant wild type patatin-2 and mutants thereof,"The invention relates a recombinant wild type patatin-2 or mutant thereof. It also relates to polynucleotide expression vector, host cell and method for producing such recombinant proteins. It also relates to composition and product comprising such recombinant proteins.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A recombinant wild type patatin-2 or mutant thereof which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. A recombinant wild type patatin-2 or mutant thereof according to claim 1, which has at least 90% sequence identity to wild type patatin-2.</div>
<div class=""indep-clm"" num=""3""><seg-main>3. A recombinant patatin-2 mutant which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2, and which comprises one or more mutations and/or one or more non-native post-translational modifications (PTMs), wherein said one or more mutations and/or said one or more non-native PTMs reduce or eliminate the lipid acyl hydrolase activity in the recombinant wild type patatin-2 mutant compared to the wild type patatin-2.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A recombinant patatin-2 mutant which comprises </seg-main><seg-clauses>or consists of an amino acid sequence having at least 80% sequence identity to wild type patatin-2, and which comprises one or more mutations selected from the list consisting of S54A and D193A.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A recombinant patatin-2 according to claim 1 or 2 or a recombinant wild type patatin- 2 mutant according to any of claims 1 to 4, wherein </seg-main><seg-clauses>the wild type patatin-2 is a wild type patatin-2 of Solanum tuberosum, preferably wild type patatin-2 of Solanum tuberosum consisting of SEQ ID NO:1.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A recombinant wild type patatin-2 according to claim 1, 2 or 5 or recombinant patatin- 2 mutant according to any of claims 1 to 5 which </seg-main><seg-clauses>does not comprise an amino acid sequence consis","C07K14/415, C12N9/20",20250612,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250327101A1,Bio-recycling of polyesters into pha,A method for producing polyhydroxyalkanoate (PHA) from polyester waste is provided. The method includes the steps of: (a) providing a culture broth comprising polyester waste; and (b) cultivating a microbe in the culture broth to produce PHA. The method may utilize a wide variety of monomers and may proceed via a one-step process.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for producing polyhydroxyalkanoate (PHA) from polyester waste, the method comprising the steps of:</seg-main>
<seg-clauses>(a) providing a culture broth comprising polyester waste; and</seg-clauses>
<seg-clauses>(b) cultivating a microbe in the culture broth to produce PHA, wherein the microbe utilises a plurality of polyester monomers from the polyester waste to produce the PHA.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the microbe is from the genus <i>Paracoccus</i>, optionally wherein the microbe is a <i>Paracoccus denitrificans. </i></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the microbe is <i>Paracoccus denitrificans </i>DSM 413, or a derivative thereof, optionally wherein the microbe is <i>Paracoccus denitrificans </i>DSM 413, <i>Paracoccus denitrificans </i>PD1222, <i>Paracoccus denitrificans </i>CNCM 1-5881, <i>Paracoccus denitrificans </i>ATCC 19367, <i>Paracoccus denitrificans </i>ATCC 17741, <i>Paracoccus denitrificans </i>ATCC 13543, <i>Paracoccus denitrificans </i>NCIB 8944, <i>Paracoccus denitrificans </i>NRRL B-3785, <i>Paracoccus denitrificans </i>CCM 982, <i>Paracoccus denitrificans </i>LMD 22.21, <i>Paracoccus denitrificans </i>JCM 21484, <i>Paracoccus denitrificans </i>NBRC 102528, or <i>Paracoccus denitrificans </i>NCCB 22021.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the polyester waste comprises two or more polyester monomers selected from the group consisting of succinic acid, lactic acid, ethylene glycol, adipic acid, 6-hydroxycaproic acid, 3-hydroxybutyric acid, 3-hydroxyvaleric acid, and 1,4-butanediol.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1,","C12P7/625, C08J11/04, C12R1/01",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023316798A1,Beverage or foodstuff preparation system,"A system (2) comprising a container (6) and a machine (4) for preparing a beverage and/ or foodstuff thereof, the container (6) including: a body portion (62) comprising a storage portion (58) for containing a precursor material; a closing member (56) to close the storage portion (62), and; a machine-readable code (44) storing preparation information, the machine (4) including: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6), and; electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), the code reading system (18) including a code reader (46) to obtain a digital image of the code (44), and the code reading system (18) includes electrical circuitry (16) to determine from the digital image of the code (44) if the container (6) is in a reading position based on a predetermined condition, and if said condition is met, then the electrical circuitry (16) configured to process the code (44) to extract the preparation information in the reading position.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container and a machine for preparing a beverage and/or foodstuff thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body portion comprising a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine-readable code storing preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code of the container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information read from the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the code reading system including a code reader to obtain a digital image of the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and the code reading system includes electrical circuitry to determine from the digital image of the code if the container is in a reading position based on a predetermined condition of the digital image of the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and if said condition is met, then the electrical circuitry configured to process the code to extract the preparation information in the reading position.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the predetermined condition is based on a geometric property of the code.</seg-refi></div>
<di","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119277978A,Coffee brewing equipment,"The invention relates to a fully automatic coffee machine (100) comprising: a brewing chamber (1), an upper piston (2), a lower piston (3) which can be moved within the brewing chamber (1), the brewing chamber and/or the upper piston is relatively movable between a first closed position configured to compact coffee during brewing and a second closed position configured to not compact coffee during brewing; -a pressurized hot water fluid system comprising at least a water supply system (101), a water heating device (104) and a water pump (102), where the system is connected to the water inlet (13) of the coffee extraction unit, where the fluid supply system comprises a pressure bypass valve (107) downstream of the water pump, and where the fluid supply system comprises a pressure bypass valve (107) downstream of the water pump. The predetermined threshold pressure of the fluid dispensed by said pressure bypass valve is adjustable, and wherein the fully automatic coffee machine comprises a control system configured to:-move the brewing chamber and/or the upper piston to the first closed position or the second closed position for brewing coffee powder; and-adjusting a predetermined threshold pressure of the fluid dispensed by the pressure bypass valve to a first predetermined threshold pressure and a second predetermined threshold pressure, respectively, when the brewing chamber and/or the upper piston are moved to the first closed position and the second closed position, respectively.","<div class=""indep-clm"" num=""1""><seg-con>1.全自动咖啡机(100)，所述机器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-咖啡提取单元(10)，所述咖啡提取单元包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.冲泡腔室(1)，所述冲泡腔室用于接收经烘焙并且研磨的咖啡粉，所述腔室包括上部边缘(12)和底壁(11)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.上部活塞(2)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.所述上部活塞被配置为能够移动穿过所述冲泡腔室的所述上部边缘，并且在所述冲泡腔室内进一步移动以使所述冲泡腔室和所述上部活塞相对移动，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.进水口(13)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.液体出口导管(21)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.下部活塞(3)，所述下部活塞能够在所述冲泡腔室(1)内在以下位置之间移动：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.最低位置，其中，所述下部活塞位于所述冲泡腔室的所述底壁(11)处，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.最高位置，其中，所述下部活塞位于所述冲泡腔室的所述上部边缘(12)处，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.咖啡渣的排放装置(4)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.其中，所述冲泡腔室和/或所述上部活塞能够在以下位置之间相对移动：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.打开位置，用于引入经烘焙并且研磨的咖啡粉或排出提取后的经烘焙并且研磨的咖啡粉；和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.至少两个不同的第一关闭位置和第二关闭位置，所述至少两个不同的第一关闭位置和第二关闭位置被配置用于冲泡经烘焙并且研磨的咖啡粉，其中，所述第一关闭位置被配置用于在冲泡期间压实咖啡，并且所述第二关闭位置被配置用于在冲泡期间不压实咖啡，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-加压热水流体系统，所述加压热水流体系统至少包括供水系统(101)、水泵(102)和优选地水加热装置(104)，其中，所述系统连接到所述咖啡提取单元的所述进水口(13)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，所述流体供应系统包括在所述水泵下游的压力旁通阀(107)，并且其中，由所述压力旁通阀分配的所述流体的预先确定的阈值压力是能够调节的，优选地能够由机动致动器(1071)调节，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，所述全自动咖啡机包括控制系统，所述控制系统被配置为：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-将所述冲泡腔室和/或所述上部活塞移动到所述第一关闭位置或所述第二关闭位置，用于冲泡经烘焙并且研磨的咖啡粉，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-当所述冲泡腔室和/或所述上部活塞分别处于所述第一关闭位置和所述第二关闭位置时，将由所述压力旁通阀分配的所述流体的所述预先确定的阈值压力分别调节到第一预先确定的阈值压力和第二预先确定的阈值压力。</seg-refi><","A47J31/36, A47J31/46, A47J31/06",20250107,雀巢产品有限公司,['Pending']
EP4501403A2,Engineered lipase variants,"The present invention provides engineered lipase polypeptides and compositions thereof. The engineered lipase polypeptides have been optimized to provide improved thermostability, protease stability, and stability under a range of pH conditions, including acidic (pH <7) and basic (pH >7) conditions. The invention also relates to the use of compositions comprising the engineered lipase polypeptides for therapeutic and/or nutritional purposes. The present invention also provides polynucleotides encoding the engineered lipase polypeptides, as well as methods for making the engineered polynucleotides and lipase polypeptides.","<div class=""indep-clm"" num=""1""><seg-main>1.  A recombinant lipase comprising </seg-main><seg-clauses>a polypeptide sequence having at least 95%, sequence identity to SEQ ID NO: 868.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The recombinant lipase of Claim 1, wherein </seg-main><seg-clauses>said polypeptide sequence comprises at least one substitution or substitution set at one or more positions selected from 24, 38, 49, 70, 149, 161, 174, 175, 189, 193, 225, 231, 243, 252, 271, 287, 292, 293, 296, 303, 334, 344, 373, and 385, wherein the amino acid positions of the polypeptide sequence are numbered with reference to SEQ ID NO: 868.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The recombinant lipase of any of Claims 1-2, wherein: </seg-main><seg-clauses>(i) said recombinant lipase is more thermostable than the lipase of SEQ ID NO: 2; and/or </seg-clauses><seg-clauses>(ii) said recombinant lipase is more stable at acidic pH levels, than the lipase of SEQ ID NO: 2; and/or </seg-clauses><seg-clauses>(iii) said recombinant lipase is more resistant to proteolysis than the lipase of SEQ ID NO: 2; and/or </seg-clauses><seg-clauses>(iv) said recombinant lipase is more active in the presence of at least one bile salt than the lipase of SEQ ID NO: 2.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The recombinant lipase of any of Claims 1-3, wherein </seg-main><seg-clauses>said recombinant lipase is purified.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  The recombinant lipase of any of Claims 1-4, wherein </seg-main><seg-clauses><seg-main>said recombinant lipase exhibits at least one improved property selected from: </seg-main><seg-clauses>i) enhanced catalytic activity; </seg-clauses><seg-clauses>ii) increased tolerance to acid pH; </seg-clauses><seg-clauses>iii) increased tolerance to pH 3.5; </seg-clauses><seg-clauses>iv) increased tolerance to pH ",A61P5/48,20250205,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12245717B2,System for multi-ingredient beverage preparation from various container types,"A beverage preparation machine includes a fluid system comprising a fluid source, a pump, a heating element, at least two container holders adapted for receiving ingredient containers, and a control unit for controlling the fluid system to prepare a beverage by mixing fluid with the beverage ingredient contained in the containers to produce a mixed beverage component in each of the containers. The control unit is further arranged to dispense part or whole of the mixed components sequentially or simultaneously to produce the beverage. The container holders differ from one another for holding containers of different sizes and/or types. Separate fluid injection interfaces have different structural and kinematic configurations and are arranged for independently delivering fluid in one of the corresponding ingredient containers. Each interface is connected to the fluid system and adapted to a different container.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage preparation machine </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fluid system comprising a fluid source, a fluid pump, a fluid heating element, a first container holder and a second container holder, wherein each of the first and second container holders are adapted for receiving a corresponding first beverage ingredient container and second beverage ingredient container, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control unit arranged for controlling the fluid system to prepare a beverage by mixing fluid with the beverage ingredients contained in the first and second beverage ingredient containers to produce a beverage component in each of the first and second beverage ingredient containers and to dispense at least a portion of each of the beverage components of the first and second beverage ingredient containers at least sequentially in a controlled manner to produce the beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the first and second container holders differ from each other for holding the first and second beverage ingredient containers of different sizes and types, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the beverage preparation machine further comprises a first fluid delivery interface and a second fluid delivery interface which are separate and respectively arranged for independently delivering the fluid in the corresponding first and second beverage ingredient containers, each of the first and second fluid delivery interfaces being connected to the fluid system and being adapted to the different first and second beverage ingredient containers,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the separate first and second fluid delivery interfaces have different structural and kinematic configurations,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the different kinematic configu","A47J31/36, A47J31/40, A47J31/46",20250311,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2851643C1,Cocoa product and method for its production,"FIELD: food industry.SUBSTANCE: cocoa product is disclosed having a ratio of epicatechin in mas.% to theobromine in mas.% of from 0.2 to 1.2, a ratio of procyanidin C1 in mas.% to theobromine in mas.% of 0.005 to 0.3, and a ratio of procyanidin B2 in mas.% to theobromine in mas.% of 0.04 to 0.3. Its use in the production of a ready-to-drink beverage or powdered beverage or for use in a capsule and/or beverage preparation system and a method for producing this product are also described.EFFECT: product with a natural pleasant taste, colour and aroma, having improved solubility and increased antioxidant properties.13 cl, 3 dwg, 5 tbl, 3 ex","1. Какао-продукт, имеющий соотношение эпикатехина в мас.% и теобромина в мас.%, составляющее от 0,2 до 1,2, соотношение процианидина C1 в мас.% и теобромина в мас.%, составляющее от 0,005 до 0,3, и соотношение процианидина B2 в мас.% и теобромина в мас.%, составляющее от 0,04 до 0,3.
2. Какао-продукт по п. 1, содержащий от 0,8 мас.% до 4 мас.% эпикатехина.
3. Какао-продукт по п. 1 или 2, содержащий от 0,01 мас.% до 1 мас.% процианидина C1.
4. Какао-продукт по любому из предшествующих пунктов, содержащий от 0,15 мас.% до 1 мас.% процианидина B2.
5. Какао-продукт по любому из предшествующих пунктов, содержащий от 145 мкг/кг до 8000 мкг/кг алкильных и фенильных алкеналей.
6. Какао-продукт по любому из предшествующих пунктов, содержащий от 10 мкг/кг до 1000 мкг/кг 2-изопропил-5-метил-2-гексеналя и от 10 мкг/кг до 1000 мкг/кг 4-метил-2-фенил-2-пентеналя.
7. Какао-продукт по любому из предшествующих пунктов, причём указанный ингредиент находится в форме жидкости, концентрата, экстракта или порошка.
8. Какао-продукт по любому из предшествующих пунктов, который смешивают с обжаренным и молотым кофе, растворимым порошкообразным кофе, экстрактом кофе, молочным продуктом, немолочным или молочным забеливателем, цикорием или их комбинацией.
9. Применение какао-продукта по любому из предшествующих пунктов для получения готового к употреблению напитка или порошкообразного напитка или для использования в капсуле и/или системе для приготовления напитков.
10. Способ получения какао-продукта по пп. 1-8, включающий стадии
a. обеспечения обжаренных и измельченных какао-бобов;
b. получения экстракта из указанных обжаренных и измельченных какао-бобов с использованием воды при температуре от 95°C до 115°C при коэффициенте вытяжки от 2 до 4 в течение 20–40 минут;
c. получения дополнительного экстракта из обжаренных и измельченных какао-бобов со стадии b) с использованием воды при температуре от 160°C до 180°C при коэффициенте вытяжки от 2 до 4 в течение 20–40 минут.
11. Способ по п. 10, доп","A23G1/32, A23G1/56",20251126,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
RU2842290C2,Diagnosis and treatment of chronic kidney disease in felines,"FIELD: biotechnology.SUBSTANCE: disclosed is a method for diagnosing chronic kidney disease in felines, comprising measuring the absolute value of the representation of faecal bacteria, including Faecalibacterium, Turicibacter, Streptococcus, Bifidobacterium, Bacteroides, Escherichia coli and Clostridium hiranonis; calculating a dysbiosis index based on faecal bacteria; determining that the feline has chronic kidney disease if the dysbiosis index is greater than or equal to 0.5; and a method of treating or delaying the progression of chronic kidney disease in a cat, comprising diagnosing chronic kidney disease (CKD) in a feline and recommending a composition for the feline that treats or delays the progression of CKD in the feline.EFFECT: inventions provide a wider range of methods for diagnosing chronic kidney disease in a cat on the basis of a specific microbiome, including a dysbiosis index.6 cl, 5 tbl, 1 ex","1. Способ диагностики хронического заболевания почек у животного семейства кошачьих, включающий:
измерение абсолютного значения степени представленности фекальных бактерий, включаяFaecalibacterium,Turicibacter,Streptococcus,Bifidobacterium,Bacteroides,E. coliиC. hiranonis;
вычисление индекса дисбиоза на основе фекальных бактерий; и
определение того, что животное семейства кошачьих имеет хроническое заболевание почек, если индекс дисбиоза превышает или равен 0,5.
2. Способ по п. 1, в котором фекальные бактерии включают в себяBlautia.
3. Способ по п. 1, в котором фекальные бактерии включают в себяFusobacterium.
4. Способ по п. 1, дополнительно включающий определение того, что животное семейства кошачьих имеет раннюю стадию хронического заболевания почек, если индекс дисбиоза составляет от 0,5 до 1,2.
5. Способ по п. 1, дополнительно включающий определение того, что животное семейства кошачьих имеет позднюю стадию хронического заболевания почек, если индекс дисбиоза превышает 1,2.
6. Способ обеспечения лечения или замедления прогрессирования хронического заболевания почек у животного семейства кошачьих, включающий диагностику хронического заболевания почек (CKD) у животного семейства кошачьих по п. 1 и рекомендацию композиции для животного семейства кошачьих, причем композиция лечит или замедляет прогрессирование CKD у животного семейства кошачьих.","C12Q1/04, G01N33/48",20250624,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ СА,['Active']
US20250140375A1,Methods and devices for improving sleep quality and/or subsequent behavioural outcomes,"An aspect is a method of improving sleep quality and/or subsequent behavioural outcomes. The method includes providing a dietary recommendation by evaluating a parameter of the individual selected from the group consisting of sleep time, gender, age, BMI, PA, glycemic status, food preference, food sensitivity, caloric intake, nutrients, meal glycemic load, time of consumption and combinations thereof, providing a nutritional composition based on the dietary recommendation, and administering the nutritional composition to the individual. The nutritional composition is selected from the group consisting of a first composition comprising alpha-casozepine, a second composition comprising tryptophan, a third composition comprising mulberry leaf extract, and combinations thereof. Another aspect is a non-transitory computer-readable medium storing a program that causes a device to provide a dietary recommendation and order a nutritional composition based on the dietary recommendation. Yet another aspect is a device comprising a non-transitory computer-readable medium disclosed herein.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of improving sleep and/or subsequent behavioural outcomes of an individual in need thereof by a device having </seg-main><seg-clauses>one or more processors, the method comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">receiving an input from the individual, wherein the input comprises at least one of sleep quality, gender, age, body mass index, physical activity level, glycemic status, food preference, or food sensitivity,</seg-clauses>
<seg-clauses class=""seg-enter"">evaluating, by the device, a need of the individual, wherein the need is selected from the group consisting of improving sleep quality, improving falling asleep, improving sleep maintenance, maintaining sleep quality, and combinations thereof, and</seg-clauses>
<seg-clauses class=""seg-enter"">generating, by the device via an application interface and based on the input from the individual, a nutritional rule and the need of the individual, a recommendation for the individual, wherein the recommendation comprises at least one of a dietary plan comprising at least one of a recipe, a food item, a food product, or a diet tip, a dietary restriction on at least one of food sensitivity, sleep complain, or sleep comorbidity, a diet optimization of at least one of caloric intake, nutrient, meal glycemic load, or time of consumption, or sleep enhancing recommendation.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1 further comprising </seg-main><seg-clauses>assessing the individual's sleep quality.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the input comprises sleep quality,</seg-clauses>
<seg-clauses class=""seg-enter"">the method further comprising</seg-clauses>
<seg-clauses class=""seg-enter"">adopting the recommendation by the individual; and</seg-clauses>
<seg-clauses class=""seg-enter"">reassessing, by the device, the indivi","G16H20/60, A61B5/00, G16H10/60",20250501,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12458053B2,System for roasting coffee beans,"The invention concerns a system for roasting coffee beans comprising: —a roasting apparatus (<b>1</b>), said apparatus producing smoke, and—a smoke treating unit (<b>2</b>) configured to collect and treat smoke produced by the roasting apparatus, wherein: —the roasting apparatus comprises a smoke outlet (<b>11</b>), and—the smoke treating unit comprises: a smoke inlet (<b>21</b>) configured to cooperate with the smoke outlet of the roasting apparatus, a smoke filtering sub-unit (<b>22</b>) comprising at least an active carbon filter (<b>221</b>), a smoke driver (<b>23</b>) configured to circulate smoke through the smoke treating unit from the smoke collecting device to an outlet (<b>25</b>) of the smoke treating unit, wherein the smoke treating unit (<b>2</b>) comprises an air inlet (<b>24</b>) configured to mix the smoke produced by the roasting apparatus (<b>1</b>) with ambient air before the smoke is circulated through the smoke filtering sub-unit (<b>22</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A system for roasting coffee beans, the system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a roasting apparatus, the roasting apparatus configured to produce smoke, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a smoke treating unit configured to collect and treat smoke produced by the roasting apparatus,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the roasting apparatus comprises a smoke outlet, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the smoke treating unit comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a smoke inlet configured to collect smoke,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a smoke filtering sub-unit, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a smoke driver configured to circulate smoke through the smoke treating unit from the smoke collecting device to an outlet of the smoke treating unit, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the system comprises an air inlet device configured to mix the smoke produced by the roasting apparatus with ambient air in order to control the temperature of the smoke inside the smoke filtering sub-unit, wherein the air inlet device is positioned at a position that is upstream the smoke filtering sub-unit,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the air inlet device comprises a wall extending between the smoke outlet and the smoke inlet, wherein the wall includes at least one hole.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the smoke filtering sub-unit comprises at least an active carbon filter.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The system according to claim 2, </seg-con>","A23N12/12, B01D46/00, B01D46/44, B01D53/02",20251104,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250287972A1,Aerated confectionery,"The invention relates to a water-based aerated confectionery product and methods of making the same. In particular, the invention relates to stable acidic aqueous mousses comprising aggregated whey protein and sugar. In one aspect, the invention provides a water-based aerated confectionery having a pH less than 5.5 and a water activity less than 0.67, wherein the aerated confectionery comprises 30 wt % to 90 wt % sugar and between 1 wt % to 8 wt % protein. The protein stabilises the water-based aerated confectionery.","<div class=""indep-clm"" num=""1""><seg-main>1. A water-based aerated confectionery, wherein </seg-main><seg-clauses>the water-based aerated confectionery:</seg-clauses>
<seg-clauses class=""seg-enter"">has a pH less than 5.5; and</seg-clauses>
<seg-clauses class=""seg-enter"">has a water activity less than 0.67; and</seg-clauses>
<seg-clauses class=""seg-enter"">comprises 30 wt % to 90 wt % sugar;</seg-clauses>
<seg-clauses class=""seg-enter"">comprises between 1 wt % to 8 wt % protein,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the protein stabilises the water-based aerated confectionery.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the confectionery is a mousse or a foam.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the confectionery has a pH between 2 and 5.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is aggregated.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is whey protein.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A water-based aerated confectionery according to claim 1, wherein </seg-main><seg-clauses>the protein is present in an amount at least 2 wt % of the aerated confectionery.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. A water-based aerated confectionery according to claim 1, comprising </seg-main><seg-clauses>sugar at between 40 wt % and 90 wt %, wherein the sugar comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">at least two different sugars; or</seg-clauses>
<seg-clauses class=""seg-enter"">an invert","A23G3/52, A23G3/34, A23G3/44, A23G3/46, A23G3/48",20250918,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120152705A,Thymol or carvacrol for reducing biological age or rate of increase thereof,"The present disclosure relates generally to compositions and methods for reducing the biological age and/or reducing the rate of biological age increase in an adult animal. More specifically, the present disclosure relates to administering formulations comprising an effective amount of thymol and/or carvacrol, alone or in combination with a dietary regimen such as caloric restriction, elderly diet or low protein diet. The preparation can simultaneously reduce the biological age of tissues, organs or physiological systems in the adult animal in need; or treating, preventing or delaying the onset of organ disease, or the decline of organ function, or a condition associated therewith, in an adult animal in need thereof.","<div class=""indep-clm"" num=""1""><seg-con>1.用于降低有需要的成年动物的生物学年龄和/或降低有需要的成年动物的生物学年龄增加速率的方法，所述方法</seg-con><seg-trans>包括：</seg-trans><seg-refi>向所述成年动物饲喂包含有效量的百里酚和/或香芹酚的组合物。</seg-refi></div>
<div class=""indep-clm"" num=""2"">2.用于降低有需要的成年动物中的组织、器官或生理系统的生物学年龄的方法，所述方法包括向所述成年动物饲喂包含有效量的百里酚和/或香芹酚的组合物。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中所述组织、器官或生理系统是免疫、胃肠、泌尿、肌肉、心血管和/或神经系统。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的方法，其中所述组织是骨骼肌。</div>
<div class=""indep-clm"" num=""5"">5.用于治疗、预防或延缓有需要的成年动物的器官疾病的发作、或器官功能的衰退、或与其相关的病症的方法，所述方法包括向所述成年动物饲喂包含有效量的百里酚和/或香芹酚的组合物。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的方法，其中所述有需要的动物具有与其实足年龄相比增加的生物学年龄。</div>
<div class=""dep-clm"" num=""7"" parent=""3"">7.根据权利要求3所述的方法，其中所述增加的生物学年龄由所述成年动物的DNA甲基化图谱确定。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中所述动物是衰老的动物。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的方法，其中所述动物是宠物动物，优选狗或猫。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据任一前述权利要求所述的方法，其中所述动物是人。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据任一前述权利要求所述的方法，其中所述组合物选自食物组合物、膳食补充剂、营养组合物、营养制品、在食用前用水或乳重构的粉末状营养产品、食品添加剂、药物、饮品、干或湿宠物食品及其组合。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求所述的方法，其中所述组合物是以下的一部分；或与以下一起施用：选自热量限制饮食、老年饮食或低蛋白饮食的膳食方案。</div>","A61K31/05, A23K10/00, A23L33/00, A61P43/00, A23K20/111",20250613,雀巢产品有限公司,['Pending']
US20250049818A1,Prenatal supplement compositions for increasing breastmilk micronutrient levels,"A method increases a level of at least one micronutrient, such as vitamin D and/or zinc, in a subject's breastmilk. The method includes administering to the subject a nutritional composition containing at least one of vitamin D and zinc. The nutritional composition can include one or more of vitamins B<sub>2</sub>, B<sub>6 </sub>or B<sub>12</sub>.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for increasing at least one micronutrient level in breastmilk of a subject, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the subject a nutritional composition comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one of vitamin D or zinc.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition is administered to the subject from before pregnancy of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition is administered to the subject until the subject gives birth.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition further comprises at least one of:</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>myo-inositol, probiotics, vitamin B2, vitamin B6, or vitamin B12.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition further comprises at least one of:</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-refi>folic acid, Fe, Ca, I and beta-carotene.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional composition comprises vitamin D and zinc.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the increasing of the at least one micronutrient level is sustained for at least 12 months after the subject gives birth.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1","A61K31/593, A61K31/015, A61K31/047, A61K31/4415, A61K31/519",20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250193976A1,Microwave oven with redistributing element,,"<div class=""indep-clm"" num=""1""><seg-con>1. A microwave oven for heating a food product, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>two solid state microwave sources configured to generate microwaves;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>two microwave emitters configured to emit the microwaves generated by the solid state microwave sources;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a cavity defining a space for receiving the food product, the space being disposed between the microwave emitters; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one redistributing element configured to redistribute the microwaves emitted by at least one of the microwave emitters into the space towards one or more defined target areas within the space.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The microwave oven according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cavity is configured such that the microwaves generated by the solid state microwave sources do not resonate within the ISM band in the range of from 902 MHz to 928 MHz.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The microwave oven according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>each redistributing element comprises at least one of a non-metallic material and a microwave transparent material.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The microwave oven according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>each redistributing element is configured to redistribute the emitted microwaves in at least one of a focused manner and a dispersed manner in the space.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The microwave oven according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>each redistributing element comprises a lens.</seg-refi></div>
",H05B6/72,20250612,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119233761A,Coffee composition,Coffee compositions derived from medium and high yield extracts while also having improved taste and fragrance are disclosed. Methods for producing such coffee compositions are also disclosed.,"<div class=""indep-clm"" num=""1"">1.咖啡组合物，包含糠醇、吡啶和一种或多种单糖，其中所述糠醇与所述吡啶的浓度比大于或等于30；并且所述单糖的浓度总和大于或等于18重量％。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的咖啡组合物，还包含2-乙基-6-甲基吡嗪、2-乙基-5-甲基吡嗪、2-乙基-3-甲基吡嗪、2,3,5-三甲基吡嗪、2-乙基-3,6-二甲基吡嗪、2-乙基-3,5-二甲基吡嗪和2,3-二乙基-5-甲基吡嗪，其中2-乙基-6-甲基吡嗪、2-乙基-5-甲基吡嗪、2-乙基-3-甲基吡嗪、2,3,5-三甲基吡嗪、2-乙基-3,6-二甲基吡嗪、2-乙基-3,5-二甲基吡嗪和2,3-二乙基-5-甲基吡嗪的绝对含量的总和大于或等于50.0mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的咖啡组合物，其中所述糠醇的绝对含量大于或等于2,000mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的咖啡组合物，还包含一种或多种2-乙酰基噻唑、2-乙酰基吡嗪和2-乙酰基吡啶，其中2-乙酰基噻唑、2-乙酰基吡嗪和2-乙酰基吡啶的绝对含量的总和大于或等于2.70mg/kg所述咖啡组合物的可溶性咖啡固形物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的咖啡组合物，还包含2,3-丁二酮，其中所述糠醇与所述2,3-丁二酮的浓度比大于或等于30。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的咖啡组合物，其中基于所述咖啡组合物的干重，所述单糖包含大于或等于8重量％的量的半乳糖。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的咖啡组合物，其中基于所述咖啡组合物的干重，所述单糖包含大于或等于8重量％的量的甘露糖。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的咖啡组合物，还包含2-乙酰基吡嗪和(E)-β-大马烯酮，其中2-乙酰基吡嗪与(E)-β-大马烯酮的浓度比大于或等于40。</div>
<div class=""indep-clm"" num=""9"">9.咖啡组合物，包含大于或等于18重量％的量的一种或多种单糖；和</div>
<div class=""indep-clm"" num=""9"">绝对含量大于或等于50.0的一种或多种烷基吡嗪、绝对含量大于或等于2,000的糠醇、或大于或等于2.70的一种或多种N-杂环化合物。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的咖啡组合物，包含吡啶，其中所述糠醇与所述吡啶的浓度比大于或等于30。</div>
<div class=""dep-clm"" num=""11"" parent=""9,10"">11.根据权利要求9或10中任一项所述的咖啡组合物，还包含2,3-丁二酮，其中所述糠醇与所述2,3-丁二酮的浓度比大于或等于30。</div>
<div class=""dep-clm"" num=""12"" parent=""9,10,11"">12.根据权利要求9至11中任一项所述的咖啡组合物，其中基于所述咖啡组合物的干重，所述单糖包含大于或等于8重量％的量的半乳糖。</div>
<div class=""dep-clm"" num=""13"" parent=""9,10,11,12"">13.根据权利要求9至12中任一项所述的咖啡组合物，其中基于所述咖啡组合物的干重，所述单糖包含大于或等于8重量％的量的甘露糖。</div>
<div class=""dep-clm"" num=""14"" parent=""9,10,11,12,13"">14.根据权利要求9至13中任一项所述的咖啡组合物，还包含2-乙酰基吡嗪和(E)-β-大马烯酮，其中2-乙酰基吡嗪与(E)-β-大马烯酮的浓度比大于或等于40。</div>
<div class=""dep-clm"" num=""15"" parent=""1,2,3,4,5,6,7,8,9,10,11,1","A23F5/24, A23F5/28, A23F5/36",20241231,雀巢产品有限公司,['Pending']
AU2024209345A1,Microbiome ingredient combination for lowering uremic toxins in cardiometabolic or neurodegenerative conditions,"The invention relates to composition for use in lowering or avoiding accumulation of uremic toxins in cardiometabolic or neurodegenerative conditions, particularly compositions that comprise a probiotic bacteria, a prebiotic (carbohydrates or fibers), and a lipid.","<div class=""indep-clm"" num=""1""><seg-main>1. Composition for use in lowering or avoiding accumulation of uremic toxins in cardiometabolic or neurodegenerative conditions, wherein </seg-main><seg-clauses><seg-main>the composition comprises:</seg-main>
<seg-clauses>(a) a probiotic bacterium, selected from probiotic bacteria</seg-clauses>
<seg-clauses>- lacking a gene for producing at least one of urea, uric acid, p-cresol, p-cresyl sulfate, indoxyl sulfate, indole, indole acetic acid, indoxyl, trimethylamine, TMAO, dimethylglycine, betaine and/or glutarate ;</seg-clauses>
<seg-clauses>- lacking at least one bacterial enzyme selected from urease, carnitine monooxygenase & reductase, tryptophanase and/or hydroxyphenylacetate; and/or</seg-clauses>
<seg-clauses>- expressing at least one bacterial enzyme selected from a-galactosidase, P-galactosidase, glucan 1,4-P-glucosidase, cellulase, P-fructofuranosidase and/or Licheninase;</seg-clauses>
<seg-clauses>(b) a prebiotic selected from carbohydrates or fibers, wherein the carbohydrate or fiber can be hydrolyzed by at least one bacterial enzyme selected from a-galactosidase, P-galactosidase, glucan 1,4-P-glucosidase, cellulase, P-fructofuranosidase and/or Licheninase;</seg-clauses>
<seg-clauses>(c) a lipid, selected from a triglyceride, a short chain fatty acid and/or a medium chain fatty acid, wherein the triglyceride comprises, short chain fatty acids, medium chain fatty acids, or a mixture thereof.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the probiotic bacterium </seg-main><seg-clauses><seg-main>(a) is selected from at least one of the following </seg-main><seg-clauses><seg-main>a. to k.:</seg-main>
<seg-clauses>a. Bifidobacterium animalis subspecies lactis NCC 2818 (CNCM 1-3446);</seg-clauses>
<seg-clauses>b. Bifidobacterium longum subspecies infantis NCC 341 (ATCC 15697 (T));</seg-clauses>
","A61K35/747, A61K31/19, A61K31/70, A61P13/12",20250710,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2836281C1,Coffee beans roasting and grinding equipment,"FIELD: coffee industry.SUBSTANCE: disclosed is equipment for roasting and grinding coffee beans, comprising roasting device (50) and associated grinding device (60), wherein roasting device (50) is configured to receive coffee beans of a certain type and comprises reading means (53) for identifying characteristics of coffee beans fed into said device, a control unit which configures the roasting profile of the grains in accordance with the characteristics extracted from reading means (53) and/or according to the characteristics of the grains in data base (51) in this control unit, and/or in accordance with the input data entered by the user, wherein roasted coffee beans are distributed in containers (10, 20) for beans, wherein containers (10, 20) for grains contain programmable identification means, wherein parameters of roasted coffee beans of certain type are encoded by encoder (52) in roasting device, wherein grinding device (60) comprises one or more housings for receiving one or more containers (10, 20) for beans, reader (62) for obtaining information on product parameters for roasted coffee beans in one or more containers (10, 20) for grains, control unit configured to adapt the degree of grinding and the number of roasted coffee beans to be fed from coffee beans containers (10, 20), to obtain a certain amount of coffee and/or a certain amount of coffee mixture from each bean container to be ground in accordance with these product parameters and/or in accordance with recipe database (64), and/or in accordance with the input data entered user. Also described is a method of roasting and grinding coffee beans using roasting and grinding equipment and use of such equipment for dispensing a mixture of roasted and ground coffee beans in a certain amount.EFFECT: group of inventions enables to achieve end results for the coffee drink, similar to those obtained using a capsule system.17 cl, 20 dwg","1. Оборудование для обжаривания и помола кофейных зерен, содержащее обжаривающее устройство (50) и связанное с ним устройство (60) для помола;
причем обжаривающее устройство (50) выполнено с возможностью приема кофейных зерен определенного типа, подлежащих обжариванию, при этом обжаривающее устройство (50) содержит средство (53) считывания для идентификации характеристик подаваемых в это устройство кофейных зерен, причем обжаривающее устройство (50) содержит блок управления, конфигурирующий профиль обжаривания зерен в соответствии с характеристиками, извлеченными из средства (53) считывания, и/или согласно характеристикам зерен в базе (51) данных в этом блоке управления, и/или в соответствии с входными данными, введенными пользователем; причем обжаренные кофейные зерна распределяются в контейнеры (10, 20) для зерен, при этом контейнеры (10, 20) для зерен содержат программируемое идентификационное средство, причем параметры продукта обжаренных кофейных зерен определенного типа кодируются кодером (52) в обжаривающем устройстве;
причем устройство (60) для помола содержит один или более корпусов для приема одного или более контейнеров (10, 20) для зерен; при этом устройство (60) для помола содержит считывающее устройство (62) для получения информации о параметрах продукта для обжаренных кофейных зерен в одном или более контейнерах (10, 20) для зерен; причем устройство (60) для помола содержит блок управления, выполненный с возможностью адаптации степени помола и количества обжаренных кофейных зерен, подлежащих подаче из контейнеров (10, 20) для кофейных зерен, для получения определенного количества кофе и/или определенного количества кофейной смеси из каждого контейнера для зерен, подлежащего помолу в соответствии с этими параметрами продукта, и/или в соответствии с базой (64) данных рецептур, и/или в соответствии с входными данными, введенными пользователем.
2. Оборудование для обжаривания и помола кофейных зерен по п. 1, в котором характеристики кофейных зерен предста","A47J42/40, A23N12/08, A23N12/12, A47J42/32, A23F5/04",20250312,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119744132A,Beverage extraction system,"The invention relates to a system comprising an extraction device and a capsule of a beverage preparation machine, where-the capsule comprises a capsule body and a top cover, and-the extraction device comprises:-an upstream capsule enclosing part and a downstream capsule enclosing part, the present invention relates to a capsule extraction device comprising an upstream capsule enclosing member and a downstream capsule enclosing member relatively translatable between an open position for inserting and/or ejecting the capsule and a closed position for forming an extraction chamber enclosing the capsule during extraction, the downstream member comprising a downstream planar piercing arrangement for opening the cover of the capsule, and wherein the body of the pouch and the cover are made of a multi-ply paper material comprising a paper ply coated with at least one plastic ply, and wherein the multi-ply material of the downstream piercing arrangement and the second envelope wall (32) of the pouch is designed to enable progressive piercing of the top cover.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括饮料制备机器和囊包，所述囊包包含饮料配料、优选烘焙并且研磨的咖啡，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包(3)包括第一包封壁和第二包封壁(31,31',32)，所述第一囊包包封壁和所述第二囊包包封壁限定用于包封所述饮料配料(33)的腔室，并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包的所述第一囊包包封壁和所述第二囊包包封壁由多层纸材料制成，所述多层纸材料包括组装在一起的至少一个纸层(A)和至少一个塑料层(B)、优选可堆肥塑料层，并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述多层纸材料被取向成使得至少一个塑料层面向所述囊包的所述腔室的内部部分，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述饮料制备机器包括用于从所述囊包提取饮料的提取装置，并且所述提取装置</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-上游囊包包封部件(1)和下游囊包包封部件(2)，所述上游囊包包封部件和所述下游囊包包封部件能够在用于插入和/或弹出所述囊包(3)的打开位置和用于在提取期间形成包封所述囊包的提取室(5)的闭合位置之间相对移动，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述上游部件(2)承载：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·用于打开所述囊包的所述第一包封壁(31)的上游刺穿排布结构(22)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·液体注入器(25)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述下游部件(1)包括用于打开所述囊包的所述第二包封壁(32)的下游刺穿排布结构(12)，所述下游刺穿排布结构包括板(121)，其中：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·所述板的转向所述囊包的所述第二壁的表面包括从所述表面凸出的打开元件(122)，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·所述板包括穿孔，用以排出从该打开的第二壁分配的该饮料，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中在制备饮料期间，所述提取装置被构造为：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-在第一步骤中，在所述上游囊包包封部件(1)和所述下游囊包包封部件(2)之间包封所述囊包(3)，以及</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-然后，在第二步骤中，通过所述液体注入器(23)将液体引入所包封的囊包(3)内部，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述下游刺穿排布结构的所述打开元件(122)和所述囊包的所述第二包封壁(32)的多层材料被设计成使得：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-在所述第一步骤中，所述打开元件(122)仅部分地刺穿所述多层纸材料，使得面向所述囊包的所述腔室的所述内部部分的至少所述塑料层不被刺穿，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-在所","A47J31/36, B65D85/804, B65D65/46",20250401,雀巢产品有限公司,['Pending']
AU2025208481A1,"Compositions and methods using at least one glycine or derivative thereof, at least one N-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or NAD+ precursor","A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione. The composition contains an effective amount of a combination of at least one glycine or functional derivative thereof, at least one N-acetylcysteine or functional derivative thereof, and at least one nicotinamide riboside or NAD precursor. The composition can be orally administered, for example as one or more of a food product, a food for special medical purposes (FSMP), a nutritional supplement, a ready to drink formula, a dairy-based drink, a low-volume liquid supplement, powder formats for liquid reconstitution or a meal replacement beverage.20 25 20 84 81 24 J ul 2 02 5 A B S T R A C T A c o m p o s i t i o n c a n t r e a t o r p r e v e n t a t l e a s t o n e p h y s i c a l s t a t e s e l e c t e d f r o m t h e g r o u p 2 0 2 5 2 0 8 4 8 1 2 4 J u l 2 0 2 5 c o n s i s t i n g o f o x i d a t i v e s t r e s s , a c o n d i t i o n a s s o c i a t e d w i t h o x i d a t i v e s t r e s s , a r e d u c e d l e v e l o f g l u t a t h i o n e , a n d a c o n d i t i o n a s s o c i a t e d w i t h a r e d u c e d l e v e l o f g l u t a t h i o n e . T h e c o m p o s i t i o n c o n t a i n s a n e f f e c t i v e a m o u n t o f a c o m b i n a t i o n o f a t l e a s t o n e g l y c i n e o r f u n c t i o n a l d e r i v a t i v e t h e r e o f , a t l e a s t o n e N - a c e t y l c y s t e i n e o r f u n c t i o n a l d e r i v a t i v e t h e r e o f , a n d a t l e a s t o n e n i c o t i n a m i d e r i b o s i d e o r N A D p r e c u r s o r . T h e c o m p o s i t i o n c a n b e o r a l l y a d m i n i s t e r e d , f o r e x a m p l e a s o n e o r m o r e o f a f o o d p r o d u c t , a f o o d f o r s p e c i a l m e d i c a l p u r p o s e s ( F S M P ) , a n u t r i t i o n a l s u p p l e m e n t , a r e a d y t o d r i n k f o r m u l a , a d a i r y - b a s e d d r i n k , a l o w - v o l u m e l i q u i d s u p p l e m e n t , p o w d e r f o r m a t s f o r l i q u i d r e c o n s t i t u t i o n o r a m e a l r e p l a c e m e n t b e v e r a g e .","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating, reducing incidence of, or reducing severity of at least one condition selected from the group consisting of </seg-main><seg-clauses>metabolic syndrome, age-related decline in metabolic regulation, and muscle indications, the method comprising administering to an individual in need thereof or at risk thereof an effective amount of a combination of at least one glycine or functional derivative thereof, at least one N-acetylcysteine or functional derivative thereof, and at least one nicotinamide riboside or NAD+ precursor.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of Claim 1, wherein </seg-main><seg-clauses>the at least one glycine or functional derivative thereof is selected from the group consisting of L-glycine, L-glycine ethyl ester, D-Allylglycine; N-[Bis(methylthio)methylene]glycine methyl ester; Boc-allyl-Gly-OH (dicyclo hexylammonium)         salt;         Boc-D-Chg-OH;         Boc-Chg-OH;</seg-clauses>
<seg-clauses class=""seg-enter"">(R)-N-Boc-(2'-chlorophenyl)glycine; Boc-L-cyclopropylglycine; Boc-L-cyclopropylglycine; (R)-N-Boc-4-fluorophenylglycine; Boc-D-propargylglycine; Boc-(S)-3-thienylglycine; Boc-(R)-3-thienylglycine; D-a-Cyclohexylglycine; L</seg-clauses><seg-clauses>-a-Cyclopropylglycine; N-(2-fluorophenyl)-N-(methylsulfonyl)glycine;</seg-clauses>
<seg-clauses class=""seg-enter"">N-(4-fluorophenyl)-N-(methylsulfonyl)glycine; Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH; N-(2-Furoyl)glycine; L-a-Neopentylglycine; D-Propargylglycine; sarcosine; Z-a-Phosphonoglycine trimethyl ester, and mixtures thereof</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of Claim 1, wherein </seg-main><seg-clauses>the combination is administered orally.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of Claim 1, wherein </seg-main><seg-clauses>the combination is administered in a composition selected from th","A23L33/175, A23L33/18, A61K31/198, A61K31/405, A61K38/04",20250814,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2843456C1,Use of breast milk oligosaccharides in nutritional compositions for improving bone tissue development and/or bone strength,"FIELD: chemistry.SUBSTANCE: invention relates to the use of a composition comprising a mixture of oligosaccharides containing a combination of sialylated oligosaccharides of 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL), a combination of fucosylated oligosaccharides of 2'-fucosyllactose (2'FL) and difucosyllactose (diFL) and a combination of N-acetylated oligosaccharides of lacto-N-tetraose (LNT) and lacto-N-neotetrose (LNnT), as an artificial nutrient for improving bone strength in a human or domestic animal being tested. Human test subject is preferentially a child, an infant or a toddler.EFFECT: using the invention enables providing higher strength of bone tissue, particularly reducing cortical porosity.1 cl, 6 dwg, 1 ex","1. Применение композиции, включающей смесь олигосахаридов, содержащую:
комбинацию сиалилированных олигосахаридов 3’-сиалиллактозы (3’-SL) и 6’-сиалиллактозы (6’-SL),
комбинацию фукозилированных олигосахаридов 2’-фукозиллактозы (2’FL) и дифукозиллактозы (diFL) и
комбинацию N-ацетилированных олигосахаридов лакто-N-тетраозы (LNT) и лакто-N-неотетраозы (LNnT),
в качестве искусственного питательного вещества для улучшения прочности костной ткани у испытуемого-человека или домашнего животного.
2. Применение композиции по п. 1, причём испытуемый-человек представляет собой ребёнка, младенца или начинающего ходить ребёнка.
3. Применение композиции по п. 1 или 2, в которой смесь олигосахаридов включает:
- от 10 до 35 мас.%, предпочтительно от 10 до 30 мас.%, более предпочтительно от 10 до 25 мас.% относительно общей массы смеси олигосахаридов указанных сиалилированных олигосахаридов,
- от 30 до 80 мас.%, предпочтительно от 40 до 80 мас.%, более предпочтительно от 50 до 70 мас.% относительно общей массы смеси олигосахаридов указанных фукозилированных олигосахаридов и
- от 10 до 35 мас.%, предпочтительно от 15 до 30 мас.%, более предпочтительно от 15 до 20 мас.% относительно общей массы смеси олигосахаридов указанных N-ацетилированных олигосахаридов.
4. Применение композиции по любому из пп. 1-3, причём улучшение прочности костной ткани включает по меньшей мере один из следующих физиологических процессов: приобретение костной массы, оптимизация пиковой костной массы, стимулирование образования костной ткани, стимулирование анаболизма костной ткани, повышение минеральной плотности и микроархитектуры костной ткани, модулирование биомеханических свойств костной ткани, модулирование соотношения образования костной ткани и/или резорбции костной ткани, содействие регенерации костной ткани во время заживления переломов, регулирование процесса резорбции костной ткани.
5. Применение композиции по любому из пп. 1-4 для повышения минеральной плотности костной ткани (BMD), содержания минер","A61K31/702, A23L33/125, A61P19/08",20250714,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
RU2851584C1,Sealing device for container,"FIELD: packaging.SUBSTANCE: invention relates to a sealing means for a container and a system containing a container with said sealing means. The closure (1) for a container comprises a first part (2); a second part (3) designed to be movable relative to the first part (2) in order to move between a closed state, in which the opening (21) of the closure (1) is closed, and an open state, in which the opening (21) is not closed; and a tamper-evident element (5) which, on the one hand, is connected to the second part (3) by means of a fragile connection (51) and which, on the other hand, is designed to be held relative to the first part (2) in such a way that when the second part (3) is moved relative to the first part (2) from the closed state to the open state, the brittle connection (51) is broken by the opening movement. The tamper-evident element (5) is designed to be activated to break the fragile connection (51) independently of the movement of the second part (3) relative to the first part (2) by the opening movement, and the sealing means (1) additionally comprises a retaining device (22) located on the first part (2) and designed to be able to fix the opening control element (5) to the first part (2) after breaking the fragile connection (51). The retaining device prevents the loss of the opening control element.EFFECT: tamper-evident element can be recycled, for example, together with other parts of the closure and/or with the main packaging material (such as a container) in the same recycling stream.17 cl, 28 dwg","1. Укупорочное средство (1) для контейнера, содержащее:
первую часть (2),
вторую часть (3), выполненную с возможностью перемещения относительно первой части (2) для перемещения между закрытым состоянием, в котором отверстие (21) укупорочного средства (1) закрыто, и открытым состоянием, в котором отверстие (21) не закрыто, и
элемент (5) контроля вскрытия, соединенный со второй частью (3) посредством хрупкого соединения (51) и выполненный с возможностью удерживания относительно первой части (2) таким образом, что при перемещении второй части (3) относительно первой части (2) из закрытого состояния в открытое состояние происходит разрыв хрупкого соединения (51) за счет открывающего движения,
причем элемент (5) контроля вскрытия выполнен с возможностью приведения в действие для разрыва хрупкого соединения (51) независимо от перемещения второй части (3) относительно первой части (2) за счет открывающего движения,
при этом укупорочное средство (1) дополнительно содержит удерживающее устройство (22), расположенное на первой части (2) и выполненное с возможностью фиксации элемента (5) контроля вскрытия с первой частью (2) после разрыва хрупкого соединения (51),
при этом элемент (5) контроля вскрытия по меньшей мере частично выполнен в виде кнопки, например нажимной кнопки, и выполнен с возможностью нажатия для приведения в действие, и
при этом укупорочное средство частично или полностью изготовлено из материала, выбранного из следующей группы: пищевые культуры, обрезки древесины, восстановленное масло, растительное масло, отходы или остатки, использованное кулинарное масло, животный жир из отходов пищевой промышленности, отходы и остатки переработки растительного масла, рыбий жир из отходов рыбопереработки, техническое кукурузное масло и их комбинации.
2. Укупорочное средство (1) по п. 1, в котором удерживающее устройство (22) выполнено с возможностью удерживания элемента (5) контроля вскрытия относительно первой части (2), когда вторая часть (3) перемещается относительно п","B65D43/16, B65D51/24",20251125,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119698239A,Food composition comprising one or more coated food particles,A method of preparing a food composition comprising one or more coated food particles is disclosed. The method comprises the step of providing one or more food particles. The method further comprises the step of coating each of the food particles with a carbohydrate. This results in a food composition comprising one or more food particles coated with a crystalline carbohydrate layer. The crystalline carbohydrate layer comprises at least 95% crystalline carbohydrate particles and has a closed porosity of less than 10%. A food composition comprising one or more coated food particles and a coated food particle are also disclosed.,"<div class=""indep-clm"" num=""1""><seg-con>1.制备包含一个或多个包被食品颗粒的食品组合物的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)提供一个或多个食品颗粒；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)用碳水化合物对步骤a)的所述食品颗粒中的每个食品颗粒进行包衣以形成包含一个或多个包被食品颗粒的食品组合物，所述一个或多个包被食品颗粒是用结晶碳水化合物层包衣的食品颗粒，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述结晶碳水化合物层包含至少95％的结晶碳水化合物并且具有低于10％的闭合孔隙度。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的方法，其中所述包衣步骤b)用碳水化合物进行，所述碳水化合物是：</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>i)至少一种固体结晶碳水化合物，或</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>ii)至少一种固体结晶碳水化合物和至少一种水合结晶化合物，或</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>iii)至少一种固体无定形碳水化合物，或</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>iv)至少一种固体结晶碳水化合物和至少一种固体无定形碳水化合物，或</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>v)至少一种固体结晶碳水化合物和至少一种固体无定形碳水化合物以及至少一种水合结晶化合物，或</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>vi)至少一种碳水化合物的液体溶液或悬浮液；</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>其中所述步骤biii)在包衣之后包括在所述固体无定形碳水化合物的玻璃化转变温度Tg以上进行的热处理步骤和/或增湿步骤以触发碳水化合物颗粒桥接并且将无定形碳水化合物转化成结晶碳水化合物，其中所述增湿步骤之后进行干燥步骤；</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>其中所述步骤biv)在包衣之后任选地包括在所述固体无定形碳水化合物的所述玻璃化转变温度Tg以上进行的热处理步骤和/或增湿步骤以触发碳水化合物颗粒桥接并且将无定形碳水化合物转化成结晶碳水化合物，其中所述增湿步骤之后进行干燥步骤；</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>其中所述步骤bv)在包衣之后任选地包括在所述固体无定形碳水化合物的所述玻璃化转变温度Tg以上进行的热处理步骤和/或增湿步骤以触发碳水化合物颗粒桥接并且将无定形碳水化合物转化成结晶碳水化合物；</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>其中所述步骤bvi)在包衣之后包括干燥步骤，任选地在所述干燥步骤之前进行冷却步骤，以将溶解在所述至少一种碳水化合物的液体溶液或悬浮液中的碳水化合物转化成结晶碳水化合物。</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中所述包衣步骤bi)在包衣之后包括增湿步骤，优选汽蒸，并且任选地之后进行干燥步骤，以触发结晶碳水化合物颗粒桥接。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的方法，其中所述包衣步骤bii)在包衣之后包括热处理步骤以触发结晶碳水化合物颗粒桥接。</di","A23F5/14, A23B85/00, A23F5/36, A23G1/54, A23B80/00",20250325,雀巢产品有限公司,['Pending']
JP2025106460A,Composition and method for potentiating musculoskeletal effect of one or more anabolic amino acids by using one or more autophagy-inducing amino acids,"To provide a method and a composition for potentiating effect to a musculoskeletal system of one or more anabolic amino acids in an individual which requires potentiating effect to the musculoskeletal system.SOLUTION: A method includes a step of administering a composition comprising one or more anabolic amino acids to an individual, and the composition further comprises one or more amino acids or precursors thereof, which induce autophagy, in a total amount effective to make the composition at least neutral regarding autophagy. One or more amino acids which induce autophagy are selected from a group consisting of glycine, cysteine, proline, glutamic acid, valine, tyrosine, or precursors thereof and a mixture thereof.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 筋骨格系への作用を増強する必要がある個体において、１種以上の同化アミノ酸の筋骨格系への作用を増強する方法であって、前記１種以上の同化アミノ酸を含む組成物を、前記個体に投与する工程を含み、前記組成物が、オートファジーを誘導する１種以上のアミノ酸又はそれらの前駆体を、前記組成物がオートファジーに関して少なくとも中立となるのに有効な総量で更に含む、方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記オートファジーを誘導する１種以上のアミノ酸が、グリシン、システイン、プロリン、グルタミン酸、バリン、チロシン、又はこれらの前駆体、及びこれらの混合物からなる群から選択される、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 前記前駆体が、セリン、Ｎ－アセチルシステイン（ＮＡＣ）、メチオニンである、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1""> 前記１種以上の同化アミノ酸が、ロイシン、イソロイシン、アルギニン、グルタミン、シトルリン、及びこれらの混合物からなる群から選択される、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1""> 前記１種以上の同化アミノ酸が、ロイシン、アルギニン、又はグルタミンのうちの少なくとも１種を、前記個体においてｍＴＯＲを活性化するのに有効な量で含む、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1""> 前記組成物が、骨格筋においてオートファジーを誘導する、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1""> 前記個体が、高齢の個体である、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1""> 前記個体が、サルコペニア若しくはフレイルを有する、又はサルコペニア若しくはフレイルを発症するリスクがある、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""1"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""1""> 前記個体が、（ｉ）重篤、（ｉｉ）急性腎傷害、（ｉｉｉ）慢性腎傷害、（ｉｖ）慢性腎疾患による筋量の低下、及び（ｖ）慢性腎疾患による筋機能の低下からなる群から選択される少なくとも１つの状態を有する、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""10"" parent=""1"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""1""> 前記個体が、重篤なミオパチーを有する、又は重篤なミオパチーを発症するリスクがある、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""11"" parent=""1"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""1""> 前記個体が、がん、慢性閉塞性肺疾患（ＣＯＰＤ）、慢性心不全（ＣＨＦ）、急性腎疾患又は慢性腎疾患（ＣＫＤ）などの慢性疾患に続発する悪液質又は筋消耗を有する、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""12","A23L33/17, A61K31/198, A61K31/401, A61P21/00, A61P13/12",20250715,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US12233048B2,Sustained release melatonin compositions,"The present invention relates to a composition comprising melatonin encapsulated within a calcium alginate hydrogel. It further provides an orally administrable dosage form comprising such a composition held within a gel, wherein the gel is formed using starch as a gelling agent. Processes to produce these compositions, as well as their use in therapy, are also disclosed.","<div class=""indep-clm"" num=""1""><seg-con>1. An orally administrable dosage form </seg-con><seg-trans>comprising </seg-trans><seg-refi>a composition comprising melatonin encapsulated within a calcium alginate hydrogel, wherein the composition is held within a gel, wherein the gel is formed using starch as a gelling agent, and wherein the weight ratio of the melatonin to the calcium alginate hydrogel is from 5:95 to 15:85,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the dosage form further comprising additional melatonin which is not encapsulated within the calcium alginate hydrogel.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 1 to 3 wt % of the composition based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 0.01 to 0.03 wt % of the additional melatonin which is not encapsulated within the calcium alginate hydrogel, based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The dosage form according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the starch in the gelling agent comprises potato starch.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 7 to 17 wt % of the starch based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The dosage form according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>from 8 to 18 wt % water based on total weight of the dosage form.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The dosage form according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-","A61K31/4045, A61K9/00, A61K47/12, A61K47/26, A61K47/36",20250225,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2845963C1,Coffee beans roasting system checking method,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Method for checking a roasting system is described, said system comprising at least one roasting device, wherein said device produces smoke during coffee beans heating, and at least one smoke purification unit, wherein said smoke purification unit comprises at least one smoke filtering device, at least one collapsible smoke-arresting device configured to collect smoke from the outlet channel of the roasting device, at least one temperature sensor configured to measure a temperature T of the smoke stream within the smoke purification unit, a smoke pumping device configured to remove smoke from the roasting device through said smoke purification unit, during the roasting operation, the method includes the following steps: operating the roasting device to produce a hot gas, monitoring the temperature of the smoke during operation and observing at least one behaviour of the monitored temperature over time, comparing said at least one observed behaviour of the monitored temperature with a predetermined temperature behaviour, corresponding to the presence of a collapsible smoke arresting device inside the smoke purification unit, displaying an alarm signal, if at least one observed behaviour deviates from corresponding predetermined behaviour. Coffee beans roasting system and computer-readable data medium are also disclosed.EFFECT: group of inventions makes it possible to solve the problem of informing the operator that part of the collector air duct of the smoke filter is absent during the roasting operation.14 cl, 5 dwg","1. Способ проверки системы обжаривания, причем указанная система содержит:
- по меньшей мере одно устройство для обжаривания, причем указанное устройство производит дым во время нагрева кофейных зерен; и
- по меньшей мере один блок очистки дыма, выполненный с возможностью очистки потока дыма, произведенного устройством для обжаривания, причем указанный блок очистки дыма содержит:
по меньшей мере одно устройство фильтрации дыма;
по меньшей мере одно разборное дымоулавливающее устройство, выполненное с возможностью улавливать дым из выходного канала устройства для обжаривания;
по меньшей мере один датчик температуры, выполненный с возможностью измерения температуры T потока дыма внутри блока очистки дыма;
устройство перекачивания дыма, выполненное с возможностью выведения дыма из устройства для обжаривания через указанный блок очистки дыма;
причем во время операции обжаривания, реализуемой в устройстве для обжаривания, способ включает следующие стадии:
- работа устройства для обжаривания для получения горячего газа;
- контроль температуры дыма во время работы; и
- наблюдение по меньшей мере одного поведения контролируемой температуры по времени;
- сравнение указанного по меньшей мере одного наблюдаемого поведения контролируемой температуры с предварительно заданным поведением температуры, соответствующим присутствию разборного дымоулавливающего устройства внутри блока очистки дыма;
- отображение сигнала тревоги, если по меньшей мере одно наблюдаемое поведение отклоняется от соответствующего предварительно заданного поведения.
2. Способ по п. 1, в котором стадия работы устройства для обжаривания с целью получения горячего газа может быть операцией по обжариванию кофейных зерен, операцией предварительного прогрева устройства для обжаривания или операцией проверки после операции технического обслуживания устройства для очистки дыма.
3. Способ по предшествующему пункту, в котором операция по обжариванию, реализованная в устройстве для обжаривания, представляет собой перву",A23N12/08,20250828,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CA2982008C,Code and container of system for preparing a beverage or foodstuff,"A container for a foodstuff or beverage preparation machine, the container for containing beverage or foodstuff preparation material and comprising on a surface thereof a code encoding preparation information, the code comprising a reference portion and a data portion: the reference portion comprising a linear arrangement of at least two reference units defining a reference line r, the data portion comprising at least one data unit, wherein said data unit is arranged on an encoding line D that intersects the reference line r, the data unit occupies any continuous distance d along the encoding line D as a variable to at least partially encode a parameter of the preparation information, whereby said encoding line D is circular and is arranged with a tangent thereto orthogonal the reference line r at said intersection point.","25 CLAIMS: <div class=""indep-clm"" num=""1""><seg-main>1. A container for a beverage or foodstuff preparation machine, the container for containing </seg-main><seg-clauses>beverage or foodstuff material and comprising a code encoding preparation information, the code comprising a reference portion and a data portion: the reference portion comprising an arrangement of at least two reference units to define virtually a reference line (r); the data portion comprising a data unit, wherein the data unit is arranged on a virtual encoding line (D) that intersects the reference line (r) at an intersection point, the data unit is arranged a distance (d) from said intersection point as a variable to at least partially encode a parameter of the preparation information, whereby said virtual encoding line (D) is circular and is arranged with a tangent thereto orthogonal the reference line (r) at said intersection point, wherein the data unit comprises a first data unit and a second data unit, the first data unit and the second data unit arranged along the virtual encoding line (D) that intersects the reference line (r), the first data line arranged at a first associated distance (d1) from the intersection point along the virtual encoding line (D), and the second data line arranged at a second associated distance (d2) from the intersection point along the virtual encoding line (D), wherein the virtual encoding line (D) is circular or a segment of a circle and is arranged with the tangent thereto orthogonal the reference line (r) at the intersection point, wherein an overall distance (d) is determined as an average d=0.5(d1+d2) of the first associated distance and the second associated distance, and wherein a value of the parameter (Vp) is encoded in the preparation information. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The container according to claim 1, wherein </seg-main><seg-clauses>the data unit is configured to occupy any continuous distance along","A47J31/44, B65D85/804",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12440057B2,Beverage preparation machine,"Beverage preparation machines include a fluid circulation system including a fluid source, a fluid pump, and a fluid circulation conduit; a container holder to receive a corresponding container; and a fluid processing device including a fluid processing body including in turn at least one inlet member for introducing the fluid substance into the container for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container. In further detail, the fluid processing body can include at least one outlet member for dispensing the beverage product from the container and for separately moving the fluid processing device and the container relatively one to another, e.g., between a fluid introduction position (fluid processing body protrudes inside the internal volume of the container), and a beverage dispensing position (fluid processing body at least partially withdrawn from the internal volume of the container).","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage preparation machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a fluid circulation system for a fluid substance, the fluid circulation system comprising at least one fluid source, at least one fluid pump and at least one fluid circulation conduit;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one container holder adapted for receiving a corresponding container; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one fluid processing device which is part of the fluid circulation system and which comprises a fluid processing body comprising in turn at least one inlet member for introducing the fluid substance into the container for the preparation of a beverage product by mixing of the fluid substance with an ingredient contained in the container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the fluid processing body further comprises at least one outlet member for dispensing the beverage product from the container, wherein at least one movement member is provided for separately moving the at least one fluid processing device and the container relatively one to another between:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a fluid introduction position, wherein the fluid processing body protrudes inside the internal volume of the container for introducing therein the fluid substance, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a beverage dispensing position, wherein the fluid processing body is at least partially withdrawn from the internal volume of the container to allow dispensing of the beverage product from the container through the at least one outlet member.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The beverage preparation machine according to claim 1, </seg-con><seg-trans>characterized in that </seg-trans><seg-refi>the fluid processing body i","A47J31/40, A47J31/36, A47J31/44",20251014,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2839784C1,Flexible package for preparation of food or beverage product having rigid part,"FIELD: packaging and storage.SUBSTANCE: invention relates to flexible or semi-flexible closed package (1) for placement of an ingredient for preparation of a food product in a device for preparation of food or drink products. Package comprises: (i) flexible or semi-flexible side walls (2) which form a flattened package body, and (ii) cup-shaped lower part (3) made with possibility of device liquid injection element insertion. Package (1) is formed from whole elongated primary flat sheet (5) of a workpiece made of a flexible material which is U-folded about its transverse axis of symmetry (Lx) and is soldered at its side edges (4) and top edge (34), wherein said bowl-shaped bottom part (3) is a hollow volume having concave bottom side (7) and convex sides (8), and the curvature of the profile of said lower side (7) is identical to the curvature of the profile of each of said lateral sides (8).EFFECT: provision of improved connection to the beverage preparation device in a substantially tight manner.10 cl, 22 dwg","1. Гибкая или полугибкая закрытая упаковка (1) для размещения ингредиента для приготовления пищевого продукта в устройстве для приготовления пищевых или питьевых продуктов путем смешивания упомянутого ингредиента с жидкостью для смешивания, вводимой в упомянутую упаковку упомянутым устройством, причем упомянутая упаковка (1) содержит:
(i) гибкие или полугибкие боковые стенки (2), которые образуют уплощенный корпус упаковки, и
(ii) чашеобразную нижнюю часть (3), выполненную с возможностью вставки элемента впрыска жидкости устройства,
при этом упаковка (1) образована из цельного удлиненного первичного плоского листа (5) заготовки, изготовленного из гибкого материала, предпочтительно материала на основе волокон, который сложен в U-образной форме вокруг своей поперечной оси симметрии (Lx) и запаян по своим боковым краям (4) и верхнему краю (34), причем упомянутая чашеобразная нижняя часть (3) представляет собой полый объем, имеющий вогнутую нижнюю сторону (7) и выпуклые боковые стороны (8), а кривизна профиля упомянутой нижней стороны (7) идентична кривизне профиля каждой из упомянутых боковых сторон (8).
2. Упаковка (1) по п. 1, в которой упомянутая чашеобразная нижняя часть (3) имеет форму шестигранной призмы, причем упомянутая призма имеет два противоположных вертикальных края (9), выровненных относительно поперечной оси (Lx) упаковки, которые простираются вниз с образованием простирающихся вниз кончиков (10), при этом упомянутые простирающиеся края (9) имеют такую высоту, что для каждого поперечного сечения чашеобразной нижней части (3) при измерении вдоль всей поперечной оси (Lx) упаковки сумма двух высот чашеобразной нижней части плюс ширина ее нижней стороны (7) является постоянной.
3. Упаковка (1) по любому из предшествующих пп. 1 или 2, в которой упомянутый цельный удлиненный первичный плоский лист (3) заготовки изготовлен из материала на основе волокон, покрытого с его внутренней стороны герметизирующим слоем, причем упомянутый слой на основе волокон выбран из",B65D85/804,20250512,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250352567A1,Compositions comprising a combination of caffeine and oleuropein or a metabolite thereof and their use for improving muscle function,"A combination of caffeine and at least one of oleuropein or metabolite thereof for use by oral administration to an individual in an amount effective to achieve at least one result that is (i) improved mitochondrial calcium uptake in muscle cells, (ii) improved utilization of calcium in muscle cells, (iii) increased mitochondrial energy in muscle cells, (iv) improvement in at least one of muscle functionality, muscle performance, or muscle strength, (v) decreased muscle fatigue, (vi) increased mobility, and/or (vii) treatment of a muscle disorder linked to calcium depletion or deficiency. The individual can be at least one of an aging subject; an elderly subject; a subject with muscle fatigue or muscle weakness; a subject with impaired mobility; a frail subject; a pre-frail subject; a sarcopenic subject; a subject recovering from pre-frailty, frailty, sarcopenia or impaired mobility; a subject undergoing physical rehabilitation; a sportsman; or a pet.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of achieving at least one result selected from the group consisting of </seg-main><seg-clauses>(i) improved mitochondrial calcium uptake in muscle cells, </seg-clauses><seg-clauses>(ii) improved utilization of calcium in muscle cells, </seg-clauses><seg-clauses>(iii) increased mitochondrial energy in muscle cells, </seg-clauses><seg-clauses>(iv) improvement in at least one of muscle functionality, muscle performance, or muscle strength, </seg-clauses><seg-clauses>(v) decreased muscle fatigue, </seg-clauses><seg-clauses>(vi) increased mobility and </seg-clauses><seg-clauses>(vii) treatment of a muscle disorder linked to calcium depletion or deficiency, the method comprising orally administering to an individual an effective amount of a combination of caffeine and at least one of oleuropein or metabolite thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the individual is selected from the group consisting of an aging subject; an elderly subject; a subject with muscle fatigue or muscle weakness; a subject with impaired mobility; a frail subject; a pre-frail subject; a sarcopenic subject; a subject recovering from pre-frailty, frailty, sarcopenia or impaired mobility; a subject undergoing physical rehabilitation; a sportsman; and a pet.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses><seg-main>decreasing muscle fatigue is in an individual who participates in exercise, the exercise comprising at least one of </seg-main><seg-clauses>1) resistance exercise, </seg-clauses><seg-clauses>2) anaerobic or repeated sprint-type exercise, or 3) endurance exercise, the method comprising orally administering to the individual an effective amount of a combination of caffeine and at least one of oleuropein or metabolite thereof.</seg-clauses></seg-clauses></div>
<div cl","A61K31/7048, A61K31/05, A61K31/351, A61K31/522, A61P21/00",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025131785A1,"Bottle, method and kit","A bottle 200, 300 comprising: a first half-bottle shell 100, 303 comprising: - a first molded pulp layer defining a first half-bottle body 102, 302 comprising at least a first securing element 104a, 304a; - a first adhesive layer 313 provided over the interior of the first half-bottle body; and - a first metallization layer 312 provided over the interior of the first adhesive layer; and a second half-bottle shell 307 comprising: - a second molded pulp layer defining a second half-bottle body comprising at least a second securing element 304b; - a second adhesive layer provided over the interior of the second half-bottle body; and - a second metallization layer provided over the interior of the first adhesive layer; wherein the first securing element is complementary to the second securing element; and the first half-bottle shell and the second half-bottle shell are secured together by a first joint 308a between the first securing element and the second securing element.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A bottle (200, 300) comprising: </seg-main><seg-clauses><seg-main>a first half-bottle shell (100, 303) comprising:</seg-main>
<seg-clauses>- a first molded pulp layer defining a first half-bottle body (102, 302) comprising at least a first securing element (104a, 304a);</seg-clauses>
<seg-clauses>- a first adhesive layer (313) provided over the interior of the first halfbottle body; and</seg-clauses>
<seg-clauses><seg-main>- a first metallization layer (312) provided over the interior of the first adhesive layer; and a second half-bottle shell (307) comprising:</seg-main>
<seg-clauses>- a second molded pulp layer defining a second half-bottle body comprising at least a second securing element (304b);</seg-clauses>
<seg-clauses>- a second adhesive layer provided over the interior of the second halfbottle body; and</seg-clauses>
<seg-clauses><seg-main>- a second metallization layer provided over the interior of the first adhesive layer; wherein the first securing element is complementary to the second securing element; and the first half-bottle shell and the second half-bottle shell are secured together by a first joint (308</seg-main><seg-clauses>a) between the first securing element and the second securing element.</seg-clauses></seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A bottle to Claim 1, wherein </seg-main><seg-clauses>the first joint is does not provide a gap or a flange in a body of the bottle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A bottle to Claim 1 or Claim 2, wherein </seg-main><seg-clauses>the first securing element and the second securing element are mutually complementary components of a butt joint, rabbet joint, miter joint, lap joint, dado joint, spline joint, mortise and tenant joint, tongue and groove joint, finger joint, or dovetail joint.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><s","B65D6/00, B65D23/02, B65D65/46",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
WO2025045795A1,Food emulsion compositions with lentil proteins and cereal bran,,,"A23L9/20, A23C11/10, A23C11/06, A23L7/10, A23D7/005",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US12186331B2,Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children,This invention relates to compositions for use in the promotion of the development and/or of the growth of the surface area of the small intestine and in the associated improvement of the digestive capacity in an infant or in a young child.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of promoting the digestive capacity in a child in need thereof, the method comprising </seg-main><seg-clauses>administering to the child a growing-up milk comprising at least one N-acetylated oligosaccharide and at least one fucosylated oligosaccharide, wherein the growing-up milk is administered in an effective amount for improving enterohepatic circulation in the child.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The method of claim 1, for promoting the capacity to digest fat, liposoluble vitamins, proteins and carbohydrates in the child.</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3. The method of claim 1, for promoting the development and/or the growth of the surface area of the small intestine of the child.</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4. The method of claim 1, for promoting the increase of the villi length in the small intestine of the child.</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the at least one N-acetylated oligosaccharide is selected from the group consisting of lacto-N-neotetraose (LNnT), lacto-N-tetraose (LNT), para-lacto-N-neohexaose (para-LNnH), disialyllacto-N-tetraose (DSLNT) and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the at least one N-acetylated oligosaccharide comprises lacto-N-neotetraose (LNnT).</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method of claim 1, wherein </seg-main><seg-clauses>the at least one fucosylated oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3′fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohe","A61K31/702, A23L33/00, A23L33/125, A61K45/06",20250107,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
JP2024178313A,Toilet sand composition,To provide an improved toilet sand composition which overcomes demerits and drawbacks related to an existing malodor control technique.SOLUTION: Provided are compositions and a method comprising a fragrance and from about 0.5 weight % to about 5.0 weight % of a granular malodor adsorbent which can be used to eliminate malodor in animal waste. The granular malodor absorbent may be granular molecular sieves or granulated activated carbon and has a pore size from about 0.4 nm to about 2.0 nm and a total surface area from about 100 m2/g to about 1500 m2/g.SELECTED DRAWING: None,"<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 芳香剤と顆粒状悪臭吸着剤とを含む、悪臭制御用の動物用トイレ砂組成物であって、前記顆粒状悪臭吸着剤が、約０．０５重量％～約５．０重量％の量で存在し、かつ約０．４ｎｍ～約２．０ｎｍの孔径及び約１００ｍ<sup> ２</sup>／ｇ～約１５００ｍ<sup> ２</sup>／ｇの総表面積を有し、前記顆粒状悪臭吸着剤が、悪臭を実質的に吸着し、前記芳香剤を実質的に放出する、動物用トイレ砂組成物。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記顆粒状悪臭吸着剤が、モレキュラーシーブ顆粒及び活性炭顆粒からなる群から選択される、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 前記顆粒状悪臭吸着剤が、約－８～約６０のメッシュサイズを有する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""4"" parent=""1"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1""> 前記芳香剤が、約０．０５重量％～約０．４重量％の量で存在する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""5"" parent=""1"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1""> 前記芳香剤がカプセル化されていない、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""6"" parent=""1"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1""> 吸収性基材を更に含む、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""7"" parent=""6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""6""> 前記吸収性基材が、吸収性コアと前記吸収性コアを取り囲む別個の層とを含む吸収性顆粒を含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""8"" parent=""6"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""6""> 前記吸収性基材が粘土を含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""9"" parent=""6"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""6""> 前記吸収性基材が、膨潤粘土でコーティングされた非膨潤粘土コアを含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""10"" parent=""6"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""6""> 前記吸収性基材が、膨潤粘土でコーティングされた膨張パーライトコアを含む、請求項６に記載の組成物。 </div>
<div class=""dep-clm"" num=""11"" parent=""9,10"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""9,10""> 前記膨潤粘土がナトリウムベントナイトである、請求項９又は１０に記載の組成物。 </div>
<div class=""dep-clm"" num=""12"" parent=""1"">【請求項12】</div>
<div class=""dep-clm"" num=""12"" parent=""1""> 前記顆粒状悪臭吸着剤が、前記芳香剤よりも悪臭に対してより高い親和性を有する、請求項１に記載の組成物。 </div>
<div class=""dep-clm"" num=""13"" parent=""1"">【請求項13】</div>
<div class=""dep-clm"" num=""13"" parent=""1""> 前記顆粒状悪臭吸着剤が、前記悪臭の少なくとも２５％を吸着する",A01K1/015,20241224,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
RU2843233C1,Aerated confectionary composition,"FIELD: food industry.SUBSTANCE: proposed aerated confectionary composition is represented by a chocolate composition or a chocolate composite product composition and contains a lipid component in amount of 0.5–10.0 wt.% in terms of the composition. Lipidic component is neither cacao butter, cacao butter substitute, cacao butter substitute or cacao butter equivalent. Lipidic component is vegetable oil which is a fluid medium under ambient conditions. Composition does not include any ingredient produced of a dairy product; the composition has a degree of aeration equal to 5.0%–30.0%. Wherein the chocolate composition means chocolate, a composite product and other related materials that contain cocoa butter, cocoa butter equivalents, cocoa butter substitutes and/or cocoa butter substitutes, and the chocolate composite product composition means chocolate-like analogues, characterized by the presence of cocoa cake.EFFECT: invention is aimed at improving the stability of the matrix of aerated bubbles in a solid product and/or simplifying the extraction procedure from the mould and/or packaging, which also simplifies the manufacture of the product and/or provides more desirable and/or stable organoleptic properties in the final confectionary product.13 cl, 5 ex","1. Кондитерская аэрированная композиция, которая представляет собой шоколадную композицию или композицию шоколадного составного продукта и содержит липидный компонент в количестве от 0,5 мас.% до 10,0 мас.% в расчёте на композицию, причём липидный компонент не является маслом какао, заменителем масла какао, заместителем масла какао или эквивалентом масла какао, и при этом липидный компонент представляет собой растительное масло, которое представляет собой текучую среду в условиях окружающей среды,
причём композиция не включает никакого ингредиента, полученного из молочного продукта, и при этом композиция имеет степень аэрации от 5,0% до 30,0%,
при этом шоколадная композиция означает шоколад, составной продукт и другие связанные материалы, которые содержат масло какао, эквиваленты масла какао, заменители масла какао и/или заместители масла какао, а композиция шоколадного составного продукта означает шоколадоподобные аналоги, характеризующиеся наличием какао-жмыха.
2. Композиция по п. 1, в которой липидный компонент выбирают из группы, состоящей из подсолнечного масла, рапсового масла, оливкового масла, соевого масла, льняного масла, сафлорового масла, кукурузного масла, хлопкового масла, масла виноградных косточек, ореховых масел, например масла лесного ореха, масла грецкого ореха, конопляного масла, масла из рисовых отрубей, кунжутного масла, арахисового масла, пальмоядрового масла и масел из проросших семян масличных культур, например подсолнечного масла с высоким содержанием олеиновой кислоты 25, рапсового масла с высоким содержанием олеиновой кислоты, пальмового масла с высоким содержанием олеиновой кислоты, соевого масла с высоким содержанием олеиновой кислоты и подсолнечного масла с высоким содержанием стеариновой кислоты, или их комбинаций.
3. Композиция по п. 1 или 2, имеющая степень аэрации от 7,5% до 27,5% или от 10,0% до 25,0%.
4. Композиция по любому из пп. 1–3, содержащая от 1,0 мас.% до 7,5 мас.% липидного компонента.
5. Композиция по любому из пп. 1–4,","A23G1/36, A23G1/52",20250709,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025119710A1,Method for reducing emissions from manure,"The present invention relates to a method for reducing emissions from manure and improving plant growth, the method comprising adding 0.17 - 0.35 g of calcium cyanamide (CaCN2) per 1 kg manure and adding 1.7 - 3.5 g of hydrogen peroxide (H2O2) per 1 kg manure. Furthermore, the invention relates to a manure additive for reducing emissions from manure and improving plant growth comprising H2O2 and biochar. Furthermore, the invention relates to an organic fertilizer comprising manure and the manure additive.","Claims
<div class=""indep-clm"" num=""1""><seg-con>1. Method for reducing emissions from manure and improving plant growth, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>adding 0.17 - 0.35 g of calcium cyanamide (CaCN?) per 1 kg manure and adding 1.7 - 3.5 g of hydrogen peroxide (H2O2) per 1 kg manure.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Method according to any of the preceding claims, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>adding 1.7 - 2.8 g of hydrogen peroxide (H2O2) per 1 kg manure.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>calcium cyanamide</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>(CaCIS ) is added in an amount of 0.17 - 0.30 g per 1 kg of manure.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>10 - 60 g of biochar is added per 1 kg manure to manure, preferably 20 - 50 g of biochar per 1 kg manure is added to the manure.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the manure is stored with calcium cyanamide (CaCIS ) and hydrogen peroxide (H2O2) and optionally biochar, or the manure with the calcium cyanamide (CaCIS ) and hydrogen peroxide (H2O2) and optionally biochar is distributed onto fields, preferably by spray irrigation, surface spreading, injection, or broadcasting.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. Method according to any of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the calcium cyanamide (CaCIS ) and hydrogen peroxide (H2O2) are added to the manure first and mixed thoroughly, and the biochar is added su","C05C11/00, C05F3/00, A01C3/00, C05F11/02",20250612,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250127324A1,Beverage preparation machine and method for preparing a beverage product using such a beverage preparation machine,"The present invention is directed to a beverage preparation machine comprising:<ul class=""uspto-list""><li class=""uspto-list-item""><ul class=""uspto-list""><li class=""uspto-list-item"">a chamber for receiving a capsule carrying a beverage component,</li><li class=""uspto-list-item"">a beverage preparation device having:<ul class=""uspto-list""><li class=""uspto-list-item"">a delivery device for delivering a fluid to the chamber,</li><li class=""uspto-list-item"">a first and a second injection element selectively fluidly connectable to the delivery device for injecting a fluid into the chamber,</li><li class=""uspto-list-item"">a discharge device having a discharge element for discharging the delivered fluid out of the chamber,</li></ul></li></ul></li></ul>
The first injection element protrudes farther into the chamber than the second injection element. The first injection element protrudes farther into the chamber than the discharge element. A region at which the second injection element protrudes into the chamber is located higher than a region at which the discharge element protrudes into the chamber.","<div class=""indep-clm"" num=""1""><seg-main>1. Beverage preparation machine comprising:</seg-main>
<seg-clauses>a chamber for receiving a capsule carrying a beverage component,</seg-clauses>
<seg-clauses class=""seg-enter"">a beverage preparation device having:</seg-clauses>
<seg-clauses class=""seg-enter"">a delivery device for delivering a fluid to the chamber,</seg-clauses>
<seg-clauses class=""seg-enter"">a first injection element and a second injection element, the first and second injection elements being selectively fluidly connectable to the delivery device for injecting a fluid into the chamber, respectively,</seg-clauses>
<seg-clauses class=""seg-enter"">a discharge device having a discharge element for discharging the delivered fluid out of the chamber,</seg-clauses>
<seg-clauses class=""seg-enter"">the first injection element protrudes farther into the chamber than the second injection element and the first injection element protrudes farther into the chamber than the discharge element, and</seg-clauses>
<seg-clauses class=""seg-enter"">a region at which the second injection element protrudes into the chamber is located higher than a region at which the discharge element protrudes into the chamber.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Beverage preparation machine according to claim 1, wherein </seg-main><seg-clauses>the second injection element comprises an outlet opening which is directed towards the discharge element.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Beverage preparation machine according to claim 1, wherein </seg-main><seg-clauses>a region at which the first injection element protrudes into the chamber is located higher than the region at which the discharge element protrudes into the chamber.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. Beverage preparation machine according to claim 1, wherein </seg-main><seg-clauses>the second injection element protrude(s) into","A47J31/36, A47J31/06, A47J31/46, A47J31/60, B65D85/804",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2833302C2,Coffee beans roasting system,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Described is system (100) for roasting coffee beans, comprising the following components: roasting device (1), wherein said device generates smoke, and smoke treatment unit (2) configured to collect and treat smoke generated by the roasting device, wherein the roasting device comprises a smoke discharge channel (11), and the smoke treatment unit comprises the following components: smoke inlet channel (21) configured to collect smoke, smoke filtration sub-unit (22), smoke feed actuator (23), configured to circulate smoke through the smoke treatment unit from the smoke collection device into the treatment unit outlet channel (25) smoke, wherein the system comprises an air supply device (24) configured to mix the smoke generated by roasting device (1) with the ambient air to control the smoke temperature inside the smoke filtration sub-unit (22), wherein said air supply device (24) is located upstream of the smoke filtration subunit (22) and said air supply device (24) comprises the following components: first wall (241) passing between the smoke outlet channel (11) of the roasting device and the smoke inlet channel (21) of the smoke treatment unit, and at least one through hole (240) in the said wall. Invention also discloses the design of the smoke treatment unit (2), which is part of the system, and a method of roasting coffee beans using said system.EFFECT: group of inventions provides the possibility of controlling the temperature of smoke emitted by the frying machine, solving problems of protecting the filter from heated smoke, and providing not too high level of noise.15 cl, 12 dwg","1. Система (100) для обжаривания кофейных зерен, содержащая следующие компоненты:
- устройство для обжаривания (1), причем указанное устройство вырабатывает дым, и
- блок обработки дыма (2), выполненный с возможностью сбора и обработки дыма, образуемого устройством для обжаривания,
причем:
- устройство для обжаривания содержит канал выпуска дыма (11), и
- блок обработки дыма содержит следующие компоненты:
- канал впуска дыма (21), выполненный с возможностью сбора дыма,
- подблок фильтрации дыма (22),
- рабочий орган подачи дыма (23), выполненный с возможностью циркуляции дыма через блок обработки дыма из устройства для сбора дыма в канал выпуска (25) блока обработки дыма,
причем система содержит устройство подачи воздуха (24), выполненное с возможностью смешивания дыма, образуемого устройством для обжаривания (1), с окружающим воздухом для регулирования температуры дыма внутри подблока фильтрации дыма (22), при этом
указанное устройство подачи воздуха (24) расположено выше по потоку от подблока фильтрации дыма (22) и
указанное устройство подачи воздуха (24) содержит следующие компоненты:
- первую стенку (241), проходящую между каналом выпуска дыма (11) устройства для обжаривания и каналом впуска дыма (21) блока обработки дыма, и
- по меньшей мере одно сквозное отверстие (240) в указанной стенке.
2. Система по п. 1, в которой подблок фильтрации дыма (22) содержит по меньшей мере активный угольный фильтр (221).
3. Система по предшествующему пункту, в которой подблок фильтрации дыма (22) содержит по меньшей мере один дополнительный фильтр (222, 223), причем указанный дополнительный фильтр работает без нагревания.
4. Система по предшествующему пункту, в которой подблок фильтрации дыма (22) содержит последовательно: HEPA-фильтр (222), электростатический осадитель (223) и активный угольный фильтр (221).
5. Система по любому из предшествующих пунктов, в которой устройство подачи воздуха (24) расположено и выполнено с возможностью введения воздуха и дыма в одну и ту же точк","A23N12/08, A23F5/04",20250116,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CA2973536C,Method for determining the distinctive nutritional requirements of a patient,The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.,"﻿ 30 Claims <div class=""indep-clm"" num=""1""><seg-main>1. An in vitro method for determining the distinctive disease related nutritional requirements of a subject suffering from a disease characterized by </seg-main><seg-clauses><seg-main>distinctive nutritional requirements in the diseased subject over a healthy subject comprising the steps: </seg-main><seg-clauses>a. Determining in a sample of the subject suffering from the disease a profile of statuses of direct and indirect markers indicating the nutritional profile of said subject, wherein direct markers indicate the amount of a macronutrient or micronutrient, and indirect markers are derived from direct markers, wherein the status of the direct marker is measured by quantifying the direct marker and the status of the indirect marker is measured by quantifying a further marker or markers indicating the status of the direct marker, and wherein the direct and indirect markers comprise threonine, a metabolite of threonine, an essential amino acid other than threonine, and a metabolite of the essential amino acid other than threonine, </seg-clauses><seg-clauses>b. Determining in a sample of the healthy subject a profile of the statuses of the same markers determined in step a, </seg-clauses><seg-clauses>c. Comparing the profiles determined in step a. and b., and thereby determining the distinctive nutritional requirements for nutrients in a patient suffering from the disease, wherein the nutrients are macronutrients and micronutrients, and wherein the disease is inflammatory bowel disease (IBD). </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the macronutrients are selected from the group consisting of proteins, amino acids, fats, and carbohydrates, or wherein the micronutrients are selected from the group of vitamins and elements. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method ",G01N33/50,20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12232510B2,Methods of making frozen confectionary products and re-using components utilized therein,A method of dispensing a frozen confectionary product from a dispensing machine. The method can include loading one or more tubes comprising a frozen confectionary or a component of a frozen confectionary from a storage tray onto a serving station located in the dispensing machine; positioning the container in the serving station under the one or more tubes; dispensing the frozen confectionary or component of the frozen confectionary into the container; optionally placing a spoon into the container; and conveying the frozen confectionary product to an outlet located on the dispensing machine. A method of supplying a dispensing machine with frozen confectionaries and/or components of frozen confectionaries is also provided.,"<div class=""indep-clm"" num=""1""><seg-con>1. A method of dispensing a frozen confectionary product from a dispensing machine, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>loading one or more first tubes comprising a composition that is a frozen confectionary from a first storage tray onto a serving station of the dispensing machine, wherein the first storage tray is located in a first storage area of the dispensing machine, and wherein the one or more first tubes are reusable;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>positioning a container in a first position in the serving station under the one or more first tubes;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>dispensing at least a portion of the frozen confectionary into the container; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>conveying the container comprising the frozen confectionary to an outlet located on the dispensing machine;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the method further comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>receiving the first storage tray from a location remote from the dispensing machine;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>placing the first storage tray directly into the first storage area;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>detecting when contents of one of the one or more first tubes is below a pre-determined threshold; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>moving the one of the one or more first tubes having contents below the pre-determined threshold into an empty tube position in the dispensing machine.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dispensing of at least a portion of the frozen confectionary into the container comprises:</seg-refi></div>
<div class=","A23G9/28, G07F11/04",20250225,SOCIETE DES PRODUITS NESTLE S.A,['Active']
US12440059B2,Grinding and extraction apparatus for coffee beans,"The invention relates to a grinding and extraction apparatus for roasted coffee beans comprising a grinding device (<b>60</b>) and an associated extraction device (<b>70</b>); the grinding device (<b>60</b>) comprising one or more housings for receiving one or more beans containers (<b>10, 20</b>) with roasted coffee beans of the same or different types; the grinding device (<b>60</b>) comprising a reader (<b>62</b>) to obtain the information of the product parameters of the roasted coffee beans of the one or more beans containers (<b>10, 20</b>); the grinding device (<b>60</b>) further comprising a control unit configured to adapt the grinding size and the quantity of roasted coffee beans for obtaining a certain coffee blend from each beans container to be grinded according to these product parameters and/or according to a recipes database (<b>64</b>) comprising the beverage information associated to the beverage to be prepared; the grinding device (<b>60</b>) further comprising an encoder (<b>62</b>) to encode the beverage information on programmable identification means (<b>65</b>) on a product holder (<b>61</b>) in the grinding device (<b>60</b>), to where the grinded coffee is sent; the extraction device (<b>70</b>) being configured for receiving the product holder (<b>61</b>) and comprising reading means (<b>72</b>) to identify the beverage information in the said product holder identification means (<b>65</b>), the extraction device (<b>70</b>) further comprising a control unit to extract the beverage according to the beverage information retrieved and/or from the beverage information retrieved from a beverage database in this control unit. Moreover, the invention relates to a method for grinding roasted coffee beans and preparing a beverage from them using a grinding and extraction apparatus as the one described, and also refers to the use of a grinding and extraction apparatus as the one described for delivering a certain beverage from roasted coffee beans.","<div class=""indep-clm"" num=""1""><seg-con>1. A grinding and extraction system for roasted coffee beans </seg-con><seg-trans>comprising </seg-trans><seg-comp>a grinding device and an associated extraction device;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the grinding device comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>one or more housings configured to receive one or more beans containers with roasted coffee beans of the same or different types,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a first reader configured to obtain product parameters of the roasted coffee beans from the one or more beans containers,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control unit configured to adapt the grinding size and the quantity of roasted coffee beans to obtain a quantity of roasted coffee beans from the one or more beans containers and to cause the grinding device to grind the roasted coffee beans according to these product parameters and/or according to a recipes database comprising the beverage information associated to the beverage to be prepared, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>an encoder configured to encode the product parameters on a programmable identification member on a product holder in the grinding device to which the grinded coffee is dispensed; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the extraction device being configured to receive the product holder, the extraction device comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a second reader to identify the product parameters in the programmable identification member, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control unit configured to cause the extraction device to extract the beverage according to the product parameters retrieved from the product holder and/or beverage information retrieved from a beverage database in this control unit.</seg-comp></div>","A47J31/42, A23F5/08, A23F5/26, A47J31/44, A47J31/52",20251014,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2019407214B2,A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier,"The present invention relates to nutritional compositions comprising metabolites of HMOs to improve the gastrointestinal barrier. In particular, the invention relates to nutritional compositions comprising metabolites of HMOs for infants with impaired microbiota since their microbiota may not be able to metabolize HMOs.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and 3 years) or a child (aged from more than 3 years to less than 8 years);</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-comp>5 the method comprising </seg-comp><seg-comp>administering to the infant or young child a nutritional composition comprising metabolites of HMOs; or</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the method comprising administering to the child a nutritional composition in the form of a growing-up milk comprising metabolites of HMOs;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the metabolites of HMOs are obtained by fermenting a composition</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>10 comprising one or more HMOs selected from the group consisting of 2'FL, DiFL, 3'SL, 6'SL, LNT and LNnT in a composition comprising a baby microbiota, wherein metabolites of HMOs are obtained from 0.004-5 g/L of HMOs.</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2. Use of a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>metabolites of HMOs in the</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>15 manufacture of a medicament for improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and 3 years) or a child (aged from more than 3 years to less than 8 years);</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>wherein the nutritional composition to be administered to the child is in the form of a growing-up milk;</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>20 wherein the metabolites of HMOs are obtained by fermenting a composition comprising one or more HMOs selected from the group consisting of 2'FL, DiFL, 3'SL, 6'SL, LNT and LNnT in a composition comprising a baby microbiota, wherein metabolites of HMO","A23L33/00, A23L33/135, A23L33/21, A61K9/00, A61K31/702",20250424,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2849640C1,"Composition of chocolate product containing mixture of grains and beans (variations), method for obtaining chocolate product composition, mixture of grains and beans, and method for obtaining it","FIELD: food industry.SUBSTANCE: composition of the chocolate product contains a mixture of grains and legumes in an amount ranging from 1.0% to 50.0% by weight of the chocolate product. The grains contain more than 20.0% by mass of soluble dry matter based on the total dry matter in the grains, and the legumes contain more than 50% by mass of soluble dry matter based on the total dry matter in the legumes. Moreover, the D90 particle size of both grains and legumes is less than 250 micrometres. A method for obtaining a chocolate product composition, a vegan chocolate product composition obtained by this method, a mixture of grains and legumes for use in a chocolate product composition, and a method for obtaining said mixture of grains and legumes are also proposed.EFFECT: obtaining a chocolate composition with a reduced milk content, which retains its natural nutritional properties and does not produce graininess without losing any nutrients, in particular dietary fibre; this provides a concise composition using only natural ingredients.25 cl, 13 ex","1. Композиция шоколадного продукта, содержащая композицию, содержащую от 1,0 мас.% до 50,0 мас.% смеси зерновых и бобовых в расчёте на массу шоколадного продукта, причём упомянутые зерновые содержат более 20,0 мас.% растворимого сухого вещества в расчёте на общую массу сухого вещества в зерновых, а бобовые содержат более 50 мас.% растворимого сухого вещества в расчёте на общую массу сухого вещества в бобовых, причём размер частиц D90 как зерновых, так и бобовых составляет менее 250 мкм.
2. Композиция шоколадного продукта по п. 1, в которой упомянутые зерновые и бобовые присутствуют в количествах от 15,0 до 50,0 мас.% зерновых и от 50,0 до 85,0 мас.% бобовых в расчёте на смесь зерновых и бобовых.
3. Композиция шоколадного продукта по пп. 1, 2, которая содержит по меньшей мере 2,0 мас.% зерновых и по меньшей мере 4,0 мас.% бобовых.
4. Композиция шоколадного продукта по пп. 1-3, в которой упомянутые зерновые и бобовые присутствуют в количествах от 15 до 35 мас.% зерновых и от 65 до 85 мас.% бобовых в расчёте на смесь зерновых и бобовых.
5. Композиция шоколадного продукта по пп. 1-4, в которой зерновые представляют собой овес или киноа.
6. Композиция шоколадного продукта по пп. 1-5, в которой бобовые представляют собой нут или чечевицу.
7. Композиция шоколадного продукта по пп. 1-6, содержащая от 5,0 мас.% до 30,0 мас.% смеси зерновых и бобовых, причём зерновые и бобовые присутствуют в количествах от 20 до 35 мас.% зерновых и от 65 до 80 мас.% бобовых в расчёте на смесь зерновых и бобовых.
8. Композиция шоколадного продукта по пп. 1-7, дополнительно включающая семена масличных культур, предпочтительно подсолнечника.
9. Композиция шоколадного продукта по пп. 1-8, в которой размер частиц D90 как зерновых, так и бобовых составляет менее 200 мкм, предпочтительно менее 175 мкм.
10. Композиция шоколадного продукта по пп. 1-9, в которой зерновые содержат от 40 мас.% до 95 мас.% растворимого сухого вещества в расчёте на общую массу сухого вещества в зерновых, предпочтительно от","A23L7/10, A23G1/48, A23C11/10",20251028,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023378254A1,Compositions and methods using a combination of oleuropein and taurine,"Composition comprising a combination of oleuropein or metabolite thereof and taurine or functional derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a combination of oleuropein and/or a metabolite thereof and taurine and/or a functional derivative, in a therapeutically effective amount for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency / depletion disorder in an individual.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to Claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to Claim 1 or 2, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. The composition for use according to any of Claims 1 to 3, for preventing or treating muscle fatigue from exercise.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition for use according to any of Claim 1 to 4, wherein </seg-main><seg-clauses>the effective amount of a combination of oleuropein and/or a metabolite thereof and taurine and/or a functional derivative is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition for use accor","A61K31/351, A23L33/00, A61K31/185, A61K31/7048, A61P3/14",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
TW202529786A,Mixture of hmos and bifidobacterium longum transitional microorganism,"The present invention relates to a composition comprising a        Bifidobacterium longumtransitional microorganism and a mixture of human milk oligosaccharides (HMOs) consisting of 2'-fucosyllactose (2’-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and 3-fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT). The invention also relates to the use of the composition for preventing, reducing the risk of and/or treating an infection in a subject. The invention also provides the composition for use in promoting a long-term immune benefit in a subject, preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject.","<div class=""indep-clm"" num=""1"">1.</div>
<div class=""indep-clm"" num=""1"">一種組成物，其包含長雙歧桿菌( </div>
<div class=""indep-clm"" num=""1"">  Bifidobacterium longum)過渡微生物及HMO混合物，該HMO混合物由下列所組成：2'-岩藻糖基乳糖(2'-FL)、二岩藻糖基乳糖(DFL)、乳糖-N-四糖(LNT)、6'-唾液酸基乳糖(6SL)及3'-唾液酸基乳糖(3SL)，及可選地3-岩藻糖基乳糖(3-FL)及/或乳糖-N-新四糖(LNnT)。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.</div>
<div class=""dep-clm"" num=""2"" parent=""1"">如請求項1之組成物，其中該長雙歧桿菌過渡微生物： (i)   能夠代謝該（等）HMO； (ii)  優先利用3-FL而非2'-FL； (iii) 能夠代謝選自表1至表3中任一者中所述之群組的聚醣受質；及/或 (iv) 編碼選自表1中所述之群組的一或多種CAZyme，較佳地其中該長雙歧桿菌過渡微生物進一步編碼選自表2及表3之一或多種CAZyme。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">如請求項1或請求項2之組成物，其中該長雙歧桿菌過渡微生物與選自由下列所組成之群組中之至少一種長雙歧桿菌菌株具有至少98%之平均核苷酸同一性(Average Nucleotide Identity, ANI)：CNCM I-5683、CNCM I-5684、CNCM I-5685、CNCM I-5686、CNCM I-5687、CMCC-P0001 (ATCC BAA-2753)及其任何組合。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">如前述請求項中任一項之組成物，其中該組成物進一步包含長雙歧桿菌嬰兒亞種( </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">  Bifidobacterium longumsubsp. </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">  infantis)及/或乳雙歧桿菌( </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">  Bifidobacterium lactis)。</div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.</seg-con></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>如請求項4之組成物，</seg-con><seg-trans>其中： </seg-trans><seg-refi>(i)   該長雙歧桿菌嬰兒亞種係長雙歧桿菌嬰兒亞種LMG 11588，或與長雙歧桿菌嬰兒亞種LMG 11588具有至少99.9%之平均核苷酸同一性(ANI)；及 (ii)  該乳雙歧桿菌係乳雙歧桿菌CNCM 1-3446，或與乳雙歧桿菌CNCM 1-3446具有至少99.9% ANI之平均核苷酸同一性(ANI)。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">如前述請求項中任一項之組成物，其中該HMO混合物由2’-FL、DFL、LNT、6SL及3SL所組成。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">7.</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">如請求項1至5中任一項之組成物，其中該HMO混合物由2’-FL、DFL、LNT、6SL、3SL及3-FL所組成。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5"">8.</div>
<div class=""dep-clm"" num=""8"" par","A61K35/745, A23L33/135, A61K31/702, A61P31/04, A61P31/16",20250801,瑞士商雀巢製品股份有限公司,['Pending']
US20250032447A1,Use of urolithin in the remission phase of a preceding cancer therapy,"The current invention is directed to the therapeutic use of a composition comprising a therapeutically effective amount of a Urolithin or a precursor thereof, preferably suitable for use in reducing the risk of the recurrence of cancer or tumor formation in a patient in need thereof in the remission phase of a preceding cancer therapy in said patient. The invention is furthermore related to a corresponding composition, its method of preparation and a method of reducing the reducing the risk of the recurrence of cancer or tumor formation in a patient in need thereof in the remission phase after a preceding cancer therapy in said patient, wherein the method comprises the following steps: a) Providing a composition comprising a therapeutically effective amount of a Urolithin or a precursor thereof, the composition preferably being a composition as defined herein above; b) Administering the composition comprising the therapeutically effective amount of a Urolithin or a precursor thereof to the patient in need thereof, wherein the patient is in the remission phase after a preceding cancer therapy; and c) Optionally monitoring the patient regularly on the potential recurrence of the cancer treated in the preceding cancer therapy, preferably by using cancer specific biomarkers, preferably concurrent to administering the composition according to step b), preferably in predefined intervals.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in reducing the risk of the recurrence of cancer or tumor formation in a patient in need thereof in the remission phase of a preceding cancer therapy in said patient comprising </seg-main><seg-clauses>administering a composition comprising a therapeutically effective amount of a Urolithin or a precursor thereof to a patient in need of same.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the patient is a human or non-human mammal.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the patient is an immune-compromised patient.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the Urolithin or a precursor thereof is selected from the group consisting of a urolithin, ellagic acid, and an ellagitannin, more preferably is selected from Urolithin A, Urolithin B, Urolithin C or Urolithin D, and a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the urolithin is urolithin A, or a combination of Urolithin A with at least one of Urolithin B, Urolithin C or Urolithin D.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the urolithin is urolithin A.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clauses>the urolithin is administered in an amount of about 500 to 2000 mg/day.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The method according to claim 1, wherein </seg-main><seg-clauses>the administration of the composition comprising a Urolithin starts at day","A61K31/37, A61K31/706, A61K31/714, A61K35/04, A61K36/48",20250130,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250182905A1,method,"A method for determining a mortality risk and/or probability of a healthy lifespan of a dog, the method including a) providing a DNA methylation profile from a sample obtained from the dog; and b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile. The DNA methylation profile contains at least one methylation site as listed in Table 3.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising:</seg-main>
<seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and</seg-clauses>
<seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 3.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the determining the mortality risk and/or probability of a healthy lifespan for the dog further comprises combining the DNA methylation profile with one or more of the chronological age, breed and/or sex of the dog.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>a lifestyle regime, dietary regime or therapeutic intervention is selected based on a determination that the dog has an increased mortality risk and/or reduced probability of a healthy lifespan compared to its chronological age.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method according to claim 3, wherein </seg-main><seg-clauses>the lifestyle regime, dietary regime or therapeutic intervention is a dietary intervention.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The method according to claim 4, wherein </seg-main><seg-clauses>the dietary intervention is a calorie-restricted diet, a senior diet or a low protein diet.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the sample is a blood sample.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clauses><se","G16H50/30, C12Q1/6806, C12Q1/6827, C12Q1/6874, G16B20/20",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250288146A1,Beverage pod system with pod recognition,"The invention concerns an extraction device for extracting a beverage ingredient from a pod, said pod (<b>3</b>) comprising a code (<b>34</b>), said device comprising: —upstream and downstream pod enclosing parts (<b>1, 2</b>) relatively movable between an open position for inserting and removing the pod (<b>3</b>) and a closed position and a code reader (<b>71</b>), —a removable pod holder (<b>6</b>), —a top insertion section (<b>4</b>) for introducing the pod holder (<b>6</b>) in the device, —a pod holder stopper (<b>42</b>) to stop the pod holder (<b>6</b>) in an intermediate temporary position inside said path (<b>41</b>), and wherein, in the intermediate temporary position, the pod holder (<b>6</b>) is configured to hold the pod so that the code (<b>34</b>) arranged on the pod faces the code reader (<b>71</b>), and wherein the operation of reading the code by the code reader is triggered by the movement of the pod holder (<b>6</b>) when the pod holder reaches the intermediate temporary position during the introduction of the pod holder in the device.","<div class=""indep-clm"" num=""1""><seg-con>1. An extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said pod </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a side wall and a bottom wall defining a chamber, said chamber extending axially between the bottom and a top opening, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine-readable code storing preparation information, said code being arranged on the pod, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said device comprising upstream and downstream pod enclosing parts relatively movable, along a horizontal longitudinal axis between an open position for inserting and removing the pod and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said device comprising a code reader,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the device comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a removable pod holder, said holder comprising a pod receiving hole to receive and hold the pod,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top insertion section configured for introducing the pod holder in the device, said top insertion section comprising a path for guiding the pod holder to an extraction area between the upstream and downstream pod enclosing parts, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod holder stopper to stop the pod holder in an intermediate temporary position inside said path,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, in the intermediate","A47J31/44, A47J31/36",20250918,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250326567A1,Capsule for producing a beverage,"The invention concerns a capsule for use in a beverage preparation machine, said capsule containing a soluble and/or extractable beverage ingredient, said capsule comprising:—a capsule body (<b>2</b>) defining a chamber (<b>21</b>),—a top membrane (<b>3</b>) closing the top opening, and adapted to be punctured for liquid injection into the capsule, and—a bottom membrane (<b>4</b>), provided inside the chamber (<b>21</b>) so as to delimit between the top membrane (<b>3</b>) and said bottom membrane an ingredient chamber, and—an opening device (<b>5</b>) provided inside the chamber and adapted to open the chamber by relative engagement of said opening device with the bottom membrane (<b>4</b>) under the effect of the liquid pressure increase in the ingredient chamber during injection of said liquid, wherein said opening device (<b>5</b>) is made of a biodegradable material, and said biodegradable material is a polymeric composition, said polymeric composition comprising:—at least one polymer selected from the group consisting of polyhydroxyalkanoates (PHA),—at least one or more nucleants,—at least one or more mineral fillers.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule for use in a beverage preparation machine, said capsule </seg-con><seg-trans>containing </seg-trans><seg-refi>a soluble and/or extractable beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said capsule comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule body defining a chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top membrane closing the top opening, and adapted to be punctured for liquid injection into the capsule, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a bottom membrane, provided inside the chamber so as to define between the top membrane and said bottom membrane an ingredient chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an opening device provided inside the chamber and adapted to open the chamber by relative engagement of said opening device with the bottom membrane under the effect of the liquid pressure increase in the ingredient chamber during injection of said liquid,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein said opening device is a moulded piece made of a biodegradable material, and said biodegradable material is a polymeric composition, said polymeric composition comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one polymer selected from the group consisting of polyhydroxyalkanoates (PHA),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one or more nucleants, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one or more mineral fillers.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A capsule according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymeric composition comprises at least one polyhydroxyalkanoate containing repeating units of formula (I):</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi><img src=""https://data-","B65D85/804, B65D65/46",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023348157A1,Composition and method for treating muscle decline associated with renal disease or dysfunction,"A composition comprises at least two ingredients selected from the group consisting of: Fish oil, L-arginine, Vitamin E, Vitamin C, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B1, Vitamin B2, Folic acid, Biotin, Vitamin B12, and is formulated for use in preventing and/or treating a disease or condition associated with muscle decline in a subject in need thereof. Preferably the subject in need is an individual at risk of or suffering from a renal failure, a renal dysfunction or/and a renal disease, such as chronic kidney disease, protein-energy wasting, end- stage renal disease, kidney failure due to hospitalization in the intensive care unit, acute kidney injury, and the muscle decline is selected from muscle wasting, muscle loss due to kidney failure or dysfunction, muscle decline related to chronic kidney disease, muscle loss due to hospitalization in the intensive care unit during kidney failure, metabolic acidosis during chronic kidney disease, protein-energy wasting or combinations thereof. The method can achieve at least one result that is preventing and/or treating a disease or condition associated with muscle decline in a subject at risk of or suffering from a renal failure, a renal dysfunction or/and a renal disease. The composition and the method may be used for improving the level of at least one amino acid.","<div class=""indep-clm"" num=""1""><seg-con>1. A nutritional composition for use in preventing and/or treating a disease or condition associated with muscle decline in a subject in need thereof, </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least two ingredients selected from the group consisting of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Fish oil,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>L-arginine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin E,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin C,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B3,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B5,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B6,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin Bl,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Folic acid,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Biotin,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B12.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The nutritional composition as claimed in claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-comp>it comprises </seg-comp><seg-comp>at least two ingredients selected from the group consisting of:</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>Fish oil in a daily amount ranging from about 100 to about 5000 mg per kg of weight of the subject,</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>L-arginine in a daily amount ranging from about 100 to about 50000 mg per kg of weight of the subject,</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>Vitamin E in a daily amount ranging from about 1 to about 80000 mg per kg of weight of the subject,</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>Vitamin C in a dail","A23L33/115, A23L33/15, A23L33/175, A61P3/02, A61P13/12",20250227,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025114890A1,method,The present invention provides a method for determining a mortality risk and/or probability of a healthy lifespan of a dog; said method comprising a) providing a DNA methylation profile from a sample obtained from the dog; and b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 3.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A method for determining a mortality risk and/or probability of a healthy lifespan of a dog, said method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and </seg-clauses><seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile; wherein the DNA methylation profile comprises at least one methylation site as listed in Table 3.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for determining a biological age of a dog, said method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; and </seg-clauses><seg-clauses>b) determining a biological age for the dog using the DNA methylation profile, wherein the DNA methylation profile is linked to the mortality risk and/or probability of a healthy lifespan for the dog and wherein the DNA methylation profile comprises at least one methylation site as listed in Table 3.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A method for selecting a lifestyle regime, dietary regime or therapeutic intervention for a dog, the method comprising: </seg-main><seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog; </seg-clauses><seg-clauses>b) determining a mortality risk and/or probability of a healthy lifespan for the dog using the DNA methylation profile, wherein the DNA methylation profile comprises at least one methylation site as listed in Table 3; and </seg-clauses><seg-clauses>c) selecting a suitable lifestyle regime, dietary regime or therapeutic intervention for the dog based on the mortality risk and/or probability of a healthy lifespan determined in step b).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any preceding claim wherein </seg-main><seg-clauses>the det",C12Q1/6883,20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN223310538U,Cooking auxiliary equipment,A cooking aid includes: a sheet made of a flexible heat resistant material; a composition layer disposed on at least one surface of the sheet; wherein the sheet is configured to be selectively placed in one of the following configurations: a loading configuration for receiving food to be placed in contact with the layer of composition; a cooking configuration for at least partially surrounding food in contact with the composition layer; the cooking aid also includes a heat resistant fixture that may be configured to hold the sheet in the cooking configuration.,"<div class=""indep-clm"" num=""1""><seg-con>1.一种烹饪辅助设备，</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>由柔性耐热材料构成的片材；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>设置在所述片材的至少一个面上的组合物层；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其特征在于，所述片材构造成被选择性地置于以下构型中的一种构型：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>装料构型，用于接收待与所述组合物层接触放置的食物，和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>烹饪构型，用于至少部分地包围与所述组合物层接触的食物；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述烹饪辅助设备还包括耐热固定装置，所述耐热固定装置被构造成能够将所述片材保持在所述烹饪构型中。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述耐热固定装置是独立的并且能够与所述片材分离。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述耐热固定装置包括套筒。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述套筒由纸板构成。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-con>5.根据权利要求3所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述套筒包括：</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-refi>材料条带，其构造成能被折叠或围成环状，用于在所述烹饪构型中环绕所述片材和食物。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述材料条带包括凸部和凹部，所述凸部和凹部构造成彼此接合以将所述材料条带保持呈折叠的或环状的布置结构。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7.根据权利要求6所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述凸部包括突片。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""6,7""><seg-con>8.根据权利要求6或7所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述材料条带包括贯穿该材料条带的厚度的多个开口，所述多个开口之一形成为用于接纳所述凸部的所述凹部。</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""8""><seg-con>9.根据权利要求8所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个开口的表面积超过所述材料条带的总表面积的20％、30％、40％或50％。</seg-r",A21B3/15,20250909,雀巢产品有限公司,['Active']
RU2844748C1,Method of roasting coffee beans,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is a method for roasting coffee beans in roasting system (10) comprising roasting device (1) and smoke purification unit (2) configured to treat smoke, wherein the smoke purification unit comprises electrostatic precipitator (222), which comprises at least one cell (222a, 222b), and wherein said cell comprises ionisation wires (2221), collecting electrodes (2222), repulsive electrodes (2223) and is provided with electric power for supplying high voltage to ionisation wires and at least part of electrodes, wherein during each roasting operation, the method comprises: monitoring the voltage V on the ionisation wires and/or on the electrodes during the roasting operation, if the monitored voltage becomes below a predetermined voltage threshold value V0 during a period Δt of roasting operation time and if said period Δt time exceeds preset threshold value Δt0 time, a cleaning warning signal is displayed. Also disclosed is a coffee bean roasting system and a machine-readable data medium having a computer program stored thereon and containing instructions for enabling said system to implement the described method.EFFECT: group of inventions enables to inform operator in advance on occurrence of failure and on need to clean or carry out maintenance of electrostatic precipitating filter and providing said information in an accurate manner.12 cl, 4 dwg","1. Способ обжаривания кофейных зерен в системе (10) обжаривания, содержащей:
- устройство (1) для обжаривания, и
- блок (2) очистки дыма, выполненный с возможностью обработки дыма, образуемого устройством для обжаривания, причем указанный блок очистки дыма содержит по меньшей мере электростатический осадитель (222),
при этом указанный электростатический осадитель содержит по меньшей мере одну ячейку (222a, 222b), и
при этом указанная ячейка содержит ионизационные провода (2221), собирающие электроды (2222) и отталкивающие электроды (2223), и
при этом указанная ячейка снабжается электроэнергией для подачи высокого напряжения на ионизационные провода и по меньшей мере часть электродов,
причем во время каждой операции обжаривания, выполняемой в устройстве для обжаривания, способ включает стадии, на которых:
- контролируют напряжение V на ионизационных проводах и/или на электродах на протяжении операции обжаривания,
- если контролируемое напряжение становится ниже заданного порогового значения V0 напряжения в течение периода Δt времени операции обжаривания и
- если указанный период Δt времени превышает заданное пороговое значение Δt0 времени, то отображается предупреждающий сигнал об очистке.
2. Способ по п. 1, в котором заданное пороговое значение V0 напряжения ниже 100 В.
3. Способ по п. 1 или 2, в котором продолжительность заданного порогового значения Δt0 времени зависит от степени обжарки, получаемой во время операции обжаривания, и/или типа зерен, обжариваемых во время операции обжаривания.
4. Способ по любому из предшествующих пунктов, в котором продолжительность заданного порогового значения Δt0 времени зависит от количества операций обжаривания, выполненных с момента последней операции очистки электростатического осадителя.
5. Способ по любому из предшествующих пунктов, в котором продолжительность заданного порогового значения Δt0 времени меняется в ходе операции обжаривания.
6. Способ по любому из предшествующих пунктов, в котором заданное пороговое значение Δ","A23F5/04, A23N12/08",20250805,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2025210837A1,Mixture of HMOs and bifidobacteria,"The invention relates to a composition for infants or young children comprising at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria and a prebiotic 5 mixture of human milk oligosaccharides consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'- sialyllactose (3SL) and optionally 3-fucosyllactose (3FL) that can be useful for (i) preventing and/or treating bacterial infections; (ii) modulating the microbiota; and/or iii) preventing and/or treating allergy in an infant or a young child. 10 20 25 21 08 37 31 J ul 2 02 5 A B S T R A C T T h e i n v e n t i o n r e l a t e s t o a c o m p o s i t i o n f o r i n f a n t s o r y o u n g c h i l d r e n c o m p r i s i n g a t l e a s t o n e 2 0 2 5 2 1 0 8 3 7 3 1 J u l 2 0 2 5 p r o b i o t i c b a c t e r i a l s t r a i n , s a i d p r o b i o t i c b a c t e r i a l s t r a i n b e i n g b i f i d o b a c t e r i a a n d a p r e b i o t i c 5 m i x t u r e o f h u m a n m i l k o l i g o s a c c h a r i d e s c o n s i s t i n g o f 2 ' - f u c o s y l l a c t o s e ( 2 F L ) , l a c t o d i f u c o t e t r a o s e / d i f u c o s y l l a c t o s e ( D F L ) , l a c t o - N - t e t r a o s e ( L N T ) , 6 ' - s i a l y l l a c t o s e ( 6 S L ) , 3 ' - s i a l y l l a c t o s e ( 3 S L ) a n d o p t i o n a l l y 3 - f u c o s y l l a c t o s e ( 3 F L ) t h a t c a n b e u s e f u l f o r ( i ) p r e v e n t i n g a n d / o r t r e a t i n g b a c t e r i a l i n f e c t i o n s ; ( i i ) m o d u l a t i n g t h e m i c r o b i o t a ; a n d / o r i i i ) p r e v e n t i n g a n d / o r t r e a t i n g a l l e r g y i n a n i n f a n t o r a y o u n g c h i l d . 1 0","<div class=""indep-clm"" num=""1""><seg-main>1. A composition for infants or young children comprising </seg-main><seg-clauses><seg-main>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosy I lactose (2FL), lactodifucotetraose/difucosyllactose (DFL), 5 lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL);</seg-main>
<seg-main class=""seg-enter"">wherein the bifidobacteria comprises Bifidobacterium longum </seg-main><seg-clauses>subsp. infantis or combination of Bifidobacterium animalis </seg-clauses><seg-clauses>subsp. lactis and Bifidobacterium longum subsp. infantis., wherein at least one of the bifidobacteria is Bifidobacterium longum </seg-clauses><seg-clauses>subsp. infantis LMG 11588 10 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition of claim 1, wherein </seg-main><seg-clauses>the bifidobacteria is Bifidobacterium animalis </seg-clauses><seg-clauses>subsp. lactis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 15 3'-sialyllactose (3SL).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition of claim 1, wherein </seg-main><seg-clauses>the bifidobacteria is a combination of Bifidobacterium animalis subsp. lactis and Bifidobacterium longum subsp. infantis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), 20 lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3’-sialyllactose (3SL).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition of any one of the claims 1 to 3, wherein </seg-main><seg-","A23L33/135, A23L33/00, A23L33/21, A61K31/702, A61K31/745",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
JP2025081520A,Bioconversion of oleuropein,"To provide a composition for the treatment and prevention of a condition selected from the group consisting of (i) loss of bone or cartilage metabolism balance, (ii) loss of bone or cartilage health, (iii) loss of mobility, (iv) synovitis, and (v) combinations thereof.SOLUTION: A composition comprises oleuropein and at least one probiotic or enzyme, wherein the at least one probiotic or enzyme has β-glycosidase activity, esterase activity, or both β-glycosidase activity and esterase activity.SELECTED DRAWING: Figure 2","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 個体における状態を処置及び予防する組成物であって、前記状態は、（ｉ）骨又は軟骨代謝の均衡の喪失、（ｉｉ）骨又は軟骨の健康の喪失、（ｉｉｉ）運動性の低下、（ｉｖ）滑膜炎、及び（ｖ）これらの組み合わせからなる群から選択され、前記組成物は、オレウロペインと、少なくとも１つのプロバイオティクス又は酵素と、を含み、前記少なくとも１つのプロバイオティクス又は酵素は、（ｉ）β－グリコシダーゼ活性を有するプロバイオティクス、又はβ－グリコシダーゼ、（ｉｉ）エステラーゼ活性を有するプロバイオティクス、又はエステラーゼ、（ｉｉｉ）β－グリコシダーゼ活性及びエステラーゼ活性の両方を有するプロバイオティクス、又はβ－グリコシダーゼ活性及びエステラーゼ活性の両方を有する酵素、（ｉｖ）β－グリコシダーゼ活性を有する第１のプロバイオティクス、及びエステラーゼ活性を有する第２のプロバイオティクス、（ｖ）β－グリコシダーゼ活性を有するプロバイオティクス、及びエステラーゼ、（ｖｉ）β－グリコシダーゼ、及びエステラーゼ活性を有するプロバイオティクス、並びに（ｖｉｉ）β－グリコシダーゼ及びエステラーゼからなる群から選択され、前記組成物は、効果を得るのに有効な量で、前記少なくとも１つのプロバイオティクス又は酵素を含む、組成物。 </div>","A61K31/7048, A61K35/741, A61K38/46, A61K38/47, A61P19/08",20250527,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US20250134819A1,Oral dosage form with a gastro resistant capsule shell,The present invention relates to a gastro resistant capsule comprising one or more proteases. wherein the capsule shell comprises a water-soluble film forming polymer and a water-soluble enteric polymer. The present invention also relates to methods of manufacturing the gastro resistant capsules and uses thereof.,"<div class=""indep-clm"" num=""1""><seg-main>1. A gastro resistant capsule comprising </seg-main><seg-clauses><seg-main>one or more proteases, wherein the capsule shell comprises:</seg-main>
<seg-clauses>(i) hydroxypropyl methylcellulose (HPMC), in an amount of from about 65 wt % to about 97 wt %; and</seg-clauses>
<seg-clauses>(ii) pectin, in an amount of from about 3 wt % to about 30 wt %.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The gastro resistant capsule according to claim 1, wherein </seg-main><seg-clauses><seg-main>the pectin has:</seg-main>
<seg-clauses>(i) a degree of esterification of from about 15% to about 40%;</seg-clauses>
<seg-clauses>(ii) a degree of amidation of from about 0% to about 25%; and/or</seg-clauses>
<seg-clauses>(iii) a molecular weight of from about 20 kDa to about 1000 kDa, from about 40 kDa to about 400 kDa, or from about 50 kDa to about 200 kDa.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The gastro resistant capsule according to claim 1, wherein </seg-main><seg-clauses>the one or more proteases are selected from the group consisting of: bromelain, trypsin, papain, pancreatin, chymotrypsin, serratiopeptidase, ficain, nattokinase, and any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The gastro resistant capsule according to claim 1, wherein </seg-main><seg-clauses>the gastro resistant capsule comprises the one or more proteases in a total amount of: from about 50 mg to about 1000 mg.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The gastro resistant capsule according to claim 1, wherein </seg-main><seg-clauses>the gastro resistant capsule comprises one or more flavonoid.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The gastro resistant capsule according to claim 1, wherein </seg-main><seg-clauses>the gastro resistant capsule comprises one or more fl","A61K9/48, A61K38/48",20250501,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024247371A1,Controlled heat-induced protein aggregation for mouthfeel improvement of low fat dairy creams,"The present invention relates to a low fat dairy cream product, wherein said product is an emulsion having (a) between 1 to 5 wt%, preferably 2 to 4 wt% dairy protein; (b) between 5 to 20 wt%, preferably 10 to 18 wt% fat; (c) between 0.002 to 0.3 wt% mineral salts, for example between 0.03 to 0.3 wt% sodium chloride and/or between 0.002 to 0.02 wt% calcium chloride; (d) optionally between 0.1 to 3 wt%food additive, preferably hydrocolloid, and (e) between 70 to 90 wt% water; wherein said dairy protein is contributed by (i) skimmed milk powder or milk protein concentrate or micellar casein;","<div class=""indep-clm"" num=""1""><seg-main>1. A low fat dairy cream product, wherein </seg-main><seg-clauses><seg-main>said product is an emulsion having </seg-main><seg-clauses>(a) between 1 to 5 wt%, preferably 2 to 4 wt% dairy protein; </seg-clauses><seg-clauses>(b) between 5 to 20 wt%, preferably 10 to 18 wt% fat; </seg-clauses><seg-clauses>(c) between 0.002 to 0.3 wt% mineral salts, for example between 0.03 to 0.3 wt% sodium chloride and/or between 0.002 to 0.02 wt% calcium chloride; </seg-clauses><seg-clauses>(d) optionally between 0.1 to 3 wt% food additive, preferably hydrocolloid, and </seg-clauses><seg-clauses><seg-main>(e) between 70 to 90 wt% water; wherein said dairy protein is contributed by </seg-main><seg-clauses>(i) skimmed milk powder or milk protein concentrate or micellar casein; and </seg-clauses><seg-clauses>(ii) whey protein isolate.</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The product according to claim 1, wherein </seg-main><seg-clauses>skimmed milk powder or milk protein concentrate or micellar casein contributes between 50 to 90 wt% of the dairy protein in the emulsion, preferably 60 to 80%, and wherein whey protein isolate contributes between 10 to 50 wt% of the dairy protein in the emulsion, preferably 20 to 40%.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The product according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the emulsion has a ratio of micellar casein to whey protein between 20:80 to 80:20, preferably about 60:40.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The product according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the skimmed milk powder is low or medium heat skimmed milk powder, preferably low heat skimmed milk powder.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The product according to any one of claims 1 to 4, wherein </seg-m","A23C1/12, A23C1/14, A23C1/16, A23C13/14",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019264343B2,Handling of beverage,"A system (10,20) for processing and handling a liquid food substance, comprises: a processing device (20) that has a processing cavity (21) in which the liquid food substance is processed (21), the processing cavity (21) having an opening (22) that is configured so that the liquid food substance is removable from the processing cavity (21) via the opening (22); and a handling arrangement (10) that is configured to handle the liquid food substance when the liquid food substance is collected in an external user-recipient, such as a cup or a mug, after its processing in the processing cavity (21). The handling arrangement (10) is seizable by a human hand. The handling arrangement (10) is separate from the processing device (20) and from the external user-recipient and is freely movable relative thereto. When seized and operated by the human hand, the handling arrangement (10) is configured: to withdraw such liquid food substance upon processing from the processing cavity (21) and to deliver it into the external user-recipient; and/or to shape such processed liquid food substance upon collection in the external user-recipient.","2019264343  17 Dec 2024
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS: -
<div class=""indep-clm"" num=""1""><seg-main>1. A system for processing and handling a liquid food substance, the system comprising:</seg-main>
<seg-clauses><seg-main>5  - a processing device that has a processing cavity in</seg-main>
<seg-main class=""seg-enter"">which said liquid food substance is processed, the processing cavity having an opening that is configured so that said liquid food substance is removable from the processing cavity via the opening; and</seg-main>
<seg-main class=""seg-enter"">10   - a handling arrangement that is configured to handle</seg-main>
<seg-main class=""seg-enter"">said liquid food substance when said liquid food substance is collected in an external user-recipient after processing of said liquid food substance in the processing cavity,</seg-main>
<seg-main class=""seg-enter"">15 the handling arrangement comprising:</seg-main>
<seg-clauses>- a bowl delimiting a bowl cavity configured to collect such liquid food substance upon processing in the processing cavity and to withdraw the collected substance from the processing cavity; and further</seg-clauses>
<seg-clauses class=""seg-enter"">20   - an elongated handle seizable by a human hand, the</seg-clauses>
<seg-clauses class=""seg-enter"">handling arrangement being separate from the processing device and from said external user-recipient and being freely movable relative thereto, when seized and operated by said human hand the handling arrangement 25 being configured to withdraw the liquid food substance upon processing from the processing cavity and to deliver the liquid food substance into the external user-reciplent;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, when seized and operated by said human hand, the 30 handling arrangement is configured to shape the processed liquid food substance upon collection in said external user-reciplent,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the handle has an en","A47J43/046, A47J43/042, A47J43/07, A47J43/28",20250123,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019410757B2,Drinkable infant compositions,A drinkable infant composition comprising two or more food allergens wherein one of said food allergens is milk protein.,"<div class=""indep-clm"" num=""1""><seg-con>1. A drinkable infant composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>two or more food allergens from different foods wherein one of said food allergens is milk protein, wherein the composition has undergone pasteurisation at a temperature between 61.9°C and 72°C for between 15 and 45 minutes.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The drinkable infant composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is reconstituted with water prior to ingestion.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The drinkable infant composition according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition is in a ready to drink form.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The drinkable infant composition according to any one of the preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-refi>the food allergens are selected from the group consisting of: egg protein, wheat protein, soya protein, peanut protein, tree nut protein, fish protein, crustacean protein, shellfish protein, and sesame protein.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The drinkable infant composition according to claim 4 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises three or more of said food allergens, or four or more of said food allergens, or five or more of said food allergens, or six or more of said food allergens, or seven or more of said food allergens, or eight or more of said food allergens, or nine or more of said food allergens or all of said food allergens.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-con>6. The drinkable infant composition according to claim 4 or 5 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises milk protein and egg protein.</seg-refi></div>
<div class=""d","A23C9/20, A23L33/10, A23L33/19, A61K9/00",20250515,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US12281001B2,"Beverage mixing device, beverage preparation device and method for preparing a beverage product",,"<div class=""indep-clm"" num=""1""><seg-con>1. Beverage mixing device </seg-con><seg-trans>comprising </seg-trans><seg-refi>a mixing body defining a mixing chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one or a plurality of fluid inlets for supplying a fluid into the mixing chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a discharge opening to discharge a liquid from the mixing chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a sealing element being moveably provided between a closed position for closing the discharge opening and an open position for releasing the discharge opening to allow the liquid in the mixing chamber be discharged via the discharge opening, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an evacuation outlet for evacuating the mixing chamber by additional fluid introduced into the mixing chamber via the at least one or the plurality of fluid inlets when the discharge opening is closed by the sealing element.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Beverage mixing device according to claim 1, </seg-con><seg-trans>wherein</seg-trans><seg-refi>, in the open position, the sealing element seals the evacuation outlet from the mixing chamber.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. Beverage mixing device according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealing element is configured such that it closes the evacuation outlet-when being in the open position and releases the evacuation outlet when being in the closed position.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Beverage mixing device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the evacuation outlet is provided at a vertically moveable pipe/tube section carrying the sealing element to be moveable between the open and closed position.</seg-refi></div>
<div class=""dep-clm"" num=""5"" pare","B67D1/00, B67D1/08, B67D1/07",20250422,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2020288608B2,Reduced nicotinamideribosides for the treatment/prevention of liver disease,,"<div class=""indep-clm"" num=""1""><seg-con>1. Use of reduced nicotinamide riboside in the manufacture of a medicament for preventing and/or treating liver diseases or conditions </seg-con><seg-trans>selected from the group consisting of: </seg-trans><seg-refi>nonalcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease, hepatic steatosis, cirrhosis and/or recovery and regeneration after liver injury, transplantation or surgery, diseases and conditions associated with hepatitis A,B,C,D and E, infectious mononucleosis (Epstein Barr virus) and/or hemochromatosis, by increasing intracellular NAD+ in a subject in need thereof, wherein the reduced nicotinamide riboside is 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said medicament is for the prevention and/or treatment of liver diseases or conditions selected from the group consisting of: non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease, hepatic steatosis, cirrhosis and/or recovery and regeneration after liver injury, transplantation or surgery.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said medicament is for the prevention and/or treatment of liver diseases and conditions associated with hepatitis A,B,C,D and E, infectious mononucleosis (Epstein Barr virus) and/or hemochromatosis.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said medicament is to enhance regeneration and recovery of liver tissue after injury, trauma or liver transplantation surgery.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.Use according to any one of claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the subject is a ","A61K31/706, A23L2/00, A23L2/52, A61P1/16, A61P31/22",20250410,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025202271A1,Container for beverage or foodstuff preparation machine,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion, wherein a cavity of the storage portion is formed from an extensible paper-based sheet material by drawing to wrinkling portions in a drawn state, and the flange portion includes connecting members connected to the wrinkling portions to retain the drawn state and the connecting members are arranged as individual flaps that extend from a periphery of the storage portion into the storage portion in a depth direction.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A container for </seg-con><seg-trans>containing </seg-trans><seg-refi>a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion, wherein a cavity of the storage portion is formed from an extensible paper-based sheet material by drawing to wrinkling portions in a drawn state, and the flange portion includes connecting members connected to the wrinkling portions to retain the drawn state and the connecting members are arranged as individual flaps that extend from a periphery of the storage portion into the storage portion in a depth direction.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>an entire periphery of the storage portion comprises the wrinkling portions and the wrinkling portions extend from the periphery to at least 80% of the depth of the storage portion.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cavity is entirely formed by drawing without individual flaps.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the storage portion is drawn directly from a blank.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cavity of the storage portion is hemispherical.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the paper-based material of the storage portion has a thickness of less than 60 - 150 m",B65D85/804,20251002,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US12433314B2,Powdered thickener maintaining its extensional properties when reconstituted and for promoting safe swallowing by individuals with dysphagia,"A thickening powder promotes safe swallowing of a nutritional product by an individual with dysphagia and can be used in methods of treating dysphagia, promoting safe swallowing of a nutritional product, and mitigating a risk of aspiration during swallowing of a nutritional product. The powder contains beta-glucan and at least one carrier ingredient in an amount that is neutral toward or enhances the extensional properties of the nutritional product. The at least one carrier ingredient can be one or more of maltodextrin, isomaltulose, sucrose or lactose. The powder can be diluted in a diluent to form an aqueous solution that is at least a portion of a nutritional product and to improve the cohesiveness of the nutritional product. Preferably, the resultant nutritional product has a shear viscosity greater than 200 mPas and up to about 2,000 mPas, preferably greater than 200 mPas and up to about 500 mPas, more preferably 250 mPas to about 450 mPas, most preferably 250 mPas to about 400 mPas, when measured at a shear rate of 50 s<sup>−1 </sup>at a temperature of 20° C.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating a swallowing disorder or mitigating a risk of aspiration during swallowing in an individual having </seg-main><seg-clauses><seg-main>the swallowing disorder, the method comprising orally administering to the individual a nutritional product in which at least a portion thereof is made by diluting a thickening powder comprising a beta-glucan and at least one carrier ingredient in a weight ratio of about 10:1 to about 300:1 with a diluent to form an aqueous solution, wherein the weight ratio of diluent:thickening powder is from 50:1 to 100:1, wherein the diluting the thickening powder comprises diluting a unit dosage form of the thickening powder that is an amount effective for administration of the nutritional product to an individual who suffers from dysphagia to achieve at least one of </seg-main><seg-clauses>(i) supplemental nutrition, </seg-clauses><seg-clauses>(ii) hydration and </seg-clauses><seg-clauses>(ii) replacement of one or more full meals, the nutritional product comprising an amount of the aqueous solution that is neutral toward or enhances extensional properties of the nutritional product and provides to the nutritional product a shear viscosity greater than 200 mPas and up to about 2,000 mPas at a shear rate of 50 s<sup>−1 </sup>at 20° C.,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the at least one carrier ingredient comprises isomaltulose.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the shear viscosity provided by the aqueous solution to the nutritional product is greater than 200 mPas and up to about 500 mPas when measured at a shear rate of 50 s<sup>−1</sup>.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the amount of the aqueous solution in the nutritional product provides to t","A23L29/269, A23L33/125",20251007,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN222922139U,Dispensing device for flowable solid food product and dispensing system for flowable solid food product,"The utility model relates to a distribution device (1) for flowable solid food, which comprises a control unit and a temperature sensing unit (41), the control unit is operatively connected to a distribution unit (31) to control the distribution of the flowable solid food to a user container, and the temperature sensing unit is operatively connected to the control unit to control the distribution of the flowable solid food to the user container. The control unit (31) is connected to the dispensing opening (131) and is arranged to detect a sensed temperature relating to the temperature at the dispensing opening (131) or the temperature of the user container or the temperature of the contents of the user container, where the control unit activates the dispensing unit (31) only when the sensed temperature is below or equal to a predetermined dispensing value. The utility model further relates to a distribution system for the flowable solid food.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于可流动固体食品的分配装置(1)，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述分配装置(1)包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-储器(11)，所述储器(11)能够储存所述可流动固体食品或支承装有所述可流动固体食品的罐；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-用于用户容器的支承托盘(21)；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-分配单元(31)，所述分配单元(31)能够操作性地连接到所述储器(11)，并且具有分配口(131)以将所述可流动固体食品分配到所述用户容器中；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-控制单元，所述控制单元操作性地连接到所述分配单元(31)，以控制将所述可流动固体食品分配和分份到所述用户容器中；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，所述分配装置(1)还包括温度感测单元(41)，所述温度感测单元(41)操作性地连接到所述控制单元，并且布置成检测与所述分配口(131)处的温度或所述用户容器的温度或所述用户容器的内容物的温度有关的感测温度，以及</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，只有当所述感测温度低于或等于预定的分配值时，所述控制单元才启动所述分配单元(31)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的用于可流动固体食品的分配装置(1)，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述温度感测单元(41)包括红外温度传感器。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的用于可流动固体食品的分配装置(1)，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述分配口(131)能够相对于所述支承托盘(21)从关闭位置移动到打开位置或者从打开位置移动到关闭位置，其中在所述关闭位置，所述可流动固体食品的分配被阻止，而在所述打开位置，所述可流动固体食品的分配被允许，以及</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>其中，只有当所述感测温度低于所述预定的分配值时，所述控制单元才启动所述分配口(131)移动到所述打开位置。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2""><seg-con>4.根据权利要求1或2所述的用于可流动固体食品的分配装置(1)，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述分配装置(1)还包括一个或多个风扇单元，所述风扇单元操作性地连接到所述控制单元，并且布置成置换所述分配口(131)处的空气和/或蒸气，以及</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2""><seg-refi>其中，只有当所述感测温度高于所述预定的分配值时，所述控制单元才启动所述风扇单元。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的用于可流动固体食品的分配装置(1)，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述分配装置(1)包括两个风扇单元，其中第一风扇单元(51)布置在所述分配口(131)处，以便通过向所述分配口(131)吹送空气来置换空气和/或蒸气。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的用",B65D83/06,20250530,雀巢产品有限公司,['Active']
CN119584901A,Beverage or food preparation system,"The present disclosure provides a system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or food product, the container (6) comprising: a body portion (62) having a storage portion (58) for containing a precursor material; a closure member (56) to close the storage portion (58); a machine-readable code (44) storing preparation information, said code (44) being arranged on the closure member (56), the machine (4) comprising: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6); and electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), where the code reading system (18) comprises a code reader (46) and a positioning mechanism (110) to translate the container (6) and the code reader (46) relative to each other along an axis from a holding position to a reading position, the container (6) has a holding position in which the container (6) is separated from a read head of the code reader (46) and the code (44) is aligned with the code reader (46) along the axis, and a reading position in which the code (44) of the container (6) is in contact with the read head.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括容器以及用于制备饮料和/或食品的机器，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>主体部分，所述主体部分具有用于容纳前体材料的储存部分；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>闭合构件，所述闭合构件用以闭合所述储存部分；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>机器可读光学代码，所述代码存储制备信息，并且所述代码布置在所述闭合构件上，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述机器包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码读取系统，所述代码读取系统用以读取所述容器的所述光学代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>处理单元，所述处理单元用于处理所述容器的所述前体材料；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>电气电路系统，所述电气电路系统用以基于从所述代码读取的所述制备信息来控制所述处理单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述代码读取系统包括代码读取器和定位机构，所述定位机构用以使所述容器和所述代码读取器相对于彼此沿着轴线从保持位置平移到读取位置，在所述保持位置，所述容器与所述代码读取器的读取头分开并且所述代码沿所述轴线与所述代码读取器对准，在所述读取位置，所述容器的所述代码与所述读取头接触，并且与所述保持位置相比，所述闭合构件呈现相对更均匀的表面以用于读取所述代码。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述机器包括引导部分，所述引导部分被布置为经由重力将被插入所述引导部分中的所述容器从插入位置引导到所述保持位置以及引导到所述处理单元。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的系统，其中所述处理单元包括容器保持部分和闭合部分，所述容器保持部分和所述闭合部分能够在深度方向上在容器接收位置与容器处理位置之间移动，其中所述闭合部分包括在所述深度方向上从所述闭合构件延伸的腔体。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3中任一项所述的系统，其中所述读取头相对于所述引导部分布置成使得容器能够行进通过所述引导部分到达所述保持位置和/或从所述保持位置到达所述处理单元而不接触所述读取头。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的系统，其中所述定位机构被配置成在所述代码读取器静止的情况下使所述容器从所述保持位置平移到所述读取位置。</div>
<div class=""dep-clm"" num=""6"" parent=""2,4"">6.根据权利要求4所述的系统，当从属于权利要求2或3时，其中通过经由按压元件施加到所述容器的所述储存部分的基部的按压力来使所述容器平移，所述按压元件能够独立于所述引导部分致动。</div>
<div class=""dep-clm"" num=""7"" parent=""5,6"">7.根据权利要求5或6中任一项所述的系统，其中所述主体部分包括凸缘部分，所述凸缘部分将所述容器的所述储存部分和所述闭合构件互连，并且所述机器的所述引导部分被布置为引导所述凸缘部分，</div>
<div class=""dep-clm"" num=""7"" parent=""5,6"">其中所述引导部分包括用以接合所述凸缘的正面的正面接合部分，以及用以接合所述凸缘的背面的背面接合部分，</div>
<div class=""dep-clm"" num=""7"" parent=""5,6"">所述正面接合部分和所述背面接","A47J31/44, A47J31/36, A47J31/52, B65D85/804",20250307,雀巢产品有限公司,['Pending']
AU2024274421A1,Mixture of hmos and b. infantis,"The invention provides a composition for use in preventing and/or treating a viral infection in a subject, wherein the composition comprises Bifidobacterium longum subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL), and lacto-N-neotetraose (LNnT), and optionally 3-fucosyllactose (3FL). The invention also provides the composition for use in preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition for use in preventing and/or treating a viral infection in a subject, wherein </seg-main><seg-clauses><seg-main>the composition comprises Bifidobacterium longum </seg-main><seg-clauses>subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL), and lacto-N-neotetraose (LNnT), and optionally 3-fucosyllactose (3FL).</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A composition for use in i) preventing and/or reducing the risk of allergen sensitisation in the respiratory tract and/or ii) preventing and/or reducing the risk of developing a respiratory condition in a subject, wherein </seg-main><seg-clauses><seg-main>the composition comprises Bifidobacterium longum </seg-main><seg-clauses>subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL), and lacto-N-neotetraose (LNnT), and optionally 3-fucosyllactose (3FL), and wherein the respiratory condition is a chronic inflammatory disease of the respiratory tract or an allergic respiratory tract disease.</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A composition for use in preventing and/or reducing the risk of developing asthma in a subject, wherein </seg-main><seg-clauses><seg-main>the composition comprises Bifidobacterium longum </seg-main><seg-clauses>subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL), and lacto-N-neotetraose (LNnT), and optionally 3-fucosyllactose (3FL).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according any one of claims 1-3, wherein </seg-main><seg-clauses>the HMO mixture consis","A61K35/745, A23L33/00, A23L33/125, A23L33/135, A23L33/21",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250082125A1,Beverage preparation with a flexible outlet valve,"A machine (<b>1</b>) is provided for preparing a beverage (<b>4</b>) from a flavouring ingredient (<b>5</b><i>a</i>) in a processing cavity (<b>5</b>) by mixing the ingredient (<b>5</b><i>a</i>) with water (<b>4</b>′) and centrifugally driving the ingredient (<b>5</b><i>a</i>) and the water (<b>4</b>′) about a processing axis (<b>30</b>′). The machine (<b>1</b>) has a centrifugal valve (<b>30</b>) associated with a beverage passage (<b>26</b>) for controlling the flow and/or the pressure of the beverage (<b>4</b>) along the passage (<b>26</b>). The valve (<b>30</b>) includes a valve part (<b>31,310,311</b>) having first and second inertia bodies (<b>31;310,311</b>) that have first and second centres of inertia, respectively, that are off-set relative to the processing axis (<b>30</b>′) to move by rotation the valve part (<b>31,310,311</b>) to control the beverage flow and/or pressure. The first and second inertia bodies (<b>31;310,311</b>) move the valve part (<b>31,310,311</b>) when the ingredient (<b>5</b><i>a</i>) and water (<b>4</b>′) are rotated at first and second rotational speeds, respectively. The first and second rotational speeds are different.","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing a beverage from a flavouring ingredient in a processing cavity, such as a cavity for holding said ingredient supplied within a capsule, by mixing said ingredient with water and centrifugally driving such ingredient and said water about a processing axis to form said beverage, such machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a rotatable ingredient handling system for holding and rotating said flavouring ingredient and water during centrifugation about the processing axis, the ingredient handling system having at least one beverage outlet and at least one water inlet for supplying said water to said ingredient, optionally the system having a first ingredient handler and a second ingredient handler that are movable one relative to the other from:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an ingredient transfer configuration for receiving said ingredient by the first and second capsule handlers and/or releasing said ingredient from the first and second ingredient handlers; to</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an ingredient processing configuration for centrifuging said ingredient and water by rotation about the processing axis; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a beverage passage, the passage being configured to guide said beverage from the outlet towards a beverage dispensing outlet;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a centrifugal valve associated with the beverage passage for controlling the flow and/or the pressure of said beverage along the beverage passage, the valve being configured to increase and reduce, such as allow and interrupt, a beverage flow and/or beverage pressure at a valve portion of the passage; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the ingredient handling syst","A47J31/22, A47J31/40, A47J31/46",20250313,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12167742B2,Nutritional composition comprising 6′SL and LNT in combination to improve the gastrointestinal barrier function,"The present invention relates to nutritional compositions comprising 6′-sialyllactose (6′SL) and lacto-N-tetraose (LNT) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gut barrier function in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of improving a gastrointestinal barrier in an infant, young child or child, the method comprising </seg-main><seg-clauses><seg-main>administering a nutritional composition comprising 6′-sialyllactose (6′SL) and lacto-N-tetraose (LNT) to the infant, young child or child,</seg-main>
<seg-main class=""seg-enter"">wherein the improving the gastrointestinal barrier comprises at least one of improving barrier structure and/or improving barrier protection,</seg-main>
<seg-main class=""seg-enter"">wherein the nutritional composition has at least one formulation that is: </seg-main><seg-clauses>(i) the nutritional composition does not contain DFL and does not contain 3-FL, and/or </seg-clauses><seg-clauses>(ii) the nutritional composition does not contain LNnT, and/or </seg-clauses><seg-clauses>(iii) the nutritional composition does not contain 3′-SL.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the improving the gastrointestinal barrier further comprises improving recovery of integrity of the gastrointestinal barrier.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the method is further for at least one of improving strength of the gastrointestinal barrier, improving the gastrointestinal barrier resistance, reducing disease susceptibility, reducing severity of symptoms upon inflammatory challenge of gastrointestinal mucosa and/or reducing the gastrointestinal barrier permeability.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method according to claim 3, wherein </seg-main><seg-clauses>the reducing the gastrointestinal barrier permeability comprises reducing at least one of pathogens, allergens and/or toxic compounds migrating from gut into body through intestinal barrier in the infant, young child or ","A23L33/00, A23L33/21",20241217,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2842546C1,Coffee beans roasting system checking method,,"1. Способ проверки системы обжаривания, включающей:
- по меньшей мере одно устройство для обжаривания, причем указанное устройство производит дым во время нагревания кофейных зерен, и
- по меньшей мере один блок очистки дыма, выполненный с возможностью обработки по меньшей мере части потока дыма, образуемого по меньшей мере одним устройством для обжаривания, причем указанный блок очистки дыма содержит по меньшей мере одно съемное фильтрующее устройство,
- рабочий орган подачи дыма, выполненный с возможностью перекачивания дыма из устройства для обжаривания к указанному по меньшей мере одному фильтрующему устройству,
причем по меньшей мере один блок очистки дыма содержит по меньшей мере один расположенный ниже по потоку датчик давления, причем указанный расположенный ниже по потоку датчик давления выполнен с возможностью измерения давления ниже по потоку указанного по меньшей мере одного съемного фильтрующего устройства,
при этом способ включает стадии:
- работы по меньшей мере рабочего органа подачи дыма для перекачивания газа через блок фильтрации дыма,
- измерения давления Р на датчике давления за съемным фильтрующим устройством,
- расчета падения давления ΔP = P - Pref по сравнению с эталонным давлением Pref,
- сравнения указанного падения давления ΔP с заданным пороговым значением ΔP0, соответствующим наличию указанного по меньшей мере одного съемного фильтрующего устройства перед датчиком давления,
- если указанное падение давления ΔP ниже указанного заданного порога ΔP0, то отображение аварийного сигнала.
2. Способ по п. 1, в котором съемное фильтрующее устройство является очищаемым, одноразовым или способным к регенерации, предпочтительно состоящее из: металлического сита, электростатического осадителя, НЕРА-фильтра, бумажного фильтра, хлопкового фильтра, тканевого фильтр, фильтра из адсорбирующего материала и их комбинации.
3. Способ по любому из предшествующих пунктов, в котором эталонное давление Pref представляет собой давление окружающей среды или заданн","A23N12/08, A23F5/04",20250630,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US12383584B2,Egg protein formulations and methods of manufacture thereof,"The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating of an egg allergy by oral immunotherapy, the method comprising </seg-main><seg-clauses><seg-main>administering a composition comprising dried egg white protein powder comprising egg white protein to an allergic individual having the egg allergy, wherein the composition comprises:</seg-main>
<seg-clauses>a) about 0.1 wt. % to 90 wt. % of the egg white protein;</seg-clauses>
<seg-clauses>b) about 40-90 wt. % of one or more diluent;</seg-clauses>
<seg-clauses>c) about 1-30 wt. % of one or more filling agent;</seg-clauses>
<seg-clauses>d) about 0.01-10 wt. % of one or more lubricant and/or glidant; and</seg-clauses>
<seg-clauses>e) a capsule shell or sachet.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>a level of the egg white protein in the egg white protein powder is stable in the composition for about 3, 6, 9, 11 or 36 months.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>a concentration of one or more of ovomucoid, ovalbumin, and lysozyme proteins are stable for about 3, 6, 9, or 11 or 36 months in the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the egg white protein is about 0.1 wt. % to about 21 wt. % of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the egg white protein is about 0.1% of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the composition is housed by a capsule or sachet, and the capsule or sachet comprises an amount of the composition comprising about 0.2 mg to about 1000 mg of the egg white protein in the capsule or sachet.","A61K35/57, A61K9/48, A61K38/17, A61K38/38, A61K38/47",20250812,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025228746A1,Instant sintered three-dimensional shapes,"The present invention relates to instant beverage or food shapes. In particular, the present invention relates to sintered three-dimensional shapes comprising flavoured ingredient and amorphous carbohydrates for making a cold or hot beverage. It also relates to a method for producing the shapes thereof.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. Sintered three-dimensional shape comprising </seg-main><seg-clauses>from 1 to 85 wt. % of at least one flavoured ingredient, from 15 to 99 wt. % of at least one amorphous carbohydrate, wherein the shape has an envelope density comprised between 0.5 and 0.8 g/cm<sup>3</sup>measured with a GeoPyc density meter.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Sintered three-dimensional shape according to claim 1, wherein </seg-main><seg-clauses>the sintered three- dimensional shape comprises from 15 to 90 wt. % of at least one amorphous carbohydrate, preferably from 20 to 70 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Sintered three-dimensional shape according to claims 1 or 2, wherein </seg-main><seg-clauses>the amorphous carbohydrates originates from an ingredient selected in the group consisting of milk powder, whey powder, malt extract powder, glucose syrup powder, maltodextrin, amorphous sugars, dried syrups powder extracted from plants, dried cereal or pseudo cereal syrups powder obtained by hydrolyis or mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Sintered three-dimensional shape according to any of the preceding claims, wherein </seg-main><seg-clauses>the sintered three-dimensional shape comprises from 5 to 50 wt. % of at least one flavoured ingredient, preferably from 10 to 40 wt%, more preferably from 15 to 35 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Sintered three-dimensional shape according to any of the preceding claims, wherein </seg-main><seg-clauses>the flavoured ingredient is a powder ingredient selected from the group consisting of cocoa powder, vegetable powder, fruit powder, nuts powder, seed powder, cereal powder, powdered flavours and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. Sintered three","A23G1/56, A23L2/395, A23L2/52, A23L29/30",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2842688C1,Method of roasting coffee beans,"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is a method for roasting coffee beans in roasting system (10) comprising roasting device (2) and smoke purification unit (3), wherein said smoke purification unit comprises at least one filtering device (221, 222, 223) configured to filter particulate matter or volatile organic compounds, wherein said filtering device is configured to retain a predetermined maximum amount of particulate matter or VOC, wherein for each roasting operation carried out in the roasting device, the method includes the following steps: obtaining directly or indirectly data on the number of grains and the degree of roasting, determining the amount of solid particles or VOC held in said filtering device (221, 222, 223) during said roasting operation, based on said obtained number of roasted grains and said obtained degree of roasting, determining the total amount of specific particles or VOC held in said filtering device (221, 222, 223) during all roasting operations, estimating the number of roasting operations that can still be carried out until said total number is equal to a predetermined maximum amount of solid particles or VOCs that can be retained by the filtering device. Also disclosed is a system for roasting coffee beans indoors and a computer-readable data medium containing instructions for performing the coffee beans roasting method.EFFECT: group of inventions makes it possible to inform the operator performing frying in advance about the cleaning moment so that the operator could plan the cleaning moment, while avoiding an unnecessary cleaning operation at the too early stage or the cleaning operation at the too late stage.14 cl, 3 dwg","1. Способ обжаривания кофейных зерен в системе (10) обжаривания, содержащей:
- устройство (2) для обжаривания, и
- блок (3) очистки дыма, выполненный с возможностью очистки дыма, выделяемого устройством для обжаривания, причем указанный блок очистки дыма содержит по меньшей мере одно устройство (221, 222, 223) фильтрации, выполненное с возможностью фильтрации твердых частиц или летучих органических соединений (ЛОС), при этом указанное устройство фильтрации выполнено с возможностью удержания заранее определенного максимального количества твердых частиц или ЛОС,
причем при каждой операции обжаривания, реализуемой в устройстве для обжаривания, способ включает стадии:
- получения непосредственно или опосредованно данных о количестве зерен, обжаренных во время указанной операции обжаривания, и степени обжаривания, примененной к зернам во время указанной операции обжаривания,
- определения количества твердых частиц или ЛОС, удерживаемых в указанном устройстве (221, 222, 223) фильтрации во время указанной операции обжаривания, на основе указанного полученного количества обжаренных зерен и указанной полученной степени обжаривания,
- определения общего количества особых частиц или ЛОС, удерживаемых в указанном устройстве (221, 222, 223) фильтрации во время всех операций обжаривания, реализованных с момента последней операции очистки устройства фильтрации,
- оценки количества операций обжаривания, которые все еще могут быть реализованы, пока указанное общее количество не сравняется с заранее определенным максимальным количеством твердых частиц или ЛОС, которые могут быть удержаны устройством фильтрации.
2. Способ по п. 1, в котором блок (3) очистки дыма содержит по меньшей мере одно устройство фильтрации из следующего списка: высокоэффективный фильтр-аккумулятор (223) твердых частиц, металлический фильтр (223), электростатический осадитель (222), фильтр (221) с активированным углем.
3. Способ по любому из предшествующих пунктов, включающий стадии:
- получения типа зерен, обжа","A23F5/04, A23N12/08",20250701,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2024239874A1,Beverage capsule system with code and bit error correction,A system has a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material The container has a code to at least partially encode preparation information. The machine includes: a code reading system to read the code; a processing unit for processing the precursor material of the container; and electrical circuitry to control the processing unit based on the preparation information. The electrical circuitry is configured to: read the code to obtain a code read; determine a characteristic of a neighbouring non-code portion in proximity of a code portion of the code read; correct an associated characteristic of the code portion based on the determined characteristic of the neighbouring non-code portion to account for variations of the characteristic in the non-code portion.,"<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container for containing precursor material and a machine for preparing a beverage and/or foodstuff or a precursor thereof from said precursor material,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code encoding a binary sequence to at least partially encode preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the electrical circuitry is configured to:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>read the code to obtain the binary sequence;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>implement an error-correcting code decoder with error correction of the binary sequence to correct single bit errors in the sequence; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>identify a recipe that is associated with the corrected binary sequence.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the electrical circuitry is configured with the error-correcting code decoder to decode the binary sequence in a first forward order and in a second reverse order to account for an unknown rotational position of the code.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The system of either of claims 1 or 2, </seg-con><seg-trans>wherein </se",G06K19/06,20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024259955A1,Packaging item and packaged food product,"The present invention relates to a packaging item comprising a cylindrical container made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer The container has a dispensing opening. The packaging item further comprises at least one sleeve element with at least one sleeve element peripheral wall, the sleeve element being configured to be slid over at least a top end portion of the container peripheral wall and being made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer. The packaging item further comprises at least one base element with at least one base element peripheral wall, the base element at least partially enclosing and preferably immovably attached to a bottom end portion of the container peripheral wall. The present invention further relates to a packaged food product.","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (100) comprising:</seg-main>
<seg-clauses>-           at least one container (102) made of a multilayer oxygen and</seg-clauses>
<seg-clauses class=""seg-enter"">moisture barrier laminate comprising a cardboard and an organic and/or inorganic barrier layer, the cardboard having a grammage comprised between 120 and 600 g/m2 and a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, the container including at least one container peripheral wall (104) and a container bottom wall (106), which define at least one compartment (108) for packaging contents, and at least one dispensing opening (110) configured to allow the packaged contents to be dispensed from said container (102),</seg-clauses>
<seg-clauses>-           at least one sleeve element (114) with at least one sleeve element</seg-clauses>
<seg-clauses class=""seg-enter"">peripheral wall (116), and a sleeve element top wall (150) the sleeve element (114) being configured to be slid over at least a top end portion of the container peripheral wall such that the sleeve element peripheral wall at least partially overlaps and encloses the container peripheral wall and the sleeve element at least partially covers the dispensing opening, said sleeve element being made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic and/or inorganic barrier layer, the cardboard having a grammage comprised between 120 and 600 g/m2 and a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, and</seg-clauses>
<seg-clauses>-           at least one base element (122) with at least one base element</seg-clauses>
<seg-clauses class=""seg-enter"">peripheral wall (124) and one bottom wall (160) that at least partially closes the lower extremity of said base element (122), the base element (122) at least partially enclosing a bottom end portion of the container periphe","B65D3/12, B65D5/68, B65D5/72, B65D59/04, B65D59/06",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2833308C2,Use of nutritional composition containing sialyllactose for treating and/or preventing low attention and/or excessive impulsivity,"FIELD: food industry.SUBSTANCE: disclosed is use of a nutritional composition containing sialyllactose for preventing low attention and excessive impulsivity in an infant or a young child. Said nutritional composition is an infant formula, an initial infant formula, a mixture for fed children, infant formula for premature babies, an enriching agent, a breast milk enricher, a infant formula, a milk formula for children from 1 to 3 years old or a grain-based infant composition, and the nutritional composition contains 6'-sialyllactose (6'-SL) in amount of 50 mg to 50,000 mg per liter of the nutritional composition, preferably from 60 mg to 2000 mg per liter of the nutritional composition, more preferably from 80 mg to 1000 mg per liter of the nutritional composition and most preferably from 87.5 mg to 735 mg per liter of the nutritional composition.EFFECT: invention is aimed at preventing low attention and excessive impulsivity in an infant or a young child.3 cl, 7 dwg, 1 tbl","1. Применение питательной композиции, содержащей сиалиллактозу, для предотвращения пониженного внимания и избыточной импульсивности у младенца или ребёнка младшего возраста, причём питательная композиция представляет собой детскую смесь, начальную детскую смесь, смесь для прикармливаемых детей, детскую смесь для недоношенных детей, обогатитель, обогатитель грудного молока, смесь для детского питания, молочную смесь для детей от 1 до 3 лет или детскую композицию на зерновой основе, и при этом питательная композиция содержит 6'-сиалиллактозу (6'-SL) в количестве от 50 мг до 50 000 мг на литр питательной композиции, предпочтительно от 60 мг до 2000 мг на литр питательной композиции, более предпочтительно от 80 мг до 1000 мг на литр питательной композиции и наиболее предпочтительно от 87,5 мг до 735 мг на литр питательной композиции.
2. Применение по п. 1, причём внимание выбрано из группы, состоящей из устойчивого внимания, разделённого внимания и комбинации любого из вышеперечисленного, и предпочтительно при этом внимание представляет собой устойчивое внимание.
3. Применение по п. 1 или 2, причём указанный младенец или ребёнок младшего возраста нуждается в повышении внимания и снижении импульсивности.","A23L33/00, A23L33/125",20250117,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119506248A,Engineered lipase variants,,"<div class=""indep-clm"" num=""1"">1.一种重组脂肪酶，所述重组脂肪酶包含含有与SEQ ID NO:2的至少70％、至少75％、至少80％、至少85％、至少90％、至少91％、至少92％、至少93％、至少94％、至少95％、至少96％、至少97％、至少98％或至少99％序列同一性的氨基酸序列。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的重组脂肪酶，其中所述重组脂肪酶包含与SEQ ID NO:94、350、442、540、646、758和/或868具有至少85％、86％、87％、88％、89％、90％、91％、92％、93％、94％、95％、96％、97％、98％、99％或更多序列同一性的多肽序列。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的重组脂肪酶，其中所述重组脂肪酶包含与SEQ ID NO:2具有至少85％、86％、87％、88％、89％、90％、91％、92％、93％、94％、95％、96％、97％、98％、99％或更多序列同一性的多肽序列，并且其中所述多肽序列在选自以下的一个或更多个位置处包含至少一个取代或取代集：2、3、4、22、27/46/97/136/149/385、27/46/385、27/70/136/231/385、27/136/323/385、27/149、27/149/385、27/385、34、38、41、44、46/70、46/149/183/231/385、48、70、73、73/305、82、82/94/101/194/199、82/94/199、83、85、87、89、92、94、96、97/149/385、135、136/385、140、141、142、144、146、149、149/231/385、151、174、175、178、181、183/385、189、194、194/199、195、195/231/385、199、199/213、210、212、213、213/330、216、218、219、226、231/385、238、247、250、270、274、281、292、296、300、308、330、338、379和385，其中所述多肽序列的氨基酸位置参考SEQ ID NO:2编号。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的重组脂肪酶，其中所述重组脂肪酶包含与SEQ ID NO:94具有至少85％、86％、87％、88％、89％、90％、91％、92％、93％、94％、95％、96％、97％、98％、99％或更多序列同一性的多肽序列，并且其中所述多肽序列在选自以下的一个或更多个位置处包含至少一个取代或取代集：3/4/96/296/300、3/292/296、4、4/11/149/292/296/300、4/96/149/231/296/300、4/96/149/292/296/300、4/96/219/296、4/96/231/296/300、4/96/292/296/300、4/149/174、4/174/219/292/296、4/231/296/300、27、27/34/82、27/73/82/218、27/89、27/89/178、27/89/218、27/218、34/73/218、34/82、34/218、73/82、73/82/183、94/146/175、96/149/174/292/296、96/149/231/292/296、96/149/292/296、96/174/219/231/292/296、96/231/296、146/175/189/281、149/174/292/296、149/174/300、149/219/231/292/296/300、149/231/292/296、149/231/292/296/300、149/296、149/296/300、174/231、174/296、218、231、231/292/296、231/292/296/300、231/296、231/300、292/296、292/296/300、296和296/300，其中所述多肽序列的氨基酸位置参考SEQ ID NO:94编号。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的重组脂肪酶，其中所述重组脂肪酶包含与SEQ ID NO:350具有至少85％、86％、87％、88％、89％、90％、91％、92％、93％、94％、95％、96％、97％、98","C12N9/20, C12N15/55, C12N15/63, A61K38/46, A61P1/18",20250225,雀巢产品有限公司,['Pending']
JP2025025393A,Emulsion gels,"To provide emulsion gels, and food products comprising the same, for nourishing a subject having dysphagia, chewing difficulties, swallowing difficulties, an increased risk of aspiration, or an increased risk of choking.SOLUTION: There is provided an emulsion gel comprising 320 kcal/100 g to 480 kcal/100 g energy, wherein the emulsion gel comprises an E471 emulsifier and an E472 emulsifier, and wherein the ratio of the total weight of E471 emulsifier to the total weight of E472 emulsifier is from about 1.8:1.0 to about 1.0:1.0.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> ３２０ｋｃａｌ／１００ｇ～４８０ｋｃａｌ／１００ｇのエネルギーを含むエマルションゲルであって、前記エマルションゲルがＥ４７１乳化剤及びＥ４７２乳化剤を含み、Ｅ４７１乳化剤の合計重量の、Ｅ４７２乳化剤の合計重量に対する比が約１．８：１．０～約１．０：１．０である、エマルションゲル。 </div>
<div class=""indep-clm"" num=""2"">【請求項2】</div>
<div class=""indep-clm"" num=""2""> 少なくとも約４００ｋｃａｌ／１００ｇを含むエマルションゲルであって、前記エマルションゲルがＥ４７１乳化剤及びＥ４７２乳化剤を含み、Ｅ４７１乳化剤の合計重量の、Ｅ４７２乳化剤の合計重量に対する比が約１．８：１．０～約１．０：１．０である、エマルションゲル。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> （ａ）合計量が約１．０ｗｔ％～約１．８ｗｔ％、約１．１ｗｔ％～約１．７ｗｔ％、若しくは約１．２ｗｔ％～約１．６ｗｔ％である乳化剤、</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> （ｂ）合計量が約０．５ｗｔ％～約１．２ｗｔ％、約０．６ｗｔ％～約１．１ｗｔ％、若しくは約０．７ｗｔ％～約１．０ｗｔ％であるＥ４７１乳化剤、及び／又は</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> （ｃ）合計量が約０．３ｗｔ％～約０．９ｗｔ％、約０．４ｗｔ％～約０．８ｗｔ％、若しくは約０．５ｗｔ％～約０．７ｗｔ％であるＥ４７２乳化剤</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> を含む、請求項１又は２に記載のエマルションゲル。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> Ｅ４７１乳化剤の合計重量の、Ｅ４７２乳化剤の合計重量に対する比が、約１．７：１．０～約１．１：１．０、約１．６：１．０～約１．２：１．０、又は約１．５：１．０～約１．３：１．０であり、任意選択で、Ｅ４７１乳化剤の合計重量の、Ｅ４７２乳化剤の合計重量に対する比が約７：５である、請求項１～３のいずれか一項に記載のエマルションゲル。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> （ａ）合計量が約６．０ｗｔ％～約１４．０ｗｔ％、約７．０ｗｔ％～約１３．０ｗｔ％、若しくは約８．０ｗｔ％～約１２．０ｗｔ％であるタンパク質であって、任意選択で、大豆タンパク質、空豆タンパク質、エンドウ豆タンパク質、米タンパク質、及びオート麦タンパク質などの植物タンパク質、並びに／若しくはカゼイン及び乳清などの乳タンパク質から選択されるタンパク質、</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> （ｂ）合計量が約２４．０ｗｔ％～約３６．０ｗｔ％、約２６．０ｗｔ％～約３４．０ｗｔ％、若しくは約２８．０ｗｔ％～約３２．０ｗｔ％である脂肪であって、任意選択で、大豆油、中鎖脂肪酸トリグリセリド、菜種油、コーン油、ごま油、ごまサラダ油、えごま油、亜麻仁油、落花生油、サフラワー油、ひまわり油、綿実油、ブドウ種子油、マカダミアナッツ油、ヘーゼルナッツ油、カボチャ種子油、クルミ油、ツバキ油、茶の実油、えごま油、ルリヂサ油、オリーブ油、米油、米ぬか油、小麦胚芽油、パーム油、パーム核油、魚油、及びそれらの任意の組み合わせから選択される脂肪、</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> （ｃ）合計量が約１８．０ｗｔ％～約３０．０ｗｔ％、約２０．０ｗｔ％～約２８．０ｗｔ％、若しくは約２２．０ｗｔ％～約２６．０ｗｔ％である炭水化物であって、任意選択で、グルコース、フルクトース、及びガラクトースなどの単糖、スクロース、ラクトース、マルトースなどの二糖、オリゴ糖、マルトデキストリン及びデ","A23L33/10, A23D7/005, A23L29/238, A23L29/269, A23L29/262",20250221,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US12382933B2,Methods of monitoring feeding behaviors of pets,"The present disclosure relates to the monitoring feeding behavior(s) of a pet(s), under the control of at least one processor. An example method includes obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl. The load sensor can have a sensitivity of +/−50 grams or less and the load data is obtained can occur at a sample rate from 10 samples to 150 samples per second. The example method can also include sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples, and identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of monitoring feeding behavior of a pet, under the control of at least one processor, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>obtaining load data from a load sensor of a pet bowl while the pet is interacting with contents of the pet bowl, wherein the load sensor has a sensitivity of +/−50 grams or less and the load data is obtained at a sample rate from 10 samples to 150 samples per second;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sequentially grouping the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>identifying a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>excluding load data in identifying the feeding behavior if determined to be a result of human interaction, a false trigger, or an accidental interaction with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the feeding behavior is a count-based feeding behavior selected from lapping, licking, or biting.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The method of claim 3, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>characterizing the count-based feeding behavior by counting individual micro-events of the feeding behavior within a single time increment or a time period spanning multiple time increments, wherein the individual micro-events include individual laps, individual licks, or individual bites.</seg-","G08B23/00, A01K29/00",20250812,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025114594A1,Nutritional composition for promoting emotional development,"The present invention relates to a combination comprising osteopontin and lactoferrin in effective amount for use in promoting social-emotional development in a young individual. The present invention further relates to compositions and methods for promoting social-emotional development in a young individual, preferably in an infant.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A combination </seg-con><seg-trans>comprising </seg-trans><seg-refi>osteopontin and lactoferrin in effective amount for use in promoting social-emotional development in a young individual.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The combination according to claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-comp>it comprises </seg-comp><seg-comp>osteopontin in amount ranging from about 50 ng/pL to about 900 ng/pL, and lactoferrin in amount ranging from about 190 ng/pL to about 5050 ng/pL.</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The combination according to any one of the preceding claims, for use in promoting surgency and/or extraversion, regulation of emotions and/or behavior, and/or regulation domain on Infant Behavior Questionnaire-Revised (IBQ-R) scale in a young individual.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The combination any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the young individual is an infant, a toddler or a young child, preferably an infant.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The combination according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>it is administered to the young individual from birth to about 5 years of age, preferably from birth to 18 weeks of age, more preferably during the first 12 weeks of life of the young individual.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The combination according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>social- emotional development is promoted in a young individual from birth to about 5 years of age, preferably from birth to 18 months of age, more preferably from about 2 to about 6 months of age, more preferably in about 3 months of age.</seg-refi></div>
<div class=""dep-clm"" num=""","A61K38/19, A61K38/40, A61P25/22, A61P25/24, A61P43/00",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119157750A,Enteral nutrition container cap and methods of making and using same,"A package closure system may include a lid and a package outlet having a first connection unit, the lid configured to be removably connected to the package outlet using the first connection unit and including a second connection unit. The top cap may be configured to be removably connected to the cover using a second connection unit. A method for providing a nutritional composition from a container to the intestinal tract may include: removing a top cap from a cap configured to direct the nutritional composition through a channel within the cap, the cap removably connected to the container; sealingly connecting the cap to the intestinal tract; and applying pressure to the container to direct the nutritional composition from the container through the channel and into the intestinal tract.","<div class=""indep-clm"" num=""1""><seg-con>1.一种包装件封闭系统，所述包装件封闭系统</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>可变形的包装件[131]，所述包装件容置营养组合物[132]；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>盖[10]，所述盖包括上部部分和下部部分，所述上部部分用于连接到肠道饲管，所述下部部分用于连接到所述包装件，其中，所述上部部分配置成连接到<img src=""https://data-fulltext-image.patsnap.com/CN/A/11/91/57/75/0/1734946524080/FDA0005068008870000011.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064361%3B1765067961%26q-key-time%3D1765064361%3B1765067961%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Db5b1aed272cb228b19bc9ad36f40d9715f9fc161&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A21%20GMT"" class=""img-anchor"" img-id=""FDA0005068008870000011"" image_type=""inline"" official_size=""3722"">连接器。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的包装件封闭系统，</seg-con><seg-trans>其中，</seg-trans><seg-refi>连接螺纹[13]从所述上部部分延伸并且配置成附接到所述<img src=""https://data-fulltext-image.patsnap.com/CN/A/11/91/57/75/0/1734946524080/FDA0005068008870000012.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064361%3B1765067961%26q-key-time%3D1765064361%3B1765067961%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D2660ad7c4025c2e8aa90023c642e158d246aae39&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A21%20GMT"" class=""img-anchor"" img-id=""FDA0005068008870000012"" image_type=""inline"" official_size=""3989"">连接器。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的包装件封闭系统，还包括顶部罩帽[70]，所述顶部罩帽配置成封闭所述包装件。</div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的包装件封闭系统，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述顶部罩帽配置成使得其能从所述上部部分按扣掉。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的包装件封闭系统，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述顶部罩帽是在顶部罩帽和上部部分的界面处具有弱化部分的单个单元。</seg-refi>","A61J1/14, A61J15/00, A61J9/00, A61M5/162",20241220,雀巢产品有限公司,['Pending']
US12365497B2,System for the preparation of a packaged food composition,"The present invention relates to a system for the preparation of a packaged food composition, wherein the system comprises a collecting unit, a weighing unit, a mixing unit, a filling unit, transferring units and a control unit.","<div class=""indep-clm"" num=""1""><seg-con>1. An automatic system for a preparation of a packaged food composition, the system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a collecting unit for collecting food ingredients in primary containers;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a primary transferring unit for transferring the primary containers with the food ingredients from the collecting unit to a weighing unit;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a weighing unit for weighing and dispensing food ingredients from the primary containers into secondary containers;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a secondary transferring unit for transferring the secondary containers with the weighed food ingredients to a mixing unit;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a mixing unit for mixing the weighed food ingredients;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a tertiary transferring unit for transferring the mixed weighed food ingredients to a filling unit;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a filling unit for filling the mixed weighed food ingredients into packages;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control unit; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the control unit controls and directs the collecting unit, the weighing unit, the mixing unit, the filling unit, and the primary, secondary and tertiary transferring units in such a way as to compose, mix and pack a food composition starting from the food ingredients present in the primary containers according to a composition recipe stored in the control unit in an electronic form to result in the packaged food composition,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the secondary transferring unit is an automated guided vehicle, and</seg-comp></div>
<div class=""indep-clm"" num=""","B65B1/32, A23L5/30, B01F35/21, B01F35/22, B65B3/28",20250722,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CA3172470C,Method of tropicalizing chocolate,"The present invention relates to fat based tropicalizing agents' compositions, to methods for the preparation thereof, to methods of tropicalizing chocolate or analogues thereof, and to chocolate or analogues of chocolate containing the tropicalizing agents.","<br/>Claims:<br/><div class=""indep-clm"" num=""1""><seg-main>1. A tropicalizing agent composition comprising </seg-main><seg-clauses>a fat component, a cocoa <br/>solids <br/>component and a humectant, wherein the composition comprises between 10wt% and <br/>60wt% <br/>of the cocoa solids component based on the weight of the composition.<br/></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The tropicalizing agent composition according to claim 1, wherein </seg-main><seg-clauses>the <br/>fat component is <br/>present in an amount of between 20wt% and 80wt% based on the weight of the <br/>composition.<br/></seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The tropicalizing agent composition according to claim 1 or 2, wherein <br/></seg-main><seg-clauses>the humectant <br/>is present in an amount of between 2.5wt% and 40wt% based on the weight of the <br/>composition.<br/></seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The tropicalizing agent composition according to any of claims 1 to 3, <br/>wherein </seg-main><seg-clauses>the <br/>weight ratio of cocoa solids to humectant is between 0.25:1 and 24:1.<br/></seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The tropicalizing agent composition according to any of claims 1 to 4, <br/>wherein </seg-main><seg-clauses>the <br/>weight ratio of cocoa solids to fat component is between 0.4:1 and 2.4:1.<br/></seg-clauses></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The tropicalizing agent composition according to any of claims 1 to 5, <br/>wherein </seg-main><seg-clauses>the <br/>tropicalizing agent is in the form of an emulsion, preferably with emulsion <br/>droplet sizes D90 of <br/>between 20 and 100 microns.<br/></seg-clauses></div><div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The tropicalizing agent composition according to any of claims 1 to 6, <br/>wherein </seg-main><seg-clauses>the","A23G1/30, A23G1/32, A23G1/36",20250708,SOCIETE DES PRODUITS NESTLE SA,['Active']
US12268325B2,Capsule system with recognition means and adaptable opening and injection mechanism,,"<div class=""indep-clm"" num=""1""><seg-con>1. A beverage preparation device for preparing a beverage upon interaction of ingredients provided in a capsule with liquid supplied thereto, the device </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>an injection module comprising a first and a cooperating second enclosing member designed for being moved relatively to each other, the first enclosing member being equipped with a capsule opening and injection member for opening a first inlet face of a capsule and injecting liquid into the capsule,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the first and second enclosing members being designed for being brought into at least a first capsule insertion position for inserting a capsule between the enclosing members and a second capsule enclosing position in which the opening and injection member engages the inlet face of the capsule,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the device further comprising a control member designed for adapting the capsule enclosing position by adjusting a distance between the first and second enclosing members based on information read from the capsule and/or based on information provided by a user input.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The device according to claim 1,</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-trans>wherein </seg-trans><seg-refi>the control member is designed for adapting the enclosing position during a beverage preparation process with a capsule in the device based on information read from the capsule and/or based on information provided by a user input.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The device according to claim 1,</seg-con></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-trans>wherein </seg-trans><seg-refi>the adjusting the distance between the first and second enclosing members in the capsule enclosing positi","A47J31/36, A47J31/44, A47J31/52",20250408,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2843644C1,Cardboard packaging material suitable for recycling and comprising metallised barrier layer applied by transferring metallisation,"FIELD: packaging and storage.SUBSTANCE: invention relates to the field of paper-based packaging materials and relates to the structure of a barrier multilayer material having high barrier properties and suitable for secondary processing in secondary paper pulp flow, and carton package for beverages made from it. Paper-based packing material structure is made in the form of a single sheet and contains the following layers from its outer surface to its inner surface: (i) at least one layer of polymer dispersion coating, said coating having thickness of 1 mcm to 10 mcm, (ii) a semi-rigid or rigid cardboard having density of 120 g/m2 to 500 g/m2, (iii) a layer of solvent-free adhesive or water-based adhesive having thickness of 1 mcm to 10 mcm, (iv) at least one protective coating layer with thickness of 1 mcm to 10 mcm, (v) an aluminium layer having an equivalent optical density of 2–5, or aluminium oxide, or silicon oxide, deposited using a physical or chemical vapour deposition method or by metallization transfer, (vi) a parting coating with thickness of 0.1 mcm to 4 mcm, (vii) at least one layer of a water-resistant sealing polyolefin coating with thickness of 10 mcm to 50 mcm, wherein the total content of fibres in said structure is from 90% to 96% by weight.EFFECT: invention provides a packaging material which enables to make packages using existing moulding methods, which also have high barrier properties and a shape suitable for warehousing and transportation, which can be recycled together with other paper packaging such as old corrugated cardboard boxes (OCC) or mixed paper wastes, and to do so generally in a paper recycling stream, as well as having high abrasion resistance, and especially such, in which metal layer is not damaged by mechanical stress during storage, transportation or use of packaging material.6 cl, 1 dwg","1. Структура (1) барьерного многослойного упаковочного материала на основе бумаги, сформированная в виде полужесткого или жесткого единого листа и содержащая от ее наружной поверхности до внутренней поверхности следующие слои:
(i) по меньшей мере один слой (8) полимерного дисперсионного покрытия, выбранного из списка: сополимер этилена и акриловой кислоты или метакриловой кислоты, винилацетат, стиролакрилат, акриловый полимер, модифицированный поливиниловый спирт, этилацетат, полигидроксиалканоат (PHA) и их сополимеры, полиуретан (PU), полибутиленадипат-терефталат (PBAT), полибутиленсукцинат (PBS), поли(бутиленсукцинат-со-адипат) (PBSA), полимолочная кислота (PLA) или любая их смесь с минеральным наполнителем или без него, причем указанное покрытие имеет толщину от 1 до 10 мкм,
(ii) полужесткий или жесткий картон (7), имеющий плотность от 120 г/м<sup>2</sup>до 500 г/м<sup>2</sup>,
(iii) слой (6) не содержащего растворителей клея или клея на водной основе, выбранного из следующего списка: поливинилацетат (PVAc), полиуретан (PU), акриловый полимер, поливиниловый спирт (PVOH), этиленвиниловый спирт (EVOH), сополимер бутендиола и винилового спирта (BVOH), клей на основе крахмала или их смесь, причем указанный клеевой слой имеет толщину от 1 мкм до 10 мкм,
(iv) по меньшей мере один слой (5) защитного покрытия, выбранного из следующего списка: поливиниловый спирт (PVOH), этиленэтилакрилат (EEA) или полиуретан (PU), причем указанное защитное покрытие имеет толщину от 1 мкм до 10 мкм,
(v) слой (4) алюминия, имеющий эквивалентную оптическую плотность 2-5, или оксид алюминия, или оксид кремния, наносимые с применением способа физического или химического осаждения из паровой фазы или с помощью переноса металлизации,
(vi) разделительное покрытие (3), выбранное из следующего списка: винилхлорид, акриловый полимер, полиуретан (PU), нитроцеллюлоза или их смесь, причем указанное разделительное покрытие имеет толщину от 0,1 мкм до 4 мкм,
(vii) по меньшей мере один слой (2) устойчиво","B32B29/00, B32B27/10, D21H19/02, D21H19/84, B65D65/40",20250717,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250297083A1,A method for producing a compound comprising a polyhydroxyalcanoate and cellulose,"Process for manufacturing a biodegradable compound, said process comprising the steps of, in order: (i) providing an extruder with at least one rotating screw, at least two feeding units suitable for being fed with ingredients, and an extruder die, (ii) feeding the first feeding unit with a PHA polymer and maleic anhydride (MA), (iii) feeding the second feeding unit with cellulosic fibres, (iv) rotating the screw to mix the PHA and maleic anhydride ingredients and graft said maleic anhydride onto said PHA molecules to form PHA grafted with MA (“PHA-g-MA”) in an amount of 1 to 10%, preferably 1 to 3% of the total content of PHA, and then mixing said PHA-g-MA with cellulosic fibres to form a molten compound of PHA-g-MA and cellulosic fibres, (v) passing said molten compound through said extruder die and shaping said extruded compound into different compound formats.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for manufacturing a biodegradable compound, said compound comprising </seg-main><seg-clauses><seg-main>a mixture of cellulosic fibres and at least one type of polyhydroxyalcanoate polymer (PHA), said process comprising the steps of, in order:</seg-main>
<seg-clauses>(i) providing an extruder comprising a heater, at least one rotating screw, at least two feeding units suitable for being fed with ingredients, and an extruder die, the temperature of said extruder being set between 130° C. and 190° C.,</seg-clauses>
<seg-clauses>(ii) feeding the first feeding unit with a PHA polymer and maleic anhydride (MA), wherein the ratio of maleic anhydride to PHA is comprised between 0.1 and 10,</seg-clauses>
<seg-clauses><seg-main>(iii) feeding the second feeding unit with cellulosic fibres, said cellulosic fibres being hardwood cellulose fibres having a length of 15 μm to 150 μm, and having a density of at least </seg-main><seg-clauses>1.0 g/cm3,</seg-clauses></seg-clauses>
<seg-clauses>(iv) rotating the at least one screw to mix the PHA and maleic anhydride ingredients and graft said maleic anhydride onto said PHA molecules to form PHA grafted with MA (“PHA-g-MA”) in an amount of 1 to 10%, of the total content of PHA, and then mixing said PHA-g-MA with cellulosic fibres to form a molten compound of PHA-g-MA and cellulosic fibres,</seg-clauses>
<seg-clauses>(v) passing said molten compound through said extruder die, and shaping said extruded compound into, a product selected from the group consisting of:</seg-clauses>
<seg-clauses class=""seg-enter"">compound pellets, by cutting said extrudate compound cord with a knife system,</seg-clauses>
<seg-clauses class=""seg-enter"">a compound film or compound plates (in this case, the extruder die takes the form of a cast line), and</seg-clauses>
<seg-clauses class=""seg-enter"">a compound tridimensional item, by injection moulding or extrusion blow-moulding said extruded compound into a ","C08L1/02, B29B9/06, B29B9/14, B29K1/00, B29K67/00",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025202268A1,Container for beverage or foodstuff preparation machine,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion coupled to the storage portion, and; a separate stiffening ring arranged connected to the flange portion to stiffen a periphery of the flange portion.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A container for </seg-con><seg-trans>containing </seg-trans><seg-refi>a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion coupled to the storage portion, and; a separate stiffening ring arranged connected to the flange portion to stiffen a periphery of the flange portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stiffening ring is adhesively bonded to the flange portion by a heat activated lacquer applied to the flange portion.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stiffening ring is connected to an upper surface of the flange portion, wherein the upper surface faces away from the storage portion.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The container of any preceding claim, </seg-con><seg-trans>comprising </seg-trans><seg-comp>a liner member, which is: arranged to line an interior of the storage portion; </seg-comp><seg-comp>arranged over an upper face of the flange portion that faces away from the storage portion and not over an opposed lower face that faces the storage portion. arranged over the stiffening ring, and is arranged to bond the stiffening ring to the flange portion.</seg-comp></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The container of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liner member extends around the stiffening ring and to the upper surface of the flange portion at a periphery of the flange portion.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The container of any preceding claim, </seg-",B65D85/804,20251002,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250046423A1,Systems and methods for providing individualized nutritional recommendations for intermittent fasting,"Systems and methods provide individualized nutritional recommendations before, during and/or after an intermittent fasting (IF) diet. In several embodiments, the individualized nutritional recommendations are diets, menus and recipes for before, during and/or alter an intermittent fasting (IF) diet. In several embodiments, the nutritional recommendations are delivered by a computer-implemented system. In several embodiments, the individual is administered and/or consumes nutrients according to the nutritional recommendations, for example calcium, preferably one or more calcium salts, such as calcium acetate, calcium carbonate, calcium chloride, calcium citrate, calcium gluconate, calcium lactate or mixtures thereof; and/or a fiber supplement, preferably those containing one or more of wheat dextrin, methylcellulose, psyllium husk, polycarbophil, guar fiber, glucomannan or β-glucans.","<div class=""ccl-clm"" num=""1"">1. (canceled)</div>
<div class=""indep-clm"" num=""2""><seg-con>2. The method according to claim 11, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the recommendations comprise diet recommendations, menu recommendations and recipe recommendations.</seg-refi></div>
<div class=""ccl-clm"" num=""4"">3-4. (canceled)</div>
<div class=""indep-clm"" num=""5""><seg-con>5. The method according to claim 11, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the intermittent fasting (IF) diet is a time-restricted feeding (TRF) regimen or an alternate day fasting (ADF) regimen.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6. The method according to claim 11, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional recommendations are determined by a process comprising generating a rule for each of a plurality of nutrients or ingredients, the rule generated by defining one or more of a desired lower bound of the rule, a desired upper bound of the rule, an absolute minimum for the rule, an absolute maximum for the rule, a weight for lower bound of the rule, or a weight for upper bound of the rule; the process further comprising generating a goal for each of the plurality of nutrients or ingredients, the goal is maximizing the amount of the corresponding nutrient or ingredient or minimizing the amount of the corresponding nutrient or ingredient.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The method according to claim 11, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutritional recommendations are determined using a database of meal items and pre-created meals, wherein the pre-created meals each comprise one or more of the meal items which form an entire meal, and each of the pre-created meals are associated with summary nutrition information for the entire meal; and the process of determining the nutritional recommendations comprises generating a variable for each of the pre-created meals which","G16H20/60, G16H10/60",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250024867A1,Methods and devices for heating or cooling viscous materials,"Methods and devices heat or cool viscous materials, such as meat emulsions useful for producing food and other products. The devices have a heat exchanger including a first plate, a second plate attached to the first plate, and a first spacer and a second spacer arranged between the first plate and the second plate. The first plate, the second plate, the first spacer, and the second spacer define at least one temperature controlled passage for a product to pass through the heat exchanger.","<div class=""indep-clm"" num=""1""><seg-main>1: A device comprising:</seg-main>
<seg-clauses>a first pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a first energy exchanging plate attached to the first pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a second pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a second energy exchanging plate attached to the second pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a first spacer and a second spacer arranged between the first energy exchanging plate and the second energy exchanging plate, wherein the first energy exchanging plate, the second energy exchanging plate, the first spacer and the second spacer define a first temperature controlled passage for a first product to pass through the device;</seg-clauses>
<seg-clauses class=""seg-enter"">a third energy exchanging plate attached to the second pressure plate on an opposing side of the second pressure plate from the second energy exchanging plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a fourth energy exchanging plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a third spacer and a fourth spacer arranged between the third energy exchanging plate and the fourth energy exchanging plate, wherein the third energy exchanging plate, the fourth energy exchanging plate, the third spacer and the fourth spacer define a second temperature controlled passage for a second product to pass through the device;</seg-clauses>
<seg-clauses class=""seg-enter"">a third pressure plate attached to the fourth energy exchanging plate on an opposing side of the fourth energy exchanging plate from the second temperature controlled passage;</seg-clauses>
<seg-clauses class=""seg-enter"">a first end plate attached to a first end of the first pressure plate;</seg-clauses>
<seg-clauses class=""seg-enter"">a first temperature controlling passage in a first portion of at least one of the first energy exchanging plate, the second energy exchanging plate, th","A23L13/60, A22C7/00, A22C11/00, A23B4/005, A23B4/06",20250123,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025228766A1,Fluidic food composition based on condensed milk and pectin,"The present invention relates to a fluidic food composition comprising: between 20 and 50 wt% of a condensed milk; between 0.5 and 2.0 wt% of pectin; and aqueous phase, wherein said fluidic food composition has a pH less than 4.5, preferably between 3 and 4.2, more preferably between 3.5 and 4.0. The present invention also relates to a method of making said fluidic food composition and use of said fluidic food composition.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A fluidic food composition comprising:</seg-main>
<seg-clauses>- between 20 and 50 wt% of a condensed milk;</seg-clauses>
<seg-clauses>- between 0.5 and </seg-clauses><seg-clauses>2.0 wt% of pectin; and</seg-clauses>
<seg-clauses>- aqueous phase, wherein said fluidic food composition has a pH less than 4.5, preferably between 3 and 4.2, more preferably between 3.5 and 4.0.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The fluidic food composition according to claim 1 , wherein </seg-main><seg-clauses>the condensed milk comprises between 5 and 60 wt% of sugar, between 0.2 and 9 wt% of fat or oil, and between 5 and 8 wt% of protein based on the entire content of the condensed milk.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The fluidic food composition according to claim 1 or 2, wherein </seg-main><seg-clauses>the aqueous phase comprises any of water, a vegetable puree, a fruit puree and the combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The fluidic food composition according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>viscosity of the fluidic food composition measured at 25 °C at a shear rate of 10 s<sup>-1</sup>is between 100 and 100,000 mPa s.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The fluidic food composition according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>a protein content of the fluidic food composition is between 2 and 5 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The fluidic food composition according to claim 5, wherein </seg-main><seg-clauses>the protein content of the fluidic food composition is based only on the protein content of the condensed milk.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The fluidic food composition according to any one of c","A23C9/137, A23C9/154, A23L29/231",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025140836A1,Extracting arrangement of a beverage extraction device,"The invention concerns an extracting arrangement (121), for extracting a beverage from a pod comprising a beverage ingredient, comprising a plurality of opening elements (122) rising from at least one piercing surface (123), facing in use an enclosing wall (11) of the pod (10) to open, and a plurality of traversing holes, to evacuate the beverage dispensed from the opened enclosing wall (11), wherein each of the opening elements (122) presents an outlet opening (122'') cooperating with the traversing holes and/or a tip end (122'), wherein the extracting arrangement (121) further comprises a fitting hollow element (124) having a first end (124'), coupled to the extracting surface (123), smaller than an opposite second end (124''), and an inner lateral surface (124''') having a non-planar shape so as the inner lateral surface (124''') together with the extracting surface (123) substantially match with the non-planar enclosing wall (11) of the pod (10) to open.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Extracting arrangement (121) for extracting a beverage from a pod (10) containing </seg-main><seg-clauses>a beverage ingredient, preferably roast and ground coffee, the extracting arrangement</seg-clauses>
<seg-clauses class=""seg-enter"">(121) comprising a plurality of opening elements (122) rising from at least one extracting surface (123), facing in use a non-planar enclosing wall (11) of the pod (10) to open, and a plurality of traversing holes, to evacuate the beverage dispensed from the opened enclosing wall (11), wherein each of the opening elements (122) presents an outlet opening (122”) cooperating with the traversing holes and/or a tip end (122’), wherein the extracting arrangement (121) further comprises a fitting hollow element (124) having a first end (124’), coupled to the extracting surface (123), and an opposite second end (124”), wherein the first end (124’) and the second end (124”) are circular and the diameter of the first end (124’) is smaller than the diameter of the second end (124”), wherein the fitting hollow element (124) is provided with an inner lateral surface (124’”) connecting the first end (124’) to the second end (124”) and having a non-planar shape so as the inner lateral surface (124’”) together with the extracting surface (123) substantially match with the non-planar enclosing wall (11 ) of the pod (10) to open , and wherein the inner lateral surface (124’”) is provided with two or more discontinuities in the non-planar shape to define a different portion of the inner lateral surface (124’”) at each discontinuity.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Extracting arrangement (121) according to claim 1 , wherein </seg-main><seg-clauses>the inner lateral surface (124’”) is a curved surface or a stepped surface.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Extracting arrangement (121) according to claim 1 or 2, wherein </s","A47J31/06, A47J31/36",20250703,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2024251707A1,Machine for dispensing beverages with foam,A machine (1) for dispensing a beverage (100) comprises a beverage processing unit (5) and a beverage outlet (10) in fluid communication with the unit (5). The beverage outlet (10) has: a collection cavity (10a) delimited by a bottom (10b) and (a) sidewall(s) (10c) which are configured to collect beverage (100) from the beverage processing unit (5); a bottom dispensing opening or edge (14) configured to dispense beverage (100) from the outlet (10) to an area (2) for placing a user-recipient (9) to collect such dispensed beverage (100); and a beverage transfer channel (10a') that fluidically connects the collection cavity (10a) to the bottom dispensing opening or edge (14) and that is configured to guide beverage (100) between the collection cavity (10a) and the bottom dispensing opening or edge (14). The beverage transfer channel (10a') extends along a direction of flow (F) from the collection cavity (10a) around at least part of the sidewall (10c) of the collection cavity (10a) to the bottom dispensing opening or edge (14).,"Claims <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for dispensing a beverage (100) comprises </seg-main><seg-clauses><seg-main>a beverage processing unit (5) and a beverage outlet (10) in fluid communication with the unit (5), the beverage outlet (10) having: </seg-main><seg-clauses>- a collection cavity (10a) delimited by a bottom (10b) and (a) sidewall(s) (10c) which are configured to collect beverage (100) from the beverage processing unit (5), such as a collection cavity (10a) that is shaped substantially as a cup or a bathtub, optionally the beverage outlet (10) being configured to accumulate a pool of beverage (100) in the collection cavity (10a); </seg-clauses><seg-clauses>- a bottom dispensing opening or edge (14) configured to dispense beverage (100) from the outlet (10) to an area (2) for placing a user-recipient (9), e.g. a cup or a mug, to collect such dispensed beverage (100); and </seg-clauses><seg-clauses><seg-main>- a beverage transfer channel (10a’) that fluidically connects the collection cavity (10a) to the bottom dispensing opening or edge (14) and that is configured to guide beverage (100) between the collection cavity (10a) and the bottom dispensing opening or edge (14), optionally the beverage outlet (10) and/or the processing unit (5) being located at least partly in a stationary frame and/or housing (4), for instance: </seg-main><seg-clauses>- the beverage outlet (10) being movable relative to the stationary frame and/or housing </seg-clauses><seg-clauses>(4) between a dispensing position in which the beverage outlet (10) dispenses via the bottom dispensing opening or edge (14) said beverage (100) to said area (2) and a non- dispensing position in which the beverage outlet (10) prevents dispensing via the bottom dispensing opening or edge (14) to said area (2), e.g. the beverage outlet (10) directing waste liquid towards a waste collector (3); and/or </seg-clauses><seg-clauses>- the processing unit (5) having a first part (53) ",A47J31/46,20241212,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN120712021A,Aerated confection,The present invention relates to a water-based aerated confectionery product for use as a filling composition in chocolate or chocolate-like products and a method of making the same.,"<div class=""indep-clm"" num=""1"">1.甜食组合物，所述甜食组合物包含填充有基于水的充气甜食填充物的巧克力或巧克力类似物甜食，其中所述基于水的充气甜食填充物：</div>
<div class=""indep-clm"" num=""1"">具有大于或等于5.6的pH；并且</div>
<div class=""indep-clm"" num=""1"">具有小于0.67的水活度；并且</div>
<div class=""indep-clm"" num=""1"">包含30重量%至90重量%的糖；</div>
<div class=""indep-clm"" num=""1"">包含1重量%至8重量%之间的蛋白质，</div>
<div class=""indep-clm"" num=""1"">其中所述蛋白质使所述基于水的充气甜食稳定，并且所述蛋白质已经热变性，并且所述基于水的充气甜食被部分或完全包围或包裹在巧克力或巧克力类似物中。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的甜食组合物，其中所述基于水的充气甜食填充物具有5.6至10.0或6.0至8.0的pH。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据任一项前述权利要求所述的甜食组合物，其中所述蛋白质是乳清蛋白。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一项前述权利要求所述的甜食组合物，其中所述蛋白质以所述基于水的充气甜食填充物的至少2重量%、任选地至少2重量%、至少2.2重量%、至少3重量%或至少3.3重量%的量存在。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一项前述权利要求所述的甜食组合物，其中在所述基于水的充气甜食填充物中，所述糖包含以下项或由其</seg-con><seg-trans>组成：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>至少两种不同的糖；或</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>具有10%至70%、10%至65%、20%至60%或40%至60%的糖转化百分比的转化糖。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一项前述权利要求所述的甜食组合物，其中在所述基于水的充气甜食填充物中存在至少两种糖，其中所述糖中的一种是果糖，所述果糖形成总糖含量的至少10重量%。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一项前述权利要求所述的甜食组合物，其中在所述基于水的充气甜食填充物中，20重量%至65重量%的所述糖是葡萄糖和/或右旋糖。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一项前述权利要求所述的甜食组合物，其中10重量%至50重量%的所述糖是果糖。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一项前述权利要求所述的甜食组合物，所述甜食组合物包含40重量%至90重量%的糖。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据任一项前述权利要求所述的甜食组合物，其中所述基于水的充气甜食填充物的所述水活度大于0.45且不大于0.64或不大于0.59。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据任一项前述权利要求所述的甜食组合物，其中所述基于水的充气甜食填充物具有60%至200%、更优选60%至160%的膨胀度。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一项前述权利要求所述的甜食组合物，其中将所述基于水的充气甜食填充物充气到小于0.8gr/cm<sup>3</sup>的体积密度。</div>
<div class=""dep-clm"" num=""13""","A23G3/54, A23G1/54, A23G3/44",20250926,雀巢产品有限公司,['Pending']
US20250171221A1,Home-compostable pod for beverage preparation,"The invention relates to a home-compostable pod (<b>100, 1000</b>) for preparing a beverage in a beverage production machine. The pod (<b>100, 1000</b>) comprises a pod body (<b>110</b>) being composed of two connected half-shells (<b>101, 102</b>) that delimit a chamber (<b>103</b>) for containing a substance (<b>105</b>) for the beverage. The pod (<b>100, 1000</b>) comprises an injection wall (<b>120</b>), through which a fluid for preparing the beverage is injected into the chamber (<b>103</b>). The pod (<b>100, 1000</b>) comprises a delivery wall (<b>130</b>) for dispensing the prepared beverage from the pod (<b>100, 1000</b>) in the beverage preparation. The delivery wall (<b>130</b>) is connected to the pod body (<b>110</b>) and adapted to be opened upon interaction with opening elements of the beverage production machine under the effect of rising pressure of the injected fluid. The delivery wall (<b>130</b>) has a multi-layered structure (<b>300</b>), which comprises at least one primary layer (<b>310</b>) made of a cellulose-based material (<b>311</b>) or a regenerated cellulose material (<b>312</b>), and a secondary layer (<b>320</b>) with an oxygen barrier function. Alternatively, the delivery wall (<b>130</b>) can be provided as a multi-layered structure (<b>300</b>) that comprises a primary layer (<b>3100</b>) having the oxygen barrier function. For this, the primary layer (<b>3100</b>) is made of parchment paper or a compostable biopolymer. The invention also relates to a use of anyone of these pods (<b>100, 1000</b>) for preparing a beverage in a beverage production machine that has a pod holder with opening elements.","<div class=""indep-clm"" num=""1""><seg-con>1. A pod for preparing a beverage in a beverage production machine, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pod is made of a home-compostable material composition and comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body being composed of two half-shells being connected to each other so as to define a chamber for containing a substance for the preparation of the beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an injection wall for injecting a fluid in the chamber for preparing the beverage upon interaction of the fluid with the substance; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a delivery wall being connected to the pod body to close the chamber, the delivery wall being adapted to be opened upon interaction with external opening elements under the effect of rising pressure of the fluid being injected into the pod to dispense the prepared beverage from the pod,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the delivery wall has a multi-layered structure comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one primary layer made of a cellulose-based material or a regenerated cellulose material, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a secondary layer with an oxygen barrier function.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The pod according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the primary layer comprises a cellulose fiber material.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The pod according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the secondary layer comprises a coating.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The pod according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the coating is applied onto the primary layer.</seg-refi></di","B65D85/804, B65D65/40, B65D65/46",20250529,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025125126A1,Food powder comprising a fluid gel,"The invention relates to a food powder. The food powder comprises a carrier matrix, and a dried fluid gel. The dried fluid gel comprises particles formed of polysaccharide-based hydrocolloid and optionally, a cation. The invention also relates to a process for preparing such food powder and, food product, beverage and food supplement comprising such food powder.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A food powder which comprises:</seg-main><seg-clauses>- a carrier matrix, and,</seg-clauses><seg-clauses>- a dried fluid gel comprising particles formed of polysaccharide-based hydrocolloidand optionally, a cation.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A food powder according to claim 1, wherein </seg-main><seg-clauses>the food powder comprises 40 to 99 wt%,preferably 75 to 99wt% carrier matrix by dry weight.</seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A food powder according to claim 1 or 2, wherein </seg-main><seg-clauses>the carrier matrix is carbohydrate-based carrier matrix, preferably maltodextrin.</seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A food powder according to claim 3, wherein </seg-main><seg-clauses>the maltodextrin is having a dextroseequivalent (DE) of at least 15, more preferably of 15 to 30, most preferably of 21.</seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A food powder according to any one of the preceding claims, which comprises </seg-main><seg-clauses>from0.5 to 30wt.%, preferably from 0.5wt.% to 20wt.%, more preferably 0.9 to 17wt.%, even more preferably from 0.9 to 7wt%, even more preferably from 0.9 to 5.5wt.%, even more preferably 0.9 to 2.5wt.% polysaccharide-based hydrocolloid by dry weight.</seg-clauses></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A food powder according to any one of the preceding claims, wherein </seg-main><seg-clauses>thepolysaccharide-based hydrocolloid is selected from the list consisting of acacia gum, agar, alginate, carrageenan, cellulose, carboxymethylcellulose, colloidalmicrocrystalline cellulose (colloidal MCC), curdlan, furcellaran, gelatin, gellan, guar gum, konjac, locust bean gum, pectin, tamarind seed gum, tara gum, tragacanth gum xanthan gum, or a mixture thereof.</seg-clauses></div><div class=""dep-clm"" num=""","A23L2/39, A23C11/10, A23L2/62, A23L29/00, A23L29/212",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023378255A1,Compositions and methods using a combination of oleuropein and taurine for use in prevention or treatment of joint disorders,"The present invention relates to use of a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and taurine and/or functional derivative for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of oleuropein and/or metabolite thereof and taurine and/or functional derivative for use to prevent or treat cartilage degeneration in an individual.","<div class=""indep-clm"" num=""1""><seg-main>1. Composition comprising </seg-main><seg-clauses>an effective amount of a combination of oleuropein and/or metabolite thereof and taurine and/or functional derivative for use to prevent or treat cartilage degeneration in an individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to Claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to Claim 1 or 2, wherein </seg-main><seg-clauses>the functional derivative of taurine is selected from the group consisting of Taurolidine, taurultam, taurinamide and l,4,5-oxathiazinane-4,4-dioxide, 4-(2-hydroxyethyl)- 1 - piperazineethanesulfonic acid, N-acyltaurine, acetylhomotaurine, N,N- diacetylsalicyloxyethyltaurine, acylmethyltaurine, homotaurine and hypotaurine.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. The composition for use according to any of Claim 1 to 3, further comprising calcium.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition for use according to any of Claim 1 to 4, wherein </seg-main><seg-clauses>the composition further comprises at least one compound selected from the group consisting of antioxidants, anti-inflammatory compounds, glycosaminoglycans, prebiotics, fibres, probiotics, fatty acids, enzymes, minerals, trace elements and/or vitamins.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition for use according to any of Claim 1 to 5, wherein </seg-main><seg-clauses>the composition is selected from the group consisting of food compositions, dietary supple","A61K31/7048, A23L33/10, A61K31/185, A61P19/02",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024216147A1,"Agents, compositions, and methods for supporting behavioural development","The present invention relates to one or more human milk oligosaccharides (HMOs) for use in supporting behavioural development in a subject, wherein the one or more HMOs comprise or consist of: (a) lacto-N-difucohexaose I (LNDFHI); and/or (b) 2'-fucosyllactose (2'FL), 3- fucosyllactose (3FL), lactodifucotetraose (LDFT), lacto-N-fucopentaose II (LNFPII), lacto-N- fucopentaose I (LNFP-I), lacto-N-fucopentaose III (LNFP-III), lacto-N-difucohexaose I (LND- I), monofucosyl-lacto-N-hexaose III (MFLNH-III), lacto-N-fucopentaose V (LNFP-V), lacto-N- neodifucohexaose (LNnDFH) and lacto-N-fucopentaose VI (LNFP-VI).","<div class=""indep-clm"" num=""1""><seg-main>1. One or more human milk oligosaccharides (HMOs) for use in supporting behavioural development in a subject, wherein </seg-main><seg-clauses><seg-main>the one or more HMOs comprise or consist of: </seg-main><seg-clauses>(a) lacto-/V-difucohexaose I (LNDFHI); and/or </seg-clauses><seg-clauses>(b) 2’-fucosyllactose (2’FL), 3-fucosyllactose (3FL), lactodifucotetraose (LDFT), lacto-/V-fucopentaose II (LNFPII), lacto-/V-fucopentaose I (LNFP-I), lacto-/V-fucopentaose III (LNFP-III), lacto-N-difucohexaose I (LND-I), monofucosyl-lacto-N-hexaose III (MFLNH-III), lacto-/V-fucopentaose V (LNFP-V), lacto-N-neodifucohexaose (LNnDFH) and lacto-/V-fucopentaose VI (LNFP-VI).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The one or more HMOs for use according to claim 1, wherein </seg-main><seg-clauses>the one or more HMOs comprise or consist of LNDFHI.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The one or more HMOs for use according to claim 1 or 2, wherein </seg-main><seg-clauses>the one or more HMOs comprise or consist of 2’FL, 3FL, LDFT, LNFPII, LNFP-I, LNFP-III, LND-I, MFLNH-III, LNFP-V, LNnDFH and LNFP-VI.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The one or more HMOs for use according to any preceding claim, wherein </seg-main><seg-clauses>the one or more HMOs are administered by oral administration.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The one or more HMOs for use according to any preceding claim, wherein </seg-main><seg-clauses>the one or more HMOs are administered separately, simultaneously or sequentially, preferably wherein the one or more HMOs are administered simultaneously.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The one or more HMOs for use according to any preceding claim, wherein </seg-main><seg-clauses>the one or more HMOs are administ","A23L33/21, A23L33/00, A61K31/702, A61P25/00",20250724,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12479152B2,Method for heating a preform and corresponding method for forming a container,"A method for heating a preform (<b>1</b>) comprising a body portion (<b>4</b>) extending along a longitudinal axis (A<b>1</b>). The method comprises the following steps: —introducing the preform (<b>1</b>) into a heating apparatus (<b>5</b>) comprising an array of infrared emitters (<b>50</b>) arranged in multiple columns (Cj) and rows (Ri); —setting power levels of the infrared emitters (<b>50</b>) so as to divide said array into subsets of columns (SCn); and—heating the preform while translating it in a direction parallel to the rows (Ri), and simultaneously rotating it around its longitudinal axis, the rotation and translation speeds, and the power levels of the infrared emitters (<b>50</b>) being set so that the power levels of the subsets of columns (SCn) facing zones (<b>42</b>) of the body portion extending longitudinally are different from the power levels of the subsets of columns facing the rest of the body portion, said zones extending relative to one another in a polygonal array.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for heating a preform for manufacturing a polygonal bottle from the preform, the preform </seg-con><seg-trans>comprising </seg-trans><seg-refi>an open neck portion at a first end, a closed base portion at a second end, and a body portion extending along a longitudinal axis between the neck portion and the base portion, the method comprising the following steps:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>introducing the preform into a heating apparatus comprising an array of infrared emitters arranged in multiple columns and multiple rows, the preform and the array being disposed such that the longitudinal axis and the columns of the array of infrared emitters are parallel or directed obliquely with respect to each other;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>orienting angularly the preform at an input angular position by rotating the preform around the longitudinal axis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>setting power levels of the infrared emitters so as to divide the array of infrared emitters into subsets of columns, each subset of columns generating heat at a different power level from an adjacent subset of columns;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the preform with the array of infrared emitters while translating the preform in a direction parallel to the rows of the array at a translation speed, and simultaneously rotating the preform around the longitudinal axis in front of the infrared emitters at a rotation speed, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the rotation speed, the translation speed, the input angular position, and the power levels of the infrared emitters being set so that the power levels of the subsets of columns facing at least three zones of the body portion extending longitudinally are different from the power levels of the subsets of columns facing the rest of the body portion","B29C49/64, B29C35/08, B29C49/12, B29C49/42, B29L31/00",20251125,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019281326B2,Nutritional composition comprising a lentil product,Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.,"2019281326 23 Dec 2024
<div class=""indep-clm"" num=""1""><seg-con>1. A method of treatment of iron deficiency in a subject, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the subject a composition comprising a lentil product and one or more anti-nutritional factor,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>5           wherein the subject is an infant or young child, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the composition is selected from the group consisting of infant formula, follow on formula, growing up milk and infant cereal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the lentil product is selected from the group consisting of a yellow lentil product, a red lentil product, and a combination of the foregoing.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>0        </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Method according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more anti-nutritional factor is phytic</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>acid.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Method according to any one of claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprising one or more anti-nutritional factor is a composition comprising wholegrain.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. Method according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wholegrain is selected from the group consisting 5           of whole grain maize, wheat, rice, oat, corn, barley, rye, semolina, and a combination of any</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-refi>of the foregoing.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-c","A23L7/10, A23L11/00, A23L33/00, A23L33/16, A23L33/165",20250130,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023336149A1,Bottle for carbonated beverages having an improved petaloid base,"A bottle for holding a carbonated beverage comprising a body and a base having a substantially hemispherical underlying geometrical form (S1) extending from the lower end of the body. The base comprising a petaloid foot formation having axial symmetry around the longitudinal axis (X) of the bottle and formed from a plurality of feet projecting downwards from the underlying geometrical form (S1 ) with valleys separating adjacent pairs of feet. Each valley having a bottom line (81) following substantially the underlying geometrical form (S1). The ratio between a maximum foot depth (F) being the maximum normal distance from the underlying geometrical form (S1 ) to a surface of a foot (S2) and a sitting radius being the radius of the largest circle formed by the points of contact with the feet and a flat surface (9) when the bottle is stood vertically on the flat surface, is 0.5 ±0.01.","<div class=""indep-clm"" num=""1""><seg-main>1. A bottle (1) for holding a carbonated beverage comprising:</seg-main>
<seg-clauses>a body (5);</seg-clauses>
<seg-clauses class=""seg-enter"">a base (6) extending from the lower end of the body (5), the base having a substantially hemispherical underlying geometrical form </seg-clauses><seg-clauses>(S1), the base comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">a plurality of feet (7) projecting downwards from the underlying geometrical form </seg-clauses><seg-clauses>(S1);</seg-clauses>
<seg-clauses class=""seg-enter"">valleys (8) separating adjacent pairs of feet (7), each valley (8) having a bottom line (81) following substantially the underlying geometrical form </seg-clauses><seg-clauses>(S1);</seg-clauses>
<seg-clauses class=""seg-enter"">the feet and valleys together forming a petaloid foot formation having axial symmetry around the longitudinal axis (X) of the bottle;</seg-clauses>
<seg-clauses class=""seg-enter"">a maximum foot depth (F) being the maximum normal distance from the underlying geometrical form </seg-clauses><seg-clauses>(S1) to a surface of a foot </seg-clauses><seg-clauses>(S2);</seg-clauses>
<seg-clauses class=""seg-enter"">a sitting radius (S) being the radius of the largest circle formed by the points of contact (10) with the feet and a flat surface (9) when the bottle is stood vertically on the flat surface;</seg-clauses>
<seg-clauses class=""seg-enter"">characterized in that</seg-clauses>
<seg-clauses class=""seg-enter"">the ratio between the maximum foot depth and the sitting radius is 0.5 ±0.01.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The bottle of claim 1 wherein </seg-main><seg-clauses>the minimum radius of curvature of any part of the base (6) is 6.5 mm.</seg-clauses>
<seg-clauses class=""seg-enter"">12</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The bottle of claim 1 wherein </seg-main><seg-clauses>the minimum radius of curvature of an","B65D1/02, B29C49/00, B29C49/78, B29L31/00",20250206,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250019149A1,Capsule for the preparation of a beverage,"A capsule for the preparation of a beverage in a beverage preparation device (<b>10</b>), comprising: a cup-shaped body (<b>1</b>), a cover (<b>2</b>) for closing the cup-shaped body (<b>1</b>), and an annular flange (<b>3</b>) for the cover (<b>2</b>) to seal thereon: wherein the cup-shaped body (<b>1</b>) comprises: a bottom wall (<b>4</b>), a tubular lateral wall (<b>5</b>) and the flange (<b>3</b>); wherein the bottom wall (<b>4</b>) comprises: at least a fluid injection portion (<b>7</b>), suitable for being pierced by a piercing member (<b>12</b>) of the beverage preparation device (<b>10</b>), and at least a surrounding portion (<b>13</b>A, <b>13</b>B) surrounding said first fluid injection portion (<b>7</b>); wherein the cup-shaped body (<b>1</b>) comprises a cellulose pulp layer (<b>14</b>) made of cellulose pulp, and an oxygen barrier liner (<b>15</b>); wherein the stiffness of the cellulose pulp layer (<b>14</b>) of said fluid injection portion (<b>7</b>) is greater than the stiffness of the cellulose pulp layer (<b>14</b>) of said surrounding portion (<b>13</b>A, <b>13</b>B); wherein said cellulose pulp layer (<b>14</b>) of the fluid injection portion (<b>7</b>) comprises ultrasonically stiffened cellulose pulp, and wherein the density of the ultrasonically stiffened cellulose pulp of the fluid injection portion (<b>7</b>) is increased with respect to the density of the cellulose pulp of said surrounding portion (<b>13</b>A, <b>13</b>B).","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule for the preparation of a beverage in a beverage preparation device, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>a cup-shaped body, a cover for closing the cup-shaped body, and an annular flange for the cover to seal thereon;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the cup-shaped body comprises: a bottom wall, a tubular lateral wall and the flange;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the bottom wall comprises: at least a fluid injection portion, suitable for being pierced by a piercing member of the beverage preparation device, and at least a surrounding portion surrounding said first fluid injection portion;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the cup-shaped body comprises a cellulose pulp layer made of cellulose pulp, and an oxygen barrier liner;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the stiffness of the cellulose pulp layer of said fluid injection portion is greater than the stiffness of the cellulose pulp layer of said surrounding portion,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said cellulose pulp layer of the fluid injection portion comprises ultrasonically stiffened cellulose pulp, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the density of the ultrasonically stiffened cellulose pulp of the fluid injection portion is increased with respect to the density of the cellulose pulp of said surrounding portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The capsule according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the difference between the density D1 of the fluid injection portion and the density D2 of the surrounding portions is a value comprised between 0.1% of D1 and 20% of D1, that is:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>0.1% <i>D</i>1≤(<i>D</i>1−<i>D</i>2)≤20% <i>D</i>1.</s","B65D85/804, B65D65/46",20250116,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
EP4570079A1,Pet foods comprising gravy topping comprising methylcellulose and methods of making such pet foods,"The invention relates to a system for preparing a multi-layered pet food comprising a container loading station, a first filler for dispensing a first layer comprising a first edible composition into the container, a heating unit comprising a heat source; a second filler for dispensing a second layer comprising a second edible composition into the container and on top of the first layer; a lid setting station; and a weighing station for weighing the container comprising the first layer and the second layer","<div class=""indep-clm"" num=""1""><seg-con>1.  A system for preparing a multi-layered pet food </seg-con><seg-trans>comprising: </seg-trans><seg-comp>a container loading station; </seg-comp><seg-comp>a first filler for dispensing a first layer comprising a first edible composition into the container; a heating unit comprising a heat source; a second filler for dispensing a second layer comprising a second edible composition into the container and on top of the first layer; lid setting station; a weighing station for weighing the container comprising the first layer and the second layer.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  The system of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the heat source is an infrared heat source.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3.  The system of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the system is a continuous production line</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4.  The system of Claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a steamer or retorting station.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5.  The system of Claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>a second weighing station positioned after the filling of the first layer and before the filling of the second layer.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6.  The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the heating unit is configured to heat the first edible composition in the container from a first temperature of about 10°C to about 26°C to a second temperature of about 30°C to about 70°C, wherein the first edible composition is a gravy.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""2""><seg-con>7.  The system of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the infrared heat source is configured to heat","A23K20/163, A23K40/00",20250618,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250144176A1,Compositions comprising osteopontin (OPN),"The present invention relates to compositions comprising osteopontin (OPN) for the treatment and/or prevention of viral infections in mammals, such as humans, in particular infants, young children and pre-schoolers.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for the treatment and/or prevention of a viral infection in a mammal comprising </seg-main><seg-clauses>administering a composition comprising osteopontin (OPN) to the mammal.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>said viral infection is a viral respiratory infection.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>said viral infection causes a disease selected from the group consisting of bronchitis, bronchiolitis and pneumonia.</seg-clauses></div>
<div class=""ccl-clm"" num=""4"">4. (canceled)</div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the mammal has symptoms associated with the viral infection selected from the group consisting of irritation in the lungs, congestion in the lungs, excessive mucus production, fever, cough, wheezing, breathlessness, abdominal cramps, diarrhoea and vomiting.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The method according to claim 5, wherein </seg-main><seg-clauses>symptoms associated with a viral infection are symptoms which are caused by the viral infection.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1, wherein </seg-main><seg-clauses>said infection is caused by respiratory syncytial virus (RSV).</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The method according to claim 1, wherein </seg-main><seg-clauses>said infection is caused by respiratory syncytial virus (RSV) and wherein said disease is bronchiolitis.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-main>9. The method according to claim 1, wherein </seg-main><seg-clauses>said mammal is a human.</seg-clauses></div>
<div class=""dep-c","A61K38/19, A23L33/00, A23L33/135, A23L33/18, A23L33/21",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250099515A1,Lactobacillus acidophilus to increase agmatine production by microbiota,"Disclosed are probiotics, compositions and methods for producing agmatine using microbiota; and more particularly, isolated probiotics, compositions comprising the isolated probiotics, and methods for increasing production of agmatine and/or polyamines in the gastrointestinal tact of a subject, which provides to the subject certain health benefits, such as pain relief, antiaging effects, neuroprotective and antidepressant effects, improved vasodilatation and metabolic health, improved cellular health, decreased age-related memory loss, and/or longevity. The isolated probiotic is capable of colonizing and surviving in the gastrointestinal tract of the subject and capable of converting arginine to agmatine in the gastrointestinal tract of the subject.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving pain relief, antiaging effects, neuroprotective and antidepressant effects, improved vasodilatation and metabolic health, improved cellular health, and longevity, and/or reducing age-related memory loss of a subject in need thereof, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the subject an effective amount of a composition comprising an isolated probiotic and arginine to increase production of agmatine in a gastrointestinal tract of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a <i>Lactobacillus acidophilus </i>strain.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a bacterial strain having at least 90%, preferably at least 95% sequence identity to a strain selected from the group consisting of <i>Lactobacillus acidophilus </i>NCC 2628 (CNCM I-2453), <i>Lactobacillus acidophilus </i>NCC 2766 (CNCM I-3848), <i>Lactobacillus acidophilus </i>NCC 2775 (CNCM I-3851), and <i>Lactobacillus acidophilus </i>NCC 2619 (ATCC 700396).</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises an ingredient selected from the group consisting of a starch source, a protein source, a prebiotic source, lipid source, vitamins, sugars, salt, spices, seasonings, minerals, flavoring agents, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a <i>Lactobacillus acidophilus </i>strain selected from the group consisting of <i>Lactobacillus acidophilus </i>N","A61K35/747, A61K31/198",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024276120A1,Prebiotics for treating and/or preventing vitamin k2 deficiency,The present invention relates to a prebiotic agent for use in treating and/or preventing vitamin K2 deficiency in a subject. The present invention relates to the use of a prebiotic agent to promote vitamin K2 production in the gut of a subject.,,"A61K31/702, A23L33/125, A23L33/135, A23L33/21, A61K31/122",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250289605A1,Manufacturing line for manufacturing a compostable pod for brewing products and system for measuring and regulating the relative humidity of a biodegradable paper-based material,"A manufacturing line for manufacturing a compostable pod for brewing products, the pod made of two complementary portions. The manufacturing line includes at least one shaping line for shaping the complementary portions, and the shaping line includes: a handling unit for handling the sheet of biodegradable paper-based material with gas barrier biodegradable polymer; a humidifying unit for moistening at least one side of the sheet of biodegradable paper-based material; an optional pre-drying unit for drying, at least partially, the at least one side of the sheet of biodegradable paper-based material; a forming unit for shaping the sheet of biodegradable paper-based material into one of the complementary portions; and a drying unit for drying the at least one side of the sheet of biodegradable paper-based material forming one of the complementary portions.","<div class=""indep-clm"" num=""1""><seg-con>1: A manufacturing line for manufacturing a compostable pod for brewing products, the compostable pod being made of complementary first and second half-shells respectively made from first and second sheets of biodegradable paper-based material, each sheet of biodegradable paper-based material </seg-con><seg-trans>including </seg-trans><seg-comp>an inner side and an external side; </seg-comp><seg-comp>the manufacturing line comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a first shaping line configured for shaping the first half-shell and a second shaping line configured for shaping the second half-shell, each of the first and second shaping lines comprising:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a pre-drying unit configured for drying, at least, and at least partially, the external side of the sheet of biodegradable paper-based material;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a forming unit configured for shaping the sheet of biodegradable paper-based material into the half-shell having an internal side corresponding to the internal side of the sheet of biodegradable paper-based material and an external side corresponding to the external side of the sheet of biodegradable paper-based material;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a drying unit configured for drying the external side and/or the internal side of the half-shell; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>at least one humidity sensor for sensing a level of relative humidity of the biodegradable paper-based material forming the compostable pod at the external side of the compostable pod, the at least one humidity sensor being positioned before or after one of the pre-drying unit, the forming unit, and the drying unit.</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2: A manufacturing line for manufacturing a compostable pod for brewing products, the compost","B65B29/02, B65B9/04, B65B57/08, B65B61/06",20250918,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019389456B2,Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis,"This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing the pancreatic development and/or pancreatic maturation of infants, and/or the enhancement of the insulin biosynthesis and/or the prevention of metabolic disorder or associated diseases and/or glucose management during the nutritional intervention or later in life. The composition can be an infant formula. The composition can also comprise at least one N-acetylated oligosaccharide, preferably LnNT.","2019389456  19 Feb 2025
CLAIMS :
<div class=""indep-clm"" num=""1""><seg-con>1.    A method of enhancing the pancreatic development and/or pancreatic</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>maturation of an infant or young child,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-trans>wherein </seg-trans><seg-refi>the method comprises administering to the infant or young child a nutritional composition comprising at least one fucosylated oligosaccharide, wherein said infant or young child is a subject in need and/or is at risk of underdevelopment of pancreas and/or is born preterm and/or suffering from intrauterine-growth retardation (IUGR) and/or born with low birth weight (LBW), very-low-birth-weight (VLBW), or extremely-low-birth-weight (ELBW).</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.    The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>said at least one fucosylated</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>oligosaccharide is present in the composition in a total amount of between 0.053 g/L of the composition, and/or in a total amount of between 0.007-0.45 g/100g of composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3.    The method of claim 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>said at least one fucosylated</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-refi>oligosaccharide is present in the composition in a total amount of at least 0.2g/L or at least 0.5g/L of the composition and/or in a total amount of at least 0.03g/100g or at least 0.075g/100g of composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.    The method of any one of the preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-refi>said fucosylated</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>oligosaccharide is 2FL.</seg-refi></div>
<div class=""de","A23L33/00, A23L33/10, A61K31/702",20250814,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025012102A1,Dairy product analogues comprising vinegar,Dairy product analogues with improved sensory properties are disclosed. The dairy product analogues comprise plant proteins and vinegar. Processes for preparing such dairy product analogues are also disclosed.,,"A23C11/06, A23C11/10, A23C20/00, A23C20/02, A23L2/39",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023355743A1,Beverage or foodstuff preparation system,"A container for use with a beverage or foodstuff preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by said machine to process the precursor material, the code readable by a code reading system of the machine, which comprises: a lighting system to project an emission of greater than 700 nm or 800 nm to the code, and a camera system for obtaining a digital image of the code operating with a wavelength of above or 700 nm or 800 nm, the code is arranged to absorb and/or reflect the emission for capturing in a digital image by said camera system, and; an information carrier layer comprising container information that is visible in visible wavelengths, and has comparatively low absorbance and/or reflectivity to said emission, wherein the information carrier layer is arranged in operative proximity to the code layer to conceal the code.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for use with a beverage or foodstuff preparation machine, the container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code for storing preparation information used by said machine to process the precursor material, the code configured to be readable by a code reading system of the machine, which comprises: a lighting system to project an emission of greater than 700 nm or 800 nm to the code, and a camera system for obtaining a digital image of the code operating with a wavelength of above or 700 nm or 800 nm, the code is arranged to absorb and/or reflect the emission for capturing in a digital image by said camera system, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an information carrier layer comprising container information that is visible in visible wavelengths and configured to be readable by a user, and has comparatively low absorbance and/or reflectivity to said emission,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the information carrier layer is arranged in operative proximity to the code layer so that a positional arrangement of the information carrying layer and code is such that the code is concealed or partly concealed by the information carrying layer, reducing the visibility of the code in the visible wavelengths compared to the code being present without the information carrying layer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the information carrier layer has an absorbance to the emission of less than 20% and a reflectivity of less than 30% to said emission.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The container of either of claims 1 or 2, </seg-con><seg-trans>wherein:",B65D85/804,20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119424404A,Dietary butyric acid compounds for treatment or prevention of allergic diseases,"Compounds or combinations thereof having the formula: # imgabs0 # wherein R1, R2, R3, R4, R5 and R6 are independently long chain fatty acids having 16 to 20 carbons for use in the treatment or prevention of allergic diseases.","<div class=""indep-clm"" num=""1"">1.用于治疗或预防变态反应性疾病的具有下式的化合物或其组合：</div>
<div class=""indep-clm"" num=""1""><img src="""" class=""img-anchor"" img-id=""FDA0005141583050000011""></div>
<div class=""indep-clm"" num=""1"">其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和R<sup>6</sup>独立地为具有16至20个碳的长链脂肪酸。</div>
<div class=""indep-clm"" num=""2"">2.用于治疗或预防变态反应性疾病的包含具有下式的化合物或其组合的组合物：</div>
<div class=""indep-clm"" num=""2""><img src="""" class=""img-anchor"" img-id=""FDA0005141583050000012""></div>
<div class=""indep-clm"" num=""2"">其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和R<sup>6</sup>独立地为具有16至20个碳的长链脂肪酸。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述用于所述用途的组合物，其中所述组合物包含具有式(1)的化合物、具有式(2)的化合物、具有式(3)的化合物和具有式(4)的化合物。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或权利要求3所述用于所述用途的组合物，其中所述具有式(1)的化合物、所述具有式(2)的化合物、所述具有式(3)的化合物和所述具有式(4)的化合物占所述组合物中总甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""5"" parent=""2"">5.根据权利要求1所述用于所述用途的组合物，所述组合物包含所述具有式(4)的化合物作为所述组合物中主要的含丁酸结构部分的甘油三酯，其中所述具有式(4)的化合物占所述组合物中含丁酸结构部分的甘油三酯的至少20重量％、至少30重量％、至少40重量％、至少50重量％、或至少60重量％、至少70重量％、至少80重量％或至少90重量％。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据权利要求2至5中任一项所述用于所述用途的组合物，其中所述具有式(1)的化合物、所述具有式(2)的化合物、所述具有式(3)的化合物和所述具有式(4)的化合物占所述组合物中总的含丁酸结构部分的甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""7"" parent=""2,3,4,5,6"">7.根据权利要求2至6中任一项所述用于所述用途的组合物，其中甘油三丁酸酯占所述组合物中总甘油三酯的小于10重量％，优选地小于8重量％，更优选地占所述组合物中总甘油三酯的小于5重量％。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3,4,5,6,7"">8.根据权利要求2至7中任一项所述用于所述用途的组合物，其中所述组合物还包含维生素A和/或膳食纤维。</div>
<div class=""dep-clm"" num=""9"" parent=""2,3,4,5,6,7,8"">9.根据权利要求2至8中任一项所述用于所述用途的组合物，其中所述组合物是营养组合物，优选地其中所述营养组合物是膳食补充剂、婴儿配方食品、较大婴儿配方食品、饮料或宠物护理产品。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述用于所述用途的化合物或其组合，或根据权利要求2至9中任一项所述用于所述用途的组合物，其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和/或R<sup>6</sup>为不饱和脂肪酸，优选地为单不饱和的。</div>
<div class=""dep-clm"" num=""11"" parent=""10"">11","A61K31/23, A61K31/203, A61P37/08, A23K20/158, A23L33/115",20250214,雀巢产品有限公司,['Pending']
US12193597B2,Beverage preparation machine with manually operated pump with flow control means,"The invention relates to a beverage preparation machine (<b>20</b>) for providing a pressurized liquid to a dose of beverage ingredients (<b>10</b>) such as a coffee capsule, the machine comprising a pressurizing liquid chamber (<b>1</b>) designed for being filled with a predefined amount of liquid upon operation of a liquid pump (<b>2</b>) connected to a liquid reservoir (<b>3</b>) of the machine, a potential energy accumulator (<b>4</b>) that is associated to the pressurizing liquid chamber (<b>1</b>) and which is designed for being brought into a charged position upon filling of the pressurizing liquid chamber (<b>1</b>), a brewing chamber (<b>5</b>) for receiving the dose of beverage ingredients (<b>10</b>) and which is designed for being selectively brought in fluid communication with the pressurizing liquid chamber (<b>1</b>), the machine (<b>20</b>) further comprising flow control means (<b>6</b><i>a,</i><b>6</b><i>b</i>) designed for regulating the amount of liquid conveyed from the liquid pump (<b>2</b>) into the pressurizing liquid chamber (<b>1</b>) depending on an operating position of the potential energy accumulator (<b>4</b>) and/or on the pressure of liquid in the pressurizing chamber (<b>1</b>).",,"A47J31/38, A47J31/00, A47J31/36, A47J31/46",20250114,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025190541A1,Promoting butyrate-producing bacteria in the gut microbiome,The present invention relates to a bifidogenic prebiotic for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; wherein the bifidogenic prebiotic is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A bifidogenic prebiotic for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidogenic prebiotic is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A Bifidobacterium microorganism for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child; </seg-con><seg-trans>wherein </seg-trans><seg-refi>the Bifidobacterium is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-con>3. A combination of a bifidogenic prebiotic and a Bifidobacterium microorganism for use in promoting butyrate-producing bacteria in the gut microbiome of an infant or young child </seg-con><seg-trans>wherein </seg-trans><seg-refi>the combination is administered to the infant prior to about 12 months of age; and the butyrate-producing bacteria are promoted in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,3""><seg-con>4. A bifidogenic prebiotic, Bifidobacterium microorganism or a combination for use according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>levels of butyrate are increased in the gut microbiome of the infant or young child between about 1 and 5 years of age.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,3,4""><seg-con>5. A bifidogenic prebiotic, Bifidobacterium microorganism or a combination for use according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg","A61K35/745, A23L33/135, A23L33/00, A61K31/702, A61K45/06",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025157814A1,Structured confectionery product,"The present invention relates to a filled confectionery product comprising a cocoa-based shell and backing layer surrounding a fat-based confectionery filling, wherein the filled confectionery product has a total saturated fat content less than 6% and a total sugar content of less than 3.4%; and wherein the combined saturated fat content of the shell and backing layer comprise greater than 50% of the total saturated fat fraction in the filled confectionery product.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 A filled confectionery product comprising </seg-main><seg-clauses>a cocoa-based shell and backing layer surrounding a fat-based confectionery filling, wherein the filled confectionery product has a total saturated fat content less than 6% and a total sugar content of less than 3.4%; and wherein the combined saturated fat content of the shell and backing layer comprise greater than 50% of the total saturated fat fraction in the filled confectionery product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2 The filled confectionery product according to claim 1 , wherein </seg-main><seg-clauses>the combined saturated fat content of the shell and backing layer comprise more than 75% of the total saturated fat fraction in the filled confectionery product.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3 The filled confectionery product according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the shell has a saturated fat content of not less than 10%, preferably between 10 to 15%, when expressed as a percentage by weight of shell.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4 The filled confectionery product according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the backing layer has a saturated fat content of not less than 5%, preferably between 5 to 10%, when expressed as a percentage by weight of backing layer.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5 The filled confectionery product according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the filling has a saturated fat content of not more than 3%, when expressed as a percentage by weight of filling.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6 The filled confectionery product according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the filling comprises not less t","A23G1/00, A23G1/36, A23G1/54, A23G3/34, A23G3/40",20250731,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2838233C1,Method of roasting coffee beans,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is a method of roasting coffee beans in a room, comprising obtaining, when performing at least one roasting operation, the required roasting input data for said at least one roasting operation with said required input data, obtaining access to information on a room and a roasting device for coffee beans, as well as before initiating at least one roasting operation: determining the concentration of each contaminant formed in the room during said at least one roasting operation, for each pollutant comparing a certain concentration of said pollutant formed in the room, with concentration of said pollutant permitted in accordance with local health and safety standards and depending on whether the concentration of each pollutant is lower or higher than the permitted concentration, performing at least or displaying a hazard warning. Also disclosed is a system for roasting coffee beans in a room and a machine-readable data medium containing instructions for controlling and implementing the method of roasting coffee beans.EFFECT: group of inventions enables to predict and ensure safe operation of the roasting system in a room in accordance with health and safety standards.20 cl, 8 dwg","1. Способ обжаривания кофейных зерен в помещении (100) с использованием системы (10) обжаривания, причем упомянутая система обжаривания содержит:
- устройство (2) для обжаривания, и
при этом при реализации по меньшей мере одной операции обжаривания упомянутый способ включает в себя следующие стадии:
- получение требуемых входных данных обжаривания для упомянутой по меньшей мере одной операции обжаривания, при этом упомянутые требуемые входные данные определяют по меньшей мере:
тип обжариваемых кофейных зерен,
количество обжариваемых кофейных зерен за одну операцию обжаривания или в течение периода времени,
степень обжаривания, применимую для зерен,
и
- получение доступа к:
- информации о помещении, причем упомянутая информация о помещении включает в себя по меньшей мере: местные нормы в области здравоохранения и безопасности, объем помещения и интенсивность вентиляции упомянутого помещения,
- информации об устройстве для обжаривания кофейных зерен, причем упомянутая информация об устройстве для обжаривания включает в себя по меньшей мере количество каждого загрязняющего вещества, вырабатываемого устройством для обжаривания в процессе обжаривания конкретного количества кофейных зерен определенного типа до определенной степени обжаривания,
и
- перед инициированием по меньшей мере одной операции обжаривания:
определение концентрации каждого загрязняющего вещества, образующегося в помещении во время упомянутой по меньшей мере одной операции обжаривания, из полученных требуемых входных данных обжаривания и доступной информации об устройстве для обжаривания кофейных зерен и помещении,
для каждого загрязняющего вещества сравнение определенной концентрации упомянутого загрязняющего вещества, образующегося в помещении, с концентрацией упомянутого загрязняющего вещества, разрешенной в соответствии с местными нормами в области здравоохранения и безопасности,
выполнение по меньшей мере одной операции обжаривания, если для каждого загрязняющего вещества определенная концентрация","A23F5/04, A23N12/08",20250414,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023322541A1,System and method for manufacturing a compostable pod for beverage preparation from a paper-based material,"The invention relates to a system (100) for manufacturing a compostable pod (900) for brewing products. Therein, the pod (900) is made from a sheet (600) made of a biodegradable cellulose-based material. The system (100) comprises at least one shaping line (200), which comprises a handling unit (300) for transferring the sheet (600) along a transfer direction (TD) through the system (100). The shaping line (200) further comprises a humidifying unit (400) for moistening at least one side of the sheet (600) with a moistening agent (401), and a forming unit (800) for shaping a part of the moistened sheet (600) into a three-dimensional shape to form a pod element (910), which defines a pod cavity (911). The part (642) is located between opposite, with respect to the transfer direction (TD), lateral side edge sections (631, 632) of the sheet (600). The shaping line (200) comprises further a lateral drying unit (500) arranged to dry the opposite lateral side edge sections (631, 632) of the moistened sheet (641), while keeping at least the part (642) to be shaped moistened. Therein, the lateral drying unit (500) is arranged downstream of the humidifying unit (400) and upstream of the forming unit (800). The invention also relates to a method for manufacturing a compostable pod (900), wherein, before shaping the part (642) of the moistened sheet (641), said opposite lateral side edge sections (631, 632) of the moistened sheet (641) are dried while at least the part (642) to be shaped is kept moistened.","<div class=""indep-clm"" num=""1""><seg-main>1. System (100) for manufacturing a compostable pod (900) for brewing products from a sheet (600) made of a cellulose-based material, preferably biodegradable, the system (100) comprising </seg-main><seg-clauses><seg-main>at least one shaping line (200), which comprises:</seg-main>
<seg-clauses>• a handling unit (300) for transferring the sheet (600) along a transfer direction (TD) through the system (100);</seg-clauses>
<seg-clauses>• a humidifying unit (400) for moistening at least one side of the sheet (600) with a moistening agent (401); and</seg-clauses>
<seg-clauses><seg-main>• a forming unit (800) for shaping a part (642) of the moistened sheet (641), which part (642) is located between opposite, with respect to the transfer direction (TD), lateral side edge sections (631, 632) of the sheet (600), into a three-dimensional shape to form a pod element (910) defining a pod cavity (911);</seg-main>
<seg-main class=""seg-enter"">wherein the at least one shaping line (200) further comprises:</seg-main>
<seg-clauses>• a lateral drying unit (500) arranged to dry the opposite lateral side edge sections (631,632) of the moistened sheet (641), while keeping at least the part (642) to be shaped moistened, downstream of the humidifying unit (400) and upstream of the forming unit (800).</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. System (100) according to claim 1, wherein </seg-main><seg-clauses>the handling unit (300) comprises clamping elements (310), and wherein the clamping elements (310) are configured to clamp the sheet (600), with respect to the transfer direction (TD), at the opposite lateral side edge sections (631, 632) of the sheet (600).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. System (100) according to claim 2, wherein </seg-main><seg-clauses>the clamping elements (310) are movable along the transfer direction (TD), and wherein the cl","B65B9/04, B65B9/08, B65B29/02, B65B29/08",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119907772A,Beverage or food preparation system,"A container for use with a beverage or food preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by the machine to process the precursor material, the code being readable by a code reading system of the machine, the code reading system comprising: an illumination system for projecting emitted light to the code; and a camera system for obtaining a digital image of a code, the code being arranged to overlap with the precursor material; and a support layer supporting the code, the support layer being at least partially light transmissive to emitted light from the illumination system, where the code comprises a reflective layer configured to reflect the emitted light before the emitted light is transmitted to the support layer, and the precursor material is arranged to absorb the emitted light.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于与饮料或食品制备机器一起使用的容器，所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>储存部分，所述储存部分用于容纳前体材料；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码，所述代码用于存储由所述机器用来处理所述前体材料的制备信息，所述代码被配置为能够由所述机器的代码读取系统读取，所述代码读取系统包括照明系统，所述照明系统用于将发射光投射到所述代码，所述代码被布置成与所述前体材料重叠，使得来自所述照明系统的发射光投射到所述前体材料中；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述代码包括被配置为反射所述发射光的反射层，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述容器进一步包括支撑所述代码的支撑层，所述支撑层由对来自所述照明系统的所述发射光至少部分透明的材料制成，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述反射层被配置为在所述发射光被透射到支撑层之前反射所述发射光，并且所述前体材料被布置成吸收所述发射光。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述前体材料能够吸收来自所述照明系统的所述发射光的至少60％。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2中任一项所述的容器，</seg-con><seg-trans>其中：</seg-trans><seg-refi>所述前体材料包括研磨咖啡。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述反射层被配置为漫反射所述发射光，对所述发射光的反射率为至少70％。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述反射层由不包含炭黑的一种或多种油墨形成，并且所述前体材料包含炭黑。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>光源的所述发射光具有大于700nm或800nm的波长，并且相机系统被布置成感测所述波长的光。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述容器的包括所述支撑层和所述代码的部分被配置为当每个穿透器受到大于5N至15N的力时能够被一个或多个穿透器穿透，每个穿透器具有成70度至30度的尖端。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-con>8.根据权利要求7所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述支撑层具有50微米至150微米的厚度。</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""><seg-con>9.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中：</se",B65D85/804,20250429,雀巢产品有限公司,['Pending']
US20250059494A1,Fermented verbena beverage,,,"C12N1/16, A23F3/16, A23F3/34, C12R1/84",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250351841A1,A process for preparing a meat analogue product,"The present invention relates to a process for preparing a meat analogue product comprising a textured plant protein, water, a binder, an oil-soluble flavor, an aqueous-soluble flavor and optionally a colorant, wherein the oil-based flavor is encapsulated with a vegetable fat and wherein the vegetable fat has a solid fat content in the range of 30 to 90 wt % (based on the weight of total fat) at a temperature of 30° C.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for the preparation of a meat analogue product comprising </seg-main><seg-clauses><seg-main>a textured plant protein, water, a binder, an oil-soluble flavor, an aqueous-soluble flavor comprising the steps of:</seg-main>
<seg-clauses>a) mixing the textured plant protein with water;</seg-clauses>
<seg-clauses>b) adding the binder, and the aqueous-soluble flavor to the mix of step a);</seg-clauses>
<seg-clauses>c) encapsulation of the oil-soluble flavor with a vegetable fat and adding the encapsulated flavor after step b) and further mix; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the the encapsulated flavor has a particle size between 10 to 500 microns and wherein the vegetable fat has a solid fat content in the range of 30 to 90 wt % (based on the weight of total fat) at a temperature of 30° C.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process for the preparation of a meat analogue product according to claim 1, which does not comprise </seg-main><seg-clauses>an ingredient from an animal origin.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The process for the preparation of a meat analogue product according to claim 1, wherein </seg-main><seg-clauses>the textured plant protein is selected from the group consisting of soy bean protein, pea protein, lentil protein, lupin bean protein, wheat gluten, and a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The process for the preparation of a meat analogue product according to claim 1, wherein </seg-main><seg-clauses>the textured plant protein is in an amount of between 5 to 70 wt % (weight percent of the total composition).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The process for the preparation of a meat analogue product according to claim 1, wherein </seg-main><seg-clauses>the meat analogue product is a","A23J3/16, A23J3/18, A23L27/26, A23L33/115",20251120,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019420808B2,Process for an instant oil fried noodle,The present invention relates to a process for the production of an instant oil fried noodle. The oil used for frying the instant noodle comprises the fatty acids C16:0 in the range of 1 to 25 wt% (based on weight of total fat) and C18:1 in the range of 60 to 90 wt% (based on weight of total fat) and C18:2 in the range of 0.1 to 20 wt% (based on weight of total fat).,"<div class=""indep-clm"" num=""1""><seg-main>1.    A process for the production of an instant fried noodle comprising </seg-main><seg-clauses><seg-main>flour, Kansui</seg-main>
<seg-main class=""seg-enter"">5              salts, oil, and optionally wheat gluten, the process comprising the steps of:</seg-main>
<seg-clauses>a) Mixing the flour and other dry ingredients with the Kansui salts to form an uniform dough;</seg-clauses>
<seg-clauses>b) Sheeting and slitting the dough to obtain noodle strands;</seg-clauses>
<seg-clauses>c) Steaming the noodle strands from step b);</seg-clauses>
<seg-clauses class=""seg-enter"">0                 d) Optionally seasoning;</seg-clauses>
<seg-clauses>e) Cutting and folding the noodle strands from steps c) or d);</seg-clauses>
<seg-clauses>f) Pre-drying to remove moisture before frying;</seg-clauses>
<seg-clauses>g) Frying in the oil;</seg-clauses>
<seg-clauses>h) Cooling,</seg-clauses>
<seg-clauses class=""seg-enter"">15              wherein the oil comprises the fatty acids C16:0 in the range of 1 to 25 wt% based</seg-clauses>
<seg-clauses class=""seg-enter"">on weight of total fat and C18:1 in the range of 60 to 90 wt% based on weight of total fat and C18:2 in the range of 0.1 to 20 wt% based on weight of total fat, wherein the oil is a high oleic sunflower oil and wherein the kansui salts are dissolved in water to obtain a kansui solution and wherein the kansui solution</seg-clauses>
<seg-clauses class=""seg-enter"">20              comprises a mixture of 3 to 7wt% of alkaline salts selected from the group of</seg-clauses>
<seg-clauses class=""seg-enter"">sodium carbonate, potassium carbonate and sodium phosphate based on the total amount of the solution in 93 to 97wt% of water based on the total amount of the solution.</seg-clauses>
<seg-clauses class=""seg-enter"">25      </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.      A process for the production of an instant fried noodle as claimed in claim 1,</seg","A23L7/113, A23L7/109",20251002,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120322385A,Molded pulp cover,"The present invention relates to a removable lid (100) for closing an opening (211) of a container (210) for containing a food product (220) in an attachment direction (190), whereby the container (210) has a circumferential rim portion (212) surrounding the opening (211). The cover (100) is composed of two or more separate cover parts (101, 102) which are each integrally made by molding pulp and which are complementary to each other to form the cover (100). The lid (100) comprises: a closure portion (110) for covering the container opening (211); a skirt portion (120) extending from the cap portion (110) to circumferentially define, with the cap portion (110), a receiving space (105) for receiving the rim portion (212) inside the cap (100) when the opening (211) is closed with the cap (100); and a fastening structure (140) for providing a profile-closed and/or force-closed connection. The fastening structure (140) projects laterally from a lateral inner side (121) of the skirt portion (120) in a direction transverse to the attachment direction (190) towards and into the receiving space (105). Wherein at least two of the cover parts (101, 102) each comprise at least one section of the fastening structure (140). The invention also relates to a system (200) for storing a food product (220), comprising said removable lid (100) and a container (210) for a food product.","<div class=""indep-clm"" num=""1""><seg-con>1.一种可移除盖（100），所述可移除盖用于在附接方向（190）上封闭用于容纳食物产品（220）的容器（210）的开口（211），所述容器（210）具有围绕所述开口（211）的周向边沿部分（212），</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述盖（100）由两个或更多个单独的且连接的盖部件（101, 102）组成，所述两个或更多个单独的且连接的盖部件分别通过模制纸浆一体地制成并且彼此互补以形成所述盖（100），</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述盖（100）</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-封盖部分（110），所述封盖部分具有用于覆盖所述容器（210）的所述开口（211）的上表面（111），</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-裙部部分（120），所述裙部部分从所述封盖部分（110）延伸以与所述封盖部分（110）一起周向地界定接纳空间（105），所述接纳空间用于在利用所述盖（100）封闭所述开口（211）时在所述盖（100）内侧接纳所述边沿部分（212），和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-紧固结构（140），所述紧固结构用于提供外形封闭和/或力封闭连接，其中所述紧固结构（140）从所述裙部部分（120）的侧向内侧（121）在横向于所述附接方向（190）的方向上朝向所述接纳空间（105）侧向突出并进入所述接纳空间中，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述盖部件（101, 102）中的至少两个盖部件各自包括所述紧固结构（140）的至少一个区段。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的盖（100），其中所述盖（100）包括至少一个分型线和/或分型面（180），所述至少一个分型线和/或分型面至少部分地在邻接的盖部件（101, 102）之间延伸和/或穿过单独的盖部件（101, 102）之间的物理边界，并且</div>
<div class=""dep-clm"" num=""2"" parent=""1"">其中优选地，所述分型线和/或分型面（180）与所述上表面（111）的中心相交，或者与所述封盖部分（110）和所述裙部部分（120）的至少一个区段相交，并且/或者</div>
<div class=""dep-clm"" num=""2"" parent=""1"">其中优选地，所述分型面（180）界定所述盖部件（101, 102）中的每个盖部件，使得相应的盖部件（101, 102）在垂直于所述分型面（180）的方向上的任何横截面包括在界定所述接纳空间（105）的内侧上的几何结构，而没有底切或负拔模角。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的盖（100），其中所述紧固结构（140）包括一个或多个紧固元件（141），诸如内螺纹和/或卡扣配合连接器，其中优选地，所述盖部件（101, 102）中的每个盖部件包括所述紧固元件（141）中的至少一个紧固元件或一个区段，并且</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">其中所述紧固元件（141）沿着所述裙部部分（120）的周向部分地或间歇地延伸，并且/或者</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">其中所述紧固元件（141）优选地围绕所述裙部部分（120）的周向均匀地分布，并且/或者</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">其中所述紧固元件（141）作为一个或多个相对的对设置在所述侧向内侧（121）上，所述一个或多个相对的对相对于所述接纳空间（105）布置在相对侧上和/或优选地相对于所述分型线和/或分型面（180）布置在相对侧上。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利","B65D43/02, B65D65/46",20250715,雀巢产品有限公司,['Pending']
US12390044B2,Adaptive service unit of a beverage machine,"A machine (<b>1</b>) for preparing a beverage has: a body (<b>1</b>′) comprising a seat (<b>4</b>) and a beverage processing line (<b>1″, 1″′</b>) extending from a liquid inlet (<b>1</b>″) to a beverage dispenser (<b>1″′</b>); and a service unit (<b>10</b>) that is removably received in or on the seat (<b>4</b>) and that comprises a foot part (<b>11</b>) and a recipient part (<b>12</b>) removably received in or on the foot part (<b>11</b>) so as to be supported thereby. The foot part (<b>11</b>) has a bottom face (<b>11</b>′) configured to rest on an external horizontal support surface (<b>100</b>) when the service unit (<b>10</b>) is removed from the seat (<b>4</b>). When the recipient part (<b>12</b>) is received in or on the foot part (<b>11</b>), the recipient part (<b>12</b>) is movable relative to the foot part (<b>11</b>) from a first stable position when the service unit (<b>10</b>) rests on the external horizontal support surface (<b>100</b>) to a second stable position when the service unit (<b>10</b>) is received in or on the seat (<b>4</b>), and vice versa.","<div class=""indep-clm"" num=""1""><seg-main>1. A machine for preparing a beverage, the machine comprising:</seg-main>
<seg-clauses>a body comprising a seat and a beverage processing line extending from a liquid inlet to a beverage dispenser; and</seg-clauses>
<seg-clauses class=""seg-enter"">a service unit configured to be removably received in the seat, wherein the service unit comprises a first part and a second removably received in the first part so as to be supported thereby, the first part having a bottom face such that, when the service unit is not received in the seat, the first part is configured to rest on an external horizontal support surface, and wherein the second configured to store un-used beverage ingredient, beverage liquid, cleaning fluid to be supplied to the beverage processing line, used beverage ingredient, waste beverage liquid, or used cleaning fluid collected from the beverage processing line,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, when the second part is received in the first part, the second part is movable relative to the first part between a first position when the service unit rests on the external horizontal support surface and a second position when the service unit is received the seat, the first and second positions being different.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine of claim 1, wherein </seg-main><seg-clauses>the second part is moved into:</seg-clauses>
<seg-clauses class=""seg-enter"">the first position by gravity force onto the part and/or a biasing element; and/or</seg-clauses>
<seg-clauses class=""seg-enter"">the second position by mechanical resistance of the seat when the second part is urged against a body part delimiting the seat while the service unit is being moved into the seat.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The machine of claim 1, wherein, </seg-main><seg-clauses>when the first part of the service unit rests on the extern","A47J31/44, A47J31/46",20250819,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025056246A1,Polymorphs and compositions comprising same,Provided herein are crystalline forms of D-beta-hydroxybutyrate (D-BHB) and composition comprising one or more crystalline forms of D-BHB.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A crystalline D-BHB L-arginine salt designated as “D-BHB L-arginine Form B” having </seg-main><seg-clauses>an XRPD pattern comprising peaks at 7.30, 9.94, 11.28, 14.56, and 15.83 ± 0.2°29 using Cu Ka radiation.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The crystalline D-BHB L-arginine salt Form B of claim 1, wherein </seg-main><seg-clauses><seg-main>one or more of the following</seg-main>
<seg-clauses>(a) wherein the XRPD pattern further comprises peaks at 17.27, 18.33, 19.91, 21.90, and </seg-clauses><seg-clauses>23.49 ± 0.2°29 using Cu Ka radiation;</seg-clauses>
<seg-clauses>(b) wherein the XRPD pattern further comprises peaks at 24.12, 26.45, 26.99, 28.56, 33.56, and 34.16 ± 0.2° 29 using Cu Ka radiation;</seg-clauses>
<seg-clauses>(c) having an XRPD pattern substantially as shown in Figure 30(A);</seg-clauses>
<seg-clauses>(d) having substantially the XRPD peaks shown in Table 25; and/or</seg-clauses>
<seg-clauses>(e) having substantially the DSC of Figure 30(B) and/or substantially the TGA of Figure 30(C).</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A crystalline D-BHB sodium salt designated as “D-BHB sodium salt Form C” having </seg-main><seg-clauses>an XRPD pattern comprising peaks at 6.40, 7.07, 12.11, 14.08, and </seg-clauses><seg-clauses>17.05 ± 0.2°29 using Cu Ka radiation.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The crystalline D-BHB sodium salt Form C of claim 3, wherein </seg-main><seg-clauses><seg-main>one or more of the following</seg-main>
<seg-clauses>(a) the XRPD pattern further comprises peaks at 19.16, 22.57, 27.79, 28.75, and </seg-clauses><seg-clauses>30.11 ± 0.2°29 using Cu Ka radiation;</seg-clauses>
<seg-clauses>(b) the XRPD pattern further comprises peaks at 11.98, 30.76, 33.12, 33.63, and </seg-clauses><seg-clauses>37.08 ± 0.2° 29 using Cu Ka radiation;</seg-clauses>
<seg-clauses>(c) having ","C07C59/01, C07C279/14, C07C211/07, C07C229/26, A23L33/10",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2022214135B2,Mixture of hmos and bifidobacteria,"The invention relates to a composition for infants or young children comprising at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria and a prebiotic mixture of human milk oligosaccharides consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'- sialyllactose (SSL) and optionally 3-fucosyllactose (3FL) that can be useful for (i) preventing and/or treating bacterial infections; (ii) modulating the microbiota; and/or iii) preventing and/or treating allergy in an infant or a young child.","<div class=""indep-clm"" num=""1""><seg-con>1. A composition for infants or young children </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), 5 lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL);</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the bifidobacteria comprises Bifidobacterium longum subsp. infantis or combination of Bifidobacterium animalis subsp. lactis and Bifidobacterium longum subsp. infantis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein at least one of the bifidobacteria is Bifidobacterium longum subsp. infantis LMG 11588 .0 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidobacteria comprises Bifidobacterium longum subsp. infantis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and .5 3'-sialyllactose (3SL).</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidobacteria is a combination of Bifidobacterium animalis subsp. lactis and Bifidobacterium longum subsp. infantis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), :o lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3’-sialyllactose (3SL).</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The composition of any one of claims 1 to 3, </seg-con><seg-trans>wherein </s","A23L33/135, A23L33/00, A23L33/21, A61K31/702, A61K31/745",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CA2973536A1,Method for determining the distinctive nutritional requirements of a patient,The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.,"﻿ 30 Claims <div class=""indep-clm"" num=""1""><seg-main>1. An in vitro method for determining the distinctive disease related nutritional requirements of a subject suffering from a disease characterized by </seg-main><seg-clauses><seg-main>distinctive nutritional requirements in the diseased subject over a healthy subject comprising the steps: </seg-main><seg-clauses>a. Determining in a sample of the subject suffering from the disease a profile of statuses of direct and indirect markers indicating the nutritional profile of said subject, wherein direct markers indicate the amount of a macronutrient or micronutrient, and indirect markers are derived from direct markers, wherein the status of the direct marker is measured by quantifying the direct marker and the status of the indirect marker is measured by quantifying a further marker or markers indicating the status of the direct marker, and wherein the direct and indirect markers comprise threonine, a metabolite of threonine, an essential amino acid other than threonine, and a metabolite of the essential amino acid other than threonine, </seg-clauses><seg-clauses>b. Determining in a sample of the healthy subject a profile of the statuses of the same markers determined in step a, </seg-clauses><seg-clauses>c. Comparing the profiles determined in step a. and b., and thereby determining the distinctive nutritional requirements for nutrients in a patient suffering from the disease, wherein the nutrients are macronutrients and micronutrients, and wherein the disease is inflammatory bowel disease (IBD). </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the macronutrients are selected from the group consisting of proteins, amino acids, fats, and carbohydrates, or wherein the micronutrients are selected from the group of vitamins and elements. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method ",G01N33/50,20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12433945B2,Peanut oral immunotherapy with maintenance dose,"The present disclosure relates to improved oral immunotherapy methods for treating peanut allergy. The disclosure provides methods for treating a subject for a peanut allergy by an oral immunotherapy comprising an up-dosing phase and a maintenance phase. In certain embodiments, the methods comprise non-daily administration to the subject of a maintenance phase dose. In certain embodiments, the methods comprise administering a maintenance phase dose for more than 24 weeks. In other embodiments, the disclosure provides methods for reducing the risk of an allergic adverse event in a subject receiving an oral immunotherapy dosage therapy.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating a subject for a peanut allergy by an oral immunotherapy comprising </seg-main><seg-clauses><seg-main>an up-dosing phase and a maintenance phase, the method comprising:</seg-main>
<seg-clauses>(a) administering to the subject the up-dosing phase;</seg-clauses>
<seg-clauses>(b) administering to the subject a maintenance phase dose for more than 24 weeks;</seg-clauses>
<seg-clauses>(c) testing the subject for a highest tolerated peanut protein dose by an oral food challenge;</seg-clauses>
<seg-clauses>(d) selecting a subject for additional maintenance phase dosing based on the subject tolerating a maximum dose of less than 1,000 mg peanut protein; and</seg-clauses>
<seg-clauses>(e) continuing to administer to the selected subject the maintenance phase dose; wherein the maintenance phase dose comprises 300 mg of peanut protein.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the maintenance phase dose is administered to the selected subject for at least 4 additional weeks.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the selecting a subject for additional maintenance phase dosing is further based on the subject tolerating a cumulative dose of less than 4,043 mg of peanut protein.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the maintenance phase dose comprises 300 mg or more of peanut protein.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the subject is 12 months old or older.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the subject is 4 years old or older.</seg-clauses></div>
<div class=""","A61K39/35, A61K9/00, A61K39/00, A61P37/08",20251007,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
TW202513426A,Compostable pod for beverage preparation,said delivery portion being adapted to interact with external opening elements of the beverage production machine under the effect of rising pressure of the fluid being injected into the pod,"<div class=""indep-clm"" num=""1""><seg-con>1. 一種用於在飲料生產機器中製備飲料的囊包(100, 200)，其中該囊包(100, 200)係由生物可降解材料組成物，較佳地可堆肥材料組成物製成，且該囊包包括囊包本體(110)，該囊包本體由兩個半殼(101, 102)組成，該兩個半殼沿著其等各別周向凸緣(140)彼此連接以定界用於含有用於製備該飲料之物質(105)的腔室(103)，其中至少一個半殼以分層方式</seg-con><seg-trans>包括： </seg-trans><seg-refi>●     一級層(171)，其由紙基材料製成， ●     二級層(172)，其包括至少一氧障壁功能及/或水蒸汽或濕氣障壁功能，及 ●    至少部分三級層(173)，其包括過濾器功能， 其中該半殼(101, 102)之至少一者的該一級層(171)包括在該半殼(101, 102)之至少一遞送部分(130)上的至少一個貫穿孔(106)，該遞送部分經調適以在該流體通過另一半殼(101, 102)上的注入部分(120)注入至該囊包(100, 200)中的上升壓力的影響下與該飲料生產機器之外部開啟元件相互作用，以施配來自該囊包(100, 200)之經製備飲料。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. 如請求項1之囊包(100, 200)，其中該一級層(171)包括形成第一圖案(108)之介於1個與150個之間的貫穿孔(106)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. 如請求項1或2之囊包(100, 200)，其中該一級層(171)進一步包括至少一不貫穿元件，較佳地一刻印表面及/或刻痕，其形成第二圖案(I, CE)。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. 如前述請求項中任一項之囊包(100, 200)，其中該第一及/或第二圖案(108, I, CE)將呈標誌、商標、產品名稱、區別符號、裝飾元素、或其組合之形式的獨特資訊(I)及/或一或多個編碼元素(CE)形成或表示至在該遞送部分(130)之位置處及可選地在該注入部分(120)之位置處的該一級層(171)之外部表面上。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5. 如前述請求項中任一項之囊包(100, 200)，其中該一級層(171)係由生物可降解紙基材料，較佳地可堆肥紙基材料製成，其係選自包括紙、超級壓光紙(supercalendered paper)、濾紙、及其組合的群組，且具有包括在50 g/m <sup>2</sup>與200 g/m <sup>2</sup>之間，較佳地在80 g/m <sup>2</sup>與120 g/m <sup>2</sup>之間的克數。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. 如前述請求項中任一項之囊包(100,200)，其中該一級層(171)係由可拉伸及/或可成形的紙基材料製成，其具有至少6%的斷裂伸長率。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7. 如前述請求項中任一項之囊包(100,200)，其中該一級層(171)係相對於該二級層(172)而與該腔室(103)對向配置，且該三級層(173)係相對於該二級層(172)而面向該腔室(103)配置。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. 如前述請求項中任一項之囊包(100, 200)，其中該二級層(172)係生物可降解，較佳地可堆肥，且包括連續塗層或多層可堆肥膜結構， 其中較佳地，該塗層或該多層可堆肥塑膠結構包括以下之一或多者： -      聚乳酸衍生聚合物(Polylactic acid derived polymer, PLA)層、 -      聚丁二酸丁二醇酯(Polybutylene succinate, PBS)層、 -      聚己二酸對苯二甲酸丁二酯(Polybutylene adipate terephthalate, PBAT)層、 -      聚羥基烷酸酯(Polyhydroxy alkanoate, PHA)層、 -      聚己內酯(Polycaprolactone, PCL)層、或 -      其任何組合。</div>
<div class",B65D85/804,20250401,瑞士商雀巢製品股份有限公司,['Pending']
AU2023376688A1,Beverage or foodstuff preparation system,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising: a reference portion (R) to locate the code; a data portion (D) to store the preparation information, wherein data portion includes first and second partially overlapping predetermined positions, which encode three conditions as: an absence of a data unit at both positions; a presence of a data unit at the first position and an absence of a data unit at the second position, and; a presence of a data unit at the second position and an absence of a data unit at the first position.",,B65D85/804,20250417,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250280846A1,Use of milk protein fractions as a source of osteopontin,"The present invention relates to the use of specific milk protein fractions as a source of osteopontin, and to the use of said milk protein fractions to optimise the osteopontin concentration in a synthetic nutritional composition for an infant or child. The invention further relates to the use of said synthetic nutritional composition for an infant or child to support and/or optimise growth and development, immune response, galactose metabolism and cytoskeleton remodeling. The invention also relates to a low-protein synthetic nutritional composition for an infant or child comprising the milk protein fractions.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for producing a milk protein fraction as a source of osteopontin (OPN) in a synthetic nutritional composition for an infant or child comprising:</seg-main>
<seg-clauses>i) providing a liquid lactic raw material</seg-clauses>
<seg-clauses>ii) decationization of the liquid lactic raw material, such that the pH has a value of 1 to 4.5,</seg-clauses>
<seg-clauses>iii) bringing the said liquid into contact with a weak anionic resin of hydrophobic matrix, predominantly in alkaline form up to a stabilized pH,</seg-clauses>
<seg-clauses>iv) separation of the resin and the liquid product which is recovered,</seg-clauses>
<seg-clauses>v) desorption of CGMP from the resin,</seg-clauses>
<seg-clauses>vi) performing at least one ultrafiltration step, and</seg-clauses>
<seg-clauses>vii) collecting the permeate and/or retentate fraction rich in OPN.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method of claim 1, wherein </seg-main><seg-clauses>the steps v-vi is performed under pH ranging from 4 to 8.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. Method of claim 2, wherein </seg-main><seg-clauses>the ion balance is further modified by calcium or phosphate addition.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. Method of claim 1, wherein </seg-main><seg-clauses>the ultrafiltration step is performed using membrane size between preferably 30 to 100 KDa.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method of claim 1, wherein </seg-main><seg-clauses>said milk protein is added to said composition in an effective amount sufficient to ensure that said synthetic nutritional composition has a final concentration of osteopontin in a range found in human breast milk.</seg-clauses></div>
<div class=""indep-clm"" num=""6""><seg-main>6. A method for providing nutrition to an infant or child comprising </seg-main><seg-clauses><seg-main>admin","A23C9/142, A23L33/00, A23L33/19",20250911,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120379547A,Heat-treated beverage containing fluid gel,"The present invention relates to a heat-treated beverage containing a fluid gel comprising particles formed from gellan gum and a divalent cation, in particular calcium. The fluid gel beverage is surprisingly thermally stable and maintains suspension properties after heat treatment including UHT (ultra-high temperature) heat treatment.","<div class=""indep-clm"" num=""1"">1.包含流体凝胶的热处理饮料，所述流体凝胶包含由结冷胶和二价阳离子形成的颗粒，其中基于所述饮料的总重量，所述二价阳离子以0.001重量％至0.1重量％存在。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的热处理饮料，其中包含由结冷胶和所述二价阳离子形成的颗粒的所述流体凝胶在热处理之前和之后都存在。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的热处理饮料，其中基于所述饮料的所述总重量，所述饮料中结冷胶的量为0.05重量％至0.5重量％，优选地0.05重量％至0.11重量％。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的热处理饮料，其中所述流体凝胶中由结冷胶和二价阳离子形成的所述颗粒具有10μm至1000μm、诸如20μm至500μm、优选地30μm至100μm的粒度。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的热处理饮料，其中所述饮料具有至少4、优选地4至7的pH。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的热处理饮料，其中所述饮料具有在0.1 1/s的剪切速率下测量的在100mPa.s至15,000mPa.s、诸如1,000mPa.s至10,000mPa.s范围内的粘度。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的热处理饮料，其中所述饮料具有在100 1/s的剪切速率下测量的在1mPa.s至1000mPa.s、诸如10mPa.s至1000mPa.s范围内的粘度。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的热处理饮料，其中所述饮料具有如在实施例中根据BRUCE方案测量的4Pa至75Pa、优选地20Pa至60Pa的PhiTau。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的热处理饮料，其中所述流体凝胶颗粒完全由结冷胶和所述二价阳离子组成。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的热处理饮料，其中所述二价阳离子为二价金属阳离子。</div>
<div class=""dep-clm"" num=""11"" parent=""10"">11.根据权利要求10所述的热处理饮料，其中所述二价金属阳离子选自钙、镁、锌或它们的混合物，优选地，所述二价金属阳离子为钙(Ca<sup>2+</sup>)。</div>
<div class=""indep-clm"" num=""12""><seg-con>12.生产包含流体凝胶的热处理饮料的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""12""><seg-refi>·提供包含结冷胶、二价阳离子和水性液体的加热饮料混合物，其中基于所述饮料的总重量，所述饮料混合物包含0.001重量％至0.1重量％的二价阳离子，</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>·在剪切所述加热饮料混合物的同时进行冷却，以形成包含流体凝胶的冷却饮料，所述流体凝胶包含由所述结冷胶和所述二价阳离子形成的颗粒，</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>·对包含流体凝胶的所述冷却饮料进行热处理，以获得包含流体凝胶的热处理饮料。</seg-refi></div>
<div class=""dep-clm"" num=""13"" parent=""12"">13.根据权利要求12所述的方法，其中所述热处理步骤涉及在80℃至145℃、优选地100℃至140℃且甚至更优选地120℃至140℃的温度下加热所述饮料混合物。</div>
<div class=""de","A23L2/52, A23L2/62, A23C11/10, A23B11/13, A23B70/30",20250725,雀巢产品有限公司,['Pending']
EP4508990A2,Compositions for use in improving stool consistency or frequency in infants or young children,The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.,"<div class=""indep-clm"" num=""1""><seg-con>1.  Nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one fucosylated oligosaccharide for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2.  Nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one fucosylated oligosaccharide for use in preventing and/or treating flatulence, bloating, colics and/or gut discomfort in an infant or a young child, and wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100g of composition on a dry weight basis.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.  Nutritional composition according to any one of the preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-comp>the fucosylated oligosaccharide is selected from the list consisting of </seg-comp><seg-comp>2'-fucosyllactose, 3'fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and any combination thereof.</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  Nutritional composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fucosylated oligosaccharide comprises a 2' fucosyl-epitope.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.  Nutritional composition according to any one of the preceding claims, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fucosylated oligosaccharide is 2'-fucosy",A23L33/135,20250219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025200963A1,Handling of food processor,"A machine (1) for processing a liquid food substance includes a jug (20) that has a container (21) and a handle (31,32,33) for holding the jug by an adult human hand (40). The container (21) delimits a food cavity (21') for containing the food substance. The handle (31,32,33) has a connection member (31) projecting from the container (21) and a substantially elongated upright gripping member (32) that is connected to the connection member (31) at a distance from the container (21). The gripping member (32) has an upper portion (32a) that is above the connection member (31) and a lower portion (32b) that is below the connection member (31). The upper portion (32a) is configured to support a thumb (41) of the hand (40) and delimits with the connection member (31) an upper seat (31a) for accommodating an index finger (42) of the hand (40). The handle (31,32,33) has a confinement member (33) that extends: substantially uprightly between the container (21) and the lower portion (32b) of the gripping member (32); and downwardly from the connection member (31) or from close thereto. The confinement member (33) and the lower portion (32b) and the connection member (31) delimit a lower seat (31b) for accommodating a portion of a middle finger (43) of the hand (40).","2025200963   12 Feb 2025
<div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for processing a liquid food substance, such as milk or a milk-based substance, 5 comprising:</seg-main>
<seg-clauses>- a jug (20) having a container (21) and a handle (31,32,33) for holding the jug by an adult human hand (40), the container (21) delimiting a food cavity (21') for containing said liquid food substance, such 10 as a container (21) having a removable lid (22) for covering the cavity (21'); and optionally</seg-clauses>
<seg-clauses><seg-main>- a base (10) that has one or more walls (11) forming a seat (11') for removably receiving the container (21),</seg-main>
<seg-main class=""seg-enter"">the handle (31,32,33) having a connection member (31) 15 projecting from the container (21) and a substantially</seg-main>
<seg-main class=""seg-enter"">elongated upright gripping member (32) that is connected to the connection member (31) at a distance from the container (21), the gripping member (32) having an upper portion (32a) that is above the connection member (31) 20 and a lower portion (32b) that is below the connection</seg-main>
<seg-main class=""seg-enter"">member (31), the upper portion (32a) being configured to support a thumb (41) of said hand (40) and delimiting with the connection member (31) an upper seat (31a) for accommodating an index finger (42) of said hand (40) when 25 the handle (31,32,33) is held by said hand (40),</seg-main>
<seg-main class=""seg-enter"">optionally:</seg-main>
<seg-clauses>- the connection member (31) being horizontal or at an angle of less than 30 deg thereto, such as less than 15 deg. thereto, when the jug (20) is oriented for 30 processing said liquid food substance; and/or</seg-clauses>
<seg-clauses><seg-main>- the upright gripping member extending vertically or at an angle of less than 30 deg thereto, such as less than 15 deg. thereto,</seg-main>
<seg-main class=""seg-enter"">characterised in that the handle (31,32,33) has a 35 confinement member","A47J45/06, A47J41/00, A47J43/046",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250331505A1,Methods of monitoring feeding behaviors of pets,"The present disclosure relates to the monitoring feeding behavior(s) of a pet(s), under the control of at least one processor. An example system includes a pet bowl comprising a load sensor configured to obtain load data while the pet is interacting with contents of the pet bowl. The load sensor can have a sensitivity of +/−50 grams or less and the load data can occur at a sample rate from 10 samples to 150 samples per second. The system also includes a processor configured to sequentially group the load data in 0.01 second to 5 second time increments. The individual time increments can include multiple samples. The processor can also identify a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.","<div class=""indep-clm"" num=""1""><seg-con>1. A system for monitoring feeding behavior of a pet, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pet bowl comprising a load sensor configured to obtain load data while the pet is interacting with contents of the pet bowl, wherein the load sensor has a sensitivity of +/−50 grams or less and the load data is obtained at a sample rate from 10 samples to 150 samples per second;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processor configured to sequentially group the load data in 0.01 second to 5 second time increments, wherein individual time increments include multiple samples; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the processor further configured to identify a feeding behavior occurring within one or more of the time increments based on the load data resulting from the pet interacting with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the processor is further configured to exclude load data in identifying the feeding behavior if determined to be a result of human interaction, a false trigger, or an accidental interaction with the pet bowl or the contents of the pet bowl.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the feeding behavior is a count-based feeding behavior selected from lapping, licking, or biting.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The system of claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the processor is further configured to characterize the count-based feeding behavior by counting individual micro-events of the feeding behavior within a single time increment or a time period spanning multiple time increments, wherein the individual micr",A01K29/00,20251030,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250057355A1,Beverage pod system with pod catcher,"The invention concerns a device for extracting a beverage ingredient by supplying an extraction liquid into in a pod, and comprising: —upstream and downstream pod enclosing parts (<b>1, 2</b>) relatively translatable between an open position for inserting and/or ejecting the pod (<b>3</b>) and a closed position for forming an extraction chamber (<b>5</b>) enclosing the pod during extraction, —an insertion section (<b>4</b>) for inserting the pod in the device, said insertion section being designed to position the pod with the lid facing the downstream piercing arrangement (<b>12</b>), and —a pod holder (<b>11</b>), said pod holder being attached to said peripheral area (<b>13</b>) of the downstream part and said pod holder being movable between a receiving position and a retracted position, wherein the retaining and positioning elements (<b>11</b><i>a, </i><b>11</b><i>b</i>) move from the receiving position to the retracted position along diverging directions.","<div class=""indep-clm"" num=""1""><seg-con>1. A device for extracting a beverage ingredient by supplying an extraction liquid such as heated water into a pod,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said pod </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a side wall and a bottom wall defining a chamber, said chamber extending axially between the bottom and a top opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a circumferential annular flange projecting radially outward from the top opening, said flange comprising a top surface opposite to the chamber with respect to the opening,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pod body containing a beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top lid attached to the top surface of the circumferential flange, said top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said device comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a fixed downstream pod enclosing part and a movable upstream pod enclosing part, said upstream pod enclosing part being translatable along a longitudinal axis (XX′) between an open position for inserting and/or ejecting the pod and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the upstream part defining a cage and bearing an upstream piercing arrangement for opening the bottom wall of the pod and a liquid injector,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the downstream part defining a plate transverse to the longitudinal axis (XX′) and, said plate comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a downstr",A47J31/36,20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2021388792A9,Binder system for a meat analogue product,"The present invention relates to a method of making a meat analogue, said method comprising a) mixing in water a cold set gelling dietary fibre, preferably psyllium fibre; a heat-set gelling plant based ingredient, preferably flour; and optionally calcium salt to form a binder aqueous phase; b) adding lipid to the binder aqueous phase and homogenizing to form an emulsion gel binder; and c) mixing plant extract with the emulsion gel binder, optionally adding solid fat, and optionally molding to form a meat analogue.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a meat analogue, said method comprising</seg-main>
<seg-clauses>a. Mixing in water a cold set gelling dietary fibre, preferably psyllium fibre; a heatset gelling plant based ingredient, preferably flour; and optionally calcium salt to form a binder aqueous phase;</seg-clauses>
<seg-clauses>b. Adding lipid to the binder aqueous phase and homogenizing to form an emulsion gel binder;</seg-clauses>
<seg-clauses>c. Mixing plant extract with the emulsion gel binder, optionally adding solid fat, and optionally molding, to form a meat analogue.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the meat analogue comprises 20 to 85 wt.% emulsion gel binder.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to claims 1 or 2, wherein </seg-main><seg-clauses><seg-main>the emulsion gel binder comprises </seg-main><seg-clauses>0.5 to 20 wt.% cold set gelling dietary fibre.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to claims 1 to 3, wherein </seg-main><seg-clauses>the cold set gelling dietary fibre at 6 wt. % in an aqueous solution at 7°C exhibits a G' (storage modulus) greater than 40 Pa and G"" (loss modulus) lower than 150Pa at 1Hz frequency and a strain of 0.2%.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to claims 1 to 4, wherein </seg-main><seg-clauses>the cold set gelling dietary fibre has a soluble fraction of greater than 50 wt.%.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The method according to claims 1 to 5, wherein </seg-main><seg-clauses>the cold set gelling dietary fibre is or comprises psyllium fibre.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The method according to claims","A23J3/22, A23L11/00, A23L25/00, A23L33/105, A23L33/185",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
AU2023385377A1,Reduction of astringency in plant protein based beverages,"The invention relates to a plant protein based drink comprising oat bran or oat bran extract, wherein said oat bran or oat bran extract comprises between 0.1% to 6% of the total solid content on a dry basis in the plant protein based drink, and wherein at least 15% of the solids on a dry basis contributed by the oat bran or oat bran extract are beta-glucans.","<div class=""indep-clm"" num=""1""><seg-con>1. A plant protein based drink </seg-con><seg-trans>comprising </seg-trans><seg-refi>oat bran or oat bran extract, wherein said oat bran or oat bran extract comprises between 0.1% to 6% of the total solid content on a dry basis in the plant protein based drink, and wherein at least 15% of the solids on a dry basis contributed by the oat bran or oat bran extract are beta-glucans.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Plant protein based drink according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oat bran or oat bran extract comprises between 1 to 5% of the total solid content on a dry basis in the plant protein based drink.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Plant protein based drink according to any one of claims 1 to 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant protein based drink comprises between 0.3 wt% to 0.5 wt% oat bran.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Plant protein based drink according to any one of claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant protein is pea protein, fava protein, or soy protein.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Plant protein based drink according to claim 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant protein is pea protein isolate.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. Plant protein based drink according to any of claims 1 to 5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant protein based drink comprises less than 4.5 wt% plant protein.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. Plant protein based drink according to any one of claims 1 to 6, </seg-con><seg-trans>wherein </seg-trans><seg-refi>up to 50% of the solids contributed on a dry basis by the oat bran extract are b","A23L2/52, A23L2/66, A23L29/206, A23L33/185",20250515,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025132743A1,Machine with liquid guard,"A machine (10, 88) for processing a liquid food substance, such as milk or a milk-based substance, is provided. The machine (10, 88) comprises a jug (14) having a container (16) delimiting a food cavity for containing said liquid food substance; an impeller (17) for driving said liquid food substance, a motor (60) for driving the impeller (17); a base (12) forming a seat (52) for removably receiving the container (16) and forming a motor chamber (62) for containing the motor (60), the motor chamber (62) having at least one ventilation opening (64) for exchange of air between an inside of the motor chamber (62) and an outside of the motor chamber (62), the at least one ventilation opening (64) being located at a bottom face (18) of the base; and a liquid guard (68) extending around a portion of a periphery of the bottom face (18) and configured for hindering liquid from flowing under the machine (10, 88), wherein the liquid guard (68) extends at least along a front portion (24) of a peripheral side face (22) of the machine (10, 88), the front portion (24) being configured for facing a user of the machine (10, 88) when processing said liquid substance, and wherein the liquid guard does at least not fully extend along a rear portion (26) of the peripheral side face (22) of the machine (10, 88), the rear portion (26) being configured for facing away from the user when processing said liquid food substance.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A machine (10, 88) for processing a liquid food substance,such as milk or a milk-based substance, comprising:</seg-main><seg-clauses>- a jug (14) having a container (16) delimiting a food cavityfor containing said liquid food substance, such as a container (16) provided with a removable lid (38) for covering the food cavity;</seg-clauses><seg-clauses>- an impeller (17) for driving said liquid food substance inthe container (16),</seg-clauses><seg-clauses>- a motor (60) for driving the impeller (17);</seg-clauses><seg-clauses>- a base (12) having one or more walls forming a seat (52) forremovably receiving the container (16) and forming a motor chamber (62) for containing the motor (60), the motor chamber (62) having at least one ventilation opening (64) for exchange of air between an inside of the motor chamber (62) and an outside of the motor chamber (62), the at least one ventilation opening (64) being located at a bottom face (18) of the base; and</seg-clauses><seg-clauses>- a liquid guard (68) extending around a portion of a peripheryof the bottom face (18) and configured for hindering liquid from flowing under the machine (10, 88), wherein the liquid guard (68) extends at least along a front portion (24) of a peripheral side face (22) of the machine (10, 88), the front portion (24) being configured for facing a user of the machine (10, 88) when processing said liquid substance, and wherein the liquid guard does at least not fully extend along a rear portion (26) of the peripheral side face (22) of the machine (10, 88), the rear portion (26) being configured for facing away from the user when processing said liquid food substance.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine (10, 88) of claim 1, wherein </seg-main><seg-clauses>the liquid guard(68) extends uninterruptedly along the front portion (24) of the machine (10, 88).</seg-clauses></div><div class=""dep-clm"" num=""3"" par","A47J31/44, A47J43/046, A47J43/07",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20250338876A1,"Pet foods made by retorting at least one of yogurt, cheese, animal milk, or plant milk; and methods of making and using such pet foods","A method of manufacturing a pet food may include retorting a composition comprising at least one material selected from the group consisting of (i) yogurt, (ii) cheese and (iii) a combination of one or more hydrocolloids and at least one of an animal milk or a plant-based dairy alternative to form the shelf-stable pet food. A product may include the pet food and also a container housing the pet food, the container including instructions to administer the pet food to a pet, preferably a companion animal, most preferably a cat. A method of providing nutrition to a pet may include administering the pet food to a pet, preferably a companion animal, most preferably a cat. The pet food optionally consists of the retorted material. The pet food optionally is low in lactose or lactose-free and optionally includes no added sugar relative to that in the material subjected to the retorting.","<div class=""indep-clm"" num=""1""><seg-main>1: A method of manufacturing a pet food, the method comprising:</seg-main>
<seg-clauses><seg-main>retorting a composition comprising at least one material selected from the group consisting of </seg-main><seg-clauses>(i) a combination of an animal milk and one or more hydrocolloids, </seg-clauses><seg-clauses>(ii) yogurt and </seg-clauses><seg-clauses>(iii) cheese to form the pet food.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2: The method of claim 1, further comprising </seg-main><seg-clauses>providing the pet food in a container comprising instructions to administer the pet food to a pet.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3: The method of claim 2, wherein </seg-main><seg-clauses>the at least one material is retorted in the container.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4: The method of claim 1, wherein </seg-main><seg-clauses>the pet food has only one single dairy ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5: The method of claim 1, wherein </seg-main><seg-clauses>the pet food contains no added sugar relative to that present in the at least one material which is retorted.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6: The method of claim 1, wherein </seg-main><seg-clauses>the pet food contains no additional ingredients relative to the at least one material which is retorted, such that the pet food consists of the at least one material which is retorted.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7: The method of claim 1, wherein </seg-main><seg-clauses>the pet food contains less than about 4.0 wt. % lactose.</seg-clauses></div>
<div class=""indep-clm"" num=""8""><seg-main>8: A product comprising </seg-main><seg-clauses><seg-main>a pet food in a container, the container comprising instructions to administer the pet food to a pet","A23K40/00, A23K10/30, A23K20/163, A23K50/45, A23K50/48",20251106,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023312961A1,Beverage or foodstuff container and preparation system,"The invention concerns container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including: a storage portion for containing a precursor material, a closing member to close the storage portion and an annular flange-like rim made of cellulose pulp-based material, the flange-like rim comprising an annular force ring and at least two distinct additional portions, namely - a first portion (61) connected to the annular force ring (63); and - a second portion (62) extending from the storage portion (58) on which the closing membrane (56) is sealed, said second portion (62) connecting the storage portion (58) and the closing membrane (56). The invention also concerns a set of different containers is also proposed as well as a container system and a system comprising a container and a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-main>1. A container designed for insertion in and use with a preparation machine for preparing a beverage and/or foodstuff or a precursor thereof from a precursor material stored in the container by introducing liquid in the container and passing liquid through the precursor material, the container including:</seg-main>
<seg-clauses>- a cup-shaped body comprising a bottom end and an open end, the cupshaped body forming a storage portion (58) for containing the precursor material;</seg-clauses>
<seg-clauses>- a closing membrane (56) to close the storage portion at the open end of the cup-shaped body; and</seg-clauses>
<seg-clauses>- an annular flange-like rim (60) at least partially engaging with a closing member (36) of the beverage preparation machine (4), said annular flange-like rim (60) being made of cellulose pulp-based material and extending outwardly from the cup-shaped body, the flange-like rim (60) comprising an annular force ring (63),</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the flange-like rim (60) further comprises at least two distinct portions,</seg-clauses>
<seg-clauses>- a first portion (61) connected to the annular force ring (63); and</seg-clauses>
<seg-clauses>- a second portion (62) extending from the storage portion (58) on which the closing membrane (56) is sealed, said second portion (62) connecting the storage portion (58) and the closing membrane (56).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The container of claim 1, wherein </seg-main><seg-clauses>the flange-like rim (60) including the first portion (61), the second portion (62) and the annular force ring (63), is integral with the cupshaped body.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The container of claim 1 or 2, wherein </seg-main><seg-clauses>the first (61) and second (62) portions of the flange-like rim (60) are parallel.</seg-clauses></div>
<div class=""dep-clm"" num=""4",B65D85/804,20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250287976A1,Compositions and methods using at least one of oleuropein or a metabolite thereof to treat or prevent muscle fatigue from exercise and/or for resistance to muscle fatigue from exercise,"A method of preventing or treating muscle fatigue from exercise and/or for resistance to muscle fatigue from exercise, the method including orally administering at least one of oleuropein or metabolite thereof to an individual before, during and/or after the exercise. A unit dosage form contains at least one of oleuropein or metabolite thereof in an amount effective for administration of the unit dosage form before, during and/or after exercise to thereby prevent or treat muscle fatigue from the exercise and/or for resistance to muscle fatigue from exercise. A method of making a composition for preventing or treating muscle fatigue from exercise and/or for resistance to muscle fatigue from exercise, the method including adding an effective amount of at least one of oleuropein or metabolite thereof to at least one ingredient selected from the group consisting of protein, carbohydrate, and fat. The exercise is preferably one or more of 1) resistance exercise, 2) anaerobic or repeated sprint-type exercise, or 3) endurance exercise.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of preventing or treating muscle fatigue from exercise and/or for resistance to muscle fatigue from exercise, the method comprising </seg-main><seg-clauses>orally administering an effective amount of at least one of oleuropein or metabolite thereof to an individual before, during and/or after the exercise.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the effective amount of at least one of oleuropein or metabolite thereof is administered in a composition selected from the group consisting of food compositions, dietary supplements, nutritional compositions, nutraceuticals, beverages, powdered nutritional products to be reconstituted in water or milk before consumption, food additives, medicaments, drinks, petfood, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the effective amount of at least one of oleuropein or metabolite thereof is administered in a composition further comprising calcium.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the effective amount of at least one of oleuropein or metabolite thereof is administered in a food product further comprising a component selected from the group consisting of protein, carbohydrate, fat and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-c","A23K20/121, A23K20/111, A23L33/00, A23L33/105, A23L33/16",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025003299A1,Methods and compositions comprising trigonelline for treating muscle decline and a kidney dysfunction,,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating and/ or preventing a disease or condition associated with muscle decline and/or a kidney dysfunction, the method comprising </seg-main><seg-clauses>administering to a subject in need thereof an effective amount of a composition comprising trigonelline or a trigonelline or a pharmaceutically acceptable salt thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of Claim 1, wherein </seg-main><seg-clauses>the disease or condition is selected from chronic kidney disease, metabolic induced muscle wasting, end-stage renal disease, dialysis, diabetes, muscle loss and/or kidney failure due to hospitalization in the intensive care unit, Pompe disease, metabolic acidosis, methylmalonic aciduria, disuse atrophy, protein-energy wasting and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of Claim 1, wherein </seg-main><seg-clauses>the muscle decline and/or the kidney dysfunction is treated and/ or prevented in an early stage of chronic kidney disease and/ or a late stage of chronic kidney disease.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of Claim 1, wherein </seg-main><seg-clauses>the muscle is tibialis anterior and/or extensor digitorum longus (EDL), and/or soleus muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of Claim 1, wherein </seg-main><seg-clauses>the composition comprising trigonelline or trigonelline or a pharmaceutically acceptable salt thereof is administered enterally.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of Claim 1, wherein </seg-main><seg-clauses>the composition comprising trigonelline or trigonelline or a pharmaceutically acceptable salt thereof is administered parenterally.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method of Claim","A61K31/4425, A61P13/12, A61P21/00",20250102,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN120659544A,Fermented fructus cannabis beverage,The present invention relates to a beverage composition comprising fermented cannabis or a fermented cannabis extract. A further aspect of the invention is a method of preparing a beverage composition.,"<div class=""indep-clm"" num=""1"">1.包含经发酵的火麻仁或经发酵的火麻仁提取物的饮料组合物，其中乙酸3-甲基丁酯和3-甲基丁醇的总和与3-甲基丁醛的重量比大于2000，其中所述饮料组合物不含Δ<sup>9</sup>-四氢火麻酚(Δ<sup>9</sup>-tetrahydrocannabinol，THC)。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的饮料组合物，其中乙酸2-甲基丁酯和2-甲基丁醇的总和与2-甲基丁醛的重量比大于2000。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的饮料组合物，其中乙酸3-甲基丁酯、乙酸2-甲基丁酯、乙酸异丁酯、乙酸2-苯基乙酯和2-苯基乙醇的总和与2,3-丁二酮的重量比大于50。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的饮料组合物，所述饮料组合物具有低于1.2重量％的乙醇含量。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的饮料组合物，其中所述饮料组合物选自由以下项组成的组：即饮饮料、饮料液体浓缩物、可溶性饮料粉末、干燥的芳香植物材料以及这些的组合。</div>
<div class=""indep-clm"" num=""6"">6.用于饮料制备装置中的容器，所述容器含有根据权利要求1至5中任一项所述的饮料组合物。</div>
<div class=""indep-clm"" num=""7""><seg-con>7.制备饮料组合物的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""7""><seg-comp>a.将火麻仁浸泡在水中以形成水性火麻仁提取物和经浸泡的火麻仁；</seg-comp></div>
<div class=""indep-clm"" num=""7""><seg-comp>b.在存在或不存在所述经浸泡的火麻仁的情况下发酵所述水性火麻仁提取物；</seg-comp></div>
<div class=""indep-clm"" num=""7""><seg-comp>其中所述发酵通过包括毕赤酵母(Pichia)的酵母进行。</seg-comp></div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的方法，其中所述毕赤酵母是克鲁维毕赤酵母(Pichiakluyveri)。</div>
<div class=""dep-clm"" num=""9"" parent=""7,8"">9.根据权利要求7至8中任一项所述的方法，其中所述毕赤酵母包含与SEQ ID NO:1-12的组合具有至少98％的总体核苷酸同一性的遗传序列。</div>
<div class=""dep-clm"" num=""10"" parent=""7,8,9"">10.根据权利要求7至9中任一项所述的方法，其中所述发酵在不存在酿酒酵母(Saccharomyces cerevisiae)的情况下进行。</div>
<div class=""dep-clm"" num=""11"" parent=""7,8,9,10"">11.根据权利要求7至10中任一项所述的方法，其中所述发酵在不存在乙酸细菌的情况下进行。</div>
<div class=""dep-clm"" num=""12"" parent=""7,8,9,10,11"">12.根据权利要求7至11中任一项所述的方法，所述方法包括在发酵后从所述经浸泡的火麻仁中分离所述水性火麻仁提取物。</div>
<div class=""dep-clm"" num=""13"" parent=""7,8,9,10,11"">13.根据权利要求7至11中任一项所述的方法，其中将在所述水性火麻仁提取物的所述发酵期间存在的所述经浸泡的火麻仁与发酵后的所述水性火麻仁提取物一起干燥。</div>
<div class=""dep-clm"" num=""14"" parent=""7,8,9,10,11,12,13"">14.根据权利要求7至13中任一项所述的方法，其中所述饮料组合物是根据权利要求1至5中任一项所述的。</div>
<div class=""indep-clm"" num=""15"">15.用克鲁维毕赤酵母NYSC 5485(CNCM I-5525)发酵的火麻仁用于生产饮料的用途。</div>","A23L2/38, A23L2/84, A23L33/14, C12N1/16, C12R1/84",20250916,雀巢产品有限公司,['Pending']
RU2851627C2,Method for obtaining milk-like products,"FIELD: biotechnology.SUBSTANCE: method for producing a product similar to human breast milk includes obtaining lactocyte-like mammary gland organoids derived from adult human breast milk stem cells (hBSCs) by aggregating and culturing hBSCs in a 3D suspension to form mammospheres, and culturing said mammospheres in a 3D suspension for at least 10 days to obtain lactocytes and secrete a product similar to human breast milk from said lactocytes.EFFECT: present invention provides an effective method for producing human milk-like products.8 cl, 5 dwg, 7tbl, 4 ex",,"A23C9/00, A23L33/19, C12N5/071",20251126,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250151944A1,Beverage preparation by centrifugation with reliable capsule transfer,"A capsule processing machine (<b>1</b>) is configured for preparing a beverage from a capsule (<b>5</b>) having a body containing an ingredient by circulating a liquid into such capsule (<b>5</b>) and centrifugally driving such capsule (<b>5</b>). The machine (<b>1</b>) has a first capsule handler (<b>10</b>) and a second capsule handler (<b>20</b>) that are movable one relative to the other from: a capsule transfer configuration for receiving/releasing the capsule (<b>5</b>); to a capsule processing configuration for centrifuging the capsule (<b>5</b>) about a processing axis (<b>30</b>′). At least one of the first and second capsule handlers (<b>10, 20</b>) is fixed to or integral with or connected to a positioning device (<b>30″, 40</b>″) configured to position such capsule handler(s) (<b>10, 20</b>) at a predetermined angular position about the processing axis (<b>30</b>′) when the capsule handlers (<b>10, 20</b>) are in the capsule transfer configuration.","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule processing machine for preparing a beverage from a capsule </seg-con><seg-trans>having </seg-trans><seg-refi>a body containing an ingredient by circulating a liquid into such capsule and centrifugally driving such capsule, comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first capsule handler and a second capsule handler that are movable one relative to the other from:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule transfer configuration for receiving said capsule by the first and second capsule handlers and/or releasing said capsule from the first and second capsule handlers; to</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule processing configuration for centrifuging said capsule by rotation about a processing axis of the first and second capsule handlers; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the first and second capsule handlers are rotated for centrifugation and which supports the first and second capsule handlers,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one of the first and second capsule handlers is fixed to or integral with or connected to a positioning device configured to position the at least one of the first and second capsule handlers at a predetermined angular position about the processing axis when the first and second capsule handlers are in the capsule transfer configuration and optionally in the processing configuration when rotation of the first and second capsule handlers about the processing axis is at a stop.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The machine of claim 1, which has a handler support device for supporting the first and second capsule handlers, the handler support device being configured to be and remain angularly fixed relative to the first and second capsule handlers and to rotate therewit","A47J31/22, A47J31/44",20250515,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250342954A1,Systems and methods for animal health monitoring,"Methods of animal health monitoring under the control of at least one processor can include obtaining load data from an animal monitoring device including a plurality of load sensors associated with a platform carrying contained litter thereabove. Individual load sensors can be separated from one another and receive and communicate pressure input from the platform independent of one another. The method can also include recognizing an animal behavior property associated with the animal based on the load data collected independently from the plurality of load sensors, classifying the animal behavior property into an animal classified event using a machine learning classifier, and correlating the animal classified event with a physical, behavioral, or mental health issue associated with the animal. Classifying the animal behavior property can include using both a time domain based on a time domain feature and a frequency domain based on a frequency domain feature.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of monitoring health of an animal, under the control of at least one processor, </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>obtaining load data from an animal monitoring device including a plurality of load sensors associated with a platform carrying contained litter thereabove, wherein individual load sensors of the plurality of load sensors are separated from one another and receive and communicate pressure input from the platform independent of one another;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>recognizing an animal behavior property associated with the animal based on the load data collected independently from the plurality of load sensors;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>classifying the animal behavior property into an animal classified event using a machine learning classifier, wherein classifying the animal behavior property includes using both a time domain based on a time domain feature and a frequency domain based on a frequency domain feature; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>correlating the animal classified event with a physical, behavioral, or mental health issue associated with the animal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the time domain feature comprises a mean, a median, a standard deviation, a range, an autocorrelation, or a combination thereof, wherein the frequency domain feature comprises a median, an energy, a power spectral density, or a combination thereof, and wherein both the time domain feature and the frequency domain feature are created as an input or inputs for the machine learning classifier.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>classifying the animal ",G16H40/63,20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250280863A1,Compositions and their use,"A synthetic nutritional composition including folic acid to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for promoting, supporting or optimizing de novo myelination, and/or brain structure, and/or brain connectivity, and/or intellectual potential, and/or cognitive potential, and/or learning potential and/or cognitive functioning in a formula fed subject, the method comprising:</seg-main>
<seg-clauses>administering to the subject a synthetic nutritional composition comprising folic acid, wherein brain structure refers to the amount and/or spatial distribution of myelinated matter throughout the brain, and/or in specific brain regions, and wherein said cognitive function is optimized if the subject's scores in a standardized neurodevelopmental test are less than one standard deviation different from that of an exclusively breastfed subject of a well-nourished mother.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the subject is a human infant or child.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the composition further comprises vitamin B12.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the composition comprises the folic acid in an amount greater than 50 mcg/100 g dry weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the composition further comprises an ingredient selected from the group consisting of a mineral, choline, a phospholipid, and a fatty acid derivative.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The method according to claim 5, wherein </seg-main><seg-clauses>the mineral is selected from the group consisting of iron, zinc, calcium, phosphorus, copper and combinations thereof; wherein the fatt","A23L33/00, A23L33/12, A23L33/15, A23L33/16, A24B15/38",20250911,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025012100A1,Dairy product analogues comprising milk fat,The dairy product analogues comprise plant proteins and milk fat. Processes for preparing such dairy product analogues are also disclosed.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A dairy product analogue which comprises </seg-main><seg-clauses>plant proteins, milk fat and wherein less than 20% of all the proteins of the dairy product analogue are milk proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A dairy product analogue according to claim 1, wherein </seg-main><seg-clauses>the milk fat is provided as milk fat isolate.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the dairy product analogue is devoid of milk proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the dairy product analogue is devoid of any milk compound except milk fat.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the plant proteins comprise, preferably consist of plant proteins selected from the group consisting of cereal proteins, pulse proteins and combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% plant proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% milk fat.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. A dairy product analogue according to any one of the preceding claims, which is beverage.</div>
<div class=""dep-clm"" num=""9"" parent=""8""><seg-main>9. A dairy product analogue according to claim 8, wherein </seg-main><seg-clause","A23C11/06, A23L9/20, A23L11/50, A23L11/60, A23L11/65",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2022214135B2,Mixture of hmos and bifidobacteria,"The invention relates to a composition for infants or young children comprising at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria and a prebiotic mixture of human milk oligosaccharides consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'- sialyllactose (SSL) and optionally 3-fucosyllactose (3FL) that can be useful for (i) preventing and/or treating bacterial infections; (ii) modulating the microbiota; and/or iii) preventing and/or treating allergy in an infant or a young child.","<div class=""indep-clm"" num=""1""><seg-con>1. A composition for infants or young children </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), 5 lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL);</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the bifidobacteria comprises Bifidobacterium longum subsp. infantis or combination of Bifidobacterium animalis subsp. lactis and Bifidobacterium longum subsp. infantis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein at least one of the bifidobacteria is Bifidobacterium longum subsp. infantis LMG 11588 .0 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidobacteria comprises Bifidobacterium longum subsp. infantis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and .5 3'-sialyllactose (3SL).</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The composition of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bifidobacteria is a combination of Bifidobacterium animalis subsp. lactis and Bifidobacterium longum subsp. infantis and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), :o lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3’-sialyllactose (3SL).</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The composition of any one of claims 1 to 3, </seg-con><seg-trans>wherein </s","A23L33/135, A23L33/00, A23L33/21, A61K31/702, A61K31/745",20250515,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119173155A,Fermented acerola cherry beverage,The present invention relates to a beverage composition comprising fermented acerola cherry or a fermented acerola cherry extract. A further aspect of the invention is a method of preparing a beverage composition.,"<div class=""indep-clm"" num=""1"">1.饮料组合物，所述饮料组合物包含经发酵的针叶樱桃或经发酵的针叶樱桃提取物，其中乙酸3-甲基丁酯、乙酸2-甲基丁酯、乙酸异丁酯、乙酸2-苯基乙酯和2-苯基乙醇的总和与2,3-丁二酮的重量比大于150。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的饮料组合物，其中乙酸2-苯基乙酯和2-苯基乙醇的总和与2-苯基乙醛的重量比大于3000。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的饮料组合物，所述饮料组合物具有低于1.2重量％的乙醇含量。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的饮料组合物，其中所述饮料组合物选自由以下项组成的组：即饮饮料、饮料液体浓缩物、可溶性饮料粉末、干燥的芳香植物材料以及这些的组合。</div>
<div class=""indep-clm"" num=""5"">5.用于饮料制备装置中的容器，所述容器含有根据权利要求1至4中任一项所述的饮料组合物。</div>
<div class=""indep-clm"" num=""6"">6.制备饮料组合物的方法，所述方法包括发酵水性针叶樱桃提取物，其中所述发酵通过包括毕赤酵母(Pichia)的酵母进行。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的方法，其中所述毕赤酵母是克鲁维毕赤酵母(Pichiakluyveri)。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的方法，其中所述毕赤酵母是克鲁维毕赤酵母NYSC 5485(CNCMI-5525)。</div>
<div class=""dep-clm"" num=""9"" parent=""6,7,8"">9.根据权利要求6至8中任一项所述的方法，其中所述毕赤酵母包含与SEQ ID NO:1-12的组合具有至少98％的总体核苷酸同一性的遗传序列。</div>
<div class=""dep-clm"" num=""10"" parent=""6,7,8,9"">10.根据权利要求6至9中任一项所述的方法，其中所述发酵在不存在酿酒酵母(Saccharomyces cerevisiae)的情况下进行。</div>
<div class=""dep-clm"" num=""11"" parent=""6,7,8,9"">11.根据权利要求6至9中任一项所述的方法，所述方法包括在发酵后从浸泡的针叶樱桃中分离所述水性针叶樱桃提取物。</div>
<div class=""dep-clm"" num=""12"" parent=""6,7,8,9"">12.根据权利要求6至9中任一项所述的方法，其中将在所述水性针叶樱桃提取物的所述发酵期间存在的所述浸泡的针叶樱桃与发酵后的所述水性针叶樱桃提取物一起干燥。</div>
<div class=""dep-clm"" num=""13"" parent=""6,7,8,9,10,11,12"">13.根据权利要求6至12中任一项所述的方法，其中所述饮料组合物是根据权利要求1至4中任一项所述的。</div>
<div class=""indep-clm"" num=""14"">14.用克鲁维毕赤酵母NYSC 5485(CNCMI-5525)发酵的针叶樱桃用于生产饮料的用途。</div>","A23L2/38, A23L2/84, A23L33/14, C12N1/16, C12R1/84",20241220,雀巢产品有限公司,['Pending']
US12245614B2,Use of whey protein micelles for improving insulin profile in diabetic patients,The present invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in plasma postprandial insulin and/or plasma postprandial glucagon concentration in a subject. The invention relates also to a non-therapeutic use of whey protein micelles to decrease plasma postprandial insulin and/or glucagon concentration in healthy subjects.,"<div class=""indep-clm"" num=""1""><seg-con>1. A method for decreasing plasma postprandial insulin and plasma postprandial glucagon concentration in a human subject, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the human subject a nutrition composition that is a meal replacement comprising a daily dose of whey protein micelles 30 g dry weight, lipids 11.7 g dry weight, carbohydrates 42.7 g dry weight, and fibers 6.3 g dry weight in,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the meal replacement is a liquid food product, and the meal replacement decreases the plasma postprandial insulin and the plasma postprandial glucagon concentration relative to a composition containing an equal amount of whey protein isolate.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the whey protein micelles are the only protein in the meal replacement.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the meal replacement induces a lower concentration of plasma amino acids thirty minutes after ingestion relative to a composition containing an equal amount of whey protein isolate.</seg-refi></div>","A23J1/20, A23C21/00, A23L2/52, A23L2/66, A23L33/00",20250311,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN120076789A,Slow release melatonin compositions,The present invention relates to a composition comprising melatonin encapsulated within a calcium alginate hydrogel. The invention also provides an orally administrable dosage form comprising the composition retained within a gel wherein the gel is formed using starch as a gelling agent. Methods of making these compositions and their use in therapy are also disclosed.,"<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含包封在藻酸钙水凝胶内的褪黑激素，并且任选地还包含未被所述钙包封的另外的褪黑激素。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中褪黑激素与藻酸钙水凝胶的重量比为5:95至15:85。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的组合物，其中褪黑激素与藻酸钙水凝胶的重量比为约10:90。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，基于所述组合物的总重量，所述组合物包含4wt％至10wt％的水。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的组合物，基于所述组合物的总重量，所述组合物包含6wt％至8wt％的水。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，所述组合物还包含钠离子和乳酸根离子。</div>
<div class=""indep-clm"" num=""7"">7.可口服施用的剂型，所述可口服施用的剂型包含保持在凝胶内的根据权利要求1至6中任一项所述的组合物，其中所述凝胶使用淀粉作为胶凝剂形成。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,5,7"">8.根据权利要求7所述的剂型，基于所述剂型的总重量，所述剂型包含1wt％至3wt％的根据权利要求1至6中任一项所述的组合物。</div>
<div class=""dep-clm"" num=""9"" parent=""7,8"">9.根据权利要求7或权利要求8所述的剂型，所述剂型还包含未包封在所述藻酸钙水凝胶内的褪黑激素。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的剂型，基于所述剂型的总重量，所述剂型包含0.01wt％至0.03wt％的未包封在所述藻酸钙水凝胶内的褪黑激素。</div>
<div class=""dep-clm"" num=""11"" parent=""7,8,9,10"">11.根据权利要求7至10中任一项所述的剂型，其中所述凝胶使用马铃薯淀粉作为胶凝剂形成。</div>
<div class=""dep-clm"" num=""12"" parent=""7,8,9,10,11"">12.根据权利要求7至11中任一项所述的剂型，基于所述剂型的总重量，所述剂型包含7wt％至17wt％的淀粉。</div>
<div class=""dep-clm"" num=""13"" parent=""7,8,9,10,11,12"">13.根据权利要求7至12中任一项所述的剂型，基于所述剂型的总重量，所述剂型包含8wt％至18wt％的水。</div>
<div class=""dep-clm"" num=""14"" parent=""7,8,9,10,11,12,13"">14.根据权利要求7至13中任一项所述的剂型，所述剂型还包含一种或多种甜味剂。</div>
<div class=""dep-clm"" num=""15"" parent=""14"">15.根据权利要求14所述的剂型，基于所述剂型的总重量，所述剂型包含52wt％至82wt％的所述一种或多种甜味剂。</div>
<div class=""dep-clm"" num=""16"" parent=""14,15"">16.根据权利要求14或权利要求15所述的剂型，其中所述一种或多种甜味剂选自由蔗糖和玉米糖浆组成的组。</div>
<div class=""dep-clm"" num=""17"" parent=""16"">17.根据权利要求16所述的剂型，其中所述甜味剂是蔗糖、53DE至73DE玉米糖浆和32DE至52DE玉米糖浆。</div>
<div class=""dep-clm"" num=""18"" parent=""17"">18.根据权利要求17所述的剂型，基于所述剂型的总重量，所述剂型包含26wt％至36wt％的蔗糖、18wt％至28wt％的53DE至73DE玉米糖浆和8wt％至18wt％的32DE至52DE玉米糖浆。</div>
<div class=""dep-clm"" num=""19"" parent=""7,8,9,10,11,12,13,14,15,16,17,18"">19.根据权利要求7至18中任一项所述的剂型，所述剂型还包含一种或多种酸化","A61K9/06, A61K31/198, A61K31/4045, A61K47/36, A61P25/20",20250530,雀巢产品有限公司,['Pending']
US20250241473A1,Beverage pod system,"The invention concerns n extraction device for extracting a beverage ingredient from a pod (<b>3</b>) said device comprising upstream and downstream pod enclosing parts (<b>1, 2</b>) movable between an open position for inserting and removing the pod (<b>3</b>) and a closed position for forming an extraction chamber (<b>5</b>), and wherein, in the upstream pod enclosing part (<b>1</b>), the cage (<b>21</b>) comprises: —a side wall (<b>211</b>) movable between the open position and the closed position, and —an end wall (<b>22</b>) presenting a front face (<b>22</b><i>a</i>) bearing piercing elements (<b>222</b>) and liquid outlet openings (<b>223</b>), said end wall (<b>22</b>) being movable inside the side wall (<b>211</b>), and wherein: —in the opened position for inserting and removing the pod (<b>3</b>), said end wall (<b>22</b>) is positioned at the opened front end (<b>214</b>) of the side wall, and is freely movable in direction of the back end (<b>213</b>)—in the course of the movement of the upstream enclosing part (<b>2</b>) from the opened position to the closed position, the free movement of the end wall (<b>22</b>) is automatically mechanically blocked when the chamber upstream enclosing part (<b>2</b>) reaches a pre-determined position.","<div class=""indep-clm"" num=""1""><seg-con>1. An extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod,</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>said pod </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod body, said pod body comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a side wall and a bottom wall defining a chamber, said chamber extending axially between the bottom and a top opening, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top lid closing the top opening of the pod body,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said device comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>upstream and downstream pod enclosing parts, wherein at least the upstream enclosing part is movable, along a horizontal longitudinal axis between an open position for inserting and removing the pod and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the upstream part defining a cage and comprising piercing elements for piercing the bottom wall of the pod and liquid outlet openings,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the downstream part defining a plate transverse to the longitudinal axis, said plate comprising a downstream plane piercing arrangement for opening the lid of the pod,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pod holder configured to hold the pod between the upstream and downstream pod enclosing parts when these parts are in the opened position, said holder being configured to hold the lid of the pod in front of the downstream plane piercing arrangement,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, in the upstream pod enclosing part, the cage comprises:</seg-refi></div>
<div ",A47J31/36,20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023206185B2,Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines,"A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of reducing the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>administering to the patient a specialized immunonutrition supplement comprising L-arginine, omega-3 fatty acids, and nucleotides, wherein the patient has a tumor.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of Claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the patient has or is at risk of a Staphylococcus aureus infection.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method of Claim 1 or Claim 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to removal of all or part of the tumor to a post-operative day that is three to seven days after the removal.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.     The method of any one of Claims 1 to 3 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the patient has bladder cancer</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-refi>associated with the tumor.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The method of any one of Claims 1 to 4 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement comprises L-arginine and is administered to the patient in a daily dose that provides between about 5 g and about 30 g of the L-arginine per day.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The method of any one of Claims 1 to 5 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the supplement further comprises Vitamin A.</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-con>7. Use of a specialized immunonutritio","A61K31/07, A61K31/198, A61K31/202, A61K31/70, A61P35/00",20250102,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2020210541B2,Roasting apparatus,"The invention concerns an apparatus (10) for roasting coffee beans comprising: - a housing (4), - a roasting chamber (1) presenting a bottom opening (11), - an air driver (2) configured to drive air inside the roasting chamber through the bottom opening of said chamber, - an electrical heater (3) positioned below the bottom opening of the roasting chamber, said electrical heater being configured to heat air driven inside the roasting chamber, - the air driver and the electrical heater being positioned inside the housing (4) and the housing comprising a hot air outlet hole (41) designed to enable the passage of hot air from the housing inside the bottom opening (11) of the roasting chamber, and the electrical heater (3) being positioned just below the hot air outlet hole (41), - the roasting chamber (1) being removably mounted to the housing (4), the bottom opening (11) of the roasting chamber cooperating with the hot air outlet hole (41) of the housing when the roasting chamber is mounted to the housing, wherein the apparatus comprises a movable closure device (5) configured : - to cover the hot air outlet hole (41) while the roasting chamber is being removed from the housing, and - to uncover the hot air outlet hole (41) while the roasting chamber is being mounted to the housing.","<div class=""indep-clm"" num=""1""><seg-main>1. Apparatus for roasting coffee beans comprising :</seg-main>
<seg-clauses>5   - a housing,</seg-clauses>
<seg-clauses>- a roasting chamber comprising a bottom opening,</seg-clauses>
<seg-clauses>- an air driver configured to drive air inside the roasting chamber through the bottom opening of said chamber,</seg-clauses>
<seg-clauses>- an electrical heater positioned below the bottom opening of the roasting chamber, said 0 electrical heater being configured to heat air driven inside the roasting chamber,</seg-clauses>
<seg-clauses><seg-main>- the air driver and the electrical heater being positioned inside the housing and the housing comprising a hot air outlet hole designed to enable the passage of hot air from the housing inside the bottom opening of the roasting chamber, and the electrical heater being positioned just below the hot air outlet hole,</seg-main>
<seg-main class=""seg-enter"">5   - the roasting chamber being removably mounted to the housing, the bottom opening of the</seg-main>
<seg-main class=""seg-enter"">roasting chamber cooperating with the hot air outlet hole of the housing when the roasting chamber is mounted to the housing,</seg-main>
<seg-main class=""seg-enter"">wherein the apparatus comprises a movable closure device configured:</seg-main>
<seg-clauses>- to cover the hot air outlet hole while the roasting chamber is being removed from the :0 housing, and</seg-clauses>
<seg-clauses>- to uncover the hot air outlet hole while the roasting chamber is being mounted to the housing.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Apparatus according to claim 1 wherein </seg-main><seg-clauses>the movements of the movable closure device are 25 passively mechanically actuated by the movement of removing the roasting chamber from the housing and by the movement of mounting the roasting chamber to the housing.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-mai","A23N12/08, A23F5/04, A23N12/12",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20250271432A1,"Methods of determining a health status of a cat based on one or more biomarkers, and methods of treating a mortality risk identified by the health status","The present invention provides a method for determining a mortality risk and/or probability of healthy lifespan of a cat; said method comprising determining the level of one or more biomarker(s) in one or more samples obtained from the cat, wherein the one or more biomarker(s) is selected from white blood cell count, haemoglobin, serum urea nitrogen, serum AST, serum chloride, serum total bilirubin, serum globulin, red blood cell count, serum sodium, serum cholesterol, serum potassium, serum alkaline phosphatase, and/or serum GGT.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for determining a mortality risk and/or probability of a healthy lifespan of a cat; said method comprising </seg-main><seg-clauses>determining the level of one or more biomarker(s) in one or more samples obtained from the cat, wherein the one or more biomarker(s) is selected from the group consisting of white blood cell count, haemoglobin, serum urea nitrogen, serum AST, serum chloride, serum total bilirubin, serum globulin, haematocrit, red blood cells count, serum albumin, and mean corpuscular hemoglobin concentration.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for determining a mortality risk and/or probability of a healthy lifespan of a cat; said method comprising </seg-main><seg-clauses>determining the level of one or more biomarker(s) in one or more samples obtained from the cat, wherein the one or more biomarker(s) is selected from the group consisting of white blood cell count, haemoglobin, serum urea nitrogen, serum AST, serum chloride, serum total bilirubin, serum globulin, and red blood cell count.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is white blood cell count.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is haemoglobin.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is serum urea nitrogen.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1 wherein </seg-main><seg-clauses>the biomarker is serum AST.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method according to claim 1 wherein </seg-main><seg-clauses>the method comprises determining the level of each of white blood cell","G01N33/573, G01N33/569, G01N33/68, G01N33/72, G01N33/80",20250828,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025238443A1,Identifying separation-related problems in pets,"The present disclosure relates to systems, methods, and program applications for identifying separation-related problems in a pet. The methods, for example, can include identifying the presence or absence of multiple behavioral signs exhibited by a pet where each of the multiple behavioral signs are given a sign score based on binary annotations representing either the presence or the absence of each of the behavioral signs, and grouping subsets of the multiple behavioral signs into one of multiple principal component behavioral groupings using the binary annotations to generate principal component scores for each of the multiple principal component behavioral groupings. Methods can also include using one or more machine-learning algorithms under the control of at least one processor for accessing and correlating the principal component scores for each of the multiple principal component behavioral groupings with a population cluster associated with a type of separation-related problem.","19473 CLAIMS What Is Claimed Is: <div class=""indep-clm"" num=""1""><seg-con>1. A method of generating a machine-learning workflow for identifying separation- related problems in a pet, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>identifying the presence or absence of multiple behavioral signs exhibited over a population of pets, wherein each of the multiple behavioral signs are given a sign score based on binary annotations representing either the presence or the absence of each of the behavioral signs; grouping subsets of the multiple behavioral signs into one of multiple principal component behavioral groupings using the binary annotations to generate principal component scores for each of the multiple principal component behavioral groupings for at least a plurality of pets across the population of pets; correlating the principal component scores for each of the multiple principal component behavioral groupings across the plurality of pets, each pet of the plurality of pets being assigned to a population cluster associated with a type of separation-related problem for the plurality, wherein the population cluster for each of the plurality of pets has a better fit for the separation- related problem than other population clusters associated with other types of separation-related problems; and training an artificial intelligence with one or more machine-learning algorithms under the control of at least one processor using a training dataset loaded on a memory device, wherein the training dataset is based on the principal component scores related to the plurality of pets as correlated with the population clusters. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>training the artificial intelligence includes finding or optimizing a machine-learning pipeline.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>19473 </seg-refi></div><div class=""dep-clm""",A01K29/00,20251120,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
WO2025026960A1,Capsule for the preparation of a beverage,"A biodegradable and/or compostable capsule for use with a beverage preparation machine for preparing a beverage and/or foodstuff thereof is disclosed. The capsule comprises a cup-shaped body and a closing membrane for closing the cup-shaped body, both elements defining a closed cavity for a beverage and/or foodstuff ingredient, preferably roast and ground coffee, and a liner or a coating having barrier function, providing barrier function to the cup-shaped body. The cup-shaped body is made of cellulose-based material, preferably molded pulp-based material and comprises a bottom wall, a tubular lateral side wall, an annular flange connected to the lateral wall for the closing membrane to seal thereon, and an outwardly extending rim portion connected to the annular flange. The annular flange is made of cellulose-based material and comprises a first portion in which the cellulose-based material has a porosity comprised between 30% and 70%, preferably between 50% and 70% and the first portion of the annular flange cooperates with an edge of a capsule enclosing member of the beverage preparation machine for improving leak tightness during the preparation of the beverage.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A capsule for use with a beverage preparation machine (10) for preparing a beverage and/or foodstuff thereof, the capsule is biodegradable and/or compostable and comprises: </seg-main><seg-clauses>a cup-shaped body (1) and a closing membrane (2) for closing the cupshaped body (1), the cup-shaped body (1) and the closing membrane </seg-clauses><seg-clauses>(2) defining a closed cavity for holding a beverage and/or foodstuff ingredient, preferably roast and ground coffee, and a body liner (20) or a coating having barrier function providing barrier function to the cup-shaped body (1); said cup-shaped body (1) is made of cellulose-based material, preferably pulp-base material, and comprises a bottom wall (4), a tubular lateral side wall (5), an annular flange (3) connected to the lateral wall (5) for the closing membrane (2) to seal thereon, and an outwardly extending rim portion (6) connected to the annular flange (3), characterized in that the annular flange (3) is made of cellulose-based material and comprises a first portion (3A) in which the cellulose-based material has a porosity comprised between 30% and 70%, preferably between 50% and 70%, said first portion (3A) of the annular flange (3) cooperating with an edge (8) of a capsule enclosing member (9) of the beverage preparation machine (10) for improving leak tightness during the preparation of the beverage.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The capsule according to claim 1, characterized in that </seg-main><seg-clauses>the first portion (3A) of the annular flange (3) extends from the side wall (5) and is integral with both the side wall (5) and the annular flange (3) of the capsule.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The capsule according to any of claims 1 or 2, wherein </seg-main><seg-clauses><seg-main>the first portion (3A) extends on the annular flange (3) over a radial distance ",B65D85/804,20250206,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2023398740A1,"A process and composition for preparing a hydrolyzed low fat coconut product, useful for example, as a beverage or as a powder for deserts and cooking","The present invention relates to a process and composition for preparing a hydrolyzed coconut product. The process of the present invention comprises the steps of enzymatically hydrolyzing a wet pressed coconut cake and liquefying the wet pressed coconut cake. Advantageously, the subject matter of the present invention allows it, for example, to use side streams of coconut processes i.e., wet pressed coconut cake and coconut water or water to prepare a low fat containing hydrolyzed coconut product.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for making a low-fat coconut product comprising the steps of:</seg-main>
<seg-clauses>a) Adding coconut water or water or a combination thereof to a wet pressed coconut cake, wherein the wet pressed coconut cake has a moisture content of 20 to 55 weight-% (based on total composition of the wet pressed coconut cake);</seg-clauses>
<seg-clauses>b) enzymatically hydrolyzing the aqueous mixture of wet pressed coconut cake; </seg-clauses><seg-clauses>c) liquefying the aqueous mixture of wet pressed coconut cake;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the enzymatic hydrolysis is carried out by an enzyme selected from a combination of cellulases, mannanases, glucanases and xylanases.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process according to one of claims 1, wherein </seg-main><seg-clauses>the low-fat coconut product has a fat content from 1-20 weight-%, preferably from 1-13 weight-%.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The process according to claim 1-2, wherein </seg-main><seg-clauses>the amount of coconut water or water or combination thereof before adding the enzymes is between 20 to 90 weight-% and the amount of wet pressed coconut cake before adding the enzymes is between 10 to 80 weight-%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The process according to claim 1-3, wherein </seg-main><seg-clauses>the enzymatic hydrolysis is carried out by the enzyme selected from a combination of cellulases, mannanases, glucanases and xylanases in an amount of 0.2 to 5 weight-%, preferably from 0.5 to 3 weight-% (based on aqueous mixture).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The process according to claim 1-4, wherein </seg-main><seg-clauses>the enzymatic hydrolysis is carried out at a temperature between 40 to 70°C for 30 to 180min.</seg-clauses></div>
<div cla","A23L5/20, A23L19/00, A23L25/00, C11B1/06",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025238243A1,Pectin emulsion hydrocolloid-based gel composition for a confectionery product,"The invention relates to a hydrocolloid-based gel composition for a confectionery product, said composition comprising 0.5 – 3.5 wt% pectin, wherein the pectin is equal or greater than 50% methylesterified; 5 – 20 wt% oil or melted fat; 0 – 0.15 wt% divalent ions, preferably calcium or magnesium ions; not less than 55 wt% sugars, preferably sucrose, maltose, glucose syrup, and/or maltodextrin; water; and wherein the composition has a pH not greater than pH 4.5, preferably a pH between 2.0 to 4.5.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A hydrocolloid-based gel composition for a confectionery product, said composition comprising</seg-main>
<seg-clauses>0.5 - 3.5 wt% pectin, wherein the pectin is equal or greater than 50% methylesterified;</seg-clauses>
<seg-clauses class=""seg-enter"">5 - 20 wt% oil or melted fat;</seg-clauses>
<seg-clauses class=""seg-enter"">0 - 0.15 wt% divalent ions, preferably calcium or magnesium ions; not less than 55 wt% sugars, preferably sucrose, maltose, glucose syrup, and/or maltodextrin;</seg-clauses>
<seg-clauses class=""seg-enter"">Water; and wherein the composition has a pH not greater than pH 4.5, preferably a pH between 2.0 to 4.5.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the pectin equal or greater than 60% methylesterified, most preferably equal or greater than 70% methylesterified.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the composition comprises between 1.5 to 3.5 wt% pectin, or between 1.5 to </seg-clauses><seg-clauses>2.5 wt% pectin.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the pectin comprises between 15 to 80% galacturonic acid.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the composition comprises between 10 to 20 wt% oil or melted fat.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any one of claims 1 to 5, wherein </seg-main><seg-clauses>the pectin is citrus pectin or a mixture of citrus pectin and apple pectin.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-m","A23G1/40, A23G3/42, A23L29/231",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025132744A1,Machine with whisk retainer,,"CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A machine (60, 66) for processing a liquid food substance,such as milk or a milk-based substance, comprising:</seg-main><seg-clauses>- a jug (10) having a container (12) delimiting a food cavityfor containing said liquid food substance, such as a container (12) provided with a removable lid (14) for covering the food cavity;</seg-clauses><seg-clauses>- an impeller (30) removably received by the container (12) andconfigured for driving said liquid food substance in the container (12); and</seg-clauses><seg-clauses><seg-main>- a base (62) having one or more walls forming a seat forremovably receiving the container (12), the base including a motor with a magnetic drive magnetically coupled to the impeller (30) for driving the same, wherein</seg-main><seg-clauses>- the container (12) includes a first magnetic element (38)coupled thereto,</seg-clauses><seg-clauses>- the impeller (30) includes a second magnetic element (40),and</seg-clauses><seg-clauses>- the first magnetic element (38) and the second magneticelement (40) are configured to be magnetically coupled so as to retain the impeller (30) in the container (12).</seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The machine (60, 66) of claim 1, wherein</seg-main><seg-clauses>- one of the first magnetic element (38) and the second magneticelement (40) is a coupling magnetic-field generating element and the other one of the first magnetic element (38) and the second magnetic element (40) is a ferromagnetic element that is configured to be magnetically coupled to the coupling magnetic-field generating element, or</seg-clauses><seg-clauses>- the first magnetic element (38) and the second magneticelement (40) are each coupling magnetic-field generating elements and configured to be magnetically coupled to one another in a mutually attracting orientation.</seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The machi",A47J43/046,20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2024235840A1,An extrusion process for preparing a food flavor product,"The invention relates generally to an extrusion process for preparing a food flavor product. More specifically, the present invention relates to an extrusion process for preparing a food flavor product wherein at least one vent stuffer is located within the last 2/3 part of the total length of the extruder barrel.","<div class=""indep-clm"" num=""1""><seg-main>1. An extrusion process for preparing a food flavor product comprising the steps of:</seg-main>
<seg-clauses>a) feeding an extruder barrel (7) with a composition comprising at least one carrier, at least one amino nitrogen source and at least one sugar source;</seg-clauses>
<seg-clauses><seg-main>b) extruding the composition from step </seg-main><seg-clauses>a) at a temperature between 35 to 170°C, wherein at least one vent stuffer is located within the last 2/3 part of the total length of the extruder barrel.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The extrusion process for preparing a food flavor product as claimed in claim 1, wherein </seg-main><seg-clauses>the carrier is selected from the group of maltodextrin, starch, flour, salt, fibers or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 2, wherein </seg-main><seg-clauses>the food flavor product comprises the carrier in an amount of 5-95wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 3, wherein </seg-main><seg-clauses>the amino nitrogen source is selected from the group of cysteine, methionine, arginine, glutathione, asparagine, glutamic acid, lysine, glutamine, thiamine, alanine, glycin, threonine, plant protein, yeast extract, bacterial extract, vegetable extract, hydrolyzed plant protein or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The extrusion process for preparing a food flavor product as claimed in any one of the claims 1 to 4, wherein </seg-main><seg-clauses>the</seg-clauses>
<seg-clauses class=""seg-enter"">food flavor product comprises the amino nitrogen source in an amount of 0.1-","A23L27/26, A23L27/21",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250344899A1,Fluid flow,"A method for estimating a volume of liquid output from an electric pump during an operation period of the electric pump, the method comprising: determining a current delay of the pump, wherein the current delay is a period between a first time corresponding to a first current drawn by the pump, and a second time corresponding to a second current drawn by the pump; and generating, based on the current delay, an estimate of the volume of liquid output from the electric pump during the operation period.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for estimating a volume of liquid output from an electric pump during an operation period of the electric pump, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>determining a current delay of the pump, wherein the current delay is a period between a first time corresponding to a first current drawn by the pump, and a second time corresponding to a second current drawn by the pump; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>generating, based on the current delay, an estimate of the volume of liquid output from the electric pump during the operation period.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the first current substantially corresponds to a zero-crossing of an alternating supply voltage supplied to the pump.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>further comprising:</seg-trans></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-refi>determining an average of an alternating supply voltage supplied to the electric pump, wherein generating the estimate of the volume is further based on the average of the alternating supply voltage.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>determining the current delay of the pump comprises:</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>determining the first time based on measurements of an alternating supply voltage supplied to the pump during the operation period;</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>determining the second time based on measurements of a current drawn by the pump during the operation period; and</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>calculat","A47J31/46, A47J31/52, G01F9/00",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119700815A,Compositions comprising minerals and uses thereof,"The present invention relates to a composition comprising one or more mineral nutrients selected from the group consisting of iron, zinc, calcium, phosphorus, copper, magnesium, iodine, manganese, chlorine, potassium, sodium, selenium, chromium and combinations thereof, the compositions are used to promote, support or optimize one or more of the following: (i) de novo myelination; (ii) brain structure; (iii) brain connection; (iv) intellectual potential; (v) cognitive potential; (vi) learning potential; and (vii) cognitive function, wherein the composition is for administration to the female subject.","<div class=""indep-clm"" num=""1"">1.一种组合物，所述组合物包含一种或多种矿物质，用于促进、支持或优化雌性个体的后代的以下各项中的一个或多个：</div>
<div class=""indep-clm"" num=""1"">(i)从头髓鞘形成；</div>
<div class=""indep-clm"" num=""1"">(ii)脑结构；</div>
<div class=""indep-clm"" num=""1"">(iii)脑连接；</div>
<div class=""indep-clm"" num=""1"">(iv)智力潜能；</div>
<div class=""indep-clm"" num=""1"">(v)认知潜能；</div>
<div class=""indep-clm"" num=""1"">(vi)学习潜能；以及</div>
<div class=""indep-clm"" num=""1"">(vii)认知功能，</div>
<div class=""indep-clm"" num=""1"">其中所述组合物用于施用于所述雌性个体，并且其中所述后代为胎儿、新生儿、婴儿或儿童，并且其中所述组合物用于在孕前、怀孕期间或泌乳期间或它们的组合施用于所述雌性个体。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述组合物包含一种或多种矿物质营养物质，所述一种或多种矿物质营养物质选自铁、锌、钙、磷、铜和镁。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据任一前述权利要求所述的组合物，其中所述组合物促进、支持或优化整个脑的有髓鞘物质的量和/或空间分布。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的组合物，其中所述组合物促进、支持或优化从头髓鞘形成轨迹。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的组合物，其中所述雌性个体为人类。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的组合物，其中所述组合物还包含以下成分中的一种或多种：维生素、磷脂或其代谢物或代谢前体、脂肪酸衍生物和胆碱。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的组合物，其中所述磷脂选自：磷脂酰胆碱、磷脂酰肌醇、磷脂酰丝氨酸、磷脂酰乙醇胺、鞘磷脂以及它们的混合物、以及前述物质中任一者的代谢前体和代谢物、以及它们的混合物。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的组合物，其中所述组合物为孕前(怀孕之前)补充剂和/或母体补充剂(怀孕和/或泌乳补充剂)的形式。</div>
<div class=""indep-clm"" num=""9"">9.一种或多种矿物质营养物质，所述一种或多种矿物质营养物质选自铁、锌、钙、磷、铜、镁以及它们的组合，用于促进、支持或优化雌性个体的后代的以下各项中的一个或多个：</div>
<div class=""indep-clm"" num=""9"">(i)从头髓鞘形成；</div>
<div class=""indep-clm"" num=""9"">(ii)脑结构；</div>
<div class=""indep-clm"" num=""9"">(iii)脑连接；</div>
<div class=""indep-clm"" num=""9"">(iv)智力潜能；</div>
<div class=""indep-clm"" num=""9"">(v)认知潜能；</div>
<div class=""indep-clm"" num=""9"">(vi)学习潜能；以及</div>
<div class=""indep-clm"" num=""9"">(vii)认知功能，</div>
<div class=""indep-clm"" num=""9"">其中所述矿物质营养物质用于在孕前、怀孕期间或泌乳期间或它们的组合施用于所述雌性个体。</div>
<div class=""indep-clm"" num=""10"">10.一种促进、支持或优化雌性个体的后代的以下各项中的一个或多个的方法：</div>
<div class=""indep-clm"" num=""10"">(i)从头髓鞘形成；</div>
<div class=""indep-clm"" num=""1","A61K33/42, A61K33/26, A61K33/30, A61K33/06, A61K33/34",20250328,雀巢产品有限公司,['Pending']
US20250026560A1,Beverage or foodstuff container and preparation system,"A container for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including: a storage portion for containing a precursor material, a closing member to close the storage portion and an annular flange-like rim comprising an annular force ring made of a wood pulp-based material, wherein the annular force ring is of essentially S-shaped when seen in transversal cross-section. A set of different containers is also proposed as well as a container system and a system comprising a container and a beverage preparation machine.","<div class=""indep-clm"" num=""1""><seg-con>1. A container designed for insertion in and use with a preparation machine for preparing a beverage and/or foodstuff or a precursor thereof from a precursor material stored in the container by introducing liquid in the container and passing liquid through the precursor material, the container </seg-con><seg-trans>including:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container body comprising a bottom end and an open end, the container body forming a storage portion for containing the precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion at the open end of the container body; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an annular flange-like rim at least partially made of cellulose pulp-based material, extending outwardly from the container body and connecting the storage portion and the closing member, the rim having at least a flat segment and comprising an annular force ring designed for being engaged by an enclosing member of the preparation machine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the annular force ring is made of cellulose pulp-based material and is of essentially S-shaped when seen in transversal cross-section, comprising at least:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first portion linked to the flat segment of the rim, and forming with said flat segment an angle comprised between 2° and 85°; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a second portion extending from the first portion on the side opposite the flat segment of the rim, said second portion comprising at least a flat and/or curved extension.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the annular force ring comprises a third portion extending between the flat segment of the flang","B65D85/804, A47J31/36, A47J31/44",20250123,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2020214721B2,"Syrup binder system for preparing food, and preparation process and use thereof","The present invention relates to the food field. Specifically, the present invention relates to a syrup binder system for preparing a food containing extruded or puffed cereal and/or nuts, such as compound sachima (complexed sachima), cereal bars, crunchy rice candy or nut bars, etc., a preparation process and use thereof, and a food containing the syrup binder system.","<div class=""indep-clm"" num=""1""><seg-main>1. Syrup binder system for food, which binder system comprises </seg-main><seg-clauses>a sugar, a polyol, dietary fiber having water holding capacity greater than 8 ml/g, preferably of 8-15 mg/g, and more preferably of 9-14 mg/g, an emulsifier, edible oil, and water.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Syrup binder system according to claim 1, further comprising </seg-main><seg-clauses>cellulose or a derivative thereof, e.g., cellulose ether, cellulose ester, or cellulose ether ester, preferably cellulose ether, e.g., carboxymethylcellulose or a derivative thereof, e.g., a salt, such as sodium carboxymethylcellulose or calcium carboxymethylcellulose; preferably, the cellulose or the derivative thereof is present in an amount of 0.002-2 wt%, preferably 0.005-1.5 wt % and more preferably 0.011 wt % based on the total weight of the syrup binder system.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Syrup binder system according to any one of the preceding claims, wherein </seg-main><seg-clauses>the polyol is a polyol having 2-5 hydroxy groups, preferably a polyol having 2-5 hydroxy groups and 3-5 carbon atoms, such as dihydric alcohol, e.g., propylene glycol, and trihydric alcohol, e.g. glycerol; preferably, the polyol is present in an amount of 1-25 wt%, preferably 5-20 wt % and more preferably 6-15 wt % based on the total weight of the syrup binder system.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Syrup binder system according to any one of the preceding claims, wherein </seg-main><seg-clauses>the dietary fiber is present in an amount of 0.1-8 wt%, preferably 0.2-6 wt% and more preferably 0.5-5 wt% based on the total weight of the syrup binder system; preferably, the dietary fiber is selected from one or more of citric fiber, soy fiber, potato fiber, and wax gourd fiber.</seg-clauses>
<seg-clauses class=""seg-enter"">2020214721  1","A23G3/34, A23G3/48, A23L7/109, A23L7/126, A23L25/00",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120077142A,Biorecycling polyester to PHA,"The present invention provides a method of producing a polyhydroxyalkanoate (PHA) from polyester waste, the method comprising the steps of: (a) providing a culture solution comprising polyester waste; and (b) culturing a microorganism in the culture solution to produce PHA.","<div class=""indep-clm"" num=""1""><seg-con>1.用于由聚酯废物产生多羟基链烷酸酯(PHA)的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>(a)提供包含聚酯废物的培养液；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>(b)在所述培养液中培养微生物以产生PHA，其中所述微生物利用来自所述聚酯废物的多种聚酯单体来产生所述PHA。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述微生物来自副球菌属，任选地其中所述微生物是脱氮副球菌。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的方法，其中所述微生物是脱氮副球菌DSM 413或其衍生物，任选地其中所述微生物是脱氮副球菌DSM 413、脱氮副球菌PD1222、脱氮副球菌CNCM I-5881、脱氮副球菌ATCC 19367、脱氮副球菌ATCC 17741、脱氮副球菌ATCC 13543、脱氮副球菌NCIB 8944、脱氮副球菌NRRL B-3785、脱氮副球菌CCM 982、脱氮副球菌LMD 22.21、脱氮副球菌JCM 21484、脱氮副球菌NBRC 102528和脱氮副球菌NCCB 22021。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的方法，其中所述聚酯废物包含选自以下项的两种或更多种、三种或更多种、四种或更多种、五种或更多种、六种或更多种、或七种或更多种聚酯单体：琥珀酸、乳酸、乙二醇、己二酸、6-羟基己酸、3-羟基丁酸、3-羟基戊酸和1,4-丁二醇。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的方法，其中所述聚酯废物被预处理，任选地其中所述聚酯废物被机械处理和/或化学处理。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的方法，其中所述微生物在缺氧条件下培养，任选地其中培养单个微生物菌株并且/或者其中所述方法包括单个培养步骤。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的方法，其中在所述培养期间利用至少约50重量％、至少约60重量％、至少约70重量％、至少约75重量％或至少约80重量％的所述聚酯废物。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中所述PHA包含聚羟基丁酸酯(PHB)或其共聚物和/或聚羟基戊酸酯(PHV)或其共聚物，或者由聚羟基丁酸酯(PHB)或其共聚物和/或聚羟基戊酸酯(PHV)或其共聚物组成，任选地其中所述PHA包含聚(3-羟基丁酸酯-共-3-羟基戊酸酯)(PHBV)，或者由聚(3-羟基丁酸酯-共-3-羟基戊酸酯)(PHBV)组成。</div>
<div class=""indep-clm"" num=""9"">9.包含聚酯废物和微生物的培养液，其中所述微生物能够利用来自所述聚酯废物的多种聚酯单体来产生PHA。</div>
<div class=""indep-clm"" num=""10"">10.多羟基链烷酸酯(PHA)，所述PHA通过根据权利要求1至8中任一项所述的方法产生。</div>
<div class=""indep-clm"" num=""11"">11.制品，所述制品包含根据权利要求10所述的PHA，或由根据权利要求10所述的PHA组成。</div>
<div class=""indep-clm"" num=""12"">12.微生物用于由聚酯废物产生多羟基链烷酸酯(PHA)的用途，其中所述微生物利用来自所述聚酯废物的多种聚酯单体来产生所述PHA。</div>
<div class=""indep-clm"" num=""13"">13.用于由聚酯废物产生多羟基链烷酸酯(PHA)的微生物，所述微生物包含编码用于利用多种聚酯单体的途径和用于合成PHA的途径的基因，其中所述微生物已经被遗传工程化以表达所述途径中的一条或多条途径的至少一部分。</","C12P7/625, C08L67/00, C07K14/195, C12R1/01",20250530,雀巢产品有限公司,['Pending']
US20250040561A1,"Fermented beverage composition comprising nuts, optionally seeds, and legume","The invention relates to a fermented plant-based beverage composition comprising nuts, optionally seeds, and legumes, the nuts, optionally seeds and legumes present 25 to 50 wt. % of the total solids in the beverage composition, at least 50 wt. % of the nuts are roasted, preferably least 50 wt. % of the nuts and optionally seeds are roasted, and at least 50 wt. % of the nuts and seeds are milled wholesome nuts and seeds, and wherein the beverage composition being fermented with strains comprising lactic acid bacteria 1) <i>Lactobacillus delbrueckii </i>subsp. <i>bulgaricus </i>and 2) <i>Streptococcus thermophilus</i>, and having a pH of 4.0 to 5.5, preferably a pH of 4.2-4.5. The invention also relates to a process of making such a beverage.","<div class=""indep-clm"" num=""1""><seg-main>1. A fermented plant-based beverage composition comprising </seg-main><seg-clauses><seg-main>nuts and legumes,</seg-main>
<seg-main class=""seg-enter"">the nuts and legumes present 25 to 50 wt. % of the total solids in the beverage composition,</seg-main>
<seg-main class=""seg-enter"">at least 50 wt. % of the nuts are roasted, and</seg-main>
<seg-main class=""seg-enter"">at least 50 wt. % of the nuts, and wherein</seg-main>
<seg-main class=""seg-enter"">the beverage composition being fermented with strains comprising lactic acid bacteria </seg-main><seg-clauses>1) <i>Lactobacillus delbrueckii </i></seg-clauses><seg-clauses>subsp. <i>bulgaricus </i>and </seg-clauses><seg-clauses>2) <i>Streptococcus thermophilus</i>, and having a pH of 4.0 to 5.5, preferably a pH of 4.2-4.5.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A fermented beverage composition according to claim 1, comprising </seg-main><seg-clauses>5-20 wt. % total solids (TS).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses><seg-main>the fermented beverage composition comprises </seg-main><seg-clauses>0.5-3 wt. % legumes.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses>the legumes are selected from the group consisting of pea, soy, faba, chickpea and a combination thereof, wherein the legumes are preferably in the form of protein isolates or concentrates.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A fermented beverage composition according to claim 1, wherein </seg-main><seg-clauses>nuts are present in amounts of 1 to 6 wt. %.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A fermented beverage composition according to claim 1, comprising </seg-ma","A23C11/10, A23C9/127",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119698380A,System and method for preparing compostable capsules from paper material for beverage preparation,"The present invention relates to a system (100) for preparing compostable capsules (900) for brewing products. Wherein the capsule (900) is made of a sheet (600) made of a biodegradable cellulose-based material. The system (100) comprises at least one forming line (200) comprising a handling unit (300) for conveying a sheet (600) through the system (100) in a conveying direction (TD). The forming line (200) further comprises a humidification unit (400) for wetting at least one side of the sheet (600) with a wetting agent (401), and a forming unit (800) for forming a portion of the wetted sheet (600) into a three-dimensional shape to form an encapsulation element (910) defining an encapsulation cavity (911). The portion (642) is located between opposite lateral side edge sections (631, 632) of the sheet (600) with respect to the transport direction (TD). The forming line (200) further comprises a transverse drying unit (500) arranged to dry the opposite transverse side edge sections (631, 632) of the wet sheet (641) while keeping at least the portion (642) to be formed wet. Wherein the transverse drying unit (500) is arranged downstream of the humidifying unit (400) and upstream of the forming unit (800). The invention also relates to a method for preparing a compostable capsule (900) in which the opposite lateral side edge sections (631, 632) of a wet sheet (641) are dried while at least the portion (642) to be formed is kept wet prior to forming the portion (642) of the wet sheet (641).","<div class=""indep-clm"" num=""1""><seg-con>1.用于从由优选地可生物降解的纤维素基材料制成的片材(600)制备用于冲泡产品的可堆肥囊包(900)的系统(100)，所述系统(100)包括至少一条成形线(200)，所述至少一条成形线</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>●操纵单元(300)，所述操纵单元用于沿着传送方向(TD)传送所述片材(600)通过所述系统(100)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>●加湿单元(400)，所述加湿单元用于使用湿润剂(401)来湿润所述片材(600)的至少一侧；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>●成形单元(800)，所述成形单元用于将湿润片材(641)的部分(642)成形为三维形状，以形成限定囊包腔(911)的囊包元件(910)，所述部分(642)位于所述片材(600)的相对于所述传送方向(TD)的相对的横向侧边缘区段(631,632)之间；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述至少一条成形线(200)还包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>●横向干燥单元(500)，所述横向干燥单元被布置成干燥所述湿润片材(641)的所述相对的横向侧边缘区段(631,632)，同时至少保持待成形的所述部分(642)湿润，所述横向干燥单元位于所述加湿单元(400)的下游和所述成形单元(800)的上游。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统(100)，其中所述操纵单元(300)包括夹紧元件(310)，并且其中所述夹紧元件(310)被构造成在所述片材(600)的相对于所述传送方向(TD)的所述相对的横向侧边缘区段(631,632)处夹紧所述片材(600)。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的系统(100)，其中所述夹紧元件(310)能够沿传送方向(TD)移动，并且其中所述夹紧元件(310)被构造成在所述片材(600)的相对于所述传送方向(TD)的所述相对的横向侧边缘区段(631,632)处夹紧所述片材(600)，从而使得能沿所述传送方向(TD)传送夹紧的片材(600)通过所述系统(100)。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或权利要求3所述的系统(100)，其中所述横向干燥单元(500)被布置成在由所述夹紧元件(310)夹紧之前或期间干燥所述湿润片材(641)的所述相对的横向侧边缘区段(631,632)，同时至少保持待成形的所述部分(642)湿润，其中优选地，所述横向干燥单元(500)与所述夹紧元件(310)成一体。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的系统(100)，其中所述横向干燥单元(500)包括热风鼓风机和/或加热元件(510)，其中优选地，所述夹紧元件(310)，如果存在的话，包括所述加热元件(510)。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的系统(100)，其中所述横向干燥单元(500)设置在用于将所述片材(600)进给到系统(100)中的进给区段与所述夹紧元件(310)之间。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的系统(100)，其中所述加湿单元(400)被布置成在所述片材(600)优选地被水平传送通过所述加湿单元(400)的情况下仅湿润所述片材(600)的一侧，优选湿润所述片材(600)的下侧(601)。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的系统(100)，其中所述加湿单元(","B65B9/04, B65B9/08, B65B29/02, B65B29/08",20250325,雀巢产品有限公司,['Pending']
CN119300723A,Non-alkalized boiled cocoa powder,"The present invention relates to non-alkalized, boiled and baked cocoa solids comprising less than 0.14% by weight of caffeine and less than 1.2% by weight of theobromine, preferably less than 0.9% by weight of theobromine. The invention also relates to cocoa beverage liquids and powders having these characteristics. Furthermore, the present invention relates to a process for preparing a non-alkalized, boiled and baked cocoa solid comprising: providing cocoa crumbs, boiling the cocoa crumbs at a pressure of 1.5 bar to 4 bar for a time period of 10 min to 60 min, filtering the boiled cocoa crumbs to a moisture content of 30% to 80% by weight, preferably 50% to 75% by weight, and drying the cocoa crumbs to obtain the non-alkalized, boiled and baked cocoa solid. The invention relates to a method for producing cocoa cakes, comprising the following steps: boiling a plurality of crumbles, baking the boiled crumbles to a moisture content of less than 4% by weight, and grinding the baked crumbles to provide cocoa liquor, pressing to obtain cocoa cakes, preferably having a fat level of 10% to 12% by weight or fat of 20% to 22% by weight, and grinding the cocoa cakes into cocoa solids.","<div class=""indep-clm"" num=""1"">1.非碱化的、煮沸和烘烤的可可固体，所述可可固体包含</div>
<div class=""indep-clm"" num=""1"">低于0.14重量％的咖啡因和</div>
<div class=""indep-clm"" num=""1"">低于1.2重量％的可可碱，优选地低于0.9重量％的可可碱。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的非碱化的、煮沸和烘烤的可可固体，所述可可固体包含0.05重量％至0.14重量％的咖啡因和0.5重量％至1.2重量％的可可碱。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的可可固体，其中所述可可固体包含5重量％至25重量％、优选地10重量％至12重量％的可可脂或20重量％至22重量％的可可脂。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据前述权利要求中任一项所述的可可固体，所述可可固体具有至少(43，13，20)的颜色LAB最小值。</div>
<div class=""indep-clm"" num=""5"">5.可可饮料粉末，所述可可饮料粉末包含</div>
<div class=""indep-clm"" num=""5"">根据前述权利要求中任一项所述的可可固体，以及</div>
<div class=""indep-clm"" num=""5"">1重量％至75重量％的添加的蔗糖。</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">6.根据前述权利要求中任一项所述的可可饮料粉末，所述可可饮料粉末包含：</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">10重量％至75重量％的根据权利要求1至4所述的可可固体</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">0重量％至35重量％的非脂乳固体，</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">0重量％至2.0重量％的植物油和/或乳脂，</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">0重量％至80重量％的蔗糖，以及</div>
<div class=""dep-clm"" num=""6"" parent=""3,4,5"">0重量％至50重量％的谷物粉或提取物。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的可可饮料粉末，所述可可饮料粉末包含：</div>
<div class=""dep-clm"" num=""7"" parent=""6"">25重量％至55重量％的可可固体，</div>
<div class=""dep-clm"" num=""7"" parent=""6"">20重量％至35重量％的非脂乳固体，</div>
<div class=""dep-clm"" num=""7"" parent=""6"">0重量％至2.0重量％的植物油和/或乳脂，</div>
<div class=""dep-clm"" num=""7"" parent=""6"">5重量％至35重量％的蔗糖，以及</div>
<div class=""dep-clm"" num=""7"" parent=""6"">5重量％至35重量％的谷物粉或提取物。</div>
<div class=""indep-clm"" num=""8"">8.液体可可饮料产品，所述液体可可饮料产品包含：</div>
<div class=""indep-clm"" num=""8"">1重量％至5重量％的根据权利要求1至4所述的可可固体，</div>
<div class=""indep-clm"" num=""8"">3重量％至10重量％的非脂乳固体，以及</div>
<div class=""indep-clm"" num=""8"">0重量％至5重量％的蔗糖。</div>
<div class=""indep-clm"" num=""9"">9.液体可可饮料产品，所述液体可可饮料产品包含：</div>
<div class=""indep-clm"" num=""9"">1重量％至5重量％的根据权利要求1至4所述的可可固体</div>
<div class=""indep-clm"" num=""9"">4重量％至12重量％的基于植物的细粉，以及</div>
<div class=""indep-clm"" num=""9"">0重量％至","A23G1/00, A23G1/30, A23G1/32, A23G1/56, A23G1/36",20250110,雀巢产品有限公司,['Inactive']
US20240408044A1,composition,"The present invention relates to an amino acid composition comprising threonine, serine, proline, leucine, and cysteine for use in preventing and/or reducing glutamine deficiency and/or arginine deficiency in a subject. The present invention also relates to an enteral nutritional composition comprising threonine, serine, proline, leucine, and cysteine and a method for producing the same.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in preventing and/or reducing glutamine deficiency and/or arginine deficiency in a subject comprising </seg-main><seg-clauses>administering an amino acid composition comprising threonine, serine, proline, leucine, and cysteine to the subject.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for use in preventing and/or reducing muscle loss in a subject, wherein </seg-main><seg-clauses>the subject is at risk of or has a glutamine deficiency and/or an arginine deficiency comprising administering an amino acid composition comprising threonine, serine, proline, leucine, and cysteine to the subject.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. Method according to claim 1, wherein </seg-main><seg-clauses>the subject is a critically ill patient and has a condition selected from the group consisting of: sepsis, acute respiratory failure, trauma, surgery, shock, pancreatitis, severe burns, mucositis, inflammatory bowel disease, distorted gut barrier, intestinal mucosal lesions, and short-bowel syndrome.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition improves muscle mass and/or strength.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition is administered by enteral administration.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition is in a form selected from the group consisting of a nutritional composition, supplement, and fortifier.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. Method according to claim 1, wherein </seg-main><seg-clauses>the subject is administered each of threonine, serine, proline, leucine, a","A61K31/198, A61P21/00",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019398887B2,Methods for increasing fat oxidation or energy expenditure or satiety in an animal,"The present disclosure provides compositions and methods for increasing fat oxidation or energy expenditure or satiety in an animal comprising administering a non-ketogenic composition to the animal, wherein the non-ketogenic composition comprises about 5% to about 25% carbohydrates, about 30% to about 60% protein, and about 10% to about 40% fat. Additionally, the composition can have a protein to carbohydrate ratio of at least 2:1.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of providing a health benefit to a canine that </seg-con><seg-trans>comprises </seg-trans><seg-refi>at least one of reducing body fat, reducing weight, or reducing weight gain in the canine, by increasing fat oxidation or energy expenditure in the canine, the method comprising administering a dietary regimen in combination with a non-ketogenic food composition to the canine, wherein the at least one of reducing body fat, reducing weight, or reducing weight gain is relative to a level of body fat, weight or weight gain from the dietary regimen prior to the administering of the non-ketogenic food composition to the canine, wherein the non-ketogenic food composition comprises: from 30% to 65% protein, from 5% to 21% carbohydrate, and from 10% to 40% fat;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the non-ketogenic food composition has a protein to carbohydrate ratio of 2:1 to 3:1.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A method of at least one of reducing body fat, reducing weight, or reducing weight gain in a canine by increasing satiety in the canine, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a dietary regimen in combination with a non-ketogenic food composition to the canine, wherein the at least one of reducing body fat, reducing weight, or reducing weight gain is relative to a level of body fat, weight or weight gain from the dietary regimen prior to the administering of the non-ketogenic food composition to the canine, wherein the non-ketogenic food composition comprises: from 30% to 65% protein, from 5% to 21% carbohydrate, and from 10% to 40% fat;</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>wherein the non-ketogenic food composition has a protein to carbohydrate ratio of 2:1 to 3:1.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method of claim 1 or claim 2, </seg-con><seg-trans>wherein </","A23K10/00, A23L33/00",20250109,SOCIETE DES PRODUITS NESTLE SA,['Active']
AU2023214399B2,Compositions and their use,"Abstract: A synthetic nutritional composition comprising a vitamin for use to promote, support or optimise de nova myelination, in particular the de nova myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject. Abstract: A synthetic nutritional composition comprising a vitamin for use to promote, support or optimise de nova myelination, in particular the de nova myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive 2023214399 14 Aug 2023 potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.","<div class=""indep-clm"" num=""1""><seg-main>1. Use of a synthetic nutritional composition comprising </seg-main><seg-clauses>vitamin B12 in an amount of at least 4 mcg/100 g dry weight of the composition, in the manufacture of a</seg-clauses>
<seg-clauses class=""seg-enter"">5          medicament to promote, support or optimise de novo myelination, and/or brain</seg-clauses>
<seg-clauses class=""seg-enter"">structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential, and/or cognitive functioning in a subject, wherein the subject is a formula fed human infant or child, wherein, brain structure refers to the amount and/or spatial distribution of myelinated matter</seg-clauses>
<seg-clauses class=""seg-enter"">10          throughout the brain, and/or in specific brain regions, and wherein said cognitive</seg-clauses>
<seg-clauses class=""seg-enter"">function is optimised if said subject’s scores in a standardized neurodevelopmental test are less than one standard deviation different from that of an exclusively breastfed subject of a well-nourished mother.</seg-clauses>
<seg-clauses class=""seg-enter"">15       </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1"">2. Use according to claim 1 in the manufacture of a synthetic nutritional composition</div>
<div class=""dep-clm"" num=""2"" parent=""1"">to promote, support or optimise the de novo myelination trajectory.</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Use according to any one of claims 1 to 2 wherein </seg-main><seg-clauses>said composition comprises folic acid.</seg-clauses>
<seg-clauses class=""seg-enter"">20</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. Use according to claim 3 wherein, </seg-main><seg-clauses>said composition comprises folic acid in an amount higher than 100 mcg/100 g dry weight of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Use according to any one of","A23L33/15, A23L33/00, A23L33/12, A23L33/16, A61K45/00",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119300839A,Nutritional composition comprising GOS and HMO,"The present invention relates to a combination of a mixture of galactooligosaccharides (GOS) and human milk oligosaccharides (HMO), or a nutritional composition comprising such a combination. The combination or composition is useful for the treatment and/or prevention of stress and/or mood disorders in infants, toddlers and/or children. The mixture of HMO consists of or consists essentially of 2 '-fucosyllactose (2' FL) and difucosyllactose (DFL) or lactose-N-tetrasaccharide (LNT) and 6 '-sialyllactose (6' SL). The invention also relates to the use of a combination of a mixture of galactooligosaccharides (GOS) and human milk oligosaccharides (HMO) or a composition comprising such a combination for the treatment and/or prevention of stress and/or mood disorders in infants, toddlers and/or children, wherein the mixture of HMO consists of or consists essentially of 2 '-fucosyllactose (2' FL) and difucosyllactose (DFL) or lactose-N-tetrasaccharide (LNT) and 6 '-sialyllactose (6' SL).","<div class=""indep-clm"" num=""1"">1.用于治疗和/或预防婴儿、幼儿和/或儿童的压力和/或心境障碍的低聚半乳糖(GOS)和人乳低聚糖(HMO)的混合物的组合，其中所述HMO的混合物由或基本上由2'-岩藻糖基乳糖(2'FL)和二岩藻糖基乳糖(DFL)或乳糖-N-四糖(LNT)和6'-唾液酸乳糖(6'SL)组成。</div>
<div class=""indep-clm"" num=""2"">2.用于治疗和/或预防婴儿、幼儿和/或儿童的压力和/或心境障碍的营养组合物，所述营养组合物包含低聚半乳糖(GOS)和人乳低聚糖(HMO)的混合物的组合，其中所述HMO的混合物由或基本上由2'-岩藻糖基乳糖(2'FL)和二岩藻糖基乳糖(DFL)或乳糖-N-四糖(LNT)和6'-唾液酸乳糖(6'SL)组成。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求1所述的用于所述用途的组合或根据权利要求2所述的用于所述用途的营养组合物，其中所述组合或营养组合物将肠脑轴中的双向传输途径的功能性保持在或恢复至健康水平。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求1或3所述的用于所述用途的组合或根据权利要求2或3所述的用于所述用途的营养组合物，其中所述组合或所述营养组合物增加由所述婴儿、幼儿和/或儿童的肠道微生物群产生的γ-氨基丁酸(GABA)，并由此治疗所述婴儿、幼儿和/或儿童的压力和/或心境障碍。</div>
<div class=""indep-clm"" num=""5"">5.根据权利要求1、3或4中任一项所述的用于所述用途的组合，或根据权利要求2至4中任一项所述的用于所述用途的营养组合物，其中所述心境障碍是焦虑或抑郁。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4"">6.根据权利要求2至5中任一项所述的用于所述用途的营养组合物，其中所述GOS以2.4g/L或基于干重计1.1g/100g至2.8g/100g组合物的量存在。</div>
<div class=""dep-clm"" num=""7"" parent=""5"">7.根据权利要求1或3至5中任一项所述的用于所述用途的组合，或根据权利要求2至6中任一项所述的用于所述用途的营养组合物，其中所述HMO的混合物由或基本上由2'FL和DFL组成。</div>
<div class=""dep-clm"" num=""8"" parent=""2"">8.根据权利要求7所述的用于所述用途的组合或营养组合物，其中按重量计2'-FL与DFL的比率为6:1至10:1。</div>
<div class=""dep-clm"" num=""9"" parent=""5"">9.根据权利要求1或3至5中任一项所述的用于所述用途的组合，或根据权利要求2至6中任一项所述的用于所述用途的营养组合物，其中所述HMO的混合物由或基本上由LNT和6'SL组成。</div>
<div class=""dep-clm"" num=""10"" parent=""2"">10.根据权利要求9所述的用于所述用途的组合或营养组合物，其中按重量计LNT与6'-SL的比率为2:1至1:1。</div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4,6,8,10""><seg-con>11.根据权利要求2至10中任一项所述的用于所述用途的营养组合物，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4,6,8,10""><seg-refi>(i)a)2'FL以0.005g/L至8g/L或者基于干重计0.004g/100g至6.8g/100g组合物的量存在；并且/或者</seg-refi></div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4,6,8,10""><seg-refi>b)其中DFL以0.1g/L至0.3g/L或者基于干重计0.08g/100g至0.2g/100g组合物的量存在；或者</seg-refi></div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4,6,8,10""><seg-refi>(ii)a)LNT以0.005g/L至3g/L或者基于干重计0.004g/100g至2.3g/100g组合物的量存在；并且/或者</seg-refi></div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4","A61K31/702, A61P25/22, A61P25/24, A23L33/21",20250110,雀巢产品有限公司,['Pending']
US20250009774A1,Compositions and methods using a combination of oleuropein and magnesium,"Compositions and methods using a combination of oleuropein and Magnesium Composition comprising a combination of oleuropein or metabolite thereof and Magnesium thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency/depletion disorder in an individual. Additionally, or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency/depletion disorder in an individual comprising administering a composition comprising a combination of oleuropein and/or a metabolite thereof and magnesium, in a therapeutically effective amount to the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the effective amount of a combination of oleuropein and/or a metabolite thereof and magnesium is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures thereof.</s","A61K31/7048, A61K9/00, A61K33/06, A61P3/00",20250109,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12303522B2,"Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system","The invention relates to a nutritional composition comprising human milk oligosaccharide (HMO) having an effect on in a mammal to improve, enhance, promote or modulate a GABAergic function in the CNS, preferably in a human infant or a young children between birth and 7 years. The composition can be an infant formula. The HMO may be 2FL, diFL and/or LNT and or LNnT or combinations thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for improving, enhancing, promoting or modulating </seg-main><seg-clauses>a) a GABAergic function in the central nervous system (CNS) or </seg-clauses><seg-clauses>b) filtering of information or the capacity to focus or concentrate on a mental or physical activity in a mammal suffering from a health status or disease related to GABAergic function, the method comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">administering a nutritional composition comprising an effective amount of a combination of a bovine milk oligosaccharide (BMO) and a human milk oligosaccharide (HMO) to the mammal suffering from the health status or disease related to GABAergic function,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the HMO comprises a combination of 2′fucosyllactose (2FL) and lacto-N-neotetraose (LNnT).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the GABAergic function in the CNS comprises filtering of information or a capacity to focus or concentrate on a mental or physical activity.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the HMO is present in an amount of from 0.01 to 50 g/L of the nutritional composition.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the nutritional composition further comprises a prebiotic.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the mammal is selected from the group consisting of a human, a pet, a cat and a dog.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method according to claim 1, wherein </seg-main><seg-clauses>the nutritional composition is selected from the group consisting of ","A61K31/702, A23K10/18, A23K20/163, A23L33/00, A23L33/135",20250520,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250019108A1,"Process for the production of a container for the preparation of a beverage in a beverage preparation device, sealing station for carrying out a sealing step of said process, and a container obtained by said process","The present invention concerns a process for producing a container for the preparation of a beverage in a beverage preparation device, wherein, in the final container obtained, at least 70% of the surface of a compacted beverage ingredient body (<b>2</b>) contained therein, is in contact with the container walls (<b>3, 4</b>).","<div class=""indep-clm"" num=""1""><seg-main>1. A process for producing a container for the preparation of a beverage in a beverage preparation device, comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>a. providing an injection wall of said container comprising a paper layer, said injection wall comprising: a peripheral sealing edge, and an inner portion capable of being punctured by an injection member of the beverage preparation device for circulating water under pressure inside said container;</seg-clauses>
<seg-clauses>b. providing a beverage delivery wall of said container comprising a paper layer, said delivery wall comprising: a peripheral sealing edge, and an inner portion capable of being opened by an opening member of the beverage preparation device when the pressure inside said container presses said inner portion against said opening member, to let the beverage flow out, wherein at least one, preferably both, of said inner portions of said injection and delivery walls has a cup shape;</seg-clauses>
<seg-clauses>c. placing a compacted body of beverage ingredient in the cup-shaped inner portion of the injection or delivery wall;</seg-clauses>
<seg-clauses>d. placing the injection and delivery walls one above the other such that the sealing edges of said injection and delivery walls are superimposed, in order to form a preliminary container chamber containing said ingredient body and comprising a preliminary headspace not filled by said compacted ingredient body;</seg-clauses>
<seg-clauses><seg-main>e. providing a sealing station comprising: first and second housing elements forming a sealing chamber for housing the inner portions of said injection and delivery walls, wherein said first and second housing elements are configured for being moved towards each other for sealing said edges, and such that the surfaces of said sealing chamber are in contact with external surfaces of said inner portions of the injection and delivery wa","B65B51/10, B65B29/02, B65D85/804",20250116,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025012103A1,Dairy product analogues comprising non-dairy acidic food ingredient,Dairy product analogues with improved sensory properties are disclosed. The dairy product analogues comprise plant proteins and non-dairy acidic food ingredient. Processes for preparing such dairy product analogues are als o disclosed.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A dairy product analogue which comprises </seg-main><seg-clauses>plant proteins and a non-dairy acidic food ingredient, wherein the non-dairy acidic food ingredient comprises a compound selected from the list consisting of acetoin, 2,3-butanedione, 3-methylbutan-l-ol, pentan-l-ol, furfural, 3- methylbutyl acetate, isobutyl acetate, ethyl acetate and mixture thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A dairy product analogue according to any one of the preceding claims, which further comprises </seg-main><seg-clauses>an added fat ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the plant proteins comprise, preferably consist of plant proteins selected from the group consisting of cereal proteins, pulse proteins and combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% plant proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.05wt% non-dairy acidic food ingredient.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. A dairy product analogue according to any one of the preceding claims, which is beverage.</div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-main>7. A dairy product analogue according to claim 6, wherein </seg-main><seg-clauses>the beverage is a liquid beverage or powdered beverage.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. A dairy product analogue according to any one of the preceding claims, which is free from milk ingredients.</div>
<div class=""dep-clm"" num=""9"" ","A23C11/06, A23C11/10, A23C20/00, A23C20/02, A23L2/39",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119896332A,Compositions and their use,"The present invention relates to compositions and their use. More specifically, the present invention relates to compositions for promoting, supporting or optimizing a subject's re-myelination, and/or brain structure, and/or brain connectivity, and/or one or more of cognitive potential, learning potential, and intellectual potential, and/or cognitive function.","<div class=""indep-clm"" num=""1"">1.一种合成营养组合物，所述组合物包含维生素，用于促进、支持或优化个体、特别是配方食品喂养的个体的重新髓鞘形成、特别是重新髓鞘形成轨迹、和/或脑结构、和/或脑连接、和/或智力潜能、和/或认知潜能、和/或学习潜能和/或认知功能，其中脑结构是指整个脑的、和/或特定脑区域中的有髓鞘物质的量和/或空间分布，并且其中如果在标准化的神经发育测试中所述个体的分数与营养良好的母亲的完全母乳喂养的个体的分数的差异小于一个标准偏差，则所述认知功能被优化。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的合成营养组合物，其中所述个体为人类婴儿或儿童，并且优选地为配方食品喂养的人类婴儿或儿童。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的合成营养组合物，其中所述维生素为维生素B12和/或叶酸。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的合成营养组合物，其中所述组合物包含高于50mcg/100g所述组合物干重的量的叶酸和/或高于0.01mcg/100g所述组合物干重的量的维生素B12。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的合成营养组合物，其中所述组合物还包含以下成分中的一种或多种：矿物质、和/或胆碱、和/或磷脂、和/或脂肪酸衍生物，其中所述脂肪酸衍生物为除磷脂以外的包含脂肪酸的化合物。</div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的合成营养组合物，其中所述矿物质选自铁、锌、钙、磷、铜以及它们的组合；其中所述脂肪酸衍生物包含二十二碳六烯酸和/或花生四烯酸和/或硬脂酸和/或神经酸，并且其中所述磷脂为式(I)的化合物或式(I)的化合物的混合物</seg-con></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con><img src="""" class=""img-anchor"" img-id=""FDA0005229551750000021""></seg-con></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-trans>其中，</seg-trans></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>R<sup>1</sup>为O；</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>X为NH或O；</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>R<sup>2</sup>为C2-C44饱和或不饱和的、直链或支链的酰基基团；</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>R<sup>3</sup>为式(II)或式(III)的取代基：</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi><img src="""" class=""img-anchor"" img-id=""FDA0005229551750000022""></seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>其中，R<sup>5</sup>为C2-C44饱和或不饱和的、直链或支链的酰基基团；并且</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>R<sup>6</sup>为C2-C44饱和烷基或烯基基团；并且</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-refi>R<sup>4</sup>选自：C5或C6取代的或未取代的环状烷基或烯基基团，或者—(CH2)n—R<sup>7</sup>，其中n为在1至4、特别是1至2的范围内的整数，并且R<sup>7</sup>为—N(CH3)3+、NH3+或","A23L33/15, A23L33/16, A23L33/10, A23L33/12, A23C9/152",20250429,雀巢产品有限公司,['Pending']
EP4620861A2,A beverage capsule comprising a barrier liner attached to a pulp body,"The present invention is directed to a capsule (1) for beverage preparation, comprising a cup-shaped body (2) of moulded cellulose pulp and a closing membrane (5) attached to a peripheral rim (4) of said body (2). The capsule further comprises a multilayer polymeric liner (3) attached to the inner surface of the cellulose pulp body (2), said liner comprising: (i) an outermost polymeric layer (7), (ii) a first tie layer (8), (iii) a barrier layer (9), (iv) a second tie layer (10), (v) an innermost polymeric layer (11), In which liner, - the thickness of the outermost layer (7) and the thickness of the innermost layer (11) are comprised between 10 and 100 pm and are preferably identical; - the elongation at break of the outermost layer (7) is higher than the elongation at break of the innermost layer (11); - The melt flow rate (MFR) of the outermost layer (7) measured at 150°C during 10 minutes with a pressure of 2.16 kg, is lower than the melt flow rate (MFR) of the innermost layer (11), measured at 190°C during 10 minutes with a pressure of 2.16 kg; - The melting point temperature of the outermost layer (7) is lower than the melting point temperature of the innermost layer (11), and in which, the outermost layer serves as an adhesive to the cellulose pulp of the capsule body.","<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule (1) for beverage preparation, comprising </seg-main><seg-clauses>a cup-shaped body (2) and a closing membrane (5) attached to a peripheral rim (4) of said body (2), said body (2) and membrane </seg-clauses><seg-clauses><seg-main>(5) defining a closed ingredient compartment (6), said capsule being adapted to be pierced by water injection means of a beverage preparation machine for injecting water under pressure in the compartment, and said membrane (5) being adapted to pierce onto opening means of said machine for dispensing a beverage prepared within said compartment when water pressure inside the compartment reaches a predetermined value, at least said capsule body being made of rigid or semirigid molded cellulose pulp, said the capsule comprising a multilayer polymeric liner (3) attached to the inner surface of the cellulose pulp body (2), said liner comprising: </seg-main><seg-clauses>(i) an outermost polymeric layer (7) comprising a biodegradable polymer selected within the list of: polybutylene succinate (PBSA / bioPBS), polybutylene adipate terephthalate (PBAT), starch, cellulose derivates, polylactic acid (PLA), polyhydroxyalcanoates (PHA), or a combination thereof, </seg-clauses><seg-clauses>(ii) a first tie layer (8) comprising a biodegradable modified or functionalized polyolefin, having a melting point temperature comprised between 180°C and 230°C and a thickness comprised between 1 and 12 pm, </seg-clauses><seg-clauses>(iii) a barrier layer (9) comprising a polymer selected within the list of: butenediol vinyl alcohol copolymer (BVOH), polyvinyl alcohol (PVOH) or a combination thereof, and having a melting point temperature comprised between 180°C and 230°C and a thickness comprised between 1 and 15 pm, </seg-clauses><seg-clauses>(iv) a second tie layer (10) comprising a biodegradable modified or functionalized polyolefin, having a melting point temperature comprised between 180°C and 230°C and a thi",B65D85/804,20250924,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2836836C1,Apparatus and system for roasting coffee beans,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is apparatus (1) for roasting coffee beans, comprising: chamber (10) for accommodating coffee beans and a device for creating an air flow for stirring coffee beans, a heater for heating air, so that the heated air is blown by the device into chamber (10), a control unit for switching apparatus (1) between the roasting mode and the unloading mode, wherein control unit is functionally connected to device for creation of air flow and/or heater, wherein chamber (10) is limited by lower part (11), upper part (12) and side wall (13) passing from lower part (11) to upper part (12), wherein side wall (13) comprises outlet port (30), which is configured to selectively move between a closed position and an open position, wherein in roasting mode, outlet port (30) is in a closed position and the device is configured to create a heated air flow for roasting coffee beans placed in chamber (10), and wherein in unloading mode, outlet port (30) is in an open position and apparatus (1) is configured to use the air flow generated by the device to move coffee beans through outlet port (30) for unloading from chamber (10), wherein outlet port (30) is located closer to lower part (11) than to upper part (12), wherein lower part (11) comprises an air inlet, and wherein the device is configured to blow air through said inlet to create an air flow inside chamber (10), and wherein outlet port (30) is located at some distance from lower part (11) or in lower part above air inlet. Also disclosed is system (100) for roasting coffee beans, comprising roasting apparatus (1) and an additional apparatus functionally connected to apparatus (1) for processing coffee beans discharged from apparatus (1) through outlet port (30).EFFECT: group of inventions makes it possible to reduce consumption of electric power or energy for roasting and unloading of coffee beans with an efficient method of unloading coffee beans with an air flow even without inclination of the roasting chamber, optimizing overall dimensions of the apparatus, making it compact.9 cl, 17 dwg","1. Аппарат (1) для обжаривания кофейных зерен, содержащий:
камеру (10), в которой могут быть размещены кофейные зерна для обжаривания, и
устройство для создания потока воздуха для перемешивания кофейных зерен, размещенных в камере (10),
нагреватель для нагрева воздуха, так что нагретый таким образом воздух продувается устройством в камеру (10) для создания нагретого потока воздуха,
блок управления для переключения аппарата (1) между режимом обжаривания и режимом выгрузки, причем блок управления функционально связан с устройством для создания потока воздуха и/или нагревателем,
причем камера (10) ограничена нижней частью (11), верхней частью (12) и боковой стенкой (13), проходящей от нижней части (11) к верхней части (12), при этом боковая стенка (13) содержит выпускной порт (30), который выполнен с возможностью избирательного перемещения между закрытым положением и открытым положением,
причем в режиме обжаривания выпускной порт (30) находится в закрытом положении и устройство выполнено с возможностью создания нагретого потока воздуха для обжаривания кофейных зерен, размещенных в камере (10), и при этом в режиме выгрузки выпускной порт (30) находится в открытом положении и аппарат (1) выполнен с возможностью использования потока воздуха, создаваемого устройством, для продвижения кофейных зерен через выпускной порт (30) для выгрузки из камеры (10),
причем выпускной порт (30) расположен ближе к нижней части (11), чем к верхней части (12),
причем нижняя часть (11) содержит впускное отверстие для воздуха, и при этом устройство выполнено с возможностью продувания воздуха через указанное впускное отверстие для создания потока воздуха внутри камеры (10), и
причем выпускной порт (30) расположен отстоящим от нижней части (11) на некоторое расстояние или в нижней части над впускным отверстием для воздуха.
2. Аппарат (1) по п. 1, в котором выпускной порт (30) выполнен с возможностью перемещения вручную между закрытым положением и открытым положением, и/или при этом аппарат (1) с","A23N12/08, A47J31/42",20250324,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN120660883A,Mixtures of HMO and bifidobacteria,"The present invention relates to a composition for infants or young children comprising at least one probiotic strain and a prebiotic mixture of human milk oligosaccharides, said probiotic strain being Bifidobacteria, the present invention relates to a composition comprising a prebiotic mixture of human milk oligosaccharides consisting of 2 '-fucosyllactose (2FL), milk difucosyltetraose/difucosyllactose (DFL), milk-N-tetraose (LNT), 6'-sialyllactose (6SL), 3 '-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL), which composition is useful for (i) preventing and/or treating a bacterial infection in an infant or a young child; (ii) modulate the microbiota in the infant or young child; and/or iii) preventing and/or treating allergies in infants or young children.","<div class=""indep-clm"" num=""1"">1.用于婴儿或幼儿的组合物，所述组合物包含至少一种益生菌菌株和益生元低聚糖混合物，所述益生菌菌株是双歧杆菌，所述益生元低聚糖混合物由2'-岩藻糖基乳糖(2FL)、乳二岩藻糖基四糖/二岩藻糖基乳糖(DFL)、乳-N-四糖(LNT)、6'-唾液酸乳糖(6SL)和3'-唾液酸乳糖(3SL)以及任选的3-岩藻糖基乳糖(3FL)组成；</div>
<div class=""indep-clm"" num=""1"">其中所述双歧杆菌包含长双歧杆菌婴儿亚种(Bifidobacteriumlongumsubsp.infantis)或者动物双歧杆菌乳酸亚种(Bifidobacterium animalissubsp.lactis)和长双歧杆菌婴儿亚种(longum subsp.infantis)的组合；</div>
<div class=""indep-clm"" num=""1"">其中所述双歧杆菌中的至少一种是长双歧杆菌婴儿亚种LMG 11588。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其包含至少一种益生菌菌株和益生元低聚糖混合物，所述益生菌菌株是双歧杆菌，所述益生元低聚糖混合物由2'-岩藻糖基乳糖(2FL)、乳二岩藻糖基四糖/二岩藻糖基乳糖(DFL)、乳-N-四糖(LNT)、6'-唾液酸乳糖(6SL)和3'-唾液酸乳糖(3SL)以及3-岩藻糖基乳糖(3FL)组成；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">其中所述双歧杆菌包含长双歧杆菌婴儿亚种(Bifidobacteriumlongumsubsp.infantis)或者动物双歧杆菌乳酸亚种(Bifidobacterium animalissubsp.lactis)和长双歧杆菌婴儿亚种(longum subsp.infantis)的组合；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">其中所述双歧杆菌中的至少一种是长双歧杆菌婴儿亚种LMG 11588。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的组合物，其中所述双歧杆菌是长双歧杆菌婴儿亚种LMG 11588并且所述益生元低聚糖混合物由2'-岩藻糖基乳糖(2FL)、乳二岩藻糖基四糖/二岩藻糖基乳糖(DFL)、乳-N-四糖(LNT)、6'-唾液酸乳糖(6SL)和3'-唾液酸乳糖(3SL)组成。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的组合物，其中所述双歧杆菌是动物双歧杆菌乳酸亚种(Bifidobacterium animalis subsp.Lactis)CNCM I-3446和长双歧杆菌婴儿亚种LMG11588的组合，并且所述益生元低聚糖混合物由2'-岩藻糖基乳糖(2FL)、乳二岩藻糖基四糖/二岩藻糖基乳糖(DFL)、乳-N-四糖(LNT)、6'-唾液酸乳糖(6SL)和3'-唾液酸乳糖(3SL)组成。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1-4中任一项所述的组合物，其中所述至少一种双歧杆菌是动物双歧杆菌乳酸亚种CNCM I-3446。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据前述权利要求中任一项所述的组合物，其中所述益生元低聚糖混合物基本上由以下物质</seg-con><seg-trans>组成：</seg-trans></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-comp>i.42重量％至71重量％的2FL；</seg-comp></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-comp>ii.10重量％至40重量％的LNT；</seg-comp></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-comp>iii.4重量％至14重量％的DFL；以及</seg-comp></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-comp>iv.9重量％至31重量％的组合的6SL和3SL。</seg-comp></div>
<","A23L33/135, A23L33/21, A23C9/20, A61K35/745, A61K31/702",20250919,雀巢产品有限公司,['Pending']
US20250072650A1,Beverage preparation system,"The invention concerns a beverage production system comprising a pack (<b>10</b>) and a module (<b>1</b>) for producing a beverage from said pack,—said module (<b>1</b>) comprising:. a movable fluid processing device (<b>11</b>) to introduce a fluid in said pack and to dispense a beverage from the pack, and.a pack holder assembly (<b>2</b>), said pack holder assembly comprising a pack chamber (<b>22</b> and a door (<b>23</b>),. the door (<b>23</b>) is movable relatively to the pack chamber and is configured to be positioned in at least:. a first opened position wherein said door uncovers the pack inlet (<b>222</b>) of the pack chamber, and. a second closed position wherein said door covers the pack inlet (<b>222</b>) of the pack chamber and is able to enclose the pack inside the pack chamber, wherein, when the door (<b>23</b>) is in the first opened position, the whole pack holder assembly (<b>2</b>) is removable from the module (<b>1</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage production system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a pack and a module for producing a beverage from said pack,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising an ingredient, said ingredient being configured to be mixed with a fluid to produce a beverage, said pack presenting a plane shape oriented along a plane, and the bottom side of said pack being configured for being openable,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said module comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a movable fluid processing device configured to cooperate with the bottom of the pack to introduce a fluid in said pack and to dispense a beverage from the pack, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pack holder assembly, said pack holder assembly comprising a pack chamber and a door, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pack chamber is adapted for receiving said pack through an upper pack inlet and for holding said pack so that the plane of the plane shape is oriented in an essentially vertical position inside the module, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamber presenting a bottom opening configured to enable access of the movable fluid processing device to at least the bottom side of said pack hold in the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the door is movable relatively to the pack chamber and is configured to be positioned in at least:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first opened position wherein said door uncovers the pack inlet of the pack chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a second closed position wherein said door covers the pack inlet of the pack chamber and is able to enclose the pack inside the pack chamber, and</seg-refi></div>
<div class=""indep","A47J31/40, A47J31/44, A47J31/52",20250306,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3025044A1,Removal of a capsule from a capsule holder,"A capsule processing machine (1) for preparing a beverage from a capsule (5) having a body (50) containing an ingredient. The machine (1) has a holder (10) with a cavity (11) having an upwardly oriented mouth (12) and a cover (20) cooperating with the holder (10). The cover (20) and the holder (10) are relatively movable along a movement path (14) from: an open position for inserting the capsule (5) inbetween the holder (10) and cover (20) into the cavity (11) and/or for removing the capsule (5) therefrom; to a closed position for extracting the capsule (5) in the cavity (11). The machine (1) includes a capsule transfer device (30) having a capsule guide (31) for guiding the capsule (5) from the holder (10) to a used- capsule evacuation area (40). The capsule guide (31) extends along an evacuation direction (31') and is configured to seize the capsule (5) and hold the capsule (5) above the holder (10) and to guide the capsule (5) towards the evacuation area (40) along the evacuation direction (31'). The movement path (14) and the evacuation direction (31') are at an angle (α1,α2,α3,α4) favouring a movement of the capsule (5) under the effect of gravity along the capsule guide (31) towards the evacuation area (40). The capsule guide (31) is tiltable during the relative movement of the holder (10) and the cover (20) from the closed position to the open position to reduce the angle (α1,α2,α3,α4) so as to increase the effect of gravity for moving the capsule (5).","<br/>18<br/> Claims <br/><div class=""indep-clm"" num=""1""><seg-main>1. A capsule processing machine (1) for preparing a <br/>beverage from a capsule (5) having </seg-main><seg-clauses><seg-main>a body (50) containing <br/>an ingredient, such as a beverage prepared by circulating <br/>a liquid into such capsule and centrifugally driving such <br/>capsule (5), comprising:<br/></seg-main><seg-clauses>- a holder (10) with a cavity (11) having an upwardly <br/>oriented mouth (12), such as a mouth (12) generally <br/>contained in a horizontal plane, for receiving said <br/>capsule (5) via the mouth (12), said capsule (5) <br/>having for instance a capsule flange (51) extending <br/>generally in parallel to the mouth (12), optionally <br/>the holder (10) being drivable in rotation by a <br/>motorized drive axis (14); and<br/></seg-clauses><seg-clauses><seg-main>- a cover (20) cooperating with the holder (10) such <br/>that the cover (20) and the holder (10) are relatively <br/>movable, e.g. manually or automatically, along a <br/>movement path (14) from:<br/></seg-main><seg-clauses>- an open position for inserting said capsule (5) <br/>inbetween the holder (10) and cover (20) into the <br/>cavity (11) and/or for removing said capsule (5) <br/>from inbetween the holder (10) and cover (20); to<br/></seg-clauses><seg-clauses>- a closed position for extracting said capsule (5) in <br/>the cavity (11),<br/>optionally the cover (20) being associated with a <br/>pusher (22) for separating said capsule </seg-clauses><seg-clauses>(5) from the <br/>cover (20) in the open position, such as a pusher (22) <br/>movable between a retracted position in the closed <br/>position and a deployed position in the open position, <br/></seg-clauses><seg-clauses>e.g. a pusher (22) that is resiliently assembled to <br/>the cover (20);<br/>and<br/></seg-clauses><seg-clauses>- a capsule transfer device (30) having a capsule guide <br/>(31) for guiding said capsule (5) from the holder (10) <br/>to a use",A47J31/36,20250923,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023327690A1,Kit to promote developmental myelination,"The present invention relates to a kit of nutrient blend compositions for young individuals, in particular children aged between 0 and 66 months, each one of the compositions having age-specific ingredients. The kit of nutrient blend compositions is specifically aimed at promoting myelination of targeted brain regions, in particular the social brain, of children at specific ages and stages of brain development.","<div class=""indep-clm"" num=""1""><seg-main>1. An age-tailored kit of nutrient blend compositions to be sequentially administrated to a young individual for use to promote myelination of targeted brain regions comprising </seg-main><seg-clauses><seg-main>at least two of the following compositions:</seg-main>
<seg-clauses>a) a nutrient blend composition A to be administrated to a young individual at age from 0 to 20 months comprising at least three ingredients chosen from the group consisting of vitamin Bl, vitamin B2, vitamin B6, zinc, iron, copper, histidine, isoleucine, lysine, leucine, vitamin A, folate, magnesium, phosphorus, potassium, selenium, 3'-SL, alanine, cystine, glutamic acid, phenylalanine, proline, serine, threonine, tyrosine, valine;</seg-clauses>
<seg-clauses>b) a nutrient blend composition B to be administrated to a young individual at age from 20 to 30 months comprising at least three ingredients chosen from the group consisting of DPA, ARA, sphingomyelin, phosphatidylcholine, octadecatetraenoic acid, oligofructose, 6'-SL, stearidonic acid, beta cryptoxanthin, alpha lactalbumin, gangliosides, phosphatidylinositol, 3'-SL, eicosatetraenoic acid;</seg-clauses>
<seg-clauses>c) a nutrient blend composition C to be administrated to a young individual at age from 30 to 66 months comprising at least three ingredients chosen from the group consisting of DHA, sphingomyelin, phosphatidylcholine, histidine, isoleucine, leucine, valine, alpha carotene, folic acid, alpha lactalbumin, gangliosides, phosphatidylinositol, phosphatidylethanolamine, eicosenoic acid, stearidonic acid, DPA, 3'-SL, 6'-SL, alanine, arginine, aspartic acid, cystine, glutamic acid, glycine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, alpha tocopherol, octadecatetraenoic acid, eicosapentaenoic acid, phosphorus, phosphatidylserine.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The kit as claimed in claim 1 wherei","A23L33/12, A23L33/15, A23L33/155, A23L33/175, A23L33/28",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023353523A1,A beverage capsule made of moulded cellulose with improved oxygen and moisture barrier,"The present invention concerns an improved packaging item (1) comprising a body (2) made of rigid or semi-rigid moulded cellulose pulp, said item further comprising a multilayer film liner (3) attached to the inner surface of the cellulose pulp body (2), said liner comprising from inside to outside, a biodegradable outermost organic adhesive layer (7) for attaching the liner to the moulded cellulose pulp, an organic middle barrier layer (8) comprising a modified alcohol-based polymer (BVOH), and an innermost biodegradable organic structural layer (9).","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (1) comprising </seg-main><seg-clauses><seg-main>a body (2) made of rigid or semi-rigid moulded cellulose pulp, characterized in that said item (1) further comprises a multilayer film liner (3) attached to the inner surface of the cellulose pulp body (2), said liner comprising from outside to inside:</seg-main>
<seg-clauses>(i) an outermost organic adhesive layer (7) for attaching the liner to the moulded cellulose pulp, said adhesive layer comprising a biodegradable polymer selected within the list of: polybutylene succinate (PBSA / bioPBS), polybutylene adipate terephthalate (PBAT), starch, cellulose derivates, polylactic acid (PLA), polyhydroxyalcanoates (PHA), or a combination thereof, said outermost layer having a thickness comprised between 10 and 100 pm, an elongation at break comprised between 10% and 800%, a melt flow rate (MFR) comprised between 2 and 4 when measured at 150°C during 10 minutes with a pressure of 2.16 kg, and said outermost layer having a melting point temperature comprised below 80°C,</seg-clauses>
<seg-clauses><seg-main>(ii) an organic middle barrier layer (8) comprising a butenediol vinyl alcohol copolymer </seg-main><seg-clauses>(BVOH) grafted with maleic anhydride, a polyglycolic acid (PGA) grafted with maleic anhydride, or a mixture thereof, and having a melting point temperature comprised between 180°C and 230°C and a thickness comprised between 1 and 20 pm,</seg-clauses></seg-clauses>
<seg-clauses>(iii) an innermost organic structural layer (9) comprising a biodegradable polymer selected within the list of: polybutylene succinate (PBSA), polybutylene adipate terephthalate (PBAT),</seg-clauses>
<seg-clauses class=""seg-enter"">starch, cellulose derivates, polylactic acid (PLA), polyhydroxyalcanoates (PHA) or a combination thereof, said layer having a thickness comprised between 10 and 100 pm, an elongation at break comprised between 10% and 1000%, a melt flow rate (MFR) compr",B65D85/804,20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119451577A,Method for treating protein-containing compositions,"The present invention relates to a method for treating a protein-containing composition. The method comprises providing a protein-containing composition, wherein the protein comprises a milk protein and the milk protein comprises at least 90% by weight of beta-lactoglobulin. The composition is contacted with a transglutaminase to obtain a composition comprising a cross-linked protein. The method not only enhances the thermal stability, particularly in the presence of calcium, but also enhances the texture properties of such protein-containing compositions. The invention also relates to a cross-linked protein-containing composition obtainable or obtained by said process, to a process for the preparation of a dairy product or a substitute thereof with such a composition, and to the resulting dairy product or substitute thereof.","<div class=""indep-clm"" num=""1"">1.用于处理含蛋白质的组合物的方法，所述方法包括由以下项组成的步骤：</div>
<div class=""indep-clm"" num=""1"">a)提供含蛋白质的组合物，其中所述含蛋白质的组合物的所述蛋白质包含乳蛋白质，并且其中所述含蛋白质的组合物的所述乳蛋白质包含至少90重量％的β-乳球蛋白，其中所述含蛋白质的组合物是液体，</div>
<div class=""indep-clm"" num=""1"">b)使所述含蛋白质的组合物与至少一种转谷氨酰胺酶接触以获得含交联蛋白质的组合物。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用于处理含蛋白质的组合物的方法，其中所述含蛋白质的组合物可具有至少2重量％的乳蛋白质，优选2重量％至30重量％的乳蛋白质。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的用于处理含蛋白质的组合物的方法，所述方法包括在步骤b)之前向所述含蛋白质的组合物中添加至少一种脂肪组分的步骤。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的用于处理含蛋白质的组合物的方法，其中在步骤b)中使所述转谷氨酰胺酶与所述含蛋白质的组合物接触，其中乳蛋白质与转谷氨酰胺酶的重量比为20:1至1000:1，优选20:1至500:1，更优选25:1至75:1。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的用于处理含蛋白质的组合物的方法，其中在步骤b)中使所述转谷氨酰胺酶与所述含蛋白质的组合物在40℃至68℃的温度下反应20分钟至4小时。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的用于处理含蛋白质的组合物的方法，其中所述含蛋白质的组合物的所述乳蛋白质，优选非转谷氨酰胺酶蛋白质仅由β-乳球蛋白组成。</div>
<div class=""indep-clm"" num=""7"">7.含交联蛋白质的组合物，其中所述含交联蛋白质的组合物的所述蛋白质包含乳蛋白质，并且其中所述含交联蛋白质的组合物的所述乳蛋白质包含至少90重量％的β-乳球蛋白并且是交联的。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的含交联蛋白质的组合物，其中所述含交联蛋白质的组合物的所述乳蛋白质，优选所述非转谷氨酰胺酶蛋白质仅由β-乳球蛋白组成。</div>
<div class=""dep-clm"" num=""9"" parent=""1,7,8"">9.根据权利要求7或8所述的含交联蛋白质的组合物，所述含交联蛋白质的组合物能够通过根据权利要求1至6中任一项所述的方法获得或通过根据权利要求1至6中任一项所述方法获得。</div>
<div class=""dep-clm"" num=""10"" parent=""7,8,9"">10.根据权利要求7至9中任一项所述的含交联蛋白质的组合物，所述含交联蛋白质的组合物包含分子量为34kDa至38kDa的蛋白质和/或分子量为52kDa至56kDa的蛋白质和/或分子量为70kDa至74kDa的蛋白质。</div>
<div class=""indep-clm"" num=""11"">11.用于制备乳制品或其替代物的方法，其中所述乳制品或其所述替代物的所述蛋白质包含乳蛋白质，并且所述乳制品或其所述替代物的所述乳蛋白质包含至少90重量％的β-乳球蛋白，所述方法包括由以下项组成的步骤：</div>
<div class=""indep-clm"" num=""11"">a)根据权利要求1至6中任一项所述的方法处理含蛋白质的组合物以获得含交联蛋白质的组合物或提供根据权利要求7至10中任一项所述的含交联蛋白质的组合物，</div>
<div class=""indep-clm"" num=""11"">b)将所述含交联蛋白质的组合物与钙或其盐混合以获得食物组合物，</div>
<div class=""indep-clm"" num=""11"">c)将所述食物组合物均质化，</div>
<div class=""indep-clm"" num=""11"">d)热处理所述食物组合物，</div>
<div class=""indep-clm"" num=""11"">e)任选地，蒸发所述食物组合物，</div>
<div class=""indep-clm"" nu","A23C9/12, A23C9/152, A23C9/154, A23C11/06, A23C21/02",20250214,雀巢产品有限公司,['Pending']
CA3135952C,"Foodstuff and beverage products, ingredients, processes and uses","The present invention provides the use of a composition obtainable from the pulp of a plant in the theobroma genus or an extract of said pulp, as an ingredient in a foodstuff product.","Claims <div class=""indep-clm"" num=""1""><seg-con>1. A process for drying pulp from a plant in the theobroma genus and/or an extract of pulp from a plant in the theobroma genus, </seg-con><seg-trans>comprising </seg-trans><seg-refi>spraying and drying, comprising drying a composition comprising pulp from a plant in the theobroma genus and/or an extract of pulp from a plant in the theobroma genus in combination with a stabilizer, wherein the stabilizer is selected from the group consisting of cocoa powder, cocoa fibres, guar gum, psyllium husk, carnuba wax, glycerin, beta glucan, polysaccharides, dietary fibres, polydextrose, methylcellulose, maltodextrins, inulin, milk powder, whey, demineralised whey powder, dextrins soluble fibre and any combination thereof. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The process of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pulp or extract of pulp is cocoa pulp or an extract of cocoa pulp. </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The process of claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the drying reduces the water content to less than 10.0% by weight of water in the composition obtained. </seg-refi></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The process of any one of claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the content of the stabilizer in a wet basis in the composition also comprising pulp and/or pulp extract is at least 4.0% by weight of the composition. </seg-refi></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The process of any one of claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the content of the stabilizer in a wet basis in the composition is at most 25.0% by weight of the composition. </seg-refi></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The process of any one of claims 1 to 5, </seg-con><seg-trans>wherein </seg-trans><seg-ref","A23C9/13, A23G1/32, A23G1/48, A23G3/36, A23G9/32",20251007,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025176584A1,Packaging film,"The present invention relates to a sealable paper-based film comprising: a paper layer; a first adhesive layer comprising a water sensitive adhesive; a first polymer film and a first barrier layer, wherein said first barrier layer is in direct contact with said first polymer film; a second adhesive layer comprising a water stable adhesive; a second polymer film and a second barrier layer; and a continuous or discontinuous sealing layer; wherein said first polymer film is connected to said paper layer via said first adhesive layer; and said first barrier layer is connected to said second polymer film via said second adhesive layer, to a process for the preparation of the sealable paper- based film, to uses of the sealable paper-based film, to a package or a sealed package comprising the sealable paper-based film, and to processes for the preparation of the package or sealed package.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A sealable paper-based film comprising: </seg-main><seg-clauses>a paper layer; a first adhesive layer comprising a water sensitive adhesive; a first polymer film and a first barrier layer, wherein said first barrier layer is in direct contact with said first polymer film; a second adhesive layer comprising a water stable adhesive; a second polymer film and a second barrier layer; and a continuous or discontinuous sealing layer; wherein said first polymer film is connected to said paper layer via said first adhesive layer; and said first barrier layer is connected to said second polymer film via said second adhesive layer.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A sealable paper-based film as claimed in claim 1, wherein </seg-main><seg-clauses>the weight of said paper layer is at least 80% based upon the total weight of the sealable paper-based film, preferably at least 85% based upon the total weight of the sealable paper-based film, more preferably at least 90% based upon the total weight of the sealable paper-based film, even more preferably at least 95% based upon the total weight of the sealable paper-based film.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A sealable paper-based film as claimed in claim 1 or claim 2, wherein </seg-main><seg-clauses>said first polymer film and/or said second polymer film comprises at least one oriented or unoriented polymer in a mono or multilayer structure preferably wherein the at least one oriented or unoriented polymer is selected from low-density polyethylene, high- density polyethylene, polypropylene, polybutylene, polyisobutylene, polyethylene terephthalate, polyamide, ethylene vinyl alcohol, poly(vinyl alcohol), polylactic acid, or combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A sealable paper-based film as claimed in claim 3, wherein </seg-main><seg-clauses>sa","B32B1/00, B32B7/04, B32B7/12, B32B9/02, B32B23/06",20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
MX379145B,Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section,,,"A23L33/10, A23L33/125, A61K31/702, A61P37/08, A23L33/00",20250311,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US12439936B2,Process and device for application of particles onto frozen confectionery,"The invention relates to an apparatus for decorating frozen confectionery (<b>1</b>) on sticks, the apparatus comprising: a coating station (<b>4</b>) for applying coating material onto the frozen confectionery (<b>1</b>), a particle dispensing station (<b>7</b>) for applying particles onto the coated frozen confectionery, a conveyor (<b>3</b>) for moving the frozen confectionery past the coating station and the particle dispensing station, the conveyor (<b>3</b>) comprising gripping means (<b>2</b>) arranged on the conveyor (<b>3</b>) and having a product attached position and an opened position for gripping and releasing the stick of the frozen confectionery (<b>1</b>), and the conveyor (<b>3</b>) comprising guides for moving the gripping means with the frozen confectionery between a vertical position and a horizontal position, and wherein the apparatus further comprises a heating station (<b>11</b>) installed at a position between the coating station (<b>4</b>) and the particle dispensing station (<b>7</b>), and wherein the gripping means (<b>2</b>) are arranged to hold the frozen confectionery in the horizontal position when passing the heating station (<b>11</b>) and the particle dispensing station (<b>7</b>), and optionally coating removal means (<b>6</b>) for removing coating material on one side of the frozen confectionery, which coating removal means (<b>6</b>) are at a position after the coating station (<b>4</b>) in the direction of the movement of the conveyor (<b>3</b>) and before the particle dispensing station. The invention also relates to a method for manufacturing decorated frozen confectionery on sticks making use of the apparatus.","<div class=""indep-clm"" num=""1""><seg-con>1. Apparatus for decorating frozen confectionery on sticks, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a coating station for applying coating material onto the frozen confectionery,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a particle dispensing station for applying particles onto the coated frozen confectionery,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a conveyor for moving the frozen confectionery past the coating station and the particle dispensing station, the conveyor comprising a gripper arranged on the conveyor and having a product attached position and an opened position for gripping and releasing the stick of the frozen confectionery, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the conveyor comprising guides for moving the gripper with the frozen confectionery between a vertical position and a horizontal position, and wherein the apparatus further comprises</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a heating station installed at a position between the coating station and the particle dispensing station, and wherein the gripper is arranged to hold the frozen confectionery in the horizontal position when passing the heating station and the; particle dispensing station and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a coating removal means for removing coating material on one side of the frozen confectionery, which coating removal means are at a position after the coating station in the direction of the movement of the conveyor and before the particle dispensing station wherein the coating removal means comprises airflow means adapted to partially remove coating material from one side of the frozen confectionery.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Apparatus according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the heating stati","A23G9/24, A23G9/26, A23G9/48, A23G9/50, B65G47/90",20251014,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250187894A1,System for introducing an additive into a container comprising a static microdoser,"A system for introducing an additive into a container includes an automated device for transporting the container in a horizontal plane (P), such as a rotary wheel. The system further includes a static microdoser having a nozzle from which a jet of an additive issues upon passage of an opening of the container. Additive is so injected into the container. The nozzle of the static microdoser is inclined relative to a direction orthogonal to the horizontal plane. This limits splashing, in particular when the jet of additive hits an inner wall of the container that is free of liquid. This can be facilitated by an acceleration applied on the container which inclines the free surface of the liquid material present in the container. A preferred application is the introduction of a flavored concentrate into a bottle of water.","<div class=""indep-clm"" num=""1""><seg-con>1: A system for introducing an additive into a container, the system </seg-con><seg-trans>comprising </seg-trans><seg-refi>an automated device for transporting the container along a trajectory in a horizontal plane, the system further comprising a static microdoser having a nozzle from which a jet of an additive issues upon passage of an opening of the container in proximity to the nozzle to introduce the additive into the container, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the nozzle of the static microdoser is inclined relative to a direction orthogonal to the horizontal plane.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The system according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nozzle of the static microdoser is inclined such that the jet of additive enters into the container through the opening and hits a lateral inner wall of the container.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The system according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the container is partially filled with a main liquid material before introduction of the additive, and wherein the lateral inner wall hit by the jet of additive is situated above a free surface of the main liquid material.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4: The system according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the automated device for transporting the container applies an acceleration to the container, the acceleration having at least a horizontal component causing the free surface of the main liquid material to be at an angle with the horizontal plane, the free surface of the main liquid thus having a highest level and a lowest level in the container, the nozzle of the static microdoser being placed such that the jet of the additive hits the lateral inner wall on the side of the container where the","B67C3/20, B65B3/12",20250612,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025120121A1,Used capsule receptacle for beverage machines,"A machine (1) configured for preparing a beverage from an ingredient contained in a capsule (100) has: a passage (2) for evacuating such ingredient capsule (100) upon preparing a beverage from such capsule (100) in the machine (1); a seat (20) positioned so that the evacuation passage (2) leads into the seat (20), the seat (20) having a bottom end (21); a capsule collector (10) having a bottom (11) and sidewalls (12,12') delimiting a cavity (13) with a cavity entry opening (14), the cavity (13) being configured for storing such used capsules (100); and a spacer (15). The capsule collector (10) has a collection position in which the capsule collector (10) is located in the seat (20) above the seat bottom end (21) for collecting in the storage cavity (13) capsules (100) delivered into the storage cavity (13) via the evacuation passage (2) and the entry opening (14). The spacer (15) has a spacing position in which the spacer (15) is located in the seat (20). The capsule collector (10) and the spacer (15) are removable by a user from the seat (20). The spacer (15) is removable from the seat (20) independently from the capsule collector (10) when the capsule collector (10) is blocked in the seat (20) by one or more capsules (100) protruding above the entry opening (14) of the collector (10), whereby a space (22) in the seat (20) is freed below the collector (10) to lower the collector (10) and the protruding capsule(s) (100) under the evacuation passage (2) so as to allow removal from the seat (20) of the collector (10) after removal of the spacer (15).","Claims <div class=""indep-clm"" num=""1""><seg-main>1. A machine (1) for preparing a beverage from an ingredient contained in a capsule (100), comprising: </seg-main><seg-clauses>- a passage (2) for evacuating such ingredient capsule (100) upon preparing a beverage from such capsule (100) in said machine (1); </seg-clauses><seg-clauses>- a seat (20) positioned so that the evacuation passage (2) leads into the seat (20), the seat (20) having a bottom end (21); </seg-clauses><seg-clauses>- a capsule collector (10) having a bottom (11) and sidewalls (12,12’) delimiting a cavity (13) with a cavity entry opening (14), such as a top opening, the cavity (13) being configured for storing such used capsules (100); and </seg-clauses><seg-clauses>- a spacer (15); the capsule collector (10) having a collection position in which the capsule collector (10) is located in the seat (20) above the seat bottom end (21) for collecting in the storage cavity (13) capsules (100) delivered into the storage cavity (13) via the evacuation passage (2) and the entry opening (14), the spacer (15) having a spacing position in which the spacer (15) is located in the seat (20), e.g. at said seat bottom end (21) and below the capsule collector (10), the capsule collector (10) and the spacer (15) being removable by a user, such as for cleaning and/or servicing e.g. emptying collected capsules (100), from the seat (20), such as removable via a seat opening (25) e.g. a seat opening (25) on a machine dispensing side (3’) fitted with a beverage outlet (3), characterised in that the spacer (15) is removable from the seat (20) independently from the capsule collector (10) when the capsule collector (10) is blocked in the seat (20) by one or more capsules (100) protruding above the entry opening (14) of the collector (10), whereby a space (22) in the seat (20) is freed below the collector (10) to lower the collector (10) and said protruding capsule(s) (100) under the evacuation passage (2) so as</seg-clauses>
",A47J31/44,20250612,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
US20240409912A1,Engineered protease polypeptides,"The present disclosure provides engineered protease polypeptides, recombinant polynucleotides encoding the engineered protease polypeptides, and uses of the engineered protease polypeptides in therapeutic applications.","<div class=""indep-clm"" num=""1""><seg-main>1. An engineered protease polypeptide, or a biologically active fragment thereof, comprising </seg-main><seg-clauses>an amino acid sequence having at least 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, or more sequence identity to a reference sequence corresponding to residues 135-413 of SEQ ID NO: 4, 628, 948, 1126, 1368, or 1548, or to a reference sequence corresponding to SEQ ID NO: 4, 628, 948, 1126, 1368, or 1548, wherein the amino acid sequence comprises one or more substitutions relative to the reference sequence corresponding to residues 135-413 of SEQ ID NO: 4, 628, 948, 1126, 1368, or 1548, or relative to the reference sequence corresponding to SEQ ID NO: 4, 628, 948, 1126, 1368, or 1548.</seg-clauses></div>
<div class=""ccl-clm"" num=""2"">2. (canceled)</div>
<div class=""ccl-clm"" num=""3"">3. (canceled)</div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The engineered protease polypeptide of claim 1, comprising </seg-main><seg-clauses>an amino acid sequence having at least 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, or more sequence identity to a reference sequence corresponding to residues 135-413 of an even-numbered SEQ ID NO. of SEQ ID NOs: 6-1710, or to a reference sequence corresponding to an even-numbered SEQ ID NO. of SEQ ID NOs: 6-1710, wherein the amino acid sequence comprises one or more substitutions relative to the reference sequence corresponding to residues 135-413 of SEQ ID NO: 4 or 628, or relative to the reference sequence corresponding to SEQ ID NO: 4 or 628.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The engineered protease polypeptide of claim 1, wherein </seg-main><seg-clauses>the amino acid sequence of the engineered protease polypeptide comprises at least a substitution at amino acid position 11, 31, 42, 45, 50, 53, 84, 99, 100","C12N9/54, C12N9/96",20241212,"CODEXIS, INC.",['Pending']
AU2023378253A1,Compositions and methods using glycine to reduce biological age of an adult animal,,"<div class=""indep-clm"" num=""1""><seg-con>1. A method for reducing the biological age and/ or reduce the rate of increase of the biological age of an adult animal in need, the method </seg-con><seg-trans>comprising: </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of glycine and/ or functional derivatives.</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-con>2. A method for reducing the biological age of a tissue, organ or physiological system in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of glycine and/ or functional derivatives.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue, organ or physiological system is immune, gastrointestinal, urinary, muscular, cardiovascular, and/or neurological system.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. A method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue is one having a deficiency in glycine.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A method according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tissue is skeletal muscle.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A method according to any preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine is provided in a dipeptide, such as N-acetylcysteinylglycine (GlyNAC)</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-con>7. A method for treating, preventing, or delaying the onset of an organ disease, or decline of organ function, or condition relating thereto in an adult animal in need, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>feeding the adult animal a composition comprising an effective amount of","A61K31/198, A61K38/05, A61P39/00",20250424,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2834714C1,Coffee beans grinding and extraction equipment,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is equipment for grinding and extraction of roasted coffee beans, including device (60) for grinding and associated extraction device (70), wherein device (60) includes one or more housings for receiving one or more containers (10, 20) for beans with roasted coffee beans of the same or different types, reading device (62) for obtaining information on product parameters for roasted coffee beans in one or more containers (10, 20), control unit configured to adapt the degree of grinding and the amount of roasted coffee beans to obtain a certain coffee mixture, encoder (62) for encoding beverage information on programmable identification means (65) on product holder (61), wherein extraction device (70) is configured to receive product holder (61) and includes reading means (72) for identifying information on the beverage in said identification means (65) on the product holder, a control unit for extracting the beverage in accordance with the extracted beverage information and/or according to the beverage information extracted from the beverage database in this control unit. Also described is a method of grinding roasted coffee beans and making a beverage from them using said equipment and the use of this equipment to supply a certain beverage from roasted coffee beans.EFFECT: group of inventions provides a fully automatic process, starting with storage of fried coffee beans and ending with feeding a coffee drink into a cup with higher flexibility of the process.13 cl, 20 dwg","1. Оборудование для помола и экстракции обжаренных кофейных зерен, включающее устройство (60) для помола и связанное устройство (70) экстракции;
причем устройство (60) для помола включает в себя один или более корпусов для приема одного или более контейнеров (10, 20) для зерен с обжаренными кофейными зернами одного и того же или разных типов; при этом устройство (60) для помола включает в себя считывающее устройство (62) для получения информации о параметрах продукта для обжаренных кофейных зерен в одном или более контейнерах (10, 20) для зерен; причем устройство (60) для помола включает в себя блок управления, выполненный с возможностью адаптации степени помола и количества обжаренных кофейных зерен для получения определенной кофейной смеси из каждого контейнера для зерен, подлежащей помолу в соответствии с этими параметрами продукта и/или в соответствии с базой (64) данных рецептур, содержащей информацию о напитке, связанную с напитком, подлежащим приготовлению;
при этом устройство (60) для помола включает в себя кодер (62) для кодирования информации о напитке на программируемом идентификационном средстве (65) на держателе (61) продукта в устройстве (60) для помола, куда направляется молотый кофе;
причем устройство (70) экстракции выполнено с возможностью приема держателя (61) продукта и включает в себя средство (72) считывания для идентификации информации о напитке в упомянутом идентификационном средстве (65) на держателе продукта, при этом устройство (70) экстракции включает в себя блок управления для экстракции напитка в соответствии с извлеченной информацией о напитке и/или согласно информации о напитке, извлеченной из базы данных о напитках в этом блоке управления.
2. Оборудование для помола и экстракции обжаренных кофейных зерен по п. 1, в котором информация о напитке включает в себя одно или множество из следующих данных: тип напитка, объем напитка, температура варки и/или профиль работы варочного насоса, варочный профиль с учетом времени.
3. Оборудование д","A47J31/42, A47J31/44, A23F5/08",20250213,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023362000A1,Foaming ingredient,"The present invention relates to a foaming ingredient comprising one or more branched polysaccharide. The present invention also relates to a beverage powder comprising said foaming ingredient, a method for preparing said foaming ingredient and the use of said foaming ingredient to prepare a foaming beverage or foodstuff.","<div class=""indep-clm"" num=""1""><seg-main>1. A foaming ingredient comprising </seg-main><seg-clauses>carbohydrate and entrapped gas, wherein the carbohydrate comprises or consists of one or more branched polysaccharide.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The foaming ingredient according to claim 1, wherein </seg-main><seg-clauses><seg-main>the one or more branched polysaccharide has: </seg-main><seg-clauses>(i) a degree of branching of about 20% or more, about 25% or more, about 30% or more, about 35% or more, about 40% or more, about 45% or more, or about 50% or more; </seg-clauses><seg-clauses>(ii) a conformation slope of about 0.49 or less, about 0.48 or less, about 0.47 or less, about 0.46 or less, about 0.45 or less, about 0.44 or less, or about 0.43 or less; and/or </seg-clauses><seg-clauses>(iii) a Mark-Houwink-Sakurada (MHS) slope of about 0.40 or less, about 0.39 or less, about 0.38 or less, about 0.37 or less, or about 0.36 or less.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The foaming ingredient according to claim 1 or 2, wherein </seg-main><seg-clauses>the one or more branched polysaccharide comprises or consists of one or more branched dextrin, one or more polydextrose, one or more arabinogalactan, or any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The foaming ingredient according to any preceding claim, wherein </seg-main><seg-clauses>the foaming ingredient comprises the one or more branched polysaccharide in a total amount of from about 50 wt% to about 90 wt%, from about 55 wt% to about 90 wt%, or from about 60 wt% to about 90 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The foaming ingredient according to any preceding claim, wherein </seg-main><seg-clauses>the foaming ingredient comprises one or more emulsifier in an amount of from about 5 wt% to about 30 wt%, from about 5 wt","A23F5/40, A23C9/152, A23C13/12, A23L2/54, A23L29/25",20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024264521A1,Packaging item with fragrance diffusor and packaged food product,"The present invention relates to a packaging item comprising a cylindrical container made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer The container has a dispensing opening. The packaging item further comprises at least one sliding closure element with at least one sliding closure element peripheral wall, the sliding closure element being configured to be slid over at least a top end portion of the container peripheral wall and being made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer. The present invention further relates to a packaged food product.","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (1) comprising:</seg-main>
<seg-clauses>(i) At least one tridimensional internal packaging element (2) having a peripheral wall (4) closed at one end with a closing wall (5) so as to define a cavity (8) for a product, and</seg-clauses>
<seg-clauses>(ii) At least one tridimensional external packaging element (11) having a peripheral wall (12) closed at one end with a closing wall (13) so as to define a cavity having a shape that matches the external shape of said internal packaging element (2),</seg-clauses>
<seg-clauses class=""seg-enter"">the external packaging element (11) being slidably connected to the internal packaging element (2), in order to open or close the packaging item (1), and wherein the peripheral wall (12) of the external packaging element comprises at least one fragrance vent (20) allowing passage of volatile compounds entrapped in the packaging contents together with gas contained within the cavity (8), outside of said packaging item (1), when the external packaging element (11) is slid overthe internal packaging element </seg-clauses><seg-clauses>(2) during closing of the packaging item (1).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A packaging item (1) according to claim 1, wherein:</seg-main>
<seg-clauses>-           The internal packaging element is a core container (2) made of a</seg-clauses>
<seg-clauses class=""seg-enter"">multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic and/or inorganic barrier layer, the cardboard having a grammage comprised between 120 and 600 g/m2 and a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, such that the Oxygen Transmission Rate (OTR) is below 1, preferably below 0.5 cm3/m2/day measured at 23°C and 50% relative humidity (RH), and the Water Vapour Transmission rate (WVTR) is below 1, preferably below 0.5 g/m2/day measured at 23°C and 85% RH,","B65D3/22, B65D5/72, B65D83/06",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025228992A1,Exosomes and uses thereof,,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1. An isolated human breast milk exosome, wherein </seg-main><seg-clauses>Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4) and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) are not detected by liquid chromatography - mass spectrometry in the exosome, for use in preventing, treating, or ameliorating systemic inflammation or symptoms associated with systemic inflammation.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of preventing, treating, or ameliorating systemic inflammation or symptoms associated with systemic inflammation, the method comprising </seg-main><seg-clauses>administering to a subject in need thereof a therapeutically effective amount of an isolated human breast milk exosome, wherein Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (AP0A4) and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) are not detected by liquid chromatography - mass spectrometry in the exosome.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. An isolated human breast milk exosome, wherein </seg-main><seg-clauses>Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4) and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) are not detected by liquid chromatography - mass spectrometry in the exosome, for use in preventing, treating or ameliorating diseases or conditions associated with reduced systemic immunity.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-main>4. A method of preventing, treating or ameliorating diseases or conditions associated with reduced systemic immunity, the method comprising </seg-main><seg-clauses>administering to a subject in need thereof a therapeutically effective amount of an isolated human breast milk exosome, wherein Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (AP0A4) and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) are not detected by liquid chromatograp","C12N5/071, A61K35/20",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025191059A1,Diets and compositions for improving or maintaining cardiovascular health,"The present invention provides a diet, and a nutritional composition or supplement, for use in improving or maintaining cardiovascular health in a subject, wherein the diet comprises a total energy intake of 16.0 MJ/day or less, and wherein the diet, or the nutritional composition or supplement, comprises from 10 E% to 35 E% protein, from 8 E% to 22 E% fat, and from 55 E% to 80 E% carbohydrate.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A predetermined diet for use in improving or maintaining cardiovascular health in a subject, wherein </seg-main><seg-clauses>the diet comprises a total energy intake of 16.0 MJ/day or less, and wherein the diet comprises from 20 E% to 45 E% protein, from 35 E% to 62 E% fat, and from 15 E% to 35 E% carbohydrate.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The diet for use according to claim 1 , wherein </seg-main><seg-clauses><seg-main>the diet comprises:</seg-main>
<seg-clauses>(a) protein in an amount of from 20 E% to 44 E%, from 20 E% to 43 E%, from 21 E% to 43 E%, from 21 E% to 42 E%, or from 22 E% to 42 E%;</seg-clauses>
<seg-clauses>(b) fat in an amount of from 35 E% to 61 E%, from 35 E% to 60 E%, from 36 E% to 60 E%, from 37 E% to 60 E%, from 38 E% to 60 E%, from 39 E% to 60 E%, or from 40 E% to 60 E%; and/or</seg-clauses>
<seg-clauses>(c) carbohydrate in an amount of from 15 E% to 30 E%, from 15 E% to 29 E%, from 15 E% to 28 E%, from 16 E% to 27 E%, from 17 E% to 26 E%, or from 18 E% to 25 E%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The diet for use according to claim 1 or 2, wherein </seg-main><seg-clauses>the diet is administered to the subject for at least one month, at least two months, at least three months, at least six months, at least nine months, or at least twelve months.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The diet for use according to any preceding claim, wherein </seg-main><seg-clauses>the diet comprises at least 4 food groups per day, at least 5 food groups per day, at least 6 food groups per day, or at least 7 food groups per day.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The diet for use according to any preceding claim, wherein </seg-main><seg-clauses>the subject is human, preferably wherein the subject is an adult, more preferably wherein","A23L33/00, A61P3/00, A61P9/00, A61P9/10",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN120154071A,Dietary butyrates,"The present invention relates to dietary butyrates, in particular compounds having the formula (1), (2), (3), (4) wherein R1, R2, R3, R4, R5 and R6 are independently long chain fatty acids having 16 to 20 carbons, or combinations thereof, for use in the treatment or prevention of cardiovascular disorders in a subject. # imgabs0 #","<div class=""indep-clm"" num=""1"">1.具有下式的化合物，</div>
<div class=""indep-clm"" num=""1"">(1)<img src="""" class=""img-anchor"" img-id=""FDA0005285675140000011""></div>
<div class=""indep-clm"" num=""1"">或其组合，其用于预防或治疗个体的心血管障碍，其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和R<sup>6</sup>独立地为具有16至20个碳的长链脂肪酸。</div>
<div class=""indep-clm"" num=""2"">2.组合物，所述组合物包含具有下式的化合物</div>
<div class=""indep-clm"" num=""2"">(1)<img src="""" class=""img-anchor"" img-id=""FDA0005285675140000012""></div>
<div class=""indep-clm"" num=""2"">或其组合，其用于预防或治疗个体的心血管障碍，其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和R<sup>6</sup>独立地为具有16至20个碳的长链脂肪酸。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2用于所述用途的组合物，其中所述组合物包含具有式(1)的化合物、具有式(2)的化合物、具有式(3)的化合物和具有式(4)的化合物。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或权利要求3用于所述用途的组合物，其中所述具有式(1)的化合物、所述具有式(2)的化合物、所述具有式(3)的化合物和所述具有式(4)的化合物占所述组合物中总甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">5.根据权利要求2至4中任一项用于所述用途的组合物，其中所述具有式(1)的化合物、所述具有式(2)的化合物、所述具有式(3)的化合物和所述具有式(4)的化合物占所述组合物中总的含丁酸酯部分的甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据权利要求2至5中任一项用于所述用途的组合物，其中甘油三丁酸酯占所述组合物中总甘油三酯的小于10重量％，优选地小于8重量％，更优选地占所述组合物中总甘油三酯的小于5重量％。</div>
<div class=""dep-clm"" num=""7"" parent=""2,3,4,5,6"">7.根据权利要求2至6中任一项用于所述用途的组合物，其中所述组合物还包含膳食纤维。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3,4,5,6,7"">8.根据权利要求2至7中任一项用于所述用途的组合物，其中所述组合物是营养组合物、膳食补充剂或宠物护理产品。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1用于所述用途的化合物或其组合，或根据权利要求2至8中任一项用于所述用途的组合物，其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和/或R<sup>6</sup>为不饱和脂肪酸，优选地为单不饱和的。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求1或权利要求9用于所述用途的化合物或其组合，或根据权利要求2至9中任一项用于所述用途的组合物，其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和/或R<sup>6</sup>选自油酸、棕榈酸或亚油酸，优选地其中R<sup>1</sup>、R<sup>2</sup>、R<sup>3</sup>、R<sup>4</sup>、R<sup>5</sup>和R<sup>6</sup>均为油酸。</div>
<div cla","A23K20/158, A23L33/12, A61K31/231, A61P9/10, A61P9/04",20250617,雀巢产品有限公司,['Pending']
US12245717B2,System for multi-ingredient beverage preparation from various container types,"A beverage preparation machine includes a fluid system comprising a fluid source, a pump, a heating element, at least two container holders adapted for receiving ingredient containers, and a control unit for controlling the fluid system to prepare a beverage by mixing fluid with the beverage ingredient contained in the containers to produce a mixed beverage component in each of the containers. The control unit is further arranged to dispense part or whole of the mixed components sequentially or simultaneously to produce the beverage. The container holders differ from one another for holding containers of different sizes and/or types. Separate fluid injection interfaces have different structural and kinematic configurations and are arranged for independently delivering fluid in one of the corresponding ingredient containers. Each interface is connected to the fluid system and adapted to a different container.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage preparation machine </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fluid system comprising a fluid source, a fluid pump, a fluid heating element, a first container holder and a second container holder, wherein each of the first and second container holders are adapted for receiving a corresponding first beverage ingredient container and second beverage ingredient container, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control unit arranged for controlling the fluid system to prepare a beverage by mixing fluid with the beverage ingredients contained in the first and second beverage ingredient containers to produce a beverage component in each of the first and second beverage ingredient containers and to dispense at least a portion of each of the beverage components of the first and second beverage ingredient containers at least sequentially in a controlled manner to produce the beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the first and second container holders differ from each other for holding the first and second beverage ingredient containers of different sizes and types, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the beverage preparation machine further comprises a first fluid delivery interface and a second fluid delivery interface which are separate and respectively arranged for independently delivering the fluid in the corresponding first and second beverage ingredient containers, each of the first and second fluid delivery interfaces being connected to the fluid system and being adapted to the different first and second beverage ingredient containers,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the separate first and second fluid delivery interfaces have different structural and kinematic configurations,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the different kinematic configu","A47J31/36, A47J31/40, A47J31/46",20250311,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250279179A1,"Methods, devices, and compositions to meet nutritional needs in an environmentally sustainable manner","A tailored dietary product recommendation tool, more specifically, a tool for providing optimized nutrition recommendations and products is provided in an environmentally sustainable manner tailored to a dietary pattern of a user. The tool can be used for preventing and/or reducing a risk of a nutrient inadequacy, achieving a nutrient adequacy, meeting a nutrition need, and/or minimizing a nutrient gap in a subject in need thereof in an environmentally sustainable manner. For example, a nutrition need of the user can be assessed. Then, potential environmental impacts can be estimated for combinations of existing food products that meet the nutrient need of the user. The combination with the lowest environmental impact can be recommended to the user, who can then place an order accordingly. The producer can pre-pack existing products according to the order and ship them to the user.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of preventing and/or reducing a risk of a nutrient inadequacy, achieving a nutrient adequacy, meeting a nutrition need, and/or minimizing a nutrient gap in a subject in need thereof in an environmentally sustainable manner, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>assessing a nutrition need of the subject;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>providing combinations of existing food products that meet the nutrient need of the subject;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>estimating a potential environmental impact value for each of the combinations of the existing food products;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>selecting a combination of the existing food products with a lowest potential environmental impact value;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>placing an order of the combination of the existing food products with the lowest potential environmental impact; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>providing a pre-packed article in reply to the order, the pre-packed article comprising the combination of the existing food products with the lowest potential environmental impact value.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the assessing of the nutrition need of the subject comprises calculating a nutrient gap of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method according to claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the nutrient gap is calculated as (a daily nutrient intake recommendation−an average nutrient intake in a cluster of subjects)/the daily nutrient intake recommendation, and nutrient intakes within the cluster are more similar to each other than to those in other ","G16H20/60, G06Q30/0601",20250904,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119731097A,Beverage extraction system,"The invention relates to a system comprising an extraction device and a capsule of a beverage preparation machine, where-the capsule comprises a capsule body and a top cover, and-the extraction device comprises:-an upstream capsule enclosing part and a downstream capsule enclosing part, the present invention relates to a capsule extraction device comprising an upstream capsule enclosing member and a downstream capsule enclosing member relatively translatable between an open position for inserting and/or ejecting the capsule and a closed position for forming an extraction chamber enclosing the capsule during extraction, the downstream member comprising a downstream planar piercing arrangement for opening the cover of the capsule, and wherein the body of the pouch and the cover are made of a multilayer paper material comprising a paper layer coated with at least one plastic layer, and the outer surface of the multilayer paper material of the top cover is covered with a layer having a surface tension of less than 40 dynes/cm.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括饮料制备机器和囊包，所述囊包包含饮料配料，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包(3)包括第一包封壁(31)和第二包封壁(31'、32)，所述第一囊包包封壁和所述第二囊包包封壁限定用于包封所述饮料配料(33)的腔室，并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包的所述第一囊包包封壁和所述第二囊包包封壁由多层纸材料制成，所述材料包括组装在一起的纸层(A)和至少一个塑料层(B)、优选可堆肥塑料层，并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述多层纸材料被取向成使得所述塑料层面向所述囊包的所述腔室的内部部分，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述饮料制备机器包括提取装置，并且所述提取装置</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-上游囊包包封部件(2)和下游囊包包封部件(1)，所述上游囊包包封部件和所述下游囊包包封部件能够沿着纵向轴线(XX')在用于插入和/或弹出所述囊包(3)的打开位置和用于在提取期间形成包封所述囊包的提取室(5)的闭合位置之间相对平移，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述上游部件(2)承载用于打开所述囊包的所述第一包封壁(31)的上游刺穿排布结构(22)和液体注入器(25)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述下游部件(1)包括用于打开所述囊包的所述第二包封壁(32)的下游刺穿排布结构(12)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中在至少所述第二囊包包封壁(32)中，所述多层纸材料的外表面被保护层(C)覆盖，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述保护层的外表面具有低于40达因/厘米、优选地低于38达因/厘米、甚至更优选地低于36达因/厘米的表面张力。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据前述权利要求中任一项所述的系统，其中用于打开所述囊包的所述第二包封壁(32)的所述下游平面刺穿排布结构(12)包括刚性板，并且</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-所述刚性板的转向所述囊包的所述第二壁的表面包括打开元件，</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-所述刚性板包括穿孔用以排出从打开的第二壁分配的饮料。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的系统，其中所述塑料层选自以下各项的列表：</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-聚乳酸(PLA)层，</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-聚琥珀酸丁二醇酯(PBS)层，</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-聚己二酸对苯二甲酸丁二醇酯(PBAT)层，</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-聚羟基链烷酸酯(PHA)层，</div>
<div class=""",B65D85/804,20250328,雀巢产品有限公司,['Pending']
WO2025008458A1,Functionalized biocatalytical compositions comprising pancreatic enzymes,"The present invention relates to a composition comprising a solid carrier, a lipase or a fragment thereof immobilized on the surface of the solid carrier wherein the lipase or a fragment thereof is in the open conformation, a protease or a fragment thereof immobilized on the surface of the solid carrier, an amylase or a fragment thereof immobilized on the surface of the solid carrier, an agent which interacts with the lid domain of the lipase or a fragment thereof, a protective layer to protect the lipase or a fragment thereof, the protease or a fragment thereof and the amylase or a fragment thereof by embedding the lipase or a fragment thereof, the protease or a fragment thereof and the amylase or a fragment thereof, and a functional constituent immobilized on the surface of the protective layer, wherein the functional constituent immobilized on the surface of the protective layer is a polymer comprising repeat units wherein each repeat unit comprises at least one amino group and/or at least one thiol group.",,"A61K38/46, A61P1/14, A61P1/18, A61K38/54, C12N9/94",20250109,PERSEO PHARMA AG,['PCT designated period']
AU2023347035A1,Method for obtaining outlet openings of a capsule,,,"B26F1/04, B26F1/24, B26F1/38, B65D85/804",20250220,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250368425A1,Reusable container for frozen products,"A method stores or transports a frozen food composition in a reusable container. The method includes receiving the food composition in a first container, the first container comprising an opening and a bottom, and a portion of the first container has a frustoconical shape. The method also includes attaching a first lid to the first container to cover the opening in a closed position in which the first lid closes off the opening of the first container. The method further includes forming an air gap between the first container and a first jacket, by moving a fastening member into an engaged position that engages the first jacket to at least one of the first container with a frozen food composition therein or the first lid on the first container with the first frozen food composition therein. The first container, the first lid and the first jacket are separate parts in a non-engaged position of the fastening member. The fastening member, in the engaged position where the fastening member engages the first jacket to the at least one of the first container or the first lid on the first container, does not hermetically seal the air gap that is created between the first container and the first jacket. The method yet further includes causing a convection of air between a wall of the first jacket and the portion of the first container having the frustoconical shape, while the fastening member is in the engaged position, whereby the air receives heat transfer from the wall of the first jacket and rises along the wall of the first jacket towards a wall of a top half of the first container, the air then cools down due to a temperature of the frozen food composition and begins to move downwards along the wall of the first portion of the first container toward the bottom of the first jacket where the air is heated up again, thereby causing a circulation of the air.","<div class=""indep-clm"" num=""1""><seg-con>1: A method of storing or transporting a frozen food composition in a reusable container, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>receiving the food composition in a first container, the first container comprising an opening and a bottom, and a portion of the first container has a frustoconical shape;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>attaching a first lid to the first container to cover the opening in a closed position in which the first lid closes off the opening of the first container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>forming an air gap between the first container and a first jacket, by moving a fastening member into an engaged position that engages the first jacket to at least one of the first container with a frozen food composition therein or the first lid on the first container with the first frozen food composition therein, and wherein the first container, the first lid and the first jacket are separate parts in a non-engaged position of the fastening member,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the fastening member, in the engaged position wherein the fastening member engages the first jacket to the at least one of the first container or the first lid on the first container, does not hermetically seal the air gap that is created between the first container and the first jacket; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>causing a convection of air between a wall of the first jacket and the portion of the first container having the frustoconical shape, while the fastening member is in the engaged position, whereby the air receives heat transfer from the wall of the first jacket and rises along the wall of the first jacket towards a wall of a top half of the first container, the air then cools down due to a temperature of the frozen food composition and begins to","B65D81/38, B65D85/78",20251204,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12178354B2,Automatic beverage machine,"The invention pertains to the field of the beverage preparation machines having an ingredient processing module for preparing a beverage with at least one ingredient supplied with a capsule. The machine comprises a positioner arranged to hold at least one capsule out of the ingredient processing module. It further comprises a sensing arrangement adapted to detect an event related to the insertion by a user of a capsule and/or the presence of the capsule on or into the positioner. The machine is configured, upon detection of the event, to transfer the capsule to the ingredient processing module by using transfer means, and then to start the preparation of the beverage. More particularly, the invention relates to a machine providing a convenient and safe solution to fully automate the preparation of a beverage.",,"A47J31/44, A47J31/36, A47J31/52",20241231,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20250344713A1,Soluble coffee powder,A soluble beverage powder includes dried coffee extract particles having two essentially flat surfaces and a uniform thickness. A further aspect is a process for making a freeze-dried soluble beverage powder.,"<div class=""indep-clm"" num=""1""><seg-con>1: A process for making a soluble beverage powder, the process </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing a liquid coffee extract having a total solids content between 5 and 65%;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>forming a layer of the liquid coffee extract between and in contact with flat surfaces, the layer of the liquid coffee extract having a thickness from 0.1 to 10 mm;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>cooling the layer of the liquid coffee extract to below −25° C. to form a frozen coffee extract; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>drying the frozen coffee extract.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The process of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the flat surfaces comprise one or more moving bands.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The process of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cooling is applied to at least one of the one or more moving bands.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4: The process of claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-comp>greater cooling is applied to one moving band than another moving band.</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-comp>5</seg-comp><seg-comp>: </seg-comp></div><div class=""dep-clm"" num=""5"" parent=""2""><seg-con>The process of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more moving bands pass through multiple cooling zones.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6: The process of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>belts are oriented vertically, and the liquid coffee extract is fed between the belts at the top and travels downwards in contact with the belts to form the frozen coffee extrac","A23F5/32, A23F5/38",20251113,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12324450B2,"Beverages having clear appearance, shelf stability, high protein, and neutral pH","A method of making a beverage includes adding one or more other ingredients to hydrolyzed protein to form the beverage, which is clear, shelf-stable, and high protein and has a neutral pH and an energy content of at least about 100 kcal per 240 ml of the beverage. Optionally the hydrolyzed protein is obtained by subjecting protein to a protease. In some embodiments, the high protein is at least about 15 g or at least about 20 g of protein/100 kcal, and in some embodiments the energy content is at least about 150 kcal/240 ml or at least about 200 kcal/240 ml. Other aspects are directed to the resultant beverage, a method of producing a high protein beverage containing hydrolyzed protein, a method of increasing transparency in a high protein beverage containing hydrolyzed protein, and a method of providing nutrition to an individual.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of making a beverage, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>hydrolyzing protein with a protease; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>adding one or more other ingredients to the hydrolyzed protein to form the beverage, which has an absorbance of 0.35 or lower at a wavelength of 600 nm measured using an ultraviolet and visible spectrophotometer, shelf-stability, about 15 g to about 25 g protein/100 kcal of the beverage, a neutral pH and an energy content of about 200 kcal to about 360 kcal per 240 ml of the beverage,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the hydrolyzed protein is at least 50 wt. % of the protein in the beverage.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the protease is selected from the group consisting of trypsin, chymotrypsin, pancreatin, papain, bromelain, and pepsin and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage comprises the protease.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage is a ready-to-drink (RTD) beverage.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage contains zero fat.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more other ingredients comprise sugar in an amount up to 25% of the energy content of the beverage.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-tr","A23L2/66, A23F3/00, A23L2/60, A23L2/84",20250610,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2837747C1,dispenser,"FIELD: dosing devices.SUBSTANCE: invention relates to dispenser (100) made as an integral part of moulded fibrous semi-finished product. Dispensing device (100) comprises container part (200) for receiving and retaining dispensed material, having opening (250) on upper side (US) of dispensing device (100) for access to dispensed material. Dispensing device (100) comprises handle (300) for manual movement of container part (200) during dispensing. Handle (300) is connected to outer surface (211) of container body (210) by means of connecting part (350) of handle (300). Rim zone (252) of container part (200), which limits opening (250), and handle (300) pass in common plane (CP) and form peripheral edge (101) of dispenser (100). Dispenser (100) comprises ribbed part (400), which passes from peripheral edge (101) at least on handle (300) to lower side of dispenser (100), for dissipation of mechanical stresses occurring during dosing process. Invention also relates to a method of making dispenser (100) and use of dispenser (100) for dispensing the material to be dispensed.EFFECT: providing a dispensing device which is flexible and mechanically resilient, made from a processed and environmentally safe material, such as a moulded fibrous semi-finished product, which is suitable for multiple and frequent use during manual dispensing.15 cl, 7 dwg","1. Дозирующее устройство (100), выполненное за одно целое из формованного волокнистого полуфабриката, содержащее:
- контейнерную часть (200), имеющую заданный объем (255) для приема и удерживания дозируемого материала, причем контейнерная часть (200) имеет корпус (210) контейнера, который имеет заданный объем (255), при этом корпус (210) контейнера имеет ободковую зону (252), которая по окружности образует проем (250) на верхней стороне (US) дозирующего устройства (100) для доступа к заданному объему (255);
- рукоятку (300) для перемещения контейнерной части (200) относительно дозируемого материала вручную в процессе дозирования;
причем рукоятка (300) соединена с наружной поверхностью (211) корпуса (210) контейнера посредством соединительной части (350) рукоятки (300) и проходит от корпуса (210) контейнера вдоль продольной оси (LA);
при этом ободковая зона (252) и рукоятка (300) проходят в общей плоскости (CP) и образуют периферийный край (101) дозирующего устройства (100), проходящий в общей плоскости (CP); и
- ребристую часть (400), которая проходит от периферийного края (101) по меньшей мере на рукоятке (300) к нижней стороне дозирующего устройства (100) таким образом, что механические напряжения, действующие на корпус (210) контейнера в процессе дозирования, рассеиваются рукояткой (300).
2. Дозирующее устройство (100) по п. 1, в котором ребристая часть (400) проходит от периферийного края (101) по меньшей мере на рукоятке (300) на противоположных сторонах продольной оси (LA), и при этом предпочтительно ребристая часть (400) проходит от периферийного края (101) на ободковой зоне (252) и/или предпочтительно от всего периферийного края (101) дозирующего устройства (100), более предпочтительно непрерывно проходит вдоль периферийного края (101).
3. Дозирующее устройство (100) по п. 1 или 2, в котором ребристая часть (400) на ее конце, противоположном периферийному краю (101), проходит по меньшей мере частично в плоскости нижней стороны (LSP), которая предпочтительно ","G01F19/00, A47G21/00",20250403,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN120513027A,"Aerated creamers, packaged ready-to-use aerated creamers, and methods of making and using such creamers","An aerated creamer containing: a lipid selected from the group consisting of a combination of saturated fat and liquid fat, coconut oil, hydrogenated vegetable oil, and hydrogenated palm oil; a first emulsifier selected from the group consisting of diacetyl tartaric acid mono/diglycerides (DATEM), monoglycerides, diglycerides, lecithin, and mixtures thereof; a second emulsifier selected from the group consisting of polyoxyethylene-20 sorbitan monooleate (polysorbate 80), lactic acid mono/diglyceride (LACTEM), and mixtures thereof; and a stabilizer blend comprising cellulose and K-carrageenan. The aerated creamer has an expansion rate of 105% to 135%. A method of making a foamy beverage, the method comprising adding the aerated creamer to ice coffee or hot coffee. A packaged product, the packaged product comprising a container; and an aerated creamer, the aerated milk being precisely enclosed in the container. A method of making a foamed beverage, the method comprising opening the container of the packaged product; and adding the aerated creamer from the open container to ice coffee or hot coffee.","<div class=""indep-clm"" num=""1"">1.充气奶精，所述充气奶精包含：</div>
<div class=""indep-clm"" num=""1"">脂质，所述脂质选自椰子油、氢化植物油以及饱和脂肪与不饱和脂肪的组合；</div>
<div class=""indep-clm"" num=""1"">第一乳化剂，所述第一乳化剂选自双乙酰酒石酸单双甘油酯(DATEM)、单甘油酯、双甘油酯、卵磷脂、及其混合物；</div>
<div class=""indep-clm"" num=""1"">第二乳化剂，所述第二乳化剂选自聚氧乙烯-20脱水山梨糖醇单油酸酯(聚山梨酯80)、乳酸单双甘油酯(Lactem)、及其混合物；以及</div>
<div class=""indep-clm"" num=""1"">包含纤维素和κ-角叉菜胶的稳定剂共混物，</div>
<div class=""indep-clm"" num=""1"">其中所述充气奶精具有105％至135％的膨胀率。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的充气奶精，其中所述脂质包含椰子油，优选所述椰子油的量为所述充气奶精的25.0重量％至30.0重量％。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或权利要求2所述的充气奶精，其中所述第一乳化剂包含DATEM和单甘油酯，并且/或者所述第二乳化剂包含聚山梨酯80。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的充气奶精，其中(DATEM+单甘油酯)：聚山梨酯80的重量比在2.0：1至3.0：1的范围内，并且/或者(DATEM+单甘油酯+聚山梨酯80)：椰子油的重量比在1：50至1：60的范围内。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的充气奶精，其中所述膨胀率为约120％。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的充气奶精，所述充气奶精还包含至少一种选自水、甜味剂、缓冲盐、风味剂、着色剂、氯化钠、及其混合物的另外的组分。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的充气奶精，所述充气奶精未被冷冻。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的充气奶精，所述充气奶精不是粉末。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的充气奶精，所述充气奶精还包含蛋白质。</div>
<div class=""indep-clm"" num=""10"">10.制作泡沫饮料的方法，所述方法包括将根据权利要求1至9中任一项所述的充气奶精添加到冰咖啡或热咖啡中。</div>
<div class=""dep-clm"" num=""11"" parent=""10"">11.根据权利要求10所述的方法，其中消费者将所述充气奶精添加到所述冰咖啡或热咖啡中，并且所述充气奶精与所述冰咖啡或热咖啡是分开提供的。</div>
<div class=""dep-clm"" num=""12"" parent=""10,11"">12.根据权利要求10或权利要求11所述的方法，其中所述消费者在将所述充气奶精添加到所述冰咖啡或热咖啡中之前将所述充气奶精储存在冷藏温度下；并且所述充气奶精不经受所述消费者的任何冷冻，不储存在气溶胶罐中，并且不通过气溶胶罐添加到所述冰咖啡或热咖啡中。</div>
<div class=""dep-clm"" num=""13"" parent=""10,11,12"">13.根据权利要求10至12中任一项所述的方法，其中将所述充气奶精添加到所述冰咖啡或热咖啡中不使用致动器，并且不使所述充气奶精经受推进剂。</div>
<div class=""indep-clm"" num=""14""><seg-con>14.包装产品，所述包装产品</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""14""><seg-comp>容器；</seg-comp><seg-comp>和</seg-comp",A23F5/24,20250819,雀巢产品有限公司,['Pending']
EP4588408A1,Machine for homogenising a food substance,"A machine (1) for homogenising a food substance has: a container (10) with a side wall (11) and a bottom wall (12) delimiting a cavity (10'); an impeller (30) with an impelling member (31) forming an impelling surface (31',31"",31‴) that is drivable in rotation (r) about a central axial direction (30') of the impelling surface (31',31"",31‴) for imparting a mechanical effect to the food substance; and a module (20) which has a housing means (22') that contains an inner chamber (22,22a) and that delimits a seat (21) for the container (10), the chamber (22,22a) containing an electric motor (24). The electric motor (24) has an output drive axis (24') with a driver device (24'') configured to drive a follower device (35) of the impeller (30). The driver device (24'') and the follower device (35) are magnetically coupled through a sidewall (11) and/or bottom wall (12) of the container (10). The driver device (24'') comprises a ferromagnetic or magnetic field-generating element (24a) that is arranged to be magnetically coupled to a corresponding ferromagnetic or magnetic field-generating element (36) of the follower device (35). The follower device (35) extends over a predominant part of the bottom wall (12) of the container (10) or across a substantial part of the wall (12) along a diameter thereof. The driver device (24) extends over a predominant part of a bottom part of the seat (21) or across a substantial part of the bottom part of the seat (21) along a diameter thereof. The ferromagnetic and magnetic field generating elements (24a,36) are positioned at extremal or peripheral parts of the follower device (35) and of the driver device (24"").","<div class=""indep-clm"" num=""1""><seg-main>1.  A machine (1) for homogenising a food substance, such as frothing milk or a milk-based substance, as a standalone machine or as a machine incorporated in a food processor such as a beverage maker e.g. a coffee maker, such machine (1) comprising: </seg-main><seg-clauses>- a container (10), such as a mechanically and/or electrically passive container (10), having a side wall (11) and a bottom wall (12) delimiting a cavity (10'), the container being optionally - generally cup-shaped or bowl-shaped or cylinder-shaped wherein the sidewall (11) is generally upright and the bottom wall (12) is generally flat or curved; and/or </seg-clauses><seg-clauses>- provided with a thermally insulating outside material (10'') and/or with a handle, for seizure and optional displacement of the container (10) by a human hand; </seg-clauses><seg-clauses>- an impeller (30) comprising an impelling member (31) forming an impelling surface (31',31'',31''') that is drivable in rotation (r) about a central axial direction (30') of the impelling surface (31', 31'', 31‴) for imparting a mechanical effect to said food substance in the container (10) to homogenise different phases in the food substance, optionally the impelling surface (31', 31'', 31‴) extends over a predominant part of the bottom wall (12), such as an impelling surface having a surface area that is greater than 75 or 85% of the cavity's bottom wall (12); and </seg-clauses><seg-clauses><seg-main>- a module (20) which has a housing means (22') that contains an inner chamber (22,22a) and that delimits a seat (21), such as a generally planar or cylindrical or cup-shaped seat (21), on or in which the container (10) is mounted, such as removably mounted, the chamber (22,22a) containing one or more electric components (23,24,25,26) that include an electric motor (24) for driving the impelling member (31) in the container (10) and optionally a control unit (25) and/or a power management unit (2","A47J43/046, A47J27/00, B01F23/235, B01F27/1151, B01F35/92",20250723,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250057356A1,Beverage or foodstuff preparation system,"A system comprising: a container for containing precursor material, the container comprising a machine readable code, and; a machine for preparing a beverage or a foodstuff by processing said precursor material, the machine comprising: a code reading system to read said code; a processing unit for processing the precursor material of the container to the beverage or foodstuff; electronic memory storing a plurality of predefined recipes for controlling the processing unit; a user interface, and; electrical circuitry configured to control the processing unit to process the container based on a recipe stored in association with information encoded by the code, wherein the electrical circuitry is configured to select one of said recipes from the plurality of recipes based on both information encoded by the code and an input from the user interface.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container for containing precursor material, the container comprising a machine readable code, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine for preparing a beverage or a potable foodstuff by processing said precursor material, the machine comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read said code;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container to the beverage or foodstuff;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electronic memory storing a plurality of predefined recipes for controlling the processing unit to execute a preparation process in which the container is processed, wherein each recipe comprises a set of fixed value parameters that are required as input by the processing unit for the preparation process;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a user interface, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry configured to control the processing unit to execute a preparation process based on one of said recipes selected from said recipes,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein said recipes are stored in association with information encoded by the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an the electrical circuitry is configured to select one of said recipes from the plurality of recipes based on both information encoded by the code and an input from the user interface.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said parameters of the recipe are not individually adjustable by the user input.</seg-refi></div>
<div class=""dep-clm"" num=""3"" p","A47J31/44, A47J31/40, A47J31/52, B65D85/804",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119894390A,Compositions and methods for treating muscle decline associated with kidney disease or dysfunction,"The compositions comprise medium chain triglyceride (MCT) and at least one ingredient selected from the group consisting of fish oil, L-arginine, vitamin E, vitamin C, vitamin B3, vitamin B5, vitamin B6, vitamin B1, vitamin B2, folic acid, biotin, vitamin B12, and are formulated for the prevention and/or treatment of a disease or condition associated with muscle decline in a subject in need thereof. Preferably, the subject in need is an individual at risk of or having renal failure, renal dysfunction or/and nephropathy, such as chronic nephropathy, protein energy consumption, end-stage nephropathy, renal failure due to hospitalization in an intensive care unit, acute kidney injury, and the muscle decline is selected from the group consisting of muscle depletion, muscle loss due to renal failure or dysfunction, muscle decline associated with chronic kidney disease, muscle loss due to hospitalization in intensive care units during renal failure, metabolic acidosis during chronic kidney disease, protein energy depletion, or a combination thereof. The method enables the prevention and/or treatment of at least one outcome of a disease or condition associated with muscle decline in a subject at risk of or having renal failure, renal dysfunction or/and kidney disease. The composition and the method can be used to improve the level of at least one amino acid.","<div class=""indep-clm"" num=""1"">1.用于预防和/或治疗有需要的受试者的与肌肉衰退相关联的疾病或病症的营养组合物，所述营养组合物包含中链甘油三酯(MCT)和至少一种选自由以下项组成的组的成分：</div>
<div class=""indep-clm"" num=""1"">鱼油，</div>
<div class=""indep-clm"" num=""1"">L-精氨酸，</div>
<div class=""indep-clm"" num=""1"">维生素E，</div>
<div class=""indep-clm"" num=""1"">维生素C，</div>
<div class=""indep-clm"" num=""1"">维生素B3，</div>
<div class=""indep-clm"" num=""1"">维生素B5，</div>
<div class=""indep-clm"" num=""1"">维生素B6，</div>
<div class=""indep-clm"" num=""1"">维生素B1，</div>
<div class=""indep-clm"" num=""1"">维生素B2，</div>
<div class=""indep-clm"" num=""1"">叶酸，</div>
<div class=""indep-clm"" num=""1"">生物素，</div>
<div class=""indep-clm"" num=""1"">维生素B12。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的营养组合物，其中所述营养组合物包含每日量范围为每kg所述受试者的体重1000mg至约20000mg的中链甘油三酯(MCT)和至少一种选自由以下项组成的组的成分：</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约100mg至约5000mg的鱼油，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约100mg至约50000mg的L-精氨酸，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约1mg至约80000mg的维生素E，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.1mg至约2000mg的维生素C，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.2mg至约10mg的维生素B3，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.08mg至约500mg的维生素B5，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约50mg的维生素B6，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约5mg的维生素B1，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.03mg至约5mg的维生素B2，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.01mg至约5mg的叶酸，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.01mg至约0.1mg的生物素，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">每日量范围为每kg所述受试者的体重约0.001mg至约5mg的维生素B12。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的营养组合物，其中所述受试者是处于肾衰竭、肾功能障碍或/和肾病的风险或患有肾衰竭、肾功能障碍或/和肾病的个体。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的营养组合物，其中所述个体是人、家畜或宠物。</div>
<div class=""dep","A23L33/115, A23L33/12, A23L33/15, A23L33/175, A23K20/158",20250425,雀巢产品有限公司,['Pending']
AU2023374344A1,Roasted coffee,"The present invention relates to a process for roasting coffee, in particular to roasting extracted green coffee at elevated pressure followed by roasting at lower pressures. Further aspects of the invention are a roast coffee and a container for use in a beverage preparation device, the container containing the roast coffee.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for roasting coffee comprising</seg-main>
<seg-clauses>a. roasting extracted green coffee at a pressure greater than 2 bar for a period between 20 and 900 seconds, wherein the extracted green coffee before roasting comprises sucrose at an amount of less than 80% of the amount of sucrose in an un-extracted sample of the same coffee; and</seg-clauses>
<seg-clauses>b. roasting the roasted extracted coffee of step a at a pressure between 0.5 bar and 1.5 bar and at a coffee temperature of between 180°C and 260°C for a period between 20 and 1200 seconds.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process of claim 1 wherein </seg-main><seg-clauses>the extracted green coffee is obtained by extracting green coffee with an aqueous liquid and then separating the extracted green coffee from the extract.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The process of claim 2 wherein </seg-main><seg-clauses>the green coffee has not been heated to temperatures above 110°C before extraction.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The process of one of claims 1 to 3 wherein </seg-main><seg-clauses>the roasted extracted coffee of step a is combined with aqueous green coffee extract before being roasted in step b.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The process of claim 4 wherein </seg-main><seg-clauses>the aqueous green coffee extract is obtained by extracting green coffee with an aqueous liquid and then separating the extracted green coffee from the extract.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The process of any one of claims 1 to 5 wherein </seg-main><seg-clauses>the extracted green coffee is roasted in the presence of superheated steam at a pressure greater than 9.5 bar in step a).</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5""><seg","A23F5/04, A23F5/06, A23F5/16",20250410,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
MX374581B,Beverage preparation machine with refillable multi-dose container,"The invention concerns a machine for preparing beverages from a bulk beverage ingredient comprising : - a refillable multi-dose storing container (2) for storing the bulk beverage ingredient, said container presenting a storing volume defined between an opened bottom wall (201), a top wall (202) and lateral walls (203), and said refillable multi-dose storing container comprising an opening (21) for refilling the container with a bulk beverage ingredient and a removable cover (22) for closing the opening for refilling the container, - a dosing unit (3) for dosing the stored bulk beverage ingredient, said dosing unit cooperating with the opened bottom (202) of the refillable multi-dose storing container, wherein the machine comprises a receiving area (11) for removably receiving the assembly of the refillable multi-dose storing container (2) and the dosing unit (3) positioned at the bottom of the container, and wherein the opening (21) for refilling the container with a bulk beverage ingredient is positioned on one first portion (23) of the lateral walls of the refillable multi-dose storing container.","REIVINDICACIONES
<div class=""indep-clm"" num=""1""><seg-main>1. Una maquina </seg-main><seg-clauses>(1) para preparar bebidas a partir de un ingrediente a granel de bebidas, la maquina comprende:</seg-clauses>
<seg-clauses class=""seg-enter"">un recipiente de almacenamiento multidosis rellenable </seg-clauses><seg-clauses>(2) para almacenar el ingrediente a granel de bebida, el recipiente presenta un volumen de almacenamiento definido entre una pared inferior abierta (201), una pared superior (202) y paredes laterales (203), y el recipiente de almacenamiento multidosis rellenable comprende una abertura (21) para rellenar el recipiente con un ingrediente a granel de bebida y una cubierta retirable (22) para cerrar la abertura para rellenar el recipiente,</seg-clauses>
<seg-clauses class=""seg-enter"">una unidad dosificadora (3) para dosificar el ingrediente a granel de bebida almacenado, la unidad dosificadora coopera con la parte inferior abierta (202) del recipiente de almacenamiento multidosis rellenable,</seg-clauses>
<seg-clauses class=""seg-enter"">caracterizada porque la maquina comprende un area de recepcion (11) para recibir de manera retirable el recipiente de almacenamiento multidosis rellenable </seg-clauses><seg-clauses>(2) y la unidad dosificadora (3) posicionada en la parte inferior del recipiente, y</seg-clauses>
<seg-clauses class=""seg-enter"">donde la abertura (21) para el rellenado del recipiente con el ingrediente a granel de bebida se posiciona en una primera porcion (23) de las paredes laterales del recipiente de almacenamiento</seg-clauses>
<seg-clauses class=""seg-enter"">multidosis rellenable.</seg-clauses>
<seg-clauses class=""seg-enter"">INSTITUTO MEXICAN* DE LA PROPIEDAD INDUSTRIAL</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. Una maquina de conformidad con la reivindicacidn 1, caracterizada ademas porque una segunda porcion (24) de las paredes laterales del recipiente de almacenamiento multidosis rellenable, opuesta a la primera porci",A47J31/40,20250306,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250064252A1,Beverage preparation with compact conditioning chamber,"A machine (<b>1</b>) is configured for preparing a beverage (<b>4</b>) from an ingredient (<b>5</b><i>a</i>) in a processing cavity (<b>5</b>) by mixing it with water (<b>4′</b>) and centrifugally driving such ingredient (<b>5</b><i>a</i>) with the water (<b>4′</b>) about a processing axis (<b>30′</b>). The machine (<b>1</b>) comprises: a rotatable ingredient handling system (<b>10,20</b>) for holding and rotating the flavouring ingredient (<b>5</b><i>a</i>) and water during centrifugation about the processing axis (<b>30′</b>), the ingredient handling system (<b>10,20</b>) having a beverage outlet (<b>25</b>) and a water inlet (<b>24</b>); and a beverage conditioner (<b>50</b>) in fluid communication with the beverage outlet (<b>25</b>) and downstream thereof, the beverage conditioner (<b>50</b>) comprising a conditioning cavity (<b>51</b>) in which the beverage (<b>4</b>) supplied from the outlet (<b>25</b>) is refined. The conditioning cavity (<b>51</b>) is at least partly off-set relative to the processing cavity (<b>5</b>) along the processing axis (<b>30</b>′).","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing a beverage from a flavouring ingredient in a processing cavity by mixing said ingredient with water and centrifugally driving such ingredient and said water about a processing axis to form said beverage, such machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a rotatable ingredient handling system for holding and rotating said flavouring ingredient and water during centrifugation about the processing axis, the ingredient handling system having at least one beverage outlet and at least one water inlet for supplying said water to said ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a beverage conditioner in fluid communication with said at least one beverage outlet and downstream thereof, the beverage conditioner comprising a conditioning cavity in which said beverage supplied from the outlet is refined, the conditioning cavity extending about the processing axis and leading into a beverage exit passage e.g. exit conduit; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the ingredient handling system is rotated for centrifugation and which supports the ingredient handling system,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the conditioning cavity is at least partly off-set relative to the processing cavity along the processing axis.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the processing cavity extends about the processing axis up to a maximum processing distance from the processing axis and in that the conditioning cavity extends about the processing axis up to a maximum conditioning distance from the processing axis, the conditioning distance being equal to or smaller than the processing distance.</seg-refi></div>
<div class=""dep-clm"" num=""3"" paren",A47J31/22,20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
JP2025118885A,"Chocolate products, ingredients, processes and uses","To provide a method for producing an intermediate material for use in the manufacture of chocolate product compositions, the produced material, and a method for producing a chocolate product.SOLUTION: A process for producing an intermediate material comprises: a. a step of reducing the size of seeds and/or a portion of seeds of a plant in the Theobroma genus in the presence of i. pulp and/or an extract of pulp of a plant in the Theobroma genus, and/or ii. a non-pulp and non-seed portion of the fruit of a plant in the Theobroma genus, thereby producing a paste, or b. a step of reducing the size of seeds and/or a portion of seeds of a plant in the Theobroma genus, and mixing with either or both of i. and/or ii. to produce a paste, wherein the total amount of i. and ii. in the paste produced in step a. or step b. is 1.0 to 80.0 wt.% of the paste, and the amount of seeds and/or a portion of seeds in the paste produced in step a. or step b. is 20.0 to 99.0 wt.% of the paste.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> チョコレート製品組成物の製造に使用するための中間材料を製造する方法であって、前記方法は、</div>
<div class=""indep-clm"" num=""1""> ａ．テオブロマ属の植物の種子及び／又は種子の一部の、サイズを減少させる工程であって、</div>
<div class=""indep-clm"" num=""1""> ｉ．テオブロマ属の植物のパルプ及び／若しくはパルプ抽出物、及び／又は</div>
<div class=""indep-clm"" num=""1""> ｉｉ．テオブロマ属の植物の果実の非パルプかつ非種子部分、の存在下でサイズを減少させてペーストを生成する、工程、又は、</div>
<div class=""indep-clm"" num=""1""> ｂ．テオブロマ属の植物の種子及び／又は種子の一部の、サイズを減少させ、ｉ及び／若しくはｉｉのいずれか又は両方と混合してペーストを生成する工程と、</div>
<div class=""indep-clm"" num=""1""> を含む、テオブロマ属の植物由来の材料を製造することを含み、</div>
<div class=""indep-clm"" num=""1""> 工程ａ．又は工程ｂ．で生成されるペースト中のｉ．及びｉｉ．の総量が、前記ペーストの重量パーセントとして１．０～８０．０であり、工程ａ．又は工程ｂ．で生成されるペースト中の種子及び／又は種子の一部の、量が、前記ペーストの重量パーセントとして２０．０～９９．０である、方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記ペースト中のｉ．及び／又はｉｉ．の総量が、前記ペーストの重量パーセントとして１０．０～７０．０である、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記ペースト中の種子及び／又は種子の一部の、量が、前記ペーストの重量パーセントとして３０．０～９０．０である、請求項１又は２に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記サイズの減少が、粉砕、摩砕、破砕、磨り下ろし、及び／又は粉末化の工程を含む、請求項１～３のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記サイズの減少が、１０～５００μｍのサイズへの減少を含む、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> 前記ペーストがペーストの重量パーセントとして０．５～８０％の水分含有量を有する、請求項１～５のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記種子及び／又は種子の一部が、非焙煎及び／又は未発酵である、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記非パルプかつ非種子部分が、珠柄、胎座、内果皮、及び／又は中果皮を含む群から選択される、請求項１～７のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,",A23G1/06,20250813,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
EP4537676A2,Xanthan-based liquid concentrate,"A liquid thickener composition useful for subjects suffering from a dehydration, mastication and/or deglutination disease, disorder or condition, a container comprising the liquid thickener composition, a system comprising the container and a dispenser, a thickened liquid composition comprising the liquid thickener composition, a method for producing the liquid thickener composition and the thickened liquid composition are provided.","<div class=""indep-clm"" num=""1""><seg-main>1.  Liquid thickener composition comprising </seg-main><seg-clauses>about 1% to about 20 % by weight xanthan gum and about 10 % to about 50 % by weight acacia gum.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  Liquid thickener composition according to claim 1 comprising </seg-main><seg-clauses>about 4% to about 15%, about 4% to about 12 %, about 5% to about 11 %, about 6 % to about 10 %, about 7 % to about 9 %, about 8 % to about 9 %, or about 8% by weight xanthan gum.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  Liquid thickener composition according to any of the preceding claims comprising </seg-main><seg-clauses>about 10 % to about 40 %, about 10 % to about 30 %, about 15 % to about 20 %, about 17 to about 18, or about 18% by weight acacia gum, preferably selected from acacia Senegal, or alternatively about 20 % to about 50 %, about 20 % to about 40 %, or about 25 % to about 35 %, and most preferably about 27.5 % to about 32.5 %, or about 30% by weight acacia gum, preferably selected from acacia seyal.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  Liquid thickener composition according to any of the preceding claims, wherein </seg-main><seg-clauses>the acacia gum is selected from acacia senegal or acacia seyal.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  Liquid thickener composition according to any of the preceding claims, further comprising: </seg-main><seg-clauses>a. pectin or low methoxy pectin; and / or </seg-clauses><seg-clauses>b. a divalent earth alkaline salt optionally wherein the divalent earth alkaline salt is CaCl<sub>2</sub>.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6.  Liquid thickener composition according to any of the preceding claims, further comprising </seg-main><seg-clauses>at least one preservative, optionally, wherein the preservative is",A23L29/294,20250416,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2844180C1,Foaming ingredient,"FIELD: food industry.SUBSTANCE: disclosed is a porous soluble foaming ingredient. Ingredient has closed porosity from 20% to 80%, contains gas inclusions at pressure above atmospheric, wherein the ingredient contains from 60 to 97% of one or more carbohydrates in terms of dry substance and from 3% to 40% of vegetable protein in terms of dry substance. Vegetable protein is selected from the group consisting of pea protein, broad bean protein, gram protein, lentil protein, potato protein and combinations thereof, and the porous soluble foaming ingredient has a glass transition temperature of 50 °C to 90 °C, wherein the inclusions of gas are present in an amount sufficient to release at least 1 ml of gas at ambient conditions per gram of ingredient when adding aqueous liquid. Disclosed are: a soluble beverage powder containing a porous soluble foaming ingredient, a method of producing a porous soluble foaming ingredient comprising the following steps: a) spray drying a pressurized gas-saturated aqueous mixture containing vegetable protein and one or more carbohydrates to form a porous powder having a glass transition temperature, wherein aqueous mixture contains from 3 to 40% of vegetable protein in terms of dry substance, and the vegetable protein is subjected to homogenisation performed by means of a high pressure homogeniser; b) exposing the porous powder to a gas under pressure, wherein the porous powder is at a temperature above its glass transition temperature, such that closed pores present in the porous powder are filled with gas under pressure; c) cooling the porous powder to a temperature below its glass transition temperature; d) pressure release. Disclosed is use of porous soluble foaming ingredient for preparation of foaming beverage.EFFECT: porous soluble foaming ingredient whose characteristics are close to those of milk-based ingredients, forms a greater volume of foam than casein milk protein; foam is more rigid and more stable.12 cl, 2 dwg, 4 tbl, 3 ex","1. Пористый растворимый вспенивающий ингредиент, имеющий закрытую пористость от 20 до 80%, содержащий включения газа при давлении выше атмосферного, причём ингредиент содержит:
от 60 до 97% одного или более углеводов в пересчёте на сухое вещество;
от 3 до 40% растительного белка в пересчёте на сухое вещество;
причём растительный белок выбран из группы, состоящей из горохового белка, белка кормовых бобов, нутового белка, чечевичного белка, картофельного белка и их комбинаций, и пористый растворимый вспенивающий ингредиент имеет температуру стеклования от 50 до 90°C, и
при этом включения газа присутствуют в количестве, достаточном для высвобождения по меньшей мере 1 мл газа при условиях окружающей среды на грамм ингредиента при добавлении водной жидкости.
2. Пористый растворимый вспенивающий ингредиент по п. 1, в котором ингредиент приемлем для лиц, придерживающихся веганского рациона питания.
3. Пористый растворимый вспенивающий ингредиент по п. 1 или 2, содержащий менее 0,5 мас. % жира.
4. Пористый растворимый вспенивающий ингредиент по любому из предшествующих пунктов, имеющий форму порошка с распределением частиц по размерам D<sub>3,2</sub>от 10 до 500 мкм.
5. Пористый растворимый вспенивающий ингредиент по любому из предшествующих пунктов, в котором поры имеют распределение частиц по размерам D<sub>3,2</sub>от 0,1 до 40 мкм.
6. Растворимый порошок напитка, содержащий пористый растворимый вспенивающий ингредиент по любому из пп. 1-5.
7. Растворимый порошок напитка по п. 6, представляющий собой растворимый порошкообразный забеливатель.
8. Растворимый порошок напитка по п. 6 или 7, содержащий от 15 до 50 мас. % пористого растворимого вспенивающего ингредиента в пересчёте на сухое вещество.
9. Способ получения пористого растворимого вспенивающего ингредиента, включающий стадии:
a) распылительной сушки насыщенной газом, подаваемым под давлением, водной смеси, содержащей растительный белок и один или более углеводов, с образованием пористого порошка, имеющего температу","A23C11/02, A23C11/10, A23P10/40, A23P30/40, A23J3/14",20250728,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US12329179B2,Process and device for application of particles onto frozen confectionery,,"<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for decorating frozen confectionery on sticks, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a coating station configured for applying coating material onto the frozen confectionery,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a particle dispensing station configured for applying particles onto the frozen confectionery,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a conveyor configured for moving the frozen confectionery past the coating station and the particle dispensing station, the conveyor comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>gripping means arranged on the conveyor, the gripping means having a product attached position and an opened position configured for gripping and releasing a stick of the frozen confectionery, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>guides configured for moving the gripping means with the frozen confectionery between a vertical position and a horizontal position, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>coating removal means configured for removing the coating material on one side of the frozen confectionery, the coating removal means are positioned after the coating station in a direction of movement of the conveyor, and wherein the particle dispensing station is positioned after the coating removal means, and wherein the gripping means are arranged to hold the frozen confectionery in the horizontal position when passing the particle dispensing station.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The apparatus according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>in the coating removal means comprises airflow means adapted to partially remove the coating material from the one side of the frozen confectionery.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The","A23G9/24, A23G9/26, A23G9/48, A23G9/50",20250617,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120685806A,Determining and quantifying peptone content and/or beta-casein content and nutritional compositions with reduced beta-casein derived peptone content,,"<div class=""indep-clm"" num=""1""><seg-con>1.用于确定和/或量化β-酪蛋白衍生的<img src=""https://data-fulltext-image.patsnap.com/CN/A/12/06/85/80/6/1758616343706/FDA0005460228970000011.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064315%3B1765067915%26q-key-time%3D1765064315%3B1765067915%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Dadd5cfde05b665170b0d78b7079c68f77915e1e1&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A35%20GMT"" class=""img-anchor"" img-id=""FDA0005460228970000011"" image_type=""inline"" official_size=""2285"">蛋白胨和/或β-酪蛋白的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>(i)提供待分析的乳基产品；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>(ii)使用液相色谱-质谱使所述产品经受分析；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>(iii)通过检测具有定义的m/z值的化合物或解卷积一个或多个质谱谱图来计算单一同位素质量以确定和/或量化所述产品中的所述β-酪蛋白衍生的<img src=""https://data-fulltext-image.patsnap.com/CN/A/12/06/85/80/6/1758616343706/FDA0005460228970000012.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064315%3B1765067915%26q-key-time%3D1765064315%3B1765067915%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Def224d7edc0065676afe6ee22450b39116331f0f&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A35%20GMT"" class=""img-anchor"" img-id=""FDA0005460228970000012"" image_type=""inline"" official_size=""2277"">蛋白胨和/或β-酪蛋白。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述β-酪蛋白衍生的<img src=""https://data-fulltext-image.patsnap.com/CN/A/12/06/85/80/6/1758616343706/FDA0005460228970000013.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064315%3B1765067915%26q-key-time%3D1765064315%3B1765067915%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Df8ca04f20ed69f66db8a5c600fd1c0c3dede48f7&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A3","G01N30/02, G01N30/72, G01N33/68, A23L33/19",20250923,雀巢产品有限公司,['Pending']
CN119403452A,Coffee beverage,The present invention relates to a coffee beverage and a method of making a coffee beverage.,"<div class=""indep-clm"" num=""1"">1.包含咖啡提取物的咖啡饮料组合物，其中存在的至少8重量％的咖啡提取物固体是甘露聚糖，并且小于4.2重量％的所述咖啡提取物固体是分子量大于5000Da的甘露聚糖。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的咖啡饮料组合物，其中所述咖啡饮料组合物是可溶咖啡粉末。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的咖啡饮料组合物，其在4℃下具有小于3重量％的非可溶性级分。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或权利要求3所述的咖啡饮料组合物，其在4℃下具有小于40s的重构时间t90。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">5.根据权利要求2至4中任一项所述的咖啡饮料组合物，其具有小于20％的闭合孔隙度。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的咖啡饮料组合物，其中所述饮料不含酶。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的咖啡饮料组合物，其中所述咖啡饮料组合物包含的甘露三糖的量按重量计小于甘露二糖的量的1.5倍。</div>
<div class=""indep-clm"" num=""8"">8.用于饮料制备装置中的容器，所述容器含有根据权利要求1至7中任一项所述的咖啡饮料组合物。</div>
<div class=""indep-clm"" num=""9""><seg-con>9.制造咖啡饮料组合物的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""9""><seg-refi>a.在80℃至150℃的温度下使用水性提取流体在第一提取阶段中从研磨的烘焙咖啡中提取可溶咖啡固体，持续1分钟至60分钟，以提供一级咖啡提取物和一级提取的咖啡研磨物，</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-refi>b.在151℃至190℃的温度下使用水性提取流体在第二提取阶段中从所述一级提取的研磨物中提取可溶咖啡固体，持续1分钟至80分钟，以提供二级咖啡提取物和二级提取的咖啡研磨物，</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-refi>c.任选地使所述二级提取的咖啡研磨物在水的存在下经受191℃至260℃的热处理，持续1分钟至15分钟，并且将液体部分作为三级咖啡提取物分离或对经热处理的二级提取的咖啡研磨物进行水性提取以提供三级咖啡提取物。</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-refi>d.在170℃至220℃的温度下处理所述二级咖啡提取物的至少一部分持续1分钟至60分钟以提供水解的二级咖啡提取物，</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-refi>e.任选地在170℃至220℃的温度下处理所述三级咖啡提取物的至少一部分持续1分钟至60分钟以提供水解的三级咖啡提取物，</seg-refi></div>
<div class=""indep-clm"" num=""9""><seg-refi>f.形成组合的咖啡提取物，所述组合的咖啡提取物以固体计包含20重量％至60重量％一级咖啡提取物、0重量％至25重量％二级咖啡提取物、20重量％至70重量％水解的二级咖啡提取物、0重量％至30重量％三级提取物以及0重量％至30重量％水解的三级咖啡提取物。</seg-refi></div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的方法，其中步骤a和/或b中的所述水性提取流体是水。</div>
<div class=""dep-clm"" num=""11"" parent=""9,10"">11.根据权利要求9或权利要求10所述的方法，其中在步骤c中通过形成浆料来对所述二级提取的咖啡研磨物进行热处理，所述浆料包含水和按浆料的重量计5％至20％之间的所述二级提取的咖啡研磨物。</div>
<div class=""dep-clm"" num","A23F5/26, A23F5/36",20250207,雀巢产品有限公司,['Pending']
US12268324B2,Beverage machine with a partly closed dispensing face,"A machine (<b>1</b>) for preparing a beverage from an ingredient includes an extraction unit (<b>2</b>) that has: an ingredient extraction seat (<b>20</b>); an inlet arrangement (<b>21</b>) for guiding water into the seat (<b>20</b>); and a dispensing arrangement (<b>22</b>) for guiding beverage out of the seat (<b>20</b>). The dispensing arrangement (<b>22</b>) has a face (<b>220</b>) delimiting a downstream part of the seat (<b>20</b>) and having a flow-through portion (<b>221</b>) configured such that beverage flowing out the seat (<b>20</b>) flows through the flow-through portion (<b>221</b>) towards a beverage dispensing area (<b>1</b>′). The face (<b>220</b>) has a flow-inhibiting portion (<b>222, 222</b><i>a, </i><b>222</b><i>b, </i><b>222</b><i>c</i>) that is at least substantially flush with the flow-through portion (<b>221</b>) so as to delimit the seat (<b>20</b>). The flow-inhibiting portion (<b>222, 222</b><i>a, </i><b>222</b><i>b, </i><b>222</b><i>c</i>) is configured such that beverage flowing out the seat (<b>20</b>) is inhibited, e.g. prevented, from passing through the flow-inhibiting portion (<b>222, 222</b><i>a, </i><b>222</b><i>b, </i><b>222</b><i>c</i>).","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing a beverage from an ingredient, the machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>an extraction unit having an ingredient extraction seat;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an inlet arrangement for guiding water into the ingredient extraction seat; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a dispensing arrangement for guiding the beverage out of the ingredient extraction seat, the dispensing arrangement comprising a face delimiting a downstream part of the ingredient extraction seat and having a flow-through portion configured such that the beverage flowing out of the ingredient extraction seat flows through the flow-through portion towards a beverage dispensing area,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the face further having a flow-inhibiting portion that is at least substantially flush with the flow-through portion so as to delimit the ingredient extraction seat, the flow-inhibiting portion being configured such that the beverage flowing out of the ingredient extraction seat is inhibited from passing through the flow-inhibiting portion, wherein the flow-through portion and the flow-inhibiting portion have a surface area ratio in the range of 0.66 to 1.5;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the dispensing arrangement has a wall forming the face, the wall having an opened, cut-away, or interrupted part forming or delimiting the flow-through portion and the wall having the flow-inhibiting portion being formed by a closed part of the wall.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-comp>the wall is formed by a plate-like or sheet-like member that has at the flow-through portion a flow-through structure formed by at least one of: a plurality of through holes; </","A47J31/36, A47J31/46",20250408,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119183378A,Compositions and methods for cartilage degeneration using combination of oleuropein and fisetin,"The present invention relates to the use of a composition comprising an effective amount of oleuropein and/or a metabolite thereof in combination with fisetin and/or a derivative for maintaining joint health in a subject or preventing or treating joint disorders in a subject. In particular, the present invention relates to a composition comprising an effective amount of oleuropein and/or a metabolite thereof in combination with fisetin and/or a derivative for use in the prevention or treatment of cartilage degeneration in a subject.","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含有效量的橄榄苦苷和/或其代谢物与漆黄素和/或衍生物的组合，所述组合物用于预防或治疗个体的软骨退化。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的组合物，其中所述橄榄苦苷的代谢物选自橄榄苦苷苷元、羟基酪醇、橄榄酸、高香草醇、异高香草醇、其葡糖醛酸化形式、其硫酸化形式、其衍生物、及其混合物。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2用于所述用途的组合物，其中所述漆黄素的代谢物选自其葡糖醛酸化形式、其硫酸化形式、其衍生物及其混合物，优选gerardol。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项用于所述用途的组合物，所述组合物还包含钙。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项用于所述用途的组合物，其中所述组合物还包含至少一种选自以下的化合物：抗氧化剂、抗炎化合物、糖胺聚糖、益生元、纤维、益生菌、脂肪酸、酶、矿物质、微量元素和/或维生素。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项用于所述用途的组合物，其中所述组合物选自食物组合物、膳食补充剂、营养组合物、口服营养补充剂、医疗食品、营养品、饮料、在食用前在水或乳中重构的粉末状营养产品、食品添加剂、特殊医疗用途食品(FSMP)、药物、饮品、宠物食品及其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项用于所述用途的组合物，其中所述组合物呈固体粉末、粉末状棒、胶囊或溶液的形式。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项用于所述用途的组合物，其中所述用途用于i)维持或改善衰老期间的关节功能，包括软骨功能，ii)减轻关节疼痛，包括炎性疼痛和/或伤害感受性疼痛。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项用于所述用途的组合物，其中所述用途是改善所述个体的活动性和/或运动性。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项用于所述用途的组合物，其中所述用途是抑制或减少骨关节炎中的软骨退化。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项用于所述用途的组合物，其中所述个体为中老年、老年人。</div>
<div class=""indep-clm"" num=""12""><seg-con>12.制造根据前述权利要求中任一项用于所述用途的营养组合物的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans><seg-refi>提供用于营养组合物的一种或多种成分、橄榄苦苷或其代谢物和漆黄素和/或衍生物以及任选的另外的钙，以及混合。</seg-refi></div>
<div class=""indep-clm"" num=""13"">13.药盒，所述药盒包含橄榄苦苷和/或其代谢物与漆黄素和/或衍生物的组合在一个或多个容器中的组合。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的药盒，其中所述一个或多个容器包含至少一个第一容器，所述至少一个第一容器储存与所述漆黄素和/或衍生物分开的橄榄苦苷和/或代谢物，所述漆黄素和/或衍生物储存在至少一个第二容器中，并且所述药盒还包含用于将所述橄榄苦苷与所述漆黄素混合成单位剂型的说明书。</div>
<div class=""dep-clm"" num=""15"" parent=""13,14"">15.根据权利要求13或14所述的药盒，其中所述一个或多个容器各自包含橄榄苦苷和/或其代谢物与漆黄素和/或衍生物的组合的单位剂型。</div>","A61K31/7048, A61K31/352, A61P19/02, A61P29/00, A23L33/105",20241224,雀巢产品有限公司,['Pending']
CN119923358A,Compostable capsules formed from sheets of cellulose-based material,"The invention relates to a capsule (100) for preparing a beverage in a beverage production machine. The capsule (100) is made of a domestic compostable material composition and comprises a capsule body (120) consisting of two half shells (200). The half shells (200) engage one another so as to define a chamber (211) for containing a substance (500) for preparing a beverage. Each of the half shells (200) is formed from a sheet of biodegradable cellulose-based material having a barrier function. Each of the half shells (200) includes a bottom (250), a circumferential side wall (240), and a circumferential rim (230) at which the rim (230) of the respective other half shell (200) is engaged. The rim (230) and the side wall (240) are directly connected by a circumferential rim transition region (234) having a rim radius (R34) of between 1 mm and 3 mm. In addition, the side wall (240) and the bottom (250) are directly connected by a circumferential bottom transition region (254) having a bottom radius (R452) of between 10 mm and 20 mm.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于在饮料生产机器中制备饮料的囊包(100)，其中所述囊包(100)由可家庭堆肥的材料组合物制成，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述囊包(100)包括囊包主体(120)，所述囊包主体由彼此接合的两个半壳(200)构成，以便界定用于容纳用于制备所述饮料的物质(500)的腔室(211)，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述半壳(200)中的每一者由具有阻隔功能的可生物降解的纤维素基材料片材成型，并且</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>其中所述半壳(200)中的每一者</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>●底部(250)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●周向侧壁(240)，所述周向侧壁从所述底部(250)延伸到所述侧壁(240)的周向边缘(241)以限定腔(210)，其中所述侧壁(240)从所述周向边缘(241)朝向所述底部(250)渐缩，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>●周向边沿(230)，所述周向边沿从所述周向边缘(241)侧向向外延伸，以便与相应的另一个半壳(200)的所述边沿(230)接合，使得它们的腔(210)一起限定所述腔室(211)，其中所述边沿(230)的周向内边缘(231)界定所述腔(210)的开口(212)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中直接连接所述边沿(230)和所述侧壁(240)的周向边沿过渡区域(234)具有1mm与3mm之间的边沿半径(R34)，并且其中直接连接所述侧壁(240)和所述底部(250)的周向底部过渡区域(254)具有10mm与20mm之间的底部半径(R452)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的囊包(100)，其中所述边沿半径(R34)在1.5mm与2.5mm之间，优选为2mm，并且/或者相对于所述腔(210)向内凸起。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据前述权利要求中任一项所述的囊包(100)，</seg-con><seg-trans>其中，</seg-trans><seg-refi>在竖直横截面中，所述边沿过渡区域(234)以90°至160°之间、优选地110°至140°之间、最优选地120°至130°之间的顶部过渡角度延伸。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的囊包(100)，其中所述底部半径(R452)在12mm与15mm之间，优选地在13mm与14mm之间，并且/或者相对于所述腔(210)向外凸起。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据前述权利要求中任一项所述的囊包(100)，</seg-con><seg-trans>其中，</seg-trans><seg-refi>在竖直横截面中，所述底部过渡区域(254)以10°至90°之间、优选地15°至60°之间、最优选地20°至40°之间的底部过渡角度延伸。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的囊包(100)，其中将所述侧壁(240)的底侧区段与所述侧壁(240)的边沿侧区段直接连接的周向侧壁过渡区域(244)具有2mm与4mm之间、优选地约3mm、最优选地3mm的侧壁半径(R451)，并且优选地相对于所述腔(210)向外凸起。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7.根据前述权利要求中任一项所述的",B65D85/804,20250502,雀巢产品有限公司,['Pending']
AU2023329104A1,Food composition comprising one or a plurality of coated food particles,A method of making a food composition comprising one or a plurality of coated food particles is disclosed. The method comprises a step of providing one or a plurality of food particles. It further comprises a step of coating each of the food particle with carbohydrate. This results in a food composition comprising one or a plurality of food particles coated with crystalline carbohydrate layer. The crystalline carbohydrate layer comprises at least 95% crystalline carbohydrate particles and has a closed porosity lower than 10%. A food composition comprising one or a plurality of coated food particles and a coated food particle are also disclosed.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a food composition comprising </seg-main><seg-clauses><seg-main>one or a plurality of coated food particles, said method comprising the steps of:</seg-main>
<seg-clauses>a) providing one or a plurality of food particles,</seg-clauses>
<seg-clauses>b) coating each of the food particle of step a) with a carbohydrate to form a food composition comprising one or a plurality of coated food particles, said one or a plurality of coated food particles are food particles coated with crystalline carbohydrate layer, wherein the crystalline carbohydrate layer comprises at least 95% crystalline carbohydrate and has a closed porosity lower than 10%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the step b) of coating is performed with a carbohydrate which is:</seg-main>
<seg-clauses>i)      at least one solid crystalline carbohydrate, or,</seg-clauses>
<seg-clauses>ii)     at least one solid crystalline carbohydrate and at least one hydrated crystalline</seg-clauses>
<seg-clauses class=""seg-enter"">compound, or</seg-clauses>
<seg-clauses>iii)     at least one solid amorphous carbohydrate, or,</seg-clauses>
<seg-clauses>iv)    at least one solid crystalline carbohydrate and at least one solid amorphous</seg-clauses>
<seg-clauses class=""seg-enter"">carbohydrate, or,</seg-clauses>
<seg-clauses>v) at least one solid crystalline carbohydrate and at least one solid amorphous carbohydrate and at least one hydrated crystalline compound, or,</seg-clauses>
<seg-clauses>vi) a liquid solution or suspension of at least one carbohydrate;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the step biii) comprises, after coating, a step of heat treatment and/or humidification above the glass transition temperature Tg of the solid amorphous carbohydrate to trigger carbohydrate particles bridging and convert amorphous carbo","A23F5/14, A23F5/36, A23G1/00, A23L2/395, A23L7/191",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025103914A1,A compostable cellulose-based capsule for containing beverage ingredients,"The invention concerns a compostable food and/or beverage container (1) comprising cellulose-based material comprising cellulose fibers, for containing a food and/or beverage ingredient (7) for use with a beverage preparation machine for preparing a beverage and/or foodstuff thereof, the container (1) comprising a container body (2) forming a storage portion (4) to host the food and/or beverage ingredient (7) and a closing member (6) for closing the storage portion (4) of the body (2), said container body (2) comprising an outwardly extending rim portion (5) for the closing member (6) to seal thereon, wherein the body (2) and/or the closing member (6) comprises a laser marked pattern (11) on its external surface facing away from the storage portion (4), said marked pattern (11) comprising, on its surface, cellulose fibers having an external diameter at least 5% larger than the external diameter of the cellulose fibers of the container body (2) and/or of the closing member (6) located outside of the marked pattern (11). The invention also concerns a method of manufacturing said compostable food and/or beverage container and the use of said container.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A compostable food and/or beverage container (1) comprising </seg-main><seg-clauses>cellulose- based material comprising cellulose fibers, for containing a food and/or beverage ingredient (7) for use with a beverage preparation machine for preparing a beverage and/or foodstuff thereof, the container (1) comprising a container body (2) forming a storage portion (4) to host the food and/or beverage ingredient (7) and a closing member (6) for closing the storage portion (4) of the body (2), said container body (2) comprising an outwardly extending rim portion (5) for the closing member (6) to seal thereon, wherein the body (2) and/or the closing member (6) comprises a laser marked pattern (11) on its external surface facing away from the storage portion (4), said marked pattern (11) comprising, on its surface, cellulose fibers having an external diameter at least 5% larger than the external diameter of the cellulose fibers of the container body (2) and/or of the closing member (6) located outside of the marked pattern (11).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The compostable food and/or beverage container of claim 1, wherein </seg-main><seg-clauses>the cellulose fibers of the marked pattern (11) of the container body (2) and/or of the closing member (6) having the enlarged external diameter, are extending from the external surface of the container body (2) and/or of the closing member (6) over a thickness comprised between 1 micron and 40 microns.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The compostable food and/or beverage container of claim 1 or 2, wherein </seg-main><seg-clauses>the cellulose fibers of the marked pattern (11) have a different light diffraction than the one of the cellulose fibers outside of the marked pattern (11).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The compostable food and/or beverage co",B65D85/804,20250522,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN119654077A,Methods of enhancing palatability and/or reducing sugars therein of wet pet food,"A method of preparing a wet grain formulated for application to pets includes incorporating into the wet grain at least one of spinach or tomato in an amount effective to enhance the palatability of the wet grain and/or to reduce added sugar in the wet grain. The method may comprise producing the wet grain as a gravy composition comprising masses, and may comprise one or more of the following steps: (i) producing the gravy by a method comprising adding spinach to one or more other ingredients of the gravy; (ii) producing the gravy by a process comprising adding tomatoes to one or more other ingredients of the gravy, and preferably also incorporating cysteine in free form into the gravy; and (iii) producing the masses by a method comprising adding both spinach and tomato to one or more other ingredients of the masses. The method can include producing the wet grain as a cake composition, preferably by incorporating both spinach and tomato into the cake composition.","<div class=""indep-clm"" num=""1"">1.制备被调配用于施用于宠物的湿粮的方法，所述方法包括将菠菜或番茄中的至少一种以有效增强所述湿粮的适口性和/或减少所述湿粮中的添加的糖的量掺入到所述湿粮中。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，所述方法包括生产作为含块状物的肉汁组合物的所述湿粮。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中将菠菜或番茄中的所述至少一种掺入到所述湿粮中包括通过包括将菠菜添加到所述肉汁的一种或多种其他成分中的方法生产所述肉汁。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的方法，其中将菠菜或番茄中的所述至少一种掺入到所述湿粮中包括通过包括将番茄添加到所述肉汁的一种或多种其他成分中的方法生产所述肉汁。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的方法，其中生产所述肉汁的所述方法还包括将游离形式半胱氨酸掺入到所述肉汁中。</div>
<div class=""dep-clm"" num=""6"" parent=""2"">6.根据权利要求2所述的方法，其中将菠菜或番茄中的所述至少一种掺入到所述湿粮中包括通过包括将菠菜和番茄两者添加到所述块状物的一种或多种其他成分中的方法生产所述块状物。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的方法，所述方法包括生产作为糕组合物的所述湿粮。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的方法，其中生产作为所述糕组合物的所述湿粮包括将菠菜和番茄两者掺入到所述糕组合物中。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的方法，其中所述方法不包括向所述湿粮中添加除存在于菠菜或番茄中的所述至少一种中的任何糖以外的糖。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的方法，其中所述湿粮被调配用于施用于猫。</div>
<div class=""dep-clm"" num=""11"" parent=""1"">11.根据权利要求1所述的方法，所述方法还包括将酱油掺入到所述湿粮中。</div>
<div class=""indep-clm"" num=""12"">12.制备产品的方法，所述方法包括将根据权利要求1所述的湿粮密封在容器中，并且然后对所密封的容器进行蒸煮。</div>
<div class=""indep-clm"" num=""13"">13.向宠物提供营养的方法，所述方法包括将通过根据权利要求1所述的方法制备的湿粮施用于所述宠物。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的方法，其中所述宠物是猫。</div>
<div class=""dep-clm"" num=""15"" parent=""13"">15.根据权利要求13所述的方法，其中所述宠物患有肾衰竭或处于肾衰竭的风险中，并且所述湿粮不含或基本上不含添加的磷酸盐或多磷酸盐。</div>","A23K10/30, A23K50/48, A23K50/45",20250318,雀巢产品有限公司,['Pending']
CN120712364A,Beet-derived products for crystalline sugars and methods of making same,"The present invention relates to a method of making a sugar beet powder product, the method comprising the steps of: obtaining a solid fraction and a liquid fraction from sugar beet; crystallizing the sucrose contained in the liquid fraction; treating the solid fraction to reduce geosmin content; mixing the solid fraction and the liquid fraction; and reducing the granularity.","<div class=""indep-clm"" num=""1""><seg-con>1.制作糖用甜菜衍生产品的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)提供切割的糖用甜菜块；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)通过热处理使存在于所述糖用甜菜块中的酶失活，优选地通过蒸汽处理；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>c)使用压榨装置从所述糖用甜菜块中获得固体级分和液体级分，并且任选地还包括离心；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>d)使包含在所述液体级分中的蔗糖结晶，例如通过在大气压或真空下蒸发；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>e) 将所述固体级分热处理以降低土臭素含量，优选地通过蒸汽处理；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>f)将所述固体级分和所述液体级分混合；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>g)将所述混合物干燥，优选地干燥至水分含量低于3.5重量%，优选地通过对流加热或通过真空干燥；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>h)减小所述混合物的粒度以形成糖用甜菜衍生产品。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据任一前述权利要求所述的方法，其中步骤b)中的所述热处理包括加热至介于40℃至100℃之间的温度持续至少1分钟。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据任一前述权利要求所述的方法，其中通过以下操作来处理所述液体级分：(i)将所述液体级分的pH调节至小于5的pH值；或(ii)对所述液体级分施加热处理，其中所述热处理的范围介于70℃至90℃之间；或(iii)对所述液体级分施加增加的大气压处理。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4. 根据权利要求3所述的方法，其中通过以下操作来处理所述液体级分：(i)将所述液体级分的所述pH调节至小于pH 5的pH值；和(ii)对所述液体级分施加范围介于70℃至90℃之间的热处理。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的方法，其中通过(iv)将所述液体级分的所述pH增加至至少5的值来处理所述液体级分。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的方法，其中所述方法不使用有机溶剂。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的方法，其中在步骤h)中减小所述粒度，使得D50粒度介于200微米至300微米之间，并且使得D90粒度介于800微米至1mm之间。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中干燥步骤是对流加热或真空干燥。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的方法，其中在步骤h)中通过磨削，并且任选地通过研磨来减小所述混合物的所述粒度。</div>
<div class=""indep-clm"" num=""10"">10.糖用甜菜衍生产品，其中所述产品具有介于1%至4%之间的蛋白质、介于1%至4%之间的灰分、介于70%至85%之间的总糖和介于10%至20%之间的膳食纤维，其中所述膳食纤维级分由介于24%至34%之间的可溶性纤维和介于66%至76%之间的不溶性纤维构成。</div>
<div class=""indep-clm"" num=""11"">11.糖用甜菜衍生产品，其中所述产品具有小于0.05","C13B10/08, C13B30/00, C13B30/02, C13B40/00",20250926,雀巢产品有限公司,['Pending']
US12426617B2,Infant formula,"An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein the infant formula comprises 0.8-2.5 g/L 2′-fucosyllactose (2′FL) and/or 0.05-0.2 g/L lacto-N-neotetraose (LNnT).","<div class=""indep-clm"" num=""1""><seg-main>1. A method for preventing or reducing the occurrence of allergic sensitization in an infant comprising </seg-main><seg-clauses><seg-main>administering to the infant an infant formula, wherein the infant formula comprises </seg-main><seg-clauses><seg-main>0.8-2.5 g/L 2′-fucosyllactose (2′FL) and 0.05-0.2 g/L lacto-N-neotetraose (LNnT), and comprising:</seg-main>
<seg-clauses>(a) 1.8-3.2 g protein per 100 kcal;</seg-clauses>
<seg-clauses>(b) 9-14 g carbohydrate per 100 kcal; and</seg-clauses>
<seg-clauses>(c) 4.0-6.0 g fat per 100 kcal.</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises 2′FL in a concentration selected from the group consisting of </seg-main><seg-clauses>0.8-1.5 g/L, 1-1.5 g/L, or about 1 g/L.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises 2′FL in a concentration selected from the group consisting of </seg-main><seg-clauses>1.5-2.5 g/L, 1.5-2 g/L, 1.6-2 g/L, or about 1.8 g/L.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the infant formula comprises LNnT in a concentration selected from the group consisting of </seg-main><seg-clauses>0.05-0.15 g/L or about 0.1 g/L.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the infant formula comprises 2′FL and LNnT.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. The method according to claim 5, wherein </seg-main><seg-clauses>the infant formula comprises about 1.8 g/L 2′FL and about 0.1 g/L LNnT.</seg-clauses></div>
<div class=""dep-clm"" ","A23L33/00, A23L33/115, A23L33/125, A23L33/17, A61P37/00",20250930,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119156539A,Methods of determining health status of dogs based on one or more biomarkers and methods of treating risk of death identified by health status,,"<div class=""indep-clm"" num=""1"">1.用于确定狗的死亡风险和/或健康寿命的概率的方法；所述方法包括确定从所述狗获得的一个或多个样本中的一种或多种生物标志物的水平，其中所述一种或多种生物标志物选自白细胞计数、血清白蛋白、血清碱性磷酸酶、血清肌酸激酶、血红蛋白、血细胞比容、平均红细胞血红蛋白、血清葡萄糖、平均红细胞体积、血清球蛋白、血清钙、血小板计数和/或红细胞计数。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述生物标志物是白细胞计数。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的方法，其中所述生物标志物是血清白蛋白。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的方法，其中所述生物标志物是血清碱性磷酸酶。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的方法，其中所述方法包括测量白细胞计数、血清白蛋白和血清碱性磷酸酶中的每一者。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的方法，其中所述方法包括测量白细胞计数、血清白蛋白、血清碱性磷酸酶、血清肌酸激酶、血红蛋白、血细胞比容、平均红细胞血红蛋白、血清葡萄糖、平均红细胞体积和血清球蛋白中的每一者。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的方法，其中所述一个或多个样本是血液样本。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的方法，其中所述方法还包括将所述一种或多种生物标志物的所述水平与所述狗的实足年龄、品种和/或性别中的一者或多者相组合。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的方法，其中所述狗被分类为小型、中型、大型或巨型和/或健壮型或运动型。</div>
<div class=""indep-clm"" num=""10""><seg-con>10.用于确定狗的死亡风险和/或健康寿命的概率的方法；所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""10""><seg-comp>a.确定以下生物标志物的水平；</seg-comp><seg-comp>从所述狗获得的一个或多个样本中的白细胞计数、血清白蛋白、血清碱性磷酸酶、血清肌酸激酶、血红蛋白、血细胞比容、平均红细胞血红蛋白、血清葡萄糖、平均红细胞体积和血清球蛋白；并且</seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp>b.使用公式(1)确定所述狗的表型年龄(Phenoage)：</seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp><img src="""" class=""img-anchor"" img-id=""FDA0005074630450000021""></seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp>其中xb是根据公式(2)的每种生物标志物、性别和品种的值乘以它们的相应系数的总和：</seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp><img src="""" class=""img-anchor"" img-id=""FDA0005074630450000022""></seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp>其中性别被编码为数值，其中0代表雌性，而1代表雄性，</seg-comp></div>
<div class=""indep-clm"" num=""10""><seg-comp>其中品种被编码为数值，其中0代表小型品种，而1代表中型品种；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""10""","G01N33/569, G01N33/80, G01N33/84, G01N33/68, G01N33/66",20241217,雀巢产品有限公司,['Pending']
US20240407406A1,Increasing hydrolysis efficiency in cereal process by employing lytic polysaccharides monooxygenease (LPMO) in combination with proteases,"The present invention relates a process for preparing a cereal-based extract; said process comprises the steps of: (i) providing a whole grain cereal, (ii) subjecting the whole grain cereal to a single grinding and subsequently combining the whole grain cereal and water, (iii) subjecting the slurry of ground whole grain cereal and water to an enzymatic hydrolysis step, (iv) separating a soluble fraction of the whole grain cereal from an insoluble fraction through filtration, decantation or centrifugation and wherein the enzymatic hydrolysis step makes use of lytic polysaccharides monooxygeneases (LPMOs) in combination with carbohydrate hydrolysing enzymes and at least one protease. The invention also relates to a concentrated cereal-based extract ingredient comprising based on a dry matter basis, 40-90% (w/w) of carbohydrate, 5-20% (w/w) of protein, 0.5-20% (w/w) of total dietary fiber, optionally 1-4% (w/w) of ash and 0-10% (w/w) of fat, and such a extract obtained with the process.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for preparing a cereal-based extract; said process comprises </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>(i) providing a whole grain cereal,</seg-clauses>
<seg-clauses>(ii) subjecting the whole grain cereal to a single grinding and subsequently combining the whole grain cereal and water,</seg-clauses>
<seg-clauses>(iii) subjecting the slurry of ground whole grain cereal and water to an enzymatic hydrolysis step,</seg-clauses>
<seg-clauses>(iv) separating a soluble fraction of the whole grain cereal from an insoluble fraction through filtration, decantation, or centrifugation, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the enzymatic hydrolysis step makes use of lytic polysaccharides monooxygeneases (LPMOs) in combination with at least one protease.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A process according to claim 1, wherein </seg-main><seg-clauses>the whole grain cereal is un-malted whole grain cereal, derived from barley or oat.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A process according to claim 1, wherein </seg-main><seg-clauses>the soluble fraction obtained from the separation in step (iv) is concentrated.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. A process according to claim 3, wherein </seg-main><seg-clauses>the concentrate comprises at least of 30% and up to 97.5% (w/w) of the soluble fraction after concentration.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A process according to claim 1, wherein </seg-main><seg-clauses>the slurry of wholegrain cereal in step (ii) is heated to gelatinise the starch.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A process according to claim 1, wherein </seg-main><seg-clauses>the hydrolysis is carried out with additional enzymes with different functionalities.</seg-cl","A23L7/104, C12N9/48",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250057194A1,Fermented acerola beverage,The present invention relates to a beverage composition comprising fermented acerola or fermented acerola extract. A further aspect of the invention is a method of preparing a beverage composition.,"<div class=""indep-clm"" num=""1""><seg-con>1. A beverage composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>fermented acerola or fermented acerola extract wherein the weight ratio of the sum of 3-methylbutyl acetate, 2-methylbutyl acetate, isobutyl acetate, 2-phenylethyl acetate and 2-phenylethanol to 2,3-butanedione is greater than 150.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The beverage composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight ratio of the sum of 2-phenylethyl acetate and 2-phenylethanol to 2-phenylacetaldehyde is greater than 3000.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The beverage composition of claim 1 </seg-con><seg-trans>having </seg-trans><seg-refi>an ethanol content below 1.2 wt %.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The beverage composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the beverage composition is selected from the group consisting of a ready to drink beverage, a beverage liquid concentrate, a soluble beverage powder, dried aromatic plant material and combinations of these.</seg-refi></div>
<div class=""ccl-clm"" num=""5"">5. (canceled)</div>
<div class=""indep-clm"" num=""6""><seg-con>6. A method of preparing a beverage composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>fermenting an aqueous acerola extract wherein the fermentation is performed by yeast comprising <i>Pichia </i>yeast.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7. The method of claim 6 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Pichia </i>yeast is <i>Pichia kluyveri. </i></seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Pichia </i>yeast is <i>Pichia kluyveri </i>NYSC 5485 (CNCM I-5525).</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""6""><seg-con>9. The method of ","A23L2/38, C12N1/16, C12R1/84",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023374669A1,Beverage or foodstuff preparation system,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising: a reference portion (R) to locate the code, and; a data portion (D) to store the preparation information, wherein the reference portion comprises reference units arranged to uniquely define a linear virtual reference line (r), wherein the data portion comprises data units which at least partially encode values of parameters of the preparation information as geometric distances (d) of the data units from a start position along each of a plurality of virtual encoding lines (E), wherein said plurality of encoding lines are circular and are arranged to intersect the reference line (r), and an innermost encoding line has a smaller radii than an outermost encoding line, wherein: 1) an outermost encoding line encodes two or more values of the same parameter, which are encoded in a sequence according to an order of use of the parameter, each of said values being encoded with a single data unit arrangeable at any continuous position from a start position; 2) an innermost encoding line encodes a value of a parameter, which is encoded as an average distance of two data units from a start position, and; 3) said innermost encoding line encodes binary information of the preparation information, which is encoded as an absence or presence of a unit at a predetermined position with respect to one of the units encoding the parameter on the innermost encoding line.","<div class=""indep-clm"" num=""1""><seg-main>1. A container for containing </seg-main><seg-clauses>a precursor material for use with a machine for preparing a beverage and/or foodstuff ora precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">a reference portion (R) to locate the code, and; a data portion (D) to store the preparation information, wherein the reference portion comprises reference units arranged to uniquely define a linear virtual reference line (r), wherein the data portion comprises data units which at least partially encode values of parameters of the preparation information as geometric distances </seg-clauses><seg-clauses><seg-main>(d) of the data units from a start position along each of a plurality of virtual encoding lines (E),</seg-main>
<seg-main class=""seg-enter"">wherein said plurality of encoding lines are circular and are arranged to intersect the reference line (r), and an innermost encoding line has a smaller radii than an outermost encoding line,</seg-main>
<seg-main class=""seg-enter"">wherein:</seg-main>
<seg-clauses>1) an outermost encoding line encodes two or more values of the same parameter, which are encoded in a sequence according to an order of use of the parameter, each of said values being encoded with a single data unit arrangeable at any continuous position from a start position;</seg-clauses>
<seg-clauses>2) an innermost encoding line encodes a value of a parameter, which is encoded as an average distance of two data units from a start position, and;</seg-clauses>
<seg-clauses>3) said innermost encoding line encodes binary information of the preparation information, which is encoded as an absence or presence of a unit at a predetermined position with respect to one of the units encoding the parameter on the innermost encoding line.</seg-clauses></seg-clauses",B65D85/804,20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12344414B2,Manufacturing line for manufacturing a compostable pod for brewing products and system for measuring and regulating the relative humidity of a biodegradable paper-based material,"The invention concerns a manufacturing line (<b>1</b>) for manufacturing a compostable pod (<b>5</b>) for brewing products (<b>5</b><i>a</i>), said pod (<b>5</b>) being made of two complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>). The manufacturing line (<b>1</b>) comprises at least one shaping line (<b>2</b>) for shaping the complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>), the shaping line (<b>2</b>) comprising: —a handling unit (<b>7</b>) for handling the sheet (<b>3</b>) of biodegradable paper-based material with gas barrier biodegradable polymer; —a humidifying unit (<b>8</b>) for moistening at least one side of the sheet (<b>3</b>) of biodegradable paper-based material; —an optional pre-drying unit (<b>17</b>) for drying, at least partially, the at least one side of the sheet (<b>3</b>) of biodegradable paper-based material; —a forming unit (<b>8</b>) for shaping the sheet (<b>3</b>) of biodegradable paper-based material into one of the complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>); and—a drying unit (<b>10</b>) for drying the at least one side of the sheet (<b>3</b>) of biodegradable paper-based material forming one of the complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>); According to the invention, the shaping line (<b>2</b>) comprises at least one humidity sensor (S<b>1</b>, S<b>2</b>, S<b>3</b>, S<b>4</b>) for sensing the level of relative humidity of the biodegradable paper-based material forming the pod (<b>5</b>) said at least one humidity sensor (S<b>1</b>, S<b>2</b>, S<b>3</b>, S<b>4</b>) being positioned before or after at least said one of the handling unit (<b>7</b>), the humidifying unit (<b>8</b>), the optional pre-drying unit (<b>17</b>), the forming unit (<b>9</b>) and the drying unit (<b>10</b>). The invention further comprises a system for measuring and regulation the relative humidity of the biodegradable paper-based material forming the complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>) of the pod (<b>5</b>). Additionally, the invention relates to a manufacturing process comprising the steps of measuring the relative humidity of at least one side of the sheet (<b>3</b>) of biodegradable paper-based material forming one of the complementary portions (<b>4</b><i>a, </i><b>4</b><i>b, </i><b>6</b>) of the pod (<b>5</b>) and regulating different steps of this process according the relative humidity measured in one or more of the shaping steps.","<div class=""indep-clm"" num=""1""><seg-main>1. Manufacturing line for manufacturing a compostable pod for brewing products, said pod being made of complementary first and second half-shell respectively made from a first and second sheet of biodegradable paper-based material, said manufacturing line comprising </seg-main><seg-clauses><seg-main>a first shaping line for shaping the first half-shell and a second shaping line for shaping the second half-shell, each of the first and second shaping lines comprising:</seg-main>
<seg-main class=""seg-enter"">a handling unit for handling the sheet of biodegradable paper-based material; the sheet of biodegradable paper-based material being coated on one side (B), defined as the inner side, with a gas barrier biodegradable polymer, the other side (A) of the sheet being defined as the external side;</seg-main>
<seg-main class=""seg-enter"">a humidifying unit for moistening the external side </seg-main><seg-clauses>(A) of the sheet of biodegradable paper-based material;</seg-clauses>
<seg-clauses class=""seg-enter"">a forming unit for shaping the sheet of biodegradable paper-based material into a half-shell having an internal side </seg-clauses><seg-clauses><seg-main>(B) corresponding to the internal side (B) of the sheet of biodegradable paper-based material and an external side </seg-main><seg-clauses><seg-main>(A) corresponding to the external side (A) of the sheet of biodegradable paper-based material;</seg-main>
<seg-main class=""seg-enter"">a drying unit for drying the external side (A) and/or the internal side (B) of the half-shell; and</seg-main>
<seg-main class=""seg-enter"">the shaping line comprises at least one humidity sensor for sensing the level of relative humidity of the biodegradable paper-based material forming the pod at the external side </seg-main><seg-clauses>(A) of the pod, said at least one humidity sensor being positioned before or after at least said one of the handling unit, the humidifying unit.</seg-clauses></seg","B65B29/02, B65B9/04, B65B57/08, B65B61/06",20250701,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019370721B2,Coffee container for beverage preparation and method of manufacturing a coffee container,"The invention relates to a method of manufacturing a coffee container (1a-1g) for preparing a coffee beverage upon injection of liquid into the container, the method comprising the steps of: - selecting and providing container wall means (2, 2a, 3a-3g) for enclosing a predefined container, - compacting an amount of bulk coffee material such as roast and ground coffee particles to a coffee tablet under predefined compaction force in the container volume between the container wall means (2, 2a, 3a-3g), - wherein the applied compaction force is set based on at least the provided container volume and/or on a particular type of beverage to be prepared from the provided container, and wherein the applied compaction force is set to a value between 0.5 to 15kN, preferably between 1kN and 10kN.","2019370721   10 Feb 2025
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS: -
<div class=""indep-clm"" num=""1""><seg-main>1. A method of manufacturing a coffee container for preparing a coffee beverage upon injection of liquid 5       into the container, the method comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>- selecting and providing container wall means for enclosing a predefined container volume,</seg-clauses>
<seg-clauses>- compacting an amount of bulk coffee material such as roast and ground coffee particles to a coffee tablet 10          under predefined compaction force in the container</seg-clauses>
<seg-clauses class=""seg-enter"">volume between the container wall means,</seg-clauses>
<seg-clauses>- wherein the applied compaction force is set based on at least the provided container volume and/or on a particular type of beverage to be prepared from the 15           provided container,</seg-clauses>
<seg-clauses>-   wherein the applied compaction force is set to a</seg-clauses>
<seg-clauses class=""seg-enter"">value between 0.5 to 15 kN</seg-clauses>
<seg-clauses>-   wherein the different selectable container wall</seg-clauses>
<seg-clauses class=""seg-enter"">means are designed for forming alternative types of 20           containers such as at least a first and a second</seg-clauses>
<seg-clauses class=""seg-enter"">predefined container type for preparing a short and a long coffee beverage, and optionally at least a third predefined container type for preparing a medium size coffee beverage; and</seg-clauses>
<seg-clauses class=""seg-enter"">25       - wherein the compaction force for a container type</seg-clauses>
<seg-clauses class=""seg-enter"">designed for preparing a short coffee beverage is set to a value between 0.5 kN and 5 kN, for a container type designed for preparing a long coffee beverage is set to a value between 0.5 kN and 15 kN,</seg-clauses>
<seg-clauses class=""seg-enter"">30           and for a container type designed","B65B29/02, B65D85/804",20250529,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
AU2024209345A1,Microbiome ingredient combination for lowering uremic toxins in cardiometabolic or neurodegenerative conditions,"The invention relates to composition for use in lowering or avoiding accumulation of uremic toxins in cardiometabolic or neurodegenerative conditions, particularly compositions that comprise a probiotic bacteria, a prebiotic (carbohydrates or fibers), and a lipid.","<div class=""indep-clm"" num=""1""><seg-main>1. Composition for use in lowering or avoiding accumulation of uremic toxins in cardiometabolic or neurodegenerative conditions, wherein </seg-main><seg-clauses><seg-main>the composition comprises:</seg-main>
<seg-clauses>(a) a probiotic bacterium, selected from probiotic bacteria</seg-clauses>
<seg-clauses>- lacking a gene for producing at least one of urea, uric acid, p-cresol, p-cresyl sulfate, indoxyl sulfate, indole, indole acetic acid, indoxyl, trimethylamine, TMAO, dimethylglycine, betaine and/or glutarate ;</seg-clauses>
<seg-clauses>- lacking at least one bacterial enzyme selected from urease, carnitine monooxygenase & reductase, tryptophanase and/or hydroxyphenylacetate; and/or</seg-clauses>
<seg-clauses>- expressing at least one bacterial enzyme selected from a-galactosidase, P-galactosidase, glucan 1,4-P-glucosidase, cellulase, P-fructofuranosidase and/or Licheninase;</seg-clauses>
<seg-clauses>(b) a prebiotic selected from carbohydrates or fibers, wherein the carbohydrate or fiber can be hydrolyzed by at least one bacterial enzyme selected from a-galactosidase, P-galactosidase, glucan 1,4-P-glucosidase, cellulase, P-fructofuranosidase and/or Licheninase;</seg-clauses>
<seg-clauses>(c) a lipid, selected from a triglyceride, a short chain fatty acid and/or a medium chain fatty acid, wherein the triglyceride comprises, short chain fatty acids, medium chain fatty acids, or a mixture thereof.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the probiotic bacterium </seg-main><seg-clauses><seg-main>(a) is selected from at least one of the following </seg-main><seg-clauses><seg-main>a. to k.:</seg-main>
<seg-clauses>a. Bifidobacterium animalis subspecies lactis NCC 2818 (CNCM 1-3446);</seg-clauses>
<seg-clauses>b. Bifidobacterium longum subspecies infantis NCC 341 (ATCC 15697 (T));</seg-clauses>
","A61K35/747, A61K31/19, A61K31/70, A61P13/12",20250710,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024238799A1,Process for a legume based dried instant noodle,"The present invention relates to a process for the production of a legume based dried instant noodle. In particularly the invention relates to a process for the production of a legume based dried instant noodle using roasted legume flour selected from the group of chickpea splits, lentil splits, or a combination thereof, and cereal flour and starch and wheat gluten.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for the production of a legume based dried instant noodle comprising </seg-main><seg-clauses><seg-main>legume flour, cereal flour, Kansui salts, starch and wheat gluten, the process comprising the steps of:</seg-main>
<seg-clauses>a) Roasting legume splits selected from the group of chickpea splits, lentil splits, or a combination thereof and milling the roasted legume splits to obtain roasted legume flour or roasting legume flour selected from the group of chickpea flour, lentil flour, or a combination thereof to obtain roasted legume flour;</seg-clauses>
<seg-clauses>b) Mixing the roasted legume flour, cereal flour, starch, wheat gluten and optionally other dry ingredients with the Kansui salts and water to form a dough;</seg-clauses>
<seg-clauses>c) Sheeting and slitting the dough to obtain noodle strands;</seg-clauses>
<seg-clauses>d) Steaming the noodle strands from step c);</seg-clauses>
<seg-clauses>e) Cutting the noodle strands from step d) and optionally folding;</seg-clauses>
<seg-clauses>f) Frying the noodle strands from step e) in oil or air drying the noodle strands from step e);</seg-clauses>
<seg-clauses>g) Cooling.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A process for the production of a legume based dried instant noodle as claimed in claim 1, comprising </seg-main><seg-clauses>10 to 60wt% of legume flour (by weight of the total composition), 5 to 70wt% of cereal flour (by weight of the total composition), 0.2 to 3.5wt% of Kansui salts (by weight of the total composition), 0.5 to 10wt% of wheat gluten (by weight of the total composition), 1 to 20wt% of starch (by weight of the total composition).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A process for the production of a legume based dried instant noodle in any one of claims 1 to 2, wherein </seg-main><seg-clauses>the legume based dried instant noodle has a ratio betwe",A23L7/113,20250911,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250302083A1,Extensively hydrolysed infant formula,"An extensively hydrolysed infant formula (eHF) containing protein, carbohydrate and fat. The eHF includes about 2.4 g or less of the protein per 100 kcal. The eHF contains no medium chain triglycerides (MCTs). The eHF may further include 2′-fucosyllactose (2′FL) and/or lacto-N-neotetraose (LNnT). The eHF may be suitable for infants with cow's milk protein allergy.","<div class=""indep-clm"" num=""1""><seg-con>1: An extensively hydrolysed infant formula (eHF) suitable for infants with cow's milk protein allergy, the eHF </seg-con><seg-trans>comprising </seg-trans><seg-refi>protein, carbohydrate and fat, wherein the eHF comprises about 2.4 g or less protein per 100 kcal, wherein the eHF comprises no medium chain triglycerides (MCTs) and wherein the eHF comprises 2′-fucosyllactose (2′FL) and/or lacto-N-neotetraose (LNnT).</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises 0.5-3 g/L of the 2′FL.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises 0.2-1 g/L of the LNnT.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the eHF comprises about 1.8 g to about 2.4 g of the protein per 100 kcal.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1"">5: The eHF according to claim 1, at least about 95% by weight of peptides in the eHF have a molecular mass of less than about 3000 Da.</div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least about 85% by weight of peptides in the eHF have a molecular weight of less than about 1200 Da.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least about 45% by weight of peptides in the eHF are di- and tri-peptides.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8: The eHF according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least about 45% by weight of peptides in the eHF have a molecular weight of between 240 and 600 Da.</seg-refi></div>
<di","A23L33/00, A23L33/12, A23L33/125, A23L33/175, A23L33/18",20251002,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12193596B2,Method for preparing a beverage or liquid food and system using brewing centrifugal force,"A method and system for preparing a beverage or liquid from a food substance contained in a filtering receptacle by passing water through the substance using brewing centrifugal forces. The method includes feeding water into the receptacle, and driving the receptacle in centrifugal rotation to force water to flow through the substance in a centrifugal flow path to the outlet of the receptacle. The system includes equipment necessary to carry out the method. The receptacle is a sealed capsule which is opened for water to be introduced into the capsule, contains a predetermined dose of food substance and is discarded after use.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for preparing a beverage or liquid food from a predetermined dose of a substance contained in a filtering capsule, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>inserting the filtering capsule into a capsule holder of a preparation device, the capsule holder connected to a central rotating rod supported by a support;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>passing water through the substance in the filtering capsule using centrifugal forces to force water to flow through the substance in the filtering capsule in a centrifugal flow path to form the beverage or liquid food and direct the beverage or liquid food through at least one peripheral outlet of the filtering capsule; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>collecting the beverage or liquid food in a collecting chamber of the support, the collecting chamber is heated by heating elements associated with the collecting chamber,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein a lid of the capsule holder is associated with an upper bearing of the preparation device, the lid is associated to the upper bearing along a hollow rotating rod above the central rotating rod and configured for entry of the water into the filtering capsule through a conduit traversing the hollow rotating rod.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>draining the beverage or liquid food from the collecting chamber through a collecting tube extending from the collecting chamber.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the collecting tube is inclined downward from the collecting chamber, and the method further comprises directing the beverage or liquid food toward a us","A47J31/22, A47J31/40, B65D85/804",20250114,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119836250A,Beverage or food preparation system,"A system comprising: a container for containing a precursor material, the container for use with a machine for preparing a beverage and/or a food product or a precursor thereof, the container comprising a plurality of machine-readable codes, each code storing preparation information for use with a preparation process performed by the machine, each code comprising a plurality of units, a plurality of cells defining a data portion arranged at a predetermined position relative to a reference portion, the reference portion of an adjacent code being arranged to define a vertex of a quadrangle having at least two equilateral sides; a machine for preparing a beverage and/or food product or a precursor thereof, the machine comprising: a processing unit for processing a precursor material of the container; and electrical circuitry to control the processing unit based on preparation information read from the code; and a code reading system for reading the code of the container by obtaining a digital image of the code in the shape of an equiangular quadrangle with an image capture device; wherein the container and the code reading system are configured to obtain a digital image of the quadrilateral shape, the digital image of the quadrilateral shape being arranged obliquely to the quadrilateral defined by the adjacent code having the digital image to include at least two reference portions of the code.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>用于容纳前体材料的容器，所述容器用于与用于制备饮料和/或食品或其前体的机器一起使用，所述容器包括多个机器可读代码，每个代码存储与由所述机器执行的制备过程一起使用的制备信息，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>每个代码包括多个单元，所述多个单元限定相对于参考部分被布置在预先确定的位置处的数据部分，相邻代码的所述参考部分被布置成限定具有至少两条等边的等角四边形的顶点；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>用于制备饮料和/或食品或者其前体的机器，所述机器包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>处理单元，所述处理单元用于处理所述容器的前体材料；和电气电路系统，所述电气电路系统用以基于从所述代码读取的制备信息来控制所述处理单元；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码读取系统，所述代码读取系统用于通过利用图像捕获装置获得形状为等角四边形的所述代码的数字图像来读取所述容器的所述代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述容器和代码读取系统被配置为获得所述四边形形状的数字图像，所述四边形形状的数字图像被布置成倾斜于由具有所述数字图像的所述相邻代码限定的所述四边形，以包括所述代码的至少两个参考部分，所述四边形形状的数字图像的边与由所述相邻代码限定的所述四边形成角度。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中由所述代码限定的所述四边形的边长小于所述数字图像的所述四边形形状的滑动长度。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项所述的系统，其中所述代码中的每个代码被布置在正方形平面内并且所述代码被布置成彼此相邻。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的系统，其中代码的顶点被三个或两个其他代码相邻。</div>
<div class=""dep-clm"" num=""5"" parent=""3,4"">5.根据权利要求3或4中任一项所述的系统，其中所述数字图像的所述四边形形状的边长是所述代码的边长的至少两倍。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的系统，其中所述倾斜布置包括由与所述数字图像的所述四边形形状成45度布置的所述代码限定的所述四边形。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的系统，其中所述电气电路系统被配置为使用所述至少两个参考部分定位所述数字图像中的至少一个数据部分。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的系统，其中所述数字图像的所述四边形和由所述代码限定的所述四边形被配置为使得如果彼此对准，则仅单个参考部分可被布置在所述数字图像中。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的系统，其中由所述相邻代码限定的所述四边形被布置成倾斜于所述容器的边缘，其中所述代码读取系统被配置为用于在获得所述数字图像时进行对准。</div>
<div class=""indep-clm"" num=""10""><seg-con>10.一种用于制备饮料和/或食品或其前体的机器，所述机器</seg-con><seg-trans>包括：</seg-trans><seg-comp>代码读取系统，所述代码读取系统用以读取容器的代码；</seg-comp><seg-comp>处理单元，所述处理单元用于处理所述容器的前体材料；</seg","A47J31/44, A47J31/52",20250415,雀巢产品有限公司,['Pending']
US20250295263A1,Beverage preparation system,"The invention concerns a beverage production system comprising a module (<b>1</b>) for producing a beverage from a pack (<b>10</b>). The pack can include a bottom side (<b>101</b>) with an area (<b>104</b>) configured for being openable. The openable area can be made of a flexible material. Module (<b>1</b>) can include a pack holder assembly (<b>2</b>), a fluid processing device (<b>11</b>) designed to open the openable area (<b>104</b>) of the pack, and an actuating device (<b>12</b>) to move said fluid processing device (<b>11</b>) and said pack (<b>10</b>) one to the other. The pack holder assembly (<b>2</b>) can include a movable locking device (<b>24</b>) to position the pack (<b>10</b>) inside the pack chamber (<b>22</b>) when a beverage is prepared, and the bottom part of the pack (<b>10</b>) can include at least two fixing means (<b>103</b>) of a hole or a deformable area. The movable locking device (<b>24</b>) can include at least two positioning means (<b>242</b>), each being configured to move inside at least one respective hole (<b>103</b>) of the pack hold in the chamber, or to move inside at least one respective deformable area (<b>103</b>) of the pack hold in the chamber and to fit in the resulting deformed area.","<div class=""ccl-clm"" num=""11"">1-11. (canceled)</div>
<div class=""indep-clm"" num=""12""><seg-con>12. A pack </seg-con><seg-trans>containing </seg-trans><seg-refi>a beverage ingredient and configured for preparing a beverage by injection of fluid therein, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>the beverage ingredient is a water soluble, dilutable or infusible beverage ingredient, said pack presents:</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>a plane shape, said plane shape being oriented along a plane vertically oriented during beverage production, and</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>a bottom side comprising an area configured for being openable, said openable area being made of a flexible material, and</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>the bottom part of the pack comprises at least two fixing members, said fixing members being a hole or a deformable area, said two fixing members being positioned around the openable area of the bottom side of the pack, and each of the holes and/or deformable areas of the pack encompasses one circular fixing areas, and</seg-refi></div>
<div class=""indep-clm"" num=""12""><seg-refi>the distance between the centres of said circular fixing areas being at most 52 mm.</seg-refi></div>
<div class=""dep-clm"" num=""13"" parent=""12""><seg-con>13. A pack according to claim 12, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the openable area is made of a stretchable material.</seg-refi></div>
<div class=""dep-clm"" num=""14"" parent=""12""><seg-con>14. A pack according to claim 12, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stretchable material is selected from the group consisting of: polyethylene (PE), polypropylene (PP), polylactide (PLA), polyhydroxyalcanoates (PHA), polybutylene adipate terepthalate (PBAT), polybutylene succinate (PBS), polyvinyl alcohol (PVOH), starch-based polymers, a polymer comprising food-grade oxygen and/or moisture scaveng","A47J31/40, A47J31/44, A47J31/46, B65D75/30, B65D85/804",20250925,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023351581A1,Methods for providing health benefits in animals,"The present disclosure provides methods and compositions for treating glomerular hyperfiltration, reducing glycogen storage in tissues, or reducing uremic toxins in an animal, comprising orally administering a composition comprising medium chain triglycerides, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arginine, antioxidants, and B vitamins to the animal.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for treating glomerular hyperfiltration, reducing glycogen storage in tissues, or reduce uremic toxins in an animal, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>orally administering a composition comprising medium chain triglycerides, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arginine, antioxidants, and B vitamins to the animal.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the B vitamins include niacin, pantothenate, pyridoxine, thiamine, riboflavin, biotin, folic acid, and cobalamin.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The method of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the niacin is about 1 to about 30 times of RD A, the pantothenate is about 1 to about 50 times of the RD A, the pyridoxine is about 1 to about 30 times of the RD A, the thiamine is about 1 to about 200 times of the RD A, the riboflavin is about 1 to about 100 times of the RD A, the biotin is about 1 to about 40 times of the RD A, the folic acid is about 1 to about 50 times of the RD A, and the cobalamin is about 1 to about 50 times of the RD A.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the medium chain triglycerides are about 0.1 wt% to about 60 wt% of the composition.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the medium chain triglycerides are about lwt% to about 20 wt% of the composition</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the medium chain triglycerides include a medium-chain fatty acid selected from the group consisting of caprylic acid, capric acid, and a ","A23K20/142, A23K20/158, A23K20/174, A23K50/40",20250306,SOCIETE DES PRODUITS NESTLE SA,['Pending']
CA3025173C,Compositions and methods that modulate phosphorus or enzymes in a companion animal,"A specific type of organ health marker in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of organ health marker or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the specific type of organ health marker. The specific type of organ health marker can be one or more of phosphorus, alkaline phosphatase, aspartate aminotransferase, or gamma- glutamyltransferase.","CLAIMS: <div class=""indep-clm"" num=""1""><seg-con>1. A pet food composition, </seg-con><seg-trans>comprising: </seg-trans><seg-refi>protein, carbohydrates, fat, fiber, and at least 8 distinct metabolites including at least 2 distinct metabolites for modulating each of phosphorus, alkaline phosphatase, aspartate aminotransferase, and gamma-glutamyltransferase in a companion animal; wherein the metabolite that modulates phosphorus is selected from the group consisting of homocysteine, erythritol, arabitol, betaine, N-acetylphenylalanine, 3-hydroxybutyrate (BHBA), citrulline, mannose, 2-oxindole-3-acetate, N-acetyltryptophan, glycerate, xylonate, threitol, 3-aminoisobutyrate, arachidonate (20:4n6), gamma-glutamylphenylalanine, phenylalanine, trigonelline (N1-methylnicotinate), allantoin, glutathione (oxidized (GSSG)), Nacetylserine, arabinose, and mixtures thereof; wherein the metabolite that modulates alkaline phosphatase is selected from the group consisting of lysine, gamma-glutamylphenylalanine, arabinose, phenylalanine, and mixtures thereof; wherein the metabolite that modulates aspartate aminotransferase is selected from the group consisting of 3-ureidopropionate, threitol, erythronate, gulono-l,4-lactone, Cglycosyltryptophan, urea, 2-hydroxyglutarate, butyrylcamitine, dimethylglycine, pseudouridine, eicosapentaenoate (EPA; 20:5n3), uracil, 1-linoleoylglycerophosphoinositol, dihomo-linolenate (20:3n3 or n6), phosphate, and mixtures thereof; wherein the metabolite that modulates gamma-glutamyltransferase is selected from the group consisting of 3-aminoisobutyrate, trigonelline (N'-methylnicotinate), N-acetylserine, taurochenodeoxycholate, erythritol, 15-methylpalmitate, allantoin, taurocholate, threitol, 3- phosphoglycerate, betaine, arabitol, sebacate (decanedioate), stachydrine, citrulline, citrate, glycolate (hydroxyacetate), campesterol, and mixtures thereof; wherein the pet food composition provides at least a 5% increase or at least a 5% decrease in the amount","A23K10/00, A23K20/142, A23K20/153, A23K20/158, A23K50/40",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024239231A1,Compostable top lid structure for a beverage preparation capsule,"The invention relates to a capsule (100) for preparing a beverage in a beverage production machine, the capsule (100) comprising a capsule body (200) delimiting a chamber (250) for containing a beverage substance (500), an injection wall (220) closing the chamber at a first end and a delivery wall (300) closing the chamber (250) at a second end of the capsule body (200). The delivery wall (300) comprises in a layered manner a carrier layer (320) for carrying the subsequent layers, an optional filter layer (310) and a barrier layer (340) applied on the carrier layer (320), the barrier layer (310) providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340). As proposed the barrier layer (340) is applied in one or more layers in a total quantity of 0,5 to 10 gsm (g/m2), preferably of 1,5 to 4 gsm (g/m2) and is applied on least one of the carrier layer's surfaces, said surface having a surface roughness lower than 1;3 microns when measured according to ISO 3274. The invention also relates to a system comprising the proposed capsule and to a use of the proposed capsule for preparing a beverage in a beverage production machine","<div class=""indep-clm"" num=""1""><seg-main>1. A capsule (100) for preparing a beverage in a beverage production machine, wherein </seg-main><seg-clauses><seg-main>the capsule (100) comprises:</seg-main>
<seg-clauses>- a capsule body (200) comprising a sidewall (210) delimiting a chamber (250) for containing a substance (500) forthe preparation of the beverage, and a rim portion (211) delimiting an opening (230) in the sidewall (210);</seg-clauses>
<seg-clauses>- an injection wall (220), closing the chamber at a first end, for injecting a fluid in the chamber (250) for preparing the beverage upon interaction of the fluid with the substance (500); and</seg-clauses>
<seg-clauses>- a delivery wall (300) being connected to the capsule body (200), preferably to the rim portion (211), to close the chamber (250) at a second end of the capsule body (200), the delivery wall (300) comprising in a layered manner:</seg-clauses>
<seg-clauses class=""seg-enter"">o a carrier layer (320) made of biodegradable material, the carrier layer (320) being adapted to be opened under the effect of rising pressure of the fluid being injected into the capsule (100), and</seg-clauses>
<seg-clauses class=""seg-enter"">o optionally a filter layer (310) made of biodegradable material for filtering out particles from the prepared beverage dispensed via the delivery wall (300),</seg-clauses>
<seg-clauses class=""seg-enter"">o a barrier layer (340) made of biodegradable material for providing a preferably bidirectional barrier against moisture and/or gas, the barrier layer (340) being preferably made of a different material than the filter layer (310) and/or the carrier layer (320); the barrier layer (340) being applied on the carrier layer (320).</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the barrier layer (340) is applied in one or more layers in a total quantity of 0,5 to 10 gsm (g/m2), preferably of 1,5 to 4 gsm (g/m2) and is applied on least one of the carrier layer's surfaces, said surface ha",B65D85/804,20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
JP2025063271A,Dietary butyrate and its uses,"To provide a novel method for using butyrate as a food ingredient having improved organoleptic properties.SOLUTION: There are provided a compound having the formula (1), (2), (3) or (4), or combinations thereof, for use in the maintenance of bone health and/or the prevention and/or treatment of bone disorder associated with unbalanced bone catabolism, where R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having 16 to 20 carbons.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 骨の健康維持並びに／又は不均衡な骨異化に関連した骨障害の予防及び／若しくは治療に使用するための、次式を有する化合物又はこれらの組み合わせ。</div>
<div class=""indep-clm"" num=""1""> 【化1】<img src=""https://data-fulltext-image.patsnap.com/JP/A/20/25/06/32/71/1744739007757/2025063271000015.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064343%3B1765067943%26q-key-time%3D1765064343%3B1765067943%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Dd803b28202189a71e1a199762775a69c724f2035&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A03%20GMT"" class=""img-anchor img-center"" img-id=""2025063271000015"" image_type=""chemistry"" official_size=""21798""></div>
<div class=""indep-clm"" num=""1""> ［式中、Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及びＲ<sup> ６</sup>は、独立して、１６～２０個の炭素を有する長鎖脂肪酸である。］ </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 式（１）を有する化合物と式（２）を有する化合物との組み合わせが使用され、好ましくは、前記組み合わせが、式（１）を有する化合物をトリグリセリド全量の少なくとも１０重量％の量で含み且つ式（２）を有する化合物をトリグリセリド全量の少なくとも１０重量％の量で含む組成物中に存在する、請求項１に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""3"" parent=""1"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1""> 式（１）を有する化合物と式（２）を有する化合物との組み合わせが使用され、前記組み合わせが、式（１）を有する化合物をブチレート部分含有トリグリセリド全量の少なくとも１０重量％の量で含み且つ式（２）を有する化合物をブチレート部分含有トリグリセリド全量の少なくとも１０重量％の量で含む組成物中に存在する、請求項１に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 式（１）を有する化合物と、式（２）を有する化合物と、式（３）を有する化合物と、式（４）を有する化合物と、の組み合わせが使用された、請求項１、２、又は３に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> Ｒ<sup> １</sup>、Ｒ<sup> ２</sup>、Ｒ<sup> ３</sup>、Ｒ<sup> ４</sup>、Ｒ<sup> ５</sup>、及び／又はＲ<sup> ６</sup>が、不飽和脂肪酸であり、好ましくはモノ不飽和脂肪酸である、請求項１又は２～４のいずれか一項に記載の使用のための化合物。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4""> ","A61K31/23, A61P19/00, A23L33/10, A23C9/152",20250415,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US20250248428A1,Plant based whipping cream,The present invention relates to an emulsion composition comprising 1 to 5% wt non-fractionated chickpea; 0.25 to 3%<sub>wt </sub>non-fractionated oat; 20.5 to 35%<sub>wt </sub>lipid source; and 50 to 75%<sub>wt </sub>water. Preferred emulsion compositions further comprise non-fractionated lentil. Whipped cream compositions made from the emulsion composition are also provided.,"<div class=""indep-clm"" num=""1""><seg-main>1. An emulsion composition, said composition comprising</seg-main>
<seg-clauses>a. 1 to 5%<sub>wt </sub>non-fractionated chickpea;</seg-clauses>
<seg-clauses>b. 0.25 to 3%<sub>wt </sub>non-fractionated oat;</seg-clauses>
<seg-clauses>c. 20.5 to 35%<sub>wt </sub>lipid source; and</seg-clauses>
<seg-clauses>d. 50 to 75%<sub>wt </sub>water.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the composition further comprises 1 to 5%<sub>wt </sub>non-fractionated lentil.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition according to claim 1, wherein </seg-main><seg-clauses><seg-main>the composition comprises </seg-main><seg-clauses>0.5 to 1%<sub>wt </sub>protein.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. The composition according to claim 2, wherein </seg-main><seg-clauses>greater than 90% of the protein is provided by the non-fractionated chickpea, non-fractionated oat, and non-fractionated lentil.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The composition according to claim 1, wherein </seg-main><seg-clauses>the non-fractionated chickpea is chickpea flour and the non-fractionated oat is hydrolyzed oat flour.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The composition according to claim 1, wherein </seg-main><seg-clauses>the lipid source is coconut oil.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The composition according to claim 1, wherein </seg-main><seg-clauses><seg-main>the composition further comprises an emulsifier selected from the group consisting of</seg-main>
<seg-clauses>a. Monoglyceride, wherein said monoglyceride comprises a minimum 90% of monoglycerides from edible and fully hydrogenated palm oil;</seg-clauses>
<seg-clauses>b. Lecithin, monoglyceride, and ","A23L9/20, A23D7/005, A23D7/01, A23D7/04",20250807,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024220279A1,"A combination of a source of isoflavones and at least a natural extract for treatment, prevention, or supporting improvement of cognitive symptoms related to menopause","A method treats or prevents cognitive menopausal symptoms and includes administering, to a human woman having or at risk of the cognitive menopausal symptoms, an effective amount of a combination of a source of isoflavones and at least one of a natural extract for supporting cognitive performance and a natural extract for promoting calmness and reducing stress. The combination may be administered in a composition that further includes one or more of Vitamin B12, Vitamin B6, Vitamin B complex, iron, magnesium, and/or a refreshing/cooling agent. Single or multiple doses of the composition may be administered per day, the multiple doses including a first dose and a second dose. The first dose may be administered to the human woman in the morning, and the second dose may be administered to the human woman in the night.",,"A23L33/105, A61K31/4415, A61K31/714, A61K36/258, A61K36/53",20250731,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4491068A1,"Machine, crushing unit for such a machine and method for preparing a beverage with such a machine","The preparation machine (1) comprises: - a preparation unit (2) having i) a preparation chamber (6) for receiving the capsule (100) and ii) means for injecting the fluid in the capsule (100) to prepare the beverage, and - a crushing unit (4) having a crushing element (7) movable so as to crush the capsule body (101) such that at least part of the beverage component (103) is released from the cavity (102) after the capsule (100) has been processed in the preparation unit (2).","<div class=""indep-clm"" num=""1""><seg-main>1.  Preparation machine (1) for preparing a beverage by injecting a fluid in a capsule (100), the capsule (100) having </seg-main><seg-clauses>i) a capsule body (101) defining a cavity (102) and </seg-clauses><seg-clauses><seg-main>ii) a beverage component (103) contained within the cavity (102), wherein the preparation machine (1) comprises: </seg-main><seg-clauses><seg-main>- a preparation unit (2) having </seg-main><seg-clauses>i) a preparation chamber (6) for receiving the capsule (100) and </seg-clauses><seg-clauses>ii) means for injecting the fluid in the capsule (100) to prepare the beverage, and </seg-clauses></seg-clauses><seg-clauses>- a crushing unit (4) having a crushing element (7), the crushing element (7) being movable so as to crush the capsule body (101) such that at least part of the beverage component (103) is released from the cavity (102) after the capsule (100) has been processed in the preparation unit (2).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  Preparation machine (1) according to claim 1, wherein </seg-main><seg-clauses>the crushing element (7) includes a crusher or a shredder.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  Preparation machine (1) according to claim 1 or 2, wherein </seg-main><seg-clauses>the crushing element (7) is movable in rotation so as to crush the capsule body (101), the crushing element (7) preferably forming a crushing mill.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  Preparation machine (1) according to any one of the preceding claims, wherein </seg-main><seg-clauses>the crushing element (7) comprises at least one crushing tool having a plurality of sharp sections (7.4).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5.  Preparation machine (1) according to claims 3 and 4, wherein </seg-main><seg-clauses>the crushing element (7) comprises a","A47J31/36, A47J31/44, A47J31/60",20250115,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025204064A1,Mixed triglyceriges,"Abstract The present invention relates to a dietary source of butyric acid containing triglycerides having improved organoleptic properties. The present invention also provides butyric acid containing triglycerides that provide a rich source of ketones. More particularly, the inventon relates to a composition comprising a compound having the formula (1), (2), (3), (4) or combinations thereof, wherein n1, n2, n3, n4, n5 and n6 are independently 4 to 10.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a compound having the formula (1) and a compound having the formula (2), wherein the compound having the formula (1) comprises at least 5% by</seg-main>
<seg-main class=""seg-enter"">5 weight of the total butyrate moiety containing triglycerides in the composition, and wherein the compound having the formula (2) comprises at least 5% by weight of the total butyrate moiety containing triglycerides in the composition</seg-main>
<seg-clauses>(1)</seg-clauses>


<seg-clauses class=""seg-enter"">10 wherein n1, n2, and n3 are independently 4 to 10.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the compound having the formula (1) comprises at least 10% by weight of the total butyrate moiety containing triglycerides in the composition, and wherein the compound having the formula (2) comprises at least 10% by weight of the total butyrate moiety containing triglycerides in the composition.</seg-clauses>
<seg-clauses class=""seg-enter"">15   </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim 1 or 2, further comprising </seg-main><seg-clauses>a compound having the</seg-clauses>
<seg-clauses class=""seg-enter"">formula (3)</seg-clauses>

<seg-clauses class=""seg-enter"">wherein n4 is 4 to 10.</seg-clauses>
<seg-clauses class=""seg-enter"">2025204064   30 May 2025</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The composition according to claim 3, wherein </seg-main><seg-clauses>the compound having the formula (3) comprises at least 5% by weight of the total butyrate moiety containing triglycerides in the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The composition according to claim 4, wherein </seg-main><seg-clauses>the compound having the formula (3) 5 co","A23D9/02, A61K31/215, C11C3/10",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025202272A1,Container for beverage or foodstuff preparation machine,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion, wherein the storage portion is formed from a blank of paper-based material and comprises, in a hemispherical state, a hemispherical shaped cavity formed of flaps which extend in a radial direction, and which directly adjoin each other, the flange portion including connecting members to retain the storage portion in the hemispherical state.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A container for </seg-con><seg-trans>containing </seg-trans><seg-refi>a precursor material for use with a machine for preparing a beverage and/or foodstuff, the container comprising: a body portion having a storage portion for storage of the precursor material and a separate flange portion, wherein the storage portion is formed from a blank of paper-based material and comprises, in a hemispherical state, a hemispherical shaped cavity formed of flaps which extend in a radial direction, and which directly adjoin each other, the flange portion including connecting members to retain the storage portion in the hemispherical state.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>there at least 8 flaps.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The container of either of claims 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hemispherical shaped cavity is formed by bending of the flaps without forming fold lines.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the flaps extend from distal a height of a base of the storage portion to a periphery of the storage portion.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The container of any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the hemispherical shape is formed by pressing the paper-based material to have a flat or curved base.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The container of any preceding claim formed from a blank </seg-con><seg-trans>comprising: </seg-trans><seg-comp>a circular central portion to form a base of the hemisphere, the circular central portion delineated by vertices; </seg-comp><seg-comp>the flaps extending radia",B65D85/804,20251002,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CA3006448A1,Heat sterilized high protein compositions with hydrolyzed protein from a continuous process with at least one endopeptidase,"The present invention is directed to a heat sterilized composition comprising: a protein source in an amount of 5 to 20% by weight of the composition, said protein source comprising hydrolyzed protein; wherein the protein source has been treated in a continuous process with at least one endopeptidase, typically for a finite length of time. Furthermore, the invention concerns a heat sterilized high protein composition having low viscosity and being devoid of bitterness, comprising hydrolyzed heat sensitive protein source having a degree of protein hydrolysis in NPN/TN of 20 to 50% and at least one heat inactivated endopeptidase. The present invention is furthermore directed to a continuous process for preparing a heat sterilized composition which comprises a protein source containing hydrolyzed protein, the process comprising the following steps: (i) Providing an aqueous solution of a protein source; (ii) Performing a continuous hydrolysis step wherein the aqueous solution of a protein source is treated with at least one endopeptidase by heating at 40 to 90°C and for a finite length of time of 2 to 20 minutes; (iii) heat inactivation of the endopeptidase. The invention also concerns a method of controlling viscosity and preventing bitter taste of a heat sterilized high protein composition, the method comprising providing an aqueous solution of a protein source and continuously hydrolyzing the aqueous solution of a protein source with at least one endopeptidase prior to heat inactivation of the said endopeptidase. Finally, the invention concerns the use of hydrolyzed protein prepared in a continuous process as described herein by treatment with at least one endopeptidase for a finite length of time, for preparing a heat sterilized composition and/or for controlling the viscosity of a liquid composition, wherein the composition comprises 5 to 20 weight % total protein. The invention also concerns medical uses and treatments applying or using the inventive heat sterilized composition.","<div class=""indep-clm"" num=""1""><seg-main>35 Claims 1. Aliquid heat sterilized composition comprising: </seg-main><seg-clauses>a protein source in an amount of 5 to 20% byweight of the composition, said protein source comprising hydrolyzed protein; wherein the protein source has been treated in a continuous process with at least one endopeptidase comprising a serine protease by heating at 40 to 9O°Cfor a finite length of time selected from a period of 2 to 20 minutes, wherein the degree of protein hydrolysis in non-protein nitrogen/total nitrogen (NPN/TN) is 20 to 50%, wherein the liquid heat sterilized composition has a viscosity of below875 mPa s at 2O°C/1OO s1. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according toclaim1wherein </seg-main><seg-clauses>the protein sourceis selected from a heat sensitive protein from animal or plant origin. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim1or claim 2 wherein </seg-main><seg-clauses>the protein source isselected from whey protein, pea protein, potato protein, wheat protein, sunflower protein, soy protein or mixtures thereof. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of claims1to3wherein </seg-main><seg-clauses>the at least one endopeptidase consists of a serine protease. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of claims1to 4 which is a liquid composition, having </seg-main><seg-clauses>a viscosity of below 200 mPas at 2O°C/ioo s1. </seg-clauses></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any one of claims1to5 having </seg-main><seg-clauses>a protein concentration of up to17 g/mL of the composition. </seg-clauses></div><div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7. The composition according to any one of claims","A23J3/08, A23J3/34",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024237946A1,Capsule for the preparation of a beverage,"A capsule for the preparation of a beverage in a beverage preparation machine is disclosed. The capsule comprises a cup-shaped body and a closing membrane for closing the cup-shaped body. The cup-shaped body comprises an annular flange for the closing membrane to seal thereon. At least the cup-shaped body is made of cellulose pulp and comprises: a bottom wall, a tubular lateral wall and the annular flange. The annular flange further comprises a portion having a surface roughness comprised between 27 and 32 microns. This flange portion having specific roughness characteristics cooperates with an edge of a capsule enclosing member of the beverage preparation machine for improving leak tightness during the preparation of the beverage.",,B65D85/804,20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250176582A1,confectionery,The present invention relates to milk-based confectionery comprising an oligosaccharide mixture.,"<div class=""indep-clm"" num=""1""><seg-main>1. A chocolate product comprising:</seg-main>
<seg-clauses>a. a milk product comprising a carbohydrate mixture, wherein the milk product is present in an amount of between 0.5 wt % and 50 wt % of the chocolate product and the milk product comprises between 10 wt % and 90 wt % carbohydrate mixture based on the weight of the milk product, wherein the carbohydrate mixture comprises between 10 wt % and 100 wt % galactooligosaccharide, and</seg-clauses>
<seg-clauses>b. a polyol present in an amount of between 30 wt % and 65 wt % of the chocolate product.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the polyol is selected from the group comprising isomalt, sorbitol, maltitol, mannitol, xylitol, erythritol, threitiol, arabitol, lactitol, galactitol and hydrogenated starch hydrolysates and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the chocolate product comprises between 5 wt % and 22 wt % of the milk product.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>the chocolate product comprises between 41 wt % and 56 wt % of the polyol.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. A chocolate product according to claim 1, wherein </seg-main><seg-clauses>from 0 wt % to 15 wt % of the total carbohydrates in the mixture is lactose.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. A chocolate product according to claim 1, wherein </seg-main><seg-clauses><seg-main>the carbohydrate mixture is a composition expressed as dry matter percentage by weight of the mixture:</seg-main>
<seg-clauses>a. Lactose 0-40%;</seg-clauses>
<seg-clauses>b. Glucose 0-40%;</seg-clauses>
<seg-clauses","A23G1/46, A23C9/12, A23G1/40",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024228052A1,Aerated confectionery,The invention relates to a water-based aerated confectionery product used as a filling composition in a chocolate or chocolate-analogue product and methods of making the same.,"<div class=""indep-clm"" num=""1""><seg-main>1. A confectionery composition comprising </seg-main><seg-clauses>a chocolate or chocolate analogue confectionery filled with water-based aerated confectionery filling, wherein the waterbased aerated confectionery filling:</seg-clauses>
<seg-clauses class=""seg-enter"">has a pH of greater than or equal to 5.6; and</seg-clauses>
<seg-clauses class=""seg-enter"">has a water activity less than 0.67; and</seg-clauses>
<seg-clauses class=""seg-enter"">comprises 30wt% to 90wt% sugar;</seg-clauses>
<seg-clauses class=""seg-enter"">comprises between 1wt% to 8wt% protein,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the protein stabilises the water-based aerated confectionery and the protein has been thermally denatured and the water-based aerated confectionery is partly or completely surrounded or encased in chocolate or chocolate analogue.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A confectionery composition according to claim 1, wherein </seg-main><seg-clauses>the water-based aerated confectionery filling has a pH between 5.6 and 10.0, or between 6.0 and 8.0.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A confectionery composition according to any preceding claim, wherein </seg-main><seg-clauses>the protein is whey protein.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A confectionery composition according to any preceding claim, wherein </seg-main><seg-clauses>the protein is present in an amount at least 2wt% of the water-based aerated confectionery filling, optionally at least 2wt%, at least 2.2wt%, at least 3wt% or at least 3.3wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A confectionery composition to any preceding claim, wherein </seg-main><seg-clauses>in the water-based aerated confectionery filling, the sugar comprises or consists of:</seg-clauses>
<seg-clauses class=""seg-enter"">at least two diffe","A23G3/54, A23G1/54, A23G3/44",20250814,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120152710A,Nutritional composition for improving social emotion development,"The present invention relates to combinations of DHA, ARA, iron, folic acid, vitamin B12 and phospholipids, and nutritional compositions comprising such combinations, for use in improving social emotional skills and/or promoting emotional, social and pleasant related behaviors in infants, toddlers or young children. The invention also relates to a synthetic nutritional composition comprising specific amounts of DHA, ARA, iron, folic acid, vitamin B12 and a phospholipid. The invention also relates to uses and methods for improving social emotional skills of infants, toddlers or young children and/or for promoting emotional, social and pleasant related behaviors of infants, toddlers or young children.","<div class=""indep-clm"" num=""1"">1.DHA、ARA、铁、叶酸、维生素B12和磷脂的组合，所述组合在改善婴儿、学步儿童或幼儿的社会情感技能和/或促进所述婴儿、所述学步儿童或所述幼儿的情绪和愉悦行为中使用。</div>
<div class=""indep-clm"" num=""2"">2.根据权利要求1用于所述用途的组合，其中所述磷脂是鞘磷脂、磷脂酰胆碱、磷脂酰肌醇、磷脂酰丝氨酸和磷脂酰乙醇胺。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求1或2用于所述用途的组合，其中所述磷脂是磷脂酰胆碱、磷脂酰肌醇、磷脂酰丝氨酸、磷脂酰乙醇胺和鞘磷脂，并且其中此类磷脂分别以下述量被包含：基于总磷脂在25％w/w至35％w/w范围内的磷脂酰胆碱、基于总磷脂在5％w/w至15％w/w范围内的磷脂酰肌醇、基于总磷脂在5％w/w至10％w/w范围内的磷脂酰丝氨酸、基于总磷脂在21％w/w至30％w/w范围内的磷脂酰乙醇胺和基于总磷脂在20％w/w至30％w/w范围内的鞘磷脂。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求1至3中任一项用于所述用途的组合，社交恐惧，特别是用于改善大于12个月的婴儿、学步儿童或幼儿在涉及新异性/不确定性的社会情境中的趋近行为抑制和/或痛苦。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3"">5.根据权利要求1至3中任一项用于所述用途的组合，所述组合用于促进高强度愉悦，特别是与高刺激强度、速率、复杂性、新异性和不协调性相关的愉悦和享用乐趣，以及用于减少悲伤，特别是减少与婴儿的痛苦身体状态、客体丧失或不能执行期望动作相关的情绪低落和活动。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据前述权利要求中任一项用于所述用途的组合，其中所述组合在受试者生命的前1个月、3个月、6个月、9个月、12个月、18个月、24个月或36个月期间施用。</div>
<div class=""dep-clm"" num=""7"" parent=""2,3,4,5,6"">7.根据前述权利要求中任一项用于所述用途的组合，其中在12月龄、18月龄、24月龄或36月龄的受试者中改善社会情感技能。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3,4,5,6,7"">8.根据前述权利要求中任一项用于所述用途的组合，其中在0月龄至18月龄之间，优选在0月龄至12月龄之间的受试者中促进情绪和愉悦行为。</div>
<div class=""indep-clm"" num=""9"">9.营养组合物，所述营养组合物根据权利要求1至10中任一项用于所述用途，所述营养组合物包含根据权利要求1至3中任一项所述的DHA、ARA、铁、叶酸、维生素B12和磷脂的组合。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据前述权利要求中任一项用于所述用途的营养组合物，所述营养组合物是合成营养组合物。</div>
<div class=""dep-clm"" num=""11"" parent=""9"">11.根据权利要求12用于所述用途的合成营养组合物，其中所述合成营养组合物是婴儿配方食品、1段婴儿配方食品、较大或2段婴儿配方食品、婴孩食物、成长乳、婴儿谷物组合物、强化剂或补充剂。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11和12用于所述用途的合成营养组合物，所述合成营养组合物包含量在300mg/kg至820mg/kg范围内的鞘磷脂、量在500mg/kg至1.3g/kg范围内的磷脂酰胆碱、量在400mg/kg至800mg/kg范围内的磷脂酰肌醇、量在200mg/kg至1000mg/kg范围内的磷脂酰丝氨酸、量在250mg/kg至800mg/kg范围内的磷脂酰乙醇胺、量在3.5mg/100g至7mg/100g范围内的铁、量在0.1mcg/100g至10mcg/100范围内的维生素B12、量在110mcg/100g至400mcg/100g范围内的叶酸以及量在30mg/100g至300mg/100g范围内的DHA和ARA。</div>
<div class=""indep-clm"" num=""13"">13.DHA、ARA、铁、叶酸、维生素B12和磷脂的组合，其中所述磷脂是鞘磷脂、磷脂酰胆碱、磷脂酰肌醇、磷脂酰丝氨酸和磷脂酰乙醇胺，并且其中磷脂分别以下述量被包含：基于总磷脂在25％w","A61K31/202, A61K31/683, A61K31/685, A61K31/688, A61K31/714",20250613,雀巢产品有限公司,['Pending']
RU2834436C1,Method of making package from recyclable material,"FIELD: packing and storage.SUBSTANCE: invention relates to a method of making package (200) for enclosing substance (500). Flat sheet (100) made from recyclable paper material and having two opposite side edge portions (101, 102), is provided and moulded into tube (120) by folding flat sheet (100) so that two side edge sections (101, 102) overlap each other on overlap section (123). Tube (120) is thermally sealed along section (123) of overlap with formation of longitudinal sealing seam (130) and thermally sealed across longitudinal sealing seam (130) to close tube (120) by means of first transverse sealing seam (141) at first end (121) of tube. Tube (120) is filled with substance (500) and thermally sealed across longitudinal sealing seam (130) to close tube (120) by means of second transverse sealing seam (142) at second end (122) of the tube. First and second amounts of glue (300–302) are applied on flat sheet (100) at first and second sections (151, 152) of triple joint, where longitudinal sealing seam (130) and corresponding transverse sealing seams (141, 142), respectively, intersect. Glue (300–302) bonds corresponding section (151, 152) of the triple joint when thermally sealing corresponding end (121, 122) of the tube to form a corresponding transverse sealing seam (141, 142). Invention also relates to package (200) containing substance (500), and device (600) for production of such package (200).EFFECT: thus, it is possible to produce packing with high speed and in completely automated process, as well as without excessive costs for reconfiguration or re-equipment of already existing devices.15 cl, 7 dwg","1. Способ изготовления упаковки (200) для заключения в ней вещества (500), включающий:
<img src='' class=""img-anchor"" img-id=""00000001""/>обеспечение плоского листа (100), изготовленного из пригодного для вторичной переработки бумажного материала и имеющего два противоположных боковых краевых участка (101, 102),
<img src='' class=""img-anchor"" img-id=""00000001""/>формование плоского листа (100) в трубку (120) путем складывания плоского листа (100) таким образом, чтобы два боковых краевых участка (101, 102) по меньшей мере частично перекрывали друг друга на участке (123) перекрытия,
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) вдоль участка (123) перекрытия с образованием продольного запечатывающего шва (130),
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) поперек продольного запечатывающего шва (130) для закрытия трубки (120) с помощью первого поперечного запечатывающего шва (141) на первом конце (121) трубки,
<img src='' class=""img-anchor"" img-id=""00000001""/>наполнение трубки (120) веществом (500), подлежащим упаковыванию,
<img src='' class=""img-anchor"" img-id=""00000001""/>термозапечатывание трубки (120) поперек продольного запечатывающего шва (130) для закрытия трубки (120) с помощью второго поперечного запечатывающего шва (142) на втором конце (122) трубки, противоположном первому концу (121) трубки по отношению к веществу (500), подлежащему упаковыванию, с образованием упаковки (200), заключающей в себе указанное вещество (500),
отличающийся тем, что способ дополнительно включает:
<img src='' class=""img-anchor"" img-id=""00000001""/>нанесение первого количества клея (300, 301) на плоский лист (100) на первом участке (151) тройного стыка, на котором пересекаются продольный запечатывающий шов (130) и первый поперечный запечатывающий шов (141),
<img src='' class=""img-anchor"" img-id=""00000001""/>нанесение второго количества клея (300, 302) на плоский лист (100) на втором участке (152) тройного стыка, на","B65B9/06, B65B51/02, B65B51/10, B65B51/26, B65D65/46",20250210,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
RU2832710C2,Food butyrate,"FIELD: chemistry.SUBSTANCE: present invention relates to use of a compound selected from compounds of formulas (1), (2), (3), (4):or a combination thereof for increasing the concentration of ketones in blood and/or therapy of diseases amenable to treatment by increasing the concentration of ketones in the blood. In formulas (1), (2), (3), (4) R1, R2, R3, R4, R5 and R6 independently represent a long-chain fatty acid having from 16 to 20 carbon atoms.EFFECT: development of a food source of butyrate, having improved organoleptic properties as compared to available products, and potential of high formation of ketones after oral or enteral intake by humans and other mammals.15 cl, 2 dwg, 2 tbl, 6 ex","1. Применение соединения, выбранного из соединения формулы (1), (2), (3), (4):

<img src='' class=""img-anchor img-center"" img-id=""00000017""/>

или их комбинации для повышения концентрации кетонов в крови и/или терапии заболеваний, поддающихся лечению посредством повышения концентрации кетонов в крови, где заболевание выбрано из следующего перечня: нехватка энергии для головного мозга, неврологическое заболевание, мигрень, расстройство памяти, возрастное расстройство памяти, повреждение головного мозга, инсульт, боковой амилоидный склероз, рассеянный склероз, нарушение когнитивных функций, нарушение когнитивных функций после интенсивного лечения, возрастное нарушение когнитивной функции, болезнь Альцгеймера, болезнь Паркинсона, болезнь Хантингсона, наследственные метаболические расстройства (такие как синдром дефицита транспортера глюкозы 1 типа и недостаточность пируватдегидрогеназного комплекса), депрессия, шизофрения, эпилепсия, нарколепсия, неалкогольная жировая дистрофия печени и синдром поликистоза яичников, где R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>и R<sup>6</sup>независимо представляют собой длинноцепочечную жирную кислоту, имеющую от 16 до 20 атомов углерода.
2. Применение по п. 1, в котором используется комбинация соединения формулы (1) и соединения формулы (2), где предпочтительно комбинация присутствует в композиции, содержащей соединение формулы (1) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов в композиции и соединение формулы (2) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов в композиции.
3. Применение по п. 1, в котором используется комбинация соединения формулы (1) и соединения формулы (2), где предпочтительно комбинация присутствует в композиции, содержащей соединение формулы (1) в количестве по меньшей мере 10 масс.% от общего содержания триглицеридов, содержащих бутиратный остаток, в композиции и соединение формулы (2) в количестве по меньшей мере 10 масс.% ","A23L33/135, A61K31/22, A61K31/23, A61K31/231, A61P3/02",20241227,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2023315166A1,Beverage or foodstuff preparation system,"A system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or foodstuff, the container (6) including: a body portion (62) with a storage portion (58) comprising a cavity that extends in a depth direction for containing a precursor material; a closing member (56) to close the storage portion (58); a machine-readable code (44) storing preparation information, said code (44) arranged on the closing member (56), the machine (4) including: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6), and; electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), wherein the code reading system (18) includes a code reader (46) and a positioning mechanism (110) to deform the body portion (62) of the container (6) from an undeformed configuration to a deformed configuration, wherein the positioning mechanism (110) is adapted to deform the body portion (62) in the deformed configuration to effect subsequent deformation of the closing member(56) so that it presents a comparatively more uniform surface for reading the code (44).","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container and a machine for preparing a beverage and/or foodstuff,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body portion with a storage portion comprising a cavity that extends in a depth direction for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine-readable code storing preparation information, said code arranged on the closing member,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the code of the container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information read from the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the code reading system includes a code reader and a positioning mechanism to deform the body portion of the container from an undeformed configuration to a deformed configuration,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the positioning mechanism is adapted to deform the body portion in the deformed configuration to effect subsequent deformation of the closing member so that it presents a comparatively more uniform surface for reading the code.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the body portion of the container comprises a flange portion connecting the storage portion and closing membe","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2024261204A1,Iron-containing green plant material concentrate,"A process for preparing an iron-containing green plant material concentrate is disclosed. The process comprises the steps of suspending a green plant in an aqueous liquid to form a green plant material suspension. The green plant material suspension is then blended, processed through physical mean, and optionally dried. Such an iron-containing green plant material concentrate is also disclosed. In addition, food product, beverage, food supplement, cosmetic composition or pharmaceutical composition comprising such an iron-containing green plant material concentrate and a method for fortifying a food product or beverage with iron are also disclosed.","CLAIMS <div class=""indep-clm"" num=""1""><seg-main>1. Process for preparing an iron-containing </seg-main><seg-clauses><seg-main>green plant material concentrate comprising the steps of: </seg-main><seg-clauses>a) suspending a green plant material in an aqueous liquid to form a green plant material suspension, </seg-clauses><seg-clauses>b) blending the green plant material suspension to obtain a green plant material slurry, </seg-clauses><seg-clauses>c) applying a physical mean on the green plant material slurry to separate and obtain an iron-containing green plant material concentrate, </seg-clauses><seg-clauses>d) optionally, drying the iron-containing green plant material concentrate. </seg-clauses></seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process according to claim 1, wherein </seg-main><seg-clauses>the step c) is performed through filtration and/or centrifugation and/or decantation and/or heat treatment. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The process according to any one of the preceding claims, wherein </seg-main><seg-clauses>the step c) of applying a physical mean is performed through the steps of: c1) filtering the green plant material slurry to obtain a permeate, c2) optionally, heat-treating the permeate, c3) centrifugating or decanting the permeate to obtain an iron-containing green plant material concentrate. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The process according to any one of the preceding claims, wherein </seg-main><seg-clauses>the green plant material comes from herb or duckweed. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The process according to claim 4 wherein </seg-main><seg-clauses>the herb is selected from the group consisting of parsley, coriander, mint, thyme, lemon balm, nettle, sage, oregano, rosemary, basil, dill, chervil, savory or a mixture thereof. </seg-clauses></div><div class=""dep-clm"" num=""6","A23L2/02, A23L2/52, A23L33/105, A23L33/16, A61K8/9789",20241226,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
EP4483759A2,Beverage preparation system,"There is described a beverage preparation machine comprising a centrifugal brewing unit (2) for preparing a beverage by centrifugation of an ingredient contained in a capsule and mixed with a carrier liquid, the centrifugal brewing unit (2) comprising a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C); driving means (5) for rotating the centrifugal cell (3); a regulator for regulating a rotation speed of the centrifugal cell (3) by controlling the driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in the centrifugal cell (3); the machine further comprising: liquid supply means (6, 4) for supplying carrier liquid to the centrifugal brewing unit (2); an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while the capsule (2A, 2B, 2C) is rotated relative to the optical reading arrangement (100) in the centrifugal cell (3) and generating an output signal representative of the code; wherein the beverage preparation machine is configured to compute the feedback signal using an output signal of the optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by the optical reading arrangement (100)..","<div class=""indep-clm"" num=""1""><seg-main>1.  Beverage preparation machine comprising: </seg-main><seg-clauses><seg-main>- a centrifugal brewing unit (2) for preparing a beverage by centrifugation of an ingredient contained in a capsule and mixed with a carrier liquid, said centrifugal brewing unit (2) comprising: </seg-main><seg-clauses>- a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C); </seg-clauses><seg-clauses>- driving means (5) for rotating said centrifugal cell (3); </seg-clauses><seg-clauses><seg-main>- a regulator for regulating a rotation speed of said centrifugal cell (3) by controlling said driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in said centrifugal cell (3); the beverage preparation machine further comprising: </seg-main><seg-clauses>- liquid supply means (6, 4) for supplying carrier liquid to the centrifugal brewing unit (2); </seg-clauses><seg-clauses>- an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while said capsule (2A, 2B, 2C) is rotated in said centrifugal cell (3) relative to said optical reading arrangement (100) and generating an output signal representative of said code; wherein said beverage preparation machine is configured to compute said feedback signal using an output signal of said optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by said optical reading arrangement (100).</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The beverage preparation machine according to claim 1, wherein </seg-main><seg-clauses>the rotation speed of the capsule is regulated using one or more measured bit periods T<sub>Bit</sub>,</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.  The beverage preparation machine according to either of claims",A47J31/44,20250101,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2024252582A1,Decanoic acid and its compositions for use in the prevention and/or treatment of peroxisomal disorders.,The present invention relates to decanoic acid and compositions comprising the same for treating and/or preventing a peroxisomal disorder.,"<div class=""indep-clm"" num=""1"">1. Decanoic acid for use in treating and/or preventing a peroxisomal disorder.</div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Decanoic acid for use according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the peroxisomal disorder is a peroxisome biogenesis disorder (PBD) or a peroxisomal enzyme deficiency (PED), optionally wherein the peroxisomal disorder is a Zellweger spectrum disorder (ZSD); rhizomelic chondriodysplasia punctata (RCDP) type 1; RCDP type 5; x-linked adrenoleukodystrophy (X-ALD); acyl-CoA oxidase deficiency; D-bifunctional protein deficiency; SCPx deficiency; 2-methylacyl-CoA racemace (AMACR) deficiency; Refsum disease; primary hyperoxaluria type 1; RCDP type 2; RCDP type 3; RCDP type 4; ABCD3 deficiency; BAAT deficiency; or Acatalasemia.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. Decanoic acid for use according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the subject has a defect in a PEX gene or a gene encoding a peroxisomal protein, optionally wherein the subject has a defect in one or more gene selected from: PEX1, PEX2, PEX3, PEX5, PEX6, PEX7, PEX10, PEX11p, PEX12, PEX13, PEX14, PEX16, PEX19, PEX26, ABCD1, ACOX1, HSD17B4, SCP2, AMACR, PHYH, AGXT, GNPAT, AGPS, FAR1, ABCD3, BAAT, and CAT.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. Decanoic acid for use according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the decanoic acid is in the form of triglycerides, diacyl-glycerides, monoacyl-glycerides, a pharmaceutically acceptable salt, and/or an ester.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. Decanoic acid for use according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the decanoic acid is in the form of a C10 homotriglyceride.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. Decanoic acid for u","A61K31/20, A61K31/23, A61P3/00",20251002,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250107653A1,Method for preparing a beverage or liquid food and system using brewing centrifugal force,"A method and system for preparing a beverage or liquid from a food substance contained in a filtering receptacle by passing water through the substance using brewing centrifugal forces. The method includes feeding water into the receptacle, and driving the receptacle in centrifugal rotation to force water to flow through the substance in a centrifugal flow path to the outlet of the receptacle. The system includes equipment necessary to carry out the method. The receptacle is a sealed capsule which is opened for water to be introduced into the capsule, contains a predetermined dose of food substance and is discarded after use.","<div class=""indep-clm"" num=""1""><seg-main>1: A capsule for preparing a beverage in a centrifugal brewing device from a food substance contained in the capsule by passing water through the substance using centrifugal brewing forces, the capsule comprising:</seg-main>
<seg-clauses>an enclosure containing a predetermined dose of substance, the enclosure comprising a cup-shaped body for holding the food substance, the body having an upper rim, and a lid or membrane for closing the body at the upper rim,</seg-clauses>
<seg-clauses class=""seg-enter"">the capsule having a flared design the larger side of the flared design proximal the upper rim,</seg-clauses>
<seg-clauses class=""seg-enter"">the capsule arranged for engaging an external rotational driving means of the centrifugal brewing device at a periphery of the capsule with respect to an axis of rotation of the capsule.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2: The capsule of claim 1, wherein </seg-main><seg-clauses>the capsule is configured for rotation at a centrifugal speed of at least 5000 rpm or 7000 rpm or 1000 to 20000 rpm.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3: The capsule of claim 1, wherein </seg-main><seg-clauses>the cup-shaped body is formed from aluminium and/or plastic.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4: The capsule of claim 1, wherein </seg-main><seg-clauses>lid is welded on upper edges of the body, including by ultrasonic welding.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5: The capsule of claim 1, wherein </seg-main><seg-clauses>the cup-shaped body comprises least one recess portion.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6: The capsule of claim 1, wherein </seg-main><seg-clauses>the cup-shaped body comprises a roughened portion at the surface of the capsule.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7: The capsule cla","A47J31/22, A47J31/40, B65D85/804",20250403,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12329176B2,Coffee compositions,Coffee compositions that are derived from medium- and high-yield extracts while also having improved taste and aroma. Processes for producing such coffee compositions are also shown.,"<div class=""indep-clm"" num=""1""><seg-con>1. A coffee composition </seg-con><seg-trans>comprising </seg-trans><seg-comp>furfuryl alcohol; pyridine; </seg-comp><seg-comp>and one or more monosaccharides, wherein a ratio of concentrations of the furfurylalcohol to the pyridine is greater than or equal to 30; and a total sum of the concentrations of the one or more monosaccharides is greater than or equal to 18 wt. %.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The coffee composition of claim 1 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>2-ethyl-6-methylpyrazine, 2-ethyl-5 methylpyrazine, 2-ethyl-3-methylpyrazine, 2,3,5-trimethylpyrazine, 2-ethyl-3,6 dimethylpyrazine, 2-ethyl-3,5-dimethylpyrazine, and 2,3-diethyl-5-methylpyrazine,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>wherein the sum of the absolute content of 2-ethyl-6-methylpyrazine, 2-ethyl-5-methylpyrazine, 2-ethyl-3 methy 1 pyrazine, 2,3,5-trimethy 1 pyrazine, 2-ethy 1-3,6-dimethy 1 pyrazine, 2-ethy 1-3,5 dimethy 1 pyrazine, and 2,3-diethyl-5-methylpyrazine is greater than or equal to 50.0 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The coffee composition of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the absolute content of the furfuryl alcohol is greater than or equal to 2,000 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The coffee composition of claim 1 </seg-con><seg-trans>further comprising </seg-trans><seg-refi>one or more of 2-acethylthiazole, 2-acetylpyrazine, and 2-acetylpyridine,</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-refi>wherein the sum of the absolute content of 2-acethylthiazole, 2-acetylpyrazine, and 2-acetylpyridine is greater than or equal to 2.70 mg/kg of soluble coffee solids of the coffee composition.</seg-refi></div>
<div clas","A23F5/24, A23F5/36",20250617,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2019394578B2,Food or beverage product with agglomerated pea protein,"The present invention relates to a method of producing a food or beverage product, in particular to a method for forming agglomerated pea proteins in an ingredient composition. The invention also relates food or beverage product comprising agglomerated pea proteins.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of producing a food or beverage product, the method </seg-con><seg-trans>comprising;</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing an aqueous ingredient composition comprising pea protein at a concentration of 1.0 to 6 wt.%;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>adding to the ingredient composition 4.0 - 20 mM of divalent cations available to complex the pea protein;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and subsequently heat treating the ingredient composition at a pH of to 6.6 - 7.3 to form agglomerates comprising pea protein wherein the heat treatment is performed at a temperature of 80°C to 125°C for a period of 30 seconds to 20 minutes, or at a temperature of above 125 °C for 3 - 45 seconds.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A method according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the agglomerates have a D[4,3] mean diameter as measured by laser diffraction of 2 to 50 microns.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A method according to claim 1 or 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ingredient composition is subjected to homogenization.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A method according to any one of claims 1 to 3 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pea protein is a pea protein isolate.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A method according to any one of claims 1 to 4 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the divalent cations are selected from the group consisting of calcium cations, magnesium cations and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A method according to any one of claims 1 to 5 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the divalent cations are provi","A23L2/62, A23C11/06, A23J3/14, A23J3/28, A23L2/66",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
AU2019400658B2,A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier,"The present invention relates to nutritional compositions comprising 2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) for use in improving gastrointestinal barrier. In particular, the present invention relates to improving the gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving a gastrointestinal barrier in a subject </seg-con><seg-trans>selected from the group consisting of </seg-trans><seg-refi>an infant (child under the age of 12 months),a young child (between 1 year and less than 3 years) and a child (aged from 3 years to 8 years), 5 the method comprising administering a synthetic nutritional composition comprising 2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) to the subject, wherein the improving the gastrointestinal barrier comprises improving barrier protection and/or improving barrier structure.</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improving the gastrointestinal barrier further comprises improving barrier maturation, improving barrier function, and/or improving barrier repair.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>15 </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improving the gastrointestinal barrier further comprises improving barrier function.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the improving barrier protection comprises improving prevention of barrier dysfunction, improving prevention of 20 barrier leakiness, improving protection of tight junction structure, and improving protection of intestinal epithelial lining integrity.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the prevention of barrier leakiness comprises preven","A23L33/00, A23C9/20, A23L33/21, A61K31/702, A61P1/00",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023359385A1,Beverage pod system,"The invention concerns an extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod, said extraction device comprising : - upstream and downstream pod enclosing parts (1, 2), wherein the upstream pod enclosing part (2) is translatable along a horizontal longitudinal axis (XX') between an open position for inserting and removing the pod (3) and a closed position for forming an extraction chamber enclosing the pod during extraction, wherein, in the upstream pod enclosing part (1), the cage (21) comprises a side wall (211) translatable between the open position and the closed position and an end wall (22) movable inside the side wall (211), wherein the side wall (211) and the end wall (22) are actuated by one common motor (10) and a common actuator (8).","<div class=""indep-clm"" num=""1""><seg-main>1. An extraction device for extracting a beverage ingredient by supplying an extraction liquid into a pod, said extraction device comprising :</seg-main>
<seg-clauses>- upstream and downstream pod enclosing parts (1, 2), wherein the upstream pod enclosing part (2) is translatable along a horizontal longitudinal axis (XX1) between an open position for inserting and removing the pod (3) and a closed position for forming an extraction chamber enclosing the pod during extraction,</seg-clauses>
<seg-clauses>- the upstream part (2) defining a cage (21) and comprising piercing elements (222) for piercing the bottom wall (313) of the pod and liquid outlet openings (223),</seg-clauses>
<seg-clauses>- the downstream part (1) comprising a plate transverse to the longitudinal axis (XX1), said plate comprising a downstream plane piercing arrangement (12) for opening the lid (32) of the pod,</seg-clauses>
<seg-clauses><seg-main>- a pod holder configured to hold the pod between the upstream and downstream pod enclosing parts when these parts are in the opened position, said pod holder being configured to hold the lid (32) of the pod in front of the downstream plane piercing arrangement (12), and</seg-main>
<seg-main class=""seg-enter"">wherein, in the upstream pod enclosing part (1), the cage (21) comprises :</seg-main>
<seg-clauses>- a side wall (211) extending between an opened front end (214) and a back end (213) along a cage longitudinal axis, said side wall being translatable between the open position and the closed position, and</seg-clauses>
<seg-clauses><seg-main>- an end wall (22) transverse to said longitudinal axis of the cage, said end wall presenting a front face (22a), said front face bearing the piercing elements (222) and the liquid outlet openings (223), wherein said end wall (22) is movable longitudinally inside the side wall (211) of the cage of said upstream pod enclosing part, and</seg-main>
<seg-main class=""seg-enter"">wh",A47J31/36,20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4477262A2,Nutritional compositions for infants and/or young children,"The present invention relates to nutritional compositions for infants or young children and their health effects. In particular, it relates to nutritional compositions comprising specific oligosaccharides for use to prevent and/or treat infection in an infant or young child, by promote and/or reduce specific microbiota communities in an infant or young child.","<div class=""indep-clm"" num=""1""><seg-con>1.  Nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use to prevent and/or treat infection by promoting in an infant or young child a Community type B and/or by reducing a Community type C, wherein Community type B is defined as a microbiota community comprising at least 80% Bifidobactera (% relative abundance ); Community type C is defined as a microbiota community comprising from 50 to 80% Bifidobacteria (% relative abundance), and further comprising one or more of Firmicutes, Bacteroidetes and/or Proteobacteria; and wherein said promoting or reducing is in comparison to the microbiota in the gut of infants or young children fed predominantly or exclusively with the conventional nutritional composition not comprising said oligosaccharides.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  Nutritional composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the use is to prevent and/or treat infection later in life.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.  Nutritional composition for use according to any of the preceding claims </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fucosylated oligosaccharide is selected from the group consisting of the fucosylated oligosaccharide is selected from the list consisting of 2'-fucosyllactose, 3'fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and any combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.  Nutritional ",A61P1/12,20241218,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2846023C2,Microporous chocolate material and method for production thereof,"FIELD: food industry.SUBSTANCE: disclosed microporous chocolate material has a plastic viscosity before aeration according to measurement results according to ICA method 46 (2000) from 0.1 Pa⋅s to 20 Pa⋅s. Said composition has inert gas bubbles dispersed therein. Dispersed bubbles are characterized by average bubble size less than or equal to 100 mcm and mean-square deviation of the bubble size being less than or equal to 60 mcm. Said bubble size parameters are determined by X-ray tomography and/or confocal laser scanning microscopy. Total bubble surface area (TSA) ranges from 0.5 m2 to 1.10 m2 per 100 g of porous chocolate material. Gas bubbles are uniformly distributed in the porous chocolate material with homogeneity index equal to at least 0.8. Additionally, proposed is a method for production of a microporous chocolate material.EFFECT: invention is aimed at improvement of the organoleptic characteristics of the chocolate material, reduction of sugar intensity and simplification of the products manufacture.5 cl, 35 dwg, 2 tbl, 10 ex","1. Микропористый шоколадный материал с пластической вязкостью до аэрации, которая по результатам измерения по методу 46 ICA (2000) составляет от 0,1 до 20 Па⋅с, где:
(i) композиция имеет диспергированные в ней пузырьки инертного газа, причем диспергированные пузырьки характеризуются следующими параметрами:
(a) средний размер пузырьков меньше или равен 100 мкм,
(b) среднеквадратичное отклонение размера пузырьков меньше или равно 60 мкм;
(c) общая площадь поверхности пузырька (TSA) составляет от 0,5 до 1,2 м<sup>2</sup>на 100 г пористого шоколадного материала;
где параметры (a) и (b) определяют рентгеновской томографией и/или конфокальной лазерной сканирующей микроскопией (CLSM); и где
(ii) пузырьки газа равномерно распределены в пористом шоколадном материале с индексом однородности по меньшей мере 0,8,
причём шоколадный материал представляет собой формованную плитку из молочного шоколада.
2. Микропористый шоколадный материал по п. 1, в котором параметр TSA рассчитывают по уравнению (1):
<img src='' class=""img-anchor"" img-id=""00000011""/>(1),
где TSA - общая площадь поверхности пузырька, P - пористость пористого шоколадного материала; m<sub>ac</sub>- масса аэрированной композиции, г; d<sub>ac</sub>- плотность аэрированной композиции, г/см<sup>3</sup>, и r - радиус пузырька среднего размера, см.
3. Микропористый шоколадный материал по п. 2, в котором Р - пористость пористого шоколадного материала от 11 до 19%.
4. Микропористый шоколадный материал по любому из предшествующих пунктов, который получен способом, включающим следующие стадии:
(I) перемешивание шоколадного материала в условиях высокого усилия сдвига, по меньшей мере 200 с<sup>-1</sup>, при этом этот шоколадный материал обладает пластической вязкостью до аэрации, которая по результатам измерения по методу 46 ICA (2000) составляет от 0,1 до 20 Па⋅с, и
(II) прохождение шоколадного материала после стадии (I) через зону впрыска, находящуюся между двумя областями под разным давлением,
(III) впрыск инертного газа при",A23G1/52,20250829,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119768062A,Edible oil-in-water (O/W) emulsions comprising pea proteins,"The present invention relates to an edible oil-in-water (o/w) emulsion comprising (a) from 50% to 80% by weight of an aqueous phase, (b) from 20% to 50% by weight of a vegetable lipid phase, and (c) from 0.25% to 1.50% by weight of a vegetable-based protein, based on the total weight of the emulsion, (d) optionally, an acidity regulator, wherein the pea protein constitutes at least 50% by weight of all plant-based proteins present in the emulsion, and wherein the emulsion is substantially free, preferably free, of dairy and animal-derived ingredients. The invention also relates to a whipped cream thereof and to a method for producing an edible o/w emulsion.","<div class=""indep-clm"" num=""1"">1.可食用水包油(o/w)乳液，基于所述乳液的总重量计，所述乳液包含</div>
<div class=""indep-clm"" num=""1"">(a)50重量％至80重量％的水相，</div>
<div class=""indep-clm"" num=""1"">(b)20重量％至50重量％的植物脂质相，以及</div>
<div class=""indep-clm"" num=""1"">(c)0.25重量％至1.50重量％的植物基蛋白质，</div>
<div class=""indep-clm"" num=""1"">(d)任选的，酸度调节剂，</div>
<div class=""indep-clm"" num=""1"">其中豌豆蛋白质构成所述乳液中存在的所有植物基蛋白质的至少50重量％，并且</div>
<div class=""indep-clm"" num=""1"">其中所述乳液基本上不含、优选不含乳品和动物来源的成分。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的乳液，其中豌豆蛋白质是所述乳液中的唯一蛋白质。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的乳液，其中所述乳液基本上不含增稠剂和/或乳化剂和/或除所述植物基蛋白质以外的乳化剂。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的乳液，其中豌豆蛋白质是所述乳液中的唯一蛋白质，并且其中所述乳液基本上不含、优选不含增稠剂和/或稳定剂和/或除所述豌豆蛋白质以外的乳化剂。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的乳液，其中所述植物脂质相包含植物液体油和植物固体脂肪的共混物，优选由所述共混物组成。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的乳液，其中所述共混物含有10重量％至30重量％的植物液体油和70重量％至90重量％的植物固体脂肪。</div>
<div class=""dep-clm"" num=""7"" parent=""5"">7.根据权利要求5所述的乳液，其中所述共混物含有30重量％至50重量％的植物液体油和50重量％至70重量％的固体脂肪。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5"">8.根据权利要求1至5中任一项所述的乳液，其中所述植物脂质相包含第一植物固体脂肪和第二植物固体脂肪的共混物。</div>
<div class=""dep-clm"" num=""9"" parent=""7"">9.根据权利要求7所述的乳液，其中所述第一植物固体脂肪以80重量％至99重量％的量存在于所述共混物中，并且所述第二植物固体脂肪以1重量％至20重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""10"" parent=""5,6,7,8,9"">10.根据权利要求5至9中任一项所述的乳液，其中所述共混物具有在20℃下至少50重量％的植物固体脂肪含量(SFC)。</div>
<div class=""dep-clm"" num=""11"" parent=""6,7,8,9"">11.根据权利要求6至9中任一项所述的乳液，其中所述共混物具有在20℃下40重量％至60重量％、优选40重量％至55重量％的植物固体脂肪含量(SFC)。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项所述的乳液，所述乳液包含酸度调节剂。</div>
<div class=""indep-clm"" num=""13"">13.打发奶油，所述打发奶油能够通过打发根据前述权利要求中任一项所述的乳液获得。</div>
<div class=""indep-clm"" num=""14"">14.打发奶油，所述打发奶油能够通过将空气掺入根据权利要求1至12中任一项所述的乳液中获得。</div>
<div class=""indep-clm"" num=""15"">15.食物产品，所述食物产品包含根据权利要求1至12中任一项所述的乳液。</div>
<div class=""indep-clm"" num=""16"">16.食物产品，所述食物产品包含根据权利要求13或14所述的打发奶油。</div>
<div c","A23D7/00, A23C11/06, A23D7/005, A23L9/20, A23L23/10",20250404,雀巢产品有限公司,['Pending']
AU2023313050A1,Beverage or foodstuff preparation system,"A system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or foodstuff, the container (6) including: a body portion (62) with a storage portion (58) for containing a precursor material; a closing member (56) to close the storage portion (58); a machine-readable code (44) storing preparation information, said code (44) arranged on the closing member (56), the machine (4) including: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6), and; electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), wherein the code reading system (18) includes a code reader (46), and a positioning mechanism (110) to translate along an axis the container (6) and code reader (46) relative to each other from a holding position, in which the container (6) is separated from a reading head of the code reader (46) and the code (44) is aligned along said axis with the code reader (46), to a reading position, in which the code (44) of the container (6) is in contact with the reading head.","<div class=""indep-clm"" num=""1""><seg-con>1. A system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container and a machine for preparing a beverage and/or foodstuff,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body portion with a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a closing member to close the storage portion;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine-readable optical code storing preparation information, said code arranged on the closing member,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine including:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reading system to read the optical code of the container;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a processing unit for processing the precursor material of the container, and;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>electrical circuitry to control the processing unit based on the preparation information read from the code,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the code reading system includes a code reader, and a positioning mechanism to translate along an axis the container and code reader relative to each other from a holding position, in which the container is separated from a reading head of the code reader and the code is aligned along said axis with the code reader, to a reading position, in which the code of the container is in contact with the reading head, and in which the closing member presents a comparatively more uniform surface for reading of the code compared to the holding position.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the machine includes a guide portion, which is arranged to guide the cont","A47J31/44, A47J31/36, A47J31/52, B65D85/804",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025200579A1,Beverage preparation system,"Abstract There is described a beverage preparation machine comprising a centrifugal brewing unit (2) for preparing a beverage by centrifugation of an ingredient contained in a capsule and mixed with a carrier liquid, the centrifugal brewing unit (2) comprising a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C); driving means (5) for rotating the centrifugal cell (3); a regulator for regulating a rotation speed of the centrifugal cell (3) by controlling the driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in the centrifugal cell (3); the machine further comprising: liquid supply means (6, 4) for supplying carrier liquid to the centrifugal brewing unit (2); an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while the capsule (2A, 2B, 2C) is rotated relative to the optical reading arrangement (100) in the centrifugal cell (3) and generating an output signal representative of the code; wherein the beverage preparation machine is 15 configured to compute the feedback signal using an output signal of the optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by the optical reading arrangement (100). (Fig 2a) 2/6 C) C) 0C. Z - ZC C) N--- ---------- --- 4------N U M CN | ce) CC","<div class=""indep-clm"" num=""1""><seg-main>1. Beverage preparation machine comprising:</seg-main>
<seg-clauses><seg-main>- a centrifugal brewing unit (2) for preparing a beverage by centrifugation of 5 an ingredient contained in a capsule and mixed with a carrier liquid, said centrifugal brewing unit (2) comprising:</seg-main>
<seg-clauses>- a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C);</seg-clauses>
<seg-clauses>- driving means (5) for rotating said centrifugal cell (3);</seg-clauses>
<seg-clauses><seg-main>- a regulator for regulating a rotation speed of said centrifugal cell (3) by 10 controlling said driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in said centrifugal cell (3);</seg-main>
<seg-main class=""seg-enter"">the beverage preparation machine further comprising:</seg-main>
<seg-clauses>- liquid supply means (6, 4) for supplying carrier liquid to the centrifugal 15 brewing unit (2);</seg-clauses>
<seg-clauses>- an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while said capsule (2A, 2B, 2C) is rotated in said centrifugal cell (3) relative to said optical reading arrangement (100) and generating an output signal representative of said code;</seg-clauses>
<seg-clauses class=""seg-enter"">20 wherein said beverage preparation machine is configured to compute said feedback signal using an output signal of said optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by said optical reading arrangement (100).</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. Beverage preparation machine according to the previous claim, configured to 25 determine, from said output signal of said optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by sai","A47J31/22, A47J31/44",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019406448B2,Method for roasting coffee beans,"The invention concerns an apparatus for roasting partially pre-roasted coffee beans comprising : - a vessel (1) to contain coffee beans, - an electrical heater (13) to heat coffee beans contained in the vessel, - at least one temperature sensor (23) to measure temperature in the vessel, - a control system (180) operable to control the heater, wherein the control system is configured to : - apply a roasting recipe dedicated to the roasting of partially pre-roasted beans comprising at least a temperature versus time profile, - measure the concentration of at least one volatile organic component (VOC) in the smoke produced in the vessel during the time the roasting recipe is applied, - detect an increase of the measured concentration in function of time, - stop heating if no increase of the measured concentration happens after a set reference time t","<div class=""indep-clm"" num=""1""><seg-main>1. An apparatus for roasting partially pre-roasted coffee beans comprising :</seg-main>
<seg-clauses>- a vessel to contain coffee beans,</seg-clauses>
<seg-clauses class=""seg-enter"">5   - an electrical heater to heat coffee beans contained in the vessel,</seg-clauses>
<seg-clauses>- at least one temperature sensor to measure temperature in the vessel,</seg-clauses>
<seg-clauses><seg-main>- a control system operable to control the heater, wherein the control system is configured to :</seg-main>
<seg-clauses>- apply a roasting recipe dedicated to the roasting of partially pre-roasted beans comprising 0 at least a temperature versus time profile,</seg-clauses>
<seg-clauses>- measure the concentration of at least one volatile organic component (VOC) in the smoke produced in the vessel during the time the roasting recipe is applied,</seg-clauses>
<seg-clauses>- detect an increase of the measured concentration in function of time,</seg-clauses>
<seg-clauses>- stop heating if no increase of the measured concentration happens after a set reference 5 timeti.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The apparatus according to Claim 1, wherein </seg-main><seg-clauses>the concentration at least one component from the list of: CO, CO2, NO, NO2, SO2, formaldehyde is measured.</seg-clauses>
<seg-clauses class=""seg-enter"">!0   </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The apparatus according to Claim 1 or 2, wherein </seg-main><seg-clauses>the reference time ti is set to 5 minutes.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The apparatus according to any one of the preceding claims, wherein </seg-main><seg-clauses>the control system is configured to stop the electrical heater if the first increase of the measured concentration of the at least one volatile organic component (VOC) happens before a set reference time to.</seg-clauses","A23N12/08, A23F5/04, A23N12/12",20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Inactive']
CN119156330A,Capsule for producing beverage,"The invention relates to a capsule for use in a beverage preparation machine, said capsule containing soluble and/or extractable beverage ingredients, said capsule comprising:-a capsule body (2) defining a chamber (21),-a top membrane (3) closing a top opening and adapted to be pierced to inject a liquid into the capsule, and-a bottom membrane (4) arranged inside the chamber (21) so as to define a dosing chamber between the top membrane (3) and said bottom membrane, and-an opening device (5), and an opening device (5) provided inside the chamber and adapted to open the chamber during injection of the liquid by relative engagement of the opening device with the bottom membrane (4) under the action of an increase in liquid pressure in the dispensing chamber, where the opening device (5) is made of a biodegradable material, and the biodegradable material is a polymer composition comprising:-at least one polymer selected from the group consisting of a polyhydroxyalkanoate (PHA),-at least one or more nucleating agents,-at least one or more mineral fillers.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于在饮料制备机器中使用的胶囊(1)，所述胶囊含有可溶和/或可提取的饮料配料，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述胶囊</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-胶囊主体(2)，所述胶囊主体限定腔室(21)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部膜片(3)，所述顶部膜片封闭顶部开口，并且被适配为被刺破以将液体注入到所述胶囊中，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-底部膜片(4)，所述底部膜片设置在所述腔室(21)内部以便在所述顶部膜片(3)与所述底部膜片之间界定配料腔室，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-打开装置(5)，所述打开装置设置在所述腔室内部并且被适配为在注入所述液体期间在所述配料腔室中的液体压力增加的作用下通过所述打开装置与所述底部膜片(4)的相对接合来打开所述腔室，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述打开装置(5)是由可生物降解材料制成的模制件，并且所述可生物降解材料是聚合物组合物，所述聚合物组合物包含：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-至少一种选自由以下项组成的组的聚合物：聚羟基链烷酸酯(PHA)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-至少一种或多种成核剂，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-至少一种或多种矿物填料。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的胶囊，其中所述聚合物组合物包含至少一种含有式(I)重复单元的聚羟基链烷酸酯：</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>-O-CHR<sub>i</sub>-(CH<sub>2</sub>)<sub>n</sub>-CO-</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>其中</seg-con><seg-trans>：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-Ri选自-H、C<sub>1</sub>-C<sub>12</sub>烷基、C-C<sub>16</sub>环烷基、C<sub>2-C1</sub>2烯基，其任选地被至少一个选自以下的基团取代：卤素(F、Cl、Br)、-CN、-OH、</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-COOH、-OR、-COOR(其中R＝C<sub>1</sub>-C<sub>4</sub>烷基、苄基)，</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>-n为零或1至6的整数，优选为1或2。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的胶囊，其中所述聚合物组合物包含至少一种聚羟基链烷酸酯，其中Ri是甲基或乙基，并且n为1或2。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3所述的胶囊，其中所述聚羟基链烷酸酯是含有式(I)重复单元与至少一种来源于能够与羟基链烷酸酯共聚合的共聚单体的重复单元组合的共聚物或三元共聚物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要",B65D85/804,20241217,雀巢产品有限公司,['Pending']
CN119816401A,Method for obtaining outlet opening of capsule,"The invention relates to a method for obtaining at least an outlet opening (8) of a carrier tray (7) which can be arranged in an interior space of a capsule (1) for preparing a beverage, the outlet opening (8) being adapted to allow the prepared beverage to flow out of the interior space towards the outside of the capsule (1) when the capsule (1) is used in the beverage preparation device. The method comprises the steps of:-providing a sheet material (70) from which the carrier tray (7) having the outlet openings (8) can be obtained,-cutting the sheet material (70) by means of a cutting device to obtain a first set of outlet openings (8),-cutting the sheet material (70) by means of an alignment element (101) extending through an alignment opening (71) provided in the sheet material (70) to obtain a second set of outlet openings (71), the first set of outlet openings is aligned with respect to the cutting device,-the sheet material (70) having the first set of outlet openings so aligned is cut by the cutting device to obtain a second set of outlet openings, and-the sheet material (70) is intermittently moved along different distances with respect to the cutting device.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于至少获得承载盘(7)的出口开口(8)的方法，所述承载盘能够设置在用于制备饮料的胶囊(1)的内部空间中，其中当在饮料制备装置中使用所述胶囊(1)时，所述出口开口(8)适于使制备的饮料从所述内部空间朝所述胶囊(1)的外部流出，其中所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>提供能够从中获得具有所述出口开口(8)的所述承载盘(7)的片材材料(70)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>通过切割装置切割所述片材材料(70)以获得所述出口开口(8)的第一集合，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>通过延伸穿过设置在所述片材材料(70)中的对齐开口(71)的对齐元件(101)，相对于所述切割装置对齐所述出口开口的所述第一集合，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>通过所述切割装置切割具有如此对齐的出口开口的第一集合的所述片材材料(70)，以获得所述出口开口的第二集合，以及</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>相对于所述切割装置沿不同距离间歇地移动所述片材材料(70)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的方法，所述方法还</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>通过延伸穿过设置在所述片材材料(70)中的另外的对齐开口(72)的所述对齐元件(101)，相对于所述切割装置对齐所述出口开口(8)的所述集合，以及</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>通过所述切割装置切割具有如此对齐的所述出口开口(8)的集合的所述片材材料(70)，以获得所述出口开口(8)的另外的集合。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的方法，所述方法还</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>通过延伸穿过设置在所述片材材料(70)中的所述对齐开口(71)的另外的对齐元件(102)，相对于所述切割装置对齐所述出口开口(8)的所述集合，以及</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>通过所述切割装置切割具有如此对齐的所述出口开口(8)的集合的所述片材材料(70)，以获得所述出口开口的附加集合。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的方法，其中所述出口开口(8)的一个集合的所述出口开口的至少一部分布置在所述出口开口(8)的相应其他集合的所述出口开口(8)之间。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的方法，所述方法还包括通过所述切割装置切割所述片材材料以获得所述对齐开口(71)的步骤。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的方法，其中在用以获得所述出口开口的所述第一集合的切割步骤中获得所述对齐开口(71)。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7.根据前述权利要求中任一项所述的方法，所述方法还</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div cl","B26F1/04, B26F1/24, B65D85/804, B26F1/38",20250411,雀巢产品有限公司,['Pending']
US20250019654A1,Method for producing milk like products,"A method for producing mammary gland cells and a method of producing a mammalian milk like product, for example a human milk like product comprising generating lactocytes derived from mammalian induced pluripotent stem cells (miPSC), for example human induced pluripotent stem cells (hiPSC), and expressing the mammalian milk like product, for example the human milk like product from lactocytes.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of producing a population of mammary gland cells, comprising:</seg-main>
<seg-clauses>i) culturing mammalian induced pluripotent stem cells (miPSCs) in a culture medium comprising bone morphogenic protein 4 (BMP4) to generate embryoid bodies (EBs), and</seg-clauses>
<seg-clauses>ii) growing the EBs to generate a population of mammary cells.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the culturing step i) comprises culturing the miPSCs in MammoCult medium and BMP4, in a 3D-suspension culture system thereby directing the iPSCs to differentiate towards non-neural ectoderm cells.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the growing step ii) comprises growing the formed EBs in a 3D embedding system for at least 30 days, for example for 32 days, to generate lactocytes.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the mammary gland cells are human mammary gland cells.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>BMP4 is added to the culture medium between day 0 and day 10 where day 0 is the time point where the iPSCs are first added to the culture medium.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>BMP4 is added to the culture medium for 3 days.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The method of claim 1, wherein </seg-main><seg-clauses>BMP4 is added to the culture medium in a concentration of 5 to 20 ng/ml.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The method of claim 1, wherein </seg-main><seg-clauses>the EBs express one or more mammary gla","C12N5/071, A23C9/20",20250116,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023353552A1,"Capsule, system and method for delivering a filter-like coffee extract","The invention concerns a capsule for preparing a filter-type coffee extract comprising a substantially rigid capsule body having a circumferential sidewall extending around an inner space of the capsule, a base wall covering the inner space at a first end of the sidewall, a flange arranged circumferentially at a second end of the sidewall of the base body, a lid removably attached to the flange and covering the inner space at a second end of the sidewall opposite the base wall and tightly closing the capsule, and a filter element positioned in the inner space of the capsule between the beverage ingredient and the lid in which the inner space of the capsule is at least partially filled with ground coffee, preferably roast and ground coffee, having a particle size distribution D4,3 of 500 microns +/- 30 microns and a fraction of fine particles between 2 and 9 % of the roast and ground coffee. The invention also relates to a system comprising said capsule, to the use of said capsule or system and to a method for delivering a filter-like coffee extract.","<div class=""indep-clm"" num=""1""><seg-main>1. Capsule for preparing a filter-type coffee extract comprising</seg-main>
<seg-clauses>- a substantially rigid capsule body having a circumferential sidewall extending around an inner space of the capsule,</seg-clauses>
<seg-clauses>- a base wall covering the inner space at a first end of the sidewall,</seg-clauses>
<seg-clauses>- a flange arranged circumferentially at a second end of the sidewall of the capsule body,</seg-clauses>
<seg-clauses>- a lid removably attached to the flange and covering the inner space at a second end of the sidewall opposite the base wall and tightly closing the capsule, and</seg-clauses>
<seg-clauses>- a filter element positioned in the inner space of the capsule between the beverage ingredient and the lid,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the inner space of the capsule is at least partially filled with ground coffee, preferably roast and ground coffee, having a particle size distribution D4,3 of 500 microns +/- 30 microns and a fraction of fine particles between 2 and 9 % of the roast and ground coffee.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Capsule according to claim 1 wherein </seg-main><seg-clauses>the fine particles have an average diameter of less than 50 microns.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Capsule according to claim 1 or 2 wherein </seg-main><seg-clauses>the ground coffee inside the capsule is in an amount between 4 and 5.5 grams.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Capsule according to anyone of the preceding claims, wherein </seg-main><seg-clauses>the ground coffee in the capsule has a density between 380 and 450 g/l.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Capsule according to anyone of the preceding claims, wherein </seg-main><seg-clauses>the coffee extract is delivered in a flow time of less than 40 s fo",B65D85/804,20250220,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025125106A1,Process for a dried instant noodle,,"Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A process for the production of a dried instant noodle comprising </seg-main><seg-clauses><seg-main>cereal flour, Kansui salts, soy protein source and a flour selected from the group of a pulse flour, a flour from an oilseed press cake, a flour from a nut press cake, a flour from a barley spent grain or a combination thereof, the process comprising the steps of: </seg-main><seg-clauses>a) Mixing the cereal flour, the soy protein source, the flour selected from the group of a pulse flour, a flour from an oilseed press cake, a flour from a nut press cake, a flour from a barley spent grain or a combination thereof and optionally other dry ingredients with the Kansui salts and water to form a dough; </seg-clauses><seg-clauses>b) Sheeting and slitting the dough to obtain noodle strands; </seg-clauses><seg-clauses>c) Steaming the noodle strands from step b); </seg-clauses><seg-clauses>d) Cutting the noodle strands from step c) and optionally folding; </seg-clauses><seg-clauses>e) Frying the noodle strands from step d) in oil or air drying the noodle strands from step d); </seg-clauses><seg-clauses>f) Cooling.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A process for the production of a dried instant noodle as claimed in claim 1 , comprising </seg-main><seg-clauses>10 to 70wt% of cereal flour (by weight of the total composition), 0.2 to 3.5wt% of Kansui salts (by weight of the total composition), 3 to 20wt% of soy protein source (by weight of the total composition) and 5 to 40wt% of flour selected from the group of a pulse flour, a flour from an oilseed press cake, a flour from a nut press cake, a flour from a barley spent grain or a combination thereof (by weight of the total composition).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A process for the production of a dried instant noodle in any one of claims 1 to 2, wherein </seg-main><seg-clauses>t","A23L7/10, A23L11/00, A23L25/00",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2019407214B2,A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier,"The present invention relates to nutritional compositions comprising metabolites of HMOs to improve the gastrointestinal barrier. In particular, the invention relates to nutritional compositions comprising metabolites of HMOs for infants with impaired microbiota since their microbiota may not be able to metabolize HMOs.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and 3 years) or a child (aged from more than 3 years to less than 8 years);</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-comp>5 the method comprising </seg-comp><seg-comp>administering to the infant or young child a nutritional composition comprising metabolites of HMOs; or</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the method comprising administering to the child a nutritional composition in the form of a growing-up milk comprising metabolites of HMOs;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the metabolites of HMOs are obtained by fermenting a composition</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>10 comprising one or more HMOs selected from the group consisting of 2'FL, DiFL, 3'SL, 6'SL, LNT and LNnT in a composition comprising a baby microbiota, wherein metabolites of HMOs are obtained from 0.004-5 g/L of HMOs.</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2. Use of a nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>metabolites of HMOs in the</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>15 manufacture of a medicament for improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and 3 years) or a child (aged from more than 3 years to less than 8 years);</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>wherein the nutritional composition to be administered to the child is in the form of a growing-up milk;</seg-refi></div>
<div class=""indep-clm"" num=""2""><seg-refi>20 wherein the metabolites of HMOs are obtained by fermenting a composition comprising one or more HMOs selected from the group consisting of 2'FL, DiFL, 3'SL, 6'SL, LNT and LNnT in a composition comprising a baby microbiota, wherein metabolites of HMO","A23L33/00, A23L33/135, A23L33/21, A61K9/00, A61K31/702",20250424,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
EP4556226A1,Bio-based polymer beverage capsules,"The present invention relates to capsules for preparation of a beverage upon injection of liquid under pressure into the capsule, wherein the capsule body comprises or consists of a biopolymer film comprising polyhydroxyalkanoate (PHA) and polyglycolide (PGA), wherein the biopolymer film comprises a layered structure comprising PHA layer - PGA layer - PHA layer, and wherein the PHA has been chemically modified with one or more chain extenders and/or one or more compatibilizers.","<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule for preparation of a beverage upon injection of liquid under pressure into the capsule, wherein </seg-main><seg-clauses>the capsule body comprises or consists of a biopolymer film comprising polyhydroxyalkanoate (PHA) and polyglycolide (PGA), wherein the biopolymer film comprises a layered structure comprising PHA layer - PGA layer - PHA layer, and wherein the PHA has been chemically modified with one or more chain extenders and/or one or more compatibilizers.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The capsule according to claim 1, wherein </seg-main><seg-clauses>the PHA is functionalised, optionally wherein the PHA is functionalised by carboxylation, hydroxylation, epoxidation, or by grafting.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The capsule according to claim 1 or 2, wherein </seg-main><seg-clauses><seg-main>the one or more chain extenders are multi-functional addition-type chain extenders that react with carboxyl and/or hydroxyl terminal groups, preferably wherein the one or more chain extenders comprise or consist of: </seg-main><seg-clauses>(a) an epoxy-based chain extender, optionally wherein the one or more chain extenders comprise or consist of a Joncryl chain extender; </seg-clauses><seg-clauses>(b) a phosphate/phosphite-based chain extender, optionally wherein the one or more chain extenders comprise or consist of triphenylphosphite (TPP) or tris(nonyl-phenyl)phosphite (TNPP); </seg-clauses><seg-clauses>(c) a carbodiimide-based chain extender, optionally wherein the one or more chain extenders comprise or consist of polycarbodiimide (PCDI); and/or </seg-clauses><seg-clauses>(d) an anhydride-based chain extender, optionally wherein the one or more chain extenders comprise or consist of pyromellitic dianhydride (PMDA).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4.  The capsule according to","B32B27/36, B32B1/00, B32B7/02, B32B7/12, B32B27/08",20250521,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250248558A1,Beverage preparation system,"The invention concerns a machine for preparing beverages from at least two different types of containers, said machine comprising: —a first extraction device (<b>1</b>) and a second extraction device (<b>1</b>) configured to prepare beverages from different types of containers, wherein the first extraction device is a motorised extraction device actuated by a motor (<b>121</b>) during the preparation of a beverage from the first type of container, —a fluid supply system (<b>3</b>), said system comprising at least a fluid source (<b>31</b>), a pumping means (<b>32</b>), a heating and/or cooling means (<b>33</b>) and a valve (<b>4</b>) configured for supplying the fluid either to the first extraction device (<b>1</b>) through a first outlet (<b>422</b><i>a</i>) or to the second extraction device (<b>2</b>) through a second outlet (<b>422</b><i>b</i>).","<div class=""indep-clm"" num=""1""><seg-con>1. Machine for preparing beverages from at least two different types of containers, said machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a first extraction device for extracting a first beverage by supplying an extraction liquid into a first type of pre-portioned single-serving container comprising a first beverage ingredient and a second extraction device for extracting a second beverage by supplying an extraction liquid into a second type of pre-portioned single-serving container comprising a second beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said devices being of different types, wherein the first extraction device is a motorised extraction device actuated by a motor during the preparation of a first beverage from the first type of container,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a fluid supply system, said system comprising at least a fluid source, a pumping means, a heating and/or cooling means and a valve configured for supplying the fluid either to the first extraction device through a first outlet or to the second extraction device through a second outlet,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the valve comprises a movable part configured to dispense the fluid through said first outlet or through said second outlet depending on the position of said movable part, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the movable part of the valve is indirectly actuated by the motor of the motorised extraction device, when said motor actuates the motorised extraction device for the preparation of a beverage by said extraction device and is moved to a position where the fluid is dispensed through the first outlet, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, at rest, the movable part is positioned so that the fluid is dispensed through the second outlet.</s","A47J31/36, A47J31/46",20250807,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023331998A1,Savory product comprising stable polyunsaturated fatty acid,"The invention relates to a method of making a savory product, said method comprising wet mixing a composition comprising (i) one or more of flax seed, hemp or chia; (ii) oil source; and (iii) protein source; blending the wet mix; heating the blended mix; and cooling to form a savory product with a total solid content of between 10 to 65 wt%.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a savory product, said method comprising</seg-main>
<seg-clauses><seg-main>a) wet mixing a composition comprising </seg-main><seg-clauses>(i) one or more of flax seed, hemp or chia;</seg-clauses>
<seg-clauses>(ii) oil source; and </seg-clauses><seg-clauses>(iii) protein source;</seg-clauses></seg-clauses>
<seg-clauses>b)     blending the wet mix;</seg-clauses>
<seg-clauses>c)     heating the blended mix; and</seg-clauses>
<seg-clauses>d) cooling to form a savory product with a total solid content of between 10 to 65 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the oil source and protein source are not derived from flax seed, hemp, or chia.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>mucilage has been substantially removed from the flax seed.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method according to claim 3, wherein </seg-main><seg-clauses>the mucilage has been substantially removed by mixing the flax seeds in water, adjusting the pH to about 6, and applying heat to the mixture.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the flax seeds are at least 50% dehulled.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4""><seg-main>6. The method according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the flax seeds are whole flax seeds.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The method according to any one of claims 1 to 6, wherein </seg-main><seg-clauses>the wet mix is formed by shearing the one or more of flax seeds, hemp, or chia in water with crystals and with the protein sour","A23L23/00, A23L23/10, A23L25/00, A23L29/00, A23L29/238",20250123,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120112911A,Beverage or food preparation system,"A system comprising: a container for containing a precursor material, the container for use with a machine for preparing a beverage and/or a food product or a precursor thereof, the container comprising a machine-readable code storing preparation information for use with a preparation process performed by the machine, wherein the code comprises a reference portion for locating a data portion, where the data portion comprises at least one data unit arranged at an encoding distance (d) from the starting position along a virtual encoding line (D) as a variable to at least partially encode a value of a parameter of the preparation information; and a machine for preparing a beverage and/or food product or a precursor thereof, the machine comprising: a code reading system to read the code of the container; a processing unit for processing the precursor material of the container; and an electrical circuit to control the processing unit based on the preparation information read from the code, where the electrical circuit is configured to: read one or more of the coded distances (d) from the code; it is determined whether a validity condition associated with the or each data unit's location is satisfied based on one or more of the following: 1) identifying a predetermined number of data units on a portion of the encoding line; 2) the part of the coding line has no data unit or comprises a single data unit; and 3) a distance between the data units on the encoding line along the encoding line is greater than or less than a predetermined amount; converting the or each coded distance (d) into one or more values of the parameter; and control the processing unit based on the value of the parameter.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于制备饮料和/或食品或其前体的机器，所述机器</seg-con><seg-trans>包括：</seg-trans><seg-comp>代码读取系统，所述代码读取系统用于读取容器的代码，所述代码包括用于定位数据部分(D)的参考部分(R)，其中所述数据部分包括至少一个数据单元，所述至少一个数据单元被布置在沿着虚拟编码线(E)距起始位置的编码距离(d)处，作为至少部分地对所述制备信息的参数的值进行编码的变量；</seg-comp><seg-comp>处理单元，所述处理单元用于处理所述容器的前体材料；</seg-comp><seg-comp>和电气电路，所述电气电路用以基于从所述代码读取的所述制备信息来控制所述处理单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述电气电路被配置为：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>确定所述代码的所述数据单元的位置；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>基于以下中的一者或多者来确定是否满足与所述数据单元或每个数据单元的位置相关联的有效性条件：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>1)在所述编码线的一部分上识别到数据单元的预定数量；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>2)所述编码线的一部分不存在数据单元，其中所述部分位于不同编码距离的相邻结束位置与起始位置之间；并且</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>3)沿着所述编码线在所述编码线上的数据单元之间的距离大于或小于预定量；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且如果不满足所述有效性条件，则所述电气电路被配置为不进行以下操作：将所述编码距离或每个编码距离(d)转换为所述参数的一个或多个值，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且如果满足所述有效性条件，则所述电气电路被配置为：将所述编码距离或每个编码距离(d)转换为所述参数的一个或多个值；并且基于所述参数的所述值来控制所述处理单元。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据任一前述权利要求所述的机器，其中在所述容器上存在多个代码，并且如果不满足所述有效性条件，则所述电气电路被配置为：</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>确定部分读取条件，所述部分读取条件基于以下中的一者或多者；</seg-con></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>识别到所述代码的参考部分的预定数量；</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>识别到所述代码的单元的预定数量；</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>如果满足所述部分读取条件，则所述代码读取系统被配置为再次读取所述代码。</seg-comp></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的机器，其中如果不满足所述部分读取条件，则所述电气电路被配置为不进行以下操作：将所述编码距离或每个编码距离(d)转换为所述参数的一个或多个值；并且基于所述参数的所述值来控制所述处理单元。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3中任一项所述的机器，其中所述代码读取系统通过处理所述代码的数字图像来读取所述代码，并且再次读取所述代码包括指示所述代码读取系统的摄像机系统来获得所述代码的后续数字图像。</div>
<div class=""dep-clm"" num=""5"" pare","G06K19/06, A47J31/44, B65D85/804",20250606,雀巢产品有限公司,['Pending']
AU2020287907B2,Compositions and methods using one or more autophagy-inducing amino acids to potentiate musculoskeletal effect of one or more anabolic amino acids,,"<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating sarcopenia or frailty in an individual in need thereof, the method comprising </seg-main><seg-clauses>administering to the individual in need thereof a composition comprising Lysine, anabolic amino acids and autophagy-inducing amino acids, wherein the anabolic amino acids consist of Leucine and Isoleucine, and wherein the autophagy-inducing amino acids consist of Proline, Glycine, Cysteine and Valine.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the composition induces autophagy in skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.     The method of claim 1 or 2, wherein </seg-main><seg-clauses>the individual is an ageing individual.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.     The method of any one of claims 1 to 3, wherein </seg-main><seg-clauses><seg-main>the composition comprises</seg-main>
<seg-main class=""seg-enter"">protein that provides at least a portion of the anabolic amino acids and/or at least a portion of the autophagy-inducing amino acids, wherein the protein is selected from the group consisting of </seg-main><seg-clauses>(i) protein from an animal source, </seg-clauses><seg-clauses>(ii) protein from a plant source and </seg-clauses><seg-clauses>(iii) a mixture thereof.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The method of claim 4, wherein </seg-main><seg-clauses><seg-main>the protein is selected from the group consisting of </seg-main><seg-clauses>(i) milk protein, </seg-clauses><seg-clauses>(ii) whey protein, </seg-clauses><seg-clauses>(iii) caseinate, </seg-clauses><seg-clauses>(iv) micellar casein, </seg-clauses><seg-clauses>(v) pea protein, </seg-clauses><seg-clauses>(vi) soy protein and </seg-clauses><seg-clauses>(vii) mixtures thereof.</seg-clauses></seg-clauses></div>
<div cla","A61K31/198, A23L33/175, A23L33/18, A23L33/185, A23L33/19",20250522,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
CN120751933A,Extrusion process for preparing food flavor products,"The present invention generally relates to extrusion methods for making food flavor products. More specifically, the present invention relates to an extrusion process for preparing a food flavor product in which at least one vented obturator is located within the last 2/3 part of the total length of the extruder cartridge.","<div class=""indep-clm"" num=""1""><seg-con>1.用于制备食物风味产品的挤出方法，所述挤出方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a)向挤出机料筒（7）进料组合物，所述组合物包含至少一种载体、至少一种氨基氮源和至少一种糖源；</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>b)在35℃至170℃的温度下挤出来自步骤a)的所述组合物，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中至少一个通气填塞器位于所述挤出机料筒的总长度的最后2/3部分内。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的用于制备食物风味产品的挤出方法，其中所述载体选自麦芽糖糊精、淀粉、面粉、盐、纤维或其组合。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1至2中任一项所述的用于制备食物风味产品的挤出方法，其中所述食物风味产品包含5重量%至95重量%的量的所述载体。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的用于制备食物风味产品的挤出方法，其中所述氨基氮源选自半胱氨酸、甲硫氨酸、精氨酸、谷胱甘肽、天冬酰胺、谷氨酸、赖氨酸、谷氨酰胺、硫胺素、丙氨酸、甘氨酸、苏氨酸、植物蛋白质、酵母提取物、细菌提取物、蔬菜提取物、水解植物蛋白质或其组合。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的用于制备食物风味产品的挤出方法，其中所述食物风味产品包含0.1重量%至35重量%的量的所述氨基氮源。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的用于制备食物风味产品的挤出方法，其中所述糖源选自蔗糖、木糖、核糖、葡萄糖、果糖、半乳糖、乳糖、阿拉伯糖、核糖、右旋糖、赤藓糖、鼠李糖、甘露糖、异麦芽糖、山梨糖、阿洛酮糖、麦芽提取物、稻米糖浆、玉米糖浆、角豆糖浆或其组合。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的用于制备食物风味产品的挤出方法，其中所述食物风味产品包含1重量%至35重量%的量的所述糖源。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的用于制备食物风味产品的挤出方法，其中步骤a)中的所述组合物还包含0.5重量%至10重量%的量的脂质。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的用于制备食物风味产品的挤出方法，其中在步骤a)中向所述挤出机料筒进料之前，将所述脂质与包含至少一种载体、至少一种氨基氮源和至少一种糖源的组合物混合，或者在向所述挤出机料筒干式进料之后注入所述脂质。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的用于制备食物风味产品的挤出方法，其中在步骤b)之后不使用干燥步骤。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据权利要求1至10中任一项所述的用于制备食物风味产品的挤出方法，其中在没有第一捏合和熔融区段的上游位置处不使用另外的通气填塞器（4）。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据权利要求1至11中任一项所述的用于制备食物风味产品的挤出方法，其中还将0重量%至10重量%的量的水加入到步骤a)的所述组合物中。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据权利要求1至12中任一项所述的用于制备食物风味产品的挤","A23L27/26, A23L27/21",20251003,雀巢产品有限公司,['Pending']
WO2025056775A1,Method for preparing coffee,"The invention concerns a method for producing a coffee beverage in a beverage preparation apparatus, said apparatus comprising : - at least one supply of roasted and ground coffee : beans container + grinder - at least one supply of soluble coffee : powder or liquid - a water supply system, - at least one extraction unit for receiving and extracting roasted and ground coffee with water, where the method for producing a coffee beverage comprises at least the following steps : - preparing a first coffee beverage (C1) in the extraction unit, and - preparing a second coffee beverage (C2) from soluble coffee, - producing the final coffee beverage by mixing the first and the second coffee beverages (C1, C2).","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Method for producing a coffee beverage in a beverage preparation apparatus, said apparatus comprising :</seg-main>
<seg-clauses>- at least one supply of roasted and ground coffee,</seg-clauses>
<seg-clauses>- at least one supply of soluble coffee,</seg-clauses>
<seg-clauses>- a water supply system,</seg-clauses>
<seg-clauses><seg-main>- at least one extraction unit for receiving and extracting roasted and ground coffee with water, said extraction unit comprising a brewing chamber, where the method for producing a coffee beverage comprises at least the following steps :</seg-main>
<seg-clauses>- ordering one final coffee beverage,</seg-clauses>
<seg-clauses>- preparing a first coffee beverage (C1) in the extraction unit, and</seg-clauses>
<seg-clauses>- preparing a second coffee beverage (C2) from soluble coffee,</seg-clauses>
<seg-clauses>- producing the ordered final coffee beverage by mixing the first and the second coffee beverages (C1 , C2).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Method according to Claim 1 , wherein </seg-main><seg-clauses>the volume of the first coffee beverage (C1) represents 10 to 90 % of the volume of the final beverage.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Method according to Claim 1 ,or 2 wherein </seg-main><seg-clauses><seg-main>the extraction unit comprises :</seg-main>
<seg-clauses>- a brewing chamber for receiving roasted and ground coffee powder, and</seg-clauses>
<seg-clauses>- an upper piston, and</seg-clauses>
<seg-clauses>- a water inlet, and</seg-clauses>
<seg-clauses>- a liquid outlet duct guiding extracted coffee beverage to a dispensing area, and</seg-clauses>
<seg-clauses>- a lower piston wherein the brewing chamber and/or the pistons are relatively movable between :</seg-clauses>
<seg-clauses class=""seg-enter"">. an open position for introducing roast and ground coffee powder or ejecting ex","A47J31/00, A47J31/36, A47J31/40, A47J31/52, A47J31/41",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2024228702A1,Filling for confectionery and confectionery comprising that filling,"The invention relates to a confectionery composition and methods of making the same. In particular, the invention relates to confectionery fillings comprising water, sugar fat, and protein, and wherein the confectionery composition does not comprise hydrocolloid. Also provided is a process for the manufacture of a confectionery composition.","<div class=""indep-clm"" num=""1""><seg-con>1. A confectionery composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>protein in an amount of 0.5wt% to 15wt%, preferably, 1.7 to 6.5wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>water in an amount of 10wt% to 40wt%, preferably 10 to 20wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>sugar in an amount of 35wt% to 80wt%, preferably 35 to 67wt%</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>fat in an amount of 2wt% to 35wt%, wherein the percentages are the weight percentages of the confectionery composition, and wherein the confectionery composition does not comprise hydrocolloid.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A confectionery composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the viscosity of the composition is between 5 Pa.S1 and 40 Pa.S1.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A confectionery composition according to claims 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sugar comprises a mixture of fructose and glucose.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A confectionery composition according to claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 10wt% to 50wt% of the sugar in the aqueous phase is fructose.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A confectionery composition according to claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>sugar is comprised in an aqueous phase, and from 20wt% to 65wt% of the sugar in the aqueous phase is glucose and/or dextrose.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A confectionery composition according to any preceding claim, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fat comprises, con","A23G1/54, A23G3/34, A23G3/40, A23G3/42, A23G3/44",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023306582A1,Confectionery product,,,"A23G1/00, A23G1/54, A23G3/34, A23G3/54",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023378680A1,Method for determining the contribution of a dog breed to a test dog genome,"The present invention relates to a method of determining the contribution of a dog breed to a test dog genome, comprising: a) providing a DNA methylation profile from a sample obtained from the test dog; and b) determining the contribution of a dog breed to the test dog genome by comparing at least part of the DNA methylation profile of the test dog to reference DNA methylation profiles from different dog breeds.",,C12Q1/6888,20250417,SOCIETE DES PRODUITS NESTLE SA,['Pending']
US20250098698A1,"Chocolate products, ingredients, processes and uses",The present invention provides a new composition obtainable from a plant in the <i>theobroma </i>genus and the use of that composition as an ingredient in a chocolate product.,"<div class=""indep-clm"" num=""1""><seg-main>1. A paste derived from </seg-main><seg-clauses>i) seeds and/or a portion of seeds of a plant in the <i>Theobroma </i>genus and </seg-clauses><seg-clauses>ii) pulp and/or an extract of pulp of a plant in the <i>Theobroma </i>genus, the paste comprises:</seg-clauses>
<seg-clauses class=""seg-enter"">a sugar content,</seg-clauses>
<seg-clauses class=""seg-enter"">a total dietary fibre content, and</seg-clauses>
<seg-clauses class=""seg-enter"">a moisture content of between 20.0 wt % and 80 wt %.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The paste of claim 1, comprising </seg-main><seg-clauses>between 20.0 wt % and 99.0 wt % of the seeds and/or portion of seeds, between 0.0 wt % and 80.0 wt % of a non-pulp and non-seed portion, and between 1.0 wt % and 80.0 wt % of the pulp and/or extract of the pulp.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A dried mass derived from </seg-main><seg-clauses>i) seeds and/or a portion of seeds of a plant in the <i>Theobroma </i>genus and </seg-clauses><seg-clauses>ii) pulp and/or an extract of pulp of a plant in the <i>Theobroma </i>genus that comprises a sugar content, of a mono- and di-saccharide content, from 8.0 wt % to 35.0 wt % and a fat content of from 18.0 wt % to 50.0 wt %.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3"">4. The dried mass of claim 3, with a total dietary fibre content from 2.0 wt % to 40.0 wt %.</div>","A23G1/48, A23G1/02",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120203223A,Personalized supplementation of nutrients,"The present invention provides a nutritional composition (preferably a printed nutritional composition) comprising at least one nutritional substance for which a lack of nutritional substance intake and/or nutritional substance state is detected in an individual. Such a nutritional composition is included in an administration unit and the nutrient is present in an amount corresponding to a difference between a target value and an actual value of the nutrient intake and/or status of the individual. The invention also provides medical uses of such printed nutritional compositions, for example for the treatment or prevention of malnutrition. Also provided are administration units comprising such nutritional compositions, as well as systems and methods for producing the nutritional compositions and the administration units.","<div class=""indep-clm"" num=""1""><seg-con>1.一种营养组合物，所述营养组合物包含至少一种营养物质，对于所述营养物质，在个体中检测到营养物质摄入量和/或营养物质状态的缺乏，所述营养组合物包含在施用单元中，</seg-con><seg-trans>其特征在于</seg-trans><seg-refi>所述营养物质在所述施用单元中存在的量对应于所述个体的所述营养物质摄入量和/或状态的目标值和实际值之间的差值。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述营养组合物为打印的营养组合物。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的组合物，其中所述打印的营养组合物为喷墨打印或3D打印的营养组合物、2D打印的组合物，或被喷涂到食物产品或其他可食用产品上。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，其中所述营养物质为选自以下物质的常量营养素或微量营养素：蛋白质、氨基酸、碳水化合物、低聚糖、脂肪、脂质、脂肪酸、核苷酸、维生素、抗氧化剂、矿物质、痕量元素和电解质。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，其中所述目标值和/或所述实际值以每餐或每种食物产品中的营养物质的量表示。</div>
<div class=""indep-clm"" num=""6"">6.一种包含根据权利要求1至5中任一项所述的营养组合物的施用单元，其中所述施用单元被设计用于口服施用，优选舌下施用、经舌施用或经颊施用。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的施用单元，其中所述施用单元以选自以下的施用形式被提供：片剂、箔、膜以及糯米纸囊剂。</div>
<div class=""dep-clm"" num=""8"" parent=""6,7"">8.根据权利要求6或7所述的施用单元，其中所述施用单元和所述打印的营养组合物基于至少一种可溶于口腔流体中的药学上可接受的化合物，所述口腔流体优选为唾液。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,8"">9.根据权利要求1至5中任一项所述的营养组合物，或根据权利要求6至8中任一项所述的施用单元，所述营养组合物或所述施用单元用于预防或治疗个体营养不良。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求9所述的组合物，或根据权利要求8所述的施用单元，其中所述个体为住在医院、公共机构或疗养院中的住院患者，优选外科患者和/或正经历创伤愈合的患者，或者正接受化疗或放射治疗的患者。</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">11.根据权利要求9或10所述的组合物，或根据权利要求8或9所述的施用单元，其中所述个体患有选自以下的病症：手术前或手术后的食欲不振或食欲丧失、恶心、呕吐、厌食、咽下困难、食管狭窄、咀嚼或吞咽障碍、口腔或咽喉的刺激或损伤或炎症或感染、口腔或咽喉的疾病或恶性肿瘤、甲状腺功能失调、甲状腺肿、定向障碍以及痴呆症。</div>
<div class=""dep-clm"" num=""12"" parent=""9,10,11"">12.根据权利要求9至11中任一项所述的组合物，或根据权利要求9至11中任一项所述的施用单元，其中所述个体患有术后恶心和呕吐(PONV)。</div>
<div class=""indep-clm"" num=""13""><seg-con>13.一种用于生产根据权利要求1至5中任一项所述的营养组合物，或用于生产根据权利要求6至8中任一项所述的施用单元的方法，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""13""><seg-comp>(a)确定个体至少一种营养物质的目标值；</seg-comp></div>
<div class=""indep-clm"" num=""13""><seg-comp>(b)计算所述营养物质的所述目标值和实际值之间的差值；</seg-comp></div>
<div class=""indep-clm"" num=""13""><","A23L33/00, A23P30/20",20250627,雀巢产品有限公司,['Pending']
WO2025061642A1,Improved composite materials for the preparation of coffee capsules,"The present invention relates to a method of manufacturing a fibre-based composite material, to the fibre-based composite material thus obtained, and to the use of the fibre-based composite material for the preparation of capsules for use in capsule coffee machines.","CLAIMS:
<div class=""indep-clm"" num=""1""><seg-main>1. A method for manufacturing a fibre-based composite material, comprising the steps of: </seg-main><seg-clauses>a) providing a substrate comprising cellulosic fibres; </seg-clauses><seg-clauses>b) preparing a mixture comprising one or more alkoxy silane monomers and an acid catalyst in water; </seg-clauses><seg-clauses>c) applying said mixture to said substrate; </seg-clauses><seg-clauses>d) reacting said mixture with the cellulosic fibres of said substrate; </seg-clauses><seg-clauses>e) subjecting said mixture to the sol-gel process; </seg-clauses><seg-clauses>f) drying the treated substrate to obtain the composite material.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1 , wherein </seg-main><seg-clauses>said cellulosic fibres are selected from the group consisting of cellulose fibres, jut, beggase, hemp, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of claim 1 or claim 2, wherein </seg-main><seg-clauses>the one or more alkoxy silane monomers are selected from the group tetraethyl orthosilicate, triethoxy(methyl)alkoxy silane, triethoxy(ethyl)alkoxy silane, riethoxy(propyl)alkoxy silane, butyltriethoxyalkoxy silane, triethoxy(isopentyl)alkoxy silane, (3,3-dimethylbutyl)triethoxyalkoxy silane, triethoxy(vinyl)alkoxy silane, 3-(triethoxysilyl)propan-1 -amine, 3- (triethoxysilyl)propyl methacrylate, tetraethyl orthosilicate, trimethoxy(methyl)alkoxy silane, trimethoxy(ethyl)alkoxy silane, trimethoxy(propyl)alkoxy silane, butyltrimethoxyalkoxy silane, trimethoxy(isopentyl)alkoxy silane, (3,3-dimethylbutyl)trimethoxyalkoxy silane, trimethoxy(vinyl)alkoxy silane, 3-(trimethoxysilyl)propan-1 -amine, and 3- (trimethoxysilyl)propyl methacrylate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of any of claims 1 to 3, wherein </seg-main><seg-clauses>alkoxy silane-to-cellulos","D21H17/13, B65D65/42, B65D85/804, D21H19/16, D21H19/20",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
JP2025003996A,Effect of replenishment of n-acetylcysteine and glycine for improving glutathione level,,,"A61K31/198, A61P9/04, A61P43/00, A61P35/00, A61P3/10",20250114,ベイラー カレッジ オブ メディスン,['Inactive']
RU2845898C1,"Method for producing chocolate product, material obtained from plant of genus theobroma and chocolate product containing obtained material","FIELD: food industry.SUBSTANCE: invention relates to confectionary industry. Disclosed is a method of obtaining an intermediate product for production of a chocolate product composition. Intermediate product is a material obtained from a plant of Theobroma genus. Method involves reduction of size of seeds and/or part of seeds of plants of genus Theobroma, optionally in presence of following components: i. pulp and/or pulp extract of a plant of Theobroma genus and/or ii. a part of Theobroma genus plant fruit that does not contain pulp and seeds. If both of i and ii are not present at the step of reducing the size of seeds and/or part of seeds of the genus Theobroma plant, the product is mixed with each component or both components of both i and/or ii. Process steps a or b enable to obtain a paste. Preferably, the total amount of i and/or ii in the mixture ranges from 1.0 wt. % to 80.0 wt. % of the mixture and the amount of seeds and/or part of the seed in the mixture ranges from 20.0 wt. % to 99.0 wt. % of the mixture. Additionally one proposes a material for the chocolate product composition production, the dried mass for the chocolate product composition production and a chocolate product containing the said dried mass.EFFECT: invention provides improved consistency of product and process by fermentation and/or enzymatic hydrolysis of paste, and not separate beans (reduced number of poorly fermented beans); providing controlled fermentation of paste with specific controlled microorganisms; reduced contamination, since the cocoa shell is not subjected to fermentation and drying in potentially unsuitable conditions; increase of fibre content in chocolate products in a controlled manner within the framework of a more ordered process and more homogeneous drying and frying conditions due to removal of separate beans from the process.24 cl, 9 ex","1. Способ получения промежуточного продукта для производства композиции шоколадного продукта, причём промежуточный продукт представляет собой материал, полученный из растения рода Theobroma, при этом способ включает следующие стадии:
а. уменьшение размера семян и/или части семян растения рода Theobroma, необязательно в присутствии следующих компонентов:
i. мякоть и/или экстракт мякоти растения рода Theobroma и/или
ii. не содержащая мякоти и семян часть плода растения рода Theobroma,
b. если оба из i. и ii. не присутствуют на стадии a., смешивание продукта стадии a. с каждым компонентом или обоими компонентами как из i, так и/или из ii,
причём технологические этапы a или b обеспечивают получение пасты.
2. Способ по п. 1, в котором общее количество i и/или ii в смеси составляет от 1,0 до 80,0 масс.% смеси.
3. Способ по п. 1 или 2, в котором количество семян и/или части семени в смеси составляет от 20,0 до 99,0 масс.% смеси.
4. Способ по любому из пп. 1-3, в котором уменьшение размера на стадии (a) включает этап измельчения, размалывания, дробления, грохочения и/или измельчения до порошкообразного состояния.
5. Способ по любому из пп. 1-4, в котором уменьшение размера на стадии a. включает уменьшение до размера от 10 до 500 мкм.
6. Способ по одному из пп. 1-5, в котором паста имеет содержание влаги от 0,5 до 80% от массы пасты.
7. Способ по любому из пп. 1-6, в котором семена и/или часть семян не обжарены и/или являются неферментированными.
8. Способ по любому из пп. 1-7, в котором не содержащую мякоть и семян часть выбирают из группы, содержащей семяножку, плаценту, эндокарп, мезокарп и/или эндокарп.
9. Способ по любому из пп. 1-8, в котором смесь ферментируют после стадии b.
10. Способ по любому из пп. 1-9, в котором смесь обрабатывают для уменьшения содержания полисахарида в смеси.
11. Способ по любому из пп. 1-10, в котором смесь обрабатывают для увеличения содержания моно- и/или дисахаридов в смеси.
12. Способ по п. 10 или 11, в котором обработка включает в себя о",A23G1/00,20250827,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025026703A1,Freeze induced texturization of alginate and protein for fish analogs,"The present invention relates to a method of making a plant-based fish analog, said method comprising mixing plant protein, alginate salt, and fat coated calcium salt in water to form a dough mixture; optionally emulsifying the dough mixture with oil or melted fat; transferring the dough mixture to a mold or a packaging; freezing the dough mixture so that the core temperature of the dough mixture reaches -10°C or less; thawing the dough mixture; and optionally cooking, chilling or flash freezing.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a plant-based fish analog, said method comprising </seg-main><seg-clauses>a) Mixing soy protein, rice protein, alginate salt, and fat coated calcium salt in water to form a dough mixture; </seg-clauses><seg-clauses>b) emulsifying the dough mixture with oil or melted fat; </seg-clauses><seg-clauses>c) transferring the dough mixture to a mold or a packaging; </seg-clauses><seg-clauses>d) Freezing the dough mixture so that the core temperature of the dough mixture reaches -10°C or less; </seg-clauses><seg-clauses>e) Thawing the dough mixture; and </seg-clauses><seg-clauses>f) Optionally cooking, chilling or flash freezing; wherein the dough is not heat treated before freezing the dough.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of making a plant-based fish analog according to claim 1, wherein </seg-main><seg-clauses>fat coated calcium salt is added after the alginate salt has been hydrated in the water.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of making a plant-based fish analog according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the freezing step d) is for at least 1 hour, preferably at least 5 hours, more preferably at least 9 hours.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of making a plant-based fish analog according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the soy and rice protein content of the plant-based fish analog is between 4 to 16 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3""><seg-main>5. The method of making a plant-based fish analog according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the plant-based fish analog does not comprise any further hydrocolloid.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The method of making a plant-based fish a","A23J3/14, A23J3/16, A23J3/22, A23J3/24, A23L29/256",20250206,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250102342A1,Recyclable dosing device,A dosing device made from moulded pulp fiber includes a container member with a defined volume corresponding to a pre-determined amount of composition to be dosed. The dosing device may be to be used for dosing food materials and may be biodegradable and/or compostable. A process for manufacturing such a dosing device is also provided.,"<div class=""indep-clm"" num=""1""><seg-con>1: A dosing device made from molded pulp fiber, the dosing device </seg-con><seg-trans>comprising </seg-trans><seg-refi>a container member and a handle member, wherein the container member has a defined volume corresponding to a pre-determined amount of a composition to be dosed.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the molded pulp fiber is made from pulp comprising cellulosic fibrous material prepared by chemically and mechanically separating cellulose fibers from material containing the cellulose fibers.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The dosing device in accordance with claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cellulosic fibrous material is selected from the group consisting of wood, fiber crops, waste paper, rags, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the dosing device is recyclable and/or compostable.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5: The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pulp fiber comprises cellulose, hemicellulose and lignin.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6: The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the molded pulp fiber further comprises a compound selected from the group consisting of alkyl ketene dimer wax, a fluorine containing polymer moiety, sodium silicate, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7: The dosing device in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the container member has a material thicknes","G01F19/00, D21J1/16, D21J3/00",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024200882B2,"Omega-3 fatty acid, homocystein and vitamin D levels to identify and attenuate cognitive aging in individuals","A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and 5 homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject. 20 24 20 08 82 12 F eb 2 02 4 A B S T R A C T 1 2 F e b 2 0 2 4 A m e t h o d f o r i d e n t i f y i n g p r e - d i s p o s i t i o n t o c o g n i t i v e d e c l i n e i n a s u b j e c t , t h e m e t h o d c o m p r i s i n g d e t e r m i n i n g l e v e l s o f : ( a ) o m e g a - 3 f a t t y a c i d s , a n d v i t a m i n D o r a m e t a b o l i t e t h e r e o f ; ( b ) o m e g a - 3 f a t t y a c i d s , a n d h o m o c y s t e i n e ; ( c ) v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d 5 h o m o c y s t e i n e ; o r ( d ) o m e g a - 3 f a t t y a c i d s , v i t a m i n D o r a m e t a b o l i t e t h e r e o f , a n d h o m o c y s t e i n e , i n d e p e n d e n t l y i n o n e o r m o r e s a m p l e s o b t a i n e d f r o m t h e s u b j e c t . 2 0 2 4 2 0 0 8 8 2","<div class=""indep-clm"" num=""1""><seg-main>1.     A method for identifying pre-disposition to cognitive decline in a subject, the</seg-main>
<seg-main class=""seg-enter"">method comprising </seg-main><seg-clauses>determining levels of: omega-3 fatty acids, and</seg-clauses>
<seg-clauses class=""seg-enter"">5          homocysteine; independently in one or more samples obtained from the</seg-clauses>
<seg-clauses class=""seg-enter"">subject.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.     The method of claim 1, wherein:</seg-main>
<seg-clauses>(a) a level of omega-3 fatty acids is determined and a decrease in the</seg-clauses>
<seg-clauses class=""seg-enter"">10                     level of omega-3 fatty acids in the sample from the subject</seg-clauses>
<seg-clauses class=""seg-enter"">compared to a reference value is indicative of pre-disposition to cognitive decline; and</seg-clauses>
<seg-clauses>(b) a level of homocysteine is determined and an increase in the level of homocysteine in the sample from the subject compared to a</seg-clauses>
<seg-clauses class=""seg-enter"">15                      reference value is indicative of pre-disposition to cognitive decline.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.     The method of claim 1 or claim 2, wherein </seg-main><seg-clauses>the one or more samples are</seg-clauses>
<seg-clauses class=""seg-enter"">independently selected from the group consisting of a blood sample, plasma sample and serum sample.</seg-clauses>
<seg-clauses class=""seg-enter"">20</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.     The method of any one of the preceding claims, wherein </seg-main><seg-clauses>the level of omega-3</seg-clauses>
<seg-clauses class=""seg-enter"">fatty acids is determined in a blood sample, preferably an erythrocyte sample; and/or the level of homocysteine is determined in a plasma sample.</seg-clauses>
<seg-clauses class=""seg-enter"">25   </seg-claus","A61K31/202, A61K31/14, A61K31/4415, A61K31/51, A61K31/592",20250724,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
TW202513791A,Bifidobacterium longum transitional microorganism,or a B. Longumtransitional strain having an identifying characteristic of the B. Longumtransitional strain deposited under deposit number CNCM,"<div class=""indep-clm"" num=""1"">1. 一種以寄存號CNCM I-5942寄存於國家微生物菌種收藏(Collection nationale de cultures de micro-organismes, CNCM)的長雙歧桿菌( Bifidobacterium longum)過渡微生物株或一種具有以寄存號CNCM I-5942寄存的長雙歧桿菌過渡株之辨識特徵的長雙歧桿菌過渡株。</div>
<div class=""indep-clm"" num=""2"">2. 一種長雙歧桿菌過渡微生物株，其與以寄存號CNCM I-5942寄存於CNCM的長雙歧桿菌株具有至少99%之平均核苷酸同一性(Average Nucleotide Identity, ANI)。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3. 如請求項1之長雙歧桿菌過渡株，其與以寄存號CNCM I-5942寄存的長雙歧桿菌過渡株具有至少98.1%之ANI。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. 如前述請求項中任一項之長雙歧桿菌過渡株，其中該長雙歧桿菌過渡株對四環黴素(tetracycline)、紅黴素(erythromycin)、克林達黴素(clindamycin)及胺苄青黴素(ampicillin)中之任一者均不具有抗性；較佳地，其中該長雙歧桿菌過渡株對四環黴素、紅黴素、克林達黴素、胺苄青黴素、見大黴素(gentamycin)、鏈黴素(streptomycin)、氯黴素(chloramphenicol)及萬古黴素(vancomycin)中之任一者均不具有抗性。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5. 如前述請求項中任一項之長雙歧桿菌過渡株，其中該長雙歧桿菌過渡株包含醣苷基水解酶家族43_17 (GH43_17)基因；合適地，其中該GH43_17基因包含SEQ ID NO: 7或與SEQ ID NO: 7具有至少60%序列同一性之序列。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. 如前述請求項中任一項之長雙歧桿菌過渡株，其進一步包含：主要易化子超家族(major facilitator superfamily, MFS)基因；合適地，其中該MFS基因包含SEQ ID NO: 37或與SEQ ID NO: 39具有至少60%序列同一性之序列；及/或AraC基因；合適地，其中該AraC基因包含SEQ ID NO: 39或與SEQ ID NO: 39具有至少60%序列同一性之序列；較佳地，其中該等GH43_17、MFS及AraC基因係包含在基因簇中。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7. 如請求項6之長雙歧桿菌過渡株，其中該長雙歧桿菌過渡株進一步包含GH31基因及LacI基因中之一或多者；較佳地，其中該長雙歧桿菌過渡株進一步包含木酮糖激酶基因及木糖異構酶基因；且進一步較佳地，其中該等GH43_17、MFS、AraC、GH31、LacI、木酮糖激酶及木糖異構酶基因係包含在基因簇(gene cluster)中。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. 如前述請求項中任一項之長雙歧桿菌過渡株，其進一步包含針對一或多種選自GH43_17、GH43_22、GH43_27、GH43_29、GH121、GH43_24、GH127、GH30_5、GH 43_32及GH30的醣苷水解酶進行編碼的一或多種基因。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9. 如前述請求項中任一項之長雙歧桿菌過渡株，其中該長雙歧桿菌過渡株優先利用3-岩藻糖基乳糖(3-fucosyllactose, 3-FL)；較佳地，其中當在3-FL的存在下培養時，該長雙歧桿菌過渡株具有至少0.6 k的生長速率。</div>
<div class=""indep-clm"" num=""10"">10. 一種益生菌組成物，其包含如前述請求項中任一項之長雙歧桿菌過渡株。</div>
<div class=""indep-clm"" num=""11"">11. 一種組成物，其包含如前述請求項中任一項之長雙歧桿菌過渡株以及至少一種另外的益生菌及/或益生元。</div>
<div class=""indep-clm"" num=""12"">12. 一種如前述請求","C12N1/20, A23L33/135, A61K35/745, A61P1/14, C12R1/01",20250401,瑞士商雀巢製品股份有限公司,['Pending']
RU2841782C1,Method of producing a freeze-dried soluble beverage powder,"FIELD: coffee industry.SUBSTANCE: described is a method for producing a freeze-dried soluble beverage powder comprising steps of: providing liquid aqueous beverage composition (1) having a total solids content of 5 to 65 %, formation of liquid beverage composition layer (2) between two parallel flat surfaces (3a, 3b) and in contact with them, wherein the surfaces are separated by gap of 0.1 to 10 mm, cooling the liquid beverage aqueous composition layer to a temperature below -25 °C to form a frozen beverage composition and drying the frozen beverage composition, wherein the freeze-dried soluble beverage powder contains coffee dry extract particles having two substantially flat surfaces and a uniform thickness, wherein the particles have a median thickness of 0.2 to 1.5 mm, a surface roughness measured by profilometry is less than 12 mcm and a uniformity index measured by profilometry is greater than 0.6.EFFECT: invention allows to manufacture a product with an attractive glossy appearance.12 cl, 5 dwg, 1 tbl, 4 ex","1. Способ получения сублимированного растворимого порошка напитка, включающий стадии:
a. обеспечения жидкой водной композиции (1) напитка, имеющей общее содержание твердых веществ от 5 до 65%;
b. формирования слоя (2) жидкой водной композиции напитка между двумя параллельными плоскими поверхностями (3a, 3b) и в контакте с ними, причём поверхности разделены зазором от 0,1 до 10 мм;
c. охлаждения слоя жидкой водной композиции напитка до температуры ниже -25°C с образованием замороженной композиции напитка; и
d. сушки замороженной композиции напитка;
причём сублимированный растворимый порошок напитка содержит частицы сухого экстракта кофе, имеющие две, по существу, плоские поверхности и равномерную толщину, при этом частицы имеют медианную толщину от 0,2 до 1,5 мм, шероховатость поверхности, измеренную с помощью профилометрии, менее 12 мкм и индекс однообразия, измеренный с помощью профилометрии, более 0,6.
2. Способ по п. 1, в котором водная композиция напитка представляет собой экстракт кофе.
3. Способ по п. 1 или 2, в котором плоские поверхности представляют собой движущиеся полосы (6a, 6b).
4. Способ по п. 3, в котором охлаждение применяют к по меньшей мере одной движущейся полосе.
5. Способ по п. 4, в котором к одной движущейся полосе применяют большее охлаждение, чем к другой.
6. Способ по любому из пп. 1-5, в котором движущиеся полосы проходят через множество зон охлаждения.
7. Способ по п. 1, в котором частицы имеют открытые поры с отверстиями менее 4,5 микрометра, причём объем открытых пор с отверстиями менее 4,5 микрометра составляет более 50% от общего объема открытых пор при измерении с помощью ртутной порометрии.
8. Способ по п. 1, в котором частицы имеют открытые поры с отверстиями менее 2 микрометров, причём объем открытых пор с отверстиями менее 2 микрометров составляет более 20% от общего объема открытых пор при измерении с помощью ртутной порометрии.
9. Способ по п. 1, в котором частицы имеют медианный диаметр открытых пор менее 4,5 микрометра при изм",A23F5/32,20250617,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119157749A,Enteral nutrition container cap and methods of making and using same,"A package closure system may include a lid and a package outlet having a first connection unit, the lid configured to be removably connected to the package outlet using the first connection unit and including a second connection unit. The top cap may be configured to be removably connected to the cover using a second connection unit. A method for providing a nutritional composition from a container to the intestinal tract may include: removing a top cap from a cap configured to direct the nutritional composition through a channel within the cap, the cap removably connected to the container; sealingly connecting the cap to the intestinal tract; and applying pressure to the container to direct the nutritional composition from the container through the channel and into the intestinal tract.","<div class=""indep-clm"" num=""1""><seg-con>1.一种容置营养组合物[132]的容器，所述容器包括用于与肠内饲管直接连接的一体式连接器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述一体式连接器配置成连接到<img src=""https://data-fulltext-image.patsnap.com/CN/A/11/91/57/74/9/1734946535020/FDA0005067991690000011.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064364%3B1765067964%26q-key-time%3D1765064364%3B1765067964%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3Dd01545e9e8193b6b73c51efeceea4dcb4ba65ebe&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A24%20GMT"" class=""img-anchor"" img-id=""FDA0005067991690000011"" image_type=""inline"" official_size=""3973"">连接器。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述一体式连接器包括近侧端部和远侧端部，所述近侧端部用于连接到所述容器，所述远侧端部用于连接到所述肠内饲管，连接螺纹[13]从所述远侧端部延伸并且配置成附接到所述<img src=""https://data-fulltext-image.patsnap.com/CN/A/11/91/57/74/9/1734946535020/FDA0005067991690000012.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064364%3B1765067964%26q-key-time%3D1765064364%3B1765067964%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D826b13cff1f6f8b2ed80bbbd377b5f64d48c2aba&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A24%20GMT"" class=""img-anchor"" img-id=""FDA0005067991690000012"" image_type=""inline"" official_size=""3911"">连接器。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的容器，还包括顶部罩帽[70]，所述顶部罩帽配置成封闭所述容器。</div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述顶部罩帽配置成使得其能从所述远侧端部按扣掉。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述顶部罩帽是在顶部罩帽和远侧端部的界面处具有弱化部分的单个单元。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据权利要求1至5中任一项所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述一体式连接器具有比<img s","A61J1/14, A61J15/00, A61J9/00, A61M5/162",20241220,雀巢产品有限公司,['Pending']
US12251367B2,Medium chain triglyceride compositions,A composition comprising medium-chain triglycerides (MCTs) wherein the composition comprises (i) a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8) and (ii) a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10); wherein the ratio of MCT-C8 to MCT-C10 is from 10:90 to 90:10 (mol/mol) and wherein the combined amount of MCT-C8 and MCT-C10 make up at least 50 mol % of the MCTs in the composition.,"<div class=""indep-clm"" num=""1""><seg-con>1. A method of treating an individual </seg-con><seg-trans>having </seg-trans><seg-refi>a brain energy deficiency condition or disease, the method comprising administering a composition comprising medium-chain triglycerides (MCTs) to the individual, wherein the MCTs comprise:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8); and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10);</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the ratio of the MCT-C8 to the MCT-C10 is from 10:90 to 90:10 (mol/mol), and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the combined amount of MCT-C<b>8</b> and MCT-C<b>10</b> is at least 50 mol % of the MCTs in the composition, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the composition provides increased ketones and/or fatty acids as compared to a composition comprising MCTs comprising three fatty acids moieties each with a mix of C8 and C10 moieties attached and having the same C8/C10 ratio and molar amounts.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ratio of MCT-C8 to MCT-C10 is 20:80 to 85:15 (mol/mol).</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the combined amount of MCT-C8 and MCT-C10 is at least 90 mol % of the MCTs in the composition.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4. A method of treating an individual </seg-con><seg-trans>having </seg-trans><seg-refi>a brain energy deficiency condition or disease, the method comprising administering a composition comprising medium-chain triglycerides (MCTs) to the individual, wherei","A61K31/21, A23K20/158, A23L33/12",20250318,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025132742A1,Jug with whisk retainer,"A jug (10) for processing a liquid food substance, such as milk or a milk-based substance, is provided. The jug (10) comprises a container (12) delimiting a food cavity for containing said liquid food substance, the food cavity having a top opening (22), a lid (20) connected to the container (12) and movable between a closed position in which the lid (20) covers the top opening (22) and an open position in which the lid (20) at least partially uncovers the top opening (22) for filling and/or emptying the container (12), an impeller (38) removably received by the container (12) and configured for driving said liquid food substance in the container (12), and a retaining element (46) connected to the lid (20) and configured for retaining the impeller (38) in the container (12) when the lid is in the open position.","CLAIMS<div class=""indep-clm"" num=""1""><seg-main>1. A jug (10) for processing a liquid food substance, such asmilk or a milk-based substance, comprising:</seg-main><seg-clauses>- a container (12) delimiting a food cavity for containing saidliquid food substance, the food cavity having a top opening (22),</seg-clauses><seg-clauses>- a lid (20) connected to the container (12) and movable betweena closed position in which the lid (20) covers the top opening (22) and an open position in which the lid (20) at least partially uncovers the top opening (22) for filling and/or emptying the container (12),</seg-clauses><seg-clauses>- an impeller (38) removably received by the container (12) andconfigured for driving said liquid food substance in the container (12), and</seg-clauses><seg-clauses>- a retaining element (46) connected to the lid (20) andconfigured for retaining the impeller (38) in the container (12) when the lid is in the open position.</seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The jug (10) of claim 1, wherein </seg-main><seg-clauses>the retaining element (46)is configured for holding the impeller (38) in position inside the container (12) during tilting of the container (12), such as during tilting of the container for pouring the processed liquid food substance out of the container (12), preferably wherein the retaining element (46) is configured for holding a stem (40) of the impeller (38) in place during tilting.</seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The jug (10) of claim 1 or 2, wherein </seg-main><seg-clauses>the retaining element(46) includes a catch-wall (48) configured to be abutted by a portion of the impeller (38), preferably during tilting of the container (12), more preferably during tilting of the container (12) for pouring the processed liquid food substance out of the container (12).</seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The jug (10) of claim 3, wher","A47J27/00, A47J43/046",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
AU2023219953B2,Nutritional composition and infant formula for promoting myelination of the brain,"Abstract: A synthetic nutritional composition comprising a fatty acid derivative for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject. Abstract: A synthetic nutritional composition comprising a fatty acid derivative for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential 2023219953 25 Aug 2023 and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.","<div class=""indep-clm"" num=""1""><seg-con>1. A synthetic nutritional composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fatty acid derivative, comprising arachidonic acid and iron and folic acid and vitamin B12, and sphingomyelin</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>5          wherein, the fatty acid derivative comprising arachidonic acid is comprised in the</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>composition in an amount of 60 to 120 mg/100 g, iron is present in said composition in an amount of at least 5 mg/100 g, folic acid is present in said composition in an amount of at least 100 mcg/kg, vitamin B12 is present in said composition in amount of at least 4 mcg/100 g, sphingomyelin is present in said</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10          composition it is present in an amount of at least 300 mg/kg, wherein all weights</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>are by dry weight of the composition and wherein, said composition is a composition selected from the group consisting of: an infant formula, a growing up milk, a composition for infants that is intended to be added or diluted with human breast milk, and a food stuff intended for consumption by an infant and/or</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>15          child either alone or in combination with human breast milk.</seg-refi></div>
<div class=""indep-clm"" num=""2"">2. Use of a synthetic nutritional composition according to claim 1 in the manufacture of a medicament to promote, support or optimise de novo myelination, and/or brain structure, and/or brain connectivity, and/or intellectual</div>
<div class=""indep-clm"" num=""2"">20          potential and/or cognitive potential and/or learning potential and/or cognitive</div>
<div class=""indep-clm"" num=""2"">functioning in a subject.</div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. Use according to claim 2, </seg-con><seg-trans>wherein <","A23L33/12, A23L33/00, A23L33/15, A23L33/16, A61K31/30",20250814,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023355740A1,Beverage or foodstuff preparation system,"A container for use with a beverage or foodstuff preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by said machine to process the precursor material, the code readable by a code reading system of the machine, which comprises: a lighting system to project an emission to the code, and; a camera system for obtaining a digital image of the code, the code arranged to overlap the precursor material, and; a support layer to support the code, the support layer at least partially transparent to the emission from the lighting system, the code comprising: an absorber layer, which is configured to absorb the emission and a reflector layer, which is configured to reflect the emission, the reflector layer is arranged to reflect the emission before it is transmitted to the support layer.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for use with a beverage or foodstuff preparation machine, the container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a storage portion for containing a precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code for storing preparation information used by said machine to process the precursor material, the code configured to be readable by a code reading system of the machine, which comprises a lighting system to project an emission to the code, the code arranged to overlap the precursor material such that an emission from the lighting system projects into the precursor material;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the code comprising: an absorber layer, which is configured to absorb the emission and a reflector layer, which is configured to reflect the emission,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the container further comprising a support layer to support the code, the support layer being made with a material at least partially transparent to the emission from the lighting system,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the reflector layer is arranged to reflect the emission before it is transmitted to the support layer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein:</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the reflector layer is continuous;</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the reflector layer is connected to the support layer to adjoin the support layer, and;</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>the support layer extends in a plane defined by lateral and longitudinal directions and has a through thickness in a depth direction, and where the reflector layer to overlap the entire the support layer when vie",B65D85/804,20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025074177A1,"Edible animal chews containing concentrated fruit juice, and methods of making and using such edible animal chews","An edible pet chew contains a concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible pet chew. A method of making an edible pet chew includes extruding a composition containing concentrated fruit juice, the concentrated fruit juice present in the composition in an amount effective as both a humectant and a plasticizer in the composition being extruded. A method of cleaning teeth of a pet includes orally administering an edible chew to the pet, the edible chew containing concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible chew. The concentrated fruit juice may replace at least a portion of glycerin and/or propylene in the edible chew, while maintaining or increasing at least one of texture or occupation time for the edible pet chew.","<div class=""indep-clm"" num=""1""><seg-con>An edible pet chew </seg-con><seg-trans>comprising </seg-trans><seg-refi>concentrated fruit juice in an amount effective as both a humectant and a plasticizer in the edible pet chew.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>The edible pet chew of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible chew is substantially free of glycerin and substantially free of propylene glycol.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>The edible pet chew of Claim 1 or Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible pet chew further comprises a starch.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>The edible pet chew of any of Claims 1-3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the concentrated fruit juice is selected from the group consisting of: plum, apple, carob, dates, blueberry, strawberry, pear, grape, peach, and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>The edible pet chew of any of Claims 1-4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the concentrated fruit juice is a mixture of apple and carob.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>The edible pet chew of any of Claims 1-5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the edible pet chew has a property that is at least one of improved texture or increased occupation time, relative to a reference edible pet chew that comprises glycerin and/or propylene glycol instead of the concentrated fruit juice but otherwise identically formulated.</seg-refi></div>
<div class=""indep-clm"" num=""7""><seg-con>A method of making an edible pet chew, the method </seg-con><seg-trans>comprising:</seg-trans><seg-refi>extruding a composition comprising concentrated fruit juice, the concentrated fruit juice present in the composition in an amount effective as both a humectant and a plast","A23K10/30, A23K20/163, A23K50/45, A23K50/48",20250410,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
AU2019407123B2,A nutritional composition comprising 6'SL and LNT in combination to improve the gastrointestinal barrier function,"The present invention relates to nutritional compositions comprising 6'- sialyllactose (6'SL) and lacto-N-tetraose (LNT) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gut barrier function in an infant, a young child or children aged above 3 years to 8 years.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and less than 3 years) or a child (aged from 3 years to less than 8 years);</seg-main>
<seg-main class=""seg-enter"">5 the method comprising </seg-main><seg-clauses>administering to the infant or young child a synthetic nutritional composition comprising 6'-sialyllactose (6'SL) and lacto-N-tetraose (LNT); or the method comprising administering to the child a synthetic nutritional composition in the form of a growing-up milk comprising 6'-sialyllactose (6'SL)</seg-clauses>
<seg-clauses class=""seg-enter"">10 and lacto-N-tetraose (LNT);</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said improvement to the gastrointestinal barrier is improved barrier repair, improved barrier function, improved barrier maturation, improved barrier structure, and/or improved barrier protection.</seg-clauses>
<seg-clauses class=""seg-enter"">15 </seg-clauses></div><div class=""indep-clm"" num=""2""><seg-main>2. Use of a synthetic nutritional composition comprising </seg-main><seg-clauses>6'-sialyllactose (6'SL) and lacto-N-tetraose (LNT) in the manufacture of a medicament for improving the gastrointestinal barrier in an infant (child under the age of 12 months) or a young child (between 1 year and less than 3 years) or a child (aged from 3 years to less than 8 years);</seg-clauses>
<seg-clauses class=""seg-enter"">20 wherein the synthetic nutritional composition to be administered to the child is in the form of a growing-up milk;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein said improvement to the gastrointestinal barrier is improved barrier repair, improved barrier function, improved barrier maturation, improved barrier structure, and/or improved barrier protection.</seg-clauses>
<seg-clauses class=""seg-enter"">25</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to c","A23L33/00, A23L33/21, A61K31/702, A61P1/00",20250410,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250241330A1,Process for treating protein-containing compositions,"The invention relates to a process for treating a protein-containing composition. The process includes the provision of a protein-containing composition wherein the proteins comprise milk proteins and said milk proteins comprise at least 90 wt. % β-lactoglobulins. The composition is contacted with a transglutaminase to obtain a cross-linked protein-containing composition. This process enhances not only the heat stability, in particular in presence of calcium but also the texture properties of such protein-containing compositions. The invention also relates to cross-linked protein-containing compositions obtainable or obtained by said process, to a process for preparing dairy products or alternatives thereof with such compositions and to the resulting dairy products or alternatives thereof.",,"A23C9/12, A23C9/152, A23C21/02, A23J3/08, A23J3/34",20250731,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025131783A1,Hybrid moulded pulp object,"The present invention relates to a moulded pulp article, the moulded pulp article comprising: a shaped pulp comprising cellulose fibres; and a polymer reinforcement. The polymer reinforcement may be in the form of polymer dispersed throughout the shaped pulp and/or in the form of a polymer interlayer disposed between the shaped pulp and a tactile layer.","CLAIMS:
<div class=""indep-clm"" num=""1""><seg-main>1. A moulded pulp article, the moulded pulp article comprising: </seg-main><seg-clauses>a shaped pulp comprising cellulose fibres; and a polymer reinforcement.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The moulded pulp article of claim 1 , wherein </seg-main><seg-clauses>the polymer reinforcement comprises polymer dispersed throughout the shaped pulp.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The moulded pulp article of claim 2, wherein </seg-main><seg-clauses>the polymer comprises up to 50 wt% of the total mass of the shaped pulp and the polymer reinforcement, optionally between 1 and 50 wt%, optionally between 10 and 40 wt%, optionally between 20 and 30 wt%, optionally about 30 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The moulded pulp article of any one of the preceding claims, wherein </seg-main><seg-clauses>the moulded pulp article further comprises a tactile layer and the polymer reinforcement comprises a polymer layer located between the shaped pulp and the tactile layer.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4"">5. The moulded pulp article of claim 4, herein the polymer layer is a net or a film, optionally with a thickness of from 1 to 200 pm, optionally of from 10 to 150 pm, more preferably from 20 to 120 pm, further preferably from 30 to 80 pm, yet further preferably from 40 to 60 pm, most preferably about 50 pm.</div>
<div class=""dep-clm"" num=""6"" parent=""4,5""><seg-main>6. The moulded pulp article of claim 4 or claim 5, wherein </seg-main><seg-clauses>the tactile layer has a paper feel, optionally the tactile layer is selected from a thin pulp layer, a paperboard, and a paper layer.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""4,5,6""><seg-main>7. The moulded pulp article of any one of claims 4 to 6, wherein </seg-main><seg-clauses>the tactile layer has a weight of from 5 to 150 ","B32B1/00, B32B5/02, B32B27/10, B32B27/36, B32B29/02",20250626,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
CN120187648A,Beverage or food preparation system,"The present invention provides a container for containing a precursor material for use with a machine for preparing a beverage and/or food product or a precursor thereof, the container comprising a machine-readable code storing preparation information for use with a preparation process performed by the machine, the code comprising: a reference portion (R) to locate the code; a data portion (D) to store the preparation information, where the data portion comprises a first predetermined position and a second predetermined position partially overlapping, the partially overlapping first predetermined position and second predetermined position encoding three conditions as: no data unit is present at both positions; there is a data unit at the first position and there is no data unit at the second position; and there is a data unit at the second location and there is no data unit at the first location.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于容纳前体材料的容器，所述容器用于与用于制备饮料和/或食品或者其前体的机器一起使用，所述容器包括存储与由所述机器执行的制备过程一起使用的制备信息的机器可读代码，所述代码</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>用以定位所述代码的参考部分(R)；</seg-comp><seg-comp>用以存储所述制备信息的数据部分(D)，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中数据部分包括部分重叠的第一预定位置和第二预定位置，所述部分重叠的第一预定位置和第二预定位置将三个条件中的一个条件编码为：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>在两个位置处都不存在数据单元；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>在所述第一位置处存在数据单元，并且在所述第二位置处不存在数据单元；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>在所述第二位置处存在数据单元，并且在所述第一位置处不存在数据单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>使得被编码的所述条件被紧凑地定位。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求2所述的容器，其中所述数据单元和所述预定位置大小相等。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据任一前述权利要求所述的容器，其中所述部分重叠的第一预定位置和第二预定位置以小于所述预定位置的面积的一半重叠。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的容器，其中所述部分重叠的第一预定位置和第二预定位置以大于所述预定位置的面积的5％或10％重叠。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的容器，其中所述部分重叠的第一预定位置和第二预定位置被布置在<img src=""https://data-fulltext-image.patsnap.com/CN/A/12/01/87/64/8/1750407868370/FDA0005387322460000011.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064328%3B1765067928%26q-key-time%3D1765064328%3B1765067928%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3De81698f64a22a468712a132446f0ce27b9859c4a&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A48%20GMT"" class=""img-anchor"" img-id=""FDA0005387322460000011"" image_type=""inline"" official_size=""7382"">上。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述的容器，其中所述数据部分包括至少一个数据单元，所述至少一个数据单元沿虚拟<img src=""https://data-fulltext-image.patsnap.com/CN/A/12/01/87/64/8/1750407868370/FDA0005387322460000012.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-tim",B65D85/804,20250620,雀巢产品有限公司,['Pending']
RU2845961C1,Apparatus for roasting coffee beans (embodiments),"FIELD: food industry.SUBSTANCE: inventions group relates to coffee industry. Disclosed is an embodiment of a coffee bean roasting apparatus, comprising a vessel for holding coffee beans, a heating device for heating the coffee beans, a control system configured to control the heating device and configured to apply a roasting formula (R), providing preset temperature values for use in separate successive moments in time t1, t2 and so forth, wherein for a given number of m coffee beans of the type Cy loaded inside the vessel, the control system is configured to determine the number of m coffee beans and their type Cy loaded inside the vessel, and based on the obtained type Cy and the obtained quantity m, the control system is configured to determine the recipe Rym for roasting a quantity of m coffee beans of type Cy in the roasting apparatus by accessing: to a rule for calculating a roasting recipe adapted for roasting a certain number of grains, wherein said number is included in a list of predetermined number (M, M ± Δx) from any pre-existing roasting recipe adapted to roasting another number of grains in said particular type of roasting apparatus, wherein said other number is included in a list of predetermined number (M, M ± Δx), and to a list of said predetermined quantities (M, M ± Δx), and to at least one preset initial roasting recipe RyMoriginal, wherein said roasting recipe RyMoriginal is configured to roast one predetermined number of Moriginal beans Cy in said particular type of roasting apparatus, wherein said predetermined initial roasting recipe RyMoriginal provides predetermined temperatures applied at discrete successive points in time t1, t2 and so forth, respectively, and to said predetermined number of Moriginal grains, and based on a comparison of m, the available initial predetermined number of Moriginal grains and available predetermined number of list (M, M ± Δx), determination of the roasting recipe Rym for use on said number of m coffee beans. Other embodiments of apparatus for roasting coffee beans and a system of roasting devices comprising a set of said apparatus are also described.EFFECT: group of inventions provides identical process of roasting regardless of number of roasted grains and regardless of used apparatus for roasting of same type.17 cl, 9 dwg, 3 tbl","1. Аппарат для обжаривания кофейных зерен, содержащий:
- сосуд для размещения кофейных зерен,
- нагревательное устройство для нагрева кофейных зерен, содержащихся в сосуде,
- систему управления, выполненную с возможностью управления нагревательным устройством и выполненную с возможностью применения рецептуры (R) обжаривания, обеспечивающей заданные значения температур для применения в отдельные последовательные моменты времени t<sub>1</sub>, t<sub>2</sub>и т.д., соответственно,
причем для заданного количества m кофейных зерен типа Cy, загруженных внутрь сосуда,
- система управления выполнена с возможностью определения по меньшей мере:
количества m кофейных зерен, загруженных внутрь сосуда, и
типа Cy кофейных зерен, загруженных внутрь сосуда,
и
- на основе полученного типа Cy и полученного количества m, система управления выполнена с возможностью определения рецептуры Rym для обжаривания количества m кофейных зерен типа Cy в аппарате для обжаривания путем:
- получения доступа:
к правилу для расчета рецептуры обжаривания, адаптированной для обжаривания некоторого количества зерен, при этом указанное количество включено в список предварительно заданного количества (M, M±Δx), из любой ранее существовавшей рецептуры обжаривания, адаптированной к обжариванию другого количества зерен в указанном конкретном типе аппарата для обжаривания, при этом указанное другое количество включено в список заранее заданного количества (M, M±Δx), и
к списку указанных предварительно заданных количеств (M, M±Δx), и
по меньшей мере к одной предварительно заданной исходной рецептуре обжаривания RyMoriginal, при этом указанная рецептура обжаривания RyMoriginal выполнена с возможностью обжаривания одного предварительно заданного количества Moriginal зерен типа Cy в указанном конкретном типе аппарата для обжаривания, причем указанная предварительно заданная первоначальная рецептура обжаривания RyMoriginal обеспечивает заданные значения температур, применяемых в дискретные последовательные моменты",A23N12/08,20250828,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025088004A1,Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture,"This invention relates to infant formulae or follow-on formulae suitable for children under the age of 2 years, and their use in the dietary management of phenylketonuria and tyrosinaemia. In particular, the invention relates infant formulae or follow-on formulae comprising casein glycomacropeptide and free amino acids as well as their use in the dietary management of phenylketonuria and tyrosinaemia, and the symptoms thereof. The invention relates to a mixture of free amino acids for use in manufacturing the infant formulae or follow-on formula.","CLAIMS:
<div class=""indep-clm"" num=""1""><seg-main>1. A formula for children under the age of 2 years comprising </seg-main><seg-clauses>intact casein glycomacropeptide and free amino acids for use in the dietary management of phenylketonuria or tyrosinaemia in an individual in need thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The formula for use according to claim 1, wherein </seg-main><seg-clauses><seg-main>the dietary management results in</seg-main>
<seg-clauses>(a) good metabolic control, normal growth and/or improved gastrointestinal tolerance; or</seg-clauses>
<seg-clauses>(b) good metabolic control, normal growth and improved gastrointestinal tolerance.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The formula for use according to claim 2, wherein</seg-main>
<seg-clauses>(a) the good metabolic control achieves blood phenylalanine concentrations of 120- 360 pmol/L in an individual with phenylketonuria or blood tyrosine concentrations of 200-400 pmol/L in an individual with tyrosinaemia;</seg-clauses>
<seg-clauses>(b) the normal growth results in maintenance, preferably an increase, of length for age, weight for age and/or BMI for age; or</seg-clauses>
<seg-clauses>(c) the improved gastrointestinal tolerance is selected from the group consisting of reduced vomiting, regurgitation, abdominal discomfort or colic symptoms, flatulence, proportion or loose or hard stools, and/or difficulty feeding.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The formula for use according to any one of the previous claims, wherein</seg-main>
<seg-clauses>(a) the use is for the dietary management of phenylketonuria; or</seg-clauses>
<seg-clauses>(b) the use is for the dietary management of phenylketonuria and wherein the dietary management results in prevention or reduction in severity or frequency of one or more symptom selected from the group consisting of intellectual disab","A23L33/00, A23L33/175, A23L33/18, A23L33/19, A61K31/198",20250501,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023331753A1,An aeration assembly for lipid activation,"In an embodiment to the present invention an aeration assembly (100) is disclosed. The aeration assembly (100) includes an aeration tank (102) with a closed top (110) and a curved base (112) to house a lipid to be aerated. The aeration tank (102) includes an inlet conduit (302) to allow passage of air for aeration of the lipid, a ring conduit (304) arranged along inner circumference of bottom of the aeration tank (102), a micronization assembly (306) having spargers (310) to receive air from the ring conduit (304) for micronization. Further, a propeller type impeller (308) arranged agitates the lipid in the aeration tank (102) to facilitate contact between the micronized air and the lipid for aeration of the lipid to obtain aerated lipid and by-products of aeration.","<div class=""indep-clm"" num=""1""><seg-con>1. An aeration assembly (100) </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>an aeration tank (102) with a closed top (110) and a curved base (112) to house a lipid to be aerated, the aeration tank (102) includes:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>an inlet conduit (302) to allow passage of air for aeration of the lipid to a ring conduit (304) in the aeration tank (102);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the ring conduit (304) arranged along inner circumference of bottom of the aeration tank (102);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a micronization assembly (306) including one or more spargers (310) and radially attached to the ring conduit (304) to:</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>receive air from the ring conduit (304);</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>micronize the received air by passing the received air through the one or more spargers (310); and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a propeller type impeller (308) arranged axially above the spargers (310) to agitate the lipid in the aeration tank (102) to facilitate contact between the micronized air and the lipid for aeration of the lipid to obtain aerated lipid with flavor modulation.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The aeration assembly (100) as claimed in claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-comp>an air supply device (104) configured to :</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>receive atmospheric air pulled in by a centrifugal blower (118) ;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>receive compressed air from a compressed air source;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>combine the received atmospheric air with the received compressed ai","B01F23/231, A23D9/04, B01D5/00, B01D53/00, B01F23/233",20250109,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250170163A1,Compositions and methods for reducing the occurrence of diarrhea by promoting blautia obeum in the gut microbiota,"Methods and compositions for treating diarrhea, reducing the occurrence of diarrhea and/or preventing diarrhea in an infant or young child, by promoting <i>Blautia obeum </i>in the gut microbiota of the infant or young child. Suitably, the methods and compositions use at least one arabinoxylan or arabinoxylan-containing material selected from the group consisting of (i) whole corn, (ii) corn arabinoxylan, (iii) corn bran, (iv) corn bran arabinoxylan, (v) whole wheat, (vi) wheat arabinoxylan, (vii) wheat bran, and (viii) wheat bran arabinoxylan.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for treating diarrhea, reducing the occurrence of diarrhea and/or preventing diarrhea in an infant or young child, comprising </seg-main><seg-clauses>administering a composition that promotes <i>Blautia obeum </i>in the gut microbiota of the infant or young child.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 wherein </seg-main><seg-clauses>the composition comprises at least one arabinoxylan or arabinoxylan-containing material in an amount effective to promote <i>Blautia obeum </i>in the gut microbiota of the infant or young child.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. A method for treating diarrhea, reducing the occurrence of diarrhea and/or preventing diarrhea in an infant or young child; comprising </seg-main><seg-clauses>administering an arabinoxylan or arabinoxylan-containing material to the infant or young child wherein the arabinoxylan promotes <i>Blautia obeum </i>in the gut microbiota of the infant or young child.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. The method of claim 2 wherein </seg-main><seg-clauses><seg-main>the arabinoxylan or arabinoxylan-containing material is selected from the group consisting of </seg-main><seg-clauses>(i) whole corn, </seg-clauses><seg-clauses>(ii) corn arabinoxylan, </seg-clauses><seg-clauses>(iii) corn bran, </seg-clauses><seg-clauses>(iv) corn bran arabinoxylan, </seg-clauses><seg-clauses>(v) whole wheat, </seg-clauses><seg-clauses>(vi) wheat arabinoxylan, </seg-clauses><seg-clauses>(vii) wheat bran, and </seg-clauses><seg-clauses>(viii) wheat bran arabinoxylan.</seg-clauses></seg-clauses></div>
<div class=""ccl-clm"" num=""5"">5. (canceled)</div>
<div class=""indep-clm"" num=""6""><seg-main>6. A method for use in treating diarrhea, reducing the occurrence of diarrhea and/or preventing diarrhea in an infant or young child comprising </seg-main><seg-clauses>adminis","A61K31/715, A61P1/12",20250529,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
EP4578940A2,Uses of bifidobacterium longum transitional microorganism,The present invention relates to the use of a Bifidobacterium longum transitional microorganism to metabolise one or more glycan substrates selected from the group recited in any of Tables 1 to 3.,"<div class=""indep-clm"" num=""1""><seg-con>1.  Use of a <i>Bifidobacterium longum</i> transitional microorganism to metabolize one or more glycan substrates, preferably </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycan substrate is selected from the groups recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.  Use of a <i>Bifidobacterium longum</i> transitional microorganism according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the <i>Bifidobacterium longum</i> transitional microorganism is used to promote or assist the transition from a milk-based diet to solid food in an infant and/or in a young child.</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-con>3.  Use of a combination of a <i>Bifidobacterium longum</i> transitional microorganism and one or more glycan substrates to promote or assist the transition from a milk-based diet to solid food in an infant and/or in a young child, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more glycan substrates is selected from the groups recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4.  Use of a combination of a <i>Bifidobacterium longum</i> transitional microorganism and one or more glycan substrates to increase short-chain fatty acids (SCFA) production by the gut microbiome of an infant and/or in a young child, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more glycan substrates is selected from the groups recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5.  Use of a combination of a <i>Bifidobacterium longum</i> transitional microorganism and one or more glycan substrates to modulate the gut microbiome, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the one or more glycan substrates is selected from the groups recited in any of Tables 1 to 3.</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-con>6.  Use of a glycan substr",C12N1/20,20250702,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2020271253B2,Automatic system for dispensing roasted coffee beans and related method,"The invention relates to a system (100) for dispensing a certain quantity of coffee beans into a beverage preparation machine to prepare a coffee beverage, the system comprising a tight variable volume container (20) with a volume receptacle (22) where the coffee beans are stored, the volume receptacle (22) being configured to modify its internal volume in order to adapt it to the quantity of coffee beans stored in it; the system (100) further comprising an active dosing device (30) configured to convey coffee beans with respect to the volume receptacle (22), the dosing device (30) being tight to the outside environment also while conveying coffee beans. The invention further relates to a method for actuating a system (100) for dispensing a certain quantity of coffee beans into a beverage preparation machine to prepare a coffee beverage.","<div class=""indep-clm"" num=""1""><seg-main>5       1. System for dispensing a certain quantity of coffee beans into a beverage</seg-main>
<seg-main class=""seg-enter"">preparation machine to prepare a coffee beverage, the system comprising </seg-main><seg-clauses>a tight variable volume container with a volume receptacle where the coffee beans are stored, the volume receptacle being configured to modify its internal volume in order to adapt it to the quantity of 10           coffee beans stored in it;</seg-clauses>
<seg-clauses class=""seg-enter"">the system further comprising an active dosing device configured to convey coffee beans with respect to the volume receptacle, the dosing device being tight to the outside environment also while conveying coffee beans;</seg-clauses>
<seg-clauses class=""seg-enter"">the dosing device in contact with the coffee beans being made of a compressible 15          material having a hardness that is lower than the hardness of the coffee beans.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. System according to claim 1, wherein </seg-main><seg-clauses>the dosing device is configured to act as a pump or as a reverse pump in order to convey coffee beans out of the volume receptacle or inside of the volume receptacle, respectively.</seg-clauses>
<seg-clauses class=""seg-enter"">20</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. System according to any one of the previous claims, wherein </seg-main><seg-clauses>the variable volume container comprises a piston element displacing by gravity inside the volume receptacle to adapt the internal volume of this receptacle to the quantity of coffee beans stored in it.</seg-clauses>
<seg-clauses class=""seg-enter"">25</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. System according to claim 3, wherein </seg-main><seg-clauses>the piston element further comprises a pressure valve with a threshold pressure equivalent to the weight of th",A47J31/44,20250522,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025067701A1,Mixture of HMOS and bifidobacterium longum transitional microorganism,"Mixture of HMOs and Bifidobacterium longum transitional microorganism The present invention relates to a composition comprising a Bifidobacterium longum transitional microorganism and a mixture of human milk oligosaccharides (HMOs) consisting of 2'-fucosyllactose (2'-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3-FL) and/or lacto-N- neotetraose (LNnT). The invention also relates to the use of the composition for preventing, reducing the risk of and/or treating an infection in a subject. The invention also provides the composition for use in promoting a long-term immune benefit in a subject, preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A composition comprising </seg-main><seg-clauses>a Bifidobacterium longum transitional microorganism and a HMO mixture consisting of 2'-fucosyllactose (2’-FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3-FL) and/or lacto-N-neotetraose (LNnT).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1 , wherein </seg-main><seg-clauses><seg-main>the Bifidobacterium longum transitional microorganism:</seg-main>
<seg-clauses>(i) is capable of metabolizing the HMO(s);</seg-clauses>
<seg-clauses>(ii) preferentially utilizes 3-FL over 2’-FL;</seg-clauses>
<seg-clauses>(iii) is capable of metabolizing a glycan substrate selected from the group recited in any of Tables 1 to 3; and/or</seg-clauses>
<seg-clauses>(iv) encodes one or more CAZymes selected from the group recited in Table 1 , preferably wherein the Bifidobacterium longum transitional microorganism further encodes one or more CAZymes selected from Table 2 and 3.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition according to claim 1 or claim 2, wherein </seg-main><seg-clauses>the Bifidobacterium longum transitional microorganism has an Average Nucleotide Identity (ANI) of at least 98% with at least one Bifidobacterium longum strain selected from the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686, CNCM I-5687, CMCC-P0001 (ATCC BAA-2753), and any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the composition further comprises Bifidobacterium longum subsp. infantis.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any one of the preceding claims, wher","A61K35/745, A23L33/135, A23L33/00, A61K31/702, A61P11/06",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN119255734A,Beverage pouch system with pouch identification,"The invention relates to an extraction device for extracting a beverage ingredient from a capsule (3), said capsule (3) comprising a code (34), said device comprising:-upstream and downstream capsule enclosing parts (1, 2), the upstream and downstream capsule encapsulating parts are relatively movable between an open position and a closed position for inserting and removing the capsule (3); the invention relates to a device (1) comprising a path (41), a code reader (71),-a removable capsule stent (6),-a top insertion section (4) for introducing the capsule stent (6) into the device,-a capsule stent stop (42) for stopping the capsule stent (6) in an intermediate temporary position inside said path (41), and wherein in the intermediate temporary position, the capsule stent (6) is inserted into the path (41). The bag holder (6) is configured to hold the bag such that the code (34) arranged on the bag faces the code reader (71), and wherein during introduction of the bag holder into the device, when the bag holder reaches the intermediate temporary position, an operation of reading the code by the code reader is triggered by movement of the bag holder (6).","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于通过将提取液体供应到囊包中来提取饮料配料的提取装置，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述囊包(3)</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-囊包主体(31)，所述囊包主体包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>侧壁(311)和底部壁(313)，所述侧壁和所述底部壁限定腔室，所述腔室在底部和顶部开口(312)之间轴向地延伸，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部封盖(32)，所述顶部封盖封闭所述囊包主体的所述顶部开口，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-机器可读代码(34)，所述机器可读代码存储制备信息，所述代码布置在所述囊包上，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述装置包括上游囊包包封部件和下游囊包包封部件(1,2)，所述上游囊包包封部件和所述下游囊包包封部件能够沿水平纵向轴线(XX')在用于插入和移除所述囊包(3)的打开位置和用于在提取期间形成包封所述囊包的提取室(5)的闭合位置之间相对移动，优选地能够相对平移，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述装置包括代码读取器(71)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述装置包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-能够移除的囊包支架(6)，所述支架包括用于接收和保持所述囊包的囊包接收孔(61)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶部插入部段(4)，所述顶部插入部段被构造用于将所述囊包支架(6)引入所述装置中，所述顶部插入部段包括路径(41)，以用于将所述囊包支架引导到所述上游囊包包封部件和所述下游囊包包封部件(1,2)之间的提取区域，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-囊包支架止动器(42)，所述囊包支架止动器用于将所述囊包支架(6)停止在所述路径(41)内部的中间临时位置，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中，在所述中间临时位置，所述囊包支架(6)被构造为保持所述囊包，使得布置在所述囊包上的所述代码(34)面向所述代码读取器(71)，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中在将所述囊包支架引入所述装置中期间，当所述囊包支架到达所述中间临时位置时，通过所述囊包支架(6)的移动触发所述代码读取器读取所述代码的操作。</seg-refi></div>
<div class=""indep-clm"" num=""2"">2.根据前一权利要求所述的提取装置，其中所述囊包接收孔(61)和所述顶部插入部段(4)被构造为当所述囊包支架(6)在中间位置时，将所述代码(34)定向在所述代码读取器(71)的前方。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的提取装置，其中所述代码读取器(71)能够在以下两者之间移动：</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">-回缩位置，在所述回缩位置处，所述代码读取器定位在所述插入部段的所述路径(41)之外，和</div>
<div class=""dep-clm"" num=""3"" ",A47J31/44,20250103,雀巢产品有限公司,['Pending']
US20250049084A1,Process for preparing a berry composition,,"<div class=""indep-clm"" num=""1""><seg-main>1. A process for preparing a berry composition comprising </seg-main><seg-clauses><seg-main>the steps consisting of:</seg-main>
<seg-clauses>i) providing whole berries, wherein the whole berries comprise skin, seeds and/or pulp which are intact, and wherein the whole berries comprise inherent insoluble fibers,</seg-clauses>
<seg-clauses>ii) grinding the whole berries to prepare a berry suspension, and</seg-clauses>
<seg-clauses>iii) micronizing said whole berries in presence of a liquid medium to prepare a micronized berry suspension having D(90) particle size of less than 200 μm,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the process does not comprise any step of removal of the inherent insoluble fibers coming from the whole berries.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process according to claim 1, wherein </seg-main><seg-clauses>the whole berries are selected from the group consisting of whole wolfberries, whole blueberries, whole cranberries, whole white currants, whole red currants, whole blackcurrants, whole mulberries, whole blackberries, whole gooseberries, whole raspberries, whole sea buckthorns, whole strawberries, whole arbutus berries, whole grapes, and combinations thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The process according to claim 2, wherein </seg-main><seg-clauses>the whole berries consist only of whole wolfberries.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The process according to claim 1, wherein </seg-main><seg-clauses>the whole berries: liquid medium ratio during the micronization step is of 1:1 to 1:20.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The process according to claim 1, wherein </seg-main><seg-clauses>the whole berries are micronized by performing 1 to 5 passes into a micronization device.</seg-clauses></div>
<div class=""dep-clm"" ","A23L19/00, A23L33/19",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20240408060A1,composition,"The present invention relates to an amino acid composition comprising threonine, serine, proline, leucine, and cysteine for use in improving liver function in a subject. The present invention also relates to an enteral nutritional composition comprising threonine, serine, proline, leucine, and cysteine and a method for producing the same.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for improving liver function in a subject by promoting gut healing comprising </seg-main><seg-clauses>administering an amino acid composition comprising threonine, serine, proline, leucine, and cysteine to the subject.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method for promoting gut healing in a subject, wherein </seg-main><seg-clauses>the subject is at risk of or has impaired liver function comprising administering an amino acid composition comprising threonine, serine, proline, leucine, and cysteine to the subject.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The a method according to claim 1, wherein </seg-main><seg-clauses>the subject is a critically ill patient and the subject has a condition selected from the group consisting of: sepsis, acute respiratory failure, trauma, surgery, pancreatitis, shock, severe burns, mucositis, inflammatory bowel disease, distorted gut barrier, intestinal mucosal lesions, and short-bowel syndrome.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. A method according to claim 2, wherein </seg-main><seg-clauses>the subject is a critically ill patient.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition resolves systemic inflammation and/or reduces liver injury in the subject.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition is administered by enteral administration.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. Method according to claim 1, wherein </seg-main><seg-clauses>the amino acid composition is in a form selected from the group consisting of a nutritional composition, supplement, and fortifier.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><","A61K31/401, A61K31/198, A61P1/16",20241212,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2024256142A1,Bulk dosing unit and related system,"The invention concerns a bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), wherein a sliding assembly (122) of the bulk dosing unit (100; 200) is provided for sliding a dosing element (121) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa, wherein in the closed position an opening portion (121'') of the dosing element (121) is able to be arranged spaced away from a container aperture (11) of a bulk product container and simultaneously a device engagement portion (123'') is able to arrange an aperture cover (12) of a bulk product container (10) to completely cover a container aperture (11) of a bulk product container (10) and in the maximum dispensing position the opening portion (121'') of the dosing element (121) is able to be superimposed to a container aperture (11) of a bulk product container (10) and simultaneously the device engagement portion (123') is able to arrange an aperture cover (12) of a bulk product container (10) to substantially completely uncover a container aperture (11) of a bulk product container (10), allowing the dosing of a bulk product to be dispensed according to the position of the dosing element (121) in between the closed position and the maximum dispensing position.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A bulk dosing unit (100; 200) of bulk products contained in a bulk product container (10), said bulk dosing unit (100; 200) comprising: </seg-main><seg-clauses>a containment housing (110) which defines a containment volume for receiving a bulk product container (10); a dispensing opening (112) defined on said containment housing (110) for dispensing a bulk product; a feeding assembly (130) arranged at least partly inside said containment housing (110) and able to move a bulk product in a bulk product container (10) toward said dispensing opening (112); a dosing device (120) able to be actuated for dispensing and dosing a bulk product; characterized in that said dosing device (120) comprises a dosing element (121) and a sliding assembly (122) for sliding said dosing element (121) at said dispensing opening (112) between a closed position, in which a bulk product is not dispensed, and a maximum dispensing position, in which a bulk product can be dispensed at the maximum flow rate, and vice versa, wherein said dosing device (120) comprises one or more device engagement portions (123’, 123”), arranged toward said containment volume and able to engage an aperture cover (12) of a bulk product container (10), wherein said dosing element (121) has at least an opening portion (121”), and wherein in said closed position said opening portion (121”) is able to be arranged spaced away from a container aperture (11) of a bulk product container (10) and simultaneously said device engagement portion (123”) is able to arrange an aperture cover (12) of a bulk product container (10) in a fully closed position, to completely cover a container aperture (11) of a bulk product container (10), and in said maximum dispensing position said opening portion (121”) is able to be superimposed to a container aperture (11) of a bulk product container (10) and simultaneously said device engagement portion (123’) is able to arrange an aperture cover","G07F11/44, G07F13/02, B65D47/00, B65D83/00, G07F11/00",20241219,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025073739A1,"Package product, package set comprising at least two package products, method for manufacturing such package products","The package product (1) comprises a container (2) and a packaging (10) The container (2) comprises: - a container body (2.0) defining a cavity (6), - a food component (4) in the cavity (6), - a membrane (9) closing the cavity (6). The packaging (10) comprises: - a protection sheet (12) covering the container body (2.0), and - a closure sheet (14) covering the membrane (9) and part of the protection sheet (12) to enclose the container (2) between the protection sheet (12) and the closure sheet (14). The closure sheet (14) and the protection sheet (12) are attached along a sheet attaching section (20) extending around the membrane (9). A line of weakness (22) extends around the membrane (9) to allow separation of a lid (24) from the closure sheet (14) under a manual force (F) for the container (2) to be released.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. Package product (1) comprising </seg-main><seg-clauses><seg-main>a container (2) and a packaging (10): wherein the container (2) comprises: </seg-main><seg-clauses>- a container body (2.0) defining a cavity (6) and an opening (8) of the cavity (6), a dose of food component (4) contained within the cavity (6), the dose of food component (4) being suitable for interacting with a fluid introduced into the cavity (6) so as to prepare a food product, and a membrane (9) attached to the container body (2.0) so as to close the cavity (6), wherein the packaging (10) comprises: a protection sheet (12) arranged to cover an outer side (2.2) of the container body (2.0), and a closure sheet (14) arranged to cover the membrane (9) and at least part of the protection sheet (12), such that the container (2) is enclosed between the protection sheet (12) and the closure sheet (14), wherein the closure sheet (14) and the protection sheet (12) are attached to each other along a sheet attaching section (20), the sheet attaching section (20) extending around the membrane (9), and wherein the closure sheet (14) has a line of weakness (22) extending near or around part or all of the membrane (9), the line of weakness (22) being configured such that it allows at least partial separation of a lid portion (24) from the rest of the closure sheet (14) under a manual force (F) exerted on the protection sheet (12) to press the container (2) against the closure sheet (14) such that the line of weakness (22) tears partly or totally open and defines a release opening (26) in the closure sheet (14) for the container (2) to be released from the protection sheet (12).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Package product (1) according to claim 1, wherein </seg-main><seg-clauses>the line of weakness (22) extends around part or all of the sheet attaching section (20), preferably along part or all of the she",B65D85/804,20250410,SOCIETE DES PRODUITS NESTLE S.A.,['PCT designated period']
EP4491070A1,"Machine, cutting unit for such a machine and method for preparing a beverage with such a machine","The preparation machine (1) comprises: - a preparation unit (2) having i) a preparation chamber (6) for receiving the capsule (100) and ii) a fluid injection unit (8) for injecting the fluid in the capsule (100) to prepare the beverage, and - a cutting unit (4) having a cutting element (7), the cutting element (7) being configured to cut the capsule (100) open such that at least part of the beverage component is released from the cavity (102) after the capsule (100) has been processed in the preparation unit (2).","<div class=""indep-clm"" num=""1""><seg-main>1.  Preparation machine (1) for preparing a beverage by injecting a fluid in a capsule (100), the capsule (100) having </seg-main><seg-clauses>i) a capsule body (101) defining a cavity (102) and </seg-clauses><seg-clauses><seg-main>ii) a beverage component (103) contained within the cavity (102), wherein the preparation machine (1) comprises: </seg-main><seg-clauses><seg-main>- a preparation unit (2) having </seg-main><seg-clauses>i) a preparation chamber (6) for receiving the capsule (100) and </seg-clauses><seg-clauses>ii) a fluid injection unit (8) for injecting the fluid in the capsule (100) to prepare the beverage, and </seg-clauses></seg-clauses><seg-clauses>- a cutting unit (4) having a cutting element (7), the cutting element (7) being configured to cut the capsule (100) open such that at least part of the beverage component (103) is released from the cavity (102) after the capsule (100) has been processed in the preparation unit (2).</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  Preparation machine (1) according to claim 1, wherein </seg-main><seg-clauses>the cutting element (7) comprises a blade.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  Preparation machine (1) according to any one of the preceding claims, further comprising </seg-main><seg-clauses>a driving unit (10) configured to move the cutting element (7) to cut open the capsule (100), the driving unit (10) including a motor or a manual actuator.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  Preparation machine (1) according to any one of the preceding claims, wherein </seg-main><seg-clauses>the cutting element (7) is movable in translation.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  Preparation machine (1) according to any one of any one of the preceding claims, wherein </seg-main><seg-clauses>the cutting element (7) ","A47J31/36, A47J31/44, A47J31/60",20250115,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023343744A1,Beverage extraction system,"The invention concerns a system comprising an extraction device of a beverage preparation machine and a pod, wherein - the pod comprises a pod body and a top lid, and - the extraction device comprises : - upstream and downstream pod enclosing parts relatively translatable between an open position for inserting and/or ejecting the pod and a closed position for forming an extraction chamber enclosing the pod during extraction, the downstream part comprising a downstream plane piercing arrangement for opening the lid of the pod, and wherein the body and the lid of the pod are made of a multilayer paper material comprising a layer of paper coated with at least a layer of plastic, and the external surface of the multilayer paper material of the top lid is covered by a layer presenting a surface tension inferior to 40 dyne/cm.","<div class=""indep-clm"" num=""1""><seg-main>1. System comprising </seg-main><seg-clauses><seg-main>a beverage preparation machine and a pod containing a beverage ingredient,</seg-main>
<seg-main class=""seg-enter"">wherein the pod (3) comprises a first and a second enclosing walls (31, 3T, 32), said first and second pod enclosing walls defining a chamber for enclosing the beverage ingredient (33), and</seg-main>
<seg-main class=""seg-enter"">wherein said first and second pod enclosing walls of the pod are made of a multilayer paper material, said material comprising a layer of paper </seg-main><seg-clauses><seg-main>(A) assembled with at least a layer of plastic (B), preferably a compostable plastic layer, and</seg-main>
<seg-main class=""seg-enter"">wherein said multilayer paper material is oriented so that said layer of plastic faces the internal part of the chamber of the pod, and</seg-main>
<seg-main class=""seg-enter"">wherein the beverage preparation machine comprises an extraction device, and said extraction device comprises :</seg-main>
<seg-clauses>- upstream and downstream pod enclosing parts (1, 2) relatively translatable along a longitudinal axis (XX1) between an open position for inserting and/or ejecting the pod (3) and a closed position for forming an extraction chamber (5) enclosing the pod during extraction, </seg-clauses><seg-clauses>- the upstream part (2) bearing an upstream piercing arrangement (22) for opening the first enclosing wall (31) of the pod and a liquid injector (25),</seg-clauses>
<seg-clauses>- the downstream part (1) comprising a downstream piercing arrangement (12) for opening the second enclosing wall (32) of the pod, and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein in at least the second pod enclosing wall (32), the external surface of the multilayer paper material is covered by a protective layer (C), and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the external surface of said protective layer presents a surface tension i",B65D85/804,20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025067707A1,Methods and systems for facilitating the creation of food and/or beverage product concepts,"A computer-implemented method for facilitating the creation of food and/or beverage product concepts, comprising: providing a plurality of content items obtained from one or more sources, each content item comprising structured or unstructured text, at least one of the content items comprising text that pertains, at least in part, to one or more food and/or beverage products, assigning, to each content item, one or more taxonomic labels, wherein each label comprises a term contained in a pre-defined taxonomy of terms and each label assigned to a respective content item is selected based on the particular language used in the respective content item, receiving, from a user, a query specifying a first term; in the event that the first term comprises a taxonomic label from the pre-defined taxonomy of terms; identifying one or more pairs of terms, each pair of terms comprising the first term and a respective other one of the taxonomic labels; determining, for each pair of terms, an association score, wherein the association score is based at least in part on the number of content items that have been assigned both of the taxonomic labels in the pair; and outputting, in a user-interface, a response to the query, wherein the response provides an indication of the association score(s) for each pair of terms.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1. A computer-implemented method for facilitating the creation of food and/or beverage product concepts, the method </seg-con><seg-trans>comprising: </seg-trans><seg-refi>providing a plurality of content items obtained from one or more sources, each content item comprising structured or unstructured text, at least one of the content items comprising text that pertains, at least in part, to one or more food and/or beverage products; assigning, to each content item, one or more taxonomic labels, wherein each label comprises a term contained in a pre-defined taxonomy of terms and each label assigned to a respective content item is selected based on the particular language used in the respective content item; receiving, from a user, a query specifying a first term; in the event that the first term comprises a taxonomic label from the pre-defined taxonomy of terms; identifying one or more pairs of terms, each pair of terms comprising the first term and a respective other one of the taxonomic labels; determining, for each pair of terms, an association score, wherein the association score is based at least in part on the number of content items that have been assigned both of the taxonomic labels in the pair; and outputting, in a user-interface, a response to the query, wherein the response provides an indication of the association score(s) for each pair of terms.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A computer-implemented method according to claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>in the event that the first term in the query does not comprise one of the taxonomic labels in the pre-defined taxonomy, the method comprises: identifying one or more of the content items to which the first term is relevant, based on the particular language used in the respective content item; identifying one or more pairs of terms, each pair of terms comprising the first term and a respective one","G06F16/33, G06F16/35",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250009773A1,Compositions and methods using a combination of oleuropein and vitamin b6,"Composition comprising a combination of oleuropein or metabolite thereof and Vitamin B6 thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, an RTD, an RTD concentrate, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency/depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency/depletion disorder in an individual comprising administering a composition comprising a combination of oleuropein and/or a metabolite thereof and Vitamin B6, in a therapeutically effective amount to the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method according to claim 1, wherein </seg-main><seg-clauses>the effective amount of a combination of oleuropein and/or a metabolite thereof and Vitamin B6 is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method according to claim 1, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, glucuronidated forms thereof, sulfated forms thereof, derivatives thereof, and mixtures th","A61K31/7048, A61K31/05, A61K31/085, A61K31/351, A61K31/4415",20250109,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2839603C1,Apparatus for roasting coffee beans,"FIELD: food industry.SUBSTANCE: group of inventions relates to coffee industry. Disclosed is an apparatus for roasting coffee beans, comprising: a chamber for placing coffee beans, heating device for heating coffee beans placed in the chamber, a control system configured to control the heating device and made with possibility of application of roasting recipe R, providing temperatures applied at separate successive moments of time t1, t2, …, tfinal respectively, while for an individual mixture of coffee beans CA, CB, …, placed inside the chamber, the control system is configured to determine the roasting recipe Rym for roasting said mixture in the roasting apparatus by: obtaining for each type of coffee beans Cn, included in said mixture of at least: type Cn specified type of coffee beans, and quantity mn specified type of coffee beans Cn, placed in the chamber, and based on the obtained type Cn obtaining access to at least roasting recipes RMA, RMB, … different types of coffee beans CA, CB, ... respectively, wherein each recipe RMn is adapted to roasting one predetermined amount Mn of grains of the same type Cn and provides temperatures used at discrete successive moments of time ti, respectively, and temperature adaptation coefficients KA, KB, … said different types of coffee beans CA, CB, …, respectively, an individual mixture, and based on the obtained amounts of mn different coffee beans Cn and available recipes for roasting RMn and temperature coefficients Kn, determining the roasting recipe Rblend, which must be used for said individual mixture of coffee beans placed inside the chamber. Described also is a computer-readable data medium containing instructions which, when executed by a computer, a processor or a control unit, lead to the operation of the control system of the described apparatus.EFFECT: group of inventions makes it possible to improve the process of automatic roasting of coffee beans.12 cl, 9 dwg","1. Аппарат для обжаривания кофейных зерен, содержащий:
- камеру для размещения кофейных зерен,
- нагревательное устройство для нагрева кофейных зерен, помещенных в камеру,
- систему управления, выполненную с возможностью управления нагревательным устройством и выполненную с возможностью применения рецептуры обжаривания R, обеспечивающей температуры, применяемые в отдельные последовательные моменты времени t<sub>1</sub>, t<sub>2</sub>, …, t<sub>final</sub>соответственно,
при этом для индивидуальной смеси кофейных зерен C<sub>A</sub>, C<sub>B</sub>, …, помещенных внутрь камеры, система управления выполнена с возможностью определения рецептуры обжаривания Rym для обжаривания указанной смеси в аппарате для обжаривания путем:
- получения для каждого типа кофейных зерен C<sub>n</sub>, входящих в указанную смесь, по меньшей мере:
типа C<sub>n</sub>указанного типа кофейных зерен, и
количества m<sub>n</sub>указанного типа кофейных зерен C<sub>n</sub>, помещаемых в камеру,
и
- на основе полученного типа C<sub>n</sub>получения доступа по меньшей мере к:
рецептурам обжаривания RM<sub>A</sub>, RM<sub>B</sub>, … различных типов кофейных зерен C<sub>A</sub>, C<sub>B</sub>, … соответственно, причем каждая рецептура RM<sub>n</sub>адаптирована к обжариванию одного заранее заданного количества M<sub>n</sub>зерен одного и того же типа C<sub>n</sub>и обеспечивает температуры, применяемые в дискретные последовательные моменты времени t<sub>i</sub>соответственно,
и
температурным коэффициентам адаптации K<sub>A</sub>, K<sub>B</sub>, … указанных различных типов кофейных зерен C<sub>A</sub>, C<sub>B</sub>, …, соответственно, индивидуальной смеси,
и
- на основе полученных количеств m<sub>n</sub>разных кофейных зерен Cn и доступных рецептур обжаривания RMn и температурных коэффициентов Kn, определения рецептуры обжаривания R<sub>blend</sub>, которую необходимо применить для указанной индивидуальной смеси кофейных зерен, помещенных внутрь камеры.
2. Аппарат по п. 1, в котором рецептура обжарива",A23N12/08,20250506,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250099515A1,Lactobacillus acidophilus to increase agmatine production by microbiota,"Disclosed are probiotics, compositions and methods for producing agmatine using microbiota; and more particularly, isolated probiotics, compositions comprising the isolated probiotics, and methods for increasing production of agmatine and/or polyamines in the gastrointestinal tact of a subject, which provides to the subject certain health benefits, such as pain relief, antiaging effects, neuroprotective and antidepressant effects, improved vasodilatation and metabolic health, improved cellular health, decreased age-related memory loss, and/or longevity. The isolated probiotic is capable of colonizing and surviving in the gastrointestinal tract of the subject and capable of converting arginine to agmatine in the gastrointestinal tract of the subject.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for improving pain relief, antiaging effects, neuroprotective and antidepressant effects, improved vasodilatation and metabolic health, improved cellular health, and longevity, and/or reducing age-related memory loss of a subject in need thereof, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the subject an effective amount of a composition comprising an isolated probiotic and arginine to increase production of agmatine in a gastrointestinal tract of the subject.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a <i>Lactobacillus acidophilus </i>strain.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a bacterial strain having at least 90%, preferably at least 95% sequence identity to a strain selected from the group consisting of <i>Lactobacillus acidophilus </i>NCC 2628 (CNCM I-2453), <i>Lactobacillus acidophilus </i>NCC 2766 (CNCM I-3848), <i>Lactobacillus acidophilus </i>NCC 2775 (CNCM I-3851), and <i>Lactobacillus acidophilus </i>NCC 2619 (ATCC 700396).</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition further comprises an ingredient selected from the group consisting of a starch source, a protein source, a prebiotic source, lipid source, vitamins, sugars, salt, spices, seasonings, minerals, flavoring agents, and combinations thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the isolated probiotic comprises a <i>Lactobacillus acidophilus </i>strain selected from the group consisting of <i>Lactobacillus acidophilus </i>N","A61K35/747, A61K31/198",20250327,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119894414A,Beverage dispenser,"The invention relates to a beverage dispenser comprising: a coffee machine for producing hot coffee and hot coffee mixed with milk, said coffee machine comprising a milk tank capable of replenishing cold milk; -a refrigerator comprising a refrigerating chamber and a freezing chamber; -a coffee cooler for cooling hot coffee produced by the coffee machine, said coffee cooler comprising a container to contain coffee dispensed from the coffee machine, and a wall of said container comprising a circulation path for a cooling fluid, wherein a freezing compartment of the refrigerator comprises a cooling fluid container for storing the cooling fluid, and wherein the beverage dispenser comprises an external cooling fluid circuit configured to circulate the cooling fluid between the cooling fluid container and a circulation path of the coffee cooler.","<div class=""indep-clm"" num=""1""><seg-con>1.饮料分配器(100)，所述饮料分配器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-咖啡机(1)，用于生产热咖啡和与牛奶混合的热咖啡，所述咖啡机包括牛奶罐(12)，所述牛奶罐能够补充牛奶，优选地冷牛奶，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-冰箱(2)，所述冰箱包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.冷藏室(21)，用于在高于0℃，通常介于5℃和10℃之间的温度下储存和冷藏牛奶容器，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>.冷冻室(22)，所述冷冻室能够保持低于0℃，优选地低于</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-15℃的温度，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-咖啡冷却器(3)，用于冷却由所述咖啡机产生的热咖啡，所述咖啡冷却器包括用于容纳从所述咖啡机分配的咖啡的容器(31)，并且所述容器的壁(311)包括用于冷却流体的循环路径(32)，其中所述冰箱的所述冷冻室(22)包括用于储存和冷却所述冷却流体的冷却流体容器(4)，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述饮料分配器包括外部冷却流体回路(41)，所述外部冷却流体回路被配置成使所述冷却流体在所述冷却流体容器和所述咖啡冷却器的所述循环路径之间循环。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的饮料分配器，其中所述用于存储和冷却所述冷却流体的容器(4)包括用于所述冷却流体的冰箱外部入口(43)和冰箱外部出口(42)，并且所述冷却流体回路包括泵(44)，用于使所述冷却流体从所述出口循环到所述咖啡冷却器的所述循环路径(32)并且返回到所述容器的入口。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的饮料分配器，其中冷却液为丙二醇。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的饮料分配器，其中所述用于储存和冷却所述冷却流体的容器(4)包括搅拌器(45a,45b)。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据前述权利要求中任一项所述的饮料分配器，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>-所述冰箱包括至少一个冷量生成单元(23)，所述冷量生成单元包括具有在其中循环的制冷剂的制冷回路(231)，并且包括用于处理所述制冷剂的压缩机(232)、冷凝器(233)、膨胀装置(234)，并且</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>-所述饮料分配器包括内部冷却流体回路(7)，所述内部冷却流体回路被配置成使所述冷却流体在所述冷却流体容器(4)与热交换器(8)之间循环，所述热交换器在所述冷却流体与所述冰箱的所述冷量生成单元(23)的制冷剂之间交换热量。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求所述的饮料分配器，其中所述用于储存和冷却所述冷却流体的容器(4)包括用于所述冷却流体的冰箱内部入口(72)和冰箱内部出口(73)，并且所述内部冷却流体回路包括泵(73)，用于使所述冷却流体从所述冰箱出口循环到所述冷冻机的所述热交换器(8)并且返回到所述容器的所述冰箱内部入口(72)。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求","A47J31/46, A47J31/50, A47J31/44",20250425,雀巢产品有限公司,['Pending']
US20250049091A1,Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI),"A method of treating exocrine pancreatic insufficiency includes administering to an individual in need thereof (e.g., an individual with cystic fibrosis) an effective amount of an enteral composition having a total protein consisting essentially of hydrolyzed protein and a total fat containing monoacylglycerols (MAG) that are at least about 30 wt. % of the total fat, and the total fat optionally further contains medium chain triglycerides (MCT) and/or fatty acids. In one particular non-limiting embodiment, about 60 wt. % of the total fat is from MCT and about 40 wt. % of the total fat is from MAG; in another particular non-limiting embodiment, the total fat is MAG with free fatty acids (esterified and/or bound) without MCT; and in yet another particular non-limiting embodiment, the total fat is MAG alone without MCT.","<div class=""indep-clm"" num=""1""><seg-main>1: A method of treating exocrine pancreatic insufficiency (EPI), the method comprising </seg-main><seg-clauses><seg-main>administering to an individual in need thereof an effective amount of a nutritional composition having </seg-main><seg-clauses>(1) a total protein consisting essentially of hydrolyzed protein; and </seg-clauses><seg-clauses>(2) a total fat comprising monoacylglycerols (MAG) that are at least about 20 wt % of the total fat, the total fat optionally further comprising medium chain triglycerides (MCT) and/or fatty acids.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2: The method of claim 1, the method comprising </seg-main><seg-clauses><seg-main>administering to the individual the nutritional composition having at least one characteristic selected from the group consisting of:</seg-main>
<seg-clauses>(i) an energy density of 1.0-2.5 kcal/ml;</seg-clauses>
<seg-clauses>(ii) the total fat that is about 10 to about 90 energy % of the nutritional composition;</seg-clauses>
<seg-clauses>(iii) an amount of medium chain triglycerides (MCT) that is about 1.0 wt % to about 10.0 wt % of the nutritional composition;</seg-clauses>
<seg-clauses>(iv) the MAG that are about 0.1 wt % to about 10.0 wt % of the nutritional composition;</seg-clauses>
<seg-clauses>(v) the total protein that is about 5 to about 50 energy % of the nutritional composition;</seg-clauses>
<seg-clauses>(vi) a total carbohydrates that is about 5 to about 85 energy % of the nutritional composition; and</seg-clauses>
<seg-clauses>(vii) the total carbohydrates that consist essentially of one or more of maltodextrin, maltose, maltotriose, sucrose, fructose, lactose, galactose, and high-maltose corn syrup, and optionally comprise slowly digested carbohydrates.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3: The method of claim 2, the method comprising </seg-main><seg-clauses>admini","A23L33/00, A23L33/12, A23L33/125, A23L33/17",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250325511A1,Dietary butyrate,,,"A61K31/22, A23L33/00, A23L33/12, A61P3/02",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CA3035396C,"Process for producing a bio-based polyethylene terephthalate (PET) polymer, entirely from bio-based materials","The invention relates to a process for producing a bio-based polyethylene terephthalate (PET) polymer, from at least one terephthalate compound obtained from at least one bio- based material, and at least one monoethylene glycol compound obtained from at least one bio-based material, Said process comprising the polymerization of the terephthalate compound and of the monoethylene glycol compound in the presence of at least one crystallization retarding compound, Said process being characterized in that the crystallization retarding compound is obtained from at least one bio-based material. The invention also relates to a bio-based PET polymer obtained by said process. Preferably, the process further comprises processing the bio-based PET polymer into a bio-based product such as a bio-based container or a bio-based packaging. The invention also relates to said bio-based product.","﻿ 14 Claims <div class=""indep-clm"" num=""1""><seg-con>1. A process for producing a bio-based polyethylene terephthalate (PET) polymer from terephthalic acid obtained from at least one bio-based material, and ethylene glycol obtained from at least one bio-based material, said process </seg-con><seg-trans>comprising </seg-trans><seg-refi>polymerization through esterification of the terephthalic acid and of the ethylene glycol in the presence of at least one crystallization retarding compound at a temperature of 150-280oC, wherein the crystallization retarding compound is obtained from at least one bio¬ based material and is selected from the group consisting of isosorbide, isosorbide combined with one or more of 1,3-propanediol, 1,4-butanediol, 2,3-butanediol, 1,3- pentanediol, 1,4-pentanediol, 1,5-pentanediol, 2-methyl-l,4-butanediol (2-MBDO), diethylene glycol, triethylene glycol, propylene glycol, catechol, 2,5-dihydroxymethyl tetrahydrofuran, 2,5-bis(hydroxymethyl) furan, fumaric acid, glutaric acid, muconic acid, itaconic acid, succinic acid, adipic acid, malic acid, 2,5-furan dicarboxylic acid and p,p'- biphenyl dicarboxylic acid. </seg-refi></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A process according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the crystallization retarding compound is in an amount from 0.05 to 7% mol, preferably from 0.1to 4% mol, with respect to the bio¬ based PET polymer. </seg-refi></div><div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. A process according to claim 1or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the bio-based material leading to the bio-based crystallization retarding compound is selected from the group consisting of sugars, starches, corns, natural fibers, sugarcanes, beets, citrus fruits, woody plants, cellulosic-containing compounds, lignocellulosic-containing compounds, hemicellulosic- containing compounds, oily wood feedstock, polysaccharides such as pectin, chitin, levan,","C08G63/183, C08G63/78",20250819,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025056441A1,Method of making fermented plant-based products having umami taste and products thereof,"The invention relates to a method of making a fermented plant-based product having umami taste. The method comprises a step of providing a plant protein substrate and a step of fermenting the plant protein substrate with a starter culture comprising Lactobacillus johnsonii. It also relates to such a fermented plant-based product and to Lactobacillus johnsonii strains suitable for the invention. It also relates to peptides that impart and/or enhance umami taste, method for preparing such peptides, composition comprising such peptides and use of such peptides as flavouring agent.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a fermented plant-based product, said method comprising </seg-main><seg-clauses>providing a plant protein substrate, and fermenting the plant protein substrate with a starter culture comprising Lactobacillus johnsonii.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1, wherein </seg-main><seg-clauses>the plant protein of the plant protein substrate is pulse protein, preferably pea protein.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to claim 1 or 2, wherein </seg-main><seg-clauses>the plant protein substrate is a plant protein suspension.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the Lactobacillus johnsonii expresses the proteinase PrtP and/or the proteinase PrtM and/or the oligopeptide permease OppA.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the Lactobacillus johnsonii is selected from the list consisting of Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-5910, Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-1225, Lactobacillus johnsonii deposited at the CNCM under reference number CNCM 1-2474 or a combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fermentation step of the plant protein substrate with the starter culture lasts at least 16 hours, preferably at least 18 hours.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-main>7. The method according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fe","A23L11/30, A23L11/50, A23L11/60, A23L27/00, C12N1/20",20250320,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025003523A1,Hard-boiled egg analogue product,"The present invention relates to a method of making a plant-based cooked egg analogue product, for example a hard-boiled egg analogue product, said method comprising providing a plant protein suspension; optionally adding oil to the suspension and mixing to form an emulsion; ensuring the pH of the suspension or emulsion is between pH 5 to 10, preferably between 7 to 9; adding a firming agent and mixing; optionally performing a cold set gelation at between 0 to 30°C; and performing a freezing step.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A method of making a plant-based cooked egg analogue product, for example a hard- boiled egg analogue product, said method comprising: </seg-main><seg-clauses>a. Providing a plant protein suspension; </seg-clauses><seg-clauses>b. Optionally adding oil to the suspension and mixing to form an emulsion; </seg-clauses><seg-clauses>c. Ensuring the pH of the suspension or emulsion is between pH 5 to 10, preferably between 7 to 9; </seg-clauses><seg-clauses>d. Adding a firming agent and mixing; </seg-clauses><seg-clauses>f. Performing a freezing step, wherein the firming agent is a soluble mineral salt.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of making a product according to claim 1, said method after step d. comprising </seg-main><seg-clauses><seg-main>the step of: </seg-main><seg-clauses>e. performing a cold set gelation at between 0 to 30°C.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method of making a product according to any one of claims 1 and 2, wherein </seg-main><seg-clauses>the plant protein suspension in step a) is a legume protein suspension, preferably a pulse protein suspension, for example a soy protein suspension and wherein the plant protein suspension in step a) has a protein concentration of between 3 to 30 wt%, preferably between 5 to 15 wt%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method of making a product according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>(i) the suspension is heated in step a) to at least 60°C, preferably to at least 90°C; or </seg-clauses><seg-clauses>(ii) the emulsion is heated in step b) to at least 60°C, preferably to at least 90°C.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method of making a product according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the cold set gel","A23D7/005, A23D7/05, A23J3/14, A23J3/16, A23L15/00",20250102,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025191113A1,Arabinose-containing and galactose-containing food composition and process of preparation,"An arabinose-containing and galactose-containing food composition is disclosed. Said food food composition is liquid or semi-liquid or powdered. It comprises plant proteins, less than 5wt.%free uronicacid by dry weight and a free arabinose to free galactose weight ration of from 1:1.5 to 1:5. A process for preparing such a food composition is also disclosed. A method for selecting an enzyme comprising a pectinase activity suitable for the invention is also disclosed.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An arabinose-containing </seg-main><seg-clauses><seg-main>and galactose-containing food composition, which is liquid or semi-liquid or powdered and which comprises:</seg-main>
<seg-clauses>- plant proteins selected from the list consisting of legume proteins, seed proteins and mixture thereof,</seg-clauses>
<seg-clauses>-less than 5wt.% free uronic acid by dry weight,</seg-clauses>
<seg-clauses>-a weight ratio of free arabinose to free galactose (free arabinose: free galactose) of from 1:1.5 to 1:5, preferably 1:3.5 to 1:4.5.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The arabinose-containing </seg-main><seg-clauses>and galactose-containing food composition according to claim 1, which comprises less than 30wt.% starch.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The arabinose-containing </seg-main><seg-clauses>and galactose-containing food composition according to claim 1 or 2, which comprises at least 0.25wt.% free arabinose by dry weight, preferably free endogenous arabinose by dry weight.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The arabinose-containing </seg-main><seg-clauses>and galactose-containing food composition according to any of the preceding claims, which comprises less than 30wt% non-starch polysaccharides by dry weight.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The arabinose-containing </seg-main><seg-clauses>and galactose-containing food composition according to any of the preceding claims, which comprises less than 20wt.% pectic polysaccharides by dry weight.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The arabinose-containing </seg-main><seg-clauses>and galactose-containing food composition according to any one of the preceding claims, wherein the legume proteins come from the legume selected from the list consisting","A23C11/10, A23J1/00, A23J1/14, A23J3/14, A23J3/16",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250143353A1,Low density edible animal chews and methods of making same,Edible chews for pets have a low density (e.g. about 1.0 Kg/L or less) and a smooth exterior surface. One method by which the low density and the smooth exterior surface can be achieved uses a modified extrusion die to increase shear and restrict surface bubbles. Another method by which the low density and the smooth exterior surface can be achieved uses an extruder screw with a modified profile that holds a dough longer therein to create a whipping effect resulting in more bubble nucleation sites and hence a more uniform cellular matrix. The puffed (expanded) product was experimentally tested and provided better dental cleaning scores than a current unexpanded similarly formulated commercial dental product.,"<div class=""indep-clm"" num=""1""><seg-con>1: A method of making an edible pet chew, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>preparing a dry mix comprising a pre-gelatinized cereal flour and further comprising sodium bicarbonate that is 0.2 to 1.5 wt. % of the dry mix;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>metering the dry mix into an extruder comprising an extrusion die, the extruder further comprises a barrel comprising a vent and a vent-stuffer;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>adding a polyhydric solvent to the dry mix to form a dough;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>using the vent to provide ambient pressure in the extruder;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>aerating the dough in the barrel comprising the vent and the vent-stuffer;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>using a reverse element of the extruder to extend a time spent by the dough in the barrel comprising the vent and the vent-stuffer;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>using mixing elements in the barrel comprising the vent and the vent-stuffer to whip the dough and promote nucleation;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>promoting further nucleation of the dough by subjecting the dough to a combination of shear and temperature of at least 120° C. in the extruder, wherein the combination of shear and temperature is applied to the dough in a section of the extruder adjacent to the extrusion die, wherein the temperature in the section adjacent to the extrusion die is higher than a temperature of at least one previous section of the extruder; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>directing the nucleated dough through an opening of the extrusion die comprising grooves, each of the grooves has an open end and a bottom surface opposite to the open end, and the widt","A23K40/20, A01K15/02, A23K10/30, A23K20/22, A23K40/25",20250508,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250345348A1,AMPK activator (CBDA) and SGLT2 inhibitor for metabolic health,A composition includes a first compound having general formula I and a second compound for use in the synergistic activation of AMPK. A method of using the composition in the synergistic activation of AMPK is also provided.,"<div class=""indep-clm"" num=""1""><seg-main>1. A method for activation of AMPK comprising </seg-main><seg-clauses>administering the composition to an individual in need of same, the composition comprising:</seg-clauses>
<seg-clauses class=""seg-enter"">a first compound; and</seg-clauses>
<seg-clauses class=""seg-enter"">a second compound;</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the first compound has the general formula I,</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/03/45/34/8/1763021759957/US20250345348A1-C00045.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064306%3B1765067906%26q-key-time%3D1765064306%3B1765067906%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D502d6418eb4216ad8c7138e70c4b22e397be1675&response-expires=Sun%2C%2007%20Dec%202025%2000%3A38%3A26%20GMT"" class=""img-anchor"" img-id=""US20250345348A1-C00045"" image_type=""chemistry"" official_size=""2622""></seg-clauses>
<seg-clauses class=""seg-enter"">wherein R1 and R3 are each independently selected from the group consisting of OH; OCH<sub>3</sub>; O-aliphatic saturated or unsaturated acyl, O-glycoside; acylated O-glycoside; sulfated O-glycoside; and a sulfate;</seg-clauses>
<seg-clauses class=""seg-enter"">R2 is selected from the group consisting of OH; OCH<sub>3</sub>; O-glycoside; C-glycoside;</seg-clauses>
<seg-clauses class=""seg-enter"">acylated O-glycoside; acylated C-glycoside; sulfated O-glycoside; sulfated C-glycoside; a halogen; a primary, secondary, or tertiary alcohol; a ketone; an aldehyde; an ester; a primary, secondary, or tertiary amine; a primary or secondary amide; a cyano; a nitro; a sulfonate; a sulfate; substituted and/or branched C<sub>1 </sub>to C<sub>20 </sub>alkyl; substituted and/or branched, C<sub>2 </sub>to C<sub>20 </sub>alkenyl; substituted and branched, C<sub>4 </sub>to C<sub>20 </sub>polyalkenyl; substituted and branched C<sub>2 </sub>","A61K31/00, A61K31/351, A61P3/08",20251113,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119998215A,Device and method for separating stacked objects,"A device for separating a stack (1) of objects, in particular cup-shaped capsules (1.1-1. N), in particular having a circumferential edge, comprises separating elements (2.1, 2.7) for engaging between adjacent objects (1.1, 1.2) of the stack (1) of objects. A plurality of separating elements (2.1-2.12) are arranged around the stack (1) in such a way as to engage into the stack (1), and the plurality of separating elements (2.1-2.12) are mounted so as to be radially displaceable. According to the invention, the plurality of separating elements (2.1-2.12) are individually elastically supported (3.1-3.12), and the device comprises means (5, 11.1, 11.2) for moving the plurality of separating elements (2.1-2.12) outwardly into a position in which the plurality of separating elements (2.1-2.12) are not engaged into the stack (1). The device allows for automatic separation of stacked objects which, although fragile, are at the same time firmly inserted into each other and still have irregularities in alignment within the stack.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于分离物体堆叠的装置，所述物体特别是杯状胶囊，特别是具有圆周边缘，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-trans>其中，</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>存在分离元件，用于接合到所述物体堆叠的相邻物体之间，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>多个所述分离元件以接合到所述堆叠中的方式围绕所述堆叠布置；并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述多个分离元件可径向移动地支承，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其特征在于，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述多个分离元件单独弹性地支承，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>所述装置包括用于将所述多个分离元件向外移动到不接合到所述堆叠中的位置的机构。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个分离元件弹性地支承，使得其径向向内压靠在所述堆叠上。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个分离元件包括至少三个，特别是至少四个，其中，相邻分离元件之间的最大角度距离小于180°。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4.根据权利要求1至3中任一项所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>存在导向器，待分离的物体的所述堆叠可以位于所述导向器内。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5.根据权利要求4所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个分离元件设置在所述导向器的一端。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据权利要求1至5中任一项所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>用于移动所述分离元件的机构包括套筒，通过所述套筒沿着堆叠轴线的移动，所述多个分离元件径向移动。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7.根据权利要求1至6中任一项所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个分离元件横向于堆叠轴线围绕所述堆叠圆形布置，并径向对准。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""><seg-con>8.根据权利要求1至7中任一项所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>待从所述堆叠中移除的物体可以借助于可沿着堆叠轴线移动的载体临时固定。</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""8""><seg-con>9.根据权利要求8所述的装置，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述载体包括用于在所述待移除的物体的壁和",B65G59/10,20250513,雀巢产品有限公司,['Pending']
AU2024245901A1,Composition for use,The present invention provides methods for identifying an infant or young child at risk of stunted growth and compositions for use in preventing and/or treating stunted growth in an infant or young child.,"<div class=""indep-clm"" num=""1""><seg-con>1. A method for identifying an infant or young child at risk of stunted growth, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said method comprises determining the abundance of Bifidobacterium pseudocatenulatum and/or Streptococcus thermophilus in one or more samples obtained from the infant.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>an infant or young child with reduced levels of B. pseudocatenulatum is identified as at risk of stunted growth.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The method according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>the stunted growth is stunted height or length; optionally wherein the stunted height or length is defined as a reduced length-for-age z-score (LAZ) or a reduced LAZ over time or a reduced height-for-age z-score (HAZ) or a reduced HAZ over time.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4. A composition for use in preventing and/or treating stunted growth in an infant or young child, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition promotes B. pseudocatenulatum and/or Streptococcus thermophilus in the gut microbiota of the infant or young child.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The composition for use according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition promotes B. pseudocatenulatum in the gut microbiota of the infant or young child; optionally wherein the composition comprises a B. pseudocatenulatum microorganism.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4""><seg-con>6. The composition for use according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the composition comprises a prebiotic.</seg-refi></div>
<div class=""indep-clm"" num=""7"">7. A combination of a B. pseudocatenulatum a","C12Q1/14, A61K35/741, A61K35/745, C12Q1/06",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119744242A,Carbonated beverage bottle with improved petal-shaped bottom,"A bottle for containing a carbonated beverage, the bottle comprising a body and a bottom having a substantially hemispherical bottom geometry (S1) extending from a lower end of the body. The bottom comprises a petaloid foot formation which is axisymmetric about the longitudinal axis (X) of the bottle and is formed by a plurality of feet protruding downward from the bottom geometry (S1), the recesses of which separate adjacent pairs of feet. The bottom line (81) of each recess substantially coincides with the underlying geometry (S1). The ratio of the maximum foot depth (F), which is the maximum vertical distance from the underlying geometry (S1) to the foot surface (S2), to the base radius, which is the radius of the maximum circle formed by the points in contact with the foot and the flat surface (9) when the bottle stands vertically on the flat surface, is 0.5 +/-0.01.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于容纳碳酸饮料的瓶子(1)，所述瓶子</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>主体(5)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>底部(6)，所述底部从所述主体(5)的下端延伸，所述底部具有基本上呈半球状的底层几何形状(S 1)，所述底部包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>从所述底层几何形状(S1)向下突出的多个支脚(7)；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>凹陷部(8)，所述凹陷部将相邻的支脚(7)对分隔开，每个凹陷部(8)的底部线条(81)基本上与所述底层几何形状(S1)一致：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述支脚和凹陷部一起形成围绕所述瓶子的纵向轴线(X)具有轴对称性的花瓣状支脚形成物；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>最大支脚深度(F)，所述最大支脚深度是从所述底层几何形状(S1)到支脚表面(S2)的最大垂直距离；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>底座半径(S)，所述底座半径是当所述瓶子垂直立在平坦表面上时由与所述支脚和平坦表面(9)接触的点(10)形成的最大圆的半径；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其特征在于，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述最大支脚深度与所述底座半径之比为0.5±0.01。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的瓶子，其中所述底部(6)的任意部分的最小曲率半径为6.5mm。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的瓶子，其中所述底部(6)的任意部分的所述最小曲率半径为7mm。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的瓶子，所述瓶子的所述最大支脚深度与所述底座半径之比为0.51；并且相邻支脚(7)对的相对凹陷部侧翼(11a，11b)对之间的角度为37度。</div>
<div class=""dep-clm"" num=""5"" parent=""3"">5.根据权利要求3所述的瓶子，所述瓶子的所述最大支脚深度与所述底座半径之比为0.49；并且相邻支脚(7)对的相对凹陷部侧翼(11a，11b)对之间的角度为44度。</div>
<div class=""dep-clm"" num=""6"" parent=""3"">6.根据权利要求3所述的瓶子，所述瓶子的所述最大支脚深度与所述底座半径之比为0.51；并且相邻支脚(7)对的相对凹陷部侧翼(11a，11b)对之间的角度为41度。</div>
<div class=""dep-clm"" num=""7"" parent=""3"">7.根据权利要求3所述的瓶子，所述瓶子的所述最大支脚深度与所述底座半径之比为0.50；并且相邻支脚(7)对的相对凹陷部侧翼(11a，11b)对之间的角度为44度。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的瓶子，其中所述多个支脚(7)为五个支脚。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的瓶子，其中所述瓶子为0.5升型瓶。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8"">10.根据权利要求1至8中任一项所述的瓶子，其中所述瓶子为1.5升型瓶。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3","B65D1/02, B29C49/00, B29C49/78, B29L31/00",20250401,雀巢产品有限公司,['Pending']
CN119173447A,"Squeezable bottle filled aseptically with viscous food product, packaged viscous product, preform and method of filling queezable bottle","A semi-rigid bottle (10) for packaging viscous food products wherein the bottle (10) is made of a material suitable for sterile treatment, distillation and/or hot filling, is stable in profile, can be squeezed and collapsed by radially inward flattening grip forces, does not restore its original shape after collapsing, and is blow-molded. The bottle (10) comprises a wall (50) having at least one oxygen and light blocking layer, and a neck portion (20) extending from the wall (50) and comprising a dispensing opening (40) at the top of the neck portion (20), a thread (21), and an orifice section (41) extending from the top of the dispensing opening (40) to the thread (21) without any thread, wherein the inner diameter of the dispensing opening (40) is in the range of 6 mm to 28 mm, and wherein the nozzle section (41) extends in the range of 6 mm to 10 mm along a vertical distance.",,"B65D1/02, B65D41/34",20241220,雀巢产品有限公司,['Pending']
CN119285469A,Mixed triglycerides,"The present invention relates to mixed triglycerides, in particular, the present invention provides a composition comprising a compound having the formula (1), (2), (3), (4) or a combination thereof wherein n1, n2, n3, n4, n5, and n6 are independently 4 to 10. # imgabs0 #","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含具有下式的化合物</div>
<div class=""indep-clm"" num=""1""><img src="""" class=""img-anchor"" img-id=""FDA0005078943400000011""></div>
<div class=""indep-clm"" num=""1"">或它们的组合，其中n1、n2、n3、n4、n5和n6独立地为4至10。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述组合物包含具有式(1)的化合物、具有式(2)的化合物、具有式(3)的化合物和具有式(4)的化合物。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的组合物，其中所述具有式(1)、(2)、(3)和(4)的化合物占所述组合物中总甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的组合物，所述组合物包含具有下式的化合物</div>
<div class=""dep-clm"" num=""4"" parent=""1""><img src="""" class=""img-anchor"" img-id=""FDA0005078943400000021""></div>
<div class=""dep-clm"" num=""4"" parent=""1"">或它们的组合。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的组合物，其中所述组合物包含具有式(5)的化合物、具有式(6)的化合物、具有式(7)的化合物和具有式(8)的化合物。</div>
<div class=""dep-clm"" num=""6"" parent=""4,5"">6.根据权利要求4或5所述的组合物，其中所述具有式(5)的化合物占所述组合物中所述总甘油三酯的20重量％至30重量％，所述具有式(6)的化合物占所述组合物中所述总甘油三酯的15重量％至25重量％，所述具有式(7)的化合物占所述组合物中所述总甘油三酯的10重量％至20重量％，并且所述具有式(8)的化合物占所述组合物中所述总甘油三酯的5重量％至15重量％。</div>
<div class=""dep-clm"" num=""7"" parent=""4,5,6"">7.根据权利要求4至6中任一项所述的组合物，其中所述具有式(5)、(6)、(7)和(8)的化合物占所述组合物中所述总甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％，并且/或者占所述组合物中总的含丁酸酯部分的甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％，并且/或者占所述组合物中总的含辛酸酯部分的甘油三酯的至少50重量％、60重量％、70重量％、80重量％、90重量％、95重量％或99重量％。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的组合物，其中甘油三丁酸酯占所述组合物中所述总甘油三酯的小于10重量％，优选地占所述组合物中所述总甘油三酯的小于8重量％，更优选地占所述组合物中所述总甘油三酯的小于5重量％。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的组合物，其中所述组合物为营养组合物，优选地其中所述组合物为膳食补充剂，任选地其中所述膳食补充剂为胶囊、片剂、小袋、粉末或液体喷丸的形式。</div>
<div class=""indep-clm"" num=""10"">10.根据权利要求1至9中任一项所述的组合物用于提供具有改善的感官特性的丁酸来源的用途。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9"">11.根据权利要求1至9中任一项所述的组合物，所述组合物用于提高血液酮水平并且/或者治疗可通过提高血液酮水平治疗的疾病，优选地其中所述疾病选自由以下项组成的列表：脑能量缺乏症、神经病症、偏头痛、记忆障碍、年龄相关的记忆障碍、脑损伤、中风、淀粉样蛋白侧索硬化症、多发性硬化症、认知损害、重症监护后认知损害、年龄诱导的认知损害、阿尔茨海默病、","C07C69/30, A23D9/00, A61K31/23, A61K31/22, A61P35/00",20250110,雀巢产品有限公司,['Pending']
WO2025008450A1,Functionalized compositions comprising an engineered phenylalanine ammonia lyase (PAL),"The present invention relates to a composition comprising a solid carrier, an engineered phenylalanine ammonia lyase or a fragment thereof immobilized on the surface of the solid carrier, a protective layer to protect the engineered phenylalanine ammonia lyase or a fragment thereof by embedding the engineered phenylalanine ammonia lyase or a fragment thereof, and a functional constituent immobilized on the surface of the protective layer, wherein the functional constituent immobilized on the surface of the protective layer is a polymer comprising repeat units wherein each repeat unit comprises at least one amino group and/or at least one thiol group. The present invention also relates to methods of producing said composition and uses thereof.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>a solid carrier, an engineered phenylalanine ammonia lyase (PAL) or a fragment thereof immobilized on the surface of the solid carrier, a protective layer to protect the engineered phenylalanine ammonia lyase (PAL) or the fragment thereof by embedding the engineered phenylalanine ammonia lyase (PAL) or the fragment thereof, and a functional constituent immobilized on the surface of the protective layer, wherein the functional constituent immobilized on the surface of the protective layer is a polymer comprising repeat units wherein each repeat unit comprises at least one amino group and/or at least one thiol group.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition according to claim 1, wherein </seg-main><seg-clauses>the polymer comprising repeat units wherein each repeat unit comprises at least one amino group and/or at least one thiol group is a polyglucosamin selected from the group consisting of chitin, chitosan, polyglucosaminoglycans, chondroitin, heparin, keratan and dermatan or a derivative thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The composition according to claim 1, wherein </seg-main><seg-clauses>the polymer comprising repeat units wherein each repeat unit comprises at least one amino group and/or at least one thiol group is chitosan or a derivative thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any one of claims 1-3, wherein </seg-main><seg-clauses>the functional constituent is immobilized on the surface of the protective layer by non-covalent binding or by covalent binding.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition of any one of claims 1-4, wherein </seg-main><seg-clauses>the protective layer embeds the solid carrier and embeds the engineered phenylalanine a","A61K47/69, C12N9/88, A61K38/51, A61K51/12, C12N11/08",20250109,PERSEO PHARMA AG,['PCT designated period']
CN119212565A,Compositions and methods for dehydrated pet food blends,"The present invention provides compositions and methods relating to dehydrated pet food blends. The dehydrated pet food blend may include from about 15% to about 50% protein, from about 5% to about 40% fat, and from about 5% to about 50% carbohydrate. In addition, the blend may include a semi-wet coarse food, a dry coarse powder, and a dehydrated vegetable.","<div class=""indep-clm"" num=""1"">1.脱水宠物食品共混物，其包含：</div>
<div class=""indep-clm"" num=""1"">约15％至约50％的蛋白质；</div>
<div class=""indep-clm"" num=""1"">约5％至约40％的脂肪；以及</div>
<div class=""indep-clm"" num=""1"">约5％至约50％的碳水化合物；</div>
<div class=""indep-clm"" num=""1"">其中组合物包含半湿粗磨食物、干粗粉和脱水蔬菜。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物具有约10重量％至约30重量％的水分含量。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物以约10重量％至约50重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的脱水宠物食品共混物，其中所述干粗粉具有约5重量％至约12重量％的水分含量。</div>
<div class=""dep-clm"" num=""5"" parent=""1"">5.根据权利要求1所述的脱水宠物食品共混物，其中所述干粗粉以约40重量％至约90重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的脱水宠物食品共混物，其中所述脱水蔬菜具有约1重量％至约10重量％的水分含量。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的脱水宠物食品共混物，其中所述脱水蔬菜以约5重量％至约30重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""8"" parent=""1"">8.根据权利要求1所述的脱水宠物食品共混物，其还包含抗氧化剂、矿物质或维生素，并且还包含防腐剂。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的脱水宠物食品共混物，其中所述半湿粗磨食物涂有动物消化物。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的脱水宠物食品共混物，其中所述共混物被配制为完全且营养均衡的宠物食品。</div>
<div class=""indep-clm"" num=""11""><seg-con>11.用于制造脱水宠物食品共混物的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""11""><seg-comp>挤出半湿粗磨食物；</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>挤出干粗磨食物；</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>研磨所述干粗磨食物以形成干粗粉；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""11""><seg-comp>将所述半湿粗磨食物和所述干粗粉与脱水蔬菜混合以形成所述脱水宠物食品共混物。</seg-comp></div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中所述半湿粗磨食物具有约10重量％至约30重量％的水分含量并且以约10重量％至约50重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""13"" parent=""11"">13.根据权利要求11所述的方法，其中所述干粗粉具有约5重量％至约12重量％的水分含量，并且以约40重量％至约90重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""14"" parent=""11"">14.根据权利要求11所述的方法，其中所述脱水蔬菜具有约1重量％至约10重量％的水分含量，并且以约5重量％至约30重量％的量存在于所述共混物中。</div>
<div class=""dep-clm"" num=""15"" parent=""11"">","A23K30/20, A23K40/25",20241227,雀巢产品有限公司,['Pending']
US12245716B2,Beverage extraction unit with movable outflow obstructor,The invention relates to a beverage extraction unit (<b>1</b>) for extracting a beverage from an exchangeable single-serve portioned capsule (<b>2</b>) containing beverage ingredients and being configured with a flow restricting member for extracting capsules at different beverage pressure and flow conditions. The invention also relates to the beverage machine comprising the extraction unit.,"<div class=""indep-clm"" num=""1""><seg-con>1. A beverage extraction unit for extracting a beverage from an exchangeable capsule </seg-con><seg-trans>containing </seg-trans><seg-refi>a beverage ingredient and comprising a liquid entry wall, the exchangeable capsule further comprising a beverage outlet membrane, the beverage extraction unit comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a frame;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an injection part for accommodating the liquid entry wall of the exchangeable capsule and comprising at least a water outlet for injection of water in the exchangeable capsule; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an extraction part delimiting with the injection part an extraction chamber in which the exchangeable capsule is housed during extraction, the extraction part and the injection part being relatively movable to open and close the extraction chamber, the exchangeable capsule being insertable into and/or removable from the open extraction chamber and the exchangeable capsule being extractible when housed in the closed extraction chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the extraction part comprising an extraction plate having a plurality of beverage outlets for allowing the beverage to flow through the extraction plate; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the extraction part further comprises a flow restricting member arranged relative to the extraction plate in a moveable manner between a standard outflow position and a reduced outflow position, wherein a flow surface area of the plurality of beverage outlets in the reduced outflow position is reduced compared to a flow surface area of the plurality of beverage outlets in the standard outflow position by obstructing a part of the plurality of beverage outlets, the part of the plurality of beverage outlets obstructed by the flow restricting member being partly or enti","A47J31/36, A47J31/40, A47J31/46",20250311,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2024262894A1,Method for producing milk like products,"A method of producing mammalian breast milk exosomes, for example human breast milk exosomes comprising generating lactocytes derived from mammalian mammary epithelial cells, for example human mammary epithelial cells, expressing the mammalian milk like product, for example the human milk like product from lactocytes, and purifying the exosomes from the mammalian milk like product.","<div class=""indep-clm"" num=""1""><seg-main>1. An isolated human breast milk exosome, wherein </seg-main><seg-clauses><seg-main>Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4) and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PL0D</seg-main><seg-clauses>1) are not detected by liquid chromatography - mass spectrometry in the exosome.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The exosome of claim 1, wherein </seg-main><seg-clauses>C4a anaphylatoxin (CFA), Hypoxia up-regulated protein 1 (HYOU1), Apolipoprotein A-IV (APOA4), Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1), Threonine—tRNA ligase 1, cytoplasmic (TARSI), and Cytosolic non-specific dipeptidase (CNDP2) are not detected by liquid chromatography - mass spectrometry in the exosome.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The exosome of claim 1 or claim 2, wherein </seg-main><seg-clauses>the exosome comprises lactotransferrin (LTF), annexin A2 (ANXA2) and lactadherin (MFGE8), MUC1 and tetraspanins CD9, CD81 and CD63.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The exosome of any one of claims 1 to 3, wherein </seg-main><seg-clauses>the exosome comprises one or more miRNAs selected from miR-148a-3p, miR-22-3p, miR-125b-5b and miR-6126.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more lipids selected from cholesterol esters, ceramides, triacylglycerides, diacylglycerides, lyso-phospholipids, total phospholipids, alkanyl phospholipids, and alkenyl phospholipids.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6 The exosome of any preceding claim, wherein </seg-main><seg-clauses>the exosome comprises one or more phospholipids selected from sphingomyelins, phosphatidylcholine, phosphatidylethanolamine, phosphatidyli","C12N5/071, A61K35/20",20251016,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025088393A1,Wet pet food systems,"The present disclosure is drawn to wet pet food systems and methods of packaging wet pet foods. The wet pet food systems include a sealed pouch constructed of a monomaterial of polypropylene and a wet pet food contained within the sealed pouch. The wet pet food can include a member selected from the group consisting of a mousse, a chunk-in-loaf, and chunks-in-gravy. The wet pet food includes an antioxidant including a soy sauce.","What Is Claims Is:
<div class=""indep-clm"" num=""1""><seg-con>A wet pet food system, </seg-con><seg-trans>comprising:</seg-trans><seg-comp>a sealed pouch constructed of a monomaterial of polypropylene; </seg-comp><seg-comp>anda wet pet food contained within the sealed pouch, the wet pet food including a member selected from the group consisting of a mousse, a chunk-in-loaf, and chunks-in-gravy, wherein the wet pet food comprises an antioxidant including a soy sauce.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is recyclable. </seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is constructed of a monolayer of polypropylene. </seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sealed pouch is more permeable to oxygen and water than an aluminum barrier pouch.               </seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the soy sauce is included in the wet pet food at from about 0.1 wt% to about 3 wt% based on a dehydrated soy sauce weight of a total weight of the wet pet food.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the soy sauce is added to the wet pet food at from about 0.25 wt% to about 2 wt% based on a dehydrated soy sauce weight of a total weight of the wet pet food.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>The wet pet food system of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wet pet food includes from about 40 wt% to about 80 wt% water based a total weight of the","A23K10/20, A23K40/00, A23K50/40, A23K50/48",20250501,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
US20250261784A1,Centrifugal chamber with capsule positioning guide,"A machine (<b>1</b>) is configured for preparing a beverage (<b>4</b>) from a flavouring ingredient (<b>5</b><i>a</i>) supplied within a capsule (<b>5</b><i>b</i>) in a processing cavity (<b>5</b>) by mixing it with water (<b>4</b>′) and centrifuging them about a processing axis (<b>30</b>′). The machine (<b>1</b>) has a handling system (<b>10, 20</b>) including a first ingredient handler (<b>10</b>) and a second ingredient handler (<b>20</b>) that are movable one relative to the other from a capsule transfer configuration to an capsule processing configuration. The machine has a capsule supply passage (<b>60</b>) provided with a capsule guide (<b>61, 61</b><i>a</i>). The guide (<b>61, 61</b><i>a</i>) is associated with a capsule stop (<b>61</b><i>b</i>) to immobilize the supplied capsule (<b>5</b><i>b</i>) between the first and second ingredient handlers (<b>10, 20</b>). The guide is integral with or fixed to an elastic arm (<b>61</b><i>c</i>) to be movable towards and away from the processing axis (<b>30</b>′) between a capsule immobilization position and a release position.","<div class=""indep-clm"" num=""1""><seg-con>1. A machine for preparing a beverage from a flavouring ingredient supplied within a capsule in a processing cavity by mixing said ingredient with water in said capsule and centrifugally driving such ingredient and said water about a processing axis to form said beverage, such machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a rotatable ingredient handling system for holding said capsule and rotating said flavouring ingredient and water during centrifugation about the processing axis, the ingredient handling system having at least one beverage outlet and at least one water inlet for supplying said water to said ingredient, the system having a first ingredient handler and a second ingredient handler that are movable one relative to the other from:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an ingredient transfer configuration for receiving said ingredient within said capsule by the first and second capsule handlers and/or releasing said capsule from the first and second ingredient handlers; to</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an ingredient processing configuration for centrifuging said ingredient and water within said capsule by rotation about the processing axis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>and vice versa;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a handler actuator, such as a motor or a user-handle, configured to relatively move the first and second capsule handlers between the transfer and the processing configurations; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a machine frame and/or housing which is stationary when the ingredient handling system is rotated for centrifugation and which supports the ingredient handling system,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the machine frame and/or housing delimiting an ingredient supply passage configured to al","A47J31/22, A47J31/36, A47J31/40",20250821,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025045731A1,Piercing and fluid processing device,"The invention concerns a piercing and fluid processing device (11) for piercing a pack (10), for providing diluent inside the pack (10) to prepare a beverage by mixing said diluent with an ingredient contained in said pack (10) and for dispensing the beverage from the pack (10), comprising a piercing end (113), a diluent inlet conduit (111) for introducing a diluent into said pack (10), and a beverage outlet conduit (112) for dispensing the beverage from said pack (10), wherein a beverage inlet end (112a) of the beverage outlet conduit (112) comprises multiple outlet holes (1121).","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A piercing and fluid processing device (11) of a beverage preparation machine (1) for producing a beverage from a pack (10), said pack (10) comprises </seg-main><seg-clauses><seg-main>a beverage ingredient configured to be mixed with a fluid to produce a beverage, said pack (10) presenting a plane shape oriented along a plane (P), and the bottom side (101) of said pack (10) being configured for being openable, said piercing and fluid processing device (11) being for piercing said pack (10), for providing diluent inside said pack (10) to prepare a beverage by mixing said diluent with an ingredient contained in said pack (10) and for dispensing the beverage from said pack (10), said piercing and fluid processing device (11) comprising:</seg-main>
<seg-clauses>- a piercing end (113),</seg-clauses>
<seg-clauses>- a diluent inlet conduit (111) for introducing said diluent into said pack (10), and</seg-clauses>
<seg-clauses>- a beverage outlet conduit (112) for dispensing said beverage from said pack (1), wherein a beverage inlet end (112a) of said beverage outlet conduit (112) comprises multiple outlet holes (1121).</seg-clauses></seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. The piercing and fluid processing device (11) according to the precedent claim, wherein </seg-main><seg-clauses>the smallest dimension of said multiple outlet holes (1121) is of at most 0.7 mm, preferably at most 0.6 mm, even more preferably at most 0.5 mm.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. The piercing and fluid processing device (11) according to any one of the precedent claims, wherein </seg-main><seg-clauses>the global surface defined by said multiple outlet holes (1121) is of at least 25 mm<sup>2</sup>, preferably at least 27 mm<sup>2</sup>for a flow said diluent entering the diluent inlet conduit (111) comprised between 50 and 400 ml/min.</seg-clauses></div>
<div class=""indep-clm"" num=""4""><seg-mai",A47J31/40,20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2833704C2,Use of non-dairy beverage with rice and pea proteins for feeding babies with cow protein allergy,"FIELD: food industry.SUBSTANCE: disclosed is the use of a non-dairy beverage with improved organoleptic properties for feeding babies with cow protein allergy, where the beverage contains hydrolysed rice proteins, pea proteins and optionally free amino acids, wherein the pea proteins are used in amount of 10 wt.% to 90 wt.%, and the hydrolysed rice proteins are used in an amount of at least 10 wt.%, wherein pea proteins, hydrolysed rice proteins and an optional free amino acid form the entire protein content in the non-dairy beverage. Also disclosed is the use of pea and rice proteins for improving the organoleptic properties of a non-dairy beverage.EFFECT: group of inventions enables to use a non-dairy beverage for feeding babies with cow protein allergy without bitterness and unpleasant astringent taste with an age-appropriate amino acid profile, as well as use of pea and hydrolysed rice proteins to produce a beverage with improved organoleptic properties.14 cl, 1 dwg, 9 tbl, 4 ex","1. Применение немолочного напитка с улучшенными органолептическими свойствами для питания младенцев с аллергией на коровий белок, где немолочный напиток содержит гидролизованные рисовые белки, гороховые белки и необязательно свободные аминокислоты, причем гороховые белки используют в количестве от 10 до 90 мас.% в расчете на общее содержание белка в немолочном напитке, а гидролизованные рисовые белки используют в количестве по меньшей мере 10 мас.% в расчете на общее содержание белка в немолочном напитке, при этом гороховые белки, гидролизованные рисовые белки и необязательная свободная аминокислота образуют все содержание белка в немолочном напитке.
2. Применение по п.1, где в немолочном напитке гороховые белки присутствуют в количестве 60–80 мас.% в расчете на общую массу белкового компонента.
3. Применение по п.1, где в немолочном напитке гороховые белки присутствуют в количестве от 40 до 60 мас.% в расчете на общую массу белкового компонента.
4. Применение по любому из предшествующих пунктов, где немолочный напиток дополнительно содержит жировой компонент и углеводный компонент.
5. Применение по любому из предшествующих пунктов, где немолочный напиток дополнительно содержит крахмал, предпочтительно в количестве 2–15 мас.%.
6. Применение по любому из предшествующих пунктов, где немолочный напиток содержит L-лизин и/или L-метионин.
7. Применение по любому из предшествующих пунктов, где гороховые белки присутствуют в немолочном напитке в виде изолята.
8. Применение по любому из предшествующих пунктов, где немолочный напиток содержит:
- белковый компонент, состоящий из изолята горохового белка, гидролизата рисового белка, такого как определено выше, и свободной аминокислоты L-лизин;
- растительное масло;
- лецитин;
- легкоусвояемый углевод;
- волокно;
- минеральные вещества; и
- витамины.
9. Применение гороховых белков для улучшения органолептических свойств немолочного напитка, который содержит гидролизованные рисовые белки и необязательно свободные аминокислоты, п","A23J3/14, A23J1/14, A23L2/66",20250128,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
CN119894785A,Beverage or food preparation system,"A container for use with a beverage or food preparation machine, the container comprising: a storage portion for containing a precursor material; a code storing preparation information used by the machine to process the precursor material, the code configured to be readable by a code reading system of the machine, the code reading system comprising an illumination system for projecting emitted light greater than 700 nm or 800 nm to the code, and a camera system for receiving the emitted light from the machine, a camera system for obtaining a digital image of a code operating at a wavelength of 700 nm or more than 800 nm, the code being arranged to absorb and/or reflect emitted light for capture by said camera system in the digital image; and an information carrying layer comprising container information visible at the wavelength of visible light and having a relatively low absorptivity and/or reflectance for said emitted light, where the information carrying layer is arranged to be effective in proximity to the code layer to hide the code.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于与饮料或食品制备机器一起使用的容器，所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>储存部分，所述储存部分用于容纳前体材料；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码，所述代码用于存储由所述机器用来处理所述前体材料的制备信息，所述代码被配置为能够由所述机器的代码读取系统读取，所述代码读取系统包括照明系统和相机系统，所述照明系统用于将大于700nm或800nm的发射光投射到所述代码，所述相机系统用于获得以700nm或800nm以上的波长操作的所述代码的数字图像，所述代码被布置成吸收和/或反射所述发射光以便由所述相机系统捕获在数字图像中；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>信息承载层，所述信息承载层包括在可见光波长下可见并且被配置为能够由用户读取的容器信息，并且对所述发射光具有相对低的吸收率和/或反射率，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述信息承载层布置成有效接近代码层，使得所述信息承载层和所述代码的位置布置使得所述代码被所述信息承载层隐藏或部分隐藏，与没有所述信息承载层时所述代码的情况相比，降低了所述代码在所述可见光波长下的可见度。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述信息承载层对所述发射光具有小于20％的吸收率，并且对所述发射光具有小于30％的反射率。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2中任一项所述的容器，</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>所述信息承载层是连续的；</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>所述信息承载层邻接所述代码；并且</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-refi>所述信息承载层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，所述贯穿厚度从外表面延伸，并且其中所述信息承载层被布置成当在所述平面中观察时与整个代码重叠。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述代码相对于所述信息承载层最接近所述外表面。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一前述权利要求所述的容器，</seg-con><seg-trans>其中，</seg-trans><seg-refi>所述信息承载层在由横向方向和纵向方向限定的平面中延伸，并且在深度方向上具有贯穿厚度，并且：</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>所述代码包括被配置为吸收所述发射光的吸收层和被配置为反射所述发射光的反射层；</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>所述反射层被配置为反射可见光波长；</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-refi>所述信息承载层在深度方向上布置在所述反射层与闭合构件的外表面之间；并且</seg-refi>",B65D85/804,20250425,雀巢产品有限公司,['Pending']
CN119698384A,Beverage or food preparation system,"The invention provides a container for containing precursor material and for use with a machine for preparing beverages and/or food products or precursors thereof, the container comprising a machine-readable code storing preparation information for use with a preparation process performed by the machine, the code comprising: a reference portion (R) to locate the code; a data portion (D) to store the preparation information, and; a code identification portion (I) wherein the code identification portion (I) is separate from the reference portion (R), and wherein the code identification portion encodes information relating to a geometric arrangement of the data portion relative to the reference portion.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于容纳前体材料的容器，所述容器用于与用于制备饮料和/或食品或者其前体的机器一起使用，所述容器包括存储与由所述机器执行的制备过程一起使用的制备信息的机器可读代码，所述代码</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>用以定位所述代码的参考部分(R)；</seg-comp><seg-comp>用以存储所述制备信息的数据部分(D)，以及；代码识别部分(I)，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其中所述代码识别部分(I)与所述参考部分(R)分开，并且其中所述代码识别部分对与所述数据部分相对于所述参考部分的几何布置相关的信息进行编码。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的容器，其中所述数据部分至少部分地将所述制备信息的参数的值编码为所述代码的数据单元沿着虚拟编码线(E)距布置在所述编码线上的起始位置的几何距离(d)，其中布置在所述编码线上的结束位置限定最大可允许距离(d)，</div>
<div class=""dep-clm"" num=""2"" parent=""1"">并且与由代码识别部分编码的所述信息相关的所述数据部分的所述几何布置包括以下中的一者或多者：</div>
<div class=""dep-clm"" num=""2"" parent=""1"">所述起始位置在所述编码线上的位置；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">所述结束位置在所述编码线上的位置，以及；</div>
<div class=""dep-clm"" num=""2"" parent=""1"">所述数据单元能够被布置在其内的所述起始位置与所述结束位置之间的递增距离和/或增量数量。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的容器，其中所述数据部分被布置为多个单独数据部分，所述多个单独数据部分各自被布置在所述编码线上，</div>
<div class=""dep-clm"" num=""3"" parent=""2"">并且与由代码识别部分编码的所述信息相关的所述几何布置包括在所述编码线上的多个单独数据部分。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的容器，其中存在多条编码线，并且所述数据部分被布置为在所述多条编码线中的每一者上的一个或多个单独数据部分，</div>
<div class=""dep-clm"" num=""4"" parent=""3"">并且与由代码识别部分编码的所述信息相关的所述几何布置包括用于每条编码线的多个数据部分。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">5.根据权利要求2至4中任一项所述的容器，其中所述参考部分被布置成限定线性虚拟参考线(L)，并且所述编码线是圆形的并且被布置成与所述参考线(L)相交，</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">其中所述起始位置和/或所述结束位置相对于交点的位置与由所述代码识别部分编码的所述信息相关。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据权利要求2至5中任一项所述的容器，其中所述代码识别部分被布置为一个或多个离散位置，所述一个或多个离散位置被布置在相对于所述参考部分的预定义位置处，</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">所述离散位置包括或缺少用以将所述信息编码为与所述数据部分的所述几何布置相关的二进制信息的单元。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6所述的容器，其中所述代码识别部分被布置在所述或每条编码线远侧，其中所述或每条编码线被布置在所述代码识别部分与所述参考部分之间。</div>
<div class=""dep-clm"" num=""8"" parent=""2,3,4,5,6,7"">8.根据权利要求2至8中任一项所述的容器，其中所述代码识别部分对与数据单元的表示相关的信息进行编码，其中所述表示包括编码距离是否由一个或多个数据单元限",B65D85/804,20250325,雀巢产品有限公司,['Pending']
CN120091764A,Compositions and methods for improving and/or maintaining optimal cholesterol levels using combination of at least one fiber and at least one probiotic,"The composition contains a combination of at least one fiber and at least one probiotic and is formulated for administration to a subject in a condition of a challenged gut microbiome, such that the combination of the at least one fiber and the at least one probiotic improves and/or maintains an optimal cholesterol level in the subject under the condition of the challenged gut microbiome. Preferably, the subject is experiencing one or more of microbiome stressors, such as dietary stressors, antibiotics, other drugs, infection, strenuous exercise, stress, alcohol, travel, and combinations thereof; more preferably at least one dietary stress source; most preferably at least one high fat diet, such as a western high fat diet or ketogenic diet. The method may achieve at least one result that is to improve and/or maintain an optimal cholesterol level in a subject under the condition of a challenged gut microbiome.","<div class=""indep-clm"" num=""1"">1.用于改善和/或维持处于受挑战的肠道微生物组的状况下的受试者中的最佳胆固醇水平的组合物，所述组合物包含有效量的至少一种纤维和至少一种益生菌的组合。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的组合物，其中所述受挑战的肠道微生物组是由所述受试者经历的微生物组应激源引起的。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的组合物，其中所述微生物组应激源选自：膳食应激源；抗生素；其他药物；感染；剧烈运动；压力；酒精；旅行；</div>
<div class=""dep-clm"" num=""3"" parent=""2"">胃肠外喂养；肠道喂养；短肠综合征；肠道炎症；化疗；结肠癌；腹泻；质子泵抑制剂；无谷蛋白的饮食；不含可发酵的低聚糖、二糖、单糖和多元醇(FODMAP)的饮食；以及它们的组合；优选地至少一种膳食应激源；更优选地至少一种高脂肪饮食；最优选地西方高脂肪低纤维饮食或生酮饮食。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的组合物，其中所述至少一种纤维选自：不溶性纤维、可溶性纤维以及它们的混合物；优选地它们的混合物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项所述的组合物，其中所述至少一种纤维选自：低聚木糖、亚麻籽、部分水解的瓜尔胶(PHGG)、葡甘露聚糖、纤维素、西梅粉、果胶诸如苹果皮果胶以及它们的混合物。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的组合物，其中所述至少一种纤维包括至少两种纤维，诸如两种、三种、四种、五种、六种或七种纤维以及任选地更多种。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的组合物，其中所述至少一种益生菌选自：嗜酸乳杆菌、乳双歧杆菌、鼠李糖乳杆菌、长双歧杆菌、植物乳杆菌、两歧双歧杆菌、加氏乳杆菌以及它们的混合物。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的组合物，其中所述至少一种益生菌包括选自以下的菌株：嗜酸乳杆菌La-14、乳双歧杆菌BI-04、鼠李糖乳杆菌GG、长双歧杆菌BL-05、植物乳杆菌Lp-115、两歧双歧杆菌Bb-06、加氏乳杆菌Lg-36以及它们的混合物。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的组合物，其中所述至少一种益生菌包括至少两种益生菌菌株，诸如两种、三种、四种、五种、六种或七种益生菌菌株以及任选地更多种。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的组合物，其中将至少一种纤维和至少一种益生菌的所述组合口服施用于所述受试者。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据权利要求1至10中任一项所述的组合物，其中所述受试者选自：人类婴儿、人类儿童、人类青少年、成人、老年人以及动物诸如伴侣动物。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据权利要求1至11中任一项所述的组合物，其用于预防和/或治疗心血管、循环、内分泌系统和/或神经系统病症和/或疾病。</div>
<div class=""indep-clm"" num=""13"">13.改善和/或维持处于受挑战的肠道微生物组的状况下的受试者中的最佳胆固醇水平的方法，所述方法包括向所述受试者施用根据权利要求1至11中任一项所述的组合物。</div>
<div class=""indep-clm"" num=""14"">14.实现选自预防和/或治疗心血管、循环、内分泌系统和/或神经系统病症和/或疾病的至少一种结果的方法，所述方法包括通过向处于受挑战的肠道微生物组的状况下的受试者施用根据权利要求1至11中任一项所述的组合物来改善和/或维持","A23L33/135, A23L33/21, A23L33/00, A61K31/702, A61K35/745",20250603,雀巢产品有限公司,['Pending']
CN119947601A,Complex coacervates of lactoferrin and osteopontin,"The present invention relates to a complex coacervate comprising lactoferrin and osteopontin, a method for preparing the same, and a composition comprising the same. Furthermore, the present invention relates to a complex comprising lactoferrin and osteopontin for use in the treatment and/or prevention of metabolic and/or inflammatory diseases. Furthermore, the present invention relates to a complex comprising lactoferrin and osteopontin for use in promoting bone development, growth, strength and/or healing or in the prevention and/or treatment of bone diseases.","<div class=""indep-clm"" num=""1"">1.包含乳铁蛋白和骨桥蛋白的复合凝聚物，所述复合凝聚物用于促进受试者的骨发育、生长、强度和/或愈合或者预防和/或治疗受试者的骨疾病。</div>
<div class=""indep-clm"" num=""2"">2.根据权利要求1用于所述用途的复合凝聚物，其中所述复合凝聚物包含5％w/w至50％w/w的量、优选15％w/w至40％w/w的量以及更优选25％w/w至35％w/w的量的蛋白质。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求1或2用于所述用途的复合凝聚物，其中所述复合凝聚物包含50％w/w至95％w/w的量、优选60％w/w至85％w/w的量以及更优选65％w/w至75％w/w的量的水。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物具有在最短维度上至少500nm、优选在最短维度上至少600nm、更优选在最短维度上至少700nm以及甚至更优选在最短维度上至少900nm的直径。</div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4"">5.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物具有-15mV至+15mV范围内、优选-10mV至+10mV范围内以及更优选-8mV至+5mV范围内的ζ电位。</div>
<div class=""dep-clm"" num=""6"" parent=""2,3,4,5"">6.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物以组合物的形式施用。</div>
<div class=""dep-clm"" num=""7"" parent=""6"">7.根据权利要求6用于所述用途的复合凝聚物，其中所述组合物选自由食品组合物、宠物食品组合物、饮料、营养配方产品或营养品组成的组。</div>
<div class=""dep-clm"" num=""8"" parent=""6,7"">8.根据权利要求6或7用于所述用途的复合凝聚物，其中所述组合物是婴儿配方食品、一段婴儿配方食品、较大婴儿配方食品、婴孩食品、婴儿谷物组合物、成长乳、强化剂或补充剂。</div>
<div class=""dep-clm"" num=""9"" parent=""2,3,4,5,6,7,8"">9.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物口服施用。</div>
<div class=""dep-clm"" num=""10"" parent=""2,3,4,5,6,7,8,9"">10.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物以100mg/kg/天至10000mg/kg/天的剂量、优选以500mg/kg/天至5000mg/kg/天的剂量以及更优选以1000mg/kg/天至2000mg/kg/天的剂量施用。</div>
<div class=""dep-clm"" num=""11"" parent=""2,3,4,5,6,7,8,9,10"">11.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述复合凝聚物增加骨生长和/或骨强度，优选地其中所述复合凝聚物增加选自以下的一种或多种骨参数：小梁骨体积和组织体积分数(BV/TV)、骨矿物质密度(BMD)、骨矿物质含量(BMC)、皮质骨体积(Ct.BV)、内外直径、前后直径、骨屈服力和骨刚度。</div>
<div class=""dep-clm"" num=""12"" parent=""2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述骨疾病是代谢骨障碍，优选地其中所述骨疾病是低骨密度、骨质减少、骨质疏松、骨软化或佝偻病。</div>
<div class=""dep-clm"" num=""13"" parent=""2,3,4,5,6,7,8,9,10,11,12""><seg-con>13.根据任一前述权利要求用于所述用途的复合凝聚物，其中所述受试者是少年、青少年、儿童或婴儿，优选地</seg-con><seg-trans>其中：</seg-trans></div>
<div class=""dep-clm"" num=""13"" parent=""2,3,4,5,6,7,8,9,10,11,12""><seg-refi>(i)所述受试者早产或具有低出生体重或经历宫内生长迟滞；</seg-refi></div>
<div class=""dep-clm"" num=""13"" parent=""2,3,4,5,6,7,8,9,10,11,12""><s","A23L33/18, A61K9/00, A61K38/19, A61K38/40, A61P19/08",20250506,雀巢产品有限公司,['Pending']
AU2023337469A1,Beverage or foodstuff preparation system,"A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising: a reference portion (R) to locate the code; a data portion (D) to store the preparation information, and; a code identifying portion (I), wherein the code identifying portion (I) is separate from the reference portion (R) and wherein code identifying portion encodes information related to a geometric arrangement of the data portion relative the reference portion.","<div class=""indep-clm"" num=""1""><seg-con>1. A container for </seg-con><seg-trans>containing </seg-trans><seg-refi>a precursor material for use with a machine for preparing a beverage and/or foodstuff ora precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a reference portion (R) to locate the code; a data portion (D) to store the preparation information, and; a code identifying portion (I),</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the code identifying portion (I) is separate from the reference portion (R), and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the code identifying portion encodes information related to a geometric arrangement of the data portion relative the reference portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The container of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-comp>the data portion at least partially encodes a value of a parameter of the preparation information as a geometric distance (d) of a data unit of the code along a virtual encoding line (E) from a start position arranged on the encoding line, with an end position arranged on the encoding line defining a maximum allowable distance (d),</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>and said geometric arrangement of the data portion related to the information encoded by code identifying portion includes one or more of:</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a location of the start position on the encoding line;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a location of the end position on the encoding line, and;</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>an incremented distance and/or a number of increments between the star",B65D85/804,20250130,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119137289A,Methods for improving health outcome of dogs using biological age,"The present invention is used for selecting a lifestyle regimen, dietary regimen or therapeutic intervention for a dog, the method comprising: a) providing a DNA methylation profile from a sample obtained from the dog; b) determining the biological age of the dog using the DNA methylation profile; and c) selecting a suitable lifestyle regimen, dietary regimen or therapeutic intervention for the dog based on the biological age determined in step b).","<div class=""indep-clm"" num=""1""><seg-con>1.用于为狗选择生活方式方案、膳食方案或治疗干预的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a)提供来自从所述狗获得的样本的DNA甲基化图谱；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>b)使用所述DNA甲基化图谱来确定所述狗的生物学年龄；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>c)基于步骤b)中确定的所述生物学年龄来为所述狗选择合适的生活方式方案、膳食方案或治疗干预。</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2.用于确定生活方式方案、膳食方案或治疗干预对改善狗的生物学年龄的功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""2""><seg-comp>a)将生活方式方案、膳食方案或治疗干预应用于所述狗，其中</seg-comp><seg-comp>已经</seg-comp><seg-comp>根据权利要求1所述的方法选择所述生活方式方案、膳食方案或治疗干预；</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-comp>b)在将所述生活方式方案、膳食方案或治疗干预应用于所述狗一段时间后；使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的生物学年龄；</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-comp>c)在遵循所述生活方式方案、膳食方案或治疗干预的所述时间段后，确定所述狗的所述生物学年龄是否存在变化。</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-con>3.用于确定生活方式方案、膳食方案或治疗干预对改善狗的生物学年龄的功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-comp>a)使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的生物学年龄；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>b)将基于步骤a)中确定的所述生物学年龄选择的生活方式方案、膳食方案或治疗干预应用于所述狗；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>c)在将所述生活方式方案、膳食方案或治疗干预应用于所述狗一段时间后；使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的生物学年龄；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>d)确定所述狗的所述生物学年龄在步骤a)和步骤c)之间是否存在变化。</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-con>4.用于确定生活方式方案、膳食方案或治疗干预对改善狗的生物学年龄的功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""4""><seg-comp>a)使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的第一生物学年龄；</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>b)将生活方式方案、膳食方案或治疗干预应用于所述狗；</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>c)在将所述生活方式方案、膳食方案或治疗干预应用于所述狗一段时间后；使用来自从所述狗获得的第二样本的DNA甲基化图谱来确定所述狗的第二生物学年龄；</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>d)在遵循所述生活方式方案、膳食方案或治疗干预的所述时间段","C12Q1/6876, C12Q1/6883",20241213,雀巢产品有限公司,['Pending']
CA3028849C,Container for producing a beverage capsule and capsule thereof,"Container (3) for producing of a beverage capsule containing a beverage ingredient, consisting of a formed laminated structure comprising a cup portion (3) with a depth-to-width ratio of at least 0.3 and a peripheral flange (4); said laminated structure comprising an aluminium foil (9) as a middle layer and comprising on the inner side of the aluminium foil (9) a sealing layer (10, 16); wherein the laminated structure further comprises at least one outer polymer film (13) laminated on the outer side of the aluminium foil (9) using a laminating adhesive layer (15) and in that the outer polymer film (13) is printed at its inner surface and is made of semi-crystalline polymer.","Claims: <div class=""indep-clm"" num=""1""><seg-main>1. Container (3) for producing of a beverage capsule containing </seg-main><seg-clauses>a beverage ingredient, consisting of a formed laminated structure comprising a cup portion (3) with a depth-to-width ratio of at least 0.3 and a peripheral flange (4); said laminated structure comprising an aluminium foil (9) as a middle layer and comprising on the inner side of the aluminium foil (9) a sealing layer (10, 16); characterized in that the laminated structure further comprises at least one outer polymer film (13) laminated on the outer side of the aluminium foil (9) using a laminating adhesive layer (15) and in that the outer polymer film (13) is printed at its inner surface and is made of semi-crystalline polymer. </seg-clauses></div><div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Container according to claim 1, wherein </seg-main><seg-clauses>the outer polymer film (13) is made of semi¬ crystalline polymer having a degree of crystallization between 20 and 70%, and having a Young’s modulus of 2000 MPa to 2700 MPa. </seg-clauses></div><div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. Container according to claim 2, wherein </seg-main><seg-clauses>the degree of crystallization is between 20 and 40%. </seg-clauses></div><div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4. Container according to claim 2 or claim 3, wherein </seg-main><seg-clauses>the Young’s modulus is between 2100 MPa to 2300 MPa. </seg-clauses></div><div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Container according to any one of claims 1 to 4, wherein </seg-main><seg-clauses>the outer polymer film (13) comprises or consists of semi-crystalline polyethylene terephthalate (PET), polyamide (PA) or polypropylene (PP) or combinations thereof. </seg-clauses></div><div class=""dep-clm"" num=""6"" parent=""5""><seg-main>6. Container according to claim 5, wherein </seg-main><seg-clauses>the outer polymer film (13) comprises or consists of non-ori","B32B27/32, B65D85/804",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120201932A,Reducing astringency in vegetable protein-based beverages,"The present invention relates to a vegetable protein-based beverage comprising oat bran or an oat bran extract wherein said oat bran or oat bran extract comprises between 0.1% and 6% of the total solids content in the vegetable protein-based beverage on a dry basis, and wherein said oat bran or oat bran extract comprises, on a dry basis, between 0.1% and 6% of the total solids content in the vegetable protein-based beverage, and wherein said oat bran or oat bran extract comprises, on a dry basis, between 0.1% and 6% of the total solids content in the vegetable protein-based beverage. At least 15% of the solids contributed by the oat bran or oat bran extract are beta-glucan.","<div class=""indep-clm"" num=""1"">1.基于植物蛋白的饮料，所述基于植物蛋白的饮料包含燕麦麸或燕麦麸提取物，其中以干基计，所述燕麦麸或燕麦麸提取物占所述基于植物蛋白的饮料中的总固体含量的0.1％至6％之间，并且其中以干基计，由所述燕麦麸或燕麦麸提取物贡献的至少15％的固体是β-葡聚糖。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的基于植物蛋白的饮料，其中所述燕麦麸或燕麦麸提取物以干基计占所述基于植物蛋白的饮料中的所述总固体含量的1％至5％之间。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1至2中任一项所述的基于植物蛋白的饮料，其中所述基于植物蛋白的饮料包含介于0.3重量％至0.5重量％之间的燕麦麸。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项所述的基于植物蛋白的饮料，其中所述植物蛋白是豌豆蛋白、蚕豆蛋白或大豆蛋白。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4所述的基于植物蛋白的饮料，其中所述植物蛋白是豌豆蛋白分离物。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的基于植物蛋白的饮料，其中所述基于植物蛋白的饮料包含小于4.5重量％的植物蛋白。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项所述的基于植物蛋白的饮料，其中以干基计，由所述燕麦麸提取物贡献的至多50％的固体是β-葡聚糖。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项所述的基于植物蛋白的饮料，其中以干基计，由所述燕麦麸贡献的介于25％至35％之间的固体是β-葡聚糖。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项所述的基于植物蛋白的饮料，其中所述植物蛋白饮料包含豌豆蛋白分离物和燕麦麸提取物。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项所述的基于植物蛋白的饮料，其中所述饮料是纯素食并且不包含树胶。</div>
<div class=""indep-clm"" num=""11"">11.制备包含燕麦麸提取物的基于植物蛋白的饮料的方法，其中以干基计，所述燕麦麸提取物占小于6％的所述基于植物蛋白的饮料中的总固体含量，其中以干基计，由所述燕麦麸提取物贡献的至少15％的固体是β-葡聚糖。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的制备基于植物蛋白的饮料的方法，其中所述饮料通过在水中水合植物蛋白分离物来制备。</div>
<div class=""dep-clm"" num=""13"" parent=""11,12"">13.根据权利要求11至12中任一项所述的制备基于植物蛋白的饮料的方法，其中所述饮料通过均质化和巴氏灭菌来制备。</div>
<div class=""dep-clm"" num=""14"" parent=""11,12,13"">14.根据权利要求11至13中任一项所述的制备基于植物蛋白的饮料的方法，其中在巴氏灭菌后添加燕麦麸提取物。</div>
<div class=""dep-clm"" num=""15"" parent=""11,12,13,14"">15.根据权利要求11至14中任一项所述的制备基于植物蛋白的饮料的方法，其中当在水中水合植物蛋白分离物时添加燕麦麸。</div>
<div class=""indep-clm"" num=""16"">16.燕麦麸或燕麦麸提取物用于在基于豌豆蛋白的饮料中减少涩味持久性或用于增加浓稠感感知的用途。</div>","A23L2/52, A23L2/66, A23L33/185, A23L29/206",20250624,雀巢产品有限公司,['Pending']
US20250049250A1,Beverage preparation machine with capsule recognition,"Machine for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food, comprising a capsule recognition module for recognizing a capsule inserted in said machine at a capsule recognition position, the capsule recognition module comprising a camera for capturing an image of at least part of said capsule in said capsule recognition position; wherein the capsule recognition module comprises a neural network computing device, said neural network computing device being configured to determine a type of said capsule amongst a plurality of predefined capsule types on the basis of an image of at least part of said capsule captured by said camera.","<div class=""indep-clm"" num=""1""><seg-con>1: A machine for preparing and dispensing a beverage </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>an extraction unit for extracting a beverage ingredient capsule to form the beverage;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control unit for controlling the extraction unit to extract the capsule;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>an outlet for dispensing the beverage formed by extracting the capsule to a user-receptacle,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a capsule recognition module for recognizing a capsule inserted in the machine at a capsule recognition position, the capsule recognition module comprising a camera for capturing a digital image of at least part of the capsule in the capsule recognition position, and;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the capsule recognition module comprising a neural network computing device,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the neural network computing device being configured to determine a type of the capsule amongst a plurality of predefined capsule types on the basis of a digital image of at least part of the capsule captured by the camera.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>lighting and image capture conditions in the capsule recognition position correspond to training conditions for which the neural network computing device is configured by training to recognize the capsule.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the camera system has a fixed position in an enclosure and a light source in the enclosure is arranged to direct light to the capsule recognition position.</seg-refi></div>
<div class=""dep-clm"" num=""4"" paren","A47J31/44, A47J31/52, G06N3/08",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
EP4494482A2,Compositions for use in improving stool consistency or frequency in infants or young children,"The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.","<div class=""indep-clm"" num=""1""><seg-main>1.  Nutritional composition comprising </seg-main><seg-clauses>at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2.  Nutritional composition comprising </seg-main><seg-clauses>at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating flatulence, bloating, colics and/or gut discomfort in an infant or a young child, and wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100g of composition on a dry weight basis.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  Nutritional composition according to any one of the preceding claims wherein </seg-main><seg-clauses>the fucosylated oligosaccharide is selected from the list consisting of 2'-fucosyllactose, 3'fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and any combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  Nutritional composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fucosylated oligosaccharide comprises a 2' fucosyl-epitope.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5.  Nutritional composition according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fucosylated oligosaccharide is 2'-fucosyllact",A23L33/00,20250122,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250194643A1,Mimicking health benefits of physical exercise or voluntary cold exposure in animals,"A method of mimicking health benefits of physical exercise or voluntary cold exposure, e.g., cold plunge, in an animal can include administering to the animal a high protein diet including from about 150% to about 400% of a Recommended Daily Allowance (RDA) of protein for the animal on a daily basis. The high protein diet can be sufficient to increase a 12,13-diHOME blood level for an 18-24 hour period per day compared to a baseline blood level without the need for the physical exercise or voluntary cold exposure.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of mimicking health benefits of physical exercise or voluntary cold exposure in an animal, </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering to the animal a high protein diet including from about 150% to about 400% of a Recommended Daily Allowance (RDA) of protein for the animal on a daily basis, wherein the high protein diet is sufficient to increase a 12,13-diHOME blood level for an 18-24 hours period per day compared to a baseline blood level without the need for the physical exercise or voluntary cold exposure.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the high protein diet includes from about 175% to about 400% of the RDA of protein and the 12,13-diHOME blood level is increased by at least 2-fold over the 18-24 hour period compared to the baseline blood level.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the 12,13-diHOME blood level is higher over the 18-24 hour period compared to the baseline blood level without the animal engaging in physical exercise or voluntary cold exposure.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the animal is a pet.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the pet is a dog.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6. The method of claim 5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the RDA of protein for the dog is 18 wt % based on 100% of a maintenance energy requirement for the dog, and wherein the high protein diet includes administering a dog food on a daily basis containing from about 25 wt % to about 75 wt % protein calculated based ","A23K20/147, A23K50/42, A23L33/17",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019409518B2,"Manufacturing process for producing hermetic single-use food containers such as coffee pods, including a creasing step","The invention concerns a manufacturing process for producing hermetic single-use food containers, including: forming a 3D container body having a peripheral upper rim by stamping a 2D blank in a press, the 2D blank including a rim portion (11) and a wall portion (12); applying a closing lid over the 3D container body and sealing the closing lid with the rim. The manufacturing process is characterized in that it comprises a creasing step before forming the 3D container body, where creases (13) are formed in a peripheral zone of the 2D blank (10) by creasing or embossing the 2D blank with a creasing or embossing plate, the thus pre-creased peripheral zone covering at least a part of the rim portion (11) of the 2D blank.","2019409518  10 Dec 2024
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS :-
<div class=""indep-clm"" num=""1""><seg-main>1. Manufacturing process for producing hermetic single-use food containers, comprising:</seg-main>
<seg-clauses>5                    - forming a 3D container body having a peripheral upper</seg-clauses>
<seg-clauses class=""seg-enter"">rim, by stamping a 2D blank in a press, the 2D blank including a rim portion and a wall portion, the 2D blank comprises a sheet of laminate of paper and polylactic acid (PLA),</seg-clauses>
<seg-clauses>- applying a closing lid over the 3D container body,</seg-clauses>
<seg-clauses class=""seg-enter"">10                     - sealing the closing lid with the peripheral upper rim of</seg-clauses>
<seg-clauses class=""seg-enter"">the container body,</seg-clauses>
<seg-clauses class=""seg-enter"">a creasing step before forming the 3D container body, where creases are formed in a peripheral zone of the 2D blank, here referred to as a pre-creased peripheral zone, by creasing, stamping or embossing the 15 2D blank with a creasing or embossing plate, which pre-creased peripheral zone covers at least a part of the rim portion of the 2D blank, wherein the creases have a depth comprised between 0.1 mm and 1 mm, and a width comprised between 0.2 mm and 0.7 mm, and in that they are spaced apart with a pitch comprised between 0.2 mm and 2 mm.</seg-clauses>
<seg-clauses class=""seg-enter"">20</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Manufacturing process according to claim 1, wherein </seg-main><seg-clauses>the creases follow centrifugal directions of the 2D blank.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. Manufacturing process according to claim 2 wherein </seg-main><seg-clauses>the 2D 25 blank is a disc, characterized in that the creases are rectilinear and follow radii of the disc.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Manufacturing process","B31B50/59, B31B50/25, B31B50/88, B31F1/08, B32B27/36",20250227,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2833159C1,Equipment for dispensing and preparation of powdered food or drinking products,"FIELD: food industry.SUBSTANCE: present invention relates to equipment for dispensing and preparing powdered food or drinking products, wherein the equipment includes dispensing device (60) and associated preparation or extraction device (70); wherein dispensing device (60) includes one or more housings for receiving one or more containers (10, 20) with powdered food or drink; wherein dispensing device (60) includes reading device (62) for obtaining information on product parameters of powdered food or drinking products in one or more containers (10, 20); wherein dispensing device (60) further includes a control unit configured to dispense a certain amount of the powdered food or drink product from each container (10, 20) in accordance with these product parameters and/or in accordance with the recipe data base (64) depending on the beverage to be prepared; wherein dispensing device (60) further includes encoder 63 for encoding beverage information on programmable identification means 65 on product holder (61) in dispensing device (60), where the dispensed powdered food or drink is directed; wherein preparation or extraction device (70) is configured to receive product holder (61) and includes reading means (72) for identifying beverage information in said identification means (65) on the product holder, wherein extraction device (70) further includes a control unit for extracting the beverage in accordance with the beverage information extracted from product holder (61) and/or according to the beverage information retrieved from the beverage database in this control unit. Invention also relates to a method for dispensing powdered food or drink products and preparing a beverage therefrom using dispensing and extraction equipment similar to that described. Invention also relates to the use of equipment for dispensing and extraction, similar to that described, for dispensing a certain beverage from powdered food or drinking products.EFFECT: achieving end results for the coffee drink, similar to those obtained using the capsule system, without the need to use any package with a single portion and without the need for any special skills.13 cl, 20 dwg","1. Оборудование для выдачи и приготовления порошкообразных пищевых или питьевых продуктов, включающее в себя устройство (60) выдачи и связанное с ним устройство (70) для приготовления или экстракции;
причем устройство (60) выдачи включает в себя один или более корпусов для приема одного или более контейнеров (10, 20) с порошкообразным пищевым или питьевым продуктом; при этом устройство (60) выдачи включает в себя считывающее устройство (62) для получения информации о параметрах продукта порошкообразных пищевых или питьевых продуктов в одном или множестве контейнеров (10, 20); причем устройство (60) выдачи дополнительно включает в себя блок управления, выполненный с возможностью выдачи определенного количества порошкообразного пищевого или питьевого продукта из каждого контейнера (10, 20) в соответствии с этими параметрами продукта и/или в соответствии с базой (64) данных рецептур в зависимости от напитка, подлежащего приготовлению;
при этом устройство (60) выдачи дополнительно включает в себя кодер (63) для кодирования информации о напитке на программируемом идентификационном средстве (65) на держателе (61) продукта в устройстве (60) выдачи, куда направляется выдаваемый порошкообразный пищевой или питьевой продукт;
причем устройство (70) для приготовления или экстракции выполнено с возможностью приема держателя (61) продукта и включает в себя средство (72) считывания для идентификации информации о напитке в упомянутом идентификационном средстве (65) на держателе продукта, при этом устройство (70) экстракции дополнительно включает в себя блок управления для экстракции напитка в соответствии с информацией о напитке, извлеченной из держателя (61) продукта, и/или согласно информации о напитке, извлеченной из базы данных о напитках в этом блоке управления.
2. Оборудование для выдачи и экстракции порошкообразных пищевых или питьевых продуктов по п. 1, в котором параметры продукта включают в себя одно или множество из следующих данных: тип продукта, происхождение продукта,",A47J42/40,20250114,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2020287253B2,Instant coffee powder,"The present invention relates to an instant coffee powder, wherein the powder has a closed porosity of 15% to 50%, or 20% to 35%, or 25% to 34%, or 30 to 34%, or about 30%; use of gas hydrates for producing an instant coffee powder; and a method of producing an instant coffee powder.","<div class=""indep-clm"" num=""1""><seg-main>1.     Use of gas hydrates for producing an instant coffee powder, wherein </seg-main><seg-clauses>the gas comprises</seg-clauses>
<seg-clauses class=""seg-enter"">carbon dioxide and nitrogen.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2.     A method of producing a coffee slurry comprising </seg-main><seg-clauses><seg-main>gas hydrates, comprising:</seg-main>
<seg-clauses>(a) providing a first coffee solution;</seg-clauses>
<seg-clauses>(b) cooling the first coffee solution; and</seg-clauses>
<seg-clauses>(c) pressurising the first coffee solution with gas, to provide a coffee slurry comprising gas hydrates, wherein the gas is air and/or comprises one or more of carbon dioxide, nitrogen, nitrous oxide and argon, preferably the gas comprises carbon dioxide and/or nitrogen</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the coffee slurry has a ratio of gas in the hydrate fraction to gas in the liquid fraction (H:L) of from 1:1 to 5:1, preferably from 2:1 to 3:1.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3.     A method according to claim 2, wherein </seg-main><seg-clauses>the first coffee solution is cooled to between -</seg-clauses>
<seg-clauses class=""seg-enter"">10oC and 10oC, or to between -8oC and 7oC, or to between -5oC and 5oC, or to no lower than about -5oC and/or the gas pressure is from 10 to 300 bar, or from 10 to 150 bar, or from 10 to 100 bar, or from 10 to 50 bar, or from 15 to 40 bar, or from 15 to 35 bar, or from 15 to 30 bar.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2,3""><seg-main>4.     A method according to claim 2 or 3, wherein </seg-main><seg-clauses>the method comprises cooling the first</seg-clauses>
<seg-clauses class=""seg-enter"">coffee solution to between 0 and 5oC, or to about 3oC; and pressurising the first coffee solution with carbon dioxide, preferably at 15-25 bar, or about 20 bar, prior to pressurising the first coffee ",A23F5/32,20250828,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250359571A1,Instant food powder comprising pea and oat proteins and no dairy protein,"The present invention relates to a spray dried beverage or food powder comprising 10-35 wt. % pea protein, 2-15 wt. % other plant protein, 3-8 wt. %, preferably 4-5 wt. % fibers, selected from the group consisting of cereal, pseudo cereals seeds or a combination thereof, 0-30 wt. %, preferably 12 to 18 wt. % vegetable oil or fat, optionally a source of fortification, and optionally stabilizing salts, and wherein the total protein content is 12 to 40 wt. %. The invention also relates to a method for making the beverage or food powder.","<div class=""indep-clm"" num=""1""><seg-con>1. Spray dried beverage or food powder </seg-con><seg-trans>comprising</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>10-35 wt. % pea protein,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>2-15 wt. % other plant protein,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>3-8 wt. % fibers, selected from the group consisting of cereal, pseudo cereals seeds er and a combination thereof, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>0-30 wt. % vegetable oil or fat.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Beverage or food powder according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the other plant protein is selected from the group consisting of oat protein, rice protein, and a combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Beverage or food powder according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the powder comprises</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-refi>10-20 wt. % pea protein,</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-refi>6-12 wt. % other plant-protein,</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-refi>5-8 wt. % fibers, and</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-refi>0-25 wt. % added sugar.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Beverage or food powder according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the plant protein is in the form of isolate or concentrate or flour.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. Beverage powder or food according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>10-35 wt. % pea protein isolate.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. Beverage powder or food according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-ref","A23L2/66, A23C11/10, A23L2/39, A23L11/60, A23L33/185",20251127,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250066454A1,Complex coacervates of lactoferrin and osteopontin,"The present invention relates to a complex coacervate comprising lactoferrin and osteopontin, processes of producing the same and composition comprising the same. Moreover, the present invention relates to complexes comprising lactoferrin and osteo-pontin in the treatment and/or prevention of metabolic diseases and/or inflammatory diseases. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin for promoting bone development, growth, strength and/or healing, or preventing and/or treating a bone disease.","<div class=""indep-clm"" num=""1""><seg-main>1. A complex coacervate comprising </seg-main><seg-clauses>lactoferrin and osteopontin.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The complex coacervate according to claim 1, wherein </seg-main><seg-clauses>the complex coacervate comprise protein in an amount of 5 to 50% w/w.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The complex coacervate according to claim 1, wherein </seg-main><seg-clauses>the complex coacervate comprises water in an amount of 50 to 95% w/w.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The complex coacervates according to claim 1, wherein </seg-main><seg-clauses>the complex coacervate has a diameter of at least 500 nm in the shortest dimension.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The complex coacervates according to claim 1, wherein </seg-main><seg-clauses>the complex coacervate has a zeta potential in the range of −15 and +15 mV.</seg-clauses></div>
<div class=""indep-clm"" num=""6""><seg-main>6. A process of producing a complex coacervate comprising </seg-main><seg-clauses><seg-main>the steps of:</seg-main>
<seg-clauses>a. providing individual aqueous solutions comprising lactoferrin and osteopontin,</seg-clauses>
<seg-clauses>b. mixing the individual aqueous solutions comprising lactoferrin and osteopontin at a pH of 4 to 6 and wherein the individual aqueous solutions comprising lactoferrin and osteopontin are adjusted in that the protein mass ratio of lactoferrin to osteopontin is in the range of 2 to 8.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-main>7. The process according to claim 6, wherein </seg-main><seg-clauses>in step b. the ionic strength in the mixed aqueous solution is not greater than 30 mM.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""6""><seg-main>8. The process according to claim 6, wherein </seg-main><seg-clauses>the i","C07K14/79, A61K38/00, A61P3/00, C07K14/52",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019370732B2,"Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product","A powder contains a buffer salt and an amino acid, for example one or both of (i) least one glycine or functional derivative thereof or (ii) at least one N-acetylcysteine, L-cysteine or functional derivative thereof. Optionally the powder additionally includes at least one vitamin or mineral. Preferably the powder has at least one characteristic selected from the group consisting of (i) the amino acid is present in an amount that at least partially comprises the amino acid in a form selected from the group consisting of free form, dipeptides, tripeptides and mixtures thereof and (ii) the powder is substantially free of enzymes and antibodies. The powder can be reconstituted in a liquid containing an acidic component, such as juice or a polyphenol, and/or a protein, such as milk protein, plant protein, collagen or blends thereof. The buffer salt can minimize or prevent denaturation of protein and/or coagulation of protein upon reconstitution of the powder in the liquid.","<div class=""indep-clm"" num=""1""><seg-main>1. A powder comprising </seg-main><seg-clauses><seg-main>a phosphate salt, at least one glycine or functional derivative thereof, at least one N-acetylcysteine or L-cysteine, Vitamin E, Vitamin C, Vitamin B2 and Zinc, the powder comprising less than </seg-main><seg-clauses><seg-main>1.0 wt.% of proteins of four or more amino acid residues, and the powder having at least one characteristic selected from the group consisting of </seg-main><seg-clauses>(i) the amino acids in the powder are present in an amount that at least partially comprises the amino acid in a form selected from the group consisting of free form, dipeptides, tripeptides and mixtures thereof, and </seg-clauses><seg-clauses>(ii) the powder is substantially free of enzymes and antibodies,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the functional derivative of glycine is selected from D-Allylglycine, N-[Bis(methylthio)methylene]glycine methyl ester, Boc-allyl-Gly-OH (dicyclohexylammonium)         salt,         Boc-D-Chg-OH,         Boc-Chg-OH;</seg-clauses>
<seg-clauses class=""seg-enter"">(R)-N-Boc-(2'-chlorophenyl)glycine,                            Boc-L-cyclopropylglycine,</seg-clauses>
<seg-clauses class=""seg-enter"">(R)-N-Boc-4-fluorophenylglycine, Boc-D-propargylglycine, Boc-(S)-3-thienylglycine, Boc-(R)-3-thienylglycine, D-a-Cyclohexylglycine, L-a-Cyclopropylglycine, N-(2-fhiorophenyl)-N-(methylsulfonyl)glycine, N-(4-fluorophenyl)-N-(methylsulfonyl)glycine, Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH, N-(2-Furoyl)glycine, L-a-Neopentylglycine, D-Propargylglycine, sarcosine, and Z-a-Phosphonoglycine trimethyl ester.</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The powder according to Claim 1, which comprises glycine.</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The powder according to Claim 1 or 2, which further contains selenium.</div>","A61K31/198, A23L33/16, A23L33/175, A61K45/06",20250403,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US20240423236A1,Use of whey protein micelles for improving insulin profile in diabetic patients,The present invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in plasma postprandial insulin and/or plasma postprandial glucagon concentration in a subject. The invention relates also to a non-therapeutic use of whey protein micelles to decrease plasma postprandial insulin and/or glucagon concentration in healthy subjects.,"<div class=""indep-clm"" num=""1""><seg-con>1: A non-therapeutic method to decrease plasma postprandial insulin and/or plasma postprandial glucagon concentration in a subject in need thereof, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a whey protein micelles composition to the subject.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The non-therapeutic method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the subject is a human being or an animal.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The non-therapeutic method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the whey protein micelles composition comprises about 7.2 wt % of whey protein micelles, about 2.8 wt % of lipids, about 10.2 wt % of carbohydrates, and about 1.5 wt % of fibers.</seg-refi></div>
<div class=""indep-clm"" num=""4""><seg-con>4: A liquid meal replacement </seg-con><seg-trans>comprising </seg-trans><seg-comp>whey protein micelles.</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>5</seg-comp><seg-comp>: </seg-comp></div><div class=""dep-clm"" num=""5"" parent=""4""><seg-con>The liquid meal replacement of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the whey protein micelles are present in an amount of at least 15 wt % of the liquid meal replacement.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""4""><seg-con>6: The liquid meal replacement of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the liquid meal replacement comprises about 7.2 wt % of the whey protein micelles, about 2.8 wt % of lipids, about 10.2 wt % of carbohydrates, and about 1.5 wt % of fibers.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""4"">7: The liquid meal replacement of claim 4 for use in enteral nutrition.</div>","A23J1/20, A23C21/00, A23L2/52, A23L2/66, A23L33/00",20241226,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019290925B2,Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor,"A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD + ) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating or preventing at least one physical state selected from the group consisting of </seg-main><seg-clauses>oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, the method comprising administering to an individual in need thereof an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of P-hydroxybutyrate (BHB) and salts thereof and P-hydroxypentanoate (BHP) and salts thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of Claim 1, wherein </seg-main><seg-clauses>the at least one physical state is selected from the group consisting of deleterious effects of aging, muscle loss, type I diabetes, type II diabetes, complications from diabetes, insulin resistance, metabolic syndrome, dyslipidemia, overweight, obesity, raised cholesterol levels, raised triglyceride levels, elevated fatty acid levels, fatty liver disease, cardiovascular disease, myopathy such as statin-induced myopathy, non-alcoholic steatohepatitis, tinnitus, dizziness, alcohol hangover, hearing impairment, osteoporosis, hypertension, atherosclerosis/coronary artery disease, myocardial damage after stress, traumatic brain injury, cystic fibrosis, inflammation, cancer, HIV infection, stroke, migraine and brain ischemia.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3. Use of an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of P-hydroxybutyrate (BHB) and salts thereof and P-hydroxypentanoate (BHP) and salts thereof in the manufacture of a medicament for treating or preventing at least one physical state selected from the group consisting of </seg-main><seg-clauses>type I diabetes, type II diabetes, complications from diabetes, insulin resistance, metabolic syndrome, dyslipidemia, overweight, obesity, fatty liver disease, cardi","A61K31/19, A61K31/405, A61K31/4425, A61K31/455, A61K31/706",20250417,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119584899A,Beverage or food preparation system,"The present disclosure provides a system (2) comprising a container (6) and a machine (4) for preparing a beverage and/or a food product thereof, the container (6) comprising: a body portion (62) comprising a storage portion (58) for containing a precursor material; a closure member (56) to close the storage portion (62); and a machine-readable code (44) storing preparation information, the machine (4) comprising: a code reading system (18) to read the code (44) of the container (6); a processing unit (14) for processing the precursor material of the container (6); and electrical circuitry (16) to control the processing unit (14) based on the preparation information read from the code (44), the code reading system (18) comprising a code reader (46) to obtain a digital image of the code (44), and the code reading system (18) comprises electrical circuitry (16) to determine from the digital image of the code (44) whether the container (6) is in a read position based on a predetermined condition, and in the event that said condition is met, the electrical circuitry (16) is configured to process the code (44) to extract the preparation information at the read position.","<div class=""indep-clm"" num=""1""><seg-con>1.一种系统，所述系统包括容器以及用于制备饮料和/或其食品的机器，</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>所述容器</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>主体部分，所述主体部分包括用于容纳前体材料的储存部分；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>闭合构件，所述闭合构件用以闭合所述储存部分；</seg-comp><seg-comp>和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>机器可读代码，所述机器可读代码存储制备信息，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述机器包括：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>代码读取系统，所述代码读取系统用以读取所述容器的代码；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>处理单元，所述处理单元用于处理所述容器的所述前体材料；和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>电气电路系统，所述电气电路系统用以基于从所述代码读取的所述制备信息来控制所述处理单元，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述代码读取系统包括用以获得所述代码的数字图像的代码读取器，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且所述代码读取系统包括用以基于所述代码的所述数字图像的预定条件来从所述代码的所述数字图像确定所述容器是否处于读取位置的电气电路系统，</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>并且在满足所述条件的情形下，所述电气电路系统被配置为处理所述代码以在所述读取位置提取所述制备信息。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的系统，其中所述预定条件基于所述代码的几何属性。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的系统，其中所述几何属性基于形成所述代码的一个或多个单元的尺寸超过阈值尺寸。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的系统，其中所述几何属性基于形成所述代码的且布置在预定区域内的单元的数量超过阈值。</div>
<div class=""dep-clm"" num=""5"" parent=""2"">5.根据权利要求2所述的系统，其中所述几何属性基于所述代码的几何图案。</div>
<div class=""dep-clm"" num=""6"" parent=""1"">6.根据权利要求1所述的系统，其中所述预定条件基于所述代码的光学属性。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的系统，其中所述代码由50μm至200μm的单元形成，并且布置在600μm至1600μm的区域内。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的系统，其中所述代码读取系统包括用以施加加载条件以将所述容器转移到读取位置的定位机构，并且在所述读取位置获得所述数字图像。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的系统，其中所述定位机构被布置为随着量值增加而施加所述加载条件，并且所述检测系统被布置为在所述量值增加的加载条件施加期间确定所述预定条件。</div>
<div class=""dep-clm"" num=""10"" parent=""8"">10.根据权利要求8所述的系统，其中所述电气电路系统","A47J31/36, A47J31/44, A47J31/52, B65D85/804",20250307,雀巢产品有限公司,['Pending']
CN119947737A,Application of bifidobacterium longum transition type microorganism,The present invention relates to Bifidobacterium longum transition microorganisms for use in preventing and/or reducing the risk of infection in infants or young children.,"<div class=""indep-clm"" num=""1"">1.长双歧杆菌过渡型微生物，所述长双歧杆菌过渡型微生物用于预防和/或降低婴儿或幼儿的感染的风险。</div>
<div class=""indep-clm"" num=""2"">2.益生元，所述益生元用于预防和/或降低婴儿或幼儿的感染的风险；</div>
<div class=""indep-clm"" num=""2"">其中所述益生元是聚糖底物或人乳低聚糖(HMO)。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1用于所述用途的长双歧杆菌过渡型微生物，其中所述长双歧杆菌过渡型微生物与益生元结合地使用，所述益生元选自聚糖底物或人乳低聚糖(HMO)。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2用于所述用途的益生元，其中所述益生元与长双歧杆菌过渡型微生物结合地使用。</div>
<div class=""indep-clm"" num=""5"">5.长双歧杆菌过渡型微生物和益生元的组合，所述组合用于预防和/或降低婴儿或幼儿的感染的风险；其中所述益生元选自聚糖底物或人乳低聚糖(HMO)。</div>
<div class=""dep-clm"" num=""6"" parent=""2"">6.根据权利要求2至5中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述益生元是选自表1至表3中任一者列举的组的聚糖底物。</div>
<div class=""dep-clm"" num=""7"" parent=""2"">7.根据权利要求2至5中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述益生元是选自由2'-FL、3-FL、di-FL、3'-SL、6'-SL、LNT和LNnT以及它们的任何组合组成的组的HMO。</div>
<div class=""dep-clm"" num=""8"" parent=""2"">8.根据权利要求2至5中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述HMO是3-FL。</div>
<div class=""dep-clm"" num=""9"" parent=""6,7,8"">9.根据前述权利要求中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述长双歧杆菌过渡型微生物：(i)能够代谢所述HMO和/或所述聚糖底物；(ii)优先地利用3'-岩藻糖基乳糖(3-FL)而不是2'-岩藻糖基乳糖(2'-FL)；(iii)能够代谢选自表1至表3中任一者列举的组的聚糖底物；和/或(iv)编码一种或多种选自表1中列举的组的CAZyme，优选地其中所述长双歧杆菌过渡型微生物还编码一种或多种选自表2和表3的CAZyme。</div>
<div class=""dep-clm"" num=""10"" parent=""6,7,8,9"">10.根据前述权利要求中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述长双歧杆菌过渡型微生物与至少一种选自由CNCM I-5683、CNCM I-5684、CNCM I-5685、CNCM I-5686、CNCM I-5687、CMCC-P0001(ATCC BAA-2753)以及它们的任何组合组成的组的长双歧杆菌菌株具有至少98％的平均核苷酸同一性(ANI)。</div>
<div class=""dep-clm"" num=""11"" parent=""6,7,8,9,10"">11.根据前述权利要求中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述长双歧杆菌过渡型微生物和/或益生元：</div>
<div class=""dep-clm"" num=""11"" parent=""6,7,8,9,10"">(i)增加所述婴儿或幼儿的IL-6的水平；(ii)增加所述婴儿或幼儿的短链脂肪酸(SCFA)的水平，优选地其中所述SCFA选自乙酸盐、丁酸盐和/或丙酸盐；和/或(iii)调节肠道上皮屏障的渗透性；优选地其中所述长双歧杆菌过渡型微生物和/或益生元降低所述肠道上皮屏障的所述渗透性。</div>
<div class=""dep-clm"" num=""12"" parent=""6,7,8,9,10,11"">12.根据前述权利要求中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述感染是病毒感染、细菌感染或真菌感染。</div>
<div class=""dep-clm"" num=""13"" parent=""6,7,8,9,10,11,12"">13.根据前述权利要求中任一项用于所述用途的长双歧杆菌过渡型微生物、益生元或组合，其中所述感染是气道感染。</div>
<div class","A61K35/745, A61K31/702, A61P31/12, A61P11/00",20250506,雀巢产品有限公司,['Pending']
US20250083425A1,A multi-layer flexible packaging material,"The present invention relates generally to the field of multi-layer flexible packaging material. In particularly, the present invention relates to a multi-layer flexible packaging material to package dry food, preferably confectionery.","<div class=""indep-clm"" num=""1""><seg-con>1. A multi-layer flexible packaging material </seg-con><seg-trans>comprising </seg-trans><seg-refi>the following layers from the outer surface to the inner surface:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a paper layer with a grammage of from 40 to 120 g/m2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an optional hydrophilic layer with a grammage of at least 1.5 g/m2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a barrier layer comprising a material selected from the group consisting of metallized material, aluminium oxide, silicon oxide and mixtures thereof with a thickness from 20 to 300 nm, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a polymeric layer with a grammage of from 1.0 to 15.0 g/m2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the polymeric layer comprises at least one plastic polymer.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. A multi-layer flexible packaging material in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the barrier layer is metallised aluminium.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. A multi-layer flexible packaging material in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymeric layer comprises a polyolefin or polyester.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. A multi-layer flexible packaging material in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the polymeric layer comprises a polymer selected from the group consisting of polyethylene, polypropylene, polyethylene terephthalate, polyhydroxyalkanoates, polylactic acid and copolymers thereof and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. A multi-layer flexible packaging material in accordance with claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-","B32B27/10, B32B27/16, B32B27/32, D21H19/08, D21H19/22",20250313,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119156454A,Method for improving healthy life of dogs,The present invention provides a method for determining the risk of death and/or the probability of healthy lifetime of a dog; the method comprises a) providing a DNA methylation profile from a sample obtained from the dog; and b) using the DNA methylation profile to determine the probability of mortality risk and/or healthy lifespan of the dog.,"<div class=""indep-clm"" num=""1""><seg-con>1.用于确定狗的死亡风险和/或健康寿命的概率的方法；所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a)提供来自从所述狗获得的样本的DNA甲基化图谱；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>b)使用所述DNA甲基化图谱来确定所述狗的死亡风险和/或健康寿命的概率。</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-con>2.用于确定狗的生物学年龄的方法；所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""2""><seg-comp>a)提供来自从所述狗获得的样本的DNA甲基化图谱；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""2""><seg-comp>b)使用所述DNA甲基化图谱来确定所述狗的生物学年龄，其中所述DNA甲基化图谱与所述狗的死亡风险和/或健康寿命的概率相关。</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-con>3.用于为狗选择生活方式方案、膳食方案或治疗干预的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-comp>a)提供来自从所述狗获得的样本的DNA甲基化图谱；</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>b)使用所述DNA甲基化图谱来确定所述狗的死亡风险和/或健康寿命的概率；以及</seg-comp></div>
<div class=""indep-clm"" num=""3""><seg-comp>c)基于步骤b)中确定的所述死亡风险和/或健康寿命的概率来为所述狗选择合适的生活方式方案、膳食方案或治疗干预。</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-con>4.用于确定生活方式方案、膳食方案或治疗干预对改善狗的死亡风险的功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""4""><seg-comp>a)将生活方式方案、膳食方案或治疗干预应用于所述狗，其中已经根据权利要求3所述的方法选择所述生活方式方案、膳食方案或治疗干预；</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>b)在将所述生活方式方案、膳食方案或治疗干预应用于所述狗一段时间后；使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的死亡风险和/或健康寿命的概率；</seg-comp></div>
<div class=""indep-clm"" num=""4""><seg-comp>c)在遵循所述生活方式方案、膳食方案或治疗干预的所述时间段后，确定所述狗的所述死亡风险和/或健康寿命的概率是否存在变化。</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-con>5.用于确定生活方式方案、膳食方案或治疗干预对改善狗的死亡风险和/或健康寿命的概率的功效的方法，所述方法</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""5""><seg-comp>a)使用来自从所述狗获得的样本的DNA甲基化图谱来确定所述狗的死亡风险和/或健康寿命的概率；</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>b)将基于步骤a)中确定的所述死亡风险和/或健康寿命的概率选择的生活方式方案、膳食方案或治疗干预应用于所述狗；</seg-comp></div>
<div class=""indep-clm"" num=""5""><seg-comp>c)在将生活方式方案、膳食方案或治疗干预应用于所述狗一段时间后；使用来自从所述狗获得的样本的","C12Q1/6876, C12Q1/6883",20241217,雀巢产品有限公司,['Pending']
RU2837191C1,Fully automatic coffee machine and method for preparing coffee drink using such coffee machine,"FIELD: beverage preparation devices.SUBSTANCE: group of inventions relates to a fully automatic coffee machine (100) and a method for preparing a coffee drink using such a coffee machine, comprising a coffee extraction unit (10) with brewing chamber (1) for receiving powdered coffee, upper piston (2), lower piston (3) configured to move inside said cooking chamber (1) between a lower position and an upper position. Lower piston (3) comprises piston rod (31), which comprises inner channel (311) passing from channel inlet (311a) on the surface of the side wall of the rod to channel outlet (311b) on the rod bottom wall surface, and channel inlet (311a) is made and located on the rod side wall surface so that said channel inlet (311a) overlaps cooking chamber bottom wall (11) only when the lower piston is in upper position.EFFECT: possibility to discharge residual liquid in a fully automatic coffee machine, in particular, without contamination of the water supply line and without using a three-way valve.13 cl, 8 dwg","1. Полностью автоматическая кофемашина (100), содержащая блок (10) экстракции кофе, причем упомянутый блок экстракции кофе содержит:
- варочную камеру (1) для приема обжаренного и молотого порошкообразного кофе, причем упомянутая камера содержит верхний край (12), донную стенку (11) и штуцер (13) подвода воды,
- верхний поршень (2),
причем упомянутый верхний поршень выполнен с возможностью перемещения через верхний край варочной камеры и внутрь варочной камеры в дополнение к относительному перемещению варочной камеры и верхнего поршня, и
упомянутый верхний поршень содержит выходной канал (21) для жидкости,
- нижний поршень (3), выполненный с возможностью перемещения внутри упомянутой варочной камеры (1) между:
нижним положением, в котором нижний поршень опирается на донную стенку (11) варочной камеры, и
верхним положением, в котором нижний поршень находится у верхнего края (12) варочной камеры,
- причем нижний поршень (3) содержит стержень (31) поршня, при этом упомянутый стержень поршня проходит через донную стенку (11) варочной камеры, и
при этом стержень (31) поршня содержит внутренний канал (311), проходящий от входа (311a) канала на поверхности боковой стенки стержня к выходу (311b) канала на поверхности донной стенки стержня, и
при этом вход (311a) канала выполнен и расположен на поверхности боковой стенки стержня таким образом, что упомянутый вход (311a) канала перекрывает донную стенку (11) варочной камеры, только когда нижний поршень находится в верхнем положении.
2. Полностью автоматическая кофемашина по п. 1, причем машина содержит коллектор (8) жидких отходов, и выход (311b) канала на поверхности донной стенки стержня соединен с упомянутым коллектором жидких отходов.
3. Полностью автоматическая кофемашина по п. 1 или 2, в которой варочная камера (1) выполнена с возможностью перемещения посредством привода (6).
4. Полностью автоматическая кофемашина по предшествующему пункту, в которой:
- верхний поршень (2) зафиксирован,
- стержень (31) нижнего поршня со","A47J31/36, A47J31/44, A47J31/46",20250326,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2020322657B2,Confectionery,"The present invention relates to confectionery material, preferably milk-based confectionery, comprising an oligosaccharide mixture.","<div class=""indep-clm"" num=""1""><seg-main>1. A confectionery material comprising </seg-main><seg-clauses><seg-main>a carbohydrate mixture derived from a milk product, wherein the carbohydrate mixture is present in an amount greater than 0wt% and less than or equal to 35wt% of the confectionery material and the carbohydrate mixture comprises galactooligosaccharides, in an amount of 10-100wt% of the carbohydrate mixture, wherein the confectionery material comprises at least </seg-main><seg-clauses>1.0% and less than 32.5% by weight of the material of non-carbohydrate milk solids and at most 40wt% of the carbohydrate mixture is lactose.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A confectionery material according to claim 1, wherein </seg-main><seg-clauses><seg-main>at least </seg-main><seg-clauses>1.0% and less than 32.5% by weight of the confectionery material is the carbohydrate mixture.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A confectionery material according to claim 1 or claim 2, wherein </seg-main><seg-clauses>at most 30wt% of the carbohydrate in the mixture is lactose.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A confectionery material according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>from 0wt% to 15wt% of the total carbohydrates in the mixture is lactose.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A confectionery material according to any one of claims 1 to 4, wherein </seg-main><seg-clauses><seg-main>the carbohydrate mixture is a composition expressed as dry matter percentage by weight of the mixture:</seg-main>
<seg-clauses>a. Lactose 0-40%</seg-clauses>
<seg-clauses>b. Glucose 0-40%</seg-clauses>
<seg-clauses>c. Galactose 0-40%</seg-clauses>
<seg-clauses>d. Galactooligosaccharides 10-80%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-ma","A23G1/32, A23G1/40, A23G1/46, A23G3/36, A23G3/38",20251009,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250049080A1,Fermented hemp beverage,The present invention relates to a beverage composition comprising fermented hemp or fermented hemp extract. A further aspect of the invention is a method of preparing a beverage composition.,"<div class=""indep-clm"" num=""1""><seg-main>1. A beverage composition comprising </seg-main><seg-clauses>fermented hemp or fermented hemp extract wherein the weight ratio of the sum of 3-methylbutyl acetate and 3-methylbutanol to 3-methylbutanal is greater than 2000.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The beverage composition of claim 1 wherein </seg-main><seg-clauses>the weight ratio of the sum of 2-methylbutyl acetate and 2-methylbutanol to 2-methylbutanal is greater than 2000.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The beverage composition of claim 1 wherein </seg-main><seg-clauses>the weight ratio of the sum of 3-methylbutyl acetate, 2-methylbutyl acetate, isobutyl acetate, 2-phenylethyl acetate and 2-phenylethanol to 2,3-butanedione is greater than 50.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The beverage composition of claim 1 having </seg-main><seg-clauses>an ethanol content below 1.2 wt %.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The beverage composition of claim 1 wherein </seg-main><seg-clauses>the beverage composition is selected from the group consisting of a ready to drink beverage, a beverage liquid concentrate, a soluble beverage powder, dried aromatic plant material and combinations of these.</seg-clauses></div>
<div class=""ccl-clm"" num=""6"">6. (canceled)</div>
<div class=""indep-clm"" num=""7""><seg-main>7. A method of preparing a beverage composition comprising;</seg-main>
<seg-clauses>a. steeping hemp in water to form an aqueous hemp extract and steeped hemp;</seg-clauses>
<seg-clauses>b. fermenting the aqueous hemp extract in the presence or absence of the steeped hemp; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the fermentation is performed by yeast comprising <i>Pichia </i>yeast.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8. The method of claim 7 wherein </seg-main><seg-clauses>","A23L2/38, C12N1/16, C12R1/84",20250213,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2836324C1,Method for production of chocolate product (embodiments) and chocolate product,"FIELD: food industry.SUBSTANCE: invention relates to confectionary industry. Proposed is a method for production of a chocolate product involving production of material obtained from a cocoa-based substrate. Method involves treating a cocoa-based substrate with at least one enzyme selected from amylases, wherein the cocoa-based substrate is selected from cocoa powder and/or cocoa mass. Method also involves treating cocoa flesh with at least one enzyme selected from at least one cellulase and/or at least one pectinase. Method involves mixing cocoa pulp and a cocoa-based substrate. Then the dried product is dried and mixed with cocoa butter. In another embodiment, the method for production of a chocolate product involves additional mixing with ingredients selected from a group containing sugar, an emulsifier, milk-based ingredients and flavor additives and mixtures thereof. Also disclosed is a chocolate product produced by said method, containing cocoa butter and 20.0 wt.% to 90.0 wt.% of a mixture of cocoa pulp treated with an enzyme and a cocoa-based substrate treated with an enzyme.EFFECT: invention is aimed at improving the consistency of the product and the process by fermentation and/or enzymatic hydrolysis of the paste, and not individual beans (reducing the number of poorly fermented beans); providing controlled fermentation of paste with specific controlled microorganisms; reduced contamination, since the cocoa shell is not subjected to fermentation and drying in potentially unsuitable conditions; increased content of fibers in chocolate products in a controlled manner within the framework of a more orderly process and more homogeneous conditions of drying and roasting due to removal of individual beans from the process.13 cl, 3 dwg, 12 ex","1. Способ производства шоколадного продукта, включающий получение материала, полученного из субстрата на основе какао, включающий следующие стадии:
i. обработка субстрата на основе какао по меньшей мере одним ферментом, причём субстрат на основе какао выбран из какао-порошка и/или какао-массы;
ii. обработка мякоти какао по меньшей мере одним ферментом,
при этом способ включает смешивание мякоти какао и субстрата на основе какао;
iii. стадия сушки; и
iv. смешивание высушенного продукта с маслом какао,
причём по меньшей мере один фермент на стадии i. выбран из амилаз
и по меньшей мере один фермент на стадии ii. выбран из по меньшей мере одной целлюлазы и/или по меньшей мере одной пектиназы.
2. Способ по п. 1, в котором по меньшей мере один фермент на стадии i. выбран из амилоглюкозидазы, глюкоамилазы и альфа-амилазы.
3. Способ по п. 1 или 2, в котором на стадии сушки получают высушенную смесь, содержащую менее 10,0 масс.% воды.
4. Способ по п. 3, в котором смесь содержит от 40 масс.% до 95 масс.% мякоти и от 5 масс.% до 60 масс.% субстрата на основе какао.
5. Способ по любому из пп. 1–4, в котором общее количество используемого фермента составляет от 0,10 до 20% суммарной массы субстрата и мякоти какао, предпочтительно от 0,20 до 10%, более предпочтительно от 0,5 до 5,0%.
6. Способ по любому из пп. 2–5, в котором смесь ферментов содержит целлюлазу, пектиназу, альфа-амилазу и амилоглюкозидазу.
7. Способ по любому из пп. 1–6, в котором субстрат на основе какао и мякоть какао смешивают перед обработкой ферментом.
8. Способ по любому из пп. 1–7, в котором этапы обработки ферментами на стадиях i. и ii. являются параллельными или последовательными.
9. Способ по любому одному из пп. 1–8, который включает:
ферментативную обработку смеси мякоти какао и какао-порошка и/или тёртого какао, причём для ферментативной обработки используется смесь ферментов, которая содержит по меньшей мере одну целлюлазу, по меньшей мере одну пектиназу и по меньшей мере одну амилазу, причём общее ко",A23G1/00,20250312,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US12285039B2,Apparatus and method for roasting coffee beans,"The invention concerns an apparatus for roasting coffee beans comprising: —a vessel (<b>1</b>) to contain coffee beans, —a heating device (<b>12</b>) to heat coffee beans contained in the vessel, —a control system (<b>180</b>) operable to control the heating device and configured to apply a roasting recipe (R), wherein for a customised quantity m of coffee beans of type Ny introduced inside the vessel, —the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel and the type Ny of coffee beans introduced inside the vessel, and —based on the obtained type Ny, the control system is configured to get access at least to a roasting recipe Ry, said recipe being adapted to the roasting of one pre-determined quantity M of beans of type Ni, and to said pre-determined quantity M, and —based on the accessible roasting recipe Ry and on said obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe (R) to be applied to the quantity m of coffee beans of type Ny introduced inside the vessel.","<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for roasting coffee beans, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a vessel configured to contain the coffee beans,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a heating device configured to heat the coffee beans contained in the vessel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control system operable to control the heating device and configured to apply a roasting recipe by providing a temperature T<sub>@t1 </sub>to be applied at discrete successive times t<sub>1</sub>, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a measuring device configured to measure a customized quantity m of coffee beans introduced in the vessel,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, for the customized quantity m of coffee beans of type Ny introduced inside the vessel, the control system is configured to obtain at least:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the customized quantity m of coffee beans introduced inside the vessel, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the type Ny of coffee beans introduced inside the vessel, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the customized quantity m of coffee beans is automatically measured by the measuring device,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein, based on the type Ny, the control system is configured to access a roasting recipe Ry, the roasting recipe Ry being adapted to roast a pre-determined quantity M of coffee beans of type Ny and to the pre-determined quantity M, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>based on the roasting recipe Ry, on the pre-determined quantity M, and on the customized quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe to be applied","A23N12/12, A23F5/04, A23N12/08, A47J31/42, A47J42/52",20250429,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120152712A,Compositions and methods using combination of oleuropein and taurine,"The present invention provides a composition comprising oleuropein or a metabolite thereof in combination with taurine or a functional derivative thereof. The composition may be an oral nutritional composition, such as a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical use (FSMP). The composition may be administered to a subject in need thereof for improving a physiological state associated with metabolic fatigue in one or more cells in a subject, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress, and/or enhancing mitochondrial function, such as metabolic fatigue in one or more cells, in a subject. (iv) treating or preventing calcium deficiency/depletion disorders. Additionally or alternatively, the methods may treat or prevent a mitochondrial-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1"">1.组合物，所述组合物包含治疗有效量的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合，所述组合物用于在个体中(i)改善与一种或多种细胞中的代谢疲劳相关的生理状态，(ii)增加一种或多种细胞中的线粒体能量和线粒体钙摄取，以及(iii)增加抗氧化能力、降低氧化应激和/或增强线粒体功能，(iv)治疗或预防钙缺乏/耗竭障碍。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的组合物，其中所述一种或多种细胞的至少一部分是选自肝脏、肾、脑和骨骼肌的至少一个身体部分的一部分。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2用于所述用途的组合物，其中所述与代谢疲劳相关的生理状态包括肌肉疲劳或虚弱、缺乏能量、体能、缺乏活力或虚弱。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中任一项用于所述用途的组合物，所述组合物用于预防或治疗由运动引起的肌肉疲劳。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据权利要求1至4中任一项用于所述用途的组合物，其中所述有效量的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合每日口服施用持续至少一周。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项用于所述用途的组合物，其中所述橄榄苦苷的代谢物选自：橄榄苦苷苷元、羟基酪醇、橄榄酸、高香草醇、异高香草醇、其葡糖醛酸化形式、其硫酸化形式、其衍生物及其混合物。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据权利要求1至6中任一项用于所述用途的组合物，其中所述牛磺酸的官能衍生物选自牛磺罗定、牛磺胺、牛磺酰胺和1,4,5-氧杂噻嗪烷-4,4-二氧化物、4-(2-羟基乙基)-1-哌嗪乙磺酸、N-酰基牛磺酸、乙酰基高牛磺酸、N,N-二乙酰基水杨基氧乙基牛磺酸、酰基甲基牛磺酸、高牛磺酸和亚牛磺酸。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据权利要求1至7中任一项用于所述用途的组合物，其中所述组合物还包含至少一种选自以下的化合物：抗氧化剂、抗炎化合物、糖胺聚糖、益生元、纤维、益生菌、脂肪酸、酶、矿物质、微量元素和/或维生素。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据权利要求1至8中任一项用于所述用途的组合物，其中所述组合物选自食物组合物、膳食补充剂、营养组合物、口服营养补充剂、医疗食品、营养品、饮料、在食用前用水或乳重构的粉末状营养产品、食品添加剂、特殊医疗用途食品(FSMP)、药物、饮品、宠物食品及其组合。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据权利要求1至9中任一项用于所述用途的组合物，其中所述组合物呈固体粉末、粉末棒、胶囊或溶液的形式。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据权利要求1至10中任一项用于所述用途的组合物，其中所述有效量的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合在食物产品中施用，所述食物产品还包含选自以下的组分：蛋白质、碳水化合物、脂肪及其混合物。</div>
<div class=""indep-clm"" num=""12"">12.组合物，所述组合物包含治疗有效量的橄榄苦苷和/或其代谢物与牛磺酸和/或官能衍生物的组合，所述组合物用于在对其有需要或处于其风险中的个体中治疗线粒体相关疾病或与改变的线粒体功能相关的病症、降低所述疾病或病症的发病率和/或降低所述疾病或病症的严重性，所述方法包括向对其有需要或处于其风险中的个体口服施用有效量的组合物。</div>
<div class=""dep-clm"" num=""13"" parent=""12"">13.根据权利要求12用于所述用途的组合物，其中所述线粒体相关疾病或病症选自：应激、生理性衰老、肥胖、代谢率降低、代谢综合征、糖尿病、糖尿病并发症、高脂血症、神经退行性疾病、认知障碍、应激诱导的或应激相关的认知功能障碍、心境障碍、焦虑障碍、年","A61K31/351, A61K31/185, A61K31/7048, A61P3/14, A61P21/00",20250613,雀巢产品有限公司,['Pending']
CN120018777A,Foaming composition,"The present invention relates to foaming ingredients comprising one or more branched polysaccharides. The invention also relates to a beverage powder comprising said foaming ingredient, to a method for preparing said foaming ingredient, and to the use of said foaming ingredient for preparing a foaming beverage or food product.","<div class=""indep-clm"" num=""1"">1.包含碳水化合物和包载气体的发泡成分，其中所述碳水化合物包含一种或多种支化多糖，或者由一种或多种支化多糖组成。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的发泡成分，其中所述一种或多种支化多糖具有：(i)约20％或更大、约25％或更大、约30％或更大、约35％或更大、约40％或更大、约45％或更大，或者约50％或更大的支化度；(ii)约0.49或更小、约0.48或更小、约0.47或更小、约0.46或更小、约0.45或更小、约0.44或更小，或者约0.43或更小的构象斜率；以及/或者(iii)约0.40或更小、约0.39或更小、约0.38或更小、约0.37或更小，或者约0.36或更小的Mark-Houwink-Sakurada(MHS)斜率。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的发泡成分，其中所述一种或多种支化多糖包含以下项或由以下项</seg-con><seg-trans>组成：</seg-trans><seg-refi>一种或多种支化糊精、一种或多种聚右旋糖、一种或多种阿拉伯半乳聚糖，或其任何组合。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述的发泡成分，其中所述发泡成分包含总量为约50重量％至约90重量％、约55重量％至约90重量％，或约60重量％至约90重量％的所述一种或多种支化多糖。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述的发泡成分，其中所述发泡成分包含其量为约5重量％至约30重量％、约5重量％至约25重量％，或约5重量％至约20重量％，或约5重量％至约15重量％的一种或多种乳化剂，任选地其中所述一种或多种乳化剂包含蛋白质或由蛋白质组成。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据任一前述权利要求所述的发泡成分，其中所述发泡成分包含其量为约1重量％至约50重量％、约2重量％至约50重量％、约5重量％至约50重量％，或约10重量％至约50重量％的一种或多种增塑剂，任选地其中所述一种或多种增塑剂包含以下项或由以下项</seg-con><seg-trans>组成：</seg-trans><seg-refi>一种或多种麦芽糖糊精、一种或多种葡萄糖糖浆、一种或多种单糖、一种或多种二糖、一种或多种盐、一种或多种多元醇，或其任何组合。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述的发泡成分，其中所述发泡成分为多孔可溶性粉末形式。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述的发泡成分，其中所述包载气体以约6.0ml/g或更多、约6.5ml/g或更多、约7.0ml/g或更多、约7.5ml/g或更多，或者约8.0ml/g或更多的量存在。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据任一前述权利要求所述的发泡成分，其中所述发泡成分在室温处在12个月时期内损失少于约30％、少于约29％、少于约28％、少于约27％、少于约26％、少于约25％、少于约24％、少于约23％、少于约22％、少于约21％、少于约20％、少于约19％、少于约18％、少于约17％、少于约16％、少于约15％的所述包载气体。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据任一前述权利要求所述的发泡成分，其中所述发泡成分当在液体中复溶时，产生约8cm<sup>3</sup>/g或更多、约9cm<sup>3</sup>/g或更多，或者约10cm<sup>3</sup>/g或更多的泡沫体积，任选地其中约60％或更多、约65％或更多、约70％或更多，或者约75％或更多的所述泡沫体积在所述泡沫产生后保留5分钟。</div>
<div class=""indep-clm"" num=""11""><seg-con>11.用于制备发泡成分的方法，</seg-con><seg-trans","A23F5/40, A23L29/25, A23L29/30, A23P30/40, A23C9/152",20250516,雀巢产品有限公司,['Pending']
WO2025228945A1,Edible chew for oral use by infants and young children,"The present invention relates to an article, also referred to as an edible chew, which can be applied to oral use by infants and young children, especially during teething and/or for soothing, as well as to a method of manufacture of this edible chew.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. An article comprising </seg-main><seg-clauses>at least one cereal flour, at least one plasticizer and milk powder wherein the article comprises a first part extending into a first direction, a second part extending into a second direction and a third part extending into a third direction, wherein each of the first, second and third directions extend from a common origin.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The article according to claim 1, wherein </seg-main><seg-clauses>the common origin is the point where the center lines of each of the first part, the second part and the third part intersect and wherein the first, second and third directions and the common origin are preferably in the same plane.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The article according to claim 1 or 2, wherein </seg-main><seg-clauses><seg-main>one, two or three of the following are fulfilled:</seg-main>
<seg-clauses>(i) the angle between the second and third directions is in the range of from 60 to 120°, preferably 70 to 110°, more preferably 80 to 100°, even more preferably 85 to 95°, most preferably about 90°;</seg-clauses>
<seg-clauses>(ii) the angle between the first and second directions is in the range of from 110 to 160°, preferably 115 to 155°, more preferably 120 to 150°, even more preferably 125 to 145°, most preferably about 135°;</seg-clauses>
<seg-clauses>(iii) the angle between the first and third directions is in the range of from 110 to 160°, preferably 115 to 155°, more preferably 120 to 150°, even more preferably 125 to 145°, most preferably about 135°.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The article according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>one or both of the second and third parts are bent away from the first part and preferably form a curved part, which may have the f","A21D13/06, A21D13/40, A21D13/48, A23L33/00, A23P30/10",20251106,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250346954A1,Method to improve health outcomes of a dog using biological age,"The present invention for selecting a lifestyle regime, dietary regime or therapeutic intervention for a dog, the method comprising: a) providing a DNA methylation profile from a sample obtained from the dog; b) determining a biological age of the dog using the DNA methylation profile; and c) selecting a suitable lifestyle regime, dietary regime or therapeutic intervention for the dog based on the biological age determined in step b).","<div class=""indep-clm"" num=""1""><seg-main>1. A method for selecting a lifestyle regime, dietary regime or therapeutic intervention for a dog, the method comprising:</seg-main>
<seg-clauses>a) providing a DNA methylation profile from a sample obtained from the dog;</seg-clauses>
<seg-clauses>b) determining a biological age of the dog using the DNA methylation profile; and</seg-clauses>
<seg-clauses>c) selecting a suitable lifestyle regime, dietary regime or therapeutic intervention for the dog based on the biological age determined in step b).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A method for determining the efficacy of a lifestyle regime, dietary regime or therapeutic intervention for improving the biological age of a dog, said method comprising:</seg-main>
<seg-clauses>a) applying a lifestyle regime, dietary regime or therapeutic intervention to the dog, wherein the lifestyle regime, dietary regime or therapeutic intervention has been selecting according to the method of claim <b>1</b>;</seg-clauses>
<seg-clauses>b) after a time period of applying the lifestyle regime, dietary regime or therapeutic intervention to the dog; determining a biological age of the dog using a DNA methylation profile from a sample obtained from the dog;</seg-clauses>
<seg-clauses>c) determining if there has been a change in the biological age of the dog after the time period of following the lifestyle regime, dietary regime or therapeutic intervention.</seg-clauses></div>
<div class=""ccl-clm"" num=""5"">3-5. (canceled)</div>
<div class=""indep-clm"" num=""6""><seg-main>6. A method for preventing or reducing the risk of a dog developing a disease; the method comprising:</seg-main>
<seg-clauses>a) determining a biological age of the dog using a DNA methylation profile from a sample obtained from the dog; wherein the biological age determined for the dog is associated with an increased likelihood to develop the disease; and</seg-clauses>
<seg-clauses>b) selecting ",C12Q1/6876,20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2835402C1,Coffee beans roasting and processing equipment,"FIELD: food industry.SUBSTANCE: invention relates to equipment for roasting and processing coffee beans, including roasting device (50) and associated processing device (60, 70); wherein roasting device (50) is configured to receive coffee beans of a certain type, wherein roasting device includes reading means (53) for identifying characteristics of coffee beans dispensed into it, wherein roasting device (50) further includes a control unit, configuring the roasting profile of the grains in accordance with the characteristics extracted from reading means (53) and/or according to the grains characteristics in data base (51) in the control unit, and/or in accordance with the data entered by the user; wherein the roasted coffee beans are transferred to coffee treatment device (60, 70) for the beverage preparation, wherein roasting device (50) includes a data transmission function for transmitting the roasted coffee bean type parameters to treatment device (60, 70) for the treatment coffee; wherein coffee processing device (60, 70) receives roasted coffee beans of one or more types from roasting device (50); wherein the coffee processing device comprises data reading device (62, 72) for obtaining information on roasted coffee beans product parameters; wherein coffee processing device (60, 70) additionally contains a control unit configured to adapt the processing parameters used for the beverage preparation depending on the roasted coffee beans product parameters. Invention also relates to a method of roasting and treating coffee beans using roasting and processing equipment similar to that described. Furthermore, the invention relates to the use of roasting and processing equipment similar to that described for dispensing a coffee drink of a certain type and/or a certain amount of ground coffee.EFFECT: coffee machine can adjust the processing parameters in accordance with the required target output and depending on the beans used, integrity of the procedure and information is also ensured by reporting the correct parameters to be used.15 cl, 20 dwg","1. Оборудование для обжаривания и обработки кофейных зерен, включающее в себя обжаривающее устройство (50) и связанное с ним устройство (60, 70) для обработки кофе;
причем обжаривающее устройство (50) выполнено с возможностью приема кофейных зерен определенного типа, подлежащих обжариванию, при этом обжаривающее устройство включает в себя средство (53) считывания для идентификации характеристик кофейных зерен, выдаваемых в него, причем обжаривающее устройство (50) дополнительно включает в себя блок управления, конфигурирующий профиль обжаривания зерен в соответствии с характеристиками, извлеченными из средства (53) считывания, и/или согласно характеристикам зерен в базе (51) данных в этом блоке управления, и/или в соответствии с данными, введенными пользователем; при этом обжаренные кофейные зерна переносятся в устройство (60, 70) для обработки кофе для приготовления напитка, причем обжаривающее устройство (50) включает в себя функцию передачи данных для передачи параметров продукта обжаренных кофейных зерен определенного типа в устройство (60, 70) для обработки кофе;
при этом устройство (60, 70) для обработки кофе принимает обжаренные кофейные зерна одного или более типов из обжаривающего устройства (50); причем устройство для обработки кофе содержит устройство (62, 72) считывания данных для получения информации о параметрах продукта обжаренных кофейных зерен; при этом устройство (60, 70) для обработки кофе дополнительно содержит блок управления, выполненный с возможностью адаптации параметров обработки, используемых для приготовления напитка, в зависимости от параметров продукта обжаренных кофейных зерен.
2. Оборудование для обжаривания и обработки кофейных зерен по п. 1, в котором устройство (60, 70) для обработки кофе содержит кофемолку (60) и/или устройство (70) экстракции кофейного напитка.
3. Оборудование для обжаривания и обработки кофейных зерен по любому из пп. 1, 2, в котором параметры обработки, используемые для приготовления напитка, включают в себя пар",A47J31/42,20250225,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250040728A1,Bulk dosing system,"The invention relates to a food and/or beverage product container, a dispensing unit and a dispensing system comprising the product container and the dispensing unit. The dispensing unit comprises a handle, the downwards movement of the handle causes the tilting plate of the dispensing unit to be lifted which allows the delivery of the product from the inner volume of the product container through an aperture.","<div class=""indep-clm"" num=""1""><seg-con>1. Product container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>an inner volume for receiving a food and/or beverage product,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a rigid insert comprising a linking member and an aperture allowing the delivery of the food and/or beverage product out of the inner volume of the product container and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an interface comprising an outlet linked to the rigid insert via the linking member, the interface being connectable to an external dispensing unit</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the interface is movable for covering and uncovering the aperture completely or to a certain extent.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Product container according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the interface is detachable from the product container.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Product container according to claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the linking member is configured as a slider.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Product container according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the movement of the interface is vertical.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. Product container according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>it is flexible and compressible.</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-con>6. Dispensing unit for receiving a product container </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""6""><seg-refi>a frame surrounding the dispensing unit,</seg-refi></div>
<div class=""indep-clm"" num=""6""><seg-refi>a handle attached to the frame in an initial position,</seg-refi></",A47F1/03,20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12403151B2,Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility,"This invention relates to nutritional compositions comprising at least one N-acetylated oligosaccharide for use in the promotion of the development and/or of the growth of the intestinal muscles, in the promotion of contractile capacity and/or the motility in the intestine, in the promotion of enteral feeding tolerance and in prevention and/or treatment of small intestinal bacterial overgrowth (SIBO) in an infant, a young child or, when the composition is a growing-up milk, in a child.",,"A61K31/702, A23L33/00, A23L33/135",20250902,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2847358C2,"Liquid hydrolysates of animal origin, including milk fat","FIELD: protein production.SUBSTANCE: a group of inventions relates to the production of protein and its use in feed production. A liquid hydrolysate of animal protein is disclosed, containing hydrolysed animal tissue, an antioxidant and from approximately 0.1% by weight to approximately 5% by weight of milk fat, calculated on the total weight of the liquid hydrolysate of animal protein. A pet food composition containing a granule and the specified liquid hydrolysate is also described. A method for obtaining a composition suitable for consumption by pets is also disclosed.EFFECT: increased palatability of the feed.15 cl, 2 tbl, 3 ex","1. Жидкий гидролизат белка животного происхождения, содержащий:
гидролизованную ткань животного;
антиоксидант; и
от примерно 0,1 мас.% до примерно 5 мас.% молочного жира в расчёте на общую массу жидкого гидролизата белка животного происхождения.
2. Жидкий гидролизат белка животного происхождения по п. 1, в котором молочный жир не является липолизированным и присутствует в количестве от более 1 мас.% до примерно 5 мас.%.
3. Жидкий гидролизат белка животного происхождения по п. 1, в котором молочный жир является липолизированным и присутствует в количестве от более 2 мас.% до примерно 5 мас.%.
4. Жидкий гидролизат белка животного происхождения по п. 1, дополнительно включающий в себя от примерно 5 мас.% до примерно 25 мас.% холинового соединения в расчёте на общую массу жидкого гидролизата белка животного происхождения.
5. Жидкий гидролизат белка животного происхождения по п. 1, в котором молочный жир включает в себя молочный жир, сливочный жир, сырный жир или их комбинацию.
6. Жидкий гидролизат белка животного происхождения по п. 2, представляющий собой натуральный жидкий гидролизат белка животного происхождения.
7. Композиция корма для домашних животных, содержащая:
гранулу; и
жидкий гидролизат белка животного происхождения, нанесённый на гранулу в виде покрытия или включённый в гранулу, причём жидкий гидролизат белка животного происхождения включает в себя:
гидролизованную ткань животного;
антиоксидант; и
молочный жир,
причём молочный жир присутствует в составе композиции корма для домашних животных в количестве от примерно 0,001 мас.% до примерно 0,15 мас.% в расчёте на содержание сухих веществ.
8. Композиция корма для домашних животных по п. 7, в которой молочный жир не является липолизированным и включён в состав композиции корма для домашних животных в количестве от примерно 0,015 мас.% до примерно 0,15 мас.% либо молочный жир является липолизированным и включён в состав композиции корма для домашних животных в количестве от примерно 0,025 мас.% до примерно 0,1","A23J1/02, A23J3/04, A23K10/20",20251003,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250344710A1,Foaming creamer,"Creamers for food products, such as coffee and tea, and a foaming liquid creamer provides a foam layer when added to a beverage.","<div class=""indep-clm"" num=""1""><seg-con>1: A process of preparing a foaming liquid creamer, the process </seg-con><seg-trans>comprising;</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>mixing protein at a level from 1 to 6%, fat at a level from 1 to 8%, and less than 0.01% of monoacylglycerols, diacylglycerols, diacetylated tartaric acid esters of monoglycerides, propylene glycol monostearate and sorbitan tristearate, to create a liquid at a solids content from 20 to 40%;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>sterilizing the liquid using ultra-high temperature (UHT) treatment; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>homogenizing the liquid;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein the homogenizing is performed before UHT treatment, after UHT treatment, or before and after UHT treatment.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The process according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the foaming liquid creamer is filled into a container which is then closed, leaving a headspace representing 15 to 40% of the internal volume of the container.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3: The process according to claim 2 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the container is aseptically filled and sealed.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The process according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the foaming liquid creamer comprises cellulose at a level from 0.1 to 0.3% and alginate at a level from 0.1 to 0.3%.</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-con>5: A packaged foaming liquid creamer </seg-con><seg-trans>comprising </seg-trans><seg-refi>a foaming liquid creamer comprising protein and fat, wherein</seg-refi></div>
<div class=""indep-clm"" num=""5""><seg-refi>the protein is present at a level from 1 to 6%;</seg-refi></div>
<div c","A23C11/04, A23B11/123, A23L27/30, A23L29/212, A23L29/256",20251113,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2019380497B2,Liquid creamer,"The present invention relates to creamers for food products such as coffee and tea. In particular, the invention relates to a liquid creamer comprising casein based protein, pea protein, gellan gum, bicarbonate, citrate and oil. Further aspects of the invention are a beverage comprising a liquid creamer and a process for preparing a liquid creamer.","<div class=""indep-clm"" num=""1""><seg-con>1. A liquid creamer </seg-con><seg-trans>comprising </seg-trans><seg-refi>casein-based protein, pea protein, gellan gum, bicarbonate, citrate and oil, wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the casein-based protein is present at a level between 0.7 and 1.4 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pea protein is present at a level between 0.07 and 0.4 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the gellan gum is present at a level between 0.025 and 0.045 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the bicarbonate is present at a level between 0.07 and 0.15 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the citrate is present at a level between 0.18 and 0.24 %, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the oil is present at a level between 6 and 12 %,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>all percentages being as a weight percentage of the liquid creamer,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the casein-based protein is selected from the group consisting of caseinate, micellar casein and combinations of these.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The liquid creamer according to claim 1, which contains less than 0.001 wt.% monoacylglycerols, diacylglycerols and diacetylated tartaric acid esters of monoglycerides.</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The liquid creamer according to claim 1 or 2, which contains less than 0.001 wt.% phosphate salts.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4. The liquid creamer according to any one of claims 1 to 3, which contains less than 0.001 wt.% polysaccharides other than gellan gum.</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The liquid creamer according to any one of claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the gellan gum is a high acyl ","A23F5/02, A23C11/02, A23L29/269",20250102,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
US12397271B2,Apparatus comprising a hygienic cooling system and method,"An apparatus for mixing a liquid or pasty product. The apparatus includes a first housing part (<b>11</b>) and a second housing part (<b>12</b>) assembled together. The assembly of the first housing part (<b>11</b>) and the second housing (<b>12</b>) part forms •—a housing inner space (<b>17</b>) between an inlet (<b>4</b>) and an outlet (<b>5</b>), •—a cooling jacket (<b>7</b>) for circulation of a coolant fluid around the housing inner space (<b>17</b>), and •—a buffer jacket (<b>9</b>) for circulation of a clean fluid, the buffer jacket (<b>9</b>) being formed between the cooling jacket (<b>7</b>) and the housing inner space (<b>17</b>). The buffer jacket protects the mixed product from contamination by the coolant fluid. It also facilitates detection of leakage between the housing inner space and the buffer jacket. The invention also relates to a corresponding method.","<div class=""indep-clm"" num=""1""><seg-con>1. An apparatus for mixing a liquid or pasty product, the apparatus </seg-con><seg-trans>comprising </seg-trans><seg-refi>a housing, said housing comprising an inlet for the liquid or pasty product to be mixed and an outlet for the mixed liquid or pasty product, and at least one set of a rotor and a stator for mixing the liquid or pasty product,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the apparatus comprising at least a first housing part and a second housing part,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the first housing part being assembled to the second housing part,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the assembly of the first housing part and the second housing part forming a housing inner space between the inlet and the outlet where the liquid or pasty product flows,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the assembly of the first housing part and the second housing part forming a cooling jacket for circulation of a coolant fluid around the housing inner space, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the assembly of the first housing part and the second housing part forms a buffer jacket for circulation of a clean fluid, the buffer jacket being formed between the cooling jacket and the housing inner space.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. An apparatus for mixing a liquid or pasty product according to claim 1, </seg-con><seg-trans>wherein</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>an inner seal is interposed, at an interface between the first housing part and the second housing part, between the housing inner space and the buffer jacket,</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-comp>a middle seal is interposed, at an interface between the first housing part and the second housing part, between the buffer jacket and the cooling jacket; and</seg-","B01F27/27, A23P30/40, B01F23/235, B01F27/271, B01F35/92",20250826,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN120051215A,Roasted coffee,"The invention relates to a method for roasting coffee, in particular roasting extracted raw coffee at elevated pressure followed by roasting at lower pressure. Other aspects of the invention are roasted coffee and a container for use in a beverage preparation device, the container containing the roasted coffee.","<div class=""indep-clm"" num=""1"">1.用于烘焙咖啡的方法，所述方法包括</div>
<div class=""indep-clm"" num=""1"">a.将经提取的生咖啡在大于2巴的压力下烘焙20秒与900秒之间的时间段，其中在烘焙之前，所述经提取的生咖啡包含量小于相同咖啡的未提取样品中的蔗糖的量的80％的蔗糖；以及</div>
<div class=""indep-clm"" num=""1"">b.将步骤a的烘焙的经提取的咖啡在0.5巴与1.5巴之间的压力和180℃与260℃之间的咖啡温度下烘焙20秒与1200秒之间的时间段。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中所述经提取的生咖啡是通过用含水液体提取生咖啡然后从提取物中分离所述经提取的生咖啡而获得的。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的方法，其中在提取之前，尚未将所述生咖啡加热至高于110℃的温度。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据权利要求1至3中一项所述的方法，其中在步骤b中进行烘焙之前，将步骤a的烘焙的经提取的咖啡与含水生咖啡提取物组合。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的方法，其中所述含水生咖啡提取物是通过用含水液体提取生咖啡然后从提取物中分离所述经提取的生咖啡而获得的。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据权利要求1至5中任一项所述的方法，其中在步骤a)中在高于9.5巴的压力下在过热蒸汽的存在下烘焙所述经提取的生咖啡。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5"">7.根据权利要求1至5中任一项所述的方法，其中在步骤a)中在惰性气体的存在下烘焙所述经提取的生咖啡。</div>
<div class=""indep-clm"" num=""8"">8.烘焙咖啡，所述烘焙咖啡具有大于4的二甲基二硫化物与2，3-二乙基-5-甲基吡嗪的重量比。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的烘焙咖啡，其中愈创木酚与二甲基二硫化物的重量比小于30。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求8或权利要求9所述的烘焙咖啡，其中二甲基三硫化物与2，3-二乙基-5-甲基吡嗪的重量比大于0.6。</div>
<div class=""dep-clm"" num=""11"" parent=""8,9,10"">11.根据权利要求8至10中任一项所述的烘焙咖啡，其中二甲基二硫化物与甲硫醇的重量比大于1.5。</div>
<div class=""dep-clm"" num=""12"" parent=""8,9,10,11"">12.根据权利要求8至11中任一项所述的烘焙咖啡，所述烘焙咖啡具有30CTN与100CTN之间的烘焙颜色。</div>
<div class=""dep-clm"" num=""13"" parent=""8,9"">13.根据权利要求8或权利要求9所述的烘焙咖啡，所述烘焙咖啡是用于进一步烘焙的封装的烘焙咖啡。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的烘焙咖啡，其中所述咖啡具有75CTN与160CTN之间的烘焙颜色。</div>
<div class=""indep-clm"" num=""15"">15.用于在饮料制备装置中使用的容器，所述容器含有根据权利要求8至12中任一项所述的烘焙咖啡。</div>","A23F5/04, A23F5/06, A23F5/16",20250527,雀巢产品有限公司,['Pending']
AU2023348158A1,Composition and method for treating muscle decline associated with renal disease or dysfunction,,"<div class=""indep-clm"" num=""1""><seg-con>1. A nutritional composition for use in preventing and/or treating a disease or condition associated with muscle decline in a subject in need thereof, </seg-con><seg-trans>comprising </seg-trans><seg-refi>medium-chain triglycerides (MCT) and at least one ingredient selected from the group consisting of:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Fish oil,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>L-arginine,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin E,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin C,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B3,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B5,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B6,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin Bl,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Vitamin B2,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Folic acid,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Biotin,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>Bitamin B12.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The nutritional composition as claimed in claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>it comprises medium-chain triglycerides (MCT) in a daily amount ranging from 1000 to about 20000 mg per kg of weight of the subject and at least one ingredient selected from the group consisting of:</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>Fish oil in a daily amount ranging from about 100 to about 5000 mg per kg of weight of the subject,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>L-arginine in a daily amount ranging from about 100 to about 50000 mg per kg of weight of the subject,</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>Vitamin E in a daily amount ranging from about 1 ","A23L33/115, A23K20/142, A23K20/158, A23K20/174, A23L33/12",20250227,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019410752B2,Enteral nutrition container cap and methods of making and using the cap,"A package closure system may include a package outlet including a first connection element and a cap configured to removably connect to the package outlet using the first connection element and comprising a second connection element. An overcap can be configured to removably connect to the cap using the second connection element. A method for providing a nutritional composition from a container to an enteral line may include: removing an overcap from a cap, the cap is configured to direct a nutritional composition through a channel within the cap, the cap removably connected to the container; connecting the cap sealingly to the enteral line; and applying a pressure to the container to direct the nutritional composition from the container through the channel and into the enteral line.","<div class=""indep-clm"" num=""1""><seg-con>Claim 1: A package closure system </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a deformable package housing a nutritional composition;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a spout extending from the package, the spout comprising a first connection element;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a cap comprising an upper portion, a lower portion and a channel, the cap being configured to removably connect directly to the first connection element, and comprising a second connection element, the second connection element configured to connect to an enteral line to position the channel leading from the spout to the enteral line such that the cap indirectly connects the spout to the enteral line by the channel, wherein the second connection element is a connector according to ISO 80369-3, and wherein the upper portion comprises one or more further connection elements in addition to the second connection element.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>Claim 2: The system according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the first connection element comprises a first threaded connection element.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>Claim 3: The system according to claim 1 or 2, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>an overcap, the overcap configured to close the channel of the cap.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>Claim 4: The system according to claim 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the cap is configured to be disconnectable from the spout,</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-refi>wherein the overcap is configured to be disconnectable from the cap, and</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-refi>wherein the overcap, the cap, and the spout mai","A61J1/14, A61J9/00, A61M5/162, B65D5/74",20250626,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
RU2844513C1,Method for production of milk-like products,"FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology, in particular to a method for producing a product similar to human milk. Said method includes: A) obtaining lactocytic, mammary gland-like, organoids obtained from induced pluripotent human stem cells (hiPSC), by culturing hiPSC in 3D suspension conditions to form mammospheres and culturing mammospheres in 3D suspension conditions for at least 10 days to obtain lactocytes; and B) secretion of a product similar to human milk from such lactocytes from induced pluripotent human stem cells (hiPSC).EFFECT: present invention provides an efficient method of producing a product similar to human milk.12 cl, 4 dwg, 3 tbl, 4 ex","1. Способ получения продукта, подобного человеческому молоку, включающий:
A) получение лактоцитарных, подобных молочной железе, органоидов, полученных из индуцированных плюрипотентных стволовых клеток человека (hiPSC), путем культивирования hiPSC в условиях 3D-суспензии для образования маммосфер и культивирование маммосфер в условиях 3D-суспензии по меньшей мере в течение 10 дней для получения лактоцитов; и
B) секрецию продукта, подобного человеческому молоку, из таких лактоцитов из индуцированных плюрипотентных стволовых клеток человека (hiPSC).
2. Способ по п. 1, где стадию A) проводят в течение по меньшей мере 42 дней.
3. Способ по п. 1 или 2, где стадию A) проводят в биореакторе.
4. Способ по любому из пп. 1-3, в котором стадию A) определяют следующим образом:
i) получение эмбриоидных телец (ЭТ) из hiPSC путем инкубации в стандартной для iPSC среде E8, содержащей DMEM/F12, магния L-аскорбиновая кислота-2-фосфат, селенит натрия, FGF2, инсулин, NaHCO<sub>3</sub>и трансферрин, TGFβ1 или NODAL, или в среде mTeSR™ в течение двух дней и получение эмбриоидных телец, культивированных в среде MammoCult, (мЭТ) сильно обогащенных неневральными эктодермальными клетками, путем инкубации ЭТ в полной среде MammoCult, содержащей базальную среду, добавку для пролиферации и дополненной гепарином и гидрокортизоном, в течение 10 дней,
и в котором стадия A) подразделяется на дополнительные подстадии и включает в себя следующие стадии: ii), iii) и iv):
ii) инкубация мЭТ в полной среде EpiCultB, дополненной добавкой EpiCult для пролиферации и паратиреоидным гормоном (pTHrP), в течение 5 дней,
iii) стимулирование дифференцировки ветвей и альвеол и спецификации клеток молочной железы путем инкубации мЭТ в среде EpiCultB, дополненной добавкой EpiCult для пролиферации, гидрокортизоном, инсулином, FGF10 и HGF, в течение 20 дней, и
iv) индукция экспрессии молочного белка путем инкубации мЭТ в среде EpiCultB, дополненной добавкой EpiCult для пролиферации, гидрокортизоном, инсулином, FBS, про","A23L33/19, A23C9/00, C12N5/071, A23C9/13",20250801,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025119709A1,Method for reducing emissions from manure,,,"C05C11/00, C05F3/00, C05F11/02, A01C3/00",20250612,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2023378946A1,Beverage preparation machine,"The invention concerns a a beverage preparation machine and a pod containing a beverage ingredient, wherein a machine-readable code (34) storing preparation information is arranged on the surface of at least one of the enclosing walls, wherein the beverage preparation machine comprises : - an extraction device for extracting a beverage from the pod, and - a code reading system to read the code of the pod, and wherein the code reading system includes a code reader (9) and a positioning mechanism to move the pod and the code reader relative to each other :. from a holding position, in which the pod is separated from a reading head (91) of the code reader,. to a reading position, in which the code of the pod is in contact with the reading head, and wherein the beverage preparation machine comprises a pre-piercing arrangement (28) configured to pierce the pod before the code of the pod is read in the reading position.","<div class=""indep-clm"" num=""1""><seg-main>1. System comprising </seg-main><seg-clauses><seg-main>a beverage preparation machine and a pod containing a beverage ingredient,</seg-main>
<seg-main class=""seg-enter"">wherein the pod (3) comprises a first and a second enclosing walls (31, 3T, 32), said first and second enclosing walls defining a chamber for enclosing the beverage ingredient (33), and wherein a machine-readable code (34) storing preparation information is arranged on the surface of at least one of the enclosing walls,</seg-main>
<seg-main class=""seg-enter"">wherein the beverage preparation machine comprises :</seg-main>
<seg-clauses>- an extraction device for extracting a beverage from the pod, and</seg-clauses>
<seg-clauses>- a code reading system to read the code of the pod, and</seg-clauses>
<seg-clauses>- electrical circuitry to control the extraction device based on the preparation information read from the code,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the code reading system includes a code reader (9) and a positioning mechanism to move the pod and the code reader relative to each other:</seg-clauses>
<seg-clauses class=""seg-enter"">. from a holding position, in which the pod is separated from a reading head (91) of the code reader,</seg-clauses>
<seg-clauses class=""seg-enter"">. to a reading position, in which the code of the pod is in contact with the reading head,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the beverage preparation machine comprises a pre-piercing arrangement (28) configured to pierce the pod before the code of the pod is read in the reading position.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. System according to Claim 1, wherein </seg-main><seg-clauses>the pre-piercing arrangement (28) is configured to pierce the wall opposed to the wall to be contacted by the reading head.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. System according to Cl",A47J31/44,20250327,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12337569B2,System and method for forming a compostable pod for beverages from a sheet having a controlled moisture level,"The invention relates to a system (<b>100</b>) for manufacturing a compostable pod (<b>900</b>) for brewing products. Therein, the pod (<b>900</b>) is made from a sheet (<b>600</b>) made of a biodegradable cellulose-based material. The system (<b>100</b>) comprises at least one shaping line (<b>200</b>), which comprises a handling unit (<b>300</b>) for transferring the sheet (<b>600</b>) along a transfer direction (TD) through the system (<b>100</b>). The shaping line (<b>200</b>) further comprises a humidifying unit (<b>400</b>) for moistening at least one side of the sheet (<b>600</b>) with a moistening agent (<b>401</b>), and a forming unit (<b>800</b>) for shaping a part of the moistened sheet (<b>600</b>) into a three-dimensional shape to form a pod element (<b>910</b>), which defines a pod cavity (<b>911</b>). The shaping line (<b>200</b>) comprises further a humidity sensor system (<b>500</b>) for visually sensing a level of humidity of at least a section of the moistened sheet (<b>600</b>). Values related to the level of humidity sensed by the humidity sensor system (<b>500</b>) are received by a control unit (<b>700</b>), which is further configured to control the humidifying unit (<b>400</b>) based on these values. The invention also relates to a method for manufacturing a compostable pod (<b>900</b>), whereby a level of humidity of at least a section of the moistened sheet (<b>600</b>) is visually sensed and forwarded for controlling the moistening process of the at least one side of the sheet (<b>600</b>) correspondingly.","<div class=""indep-clm"" num=""1""><seg-con>1. System for manufacturing a compostable pod for brewing products from a sheet made of a biodegradable cellulose-based material, the system </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least one shaping line, which comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a handling unit for transferring the sheet along a transfer direction through the system;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a humidifying unit for moistening at least one side of the sheet with a moistening agent; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a forming unit for shaping a part of the moistened sheet into a three-dimensional shape to form a pod element defining a pod cavity;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the at least one shaping line further comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a humidity sensor system for visually sensing a level of humidity of at least a section of the moistened sheet, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a control unit configured to receive values related to the level of humidity sensed by the humidity sensor system, and to control the humidifying unit based on these values.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. System according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the humidity sensor system comprises an optical instrument to capture a visual image of at least the section of the moistened sheet representing the level of humidity.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. System according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the humidity sensor system comprises a light source for emitting light of one or more defined wavelengths within the visible spectrum, wherein the light source is arranged such that the emitted light is directed onto at least the section of th","B65B29/02, B31B50/00, B31B50/59, B31B50/74, B65B9/04",20250624,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
RU2838546C1,Compositions and methods for providing health effects in animals,"FIELD: biotechnology; medicine.SUBSTANCE: disclosed is a composition for use in treating or preventing allergy or treating or preventing an autoimmune disease in an animal. Also disclosed is a composition for use in improving the effectiveness of the vaccine in an elderly animal, containing colostrum in amount of 0.1 wt.% to 1 wt.%.EFFECT: use of said compositions enables to overcome a variety of side effects arising in the treatment of allergy or autoimmune disease in an animal.13 cl, 4 tbl, 1 ex","1. Композиция, содержащая молозиво, для применения в лечении или профилактике аллергии либо лечении или профилактике аутоиммунного заболевания у животного, причём молозиво присутствует в композиции в количестве от 0,1 мас.% до 1 мас.%.
2. Композиция для применения по п. 1, которая предназначена для потребления животным на регулярной основе.
3. Композиция для применения по пп. 1 и 2, которая представляет собой композицию корма для домашних животных.
4. Композиция для применения по п. 3, в которой композиция корма для домашних животных подобрана по составу для собаки или кошки.
5. Композиция для применения по пп. 1-4, в которой животное представляет собой животное-компаньона.
6. Композиция для применения по пп. 1-5, в которой животное представляет собой животное из семейства собачьих.
7. Композиция для применения по пп. 1-6 у животного, имеющего аллергию или подверженного риску наличия аллергии.
8. Композиция для применения по пп. 1-6 у животного, имеющего аутоиммунное заболевание или подверженного риску наличия аутоиммунного заболевания.
9. Композиция, содержащая молозиво, для применения в повышении эффективности вакцины у пожилого животного, причём молозиво присутствует в композиции в количестве от 0,1 мас.% до 1 мас.%.
10. Композиция для применения по п. 9, которая предназначена для потребления животным на регулярной основе.
11. Композиция для применения по пп. 9 и 10, причём композиция представляет собой композицию корма для домашних животных.
12. Композиция для применения по пп. 9-11, в которой животное представляет собой животное-компаньона.
13. Композиция для применения по пп. 9-12, в которой животное представляет собой животное из семейства собачьих.","A23C9/20, A23K50/40, A61K35/20",20250421,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ СА,['Active']
EP4556224A1,Methods of manufacturing bio-based polymer beverage capsules,"The present invention relates to methods of manufacturing beverage capsules, the method comprising: (a) providing a biopolymer film, wherein the biopolymer film comprises a layered structure comprising biopolymer layer - polyglycolide (PGA) layer - biopolymer layer; and (b) thermoforming the biopolymer film to form at least one layer of a capsule body comprising or consisting of the biopolymer film.","<div class=""indep-clm"" num=""1""><seg-main>1.  A method of manufacturing a beverage capsule, the method comprising: </seg-main><seg-clauses>(a) providing a biopolymer film, wherein the biopolymer film comprises a layered structure comprising biopolymer layer - polyglycolide (PGA) layer - biopolymer layer; and </seg-clauses><seg-clauses>(b) thermoforming the biopolymer film to form at least one layer of a capsule body comprising or consisting of the biopolymer film.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The method according to claim 1, wherein </seg-main><seg-clauses>the capsule body consists of the biopolymer film.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3.  The method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the method comprises: </seg-main><seg-clauses>(i) thermoforming the biopolymer film, optionally into a cup-shape; </seg-clauses><seg-clauses>(ii) inserting the thermoformed biopolymer film into a paper-based capsule body; and </seg-clauses><seg-clauses>(iii) optionally, further forming or moulding the biopolymer film, to provide a capsule body comprising a paper-based layer and the biopolymer film.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4.  The method according to claim 1, wherein </seg-main><seg-clauses>the method comprises thermoforming the biopolymer film inside a paper-based capsule body to provide a capsule body comprising a paper-based layer and the biopolymer film.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5.  The method according to claim 1, wherein </seg-main><seg-clauses><seg-main>the method comprises: </seg-main><seg-clauses>(i) attaching the biopolymer layer to a paper-based layer to provide a multi-layer structure; and </seg-clauses><seg-clauses>(ii) forming the multi-layer structure to provide a capsule body comprising a paper-based layer and the biopolymer film, optionally wherein the pape","B32B27/36, B32B1/00, B32B7/02, B32B7/027, B32B27/08",20250521,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250295153A1,Texturized fruit-like inclusion product,"The invention relates to a method of making a texturized fruit-like inclusion product, said product comprising 50 to 80 wt % non-dietary fiber carbohydrate; and 5 to 20 wt % dietary fiber. The ratio of wt % dietary fiber to wt % non-dietary fiber carbohydrate is between 1:10 to 1:2, preferably between 1:5 to 1.4. The invention further relates to a texturized fruit-like inclusion product, wherein said product comprises ingredients derived from different fruit sources. The use of a pectin methyl esterase source derived from a <i>papaya </i>plant to make a texturized fruit-like inclusion product is also described.","<div class=""indep-clm"" num=""1""><seg-main>1. A texturized fruit-like inclusion product, said product comprising</seg-main>
<seg-clauses>a. 50 to 80 wt % non-dietary fiber carbohydrate;</seg-clauses>
<seg-clauses>b. 5 to 20 wt % dietary fiber; and</seg-clauses>
<seg-clauses>c. the ratio of wt % dietary fiber to wt % non-dietary fiber carbohydrate is between 1:10 to 1:2.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The product according to claim 1, wherein </seg-main><seg-clauses>the product comprises between 0.1 to 2 wt % calcium source.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The product according to claim 1, wherein </seg-main><seg-clauses>the product comprises about 25 wt % glucose syrup.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The product according to claim 1, wherein </seg-main><seg-clauses>the product has a fructose to glucose ratio of between 1:1 to 2:1.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The product according to claim 1, wherein </seg-main><seg-clauses>the dietary fiber is citrus fiber.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The product according to claim 1, wherein </seg-main><seg-clauses>the calcium source is calcium chloride.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The product according to claim 1, wherein </seg-main><seg-clauses>the product has a water activity (A<sub>w</sub>) between 0.45 and 0.65 and a pH of about 3.4.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The product according to claim 1, wherein </seg-main><seg-clauses>the product has a total solids (TS) content of between 80 to 95%.</seg-clauses></div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-main>9. The product according to claim 1, wherein </seg-main><seg-clauses>the product comprises apple and blueberry derived ingredients.</seg-clauses></div>
<div class=""ccl-clm"" ","A23L21/18, A23G3/34, A23G3/36, A23G3/42, A23G3/48",20250925,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250333236A1,"Capsule, water distribution wall for such a capsule, and method for manufacturing such a capsule","The present invention concerns a capsule (<b>1</b>) comprises a cup-shaped capsule body (<b>2</b>), a water distribution wall (<b>10</b>) delimiting a chamber (<b>12</b>) for a substance, and a bottom wall (<b>14</b>). The cup-shaped capsule body (<b>2</b>) comprises: a cellulose-based body layer (<b>18</b>) and a liner (<b>20</b>) comprising a liner barrier layer (<b>22</b>). The water distribution wall (<b>10</b>) and/or the bottom wall (<b>14</b>) comprises a wall barrier layer (<b>32</b>). The water distribution wall (<b>10</b>) and/or the bottom wall (<b>14</b>) is/are connected to the cup-shaped capsule body (<b>2</b>) such that the liner barrier layer (<b>22</b>) and the respective wall barrier layer (<b>32</b>) are united along a circumference of the body (<b>2</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule for producing a beverage in a beverage production machine by injecting a fluid under pressure in said capsule, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the capsule comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a cup-shaped capsule body with a cavity, a top opening and a bottom opening, the top opening and the bottom opening being located at substantially opposite sides of the cup-shaped capsule body with respect to the cavity,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a water distribution wall connected to the cup-shaped capsule body to delimit a chamber within the cavity, the water distribution wall being configured to allow passage of the fluid, the chamber being configured for containing a substance for the production of the beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top wall for closing the top opening, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a bottom wall for closing the bottom opening, said bottom wall being adapted to be opened when pressure increases inside the capsule, in order to allow the beverage produced in the chamber to flow out of the capsule,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the cup-shaped capsule body has a layered structure comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a body layer moulded out of cellulose-based material, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a liner applied on an inner face of the body layer,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the liner comprises a liner barrier layer configured to provide a moisture and/or gas barrier function,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the water distribution wall and/or the bottom wall respectively comprise(s) a wall barrier layer configured to provide a moisture and/or gas barrier function, and</seg-refi></div>
<","B65D85/804, A47J31/36, B32B1/00, B32B23/08",20251030,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN120077417A,Lockable top-open cabinet freezer,"A method for dispensing one or more frozen food products from a lockable top-open freezer, where the freezer defines a volume accessible through a door of the freezer, the volume containing the one or more frozen food products, and the freezer includes an electronically controlled lock, and an electronically controlled lock configured to be controlled to lock and unlock the door to prevent and permit access to the volume and access to the one or more frozen food products, the method comprising the steps of: identifying the freezer with a user mobile device; communicating with the electronic control lock to unlock the door of the freezer; identifying one or more frozen food products on the user mobile device and initiating a payment process; and optionally in communication with the electronically controlled lock to lock the door of the freezer.","<div class=""indep-clm"" num=""1""><seg-con>1.一种用于从可锁定顶开式冷冻柜分配一个或多个冷冻食物产品的方法，其中所述冷冻柜限定能够通过所述冷冻柜的门进入的容积，所述容积容纳所述一个或多个冷冻食物产品，并且所述冷冻柜包括电子控制锁，所述电子控制锁被配置为被控制以对所述门进行锁定和解锁，从而防止和准许进入所述容积并获取所述一个或多个冷冻食物产品，所述方法</seg-con><seg-trans>包括以下步骤：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>利用用户移动设备识别所述冷冻柜；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>与所述电子控制锁进行通信以对所述冷冻柜的所述门进行解锁；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>在所述用户移动设备上识别一个或多个冷冻食物产品并且发起支付过程；</seg-comp><seg-comp>以及</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>可选地与所述电子控制锁进行通信以对所述冷冻柜的所述门进行锁定。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中利用所述用户移动设备来识别所述冷冻柜基于接收指示所述冷冻柜的标识符的用户输入。</div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3.根据权利要求2所述的方法，其中接收指示所述冷冻柜的所述标识符的用户输入</seg-con><seg-trans>包括：</seg-trans><seg-refi>从所述用户移动设备的相机接收所述冷冻柜的所述标识符的数字图像。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4.根据权利要求2所述的方法，其中接收指示所述冷冻柜的所述标识符的所述用户输入</seg-con><seg-trans>包括：</seg-trans><seg-refi>从所述用户移动设备的输入设备接收所述冷冻柜的所述标识符。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5.根据任一前述权利要求所述的方法，其中与所述电子控制锁进行通信以对所述冷冻柜的所述门进行解锁</seg-con><seg-trans>包括：</seg-trans><seg-refi>生成指令并将所述指令发送到所述电子控制锁以使得所述电子控制锁对所述冷冻柜的所述门进行解锁。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6.根据任一前述权利要求所述的方法，其中在所述用户移动设备上识别一个或多个冷冻食物产品</seg-con><seg-trans>包括：</seg-trans><seg-refi>从所述用户移动设备接收所述一个或多个冷冻食物产品的一个或多个标识符。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7.根据权利要求6所述的方法，其中从所述用户移动设备接收所述一个或多个冷冻食物产品的所述一个或多个标识符</seg-con><seg-trans>包括：</seg-trans><seg-refi>从所述用户移动设备的相机接收所述一个或多个冷冻食物产品的所述一个或多个标识符的一个或多个数字图像。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的方法，其中所述一个或多个冷冻食物产品的所述一个或多个标识符是一个或多个条形码。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""><seg-con>9.根据任一前述权利要求所述的方法，其中发起所述支付过程</seg-con><seg-trans>包括：</seg-trans><seg-refi>在所述用户移动设备上显示用于接收与所述一个或多个冷冻食物产品相关联的用户支付输入的支付门户。</seg-refi></div>
<div c",G07C9/00,20250530,雀巢产品有限公司,['Pending']
EP4530219A1,Beverage preparation capsule and method of producing the same,"A capsule (10) configured for preparing a beverage upon injection of liquid into the capsule (10) is provided. The capsule (10) comprises: a cup-shaped main body (12) including a bottom wall (14) and a side wall (16), a sealing lid (18) connected to the side wall (16), wherein the lid (18), the bottom wall (14), and the side wall (16) define a compartment for holding beverage preparation ingredients therein, and a scoring line (24) extending on the side wall (16) and being configured for weakening the side wall (16).","<div class=""indep-clm"" num=""1""><seg-main>1.  A capsule (10) configured for preparing a beverage upon injection of liquid into the capsule (10), the capsule (10) comprising: </seg-main><seg-clauses>- a cup-shaped main body (12) including a bottom wall (14) and a side wall (16), </seg-clauses><seg-clauses>- a sealing lid (18) connected to the side wall (16), wherein the lid (18), the bottom wall (14), and the side wall (16) define a compartment for holding beverage preparation ingredients therein, and </seg-clauses><seg-clauses>- a scoring line (24) extending on the side wall (16) and being configured for weakening the side wall (16) and/or extending on the bottom wall (14) and being configured for weakening the bottom wall (14).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The capsule (10) of claim 1, wherein </seg-main><seg-clauses>the scoring line (24) extends in circumferential direction and/or in a longitudinal direction of the side wall (16).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The capsule of any one of claims 1-2, wherein </seg-main><seg-clauses>the scoring line (24) extends - along between 30% and 100%, preferably between 30% and 90%, more preferably between 50% and 85%, even more preferably between 60% and 85%, of a circumferential and/or longitudinal dimension of the side wall (16); and/or </seg-clauses><seg-clauses>- at least along 50%, preferably at least around 60%, of a circumferential and/or longitudinal dimension of the side wall (16); and/or </seg-clauses><seg-clauses>- along 90% or less, preferably along 85% or less, more preferably along 75% or less, of a circumferential and/or longitudinal dimension of the side wall (16).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The capsule (10) of any one of claims 1-3, wherein </seg-main><seg-clauses>the scoring line (24) extends in circumferential direction of the side wall (16), preferably in a substantiall",B65D85/804,20250402,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250302789A1,Compositions comprising a combination of creatine and oleuropein or a metabolite thereof and their use for improving muscle function,"A combination of creatine and at least one of oleuropein or metabolite thereof for use by oral administration to an individual in an amount effective to achieve at least one result that is (i) improved mitochondrial calcium uptake in muscle cells. (ii) improved utilization of calcium in muscle cells, (iii) increased mitochondrial energy in muscle cells, (iv) improvement in at least one of muscle functionality, muscle performance, lean muscle mass or muscle strength, (v) decreased muscle fatigue, (vi) increased mobility, and/or (vii) treatment of a muscle disorder linked to calcium depletion or deficiency. The individual can be at least one of an aging subject; an elderly subject; a subject with muscle fatigue or muscle weakness; a subject with impaired mobility; a frail subject; a pre-frail subject; a sarcopenic subject; a subject recovering from pre-frailty, frailty, sarcopenia or impaired mobility; a subject undergoing physical rehabilitation; a sportsman; or a pet.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of achieving at least one result selected from the group consisting of </seg-main><seg-clauses>(i) improved mitochondrial calcium uptake in muscle cells, </seg-clauses><seg-clauses>(ii) improved utilization of calcium in muscle cells, </seg-clauses><seg-clauses>(iii) increased mitochondrial energy in muscle cells, </seg-clauses><seg-clauses>(iv) improvement in at least one of muscle functionality, muscle performance, lean muscle mass or muscle strength, </seg-clauses><seg-clauses>(v) decreased muscle fatigue, </seg-clauses><seg-clauses>(vi) increased mobility and </seg-clauses><seg-clauses>(vii) treatment of a muscle disorder linked to calcium depletion or deficiency, the method comprising orally administering to an individual an effective amount of a combination of creatine and at least one of oleuropein or metabolite thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the individual is selected from the group consisting of an aging subject; an elderly subject; a subject with muscle fatigue or muscle weakness; a subject with impaired mobility; a frail subject; a pre-frail subject; a sarcopenic subject; a subject recovering from pre-frailty, frailty, sarcopenia or impaired mobility; a subject undergoing physical rehabilitation; a sportsman; and a pet.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses><seg-main>decreasing muscle fatigue is in an individual who participates in exercise, the exercise comprising at least one of </seg-main><seg-clauses>1) resistance exercise, </seg-clauses><seg-clauses>2) anaerobic or repeated sprint-type exercise, or 3) endurance exercise, the method comprising orally administering to the individual an effective amount of a combination of creatine and at least one of oleuropein or metabolite thereof.</seg-clauses></seg-claus","A61K31/198, A61K31/351, A61K31/7048",20251002,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN223310538U,Cooking auxiliary equipment,A cooking aid includes: a sheet made of a flexible heat resistant material; a composition layer disposed on at least one surface of the sheet; wherein the sheet is configured to be selectively placed in one of the following configurations: a loading configuration for receiving food to be placed in contact with the layer of composition; a cooking configuration for at least partially surrounding food in contact with the composition layer; the cooking aid also includes a heat resistant fixture that may be configured to hold the sheet in the cooking configuration.,"<div class=""indep-clm"" num=""1""><seg-con>1.一种烹饪辅助设备，</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>由柔性耐热材料构成的片材；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>设置在所述片材的至少一个面上的组合物层；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>其特征在于，所述片材构造成被选择性地置于以下构型中的一种构型：</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>装料构型，用于接收待与所述组合物层接触放置的食物，和</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>烹饪构型，用于至少部分地包围与所述组合物层接触的食物；</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>所述烹饪辅助设备还包括耐热固定装置，所述耐热固定装置被构造成能够将所述片材保持在所述烹饪构型中。</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述耐热固定装置是独立的并且能够与所述片材分离。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3.根据权利要求1或2所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述耐热固定装置包括套筒。</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4.根据权利要求3所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述套筒由纸板构成。</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-con>5.根据权利要求3所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述套筒包括：</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""3""><seg-refi>材料条带，其构造成能被折叠或围成环状，用于在所述烹饪构型中环绕所述片材和食物。</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""5""><seg-con>6.根据权利要求5所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述材料条带包括凸部和凹部，所述凸部和凹部构造成彼此接合以将所述材料条带保持呈折叠的或环状的布置结构。</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-con>7.根据权利要求6所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述凸部包括突片。</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""6,7""><seg-con>8.根据权利要求6或7所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述材料条带包括贯穿该材料条带的厚度的多个开口，所述多个开口之一形成为用于接纳所述凸部的所述凹部。</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""8""><seg-con>9.根据权利要求8所述的烹饪辅助设备，</seg-con><seg-trans>其特征在于，</seg-trans><seg-refi>所述多个开口的表面积超过所述材料条带的总表面积的20％、30％、40％或50％。</seg-r",A21B3/15,20250909,雀巢产品有限公司,['Active']
WO2025093389A1,Packaging collecting process with token reward and block use function,"The present invention relates to a packaging collecting process comprising the steps of providing a packaging with an embedded crypto token value comprising a serialized code, one or more packaging scanning devices able to scan the serialized code, the packaging scanning devices being connected to a token transfer system for transferring token or part of token to a user or users of the packaging collecting process, and wherein the token transfer system comprising a blockchain smart contract with a token block use function. The serialized code may be printed on or embedded in the packaging.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1. A packaging collecting process comprising </seg-main><seg-clauses><seg-main>the steps of providing</seg-main>
<seg-clauses>- a packaging with an embedded crypto token value comprising a serialized code,</seg-clauses>
<seg-clauses>- one or more packaging scanning devices able to scan the serialized code, the packaging scanning devices being connected to a token transfer system for transferring token or part of token to a user or users of the packaging collection process, and</seg-clauses>
<seg-clauses>- wherein the token transfer system comprising a blockchain smart contract with a token block use function.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Process according to claim 1, wherein </seg-main><seg-clauses>the serialized code is printed on or embedded in the packaging.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Process according to any of the preceding claims, wherein </seg-main><seg-clauses>the blockchain smart contract in the token transfer system comprises a recording function for recording on the blockchain an association of the serialized code and the crypto token value.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Process according to any of the preceding claims, comprises, </seg-main><seg-clauses>upon a scanning of a packaging in the one or more packaging scanning devices, the step of transferring crypto token value to a user’s account, the user’s account is connected to the blockchain smart contract comprising the token block use function.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. Process according to any of the preceding claims, wherein </seg-main><seg-clauses>the token block use function comprises a validation function, the validation function comprises an unblocking function to reserved amounts of crypto token value to the user of the packaging collection proc","G06Q10/0833, G06Q10/0837, G06Q10/30, G06Q20/38, G06Q30/018",20250508,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250040750A1,Beverage menu creation,The invention relates to a to a computer-implemented method for displaying automatically on an electronic device the updated beverage menu of a beverage dispensing machine configured to dispense a plurality of beverages. The method comprises steps for transmitting machine and beverage data from a beverage dispensing machine to a remote server and updating a database of the remote server using said machine and beverage data.,"<div class=""indep-clm"" num=""1""><seg-main>1. A computer-implemented method for displaying on an electronic device the beverage menu of a beverage dispensing machine, said machine being configured for dispensing a plurality of different beverages, the method comprising </seg-main><seg-clauses><seg-main>the following steps:</seg-main>
<seg-clauses>a. transmitting machine and beverage data from the beverage dispensing machine to a remote server by a computer program executed on the electronic device;</seg-clauses>
<seg-clauses>b. compiling said machine and beverage data into a beverage menu at the remote server; and</seg-clauses>
<seg-clauses>c. transmitting the beverage menu compiled at the remote server to the computer program via a communication network and displaying the beverage menu on the electronic device,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the remote server stores a database of information relative to a plurality of beverage dispensing machines and the method comprises the step of updating the database with said machine and beverage data between steps a and b.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 wherein </seg-main><seg-clauses>the beverage menu displayed on the electronic device is a replication of the beverage menu displayed simultaneously on a screen of the beverage dispensing machine.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1 wherein </seg-main><seg-clauses>said machine and beverage data comprises at least:</seg-clauses>
<seg-clauses class=""seg-enter"">an identifier of the beverage dispensing machine, and</seg-clauses>
<seg-clauses class=""seg-enter"">an identifier of each of the different beverages dispensed by the beverage dispensing machine.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-main>4. The method according to claim 3 wherein </seg-main><seg-clauses>said machine and beve","A47J31/52, B67D1/00, B67D1/08, G06F3/14, G07F9/00",20250206,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250089929A1,Beverage preparation system,"The invention concerns a beverage production system comprising a pack (<b>10</b>) comprising a readable code and a module (<b>1</b>) for producing a beverage from said pack,—said module (<b>1</b>) comprising: a code reader, a movable fluid processing device (<b>11</b>) to introduce a fluid in said pack and to dispense a beverage from the pack, and. a pack holder assembly (<b>2</b>) comprising a pack chamber (<b>22</b>) and a movable interacting device (<b>24</b>) configured to move between:—a first interacting position wherein said locking device interacts with the pack (<b>10</b>) received in the chamber inside the pack holder assembly, and,—a second release position wherein said interacting device does not interact with the pack (<b>10</b>) received in the chamber, and said movable interacting device (<b>24</b>) comprises a movable pushing device configured to push the readable code (<b>102</b>) of the pack to the code reader (<b>4</b>) when the movable interacting device (<b>24</b>) is in the first fixing position.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage production system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a pack and a module for producing a beverage from said pack,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising an ingredient, said ingredient being configured to be mixed with a fluid to produce a beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack presenting a plane shape oriented along a plane and comprising two longitudinal plane walls extending along this plane, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the bottom side of said pack being configured for being openable, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising at least one readable code, said code being positioned on at least one of the two longitudinal plane walls, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said module comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a movable fluid processing device configured to cooperate with the bottom of the pack to introduce a fluid in said pack and to dispense a beverage from the pack, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reader,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pack holder assembly, said pack holder assembly comprising a pack chamber and a movable interacting device wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pack chamber is adapted for receiving said pack through an upper pack inlet and for holding said pack so that the plane of the plane shape is oriented in an essentially vertical position inside the module, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamber presenting a bottom opening configured to enable access of the movable fluid processing device to at least the bottom side of said pack hold in the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamb","A47J31/44, A47J31/40",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
RU2849903C2,Centrifugal chamber for beverages with closed position fixator,"FIELD: devices for preparing beverages.SUBSTANCE: invention relates to devices for preparing beverages by centrifuging capsules containing the ingredient of the beverage being prepared. The device (1) is designed to prepare a beverage (4) from a flavouring ingredient (5a) in a processing cavity (5) by mixing it with water (4') and centrifuging them around a processing axis (30'). The device (1) has a manipulation system (10, 20) for the ingredient with at least one outlet (25) for the beverage and at least one water supply nozzle (24). The system (10, 20) has a first ingredient manipulator (10) and a second ingredient manipulator (20) that are movable relative to each other from an ingredient transfer configuration to an ingredient processing configuration. The device has: a manipulator drive (41) designed to allow relative movement of the first and second ingredient manipulators (10, 20) between the transfer and processing configurations; and at least one lock (41') designed to be selectively moved into a locking position to fasten the first and second ingredient manipulators (10, 20) together in the processing configuration and into an unlocking position. The fastener (41') is moved by the manipulator drive (41) into the fastening position and/or the release position.EFFECT: creation of a device that allows a beverage to be prepared from a flavouring ingredient.23 cl, 12 dwg","1. Устройство (1) для приготовления напитка (4) из вкусоароматического ингредиента (5a) в полости (5) обработки, например полости (5) для удержания упомянутого ингредиента (5a), подаваемого внутри капсулы (5b), путем смешивания упомянутого ингредиента (5a) с водой (4’) и приведения в центробежное движение такого ингредиента (5a) и упомянутой воды (4’) вокруг оси (30’) обработки с образованием упомянутого напитка (4), причем такое устройство (1) содержит:
- вращающуюся систему (10, 20) манипулирования для ингредиента для удерживания и вращения упомянутого вкусоароматического ингредиента (5a) и воды во время центрифугирования вокруг оси (30’) обработки, причем система (10, 20) манипулирования для ингредиента имеет по меньшей мере одно выходное отверстие (25) для напитка и по меньшей мере один штуцер (24) подвода воды для подачи упомянутой воды (4’) к упомянутому ингредиенту (5a), например внутри упомянутой капсулы (5b), при этом система (10, 20) имеет первый манипулятор (10) для ингредиента и второй манипулятор (20) для ингредиента, которые выполнены с возможностью перемещения относительно друг друга из
конфигурации передачи ингредиента для приема упомянутого ингредиента (5a) первым и вторым манипуляторами (10, 20) для ингредиента и/или высвобождения упомянутого ингредиента (5a) из первого и второго манипуляторов (10, 20) для ингредиента в
конфигурацию обработки ингредиента для центрифугирования упомянутого ингредиента (5a) и воды (4’) путем вращения вокруг оси (30’) обработки
и наоборот;
- привод (41) манипулятора, например двигатель или рукоятку, приводимую в действие пользователем, выполненный с возможностью относительного перемещения первого и второго манипуляторов (10, 20) для ингредиента между конфигурациями передачи и обработки;
- по меньшей мере один фиксатор (41’), выполненный с возможностью выборочного перемещения в положение фиксации для скрепления вместе первого и второго манипуляторов (10, 20) для капсулы в конфигурации обработки и в положение расфиксации",A47J31/22,20251031,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
WO2025032028A1,Apparatus for introducing a medium into a foodstuff precursor,"A stator (22) or rotor (24) for apparatus (4) for introduction of a medium into a foodstuff precursor by agitation of the foodstuff precursor to form a foodstuff material therefrom, the stator or rotor comprising: a respective stator axis of rotational symmetry or rotor axis of rotation, an support portion (26) arranged about said stator axis of rotational symmetry or rotor axis of rotation, and; agitation members (28) arranged on the support portion and circumferentially disposed about said stator axis of rotational symmetry or rotor axis of rotation, wherein the agitation members each comprise an extension that extends from the support portion and has a cross-sectional shape selected to have a drag coefficient of less than one or more of: a square section with a front face arranged normal to a flow direction; a rectangular section with a front face arranged normal to a flow direction; a convex quadrilateral with parallel sides arranged normal to a flow direction and with convex sides radially aligned to said stator axis of rotational symmetry or rotor axis of rotation.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-con>1 . Apparatus for introduction of a medium into a foodstuff precursor, the apparatus </seg-con><seg-trans>comprising: </seg-trans><seg-comp>a processing chamber; </seg-comp><seg-comp>a foodstuff precursor inlet for introduction of foodstuff precursor into the processing chamber; </seg-comp><seg-comp>a foodstuff material outlet for outlet of the foodstuff material from the processing chamber; </seg-comp><seg-comp>an injector for injection of a medium into the processing chamber, and; </seg-comp><seg-comp>at least one stator and/or rotator comprising: a respective stator axis of rotational symmetry or rotor axis of rotation, a support portion arranged about said stator axis of rotational symmetry or rotor axis of rotation, and; agitation members arranged on the support portion and circumferentially disposed about said stator axis of rotational symmetry or rotor axis of rotation, wherein the agitation members each comprise an extension that extends from the support portion and has a cross-sectional shape selected to have a drag coefficient of less than one or more of the following shapes: a square section with a front face arranged normal to a flow direction; a rectangular section with a front face arranged normal to a flow direction; a convex quadrilateral with parallel sides arranged normal to a flow direction and with convex sides radially aligned in respect of a radial direction to said stator axis of rotational symmetry or rotor axis of rotation.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The apparatus of claim 1 , </seg-con><seg-trans>wherein </seg-trans><seg-refi>the drag coefficient of the cross-sectional shape of the agitation members is less than 2 or 1 .9 or 1 .8 or 1.7 or 1 .6.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3. The apparatus of claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the drag factor is defined for a 2-dimensional cross section for ",B01F27/271,20250213,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2851621C2,Coffee blends,"FIELD: coffee industry.SUBSTANCE: variants of coffee compositions are disclosed, one of which contains furyl alcohol, pyridine and one or more monosaccharides, wherein the ratio of the concentrations of furyl alcohol and pyridine is greater than or equal to 30, and the total sum of the concentrations of monosaccharides is from 18 mas.% to 46 mas.%, and the second contains one or more monosaccharides in an amount from 18% by mass to 46% by mass and one or more alkylpyrazines with an absolute content of from 50.0 to 120 mg/kg of soluble coffee solids, furyl alcohol with an absolute content of 2000 to 3000 mg/kg of soluble coffee solids, or one or more N-heterocycles with an absolute content of 2.60 to 7.00 mg/kg of soluble coffee solids.EFFECT: coffee compositions that are obtained from extracts with medium and high yields and which have improved taste and aroma.15 cl, 3 tbl, 6 ex","1. Кофейная композиция, содержащая фуриловый спирт, пиридин и один или более моносахаридов, причем отношение концентраций фурилового спирта и пиридина больше или равно 30, а общая сумма концентраций моносахаридов составляет от 18 мас.% до 46 мас.%.
2. Кофейная композиция по п. 1, дополнительно содержащая 2-этил-6-метилпиразин, 2-этил-5-метилпиразин, 2-этил-3-метилпиразин, 2,3,5-триметилпиразин, 2-этил-3,6-диметилпиразин, 2-этил-3,5-диметилпиразин и 2,3-диэтил-5-метилпиразин, причем сумма абсолютного содержания 2-этил-6-метилпиразина, 2-этил-5-метилпиразина, 2-этил-3-метилпиразина, 2,3,5-триметилпиразина, 2-этил-3,6-диметилпиразина, 2-этил-3,5-диметилпиразина и 2,3-диэтил-5-метилпиразина больше или равна 50,0 мг/кг растворимых твердых веществ кофе в кофейной композиции.
3. Кофейная композиция по любому из пп. 1 или 2, в которой абсолютное содержание фурилового спирта больше или равно 2000 мг/кг растворимых твёрдых веществ кофе в кофейной композиции.
4. Кофейная композиция по любому из пп. 1–3, дополнительно содержащая одно или более из 2-ацетилтиазола, 2-ацетилпиразина и 2-ацетилпиридина, причём сумма абсолютного содержания 2-ацетилтиазола, 2-ацетилпиразина и 2-ацетилпиридина больше или равна 2,70 мг/кг растворимых твёрдых веществ кофе в кофейной композиции.
5. Кофейная композиция по любому из пп. 1–4, дополнительно содержащая 2,3-бутандион, причем отношение концентраций фурилового спирта и 2,3-бутандиона больше или равно 30.
6. Кофейная композиция по любому из пп. 1–5, в которой моносахариды содержат галактозу в количестве, превышающем или равном 8 мас.%, в пересчёте на сухую массу кофейной композиции.
7. Кофейная композиция по любому из пп. 1–6, в которой моносахариды содержат маннозу в количестве, превышающем или равном 8 мас.%, в пересчёте на сухую массу кофейной композиции.
8. Кофейная композиция по любому из пп. 1–7, дополнительно содержащая 2-ацетилпиразин и (E)-β-дамасценон, причем отношение концентраций 2-ацетилпиразина и (E)-β-дамасценона больше или равно 4","A23F5/24, A23F5/20",20251126,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2024242505A1,Methods for improving sleep quality and/or subsequent behavioural outcomes using a flavonoid or phenolic acid,"The present invention generally relates to the use of a composition to improve sleep quality and/or subsequent behavioural outcomes, in particular whole day sustained cognitive performance. More particularly, the present disclosure relates to administration of a composition comprising a flavonoid and/ or phenolic acid compound, at a predetermined time before consumption of a meal, concurrently with consumption of a meal or at a predetermined time before sleep.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of improving sleep quality and/or subsequent behavioural outcomes, the method comprising </seg-main><seg-clauses>orally administering to an individual, a composition comprising an effective amount of at least one compound selected from the group consisting of a flavonoid, a phenolic acid or combination thereof.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A method of treating, preventing, and/or reducing at least one of risk, incidence or severity of at least one condition for which improved sleep quality is beneficial, the method comprising </seg-main><seg-clauses>orally administering to an individual, a composition comprising at least one compound selected from the group consisting of a flavonoid, a phenolic acid or comibination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to any of claim 1 or 2, wherein </seg-main><seg-clauses>the flavonoid is one of rutin, quercetin, isoquercetin, luteolin or combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any of claim 1 to 3, wherein </seg-main><seg-clauses>the phenolic acid is one of caffeic acid, vanillic acid, chlorogenic acid, syringic acid or combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The method of any of Claims 1-4, wherein </seg-main><seg-clauses><seg-main>subsequent behavioural outcome includes one or more of </seg-main><seg-clauses>(a) less frequent and/or less severe sleepiness, stress, tension/anxiety, fatigue/inertia or depression/dejection, anger/hostility, subjective frustration and/or </seg-clauses><seg-clauses>(b) more and/or better sleep initiation, relaxation, calmness, alertness, vigor/activity, friendliness, cognition, memory, working memory, attention, vigilance, processing speed, fat utilization, weight management, immunity, subjective perceptions ","A61K31/7048, A61K9/00, A61K31/192, A61K31/216, A61K31/352",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2025256158A1,Use of whey protein micelles for controlling postprandial glucose response,"A method for reducing postprandial glucose from a meal includes orally administering to an individual a composition containing whey protein micelles (WPM) and then subsequently orally administering the meal to the individual after the oral administration of the composition containing the WPM and within about one hour of the oral administration of the composition containing the WPM. For example, the meal can be administered about thirty minutes after the administration of the composition containing the WPM. The postprandial glucose is reduced relative to postprandial glucose from administering a corresponding composition comprising whey protein isolate. 20 25 25 61 58 23 O ct 2 02 5 A B S T R A C T 2 0 2 5 2 5 6 1 5 8 2 3 O c t 2 0 2 5","<div class=""indep-clm"" num=""1""><seg-con>1. A method of reducing postprandial glucose from a meal, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>5          orally administering to an individual a composition comprising whey protein micelles</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>(WPM); and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>subsequently orally administering the meal to the individual after the oral administration of the composition comprising the WPM and within about one hour of the oral administration of the composition comprising the WPM.</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>10</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual has at least one condition selected from the group consisting of overweight, obesity, type-1 diabetes, type-2 diabetes, gestational diabetes mellitus and pre-diabetes.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>15          </seg-refi></div><div class=""indep-clm"" num=""3""><seg-con>3. A method of treating or preventing at least one condition for which reduced</seg-con></div>
<div class=""indep-clm"" num=""3""><seg-con>postprandial glucose from a meal is beneficial, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""3""><seg-refi>orally administering to an individual in need thereof or at risk thereof a composition comprising whey protein micelles (WPM); and</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>subsequently orally administering the meal to the individual after the oral</seg-refi></div>
<div class=""indep-clm"" num=""3""><seg-refi>20 administration of the composition comprising the WPM and within about one hour of the oral administration of the composition comprising the WPM.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""3""><seg-con>4. The met","A61K38/01, A23C21/00, A23L33/19, A61K9/51, A61K35/20",20251113,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12310391B2,Cohesive thin liquids to promote safe swallowing in dysphagic patients,"Nutritional products having improved cohesiveness for promoting safer swallowing of food boluses for patients having swallowing conditions are provided as well as methods of making and using such products. The nutritional products may include nutritional compositions and high molecular weight, water-soluble polymers such that the nutritional products have extensional viscosities that provide improved cohesiveness to the nutritional products. Methods of administering such nutritional products to patients having impaired swallowing ability and/or dysphagia are also provided.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of replacing saliva in an individual in need thereof, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>administering an effective amount of a liquid nutritional product to the individual, the liquid nutritional product comprising a nutritional composition and a food-grade polymer, wherein the food-grade polymer is selected from the group consisting of okra gum, konjac mannan, tara gum, fenugreek gum, tamarind gum, <i>cassia </i>gum, kiwi fruit mucilage, cactus mucilage, chia seed mucilage, mallow mucilage, flax seed mucilage, marshmallow mucilage, ribwort mucilage, mullein mucilage, cetraria mucilage, and mixtures thereof,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the liquid nutritional product comprises an amount of the food-grade polymer such that the liquid nutritional product the liquid nutritional product has an increased cohesiveness relative to the nutritional composition, has a shear viscosity less than about 100 mPas when measured at a shear rate of 50 s<sup>−1 </sup>and has a relaxation time, determined by a Capillary Breakup Extensional Rheometry (CaBER) experiment, more than 10 milliseconds at a temperature of 20° C.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the shear viscosity of the liquid nutritional product is 5 mPas to 20 mPas when measured at a shear rate of 50 s<sup>−1</sup>.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the relaxation time of the liquid nutritional product is about 100 milliseconds to about 200 milliseconds.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual has at least one of dysphagia or compromised saliva e","A61K36/185, A23L29/20, A23L29/206, A23L29/238, A23L29/256",20250527,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
EP4574158A2,Mixture of hmos and bifidobacteria,"The invention relates to a composition for infants or young children comprising at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria and a prebiotic mixture of human milk oligosaccharides consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL) that can be useful for (i) preventing and/or treating bacterial infections; (ii) modulating the microbiota; and/or iii) preventing and/or treating allergy in an infant or a young child.","<div class=""indep-clm"" num=""1""><seg-main>1.  A composition for infants or young children comprising </seg-main><seg-clauses><seg-main>at least one probiotic bacterial strain, said probiotic bacterial strain being bifidobacteria, and a prebiotic oligosaccharides mixture consisting of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL) and optionally 3-fucosyllactose (3FL); wherein the bifidobacteria comprises <i>Bifidobacterium longum</i> </seg-main><seg-clauses>subsp. <i>infantis</i> or combination of <i>Bifidobacterium animalis</i> </seg-clauses><seg-clauses>subsp. <i>lactis</i> and <i>Bifidobacterium longum</i> subsp. <i>infantis;</i> wherein at least one of the bifidobacteria is <i>Bifidobacterium longum</i> </seg-clauses><seg-clauses>subsp. <i>infantis</i> LMG 11588 or a strain having an Average Nucleotide Identity (ANI) of at least 99.9% with this strain.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The composition of claim 1, wherein </seg-main><seg-clauses>the bifidobacteria is <i>Bifidobacterium animalis</i> </seg-clauses><seg-clauses>subsp. <i>lactis</i> and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3.  The composition of claim 1, wherein </seg-main><seg-clauses>the bifidobacteria is a combination of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> and <i>Bifidobacterium longum</i> subsp. <i>infantis</i> and the prebiotic oligosaccharides mixture consists of 2'-fucosyllactose (2FL), lactodifucotetraose/difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The composition of any o",A61K31/745,20250625,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12408686B2,"Support and capsule for preparing a beverage by centrifugation, system and method for preparing a beverage by centrifugation","A capsule for preparation of a beverage can include a container and a beverage ingredient contained therein. The container can include at least one support having a section on which a plurality of sequences of symbols is represented; each symbol is sequentially readable, by a reading arrangement of an external device, while the capsule is rotated along an axis of rotation. Each sequence can code a set of information related to the capsule, and at least one of the sequences can include symbols defining a preamble sequence that allows determination of a position of the symbols in the associated sequence coding the set of information related to the capsule. The container can include a cup-shaped body having a flange-like rim and a lid connected to the body, the support can be on a bottom of the rim, and the bottom of the rim can be opposed to the lid.","<div class=""indep-clm"" num=""1""><seg-con>1. A support adapted to be associated with, or part of, a capsule for the preparation of a beverage, the support </seg-con><seg-trans>comprising </seg-trans><seg-refi>a section on which at least one sequence of symbols is represented so as that each symbol is sequentially readable, by a reading arrangement of an external device, while the capsule is driven in rotation along an axis of rotation, each sequence coding a set of information related to the capsule, the information including a speed of rotation of the capsule during a centrifugation extraction process performed on the capsule.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The support of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the capsule comprises a body and a lid connected at a rim to the body and the support is adapted for connection to a bottom of the rim, which is opposed to the lid of the capsule.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The support of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the information includes: liquid flow rate and/or liquid temperature, for liquid that traverses a coffee in the capsule during the centrifugation extraction process.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The support according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the set of information of at least one of the sequences comprises information for recognizing a type associated to the capsule.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The support according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the set of information of at least one of the sequences comprises information for detecting errors, and/or for correcting errors in said set of information.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The support according to claim 1, </seg-con><seg-trans>wherein </seg-t","A47J31/44, A23L2/38, A47J31/22, B65D85/804",20250909,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250064075A1,Fermented tea beverage,,"<div class=""indep-clm"" num=""1""><seg-main>1. A beverage composition comprising </seg-main><seg-clauses>fermented tea or fermented tea extract wherein the weight ratio of the sum of isobutyl acetate and isobutanol to isobutanal is greater than 400.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The beverage composition of claim 1 wherein </seg-main><seg-clauses>the weight ratio of the sum of 3-methylbutyl acetate, 2-methylbutyl acetate, isobutyl acetate, 2-phenylethyl acetate and 2-phenylethanol to 2,3-butanedione is greater than 50.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The beverage composition of claim 1 having </seg-main><seg-clauses>an ethanol content below 1.2 wt %.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The beverage composition of a claim 1 wherein </seg-main><seg-clauses>the beverage composition is selected from the group consisting of a ready to drink beverage, a beverage liquid concentrate, a soluble beverage powder, dried aromatic plant material and combinations of these.</seg-clauses></div>
<div class=""ccl-clm"" num=""5"">5. (canceled)</div>
<div class=""indep-clm"" num=""6""><seg-main>6. A method of preparing a beverage composition comprising;</seg-main>
<seg-clauses>a. steeping tea in water to form an aqueous tea extract and steeped tea;</seg-clauses>
<seg-clauses>b. fermenting the aqueous tea extract in the presence or absence of the steeped tea; and</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the fermentation is performed by yeast comprising <i>Pichia </i>yeast.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-main>7. The method of claim 6 wherein </seg-main><seg-clauses>the <i>Pichia </i>yeast is <i>Pichia kluyveri. </i></seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-main>8. The method of claim 7 wherein </seg-main><seg-clauses>the <i>Pichia </i>yeast is <i>Pichia kluyveri </i>NYSC 5485.</seg-clauses></div>
<div class=""dep-",A23F3/10,20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120569137A,"Medicaments, compositions and methods for supporting athletic progression","The present invention relates to one or more human milk oligosaccharides (HMOs) for use in supporting motor development in a subject, wherein the one or more HMOs comprise or consist of the following: 3 '-sialic acid lactose (3'-SL), lactose-N-hexaose (LNH) and/or disialic acid lactose-N-tetraose (DSLNT).","<div class=""indep-clm"" num=""1""><seg-con>1.在支持受试者的运动发展中使用的一种或多种人乳低聚糖（HMO），其中所述一种或多种HMO包含以下或由以下</seg-con><seg-trans>组成：</seg-trans><seg-refi>3'唾液酸乳糖（3'-SL）、乳糖-N-六糖（LNH）和/或二唾液酸乳糖-N-四糖（DSLNT）。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述使用的一种或多种HMO，其中所述一种或多种HMO包含3'-SL或由其组成。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述使用的一种或多种HMO，其中所述一种或多种HMO包含LNH或由其组成。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO包含DSLNT或由其组成。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO通过口服施用进行施用。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO单独、同时或顺序施用，优选地其中所述一种或多种HMO同时施用。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO以约0.05g/天至约5g/天的总量施用于所述受试者。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO呈营养组合物的形式。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述使用的一种或多种HMO，其中所述营养组合物是婴儿配方食品、较大婴儿配方食品或成长乳，优选地其中所述营养组合物是婴儿配方食品。</div>
<div class=""dep-clm"" num=""10"" parent=""8,9"">10.根据权利要求8或9所述使用的一种或多种HMO，其中所述营养组合物包含约0.05g/L至约5g/L的总量的所述一种或多种HMO。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据任一前述权利要求所述使用的一种或多种HMO，其中所述受试者是婴儿、学步儿童或幼儿，优选地其中所述受试者是婴儿。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据任一前述权利要求所述使用的一种或多种HMO，其中所述受试者的年龄为约12个月或更小、约11个月或更小、约10个月或更小、约9个月或更小、约8个月或更小、约7个月或更小或约6个月或更小。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO促进所述受试者的精细运动技能和/或粗大运动技能的发展。</div>
<div class=""dep-clm"" num=""14"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13"">14.根据任一前述权利要求所述使用的一种或多种HMO，其中所述一种或多种HMO提高所述受试者控制和协调肌肉以进行期望运动的能力。</div>
<div class=""dep-clm"" num=""15"" parent=""1,2,3,4,5,6,7,8,9,10,11,12,13,14"">15.根据任一前述权利要求所述使用的一种或多种HMO，其中使用贝利量表诸如贝利-III来确定所述受试者的运动技能。</div>","A23L33/21, A23L33/00, A61K31/702, A61P21/00",20250829,雀巢产品有限公司,['Pending']
US12186292B2,Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels,"A method of neutralizing or mitigating a drug-induced mitochondrial dysfunction or impairment for an individual, the method including providing to the individual an effective amount of a composition containing glycine or a functional derivative thereof and N-acetylcysteine or a functional derivative thereof. The drug-induced mitochondrial dysfunction or impairment is from at least one drug consumed by the individual selected from the group consisting of an anticonvulsant; a psychotropic other than an antipsychotic drug; an analgesic/anti-inflammatory drug other than acetaminophen; an antibiotic; an anti-arrhythmic drug; a steroid; a beta-blocker; and an immunization.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of neutralizing or mitigating a drug-induced mitochondrial dysfunction or impairment for an individual, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>providing to the individual an effective amount of a composition comprising glycine and N-acetylcysteine, wherein the drug-induced mitochondrial dysfunction or impairment is from.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided to the individual in the same composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided to the individual in different compositions.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided orally to the individual.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided in the form of a pill, tablet, or capsule.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided to the individual at a same time as the Metformin.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the glycine and the N-acetylcysteine are provided to the individual at a different time as the Metformin.</seg-refi></div>","A61K31/155, A23K20/142, A23K50/50, A61K31/167, A61K31/198",20250107,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US20250057203A1,Apparatus and method for roasting coffee beans,"An apparatus for roasting coffee beans includes: a vessel to contain coffee beans, a heating device to heat coffee beans contained in the vessel, and a control system operable to control the heating device and configured to apply a roasting recipe (R) providing the temperature T<sub>@t1</sub>, T<sub>@t2</sub>, . . . to be applied at discrete successive times t<sub>1</sub>, t<sub>2</sub>, . . . , respectively. For a customised quantity m of coffee beans introduced inside the vessel, the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel. The control system is configured to access at least one series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and to the pre-determined quantities Mi, Mi+1, . . . , and based on the accessible series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type. Based on the obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe (R) to be applied on the obtained quantity m of coffee beans introduced inside the vessel.","<div class=""indep-clm"" num=""1""><seg-con>1: An apparatus for roasting coffee beans, the apparatus </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>a vessel to contain coffee beans;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a heating device to heat coffee beans contained in the vessel; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a control system operable to control the heating device and configured to apply a roasting recipe providing the temperature T<sub>@t1</sub>, T<sub>@t2</sub>, . . . to be applied at discrete successive times t<sub>1</sub>, t<sub>2</sub>, . . . , respectively,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>wherein, for a customised quantity m of coffee beans introduced inside the vessel,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the control system is configured to obtain at least the quantity m of coffee beans introduced inside the vessel, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the control system is configured to get access to at least one series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and to the pre-determined quantities Mi, Mi+1, . . . , and based on the accessible series of roasting recipes (R<sub>i</sub>, R<sub>i+1</sub>, . . . ) adapted to the roasting of different successive pre-determined quantities (M<sub>i</sub>, M<sub>i+1</sub>, . . . ) of beans of same type and based on the obtained quantity m of coffee beans introduced inside the vessel, the control system is configured to determine the roasting recipe to be applied on the obtained quantity m of coffee beans introduced inside the vessel.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The apparatus according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the control s","A23N12/12, A23F5/04, A23N12/08, A47J42/52",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12458173B2,Method for dispensing ground coffee,"The invention relates to a method for dispensing ground coffee for preparing a coffee beverage. The method comprises the steps of: providing a machine (<b>110</b>), which comprises one or more receptacles (<b>13, 14</b>) for storing one or different types of roasted coffee beans, one or more dosing devices (<b>60, 70</b>) for dispensing coffee beans, which are stored in the one or more receptacles (<b>13, 14</b>), and a grinder (<b>30</b>) for receiving coffee beans, which are dispensed by the one or more dosing devices (<b>60, 70</b>), the grinder (<b>30</b>) being configured to move into different grinding positions for different grinding degrees, respectively; setting up the grinder (<b>30</b>) so that the grinder (<b>30</b>) is in a specific grinding position; dispensing, with the one or more dosing devices (<b>60, 70</b>), a specific amount of coffee beans to the grinder (<b>30</b>) subsequent to the step of setting up the grinder (<b>30</b>); and grinding, with the grinder (<b>30</b>), said specific amount of coffee beans and, thus, dispensing the so ground coffee beans until the grinder (<b>30</b>) is free from coffee beans.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for dispensing ground coffee for preparing a coffee beverage, the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>providing a machine, which comprises one or more receptacles for storing one or different types of roasted coffee beans, one or more dosing devices each including two counter-rotating cylinders arranged to rotate towards an inner center for dispensing the coffee beans from the one or more receptacles to a location between the two counter-rotating cylinders, wherein the two counter-rotating cylinders are at least in part made of a compressible or soft material having a hardness less than a hardness of the coffee beans, wherein the compressible or soft material provides a tight outlet that prevents air from entering the one or more receptacles, wherein each of the one or more dosing devices is configured to act as a pump or as a reverse pump in dispensing the coffee beans, and a grinder for receiving the coffee beans, which are dispensed by the one or more dosing devices, the grinder being configured to move into different grinding positions for different grinding degrees, respectively,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>setting up the grinder so that the grinder is in a specific grinding position,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>dispensing, with the one or more dosing devices, a specific amount of the coffee beans to the grinder subsequent to the setting up of the grinder, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>grinding, with the grinder, said specific amount of the coffee beans and, thus, dispensing the ground coffee beans until the grinder is free from coffee beans.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>further comprising </seg-trans><seg-refi>moving the grinder in one of the different grinding pos","A47J42/50, A23F5/08, A47J31/42, A47J42/08, A47J42/10",20251104,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025012101A1,Dairy product analogues comprising coconut fat or cocoa fat,"The dairy product analogues comprise plant proteins and fruit fat. The fruit fat is selected from coconut fat, cocoa fat and mixture thereof. Processes for preparing such dairy product analogues are also disclosed.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A dairy product analogue which comprises </seg-main><seg-clauses>plant proteins and fruit fat, wherein the fruit fat and at least 80% of all the plant proteins of the dairy product analogue are coming from different plant sources, and wherein the fruit fat is selected from the group consisting of coconut fat, cocoa fat and mixture thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the fruit fat is provided as fruit butter, in particular fruit butter selected from the list consisting of coconut butter, cocoa butter and mixture thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. A dairy product analogue according to any one of the preceding claims, wherein </seg-main><seg-clauses>the plant proteins comprise, preferably consist of plant proteins selected from the group consisting of cereal proteins, pulse proteins and combination thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% plant proteins.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. A dairy product analogue according to any one of the preceding claims, comprising </seg-main><seg-clauses>at least 0.5wt% fruit fat.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6. A dairy product analogue according to any one of the preceding claims, which is beverage.</div>
<div class=""dep-clm"" num=""7"" parent=""6""><seg-main>7. A dairy product analogue according to claim 6, wherein </seg-main><seg-clauses>the beverage is a liquid beverage or powdered beverage.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8. A dairy product analogue according to any one of the preceding claims, which i","A23C11/06, A23C11/10, A23L11/60, A23L11/65, A23L11/50",20250116,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CA3172470A1,Method of tropicalizing chocolate,"The present invention relates to fat based tropicalizing agents' compositions, to methods for the preparation thereof, to methods of tropicalizing chocolate or analogues thereof, and to chocolate or analogues of chocolate containing the tropicalizing agents.","Claims:  <div class=""indep-clm"" num=""1""><seg-con>1. A tropicalizing agent composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>a fat component, a cocoa solids component and a humectant, wherein the composition comprises between 10wt% and </seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi> 6.wt% of the cocoa solids component based on the weight of the composition. </seg-refi></div>
 <div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The tropicalizing agent composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fat component is present in an amount of between 20wt% and 80wt% based on the weight of the composition. </seg-refi></div>
 <div class=""dep-clm"" num=""3"" parent=""1,2""><seg-con>3. The tropicalizing agent composition according to claim 1 or 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the humectant is present in an amount of between 2.5wt% and 40wt% based on the weight of the composition. </seg-refi></div>
 <div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. The tropicalizing agent composition according to any of claims 1 to 3, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight ratio of cocoa solids to humectant is between 0.25:1 and 24:1. </seg-refi></div>
 <div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. The tropicalizing agent composition according to any of claims 1 to 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the weight ratio of cocoa solids to fat component is between 0.4:1 and 2.4:1. </seg-refi></div><div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. The tropicalizing agent composition according to any of claims 1 to 5, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tropicalizing agent is in the form of an emulsion, preferably with emulsion droplet sizes D90 of between 20 and 100 microns. </seg-refi></div>
 <div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""><seg-con>7. The tropicalizing agent composition according to any of claims 1 to 6, </s","A23G1/00, A23G1/30, A23G1/32, A23G1/36",20250708,SOCIETE DES PRODUITS NESTLE SA,['Active']
WO2025045656A1,Compositions comprising human milk oligosaccharides for use in a subject to support brain development and/or vision development,"The invention provides a fucosylated human milk oligosaccharide (HMO) for use in improving brain development and/or vision development in a subject, wherein: a) the fucosylated HMO is lacto-N-fucopentaose-I (LNFP-I) and the subject is an infant up to 12 months old; and/or b) the fucosylated HMO is A-tetrasaccharide, wherein the subject is an infant, a young child or a child.","Claims
<div class=""indep-clm"" num=""1""><seg-main>1 . A fucosylated human milk oligosaccharide (HMO) for use in improving brain development and/or vision development in a subject, wherein: </seg-main><seg-clauses>a) the fucosylated HMO is lacto-N-fucopentaose-l (LNFP-I) and the subject is an infant up to 12 months old; and/or </seg-clauses><seg-clauses>b) the fucosylated HMO is A-tetrasaccharide, wherein the subject is an infant, a young child or a child, preferably an infant up to 12 months old.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. A nutritional composition comprising </seg-main><seg-clauses><seg-main>a fucosylated HMO for use in improving brain development and/or vision development in a subject, wherein: </seg-main><seg-clauses>a) the fucosylated HMO is lacto-N-fucopentaose-l (LNFP-I) and the subject is an infant up to 12 months old; and/or </seg-clauses><seg-clauses>b) the fucosylated HMO is A-tetrasaccharide, wherein the subject is an infant, a young child or a child, preferably an infant up to 12 months old.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The fucosylated HMO for use according to claim 1 or the nutritional composition for use according to claim 2, wherein </seg-main><seg-clauses>the improvement in brain development and/or vision development in the subject comprises or consists of an improvement in the development of visual brain networks.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The fucosylated HMO for use according to claim 1 or claim 3, or the nutritional composition for use according to claim 2 or claim 3, wherein </seg-main><seg-clauses>improving brain development and/or vision development in the subject comprises or consists of promoting the lateral visual network (LVN).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""2,3,4""><seg-main>5. The nutritional composition for use according to any one of claims 2 to 4, wherein </seg-main><","A23L33/22, A23L33/00",20250306,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
WO2025052201A1,Smart pet bowls,"The present disclosure includes a smart pet bowl to monitor pet feeding behavior, which includes a pet bowl to carry pet food or water or carry a bowl insert to carry pet food or water. The smart pet bowl also can include a load sensor associated with the pet bowl that is sensitive to load changes of pet food or water carried within the pet bowl. The load sensor has a sensitivity of +/-50 grams or less and load data collectable therefrom is at a sample rate from 10 to 150 samples per second in sequential time increments from about 0.01 second to 5 seconds. The smart pet bowl may also include a data communicator to communicate the load data over a computer network, a processor, and a memory storing instructions that, when executed by the processor, communicates the load data over the computer network.","CLAIMS
What Is Claimed Is:
<div class=""indep-clm"" num=""1""><seg-main>1. A smart pet bowl to monitor pet feeding behavior, comprising: </seg-main><seg-clauses><seg-main>a pet bowl to </seg-main><seg-clauses>i) carry pet food or water or </seg-clauses><seg-clauses>ii) carry a bowl insert to carry pet food or water; a load sensor associated with the pet bowl that is sensitive to load changes of pet food or water carried within the pet bowl, wherein the load sensor has a sensitivity of +/-50 grams or less and load data collectable therefrom is at a sample rate from 10 to 150 samples per second in sequential time increments from about 0.01 second to 5 seconds; a data communicator to communicate the load data over a computer network; a processor; and a memory storing instructions that, when executed by the processor, communicates the load data over the computer network.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The smart pet bowl of claim 1, wherein </seg-main><seg-clauses>the smart pet bowl includes a bowl support which carries the load sensor and a bowl insert to carry the pet food or water and which is configured to transfer loads from the bowl insert to the load sensor.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The smart pet bowl of claim 1, wherein </seg-main><seg-clauses>the smart pet bowl is a single integrated pet bowl configured to directly carried pet food or water, wherein the single integrated pet bowl also carries the load sensor at a location where animal interaction with the pet food generates load data.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The smart pet bowl of claim 1, wherein </seg-main><seg-clauses>the sample rate, the sequential time increments, or both are controlled onboard by the smart pet bowl.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The smart pet bowl of claim 1, wherein </seg-main><seg-clauses>the sample ","A01K5/01, A01K5/02, A01K29/00",20250313,SOCIETE DES PRODUITS NESTLE SA,['PCT designated period']
AU2022225057A9,Compositions and methods using a combination of oleuropein and magnesium,"Compositions and methods using a combination of oleuropein and MagnesiumComposition comprising a combination of oleuropein or metabolite thereof and Magnesium thereof are provided. The composition may be an oral nutritional composition, for example anutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv)treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally, or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses><seg-main>a combination of oleuropein and/or a metabolite thereof and Magnesium, in a therapeutically effective amount for use in </seg-main><seg-clauses>(i) improving a physiological state linked to metabolic fatigue in one or more cells, </seg-clauses><seg-clauses>(ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and </seg-clauses><seg-clauses>(iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, </seg-clauses><seg-clauses>(iv) treating or preventing a calcium deficiency I depletion disorder in an individual.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The composition for use according to Claim 1, wherein </seg-main><seg-clauses>at least a portion of the one or more cells are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The composition for use according to Claim 1 or 2, wherein </seg-main><seg-clauses>the physiological state linked to metabolic fatigue comprises muscle fatigue or weakness, lack of energy, physical energy, lack of vitality or weakness.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition for use according to any of Claim 1 to 3, wherein </seg-main><seg-clauses>the effective amount of a combination of oleuropein and/or a metabolite thereof and Magnesium is orally administered daily for at least one week.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition for use according to any of Claim 1 to 4, wherein </seg-main><seg-clauses>the metabolite of oleuropein is selected from the group consisting of oleuropein aglycone, hydroxytyrosol, elenolic acid, homovanillyl alcohol, isohomovanillyl alcohol, g","A61K31/05, A23K10/00, A23L33/00, A61K31/08, A61K31/351",20250313,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US12371250B2,Kit for the preparation of a beverage in a centrifugal brewing device,"Kit for the preparation of a beverage in a centrifugal brewing device comprising a capsule by feeding liquid in the capsule and rotating the capsule along a central axis to produce centrifugal forces on the liquid traversing the capsule thereby forcing the beverage out of the capsule by such centrifugal forces, wherein the capsule comprises containment walls forming a main cavity of central axis containing beverage ingredients; wherein said kit further comprising an insert which is separate from the capsule and comprising a ring-shaped portion intended to form a valve engaging portion engaging against a valve means of the centrifugal brewing device.","<div class=""indep-clm"" num=""1""><seg-con>1. A kit to be inserted in a centrifugal brewing device, the kit </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule configured for preparation of a beverage in the centrifugal brewing device by feeding liquid in the capsule and rotating the capsule along a central axis to produce a centrifugal force on the liquid traversing the capsule to force the beverage out of the capsule by the centrifugal force, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the capsule comprises containment walls forming a main cavity of the central axis; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the kit further comprising an insert independent from the centrifugal brewing device and which is separate from the capsule,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert comprises a ring-shaped portion forming a valve engaging portion configured for engagement against a valve means of the centrifugal brewing device,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert further comprises a transversal annular or circular portion which is inwardly and integrally connected to the ring-shaped portion,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the insert is hollow at and around the central axis, the transversal annular or circular portion has one or more through-openings for allowing liquid to flow through the insert, and the insert is configured to allow gas to flow through the insert and into the capsule prior to insertion of the kit in the centrifugal brewing device, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the ring-shaped portion extends axially above and below the transversal annular or circular portion to form a “T” in transversal cross section, the ring-shaped portion has an outer diameter larger than the largest diameter of the capsule, and the ring-shaped portion has a structure in relief and/or re","B65D85/804, A23F5/26, A47J31/22, A47J31/36",20250729,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
CN119677415A,Wet pet food with at least one of enhanced palatability or reduced sugar provided by at least one of spinach or tomato,"A wet grain is formulated for application to pets and the wet grain contains at least one of spinach or tomato effective to enhance the palatability of the wet grain and/or to reduce the amount of sugar in the wet grain. The wet grain may be a mash-containing gravy composition, which may have at least one of the following formulations: (i) at least a portion of at least one of spinach or tomato includes spinach in the gravy; (ii) at least a portion of at least one of spinach or tomato comprises tomato in the gravy, and preferably, in addition to the tomato in the gravy, the gravy further comprises cysteine in free form; and (iii) at least a portion of at least one of spinach or tomato comprises both spinach and tomato included in the mass. The wet grain may be a cake composition that may include both spinach and tomato.","<div class=""indep-clm"" num=""1"">1.被调配用于施用于宠物的湿粮，所述湿粮包括有效增强所述湿粮的适口性和/或减少所述湿粮中的糖的量的菠菜或番茄中的至少一种。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的湿粮，其中所述湿粮是含块状物的肉汁组合物。</div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的湿粮，其中菠菜或番茄中的所述至少一种的至少一部分在所述肉汁中包括菠菜。</div>
<div class=""dep-clm"" num=""4"" parent=""2"">4.根据权利要求2所述的湿粮，菠菜或番茄中的所述至少一种的至少一部分在所述肉汁中包括菠菜。</div>
<div class=""dep-clm"" num=""5"" parent=""4"">5.根据权利要求4所述的湿粮，其中除了所述肉汁中的所述番茄之外，所述肉汁还包括游离形式半胱氨酸。</div>
<div class=""dep-clm"" num=""6"" parent=""2"">6.根据权利要求2所述的湿粮，其中菠菜或番茄中的所述至少一种的至少一部分包括被包括在所述块状物中的菠菜和番茄两者。</div>
<div class=""dep-clm"" num=""7"" parent=""1"">7.根据权利要求1所述的湿粮，其中所述湿粮是糕组合物。</div>
<div class=""dep-clm"" num=""8"" parent=""7"">8.根据权利要求7所述的湿粮，其中所述糕组合物包括菠菜和番茄两者。</div>
<div class=""dep-clm"" num=""9"" parent=""1"">9.根据权利要求1所述的湿粮，其中相对于存在于菠菜或番茄中的所述至少一种中的任何糖，所述湿粮不包括任何添加的糖。</div>
<div class=""dep-clm"" num=""10"" parent=""1"">10.根据权利要求1所述的湿粮，其中所述湿粮被调配用于施用于猫。</div>
<div class=""dep-clm"" num=""11"" parent=""1"">11.根据权利要求1所述的湿粮，所述湿粮还包括酱油。</div>
<div class=""indep-clm"" num=""12"">12.包括容器和根据权利要求1所述的湿粮的产品，其中所述湿粮已经在所述容器中蒸煮并且密封。</div>
<div class=""indep-clm"" num=""13"">13.向宠物提供营养的方法，所述方法包括将根据权利要求1所述的湿粮施用于所述宠物。</div>
<div class=""dep-clm"" num=""14"" parent=""13"">14.根据权利要求13所述的方法，其中所述宠物是猫。</div>
<div class=""dep-clm"" num=""15"" parent=""13"">15.根据权利要求13所述的方法，其中所述宠物患有肾衰竭或处于肾衰竭的风险中，并且所述湿粮不含或基本上不含添加的磷酸盐或多磷酸盐。</div>","A23K10/30, A23K50/45, A23K50/48",20250321,雀巢产品有限公司,['Pending']
CN120500288A,Mixing device for beverage preparation,"The invention relates to a mixing device (1) comprising:-a whipper housing (2), a whipper (3) and a rear wall (4); -a drive shaft (81) for driving the beater,-the beater housing comprises a front wall (21) facing a radial front surface (32) of the beater, and wherein the beater (3) is disc-shaped, and wherein at least a portion of the surface of the radial front surface (32) of the beater is rough and has an arithmetic maximum surface roughness (Sz) of at least 200 [mu] m.","<div class=""indep-clm"" num=""1""><seg-con>1.混合设备(1)，所述混合设备</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-搅打器壳体(2)、搅打器(3)和后壁(4)，所述搅打器壳体和所述后壁形成其中存放所述搅打器的搅打器室，并且所述搅打器壳体包括饮料入口(11)和饮料出口(7)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-用于驱动所述搅打器的驱动轴(81)，所述驱动轴由所述后壁支撑，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>并且其中：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述搅打器具有面向所述搅打器壳体后壁(4)的径向后表面(33)和与所述径向后表面相对的径向前表面(32)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-所述搅打器壳体包括前壁(21)，所述前壁面向所述搅打器的所述径向前表面(32)，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述搅打器(3)是盘形的，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述搅打器的所述径向前表面(32)的表面的至少一部分是粗糙的，并且具有至少200μm、优选地至少400μm的算术最大表面粗糙度(Sz)。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的混合设备，其中所述搅打器的所述径向前表面(32)的所述表面的粗糙部分具有至少30μm、优选地至少40μm的算术平均表面粗糙度(Sa)。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2所述的混合设备，其中所述搅打器的所述径向前表面(32)的粗糙表面具有图案、优选地具有几何图案，所述图案被雕刻在所述搅打器的所述径向前表面(32)的所述表面上。</div>
<div class=""dep-clm"" num=""4"" parent=""3"">4.根据权利要求3所述的混合设备，其中算术最大表面粗糙度(Sz)与所雕刻的图案相关。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的混合设备，其中所述搅打器的所述前表面(32)包括在所述表面上径向延伸的沟槽(31)。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求所述的混合设备，其中所述沟槽(31)的表面是平滑的。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的混合设备，其中所述搅打器壳体前壁(21)具有从所述前壁的表面(211)升高的隆起块(5)，每个隆起块的上表面(51)是平坦的，并且所述上表面的边缘(52)是尖锐的。</div>
<div class=""indep-clm"" num=""8"">8.用于混合设备的搅打器，其中所述搅打器(3)是盘形的并且具有：</div>
<div class=""indep-clm"" num=""8"">-中心孔(34)，所述中心孔被配置为与驱动轴协作，</div>
<div class=""indep-clm"" num=""8"">-后侧表面(33)和前表面(32)，</div>
<div class=""indep-clm"" num=""8"">其中所述搅打器的所述径向前表面(32)的所述表面是粗糙的，并且具有至少200μm、优选地至少400μm的算术最大表面粗糙度(Sz)。</div>
<div class=""dep-clm"" num=""9"" parent=""8"">9.根据权利要求8所述的搅打器，其中所述径向前表面(32)包括在所述前表面(32)上径向延伸的沟槽(34)，所述沟槽彼此等距。</div>
<div class=""indep-clm"" num=""10""><seg-con>10.饮料制备机，所述饮料制备机</seg-con><seg",A47J31/40,20250815,雀巢产品有限公司,['Pending']
MX379150B,Code and container of system for preparing a beverage or foodstuff,"A container for a foodstuff or beverage preparation machine, the container for containing beverage or foodstuff preparation material and comprising on a surface thereof a code encoding preparation information, the code comprising a reference portion and a data portion: the reference portion comprising a linear arrangement of at least two reference units defining a reference line <i>r</i>, the data portion comprising at least one data unit, wherein said data unit is arranged on an encoding line <i>D</i> that intersects the reference line <i>r</i>, the data unit occupies any continuous distance <i>d </i>along the encoding line <i>D</i> as a variable to at least partially encode a parameter of the preparation information, whereby said encoding line <i>D</i> is circular and is arranged with a tangent thereto orthogonal the reference line <i>r</i> at said intersection point.","REIVINDICACIONES
<div class=""indep-clm"" num=""1"">1. Contenedor (6) para una maquina de preparation de bebida o maquina de preparation de producto alimenticio, el contenedor (6) para contener material de bebida o producto alimenticio y comprende una information de preparation de codification de codigo (74), el codigo (74) comprende una portion de referencia (80) y una portion de datos (78):</div>
<div class=""indep-clm"" num=""1"">la portion de referencia (80) comprende un arreglo de al menos dos unidades de referencia (86) para definir una linea de referencia virtual W;</div>
<div class=""indep-clm"" num=""1"">la portion de datos (78) comprende dos unidades de datos (82), en donde las dos unidades de datos (82) se disponen a Io largo de una linea virtual de codification (D) que interseca la linea virtual de referencia (r), las dos unidades de datos (82) se disponen cada una con una distancia asociada diferente (d</div>
<div class=""indep-clm"" num=""1"">1t</div>
<div class=""indep-clm"" num=""1"">d</div>
<div class=""indep-clm"" num=""1"">2</div>
<div class=""indep-clm"" num=""1"">) a Io largo de dicha linea virtual de codification (D) desde dicha intersection, de manera que dicha linea virtual de codification (D) sea circular o un segmento de un circulo y se disponga con una tangente a esta ortogonal a la linea virtual de referencia (r) en dicho punto virtual de intersection (84), caracterizado porque una distancia total (d), determinada como un promedio (d = 0.5 (d! + d</div>
<div class=""indep-clm"" num=""1"">2</div>
<div class=""indep-clm"" num=""1"">)) de dichas distancias (d</div>
<div class=""indep-clm"" num=""1"">1t</div>
<div class=""indep-clm"" num=""1"">d</div>
<div class=""indep-clm"" num=""1"">2</div>
<div class=""indep-clm"" num=""1"">) asociadas con cada una de dichas dos unidades de datos (82), codifica un valor de un parametro (Vp) de la information de preparation.</div>
<div class=""indep-clm"" num=""2"">2. Contenedor (6) de conformidad con la reivindicacion 1, caracterizado porque las dos unidades d","A47J31/44, B65D85/804",20250311,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
JP2025084779A,Ω3 fatty acids and choline as neuroprotectant in patients with no dementia,"To provide a method for attenuating, treating or preventing cognitive aging in an individual who doe not have dementia.SOLUTION: A method includes a step of administering to the individual a therapeutically effective amount of a composition containing ω3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining the number of synapses, increasing amyloid-β phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> 認知的加齢の低減、治療又は予防を必要とするか、あるいは認知的加齢のリスクがある認知症ではない個体の認知的加齢を低減、治療又は予防する方法であって、ω３脂肪酸及びコリンを含む組成物を治療的に有効な量で前記個体に投与するステップを含む方法。 </div>
<div class=""dep-clm"" num=""2"" parent=""1"">【請求項2】</div>
<div class=""dep-clm"" num=""2"" parent=""1""> 前記個体が、高齢成体である、請求項１に記載の方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""1,2""> 前記個体が、老齢のヒトである、請求項１又は２に記載の方法。 </div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">【請求項4】</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""> 前記組成物が、前記個体に少なくとも１ヶ月間、毎日経口投与される、請求項１～３のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記組成物が、一酸化窒素放出化合物を更に含む、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""5""> 前記一酸化窒素放出化合物が、シトルリンを含む、請求項５に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記ω３脂肪酸が、ドコサヘキサエン酸、エイコサペンタエン酸及びそれらの混合物からなる群から選択される脂肪酸を含む、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記コリンが、塩化コリン、コリン重酒石酸塩、シチコリン、Ｌ－α－グリセロホスホコリン、レシチン、ホスファチジルコリン及びそれらの混合物からなる群から選択される、前記組成物の成分によって提供される、請求項１～７のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""> 前記組成物が、ビタミンＢ１、ビタミンＢ２、ビタミンＢ３、ビタミンＢ５、ビタミンＢ６、ビタミンＢ７、ビタミンＢ９及びビタミンＢ１２からなる群から選択される１種以上のビタミンＢ類を含む、請求項１～８のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">【請求項10】</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9""> 前記組成物が、ビタミンＣ、ビタミンＤ、ビタミンＥ及びセレンからなる群から選択される１つ以上の抗酸化剤を含む、請求項１～９のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">【請求項11】</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10""> 前記個体がベースラインにおいて低ＤＨＡ状態を有する、請求項１～１０のいずれか一項に記載の方法。 </d","A61K31/14, A61P25/28, A61P43/00, A61K45/00, A61K31/202",20250603,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
WO2025114892A1,Method for generating a biological clock comprising a DNA methylation profile,"The present invention provides a method for generating a biological clock comprising a DNA methylation profile which is suitable for use with at least two different sample types, the method comprising: (i) providing a first set of DNA methylation profiles generated from the at least two different sample types from a plurality of subjects; (ii) generating a composite DNA methylation profile from the first set of DNA methylation profiles, wherein the composite DNA methylation profile comprises methylation sites that have a matched status in the different sample types; (iii) using the composite DNA methylation profile to generate a biological clock using reference DNA methylation profiles from one of the at least two sample types.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . A method for generating a biological clock comprising </seg-main><seg-clauses><seg-main>a DNA methylation profile which is suitable for use with at least two different sample types, the method comprising:</seg-main>
<seg-clauses>(i) providing a first set of DNA methylation profiles generated from the at least two different sample types from a plurality of subjects;</seg-clauses>
<seg-clauses>(ii) generating a composite DNA methylation profile from the first set of DNA methylation profiles, wherein the composite DNA methylation profile comprises methylation sites that have a matched status in the at least two different sample types;</seg-clauses>
<seg-clauses>(iii) using the composite DNA methylation profile to generate a biological clock using reference DNA methylation profiles from at least of one of the at least two sample types.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method according to claim 1 wherein </seg-main><seg-clauses><seg-main>step (ii) comprises comparing the first set of DNA methylation profiles and:</seg-main>
<seg-clauses>(1) including a methylation site in the composite DNA methylation profile if the methylation site has a matched status in the DNA methylation profiles from the at least two different sample types; and/or</seg-clauses>
<seg-clauses>(2) excluding a methylation site from the composite DNA methylation profile if the methylation site does not have a matched status in the DNA methylation profiles from the at least two different sample types.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The method according to claim 1 or 2 wherein </seg-main><seg-clauses>a matched DNA methylation site has a substantially identical methylation status in the at least two different sample types.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The method according to any preceding claim","G16B20/50, G16B40/00, G16B5/00",20250605,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
CN120457218A,Milk-derived miRNA as indicator of stress in bovine animals,"The present invention relates to miRNA biomarkers from milk, such as exosome-derived microRNAs from milk, as an indicator of welfare in bovine animals. In particular, the present invention relates to the identification of heat stress in bovine animals, allowing management measures to be proposed to improve productive animal welfare at individual or veterinary levels.","<div class=""indep-clm"" num=""1"">1.确定至少一头牛的至少一个福利参数的方法，所述方法包括</div>
<div class=""indep-clm"" num=""1"">i.确定乳样品中至少调节细胞周期的至少一种miRNA的水平，其中所述miRNA选自SEQID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111或其功能变体，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的总体序列同一性；以及</div>
<div class=""indep-clm"" num=""1"">ii.将所述至少一种miRNA的水平与参考水平进行比较，其中如果所述选自SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111的一种或多种miRNA高于所述参考水平，则所述至少一头牛的至少一个福利参数已经受到损害或受到损害，或者如果所述选自SEQ IDNO:81和134的一种或多种miRNA低于所述参考水平，则所述至少一头牛的至少一个福利参数已经受到损害或受到损害。</div>
<div class=""indep-clm"" num=""2"">2.改善至少一头牛的至少一个福利参数的方法，所述方法包括</div>
<div class=""indep-clm"" num=""2"">i.确定第一乳样品中至少调节细胞周期的至少一种miRNA的水平，其中所述miRNA选自SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111或其功能变体，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的序列同一性；</div>
<div class=""indep-clm"" num=""2"">ii.将所述至少一种miRNA的水平与参考水平进行比较，其中如果所述选自SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111的一种或多种miRNA高于所述一个或多个参考水平，则所述至少一头牛的至少一个福利参数已经受到损害，或者如果所述选自SEQ IDNO:81和134的一种或多种miRNA低于所述一个或多个参考水平，则所述至少一头牛的至少一个福利参数已经受到损害；</div>
<div class=""indep-clm"" num=""2"">iii.改善所述至少一头牛的福利；</div>
<div class=""indep-clm"" num=""2"">iv.确定第二乳样品中选自SEQ ID NO:94、123、93、84、81、134、</div>
<div class=""indep-clm"" num=""2"">85、74、83、113、1、132、112和111或其功能变体的至少一种miRNA的水平，其中所述功能变体分别与SEQ ID NO:94、123、93、84、81、134、85、74、83、113、1、132、112和111具有至少60％的序列同一性；以及</div>
<div class=""indep-clm"" num=""2"">v.将所述第一乳样品中的所述至少一种miRNA的水平与所述第二乳样品中的所述水平进行比较，其中如果所述第二乳样品中的SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111或55或其功能变体的水平低于所述第一乳样品中的水平或低于所述参考样品中的水平，则所述一头牛的福利已经改善，</div>
<div class=""indep-clm"" num=""2"">其中所述功能变体分别与SEQ ID NO:94、123、93、84、85、74、83、113、1、132、112和111具有至少60％的序列同一性；或者</div>
<div class=""indep-clm"" num=""2"">如果所述第二乳样品中的SEQ ID NO:81或134的水平高于所述第一乳样品中的水平或高于所述参考样品，则所述一头牛的福利已经改善。</div>
<div class=""indep-clm"" num=""3"">3.改善至少一头牛的乳产量、乳质量、肉产量或肉质量中的至少一者的方法，所述方法包括</div>
<div class=""indep-clm"" num=""3"">i.确定第一乳样品中至少调节细胞周期的至少一种miRNA的水平，</div>
<div class=""indep-clm"" num=""3"">其中所述miRNA选自SEQ ID NO:94、123、9",C12Q1/6876,20250808,雀巢产品有限公司,['Pending']
EP4505914A2,Device for preparing a beverage by centrifugation comprising a valve in the beverage draining means,"The invention relates to a device (1) for preparing a beverage from a substance contained in a capsule, (17). The device comprises: - a capsule holder (16) arranged for holding such capsule (17), - means (40) for rotationally driving the capsule at a rotational speed, - a liquid feeding unit (3, 35) for feeding liquid into the capsule (17) , and - beverage draining means (40) for draining a beverage produced in the capsule (17). The beverage draining means (40) comprise at least one valve (50) and at least one external valve operating means (56) controls the state of the valve (50) in order to modify the flow resistance of the beverage draining means (40).","<div class=""indep-clm"" num=""1""><seg-main>1.  A system (1,17) comprising </seg-main><seg-clauses><seg-main>a capsule (17) and a device (1) for preparing a beverage from a substance contained in the capsule (17), the device (1) comprising: </seg-main><seg-clauses>- a capsule holder (16) arranged for holding the capsule (17), </seg-clauses><seg-clauses>- means (7, 60) for rotationally driving the capsule (17) at an adjustable rotational speed, </seg-clauses><seg-clauses>- a liquid feeding unit (3, 35) for feeding liquid into the capsule (17), and </seg-clauses><seg-clauses><seg-main>- beverage draining means (40) for draining a beverage produced in the capsule (17), <b><u>characterized in that</u></b> the beverage draining means (40) comprise </seg-main><seg-clauses><seg-main>- at least one valve (50), <u>and <b>in that</b></u> </seg-main><seg-clauses>- at least one external valve operating means (56, 57, 58, 61, 74, 77, 78, 79) is arranged to control the state of the valve (50) in order to modify the flow resistance of the beverage draining means (40).</seg-clauses></seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The system of claim 1, wherein </seg-main><seg-clauses>the external valve operating means (56, 57, 58, 61, 74, 77, 78, 79) is arranged to control the state of the valve (50) such that the higher the rotational speed, the higher the closing force of the valve.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3.  The system of claim 1 or 2, wherein </seg-main><seg-clauses>the rotational speed is adjusted by flow-rate control means (7, 62) adjusting the flow rate such that a desired flow rate of the beverage is achieved.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4.  The system of any of the preceding claims, wherein </seg-main><seg-clauses>the valve operating means (56, 57, 58, 61, 74, 77, 78, 79) may control the state of the valve such that the flow resi",A47J31/22,20250212,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
CN119365395A,"Capsule, water dispensing wall for such capsule and method for manufacturing such capsule","The invention relates to a capsule (1) comprising a cup-shaped capsule body (2), a water dispensing wall (10) delimiting a chamber (12) for a substance, and a bottom wall (14). The cup-shaped capsule body (2) comprises a cellulose-based body layer (18) and a liner (20) comprising a liner barrier layer (22). The water distribution wall (10) and/or the bottom wall (14) comprise a wall barrier layer (32). The water dispensing wall (10) and/or the bottom wall (14) are/is connected to the cup-shaped capsule body (2) such that the liner barrier layer (22) and the corresponding wall barrier layer (32) are bonded along the periphery of the body (2).","<div class=""indep-clm"" num=""1""><seg-con>1.胶囊(1)，所述胶囊用于在饮料生产机器中通过在压力下将流体注入所述胶囊中来生产饮料，其中所述胶囊(1)</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>-杯形胶囊主体(2)，所述杯形胶囊主体具有腔体(4)、顶部开口(6)和底部开口(8)，所述顶部开口(6)和所述底部开口(8)相对于所述腔体(4)定位于所述杯形胶囊主体的基本上相对侧处，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-水分配壁(10)，所述水分配壁连接至所述杯形胶囊主体(2)</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>以在所述腔体(4)内界定腔室(12)，所述水分配壁(10)被构造成允许流体通过，所述腔室被构造成用于容纳用于生产所述饮料的物质，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-顶壁，所述顶壁用于封闭所述顶部开口(8)，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>-底壁(14)，所述底壁用于封闭所述底部开口(8)，所述底壁(14)被适配为在所述胶囊(1)内部的压力增加时开启，以便允许在所述腔室(12)中生产的所述饮料从所述胶囊(1)流出，其中所述杯形胶囊主体(2)具有层状结构，所述层状结构包括：</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·主体层(18)，所述主体层由纤维素基材料模制，和</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>·衬里(20)，所述衬里被施加在所述主体层(18)的内面上，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述衬里(20)包括被构造成提供水分和/或气体阻隔功能的衬里阻隔层(22)，</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述水分配壁(10)和/或所述底壁(14)分别包括壁阻隔层(32)，所述壁阻隔层被构造成提供水分和/或气体阻隔功能，并且</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>其中所述水分配壁(10)和/或所述底壁(14)连接至所述杯形胶囊主体(2)，使得所述衬里阻隔层(22)和相应的壁阻隔层(32)沿着所述主体(2)的周边结合。</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.根据权利要求1所述的胶囊(1)，其中所述衬里(20)具有多层结构，所述多层结构除了所述衬里阻隔层(22)之外还</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>·外衬层(26)，所述外衬层在所述主体层(18)的一侧处覆盖所述衬里阻隔层(22)，和/或</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-refi>·内衬层(24)，所述内衬层在所述腔体(4)的一侧处覆盖所述衬里阻隔层(22)。</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2"">3.根据权利要求2所述的胶囊(1)，其中所述外衬层(26)被布置成位于所述主体层(18)与所述衬里阻隔层(22)之间，用于将所述衬里(20)施加到所述主体层(18)。</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">4.根据权利要求2或3所述的胶囊(1)，其中外接合层(25)被布置成接合所述衬里阻隔层(22)和所述外衬层(26)，并且</div>
<div class=""dep-clm"" num=""4"" parent=""2,3"">其中内接合层(23)被布置成接合所述衬里阻隔层(22)和所述内衬层(24)。</div>
<div class=""dep-","B65D85/804, B65D65/40",20250124,雀巢产品有限公司,['Pending']
US12384984B2,Prevention of MCPD formation by auxiliary degumming,"A method is provided for preventing or reducing the formation of monochloropropanediols (MCPDs) or monochloropropanediol esters (MCPDEs) in triacylglyceride oil, comprising the steps: (a) admixing the triacylglyceride oil with (1) an auxiliary oil wherein the auxiliary triacylglyceride oil has higher phospholipid and/or wax content than the triacylglyceride oil; and/or (2) the gum extract from an oil; (b) degumming the triacylglyceride oil admixture and/or optionally allowing the insoluble components to crystallize; (c) optionally concentrating the insoluble and crystallized components from the triacylglyceride oil admixture (1) by applying a centrifugational force on the triacylglyceride oil admix and/or (2) by allowing the insoluble and crystallized components to settle by gravity; (d) separating insoluble and crystallized components from the triacylglyceride oil admixture and/or optionally applying one or more processes selected from degumming, physical refining, chemical refining, neutralization, interesterification, bleaching, dewaxing and fractionation; (e) applying heat treatment to the triacylglyceride oil admixture.","<div class=""indep-clm"" num=""1""><seg-main>1. A method for preventing or reducing the formation of monochloropropanediols (MCPDs) or monochloropropanediol esters (MCPDEs) in a triacylglyceride oil, comprising the steps:</seg-main>
<seg-clauses>(a) admixing the triacylglyceride oil with</seg-clauses>
<seg-clauses>1. an auxiliary triacylglyceride oil wherein the auxiliary triacylglyceride oil has higher phospholipid and/or wax content than the triacylglyceride oil; and/or</seg-clauses>
<seg-clauses>2. a gum extract;</seg-clauses>
<seg-clauses>(b) degumming the triacylglyceride oil admixture and/or optionally allowing insoluble components to crystallize;</seg-clauses>
<seg-clauses>(c) separating insoluble and crystallized components from the triacylglyceride oil admixture and/or applying one or more processes selected from the group consisting of degumming, physical refining, chemical refining, neutralization, interesterification, bleaching, dewaxing and fractionation; and</seg-clauses>
<seg-clauses>(d) applying heat treatment to the triacylglyceride oil admixture.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1, wherein </seg-main><seg-clauses>the triacylglyceride oil is selected from the group consisting of a plant oil, animal oil, fish oil, yeast oil, and fungi or algal oil.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the triacylglyceride oil is palm oil or fractions obtained from palm oil.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the triacylglyceride oil is fish oil or fractions obtained from fish oil.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the triacylglyceride oil is a crude oil.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of","C11B3/16, C11B3/00",20250812,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
WO2025181072A1,Ambient storage acidic dairy products or plant based analogues thereof or synthetic analogues thereof with carbohydrates DP3+ and processes of production,The invention relates to ambient storage acidic dairy products or plant-based analogues thereof with live lactic acid bacteria and with carbohydrates DP3+. The ambient storage acidic dairy products may be fermented or acidified. The invention also relates to processed for producing such ambient storage acidic dairy products or plant-based analogues thereof.,"CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Process for producing an ambient storage acidic dairy product or plant-based analogue thereof or synthetic analogue thereof with live lactic acid bacteria, wherein </seg-main><seg-clauses><seg-main>the ambient storage acidic dairy product or plant-based analogue thereof or synthetic analogue thereof is acidified, and wherein said process comprises the steps of: </seg-main><seg-clauses>a) Providing a milk base or the plant-based milk analogue base or the synthetic milk analogue base comprising less than 5.0wt.% metabolizable carbohydrates having a degree of polymerization of DPI to DP2, </seg-clauses><seg-clauses>b) Adding in the milk base or the plant-based milk analogue base or the synthetic milk analogue base a carbohydrate DP3+ ingredient comprising carbohydrates having a degree of polymerization of DP3 and/or above to form a milk base or a plant-based milk analogue base or synthetic milk analogue base with carbohydrates DP3+, </seg-clauses><seg-clauses>c) Acidifying said milk base or said plant-based milk analogue base or said synthetic milk analogue base with carbohydrates DP3+ by adding an acidifying ingredient until reaching a pH of 4.7 or less to obtain an acidified dairy product or plant-based analogue thereof or synthetic analogue thereof, when the pH of the milk base or the plant-based milk analogue base or the synthetic milk analogue base with carbohydrates DP3+ is higher than 4.7, </seg-clauses><seg-clauses>d) Treating the acidified sdairy product or plant-based analogue thereof or synthetic analogue thereof to extend its shelf-life and obtain an ambient storage acidified dairy product or plant-based analogue thereof or synthetic analogue thereof, </seg-clauses><seg-clauses><seg-main>e) adding a lactose negative culture comprising one or more lactic acid bacteria strains to the ambient storage acidified dairy product or plant-based analogue thereof or synthetic analogue thereof to obtain an ambient stor","A23C9/123, A23C9/152, A23C9/154",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250289651A1,Capsule for producing a beverage,"The invention concerns a capsule for use in a beverage preparation machine, said capsule containing a soluble and/or extractable beverage ingredient, said capsule comprising: -a capsule body (<b>2</b>) defining a chamber (<b>21</b>), -a top membrane (<b>3</b>) closing the top opening, and adapted to be punctured for liquid injection into the capsule, and a bottom membrane (<b>4</b>), provided inside the chamber (<b>21</b>) so as to delimit between the top membrane (<b>3</b>) and said bottom membrane an ingredient chamber, and -an opening device (<b>5</b>) provided inside the chamber and adapted to open the chamber by relative engagement of said opening device with the bottom membrane (<b>4</b>) under the effect of the liquid pressure increase in the ingredient chamber during injection of said liquid, wherein the bottom membrane is a laminated multilayer material comprising successively: -a vegetable parchment layer (<b>41</b>), and -an adhesive layer (<b>42</b>), and -a non-woven material layer (<b>43</b>) comprising fibres, wherein said fibres are biodegradable fibres, and wherein the vegetable parchment layer faces the opening device (<b>5</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A capsule for use in a beverage preparation machine, said capsule </seg-con><seg-trans>containing </seg-trans><seg-refi>a soluble and/or extractable beverage ingredient,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said capsule comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a capsule body defining a chamber,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a top membrane closing the top opening, and adapted to be punctured for liquid injection into the capsule, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a bottom membrane, provided inside the chamber so as to define between the top membrane and said bottom membrane an ingredient chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an opening device provided inside the chamber and adapted to open the chamber by relative engagement of said opening device with the bottom membrane under the effect of the liquid pressure increase in the ingredient chamber during injection of said liquid,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the bottom membrane is a laminated multilayer material comprising successively:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a vegetable parchment layer, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>an adhesive layer, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a non-woven material layer comprising fibres, wherein said fibres are biodegradable fibres, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the vegetable parchment support faces the opening device.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The capsule according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-comp>the biodegradable fibers of the non-woven material layer </seg-comp><seg-comp>are selected from the group of fibers consisting of PLA, PHA (polyhydroxyalkanoate), PHB (Poly(hydrox","B65D85/804, A47J31/06, B32B1/00, B32B5/02, B32B7/12",20250918,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN119947593A,Compositions and methods for digestive health of canines,"Compositions and methods for providing digestive health benefits to canine animals comprise the use of a prebiotic fiber blend comprising pumpkin, inulin, and optionally semen plantaginis.","<div class=""indep-clm"" num=""1"">1.用于犬科动物的益生元纤维共混物，所述益生元纤维共混物包含南瓜、菊粉和任选的车前子。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的益生元纤维共混物，其中所述南瓜以约20％至约50％的量存在于所述纤维共混物中。</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3.根据权利要求1所述的益生元纤维共混物，其中所述菊粉以约10％至约40％的量存在于所述纤维共混物中。</div>
<div class=""dep-clm"" num=""4"" parent=""1"">4.根据权利要求1所述的益生元纤维共混物，其中所述纤维共混物包含车前子，并且其中所述车前子以约20％至约50％的量存在于所述纤维共混物中。</div>
<div class=""indep-clm"" num=""5"">5.宠物食物组合物，所述宠物食物组合物包含根据权利要求1所述的益生元纤维共混物。</div>
<div class=""dep-clm"" num=""6"" parent=""5"">6.根据权利要求5所述的宠物食物组合物，所述宠物食物组合物还包含蛋白质、碳水化合物、脂肪和防腐剂，其中所述纤维共混物以约0.1％至约10％的量存在于所述宠物食物组合物中。</div>
<div class=""dep-clm"" num=""7"" parent=""5"">7.根据权利要求5所述的宠物食物组合物，其中所述南瓜以约0.01％至约5％的量存在于所述宠物食物组合物中，所述菊粉以约0.01％至约5％的量存在于所述宠物食物组合物中，并且所述车前子以约0.01％至约5％的量存在于所述宠物食物组合物中。</div>
<div class=""dep-clm"" num=""8"" parent=""5"">8.根据权利要求5所述的宠物食物组合物，其中所述宠物食物组合物为完全且均衡的宠物食物。</div>
<div class=""indep-clm"" num=""9"">9.补充剂，所述补充剂包含根据权利要求1所述的益生元纤维共混物。</div>
<div class=""dep-clm"" num=""10"" parent=""9"">10.根据权利要求9所述的补充剂，其中所述纤维共混物以约0.1％至约50％的量存在于所述补充剂中。</div>
<div class=""indep-clm"" num=""11"">11.向犬科动物提供消化健康益处的方法，所述方法包括向所述犬科动物施用益生元纤维共混物，其中所述益生元纤维共混物包含南瓜、菊粉和任选的车前子。</div>
<div class=""dep-clm"" num=""12"" parent=""11"">12.根据权利要求11所述的方法，其中将所述益生元纤维共混物定期施用于所述犬科动物。</div>
<div class=""dep-clm"" num=""13"" parent=""11"">13.根据权利要求11所述的方法，其中所述益生元纤维共混物作为宠物食物组合物的一部分施用于所述犬科动物。</div>
<div class=""dep-clm"" num=""14"" parent=""11"">14.根据权利要求11所述的方法，其中所述消化健康益处选自治疗腹泻、增加粪便质量、增加微生物组多样性、减少炎症、减少病原菌、增加迁移率、增加粪便IgA、减少蛋白质分解代谢产物、减少餐后葡萄糖波动及其组合。</div>
<div class=""dep-clm"" num=""15"" parent=""11"">15.根据权利要求11所述的方法，其中所述南瓜以约20％至约50％的量存在于所述纤维共混物中，其中所述菊粉以约10％至约40％的量存在于所述纤维共混物中，并且其中所述车前子以约20％至约50％的量存在于所述纤维共混物中。</div>","A23K10/30, A23K20/163, A23K50/40, A23K50/42",20250506,雀巢产品有限公司,['Pending']
AU2023357845A1,Palatability enhancement of dry pet foods by fat modification,"A pet food product can include a dry pet food kibble; a modified fat which contains a first lipid and also contains a second lipid such that the modified fat has at least one property which is increased relative to the first lipid, the at least one increased property selected from the group consisting of hardness, crystallinity, viscosity, and solid fat content; a liquid digest on the dry pet food kibble and/or the modified fat; and a dried animal digest on at least one of the dry pet food kibble, the modified fat, and the liquid digest.","<div class=""indep-clm"" num=""1""><seg-main>1.     A pet food product comprising:</seg-main>
<seg-clauses>a dry pet food kibble;</seg-clauses>
<seg-clauses class=""seg-enter"">a modified fat which comprises a first lipid and further comprises a second lipid such that the modified fat has at least one property which is increased relative to the first lipid, the at least one increased property selected from the group consisting of hardness, crystallinity, viscosity, and solid fat content;</seg-clauses>
<seg-clauses class=""seg-enter"">a liquid digest on the dry pet food kibble and/or the modified fat; and</seg-clauses>
<seg-clauses class=""seg-enter"">a dried animal digest on at least one of the dry pet food kibble, the modified fat, and the liquid digest.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The pet food product of Claim 1, wherein </seg-main><seg-clauses>the dry pet food kibble comprises an extrudate comprising at least one of protein, carbohydrate, or fat.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The pet food product of Claim 1 or Claim 2, wherein </seg-main><seg-clauses>the first lipid in the modified fat comprises a 0’ structure and/or a 0 structure.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The pet food product of any of Claims 1-3, wherein </seg-main><seg-clauses>the first lipid in the modified fat is at least one of beef tallow, pork lard, or poultry fat.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The pet food product of any of Claims 1-4, wherein </seg-main><seg-clauses>the first lipid in the modified fat comprises poultry fat.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The pet food product of any of Claims 1-5, wherein </seg-main><seg-clauses>the second lipid in the modified fat comprises a 0 structure or a 0’ structure, preferably a 0 structure</seg-clauses></div>
<div class=""dep-clm"" num=""","A23K10/20, A23K20/147, A23K40/25, A23K40/30, A23K50/42",20250313,SOCIETE DES PRODUITS NESTLE SA,['Pending']
WO2025124926A1,Forming station of cellulose-based container bodies,"The invention concerns a forming station (10; 20; 30) of cellulose-based container bodies (151) wherein a clamping assembly (110; 120; 130) comprising two opposite jaw elements (111, 112; 121, 122; 131, 132) configured to clamp a portion of a multilayer cellulose-based material (50) between them and to define a perimetral flange (151') of said of cellulose-based container bodies (151), and wherein the clamping assembly (110; 120; 130) comprises at least a sliding portion (510; 520; 530) arranged in one of the jaw elements (111; 121; 131) to be at least partly in contact with a plastic layer (50A) of the multilayer cellulose-based material (50) and made of, or coated by, a material comprising polyethylene terephthalate (PET) modified with polytetrafluoroethylene (PTFE) additives allowing the sliding of at least the plastic layer (50A) during the deep-drawing of the cellulose-based container body (151).","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . Forming station (10; 20; 30) of cellulose-based container bodies (151 ) comprising:</seg-main>
<seg-clauses>- a clamping assembly (110; 120; 130), configured to clamp a portion of a multilayer cellulose-based material (50) provided with at least a cellulose layer (50B) and a plastic layer (50A), and</seg-clauses>
<seg-clauses>- a deep-drawing assembly (210; 220; 230), configured to define a cellulose-based container body (151 ) by deep-drawing said multilayer cellulose-based material (50) while clamped by said clamping assembly (110; 120; 130), wherein said clamping assembly (110; 120; 130) comprises two opposite jaw elements (1 11 , 112; 121 , 122; 131 , </seg-clauses><seg-clauses>132) configured to clamp a portion of said multilayer cellulose-based material (50) between them and to define a perimetral flange (151 ’) of said of cellulose-based container bodies (151 ), and wherein said clamping assembly (1 10; 120; 130) comprises at least a sliding portion (510; 520; 530) arranged in one of said jaw elements (1 11 ; 121 ; </seg-clauses><seg-clauses>131 ) configured to be at least partly in contact with said plastic layer (50A) and made of, or coated by, a material comprising polyethylene terephthalate (PET) modified with polytetrafluoroethylene (PTFE) additives allowing the sliding of at least said plastic layer (50A) during the deep-drawing of said cellulose-based container body (151 ).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Forming station (10; 20; 30) of cellulose-based container bodies (151 ) according to claim 1 , wherein </seg-main><seg-clauses>said sliding portion (510; 520; 530) is made of, or coated by, a material having a lower coefficient of friction with respect to the other jaw element (112; 122; 132) or having a lower coefficient of friction with respect to the other jaw element (1 12; 122; 132) and to the deep-drawing assembly (210; 220; 230).</seg-clauses></div>
<di","B29C51/08, B29C51/14, B29C51/26, B29C51/04, B29K1/00",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250089929A1,Beverage preparation system,"The invention concerns a beverage production system comprising a pack (<b>10</b>) comprising a readable code and a module (<b>1</b>) for producing a beverage from said pack,—said module (<b>1</b>) comprising: a code reader, a movable fluid processing device (<b>11</b>) to introduce a fluid in said pack and to dispense a beverage from the pack, and. a pack holder assembly (<b>2</b>) comprising a pack chamber (<b>22</b>) and a movable interacting device (<b>24</b>) configured to move between:—a first interacting position wherein said locking device interacts with the pack (<b>10</b>) received in the chamber inside the pack holder assembly, and,—a second release position wherein said interacting device does not interact with the pack (<b>10</b>) received in the chamber, and said movable interacting device (<b>24</b>) comprises a movable pushing device configured to push the readable code (<b>102</b>) of the pack to the code reader (<b>4</b>) when the movable interacting device (<b>24</b>) is in the first fixing position.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage production system </seg-con><seg-trans>comprising </seg-trans><seg-refi>a pack and a module for producing a beverage from said pack,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising an ingredient, said ingredient being configured to be mixed with a fluid to produce a beverage,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack presenting a plane shape oriented along a plane and comprising two longitudinal plane walls extending along this plane, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the bottom side of said pack being configured for being openable, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said pack comprising at least one readable code, said code being positioned on at least one of the two longitudinal plane walls, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said module comprising:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a movable fluid processing device configured to cooperate with the bottom of the pack to introduce a fluid in said pack and to dispense a beverage from the pack, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a code reader,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a pack holder assembly, said pack holder assembly comprising a pack chamber and a movable interacting device wherein:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the pack chamber is adapted for receiving said pack through an upper pack inlet and for holding said pack so that the plane of the plane shape is oriented in an essentially vertical position inside the module, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamber presenting a bottom opening configured to enable access of the movable fluid processing device to at least the bottom side of said pack hold in the chamber, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>said chamb","A47J31/44, A47J31/40",20250320,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
SG10202500521RA,Apparatus and method for roasting coffee beans,,"<div class=""indep-clm"" num=""1""><seg-main>1. An apparatus for roasting coffee beans comprising :</seg-main>
<seg-clauses>- a vessel (1) to contain coffee beans,</seg-clauses>
<seg-clauses class=""seg-enter"">5 - a heating device (12) to heat coffee beans contained in the vessel,</seg-clauses>
<seg-clauses>- a control system (180) operable to control the heating device and configured to apply a</seg-clauses>
<seg-clauses class=""seg-enter"">roasting recipe (R) providing the temperature T@t1, T@t2, … to be applied at discrete</seg-clauses>
<seg-clauses class=""seg-enter"">successive times t1, t2, …, respectively,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein, for any customised quantity m of coffee beans of type Ny introduced inside the</seg-clauses>
<seg-clauses class=""seg-enter"">10 vessel,</seg-clauses>
<seg-clauses>- the control system is configured to obtain at least :</seg-clauses>
<seg-clauses class=""seg-enter"">. the customised quantity m of coffee beans introduced inside the vessel, and</seg-clauses>
<seg-clauses class=""seg-enter"">. the type Ny of coffee beans introduced inside the vessel,</seg-clauses>
<seg-clauses class=""seg-enter"">and</seg-clauses>
<seg-clauses class=""seg-enter"">15 - based on the obtained type Ny, the control system is configured to get access at least :</seg-clauses>
<seg-clauses class=""seg-enter"">. to a roasting recipe Ry, said recipe being adapted to the roasting of one pre-determined</seg-clauses>
<seg-clauses class=""seg-enter"">quantity M of beans of type Ny, said roasting recipe Ry providing the temperatures TM@t1,</seg-clauses>
<seg-clauses class=""seg-enter"">TM@t2, , .respectively to be applied at discrete successive times t1, t2, …,</seg-clauses>
<seg-clauses class=""seg-enter"">and</seg-clauses>
<seg-clauses>20 . to said pre-determined quantity M,</seg-clauses>
<seg-clauses class=""seg-enter"">and</seg-clauses>
<seg-clauses>- based on the accessible roasting recipe Ry, on the accessible pre-determined quantity M</seg-clauses>
<seg-clause",,20250530,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
EP4505916A2,Beverage preparation machine with capsule recognition,"Method for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food, comprising inserting a capsule in a capsule feeder, recognizing a type of the capsule by a capsule recognition module, relatively moving a first and a second parts of an extraction unit into their distant position, supplying the capsule to an extraction chamber, relatively moving the first and second parts into their close position to position the capsule in the extraction chamber, extracting the capsule applying extraction parameters determined on the basis of the recognised type of the capsule to prepare a beverage, and dispensing the prepared beverage, wherein the capsule recognition module is configured to determine a type of a capsule at the capsule recognition position by capturing an image of said capsule and processing said image by a neural network computing device.","<div class=""indep-clm"" num=""1""><seg-main>1.  A method for preparing and dispensing a beverage, such as tea, coffee, hot chocolate, cold chocolate, milk, soup or baby food, comprising: </seg-main><seg-clauses>- inserting a capsule in a capsule feeder (2) of a machine for preparing and dispensing a beverage; </seg-clauses><seg-clauses>- recognizing a type of the capsule by a capsule recognition module (4) of the machine for preparing and dispensing a beverage; </seg-clauses><seg-clauses>- relatively moving a first and a second parts of an extraction unit of the machine for preparing and dispensing a beverage into their distant position automatically, semi-automatically or manually; </seg-clauses><seg-clauses>- supplying the capsule to an extraction chamber of the machine for preparing and dispensing a beverage; </seg-clauses><seg-clauses>- relatively moving the first and second parts into their close position to position the capsule in the extraction chamber; </seg-clauses><seg-clauses>- extracting the capsule in the extraction chamber applying extraction parameters determined on the basis of the recognised type of the capsule to prepare a beverage; and </seg-clauses><seg-clauses>- dispensing the prepared beverage via an outlet (16) to a receptacle in a receptacle placing area of the machine for preparing and dispensing a beverage. wherein the capsule recognition module (4) is configured to determine a type of a capsule inserted in the beverage preparation machine at the capsule recognition position (20) by capturing an image of said capsule and processing said image by a neural network computing device.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2.  The method according to claim 1, wherein </seg-main><seg-clauses>the recognizing a type of the capsule by the capsule recognition module (4) comprises lighting up a capsule at a capsule recognition position by at least one source of light, for example at least one LED.</seg-clauses></div>
<div c",A47J31/44,20250212,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250064254A1,Automatic beverage machine,"A beverage preparation machine having an ingredient processing module for preparing a beverage with at least one ingredient supplied with a capsule. The machine includes a positioner arranged to hold at least one capsule out of the ingredient processing module. The machine further includes a sensing arrangement adapted to detect an event related to the insertion by a user of a capsule and/or the presence of the capsule on or into the positioner. The machine is configured, upon detection of the event, to transfer the capsule to the ingredient processing module by using transfer means, and then to start the preparation of the beverage. The machine provides a convenient and safe solution to fully automate the preparation of a beverage.","<div class=""indep-clm"" num=""1""><seg-con>1. A beverage preparation machine </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-comp>an ingredient processing member configured to prepare at least one beverage with at least one ingredient in at least one capsule;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a positioner arranged to hold the at least one capsule out of the ingredient processing member;</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a sensing member adapted to detect an event selected from the group consisting of insertion of the at least one capsule by a user into the positioner, presence of the at least one capsule in the positioner, and combinations thereof; and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>a transfer member configured, upon detection of the event, to transfer the at least one capsule to the ingredient processing member for the ingredient processing member to start preparation of the at least one beverage,</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the beverage preparation machine is configured to, during preparation of a first beverage with a first capsule, allow insertion of a second capsule into the positioner and detection of the second capsule by the sensing member, and</seg-comp></div>
<div class=""indep-clm"" num=""1""><seg-comp>the beverage preparation machine is configured to open the positioner, feed the ingredient processing member with the second capsule, and close the ingredient processing member automatically when the preparation of the first beverage is completed.</seg-comp></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The beverage preparation machine of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the sensing member is adapted to detect the event by receiving or reading information from the at least one capsule, and/or by measuring a characteristic of the at least one capsule selected from the group consisting ","A47J31/44, A47J31/36, A47J31/52",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2024262308A1,Packaging item and packaged food product,"The present invention relates to a packaging item (1) comprising a cylindrical container (2) made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer. The container has a dispensing opening (8). The packaging item further comprises at least one sliding closure element (11) with at least one sliding closure element peripheral wall (12), the sliding closure element being configured to be slid over at least a top end portion of the container peripheral wall (4) and being made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic or inorganic barrier layer. The present invention further relates to a packaged food item.","<div class=""indep-clm"" num=""1""><seg-main>1. A packaging item (1) comprising:</seg-main>
<seg-clauses>-           at least one core container (2) made of a multilayer oxygen and</seg-clauses>
<seg-clauses class=""seg-enter"">moisture barrier laminate comprising a cardboard and an organic and/or inorganic barrier layer, the cardboard having a grammage comprised between 120 and 600 g/m2 and a cellulose content higher than 90%, preferably higher than 95%, more preferably higher than 99%, such that the Oxygen Transmission Rate (OTR) is below 1, preferably below 0.5 cm3/m2/day measured at 23°C and 50% relative humidity (RH), and the Water Vapour Transmission rate (WVTR) is below 1, preferably below 0.5 g/m2/day measured at 23°C and 85% RH, said core container (2) including at least one core container peripheral wall (4) and a core container bottom wall (5), which define at least one compartment (7) for packaging contents, and at least one dispensing opening (8) configured to allow the packaged contents to be dispensed from said core container (2),</seg-clauses>
<seg-clauses>-           at least one sliding closure element (11) with at least one sliding</seg-clauses>
<seg-clauses class=""seg-enter"">closure element peripheral wall (12), and a sliding closure element top wall (13) the sliding closure element (11), being configured to be slid over at least a top end portion of the core container peripheral wall (4) such that when the packaging item (1) is in its fully closed configuration, the sliding closure element peripheral wall (12) at least partially overlaps and encloses the container peripheral wall (4) and the sliding closure element (11) at least partially covers the dispensing opening (8) of the core container (2), said sliding closure element (11) being made of a multilayer oxygen and moisture barrier laminate comprising a cardboard and an organic and/or inorganic barrier layer, the cardboard having a grammage comprised between 120 and 600 g/m2 and a cellulose conten","B65D3/22, B32B29/00, B65D5/68, B65D5/72, B65D83/06",20251009,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250135706A1,Method for manufacturing a bottle,"A method for manufacturing a bottle, using a preform (<b>1</b>) comprising an open neck portion (<b>2</b>) at a first end (<b>12</b>), a closed base portion (<b>3</b>) at a second end (<b>13</b>), and a body portion (<b>4</b>) extending along a longitudinal axis (A<b>1</b>) between the neck portion (<b>2</b>) and the base portion (<b>3</b>), said preform (<b>1</b>) being made in PHA. The method for manufacturing comprises the following steps:—heating the preform (<b>1</b>); and—performing stretch blow molding of the preform (<b>1</b>). The preform (<b>1</b>) has a wall thickness which varies progressively between the body portion (<b>4</b>) and the neck portion (<b>2</b>).","<div class=""indep-clm"" num=""1""><seg-con>1. A method for manufacturing a bottle, using a preform </seg-con><seg-trans>comprising </seg-trans><seg-refi>an open neck portion at a first end, a closed base portion at a second end, and a body portion extending along a longitudinal axis between the neck portion and the base portion, said preform being made in PHA, said method for manufacturing comprising the following steps:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the preform; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>performing stretch blow molding of the preform,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the preform has a wall thickness which varies progressively between the body portion and the neck portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. Method for manufacturing a bottle according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wall thickness of the preform decreases progressively from the body portion to the neck portion.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. Method for manufacturing a bottle according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the base portion and the body portion have a total longitudinal dimension taken along the longitudinal axis, a ratio between said longitudinal dimension and a thickness taken along any transverse cross-section being at least equal to 15.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. Method for manufacturing a bottle according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>said body portion comprises at least three zones extending longitudinally, said zones presenting a greater thickness than the rest of the body portion.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. Method for manufacturing a bottle according to claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the thickness of said","B29C49/00, B29L31/00",20250501,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120187441A,Compositions and methods for modulating association of intestinal bacteria to cholesterol using combination of at least one fiber and at least one probiotic,"A composition containing a combination of at least one fiber and at least one probiotic can be orally administered to a subject in an amount effective to modulate the association of intestinal bacteria to cholesterol levels in blood in the subject. The method can achieve at least one outcome of improving cholesterol levels in blood, preventing and/or treating cardiovascular, circulating, endocrine and/or nervous system conditions and/or diseases.","<div class=""indep-clm"" num=""1"">1.用于调节受试者的肠道细菌与血液中胆固醇水平的关联的方法，其中将包含有效量的至少一种纤维和至少一种益生菌的组合的组合物施用于所述受试者。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1所述的方法，其中肠道细菌选自梭菌属种、尖锐粪球菌、扭链瘤胃球菌、异黄酮转化斯莱克氏菌、粪居拟杆菌、粪便拟杆菌、马赛拟杆菌、普通拟杆菌、梭菌属种、厚壁菌门细菌、狄氏副拟杆菌、金氏副拟杆菌、双环瘤胃球菌、酸奶瘤胃球菌、异黄酮转化斯莱克氏菌。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据前述权利要求中任一项所述的方法，其中所述至少一种纤维选自不溶性纤维、可溶性纤维以及它们的混合物；优选地它们的混合物。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项所述的方法，其中所述至少一种纤维选自低聚木糖、亚麻籽、部分水解的瓜尔胶(PHGG)、葡甘露聚糖、纤维素、西梅粉、果胶诸如苹果皮果胶以及它们的混合物。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项所述的方法，其中所述至少一种纤维包括至少两种纤维，诸如两种、三种、四种、五种、六种或七种纤维以及任选地更多种。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项所述的方法，其中所述至少一种益生菌选自嗜酸乳杆菌、乳双歧杆菌、鼠李糖乳杆菌、长双歧杆菌、植物乳杆菌、两歧双歧杆菌、加氏乳杆菌以及它们的混合物。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项所述的方法，其中所述至少一种益生菌包括选自嗜酸乳杆菌La-14、乳双歧杆菌BI-04、鼠李糖乳杆菌GG、长双歧杆菌BL-05、植物乳杆菌Lp-115、两歧双歧杆菌Bb-06、加氏乳杆菌Lg-36以及它们的混合物的菌株。</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">8.根据前述权利要求中任一项所述的方法，其中所述至少一种益生菌包括至少两种益生菌菌株，诸如两种、三种、四种、五种、六种或七种益生菌菌株以及任选地更多种。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项所述的方法，其中将至少一种纤维和至少一种益生菌的所述组合口服施用于所述受试者。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项所述的方法，其中所述受试者选自人类婴儿、人类儿童、人类青少年、成人、老年人以及动物诸如伴侣动物。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项所述的方法，所述方法用于实现选自改善血液中胆固醇水平、预防和/或治疗心血管、循环、内分泌系统和/或神经系统病症和/或疾病的至少一种结果。</div>
<div class=""indep-clm"" num=""12"">12.制备用于调节被施用组合物的受试者的肠道细菌与血液中胆固醇水平的关联的所述组合物的方法，所述方法包括将至少一种纤维添加到至少一种益生菌中以及任选地添加至少一种附加组分。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12""><seg-con>13.根据前述权利要求中任一项所述的方法，其中调节所述受试者的肠道细菌与血液中胆固醇水平的关联</seg-con><seg-trans>包括：</seg-trans></div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12""><seg-refi>i.消除选自梭菌属种、尖锐粪球菌、扭链瘤胃球菌、异黄酮转化斯莱克氏菌的至少一种肠道细菌的与LDL胆固醇的关联，和/或</seg-refi></div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,","A61K35/741, A61K35/747, A61K35/745, A61K31/736, A61K31/732",20250620,雀巢产品有限公司,['Pending']
AU2024270754A1,Nutritional composition and method for promoting sleep and/or for treating and/or preventing sleep disorders,"The present invention relates to a combination of galacto-oligosaccharides (GOS) and a mix of human oligosaccharides (HMOs), or nutritional compositions comprising the combination, for use in promoting sleep and/or treating and/or preventing sleep disorders in a subject, wherein the mix consists of 2'-fucosyllactose (2'FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6'-sialyllactose (6'SL). The present invention also relates to the use of a combination of galacto- oligosaccharides (GOS) and a mix of human oligosaccharides (HMOs), or nutritional compositions comprising the combination, for use in promoting sleep and/or treating and/or preventing sleep disorders in a subject, wherein the mix consists of 2'- fucosyllactose (2'FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6'- sialyllactose (6'SL). Furthermore, the present invention relates to a method for in promoting sleep and/or in treating and/or preventing sleep disorders in a subject, the method comprising administering to the subject a combination or a nutritional composition according to the invention.",,"A23L33/125, A23L33/00, A61K31/702, A61P25/20",20251127,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023297151A1,Wet pet foods having at least one of enhanced palatability or reduced sugar provided by at least one of spinach or tomato,"A wet food is formulated for administration to a pet and contains an amount of at least one of spinach or tomato effective to enhance palatability of the wet food and/or reduce sugar in the wet food. The wet food may be a chunks-in-gravy composition which may have at least one of the following formulations: (i) at least a portion of the at least one of spinach or tomato includes spinach in the gravy; (ii) at least a portion of the at least one of spinach or tomato includes tomato in the gravy, and preferably the gravy further includes free form cysteine in addition to the tomato in the gravy; and (iii) at least a portion of the at least one of spinach or tomato includes spinach and tomato both included in the chunks. The wet food may be a loaf composition which may include both spinach and tomato.","<div class=""indep-clm"" num=""1""><seg-con>1. A wet food formulated for administration to a pet, the wet food </seg-con><seg-trans>comprising </seg-trans><seg-refi>an amount of at least one of spinach or tomato effective to enhance palatability of the wet food and/or reduce sugar in the wet food.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2.     The wet food of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wet food is a chunks-in-gravy composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-con>3.     The wet food of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the at least one of spinach</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-refi>or tomato comprises spinach in the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-con>4. The wet food of Claim 2, at least a portion of the at least one of spinach or tomato </seg-con><seg-trans>comprises </seg-trans><seg-refi>tomato in the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The wet food of Claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the gravy further comprises free form cysteine in addition to the tomato in the gravy.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""2""><seg-con>6. The wet food of Claim 2, </seg-con><seg-trans>wherein </seg-trans><seg-refi>at least a portion of the at least one of spinach or tomato comprises spinach and tomato both included in the chunks.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The wet food of Claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the wet food is a loaf composition.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""7""><seg-con>8. The wet food of Claim 7, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the loaf composition comprises both spinach and tomato.</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1""><seg-con>9. The wet food of Claim 1, </","A23K10/30, A23K50/45, A23K50/48",20241212,SOCIETE DES PRODUITS NESTLE SA,['Pending']
AU2025200579A1,Beverage preparation system,"Abstract There is described a beverage preparation machine comprising a centrifugal brewing unit (2) for preparing a beverage by centrifugation of an ingredient contained in a capsule and mixed with a carrier liquid, the centrifugal brewing unit (2) comprising a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C); driving means (5) for rotating the centrifugal cell (3); a regulator for regulating a rotation speed of the centrifugal cell (3) by controlling the driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in the centrifugal cell (3); the machine further comprising: liquid supply means (6, 4) for supplying carrier liquid to the centrifugal brewing unit (2); an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while the capsule (2A, 2B, 2C) is rotated relative to the optical reading arrangement (100) in the centrifugal cell (3) and generating an output signal representative of the code; wherein the beverage preparation machine is 15 configured to compute the feedback signal using an output signal of the optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by the optical reading arrangement (100). (Fig 2a) 2/6 C) C) 0C. Z - ZC C) N--- ---------- --- 4------N U M CN | ce) CC","<div class=""indep-clm"" num=""1""><seg-main>1. Beverage preparation machine comprising:</seg-main>
<seg-clauses><seg-main>- a centrifugal brewing unit (2) for preparing a beverage by centrifugation of 5 an ingredient contained in a capsule and mixed with a carrier liquid, said centrifugal brewing unit (2) comprising:</seg-main>
<seg-clauses>- a centrifugal cell (3) for receiving such a capsule (2A, 2B, 2C);</seg-clauses>
<seg-clauses>- driving means (5) for rotating said centrifugal cell (3);</seg-clauses>
<seg-clauses><seg-main>- a regulator for regulating a rotation speed of said centrifugal cell (3) by 10 controlling said driving means (5) based on a feedback signal representative of a difference between a desired rotation speed and a measured rotation speed of a capsule (2A, 2B, 2C) rotated in said centrifugal cell (3);</seg-main>
<seg-main class=""seg-enter"">the beverage preparation machine further comprising:</seg-main>
<seg-clauses>- liquid supply means (6, 4) for supplying carrier liquid to the centrifugal 15 brewing unit (2);</seg-clauses>
<seg-clauses>- an optical reading arrangement (100) for reading a code on a periphery of a capsule (2A, 2B, 2C) while said capsule (2A, 2B, 2C) is rotated in said centrifugal cell (3) relative to said optical reading arrangement (100) and generating an output signal representative of said code;</seg-clauses>
<seg-clauses class=""seg-enter"">20 wherein said beverage preparation machine is configured to compute said feedback signal using an output signal of said optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by said optical reading arrangement (100).</seg-clauses></seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. Beverage preparation machine according to the previous claim, configured to 25 determine, from said output signal of said optical reading arrangement (100) representative of at least part of a code of a capsule (2A, 2B, 2C) read by sai","A47J31/22, A47J31/44",20250220,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
AU2023381443A1,Combination for use in brain health and increasing mental performance,"The present invention relates to compositions comprising taurine and at least one of B vitamins, in particular Vitamin B9, for increasing glutathione levels in the brain and/or improving mental performance such as motivational performance, and/or the ability to remained focus and sustain attention, and/or the feeling of energy and vigor.","<div class=""indep-clm"" num=""1""><seg-main>1. A composition comprising </seg-main><seg-clauses>taurine:Vitamin B9 in a ratio of about 1:2500.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1"">2. The composition according to claim 1, for use in increasing glutathione levels in the brain and/or improving mental performance in an individual.</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3. The composition according to any of the preceding claims, for use in improving motivational performance, focus and/or sustained attention, fatigue in an individual.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The composition according to any of the preceding claims further comprising </seg-main><seg-clauses>at least one of B Vitamins.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The composition according to any of the preceding claims, wherein </seg-main><seg-clauses>the at least one of B Vitamins is selected from Vitamin B6 and/or Vitamin B12.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-main>6. The composition according to any of claims 1 to 5, wherein </seg-main><seg-clauses>taurine and Vitamin B9 are comprised in the ratio so that the respective amounts of taurine and Vitamin B9 in the composition are about 100 mg and 0.04 mg, or 120 mg and 0.05 mg, or 150 mg and 0.06 mg, or 200 mg and 0.08 mg, or 300 mg and 0.12 mg, or 400 mg and 0.16 mg, or 500 mg and 0.2 mg, or 600 mg and </seg-clauses><seg-clauses>0.24 mg, or 800 mg and 0.32 mg, or 1000 mg and 0.4 mg, or 2000 mg and 0.8 mg, or 3000 mg and 1.2 mg.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5""><seg-main>7.     The composition according to any of claims 1 to 5, wherein </seg-main><seg-clauses>taurine is administered to a</seg-clauses>
<seg-clauses class=""seg-enter"">human in an amount of at least about 500 mg.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""5""><seg-main>8. The composition according to claim 5,","A61K31/185, A61K31/4415, A61K31/519, A61K31/714, A61P17/18",20250501,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2023331752A1,A process for producing a wet savoury product,"The invention relates to a process for producing a wet savoury product. In particularly the invention relates to a process for producing a wet savoury product comprising the step of mixing a composition comprising water, oil, soluble fiber having a molecular weight below 6000 g/mol and flavor, pasteurize the mixture and after cooling adding an un-gelatinized starch followed by packaging the wet savoury product.","<div class=""indep-clm"" num=""1""><seg-main>1) A process for producing a wet savoury product comprising the steps of:</seg-main>
<seg-clauses>a) mixing a composition comprising 15 to 60wt% water based on the total wet savoury product, 0 to 25wt% oil based on the total wet savoury product, 4 to 30wt% soluble fiber based on the total wet savoury product and 5 to 65wt% of flavors based on the total wet savoury product;</seg-clauses>
<seg-clauses>b) pasteurizing the mix of step a);</seg-clauses>
<seg-clauses>c) cooling the pasteurized mix below the gelatinating temperature of the ungelatinized starch;</seg-clauses>
<seg-clauses>d) adding 0.5 to 20 wt% of un-gelatinized starch based on the total wet savoury product and mixing further;</seg-clauses>
<seg-clauses>e) packaging the wet savoury product.</seg-clauses>
<seg-clauses class=""seg-enter"">wherein the soluble fiber has a molecular weight below 6000 g/mol and wherein the wet savoury product is not a gel.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2) A process for producing a wet savoury product according to claim 1, wherein </seg-main><seg-clauses>the wet savoury product comprises a total solid content between 30 to 75wt% (based on the total wet savoury product).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3) A process for producing a wet savoury product according to any one of claims 1 to 2, wherein </seg-main><seg-clauses>the composition comprises 15 to 45wt% water (based on the total wet savoury product), 5 to 25wt% oil (based on the total wet savoury product), 4 to 30wt% soluble fiber (based on the total wet savoury product) and 5 to 60wt% of flavors (based on the total wet savoury product).</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4) A process for producing a wet savoury product according to any one of claims 1 to 3, wherein </seg-main><seg-clauses>the un-gelatinized starch is present in an amount of 3 to 20wt% (based on the total","A23L3/00, A23L3/16, A23L23/00, A23L23/10, A23L29/10",20250102,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250325576A1,Compositions for use in cartilage breakdown,"A composition containing oleuropein and/or hydroxytyrosol can be administered to maintain joint health or prevent or treat a joint disorder, for example by preventing or treating cartilage breakdown. The composition can decrease joint pain. An elderly mammal can be the recipient of administration.","<div class=""indep-clm"" num=""1""><seg-con>1. A method of preventing or treating cartilage breakdown in an individual in need thereof, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering an effective amount of oleuropein to the individual.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oleuropein is administered in a composition further comprising an additional component selected from the group consisting of Vitamin D, calcium, phosphorus, magnesium, Vitamin K and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oleuropein is the only polyphenol in the composition.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the oleuropein is administered in a tablet or capsule.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-con>5. The method of claim 4, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the tablet or capsule further comprises an additional component selected from the group consisting of a cellulosic material, lecithin, and mixtures thereof.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1 </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual is in need of maintained or improved activity and/or mobility.</seg-refi></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-con>7. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual is in need of decreased joint pain.</seg-refi></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-con>8. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the individual is in need of decreased breakdown of collagen in cartilage.</seg-refi></div>
<div class=""dep-clm"" num=""9"" parent=""1""><","A61K31/7048, A23L33/105, A23L33/155, A23L33/16, A61K9/20",20251023,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019401214B2,Peanut oral immunotherapy dosing schedule for missed doses,"The present disclosure relates to improved oral immunotherapy methods for treating peanut allergy. In certain embodiments, the disclosure provides methods for continuing an oral immunotherapy for the treatment of a peanut allergy after missing a scheduled oral administration of one or more consecutive doses of a pharmaceutical composition comprising peanut protein.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of continuing an oral immunotherapy for the treatment of a peanut allergy in a patient after missing a scheduled administration of one or more consecutive doses of a pharmaceutical composition comprising </seg-main><seg-clauses><seg-main>peanut protein, wherein the patient began an oral immunotherapy and missed one or more doses of an up-dosing phase or a maintenance phase of the oral immunotherapy, the oral immunotherapy comprising:</seg-main>
<seg-clauses>(i) the up-dosing phase comprising orally administering to the patient a series of escalating doses of the pharmaceutical composition with a single dose administered on a daily basis, wherein the series of escalating doses administered during the up-dosing phase comprises doses of 3 mg to 300 mg peanut protein, and wherein a given dose is administered to the patient for at least a predetermined period of time before the dose is escalated, and</seg-clauses>
<seg-clauses><seg-main>(ii) the maintenance phase comprising orally administering to the patient a plurality of maintenance doses of the pharmaceutical composition after completion of the up-dosing phase, wherein the maintenance dose of the pharmaceutical composition comprises about 300 mg peanut protein and are administered daily;</seg-main>
<seg-main class=""seg-enter"">the method comprising:</seg-main>
<seg-main class=""seg-enter"">orally administering to the patient a dose of the pharmaceutical composition after missing the scheduled one or more consecutive doses, wherein:</seg-main>
<seg-clauses>(1) if one or two consecutive doses are missed, the dose administered to the patient is the same as the most recently administered dose;</seg-clauses>
<seg-clauses><seg-main>(2) if three or four consecutive doses are missed, the dose administered to the patient is reduced compared to the most recently administered dose, wherein the dose is reduced by:</seg-main>
<seg-clauses>(i) 25% or more, and the dose is administe","A61K36/00, A61K36/48, A61K39/35",20250904,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
RU2850394C2,Production line for manufacture of compostable capsules for sealable products and system for measuring and regulating relative moisture content of biodegradable materials based on paperdecomposable material based on paper,"FIELD: packaging.SUBSTANCE: invention relates to a device for manufacturing a compostable capsule for brewable products, containing a moisture sensor, and to a moisture measurement and control system for such a device. According to the present invention, the moulding line includes at least one moisture sensor for measuring the relative humidity level of the biodegradable paper-based material forming the capsule. The moisture sensor is located before or after at least one of a feed unit, a moistening unit, an optional pre-drying unit, a forming unit, and a drying unit. By measuring the relative humidity of the paper-based material forming the capsule at various positions and stages of capsule production using humidity sensors, this parameter can be optimally controlled along the production line. This is important because the moisture content of the paper packaging can affect the shelf life of the end product, in this case the capsule, and can also affect the quality of the product contained in the paper packaging, in this case the brewed products.EFFECT: increased airtightness.18 cl, 5 dwg",,"B65B29/02, B65B47/04, B65B57/08, B65B61/06, B65B63/02",20251111,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20240424010A1,"Nicotinamide riboside trioleates chloride, compositions containing this compound, and methods of making and using this compound","Nicotinamide riboside trioleates chloride (NRTOC1) is a novel hydrophobic derivative of nicotinamide riboside chloride. It can be used in a composition formulated for oral administration, preferably a beverage, such as a Ready-to-Drink (RTD) beverage scaled in a container or a powder formulated for reconstitution in a diluent to form a reconstituted beverage.","<div class=""ccl-clm"" num=""1"">1. (canceled)</div>
<div class=""indep-clm"" num=""2""><seg-main>2. A composition comprising </seg-main><seg-clauses>nicotinamide riboside trioleates chloride (NRTOCl).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""2""><seg-main>3. The composition of claim 2, wherein </seg-main><seg-clauses>the composition is formulated for oral administration.</seg-clauses></div>
<div class=""ccl-clm"" num=""6"">4-6. (canceled)</div>
<div class=""indep-clm"" num=""7""><seg-main>7. A method of promoting an increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues, the method comprising </seg-main><seg-clauses>administering nicotinamide riboside trioleates chloride (NRTOCl) to an individual.</seg-clauses></div>
<div class=""indep-clm"" num=""8""><seg-main>8. A method of decreasing at least one of DNA damage or mitochondria damage and/or treating or preventing at least one condition selected from the group consisting of </seg-main><seg-clauses>(a) a neurodegenerative condition; </seg-clauses><seg-clauses>(b) overweight or obesity; </seg-clauses><seg-clauses>(c) a cardiovascular disease such as heart disease; </seg-clauses><seg-clauses>(d) one or more of diabetes, hyperinsulinemia, an insulin resistance disorder, or insulin insensitivity; </seg-clauses><seg-clauses>(d) muscle degeneration; </seg-clauses><seg-clauses>(e) a disease or disorder associated with aging; </seg-clauses><seg-clauses>(f) a viral infection such as HIV, hepatitis B, SARS-COV-2 or COVID-19; </seg-clauses><seg-clauses>(g) stress; </seg-clauses><seg-clauses>(h) a blood clotting disorder; </seg-clauses><seg-clauses>(i) inflammation; </seg-clauses><seg-clauses>(j) cancer; </seg-clauses><seg-clauses>(k) an eye disorder; and </seg-clauses><seg-clauses>(1) flushing, the method comprising administering nicotinamide riboside trioleates chloride (NRTOCl) to a subject in need thereof or at risk thereof.</seg-clauses></div>
<div class=""ccl-clm"" num=""10"">9-10. (canc","A61K31/706, A61K9/107",20241226,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250064100A1,Dietary butyrate,"A compound having the formula
<img src='' class=""img-anchor"" img-id=""US20250064100A1-C00001""/><ul class=""uspto-list""><li class=""uspto-list-item""><ul class=""uspto-list""><li class=""uspto-list-item"">or combinations thereof, for use to maintain or increase muscle function and/or mass in a subject, and/or prevent or reduce muscle wasting in a subject, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently, a long chain fatty acid having between 16 and 20 carbons.</li></ul></li></ul>","<div class=""indep-clm"" num=""1""><seg-main>1: A method for maintaining or increasing skeletal muscle function and/or mass and preventing or reducing muscle wasting comprising </seg-main><seg-clauses>administering to an individual in need of same a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/00/64/10/0/1740642326639/US20250064100A1-C00006.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064352%3B1765067952%26q-key-time%3D1765064352%3B1765067952%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D2b8c17ee90fada142e4a68ed8b46c4e0078b56e2&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A12%20GMT"" class=""img-anchor"" img-id=""US20250064100A1-C00006"" image_type=""chemistry"" official_size=""8046""></seg-clauses>
<seg-clauses class=""seg-enter"">or combinations thereof, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5 </sup>and R<sup>6 </sup>are independently, a long chain fatty acid having between 16 and 20 carbons.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2: A method for maintaining or increasing skeletal muscle function and/or mass and preventing or reducing muscle wasting comprising </seg-main><seg-clauses>administering to an individual in need of same a composition comprising a compound having the formula</seg-clauses>
<seg-clauses class=""seg-enter""><img src=""https://data-fulltext-image.patsnap.com/US/A1/20/25/00/64/10/0/1740642326639/US20250064100A1-C00007.png?sign=q-sign-algorithm%3Dsha1%26q-ak%3DAKIDz31lFbrtH8mIbFyaxA70x49IRP7lLiCT%26q-sign-time%3D1765064352%3B1765067952%26q-key-time%3D1765064352%3B1765067952%26q-header-list%3Dhost%26q-url-param-list%3Dresponse-expires%26q-signature%3D5a94131373842f83fd874b43f72f42577e9c760d&response-expires=Sun%2C%2007%20Dec%202025%2000%3A39%3A12%20GMT"" class=""img-anchor"" img-id=""US20250064100A1-C00007"" image_type=""chemistry"" ","A23L29/00, A23L33/115, A61K31/22, A61K31/231, A61P21/00",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
EP4556194A1,Methods of manufacturing bio-based polymer beverage capsules,"The present invention relates to methods of manufacturing beverage capsules, the method comprising: (a) providing a biopolymer film, wherein the biopolymer film comprises a layered structure comprising biopolymer layer - polyglycolide (PGA) layer - biopolymer layer; and (b) attaching the biopolymer film to the capsule body by insert moulding or in-mould labelling.",,"B29C45/14, B65D65/46, B65D85/804, B32B7/027, B32B7/12",20250521,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
US20250185684A1,Coffee composition and process,"A coffee composition has improved aroma. and a method of producing a coffee composition, includes two different types of coffee beans that are roasted separately.","<div class=""indep-clm"" num=""1""><seg-con>1: A coffee composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>furfural and (E)-β-damascenone, wherein the ratio of concentrations of furfural to (E)-β-damascenone is from 400 to 1000.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The coffee composition according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>4-ethylguaiacol and 2,3-pentanedione wherein the ratio of concentrations of 2,3-pentanedione to 4-ethylguaiacol is from 5 to 20.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The coffee composition according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>N-caffeoyl-tryptophan and 4-ethylguaiacol wherein the ratio of concentrations of 4-ethylguaiacol to N-caffeoyl-tryptophan is from 1500 to 3000.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4: The coffee composition according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-comp>at least 20 wt. % coffee solids originating from Robusta beans as a percentage of total coffee solids.</seg-comp></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-comp>5</seg-comp><seg-comp>: </seg-comp></div><div class=""dep-clm"" num=""5"" parent=""1""><seg-con>The coffee composition according to claim 1, </seg-con><seg-trans>comprising </seg-trans><seg-refi>at least 45 mg of 2,3-butanedione per kg of soluble coffee solids.</seg-refi></div>","A23F5/04, A23F5/28, A23F5/36",20250612,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250177337A1,Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health,"A method of improving and/or enhancing at least one of bone mineralization, bone strength, bone mass, and bone mineral density in an individual in need thereof, the method comprising administering to the individual a composition comprising one or more anabolic amino acids, and the composition further comprising one or more autophagy-inducing compounds. In one embodiment, the one or more autophagy-inducing compounds are selected from the group consisting of thymol, carvacrol, spermidine, urolithin (e.g., Urolithin A, B or D), rapamycin, Torin1, valproic acid, polyphenols (e.g., resveratrol), caffeine, metformin, 5′ AMP-activated protein kinase (AMPK) activators, L-type calcium channel inhibitors, ketones (e.g. beta-hydroxybutyrate, ketone salts, or ketone ester derivatives), 4,4′-dimethoxychalcone and mixtures thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of improving and/or enhancing at least one of bone mineralization, bone strength, bone mass, and bone mineral density in an individual in need thereof, the method comprising </seg-main><seg-clauses>administering to the individual a composition comprising one or more anabolic amino acids, and the composition further comprising one or more autophagy-inducing compounds.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The method of claim 1 wherein </seg-main><seg-clauses>the one or more autophagy-inducing compounds are selected from the group consisting of thymol, carvacrol, spermidine, urolithin, rapamycin, Torin1, valproic acid, polyphenols, caffeine, metformin, 5′ AMP-activated protein kinase activators, L-type calcium channel inhibitors, ketones, 4,4′-dimethoxychalcone and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method of claim 1, wherein </seg-main><seg-clauses>the one or more anabolic amino acids are selected from the group consisting of Leucine, Isoleucine, Arginine, Glutamine, Citrulline and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The method of claim 1, wherein </seg-main><seg-clauses>the one or more anabolic amino acids are selected from the group consisting of Leucine, Isoleucine, Arginine, Glutamine, Citrulline, and mixtures thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The method of claim 1, wherein </seg-main><seg-clauses>the anabolic amino acid is selected from the group consisting of Leucine, Arginine, Glutamine, and mixtures thereof, and the composition is administered in an amount effective to activate mTOR in the individual.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The method of claim 1, wherein </seg-main><seg-clauses>the composition is administered in an amount effective to induce autophagy in bone.</se","A61K31/198, A23L33/00, A23L33/105, A23L33/175, A61K31/05",20250605,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
CN120225074A,Muscle inositol and prevention of accelerated growth,"The present invention relates to a composition for preventing accelerated growth of offspring comprising a combination of Lactobacillus and Bifidobacterium, myo-inositol, and at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12, vitamin D and mixtures thereof, and wherein the composition is administered to the mother of the offspring before and/or during pregnancy and/or during lactation. The invention also relates to a multi-component kit for preventing accelerated growth of offspring.","<div class=""indep-clm"" num=""1"">1.用于预防后代的加速生长的组合物，所述组合物包含乳杆菌和双歧杆菌益生菌的组合，肌肉肌醇，以及至少一种选自维生素B2、维生素B6、维生素B12、维生素D及其混合物的维生素，并且其中将所述组合物在孕前和/或怀孕和/或哺乳期期间施用给所述后代的母亲。</div>
<div class=""dep-clm"" num=""2"" parent=""1"">2.根据权利要求1用于所述用途的组合物，所述组合物降低在后续生命中经历多余脂肪量的风险。</div>
<div class=""dep-clm"" num=""3"" parent=""1,2"">3.根据权利要求1或2中任一项用于所述用途的组合物，其中所述乳杆菌是能够以保藏号CGMCC 1.3724获得的鼠李糖乳杆菌菌株，并且所述双歧杆菌是作为CNCM I-3446保藏的乳双歧杆菌BB12菌株。</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3"">4.根据前述权利要求中任一项用于所述用途的组合物，其中所述加速生长在所述后代的生命的前2年至5年期间发生。</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">5.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物包含肌肉肌醇、维生素B2、维生素B6、维生素B12、维生素D，并包含鼠李糖乳杆菌CGMCC 1.3724和乳双歧杆菌BB12 CNCMI-3446的组合。</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">6.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物包含0.2g至5g的肌肉肌醇、0.14mg至14mg的维生素B2、0.19mg至19mg的维生素B6、0.26μg至26μg的维生素B12、1.5μg至100μg的维生素D、10<sup>5</sup>cfu至10<sup>12</sup>cfu的鼠李糖乳杆菌CGMCC 1.3724和10<sup>5</sup>cfu至10<sup>12</sup>cfu的乳双歧杆菌BB12 CNCMI-3446，所有量均由每日剂量限定。</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">7.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物还包含锌。</div>
<div class=""dep-clm"" num=""8"" parent=""6"">8.根据权利要求6用于所述用途的组合物，其中所述组合物包含每日剂量为1.1mg至40mg的量的锌。</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">9.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物通过预防所述加速生长而进一步预防所述后代在后续生命中的代谢障碍的发展。</div>
<div class=""dep-clm"" num=""10"" parent=""1,2,3,4,5,6,7,8,9"">10.根据前述权利要求中任一项用于所述用途的组合物，其中所述代谢障碍是心血管代谢障碍、肥胖、多余脂肪量堆积和/或超重。</div>
<div class=""dep-clm"" num=""11"" parent=""1,2,3,4,5,6,7,8,9,10"">11.根据前述权利要求中任一项用于所述用途的组合物，其中所述后代的母亲是哺乳动物，例如选自猫、狗和人类的哺乳动物。</div>
<div class=""dep-clm"" num=""12"" parent=""1,2,3,4,5,6,7,8,9,10,11"">12.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物用于在怀孕期间，例如在怀孕的整个第二孕期和第三孕期期间施用给所述后代的母亲。</div>
<div class=""dep-clm"" num=""13"" parent=""1,2,3,4,5,6,7,8,9,10,11,12"">13.根据前述权利要求中任一项用于所述用途的组合物，其中所述组合物呈用于在乳或水中重构的粉末状营养组合物、食物产品、饮品、营养补充剂或营养品的形式。</div>
<div class=""indep-clm"" num=""14"">14.用于预防后代的加速生长的多组分套盒，所述多组分套盒含有至少两种物理上分开的组合物，每种组合物包含至少一种选自维生素B2、维生素B6、维生素B12和维生素D的成分，所述分开的组合物中的至少一种包含肌肉肌醇并且所述分开的组合物中的至少一种包含乳杆菌和双歧杆菌益生菌的组合，其中将所述两种物理上","A23L33/125, A23L33/135, A23L33/15, A23L33/155, A23L33/16",20250627,雀巢产品有限公司,['Pending']
RU2842500C1,Recyclable paper laminate and carton for beverages made therefrom,"FIELD: packaging and storage.SUBSTANCE: invention relates to the field of paper-based packaging materials having high barrier properties and suitable for recycling in the secondary paper pulp flow, and relates to the structure of the barrier multilayer packaging sheet and the beverage package made therefrom. Paper-based packing material structure is made in the form of a single sheet and contains the following layers from its outer surface to its inner surface: polymer dispersion coating having thickness of 1 mcm to 10 mcm; cardboard having weight content from 120 g/m2 to 500 g/m2; a solvent-free or water-based adhesive having thickness of 1 mcm to 10 mcm; metallized barrier paper layer (MBPL) having a weight of substance from 30 g/m2 to 120 g/m2; and water vapor transmission rate (WVTR) from 10 to 0.1 g/m2/day measured at 38 °C and 90% RH, as well as the oxygen penetration rate (OTR) in range from 100 to 0.1 cc/m2/day when measured at 23 °C and 50% RH; at least one layer of polymer dispersion coating, having thickness from 1 mcm to 25 mcm.EFFECT: invention enables to produce a packaging laminate which enables to produce packages using existing moulding methods, which have high barrier properties and a shape suitable for storage and transportation, which have significantly reduced content of plastic polymer and can be recycled together with other paper packaging, such as old boxes of corrugated cardboard (OCC) or mixed paper wastes, and generally in a paper recycling stream, wherein having high resistance to abrasion, in which the metal layer is not damaged by mechanical stress during storage, transportation or use of the packaging material.10 cl, 1 dwg","1. Структура (1) барьерного многослойного упаковочного материала на основе бумаги, сформированная в виде единого листа и содержащая от ее наружной поверхности до внутренней поверхности следующие слои:
(i) по меньшей мере один слой полимерного дисперсионного покрытия (9), выбранного из списка: сополимер этилена и акриловой кислоты или метакриловой кислоты, винилацетат, стиролакрилат, акриловый полимер, модифицированный поливиниловый спирт, этилацетат, полигидроксиалканоат (PHA) и их сополимеры, полиуретан (PU), полибутиленадипат-терефталат (PBAT), полибутиленсукцинат (PBS), поли(бутиленсукцинат-со-адипат) (PBSA), полимолочная кислота (PLA) или любая их смесь с минеральным наполнителем или без него, причем указанное покрытие имеет толщину от 1 до 10 мкм,
(ii) картон (8), имеющий грамматуру от 120 до 500 г/м<sup>2</sup>,
(iii) слой (7) бессольвентного клея или клея на водной основе, выбранного из списка: поливинилацетат (PVAc), полиуретан (PU), акриловый полимер, поливиниловый спирт (PVOH), этиленвиниловый спирт (EVOH), сополимер бутендиола и винилового спирта (BVOH), клей на основе крахмала или их смесь, причем указанный клеевой слой имеет толщину в диапазоне от 1 до 10 мкм,
(iv) барьерная металлизированная бумага (MBPL), имеющая плотность вещества от 30 до 120 г/м<sup>2</sup>, предпочтительно от 45 до 90 г/м<sup>2</sup>, и скорость проникновения водяных паров (WVTR) от 10 до 0,1 г/м<sup>2</sup>/сут, предпочтительно значение WVTR составляет от 1,0 до 0,1 г/м<sup>2</sup>/сут при измерении при 38°C и 90% RH, а также скорость проникновения кислорода (OTR) в диапазоне от 100 до 0,1 куб.см/м<sup>2</sup>/сут при измерении при 23°C и 50% RH, предпочтительно значение OTR составляет от 1,0 до 0,1 куб.см/м<sup>2</sup>/сут,
(v) по меньшей мере один слой полимерного дисперсионного покрытия, выбранного из списка: сополимер этилена и акриловой или метакриловой кислоты, винилацетат, стиролакрилат, акриловый полимер, модифицированный поливиниловый спирт, этилацетат, полигидроксиалкан","B32B29/00, B32B7/12, B65D5/56",20250630,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
US20250324991A1,"Foaming liquid creamers for aerosol packaging, and methods of making and using such foaming liquid creamers and aerosol packagings","A foaming liquid creamer contains (i) water; (ii) at least one of micellar casein or sodium caseinate; (iii) at least one carbohydrate source; (iv) at least one lipid; (v) at least one buffer salt; (vi) at least one stabilizer; (vii) at least one sweetener; and (viii) at least one emulsifier. The carbohydrate source may include glucose syrup, preferably glucose syrup DE 25-29. The buffer salt may include dipotassium phosphate. The stabilizer may include at least one of carrageenan, carboxymethyl cellulose (CMC), or microcrystalline cellulose (MCC). The lipid may include coconut oil. The at least one emulsifier may include mono- and di-glycerides. The sweetener may include at least one of sucralose or acesulfame. The foaming liquid creamer may also contain a flavor. Another foaming liquid creamer contains (i) water; (ii) at least one of non-fat milk solids or milk fat; and (iii) sugar. Another aspect is an aerosol packaging which includes one of these foaming liquid creamers in a pressurized container, and the aerosol packaging has an actuator nozzle.","<div class=""indep-clm"" num=""1""><seg-main>1. A foaming liquid creamer comprising </seg-main><seg-clauses>(i) water; </seg-clauses><seg-clauses>(ii) at least one of micellar casein or sodium caseinate; </seg-clauses><seg-clauses>(iii) at least one carbohydrate source; </seg-clauses><seg-clauses>(iv) at least one lipid; </seg-clauses><seg-clauses>(v) at least one buffer salt; </seg-clauses><seg-clauses>(vi) at least one stabilizer; </seg-clauses><seg-clauses>(vii) at least one sweetener; and </seg-clauses><seg-clauses>(viii) at least one emulsifier.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one carbohydrate source comprises glucose syrup.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one buffer salt comprises dipotassium phosphate.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one stabilizer comprises at least one of carrageenan, carboxymethyl cellulose (CMC), or microcrystalline cellulose (MCC).</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one lipid comprises coconut oil.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-main>6. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one emulsifier comprises mono- and di-glycerides.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1""><seg-main>7. The foaming liquid creamer of claim 1, wherein </seg-main><seg-clauses>the at least one sweetener comprises at least one of sucralose or acesulfame.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1""><seg-main>8. The foaming liquid creamer of claim 1, further comprising </seg-","A23C11/08, A23C11/00, A23F3/40, A23F5/46, A47J43/12",20251023,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
JP2025102894A,Compositions and methods using adenosylcobalamin,"To provide a method for restoring mitochondrial and other cellular function and/or increasing mitochondrial energy in one or more cells.SOLUTION: The present invention provides a method that comprises administering an effective amount of adenosylcobalamin to an individual in need thereof. Preferably, the amount of the adenosylcobalamin is from 1 to 10 μg up to 100 μg to 2000 μg per day, and the adenosylcobalamin is preferably administered orally.SELECTED DRAWING: None","<div class=""indep-clm"" num=""1"">【請求項1】</div>
<div class=""indep-clm"" num=""1""> ミトコンドリア機能及び他の細胞機能を回復させる、及び／又は１つ以上の細胞においてミトコンドリアエネルギーを増加させる方法であって、前記方法が、有効量のアデノシルコバラミンを、それを必要とする個体に投与することを含む、方法。 </div>
<div class=""indep-clm"" num=""2"">【請求項2】</div>
<div class=""indep-clm"" num=""2""> １つ以上の細胞の代謝性疲労に関連付けられる生理学的状態を改善する、及び／又は個体の疲労を低減する方法であって、前記方法が、有効量のアデノシルコバラミンを、それを必要とする前記個体に投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""3"" parent=""2"">【請求項3】</div>
<div class=""dep-clm"" num=""3"" parent=""2""> 身体持久力を改善する、肉体疲労を抑制若しくは遅延させる、血中酸素濃度を高める、健康な個体におけるエネルギーを増強する、作業能力及び持久力を増強する、運動からの回復を改善する、筋肉疲労を低減する、ストレスを低減する、筋肉ＡＴＰレベルを増加させる方法である、請求項２に記載の方法。 </div>
<div class=""indep-clm"" num=""4"">【請求項4】</div>
<div class=""indep-clm"" num=""4""> 慢性疾患の治療をする、発生率を低減する、及び／又は重症度を低減する方法であって、前記方法が、有効量のアデノシルコバラミンを、それを必要とする個体に投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4"">【請求項5】</div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""> 前記１つ以上の細胞が、肝臓、腎臓、脳、心臓、腸、膵臓、免疫細胞、及び骨格筋からなる群から選択される少なくとも１つの身体部位の一部である、請求項１～４のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5"">【請求項6】</div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""> アデノシルコバラミンの量が、１日当たり１～１０μｇから最大で１００μｇ～２０００μｇまでである、請求項１～５のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6"">【請求項7】</div>
<div class=""dep-clm"" num=""7"" parent=""1,2,3,4,5,6""> 前記アデニルコバラミンが、経口投与される、請求項１～６のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7"">【請求項8】</div>
<div class=""dep-clm"" num=""8"" parent=""1,2,3,4,5,6,7""> 前記個体のメチルマロン酸の血中濃度が高い、請求項１～７のいずれか一項に記載の方法。 </div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8"">【請求項9】</div>
<div class=""dep-clm"" num=""9"" parent=""1,2,3,4,5,6,7,8""> 前記個体が、中高年者、高齢者、重篤患者、又はＩＣＵ患者からなる群から選択される、請求項１～８のいずれか一項に記載の方法。 </div>
<div class=""indep-clm"" num=""10"">【請求項10】</div>
<div class=""indep-clm"" num=""10""> ミトコンドリア関連疾患、若しくはミトコンドリア機能の変化に関連する状態、若しくはミトコンドリア密度の低下の、治療をする、発生率を低減する、及び／又は重症度を低減する方法であって、前記方法が、有効量のアデノシルコバラミンを、それを必要とする個体に経口投与することを含む、方法。 </div>
<div class=""dep-clm"" num=""11"" parent=""9"">【請求項11】</div>
<div class=""dep-clm"" ","A61K31/714, A61P43/00, A61P3/00, A61P3/02, A61P3/04",20250708,ソシエテ·デ·プロデュイ·ネスレ·エス·アー,['Pending']
US20250012612A1,Dosing device,"A dosing device is integrally made of molded pulp fiber. The dosing device includes a container portion for receiving and retaining a dosage material, the container portion having an opening at an upper side of the dosing device to access the dosage material. The dosing device includes a handle portion for manually moving the container portion in a dosing process. The handle portion is connected to an outer surface of the container body by a connecting portion of the handle portion. A rim portion of the container portion, which delimits the opening, and the handle portion extend in a common plane and define a circumferential edge of the dosing device. The dosing device includes a ribbing portion, which extends from the circumferential edge at least at the handle portion to a lower side of the dosing device, for dissipating mechanical stresses arising in the dosing process.","<div class=""indep-clm"" num=""1""><seg-con>1: A dosing device integrally made of molded pulp fiber, the dosing device </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>a container portion having a defined volume for receiving and retaining a dosage material, the container portion having a container body delimiting the defined volume, the container body having a rim portion circumferentially delimiting an opening at an upper side of the dosing device to access the defined volume;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a handle portion for manually moving the container portion relatively to the dosage material in a dosing process;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the handle portion is connected to an outer surface of the container body by a connecting portion of the handle portion and extends from the container body along a longitudinal axis;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>the rim portion and the handle portion extend in a common plane and define a circumferential edge of the dosing device extending in the common plane; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>a ribbing portion, which extends from the circumferential edge at least at the handle portion to a lower side of the dosing device such that mechanical stresses acting on the container body in the dosing process are dissipated by the handle portion.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2: The dosing device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ribbing portion extends from the circumferential edge at least at the handle portion at opposite sides of the longitudinal axis.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3: The dosing device according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ribbing portion extends at its end opposite to the circumferential edge at least partia","G01F19/00, D21J1/02, D21J1/06, D21J1/16, D21J3/00",20250109,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US20250134918A1,Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor,"A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, in particular neurodegenerative disease, depression, anxiety, decreased/low motivation, impaired cognitive function, mild cognitive impairment. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.","<div class=""indep-clm"" num=""1""><seg-main>1: A method of </seg-main><seg-clauses>(1) treating or </seg-clauses><seg-clauses>(2) reducing risk, incidence and/or severity of at least one physical state selected from the group consisting of neurodegenerative disease, depression, anxiety, decreased/low motivation, impaired cognitive function, and mild cognitive impairment, bipolar disorder, schizophrenia, autism, epilepsy, migraine, Huntington, cerebral palsy, stroke and brain ischemia in an individual in need thereof, the method comprising administering to the individual an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of β-hydroxybutyrate (BHB) and salts thereof and β-hydroxypentanoate (BHP) and salts thereof.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2: A method of increasing brain ketone uptake and/or increasing brain energy status in an individual in need thereof, the method comprising </seg-main><seg-clauses>administering to the individual an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of β-hydroxybutyrate (BHB) and salts thereof and β-hydroxypentanoate (BHP) and salts thereof.</seg-clauses></div>
<div class=""indep-clm"" num=""3""><seg-main>3: A method of </seg-main><seg-clauses>(1) reducing risk, incidence and/or severity of or </seg-clauses><seg-clauses>(2) mitigating deterioration of brain structure and function in an individual in need thereof, the method comprising administering to the individual an effective amount of a combination of Nicotinamide Riboside (NR) and at least one of β-hydroxybutyrate (BHB) and salts thereof and β-hydroxypentanoate (BHP) and salts thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-main>4: The method according to claim 1, wherein </seg-main><seg-clauses>the combination is administered enterally.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-main>5: The method according to claim 1, wherein </seg-main><s","A61K31/706, A23L33/00, A23L33/125, A61K9/00, A61K31/121",20250501,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
WO2025140823A1,Compacting station of bulk food products in container bodies,"The invention concerns a compacting station (10) of bulk food product in container bodies (151) wherein a first compacting device (211) and a second compacting device (212) able to move one relative to the other between a first compacting position, wherein a first contacting surface (211') and a second contacting surface (212') are misaligned to define two separate contacting surfaces, and a second compacting position, wherein the first contacting surface (211') and the second contacting surface (212') are aligned to define a compacting surface (213') of a continuous type, and vice versa.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. Compacting station (10) of bulk food products in container bodies (151 ) comprising:</seg-main>
<seg-clauses>- a container holder (1 10), defining a cavity portion (1 11 ) provided with a cavity base (1 11 ’) and configured to hold the container body (151 ) having a lateral wall (151 ”) and a bottom wall (151 ”’), so that the bottom wall (151 ’”) lies on the cavity base (1 11 ’) and a chamber (150’) of the container body (151 ) is able to retain a predefined amount of the bulk food product, and</seg-clauses>
<seg-clauses>- a compacting assembly (210), arranged above the container holder (1 10) and in use configured to compact the bulk food product in the chamber (150’), wherein the compacting assembly (210) comprises a clamping device (215) designed to clamp at least partly a flange (151 ’) of the container body (151 ) at the container holder (110), wherein the compacting assembly (210) further comprises a first compacting device (211 ) provided with a first contacting surface (211 ’) provided with an inclined portion (211 ”) with respect to the cavity base (11 1 ’) to push the bulk food product from the lateral wall (151 ”) toward a centre of the container body (151 ), the inclined portion (211 ”) being arranged at the periphery of the first contacting surface (21 1 ’) and designed to face the chamber (150’) of the container body (151 ) at the container holder (1 10), wherein the first compacting device (211 ) and the clamping device (215) are able to move one relative to the other, wherein the compacting assembly (210) further comprises a second compacting device (212) provided with a second contacting surface (212’) to tamp the bulk food product toward the bottom wall (151 ’”) of the container body (151 ), designed to face the chamber (150’) of the container body (151 ) at the container holder (110), wherein the second compacting device (212) and the clamping device (215) are able to move one relative to the othe","B65B1/24, B65B29/02",20250703,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
US20250064076A1,Fermented camomile beverage,,,"A23F3/16, A23F3/34",20250227,SOCIETE DES PRODUITS NESTLE S.A.,['Pending']
US12397026B2,Dietary supplement,"An oral composition comprising at least one probiotic bacteria selected from the genera: <i>Lactobacillus, Bifidobacterium</i>, and <i>Bacillus</i>, and ferric pyrophosphate.","<div class=""indep-clm"" num=""1""><seg-con>1. An oral composition </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one probiotic bacteria selected from the group consisting of: <i>Lactobacillus rhamnosus </i>CGMCC 1.3724, <i>Bifidobacterium lactis </i>CNCM I-3446, and a mixture thereof;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>ferric pyrophosphate, wherein the ferric pyrophosphate has a particle size distribution D<sub>90 </sub>of 200 microns or less, a particle size distribution D<sub>97 </sub>of 25 microns or less, and an average particle size of about 0.001 microns to about 10 microns; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>at least one pharmaceutically acceptable additive or excipient selected from the group consisting of stabilizers, fillers, emulsifiers, surfactants, solubilising agents, adsorbents, flowing agents, buffers, lubricants, wetting agents, carriers, antioxidants, thickeners, anticaking agents, coating agents, taste masking agents, preservatives, flavouring agents and dyes.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ferric pyrophosphate is in the form of a colloid.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the at least one probiotic bacteria is the mixture of <i>Lactobacillus rhamnosus </i>CGMCC 1.3724 and <i>Bifidobacterium lactis </i>CNCM I-3446.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The composition according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the at least one probiotic bacteria comprises <i>Lactobacillus rhamnosus </i>CGMCC 1.3724.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The composition according to claim 1, </seg-con><seg-trans>wherein </seg","A61K35/747, A23L33/00, A23L33/135, A23L33/16, A61K9/00",20250826,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12478085B2,Apparatus and method for roasting coffee beans,"A method of roasting coffee beans with a roasting device positioned in a room, and the roasting device includes a roasting device and a smoke treating unit configured to treat the smoke produced in the roasting device and to prevent the dispense of air contaminants in the room. The method includes introducing coffee beans in the roasting device and heating the coffee beans during a time, and a part of the whole quantity of smoke produced during the time of the step of heating is dispensed in the room without being treated by the smoke treating unit.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for roasting coffee beans</seg-con></div>
<div class=""indep-clm"" num=""1""><seg-con>the method </seg-con><seg-trans>comprising:</seg-trans></div>
<div class=""indep-clm"" num=""1""><seg-refi>introducing the coffee beans in a roasting device of a roasting apparatus, the roasting device comprising a coffee beans identification device, the roasting apparatus further comprising a contaminants treating device;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>identifying, by the coffee beans identification device, the coffee beans introduced in the roasting device in order to determine, directly or indirectly, a heating profile to be applied;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>heating the coffee beans in the roasting device according to the heating profile, during a time;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>collecting, in a smoke collecting device connected to the roasting device, smoke produced in the roasting device during the time of the heating;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>diverting, by a smoke diverting device positioned between the smoke collecting device and the contaminants treating device, a first part of the smoke produced in the roasting device during the time of the heating, wherein the smoke diverting device diverts the first part of the smoke away from the contaminants treating device and directly to the outside of the roasting apparatus without being treated by the contaminants treating device; and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>treating, in the contaminants treating device, a second part of the smoke produced in the roasting device during the time of the heating, to prevent a dispensing of coffee aromas into a room.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method according to claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the contaminants treating device is ","A23N12/12, A23F5/04",20251125,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
US12364666B2,Stable low digestive enzyme content formulation,"The present invention is directed to a pharmaceutical composition or dosage form having a stable, low (diluted) digestive enzyme content comprising at least one digestive enzyme and at least one carrier, or a dosage form thereof. The invention is also directed to a process of preparation of the composition or the dosage form. In addition the invention is directed to the treatment and prevention of disorders or conditions associated with a digestive enzyme deficiency in a patient in need thereof, comprising administering to said patient a pharmaceutically acceptable amount of the composition having a stable low digestive enzyme content or dosage form thereof.","<div class=""indep-clm"" num=""1""><seg-main>1. A process for the preparation of a pharmaceutical composition comprising </seg-main><seg-clauses><seg-main>a blend of at least one digestive enzyme and at least one carrier, the process comprising the following steps:</seg-main>
<seg-clauses>a) mixing the at least one digestive enzyme and the at least one carrier, and optional further excipients;</seg-clauses>
<seg-clauses>b) compressing the mixture into beads; and</seg-clauses>
<seg-clauses>c) optionally coating the beads with an enteric polymer,</seg-clauses>
<seg-clauses class=""seg-enter"">wherein a total amount of the at least one digestive enzyme in the pharmaceutical composition is from 4% to 19% by weight, and the at least one carrier comprises microcrystalline cellulose having an average particle size greater than 100 μm.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The process of claim 1, wherein </seg-main><seg-clauses>the process comprises step c).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The process of claim 1, wherein </seg-main><seg-clauses>the steps are carried out in a low moisture environment and the moisture of the carrier or carriers is equal to or less than 5%.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. The process of claim 2, wherein </seg-main><seg-clauses>the at least one digestive enzyme is in the form of enterically coated pancrelipase beads.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. The process of claim 4, wherein </seg-main><seg-clauses>the total amount of the at least one digestive enzyme in the pharmaceutical composition is from 10% to 15% by weight.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""4""><seg-main>6. The process of claim 4, wherein </seg-main><seg-clauses>the enterically coated pancrelipase beads comprise from 4 wt. % to 19 wt. % of pancrepliase based on a total weight of uncoated beads and ","A61K9/20, A61K9/28, A61K9/48, A61K38/46",20250722,SOCIETE DES PRODUITS NESTLE S.A.,['Active']
AU2023355482A1,Device and method for de-stacking stacked articles,"A device for de-stacking a stack (1) of articles, in particular of cup-like capsules (1.1 -1.n), in particular with a peripheral edge, comprises separating elements (2.1, 2.7) for engaging between adjacent articles (1.1, 1.2) of the stack (1) of articles. A plurality of these separating elements (2.1 - 2.12) are arranged in engagement in the stack (1) all around the stack (1), and the separating elements (2.1 - 2.12) of the plurality are mounted to be radially movable. The separating elements (2.1 - 2.12) of the plurality are each mounted resiliently (3.1 - 3.12), and the device comprises a mechanism (5, 11.1, 11.2) for moving the separating elements (2.1 - 2.12) of the plurality outwards, into a position of non-engagement in the stack (1). The device permits the automatic de-stacking of stacked articles which are fragile yet at the same time fit firmly into one another and have irregularities in terms of their orientation within the stack.","<div class=""indep-clm"" num=""1""><seg-main>1. Device for de-stacking a stack of articles, in particular cup-like capsules, in particular with a peripheral edge, wherein:</seg-main>
<seg-clauses>separating elements are present for engaging between adjacent articles of the stack of articles,</seg-clauses>
<seg-clauses class=""seg-enter"">a plurality of these separating elements are arranged in engagement in the stack all around the stack, and</seg-clauses>
<seg-clauses class=""seg-enter"">the separating elements of the plurality are mounted to be radially movable,</seg-clauses>
<seg-clauses class=""seg-enter"">characterized in that</seg-clauses>
<seg-clauses class=""seg-enter"">the separating elements of the plurality are each mounted resiliently, and in that</seg-clauses>
<seg-clauses class=""seg-enter"">the device comprises a mechanism for moving the separating elements of the plurality outwards into a position of non-engagement in the stack.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Device according to claim 1, characterized in that </seg-main><seg-clauses>the separating elements of the plurality are mounted resiliently such that they are pressed radially inwards against the stack.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Device according to claim 1 or 2, characterized in that </seg-main><seg-clauses>the plurality comprises at least three, in particular at least four, separating elements, wherein a maximum angular distance between adjacent separating elements is less than 180°.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. Device according to one of claims 1 to 3, characterized in that </seg-main><seg-clauses>a guide is provided, within which the stack of articles to be de-stacked can be located.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""4""><seg-main>5. Device according to claim 4, characterized in that </seg-main><seg-clauses>the plurality of separating elements are ",B65G59/10,20250417,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
WO2025124927A1,Forming station and forming method of cellulose-based container bodies,"The invention concerns a forming station (10; 20; 30) of cellulose-based container bodies (151) wherein a clamping assembly (110; 120; 130) comprising two opposite jaw elements (111, 112; 121, 122; 131, 132) configured to clamp a portion of a multilayer cellulose-based material (50) between them and to define a perimetral flange (151') of said of cellulose-based container bodies (151), and wherein the clamping assembly (110; 120; 130) comprises at least a sliding portion (510; 520; 530) arranged in one of the jaw elements (111; 121; 131) to be at least partly in contact with a plastic layer (50A) of the multilayer cellulose-based material (50) and made of, or coated by, a material having a lower coefficient of friction with respect to the other jaw element (112; 122; 132) allowing the sliding of at least the plastic layer (50A) during the deep-drawing of the cellulose-based container body (151).","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1 . Forming station (10; 20; 30) of cellulose-based container bodies (151 ) comprising:</seg-main>
<seg-clauses>- a clamping assembly (110; 120; 130), configured to clamp a portion of a multilayer cellulose-based material (50) provided with at least a cellulose layer (50B) and a plastic layer (50A), and</seg-clauses>
<seg-clauses>- a deep-drawing assembly (210; 220; 230), configured to define a cellulose-based container body (151 ) by deep-drawing said multilayer cellulose-based material (50) while clamped by said clamping assembly (110; 120; 130), wherein said clamping assembly (110; 120; 130) comprises two opposite jaw elements (1 11 , 112; 121 , 122; 131 , </seg-clauses><seg-clauses>132) configured to clamp a portion of said multilayer cellulose-based material (50) between them and to define a perimetral flange (151 ’) of said of cellulose-based container bodies (151 ), and wherein said clamping assembly (1 10; 120; 130) comprises at least a sliding portion (510; 520; 530) arranged in one of said jaw elements (1 11 ; 121 ; </seg-clauses><seg-clauses>131 ) configured to be at least partly in contact with said plastic layer (50A) and made of, or coated by, a material having a lower coefficient of friction with respect to the other jaw element (112; 122; 132) allowing the sliding of at least said plastic layer (50A) during the deep- drawing of said cellulose-based container body (151 ).</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. Forming station (10; 20; 30) of cellulose-based container bodies (151 ) according to claim 1 , wherein </seg-main><seg-clauses>said sliding portion (510; 520; 530) is made of, or coated by, a material having a lower coefficient of friction with respect to the other jaw element (112; 122; 132) and to the deep-drawing assembly (210; 220; 230).</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. Forming station (10; 20; 30) of cellulose-based co","B31B50/59, B31F1/00, B31B100/00, B31B120/00, B31B120/40",20250619,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
AU2020295736B2,Compositions and methods using thymol and/or carvacrol for induction of autophagy,"Compositions and methods can use a combination of thymol and/or carvacrol, optionally with high protein for induction of autophagy in an individual in need thereof. Preferably, a formulation containing a combination of thymol and/or carvacrol, optionnaly with protein is administered to the individual in an amount effective to induce autophagy, for example in muscle. The formulation can concomitantly promote protein synthesis and removal of damaged cellular materials.","<div class=""indep-clm"" num=""1""><seg-main>1. A method of treating liver disease comprising </seg-main><seg-clauses>administering to an individual in need thereof a composition comprising thymol.</seg-clauses></div>
<div class=""indep-clm"" num=""2""><seg-main>2. Use of a composition comprising </seg-main><seg-clauses>thymol in the manufacture of a medicament for the treatment of liver disease.</seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-main>3. The method according to claim 1, wherein </seg-main><seg-clauses>the composition comprises an effective amount of thymol to induce autophagy in the individual in need thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""2""><seg-main>4. The use according to claim 2, wherein </seg-main><seg-clauses>the composition comprises an effective amount of thymol to induce autophagy in an individual in need thereof.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""3,4""><seg-main>5. The method according to claim 3, or the use according to claim 4, wherein </seg-main><seg-clauses>autophagy is induced in skeletal muscle.</seg-clauses></div>
<div class=""dep-clm"" num=""6"" parent=""1,3,4,5""><seg-main>6. The method according to any one of claims 1, 3 and 5, or the use according to claim 4 or 5, wherein </seg-main><seg-clauses>the individual is critically ill.</seg-clauses></div>
<div class=""dep-clm"" num=""7"" parent=""1,3,5,6""><seg-main>7. The method according to any one of claims 1, 3, 5 and 6, or the use according to any one of claims 2 and 4 to 6, wherein </seg-main><seg-clauses>thymol is combined with high protein, and wherein the high amount of protein is an amount of the protein that is at least about 25 energy % of the composition.</seg-clauses></div>
<div class=""dep-clm"" num=""8"" parent=""1,3,5,6""><seg-main>8. The method according to any one of claims 1, 3, 5 and 6, or the use according to any one of claims 2 and 4 to 6, wherein </seg-main><seg-clauses>thymol is combined with high protein, and wherein the h","A61K31/05, A61P3/00, A61P9/00, A61P25/00, A61P35/00",20250807,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Active']
WO2025191061A1,Diets and compositions for improving or maintaining cardiovascular health,"The present invention provides a diet, and a nutritional composition or supplement, for use in improving or maintaining cardiovascular health in a subject, wherein the diet, or the nutritional composition or supplement, comprises a total energy intake of 16.0 MJ/day or less, and wherein the diet comprises from 10 E% to 35 E% protein, from 8 E% to 22 E% fat, and from 55 E% to 80 E% carbohydrate.","CLAIMS
<div class=""indep-clm"" num=""1""><seg-main>1. A predetermined diet for use in improving or maintaining cardiovascular health in a subject, wherein </seg-main><seg-clauses>the diet comprises a total energy intake of 16.0 MJ/day or less, and wherein the diet comprises from 10 E% to 35 E% protein, from 8 E% to 22 E% fat, and from 55 E% to 80 E% carbohydrate.</seg-clauses></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-main>2. The diet for use according to claim 1 , wherein </seg-main><seg-clauses><seg-main>the diet comprises:</seg-main>
<seg-clauses>(a) protein in an amount of from 10 E% to 34 E%, from 10 E% to 33 E%, from 10 E% to 32 E%, from 10 E% to 31 E%, from 10 E% to 30 E%, from 11 E% to 29 E%, or from 11 E% to 28 E%;</seg-clauses>
<seg-clauses>(b) fat in an amount of from 8 E% to 21 E%, from 8 E% to 20 E%, from 8 E% to 19 E%, from 8 E% to 18 E%, from 9 E% to 18 E%, from 10 E% to 18 E%, from 10 E% to 17 E%, from 10 E% to 16 E%, from 10 E% to 15 E%, from 10 E% to 14 E%, or from 10 E% to 13 E%; and/or</seg-clauses>
<seg-clauses>(c) carbohydrate in an amount of from 60 E% to 80 E%, from 60 E% to 79 E%, from 61 E% to 79 E%, or from 62 E% to 79 E%.</seg-clauses></seg-clauses></div>
<div class=""dep-clm"" num=""3"" parent=""1,2""><seg-main>3. The diet for use according to claim 1 or 2, wherein </seg-main><seg-clauses>the diet is administered to the subject for at least one month, at least two months, at least three months, at least six months, at least nine months, or at least twelve months.</seg-clauses></div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-main>4. The diet for use according to any preceding claim, wherein </seg-main><seg-clauses>the diet comprises at least 4 food groups per day, at least 5 food groups per day, at least 6 food groups per day, or at least 7 food groups per day.</seg-clauses></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-main>5. The diet for use according to any preceding claim, wherein </seg-main><seg-clauses>the subject","A23L33/00, A61P9/00, A23L33/115, A23L33/125, A23L33/17",20250918,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['PCT designated period']
RU2834408C2,Instant powdered coffee,"FIELD: food industry.SUBSTANCE: group of inventions relates to food industry, in particular to production of instant powdered coffee. Disclosed is a method of producing a coffee suspension containing gas hydrates, comprising: providing a first coffee solution; cooling the first coffee solution; and applying pressure to the first coffee solution using a gas to produce a coffee suspension containing gas hydrates, wherein the gas contains carbon dioxide and/or nitrogen, wherein the coffee suspension has a ratio of gas in the hydrate fraction to gas in the liquid fraction (H:L) from 1:1 to 5:1. Also described is a coffee suspension containing gas hydrates, a method of producing instant powdered coffee using said suspension and instant coffee powder obtained by said method, wherein the powder has a closed porosity of 15% to 50%, a foaming porosity of 25% to 34%, and wherein the powder has a bimodal pore distribution.EFFECT: group of inventions enables to obtain beverages with improved foaming ability using smaller portions of gas and shorter gas dosing time.24 cl, 10 dwg, 7 tbl, 5 ex","1. Способ получения суспензии кофе, содержащей газовые гидраты, включающий:
(а) обеспечение первого кофейного раствора;
(b) охлаждение первого кофейного раствора; и
(c) приложение давления к первому кофейному раствору с помощью газа для получения суспензии кофе, содержащей газовые гидраты, причём газ содержит диоксид углерода и/или азот,
при этом суспензия кофе имеет отношение газа во фракции гидрата к газу в жидкой фракции (H:L) от 1:1 до 5:1.
2. Способ по п. 1, причём суспензия кофе имеет отношение газа во фракции гидрата к газу в жидкой фракции (H:L) от 2:1 до 3:1.
3. Способ по п. 1 или 2, в котором первый кофейный раствор охлаждают до температуры от -10 до 10°C, или от -8 до 7°C, или от -5 до 5°C, или до температуры не ниже около -5°C и/или давление газа составляет от 10 до 300 бар, или от 10 до 150 бар, или от 10 до 100 бар, или от 10 до 50 бар, или от 15 до 40 бар, или от 15 до 35 бар, или от 15 до 30 бар.
4. Способ по любому из пп. 1-3, включающий охлаждение первого кофейного раствора до температуры от 0 до 5°C или до около 3°C; и приложение давления к первому кофейному раствору с помощью диоксида углерода предпочтительно при 15–25 бар или около 20 бар перед приложением давления к первому кофейному раствору с использованием азота предпочтительно при 30–300 бар, 30–150 бар, 30–100 бар, 30–50 бар, 30–40 бар или около 35 бар.
5. Способ по любому из пп. 1-4, дополнительно включающий стадию распределения газового гидрата в суспензии кофе.
6. Суспензия кофе, содержащая газовые гидраты, в которой газ содержит диоксид углерода и/или азот, и при этом суспензия кофе имеет отношение газа во фракции гидрата к газу в жидкой фракции (H:L) от 1:1 до 5:1.
7. Суспензия кофе по п. 6, которая имеет отношение газа во фракции гидрата к газу в жидкой фракции (H:L) от 2:1 до 3:1.
8. Способ по любому из пп. 1-5, причём суспензия кофе содержит диоксид углерода предпочтительно в количестве 0,5–5 моль/л, 1–5 моль/л, 1–2 моль/л, около 1 моль/л или около 1,6 моль/л; и/или азот предпочтит","A23F5/24, A23F5/32",20250207,СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А.,['Active']
AU2024279312A1,Bifidobacterium longum transitional microorganism,The present invention relates to a Bifidobacterium longum transitional microorganism strain deposited with CNCM under number CNCM I-5942 or a B. Longum transitional strain having an identifying characteristic of the B. Longum transitional strain deposited under deposit number CNCM I-5942.,"<div class=""indep-clm"" num=""1""><seg-con>1. A Bifidobacterium longum transitional microorganism strain deposited with Collection nationale de cultures de micro-organismes (CNCM) under deposit number CNCM I-5942 or a B. longum transitional strain </seg-con><seg-trans>having </seg-trans><seg-refi>an identifying characteristic of the B. longum transitional strain deposited under deposit number CNCM I-5942.</seg-refi></div>
<div class=""indep-clm"" num=""2"">2. A B. longum transitional microorganism strain which has an Average Nucleotide Identity (ANI) of at least 99% to a B. longum strain deposited with the CNCM under deposit number CNCM I-5942.</div>
<div class=""dep-clm"" num=""3"" parent=""1"">3. A B. longum transitional strain according to claim 1 which has an ANI of at least 98.1% to a B. longum transitional strain deposited under deposit number CNCM I-5942.</div>
<div class=""dep-clm"" num=""4"" parent=""1,2,3""><seg-con>4. A B. longum transitional strain according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>the B. longum transitional strain is not resistant to any one of tetracycline, erythromycin, clindamycin and ampicillin; preferably wherein the B. longum transitional strain is not resistant to any of tetracycline, erythromycin, clindamycin, ampicillin, gentamycin, streptomycin, chloramphenicol and vancomycin.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1,2,3,4""><seg-con>5. A B. longum transitional strain according to any preceding claim </seg-con><seg-trans>wherein </seg-trans><seg-refi>the B. Longum transitional strain comprises a glycosyl hydrolase family 43_17 (GH43_17) gene; suitably wherein the GH43_17 gene comprises SEQ ID NO: 7 ora sequence with at least60% sequence identity to SEQ ID NO: 7.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1,2,3,4,5""><seg-con>6. A B. longum transitional strain according to any preceding claim, which </seg-con><seg-trans>further comprises </seg-trans><seg-refi>a major facilitator superfamily","C12N1/20, A23L33/00, A23L33/135, A23L33/21, A61K31/702",20251120,SOCIÉTÉ DES PRODUITS NESTLÉ S.A.,['Pending']
AU2019396727B2,Methods for enhancing metabolic health in an animal,"The invention provides compositions and methods for metabolic health in an animal comprising administering a non-ketogenic composition to the animal, wherein the non- ketogenic composition comprises about 5% to about 25% carbohydrates, about 30% to about 60% protein, and about 10% to about 40% fat. Additionally, the composition can have a protein to carbohydrate ratio of at least 2:1.","<div class=""indep-clm"" num=""1""><seg-con>1. A method for enhancing metabolic health in an animal, the method </seg-con><seg-trans>comprising </seg-trans><seg-refi>administering a non-ketogenic food composition to the animal, wherein the non-ketogenic food composition comprises:</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from 39% to 65% protein,</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from 13% to 20% carbohydrate, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>from 30% to 40% fat;</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the non-ketogenic food composition has a protein to carbohydrate ratio 3:1 to 5:1, and</seg-refi></div>
<div class=""indep-clm"" num=""1""><seg-refi>wherein the non-ketogenic food composition further comprises one or more probiotics; one or more inactivated probiotics; one or more lipids or glycoproteins; one or more prebiotics; or a combination thereof.</seg-refi></div>
<div class=""dep-clm"" num=""2"" parent=""1""><seg-con>2. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the protein comprises 45% to 55% of the non-ketogenic food composition.</seg-refi></div>
<div class=""dep-clm"" num=""3"" parent=""1""><seg-con>3. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the carbohydrate comprises 15% to 20% of the non-ketogenic food composition.</seg-refi></div>
<div class=""dep-clm"" num=""4"" parent=""1""><seg-con>4. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the fat comprises 30% to 35% of the non-ketogenic food composition.</seg-refi></div>
<div class=""dep-clm"" num=""5"" parent=""1""><seg-con>5. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the non-ketogenic food composition is administered to the animal on a regular basis.</seg-refi></div>
<div class=""dep-clm"" num=""6"" parent=""1""><seg-con>6. The method of claim 1, </seg-con><seg-trans>wherein </seg-trans><seg-refi>the ratio of protein to carbohyd","A23K10/00, A23L33/00",20250403,SOCIETE DES PRODUITS NESTLE SA,['Active']
